PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Potkin, KT; Bunney, WE				Potkin, Katya Trudeau; Bunney, William E., Jr.			Sleep Improves Memory: The Effect of Sleep on Long Term Memory in Early Adolescence	PLOS ONE			English	Article							CONSOLIDATION; CHILDREN; DECLINE; AGE; NAP	Sleep plays an important role in the consolidation of memory. This has been most clearly shown in adults for procedural memory (i.e. skills and procedures) and declarative memory (e.g. recall of facts). The effects of sleep and memory are relatively unstudied in adolescents. Declarative memory is important in school performance and consequent social functioning in adolescents. This is the first study to specifically examine the effects of normal sleep on auditory declarative memory in an early adolescent sample. Given that the majority of adolescents do not obtain the recommended amount of sleep, it is critical to study the cognitive effects of normal sleep. Forty male and female normal, healthy adolescents between the ages of ten and fourteen years old were randomly assigned to sleep and no sleep conditions. Subjects were trained on a paired-associate declarative memory task and a control working memory task at 9am, and tested at night (12 hours later) without sleep. The same number of subjects was trained at 9pm and tested 9am following sleep. An increase of 20.6% in declarative memory, as measured by the number correct in a paired-associate test, following sleep was observed compared to the group which was tested at the same time interval without sleep (p < 0.03). The performance on the control working memory task that involved encoding and memoranda manipulation was not affected by time of day or relationship to sleep. Declarative memory is significantly improved by sleep in a sample of normal adolescents.	[Potkin, Katya Trudeau] Brown Univ, Dept Human Biol, Providence, RI 02912 USA; [Bunney, William E., Jr.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA	Brown University; University of California System; University of California Irvine	Potkin, KT (corresponding author), Brown Univ, Dept Human Biol, Providence, RI 02912 USA.	katya_potkin@brown.edu; webunney@uci.edu						Backhaus J, 2008, NEUROBIOL LEARN MEM, V89, P76, DOI 10.1016/j.nlm.2007.08.010; Backhaus J, 2007, LEARN MEMORY, V14, P336, DOI 10.1101/lm.470507; Berkman Julia M, 2006, Med Health R I, V89, P94; Campbell IG, 2011, SLEEP, V34, P83, DOI 10.1093/sleep/34.1.83; Carskadon MA, 2011, PROG BRAIN RES, V190, P137, DOI 10.1016/B978-0-444-53817-8.00008-6; Colrain IM, 2011, NEUROPSYCHOL REV, V21, P5, DOI 10.1007/s11065-010-9155-5; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Meltzer LJ, 2006, PSYCHIAT CLIN N AM, V29, P1059, DOI 10.1016/j.psc.2006.08.004; Moore M, 2008, PAEDIATR RESPIR REV, V9, P114, DOI 10.1016/j.prrv.2008.01.001; Moroni F, 2008, NEUROIMAGE, V42, P911, DOI 10.1016/j.neuroimage.2008.05.027; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Pace-Schott EF, 2011, PROG BRAIN RES, V191, P75, DOI 10.1016/B978-0-444-53752-2.00012-6; Prehn-Kristensen A, 2009, J EXP CHILD PSYCHOL, V104, P132, DOI 10.1016/j.jecp.2009.01.005; Spencer RMC, 2007, LEARN MEMORY, V14, P480, DOI 10.1101/lm.569407; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Tucker MA, 2006, NEUROBIOL LEARN MEM, V86, P241, DOI 10.1016/j.nlm.2006.03.005; Voderholzer U, 2011, SLEEP MED, V12, P170, DOI 10.1016/j.sleep.2010.07.017; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; WILSON RS, 1982, J CONSULT CLIN PSYCH, V50, P154, DOI 10.1037/0022-006X.50.1.154	24	37	37	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42191	10.1371/journal.pone.0042191	http://dx.doi.org/10.1371/journal.pone.0042191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	987SL	22879917	Green Published, gold			2022-12-27	WOS:000307437900024
J	Rishishwar, L; Varghese, N; Tyagi, E; Harvey, SC; Jordan, IK; McCarty, NA				Rishishwar, Lavanya; Varghese, Neha; Tyagi, Eishita; Harvey, Stephen C.; Jordan, I. King; McCarty, Nael A.			Relating the Disease Mutation Spectrum to the Evolution of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; R-DOMAIN; SERVER; IDENTIFICATION; CONSERVATION; MUSCLE; GENE	Cystic fibrosis (CF) is the most common genetic disease among Caucasians, and accordingly the cystic fibrosis transmembrane conductance regulator (CFTR) protein has perhaps the best characterized disease mutation spectrum with more than 1,500 causative mutations having been identified. In this study, we took advantage of that wealth of mutational information in an effort to relate site-specific evolutionary parameters with the propensity and severity of CFTR disease-causing mutations. To do this, we devised a scoring scheme for known CFTR disease-causing mutations based on the Grantham amino acid chemical difference matrix. CFTR site-specific evolutionary constraint values were then computed for seven different evolutionary metrics across a range of increasing evolutionary depths. The CFTR mutational scores and the various site-specific evolutionary constraint values were compared in order to evaluate which evolutionary measures best reflect the disease-causing mutation spectrum. Site-specific evolutionary constraint values from the widely used comparative method PolyPhen2 show the best correlation with the CFTR mutation score spectrum, whereas more straightforward conservation based measures (ConSurf and ScoreCons) show the greatest ability to predict individual CFTR disease-causing mutations. While far greater than could be expected by chance alone, the fraction of the variability in mutation scores explained by the PolyPhen2 metric (3.6%), along with the best set of paired sensitivity (58%) and specificity (60%) values for the prediction of disease-causing residues, were marginal. These data indicate that evolutionary constraint levels are informative but far from determinant with respect to disease-causing mutations in CFTR. Nevertheless, this work shows that, when combined with additional lines of evidence, information on site-specific evolutionary conservation can and should be used to guide site-directed mutagenesis experiments by more narrowly defining the set of target residues, resulting in a potential savings of both time and money.	[Rishishwar, Lavanya; Varghese, Neha; Tyagi, Eishita; Harvey, Stephen C.; Jordan, I. King] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Jordan, I. King] PanAmer Bioinformat Inst, Santa Marta, Magdalena, Colombia; [McCarty, Nael A.] Emory Univ, Sch Med, Dept Pediat, Ctr Cyst Fibrosis Res,Childrens Healthcare Atlant, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; Children's Healthcare of Atlanta (CHOA); Emory University	Rishishwar, L (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	namccar@emory.edu	Rishishwar, Lavanya/H-5587-2013	Rishishwar, Lavanya/0000-0002-2055-9392; Varghese, Neha/0000-0003-0580-0675	NIH [5R01DK075016]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075016] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the NIH, 5R01DK075016 to N.A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; DULHANTY AM, 1994, BIOCHEMISTRY-US, V33, P4072, DOI 10.1021/bi00179a036; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gaucher EA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-44; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Greenblatt MS, 2003, ONCOGENE, V22, P1150, DOI 10.1038/sj.onc.1206101; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; Miller MP, 2003, ANN HUM GENET, V67, P567, DOI 10.1046/j.1529-8817.2003.00072.x; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mooney SD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-24; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Notaro R, 2000, FASEB J, V14, P485, DOI 10.1096/fasebj.14.3.485; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Schaner P, 2001, NAT GENET, V27, P318, DOI 10.1038/85893; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith NGC, 2003, GENE, V318, P169, DOI 10.1016/S0378-1119(03)00772-8; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Valdar WSJ, 2001, PROTEINS, V42, P108; Zieve D, 2011, CYSTIC FIBROSIS	35	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42336	10.1371/journal.pone.0042336	http://dx.doi.org/10.1371/journal.pone.0042336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879944	Green Published, gold, Green Submitted			2022-12-27	WOS:000307437900029
J	Saijo, T; Maeda, J; Okauchi, T; Maeda, JI; Morio, Y; Kuwahara, Y; Suzuki, M; Goto, N; Fukumura, T; Suhara, T; Higuchi, M				Saijo, Takeaki; Maeda, Jun; Okauchi, Takashi; Maeda, Jun-ichi; Morio, Yasunori; Kuwahara, Yasuhiro; Suzuki, Masayuki; Goto, Nobuharu; Fukumura, Toshimitsu; Suhara, Tetsuya; Higuchi, Makoto			Presynaptic Selectivity of a Ligand for Serotonin 1A Receptors Revealed by In Vivo PET Assays of Rat Brain	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PLACEBO-CONTROLLED TRIAL; DORSAL RAPHE NUCLEUS; 5-HT1A RECEPTOR; REUPTAKE INHIBITORS; DOUBLE-BLIND; ANTIDEPRESSANT THERAPY; INTRINSIC ACTIVITY; MAJOR DEPRESSION; FRONTAL-CORTEX	A novel investigational antidepressant with high affinity for the serotonin transporter and the serotonin 1A (5-HT1A) receptor, called Wf-516 (structural formula: (2S)-1-[4-(3,4-dichlorophenyl) piperidin-1-yl]-3-[2-(5-methyl-1,3,4-oxadiazol-2-yl) benzo[b]furan-4-yloxy]propan-2-ol monohydrochloride), has been found to exert a rapid therapeutic effect, although the mechanistic basis for this potential advantage remains undetermined. We comparatively investigated the pharmacokinetics and pharmacodynamics of Wf-516 and pindolol by positron emission tomographic (PET) and autoradiographic assays of rat brains in order to elucidate their molecular interactions with presynaptic and postsynaptic 5-HT1A receptors. In contrast to the full receptor occupancy by pindolol in PET measurements, the binding of Wf-516 to 5-HT1A receptors displayed limited capacity, with relatively high receptor occupancy being achieved in regions predominantly containing presynaptic receptors. This selectivity was further proven by PET scans of neurotoxicant-treated rats deficient in presynaptic 5-HT1A receptors. In addition, [S-35] guanosine 5'-O-[gamma-thio] triphosphate autoradiography indicated a partial agonistic ability of Wf-516 for 5-HT1A receptors. This finding has lent support to reports that diverse partial agonists for 5-HT1A receptors exert high sensitivity for presynaptic components. Thus, the present PET data suggest a relatively high capacity of presynaptic binding sites for partial agonists. Since our in vitro and ex vivo autoradiographies failed to illustrate these distinct features of Wf-516, in vivo PET imaging is considered to be, thus far, the sole method capable of pharmacokinetically demonstrating the unique actions of Wf-516 and similar new-generation antidepressants.	[Saijo, Takeaki; Maeda, Jun; Okauchi, Takashi; Fukumura, Toshimitsu; Suhara, Tetsuya; Higuchi, Makoto] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Saijo, Takeaki; Suhara, Tetsuya; Higuchi, Makoto] Tohoku Univ, Sch Med, Dept Mol Neuroimaging, Sendai, Miyagi 980, Japan; [Saijo, Takeaki; Suzuki, Masayuki] Mitsubishi Tanabe Pharma Corp, DMPK Res Lab, Kisarazu, Japan; [Maeda, Jun-ichi] Mitsubishi Tanabe Pharma Corp, Res Qual Assurance Dept, Yokohama, Kanagawa, Japan; [Kuwahara, Yasuhiro] Mitsubishi Tanabe Pharma Corp, Adv Med Res Lab, Yokohama, Kanagawa, Japan; [Morio, Yasunori] Mitsubishi Tanabe Pharma Corp, Dev Project Management Dept, Tokyo, Japan; [Goto, Nobuharu] Mitsubishi Tanabe Pharma Corp, Early Stage Clin Res Ctr, Tokyo, Japan	National Institutes for Quantum Science & Technology; Tohoku University; Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation	Saijo, T (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan.	mhiguchi@nirs.go.jp	Fukumura, Toshimitsu/E-2847-2012		Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for the Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan. No additional external funding received for this study.	ADELL A, 1991, N-S ARCH PHARMACOL, V343, P237; ANDRADE R, 1987, J PHYSIOL-LONDON, V394, P99, DOI 10.1113/jphysiol.1987.sp016862; Andree B, 1999, PSYCHOPHARMACOLOGY, V144, P303, DOI 10.1007/s002130051009; Artigas F, 1996, TRENDS NEUROSCI, V19, P378, DOI 10.1016/S0166-2236(96)10037-0; Assie MB, 1999, EUR J PHARMACOL, V386, P97, DOI 10.1016/S0014-2999(99)00738-4; Bantick RA, 2004, NEUROPSYCHOPHARMACOL, V29, P847, DOI 10.1038/sj.npp.1300390; Berman RM, 1997, AM J PSYCHIAT, V154, P37; Castro ME, 2000, J NEUROCHEM, V75, P755, DOI 10.1046/j.1471-4159.2000.0750755.x; Celada P, 2004, J PSYCHIATR NEUROSCI, V29, P252; CHAPUT Y, 1991, NEUROPSYCHOPHARMACOL, V5, P219; Corradetti R, 1998, BRIT J PHARMACOL, V123, P449, DOI 10.1038/sj.bjp.0701632; Dawson LA, 2009, CNS NEUROSCI THER, V15, P107, DOI 10.1111/j.1755-5949.2008.00067.x; Duman RS, 2001, J PHARMACOL EXP THER, V299, P401; El Mansari M, 2008, N-S ARCH PHARMACOL, V376, P351, DOI 10.1007/s00210-007-0210-6; Finnema SJ, 2010, CURR TOP MED CHEM, V10, P1477; Fitzgerald LW, 1999, J NEUROCHEM, V72, P2127, DOI 10.1046/j.1471-4159.1999.0722127.x; GUGLER R, 1974, EUR J CLIN PHARMACOL, V7, P17, DOI 10.1007/BF00614385; Hamed A, 2004, MED CARE, V42, P551, DOI 10.1097/01.mlr.0000128002.73998.87; Hansen DG, 2003, EUR J CLIN PHARMACOL, V59, P143, DOI 10.1007/s00228-003-0593-3; Herndon Jeffrey L., 1993, P167; Hirani E, 2000, SYNAPSE, V36, P330, DOI 10.1002/(SICI)1098-2396(20000615)36:4<330::AID-SYN10>3.0.CO;2-H; HJORTH S, 1994, EUR J PHARMACOL, V260, P251, DOI 10.1016/0014-2999(94)90346-8; Hughes ZA, 2005, EUR J PHARMACOL, V510, P49, DOI 10.1016/j.ejphar.2005.01.018; HYTTEL J, 1994, INT CLIN PSYCHOPHARM, V9, P19, DOI 10.1097/00004850-199403001-00004; INVERNIZZI R, 1992, BRAIN RES, V584, P322, DOI 10.1016/0006-8993(92)90914-U; KHAWAJA X, 1995, J NEUROCHEM, V64, P2716; Kirby LG, 2003, NEUROSCIENCE, V116, P669, DOI 10.1016/S0306-4522(02)00584-5; Komori T, 1998, BIOL PHARM BULL, V21, P1376; Laughren TP, 2011, J CLIN PSYCHIAT, V72, P1166, DOI 10.4088/JCP.11r06984; Lemoine L, 2010, EUR J NUCL MED MOL I, V37, P594, DOI 10.1007/s00259-009-1274-y; MacGillivray S, 2003, BMJ-BRIT MED J, V326, P1014, DOI 10.1136/bmj.326.7397.1014; Maeda J, 2001, SYNAPSE, V40, P122, DOI 10.1002/syn.1033; MAEDA J, 2006, EUR NEUROPSYCHOPH S4, V16, pS333; Martinez D, 2001, NEUROPSYCHOPHARMACOL, V24, P209, DOI 10.1016/S0893-133X(00)00187-1; McAskill R, 1998, BRIT J PSYCHIAT, V173, P203, DOI 10.1192/bjp.173.3.203; McCarron JA, 1996, J LABELLED COMPD RAD, V38, P941, DOI 10.1002/(SICI)1099-1344(199610)38:10<941::AID-JLCR906>3.3.CO;2-P; MELLER E, 1990, MOL PHARMACOL, V37, P231; Milak MS, 2008, J NUCL MED, V49, P587, DOI 10.2967/jnumed.107.046540; Nakayama T, 2002, PSYCHOPHARMACOLOGY, V165, P37, DOI 10.1007/s00213-002-1234-8; NG GYK, 1993, BIOCHEMISTRY-US, V32, P11727, DOI 10.1021/bi00094a032; Papp M, 2006, EUR NEUROPSYCHOPHARM, V16, pS305, DOI 10.1016/S0924-977X(06)70322-4; Perez V, 1997, LANCET, V349, P1594, DOI 10.1016/S0140-6736(96)08007-5; Pike VW, 1996, EUR J PHARMACOL, V301, pR5, DOI 10.1016/0014-2999(96)00079-9; Rabiner EA, 2000, NEUROPSYCHOPHARMACOL, V23, P285, DOI 10.1016/S0893-133X(00)00109-3; Rabiner EA, 2000, NUCL MED BIOL, V27, P509, DOI 10.1016/S0969-8051(00)00120-7; Radley JJ, 2002, BRAIN RES, V955, P264, DOI 10.1016/S0006-8993(02)03477-7; Rickels K, 2009, J CLIN PSYCHIAT, V70, P326, DOI 10.4088/JCP.08m04637; Saijo T, 2009, INT J NEUROPSYCHOPH, V12, P1021, DOI 10.1017/S1461145709000042; Sanchez C, 1996, EUR J PHARMACOL, V315, P245, DOI 10.1016/S0014-2999(96)00621-8; Seeman P, 2012, SYNAPSE, V66, P88, DOI 10.1002/syn.20987; Serrats J, 2004, INT J NEUROPSYCHOPH, V7, P27, DOI 10.1017/S1461145703003924; Sprouse J, 2000, BIOL PSYCHIAT, V47, P1050, DOI 10.1016/S0006-3223(99)00322-4; Tai YC, 2005, J NUCL MED, V46, P455; Takano A, 2007, NUCL MED COMMUN, V28, P193, DOI 10.1097/MNM.0b013e328013ebec; Uchida N, 2007, PSYCHIAT CLIN NEUROS, V61, P522, DOI 10.1111/j.1440-1819.2007.01702.x; VANDENHOOFF P, 1992, BRIT J PHARMACOL, V106, P893; VANDENHOOFF P, 1991, EUR J PHARMACOL, V196, P291, DOI 10.1016/0014-2999(91)90442-S; YOCCA FD, 1992, MOL PHARMACOL, V41, P1066; Zanardi R, 1998, J CLIN PSYCHOPHARM, V18, P441, DOI 10.1097/00004714-199812000-00004; Zanardi R, 1997, J CLIN PSYCHOPHARM, V17, P446, DOI 10.1097/00004714-199712000-00002	60	8	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42589	10.1371/journal.pone.0042589	http://dx.doi.org/10.1371/journal.pone.0042589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880045	Green Submitted, Green Published, gold			2022-12-27	WOS:000307437900044
J	Liu, WJ; Schat, H; Bliek, M; Chen, Y; McGrath, SP; George, G; Salt, DE; Zhao, FJ				Liu, Wenju; Schat, Henk; Bliek, Mathijs; Chen, Yi; McGrath, Steve P.; George, Graham; Salt, David E.; Zhao, Fang-Jie			Knocking Out ACR2 Does Not Affect Arsenic Redox Status in Arabidopsis thaliana: Implications for As Detoxification and Accumulation in Plants	PLOS ONE			English	Article							PHOSPHOROLYTIC-ARSENOLYTIC ENZYMES; HYPERACCUMULATOR PTERIS-VITTATA; SACCHAROMYCES-CEREVISIAE; TYROSINE PHOSPHATASE; REDUCTION; RICE; TOLERANCE; PHYTOCHELATINS; PHOSPHORYLASE; BANGLADESH	Many plant species are able to reduce arsenate to arsenite efficiently, which is an important step allowing detoxification of As through either efflux of arsenite or complexation with thiol compounds. It has been suggested that this reduction is catalyzed by ACR2, a plant homologue of the yeast arsenate reductase ScACR2. Silencing of AtACR2 was reported to result in As hyperaccumulation in the shoots of Arabidopsis thaliana. However, no information of the in vivo As speciation has been reported. Here, we investigated the effect of AtACR2 knockout or overexpression on As speciation, arsenite efflux from roots and As accumulation in shoots. T-DNA insertion lines, overexpression lines and wild-type (WT) plants were exposed to different concentrations of arsenate for different periods, and As speciation in plants and arsenite efflux were determined using HPLC-ICP-MS. There were no significant differences in As speciation between different lines, with arsenite accounting for >90% of the total extractable As in both roots and shoots. Arsenite efflux to the external medium represented on average 77% of the arsenate taken up during 6 h exposure, but there were no significant differences between WT and mutants or overexpression lines. Accumulation of As in the shoots was also unaffected by AtACR2 knockout or overexpression. Additionally, after exposure to arsenate, the yeast (Saccharomyces cerevisiae) strain with ScACR2 deleted showed similar As speciation as the WT with arsenite-thiol complexes being the predominant species. Our results suggest the existence of multiple pathways of arsenate reduction in plants and yeast.	[Liu, Wenju; Chen, Yi; McGrath, Steve P.] Rothamsted Res, Harpenden, Herts, England; [Liu, Wenju] Hebei Agr Univ, Coll Resources & Environm Sci, Baoding, Hebei Province, Peoples R China; [Schat, Henk; Bliek, Mathijs] Vrije Univ Amsterdam, Dept Genet, Fac Earth & Life Sci, Amsterdam, Netherlands; [George, Graham] Univ Saskatchewan, Dept Geol Sci, Saskatoon, SK S7N 0W0, Canada; [Salt, David E.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Zhao, Fang-Jie] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Hebei Agricultural University; Vrije Universiteit Amsterdam; University of Saskatchewan; University of Aberdeen; Nanjing Agricultural University	Zhao, FJ (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.	Fangjie.Zhao@njau.edu.cn	George, Graham N/E-3290-2013; Zhao, Fang-Jie/A-8339-2008; McGrath, Steve P/B-5127-2008; Schat, Henk/AAB-8723-2019; Zhao, Fang-Jie/A-8339-2008	Zhao, Fang-Jie/0000-0002-0164-169X; McGrath, Steve P/0000-0003-0952-8947; Chen, Yi/0000-0001-7146-3975; George, Graham/0000-0002-0420-7493; Zhao, Fang-Jie/0000-0002-1252-1079	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); 111 project [B12009]; Biotechnology and Biological Sciences Research Council of the UK; Rothamsted International Fellowship; National Science Foundation [IOS 0844413]; Canada Research Chair; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; DOE Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; BBSRC [BBS/E/C/00005206, BBS/E/C/00004981] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); 111 project(Ministry of Education, China - 111 Project); Biotechnology and Biological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Rothamsted International Fellowship; National Science Foundation(National Science Foundation (NSF)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was financially supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and by the 111 project (B12009). Rothamsted Research receives strategic funding from the Biotechnology and Biological Sciences Research Council of the UK. W.J.L. was supported by a Rothamsted International Fellowship. This work was supported by a grant to D.E.S. from the National Science Foundation (IOS 0844413). G.N.G. was supported by a Canada Research Chair, the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program (P41RR001209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharjee H, 2007, MOL MICROBIOLOGY HEA, P371, DOI [10.1007/7171_2006_086, DOI 10.1007/7171_2006_086]; Bleeker PM, 2006, PLANT J, V45, P917, DOI 10.1111/j.1365-313X.2005.02651.x; Bolle C, 2011, CURR GENOMICS, V12, P1, DOI 10.2174/138920211794520187; Brammer H, 2009, ENVIRON INT, V35, P647, DOI 10.1016/j.envint.2008.10.004; Chen WH, 2010, PLANT PHYSIOL, V153, P1385, DOI 10.1104/pp.110.153452; DELNOMDEDIEU M, 1994, CHEM-BIOL INTERACT, V90, P139, DOI 10.1016/0009-2797(94)90099-X; Dhankher OP, 2002, NAT BIOTECHNOL, V20, P1140, DOI 10.1038/nbt747; Dhankher OP, 2006, P NATL ACAD SCI USA, V103, P5413, DOI 10.1073/pnas.0509770102; Dhankher OP, 2003, NEW PHYTOL, V159, P431, DOI 10.1046/j.1469-8137.2003.00827.x; Dissmeyer N, 2009, PLANT CELL, V21, P3641, DOI 10.1105/tpc.109.070417; Duan GL, 2007, NEW PHYTOL, V174, P311, DOI 10.1111/j.1469-8137.2007.02009.x; Ellis DR, 2006, PLANT PHYSIOL, V141, P1544, DOI 10.1104/pp.106.084079; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; Gonzalez E, 2005, PLANT CELL, V17, P3500, DOI 10.1105/tpc.105.036640; Gregus Z, 2005, TOXICOL SCI, V85, P859, DOI 10.1093/toxsci/kfi158; Gregus Z, 2002, TOXICOL SCI, V70, P13, DOI 10.1093/toxsci/70.1.13; Gregus Z, 2009, TOXICOL SCI, V110, P282, DOI 10.1093/toxsci/kfp113; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1059, DOI 10.1104/pp.107.4.1059; Hughes MF, 2002, TOXICOL LETT, V133, P1, DOI 10.1016/S0378-4274(02)00084-X; Indriolo E, 2010, PLANT CELL, V22, P2045, DOI 10.1105/tpc.109.069773; Landrieu I, 2004, BIOCHEM BIOPH RES CO, V322, P734, DOI 10.1016/j.bbrc.2004.07.182; Liu WJ, 2010, PLANT PHYSIOL, V152, P2211, DOI 10.1104/pp.109.150862; Lombi E, 2002, NEW PHYTOL, V156, P195, DOI 10.1046/j.1469-8137.2002.00512.x; Meharg AA, 2003, ENVIRON SCI TECHNOL, V37, P229, DOI 10.1021/es0259842; Moore KL, 2011, PLANT PHYSIOL, V156, P913, DOI 10.1104/pp.111.173088; Mukhopadhyay R, 1998, FEMS MICROBIOL LETT, V168, P127, DOI 10.1016/S0378-1097(98)00430-3; Nemeti B, 2007, TOXICOL SCI, V100, P36, DOI 10.1093/toxsci/kfm211; Nemeti B, 2010, TOXICOL SCI, V117, P270, DOI 10.1093/toxsci/kfq141; Nemeti B, 2009, TOXICOL SCI, V110, P270, DOI 10.1093/toxsci/kfp112; Panaullah GM, 2009, PLANT SOIL, V317, P31, DOI 10.1007/s11104-008-9786-y; Pickering IJ, 2000, PLANT PHYSIOL, V122, P1171, DOI 10.1104/pp.122.4.1171; Pickering IJ, 2006, ENVIRON SCI TECHNOL, V40, P5010, DOI 10.1021/es052559a; Raab A, 2005, NEW PHYTOL, V168, P551, DOI 10.1111/j.1469-8137.2005.01519.x; Rathinasabapathi B, 2006, PLANT MOL BIOL, V62, P845, DOI 10.1007/s11103-006-9060-8; Schmoger MEV, 2000, PLANT PHYSIOL, V122, P793, DOI 10.1104/pp.122.3.793; Sneller FEC, 1999, NEW PHYTOL, V144, P223, DOI 10.1046/j.1469-8137.1999.00512.x; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Spadafora ND, 2011, ANN BOT-LONDON, V107, P1183, DOI 10.1093/aob/mcq142; Williams PN, 2006, ENVIRON SCI TECHNOL, V40, P4903, DOI 10.1021/es060222i; Wu ZC, 2011, PLANT PHYSIOL, V157, P498, DOI 10.1104/pp.111.178921; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x; Xu XY, 2007, NEW PHYTOL, V176, P590, DOI 10.1111/j.1469-8137.2007.02195.x; Zhao FJ, 2009, NEW PHYTOL, V181, P777, DOI 10.1111/j.1469-8137.2008.02716.x; Zhao FJ, 2010, ANNU REV PLANT BIOL, V61, P535, DOI 10.1146/annurev-arplant-042809-112152; Zhao FJ, 2003, NEW PHYTOL, V159, P403, DOI 10.1046/j.1469-8137.2003.00784.x	46	41	47	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42408	10.1371/journal.pone.0042408	http://dx.doi.org/10.1371/journal.pone.0042408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879969	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000032
J	Foo, SA; Dworjanyn, SA; Poore, AGB; Byrne, M				Foo, Shawna A.; Dworjanyn, Symon A.; Poore, Alistair G. B.; Byrne, Maria			Adaptive Capacity of the Habitat Modifying Sea Urchin Centrostephanus rodgersii to Ocean Warming and Ocean Acidification: Performance of Early Embryos	PLOS ONE			English	Article							CLIMATE-CHANGE; STRONGYLOCENTROTUS-PURPURATUS; THERMAL TOLERANCE; CARBONIC-ACID; MARINE; SEAWATER; FERTILIZATION; DISSOCIATION; ADAPTATION; MECHANISMS	Background: Predicting effects of rapid climate change on populations depends on measuring the effects of climate stressors on performance, and potential for adaptation. Adaptation to stressful climatic conditions requires heritable genetic variance for stress tolerance present in populations. Methodology/Principal Findings: We quantified genetic variation in tolerance of early development of the ecologically important sea urchin Centrostephanus rodgersii to near-future (2100) ocean conditions projected for the southeast Australian global change hot spot. Multiple dam-sire crosses were used to quantify the interactive effects of warming (+2-4 degrees C) and acidification (-0.3-0.5 pH units) across twenty-seven family lines. Acidification, but not temperature, decreased the percentage of cleavage stage embryos. In contrast, temperature, but not acidification decreased the percentage of gastrulation. Cleavage success in response to both stressors was strongly affected by sire identity. Sire and dam identity significantly affected gastrulation and both interacted with temperature to determine developmental success. Positive genetic correlations for gastrulation indicated that genotypes that did well at lower pH also did well in higher temperatures. Conclusions/Significance: Significant genotype (sire) by environment interactions for both stressors at gastrulation indicated the presence of heritable variation in thermal tolerance and the ability of embryos to respond to changing environments. The significant influence of dam may be due to maternal provisioning (maternal genotype or environment) and/or offspring genotype. It appears that early development in this ecologically important sea urchin is not constrained in adapting to the multiple stressors of ocean warming and acidification. The presence of tolerant genotypes indicates the potential to adapt to concurrent warming and acidification, contributing to the resilience of C. rodgersii in a changing ocean.	[Foo, Shawna A.] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Dworjanyn, Symon A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Poore, Alistair G. B.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Byrne, Maria] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Byrne, Maria] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney; Southern Cross University; University of New South Wales Sydney; University of Sydney; University of Sydney	Foo, SA (corresponding author), Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia.	shawna@anatomy.usyd.edu.au	Byrne, Maria/K-6355-2016; Poore, Alistair/C-2934-2008; Dworjanyn, Symon A/O-5633-2017	Byrne, Maria/0000-0002-8902-9808; Poore, Alistair/0000-0002-3560-3659; Dworjanyn, Symon A/0000-0002-6690-8033; Foo, Shawna/0000-0002-7083-2377	Australian Research Council; New South Wales Environment Research trust; National Climate Change Adaptation Research Facility	Australian Research Council(Australian Research Council); New South Wales Environment Research trust; National Climate Change Adaptation Research Facility	This research was supported by grants from the Australian Research Council (http://www.arc.gov.au/), New South Wales Environment Research trust (http://www.environment.nsw.gov.au/grants/research.htm) and the National Climate Change Adaptation Research Facility (http://www.nccarf.edu.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andrew N. L., 2007, BIOL ECOLOGY EDIBLE, p[191, xxv]; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 1877, DIFFERENT FORMS FLOW; Astles PA, 2006, J EVOLUTION BIOL, V19, P114, DOI 10.1111/j.1420-9101.2005.00997.x; Baumann H, 2011, P ROY SOC B-BIOL SCI, V278, P2265, DOI 10.1098/rspb.2010.2479; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; Boudry P, 2002, AQUACULTURE, V204, P283, DOI 10.1016/S0044-8486(01)00841-9; Byrne M, 2008, MAR BIOL, V155, P473, DOI 10.1007/s00227-008-1045-5; Byrne M, 2011, DEEP-SEA RES PT II, V58, P712, DOI 10.1016/j.dsr2.2010.06.010; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Byrne M, 2011, P ROY SOC B-BIOL SCI, V278, P2376, DOI 10.1098/rspb.2010.2404; Byrne M, 2010, MAR BIOL, V157, P2061, DOI 10.1007/s00227-010-1474-9; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Csaszar NBM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009751; Davidson EH, 2002, DEV BIOL, V246, P162, DOI 10.1006/dbio.2002.0635; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doo SS, 2012, ICES J MAR SCI, V69, P460, DOI 10.1093/icesjms/fsr123; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; EISEN EJ, 1983, THEOR APPL GENET, V67, P75, DOI 10.1007/BF00303929; Ericson JA, 2010, MAR BIOL, V157, P2689, DOI 10.1007/s00227-010-1529-y; Evans JP, 2007, EVOLUTION, V61, P2832, DOI 10.1111/j.1558-5646.2007.00227.x; Evans JP, 2012, P ROY SOC B-BIOL SCI, V279, P2855, DOI 10.1098/rspb.2012.0181; Galletly BC, 2007, ECOL APPL, V17, P2290, DOI 10.1890/06-2079.1; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Hamdoun A, 2007, P NATL ACAD SCI USA, V104, P1745, DOI 10.1073/pnas.0610108104; Hammond LM, 2010, MAR BIOL, V157, P2677, DOI 10.1007/s00227-010-1528-z; Havenhand JN, 2008, CURR BIOL, V18, pR651, DOI 10.1016/j.cub.2008.06.015; Hobday AJ, 2011, MAR FRESHWATER RES, V62, P1000, DOI 10.1071/MF10302; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; IPCC (Intergovernmental Panel on Climate Change), 2007, 4 ASS REP IPCC; Kelly MW, 2012, P ROY SOC B-BIOL SCI, V279, P349, DOI 10.1098/rspb.2011.0542; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Levitan DR, 2006, SCIENCE, V312, P267, DOI 10.1126/science.1122183; Ling SD, 2009, GLOBAL CHANGE BIOL, V15, P719, DOI 10.1111/j.1365-2486.2008.01734.x; Lynch M., 1998, GENETICS ANAL QUANTI; Marshall DJ, 2000, MAR ECOL PROG SER, V195, P305, DOI 10.3354/meps195305; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Nguyen H, 2012, GLOBAL CHAN IN PRESS; Palumbi SR, 1999, P NATL ACAD SCI USA, V96, P12632, DOI 10.1073/pnas.96.22.12632; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pease CJ, 2010, AQUAT TOXICOL, V99, P10, DOI 10.1016/j.aquatox.2010.03.014; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Pierrot D., 2006, ORNLCDIAC105A US DEP; Pistevos JCA, 2011, OIKOS, V120, P675, DOI 10.1111/j.1600-0706.2010.19470.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reuter KE, 2011, GLOBAL CHANGE BIOL, V17, P163, DOI 10.1111/j.1365-2486.2010.02216.x; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; SCONZO G, 1986, CELL DIFFER DEV, V19, P173, DOI 10.1016/0045-6039(86)90093-X; Sheppard Brennand H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011372; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; Tomanek L, 2011, J EXP BIOL, V214, P1836, DOI 10.1242/jeb.055475; Willett CS, 2010, EVOLUTION, V64, P2521, DOI 10.1111/j.1558-5646.2010.01008.x; Yeh PJ, 2004, AM NAT, V164, P531, DOI 10.1086/423825	60	102	102	1	179	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42497	10.1371/journal.pone.0042497	http://dx.doi.org/10.1371/journal.pone.0042497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880005	Green Submitted, gold, Green Published			2022-12-27	WOS:000307284100110
J	Higgins, M; Miller, M; Nighorn, A				Higgins, Mark; Miller, Michael; Nighorn, Alan			Nitric Oxide Has Differential Effects on Currents in Different Subsets of Manduca sexta Antennal Lobe Neurons	PLOS ONE			English	Article							PROJECTION NEURONS; RECOGNITION MEMORY; VOLUME TRANSMITTER; S-NITROSYLATION; IN-VITRO; SYNTHASE; MOTH; EXCITABILITY; CHANNELS; PROTEIN	Nitric oxide has been shown to regulate many biological systems including olfaction. In the moth olfactory system nitric oxide is produced in the antennal lobe in response to odor stimulation and has complex effects on the activity of both projection neurons and local interneurons. To examine the cell autonomous effects of nitric oxide on these cells, we used patch-clamp recording in conjunction with pharmacological manipulation of nitric oxide to test the hypothesis that nitric oxide differentially regulates the channel properties of these different antennal lobe neuron subsets. We found that nitric oxide caused increasing inward currents in a subset of projection neurons while the effects on local neurons were variable but consistent within identifiable morphological subtypes.	[Higgins, Mark; Miller, Michael; Nighorn, Alan] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA	University of Arizona	Higgins, M (corresponding author), Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA.	nighorn@email.arizona.edu			National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders (NIDCD) [DC04292]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004292] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders (NIDCD) grant number DC04292 awarded to Alan Nighorn. www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agustin-Pavon C, 2009, PHYSIOL BEHAV, V98, P608, DOI 10.1016/j.physbeh.2009.09.011; Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; Artinian L, 2010, J NEUROSCI, V30, P1699, DOI 10.1523/JNEUROSCI.4511-09.2010; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; BREER H, 1993, TRENDS NEUROSCI, V16, P5, DOI 10.1016/0166-2236(93)90040-S; Collmann C, 2004, J NEUROSCI, V24, P6070, DOI 10.1523/JNEUROSCI.0710-04.2004; De Vente J, 1998, NEUROSCIENCE, V87, P207, DOI 10.1016/S0306-4522(98)00171-7; Ding SY, 2011, J NEUROPHYSIOL, V106, P3019, DOI 10.1152/jn.00305.2011; EGBERONGBE YI, 1994, NEUROSCIENCE, V59, P561, DOI 10.1016/0306-4522(94)90177-5; Hanafy K A, 2001, Med Sci Monit, V7, P801; Hatcher NG, 2006, J NEUROPHYSIOL, V95, P3219, DOI 10.1152/jn.0815.2005; HAYASHI JH, 1990, J NEUROSCI, V10, P848; Jacklet JW, 2004, J NEUROPHYSIOL, V91, P656, DOI 10.1152/jn.00409.2003; Jetti SK, 2010, NITRIC OXIDE-BIOL CH, V22, P213, DOI 10.1016/j.niox.2009.12.006; Juch M, 2009, NEUROBIOL LEARN MEM, V92, P469, DOI 10.1016/j.nlm.2009.06.004; Kendrick KM, 1997, NATURE, V388, P670, DOI 10.1038/41765; Kloppenburg P, 1999, J NEUROSCI, V19, P8172; KrippeitDrews P, 1996, BIOCHEM BIOPH RES CO, V224, P199, DOI 10.1006/bbrc.1996.1007; Lei H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023382; Mannick JB, 2004, FREE RADICAL RES, V38, P1, DOI 10.1080/10715760310001629065; Mercer AR, 2002, J NEUROPHYSIOL, V87, P2650, DOI 10.1152/jn.2002.87.6.2650; Molleman A., 2003, PATCH CLAMPING INTRO; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Muller U, 1996, NEURON, V16, P541, DOI 10.1016/S0896-6273(00)80073-2; Mustafa AK., 2009, SCI SIGNAL, V2, P1; Nighorn A, 1998, J NEUROSCI, V18, P7244; Nunez L, 2006, CARDIOVASC RES, V72, P80, DOI 10.1016/j.cardiores.2006.06.021; Okere CO, 1996, NEUROSCIENCE, V71, P349, DOI 10.1016/0306-4522(95)00467-X; OLAND LA, 1987, J COMP NEUROL, V255, P196, DOI 10.1002/cne.902550204; OLAND LA, 1993, J NEUROBIOL, V24, P1170, DOI 10.1002/neu.480240905; Oland LA, 1996, J NEUROSCI METH, V69, P103, DOI 10.1016/S0165-0270(96)00025-8; Park JH, 1998, J NEUROSCI, V18, P5463, DOI 10.1523/JNEUROSCI.18-14-05463.1998; Reisenman CE, 2011, J COMP PHYSIOL A, V197, P653, DOI 10.1007/s00359-011-0625-x; Ryuman N, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/450317; Sammut S, 2010, NEUROPHARMACOLOGY, V58, P624, DOI 10.1016/j.neuropharm.2009.11.011; Sanchez-Andrade G, 2009, BEHAV BRAIN RES, V200, P323, DOI 10.1016/j.bbr.2008.12.021; Secondo A, 2006, AM J PHYSIOL-CELL PH, V290, pC233, DOI 10.1152/ajpcell.00231.2005; Sokolovski S, 2004, PLANT PHYSIOL, V136, P4275, DOI 10.1104/pp.104.050344; Steinert JR, 2011, NEURON, V71, P291, DOI 10.1016/j.neuron.2011.05.037; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Steinert JR, 2008, NEURON, V60, P642, DOI 10.1016/j.neuron.2008.08.025; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wall MJ, 2003, EUR J NEUROSCI, V18, P869, DOI 10.1046/j.1460-9568.2003.02822.x; Wilson CH, 2007, J COMP PHYSIOL A, V193, P715, DOI 10.1007/s00359-007-0227-9; Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041; Yang S, 2008, J PHYSIOL-LONDON, V586, P3617, DOI 10.1113/jphysiol.2008.153312; ZHAO HQ, 1994, NEUROREPORT, V6, P149, DOI 10.1097/00001756-199412300-00038	47	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42556	10.1371/journal.pone.0042556	http://dx.doi.org/10.1371/journal.pone.0042556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880032	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100128
J	Juneau, KJ; Tarasoff, CS				Juneau, Kevyn J.; Tarasoff, Catherine S.			Leaf Area and Water Content Changes after Permanent and Temporary Storage	PLOS ONE			English	Article							STOMATAL DENSITY; ATMOSPHERIC CO2; LIGNIN CONTENT; PINE NEEDLES; TEMPERATURE; PLANTS; SHAPE; DECOMPOSITION; NITROGEN; TRANSPIRATION	Accurate measurements of leaf morphology must be taken to develop models of ecosystem productivity and climate change projections. Once leaves are removed from a plant they begin to lose water and degrade. If specimens cannot be measured immediately after harvest, it is important to store the leaves in a manner that reduces morphological changes. If preserved specimens are used, estimates that closely match fresh measurements need to be calculated. This study examined the change in leaf area after storage treatments and developed models that can be used to more accurately estimate initial leaf area. Fresh leaf area was measured from ten plant species then stored in one of two common storage treatments. After storage, leaf area was re-measured and comparisons were made between species and growth forms. Leaf area decreased the most after permanent storage treatments and the least after temporary storage. Pressed leaves shrunk over 18% while cold storage leaves shrunk under 4%. The woody dicot growth form shrunk the least in all treatments. Shrinkage was positively correlated with initial water content and dissection index, a measure of leaf shape and complexity.	[Juneau, Kevyn J.; Tarasoff, Catherine S.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Michigan Technological University	Juneau, KJ (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.	kjjuneau@mtu.edu			Minnesota Department of Transportation [89258]; Ecosystem Science Center, Michigan Technological University, Houghton, MI	Minnesota Department of Transportation; Ecosystem Science Center, Michigan Technological University, Houghton, MI	This work was supported in part by the Minnesota Department of Transportation (grant #89258) and the Ecosystem Science Center, Michigan Technological University, Houghton, MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bond-Lamberty B, 2002, TREE PHYSIOL, V22, P993, DOI 10.1093/treephys/22.14.993; Breda NJJ, 2003, J EXP BOT, V54, P2403, DOI 10.1093/jxb/erg263; Brett CT, 1996, PHYSL BIOCH PLANT CE; Brodribb TJ, 2005, PLANT PHYSIOL, V137, P1139, DOI 10.1104/pp.104.058156; Campbell MM, 1996, PLANT PHYSIOL, V110, P3, DOI 10.1104/pp.110.1.3; Cochard H, 2004, PLANT PHYSIOL, V134, P401, DOI 10.1104/pp.103.028357; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Evans GC., 1972, QUANTITATIVE ANAL PL; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Farrant JM, 2000, PLANT ECOL, V151, P29, DOI 10.1023/A:1026534305831; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; GATES DM, 1968, ANN REV PLANT PHYSIO, V19, P211, DOI 10.1146/annurev.pp.19.060168.001235; GESSNER MO, 1994, ECOLOGY, V75, P1807, DOI 10.2307/1939639; HARMON ME, 1990, FOREST ECOL MANAG, V31, P55, DOI 10.1016/0378-1127(90)90111-N; HICKS A J, 1978, Taxon, V27, P63, DOI 10.2307/1220483; Holbrook NM., 2005, VASCULAR TRANSPORT P, DOI [10.1016/B978-0-12-088457-5.X5000-X, DOI 10.1016/B978-0-12-088457-5.X5000-X]; Hultine KR, 2001, J EXP BOT, V52, P369, DOI 10.1093/jexbot/52.355.369; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; KINCAID DT, 1983, CAN J BOT, V61, P2333, DOI 10.1139/b83-256; Kouwenberg LLR, 2003, AM J BOT, V90, P610, DOI 10.3732/ajb.90.4.610; Kramer P.J., 1995, WATER RELATIONS PLAN; Li YL, 2005, BOT BULL ACAD SINICA, V46, P127; McAuslane HJ, 2000, ENTOMOL EXP APPL, V97, P283, DOI 10.1023/A:1004051527347; McLellan T, 1998, SYST BIOL, V47, P264, DOI 10.1080/106351598260914; MCLELLAN T, 1993, AM J BOT, V80, P796, DOI 10.2307/2445599; Miller-Rushing AJ, 2009, AM J BOT, V96, P1779, DOI 10.3732/ajb.0800410; MILTHORPE FL, 1957, J EXP BOT, V8, P413, DOI 10.1093/jxb/8.3.413; Nicotra AB, 2008, OECOLOGIA, V154, P625, DOI 10.1007/s00442-007-0865-1; NIKLAS KJ, 1986, AM J BOT, V73, P636; NIKLAS KJ, 1989, AM J BOT, V76, P929, DOI 10.2307/2444549; O'Neal ME, 2002, J ECON ENTOMOL, V95, P1190, DOI 10.1603/0022-0493-95.6.1190; PENUELAS J, 1990, J EXP BOT, V41, P1119, DOI 10.1093/jxb/41.9.1119; Prado CHBA, 1997, PHOTOSYNTHETICA, V33, P103, DOI 10.1023/A:1022183423630; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Reich PB, 1998, FUNCT ECOL, V12, P948, DOI 10.1046/j.1365-2435.1998.00274.x; ROBINSON JM, 1990, GEOLOGY, V18, P607, DOI 10.1130/0091-7613(1990)015<0607:LLPAFB>2.3.CO;2; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; Ryser P, 2008, J EXP BOT, V59, P2461, DOI 10.1093/jxb/ern120; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; SCHAEFER D, 1985, OECOLOGIA, V65, P382, DOI 10.1007/BF00378913; Siso S, 2001, TREES-STRUCT FUNCT, V15, P341, DOI 10.1007/s004680100110; USDA NRCS (US Department of Agriculture Natural Resources Conservation Service), 2011, PLANTS DAT; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Vicre M, 2004, PHYSIOL PLANTARUM, V120, P229, DOI 10.1111/j.0031-9317.2004.0234.x; Watanabe A, 2006, APPL SPECTROSC, V60, P611, DOI 10.1366/000370206777670549; WATSON DJ, 1947, ANN BOT-LONDON, V11, P41, DOI 10.1093/oxfordjournals.aob.a083148; Weatherley P E, 1965, Symp Soc Exp Biol, V19, P157; Wheeler DA, 2001, ENTOMOL EXP APPL, V98, P9, DOI 10.1023/A:1018755203570; WHITE RH, 1987, WOOD FIBER SCI, V19, P446; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0	52	21	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42604	10.1371/journal.pone.0042604	http://dx.doi.org/10.1371/journal.pone.0042604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880051	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100141
J	Pereira, L; Zamudio, R; Soares-Souza, G; Herrera, P; Cabrera, L; Hooper, CC; Cok, J; Combe, JM; Vargas, G; Prado, WA; Schneider, S; Kehdy, F; Rodrigues, MR; Chanock, SJ; Berg, DE; Gilman, RH; Tarazona-Santos, E				Pereira, Latife; Zamudio, Roxana; Soares-Souza, Giordano; Herrera, Phabiola; Cabrera, Lilia; Hooper, Catherine C.; Cok, Jaime; Combe, Juan M.; Vargas, Gloria; Prado, William A.; Schneider, Silvana; Kehdy, Fernanda; Rodrigues, Maira R.; Chanock, Stephen J.; Berg, Douglas E.; Gilman, Robert H.; Tarazona-Santos, Eduardo			Socioeconomic and Nutritional Factors Account for the Association of Gastric Cancer with Amerindian Ancestry in a Latin American Admixed Population	PLOS ONE			English	Article							HELICOBACTER-PYLORI; RISK; ESOPHAGEAL; PATTERNS; ADENOCARCINOMA; SUSCEPTIBILITY; PREVALENCE; ADMIXTURE; DIETARY; STATES	Gastric cancer is one of the most lethal types of cancer and its incidence varies worldwide, with the Andean region of South America showing high incidence rates. We evaluated the genetic structure of the population from Lima (Peru) and performed a case-control genetic association study to test the contribution of African, European, or Native American ancestry to risk for gastric cancer, controlling for the effect of non-genetic factors. A wide set of socioeconomic, dietary, and clinic information was collected for each participant in the study and ancestry was estimated based on 103 ancestry informative markers. Although the urban population from Lima is usually considered as mestizo (i.e., admixed from Africans, Europeans, and Native Americans), we observed a high fraction of Native American ancestry (78.4% for the cases and 74.6% for the controls) and a very low African ancestry (<5%). We determined that higher Native American individual ancestry is associated with gastric cancer, but socioeconomic factors associated both with gastric cancer and Native American ethnicity account for this association. Therefore, the high incidence of gastric cancer in Peru does not seem to be related to susceptibility alleles common in this population. Instead, our result suggests a predominant role for ethnic-associated socioeconomic factors and disparities in access to health services. Since Native Americans are a neglected group in genomic studies, we suggest that the population from Lima and other large cities from Western South America with high Native American ancestry background may be convenient targets for epidemiological studies focused on this ethnic group.	[Pereira, Latife; Zamudio, Roxana; Soares-Souza, Giordano; Kehdy, Fernanda; Rodrigues, Maira R.] Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Herrera, Phabiola; Cabrera, Lilia; Gilman, Robert H.; Tarazona-Santos, Eduardo] Asociac Benef PRISMA, Lima, Peru; [Hooper, Catherine C.; Gilman, Robert H.] Univ Peruana Cayetano Heredia, Fac Ciencias, Lab Invest & Desarrollo, Lima, Peru; [Cok, Jaime] Hosp Nacl Cayetano Heredia, Dept Patol, Lima, Peru; [Combe, Juan M.] Inst Nacl Engermedades Neoplascas, Dept Gastroenterol, Lima, Peru; [Vargas, Gloria] Hosp Nacl Arzobispo Loayza, Serv Gastroenterol, Lima, Peru; [Prado, William A.] Hosp Dos de Mayo, Serv Gastroenterol, Lima, Peru; [Schneider, Silvana] Univ Fed Minas Gerais, Dept Estat, Belo Horizonte, MG, Brazil; [Chanock, Stephen J.] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH, Gaithersburg, MD USA; [Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Gilman, Robert H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Universidade Federal de Minas Gerais; Universidad Peruana Cayetano Heredia; Universidade Federal de Minas Gerais; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Pereira, L (corresponding author), Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil.	edutars@icb.ufmg.br	Soares-Souza, Giordano Bruno/ABH-6992-2020; Tarazona-Santos, Eduardo/AAF-1110-2019; Herrera, Phabiola/AAL-7992-2021	Soares-Souza, Giordano Bruno/0000-0001-6590-5589; Kehdy, Fernanda/0000-0001-8964-9049; Tarazona, Eduardo/0000-0003-3508-3160	Fogarty International Center and National Cancer Institute [5R01TW007894]; Brazilian National Research Council; Ministry of Education; Ministry of Health (PNPD-Saude Program); Minas Gerais State Reaearch Agency; FOGARTY INTERNATIONAL CENTER [R01TW007894] Funding Source: NIH RePORTER	Fogarty International Center and National Cancer Institute; Brazilian National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Education; Ministry of Health (PNPD-Saude Program); Minas Gerais State Reaearch Agency; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Fogarty International Center and National Cancer Institute (5R01TW007894) funded this study. The study and its participants also received funding and fellowships from the following Brazilian agencies: Brazilian National Research Council, Ministry of Education, Ministry of Health (PNPD-Saude Program), and the Minas Gerais State Reaearch Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], 2012, CATEGORICAL DATA ANA; Asaka M, 2004, HELICOBACTER, V9, P35, DOI 10.1111/j.1083-4389.2004.00252.x; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Avena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034695; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Campbell DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033570; Campbell PT, 2008, AM J EPIDEMIOL, V167, P295, DOI 10.1093/aje/kwm294; Chessel D., 2004, R NEWS, V4, P5; CORREA P, 1992, CANCER RES, V52, P6735; Correa P, 2010, AM J GASTROENTEROL, V105, P493, DOI 10.1038/ajg.2009.728; Dean Bartholomew, 2003, RISK BEING HEARD IDE; DOOLEY CP, 1989, NEW ENGL J MED, V321, P1562, DOI 10.1056/NEJM198912073212302; Ferlay J, 2010, INT J CANC; FILIPE MI, 1994, INT J CANCER, V57, P324, DOI 10.1002/ijc.2910570306; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Galanter JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002554; Genta RM, 2001, ALIMENT PHARM THER, V15, P43, DOI 10.1046/j.1365-2036.2001.00110.x; Gonzalez CA, 2010, INT J CANCER, V127, P2654, DOI 10.1002/ijc.25273; Harrell FE, 2001, REGRESSION MODELING; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kersulyte D, 2000, J BACTERIOL, V182, P3210, DOI 10.1128/JB.182.11.3210-3218.2000; Kersulyte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015076; Mendoza D, 2008, INT J CANCER, V123, P414, DOI 10.1002/ijc.23420; Mohebbi M, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-13; Ohyauchi M, 2005, GUT, V54, P330, DOI 10.1136/gut.2003.033050; Perez GIP, 2005, CANCER EPIDEM BIOMAR, V14, P1869, DOI 10.1158/1055-9965.EPI-04-0889; Pritchard JK, 2000, GENETICS, V155, P945; RECAVARRENARCE S, 1991, SCAND J GASTROENTERO, V26, P51, DOI 10.3109/00365529109093208; Rocha GA, 2005, INT J CANCER, V115, P678, DOI 10.1002/ijc.20935; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Savage SA, 2004, CANCER EPIDEM BIOMAR, V13, P2251; Silvera SAN, 2011, ANN EPIDEMIOL, V21, P543, DOI 10.1016/j.annepidem.2010.11.019; Steevens J, 2011, INT J CANC; Suzuki M, 2011, J BIOL CHEM, V286, P29964, DOI 10.1074/jbc.M111.263715; Taguchi A, 2005, CANCER EPIDEM BIOMAR, V14, P2487, DOI 10.1158/1055-9965.EPI-05-0326; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; U.S. CensusBureau, 2009, 2009 AM COMM SURV 1; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505; Yang WG, 2011, WORLD J GASTROENTERO, V17, P2049, DOI 10.3748/wjg.v17.i15.2049; Zhu KX, 2011, MOL BIOL REP, V38, P649, DOI 10.1007/s11033-010-0151-x	45	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41200	10.1371/journal.pone.0041200	http://dx.doi.org/10.1371/journal.pone.0041200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870209	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100013
J	Savage, C; Thrush, SF; Lohrer, AM; Hewitt, JE				Savage, Candida; Thrush, Simon F.; Lohrer, Andrew M.; Hewitt, Judi E.			Ecosystem Services Transcend Boundaries: Estuaries Provide Resource Subsidies and Influence Functional Diversity in Coastal Benthic Communities	PLOS ONE			English	Article							STABLE-ISOTOPES; ORGANIC-MATTER; FOOD WEBS; CARBON; SEA; NITRIFICATION; DELTA-N-15; DELTA-C-13; SEDIMENTS; NITROGEN	Background: Estuaries are highly productive ecosystems that can export organic matter to coastal seas (the 'outwelling hypothesis'). However the role of this food resource subsidy on coastal ecosystem functioning has not been examined. Methodology/Principal Findings: We investigated the influence of estuarine primary production as a resource subsidy and the influence of estuaries on biodiversity and ecosystem functioning in coastal mollusk-dominated sediment communities. Stable isotope values (delta C-13, delta N-15) demonstrated that estuarine primary production was exported to the adjacent coast and contributed to secondary production up to 4 km from the estuary mouth. Further, isotope signatures of suspension feeding bivalves on the adjacent coast (Dosinia subrosea) closely mirrored the isotope values of the dominant bivalves inside the estuaries (Austrovenus stutchburyi), indicating utilization of similar organic matter sources. However, the food subsidies varied between estuaries; with estuarine suspended particulate organic matter (SPOM) dominant at Tairua estuary, while seagrass and fringing vegetation detritus was proportionately more important at Whangapoua estuary, with lesser contributions of estuarine SPOM. Distance from the estuary mouth and the size and density of large bivalves (Dosinia spp.) had a significant influence on the composition of biological traits in the coastal macrobenthic communities, signaling the potential influence of these spatial subsidies on ecosystem functioning. Conclusions/Significance: Our study demonstrated that the locations where ecosystem services like productivity are generated are not necessarily where the services are utilized. Further, we identified indirect positive effects of the nutrient subsidies on biodiversity (the estuarine subsidies influenced the bivalves, which in turn affected the diversity and functional trait composition of the coastal sediment macrofaunal communities). These findings highlight the importance of integrative ecosystem-based management that maintains the connectivity of estuarine and coastal ecosystems.	[Savage, Candida] Univ Otago, Dept Marine Sci, Dunedin, New Zealand; [Thrush, Simon F.; Lohrer, Andrew M.; Hewitt, Judi E.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand	University of Otago; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Savage, C (corresponding author), Univ Otago, Dept Marine Sci, Dunedin, New Zealand.	candida.savage@otago.ac.nz		Thrush, Simon/0000-0002-4005-3882	New Zealand Ministry of Fisheries Biodiversity Program [ZBD2008-07]	New Zealand Ministry of Fisheries Biodiversity Program	This work was funded by the New Zealand Ministry of Fisheries Biodiversity Program (project ZBD2008-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2004, ECOL APPL, V14, P1921, DOI 10.1890/03-5379; Antonio ES, 2010, ESTUAR COAST SHELF S, V86, P401, DOI 10.1016/j.ecss.2009.05.010; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Bianchi M, 1999, AQUAT MICROB ECOL, V18, P301, DOI 10.3354/ame018301; Bianchi M, 1999, AQUAT MICROB ECOL, V17, P267, DOI 10.3354/ame017267; Caraco NF, 1998, MAR ECOL PROG SER, V167, P59, DOI 10.3354/meps167059; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Cunha MA, 2003, AQUAT ECOL, V37, P45, DOI 10.1023/A:1022173730178; Dame R.F., 1993, BIVALVE FILTER FEEDE; Gattuso JP, 1998, ANNU REV ECOL SYST, V29, P405, DOI 10.1146/annurev.ecolsys.29.1.405; Gray JS, 2002, MAR ECOL PROG SER, V244, P285, DOI 10.3354/meps244285; Hewitt JE, 2008, J EXP MAR BIOL ECOL, V366, P116, DOI 10.1016/j.jembe.2008.07.016; Hewitt JE, 2007, AM NAT, V169, P398, DOI 10.1086/510925; Hocking MD, 2011, SCIENCE, V331, P1609, DOI 10.1126/science.1201079; Hume TM, 2007, OCEAN COAST MANAGE, V50, P905, DOI 10.1016/j.ocecoaman.2007.05.009; JONES GA, 1983, J SEDIMENT PETROL, V53, P655, DOI 10.1306/212F825B-2B24-11D7-8648000102C1865D; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Lorrain A, 2002, J EXP MAR BIOL ECOL, V275, P47, DOI 10.1016/S0022-0981(02)00220-4; McCullagh P, 1989, GEN LINEAR MODELS; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; NIXON S W, 1986, Journal of the Limnological Society of Southern Africa, V12, P43; ODUM WE, 1979, ECOLOGICAL PROCESSES, P69; Peterson BJ, 1999, ACTA OECOL, V20, P479, DOI 10.1016/S1146-609X(99)00120-4; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Riera P, 2002, MAR ECOL PROG SER, V240, P291, DOI 10.3354/meps240291; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Schlacher TA, 2009, AQUAT ECOL, V43, P383, DOI 10.1007/s10452-008-9196-5; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Turner S, 2006, ENV WIAKATO INTERNAL; van Oevelen D, 2006, J MAR RES, V64, P453, DOI 10.1357/002224006778189581; Vasconcelos RP, 2011, ECOL INDIC, V11, P1123, DOI 10.1016/j.ecolind.2010.12.012; Yokoyama H, 2007, MAR ECOL PROG SER, V346, P127, DOI 10.3354/meps07010	34	54	54	0	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42708	10.1371/journal.pone.0042708	http://dx.doi.org/10.1371/journal.pone.0042708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880089	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100162
J	Furtado, C; Kunrath-Lima, M; Rajao, MA; Mendes, IC; de Moura, MB; Campos, PC; Macedo, AM; Franco, GR; Pena, SDJ; Teixeira, SMR; Van Houten, B; Machado, CR				Furtado, Carolina; Kunrath-Lima, Marianna; Rajao, Matheus Andrade; Mendes, Isabela Cecilia; de Moura, Michelle Barbi; Campos, Priscila Carneiro; Macedo, Andrea Mara; Franco, Gloria Regina; Junho Pena, Sergio Danilo; Ribeiro Teixeira, Santuza Maria; Van Houten, Bennett; Machado, Carlos Renato			Functional Characterization of 8-Oxoguanine DNA Glycosylase of Trypanosoma cruzi	PLOS ONE			English	Article							BASE EXCISION-REPAIR; MITOCHONDRIAL-DNA; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; SUBCELLULAR-LOCALIZATION; OGG1 GENE; CLONING; DAMAGE; PROTEIN; EXPRESSION	The oxidative lesion 8-oxoguanine (8-oxoG) is removed during base excision repair by the 8-oxoguanine DNA glycosylase 1 (Ogg1). This lesion can erroneously pair with adenine, and the excision of this damaged base by Ogg1 enables the insertion of a guanine and prevents DNA mutation. In this report, we identified and characterized Ogg1 from the protozoan parasite Trypanosoma cruzi (TcOgg1), the causative agent of Chagas disease. Like most living organisms, T. cruzi is susceptible to oxidative stress, hence DNA repair is essential for its survival and improvement of infection. We verified that the TcOGG1 gene encodes an 8-oxoG DNA glycosylase by complementing an Ogg1-defective Saccharomyces cerevisiae strain. Heterologous expression of TcOGG1 reestablished the mutation frequency of the yeast mutant ogg1(-/-) (CD138) to wild type levels. We also demonstrate that the overexpression of TcOGG1 increases T. cruzi sensitivity to hydrogen peroxide (H2O2). Analysis of DNA lesions using quantitative PCR suggests that the increased susceptibility to H2O2 of TcOGG1-overexpressor could be a consequence of uncoupled BER in abasic sites and/or strand breaks generated after TcOgg1 removes 8-oxoG, which are not rapidly repaired by the subsequent BER enzymes. This hypothesis is supported by the observation that TcOGG1-overexpressors have reduced levels of 8-oxoG both in the nucleus and in the parasite mitochondrion. The localization of TcOgg1 was examined in parasite transfected with a TcOgg1-GFP fusion, which confirmed that this enzyme is in both organelles. Taken together, our data indicate that T. cruzi has a functional Ogg1 ortholog that participates in nuclear and mitochondrial BER.	[Furtado, Carolina; Kunrath-Lima, Marianna; Rajao, Matheus Andrade; Mendes, Isabela Cecilia; Campos, Priscila Carneiro; Macedo, Andrea Mara; Franco, Gloria Regina; Junho Pena, Sergio Danilo; Ribeiro Teixeira, Santuza Maria; Machado, Carlos Renato] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [de Moura, Michelle Barbi; Van Houten, Bennett] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [de Moura, Michelle Barbi; Van Houten, Bennett] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA USA	Universidade Federal de Minas Gerais; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Furtado, C (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	crmachad@icb.ufmg.br	TEIXEIRA, SANTUZA MR/I-8137-2013; Van Houten, Bennett/K-2284-2019; Franco, Glória/I-3654-2013; Machado, Carlos Renato/H-1043-2015; Macedo, Andréa M/C-1506-2013; MACHADO, CARLOS/AAW-1492-2020	Franco, Glória/0000-0001-5245-2365; Machado, Carlos Renato/0000-0002-8724-3165; Campos, Priscila/0000-0003-1789-3290	CNPq [474865/2010-0]; FAPEMIG [PPM-00284-11]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by CNPq Grant Process number 474865/2010-0 (www.cnpq.br) and FAPEMIG grant Process number PPM-00284-11 (www.fapemig.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Augusto-Pinto L, 2001, GENE, V272, P323, DOI 10.1016/S0378-1119(01)00549-2; Augusto-Pinto Luiz, 2003, Genet Mol Res, V2, P77; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Belousova EA, 2006, BBA-PROTEINS PROTEOM, V1764, P97, DOI 10.1016/j.bbapap.2005.11.001; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6; BOITEUX S, 1989, MOL GEN GENET, V215, P300, DOI 10.1007/BF00339732; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Cabrera G, 2011, J CELL BIOCHEM, V112, P2189, DOI 10.1002/jcb.23138; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Conlon KA, 2003, DNA REPAIR, V2, P1337, DOI 10.1016/j.dnarep.2003.08.002; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DaRocha WD, 2004, PARASITOL RES, V92, P113, DOI 10.1007/s00436-003-1004-5; de Moura MB, 2009, ENVIRON MOL MUTAGEN, V50, P375, DOI 10.1002/em.20450; de Souza W, 2009, MEM I OSWALDO CRUZ, V104, P89, DOI 10.1590/S0074-02762009000900014; DESOUZA W, 1984, INT REV CYTOL, V86, P197, DOI 10.1016/S0074-7696(08)60180-1; Downey N, 2005, EUKARYOT CELL, V4, P765, DOI 10.1128/EC.4.4.765-774.2005; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Eot-Houllier G, 2007, NUCLEIC ACIDS RES, V35, P3355, DOI 10.1093/nar/gkm190; Garcia-Ortiz MV, 2001, PLANT MOL BIOL, V47, P795, DOI 10.1023/A:1013644026132; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Glassner BJ, 1998, P NATL ACAD SCI USA, V95, P9997, DOI 10.1073/pnas.95.17.9997; Goellner EM, 2011, CANCER RES, V71, P2308, DOI 10.1158/0008-5472.CAN-10-3213; Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227; Guibourt N, 2000, BIOCHIMIE, V82, P59, DOI 10.1016/S0300-9084(00)00357-6; Gupta S., 2009, INTERDISCIP PERSPECT, V2009, P1, DOI [DOI 10.1155/2009/190354, 10.1155/2009/190354]; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hollenbach S, 1999, CARCINOGENESIS, V20, P1863, DOI 10.1093/carcin/20.9.1863; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Irigoin F, 2008, FREE RADICAL BIO MED, V45, P733, DOI 10.1016/j.freeradbiomed.2008.05.028; Jin G, 2006, INT J RADIAT BIOL, V82, P241, DOI 10.1080/09553000600649216; Kohno T, 2011, J THORAC ONCOL, V6, P813, DOI 10.1097/JTO.0b013e3181ee80ef; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Krenzlin H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002557; Krokan HE, 1997, BIOCHEM J, V325, P1; Li WQ, 2009, CARCINOGENESIS, V30, P500, DOI 10.1093/carcin/bgp018; Lopes DD, 2008, DNA REPAIR, V7, P1882, DOI 10.1016/j.dnarep.2008.07.018; Mao GG, 2007, NUCLEIC ACIDS RES, V35, P2759, DOI 10.1093/nar/gkm189; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; Meyer JN, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r70; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Mirbahai L, 2010, DNA REPAIR, V9, P144, DOI 10.1016/j.dnarep.2009.11.009; Nakabeppu Y, 2001, PROG NUCLEIC ACID RE, V68, P75; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Nussbaum K, 2010, CURR MED CHEM, V17, P1594, DOI 10.2174/092986710790979953; Pfeifer GP, 1996, TECHNOLOGIES DETECTI, pxxv; Pires SF, 2008, INT J PARASITOL, V38, P289, DOI 10.1016/j.ijpara.2007.08.013; Posnick LM, 1999, J BACTERIOL, V181, P6763, DOI 10.1128/JB.181.21.6763-6771.1999; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Rajao MA, 2009, MOL MICROBIOL, V71, P185, DOI 10.1111/j.1365-2958.2008.06521.x; Regis-Da-Silva CG, 2006, MOL BIOCHEM PARASIT, V149, P191, DOI 10.1016/j.molbiopara.2006.05.012; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Sambrook J., 2001, MOL CLONING LAB MANU; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; TCHOU J, 1993, MUTAT RES, V299, P277, DOI 10.1016/0165-1218(93)90104-L; TEIXEIRA SMR, 1994, J BIOL CHEM, V269, P20509; Thameem F, 2010, HUM HERED, V70, P97, DOI 10.1159/000291964; Thomas D, 1997, MOL GEN GENET, V254, P171, DOI 10.1007/s004380050405; Thomas S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-133; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; Yang N, 2006, DNA REPAIR, V5, P43, DOI 10.1016/j.dnarep.2005.07.003; Zhang Y., 2011, INT J COLORECTAL DIS	73	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42484	10.1371/journal.pone.0042484	http://dx.doi.org/10.1371/journal.pone.0042484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876325	Green Published, Green Accepted, gold			2022-12-27	WOS:000307184700053
J	Jazbutyte, V; Stumpner, J; Redel, A; Lorenzen, JM; Roewer, N; Thum, T; Kehl, F				Jazbutyte, Virginija; Stumpner, Jan; Redel, Andreas; Lorenzen, Johan M.; Roewer, Norbert; Thum, Thomas; Kehl, Franz			Aromatase Inhibition Attenuates Desflurane-Induced Preconditioning against Acute Myocardial Infarction in Male Mouse Heart In Vivo	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; FUNCTIONAL ESTROGEN-RECEPTORS; NITRIC-OXIDE; VOLATILE ANESTHETICS; CARDIAC-HYPERTROPHY; BLOOD-PRESSURE; ISCHEMIA; REPERFUSION; RABBITS; ISOFLURANE	The volatile anesthetic desflurane (DES) effectively reduces cardiac infarct size following experimental ischemia/reperfusion injury in the mouse heart. We hypothesized that endogenous estrogens play a role as mediators of desflurane-induced preconditioning against myocardial infarction. In this study, we tested the hypothesis that desflurane effects local estrogen synthesis by modulating enzyme aromatase expression and activity in the mouse heart. Aromatase metabolizes testosterone to 17 beta-estradiol (E2) and thereby significantly contributes to local estrogen synthesis. We tested aromatase effects in acute myocardial infarction model in male mice. The animals were randomized and subjected to four groups which were pre-treated with the selective aromatase inhibitor anastrozole (A group) and DES alone (DES group) or in combination (A+DES group) for 15 minutes prior to surgical intervention whereas the control group received 0.9% NaCl (CON group). All animals were subjected to 45 minutes ischemia following 180 minutes reperfusion. Anastrozole blocked DES induced preconditioning and increased infarct size compared to DES alone (37.94 +/- 15.5% vs. 17.1 +/- 3.62%) without affecting area at risk and systemic hemodynamic parameters following ischemia/reperfusion. Protein localization studies revealed that aromatase was abundant in the murine cardiovascular system with the highest expression levels in endothelial and smooth muscle cells. Desflurane application at pharmacological concentrations efficiently upregulated aromatase expression in vivo and in vitro. We conclude that desflurane efficiently regulates aromatase expression and activity which might lead to increased local estrogen synthesis and thus preserve cellular integrity and reduce cardiac damage in an acute myocardial infarction model.	[Jazbutyte, Virginija; Lorenzen, Johan M.; Thum, Thomas] Hannover Med Sch MHH, Inst Mol & Translat Therapeut Strategies IMTTS, Hannover, Germany; [Stumpner, Jan; Roewer, Norbert] Univ Wurzburg, Dept Anesthesia & Crit Care, Wurzburg, Germany; [Redel, Andreas] Univ Regensburg, Dept Anesthesia, Regensburg, Germany; [Kehl, Franz] Klinikum Karlsruhe, Dept Anesthesiol & Crit Care, Karslruhe, Germany	Hannover Medical School; University of Wurzburg; University of Regensburg; Municipal Hospital Karlsruhe	Jazbutyte, V (corresponding author), Hannover Med Sch MHH, Inst Mol & Translat Therapeut Strategies IMTTS, Hannover, Germany.	vjazbutyte@hotmail.com		Lorenzen, Johan/0000-0002-9132-948X; Thum, Thomas/0000-0003-4360-1511	University Clinics of Wurzburg, Germany; Else-Kroner-Fresenius Foundation; German Ministry for Education and Research (IFB-Tx) [01EO0802]	University Clinics of Wurzburg, Germany; Else-Kroner-Fresenius Foundation; German Ministry for Education and Research (IFB-Tx)	The study was supported by the University Clinics of Wurzburg, Germany, by Else-Kroner-Fresenius Foundation (FK) and by the German Ministry for Education and Research (IFB-Tx, grant 01EO0802 for TT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYARD F, 1995, ENDOCRINOLOGY, V136, P1523, DOI 10.1210/en.136.4.1523; Bayard F, 1995, CIBA F SYMP, V191, P122; Bignami E, 2009, J CARDIOTHOR VASC AN, V23, P594, DOI 10.1053/j.jvca.2009.01.022; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Head GA, 2004, ENDOCRINOLOGY, V145, P4286, DOI 10.1210/en.2004-0421; Jazbutyte V, 2008, CARDIOVASC RES, V77, P774, DOI 10.1093/cvr/cvm081; Jones MEE, 2006, TRENDS ENDOCRIN MET, V17, P53, DOI 10.1016/j.tem.2006.01.004; Kitano H, 2007, J CEREBR BLOOD F MET, V27, P1377, DOI 10.1038/sj.jcbfm.9600444; Kolodgie FD, 1997, J MOL CELL CARDIOL, V29, P2403, DOI 10.1006/jmcc.1997.0476; Landoni G, 2009, CURR DRUG TARGETS, V10, P858, DOI 10.2174/138945009789108837; Lange M, 2006, ANESTHESIOLOGY, V105, P503, DOI 10.1097/00000542-200609000-00014; Lew R, 2003, CIRC RES, V93, P1127, DOI 10.1161/01.RES.0000103633.57225.BC; Meco M, 2007, EUR J CARDIO-THORAC, V32, P319, DOI 10.1016/j.ejcts.2007.05.005; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nathan L, 2001, P NATL ACAD SCI USA, V98, P3589, DOI 10.1073/pnas.051003698; Node K, 1997, CIRCULATION, V96, P1953, DOI 10.1161/01.CIR.96.6.1953; Pelzer T, 2005, CARDIOVASC RES, V67, P604, DOI 10.1016/j.cardiores.2005.04.035; PLOURDE PV, 1994, BREAST CANCER RES TR, V30, P103, DOI 10.1007/BF00682745; Redel A, 2008, ANESTH ANALG, V106, P384, DOI 10.1213/ane.0b013e318160650f; Redel A, 2008, EXP BIOL MED, V233, P84, DOI 10.3181/0612-RM-308; Redel A, 2009, EXP BIOL MED, V234, P1186, DOI 10.3181/0902-RM-58; Sbarouni E, 1998, CARDIOVASC DRUG THER, V12, P457, DOI 10.1023/A:1007750015372; Simpson E, 1999, ENDOCR-RELAT CANCER, V6, P131, DOI 10.1677/erc.0.0060131; Smul TM, 2006, ANESTHESIOLOGY, V105, P719, DOI 10.1097/00000542-200610000-00018; Stadnicka A, 2007, J ANESTH, V21, P212, DOI 10.1007/s00540-006-0486-6; Tanaka K, 2002, ANESTHESIOLOGY, V97, P1485, DOI 10.1097/00000542-200212000-00021; Tritapepe L, 2007, EUR J ANAESTH, V24, P323, DOI 10.1017/S0265021506001931; Tsai SK, 2004, LIFE SCI, V76, P651, DOI 10.1016/j.lfs.2004.05.025; Wang C, 2006, ANESTH ANALG, V103, P274, DOI 10.1213/01.ANE.0000230389.76351.0C; Widder J, 2003, HYPERTENSION, V42, P991, DOI 10.1161/01.HYP.0000098661.37637.89; Yu CH, 2006, CAN J ANAESTH, V53, P906, DOI 10.1007/BF03022834; Zangrillo A, 2011, J CARDIOTHOR VASC AN, V25, P902, DOI 10.1053/j.jvca.2011.06.016	33	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42032	10.1371/journal.pone.0042032	http://dx.doi.org/10.1371/journal.pone.0042032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876297	Green Published, gold, Green Submitted			2022-12-27	WOS:000307184700025
J	Britta, EA; Silva, APB; Ueda-Nakamura, T; Dias-Filho, BP; Silva, CC; Sernaglia, RL; Nakamura, CV				Britta, Elizandra Aparecida; Barbosa Silva, Ana Paula; Ueda-Nakamura, Tania; Dias-Filho, Benedito Prado; Silva, Cleuza Conceicao; Sernaglia, Rosana Lazara; Nakamura, Celso Vataru			Benzaldehyde Thiosemicarbazone Derived from Limonene Complexed with Copper Induced Mitochondrial Dysfunction in Leishmania amazonensis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; IN-VITRO ACTIVITY; TRYPANOSOMA-CRUZI; SEMICARBAZONES; ORGANELLES	Background: Leishmaniasis is a major health problem that affects more than 12 million people. Treatment presents several problems, including high toxicity and many adverse effects, leading to the discontinuation of treatment and emergence of resistant strains. Methodology/Principal Findings: We evaluated the in vitro antileishmanial activity of benzaldehyde thiosemicarbazone derived from limonene complexed with copper, termed BenzCo, against Leishmania amazonensis. BenzCo inhibited the growth of the promastigote and axenic amastigote forms, with IC50 concentrations of 3.8 and 9.5 mu M, respectively, with 72 h of incubation. Intracellular amastigotes were inhibited by the compound, with an IC50 of 10.7 mu M. BenzCo altered the shape, size, and ultrastructure of the parasites. Mitochondrial membrane depolarization was observed in protozoa treated with BenzCo but caused no alterations in the plasma membrane. Additionally, BenzCo induced lipoperoxidation and the production of mitochondrial superoxide anion radicals in promastigotes and axenic amastigotes of Leishmania amazonensis. Conclusion/Significance: Our studies indicated that the antileishmania activity of BenzCo might be associated with mitochondrial dysfunction and oxidative damage, leading to parasite death.	[Britta, Elizandra Aparecida; Ueda-Nakamura, Tania; Dias-Filho, Benedito Prado; Nakamura, Celso Vataru] Univ Estadual Maringa, Programa Posgrad Ciencias Farmaceut, Maringa, Parana, Brazil; [Barbosa Silva, Ana Paula; Silva, Cleuza Conceicao; Sernaglia, Rosana Lazara] Univ Estadual Maringa, Dept Quim, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Britta, EA (corresponding author), Univ Estadual Maringa, Programa Posgrad Ciencias Farmaceut, Maringa, Parana, Brazil.	cvnakamura@uem.br	Nakamura, Celso Vataru/AAA-5620-2019; Ueda-Nakamura, Tania/P-8250-2015	Ueda-Nakamura, Tania/0000-0001-5057-3518	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos (FINEP); Programa de Nucleos de Excelencia (PRONEX/Fundacao Araucaria); INCT_if; Complexo de Centrais de Apoio a Pesquisa (COMCAP); Programa de Pos-graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Programa de Nucleos de Excelencia (PRONEX/Fundacao Araucaria)(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); INCT_if; Complexo de Centrais de Apoio a Pesquisa (COMCAP); Programa de Pos-graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa	This study was supported through grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Financiadora de Estudos e Projetos (FINEP), Programa de Nucleos de Excelencia (PRONEX/Fundacao Araucaria), INCT_if, Complexo de Centrais de Apoio a Pesquisa (COMCAP), and Programa de Pos-graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa. EAB has a Master fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriolli AC, 2007, J ENV HLTH, V8, P19; Aponte JC, 2010, BIOORG MED CHEM LETT, V20, P100, DOI 10.1016/j.bmcl.2009.11.033; Arruda DC, 2009, BIOMED PHARMACOTHER, V63, P643, DOI 10.1016/j.biopha.2009.02.004; Belicchi-Ferrari M, 2007, POLYHEDRON, V26, P5150, DOI 10.1016/j.poly.2007.07.014; Beraldo H, 2004, MINI-REV MED CHEM, V4, P31, DOI 10.2174/1389557043487484; Beraldo H, 2004, QUIM NOVA, V27, P461, DOI 10.1590/S0100-40422004000300017; Da Silva APB, 2010, THESIS U ESTADUAL MA; Das R, 2008, APOPTOSIS, V13, P867, DOI 10.1007/s10495-008-0224-7; de Souza W, 2002, PARASITOL RES, V88, P1013, DOI 10.1007/s00436-002-0696-2; Diaz A, 1999, INORG CHEM COMMUN, V2, P358, DOI 10.1016/S1387-7003(99)00093-3; Rodrigues JCF, 2008, CURR PHARM DESIGN, V14, P925, DOI 10.2174/138161208784041033; Fonseca-Silva F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014666; Foroumadi A, 2005, BIOORG MED CHEM LETT, V15, P1983, DOI 10.1016/j.bmcl.2005.02.073; Gadelha FR, 1997, ARCH BIOCHEM BIOPHYS, V345, P243, DOI 10.1006/abbi.1997.0259; Graebin CS, 2010, EUR J MED CHEM, V45, P1524, DOI 10.1016/j.ejmech.2009.12.061; Khan SA, 2009, EUR J MED CHEM, V44, P2270, DOI 10.1016/j.ejmech.2008.06.008; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; Mandelker L, 2008, VET CLIN N AM-SMALL, V38, P1, DOI 10.1016/j.cvsm.2007.10.005; Menna-Barreto RFS, 2005, J ANTIMICROB CHEMOTH, V56, P1034, DOI 10.1093/jac/dki403; Mitropoulos P, 2010, J AM ACAD DERMATOL, V63, P309, DOI 10.1016/j.jaad.2009.06.088; Moreno D, 2011, PARASITOL RES, V108, P233, DOI 10.1007/s00436-010-2073-x; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Ngure PK., 2009, REV J NANJING MEDICA, V23, P79, DOI [10.1016/S1007-4376(09)60032-0, DOI 10.1016/S1007-4376(09)60032-0]; Pelizzaro-Rocha KJ, 2011, MICROBES INFECT, V13, P1018, DOI 10.1016/j.micinf.2011.05.011; Piacenza L, 2007, BIOCHEM J, V403, P323, DOI 10.1042/BJ20061281; Rodrigues JCF, 2002, ANTIMICROB AGENTS CH, V46, P487, DOI 10.1128/AAC.46.2.487-499.2002; Roy A, 2008, MOL PHARMACOL, V74, P1292, DOI 10.1124/mol.108.050161; Santa-Rita RM, 2004, J ANTIMICROB CHEMOTH, V54, P704, DOI 10.1093/jac/dkh380; Santin MR, 2009, PARASITOL RES, V105, P1489, DOI 10.1007/s00436-009-1578-7; Santos DO, 2008, PARASITOL RES, V103, P1, DOI 10.1007/s00436-008-0943-2; SHIPMAN C, 1986, ANTIVIR RES, V6, P197, DOI 10.1016/0166-3542(86)90002-1; Soares ROA, 2011, EXP PARASITOL, V129, P381, DOI 10.1016/j.exppara.2011.08.019; Ueda-Nakamura T, 2001, PARASITOL RES, V87, P89, DOI 10.1007/s004360000319; Valdez RH, 2009, ACTA TROP, V110, P7, DOI 10.1016/j.actatropica.2008.11.008; van Hellemond JJ, 2005, BIOCHEM SOC T, V33, P967, DOI 10.1042/BST20050967; World Health Organization, PAR DIS; Yamaguchi MU, 2009, MOLECULES, V14, P1796, DOI 10.3390/molecules14051796	37	30	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41440	10.1371/journal.pone.0041440	http://dx.doi.org/10.1371/journal.pone.0041440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870222	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800019
J	Nguyen, QC; Villaveces, A; Marshall, SW; Hussey, JM; Halpern, CT; Poole, C				Nguyen, Quynh C.; Villaveces, Andres; Marshall, Stephen W.; Hussey, Jon M.; Halpern, Carolyn T.; Poole, Charles			Adolescent Expectations of Early Death Predict Adult Risk Behaviors	PLOS ONE			English	Article							SUBSTANCE USE; HOPELESSNESS SCALE; YOUNG ADULTHOOD; SUICIDE RISK; SELF-HARM; DRUG-USE; YOUTH; PERCEPTION; DEPRESSION; DEPENDENCE	Only a handful of public health studies have investigated expectations of early death among adolescents. Associations have been found between these expectations and risk behaviors in adolescence. However, these beliefs may not only predict worse adolescent outcomes, but worse trajectories in health with ties to negative outcomes that endure into young adulthood. The objectives of this study were to investigate perceived chances of living to age 35 (Perceived Survival Expectations, PSE) as a predictor of suicidal ideation, suicide attempt and substance use in young adulthood. We examined the predictive capacity of PSE on future suicidal ideation/attempt after accounting for sociodemographics, depressive symptoms, and history of suicide among family and friends to more fully assess its unique contribution to suicide risk. We investigated the influence of PSE on legal and illegal substance use and varying levels of substance use. We utilized the National Longitudinal Study of Adolescent Health (Add Health) initiated in 1994-95 among 20,745 adolescents in grades 7-12 with follow-up interviews in 1996 (Wave II), 2001-02 (Wave III) and 2008 (Wave IV; ages 24-32). Compared to those who were almost certain of living to age 35, perceiving a 50-50 or less chance of living to age 35 at Waves I or III predicted suicide attempt and ideation as well as regular substance use (i.e., exceeding daily limits for moderate drinking; smoking >= a pack/day; and using illicit substances other than marijuana at least weekly) at Wave IV. Associations between PSE and detrimental adult outcomes were particularly strong for those reporting persistently low PSE at both Waves I and III. Low PSE at Wave I or Wave III was also related to a doubling and tripling, respectively, of death rates in young adulthood. Long-term and wide-ranging ties between PSE and detrimental outcomes suggest these expectations may contribute to identifying at-risk youth.	[Nguyen, Quynh C.; Villaveces, Andres; Marshall, Stephen W.; Poole, Charles] Univ N Carolina, Dept Epidemiol, UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Villaveces, Andres; Marshall, Stephen W.] Univ N Carolina, UNC Injury Prevent Res Ctr, Chapel Hill, NC USA; [Hussey, Jon M.; Halpern, Carolyn T.] UNC Gillings Sch Global Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC USA; [Hussey, Jon M.; Halpern, Carolyn T.] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Nguyen, QC (corresponding author), Northeastern Univ, Inst Urban Hlth Res, Bouve Coll Hlth Sci, Boston, MA 02115 USA.	qu.nguyen@neu.edu	Hussey, Jon/A-9352-2009	Hussey, Jon/0000-0003-1799-9845; Villaveces, Andres/0000-0002-3725-2741; Marshall, Stephen/0000-0002-2664-9233	Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921, R24HD050924] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill. Add Health was funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design of Add Health. Information on how to obtain the Add Health data files is available on the Add Health website (http://www.cpc.unc.edu/addhealth).	[Anonymous], J PRIMARY PREVENTION, DOI DOI 10.1023/A:1021302302085; Arias E., 2002, US LIFE TABLES 2000; Bearman PS, 2004, AM J PUBLIC HEALTH, V94, P89, DOI 10.2105/AJPH.94.1.89; Beautrais AL, 2000, AUST NZ J PSYCHIAT, V34, P420, DOI 10.1080/j.1440-1614.2000.00691.x; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Bolland JM, 2003, J ADOLESCENCE, V26, P145, DOI 10.1016/S0140-1971(02)00136-7; Borges G, 2000, AM J EPIDEMIOL, V151, P781; Borowsky IW, 2009, PEDIATRICS, V124, pE81, DOI 10.1542/peds.2008-3425; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Centers for Disease Control and Prevention, 2009, SUICIDE; Cooper M.L., 1992, PSYCHOL ASSESS J CON, V4, P123, DOI DOI 10.1037/1040-3590.4.2.123; Crosby RA, 1996, J SCHOOL HEALTH, V66, P186, DOI 10.1111/j.1746-1561.1996.tb06273.x; de Bruin WB, 2000, ORGAN BEHAV HUM DEC, V81, P115, DOI 10.1006/obhd.1999.2868; Department of Health and Human Services/Department of Agriculture, 2005, DIET GUID AM; DuBois DL, 2002, AM J COMMUN PSYCHOL, V30, P157, DOI 10.1023/A:1014628810714; Duke NN, 2011, J PEDIATR HEALTH CAR, V25, P224, DOI 10.1016/j.pedhc.2010.03.004; Duke NN, 2011, CLIN PEDIATR, V50, P21, DOI 10.1177/0009922810379041; Duke NN, 2009, ACAD PEDIATR, V9, P256, DOI 10.1016/j.acap.2009.02.004; Ezzati M., 2004, COMP QUANTIFICATION; Flannery DJ, 2001, J AM ACAD CHILD PSY, V40, P435, DOI 10.1097/00004583-200104000-00012; Gould MS, 2003, J AM ACAD CHILD PSY, V42, P386, DOI 10.1097/01.CHI.0000046821.95464.CF; Harris KM, 2009, NATL LONGITUDINAL ST; Jaffee WB, 2009, BEHAV THER, V40, P93, DOI 10.1016/j.beth.2008.03.001; Jamieson PE, 2008, J ADOLESCENT HEALTH, V42, P154, DOI 10.1016/j.jadohealth.2007.07.010; Johnston LD, 2008, MONITORING FUTURE NA, VII; Marshall MM, 2011, ADDICT BEHAV, V36, P61, DOI 10.1016/j.addbeh.2010.08.022; McDade TW, 2011, SOC SCI MED, V73, P391, DOI 10.1016/j.socscimed.2011.06.005; McLauchlin JA, 1996, J ADOLESCENCE, V19, P523, DOI 10.1006/jado.1996.0051; McMillan D, 2007, PSYCHOL MED, V37, P769, DOI 10.1017/S0033291706009664; Millstein SG, 2002, J RES ADOLESCENCE, V12, P399, DOI 10.1111/1532-7795.00039; National Institute of Mental Health, 2010, SUIC US STAT PREV; Nguyen QC, 2012, SOC SCI MED, V74, P1452, DOI 10.1016/j.socscimed.2012.01.006; Olthuis JV, 2011, J AM COLL HEALTH, V59, P239, DOI 10.1080/07448481.2010.497523; Palmer RHC, 2009, DRUG ALCOHOL DEPEN, V102, P78, DOI 10.1016/j.drugalcdep.2009.01.012; Panzarella C, 2006, COGNITIVE THER RES, V30, P307, DOI 10.1007/s10608-006-9048-3; Patrick ME, 2011, J STUD ALCOHOL DRUGS, V72, P106, DOI 10.15288/jsad.2011.72.106; PETERSON C, 1987, J PERS SOC PSYCHOL, V53, P603, DOI 10.1037/0022-3514.53.3.603; PETRAITIS J, 1995, PSYCHOL BULL, V117, P67, DOI 10.1037/0033-2909.117.1.67; QUADREL MJ, 1993, AM PSYCHOL, V48, P102, DOI 10.1037/0003-066X.48.2.102; Rehkopf DH, 2006, PSYCHOL MED, V36, P145, DOI 10.1017/S003329170500588X; Rehm J, 2003, EUR ADDICT RES, V9, P157, DOI 10.1159/000072222; Stone AL, 2012, ADDICT BEHAV, V37, P747, DOI 10.1016/j.addbeh.2012.02.014; *SUBST AB MENT HLT, 2005, RES 2004 NAT SURV DR; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; Valadez-Meltzer A, 2005, PEDIATRICS, V116, P24, DOI 10.1542/peds.2004-0892; Vartanian LR, 2000, ADOLESCENCE, V35, P639	46	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41905	10.1371/journal.pone.0041905	http://dx.doi.org/10.1371/journal.pone.0041905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	984SU	22870260	gold, Green Published, Green Submitted			2022-12-27	WOS:000307212800042
J	Zhang, C; Niu, WB; Wang, ZP; Wang, XX; Xia, GL				Zhang, Cheng; Niu, Wanbao; Wang, Zhengpin; Wang, Xiaoxia; Xia, Guoliang			The Effect of Gonadotropin on Glucose Transport and Apoptosis in Rat Ovary	PLOS ONE			English	Article							FOLLICULAR DEVELOPMENT; GENE-EXPRESSION; GNRH RECEPTOR; GLUT-4; GRANULOSA; INSULIN; MUSCLE; CELLS; ACID	Although the effects of Gonadotropin on ovarian physiology have been known for many decades, its action on glucose uptake in the rat ovary remained poorly understood. Evidence also suggests that glucose uptake is mediated by a number of glucose transporter proteins (Glut). Therefore, we examined the rat ovary for the presence of Glut1-4 and blood glucose level after eCG (equine chorionic gonadotropin) and anti-eCG antiserum treatment. All of the glucose transports were present in the ovarian oocyte, granulosa cells and theca cells in different stage follicles. The expression of Glut in ovary was up-regulated by eCG, however, anti-eCG antiserum reversed eCG action. Western blot analysis also demonstrated the content of Glut1 was higher in eCG treatment group compared with anti-eCG antiserum and control group. The same tendency was shown in other glut isoforms. Moreover, there were no significant difference between the anti-eCG antiserum and control group. In additional, the level of serum glucose in eCG treatment group was significantly higher than others, which is similar with glut expression pattern. High glucose level in blood is correlated with increased expression of glucose transporter proteins in rat ovary. Meanwhile, anti-eCG antiserum increased granulosa cell apoptosis in antral follicle compared with those in eCG group. Our observations provide potential explanation for the effects of Glut on follicular development in rat ovary and a role for eCG in the regulation of ovarian glucose uptake.	[Zhang, Cheng; Wang, Xiaoxia] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Niu, Wanbao; Wang, Zhengpin; Xia, Guoliang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	Capital Normal University; China Agricultural University	Zhang, C (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	wxx@mail.cnu.edu.cn; glxiachina@sohu.com	Wang, Zhengpin/AAM-3021-2020	Xia, Guoliang/0000-0003-3674-0142; Wang, Zhengpin/0000-0001-5388-1516	China-Canada Joint Health Research Initiative of the Canadian Institutes of Health Research; National Natural Science Foundation of China [81061120522]	China-Canada Joint Health Research Initiative of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the China-Canada Joint Health Research Initiative of the Canadian Institutes of Health Research and the National Natural Science Foundation of China (Project number: 81061120522 to GLX and BKT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanderson C, 2010, J STEROID BIOCHEM, V122, P82, DOI 10.1016/j.jsbmb.2009.10.006; ASANO T, 1991, CANCER RES, V51, P4450; Bartlewski PM, 2000, ANIM REPROD SCI, V58, P273, DOI 10.1016/S0378-4320(99)00092-5; Berry GT, 2005, MOL GENET METAB, V86, P473, DOI 10.1016/j.ymgme.2005.09.010; BILL CH, 1981, BIOL REPROD, V24, P913, DOI 10.1095/biolreprod24.4.913; Choi JH, 2006, J CLIN ENDOCR METAB, V91, P4562, DOI 10.1210/jc.2006-1147; Frolova AI, 2011, REPRODUCTION, V142, P211, DOI 10.1530/REP-11-0114; Fujimoto E, 2010, J PHYSIOL SCI, V60, P95, DOI 10.1007/s12576-009-0072-4; Hagi Akifumi, 2000, Journal of Medical Investigation, V47, P19; Harris VM, 2012, J ENDOCRINOL, V212, P139, DOI 10.1530/JOE-11-0359; Hirshfield AN, 1997, ENVIRON MOL MUTAGEN, V29, P10; Kato H, 2002, ANTICANCER RES, V22, P2635; Kim JM, 1998, BIOL REPROD, V58, P1170, DOI 10.1095/biolreprod58.5.1170; Kind KL, 2005, MOL REPROD DEV, V70, P37, DOI 10.1002/mrd.20183; Kodaman PH, 1999, ENDOCRINOLOGY, V140, P3659, DOI 10.1210/en.140.8.3659; Kol S, 1997, J CLIN INVEST, V99, P2274, DOI 10.1172/JCI119403; Kuo CH, 2004, J APPL PHYSIOL, V96, P621, DOI 10.1152/japplphysiol.00830.2003; Lee AD, 1997, AM J PHYSIOL-CELL PH, V273, pC1082, DOI 10.1152/ajpcell.1997.273.3.C1082; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLean PS, 2002, BIOCHEM BIOPH RES CO, V292, P409, DOI 10.1006/bbrc.2002.6654; Nishimoto H, 2006, J ENDOCRINOL, V188, P111, DOI 10.1677/joe.1.06210; Orisaka M, 2006, MOL ENDOCRINOL, V20, P2456, DOI 10.1210/me.2005-0357; Peyron-Caso E, 2002, HORM METAB RES, V34, P360, DOI 10.1055/s-2002-33467; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Schirman-Hildesheim TD, 2005, ENDOCRINOLOGY, V146, P3401, DOI 10.1210/en.2005-0240; Stokkel MPM, 2002, J CANCER RES CLIN, V128, P393, DOI 10.1007/s00432-002-0350-5; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Wang L, 2009, ENDOCR PATHOL, V20, P227, DOI 10.1007/s12022-009-9086-y; Weissman A, 2007, FERTIL STERIL, V88, DOI 10.1016/j.fertnstert.2007.01.119; WERTHEIMER E, 1991, P NATL ACAD SCI USA, V88, P2525, DOI 10.1073/pnas.88.6.2525; Williams SA, 2001, REPRODUCTION, V122, P947, DOI 10.1530/rep.0.1220947; Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763; Yeh WL, 2008, MOL PHARMACOL, V73, P170, DOI 10.1124/mol.107.038851; Zhan T, 2011, J CELL BIOCH; Zhang Cheng, 2011, Front Biosci (Elite Ed), V3, P1401; Zhou J, 2000, GROWTH HORM IGF RES, V10, P111, DOI 10.1054/ghir.2000.0147; Zhou Shui-hong, 2006, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V41, P623	38	19	19	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42406	10.1371/journal.pone.0042406	http://dx.doi.org/10.1371/journal.pone.0042406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870326	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800089
J	Peng, Y; Zhang, Y; Kou, G; Shi, Y				Peng, Yi; Zhang, Yong; Kou, Gang; Shi, Yong			A Multicriteria Decision Making Approach for Estimating the Number of Clusters in a Data Set	PLOS ONE			English	Article							ENSEMBLE; CRITERIA	Determining the number of clusters in a data set is an essential yet difficult step in cluster analysis. Since this task involves more than one criterion, it can be modeled as a multiple criteria decision making (MCDM) problem. This paper proposes a multiple criteria decision making (MCDM)-based approach to estimate the number of clusters for a given data set. In this approach, MCDM methods consider different numbers of clusters as alternatives and the outputs of any clustering algorithm on validity measures as criteria. The proposed method is examined by an experimental study using three MCDM methods, the well-known clustering algorithm-k-means, ten relative measures, and fifteen public-domain UCI machine learning data sets. The results show that MCDM methods work fairly well in estimating the number of clusters in the data and outperform the ten relative measures considered in the study.	[Peng, Yi; Zhang, Yong; Kou, Gang] Univ Elect Sci & Technol China, Sch Management & Econ, Chengdu 610054, Sichuan, Peoples R China; [Shi, Yong] CAS Res Ctr Fictitious Econ & Data Sci, Beijing, Peoples R China; [Shi, Yong] Univ Nebraska, Coll Informat Sci & Technol, Omaha, NE 68182 USA	University of Electronic Science & Technology of China; University of Nebraska System	Peng, Y (corresponding author), Univ Elect Sci & Technol China, Sch Management & Econ, Chengdu 610054, Sichuan, Peoples R China.	kougang@uestc.edu.cn	Kou, Gang/G-3869-2010; Zhang, Yong/R-6789-2019	Kou, Gang/0000-0002-9220-8647; Zhang, Yong/0000-0003-3704-4835	National Natural Science Foundation of China [70901011, 71173028, 70901015, 70921061]; Program for New Century Excellent Talents in University [NCET-10-0293]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research has been partially supported by grants from the National Natural Science Foundation of China (# 70901011 and # 71173028 for YP, # 70901015 for GK, and # 70921061 for YS), and Program for New Century Excellent Talents in University (NCET-10-0293). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeberhard S, 1992, COMP CLASSIFIERS HIG; Brans J. P., 1994, DECIDE PROMETHEE; Brans JP, 2005, INT SER OPER RES MAN, V78, P163, DOI 10.1007/0-387-23081-5_5; BRANS JP, 1985, MANAGE SCI, V31, P647, DOI 10.1287/mnsc.31.6.647; Brans JP, 1982, AIDE DECISION NATURE, P183; Chou CH, 2004, PATTERN ANAL APPL, V7, P205, DOI 10.1007/s10044-004-0218-1; Cortez P, 2009, DECIS SUPPORT SYST, V47, P547, DOI 10.1016/j.dss.2009.05.016; Czerniak J, 2003, SPRINGER INT SER ENG, V752, P41; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Dudoit S, 2002, GENOME BIOL, V3; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Evett IW, 1987, AB BAF MU MAG KASH B; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Frank A., 2010, UCI MACHINE LEARNING; GORMAN RP, 1988, NEURAL NETWORKS, V1, P75, DOI 10.1016/0893-6080(88)90023-8; Haberman S. J., 1976, GEN RESIDUALS LOG LI, P104; Halkidi M., 2002, ACM SIGMOD RECORD, V31; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Han J., 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Hartigan J., 1975, CLUSTERING ALGORITHM; Horton P., 1996, P INT SYST MOL BIOL, V4, P109; HUBERT LJ, 1976, PSYCHOL BULL, V83, P1072, DOI 10.1037/0033-2909.83.6.1072; Hwang C. L., 1981, MULTIPLE ATTRIBUTE D; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jossinet J, 1996, MED BIOL ENG COMPUT, V34, P346, DOI 10.1007/BF02520002; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; KRZANOWSKI WJ, 1988, BIOMETRICS, V44, P23, DOI 10.2307/2531893; Little MA, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-23; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mangasarian O. L., 1990, SIAM NEWS, V23, P18; Mangasarian OL, 1990, SIAM NEWS, V23, P1; MARRIOTT FH, 1971, BIOMETRICS, V27, P501, DOI 10.2307/2528592; *MATHWORKS INC, 2005, MATLAB; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Olson DL, 2004, MATH COMPUT MODEL, V40, P721, DOI 10.1016/j.mcm.2004.10.003; Opricovic S, 2004, EUR J OPER RES, V156, P445, DOI 10.1016/s0377-2217(03)00020-1; Pakhira MK, 2004, PATTERN RECOGN, V37, P487, DOI 10.1016/j.patcog.2003.06.005; Peng Y, 2011, OMEGA-INT J MANAGE S, V39, P677, DOI 10.1016/j.omega.2011.01.009; Peng Y, 2011, INT J INF TECH DECIS, V10, P187, DOI 10.1142/S0219622011004282; Peng Y, 2008, INT J INF TECH DECIS, V7, P639, DOI 10.1142/S0219622008003204; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Salvador S, 2004, PROC INT C TOOLS ART, P576; SIGILLITO VG, 1989, J HOPKINS APL TECH D, V10, P262; Smith J. W., 1988, Proceedings. The Twelfth Annual Symposium on Computer Applications in Medical Care (IEEE Cat. No.88CH2616-1), P261; Sugar CA, 2003, J AM STAT ASSOC, V98, P750, DOI 10.1198/016214503000000666; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Triantaphyllou E, 2005, IEEE T ENG MANAGE, V52, P213, DOI 10.1109/TEM.2005.845221; Triantaphyllou E., 2000, MULTICRITERIA DECISI, P320; Vendramin Lucas, 2010, Statistical Analysis and Data Mining, V3, P209, DOI 10.1002/sam.10080; Witten I. H., 2005, DATA MINING PRACTICA; Yeh I- Cheng, 2008, EXPERT SYSTEMS APPL; ZADEH LA, 1963, IEEE T AUTOMAT CONTR, VAC 8, P59, DOI 10.1109/TAC.1963.1105511	56	20	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41713	10.1371/journal.pone.0041713	http://dx.doi.org/10.1371/journal.pone.0041713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22870181	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200093
J	Onarheim, KH; Tessema, S; Johansson, KA; Eide, KT; Norheim, OF; Miljeteig, I				Onarheim, Kristine Husoy; Tessema, Solomon; Johansson, Kjell Arne; Eide, Kristiane Tislevoll; Norheim, Ole Frithjof; Miljeteig, Ingrid			Prioritizing Child Health Interventions in Ethiopia: Modeling Impact on Child Mortality, Life Expectancy and Inequality in Age at Death	PLOS ONE			English	Article							LIVES SAVED TOOL; MILLENNIUM DEVELOPMENT GOALS; COST-EFFECTIVENESS ANALYSIS; PUBLIC-HEALTH; DEVELOPING-COUNTRIES; SYSTEMATIC ANALYSIS; NEWBORN; COUNTDOWN; SURVIVAL; AFRICA	Background: The fourth Millennium Development Goal calls for a two-thirds reduction in under-5 mortality between 1990 and 2015. Under-5 mortality rate is declining, but many countries are still far from achieving the goal. Effective child health interventions that could reduce child mortality exist, but national decision-makers lack contextual information for priority setting in their respective resource-constrained settings. We estimate the potential health impact of increasing coverage of 14 selected health interventions on child mortality in Ethiopia (2011-2015). We also explore the impact on life expectancy and inequality in the age of death (Gini(health)). Methods and Findings: We used the Lives Saved Tool to estimate potential impact of scaling-up 14 health interventions in Ethiopia (2011-2015). Interventions are scaled-up to 1) government target levels, 2) 90% coverage and 3) 90% coverage of the five interventions with the highest impact. Under-5 mortality rate, neonatal mortality rate and deaths averted are primary outcome measures. We used modified life tables to estimate impact on life expectancy at birth and inequality in the age of death (Gini(health)). Under-5 mortality rate declines from 101.0 in 2011 to 68.8, 42.1 and 56.7 per 1000 live births under these three scenarios. Prioritizing child health would also increase life expectancy at birth from expected 60.5 years in 2015 to 62.5, 64.2 and 63.4 years and reduce inequality in age of death (Gini(health)) substantially from 0.24 to 0.21, 0.18 and 0.19. Conclusions: The Millennium Development Goal for child health is reachable in Ethiopia. Prioritizing child health would also increase total life expectancy at birth and reduce inequality in age of death substantially (Gini(health)).	[Onarheim, Kristine Husoy; Johansson, Kjell Arne; Eide, Kristiane Tislevoll; Norheim, Ole Frithjof; Miljeteig, Ingrid] Univ Bergen, Res Grp Global Hlth, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Onarheim, Kristine Husoy; Johansson, Kjell Arne; Eide, Kristiane Tislevoll; Norheim, Ole Frithjof; Miljeteig, Ingrid] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Tessema, Solomon] Int Ctr AIDS Care & Treatment Programs ICAP Ethio, Addis Ababa, Ethiopia	University of Bergen; University of Bergen	Onarheim, KH (corresponding author), Univ Bergen, Res Grp Global Hlth, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway.	kristine.onarheim@isf.uib.no	Johansson, Kjell Arne/ABE-3628-2020; Miljeteig, Ingrid/AAW-8728-2020; Norheim, Ole Frithjof/AAC-8771-2020	Johansson, Kjell Arne/0000-0001-8912-8710; Norheim, Ole Frithjof/0000-0002-5748-5956; Onarheim, Kristine Husoy/0000-0001-8796-4782	Medical Students Research Program/Norwegian Research Council; NORAD/Norwegian Research Council [218694]; University of Bergen	Medical Students Research Program/Norwegian Research Council; NORAD/Norwegian Research Council; University of Bergen	This study was funded through the Medical Students Research Program/the Norwegian Research Council, a NORAD/Norwegian Research Council grant (#218694) and the University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi S, 2010, T ROY SOC TROP MED H, V104, P336, DOI 10.1016/j.trstmh.2009.12.009; Acuin CS, 2011, LANCET, V377, P516, DOI 10.1016/S0140-6736(10)62049-1; Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; [Anonymous], 2011, WORLD HLTH STAT; Baeza C, 2011, ACCOUNTABILITY IMPAC; Baltussen R, 2011, TROP MED INT HEALTH, V16, P838, DOI 10.1111/j.1365-3156.2011.02780.x; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bill and Melinda Gates Foundation, DEC VACC; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Brock DW, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P259; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Chiang CL, 1968, LIFE TABLE ITS CONST, P189; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e586; Daniels N., 2007, JUST HLTH M HLTH NEE; Darmstadt GL, 2008, HEALTH POLICY PLANN, V23, P101, DOI 10.1093/heapol/czn001; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Edejer TTT, 2005, BMJ-BRIT MED J, V331, P1177, DOI 10.1136/bmj.38652.550278.7C; EPGDC, 2019, ENV PROT GREEN DEV C; Federal Democratic Republic of Ethiopia Ministry of Health, 2011, HLTH SECT DEV PROGR; Foster J., 2007, EC INEQUALITY; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; Friberg IK, 2010, INT J EPIDEMIOL, V39, P11, DOI 10.1093/ije/dyq017; Futures Institute, ONEHEALTH TOOL; Hazel E, 2010, INT J EPIDEMIOL, V39, P32, DOI 10.1093/ije/dyq019; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jimenez J, 2007, HEALTH AFFAIR, V26, P458, DOI 10.1377/hlthaff.26.2.458; Johns B, 2004, HEALTH ECON, V13, P1117, DOI 10.1002/hec.880; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; KNIPPENBERG R, 2004, MARGINAL BUDGETING B; LEGRAND J, 1987, EUR ECON REV, V31, P182, DOI 10.1016/0014-2921(87)90030-4; Ministry of Finance and Economic Development Ethiopia, 2006, PLAN ACC SUST DEV EN; Norheim OF, 1999, BRIT MED J, V319, P1426, DOI 10.1136/bmj.319.7222.1426; Norheim OF, 2010, GINI IMPACT ANAL MEA; Okwaraji YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033564; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Robberstad B, 2011, SOC SCI MED, V72, P1711, DOI 10.1016/j.socscimed.2011.03.032; Rudan I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000308; Smits J, 2009, SOC SCI MED, V68, P1114, DOI 10.1016/j.socscimed.2008.12.034; Steinglass R, 2011, INT J EPIDEMIOL, V40, P519, DOI 10.1093/ije/dyq173; UNAIDS/WHO, 2008, EP FACT SHEET HIV AI; UNDP, 2011, HUM DEV REP; Wagstaff A, 2002, J HEALTH ECON, V21, P627, DOI 10.1016/S0167-6296(02)00006-1; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; WHO, 2010, WOR HEALT REP, P1; Winfrey W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S32; World Health Organization, WHO CHOICE POPMOD	52	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41521	10.1371/journal.pone.0041521	http://dx.doi.org/10.1371/journal.pone.0041521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	987SL	22879890	Green Published, gold			2022-12-27	WOS:000307437900011
J	Ormsby, CE; SenGupta, D; Tandon, R; Deeks, SG; Martin, JN; Jones, RB; Ostrowski, MA; Garrison, KE; Vazquez-Perez, JA; Reyes-Teran, G; Nixon, DF				Ormsby, Christopher E.; SenGupta, Devi; Tandon, Ravi; Deeks, Steven G.; Martin, Jeffrey N.; Jones, R. Brad; Ostrowski, Mario A.; Garrison, Keith E.; Vazquez-Perez, Joel A.; Reyes-Teran, Gustavo; Nixon, Douglas F.			Human Endogenous Retrovirus Expression Is Inversely Associated with Chronic Immune Activation in HIV-1 Infection	PLOS ONE			English	Article							T-CELL-ACTIVATION; VIRAL LOAD; ANTIRETROVIRAL TREATMENT; HERV-K; VIRUS; INDIVIDUALS; RESPONSES; THERAPY; FAMILY; RNA	Human endogenous retroviruses (HERV) are remnants of ancestral retroviral infections integrated into the germ line, and constitute approximately 8% of the genome. Several autoimmune disorders, malignancies, and infectious diseases such as HIV-1 are associated with higher HERV expression. The degree to which HERV expression in vivo results in persistent inflammation is not known. We studied the association of immune activation and HERV-K expression in 20 subjects with chronic, untreated progressive HIV-1 infection and 10 HIV-1 negative controls. The mean HERV-K gag and env RNA expression level in the HIV-1 infected cohort was higher than in the control group (p = 0.0003), and was negatively correlated with the frequency of activated CD38+HLA-DR+CD4+ T cells (Rho = -0.61; p = 0.01) and activated CD38+HLA-DR+CD8+ T cells (Rho = -0.51; p = 0.03). Although HIV-infected persons had higher levels of HERV-K RNA expression (as expected), the level of RNA expression was negatively associated with level of T cell activation. The mechanism for this unexpected association remains to be defined.	[Ormsby, Christopher E.; Vazquez-Perez, Joel A.; Reyes-Teran, Gustavo] Natl Inst Resp Dis, Ctr Res Infect Dis, Mexico City, DF, Mexico; [SenGupta, Devi; Tandon, Ravi; Garrison, Keith E.; Nixon, Douglas F.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA USA; [Deeks, Steven G.] San Francisco Gen Hosp, Posit Hlth Program, San Francisco, CA 94110 USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Jones, R. Brad; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Toronto	Ormsby, CE (corresponding author), Natl Inst Resp Dis, Ctr Res Infect Dis, Mexico City, DF, Mexico.	christopher.ormsby@cieni.org.mx	Nixon, Douglas/AAU-5734-2020; Vazquez-Perez, Joel/F-3476-2019	Nixon, Douglas/0000-0002-2801-1786; Vazquez-Perez, Joel/0000-0002-8508-3698; Reyes-Teran, Gustavo/0000-0002-4115-4888	Consejo Nacional de Ciencia y Tecnologia, Mexico [SALUD-2009-01-115265]; University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR); National Institutes of Health (NIH) [P30 AI027763]; University of California San Francisco (UCSF) Clinical and Translational Science Institute [UL1 RR024131]; National Institute of Allergy and Infectious Diseases (NIAID) [AI087145, AI76059, AI84113, K24AI069994]; American Foundation for AIDS Research [106710-40-RGRL]; NIH/NIAID CFAR Network of Integrated Clinical Systems (CNICS) [1 R24 AI067039-1]; Peter and Shelagh Godsoe Family Foundation; UCSF AIDS Research Institute (ARI); UC Mexus grant; Ragon Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076059, R01AI087145, P30AI027763, R56AI084113, K24AI069994, R24AI067039] Funding Source: NIH RePORTER	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco (UCSF) Clinical and Translational Science Institute; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Foundation for AIDS Research; NIH/NIAID CFAR Network of Integrated Clinical Systems (CNICS); Peter and Shelagh Godsoe Family Foundation; UCSF AIDS Research Institute (ARI); UC Mexus grant; Ragon Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Ormsby was funded by Consejo Nacional de Ciencia y Tecnologia, Mexico, SALUD-2009-01-115265 and grants from the University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR), an National Institutes of Health (NIH) funded program (P30 AI027763) and the University of California San Francisco (UCSF) Clinical and Translational Science Institute (UL1 RR024131); Additional support was provided by National Institute of Allergy and Infectious Diseases (NIAID) (AI087145, AI76059; AI84113; K24AI069994), the American Foundation for AIDS Research (106710-40-RGRL), the NIH/NIAID CFAR Network of Integrated Clinical Systems (CNICS; grant 1 R24 AI067039-1), the Peter and Shelagh Godsoe Family Foundation, the UCSF AIDS Research Institute (ARI) the Ragon Institute, and a UC Mexus grant to Dr. Nixon, Dr. Ormsby and Dr. Reyes-Teran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Arens R, 2005, J IMMUNOL, V174, P5915, DOI 10.4049/jimmunol.174.10.5915; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Chehimi J, 2007, J IMMUNOL, V179, P2642, DOI 10.4049/jimmunol.179.4.2642; Chen DY, 2011, J VIROL, V85, P2474, DOI 10.1128/JVI.01726-10; Christensen T, 2010, J NEUROIMMUNE PHARM, V5, P326, DOI 10.1007/s11481-010-9214-y; Compston LI, 2009, J MED VIROL, V81, P1860, DOI 10.1002/jmv.21614; Contreras-Galindo RA, 2011, J VIROLOGY; Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P116, DOI 10.1089/aid.2006.0117; Contreras-Galindo R, 2006, AIDS RES HUM RETROV, V22, P979, DOI 10.1089/aid.2006.22.979; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Douek Daniel, 2007, Top HIV Med, V15, P114; Dunn HS, 2002, J INFECT DIS, V186, P15, DOI 10.1086/341079; Esnault C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-75; Espinosa E, 2010, JAIDS-J ACQ IMM DEF, V55, P439, DOI 10.1097/QAI.0b013e3181ef991d; Estes JD, 2008, J IMMUNOL, V180, P6798, DOI 10.4049/jimmunol.180.10.6798; Frank O, 2008, J VIROL, V82, P1808, DOI 10.1128/JVI.02115-07; Freimanis G, 2010, CLIN EXP IMMUNOL, V160, P340, DOI 10.1111/j.1365-2249.2010.04110.x; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Gasser O, 2009, AM J TRANSPLANT, V9, P794, DOI 10.1111/j.1600-6143.2008.02539.x; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Harrer T, 1996, J IMMUNOL, V156, P2616; Huang W, 2010, SCHIZOPHR B; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; HUNT PW, 2011, 17 INT AIDS C MEX CI, V25, P2123, DOI DOI 10.1097/QAD.0B013E32834C4AC1; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-22; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; McCune JM, 2000, J CLIN INVEST, V105, pR1, DOI 10.1172/JCI8647; MIEDEMA F, 1988, J CLIN INVEST, V82, P1908, DOI 10.1172/JCI113809; Murray SM, 2010, J VIROL, V84, P12082, DOI 10.1128/JVI.01466-10; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Nellaker C, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-44; Paiardini M, 2008, AIDS REV, V10, P36; Punkosdy GA, 2011, P NATL ACAD SCI USA, V108, P3677, DOI 10.1073/pnas.1100213108; Ramos-Lopez E, 2006, TISSUE ANTIGENS, V68, P147, DOI 10.1111/j.1399-0039.2006.00637.x; Rodriguez-Garcia M, 2011, J LEUKOCYTE BIOL, V89, P507, DOI 10.1189/jlb.0610327; Romanish MT, 2010, SEMIN CANCER BIOL, V20, P246, DOI 10.1016/j.semcancer.2010.05.005; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; SenGupta D, 2011, J VIROL, V85, P6977, DOI 10.1128/JVI.00179-11; Sharp ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021135; Stauffer Yves, 2004, Cancer Immun, V4, P2; Subramanian RP, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-90; Tonjes RR, 1996, J ACQ IMMUN DEF SYND, V13, pS261; Tsibris AMN, 2010, J VIROL, V84, P5458, DOI 10.1128/JVI.02524-09; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-6; Vazquez-Perez JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-23; Villesen Palle, 2004, Retrovirology, V1, P32, DOI 10.1186/1742-4690-1-32; Weissman D, 1996, J EXP MED, V183, P687, DOI 10.1084/jem.183.2.687; World Health Organization, 2006, WHO CAS DEF HIV SURV	55	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41021	10.1371/journal.pone.0041021	http://dx.doi.org/10.1371/journal.pone.0041021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879884	Green Published, gold, Green Submitted			2022-12-27	WOS:000307437900007
J	Bidaud, P; Hebert, L; Barbey, C; Appourchaux, AC; Torelli, R; Sanguinetti, M; Laugier, C; Petry, S				Bidaud, Pauline; Hebert, Laurent; Barbey, Corinne; Appourchaux, Anne-Cecile; Torelli, Riccardo; Sanguinetti, Maurizio; Laugier, Claire; Petry, Sandrine			Rhodococcus equi's Extreme Resistance to Hydrogen Peroxide Is Mainly Conferred by One of Its Four Catalase Genes	PLOS ONE			English	Article							OXIDATIVE STRESS; LEGIONELLA-PNEUMOPHILA; PERITONEAL-MACROPHAGES; ENTEROCOCCUS-FAECALIS; SALMONELLA VIRULENCE; IN-VITRO; SURVIVAL; EXPRESSION; INFECTION; KATA	Rhodococcus equi is one of the most widespread causes of disease in foals aged from 1 to 6 months. R. equi possesses antioxidant defense mechanisms to protect it from reactive oxygen metabolites such as hydrogen peroxide (H2O2) generated during the respiratory burst of phagocytic cells. These defense mechanisms include enzymes such as catalase, which detoxify hydrogen peroxide. Recently, an analysis of the R. equi 103 genome sequence revealed the presence of four potential catalase genes. We first constructed Delta katA-, Delta katB-, Delta katC-and Delta katD-deficient mutants to study the ability of R. equi to survive exposure to H2O2 in vitro and within mouse peritoneal macrophages. Results showed that Delta katA and, to a lesser extent Delta katC, were affected by 80 mM H2O2. Moreover, katA deletion seems to significantly affect the ability of R. equi to survive within murine macrophages. We finally investigated the expression of the four catalases in response to H2O2 assays with a real time PCR technique. Results showed that katA is overexpressed 367.9 times (+/- 122.6) in response to exposure to 50 mM of H2O2 added in the stationary phase, and 3.11 times (+/- 0.59) when treatment was administered in the exponential phase. In untreated bacteria, katB, katC and katD were overexpressed from 4.3 to 17.5 times in the stationary compared to the exponential phase. Taken together, our results show that KatA is the major catalase involved in the extreme H2O2 resistance capability of R. equi.	[Bidaud, Pauline; Hebert, Laurent; Barbey, Corinne; Appourchaux, Anne-Cecile; Laugier, Claire; Petry, Sandrine] ANSES, Unit Bacteriol & Parasitol, Dozule Lab Equine Dis, Goustranville, France; [Torelli, Riccardo; Sanguinetti, Maurizio] Univ Cattolica Sacro Cuore, Inst Microbiol, I-00168 Rome, Italy	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Bidaud, P (corresponding author), ANSES, Unit Bacteriol & Parasitol, Dozule Lab Equine Dis, Goustranville, France.	sandrine.petry@anses.fr	Sanguinetti, Maurizio/A-1453-2019; Torelli, Riccardo/N-8813-2019; Hébert, Laurent/AAQ-1949-2021; Hébert, Laurent/GLV-5872-2022; Torelli, Riccardo/K-8822-2018	Sanguinetti, Maurizio/0000-0002-9780-7059; Hébert, Laurent/0000-0002-5738-9913; Torelli, Riccardo/0000-0001-7927-4343; PETRY, Sandrine/0000-0002-3091-575X	Regional Council of Low-Normandy; Research and Higher Education Ministry [R25_p3 (CPER 2007-2013)]; Anses and Regional Council of Low-Normandy; Institut Francais du Cheval et de l'Equitation	Regional Council of Low-Normandy(Region Normandie); Research and Higher Education Ministry; Anses and Regional Council of Low-Normandy(Region Normandie); Institut Francais du Cheval et de l'Equitation	P. Bidaud and L. Hebert were funded by a grant awarded by Regional Council of Low-Normandy and by Research and Higher Education Ministry, within the project R25_p3 (CPER 2007-2013). C. Barbey was supported by a thesis grant awarded by Anses and Regional Council of Low-Normandy. Financial support was obtained from Institut Francais du Cheval et de l'Equitation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo T, 2002, J BACTERIOL, V184, P3305, DOI 10.1128/JB.184.12.3305-3312.2002; Bandyopadhyay P, 1998, J BACTERIOL, V180, P5369, DOI 10.1128/JB.180.20.5369-5374.1998; Bandyopadhyay P, 2000, J BACTERIOL, V182, P6679, DOI 10.1128/JB.182.23.6679-6686.2000; Benoit S, 2002, INFECT IMMUN, V70, P3768, DOI 10.1128/IAI.70.7.3768-3776.2002; BUCHMEIER NA, 1995, J CLIN INVEST, V95, P1047, DOI 10.1172/JCI117750; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; DeLaPenaMoctezuma A, 1996, CAN J VET RES, V60, P29; DEMPLE B, 1983, J BACTERIOL, V153, P1079, DOI 10.1128/JB.153.2.1079-1082.1983; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Devi P, 2011, INDIAN J MED MICROBI, V29, P65, DOI 10.4103/0255-0857.76529; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Frederick JR, 2001, APPL ENVIRON MICROB, V67, P1375, DOI 10.1128/AEM.67.3.1375-1379.2001; Gentry-Weeks CR, 1999, INFECT IMMUN, V67, P2160, DOI 10.1128/IAI.67.5.2160-2165.1999; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Han YP, 2008, DNA CELL BIOL, V27, P453, DOI 10.1089/dna.2007.0657; HASSETT DJ, 1989, FASEB J, V3, P2574, DOI 10.1096/fasebj.3.14.2556311; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Hirose I, 2000, MICROBIOL-SGM, V146, P65, DOI 10.1099/00221287-146-1-65; HONDALUS MK, 1994, INFECT IMMUN, V62, P4167, DOI 10.1128/IAI.62.10.4167-4175.1994; Hondalus MK, 1997, VET MICROBIOL, V56, P257, DOI 10.1016/S0378-1135(97)00094-1; Janssen R, 2003, MICROBES INFECT, V5, P527, DOI 10.1016/S1286-4579(03)00069-8; Kedlaya I, 2001, CLIN INFECT DIS, V32, pE39, DOI 10.1086/318520; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Letek M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001145; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loewen PC, 2000, ASM NEWS, V66, P76; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Navas J, 2001, J BACTERIOL, V183, P4796, DOI 10.1128/JB.183.16.4796-4805.2001; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rao PSS, 2003, MICROBIOL-SGM, V149, P2635, DOI 10.1099/mic.0.26478-0; SHA ZY, 1994, J BACTERIOL, V176, P7375, DOI 10.1128/JB.176.23.7375-7377.1994; Soler-Garcia AA, 2007, INFECT IMMUN, V75, P2225, DOI 10.1128/IAI.01513-06; Steele KH, 2010, J BACTERIOL, V192, P4912, DOI 10.1128/JB.00231-10; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P8303; Topino S, 2010, AIDS PATIENT CARE ST, V24, P211, DOI 10.1089/apc.2009.0248; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Verneuil N, 2006, MICROBIOL-SGM, V152, P2579, DOI 10.1099/mic.0.28922-0; von Bargen K, 2009, FEMS MICROBIOL REV, V33, P870, DOI 10.1111/j.1574-6976.2009.00181.x	38	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42396	10.1371/journal.pone.0042396	http://dx.doi.org/10.1371/journal.pone.0042396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879963	gold, Green Published, Green Submitted			2022-12-27	WOS:000307810000031
J	Guyader, C; Ceraline, J; Gravier, E; Morin, A; Michel, S; Erdmann, E; de Pinieux, G; Cabon, F; Bergerat, JP; Poupon, MF; Oudard, S				Guyader, Charlotte; Ceraline, Jocelyn; Gravier, Eleonore; Morin, Aurelie; Michel, Sandrine; Erdmann, Eva; de Pinieux, Gonzague; Cabon, Florence; Bergerat, Jean-Pierre; Poupon, Marie-France; Oudard, Stephane			Risk of Hormone Escape in a Human Prostate Cancer Model Depends on Therapy Modalities and Can Be Reduced by Tyrosine Kinase Inhibitors	PLOS ONE			English	Article							ANDROGEN-RECEPTOR; CELL-PROLIFERATION; BREAST-CANCER; PROGRESSION; SURVIVAL; GROWTH; PHOSPHORYLATION; XENOGRAFTS; ACTIVATION; EXPRESSION	Almost all prostate cancers respond to androgen deprivation treatment but many recur. We postulated that risk of hormone escape -frequency and delay- are influenced by hormone therapy modalities. More, hormone therapies induce crucial biological changes involving androgen receptors; some might be targets for escape prevention. We investigated the relationship between the androgen deprivation treatment and the risk of recurrence using nude mice bearing the high grade, hormone-dependent human prostate cancer xenograft PAC120. Tumor-bearing mice were treated by Luteinizing-Hormone Releasing Hormone (LHRH) antagonist alone, continuous or intermittent regimen, or combined with androgen receptor (AR) antagonists (bicalutamide or flutamide). Tumor growth was monitored. Biological changes were studied as for genomic alterations, AR mutations and protein expression in a large series of recurrent tumors according to hormone therapy modalities. Therapies targeting Her-2 or AKT were tested in combination with castration. All statistical tests were two-sided. Tumor growth was inhibited by continuous administration of the LH-RH antagonist degarelix (castration), but 40% of tumors recurred. Intermittent castration or complete blockade induced by degarelix and antiandrogens combination, inhibited tumor growth but increased the risk of recurrence (RR) as compared to continuous castration (RRintermittent: 14.5, RRcomplete blockade: 6.5 and 1.35). All recurrent tumors displayed new quantitative genetic alterations and AR mutations, whatever the treatment modalities. AR amplification was found after complete blockade. Increased expression of Her-2/neu with frequent ERK/AKT activation was detected in all variants. Combination of castration with a Her2/neu inhibitor decreased recurrence risk (0.17) and combination with an mTOR inhibitor prevented it. Anti-hormone treatments influence risk of recurrence although tumor growth inhibition was initially similar. Recurrent tumors displayed genetic instability, AR mutations, and alterations of phosphorylation pathways. We postulated that Her-2/AKT pathways allowed salvage of tumor cells under castration and we demonstrated that their inhibition prevented tumor recurrence in our model.	[Guyader, Charlotte; Gravier, Eleonore; Poupon, Marie-France] Inst Curie, Translat Res Dept, Paris, France; [Ceraline, Jocelyn; Erdmann, Eva; Bergerat, Jean-Pierre] Univ Strasbourg, Signaling & Prostate Canc Grp, Strasbourg, France; [Gravier, Eleonore] Inst Curie, Dept Biostat, Paris, France; [Gravier, Eleonore] INSERM, U900, Paris, France; [Gravier, Eleonore] ParisTech, Ecole Mines Paris, Fontainebleau, France; [Morin, Aurelie; Cabon, Florence] CNRS, FRE2944, Villejuif, France; [Michel, Sandrine] BioMerieux, Biomarker Res & Validat Dept, Marcy Letoile, France; [de Pinieux, Gonzague] Hop Trousseau, Tours, France; [Oudard, Stephane] Hop Europeen Georges Pompidou, Paris, France; [Oudard, Stephane] Univ Paris 05, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Centre National de la Recherche Scientifique (CNRS); bioMerieux; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Guyader, C (corresponding author), Inst Curie, Translat Res Dept, Paris, France.	stephane.oudard@egp.aphp.fr	Cabon, Florence/B-3284-2013	Cabon, Florence/0000-0002-6149-082X; CERALINE, Jocelyn/0000-0001-6476-8797; OUDARD, Stephane/0000-0003-0893-285X	ARC; Ligue contre le cancer (Paris, France)	ARC(Australian Research Council); Ligue contre le cancer (Paris, France)	This work was supported by the ARC and the Ligue contre le cancer (Paris, France). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ARTIC funded the English editing.	[Anonymous], 1995, LANCET, V346, P265; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Bedolla R, 2007, CLIN CANCER RES, V13, P3860, DOI 10.1158/1078-0432.CCR-07-0091; Berger R, 2006, CANCER RES, V66, P5723, DOI 10.1158/0008-5472.CAN-05-3928; Ceraline J, 2003, EUR J ENDOCRINOL, V148, P99, DOI 10.1530/eje.0.1480099; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen GC, 2005, PROSTATE, V63, P395, DOI 10.1002/pros.20191; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Craft N, 1999, CANCER RES, V59, P5030; Crook J. M, 2011, ASCO ANN M; Culig Z, 2005, ENDOCR-RELAT CANCER, V12, P229, DOI 10.1677/erc.1.00775a; CULIG Z, 1994, CANCER RES, V54, P5474; D'Antonio JM, 2008, PROSTATE, V68, P698, DOI 10.1002/pros.20677; DASILVA FEC, 2009, EUR UROL; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Pinieux G, 2001, AM J PATHOL, V159, P753, DOI 10.1016/S0002-9440(10)61746-4; Doehn C, 2006, IDRUGS, V9, P565; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Festuccia C, 2007, ENDOCR-RELAT CANCER, V14, P601, DOI 10.1677/ERC-07-0118; Gottlieb B, 2004, HUM MUTAT, V23, P527, DOI 10.1002/humu.20044; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Legrier ME, 2009, INT J CANCER, V124, P1103, DOI 10.1002/ijc.24073; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Marcias G, 2010, HUM MUTAT, V31, P74, DOI 10.1002/humu.21138; Mariani G, 2009, NAT CLIN PRACT ONCOL, V6, P93, DOI 10.1038/ncponc1298; Minner S, 2010, CLIN CANCER RES, V16, P1553, DOI 10.1158/1078-0432.CCR-09-2546; Nupponen NN, 2000, MICROSC RES TECHNIQ, V51, P456, DOI 10.1002/1097-0029(20001201)51:5<456::AID-JEMT8>3.0.CO;2-H; Rouveirol C, 2006, BIOINFORMATICS, V22, P849, DOI 10.1093/bioinformatics/btl004; Ryan CJ, 2011, J CLIN ONCOL, V29, P3651, DOI 10.1200/JCO.2011.35.2005; Schayowitz A, 2010, BRIT J CANCER, V103, P1001, DOI 10.1038/sj.bjc.6605882; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Shi Y, 2006, BJU INT, V97, P170, DOI 10.1111/j.1464-410X.2006.05857.x; Steinkamp MP, 2009, CANC RES; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Wang Y, 2008, ONCOGENE, V27, P7106, DOI 10.1038/onc.2008.318; Wen Y, 2000, CANCER RES, V60, P6841; Ye CJ, 2009, J CELL PHYSIOL, V219, P288, DOI 10.1002/jcp.21663; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458	43	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42252	10.1371/journal.pone.0042252	http://dx.doi.org/10.1371/journal.pone.0042252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879924	Green Published, Green Submitted, gold			2022-12-27	WOS:000307810000021
J	Readhead, AC; Gordon, DE; Wang, ZY; Anderson, BJ; Brousseau, KS; Kouznetsova, MA; Forgione, LA; Smith, LC; Torian, LV				Readhead, Adam C.; Gordon, Daniel E.; Wang, Zhengyan; Anderson, Bridget J.; Brousseau, Kathleen S.; Kouznetsova, Maria A.; Forgione, Lisa A.; Smith, Lou C.; Torian, Lucia V.			Transmitted Antiretroviral Drug Resistance in New York State, 2006-2008: Results from a New Surveillance System	PLOS ONE			English	Article							RECENT HIV-INFECTIONS; DUAL-TROPIC HIV-1; MULTIDRUG-RESISTANT; VIROLOGICAL FAILURE; RAPID PROGRESSION; PREVALENCE; MUTATIONS; RISK; EPIDEMIOLOGY; TRANSMISSION	Background: HIV transmitted drug resistance (TDR) is a public health concern because it has the potential to compromise antiretroviral therapy (ART) at the population level. In New York State, high prevalence of TDR in a local cohort and a multiclass resistant case cluster led to the development and implementation of a statewide resistance surveillance system. Methodology: We conducted a cross-sectional analysis of the 13,109 cases of HIV infection that were newly diagnosed and reported in New York State between 2006 and 2008, including 4,155 with HIV genotypes drawn within 3 months of initial diagnosis and electronically reported to the new resistance surveillance system. We assessed compliance with DHHS recommendations for genotypic resistance testing and estimated TDR among new HIV diagnoses. Principal Findings: Of 13,109 new HIV diagnoses, 9,785 (75%) had laboratory evidence of utilization of HIV-related medical care, and 4,155 (43%) had a genotype performed within 3 months of initial diagnosis. Of these, 11.2% (95% confidence interval [CI], 10.2%-12.1%) had any evidence of TDR. The proportion with mutations associated with any antiretroviral agent in the NNRTI, NRTI or PI class was 6.3% (5.5%-7.0%), 4.3% (3.6%-4.9%) and 2.9% (2.4%-3.4%), respectively. Multiclass resistance was observed in <1%. TDR did not increase significantly over time (p for trend = 0.204). Men who have sex with men were not more likely to have TDR than persons with heterosexual risk factor (OR 1.0 (0.77-1.30)). TDR to EFV+TDF+FTC and LPV/r+TDF+FTC regimens was 7.1% (6.3%-7.9%) and 1.4% (1.0%-1.8%), respectively. Conclusions/Significance: TDR appears to be evenly distributed and stable among new HIV diagnoses in New York State; multiclass TDR is rare. Less than half of new diagnoses initiating care received a genotype per DHHS guidelines.	[Readhead, Adam C.; Forgione, Lisa A.; Torian, Lucia V.] New York City Dept Hlth & Mental Hyg, HIV Epidemiol & Field Serv Program, New York, NY USA; [Gordon, Daniel E.; Wang, Zhengyan; Anderson, Bridget J.; Brousseau, Kathleen S.; Kouznetsova, Maria A.; Smith, Lou C.] New York State Dept Hlth, Bur HIV AIDS Epidemiol, Albany, NY USA	New York City Department of Health & Mental Hygiene; State University of New York (SUNY) System	Readhead, AC (corresponding author), New York City Dept Hlth & Mental Hyg, HIV Epidemiol & Field Serv Program, New York, NY USA.	ltorian@health.nyc.gov	Readhead, Adam/AAK-3511-2021		Centers for Disease Control and Prevention [PS08-80202, UC62/CCU223595]; New York City government; New York state government	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); New York City government; New York state government	The analysis was supported in part by a cooperative agreement with the Centers for Disease Control and Prevention, PS08-80202, #UC62/CCU223595, and in part by New York City and New York state government funding for HIV/AIDS surveillance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NAT HIV AIDS STRAT U; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Blick G, 2007, J INFECT DIS, V195, P1250, DOI 10.1086/512240; Borroto-Esoda K, 2007, AIDS RES HUM RETROV, V23, P988, DOI 10.1089/aid.2006.0310; Cane P, 2005, BMJ-BRIT MED J, V331, P1368, DOI 10.1136/bmj.38665.534595.55; Centers for Disease Control, 2007, ANN REP 2007; *DEP HLTH HUM SERV, 2006, GUID US ANT AG HIV 1; Descamps D, 2005, JAIDS-J ACQ IMM DEF, V38, P545, DOI 10.1097/01.qai.0000155201.51232.2e; Grant ECG, 2002, JAMA-J AM MED ASSOC, V287, P2360, DOI 10.1001/jama.287.18.2360; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hurt CB, 2009, ANTIVIR THER, V14, P673; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Jain V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015510; Jayaraman GC, 2006, JAIDS-J ACQ IMM DEF, V42, P86, DOI 10.1097/01.qai.0000196666.16616.fe; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kuritzkes DR, 2008, J INFECT DIS, V197, P867, DOI 10.1086/528802; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Markowitz M, 2005, LANCET, V365, P1031, DOI 10.1016/S0140-6736(05)74227-6; McDavid K, 2006, AIDS PATIENT CARE ST, V20, P285, DOI 10.1089/apc.2006.20.285; Mimiaga MJ, 2009, AIDS PATIENT CARE ST, V23, P825, DOI 10.1089/apc.2009.0086; New York State Department of Health, 2008, NEW YORK STAT HIV AI; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2016, GUIDELINES USE ANTIR; Ross L, 2007, HIV CLIN TRIALS, V8, P1, DOI 10.1310/hct0801-1; Shet A, 2006, JAIDS-J ACQ IMM DEF, V41, P439, DOI 10.1097/01.qai.0000219290.49152.6a; Sohler NL, 2009, AIDS PATIENT CARE ST, V23, P775, DOI 10.1089/apc.2009.0041; SPREAD Programme, 2008, 17 INT AIDS C MEX CI, V22, P625; Torian L. V., 2006, Morbidity and Mortality Weekly Report, V55, P793; Torian LV, 2008, ARCH INTERN MED, V168, P1181, DOI 10.1001/archinte.168.11.1181; Torian LV, 2007, PUBLIC HEALTH REP, V122, P4, DOI 10.1177/00333549071220S102; Truong HHA, 2006, AIDS, V20, P2193, DOI 10.1097/01.aids.0000252059.85236.af; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685; Youmans E, 2011, SOUTH MED J, V104, P95, DOI 10.1097/SMJ.0b013e3181fcd75b	35	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e40533	10.1371/journal.pone.0040533	http://dx.doi.org/10.1371/journal.pone.0040533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879878	Green Published, gold			2022-12-27	WOS:000307810000005
J	Aliferis, KA; Jabaji, S				Aliferis, Konstantinos A.; Jabaji, Suha			FT-ICR/MS and GC-EI/MS Metabolomics Networking Unravels Global Potato Sprout's Responses to Rhizoctonia solani Infection	PLOS ONE			English	Article							PHYTOPHTHORA-INFESTANS; DISEASE RESISTANCE; PLANT DEFENSE; GLYCOALKALOIDS SOLASONINE; PHENYLPROPANOID PATHWAY; MAGNAPORTHE-GRISEA; MASS-SPECTROMETRY; FLUX ANALYSIS; TUBER TISSUE; ACID	The complexity of plant-pathogen interactions makes their dissection a challenging task for metabolomics studies. Here we are reporting on an integrated metabolomics networking approach combining gas chromatography/mass spectrometry (GC/MS) with Fourier transform ion cyclotron resonance/mass spectrometry (FT-ICR/MS) and bioinformatics analyses for the study of interactions in the potato sprout-Rhizoctonia solani pathosystem and the fluctuations in the global metabolome of sprouts. The developed bioanalytical and bioinformatics protocols provided a snapshot of the sprout's global metabolic network and its perturbations as a result of pathogen invasion. Mevalonic acid and deoxy-xylulose pathways were substantially up-regulated leading to the biosynthesis of sesquiterpene alkaloids such as the phytoalexins phytuberin, rishitin, and solavetivone, and steroidal alkaloids having solasodine and solanidine as their common aglycons. Additionally, the perturbation of the sprout's metabolism was depicted in fluctuations of the content of their amino acids pool and that of carboxylic and fatty acids. Components of the systemic acquired resistance (SAR) and hypersensitive reaction (HR) such as azelaic and oxalic acids were detected in increased levels in infected sprouts and strategies of the pathogen to overcome plant defense were proposed. Our metabolic approach has not only greatly expanded the multitude of metabolites previously reported in potato in response to pathogen invasion, but also enabled the identification of bioactive plant-derived metabolites providing valuable information that could be exploited in biotechnology, biomarker-assisted plant breeding, and crop protection for the development of new crop protection agents.	[Aliferis, Konstantinos A.; Jabaji, Suha] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada	McGill University	Aliferis, KA (corresponding author), McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada.	suha.jabaji@mcgill.ca	Jabaji, Suha/D-2479-2016	Jabaji, Suha/0000-0002-7232-9994	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work has been funded by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Farid IB, 2009, PLANT SCI, V176, P608, DOI 10.1016/j.plantsci.2009.01.017; Aliferis KA, 2010, METABOLOMICS, V6, P96, DOI 10.1007/s11306-009-0180-4; Aliferis KA, 2012, METABOLOMICS, DOI 101007/s11306-011-0340-1; Aliferis KA, 2011, PESTIC BIOCHEM PHYS, V100, P105, DOI 10.1016/j.pestbp.2011.03.004; Aliferis KA, 2011, METABOLOMICS, V7, P35, DOI 10.1007/s11306-010-0231-x; Allwood JW, 2008, PHYSIOL PLANTARUM, V132, P117, DOI 10.1111/j.1399-3054.2007.01001.x; Allwood JW, 2010, PHYTOCHEMISTRY, V71, P590, DOI 10.1016/j.phytochem.2010.01.006; Allwood JW, 2006, PLANT J, V46, P351, DOI 10.1111/j.1365-313X.2006.02692.x; Andreu A, 2001, POTATO RES, V44, P1, DOI 10.1007/BF02360281; AOKI H, 1963, NATURE, V200, P575, DOI 10.1038/200575a0; AOKI M, 1991, AGR BIOL CHEM TOKYO, V55, P715, DOI 10.1080/00021369.1991.10870632; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Becker P, 1998, FEMS MICROBIOL LETT, V167, P197, DOI 10.1111/j.1574-6968.1998.tb13228.x; Bell EA, 2003, J AGR FOOD CHEM, V51, P2854, DOI 10.1021/jf020880w; Bernards MA, 1998, PHYTOCHEMISTRY, V47, P915, DOI 10.1016/S0031-9422(98)80052-6; BOSTOCK RM, 1992, PLANT PHYSIOL, V100, P1448, DOI 10.1104/pp.100.3.1448; Bown AW, 2006, TRENDS PLANT SCI, V11, P424, DOI 10.1016/j.tplants.2006.07.002; Bown AW, 1997, PLANT PHYSIOL, V115, P1, DOI 10.1104/pp.115.1.1; CARLING DE, 1989, AM POTATO J, V66, P693, DOI 10.1007/BF02896825; Cowan D, 2009, NAT BIOTECHNOL, V27, P1132, DOI 10.1038/nbt1209-1132; Defernez M, 2004, J AGR FOOD CHEM, V52, P6075, DOI 10.1021/jf049522e; DESJARDINS AE, 1995, J AGR FOOD CHEM, V43, P2267, DOI 10.1021/jf00056a056; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Dobson G, 2010, J AGR FOOD CHEM, V58, P1214, DOI 10.1021/jf903104b; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Engstrom K, 1999, POTATO RES, V42, P43, DOI 10.1007/BF02358390; Eriksson L., 2001, MULTI MEGAVARIATE DA; Fammartino A, 2007, PLANT PHYSIOL, V143, P378, DOI 10.1104/pp.106.087304; FARMER EE, 1994, PLANT MOL BIOL, V26, P1423, DOI 10.1007/BF00016483; FEWELL AM, 1994, PHYTOCHEMISTRY, V37, P1007, DOI 10.1016/S0031-9422(00)89518-7; Fewell AM, 1997, MYCOL RES, V101, P597, DOI 10.1017/S0953756296002973; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Friedman M, 2006, J AGR FOOD CHEM, V54, P8655, DOI 10.1021/jf061471t; Geigenberger P, 2004, PLANT CELL ENVIRON, V27, P655, DOI 10.1111/j.1365-3040.2004.01183.x; Geigenberger P, 2010, TRENDS PLANT SCI, V15, P98, DOI 10.1016/j.tplants.2009.11.004; Gvozdeva EL, 2006, APPL BIOCHEM MICRO+, V42, P502, DOI 10.1134/S0003683806050103; Halliwell B, 2007, CELLULAR RESPONSES O; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; HIDE GA, 1985, ANN APPL BIOL, V106, P423, DOI 10.1111/j.1744-7348.1985.tb03133.x; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Hu X, 2003, PLANT PHYSIOL, V133, P170, DOI 10.1104/pp.103.024026; Jourdan F, 2010, METABOLOMICS, V6, P312, DOI 10.1007/s11306-009-0196-9; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884; Keller H, 1996, PHYTOCHEMISTRY, V42, P389, DOI 10.1016/0031-9422(95)00866-7; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kolomiets MV, 2000, PLANT PHYSIOL, V124, P1121, DOI 10.1104/pp.124.3.1121; Konno K, 2006, P NATL ACAD SCI USA, V103, P1337, DOI 10.1073/pnas.0506944103; Last RL, 2007, NAT REV MOL CELL BIO, V8, P167, DOI 10.1038/nrm2098; Lehtonen MJ, 2008, PHYTOPATHOLOGY, V98, P1190, DOI 10.1094/PHYTO-98-11-1190; Leiss KA, 2011, PHYTOCHEM REV, V10, P205, DOI 10.1007/s11101-010-9175-z; LI WX, 1991, AGR BIOL CHEM TOKYO, V55, P1041, DOI 10.1080/00021369.1991.10870743; Matsuda F, 2005, PLANT CELL PHYSIOL, V46, P454, DOI 10.1093/pcp/pci042; Matsuda F, 2003, PLANT CELL PHYSIOL, V44, P510, DOI 10.1093/pcp/pcg063; Moerschbacher BM, 1999, J EXP BOT, V50, P605, DOI 10.1093/jexbot/50.334.605; Morrissey JP, 1999, MICROBIOL MOL BIOL R, V63, P708, DOI 10.1128/MMBR.63.3.708-724.1999; MORROW LS, 1983, AM POTATO J, V60, P403, DOI 10.1007/BF02877246; Moulin M, 2000, PLANT PHYSIOL BIOCH, V38, P577, DOI 10.1016/S0981-9428(00)00777-4; Negrel J, 1996, PHYTOCHEMISTRY, V43, P1195, DOI 10.1016/S0031-9422(96)00500-6; Oda Y, 2002, J BIOSCI BIOENG, V94, P321, DOI 10.1016/S1389-1723(02)80171-2; OHTA H, 1991, PLANT PHYSIOL, V97, P94, DOI 10.1104/pp.97.1.94; Osbourn A, 1996, TRENDS PLANT SCI, V1, P4, DOI 10.1016/S1360-1385(96)80016-1; Lopez-Gresa MP, 2010, PHYTOCHEM ANALYSIS, V21, P89, DOI 10.1002/pca.1179; Raman SB, 2004, PLANT SCI, V167, P961, DOI 10.1016/j.plantsci.2004.06.019; RAYBURN JR, 1994, J AGR FOOD CHEM, V42, P1511, DOI 10.1021/jf00043a022; RODDICK JG, 1990, PHYTOCHEMISTRY, V29, P1513, DOI 10.1016/0031-9422(90)80111-S; Roessner U, 2001, PLANT PHYSIOL, V127, P749, DOI [10.1104/pp.010316, 10.1104/pp.127.3.749]; Sana TR, 2010, METABOLOMICS, V6, P451, DOI 10.1007/s11306-010-0218-7; Sarquis JI, 2000, AM J POTATO RES, V77, P295, DOI 10.1007/BF02853950; Schilling S, 2008, BIOL CHEM, V389, P983, DOI 10.1515/BC.2008.111; Shepherd LVT, 2010, METABOLOMICS, V6, P274, DOI 10.1007/s11306-009-0183-1; Simons SA, 1997, PLANT PATHOL, V46, P642, DOI 10.1046/j.1365-3059.1997.d01-53.x; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Southam AD, 2007, ANAL CHEM, V79, P4595, DOI 10.1021/ac062446p; Stumpe M, 2001, FEBS LETT, V507, P371, DOI 10.1016/S0014-5793(01)03019-8; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Urbanczyk-Wochniak E, 2005, PLANTA, V221, P891, DOI 10.1007/s00425-005-1483-y; Ward JL, 2010, PLANT J, V63, P443, DOI 10.1111/j.1365-313X.2010.04254.x; Weber H, 1999, PLANT CELL, V11, P485, DOI 10.1105/tpc.11.3.485; Wolski EA, 2006, PHYSIOL MOL PLANT P, V69, P93, DOI 10.1016/j.pmpp.2007.02.001; Yang WL, 2007, METABOLOMICS, V3, P147, DOI 10.1007/s11306-007-0053-7; Yao MK, 2003, MYCORRHIZA, V13, P333, DOI 10.1007/s00572-003-0267-0; Yara A, 2008, BIOCHEM BIOPH RES CO, V370, P344, DOI 10.1016/j.bbrc.2008.03.083	84	52	54	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42576	10.1371/journal.pone.0042576	http://dx.doi.org/10.1371/journal.pone.0042576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880040	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100135
J	Hatton, O; Lambert, SL; Krams, SM; Martinez, OM				Hatton, Olivia; Lambert, Stacie L.; Krams, Sheri M.; Martinez, Olivia M.			Src Kinase and Syk Activation Initiate PI3K Signaling by a Chimeric Latent Membrane Protein 1 in Epstein-Barr Virus (EBV) plus B Cell Lymphomas	PLOS ONE			English	Article							NF-KAPPA-B; TYROSINE KINASES; PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGEN RECEPTOR; EPITHELIAL-CELLS; ENCODED LMP1; FCR-GAMMA; PATHWAY; CBL; FAMILY	The B lymphotrophic gamma-herpesvirus EBV is associated with a variety of lymphoid-and epithelial-derived malignancies, including B cell lymphomas in immunocompromised and immunosuppressed individuals. The primary oncogene of EBV, latent membrane protein 1 (LMP1), activates the PI3K/Akt pathway to induce the autocrine growth factor, IL-10, in EBV-infected B cells, but the mechanisms underlying PI3K activation remain incompletely understood. Using small molecule inhibition and siRNA strategies in human B cell lines expressing a chimeric, signaling-inducible LMP1 protein, nerve growth factor receptor (NGFR)-LMP1, we show that NGFR-LMP1 utilizes Syk to activate PI3K/Akt signaling and induce IL-10 production. NGFR-LMP1 signaling induces phosphorylation of BLNK, a marker of Syk activation. Whereas Src kinases are often required for Syk activation, we show here that PI3K/Akt activation and autocrine IL-10 production by NGFR-LMP1 involves the Src family kinase Fyn. Finally, we demonstrate that NGFR-LMP1 induces phosphorylation of c-Cbl in a Syk- and Fyn-dependent fashion. Our results indicate that the EBV protein LMP1, which lacks the canonical ITAM required for Syk activation, can nevertheless activate Syk, and the Src kinase Fyn, resulting in downstream c-Cbl and PI3K/Akt activation. Fyn, Syk, and PI3K/Akt antagonists thus may present potential new therapeutic strategies that target the oncogene LMP1 for treatment of EBV+ B cell lymphomas.	[Hatton, Olivia; Lambert, Stacie L.; Krams, Sheri M.; Martinez, Olivia M.] Stanford Univ, Program Immunol, Sch Med, Stanford, CA 94305 USA; [Hatton, Olivia; Lambert, Stacie L.; Krams, Sheri M.; Martinez, Olivia M.] Stanford Univ, Dept Surg, Div Abdominal Transplantat, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Hatton, O (corresponding author), Stanford Univ, Program Immunol, Sch Med, Stanford, CA 94305 USA.	omm@stanford.edu		, Olivia/0000-0002-2798-0251; Krams, Sheri/0000-0002-6049-5119	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) [ROI AI41769]; Stanford Graduate Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041769] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Stanford Graduate Fellowship(Stanford University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by an National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) grant ROI AI41769 (OMM) (nih.gov). O.H. was supported by a Stanford Graduate Fellowship (sgf.stanford.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Arron JR, 2001, J BIOL CHEM, V276, P30011, DOI 10.1074/jbc.M100414200; Beatty PR, 1997, J IMMUNOL, V158, P4045; Brinkmann MM, 2003, J VIROL, V77, P9346, DOI 10.1128/JVI.77.17.9346-9358.2003; CALENDER A, 1987, P NATL ACAD SCI USA, V84, P8060, DOI 10.1073/pnas.84.22.8060; Chuang HC, 2005, BLOOD, V106, P3090, DOI 10.1182/blood-2005-04-1406; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Dawson CW, 2001, VIROLOGY, V289, P192, DOI 10.1006/viro.2001.1142; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Dykstra ML, 2001, IMMUNITY, V14, P57, DOI 10.1016/S1074-7613(01)00089-9; Eliopoulos AG, 1999, J VIROL, V73, P1023, DOI 10.1128/JVI.73.2.1023-1035.1999; Eliopoulos AG, 1999, J BIOL CHEM, V274, P16085, DOI 10.1074/jbc.274.23.16085; Eliopoulos AG, 1996, ONCOGENE, V13, P2243; Eliopoulos AG, 1997, ONCOGENE, V14, P2899, DOI 10.1038/sj.onc.1201258; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; GHOSH D, 1990, J VIROL, V64, P1855, DOI 10.1128/JVI.64.4.1855-1858.1990; Gottschalk S, 2005, ANNU REV MED, V56, P29, DOI 10.1146/annurev.med.56.082103.104727; Grossmann AH, 2004, FEBS LETT, V577, P555, DOI 10.1016/j.febslet.2004.10.054; Hatton O, 2011, J BIOL CHEM, V286, P37368, DOI 10.1074/jbc.M111.255125; HUEN DS, 1995, ONCOGENE, V10, P549; Hunter S, 1999, J BIOL CHEM, V274, P2097, DOI 10.1074/jbc.274.4.2097; Jakus Z, 2007, TRENDS CELL BIOL, V17, P493, DOI 10.1016/j.tcb.2007.09.001; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Kieser A, 1997, EMBO J, V16, P6478, DOI 10.1093/emboj/16.21.6478; Lam N, 2003, EMBO J, V22, P3027, DOI 10.1093/emboj/cdg284; Lambert SL, 2007, J IMMUNOL, V179, P8225, DOI 10.4049/jimmunol.179.12.8225; LONGNECKER R, 1990, J VIROL, V64, P2319, DOI 10.1128/JVI.64.5.2319-2326.1990; Lovatt M, 2006, MOL CELL BIOL, V26, P8655, DOI 10.1128/MCB.00168-06; MacGlashan D, 2004, J ALLERGY CLIN IMMUN, V114, P1317, DOI 10.1016/j.jaci.2004.08.037; Mainou BA, 2005, ONCOGENE, V24, P6917, DOI 10.1038/sj.onc.1208846; Mancao C, 2007, BLOOD, V110, P3715, DOI 10.1182/blood-2007-05-090142; MANN KP, 1985, J VIROL, V55, P710, DOI 10.1128/JVI.55.3.710-720.1985; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Rao N, 2001, EMBO J, V20, P7085, DOI 10.1093/emboj/20.24.7085; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Roberts ML, 1998, VIROLOGY, V240, P93, DOI 10.1006/viro.1997.8901; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Shao YA, 2004, J BIOL CHEM, V279, P43646, DOI 10.1074/jbc.M404082200; Urzainqui A, 2002, IMMUNITY, V17, P401, DOI 10.1016/S1074-7613(02)00420-X; Vaysberg M, 2008, J BIOL CHEM, V283, P36573, DOI 10.1074/jbc.M802968200; Vines CM, 2001, IMMUNITY, V15, P507, DOI 10.1016/S1074-7613(01)00221-7; Vockerodt M, 2001, VIROLOGY, V280, P183, DOI 10.1006/viro.2000.0768; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Ying HY, 2011, IMMUNOBIOLOGY, V216, P566, DOI 10.1016/j.imbio.2010.09.016; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zou W, 2008, MOL CELL, V31, P422, DOI 10.1016/j.molcel.2008.06.023	60	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42610	10.1371/journal.pone.0042610	http://dx.doi.org/10.1371/journal.pone.0042610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880054	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100143
J	Piao, SL; Liu, YL; Hu, J; Guo, FL; Ma, J; Sun, Y; Zhang, B				Piao, Songlin; Liu, Yanlong; Hu, Jing; Guo, Fulin; Ma, Jie; Sun, Yao; Zhang, Bin			USP22 Is Useful as a Novel Molecular Marker for Predicting Disease Progression and Patient Prognosis of Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							PROTEASE 22; CANCER; EXPRESSION; UBIQUITYLATION; METASTASIS; CHROMATIN; SURVIVAL; SUBUNIT	Background and Objective: The significance of ubiquitin-specific protease 22 (USP22) as a potential marker has been growing in the field of oncology. The aim of this study was to investigate the role of USP22 and the association with its potential targets in oral squamous cell carcinoma (OSCC). Methods: Immunohistochemistry was used to determine the expression of USP22 protein in 319 OSCC patients in comparison with 42 healthy controls. The clinical correlations and prognostic significance of the aberrantly expressed protein was evaluated to identify novel biomarker of OSCC. Results: The incidence of positive USP22 expression was 63.32% in 319 conventional OSCC tissues. The protein expression level of USP22 was concomitantly up-regulated from non-cancerous mucosa to primary carcinoma and from carcinomas to lymph node metastasis (P<0.001). Moreover, statistical analysis showed that positive USP22 expression was positively related to lymph node metastasis, Ki67, Cox-2 and recurrence. Furthermore, it was shown that patients with positive USP22 expression had significantly poorer outcome compared with patients with negative expression of USP22 for patients with positive lymph nodes. Multivariate Cox regression analysis revealed that USP22 expression level was an independent prognostic factor for both overall survival and disease-free survival (P<0.001 and P<0.001, respectively). Cancer cells with reduced USP22 expression exhibited reduced proliferation and colony formation evaluated by MTT and soft agar assays. Conclusion: To our knowledge, this is the first study that determines the relationship between USP22 expression and prognosis in OSCC. We found that increased expression of USP22 is associated with poor prognosis in OSCC. USP22 may represent a novel and useful prognostic marker for OSCC.	[Piao, Songlin; Guo, Fulin; Ma, Jie] Harbin Med Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Harbin, Heilongjiang, Peoples R China; [Liu, Yanlong] Harbin Med Univ, Affiliated Hosp 3, Dept Colorectal Surg, Harbin, Heilongjiang, Peoples R China; [Hu, Jing] Harbin Med Univ, Affiliated Hosp 3, Dept Breast Med Oncol, Harbin, Heilongjiang, Peoples R China; [Sun, Yao; Zhang, Bin] Harbin Med Univ, Affiliated Hosp 2, Hard Tissue Lab, Harbin, Heilongjiang, Peoples R China; [Zhang, Bin] Harbin Med Univ, Affiliated Hosp 2, Dept Oral & Maxillofacial Surg, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Guo, FL (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Harbin, Heilongjiang, Peoples R China.	guofulinhyd@126.com; zhangbinhyd@163.com	Liu, Yanlong/AAL-3503-2021		National Natural Science Foundation of China [81170960]; Ministry of Education College Doctoral Degree Special Fund [20102307110006]; Province Natural Science Foundation of Heilongjiang [D200848]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education College Doctoral Degree Special Fund; Province Natural Science Foundation of Heilongjiang	This work was supported by the National Natural Science Foundation of China [grant number 81170960], the Ministry of Education College Doctoral Degree Special Fund [grant number 20102307110006] and the Province Natural Science Foundation of Heilongjiang [grant number D200848]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassov BS, 2011, EMBO REP, V12, P924, DOI 10.1038/embor.2011.140; Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Chipumuro E, 2012, FASEB J, V26, P842, DOI 10.1096/fj.11-189498; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Glinsky GV, 2008, J CLIN ONCOL, V26, P2846, DOI 10.1200/JCO.2008.17.0266; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Jiang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034283; Lee HJ, 2006, GENE EXPR PATTERNS, V6, P277, DOI 10.1016/j.modgep.2005.07.007; Liu YL, 2010, J GASTROEN HEPATOL, V25, P1800, DOI 10.1111/j.1440-1746.2010.06352.x; Liu YL, 2012, CELL BIOCHEM BIOPHYS, V62, P229, DOI 10.1007/s12013-011-9287-0; Liu YL, 2011, J SURG ONCOL, V103, P283, DOI 10.1002/jso.21802; Lv L, 2011, MOL CELL BIOCHEM, V346, P11, DOI 10.1007/s11010-010-0585-4; Lv TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035065; Miller CS, 2003, ORAL SURG ORAL MED O, V95, P570, DOI 10.1067/moe.2003.108; MUIR C, 1995, CANCER, V75, P147, DOI 10.1002/1097-0142(19950101)75:1+<147::AID-CNCR2820751304>3.0.CO;2-U; Pijnappel WWMP, 2008, MOL CELL, V29, P152, DOI 10.1016/j.molcel.2008.01.007; Wolff D, 2004, J CRANIO MAXILL SURG, V32, P318, DOI 10.1016/j.jcms.2004.05.005; Xu H, 2012, INT J COLORECTAL DIS, V27, P21, DOI 10.1007/s00384-011-1275-8; Zhang XY, 2008, CELL CYCLE, V7, P1522, DOI 10.4161/cc.7.11.5962; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhang YX, 2011, J CANCER RES CLIN, V137, P1245, DOI 10.1007/s00432-011-0998-9; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	24	49	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42540	10.1371/journal.pone.0042540	http://dx.doi.org/10.1371/journal.pone.0042540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880026	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100125
J	Wu, QJ; Vogtmann, E; Zhang, W; Xie, L; Yang, WS; Tan, YT; Gao, J; Xiang, YB				Wu, Qi-Jun; Vogtmann, Emily; Zhang, Wei; Xie, Li; Yang, Wan-Shui; Tan, Yu-Ting; Gao, Jing; Xiang, Yong-Bing			Cancer Incidence among Adolescents and Young Adults in Urban Shanghai, 1973-2005	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; BREAST-CANCER; UNITED-STATES; CHILDHOOD-CANCER; KIDNEY CANCER; HEPATITIS-B; TRENDS; CHILDREN; AGE; PATTERNS	Background: Lack of cancer incidence information for adolescents and young adults led us to describe incidence trends within the young population of 15 to 49 year-olds in urban Shanghai between 1973 and 2005. Methods: During 1973 to 2005, data on 43,009 (45.8%) male and 50,828 (54.2%) female cancer cases aged 15-49 years from the Shanghai Cancer Registry were analyzed. Five-year age-specific rates, world age-standardized rates, percent change (PC), and annual percent change (APC) were calculated using annual data on population size and its estimated age structure. Results: During the 33-year study period, overall cancer incidence of adolescents and young adults among males marginally decreased by 0.5% per year (P<0.05). However, overall cancer incidence for females slightly increased by 0.8% per year (P<0.05). The leading cancer for males in rank were liver, stomach, lung, colorectal, and nasopharyngeal cancers and for females were breast, stomach, colorectal, thyroid, and ovarian cancers. Among specific sites, incidence rates significantly decreased for cancers of the esophagus, stomach, and liver in both sexes. In contrast, incidence rates significantly increased for kidney cancers, non-Hodgkin lymphoma, and brain and nervous system tumors in both sexes and increased for breast and ovarian cancers among females. Conclusions: Overall cancer incidence rates of adolescents and young adults decreased in males whereas they increased in females. Our findings suggest the importance of further epidemiology and etiologic studies to further elucidate factors contributing to the cancer incidence trends of adolescents and young adults in China.	[Wu, Qi-Jun; Vogtmann, Emily; Zhang, Wei; Xie, Li; Yang, Wan-Shui; Tan, Yu-Ting; Gao, Jing; Xiang, Yong-Bing] Shanghai Jiao Tong Univ, Dept Epidemiol, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China; [Wu, Qi-Jun; Vogtmann, Emily; Zhang, Wei; Xie, Li; Yang, Wan-Shui; Tan, Yu-Ting; Gao, Jing; Xiang, Yong-Bing] Shanghai Jiao Tong Univ, State Key Lab Oncogene & Related Genes, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China; [Vogtmann, Emily] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Alabama System; University of Alabama Birmingham	Wu, QJ (corresponding author), Shanghai Jiao Tong Univ, Dept Epidemiol, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China.	ybxiang@shsci.org	Yang, Wanshui/S-9322-2019; Vogtmann, Emily/O-9125-2017	Yang, Wanshui/0000-0002-7365-2689; Vogtmann, Emily/0000-0003-1355-5593	State Key Project Specialized for Infectious Diseases of China [2008ZX10002-015, 2012ZX10002008-002]; Fogarty International Clinical Research Scholars and Fellows Support Center at the Vanderbilt Institute for Global Health; Fogarty International Center, National Institutes of Health (NIH) [R24TW007988-5]; Cancer Prevention and Control Training Program at the University of Alabama at Birmingham; NIH [5R25 CA047888]; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R25CA047888] Funding Source: NIH RePORTER	State Key Project Specialized for Infectious Diseases of China; Fogarty International Clinical Research Scholars and Fellows Support Center at the Vanderbilt Institute for Global Health; Fogarty International Center, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Cancer Prevention and Control Training Program at the University of Alabama at Birmingham; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the funds of State Key Project Specialized for Infectious Diseases of China (No. 2008ZX10002-015 and 2012ZX10002008-002). Emily Vogtmann was also supported by the Fogarty International Clinical Research Scholars and Fellows Support Center at the Vanderbilt Institute for Global Health, funded by the Fogarty International Center, National Institutes of Health (NIH), through an R24 Training Grant (Grant number: R24TW007988-5), and the Cancer Prevention and Control Training Program at the University of Alabama at Birmingham funded through the NIH (5R25 CA047888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao PP, 2010, PEDIATR BLOOD CANCER, V54, P1009, DOI 10.1002/pbc.22383; Barr RD, 1999, MED PEDIATR ONCOL, V32, P404, DOI 10.1002/(SICI)1096-911X(199906)32:6<404::AID-MPO2>3.0.CO;2-F; Barr RD, 2011, CANCER-AM CANCER SOC, V117, P2245, DOI 10.1002/cncr.26052; Bhatia S, 1999, MED PEDIATR ONCOL, V33, P470, DOI 10.1002/(SICI)1096-911X(199911)33:5<470::AID-MPO6>3.0.CO;2-A; Bleyer A, 2006, NIH PUB; Blot W, 2006, CANC EPIDEMIOLOGY PR; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chow WH, 2000, NEW ENGL J MED, V343, P1305, DOI 10.1056/NEJM200011023431804; COLDITZ GA, 2006, CANC EPIDEMIOLOGY PR, P995; COPELAN EA, 1995, BLOOD, V85, P1151, DOI 10.1182/blood.V85.5.1151.bloodjournal8551151; Croucher C, 2009, CLIN ONCOL-UK, V21, P417, DOI 10.1016/j.clon.2009.02.006; de Camargo B, 2010, INT J CANCER, V126, P715, DOI 10.1002/ijc.24799; Desandes E, 2007, B CANCER, V94, P331; Gao S, 2012, EUR J EPIDEMIOL, V27, P39, DOI 10.1007/s10654-011-9636-8; Gao YT, 2007, CANC INCIDENCE MORT; Gatta G, 2003, EUR J CANCER, V39, P2600, DOI 10.1016/j.ejca.2003.09.004; Giovannucci E, 2006, CANC EPIDEMIOLOGY PR, P809; Hankey BF, 2000, CANCER CAUSE CONTROL, V11, P31, DOI 10.1023/A:1008953201688; HERNANDEZ JA, 1995, CANCER, V75, P381, DOI 10.1002/1097-0142(19950101)75:1+<381::AID-CNCR2820751320>3.0.CO;2-B; Howe HL, 2001, J NATL CANCER I, V93, P824, DOI 10.1093/jnci/93.11.824; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; HULKA BS, 1995, LANCET, V346, P883, DOI 10.1016/S0140-6736(95)92713-1; HUNGER SP, 1992, J CLIN ONCOL, V10, P156, DOI 10.1200/JCO.1992.10.1.156; *IARC WORK GROUP E, 1994, SCHIST LIV FLUK HEL, P177; Jin F, 1999, INT J CANCER, V83, P435, DOI 10.1002/(SICI)1097-0215(19991112)83:4&lt;435::AID-IJC1&gt;3.0.CO;2-J; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Lagergren J, 1998, CANCER EPIDEM BIOMAR, V7, P913; Lee SY, 2003, INT J CANCER, V105, P390, DOI 10.1002/ijc.11078; Leung AWH, 2008, CANCER DETECT PREV, V32, P156, DOI 10.1016/j.cdp.2008.05.004; Li WD, 2010, B CHINESE CANC, V12, P782; London WT, 2006, CANC EPIDEMIOLOGY PR, P763, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0039; McNally RJQ, 1997, HEMATOL ONCOL, V15, P173, DOI 10.1002/(SICI)1099-1069(199711)15:4<173::AID-HON610>3.0.CO;2-K; METTLIN C, 1990, AM J EPIDEMIOL, V131, P973, DOI 10.1093/oxfordjournals.aje.a115617; MUIR C, 1987, CANC INCIDENCE 5 CON, V5; National Cancer Institute, 2006, NIH PUB, V06-6067; Nepple KG, 2012, J UROLOGY, V187, P32, DOI 10.1016/j.juro.2011.09.028; Nordenstedt H, 2011, SCAND J GASTROENTERO, V46, P597, DOI 10.3109/00365521.2011.551890; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Percy C., 1990, INT CLASSIFICATION D; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; POPKIN BM, 1995, AM J PUBLIC HEALTH, V85, P690, DOI 10.2105/AJPH.85.5.690; Robison L, 1995, CHESSELLS HANN BAILL, P639; ROSS JA, 2006, CANC EPIDEMIOLOGY PR, P1251; Sandler DP, 1997, SEMIN ONCOL, V24, P3; Semenza JC, 2001, AM J EPIDEMIOL, V153, P851, DOI 10.1093/aje/153.9.851; SMITH MA, 1994, MED PEDIATR ONCOL, V23, P86, DOI 10.1002/mpo.2950230205; Spix C, 2008, INT J CANCER, V122, P1859, DOI 10.1002/ijc.23281; Steliarova-Foucher E, 2004, LANCET, V364, P2097, DOI 10.1016/S0140-6736(04)17550-8; Stuebe AM, 2009, ARCH INTERN MED, V169, P1364, DOI 10.1001/archinternmed.2009.231; SU D, 1979, CHINESE MED J-PEKING, V92, P748; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wu XC, 2005, CANCER CAUSE CONTROL, V16, P309, DOI 10.1007/s10552-004-4026-0; Wu XC, 2003, J ADOLESCENT HEALTH, V32, P405, DOI 10.1016/S1054-139X(03)00057-0; Zhang SW, 2009, B CHINESE CANC, V18, P256; [张薇 Zhang Wei], 2005, [中华老年医学杂志, Chinese Journal of Geriatrics], V24, P701; Zhou YH, 2009, CHINESE MED J-PEKING, V122, P98, DOI 10.3760/cma.j.issn.0366-6999.2009.01.018	59	38	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42607	10.1371/journal.pone.0042607	http://dx.doi.org/10.1371/journal.pone.0042607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880052	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100142
J	Zhang, L; Ding, QY; Wang, Z				Zhang, Lang; Ding, Qingyang; Wang, Zhao			Nuclear Respiratory Factor 1 Mediates the Transcription Initiation of Insulin-Degrading Enzyme in a TATA Box-Binding Protein-Independent Manner	PLOS ONE			English	Article							RNA-POLYMERASE-II; AMYLOID BETA-PROTEIN; GENOME-WIDE ANALYSIS; DNA METHYLATION; CPG ISLANDS; GENE; PROMOTER; ASSOCIATION; NRF-1; TBP	CpG island promoters often lack canonical core promoter elements such as the TATA box, and have dispersed transcription initiation sites. Despite the prevalence of CpG islands associated with mammalian genes, the mechanism of transcription initiation from CpG island promoters remains to be clarified. Here we investigate the mechanism of transcription initiation of the CpG island-associated gene, insulin-degrading enzyme (IDE). IDE is ubiquitously expressed, and has dispersed transcription initiation sites. The IDE core promoter locates within a 32-bp region, which contains three CGGCG repeats and a nuclear respiratory factor 1 (NRF-1) binding motif. Sequential mutation analysis indicates that the NRF-1 binding motif is critical for IDE transcription initiation. The NRF-1 binding motif is functional, because NRF-1 binds to this motif in vivo and this motif is required for the regulation of IDE promoter activity by NRF-1. Furthermore, the NRF-1 binding site in the IDE promoter is conserved among different species, and dominant negative NRF-1 represses endogenous IDE expression. Finally, TATA-box binding protein (TBP) is not associated with the IDE promoter, and inactivation of TBP does not abolish IDE transcription, suggesting that TBP is not essential for IDE transcription initiation. Our studies indicate that NRF-1 mediates IDE transcription initiation in a TBP-independent manner, and provide insights into the potential mechanism of transcription initiation for other CpG island-associated genes.	[Zhang, Lang; Ding, Qingyang; Wang, Zhao] Tsinghua Univ, Prot Sci Key Lab, Minist Educ, Dept Biol Sci & Biotechnol,Sch Med, Beijing 100084, Peoples R China	Tsinghua University	Zhang, L (corresponding author), Tsinghua Univ, Prot Sci Key Lab, Minist Educ, Dept Biol Sci & Biotechnol,Sch Med, Beijing 100084, Peoples R China.	zwang@tsinghua.edu.cn			National Basic Research Program (973 Project) of China [2007CB507406]; Tsinghua University Initiative Scientific Research Program [20111081143]	National Basic Research Program (973 Project) of China(National Basic Research Program of China); Tsinghua University Initiative Scientific Research Program	This work was financially supported by the National Basic Research Program (973 Project) of China (No. 2007CB507406), and the Tsinghua University Initiative Scientific Research Program (20111081143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Asangani IA, 2008, GENE, V410, P197, DOI 10.1016/j.gene.2007.12.009; Authier F, 1996, CLIN INVEST MED, V19, P149; Bajic VB, 2004, NAT BIOTECHNOL, V22, P1467, DOI 10.1038/nbt1032; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Blesa JR, 2008, BIOCHEM CELL BIOL, V86, P46, DOI [10.1139/O07-151, 10.1139/o07-151]; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cho YM, 2005, DIABETOLOGIA, V48, P2033, DOI 10.1007/s00125-005-1855-7; COOPER DN, 1983, HUM GENET, V64, P315, DOI 10.1007/BF00292363; COOPER DN, 1983, NUCLEIC ACIDS RES, V11, P647, DOI 10.1093/nar/11.3.647; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Geiman TM, 2002, J CELL BIOCHEM, V87, P117, DOI 10.1002/jcb.10286; GOMEZCUADRADO A, 1995, MOL CELL BIOL, V15, P6670; GRIPPO P, 1968, J MOL BIOL, V36, P195, DOI 10.1016/0022-2836(68)90375-6; Gugneja S, 1996, MOL CELL BIOL, V16, P5708; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Liu Y, 2008, DIABETES, V57, P777, DOI 10.2337/db07-0008; Mahishi L, 2006, BIOCHEM J, V400, P327, DOI 10.1042/BJ20060734; Martianov I, 2002, SCIENCE, V298, P1036, DOI 10.1126/science.1076327; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; Muller F, 2001, CURR BIOL, V11, P282, DOI 10.1016/S0960-9822(01)00076-8; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; PECH M, 1979, CELL, V18, P883, DOI 10.1016/0092-8674(79)90140-5; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Serretti A, 2007, J ALZHEIMERS DIS, V12, P73; SWARTZ MN, 1962, J BIOL CHEM, V237, P1961; Tokusumi Y, 2004, J VIROL, V78, P10856, DOI 10.1128/JVI.78.20.10856-10864.2004; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	45	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42035	10.1371/journal.pone.0042035	http://dx.doi.org/10.1371/journal.pone.0042035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870279	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100042
J	Roti, ECR; Leisman, SK; Abbott, DH; Salih, SM				Roti, Elon C. Roti; Leisman, Scott K.; Abbott, David H.; Salih, Sana M.			Acute Doxorubicin Insult in the Mouse Ovary Is Cell- and Follicle-Type Dependent	PLOS ONE			English	Article							RESISTANCE-ASSOCIATED PROTEIN; MULTIDRUG-RESISTANT; P-GLYCOPROTEIN; EXTRACELLULAR-MATRIX; CANCER-CELLS; INTRACELLULAR-LOCALIZATION; ENCAPSULATED DOXORUBICIN; CYTOPLASMIC ORGANELLES; DRUG SEQUESTRATION; INDUCED APOPTOSIS	Primary ovarian insufficiency (POI) is one of the many unintended consequences of chemotherapy faced by the growing number of female cancer survivors. While ovarian repercussions of chemotherapy have long been recognized, the acute insult phase and primary sites of damage are not well-studied, hampering efforts to design effective intervention therapies to protect the ovary. Utilizing doxorubicin (DXR) as a model chemotherapy agent, we defined the acute timeline for drug accumulation, induced DNA damage, and subsequent cellular and follicular demise in the mouse ovary. DXR accumulated first in the core ovarian stroma cells, then redistributed outwards into the cortex and follicles in a time-dependent manner, without further increase in total ovarian drug levels after four hours post-injection. Consistent with early drug accumulation and intimate interactions with the blood supply, stroma cell-enriched populations exhibited an earlier DNA damage response (measurable at 2 hours) than granulosa cells (measurable at 4 hours), as quantified by the comet assay. Granulosa cell-enriched populations were more sensitive however, responding with greater levels of DNA damage. The oocyte DNA damage response was delayed, and not measurable above background until 10-12 hours post-DXR injection. By 8 hours post-DXR injection and prior to the oocyte DNA damage response, the number of primary, secondary, and antral follicles exhibiting TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling)-positive granulosa cells plateaued, indicating late-stage apoptosis and suggesting damage to the oocytes is subsequent to somatic cell failure. Primordial follicles accumulate significant DXR by 4 hours post-injection, but do not exhibit TUNEL-positive granulosa cells until 48 hours post-injection, indicating delayed demise. Taken together, the data suggest effective intervention therapies designed to protect the ovary from chemotherapy accumulation and induced insult in the ovary must act almost immediately to prevent acute insult as significant damage was seen in stroma cells within the first two hours.	[Roti, Elon C. Roti; Leisman, Scott K.; Abbott, David H.; Salih, Sana M.] Univ Wisconsin Madison, Dept Obstet & Gynecol, Reprod Endocrinol & Infertil Div, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Roti, ECR (corresponding author), Univ Wisconsin Madison, Dept Obstet & Gynecol, Reprod Endocrinol & Infertil Div, Madison, WI 53706 USA.	salih@wisc.edu			University of Wisconsin-Madison; National Institutes of Health (NIH) [K12HD0558941]; UW-Madison Comprehensive Cancer Center grant National Institutes of Health (NIH)/National Cancer Institute (NCI) [P30 CA014520]; Clinical and Translational Science Award (CTSA) Program of the National Center for Research Resources [UL1RR025011]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER	University of Wisconsin-Madison; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW-Madison Comprehensive Cancer Center grant National Institutes of Health (NIH)/National Cancer Institute (NCI); Clinical and Translational Science Award (CTSA) Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by startup funds from the University of Wisconsin-Madison and National Institutes of Health (NIH) training grant K12HD0558941 to SMS, and by the UW-Madison Comprehensive Cancer Center grant National Institutes of Health (NIH)/National Cancer Institute (NCI) P30 CA014520 and UL1RR025011 grant from the Clinical and Translational Science Award (CTSA) Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAI E, 1990, CANCER CHEMOTH PHARM, V25, P295, DOI 10.1007/BF00684889; Altan N, 1998, J EXP MED, V187, P1583, DOI 10.1084/jem.187.10.1583; Altan N, 1999, P NATL ACAD SCI USA, V96, P4432, DOI 10.1073/pnas.96.8.4432; American Cancer Society, 2011, CANC FACTS FIG 2011; Anderson D, 1997, MUTAT RES-GEN TOX EN, V390, P69, DOI 10.1016/S0165-1218(96)00167-X; Andreu-Vieyra C, 2008, MOL ENDOCRINOL, V22, P2141, DOI 10.1210/me.2008-0033; ATAYA K, 1989, STEROIDS, V54, P607, DOI 10.1016/0039-128X(89)90084-6; Bar-Joseph H, 2010, REPROD TOXICOL, V30, P566, DOI 10.1016/j.reprotox.2010.07.003; Bath LE, 2002, BJOG-INT J OBSTET GY, V109, P107, DOI 10.1111/j.1471-0528.2002.t01-1-01007.x; Bath LE, 2001, HUM REPROD, V16, P1838, DOI 10.1093/humrep/16.9.1838; BECK WT, 1987, BIOCHEM PHARMACOL, V36, P2879, DOI 10.1016/0006-2952(87)90198-5; Belhoussine R, 1998, J HISTOCHEM CYTOCHEM, V46, P1369, DOI 10.1177/002215549804601205; Ben-Aharon I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-20; BENNIS S, 1995, INT J CANCER, V62, P283, DOI 10.1002/ijc.2910620309; Berkholtz CB, 2006, HISTOCHEM CELL BIOL, V126, P583, DOI 10.1007/s00418-006-0194-1; Bonilla E, 2003, BIOCHEM PHARMACOL, V65, P1701, DOI 10.1016/S0006-2952(03)00119-9; Bour-Dill C, 2000, CYTOMETRY, V39, P16, DOI 10.1002/(SICI)1097-0320(20000101)39:1<16::AID-CYTO4>3.0.CO;2-I; BREUNINGER LM, 1995, CANCER RES, V55, P5342; Brougham MFH, 2005, BRIT J HAEMATOL, V131, P143, DOI 10.1111/j.1365-2141.2005.05740.x; Burton KA, 2002, HOSP MED, V63, P522, DOI 10.12968/hosp.2002.63.9.1946; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Cleary I, 1997, BIOCHEM PHARMACOL, V53, P1493; Curnis F, 2002, J CLIN INVEST, V110, P475, DOI 10.1172/JCI200215223; Dai XW, 2008, NANOMED-NANOTECHNOL, V4, P49, DOI 10.1016/j.nano.2007.12.002; DELANGE JHM, 1992, CYTOMETRY, V13, P571, DOI 10.1002/cyto.990130604; DURAND RE, 1981, CANCER RES, V41, P3489; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Ferrao P, 2001, LEUKEMIA RES, V25, P827, DOI 10.1016/S0145-2126(01)00120-5; Flaws JA, 1997, BIOL REPROD, V57, P1233, DOI 10.1095/biolreprod57.5.1233; Gallois L, 1996, EUR J BIOCHEM, V241, P879, DOI 10.1111/j.1432-1033.1996.00879.x; GERVASONI JE, 1991, CANCER RES, V51, P4955; GOLDMAN R, 1978, BIOCHIM BIOPHYS ACTA, V512, P254, DOI 10.1016/0005-2736(78)90251-1; Gollapudi S, 1997, CANCER CHEMOTH PHARM, V40, P150, DOI 10.1007/s002800050640; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Gong YP, 2000, LEUKEMIA RES, V24, P769, DOI 10.1016/S0145-2126(00)00048-5; Gong YP, 2003, J BIOL CHEM, V278, P50234, DOI 10.1074/jbc.M306606200; Herlevsen M, 2007, MOL CANCER THER, V6, P1804, DOI 10.1158/1535-7163.MCT-06-0372; Hewitt M, 1999, J NATL CANCER I, V91, P1480, DOI 10.1093/jnci/91.17.1480; HINDENBURG AA, 1989, CANCER RES, V49, P4607; Hovorka O, 2010, EUR J PHARM BIOPHARM, V76, P514, DOI 10.1016/j.ejpb.2010.07.008; Hurwitz SJ, 1997, BLOOD, V89, P3745, DOI 10.1182/blood.V89.10.3745.3745_3745_3754; HUXHAM IM, 1994, INT J CANCER, V59, P94, DOI 10.1002/ijc.2910590118; Irving-Rodgers HF, 2006, SEMIN REPROD MED, V24, P195, DOI 10.1055/s-2006-948549; Irving-Rodgers HF, 2010, CELL TISSUE RES, V339, P613, DOI 10.1007/s00441-009-0905-8; Johnston RJ, 2009, PEDIATR BLOOD CANCER, V53, P296, DOI 10.1002/pbc.22012; Jurisicova A, 2006, CELL DEATH DIFFER, V13, P1466, DOI 10.1038/sj.cdd.4401819; Karukstis KK, 1998, BIOPHYS CHEM, V73, P249, DOI 10.1016/S0301-4622(98)00150-1; KEIZER HG, 1989, CANCER RES, V49, P2988; Kim SJ, 2006, BIOCHEM BIOPH RES CO, V339, P463, DOI 10.1016/j.bbrc.2005.11.040; Kirchmeier MJ, 2001, J LIPOSOME RES, V11, P15, DOI 10.1081/LPR-100103167; KLOHS WD, 1988, MOL PHARMACOL, V34, P180; Kramer DL, 1998, CANCER RES, V58, P3883; LANKELMA J, 1991, BIOCHIM BIOPHYS ACTA, V1093, P147, DOI 10.1016/0167-4889(91)90116-F; Lautier D, 1997, INT J CANCER, V71, P292; Loetchutinat C, 2001, EUR J BIOCHEM, V268, P4459, DOI 10.1046/j.1432-1327.2001.02370.x; Meirow D, 1999, LEUKEMIA LYMPHOMA, V33, P65, DOI 10.3109/10428199909093726; Meirow D, 2010, FERTIL STERIL, V94, pS10, DOI 10.1016/j.fertnstert.2010.07.038; Meirow D, 1996, HUM REPROD UPDATE, V2, P63, DOI 10.1093/humupd/2.1.63; Meirow D, 1999, HUM REPROD, V14, P1903, DOI 10.1093/humrep/14.7.1903; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Merlin JL, 2000, CYTOMETRY, V41, P62, DOI 10.1002/1097-0320(20000901)41:1<62::AID-CYTO9>3.0.CO;2-7; MILLER JJ, 1971, AM J MED, V50, P530, DOI 10.1016/0002-9343(71)90341-X; Millot C, 1997, J HISTOCHEM CYTOCHEM, V45, P1255, DOI 10.1177/002215549704500909; MORGENFELD MC, 1972, SURG GYNECOL OBSTETR, V134, P826; Morita Y, 1999, MOL ENDOCRINOL, V13, P841, DOI 10.1210/me.13.6.841; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Nakano K, 2007, ARCH HISTOL CYTOL, V70, P243, DOI 10.1679/aohc.70.243; Oktay K, 2006, J CLIN ONCOL, V24, P4044, DOI 10.1200/JCO.2006.06.9823; Oktay K, 2009, PEDIATR BLOOD CANCER, V53, P267, DOI 10.1002/pbc.22003; Ouar Z, 2003, BIOCHEM J, V370, P185, DOI 10.1042/BJ20021411; Paris F, 2002, NAT MED, V8, P901, DOI 10.1038/nm0902-901; PASCHOUD N, 1985, J HISTOCHEM CYTOCHEM, V33, P73, DOI 10.1177/33.1.2578145; Perez GI, 1999, MOL HUM REPROD, V5, P414, DOI 10.1093/molehr/5.5.414; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Perez-Ruiz T, 2001, ELECTROPHORESIS, V22, P134, DOI 10.1002/1522-2683(200101)22:1<134::AID-ELPS134>3.3.CO;2-O; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; RIZZO V, 1989, BIOCHEMISTRY-US, V28, P274, DOI 10.1021/bi00427a038; Rodgers RJ, 2003, REPRODUCTION, V126, P415, DOI 10.1530/rep.0.1260415; Rodgers RJ, 2001, MOL CELL ENDOCRINOL, V171, P41, DOI 10.1016/S0303-7207(00)00430-5; RUTHERFORD AV, 1993, J HISTOCHEM CYTOCHEM, V41, P1573, DOI 10.1177/41.10.7902372; Schindler M, 1996, BIOCHEMISTRY-US, V35, P2811, DOI 10.1021/bi952234e; SCHUURHUIS GJ, 1991, BRIT J CANCER, V64, P857, DOI 10.1038/bjc.1991.413; SCHUURHUIS GJ, 1993, BRIT J CANCER, V68, P898, DOI 10.1038/bjc.1993.452; SEIDEL A, 1995, VIRCHOWS ARCH, V426, P249; Shapiro AB, 1998, INT J CANCER, V76, P857, DOI 10.1002/(SICI)1097-0215(19980610)76:6<857::AID-IJC15>3.0.CO;2-#; Shen F, 2008, J PHARMACOL EXP THER, V324, P95, DOI 10.1124/jpet.107.127704; Shinoda K, 1999, ARCH TOXICOL, V73, P274, DOI 10.1007/s002040050617; SIMON S, 1994, P NATL ACAD SCI USA, V91, P4101, DOI 10.1073/pnas.91.9.4101; SLAPAK CA, 1994, BLOOD, V84, P3113, DOI 10.1182/blood.V84.9.3113.bloodjournal8493113; Smith MA, 1999, J NATL CANCER I, V91, P973; SOGNIER MA, 1994, BIOCHEM PHARMACOL, V48, P391, DOI 10.1016/0006-2952(94)90112-0; TAN C, 1967, CANCER-AM CANCER SOC, V20, P333, DOI 10.1002/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K; Wang E, 2000, J CELL PHYSIOL, V184, P263, DOI 10.1002/1097-4652(200008)184:2<263::AID-JCP15>3.0.CO;2-F; WARREN L, 1991, CANCER RES, V51, P1996; Wei GL, 2008, BIOMED CHROMATOGR, V22, P1252, DOI 10.1002/bmc.1054; Wientjes MG, 2005, CLIN CANCER RES, V11, P4204, DOI 10.1158/1078-0432.CCR-04-1969; WILLINGHAM MC, 1986, CANCER RES, V46, P5941; Wood DJT, 1996, CANCER LETT, V108, P41, DOI 10.1016/S0304-3835(96)04368-6	98	53	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42293	10.1371/journal.pone.0042293	http://dx.doi.org/10.1371/journal.pone.0042293			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876313	gold, Green Published, Green Submitted			2022-12-27	WOS:000307184700041
J	Henson, MA; Larsen, RS; Lawson, SN; Perez-Otano, I; Nakanishi, N; Lipton, SA; Philpot, BD				Henson, Maile A.; Larsen, Rylan S.; Lawson, Shelikha N.; Perez-Otano, Isabel; Nakanishi, Nobuki; Lipton, Stuart A.; Philpot, Benjamin D.			Genetic Deletion of NR3A Accelerates Glutamatergic Synapse Maturation	PLOS ONE			English	Article							NMDA RECEPTOR SUBUNITS; LONG-TERM POTENTIATION; D-ASPARTATE-RECEPTORS; DEVELOPING RAT-BRAIN; POSTNATAL-DEVELOPMENT; DIFFERENTIAL EXPRESSION; REGIONAL EXPRESSION; AMPA RECEPTORS; NR3A-CONTAINING NMDARS; HIPPOCAMPAL SYNAPSES	Glutamatergic synapse maturation is critically dependent upon activation of NMDA-type glutamate receptors (NMDARs); however, the contributions of NR3A subunit-containing NMDARs to this process have only begun to be considered. Here we characterized the expression of NR3A in the developing mouse forebrain and examined the consequences of NR3A deletion on excitatory synapse maturation. We found that NR3A is expressed in many subcellular compartments, and during early development, NR3A subunits are particularly concentrated in the postsynaptic density (PSD). NR3A levels dramatically decline with age and are no longer enriched at PSDs in juveniles and adults. Genetic deletion of NR3A accelerates glutamatergic synaptic transmission, as measured by AMPAR-mediated postsynaptic currents recorded in hippocampal CA1. Consistent with the functional observations, we observed that the deletion of NR3A accelerated the expression of the glutamate receptor subunits NR1, NR2A, and GluR1 in the PSD in postnatal day (P) 8 mice. These data support the idea that glutamate receptors concentrate at synapses earlier in NR3A-knockout (NR3A-KO) mice. The precocious maturation of both AMPAR function and glutamate receptor expression are transient in NR3A-KO mice, as AMPAR currents and glutamate receptor protein levels are similar in NR3A-KO and wildtype mice by P16, an age when endogenous NR3A levels are normally declining. Taken together, our data support a model whereby NR3A negatively regulates the developmental stabilization of glutamate receptors involved in excitatory neurotransmission, synaptogenesis, and spine growth.	[Henson, Maile A.; Philpot, Benjamin D.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA; [Larsen, Rylan S.; Lawson, Shelikha N.; Philpot, Benjamin D.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Philpot, Benjamin D.] Univ N Carolina, Neurosci Ctr, Chapel Hill, NC USA; [Philpot, Benjamin D.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC USA; [Perez-Otano, Isabel] CIMA, Dept Neurociencias, Pamplona, Spain; [Perez-Otano, Isabel] Univ Navarra, E-31080 Pamplona, Spain; [Nakanishi, Nobuki; Lipton, Stuart A.] Del E Webb Ctr Neurosci Aging & Stem Cell Res, Sanford Burnham Med Res Inst, La Jolla, CA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Navarra; Sanford Burnham Prebys Medical Discovery Institute	Henson, MA (corresponding author), Natl Inst Environm Hlth Sci, NIH, Res Triangle Pk, NC USA.	maile.henson@nih.gov	Perez-Otano, Isabel/S-9613-2017	Perez-Otano, Isabel/0000-0002-7222-8202; Lipton, Stuart/0000-0002-3490-1259; Larsen, Rylan/0000-0002-7136-1175	NARSAD; Marie Curie International Reintegration Program; UTE project CIMA; MEC [SAF2006-10025]; National Eye Institute [R01 EY018323, R01 EY05477]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01 HD29687]; UNC Charles Lee Raper Dissertation Fellowship; Society for Neuroscience/NINDS Neuroscience Scholars Program; NATIONAL EYE INSTITUTE [R01EY005477, R01EY018323] Funding Source: NIH RePORTER	NARSAD(NARSAD); Marie Curie International Reintegration Program; UTE project CIMA; MEC(European Commission); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UNC Charles Lee Raper Dissertation Fellowship; Society for Neuroscience/NINDS Neuroscience Scholars Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from NARSAD (BDP, IPO; bbrfoundation.org), Marie Curie International Reintegration Program (http://cordis.europa.eu), UTE project CIMA and MEC (IPO; SAF2006-10025), National Eye Institute (BDP, R01 EY018323; SAL, R01 EY05477), Eunice Kennedy Shriver National Institute of Child Health and Human Development (SAL, P01 HD29687), UNC Charles Lee Raper Dissertation Fellowship (MAH), and the Society for Neuroscience/NINDS Neuroscience Scholars Program (MAH; http://www.sfn.org/index.aspx?pagename = NeuroscienceScholars_Main). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; Al-Hallaq RA, 2001, J NEUROCHEM, V77, P110, DOI 10.1046/j.1471-4159.2001.t01-1-00210.x; Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Awobuluyi M, 2007, MOL PHARMACOL, V71, P112, DOI 10.1124/mol.106.03070; Brody SA, 2005, BIOL PSYCHIAT, V57, P1147, DOI 10.1016/j.biopsych.2005.01.024; Chan WS, 2003, NEUROSIGNALS, V12, P302, DOI 10.1159/000075312; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Douyard J, 2007, J COMP NEUROL, V502, P141, DOI 10.1002/cne.21294; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Eriksson M, 2007, PHYSIOL BEHAV, V92, P54, DOI 10.1016/j.physbeh.2007.05.026; Flint AC, 1997, J NEUROSCI, V17, P2469; Friedman LK, 2007, DEV NEUROSCI-BASEL, V29, P427, DOI 10.1159/000100078; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Hall BJ, 2007, J NEUROSCI, V27, P13446, DOI 10.1523/JNEUROSCI.3793-07.2007; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Henson MA, 2010, PROG NEUROBIOL, V91, P23, DOI 10.1016/j.pneurobio.2010.01.004; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Larsen RS, 2011, NAT NEUROSCI, V14, P338, DOI 10.1038/nn.2750; Lau WK, 2003, NEUROCHEM INT, V43, P47, DOI 10.1016/S0197-0186(02)00191-2; Laurie DJ, 1997, MOL BRAIN RES, V51, P23, DOI 10.1016/S0169-328X(97)00206-4; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Lim BK, 2008, NAT NEUROSCI, V11, P160, DOI 10.1038/nn2033; Lujan R, 2005, NEUROSCIENCE, V130, P567, DOI 10.1016/j.neuroscience.2004.09.042; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Martin LJ, 1998, NEUROSCIENCE, V83, P917, DOI 10.1016/S0306-4522(97)00411-9; Matsuda K, 2003, J NEUROSCI, V23, P10064; Matsuda K, 2002, MOL BRAIN RES, V100, P43, DOI 10.1016/S0169-328X(02)00173-0; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nakanishi N, 2009, J NEUROSCI, V29, P5260, DOI 10.1523/JNEUROSCI.1067-09.2009; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; Park HT, 1999, DEV BRAIN RES, V115, P83, DOI 10.1016/S0165-3806(99)00049-8; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Perez-Otano I, 2004, NEUROSIGNALS, V13, P175, DOI 10.1159/000077524; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Pina-Crespo JC, 2010, J NEUROSCI, V30, P11501, DOI 10.1523/JNEUROSCI.1593-10.2010; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; PorteraCailliau C, 1996, J NEUROCHEM, V66, P692, DOI 10.1046/j.1471-4159.1996.66020692.x; Prybylowski K, 2004, J BIOL CHEM, V279, P9673, DOI 10.1074/jbc.R300029200; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Ritter LM, 2002, DEV BRAIN RES, V139, P227, DOI 10.1016/S0165-3806(02)00572-2; RIVA MA, 1994, MOL BRAIN RES, V25, P209, DOI 10.1016/0169-328X(94)90155-4; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; Selcher JC, 2012, BRAIN RES, V1435, P8, DOI 10.1016/j.brainres.2011.11.029; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; Suen P, 1998, MOL BRAIN RES, V59, P215, DOI 10.1016/S0169-328X(98)00157-0; Tong G, 2008, J NEUROPHYSIOL, V99, P122, DOI 10.1152/jn.01044.2006; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tovar KR, 2002, NEURON, V34, P253; Tu SC, 2007, NEURON, V55, P69, DOI 10.1016/j.neuron.2007.06.021; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; VanDongen AMJ, 2004, NEUROSIGNALS, V13, P194, DOI 10.1159/000077526; Wada A, 2006, J NEUROSCI, V26, P13156, DOI 10.1523/JNEUROSCI.2552-06.2006; Wang CC, 2011, NEURON, V72, P789, DOI 10.1016/j.neuron.2011.09.023; Wenzel A, 1997, J NEUROCHEM, V68, P469; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314; Yashiro K, 2005, J NEUROSCI, V25, P11684, DOI 10.1523/JNEUROSCI.4362-05.2005; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; ZHONG J, 1995, J NEUROCHEM, V64, P531	75	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42327	10.1371/journal.pone.0042327	http://dx.doi.org/10.1371/journal.pone.0042327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870318	Green Published, Green Submitted, gold			2022-12-27	WOS:000307212800081
J	Schreiber, KJ; Ye, D; Fich, E; Jian, A; Lo, T; Desveaux, D				Schreiber, Karl J.; Ye, David; Fich, Eric; Jian, Allen; Lo, Timothy; Desveaux, Darrell			A High-Throughput Forward Genetic Screen Identifies Genes Required for Virulence of Pseudomonas syringae pv. maculicola ES4326 on Arabidopsis	PLOS ONE			English	Article							REDUCED VIRULENCE; SECRETION SYSTEM; TRANSPOSON TN5; TOMATO; MUTANTS; CBRAB; BIOSYNTHESIS; SPECIFICITY; GLUTAMINE; APOPLAST	Successful pathogenesis requires a number of coordinated processes whose genetic bases remain to be fully characterized. We utilized a high-throughput, liquid media-based assay to screen transposon disruptants of the phytopathogen Pseudomonas syringae pv. maculicola ES4326 to identify genes required for virulence on Arabidopsis. Many genes identified through this screen were involved in processes such as type III secretion, periplasmic glucan biosynthesis, flagellar motility, and amino acid biosynthesis. A small set of genes did not fall into any of these functional groups, and their disruption resulted in context-specific effects on in planta bacterial growth.	[Schreiber, Karl J.; Ye, David; Fich, Eric; Jian, Allen; Lo, Timothy; Desveaux, Darrell] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Desveaux, Darrell] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of Toronto	Schreiber, KJ (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	darrell.desveaux@utoronto.ca		Fich, Eric/0000-0002-8948-7112	Natural Science and Engineering Research Council (NSERC) of Canada; NSERC; Canadian Foundation for Innovation; Ontario Ministry of Research and Innovation	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	KS was supported by the Natural Science and Engineering Research Council (NSERC) of Canada. DD is a Canada Research Chair in Plant-Microbe Systems Biology. This work was supported by an NSERC Discovery Grant and awards from the Canadian Foundation for Innovation and the Ontario Ministry of Research and Innovation to DD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELBERG EA, 1956, ANNU REV BIOCHEM, V25, P349, DOI 10.1146/annurev.bi.25.070156.002025; ALEXEYEV MF, 1995, CAN J MICROBIOL, V41, P1053, DOI 10.1139/m95-147; Arnold C, 1991, PCR Methods Appl, V1, P39; Arnold DL, 2011, MOL PLANT PATHOL, V12, P617, DOI [10.1111/j.1364-3703.2010.00697.x, 10.1111/J.1364-3703.2010.00697.X]; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bashan Y, 2002, APPL ENVIRON MICROB, V68, P2637, DOI 10.1128/AEM.68.6.2637-2643.2002; BERG DE, 1983, GENETICS, V105, P813; BOYD LA, 1993, PLASMID, V30, P155, DOI 10.1006/plas.1993.1043; Brooks DM, 2004, MOL PLANT MICROBE IN, V17, P162, DOI 10.1094/MPMI.2004.17.2.162; Chand NS, 2011, J BACTERIOL, V193, P2989, DOI 10.1128/JB.01546-10; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; Damron FH, 2009, J BACTERIOL, V191, P2285, DOI 10.1128/JB.01490-08; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Deng WL, 2010, MOL PLANT MICROBE IN, V23, P1184, DOI 10.1094/MPMI-23-9-1184; Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299; Gao DJ, 2004, PLANT PHYSIOL, V134, P898, DOI 10.1104/pp.103.032508; Guenin-Mace L, 2009, TRANSBOUND EMERG DIS, V56, P255, DOI 10.1111/j.1865-1682.2009.01072.x; Haapalainen M, 2009, MOL PLANT MICROBE IN, V22, P282, DOI 10.1094/MPMI-22-3-0282; Hirano SS, 1999, P NATL ACAD SCI USA, V96, P9851, DOI 10.1073/pnas.96.17.9851; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; Hojo H, 2008, MICROBIOL-SGM, V154, P2920, DOI 10.1099/mic.0.2008/021097-0; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Katagiri F., 2002, ARABIDOPSIS BOOK; KING EO, 1954, J LAB CLIN MED, V44, P301; Kloek AP, 2000, MOL PLANT PATHOL, V1, P139, DOI 10.1046/j.1364-3703.2000.00016.x; Li W, 2007, J BACTERIOL, V189, P5413, DOI 10.1128/JB.00432-07; LINDOW SE, 1993, APPL ENVIRON MICROB, V59, P1593, DOI 10.1128/AEM.59.5.1593-1601.1993; Liu GS, 2010, PLANT CELL, V22, P3845, DOI 10.1105/tpc.110.079392; Munoz-Bertomeu J, 2009, PLANT PHYSIOL, V151, P541, DOI 10.1104/pp.109.143701; Nishijyo T, 2001, MOL MICROBIOL, V40, P917, DOI 10.1046/j.1365-2958.2001.02435.x; Penaloza-Vazquez A, 2010, ENVIRON MICROBIOL, V12, P1452, DOI 10.1111/j.1462-2920.2010.02160.x; Pilot G, 2004, PLANT CELL, V16, P1827, DOI 10.1105/tpc.021642; Pratelli R, 2010, PLANT PHYSIOL, V152, P762, DOI 10.1104/pp.109.151746; Preiter K, 2005, J BACTERIOL, V187, P7805, DOI 10.1128/JB.187.22.7805-7814.2005; Rainey PB, 1997, MOL GEN GENET, V256, P84, DOI 10.1007/s004380050548; Rico A, 2008, MOL PLANT MICROBE IN, V21, P269, DOI 10.1094/MPMI-21-2-0269; Roessner-Tunali U, 2003, PLANT PHYSIOL, V133, P683, DOI 10.1104/pp.103.024802; Schreiber K, 2008, PLANT J, V54, P522, DOI 10.1111/j.1365-313X.2008.03425.x; Schreiber KJ, 2011, MOL MICROBIOL, V80, P364, DOI 10.1111/j.1365-2958.2011.07571.x; SCHULMAN H, 1977, J BIOL CHEM, V252, P6299; Silipo A, 2010, GLYCOBIOLOGY, V20, P406, DOI 10.1093/glycob/cwp201; Smith KS, 2000, FEMS MICROBIOL REV, V24, P335, DOI 10.1016/S0168-6445(00)00030-9; SOMLYAI G, 1986, PHYSIOL MOL PLANT P, V29, P369, DOI 10.1016/S0048-4059(86)80053-4; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Wang L, 2007, APPL ENVIRON MICROB, V73, P8023, DOI 10.1128/AEM.01414-07; Yeung ATY, 2011, J BACTERIOL, V193, P918, DOI 10.1128/JB.00911-10; Zhang XX, 2008, GENETICS, V178, P185, DOI 10.1534/genetics.107.081984; Zhang XX, 2010, ENVIRON MICROBIOL, V12, P1674, DOI 10.1111/j.1462-2920.2010.02228.x	49	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41461	10.1371/journal.pone.0041461	http://dx.doi.org/10.1371/journal.pone.0041461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870224	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800021
J	Yan, R; Ji, HL; Wu, YH; Kerr, PG; Fang, YM; Yang, LZ				Yan, Rong; Ji, Hongli; Wu, Yonghong; Kerr, Philip G.; Fang, Yanming; Yang, Linzhang			An Investigation into the Kinetics and Mechanism of the Removal of Cyanobacteria by Extract of Ephedra equisetina Root	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; GREEN-ALGAE; GENE; EXPOSURE; STRAINS; BLOOMS; GROWTH; STATE; FLAA	An aqueous extract of Ephedra equisetina root was found to induce cyanobacterial cell death. The extract displayed no negative effects on the fish populations but instead, improved the habitat conditions for the growth of macrophytes, zooplankton and bacteria because the inhibiting effects of the extracts on cyanobacteria helped clear up the water column. The removal kinetics of cyanobacteria by E. equisetina extract appears to be a first order process with the rate constant being extract-dose-dependent. Compounds including the flavonoids found in E. equisetina root kill the cyanobacteria in vitro at a dose of 5.0 mu g extract per 100 mL water or above. The extract constituents act to disrupt the thylakoid membrane, interrupt the electronic transport, decrease the effective quantum yield, and eventually lead to the failure of photosynthesis in Microcystis aeruginosa. This study presents an easily-deployed, natural and promising approach for controlling cyanobacterial blooms as an emergency measure, and also provides insight into the dynamics and mechanism of the extract consisting of multiple compounds synergistically removing algae.	[Yan, Rong; Ji, Hongli; Fang, Yanming] Nanjing Forestry Univ, Coll Forest Resource & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Yan, Rong; Wu, Yonghong; Yang, Linzhang] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Kerr, Philip G.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia	Nanjing Forestry University; Chinese Academy of Sciences; Institute of Soil Science, CAS; Charles Sturt University	Yan, R (corresponding author), Nanjing Forestry Univ, Coll Forest Resource & Environm Sci, Nanjing, Jiangsu, Peoples R China.	yhwu@issas.ac.cn; jwu4@njfu.edu.cn	Kerr, Philip/B-4212-2013; Wu, Yonghong/B-4501-2010	Kerr, Philip/0000-0002-6406-0593; Wu, Yonghong/0000-0002-2985-219X	Priority Academic Program Development of Jiangsu High Education Institutions (PAPD); Doctorate Fellowship Foundation of Nanjing Forestry University; Innovative Project of Graduate Students in University, Jiangsu, China	Priority Academic Program Development of Jiangsu High Education Institutions (PAPD); Doctorate Fellowship Foundation of Nanjing Forestry University; Innovative Project of Graduate Students in University, Jiangsu, China	This work was jointly supported by the Priority Academic Program Development of Jiangsu High Education Institutions (PAPD), the Doctorate Fellowship Foundation of Nanjing Forestry University and the Innovative Project of Graduate Students in University, Jiangsu, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliotta G, 2005, J CHEM ECOL, V16, P9; [Anonymous], 2017, STANDARD METHODS EXA; Assmy P., 2009, ENCY MICROBIOLOGY, P27, DOI DOI 10.1016/B978-012373944-5.00001-8; Bagheri-Gavkosh S, 2009, MYCOPATHOLOGIA, V168, P249, DOI 10.1007/s11046-009-9220-x; Barrington DJ, 2008, ENVIRON SCI TECHNOL, V42, P8916, DOI 10.1021/es801717y; Cook NC, 1996, J NUTR BIOCHEM, V7, P66, DOI 10.1016/0955-2863(95)00168-9; del Pozo R, 2010, AQUAT BOT, V92, P55, DOI 10.1016/j.aquabot.2009.10.003; DeNobel WT, 1997, FEMS MICROBIOL ECOL, V24, P259, DOI 10.1111/j.1574-6941.1997.tb00443.x; Di Giovanni GD, 1999, CURR MICROBIOL, V38, P217, DOI 10.1007/PL00006790; Diaz M, 2007, LIMNOLOGICA, V37, P17, DOI 10.1016/j.limno.2006.08.006; Drabkova M, 2007, ENVIRON SCI TECHNOL, V41, P309, DOI 10.1021/es060746i; Dziga D, 2007, ENVIRON TOXICOL, V22, P341, DOI 10.1002/tox.20276; Ferrier MD, 2005, BIORESOURCE TECHNOL, V96, P1788, DOI 10.1016/j.biortech.2005.01.021; Gobler CJ, 2008, HARMFUL ALGAE, V7, P293, DOI 10.1016/j.hal.2007.12.006; Golterman H. L., 1969, IBP HDB, V8; GRAY DI, 1995, LETT APPL MICROBIOL, V20, P65, DOI 10.1111/j.1472-765X.1995.tb00409.x; HANASAKI Y, 1994, FREE RADICAL BIO MED, V16, P845, DOI 10.1016/0891-5849(94)90202-X; Jersek B, 1999, J CLIN MICROBIOL, V37, P103; Jin Q, 2003, J EXP MAR BIOL ECOL, V293, P41, DOI 10.1016/S0022-0981(03)00214-4; Kim IS, 2010, INT IMMUNOPHARMACOL, V10, P1616, DOI 10.1016/j.intimp.2010.09.019; Kuhnau J, 1976, WORLD REV NUTR DIET, V24, P8; Li FM, 2005, APPL ENVIRON MICROB, V71, P6545, DOI 10.1128/AEM.71.11.6545-6553.2005; Miao SY, 2006, SCI TOTAL ENVIRON, V371, P334, DOI 10.1016/j.scitotenv.2006.07.027; Nakai S, 2000, WATER RES, V34, P3026, DOI 10.1016/S0043-1354(00)00039-7; Nakai S, 2005, HYDROBIOLOGIA, V543, P71, DOI 10.1007/s10750-004-6822-7; NAWWAR MAM, 1984, PHYTOCHEMISTRY, V23, P2937, DOI 10.1016/0031-9422(84)83045-9; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; RIPPKA R., 1992, PASTEUR CULTURE COLL, V1; Schreiber U, 2002, PHOTOSYNTH RES, V74, P317, DOI 10.1023/A:1021276003145; Sekizuka T, 2007, J BASIC MICROB, V47, P63, DOI 10.1002/jobm.200610194; Shao JH, 2009, CHEMOSPHERE, V75, P924, DOI 10.1016/j.chemosphere.2009.01.021; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith GJ, 2000, J PHOTOCH PHOTOBIO A, V136, P87, DOI 10.1016/S1010-6030(00)00320-8; SPENCER CM, 1988, PHYTOCHEMISTRY, V27, P2397, DOI 10.1016/0031-9422(88)87004-3; Svrcek C, 2004, J ENVIRON ENG SCI, V3, P155, DOI 10.1139/S04-010; Weaver Warren, 1949, DROP CITATION; Wu Y, 2008, ALLELOPATHY J, V22; Wu YH, 2010, BIORESOURCE TECHNOL, V101, P3903, DOI 10.1016/j.biortech.2009.12.144; Yang W.D., 2005, CHIN ENV SCI, V25, P1	40	12	16	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42285	10.1371/journal.pone.0042285	http://dx.doi.org/10.1371/journal.pone.0042285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870313	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800076
J	Dieudonne, A; Torres, D; Blanchard, S; Taront, S; Jeannin, P; Delneste, Y; Pichavant, M; Trottein, F; Gosset, P				Dieudonne, Audrey; Torres, David; Blanchard, Simon; Taront, Solenne; Jeannin, Pascale; Delneste, Yves; Pichavant, Muriel; Trottein, Francois; Gosset, Philippe			Scavenger Receptors in Human Airway Epithelial Cells: Role in Response to Double-Stranded RNA	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; THYMIC STROMAL LYMPHOPOIETIN; MEMBRANE PROTEIN-A; NF-KAPPA-B; DENDRITIC CELLS; TNF-ALPHA; NEUTROPHIL RECRUITMENT; IMMUNE RECOGNITION; ENDOTHELIAL-CELLS; INNATE IMMUNITY	Scavenger receptors and Toll-like receptors (TLRs) cooperate in response to danger signals to adjust the host immune response. The TLR3 agonist double stranded (ds) RNA is an efficient activator of innate signalling in bronchial epithelial cells. In this study, we aimed at defining the role played by scavenger receptors expressed by bronchial epithelial cells in the control of the innate response to dsRNA both in vitro and in vivo. Expression of several scavenger receptor involved in pathogen recognition was first evaluated in human bronchial epithelial cells in steady-state and inflammatory conditions. Their implication in the uptake of dsRNA and the subsequent cell activation was evaluated in vitro by competition with ligand of scavenger receptors including maleylated ovalbumin and by RNA silencing. The capacity of maleylated ovalbumin to modulate lung inflammation induced by dsRNA was also investigated in mice. Exposure to tumor necrosis factor-a increased expression of the scavenger receptors LOX-1 and CXCL16 and the capacity to internalize maleylated ovalbumin, whereas activation by TLR ligands did not. In contrast, the expression of SR-B1 was not modulated in these conditions. Interestingly, supplementation with maleylated ovalbumin limited dsRNA uptake and inhibited subsequent activation of bronchial epithelial cells. RNA silencing of LOX-1 and SR-B1 strongly blocked the dsRNA-induced cytokine production. Finally, administration of maleylated ovalbumin in mice inhibited the dsRNA-induced infiltration and activation of inflammatory cells in bronchoalveolar spaces and lung draining lymph nodes. Together, our data characterize the function of SR-B1 and LOX-1 in bronchial epithelial cells and their implication in dsRNA-induced responses, a finding that might be relevant during respiratory viral infections.	[Dieudonne, Audrey; Torres, David; Pichavant, Muriel; Trottein, Francois; Gosset, Philippe] Ctr Infect & Immun Lille, Inst Pasteur Lille, Lille, France; [Dieudonne, Audrey; Torres, David; Taront, Solenne; Pichavant, Muriel; Trottein, Francois; Gosset, Philippe] Univ Lille Nord France, Lille, France; [Dieudonne, Audrey; Torres, David; Taront, Solenne; Pichavant, Muriel; Trottein, Francois; Gosset, Philippe] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8204, F-59019 Lille, France; [Dieudonne, Audrey; Torres, David; Pichavant, Muriel; Trottein, Francois; Gosset, Philippe] Inst Natl Sante & Rech Med, U1019, Lille, France; [Dieudonne, Audrey; Torres, David; Pichavant, Muriel; Trottein, Francois; Gosset, Philippe] Inst Federatif Rech 142, Lille, France; [Dieudonne, Audrey] CH Valenciennes, Serv Hematol Immunol Cytogenet, Valenciennes, France; [Blanchard, Simon; Jeannin, Pascale; Delneste, Yves] Univ Angers, LUNAM Univ, Angers, France; [Blanchard, Simon; Jeannin, Pascale; Delneste, Yves] Ctr Rech Cancerol Nantes Angers, U892, INSERM, Nantes, France; [Blanchard, Simon; Jeannin, Pascale; Delneste, Yves] CNRS, Unit 6299, Angers, France; [Blanchard, Simon; Jeannin, Pascale; Delneste, Yves] Univ Angers, CHU Angers, Lab Immunol & Allergol, Angers, France; [Taront, Solenne] IBL, CNRS, UMR8199, Lille, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; CH de Valenciennes; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Dieudonne, A (corresponding author), Ctr Infect & Immun Lille, Inst Pasteur Lille, Lille, France.	Philippe.Gosset@pasteur-lille.fr	Pichavant, Muriel/B-9036-2018; JEANNIN, Pascale/K-8656-2015; DELNESTE, Yves/K-7367-2015; TROTTEIN, Francois/C-2405-2018; Gosset, Philippe/C-6174-2018; Blanchard, Simon/L-1417-2015; Delneste, Yves/O-3956-2016; DEZITTER, Solenne/N-5219-2018	Pichavant, Muriel/0000-0002-1315-4397; DELNESTE, Yves/0000-0002-2142-596X; TROTTEIN, Francois/0000-0003-3373-1814; Gosset, Philippe/0000-0002-4043-6429; JEANNIN, Pascale/0000-0002-3666-3856; DEZITTER, Solenne/0000-0001-5850-7291	Agence de l'Environnement et de la Maitrise de l'Energie (ADEME); Conseil Regional Nord-Pas-De-Calais; FRM; fondation pour la recherche medicale (FRM) (Paris, France); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre national de recherche scientifique (CNRS); University of Lille Nord de France; Pasteur Institute of Lille; University of Angers (France)	Agence de l'Environnement et de la Maitrise de l'Energie (ADEME); Conseil Regional Nord-Pas-De-Calais(Region Hauts-de-France); FRM(Fondation pour la Recherche Medicale); fondation pour la recherche medicale (FRM) (Paris, France)(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre national de recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Lille Nord de France; Pasteur Institute of Lille; University of Angers (France)	ST was supported by a grant from Agence de l'Environnement et de la Maitrise de l'Energie (ADEME) and Conseil Regional Nord-Pas-De-Calais. DT received a grant from the FRM. This study was supported by a grant from the fondation pour la recherche medicale (FRM) (Paris, France). This work was supported by the Institut National de la Sante et de la Recherche Medicale (Inserm), the Centre national de recherche scientifique (CNRS), the University of Lille Nord de France, the Pasteur Institute of Lille. PJ is supported by the University of Angers (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; ABRAHAM R, 1995, J IMMUNOL, V154, P1; Ahmed RAM, 2009, ENDOCRINE, V35, P233, DOI 10.1007/s12020-008-9142-2; Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Basu S, 2004, AM J PHYSIOL-LUNG C, V286, pL887, DOI 10.1152/ajplung.00323.2003; Calven J, 2012, J INNATE IMMUN, V4, P86, DOI 10.1159/000329131; Chiba Y, 2001, BIOCHEM BIOPH RES CO, V286, P541, DOI 10.1006/bbrc.2001.5361; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; DeWitte-Orr SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000829; Edwards MR, 2007, MOL IMMUNOL, V44, P1587, DOI 10.1016/j.molimm.2006.08.014; Fujimoto C, 2004, INT IMMUNOL, V16, P55, DOI 10.1093/intimm/dxh025; Ganesan S, 2012, AM J PATHOL, V180, P61, DOI 10.1016/j.ajpath.2011.09.029; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Gursel M, 2006, J IMMUNOL, V177, P1575, DOI 10.4049/jimmunol.177.3.1575; HABERLAND ME, 1985, P NATL ACAD SCI USA, V82, P2693, DOI 10.1073/pnas.82.9.2693; HABERLAND ME, 1989, J IMMUNOL, V142, P855; Han HJ, 1998, HUM MOL GENET, V7, P1039, DOI 10.1093/hmg/7.6.1039; Hippenstiel S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-97; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Holgate ST, 2000, AM J RESP CRIT CARE, V162, pS113, DOI 10.1164/ajrccm.162.supplement_2.ras-12; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Jeannin P, 2000, NAT IMMUNOL, V1, P502, DOI 10.1038/82751; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Matsukura S, 2006, CLIN EXP ALLERGY, V36, P1049, DOI 10.1111/j.1365-2222.2006.02530.x; Mayer AK, 2007, J IMMUNOL, V178, P3134, DOI 10.4049/jimmunol.178.5.3134; Mukhopadhyay S, 2011, BLOOD, V117, P1319, DOI 10.1182/blood-2010-03-276733; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; Newcomb DC, 2007, AM J PHYSIOL-LUNG C, V293, pL1021, DOI 10.1152/ajplung.00060.2007; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Park HS, 2000, ANN ALLERG ASTHMA IM, V84, P623, DOI 10.1016/S1081-1206(10)62414-3; Pearson AM, 1996, CURR OPIN IMMUNOL, V8, P20, DOI 10.1016/S0952-7915(96)80100-2; Pichavant M, 2003, J IMMUNOL, V171, P6697, DOI 10.4049/jimmunol.171.12.6697; Pluddemann A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000297; Ritter Mirko, 2005, J Inflamm (Lond), V2, P16, DOI 10.1186/1476-9255-2-16; Sadik CD, 2009, NUCLEIC ACIDS RES, V37, P5041, DOI 10.1093/nar/gkp525; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Takizawa H, 1998, INT J MOL MED, V1, P367; Taront S, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-9; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Torres D, 2010, J IMMUNOL, V185, P451, DOI 10.4049/jimmunol.0902833; Uller L, 2010, THORAX, V65, P626, DOI 10.1136/thx.2009.125930; Wagsater D, 2004, BIOCHEM BIOPH RES CO, V325, P1187, DOI 10.1016/j.bbrc.2004.10.160; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yanyan JY, 2006, J BIOL CHEM, V281, P11834, DOI 10.1074/jbc.M507599200	46	36	36	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41952	10.1371/journal.pone.0041952	http://dx.doi.org/10.1371/journal.pone.0041952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879901	Green Published, gold, Green Submitted			2022-12-27	WOS:000307437900017
J	Hsu, JC; Chien, TY; Hu, CC; Chen, MJM; Wu, WJ; Feng, HT; Haymer, DS; Chen, CY				Hsu, Ju-Chun; Chien, Ting-Ying; Hu, Chia-Cheng; Chen, Mei-Ju May; Wu, Wen-Jer; Feng, Hai-Tung; Haymer, David S.; Chen, Chien-Yu			Discovery of Genes Related to Insecticide Resistance in Bactrocera dorsalis by Functional Genomic Analysis of a De Novo Assembled Transcriptome	PLOS ONE			English	Article							DETOXIFICATION ENZYMES; KNOCKDOWN RESISTANCE; FRUIT-FLIES; DROSOPHILA; EVOLUTION; FAMILY; GENERATION; DIPTERA; P450; IDENTIFICATION	Insecticide resistance has recently become a critical concern for control of many insect pest species. Genome sequencing and global quantization of gene expression through analysis of the transcriptome can provide useful information relevant to this challenging problem. The oriental fruit fly, Bactrocera dorsalis, is one of the world's most destructive agricultural pests, and recently it has been used as a target for studies of genetic mechanisms related to insecticide resistance. However, prior to this study, the molecular data available for this species was largely limited to genes identified through homology. To provide a broader pool of gene sequences of potential interest with regard to insecticide resistance, this study uses whole transcriptome analysis developed through de novo assembly of short reads generated by next-generation sequencing (NGS). The transcriptome of B. dorsalis was initially constructed using Illumina's Solexa sequencing technology. Qualified reads were assembled into contigs and potential splicing variants (isotigs). A total of 29,067 isotigs have putative homologues in the non-redundant (nr) protein database from NCBI, and 11,073 of these correspond to distinct D. melanogaster proteins in the RefSeq database. Approximately 5,546 isotigs contain coding sequences that are at least 80% complete and appear to represent B. dorsalis genes. We observed a strong correlation between the completeness of the assembled sequences and the expression intensity of the transcripts. The assembled sequences were also used to identify large numbers of genes potentially belonging to families related to insecticide resistance. A total of 90 P450-, 42 GST-and 37 COE-related genes, representing three major enzyme families involved in insecticide metabolism and resistance, were identified. In addition, 36 isotigs were discovered to contain target site sequences related to four classes of resistance genes. Identified sequence motifs were also analyzed to characterize putative polypeptide translational products and associate them with specific genes and protein functions.	[Hsu, Ju-Chun; Wu, Wen-Jer] Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan; [Hsu, Ju-Chun; Wu, Wen-Jer] Natl Taiwan Univ, Res Ctr Plant Med, Taipei 10764, Taiwan; [Chien, Ting-Ying] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Hu, Chia-Cheng; Chen, Chien-Yu] Natl Taiwan Univ, Dept Bioind Mechatron Engn, Taipei 10764, Taiwan; [Chen, Mei-Ju May; Chen, Chien-Yu] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan; [Feng, Hai-Tung] Council Agr, Taiwan Agr Chem & Tox Subst Res Inst, Taichung, Taiwan; [Haymer, David S.] Univ Hawaii Manoa, Dept Cell & Mol Biol, Honolulu, HI USA	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; University of Hawaii System; University of Hawaii Manoa	Hsu, JC (corresponding author), Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan.	cychen@mars.csie.ntu.edu.tw	Hsu, Ju-Chun/K-2917-2012; Chu, Shu-Chuan/AFQ-6798-2022	Hsu, Ju-Chun/0000-0002-8058-5090; Chu, Shu-Chuan/0000-0003-2117-0618; CHEN, CHIEN-YU/0000-0002-6940-6389	National Science Council of Republic of China, Taiwan [96-2313-B-225-001-MY3, 98-2221-E-002-137-MY2, 99-2627-B-002-004]	National Science Council of Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank National Science Council of Republic of China, Taiwan, for the financial support under the contracts: 96-2313-B-225-001-MY3, 98-2221-E-002-137-MY2 and 99-2627-B-002-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], FRUIT FLIES EC IMPOR; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000802; Beverley SM, 1984, J MOL EVOL, V21, P139; Chien TY, 2008, NUCLEIC ACIDS RES, V36, pW291, DOI 10.1093/nar/gkn324; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; DREW RAI, 1994, B ENTOMOL RES, P1, DOI 10.1017/S1367426900000278; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; FFRENCHCONSTANT RH, 1991, P NATL ACAD SCI USA, V88, P7209, DOI 10.1073/pnas.88.16.7209; Fletcher B.S., 1989, FRUIT FLIES THEIR B, P195; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; HE M, 1995, J MOL EVOL, V41, P141, DOI 10.1007/BF00170665; HOSIE AM, 1995, BRIT J PHARMACOL, V115, P909, DOI 10.1111/j.1476-5381.1995.tb15896.x; Hosie AM, 1997, TRENDS NEUROSCI, V20, P578, DOI 10.1016/S0166-2236(97)01127-2; Hsu CM, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-6; Hsu JC, 2004, J ECON ENTOMOL, V97, P1682, DOI 10.1603/0022-0493-97.5.1682; Hsu JC, 2008, INSECT BIOCHEM MOLEC, V38, P146, DOI 10.1016/j.ibmb.2007.10.002; Hsu JC, 2006, INSECT BIOCHEM MOLEC, V36, P396, DOI 10.1016/j.ibmb.2006.02.002; Jones AK, 2005, GENOMICS, V85, P176, DOI 10.1016/j.ygeno.2004.09.001; Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206; KAO PN, 1986, J BIOL CHEM, V261, P8085; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Lansdell SJ, 2000, NEUROPHARMACOLOGY, V39, P2604, DOI 10.1016/S0028-3908(00)00111-8; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Low WY, 2007, GENETICS, V177, P1363, DOI 10.1534/genetics.107.075838; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Muraji M, 2001, INSECT MOL BIOL, V10, P549, DOI 10.1046/j.0962-1075.2001.00294.x; Perry T, 2007, INSECT BIOCHEM MOLEC, V37, P184, DOI 10.1016/j.ibmb.2006.11.009; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Rinkevich FD, 2009, INSECT MOL BIOL, V18, P233, DOI 10.1111/j.1365-2583.2009.00873.x; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Roessler Y, 1989, INSECTICIDAL BAIT CO, P329; Sattelle DB, 2005, BIOESSAYS, V27, P366, DOI 10.1002/bies.20207; Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X; Shao YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-324; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Soderlund DM, 2008, PEST MANAG SCI, V64, P610, DOI 10.1002/ps.1574; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; ten Bosch JR, 2008, J MOL DIAGN, V10, P484, DOI 10.2353/jmoldx.2008.080027; Vontas J, 2011, PESTIC BIOCHEM PHYS, V100, P199, DOI 10.1016/j.pestbp.2011.04.004; Wang YJ, 2008, J STRUCT BIOL, V164, P228, DOI 10.1016/j.jsb.2008.08.003; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	53	38	45	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e40950	10.1371/journal.pone.0040950	http://dx.doi.org/10.1371/journal.pone.0040950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879883	Green Submitted, gold, Green Published			2022-12-27	WOS:000307437900006
J	Huang, YN; Zhang, YL; Wu, Y; Wang, J; Liu, XG; Dai, LS; Wang, LS; Yu, M; Mo, W				Huang, Yinong; Zhang, Yanling; Wu, Yi; Wang, Jue; Liu, Xingang; Dai, Linsen; Wang, Longsheng; Yu, Min; Mo, Wei			Expression, Purification, and Mass Spectrometric Analysis of N-15, C-13-Labeled RGD-Hirudin, Expressed in Pichia pastoris, for NMR Studies	PLOS ONE			English	Article							SPECTROSCOPY; PROTEIN; THROMBOCYTOPENIA; SENSITIVITY; HEPARIN	A novel recombinant hirudin, RGD-hirudin, inhibits the activity of thrombin and the aggregation of platelets. Here, we successfully expressed N-15, C-13-labeled RGD-hirudin in Pichia pastoris in a fermenter. The protein was subsequently purified to yield sufficient quantities for structural and functional studies. The purified protein was characterized by HPLC and MALDI-TOF mass spectroscopy. Analysis revealed that the protein was pure and uniformly labeled with N-15 and C-13. A bioassay showed that the anti-thrombin activity and the anti-platelet aggregation ability of the labeled protein were the same as those of unlabeled RGD-hirudin. Multidimensional heteronuclear NMR spectroscopy has been used to determine almost complete backbone N-15, C-13 and H-1 resonance assignments of the r-RGD-Hirudin. The N-15-H-1 HSQC spectrum of uniformly N-15, C-13-labeled RGD-hirudin allowed successful assignment of the signals. Examples of the quality of the data are provided for the N-15-H-1 correlation spectrum, and by selected planes of the CBCA(CO)NH, CBCANH, and HNCO experiments. These results provide a basis for further studies on the structure-function relationship of RGD-hirudin with thrombin and platelets.	[Huang, Yinong; Zhang, Yanling; Wu, Yi; Wang, Longsheng; Yu, Min; Mo, Wei] Fudan Univ, Key Lab Mol Med, Minist Educ, Shanghai 200433, Peoples R China; [Huang, Yinong; Zhang, Yanling; Wu, Yi; Wang, Longsheng; Yu, Min; Mo, Wei] Fudan Univ, Dept Biochem & Mol Biol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wang, Jue; Liu, Xingang; Dai, Linsen] Fudan Univ, Ctr Anal & Measurement, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Huang, YN (corresponding author), Fudan Univ, Key Lab Mol Med, Minist Educ, Shanghai 200433, Peoples R China.	minyu@shmu.edu.cn; weimo1025@shmu.edu.cn			Foundation of Ministry of Science and Technology of the People's Republic of China [2009ZX09503-006]	Foundation of Ministry of Science and Technology of the People's Republic of China	This study was supported by the Foundation of Ministry of Science and Technology of the People's Republic of China (2009ZX09503-006). The funders had no role in study design, data collection and analysis, decision to publish, or praparation of the manuscript.	AMIRAL J, 1992, THROMB HAEMOSTASIS, V68, P95; Cubeddu L, 2000, PROTEIN EXPRES PURIF, V19, P335, DOI 10.1006/prep.2000.1269; Denton H, 1998, PROTEIN EXPRES PURIF, V14, P97, DOI 10.1006/prep.1998.0924; ERNST JF, 1988, TRENDS BIOTECHNOL, V6, P196, DOI 10.1016/0167-7799(88)90046-7; GARRETT DS, 1994, BIOCHEMISTRY-US, V33, P2852, DOI 10.1021/bi00176a015; GREINACHER A, 1994, THROMB HAEMOSTASIS, V71, P247; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kay LE, 1990, J MAGN RESON, V213, P423, DOI DOI 10.1016/J.JMR.2011.09.004; MARKWARDT F, 1992, CARDIOVASC DRUG REV, V10, P211, DOI 10.1111/j.1527-3466.1992.tb00247.x; MARKWARDT F, 1967, H-S Z PHYSIOL CHEM, V348, P1381, DOI 10.1515/bchm2.1967.348.1.1381; MARKWARDT F, 1994, THROMB RES, V74, P1, DOI 10.1016/0049-3848(94)90032-9; Mo Wei, 2004, Sheng Wu Gong Cheng Xue Bao, V20, P126; Mo W, 2009, J THROMB THROMBOLYS, V28, P230, DOI 10.1007/s11239-008-0251-9; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Song X, 2007, BIOCHEM BIOPH RES CO, V360, P103, DOI 10.1016/j.bbrc.2007.06.014; Sun Z, 2009, MOL BIOL REP, V36, P1119, DOI 10.1007/s11033-008-9287-3; Wallis RB, 1996, SEMIN THROMB HEMOST, V22, P185, DOI 10.1055/s-2007-999007; Wang J, 2010, PROTEIN PEPTIDE LETT, V17, P1228, DOI 10.2174/092986610792231465; Warkentin TE, 2004, BEST PRACT RES CL HA, V17, P105, DOI 10.1016/j.beha.2004.02.002; Wendeler M, 2004, PROTEIN EXPRES PURIF, V34, P147, DOI 10.1016/j.pep.2003.11.010; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wood MJ, 1999, J BIOMOL NMR, V13, P149, DOI 10.1023/A:1008398313350	25	10	10	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42207	10.1371/journal.pone.0042207	http://dx.doi.org/10.1371/journal.pone.0042207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879918	Green Published, Green Submitted, gold			2022-12-27	WOS:000307437900025
J	Joucla, S; Branchereau, P; Cattaert, D; Yvert, B				Joucla, Sebastien; Branchereau, Pascal; Cattaert, Daniel; Yvert, Blaise			Extracellular Neural Microstimulation May Activate Much Larger Regions than Expected by Simulations: A Combined Experimental and Modeling Study	PLOS ONE			English	Article							SPINAL-CORD STIMULATION; DEEP BRAIN-STIMULATION; NERVOUS-SYSTEM NEURONS; ELECTRICAL MICROSTIMULATION; CORTICAL-NEURONS; RHYTHMIC ACTIVITY; CEREBRAL-CORTEX; MOTOR CORTEX; SPREAD; EXCITATION	Electrical stimulation of the central nervous system has been widely used for decades for either fundamental research purposes or clinical treatment applications. Yet, very little is known regarding the spatial extent of an electrical stimulation. If pioneering experimental studies reported that activation threshold currents (TCs) increase with the square of the neuron-to-electrode distance over a few hundreds of microns, there is no evidence that this quadratic law remains valid for larger distances. Moreover, nowadays, numerical simulation approaches have supplanted experimental studies for estimating TCs. However, model predictions have not yet been validated directly with experiments within a common paradigm. Here, we present a direct comparison between experimental determination and modeling prediction of TCs up to distances of several millimeters. First, we combined patch-clamp recording and microelectrode array stimulation in whole embryonic mouse spinal cords to determine TCs. Experimental thresholds did not follow a quadratic law beyond 1 millimeter, but rather tended to remain constant for distances larger than 1 millimeter. We next built a combined finite element - compartment model of the same experimental paradigm to predict TCs. While theoretical TCs closely matched experimental TCs for distances <250 microns, they were highly overestimated for larger distances. This discrepancy remained even after modifications of the finite element model of the potential field, taking into account anisotropic, heterogeneous or dielectric properties of the tissue. In conclusion, these results show that quadratic evolution of TCs does not always hold for large distances between the electrode and the neuron and that classical models may underestimate volumes of tissue activated by electrical stimulation.	[Joucla, Sebastien; Branchereau, Pascal; Cattaert, Daniel; Yvert, Blaise] Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, UMR5287, Talence, France; [Joucla, Sebastien; Branchereau, Pascal; Cattaert, Daniel; Yvert, Blaise] CNRS, Inst Neurosci Cognit & Integrat Aquitaine, UMR5287, Talence, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Joucla, S (corresponding author), Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, UMR5287, Talence, France.	blaise.yvert@u-bordeaux1.fr	Cattaert, Daniel/D-8630-2014; Branchereau, Pascal/B-9206-2011; Yvert, Blaise/E-9052-2016	Branchereau, Pascal/0000-0003-3972-8229; Yvert, Blaise/0000-0002-8850-7935	French ministry for research and technology (RMNT Neurocom project) [03J489]; French ministry for research and technology (ACI Neurosciences Integratives et Computationnelles) [2003541]; French National Research Agency (ANR) [ANR06BLAN035601, ANR07TECSAN01404]; Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME); Region Aquitaine [20030301201A, 20040301202A]; European Union (EU)	French ministry for research and technology (RMNT Neurocom project); French ministry for research and technology (ACI Neurosciences Integratives et Computationnelles); French National Research Agency (ANR)(French National Research Agency (ANR)); Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME); Region Aquitaine(Region Nouvelle-Aquitaine); European Union (EU)(CGIAREuropean Commission)	This work was supported by the French ministry for research and technology (RMNT Neurocom project No 03J489 and ACI Neurosciences Integratives et Computationnelles No 2003541), the French National Research Agency (ANR - Programme Blanc No ANR06BLAN035601 and Programme TecSan No ANR07TECSAN01404), the Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME), the Region Aquitaine (No 20030301201A and 20040301202A), and the European Union (EU) FP7 program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABZUG C, 1974, J PHYSIOL-LONDON, V243, P499, DOI 10.1113/jphysiol.1974.sp010764; Adrian ED, 1936, J PHYSIOL-LONDON, V88, P127, DOI 10.1113/jphysiol.1936.sp003427; BAGSHAW EV, 1976, EXP BRAIN RES, V25, P391; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Bossetti CA, 2008, J NEURAL ENG, V5, P44, DOI 10.1088/1741-2560/5/1/005; Branchereau P, 2002, J NEUROSCI, V22, P2598, DOI 10.1523/JNEUROSCI.22-07-02598.2002; BROOKS VB, 1959, J GEN PHYSIOL, V42, P761, DOI 10.1085/jgp.42.4.761; Butson CR, 2006, J NEURAL ENG, V3, P1, DOI 10.1088/1741-2560/3/1/001; CLARK GM, 1977, J LARYNGOL OTOL, V91, P935, DOI 10.1017/S0022215100084607; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Delpy A, 2008, J PHYSIOL-LONDON, V586, P1059, DOI 10.1113/jphysiol.2007.146993; Djilas M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046020; Eytan D, 2003, J NEUROSCI, V23, P9349; GUSTAFSSON B, 1976, J PHYSIOL-LONDON, V258, P33, DOI 10.1113/jphysiol.1976.sp011405; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Heuschkel MO, 2002, J NEUROSCI METH, V114, P135, DOI 10.1016/S0165-0270(01)00514-3; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; Joucla S, 2012, J PHYSIOL-PARIS, V106, P146, DOI 10.1016/j.jphysparis.2011.10.003; Joucla S, 2009, BIOPHYS J, V96, P3495, DOI 10.1016/j.bpj.2008.12.3961; Joucla S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004828; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Manola L, 2007, CLIN NEUROPHYSIOL, V118, P464, DOI 10.1016/j.clinph.2006.09.012; McIntyre CC, 1999, BIOPHYS J, V76, P878, DOI 10.1016/S0006-3495(99)77251-6; McIntyre CC, 2000, ANN BIOMED ENG, V28, P219, DOI 10.1114/1.262; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; McIntyre CC, 2002, J NEUROPHYSIOL, V88, P1592, DOI 10.1152/jn.2002.88.4.1592; McIntyre CC, 2001, ANN BIOMED ENG, V29, P227, DOI 10.1114/1.1352640; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; Nowak LG, 1996, J NEUROSCI METH, V67, P237, DOI 10.1016/0165-0270(96)00065-9; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; Plonsey R, 1998, IEEE ENG MED BIOL, V17, P130, DOI 10.1109/51.715497; Seidemann E, 2002, SCIENCE, V295, P862, DOI 10.1126/science.1066641; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; STONEY SD, 1968, J NEUROPHYSIOL, V31, P659, DOI 10.1152/jn.1968.31.5.659; Struijk J. J., 1993, IEEE Transactions on Rehabilitation Engineering, V1, P101, DOI 10.1109/86.242424; STRUIJK JJ, 1993, IEEE T BIO-MED ENG, V40, P632, DOI 10.1109/10.237693; STRUIJK JJ, 1992, IEEE T BIO-MED ENG, V39, P903, DOI 10.1109/10.256423; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Weiland JD, 2005, ANNU REV BIOMED ENG, V7, P361, DOI 10.1146/annurev.bioeng.7.060804.100435; Weiss G., 1901, ARCH ITAL BIOL, V35, P416; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; Winfree Christopher J, 2005, Curr Surg, V62, P476; Yvert B, 2004, J NEUROPHYSIOL, V91, P2101, DOI 10.1152/jn.01095.2003; Yvert B, 2011, J NEUROSCI, V31, P8832, DOI 10.1523/JNEUROSCI.1354-11.2011	50	11	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41324	10.1371/journal.pone.0041324	http://dx.doi.org/10.1371/journal.pone.0041324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879886	gold, Green Published, Green Submitted			2022-12-27	WOS:000307437900009
J	Huang, SS; Huang, PH; Wu, TC; Chen, JW; Lin, SJ				Huang, Shao-Sung; Huang, Po-Hsun; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong			Association of Serum Bilirubin with Contrast-Induced Nephropathy and Future Cardiovascular Events in Patients Undergoing Coronary Intervention	PLOS ONE			English	Article							ALBUMIN-BOUND BILIRUBIN; LOW-DENSITY-LIPOPROTEIN; CHRONIC-RENAL-FAILURE; ACUTE KIDNEY INJURY; CLINICAL-OUTCOMES; RISK-FACTORS; ANTIOXIDANT; PLASMA; INSUFFICIENCY; MEDIA	Objectives: Enhanced reactive oxygen species formation within the kidney following the administration of contrast media may play a key role in the development of contrast-induced nephropathy (CIN). Bilirubin has emerged as an important endogenous antioxidant molecule. This study was undertaken to determine whether bilirubin is associated with CIN and future cardiovascular events in patients undergoing coronary intervention. Methods: Totally, 544 consecutive patients received coronary intervention were enrolled. All patients were followed up for at least 3 years or until the occurrence of a major event. The primary endpoint was CIN, defined as a rise in serum creatinine (SCr) of 0.5 mg/dl or a 25% increase from the baseline value within 48 hours after the procedure. The secondary endpoint was the combined occurrence of major adverse cardiovascular events (MACE), including death, nonfatal myocardial infarction, and ischemic stroke. Results: Overall, CIN occurred in 85 (15.6%) patients. All patients were stratified into 3 groups (low/normal/high) according to the serum bilirubin levels. In a multivariate logistic analysis, the odds ratio for CIN with low-bilirubin levels relative to high-bilirubin levels was 11.82 (95% CI, 3.25-43.03). By Cox regression analysis, serum bilirubin levels was an independent predictor of MACE in patients undergoing coronary intervention (low vs. high hazard ratio 2.26; 95% CI, 1.05-4.90). Conclusions: CIN is a serious complication of coronary intervention. Higher serum bilirubin concentrations were associated with lower risk of CIN and fewer cardiovascular events. The development of interventions that promote bilirubin levels may be a potential target to reduce CIN and future MACE in patients undergoing coronary intervention.	[Huang, Shao-Sung; Huang, Po-Hsun; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan; [Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Huang, Shao-Sung; Huang, Po-Hsun; Wu, Tao-Cheng; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Huang, Po-Hsun; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Inst & Dept Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, SS (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan.	huangbs@vghtpe.gov.tw						Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; BREZIS M, 1989, NEW ENGL J MED, V320, P179, DOI 10.1056/NEJM198901193200309; Cox CD, 2004, J CLIN PHARMACOL, V44, P327, DOI 10.1177/0091270004263466; Cracowski JL, 2001, J VASC RES, V38, P93, DOI 10.1159/000051036; Erdogan D, 2006, ATHEROSCLEROSIS, V184, P431, DOI 10.1016/j.atherosclerosis.2005.05.011; Fiaccadori E, 2004, NEPHROL DIAL TRANSPL, V19, P865, DOI 10.1093/ndt/gfh039; Gleeson TG, 2004, AM J ROENTGENOL, V183, P1673, DOI 10.2214/ajr.183.6.01831673; Goldenberg I, 2005, CAN MED ASSOC J, V172, P1461, DOI 10.1503/cmaj.1040847; Goodman AI, 2007, KIDNEY INT, V72, P945, DOI 10.1038/sj.ki.5002447; Huang SS, 2010, HEART, V96, P1227, DOI 10.1136/hrt.2009.192393; Ishikawa K, 1997, J CLIN INVEST, V100, P1209, DOI 10.1172/JCI119634; Kawamura K, 2005, ARTERIOSCL THROM VAS, V25, P155, DOI 10.1161/01.ATV.0000148405.18071.6a; Martin-Mateo MC, 1999, RENAL FAILURE, V21, P155, DOI 10.3109/08860229909066980; McCullough PA, 2005, CRIT CARE CLIN, V21, P261, DOI 10.1016/j.ccc.2004.12.003; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; Mimic-Oka J, 1999, CLIN NEPHROL, V51, P233; Mori T, 2007, HYPERTENSION, V49, P1336, DOI 10.1161/HYPERTENSIONAHA.106.085811; Myers SI, 2006, J VASC SURG, V44, P383, DOI 10.1016/j.jvs.2006.04.036; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; NEUZIL J, 1994, J BIOL CHEM, V269, P16712; Ollinger R, 2005, CIRCULATION, V112, P1030, DOI 10.1161/CIRCULATIONAHA.104.528802; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; SCHWERTNER HA, 1994, CLIN CHEM, V40, P18; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; STOCKER R, 1989, FREE RADICAL RES COM, V6, P57, DOI 10.3109/10715768909073428; Wu TW, 1996, BIOCHEM PHARMACOL, V51, P859, DOI 10.1016/0006-2952(95)02395-X; Yamaguchi T, 1996, BIOCHEM BIOPH RES CO, V223, P129, DOI 10.1006/bbrc.1996.0857; Yoshimura S, 1996, NEPHRON, V73, P207; Zou AP, 2001, HYPERTENSION, V37, P547, DOI 10.1161/01.HYP.37.2.547	32	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42594	10.1371/journal.pone.0042594	http://dx.doi.org/10.1371/journal.pone.0042594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880046	Green Published, Green Submitted, gold			2022-12-27	WOS:000307810000050
J	Kim, JH; Oh, MY; Paek, J; Lee, J				Kim, Jee Hwan; Oh, Min Young; Paek, Janghyun; Lee, Jaehoon			Association between FGFR1OP2/wit3.0 Polymorphisms and Residual Ridge Resorption of Mandible in Korean Population	PLOS ONE			English	Article							COMPLETE DENTURES; TOOTH EXTRACTION; ORAL-MUCOSA; COLLAGEN	Background: A previous study on the genetic association between single nucleotide polymorphisms in FGFR1OP2/wit3.0 and the long term atrophy of edentulous mandible hypothesized that the excessive jawbone atrophy after dental extraction may be associated with abnormal oral mucosa contraction induced by the FGFR1OP2/wit 3.0 gene. It was reported that the minor allele of rs840869 or rs859024 in FGFR1OP2/wit3.0 was associated with the excessive atrophy of edentulous mandible. The present study represents an attempt to replicate the results of this previous study and to examine the genetic association between polymorphisms in FGFR1OP2 and residual ridge resorption of mandible in a Korean population. Methodology/Principal Findings: 134 subjects (70.46 +/- 9.02 years) with partially or completely edentulous mandible were recruited. The mandibular bone height was measured following the protocol of the American College of Prosthodontists (ACP). From 24 subjects, seven variants in FGFR1OP2 were discovered and four of them were novel. Selected SNPs that are not in high LD at r2 threshold of 0.8 were genotyped for the remaining population. There was no frequency of the minor allele of SNP rs859024 in Korean population. SNP rs840869 was not associated with residual ridge resorption (p = 0.479). The bone height of the subject with the ss518063493 minor allele (8.52 mm) was shorter than that of those subjects with major alleles (18.96 +/- 5.33 mm, p = 0.053). Conclusions/Significance: The patient with minor allele of ss518063493 may be associated with excessive atrophy of edentulous mandible whereas the patients with that of rs840869 are not associated in Korean population. The result from this study may assist in developing a novel genetic diagnostic test and be useful in identifying Koreans susceptible to developing excessive jawbone atrophy after dental extraction.	[Kim, Jee Hwan; Oh, Min Young; Lee, Jaehoon] Yonsei Univ, Coll Dent, Dept Prosthodont, Seoul 120749, South Korea; [Paek, Janghyun] Kyung Hee Univ, Dent Hosp, Dept Prosthodont, Seoul, South Korea	Yonsei University; Yonsei University Health System; Kyung Hee University	Kim, JH (corresponding author), Yonsei Univ, Coll Dent, Dept Prosthodont, Seoul 120749, South Korea.	jaehoon115@yuhs.ac	Kim, Jeehwan/R-7536-2019	Kim, Jeehwan/0000-0002-0872-4906; Lee, Jae Hoon/0000-0003-2281-8885	Yonsei University College of Dentistry [6-2010-0170]	Yonsei University College of Dentistry	This work was supported by intramural grants from Yonsei University College of Dentistry (Project No. 6-2010-0170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo M, 2008, INT J PERIODONT REST, V28, P123; Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x; ATWOOD DA, 1979, J PERIODONTOL, P11, DOI 10.1902/jop.1979.50.4s.11; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x; Carlsson G E, 1969, Sven Tandlak Tidskr, V62, P125; CECCONI BT, 1971, J PROSTHET DENT, V25, P44, DOI 10.1016/0022-3913(71)90148-X; JACOBSON TE, 1983, J PROSTHET DENT, V49, P5, DOI 10.1016/0022-3913(83)90228-7; JACOBSON TE, 1983, J PROSTHET DENT, V49, P165, DOI 10.1016/0022-3913(83)90494-8; JACOBSON TE, 1983, J PROSTHET DENT, V49, P306, DOI 10.1016/0022-3913(83)90267-6; Jahangiri L, 1998, J PROSTHET DENT, V80, P224, DOI 10.1016/S0022-3913(98)70116-7; Kalk W, 1993, Int Dent J, V43, P483; Lin A, 2010, CELL ADHES MIGR, V4, P396, DOI 10.4161/cam.4.3.11917; Lin A, 2010, AM J PATHOL, V176, P108, DOI 10.2353/ajpath.2010.090256; McGarry T J, 1999, J Prosthodont, V8, P27, DOI 10.1111/j.1532-849X.1999.tb00005.x; Pinho Marcia N, 2006, Implant Dent, V15, P53, DOI 10.1097/01.id.0000202596.18254.e1; SCHROEDER HE, 1986, CELL TISSUE RES, V243, P661; Simpson H E, 1969, Br Dent J, V126, P550; Sukotjo C, 2003, J BIOL CHEM, V278, P51527, DOI 10.1074/jbc.M309616200; Sukotjo C, 2002, J DENT RES, V81, P229, DOI 10.1177/154405910208100402; Suwanwela J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016204; Tallgren A, 2003, J PROSTHET DENT, V89, P427, DOI 10.1016/S0022-3913(03)00158-6; TALLGREN A, 1972, J PROSTHET DENT, V27, P120, DOI 10.1016/0022-3913(72)90188-6; TURCK D, 1965, J PROSTHET DENT, V15, P419, DOI 10.1016/S0022-3913(65)80010-5; WATSON IB, 1982, J PROSTHET DENT, V47, P133, DOI 10.1016/0022-3913(82)90176-7	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42734	10.1371/journal.pone.0042734	http://dx.doi.org/10.1371/journal.pone.0042734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880093	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000064
J	Vas, V; Senger, K; Dorr, K; Niebel, A; Geiger, H				Vas, Virag; Senger, Katharina; Doerr, Karin; Niebel, Anja; Geiger, Hartmut			Aging of the Microenvironment Influences Clonality in Hematopoiesis	PLOS ONE			English	Article							STEM-CELL NICHE; PROGENITOR CELLS; LEUKEMIA; AGE	The mechanisms of the age-associated exponential increase in the incidence of leukemia are not known in detail. Leukemia as well as aging are initiated and regulated in multi-factorial fashion by cell-intrinsic and extrinsic factors. The role of aging of the microenvironment for leukemia initiation/progression has not been investigated in great detail so far. Clonality in hematopoiesis is tightly linked to the initiation of leukemia. Based on a retroviral-insertion mutagenesis approach to generate primitive hematopoietic cells with an intrinsic potential for clonal expansion, we determined clonality of transduced hematopoietic progenitor cells (HPCs) exposed to a young or aged microenvironment in vivo. While HPCs displayed primarily oligo-clonality within a young microenvironment, aged animals transplanted with identical pool of cells displayed reduced clonality within transduced HPCs. Our data show that an aged niche exerts a distinct selection pressure on dominant HPC-clones thus facilitating the transition to mono-clonality, which might be one underlying cause for the increased age-associated incidence of leukemia.	[Vas, Virag; Senger, Katharina; Doerr, Karin; Niebel, Anja; Geiger, Hartmut] Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany; [Geiger, Hartmut] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH USA	Ulm University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Vas, V (corresponding author), Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany.	hartmut.geiger@uni-ulm.de	Vas, Virag/B-8067-2016; Virag, Vas/AAD-3532-2022	Vas, Virag/0000-0001-7249-6816; Virag, Vas/0000-0001-7249-6816; Vas, Virag/0000-0002-9722-8188	Deutsche Forschungsgemeinschaft [SFB497, TP10, KFO142, GE2063/1]; National Institute of Health [HL076604, DK077762, AG040118]; Tierforschungszentrum of University of Ulm; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040118] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tierforschungszentrum of University of Ulm; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Deutsche Forschungsgemeinschaft SFB497, TP10 and KFO142, GE2063/1 and from National Institute of Health, HL076604, DK077762 and AG040118 to HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Tierforschungszentrum of University of Ulm for supporting our animal work.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Bagby Grover C, 2011, Front Biosci (Schol Ed), V3, P487, DOI 10.2741/s167; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Bellantuono I, 2009, BBA-MOL BASIS DIS, V1792, P364, DOI 10.1016/j.bbadis.2009.01.008; Bystrykh LV, 2012, NAT METHODS, V9, P567, DOI [10.1038/NMETH.2043, 10.1038/nmeth.2043]; Carlesso N, 2010, CURR OPIN HEMATOL, V17, P281, DOI 10.1097/MOH.0b013e32833a25d8; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Daria D, 2008, BLOOD, V111, P1894, DOI 10.1182/blood-2007-02-071746; Dick JE, 2005, INT J HEMATOL, V82, P389, DOI 10.1532/IJH97.05144; Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730; Freemont AJ, 2007, J PATHOL, V211, P252, DOI 10.1002/path.2097; Geiger H, 2009, TRENDS IMMUNOL, V30, P360, DOI 10.1016/j.it.2009.03.010; Henry CJ, 2011, AGING-US, V3, P643, DOI 10.18632/aging.100351; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iwasaki H, 2009, CANCER SCI, V100, P1166, DOI 10.1111/j.1349-7006.2009.01177.x; Kustikova OS, 2007, BLOOD, V109, P1897, DOI 10.1182/blood-2006-08-044156; Kustikova Olga S., 2008, V430, P255, DOI 10.1007/978-1-59745-182-6_18; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Li ZX, 2003, EXP HEMATOL, V31, P1206, DOI 10.1016/j.exphem.2003.08.008; Raaijmakers MHGP, 2011, HAEMATOL-HEMATOL J, V96, P1041, DOI 10.3324/haematol.2010.028035; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Vianello F, 2010, HAEMATOL-HEMATOL J, V95, P1081, DOI 10.3324/haematol.2009.017178; Wagner W, 2008, EXP GERONTOL, V43, P974, DOI 10.1016/j.exger.2008.04.007; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020	26	63	63	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42080	10.1371/journal.pone.0042080	http://dx.doi.org/10.1371/journal.pone.0042080			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879906	Green Submitted, Green Published, gold			2022-12-27	WOS:000307810000014
J	Chaimowitz, NS; Kang, DJ; Dean, LM; Conrad, DH				Chaimowitz, Natalia S.; Kang, Dae-Joong; Dean, Lee M.; Conrad, Daniel H.			ADAM10 Regulates Transcription Factor Expression Required for Plasma Cell Function	PLOS ONE			English	Article							GERMINAL CENTER RESPONSE; MEMORY B-CELLS; DIFFERENTIATION; BLIMP-1; NOTCH; BCL6; MICE; CD40; INFLAMMATION; ACTIVATION	A disintegrin and metalloprotease 10 (ADAM10) is a key regulator of cellular processes by shedding extracellular domains of transmembrane proteins. We have previously demonstrated that deletion of B cell expressed ADAM10 results in changes in lymphoid tissue architecture and impaired germinal center (GC) formation. In this study, mice were generated in which ADAM10 is deleted in B cells following class switch recombination (ADAM10(Delta/Delta) IgG1-cre(+/-) mice). Despite normal GC formation, antibody responses were impaired in ADAM10(Delta/Delta)IgG1-cre(+/-) mice, implicating ADAM10 in post-GC and extrafollicular B cell terminal differentiation. Surprisingly, plasma cell (PC) numbers were normal in ADAM10(Delta/Delta) IgG1-cre(+/-) mice when compared to controls. However, PCs isolated from ADAM10(Delta/Delta)IgG1-cre(+/-) mice exhibited decreased expression of transcription factors important for PC function: Prdm1, Xbp1 and Irf4. Bcl6 is a GC transcriptional repressor that inhibits the PC transcriptional program and thus must be downregulated for PC differentiation to occur. Bcl6 expression was increased in PCs isolated from ADAM10(Delta/Delta) IgG1-cre(+/-) mice at both the mRNA and protein level. These results demonstrate that ADAM10 is required for proper transcription factor expression in PCs and thus, for normal PC function.	[Chaimowitz, Natalia S.; Kang, Dae-Joong; Dean, Lee M.; Conrad, Daniel H.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Chaimowitz, NS (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA.	dconrad@vcu.edu			National Heart Lung Blood Institute (NHLBI); National Institute of Allergy and Infections disease (NIAID) of the National Institutes of Health (NIH)	National Heart Lung Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infections disease (NIAID) of the National Institutes of Health (NIH)	This work was funded by the National Heart Lung Blood Institute (NHLBI) and the National Institute of Allergy and Infections disease (NIAID) of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Alinikula J, 2011, EUR J IMMUNOL, V41, P2404, DOI 10.1002/eji.201141553; Arima T, 2007, CANCER SCI, V98, P1720, DOI 10.1111/j.1349-7006.2007.00601.x; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Cattoretti G, 2006, J IMMUNOL, V177, P6930, DOI 10.4049/jimmunol.177.10.6930; Caven TH, 2005, CELL IMMUNOL, V238, P123, DOI 10.1016/j.cellimm.2006.03.001; Chaimowitz NS, 2011, J IMMUNOL, DOI [10.4049/jimmu-nol.1102172, DOI 10.4049/JIMMU-NOL.1102172]; Cozine CL, 2005, CURR OPIN IMMUNOL, V17, P298, DOI 10.1016/j.coi.2005.04.007; Crawford HC, 2009, CURR PHARM DESIGN, V15, P2288, DOI 10.2174/138161209788682442; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Erickson LD, 2002, J CLIN INVEST, V109, P613, DOI 10.1172/JCI200214110; Gibb DR, 2011, MOL IMMUNOL, V48, P1319, DOI 10.1016/j.molimm.2010.12.005; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Hampel F, 2011, BLOOD, V118, P6321, DOI 10.1182/blood-2010-12-325944; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oracki SA, 2010, IMMUNOL REV, V237, P140, DOI 10.1111/j.1600-065X.2010.00940.x; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sakurai N, 2011, J CLIN INVEST, V121, P2583, DOI 10.1172/JCI45682; Santos MA, 2007, P NATL ACAD SCI USA, V104, P15454, DOI 10.1073/pnas.0702891104; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Soro PG, 1999, J IMMUNOL, V163, P611; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Thomas M, 2007, BLOOD, V109, P3342, DOI 10.1182/blood-2006-09-046698; Tian L, 2008, INT IMMUNOL, V20, P1181, DOI 10.1093/intimm/dxn076; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Tsuyama N, 2005, BIOCHEM BIOPH RES CO, V337, P201, DOI 10.1016/j.bbrc.2005.09.036; Vu F, 2008, J IMMUNOL, V180, P2284, DOI 10.4049/jimmunol.180.4.2284; Wu YZ, 2009, INT IMMUNOL, V21, P745, DOI 10.1093/intimm/dxp041	45	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42694	10.1371/journal.pone.0042694	http://dx.doi.org/10.1371/journal.pone.0042694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880085	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100159
J	Chen, J; Wang, M; Xi, B; Xue, J; He, D; Zhang, J; Zhao, YR				Chen, Jie; Wang, Mei; Xi, Bo; Xue, Jian; He, Dan; Zhang, Jie; Zhao, Yueran			SPARC Is a Key Regulator of Proliferation, Apoptosis and Invasion in Human Ovarian Cancer	PLOS ONE			English	Article							PROTEIN EXPRESSION; DOWN-REGULATION; E-CADHERIN; CELL; BREAST; RICH; ACTIVATION; GROWTH; OSTEONECTIN/SPARC; IDENTIFICATION	Background: Secreted protein acidic and rich in cysteine (SPARC), a calcium-binding matricellular glycoprotein, is implicated in the progression of many cancers. In this study, we investigated the expression and function of SPARC in ovarian cancer. Methods: cDNA microarray analysis was performed to compare gene expression profiles of the highly invasive and the low invasive subclones derived from the SKOV3 human ovarian cancer cell line. Immunohistochemistry (IHC) staining was performed to investigate SPARC expression in a total of 140 ovarian tissue specimens. In functional assays, effects of SPARC knockdown on the biological behavior of ovarian cancer cells were investigated. The mechanisms of SPARC in ovarian cancer proliferation, apoptosis and invasion were also researched. Results: SPARC was overexpressed in the highly invasive subclone compared with the low invasive subclone. High SPARC expression was associated with high stage, low differentiation, lymph node metastasis and poor prognosis of ovarian cancer. Knockdown of SPARC expression significantly suppressed ovarian cancer cell proliferation, induced cell apoptosis and inhibited cell invasion and metastasis. Conclusion: SPARC is overexpressed in highly invasive subclone and ovarian cancer tissues and plays an important role in ovarian cancer growth, apoptosis and metastasis.	[Chen, Jie; Xi, Bo; Xue, Jian; He, Dan] Shandong Univ, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Jinan 250100, Peoples R China; [Wang, Mei] Shandong Univ, Shandong Prov Hosp, Dept Pharm, Jinan 250100, Peoples R China; [Zhang, Jie; Zhao, Yueran] Shandong Univ, Shandong Prov Hosp, Cent Lab, Jinan 250100, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Chen, J (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Jinan 250100, Peoples R China.	zhangjie19630711@163.com; yrzhao@sdu.edu.cn			Shandong University [2012TS088]	Shandong University	This study was supported by a grant-in-aid for scientific research (2012TS088) from the Shandong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1987, CANCER RES, V47, P3239; Atorrasagasti C, 2010, INT J CANCER, V126, P2726, DOI 10.1002/ijc.24966; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Brown TJ, 1999, GYNECOL ONCOL, V75, P25, DOI 10.1006/gyno.1999.5552; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Chen J, 2009, J CANCER RES CLIN, V135, P909, DOI 10.1007/s00432-008-0526-8; Fenouille N, 2011, ONCOGENE, V30, P4887, DOI 10.1038/onc.2011.198; Fenouille N, 2011, PIGM CELL MELANOMA R, V24, P219, DOI 10.1111/j.1755-148X.2010.00790.x; Gartel AL, 2009, BIOFACTORS, V35, P161, DOI 10.1002/biof.26; Greenaway JB, 2012, BIOCHEM CELL BIOL, V90, P96, DOI [10.1139/o11-047, 10.1139/O11-047]; Horie K, 2010, CANCER SCI, V101, P913, DOI 10.1111/j.1349-7006.2009.01476.x; Hsiao YH, 2010, BREAST J, V16, P305, DOI 10.1111/j.1524-4741.2009.00899.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Koblinski JE, 2005, CANCER RES, V65, P7370, DOI 10.1158/0008-5472.CAN-05-0807; Kunigal S, 2006, INT J ONCOL, V29, P1349; Lau CPY, 2006, J PATHOL, V210, P459, DOI 10.1002/path.2068; Le Bail B, 1999, J PATHOL, V189, P46; Liang JF, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-71; Liebermann DA, 2007, CELL CYCLE, V6, P166, DOI 10.4161/cc.6.2.3789; Lien HC, 2007, ONCOGENE, V26, P7859, DOI 10.1038/sj.onc.1210593; McClung HM, 2007, NEUROSCI LETT, V419, P172, DOI 10.1016/j.neulet.2007.04.037; Nagai MA, 2011, BREAST CANCER RES TR, V126, P1, DOI 10.1007/s10549-010-0867-2; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Paley PJ, 2000, GYNECOL ONCOL, V78, P336, DOI 10.1006/gyno.2000.5894; Rich JN, 2003, J BIOL CHEM, V278, P15951, DOI 10.1074/jbc.M211498200; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Said N, 2005, AM J PATHOL, V167, P1739, DOI 10.1016/S0002-9440(10)61255-2; Said N, 2009, ONCOGENE, V28, P3487, DOI 10.1038/onc.2009.205; Said N, 2007, AM J PATHOL, V170, P1054, DOI 10.2353/ajpath.2007.060903; Seno T, 2009, INT J ONCOL, V34, P707, DOI 10.3892/ijo_00000197; Shenhua X, 1999, J EXP CLIN CANC RES, V18, P233; Smit DJ, 2007, INT J CANCER, V121, P2653, DOI 10.1002/ijc.23039; Soumaoro LT, 2004, CLIN CANCER RES, V10, P8465, DOI 10.1158/1078-0432.CCR-04-0653; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; Thomas R, 2000, CLIN CANCER RES, V6, P1140; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Yang EN, 2007, INT J CANCER, V121, P567, DOI 10.1002/ijc.22706; Yin J, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-59; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4; Zhang LQ, 2011, CLIN LUNG CANC	43	40	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42413	10.1371/journal.pone.0042413	http://dx.doi.org/10.1371/journal.pone.0042413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879971	gold, Green Submitted, Green Published			2022-12-27	WOS:000307284100084
J	Dolan, GP; Myles, PR; Brett, SJ; Enstone, JE; Read, RC; Openshaw, PJM; Semple, MG; Lim, WS; Taylor, BL; McMenamin, J; Nicholson, KG; Bannister, B; Nguyen-Van-Tam, JS				Dolan, Gayle P.; Myles, Puja R.; Brett, Stephen J.; Enstone, Joanne E.; Read, Robert C.; Openshaw, Peter J. M.; Semple, Malcolm G.; Lim, Wei Shen; Taylor, Bruce L.; McMenamin, James; Nicholson, Karl G.; Bannister, Barbara; Nguyen-Van-Tam, Jonathan S.		Influenza Clinical Information Net	The Comparative Clinical Course of Pregnant and Non-Pregnant Women Hospitalised with Influenza A(H1N1)pdm09 Infection	PLOS ONE			English	Article							H1N1 VIRUS-INFECTION; PANDEMIC INFLUENZA; ILLNESS; PNEUMONIA; SAFETY	Introduction: The Influenza Clinical Information Network (FLU-CIN) was established to gather detailed clinical and epidemiological information about patients with laboratory confirmed A(H1N1)pdm09 infection in UK hospitals. This report focuses on the clinical course and outcomes of infection in pregnancy. Methods: A standardised data extraction form was used to obtain detailed clinical information from hospital case notes and electronic records, for patients with PCR-confirmed A(H1N1) pdm09 infection admitted to 13 sentinel hospitals in five clinical 'hubs' and a further 62 non-sentinel hospitals, between 11th May 2009 and 31st January 2010. Outcomes were compared for pregnant and non-pregnant women aged 15-44 years, using univariate and multivariable techniques. Results: Of the 395 women aged 15-44 years, 82 (21%) were pregnant; 73 (89%) in the second or third trimester. Pregnant women were significantly less likely to exhibit severe respiratory distress at initial assessment (OR = 0.49 (95% CI: 0.30-0.82)), require supplemental oxygen on admission (OR = 0.40 (95% CI: 0.20-0.80)), or have underlying co-morbidities (p-trend <0.001). However, they were equally likely to be admitted to high dependency (Level 2) or intensive care (Level 3) and/or to die, after adjustment for potential confounders (adj. OR = 0.93 (95% CI: 0.46-1.92). Of 11 pregnant women needing Level 2/3 care, 10 required mechanical ventilation and three died. Conclusions: Since the expected prevalence of pregnancy in the source population was 6%, our data suggest that pregnancy greatly increased the likelihood of hospital admission with A(H1N1)pdm09. Pregnant women were less likely than nonpregnant women to have respiratory distress on admission, but severe outcomes were equally likely in both groups.	[Dolan, Gayle P.; Myles, Puja R.; Enstone, Joanne E.; Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Hlth Protect Res Grp, Div Epidemiol & Publ Hlth, City Hosp Nottingham, Nottingham NG7 2RD, England; [Brett, Stephen J.] Imperial Coll Healthcare Natl Hlth Serv Trust, Ctr Perioperat Med & Crit Care Res, London, England; [Read, Robert C.] Univ Sheffield, Royal Hallamshire Hosp, Dept Infect & Immun, Sheffield S10 2JF, S Yorkshire, England; [Openshaw, Peter J. M.] Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect, Natl Heart & Lung Inst, London, England; [Semple, Malcolm G.] Univ Liverpool, Dept Womens & Childrens Hlth, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Lim, Wei Shen] Nottingham Univ Hosp Natl Hlth Serv Trust, Dept Resp Med, Nottingham, England; [Taylor, Bruce L.] Portsmouth Hosp Natl Hlth Serv Trust, Dept Crit Care, Portsmouth, Hants, England; [McMenamin, James] Natl Hlth Serv Natl Serv, Hlth Protect Scotland, Glasgow, Lanark, Scotland; [Nicholson, Karl G.] Univ Hosp Leicester Natl Hlth Serv Trust, Infect Dis Unit, Leicester Royal Infirm, Leicester, Leics, England; [Bannister, Barbara] Dept Hlth, London SE1 6TE, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Imperial College London; University of Sheffield; Imperial College London; University of Liverpool; Nottingham University Hospital NHS Trust; Portsmouth Hospitals NHS Trust; NHS National Services Scotland; University Hospitals of Leicester NHS Trust; University of Leicester	Dolan, GP (corresponding author), Univ Nottingham, Hlth Protect Res Grp, Div Epidemiol & Publ Hlth, City Hosp Nottingham, Clin Sci Bldg, Nottingham NG7 2RD, England.	Gayle.Dolan@hpa.org.uk	Nguyen-Van-Tam, Jonathan/I-2162-2019; Openshaw, Peter/AAL-9442-2020; Semple, Malcolm Gracie/A-8790-2008	Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Openshaw, Peter/0000-0002-7220-2555; Semple, Malcolm Gracie/0000-0001-9700-0418; Read, Robert/0000-0002-4297-6728; Myles, Puja/0000-0002-8976-890X	The Department of Health in England; The Scottish Government Chief Medical Officer and Public Health Directorate; F. Hoffmann-La Roche; GlaxoSmithKline; Baxter AG; Novartis; Sanofi-Pasteur MSD; Astra-Zeneca; F. Hoffman-La Roche Ltd; Pfizer; Roche; National Institute for Health Research; Baxter; UK NIHR Biomedical Research Centre scheme; Medical Research Council [G1000758, G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; Asthma UK [S06/001] Funding Source: researchfish	The Department of Health in England; The Scottish Government Chief Medical Officer and Public Health Directorate; F. Hoffmann-La Roche(Hoffmann-La Roche); GlaxoSmithKline(GlaxoSmithKline); Baxter AG; Novartis(Novartis); Sanofi-Pasteur MSD; Astra-Zeneca(AstraZeneca); F. Hoffman-La Roche Ltd; Pfizer(Pfizer); Roche(Roche Holding); National Institute for Health Research(National Institute for Health Research (NIHR)); Baxter; UK NIHR Biomedical Research Centre scheme(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	The Department of Health in England was the main funder for FLU-CIN (United Kingdom Influenza Clinical Information Network). The Scottish Government Chief Medical Officer and Public Health Directorate supported the centre in Scotland. Chairmanship of the FLU-CIN Strategy Group (that includes MGS, BB, JSN-V-T, WSL, PJMO, RCR, BLT, SJB, JMcM, JEE and KGN as members) was provided by the Department of Health, England. The FLU-CIN Strategy Group had final responsibility for the interpretation of findings and decision to submit for publication. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JSN-V-T has received funding to attend influenza related meetings, lecture and consultancy fees and research funding from several influenza antiviral drug and vaccine manufacturers (F. Hoffmann-La Roche, GlaxoSmithKline, Baxter AG, Novartis, Sanofi-Pasteur MSD, Astra-Zeneca). All forms of personal remuneration ceased in September 2010, but influenza-related research funding from GlaxoSmithKline, F. Hoffmann-La Roche and Astra-Zeneca remains current. He is a former employee of SmithKline Beecham plc (now GlaxoSmithKline), Roche Products Ltd, and Aventis-Pasteur MSD (now Sanofi-Pasteur MSD), all prior to 2005, with no outstanding pecuniary interests by way of shareholdings, share options or accrued pension rights. PRM holds an unrestricted educational grant from F. Hoffman-La Roche Ltd for research in the area of pandemic influenza. RCR has received funding for vaccine-related research from Novartis and travel funding from GlaxoSmithKline. WSL has received unrestricted funding from Pfizer (previously Wyeth) for research in the area of pneumonia. SJB has received consultancy fees from GlaxoSmithKline and Baxter. JEE has received consultancy fees from GlaxoSmithKline, and holds an unrestricted educational grant from Astra-Zeneca for influenza-related research. KGN has received H5 avian influenza vaccines from Novartis and H1N1 pandemic influenza vaccines from GlaxoSmithKline and to facilitate MRC and National Institute for Health Research-funded trials. He has received consultancy fees from Novartis and GlaxoSmithKline and lecture fees from Baxter AG. A colleague of KGN at the University Hospitals of Leicester Natioanl Health Service Trust was Principal Investigator and recipient of research funding from Roche on antiviral resistance and from Novartis on pandemic H1N1 vaccines. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. No aspect of the work described in this report was supported or enabled by commercial funding.; We gratefully acknowledge the teams who helped identify cases and collated clinical data: Alison Booth, Margaret Charlesworth, Sarah Rodenhurst, Angela Ballard and Alison Holmes at Imperial College Healthcare NHS Trust, London, UK; Sally Batham, Phayre Parkinson, Tracy Kumar and Aiden Dunphy at the University Hospitals of Leicester NHS Trust, Leicester, UK; Anne Tunbridge, Patty Hempsall, Joyce Linskill, Aimee Turner, Sharon Grindle, Dawn Shevlin and Eric Moulds at Sheffield University Hospitals NHS Trust, Sheffield, UK; Elvina White, Elaine Scott, Jennifer Cater, Erica Sergi and Helen Hill at Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, UK; Deborah Fleetwood, Lorna Roche, Sarah Dyas, and Maria Boswell at the Royal Liverpool and Broadgreen University Hospital's Trust, Liverpool, UK; Gillian Vernon, Gillian Houghton, Heather Longworth and Angela Kerrigan at Liverpool Women's Hospital, Liverpool, UK; Sonia Greenwood, Gemma Thompson, Emily Jarvis and Charlotte Minter at the Nottingham University Hospitals NHS Trust, Nottingham, UK; Kristina Lum Kin, Jacqueline Daglish, Sam Hayton, and Gemma Slinn at Birmingham Children's Hospital, Birmingham, UK; Michelle Lacey, Kevin Rooney, Karen Duffy, Anne Gordon, Eleanor Anderson, Hilary Davison, William Carman, Mark Cotton, Arlene Reynolds, Heather Murdoch, Karen Voy, Rosie Hague and Ali McAllister for their contribution to FLU-CIN in Scotland. Brian Smyth and Cathriona Kearns from the National Public Health Agency, Northern Ireland for identifying cases and facilitating data collection; Teresa Cunningham at the Southern Trust and Leslie Boydell at the Belfast Trust for facilitating data collection. Alemayehu Amberbir, Safaa Al-Badri, Baraa Mahgoob and Nachi Arunachalam at the University of Nottingham for data entry and obtaining background population data; also Graham Watson for database development and support; and Tom Bewick at the Nottingham University Hospitals NHS Trust, Nottingham, UK for manually reviewing the records to identify additional pneumonia cases. We also thank Professor Sir Gordon Duff, Co-Chair of the Scientific Advisory Group for Emergencies, Professor Janet Darbyshire, who Co-Chaired the Influenza Clinical Information Network Strategy Group and Elaine Gadd and Colin Armstrong at the Department of Health, London, UK for their support and constructive remarks; Dr Shona Kelly of the University of Nottingham (now at University of South Australia) for help in developing the initial data collection tool; and Dr Patrick O'Brien of University College London Hospitals NHS Foundation Trust for assistance in further developing the data set. We thank those Chief Executive Officers, clinicians, virologists and managers, too numerous to mention, who were active in notifying cases to FLU-CIN. SJB and PJMO wish to acknowledge the support of the UK NIHR Biomedical Research Centre scheme.	Centers for Disease Control and Prevention, SUMM INFL VACC REC; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Creanga AA, 2011, AM J OBSTET GYNECOL, V204, pS38, DOI 10.1016/j.ajog.2011.02.037; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Department of Health. Launch of the national pandemic flu service, LAUNCH NAT PAND FLU; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Donner B, 2010, DRUG SAFETY, V33, P631, DOI 10.2165/11536370-000000000-00000; European Medicines Agency, 2009, EMEAHA531172; Goodnight William H, 2005, Crit Care Med, V33, pS390, DOI 10.1097/01.CCM.0000182483.24836.66; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Health Protection Agency, 2011, PHARM TREATM PROPHYL; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Jimenez MF, 2010, INT J GYNECOL OBSTET, V111, P217, DOI 10.1016/j.ijgo.2010.06.024; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Maravi-Poma E, 2011, CRIT CARE MED, V39, P945, DOI 10.1097/CCM.0b013e318208ee12; Mosby LG, 2011, AM J OBSTET GYNECOL, V205, P10, DOI 10.1016/j.ajog.2010.12.033; Myles PR, 2012, THORAX, V67, P709, DOI 10.1136/thoraxjnl-2011-200266; Myles PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034428; Newsome Kimberly, 2011, Morbidity and Mortality Weekly Report, V60, P1193; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Nuzum JW, 1918, J AMER MED ASSOC, V71, P1562, DOI 10.1001/jama.1918.26020450009011a; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Rolland-Harris E, 2011, EPIDEMIOL INFECT, V16, P1; Schatz M, 2011, AM J OBSTET GYNECOL, V204, pS64, DOI 10.1016/j.ajog.2011.01.047; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Woolston WJ, 1918, J AMER MED ASSOC, V71, P1898, DOI 10.1001/jama.1918.02600490030008; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	31	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41638	10.1371/journal.pone.0041638	http://dx.doi.org/10.1371/journal.pone.0041638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870239	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100026
J	Ferrario, CR; Goussakov, I; Stutzmann, GE; Wolf, ME				Ferrario, Carrie R.; Goussakov, Ivan; Stutzmann, Grace E.; Wolf, Marina E.			Withdrawal from Cocaine Self-Administration Alters NMDA Receptor-Mediated Ca2+ Entry in Nucleus Accumbens Dendritic Spines	PLOS ONE			English	Article							PERMEABLE AMPA RECEPTORS; SYNAPTIC PLASTICITY; STRUCTURAL PLASTICITY; PREFRONTAL CORTEX; HIPPOCAMPAL; NEURONS; ACTIVATION; CHANNELS; MORPHOLOGY; INCUBATION	We previously showed that the time-dependent intensification ("incubation'') of cue-induced cocaine seeking after withdrawal from extended-access cocaine self-administration is accompanied by accumulation of Ca2+-permeable AMPA receptors (CP-AMPARs) in the rat nucleus accumbens (NAc). These results suggest an enduring change in Ca2+ signaling in NAc dendritic spines. The purpose of the present study was to determine if Ca2+ signaling via NMDA receptors (NMDARs) is also altered after incubation. Rats self-administered cocaine or saline for 10 days (6 h/day). After 45-47 days of withdrawal, NMDAR-mediated Ca2+ entry elicited by glutamate uncaging was monitored in individual NAc dendritic spines. NMDAR currents were simultaneously recorded using whole cell patch clamp recordings. We also measured NMDAR subunit levels in a postsynaptic density (PSD) fraction prepared from the NAc of identically treated rats. NMDAR currents did not differ between groups, but a smaller percentage of spines in the cocaine group responded to glutamate uncaging with NMDAR-mediated Ca2+ entry. No significant group differences in NMDAR subunit protein levels were found. The decrease in the proportion of spines showing NMDAR-mediated Ca2+ entry suggests that NAc neurons in the cocaine group contain more spines which lack NMDARs (non-responding spines). The fact that cocaine and saline groups did not differ in NMDAR currents or NMDAR subunit levels suggests that the number of NMDARs on responding spines is not significantly altered by cocaine exposure. These findings are discussed in light of increases in dendritic spine density in the NAc observed after withdrawal from repeated cocaine exposure.	[Ferrario, Carrie R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Goussakov, Ivan] Univ Chicago, Dept Pediat, Neurol Sect, Chicago, IL 60637 USA; [Stutzmann, Grace E.; Wolf, Marina E.] Rosalind Franklin Univ Med & Sci, Dept Neurosci, N Chicago, IL USA	University of Michigan System; University of Michigan; University of Chicago; Rosalind Franklin University Medical & Science	Ferrario, CR (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.	marina.wolf@rosalindfranklin.edu	Ferrario, Carrie R/L-7372-2016	Ferrario, Carrie R/0000-0002-9673-7028	National Research Service Award [DA024502];  [DA015835];  [DA029099]; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015835, K05DA029099, R01DA015835, F32DA024502] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by DA015835 and DA029099 (MEW), and National Research Service Award DA024502 (CRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara AA, 2011, SYNAPSE, V65, P309, DOI 10.1002/syn.20849; Brown TE, 2011, J NEUROSCI, V31, P8163, DOI 10.1523/JNEUROSCI.0016-11.2011; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dobi A, 2011, J NEUROSCI, V31, P1895, DOI 10.1523/JNEUROSCI.5375-10.2011; Feltenstein MW, 2008, BRIT J PHARMACOL, V154, P261, DOI 10.1038/bjp.2008.51; Ferrario CR, 2011, NEUROPHARMACOLOGY, V61, P1141, DOI 10.1016/j.neuropharm.2011.01.021; Ferrario CR, 2005, BIOL PSYCHIAT, V58, P751, DOI 10.1016/j.biopsych.2005.04.046; Finch DM, 1996, HIPPOCAMPUS, V6, P495; French SJ, 2002, J COMP NEUROL, V446, P151, DOI 10.1002/cne.10191; Garaschuk O, 1996, J PHYSIOL-LONDON, V491, P757, DOI 10.1113/jphysiol.1996.sp021255; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Goussakov I, 2010, J NEUROSCI, V30, P12128, DOI 10.1523/JNEUROSCI.2474-10.2010; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Higley MJ, 2012, COLD SPRING HARBOR P, V4; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Johnston D, 1994, FDN CELLULAR NEUROPH; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kim Y, 2009, P NATL ACAD SCI USA, V106, P2915, DOI 10.1073/pnas.0813179106; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Li YL, 2004, EUR J NEUROSCI, V20, P1647, DOI 10.1111/j.1460-9568.2004.03612.x; Majewska A, 2000, J NEUROSCI, V20, P1722; Mameli M, 2011, NAT NEUROSCI, V14, P414, DOI 10.1038/nn.2763; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; McCutcheon JE, 2011, J NEUROSCI, V31, P14536, DOI 10.1523/JNEUROSCI.3625-11.2011; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Pickens CL, 2011, TRENDS NEUROSCI, V34, P411, DOI 10.1016/j.tins.2011.06.001; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Reichel Carmela M, 2009, Curr Drug Abuse Rev, V2, P184; Reimers JM, 2011, BRAIN RES, V1367, P223, DOI 10.1016/j.brainres.2010.10.016; Ren Z, 2010, NEUROSCIENCE, V168, P48, DOI 10.1016/j.neuroscience.2010.03.034; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 2001, SYNAPSE, V39, P257; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; SESACK SR, 1990, BRAIN RES, V527, P266, DOI 10.1016/0006-8993(90)91146-8; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Striessnig J, 2004, BIOCHEM BIOPH RES CO, V322, P1341, DOI 10.1016/j.bbrc.2004.08.039; Stutzmann GE, 2005, PHYSIOLOGY, V20, P15, DOI 10.1152/physiol.00028.2004; Stutzmann GE, 2003, J NEUROSCI, V23, P758; Tippens AL, 2008, J COMP NEUROL, V506, P569, DOI 10.1002/cne.21567; Wang HX, 2010, J PHYSIOL-LONDON, V588, P2823, DOI 10.1113/jphysiol.2010.187591; Wolf ME, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00072; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	59	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e40898	10.1371/journal.pone.0040898	http://dx.doi.org/10.1371/journal.pone.0040898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870207	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100011
J	Heyerdahl, H; Abbas, N; Brevik, EM; Mollatt, C; Dahle, J				Heyerdahl, Helen; Abbas, Nasir; Brevik, Ellen Mengshoel; Mollatt, Camilla; Dahle, Jostein			Fractionated Therapy of HER2-Expressing Breast and Ovarian Cancer Xenografts in Mice with Targeted Alpha Emitting Th-227-DOTA-p-benzyl-trastuzumab	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; PROSTATE-CANCER; TRASTUZUMAB; BINDING; RADIOIMMUNOTHERAPY; MULTICENTER; RADIUM-223; EFFICACY; TUMORS	Background: The aim of this study was to investigate therapeutic efficacy and normal tissue toxicity of single dosage and fractionated targeted alpha therapy (TAT) in mice with HER2-expressing breast and ovarian cancer xenografts using the low dose rate radioimmunoconjugate Th-227-DOTA-p-benzyl-trastuzumab. Methodology/Principal Findings: Nude mice carrying HER2-overexpressing subcutaneous SKOV-3 or SKBR-3 xenografts were treated with 1000 kBq/kg Th-227-trastuzumab as single injection or four injections of 250 kBq/kg with intervals of 4-5 days, 2 weeks, or 4 weeks. Control animals were treated with normal saline or unlabeled trastuzumab. In SKOV-3 xenografts tumor growth to 10-fold size was delayed (p<0.01) and survival with tumor diameter less than 16 mm was prolonged (p<0.05) in all TAT groups compared to the control groups. No statistically significant differences were seen among the treated groups. In SKBR-3 xenografts tumor growth to 10-fold size was delayed in the single injection and 4-5 days interval groups (p<0.001) and all except the 4 weeks interval TAT group showed improved survival to the control groups (p<0.05). Toxicity was assessed by blood cell counts, clinical chemistry measurements and body weight. Transient reduction in white blood cells was seen for the single injection and 4-5 days interval groups (p<0.05). No significant changes were seen in red blood cells, platelets or clinical chemistry parameters. Survival without life threatening loss of body weight was significantly prolonged in 4 weeks interval group compared to single injection group (p<0.05) for SKOV-3 animals and in 2 weeks interval group compared with the 4-5 days interval groups (p<0.05) for SKBR-3 animals. Conclusions/Significance: The same concentration of radioactivity split into several fractions may improve toxicity of Th-227-radioimmunotherapy while the therapeutic effect is maintained. Thus, it might be possible to increase the cumulative absorbed radiation dose to tumor with acceptable toxicity by fractionation of the dosage.	[Heyerdahl, Helen; Abbas, Nasir; Mollatt, Camilla; Dahle, Jostein] Univ Oslo, Inst Canc Res, Dept Radiat Biol, Oslo, Norway; [Brevik, Ellen Mengshoel] Algeta ASA, Dept Res & Dev, Oslo, Norway; [Dahle, Jostein] Nord Nanovector AS, Dept Res & Dev, Oslo, Norway	University of Oslo	Heyerdahl, H (corresponding author), Univ Oslo, Inst Canc Res, Dept Radiat Biol, Oslo, Norway.	Helen.Heyerdahl@rr-research.no	Dahle, Jostein/AAE-7776-2020	Dahle, Jostein/0000-0002-1447-6005	Norwegian Cancer Society; South-Eastern Norway Regional Health Authority	Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority	Research support was granted by the Norwegian Cancer Society (http://www.kreftforeningen.no) (graduate student salary for HH), South-Eastern Norway Regional Health Authority (http://www. helse-sorost.no) (graduate student salary for NA). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas N, 2012, NUCL MED CO IN PRESS; Abbas N, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-18; Dahle J, 2008, INT J RADIAT ONCOL, V72, P186, DOI 10.1016/j.ijrobp.2008.05.029; Dahle J, 2007, BLOOD, V110, P2049, DOI 10.1182/blood-2007-01-066803; Dahle J, 2010, EUR J NUCL MED MOL I, V37, P93, DOI 10.1007/s00259-009-1197-7; DeNardo GL, 2002, CANCER-AM CANCER SOC, V94, P1332, DOI 10.1002/cncr.10304; Elgqvist J, 2010, J ONCOL, V2010, DOI 10.1155/2010/394913; Elgqvist J, 2006, NUCL MED BIOL, V33, P1065, DOI 10.1016/j.nucmedbio.2006.07.009; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FUJIMORI K, 1990, J NUCL MED, V31, P1191; Heyerdahl H, 2011, INT J RADIAT ONCOL, V79, P563, DOI 10.1016/j.ijrobp.2010.08.038; Illidge TM, 2009, BLOOD, V113, P1412, DOI 10.1182/blood-2008-08-175653; KENNEL SJ, 1992, CANCER RES, V52, P1284; Larsen RH, 2007, CANCER BIOTHER RADIO, V22, P431, DOI 10.1089/cbr.2006.321; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Milenic DE, 2010, MABS-AUSTIN, V2, P550, DOI 10.4161/mabs.2.5.13054; Morschhauser F, 2010, J CLIN ONCOL, V28, P3709, DOI 10.1200/JCO.2009.27.7863; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nilsson S, 2007, LANCET ONCOL, V8, P587, DOI 10.1016/S1470-2045(07)70147-X; Palm S, 2007, INT J RADIAT ONCOL, V69, P572, DOI 10.1016/j.ijrobp.2007.06.023; Parker C, 2011, EUR J CANCER, V47, P3, DOI 10.1016/S0959-8049(11)70100-9; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; SCHLOM J, 1990, JNCI-J NATL CANCER I, V82, P763, DOI 10.1093/jnci/82.9.763; Sgouros G, 1999, J NUCL MED, V40, P1935; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Steger GG, 2010, WIEN KLIN WOCHENSCHR, V122, P368, DOI 10.1007/s00508-010-1373-6; Verri E, 2005, ONCOLOGY-BASEL, V68, P154, DOI 10.1159/000086958; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2	29	41	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42345	10.1371/journal.pone.0042345	http://dx.doi.org/10.1371/journal.pone.0042345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879947	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100072
J	Huang, WC; Sala-Newby, GB; Susana, A; Johnson, JL; Newby, AC				Huang, Wei-Chun; Sala-Newby, Graciela B.; Susana, Angela; Johnson, Jason L.; Newby, Andrew C.			Classical Macrophage Activation Up-Regulates Several Matrix Metalloproteinases through Mitogen Activated Protein Kinases and Nuclear Factor-kappa B	PLOS ONE			English	Article							INTERFERON-GAMMA; EXPRESSION; MONOCYTE; CELLS; INFLAMMATION; MODULATORS; INHIBITOR; MOLECULES; ARTHRITIS; GENES	Remodelling of the extracellular matrix (ECM) and cell surface by matrix metalloproteinases (MMPs) is an important function of monocytes and macrophages. Recent work has emphasised the diverse roles of classically and alternatively activated macrophages but the consequent regulation of MMPs and their inhibitors has not been studied comprehensively. Classical activation of macrophages derived in vitro from un-fractionated CD16(+/-) or negatively-selected CD16(-) macrophages up-regulated MMP-1, -3, -7, -10, -12, -14 and -25 and decreased TIMP-3 steady-state mRNA levels. Bacterial lipopolysaccharide, IL-1 and TNF alpha were more effective than interferon gamma except for the effects on MMP-25, and TIMP-3. By contrast, alternative activation decreased MMP-2, -8 and -19 but increased MMP -11, -12, -25 and TIMP-3 steady-state mRNA levels. Up-regulation of MMPs during classical activation depended on mitogen activated protein kinases, phosphoinositide-3-kinase and inhibitor of kappa B kinase-2. Effects of interferonc depended on janus kinase-2. Where investigated, similar effects were seen on protein concentrations and collagenase activity. Moreover, activity of MMP-1 and -10 co-localised with markers of classical activation in human atherosclerotic plaques in vivo. In conclusion, classical macrophage activation selectively up-regulates several MMPs in vitro and in vivo and down-regulates TIMP-3, whereas alternative activation up-regulates a distinct group of MMPs and TIMP-3. The signalling pathways defined here suggest targets for selective modulation of MMP activity.	[Huang, Wei-Chun; Sala-Newby, Graciela B.; Susana, Angela; Johnson, Jason L.; Newby, Andrew C.] Univ Bristol, Bristol Heart Inst, Bristol, Avon, England; [Huang, Wei-Chun] Kaohsiung Vet Gen Hosp, Ctr Cardiovasc, Kaohsiung, Taiwan; [Huang, Wei-Chun] Natl Yang Ming Univ, Taiwan Sch Med, Taipei 112, Taiwan	University of Bristol; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University	Huang, WC (corresponding author), Univ Bristol, Bristol Heart Inst, Bristol, Avon, England.	a.newby@bris.ac.uk	Johnson, Jason/AAC-3124-2019	Johnson, Jason/0000-0003-0630-9183	British Heart Foundation [CH95/001, RG04/009]; National Health Research Institute (UK) Bristol Biomedical Research Unit in Cardiovascular Medicine; Yen Tjing Ling Medical Foundation; Medical Foundation in Memory of Dr. Deh-Lin Cheng, Taiwan; British Heart Foundation [FS/07/053/24069, RG/09/006/27918] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Health Research Institute (UK) Bristol Biomedical Research Unit in Cardiovascular Medicine(National Health Research Institutes - Taiwan); Yen Tjing Ling Medical Foundation; Medical Foundation in Memory of Dr. Deh-Lin Cheng, Taiwan; British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation CH95/001 and RG04/009 and the National Health Research Institute (UK) Bristol Biomedical Research Unit in Cardiovascular Medicine. W-C Huang held Fellowships from the Yen Tjing Ling Medical Foundation and Medical Foundation in Memory of Dr. Deh-Lin Cheng, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreas K, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2358; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Beck IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002343; Bond M, 1999, BIOCHEM BIOPH RES CO, V264, P561, DOI 10.1006/bbrc.1999.1551; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chase AJ, 2002, ARTERIOSCL THROM VAS, V22, P765, DOI 10.1161/01.ATV.0000015078.09208.92; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Elkington PT, 2011, EUR RESPIR J, V38, P456, DOI 10.1183/09031936.00015411; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gueders MM, 2010, AM J RESP CELL MOL, V43, P286, DOI 10.1165/rcmb.2008-0426OC; Harvey EJ, 2007, ARTERIOSCL THROM VAS, V27, P806, DOI 10.1161/01.ATV.0000258867.79411.96; Johnson JL, 2008, ARTERIOSCL THROM VAS, V28, P1647, DOI 10.1161/ATVBAHA.108.170548; Locati M, 2002, J IMMUNOL, V168, P3557, DOI 10.4049/jimmunol.168.7.3557; Lopez-Pelaez M, 2011, EUR J IMMUNOL, V41, P1733, DOI 10.1002/eji.201041101; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mauch S, 2002, J IMMUNOL, V168, P1244, DOI 10.4049/jimmunol.168.3.1244; Montero I, 2006, J AM COLL CARDIOL, V47, P1369, DOI 10.1016/j.jacc.2005.10.070; Murphy G, 2002, ARTHRITIS RES THER, V4, DOI 10.1186/ar572; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Nie J, 2004, EXP CELL RES, V296, P145, DOI 10.1016/j.yexcr.2004.02.008; O'Hara A, 2009, PFLUG ARCH EUR J PHY, V458, P1103, DOI 10.1007/s00424-009-0693-8; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; Reel B, 2011, BRIT J PHARMACOL, V163, P1679, DOI 10.1111/j.1476-5381.2011.01298.x; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Shiryaev SA, 2009, J BIOL CHEM, V284, P30615, DOI 10.1074/jbc.M109.041244; Sithu SD, 2007, J BIOL CHEM, V282, P25010, DOI 10.1074/jbc.M611273200; Sorsa T, 2006, ANN MED, V38, P306, DOI 10.1080/07853890600800103; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Walker DG, 2006, J LEUKOCYTE BIOL, V79, P596, DOI 10.1189/jlb.0705377; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	40	53	57	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42507	10.1371/journal.pone.0042507	http://dx.doi.org/10.1371/journal.pone.0042507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880008	gold, Green Submitted, Green Published			2022-12-27	WOS:000307284100113
J	Imamura, Y; Sakamoto, S; Endo, T; Utsumi, T; Fuse, M; Suyama, T; Kawamura, K; Imamoto, T; Yano, K; Uzawa, K; Nihei, N; Suzuki, H; Mizokami, A; Ueda, T; Seki, N; Tanzawa, H; Ichikawa, T				Imamura, Yusuke; Sakamoto, Shinichi; Endo, Takumi; Utsumi, Takanobu; Fuse, Miki; Suyama, Takahito; Kawamura, Koji; Imamoto, Takashi; Yano, Kojiro; Uzawa, Katsuhiro; Nihei, Naoki; Suzuki, Hiroyoshi; Mizokami, Atsushi; Ueda, Takeshi; Seki, Naohiko; Tanzawa, Hideki; Ichikawa, Tomohiko			FOXA1 Promotes Tumor Progression in Prostate Cancer via the Insulin-Like Growth Factor Binding Protein 3 Pathway	PLOS ONE			English	Article							FORKHEAD BOX A1; LARGE GENE LISTS; ANDROGEN RECEPTOR; TRANSCRIPTION FACTORS; LUMINAL SUBTYPE; BREAST-CANCER; STROMAL CELLS; HIGH-LEVEL; EXPRESSION; LNCAP	Fork-head box protein A1 (FOXA1) is a "pioneer factor" that is known to bind to the androgen receptor (AR) and regulate the transcription of AR-specific genes. However, the precise role of FOXA1 in prostate cancer (PC) remains unknown. In this study, we report that FOXA1 plays a critical role in PC cell proliferation. The expression of FOXA1 was higher in PC than in normal prostate tissues (P = 0.0002), and, using immunohistochemical analysis, we found that FOXA1 was localized in the nucleus. FOXA1 expression levels were significantly correlated with both PSA and Gleason scores (P = 0.016 and P = 0.031, respectively). Moreover, FOXA1 up-regulation was a significant factor in PSA failure (P = 0.011). Depletion of FOXA1 in a prostate cancer cell line (LNCaP) using small interfering RNA (siRNA) significantly inhibited AR activity, led to cell-growth suppression, and induced G0/G1 arrest. The anti-proliferative effect of FOXA1 siRNA was mediated through insulin-like growth factor binding protein 3 (IGFBP-3). An increase in IGFBP-3, mediated by depletion of FOXA1, inhibited phosphorylation of MAPK and Akt, and increased expression of the cell cycle regulators p21 and p27. We also found that the anti-proliferative effect of FOXA1 depletion was significantly reversed by simultaneous siRNA depletion of IGFBP-3. These findings provide direct physiological and molecular evidence for a role of FOXA1 in controlling cell proliferation through the regulation of IGFBP-3 expression in PC.	[Imamura, Yusuke; Sakamoto, Shinichi; Utsumi, Takanobu; Fuse, Miki; Suyama, Takahito; Kawamura, Koji; Imamoto, Takashi; Nihei, Naoki; Ichikawa, Tomohiko] Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan; [Endo, Takumi; Suzuki, Hiroyoshi] Toho Univ, Med Ctr, Sakura Hosp, Dept Urol, Chiba 2748510, Japan; [Yano, Kojiro] Osaka Inst Technol, Fac Informat Sci & Technol, Osaka 535, Japan; [Uzawa, Katsuhiro; Tanzawa, Hideki] Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chiba, Japan; [Mizokami, Atsushi] Kanazawa Univ, Dept Urol, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Ueda, Takeshi] Chiba Canc Ctr, Div Urol, Chiba 2608717, Japan; [Ueda, Takeshi] Chiba Canc Ctr, Prostate Ctr, Chiba 2608717, Japan; [Seki, Naohiko] Chiba Univ, Grad Sch Med, Dept Funct Genom, Chiba, Japan	Chiba University; Toho University; Osaka Institute of Technology; Chiba University; Kanazawa University; Chiba Cancer Center; Chiba Cancer Center; Chiba University	Imamura, Y (corresponding author), Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan.	rbatbat1@yahoo.co.jp		Uzawa, Katsuhiro/0000-0002-7036-0859	Ministry of Education, Science, Sports and Culture of Japan [20390420, 22791469]; Grants-in-Aid for Scientific Research [22591761] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan (no. 20390420, no. 22791469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Augello MA, 2011, EMBO J, V30, P3885, DOI 10.1038/emboj.2011.340; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Lima GAB, 2009, ARQ BRAS ENDOCRINOL, V53, P969, DOI 10.1590/S0004-27302009000800010; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; DeGraff DJ, 2009, ANDROGEN ACTION IN PROSTATE CANCER, P587, DOI 10.1007/978-0-387-69179-4_25; Dutt SS, 2009, FUTURE ONCOL, V5, P1403, DOI 10.2217/FON.09.117; Endo T, 2009, INT J ONCOL, V35, P499, DOI 10.3892/ijo_00000361; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gao N, 2005, DEVELOPMENT, V132, P3431, DOI 10.1242/dev.01917; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Gerhardt J, 2012, AM J PATHOL, V180, P848, DOI 10.1016/j.ajpath.2011.10.021; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ichikawa T, 2005, CANCER CHEMOTH PHARM, V56, pS58, DOI 10.1007/s00280-005-0100-x; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Jain RK, 2011, HISTOPATHOLOGY, V58, P766, DOI 10.1111/j.1365-2559.2011.03796.x; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kojima S, 2006, PROSTATE, V66, P971, DOI 10.1002/pros.20420; Kojima S, 2009, INT J UROL, V16, P161, DOI 10.1111/j.1442-2042.2008.02224.x; Li R, 2004, AM J SURG PATHOL, V28, P928, DOI 10.1097/00000478-200407000-00013; Lin L, 2002, CANCER RES, V62, P5273; Liu BR, 2000, J BIOL CHEM, V275, P33607, DOI 10.1074/jbc.M002547200; Lupien M, 2009, ENDOCR-RELAT CANCER, V16, P381, DOI 10.1677/ERC-09-0038; Mirosevich J, 2005, PROSTATE, V62, P339, DOI 10.1002/pros.20131; Mizokami A, 2009, ENDOCR-RELAT CANCER, V16, P1139, DOI 10.1677/ERC-09-0070; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Nucera C, 2009, CLIN CANCER RES, V15, P3680, DOI 10.1158/1078-0432.CCR-08-3155; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Silha JV, 2006, ENDOCRINOLOGY, V147, P2112, DOI 10.1210/en.2005-1270; Sun Q, 2009, MOL ENDOCRINOL, V23, P2038, DOI 10.1210/me.2009-0092; Thorat MA, 2008, J CLIN PATHOL, V61, P327, DOI 10.1136/jcp.2007.052431; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; van der Heul-Nieuwenhuijsen L, 2009, BJU INT, V103, P1574, DOI 10.1111/j.1464-410X.2009.08351.x; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Wu JD, 2006, J CELL BIOCHEM, V99, P392, DOI 10.1002/jcb.20929; Yamada PM, 2009, AM J PHYSIOL-CELL PH, V296, pC954, DOI 10.1152/ajpcell.00598.2008; Yamatoji M, 2010, ONCOL REP, V23, P61, DOI 10.3892/or_00000606; Zhang CP, 2011, CANCER RES, V71, P6738, DOI 10.1158/0008-5472.CAN-11-1882; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084	46	41	43	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42456	10.1371/journal.pone.0042456	http://dx.doi.org/10.1371/journal.pone.0042456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879989	Green Submitted, gold, Green Published			2022-12-27	WOS:000307284100098
J	Leimu, R; Kloss, L; Fischer, M				Leimu, Roosa; Kloss, Lena; Fischer, Markus			Inbreeding Alters Activities of the Stress-Related Enzymes Chitinases and beta-1,3-Glucanases	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; LYCHNIS-FLOS-CUCULI; PLANT CHITINASES; MIMULUS-GUTTATUS; HSP70 EXPRESSION; RESISTANCE; HERBIVORY; POPULATION; DEPRESSION; DEFENSE	Pathogenesis-related proteins, chitinases (CHT) and beta-1,3-glucanases (GLU), are stress proteins up-regulated as response to extrinsic environmental stress in plants. It is unknown whether these PR proteins are also influenced by inbreeding, which has been suggested to constitute intrinsic genetic stress, and which is also known to affect the ability of plants to cope with environmental stress. We investigated activities of CHT and GLU in response to inbreeding in plants from 13 Ragged Robin (Lychnis flos-cuculi) populations. We also studied whether activities of these enzymes were associated with levels of herbivore damage and pathogen infection in the populations from which the plants originated. We found an increase in pathogenesis-related protein activity in inbred plants from five out of the 13 investigated populations, which suggests that these proteins may play a role in how plants respond to intrinsic genetic stress brought about by inbreeding in some populations depending on the allele frequencies of loci affecting the expression of CHT and the past levels of inbreeding. More importantly, we found that CHT activities were higher in plants from populations with higher levels of herbivore or pathogen damage, but inbreeding reduced CHT activity in these populations disrupting the increased activities of this resistance-related enzyme in populations where high resistance is beneficial. These results provide novel information on the effects of plant inbreeding on plant-enemy interactions on a biochemical level.	[Leimu, Roosa] Univ Oxford, Dept Plant Sci, Oxford, England; [Leimu, Roosa; Kloss, Lena; Fischer, Markus] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Kloss, Lena] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland	University of Oxford; University of Potsdam; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Bern	Leimu, R (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	roosa.leimu@plants.ox.ac.uk	Fischer, Markus/C-6411-2008	Fischer, Markus/0000-0002-5589-5900	Marie Curie Intra-European Fellowship of the Academy of Finland [108784]; Swiss National Science Foundation [31-56809.99, 31-67876.02]	Marie Curie Intra-European Fellowship of the Academy of Finland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was financially supported by a Marie Curie Intra-European Fellowship for RL, grant 108784 of the Academy of Finland to RL, and grants 31-56809.99 and 31-67876.02 of the Swiss National Science Foundation to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Bello-Bedoy R, 2011, J EVOLUTION BIOL, V24, P518, DOI 10.1111/j.1420-9101.2010.02185.x; Bello-Bedoy R, 2011, EVOL ECOL, V25, P815, DOI 10.1007/s10682-010-9448-4; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; Carr DE, 2002, EVOLUTION, V56, P22, DOI 10.1111/j.0014-3820.2002.tb00846.x; Delphia CM, 2009, INT J PLANT SCI, V170, P12, DOI 10.1086/593039; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dudash MR, 1997, EVOLUTION, V51, P54, DOI [10.2307/2410960, 10.1111/j.1558-5646.1997.tb02388.x]; DUDASH MR, 1990, EVOLUTION, V44, P1129, DOI 10.1111/j.1558-5646.1990.tb05220.x; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Ferrari MJ, 2006, AM J BOT, V93, P1768, DOI 10.3732/ajb.93.12.1768; Galeuchet DJ, 2005, ECOLOGY, V86, P1002, DOI 10.1890/03-0762; Galeuchet DJ, 2005, MOL ECOL, V14, P991, DOI 10.1111/j.1365-294X.2005.02485.x; GALEUCHET DJ, 2003, THESIS U ZURICH; Hayes CN, 2005, J EVOLUTION BIOL, V18, P147, DOI 10.1111/j.1420-9101.2004.00785.x; HOEHN S, 2006, THESIS U ZURICH; Ivey CT, 2004, ECOLOGY, V85, P567, DOI 10.1890/02-0730; Kariyat RR, 2012, ECOL LETT, V15, P301, DOI 10.1111/j.1461-0248.2011.01738.x; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Krishnaveni S, 1999, PLANT SCI, V144, P9, DOI 10.1016/S0168-9452(99)00049-7; Kristensen TN, 2002, EVOL ECOL RES, V4, P1209; Kristensen TN, 2010, TRENDS ECOL EVOL, V25, P44, DOI 10.1016/j.tree.2009.06.014; Lawrence CB, 2000, PHYSIOL MOL PLANT P, V57, P211, DOI 10.1006/pmpp.2000.0298; LEGRAND M, 1987, P NATL ACAD SCI USA, V84, P6750, DOI 10.1073/pnas.84.19.6750; Leimu R, 2008, ECOL LETT, V11, P1101, DOI 10.1111/j.1461-0248.2008.01222.x; Metwally A, 2005, J EXP BOT, V56, P167; Ouborg NJ, 2000, ECOLOGY, V81, P520, DOI 10.2307/177445; Pedersen KS, 2008, GENETICS, V180, P1233, DOI 10.1534/genetics.108.089144; Pedersen KS, 2005, J EVOLUTION BIOL, V18, P756, DOI 10.1111/j.1420-9101.2005.00884.x; Ridley CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024762; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Stephenson AG, 2004, ECOLOGY, V85, P3023, DOI 10.1890/04-0005; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; TRONSMO AM, 1993, DEV PLANT PATHOL, V2, P369; Tuzun S, 2001, EUR J PLANT PATHOL, V107, P85, DOI 10.1023/A:1008784417222; Van Loon LC, 1997, EUR J PLANT PATHOL, V103, P753, DOI 10.1023/A:1008638109140; Venisse JS, 2002, MOL PLANT MICROBE IN, V15, P1204, DOI 10.1094/MPMI.2002.15.12.1204; Waller DM, 2008, EVOLUTION, V62, P917, DOI 10.1111/j.1558-5646.2008.00325.x; Wirooks Ludger, 1999, Melanargia, V11, P93; WIRTH SJ, 1992, SOIL BIOL BIOCHEM, V24, P511, DOI 10.1016/0038-0717(92)90074-8	41	12	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42326	10.1371/journal.pone.0042326	http://dx.doi.org/10.1371/journal.pone.0042326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879940	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100067
J	Pirotta, E; Milor, R; Quick, N; Moretti, D; Di Marzio, N; Tyack, P; Boyd, I; Hastie, G				Pirotta, Enrico; Milor, Rachael; Quick, Nicola; Moretti, David; Di Marzio, Nancy; Tyack, Peter; Boyd, Ian; Hastie, Gordon			Vessel Noise Affects Beaked Whale Behavior: Results of a Dedicated Acoustic Response Study	PLOS ONE			English	Article							LONG	Some beaked whale species are susceptible to the detrimental effects of anthropogenic noise. Most studies have concentrated on the effects of military sonar, but other forms of acoustic disturbance (e. g. shipping noise) may disrupt behavior. An experiment involving the exposure of target whale groups to intense vessel-generated noise tested how these exposures influenced the foraging behavior of Blainville's beaked whales (Mesoplodon densirostris) in the Tongue of the Ocean (Bahamas). A military array of bottom-mounted hydrophones was used to measure the response based upon changes in the spatial and temporal pattern of vocalizations. The archived acoustic data were used to compute metrics of the echolocation-based foraging behavior for 16 targeted groups, 10 groups further away on the range, and 26 non-exposed groups. The duration of foraging bouts was not significantly affected by the exposure. Changes in the hydrophone over which the group was most frequently detected occurred as the animals moved around within a foraging bout, and their number was significantly less the closer the whales were to the sound source. Non-exposed groups also had significantly more changes in the primary hydrophone than exposed groups irrespective of distance. Our results suggested that broadband ship noise caused a significant change in beaked whale behavior up to at least 5.2 kilometers away from the vessel. The observed change could potentially correspond to a restriction in the movement of groups, a period of more directional travel, a reduction in the number of individuals clicking within the group, or a response to changes in prey movement.	[Pirotta, Enrico; Quick, Nicola; Hastie, Gordon] SMRU Ltd, New Technol Ctr, St Andrews, Fife, Scotland; [Pirotta, Enrico; Boyd, Ian] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Milor, Rachael] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Quick, Nicola; Hastie, Gordon] Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews, Fife, Scotland; [Moretti, David; Di Marzio, Nancy] USN, Undersea Warfare Ctr Div, Newport, RI USA; [Tyack, Peter] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	University of St Andrews; Newcastle University - UK; University of St Andrews; United States Department of Defense; United States Navy; Woods Hole Oceanographic Institution	Pirotta, E (corresponding author), SMRU Ltd, New Technol Ctr, St Andrews, Fife, Scotland.	gdh@smru.co.uk	Tyack, Peter/AAC-4513-2019; Tyack, Peter L/D-6209-2013	Tyack, Peter/0000-0002-8409-4790; Tyack, Peter L/0000-0002-8409-4790; Hastie, Gordon/0000-0002-9773-2755; Quick, Nicola/0000-0003-3840-6711	United States (U.S.) Office of Naval Research [N00014-07-10988, N00014-07-11023, N00014-08-10990]; U.S. Strategic Environmental Research and Development Program [SI-1539]; Environmental Readiness Division of the U.S. Navy; U.S. Chief of Naval Operations Submarine Warfare Division (Undersea Surveillance); U.S. National Oceanic and Atmospheric Administration (National Marine Fisheries Service, Office of Science and Technology); U.S. National Oceanic and Atmospheric Administration Ocean Acoustics Program; Joint Industry Program on Sound and Marine Life of the International Association of Oil and Gas Producers; U.S. Navy; Natural Environment Research Council [smru10001] Funding Source: researchfish	United States (U.S.) Office of Naval Research(Office of Naval Research); U.S. Strategic Environmental Research and Development Program; Environmental Readiness Division of the U.S. Navy; U.S. Chief of Naval Operations Submarine Warfare Division (Undersea Surveillance); U.S. National Oceanic and Atmospheric Administration (National Marine Fisheries Service, Office of Science and Technology)(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. National Oceanic and Atmospheric Administration Ocean Acoustics Program; Joint Industry Program on Sound and Marine Life of the International Association of Oil and Gas Producers; U.S. Navy; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research reported here was financially supported by the United States (U.S.) Office of Naval Research (www.onr.navy.mil) grants N00014-07-10988, N00014-07-11023, N00014-08-10990; the U.S. Strategic Environmental Research and Development Program (www.serdp.org) grant SI-1539, the Environmental Readiness Division of the U.S. Navy (http://www.navy.mil/local/n45/), the U.S. Chief of Naval Operations Submarine Warfare Division (Undersea Surveillance), the U.S. National Oceanic and Atmospheric Administration (National Marine Fisheries Service, Office of Science and Technology) (http://www.st.nmfs.noaa.gov/), U.S. National Oceanic and Atmospheric Administration Ocean Acoustics Program (http://www.nmfs.noaa.gov/pr/acoustics/), and the Joint Industry Program on Sound and Marine Life of the International Association of Oil and Gas Producers (www.soundandmarinelife.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; While the sponsors of this study come from an international mix of sound producers and a United States regulatory agency, the majority of funding for the research reported here comes from different divisions of the U.S. Navy, and all of the authors have had at least some of the research reported here partially funded by different divisions of the U.S. Navy. The following authors are employed by the U.S. Navy: David Moretti and Nancy DiMarzio. Their primary involvement was in designing, installing, and helping to operate the passive acoustic marine mammal monitoring system at the AUTEC range; providing the sound sources used in the experiments; and with analyzing and writing up the data. The following authors are employed by a commercial marine mammal consultancy (SMRU Ltd): Enrico Pirotta, Gordon Hastie and Nicola Quick. The following authors have been asked by the U.S. Department of Justice to act as expert witnesses in cases involving the effects of naval sonar on marine mammals: Peter Tyack. Peter Tyack is also a member of Natural Resources Defense Council, which is an advocacy organization that has sued the Navy concerning effects of sonar on marine mammals. None of the analysis nor write up of the paper involved or was influenced by the sponsors of the research. Furthermore, the declarations provided do not alter the authors' adherence to all the PloSONE policies on sharing data and materials.	[Anonymous], 2008, CANADIAN ACOUSTICS; Arveson PT, 2000, J ACOUST SOC AM, V107, P118, DOI 10.1121/1.428344; Balcomb Kenneth C. III, 2001, Bahamas Journal of Science, V8, P2; Boyd IL, 2008, BEHAV RESPONSE STUDY; Cox T. M., 2005, Journal of Cetacean Research and Management, V7, P177; DiMarzio N, 2008, MARINE MAMMAL MONITO; Finley K.J., 1990, Canadian Bulletin of Fisheries and Aquatic Sciences, V224, P97; Fox J., 2019, CAR COMPANION APPL R; Frantzis A, 1998, NATURE, V392, P29, DOI 10.1038/32068; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Holt MM, 2009, J ACOUST SOC AM, V125, pEL27, DOI 10.1121/1.3040028; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Lesage V, 1999, MAR MAMMAL SCI, V15, P65, DOI 10.1111/j.1748-7692.1999.tb00782.x; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; McCarthy E, 2011, MAR MAMMAL SCI, V27, pE206, DOI 10.1111/j.1748-7692.2010.00457.x; Moretti D, 2010, APPL ACOUST, V71, P1036, DOI 10.1016/j.apacoust.2010.04.011; National Research Council, 2003, OC NOIS MAR MAMM; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Nowacek DP, 2004, P ROY SOC B-BIOL SCI, V271, P227, DOI 10.1098/rspb.2003.2570; Nowacek SM, 2001, MAR MAMMAL SCI, V17, P673, DOI 10.1111/j.1748-7692.2001.tb01292.x; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; Perry C., 1998, SCI COMM 50 M INT WH; R Core Team, 2020, R LANG ENV STAT COMP; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Sakamoto Y., 1986, AKAIKE INFORM CRITER; SIMMONDS MP, 1991, NATURE, V351, P448, DOI 10.1038/351448a0; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Southall B. L., 2005, 2004 INT S SHIPP NOI; Thompson D, 2001, ANIM BEHAV, V61, P287, DOI 10.1006/anbe.2000.1539; Thompson D., 1993, Symposia of the Zoological Society of London, V66, P349; Tyack P, 2009, MAR ECOL PROG SER, V395, P187, DOI 10.3354/meps08363; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; VINCENT HT, 2001, THESIS U RHODE ISLAN; Ward J, 2011, J ACOUST SOC AM, V129, P662, DOI 10.1121/1.3531844; Ward JP, 2008, POETRY WALES, V44, P60; Zimmer WMX, 2008, J ACOUST SOC AM, V124, P2823, DOI 10.1121/1.2988277; [No title captured]	39	39	39	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42535	10.1371/journal.pone.0042535	http://dx.doi.org/10.1371/journal.pone.0042535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880022	Green Published, gold			2022-12-27	WOS:000307284100123
J	Schmidt, F; Levin, J; Kamp, F; Kretzschmar, H; Giese, A; Botzel, K				Schmidt, Felix; Levin, Johannes; Kamp, Frits; Kretzschmar, Hans; Giese, Armin; Boetzel, Kai			Single-Channel Electrophysiology Reveals a Distinct and Uniform Pore Complex Formed by alpha-Synuclein Oligomers in Lipid Membranes	PLOS ONE			English	Article							PROTEIN AGGREGATION; COMMON MECHANISM; DISSOCIATION; HEMOLYSIN; IMPLIES	Synucleinopathies such as Parkinson's disease, multiple system atrophy and dementia with Lewy bodies are characterized by deposition of aggregated alpha-synuclein. Recent findings indicate that pathological oligomers rather than fibrillar aggregates may represent the main toxic protein species. It has been shown that alpha-synuclein oligomers can increase the conductance of lipid bilayers and, in cell-culture, lead to calcium dyshomeostasis and cell death. In this study, employing a setup for single-channel electrophysiology, we found that addition of iron-induced alpha-synuclein oligomers resulted in quantized and stepwise increases in bilayer conductance indicating insertion of distinct transmembrane pores. These pores switched between open and closed states depending on clamped voltage revealing a single-pore conductance comparable to that of bacterial porins. Pore conductance was dependent on transmembrane potential and the available cation. The pores stably inserted into the bilayer and could not be removed by buffer exchange. Pore formation could be inhibited by co-incubation with the aggregation inhibitor baicalein. Our findings indicate that iron-induced alpha-synuclein oligomers can form a uniform and distinct pore species with characteristic electrophysiological properties. Pore formation could be a critical event in the pathogenesis of synucleinopathies and provide a novel structural target for disease-modifying therapy.	[Schmidt, Felix; Levin, Johannes; Kamp, Frits; Boetzel, Kai] Univ Munich, Klinikum Univ Munchen, Neurol Klin, Munich, Germany; [Schmidt, Felix; Kretzschmar, Hans; Giese, Armin] Univ Munich, Zentrum Neuropathol & Prionforsch, Munich, Germany; [Kamp, Frits] Univ Munich, Deutsch Zentrum Neurodegenerat Erkrankungen, Munich, Germany; [Kamp, Frits] Univ Munich, Adolf Butenandt Inst, Munich, Germany	University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich	Schmidt, F (corresponding author), Univ Munich, Klinikum Univ Munchen, Neurol Klin, Munich, Germany.	Armin.Giese@med.uni-muenchen.de	Levin, Johannes/E-4052-2010; Giese, Armin/F-3271-2010	Levin, Johannes/0000-0001-5092-4306; Giese, Armin/0000-0002-8238-4102	Luneburg fund for Parkinson's disease research; DFG [SFB596-B13]	Luneburg fund for Parkinson's disease research; DFG(German Research Foundation (DFG))	This work was supported by the Luneburg fund for Parkinson's disease research and by the DFG (Grant SFB596-B13 to AG and HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENZ R, 1989, INFECT IMMUN, V57, P887, DOI 10.1128/IAI.57.3.887-895.1989; BENZ R, 1985, J BACTERIOL, V162, P722, DOI 10.1128/JB.162.2.722-727.1985; BRUNEN M, 1993, EUR J BIOCHEM, V212, P129, DOI 10.1111/j.1432-1033.1993.tb17642.x; Caruana M, 2012, BIOCH BIOPHYS ACTA; Delcour AH, 1997, FEMS MICROBIOL LETT, V151, P115, DOI 10.1016/S0378-1097(97)00166-3; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Hemmler R, 2005, BIOPHYS J, V88, P4000, DOI 10.1529/biophysj.104.058255; Hillmer AS, 2010, BIOCHEM BIOPH RES CO, V391, P461, DOI 10.1016/j.bbrc.2009.11.080; Hogen T, 2012, BIOPHYS J, V102, P1646, DOI 10.1016/j.bpj.2012.01.059; Huls S, 2011, J NEUROCHEM, V117, P868, DOI 10.1111/j.1471-4159.2011.07254.x; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HY, 2008, ANGEW CHEM INT EDIT, V47, P5046, DOI 10.1002/anie.200800342; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; KRASILNIKOV OV, 1988, GEN PHYSIOL BIOPHYS, V7, P467; LAKEY JH, 1985, BIOCHIM BIOPHYS ACTA, V817, P208, DOI 10.1016/0005-2736(85)90022-7; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Levin J, 2011, MOVEMENT DISORD, V26, pS21; Levin J, 2011, J PARKINSON DIS, V1, P205, DOI 10.3233/JPD-2011-11040; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; van Rooijen BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014292; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	31	54	54	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42545	10.1371/journal.pone.0042545	http://dx.doi.org/10.1371/journal.pone.0042545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880029	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100127
J	Simon-Vazquez, R; Dominguez, M; Lorenz-Fonfria, VA; Alvarez, S; Bourdelande, JL; de Lera, AR; Padros, E; Peralvarez-Marin, A				Simon-Vazquez, Rosana; Dominguez, Marta; Lorenz-Fonfria, Victor A.; Alvarez, Susana; Bourdelande, Jose-Luis; de Lera, Angel R.; Padros, Esteve; Peralvarez-Marin, Alex			Probing a Polar Cluster in the Retinal Binding Pocket of Bacteriorhodopsin by a Chemical Design Approach	PLOS ONE			English	Article							HALOBACTERIUM-HALOBIUM; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; PURPLE MEMBRANE; O-INTERMEDIATE; PROTON; PHOTOCYCLE; 13-CIS; ISOMERIZATION; ADAPTATION	Bacteriorhodopsin has a polar cluster of amino acids surrounding the retinal molecule, which is responsible for light harvesting to fuel proton pumping. From our previous studies, we have shown that threonine 90 is the pivotal amino acid in this polar cluster, both functionally and structurally. In an attempt to perform a phenotype rescue, we have chemically designed a retinal analogue molecule to compensate the drastic effects of the T90A mutation in bacteriorhodopsin. This analogue substitutes the methyl group at position C-13 of the retinal hydrocarbon chain by and ethyl group (20-methyl retinal). We have analyzed the effect of reconstituting the wild-type and the T90A mutant apoproteins with all-trans-retinal and its 20-methyl derivative (hereafter, 13-ethyl retinal). Biophysical characterization indicates that recovering the steric interaction between the residue 90 and retinal, eases the accommodation of the chromophore, however it is not enough for a complete phenotype rescue. The characterization of these chemically engineered chromoproteins provides further insight into the role of the hydrogen bond network and the steric interactions involving the retinal binding pocket in bacteriorhodopsin and other microbial sensory rhodopsins.	[Simon-Vazquez, Rosana; Lorenz-Fonfria, Victor A.; Padros, Esteve; Peralvarez-Marin, Alex] Univ Autonoma Barcelona, Ctr Estudis Biofis, E-08193 Barcelona, Spain; [Simon-Vazquez, Rosana; Lorenz-Fonfria, Victor A.; Padros, Esteve; Peralvarez-Marin, Alex] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Dominguez, Marta; Alvarez, Susana; de Lera, Angel R.] Univ Vigo, Fac Quim, Dept Quim Organ, Vigo 36310, Spain; [Bourdelande, Jose-Luis] Univ Autonoma Barcelona, Dept Quim Quim Organ, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Universidade de Vigo; Autonomous University of Barcelona	Simon-Vazquez, R (corresponding author), Univ Vigo, Fac Ciencias, Lab Inmunol, Campus Lagoas Marcosende, Vigo 36310, Spain.	Alex.Peralvarez@uab.cat	Peralvarez-Marin, Alex/AAH-4305-2020; Fonfria, Victor A Lorenz/B-3754-2018; Fonfria, Victor A. Lorenz/AAU-9034-2021; Dominguez, Marta/AAA-2084-2019; Peralvarez-Marin, Alex/A-8958-2017; Simón, Rosana/K-6130-2014; Simón-Vázquez, Rosana/AER-4378-2022	Fonfria, Victor A Lorenz/0000-0002-8859-8347; Fonfria, Victor A. Lorenz/0000-0002-8859-8347; Peralvarez-Marin, Alex/0000-0002-3457-0875; Simón, Rosana/0000-0001-8963-6547; Dominguez Seoane, Marta/0000-0003-4569-8011; Rodriguez de Lera, Angel/0000-0001-6896-9078	Spanish Ministry of Science and Innovation [BES-2004-5542, BFU2009-08758/BMC, SAF2010-21385, SAF2010-17935-FEDER]; Xunta de Galicia (from DXI+D+i) [08CSA052383PR]; European Commission [PIOF-GA-2009-237120]; Xunta de Galicia (from DXPCTSUG) [Consolidacion 2006/15]; Xunta de Galicia (from INBIOMED); Xunta de Galicia (from Parga Pondal)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia (from DXI+D+i)(Xunta de Galicia); European Commission(European CommissionEuropean Commission Joint Research Centre); Xunta de Galicia (from DXPCTSUG)(Xunta de Galicia); Xunta de Galicia (from INBIOMED)(Xunta de Galicia); Xunta de Galicia (from Parga Pondal)(Xunta de Galicia)	The authors want to thank the following sources of funding: the Spanish Ministry of Science and Innovation (BES-2004-5542 to RS-V, BFU2009-08758/BMC to EP, SAF2010-21385 to AP-M, SAF2010-17935-FEDER to ARdL), Xunta de Galicia (Grant 08CSA052383PR from DXI+D+i; Consolidacion 2006/15 from DXPCTSUG; INBIOMED; Parga Pondal Contract to MD), and European Commission (Marie Curie Action PIOF-GA-2009-237120 to AP-M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2001, BIOCHEMISTRY-US, V40, P13310, DOI 10.1021/bi011438u; Alvarez R, 1999, TETRAHEDRON, V55, P13779, DOI 10.1016/S0040-4020(99)00861-3; BALASHOV SP, 1993, BIOCHEMISTRY-US, V32, P10331, DOI 10.1021/bi00090a008; Brown MF, 2007, BBA-BIOMEMBRANES, V1768, P2979, DOI 10.1016/j.bbamem.2007.10.014; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CORRIU RJP, 1972, J CHEM SOC CHEM COMM, P144; Curran AR, 2003, CURRENT OPINION STRU, P13; DANON A, 1974, P NATL ACAD SCI USA, V71, P1234, DOI 10.1073/pnas.71.4.1234; Gartner W, 1988, BIOCHEMISTRY-US, V27, P6; GERGELY C, 1994, BIOPHYS J, V67, P855, DOI 10.1016/S0006-3495(94)80545-4; Gillespie NB, 2005, J PHYS CHEM B, V109, P16142, DOI 10.1021/jp052124+; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Hiraki K, 2002, BIOPHYS J, V83, P3460, DOI 10.1016/S0006-3495(02)75345-9; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Kato HE, 2012, NATURE; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Lazarova T, 2009, PHOTOCHEM PHOTOBIOL, V85, P617, DOI 10.1111/j.1751-1097.2008.00534.x; Lodowski DT, 2009, CURR OPIN HIV AIDS, V4, P88, DOI 10.1097/COH.0b013e3283223d8d; Lopez S, 2005, CHEMBIOCHEM, V6, P2078, DOI 10.1002/cbic.200500148; Luecke H, 2000, J MOL BIOL, V300, P1237, DOI 10.1006/jmbi.2000.3884; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MOWERY PC, 1979, BIOCHEMISTRY-US, V18, P4100, DOI 10.1021/bi00586a007; OESTERHELT D, 1973, EUR J BIOCHEM, V40, P453, DOI 10.1111/j.1432-1033.1973.tb03214.x; OESTERHELT D, 1974, FEBS LETT, V44, P262, DOI 10.1016/0014-5793(74)81153-1; OHNO K, 1977, BIOCHIM BIOPHYS ACTA, V462, P575, DOI 10.1016/0005-2728(77)90102-5; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Peralavarez-Marin A, 2004, J BIOL CHEM, V279, P16403, DOI 10.1074/jbc.M313988200; Peralvarez A, 2001, FEBS LETT, V508, P399, DOI 10.1016/S0014-5793(01)03080-0; Peralvarez-Marin A, 2008, BIOPHYS J, V95, P4384, DOI 10.1529/biophysj.108.136747; Peralvarez-Marin A, 2007, J MOL BIOL, V368, P666, DOI 10.1016/j.jmb.2007.02.021; Ritter E, 2009, CURR ORG CHEM, V13, P241, DOI 10.2174/138527209787314805; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Sanz C, 2001, J BIOL CHEM, V276, P40788, DOI 10.1074/jbc.M104836200; SCHERRER P, 1989, BIOCHEMISTRY-US, V28, P829, DOI 10.1021/bi00428a063; SUBRAMANIAM S, 1992, J BIOL CHEM, V267, P25730; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; SUBRAMANIAM S, 1991, P NATL ACAD SCI USA, V88, P6873, DOI 10.1073/pnas.88.15.6873; TAMAO K, 1972, J AM CHEM SOC, V94, P4374, DOI 10.1021/ja00767a075; Toth-Boconadi R, 2003, BIOPHYS J, V84, P3857, DOI 10.1016/S0006-3495(03)75113-3; TRISSL HW, 1987, BIOCHEMISTRY-US, V26, P751, DOI 10.1021/bi00377a015; Walz T, 1998, J STRUCT BIOL, V121, P142, DOI 10.1006/jsbi.1998.3945; ZHANG HZ, 1994, J AM CHEM SOC, V116, P6823, DOI 10.1021/ja00094a041	42	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42447	10.1371/journal.pone.0042447	http://dx.doi.org/10.1371/journal.pone.0042447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879987	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100096
J	Holland, D; Desikan, RS; Dale, AM; McEvoy, LK				Holland, Dominic; Desikan, Rahul S.; Dale, Anders M.; McEvoy, Linda K.		Alzheimers Dis Neuroimaging Initia	Rates of Decline in Alzheimer Disease Decrease with Age	PLOS ONE			English	Article							NEUROFIBRILLARY PATHOLOGY; BRAIN ATROPHY; OLDEST-OLD; DEMENTIA; NEUROPATHOLOGY; PREVALENCE; BIOMARKER; MODEL; DIAGNOSIS; ADULTS	Age is the strongest risk factor for sporadic Alzheimer disease (AD), yet the effects of age on rates of clinical decline and brain atrophy in AD have been largely unexplored. Here, we examined longitudinal rates of change as a function of baseline age for measures of clinical decline and structural MRI-based regional brain atrophy, in cohorts of AD, mild cognitive impairment (MCI), and cognitively healthy (HC) individuals aged 65 to 90 years (total n = 723). The effect of age was modeled using mixed effects linear regression. There was pronounced reduction in rates of clinical decline and atrophy with age for AD and MCI individuals, whereas HCs showed increased rates of clinical decline and atrophy with age. This resulted in convergence in rates of change for HCs and patients with advancing age for several measures. Baseline cerebrospinal fluid densities of AD-relevant proteins, A beta(1-42), tau, and phospho-tau(181p) (ptau), showed a similar pattern of convergence with advanced age across cohorts, particularly for ptau. In contrast, baseline clinical measures did not differ by age, indicating uniformity of clinical severity at baseline. These results imply that the phenotypic expression of AD is relatively mild in individuals older than approximately 85 years, and this may affect the ability to distinguish AD from normal aging in the very old. Our findings show that inclusion of older individuals in clinical trials will substantially reduce the power to detect disease-modifying therapeutic effects, leading to dramatic increases in required clinical trial sample sizes with age of study sample.	[Holland, Dominic; Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Desikan, Rahul S.; Dale, Anders M.; McEvoy, Linda K.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Holland, D (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	dominic.holland@gmail.com	Levey, Allan/F-2104-2011; Preda, Adrian/K-8889-2013; Hsiung, Robin/AAT-1661-2021	Levey, Allan/0000-0002-3153-502X; Preda, Adrian/0000-0003-3373-2438; Hsiung, Robin/0000-0002-8017-0856	NIH [R01AG031224, R01AG22381, U54NS056883, P50NS22343, P50MH081755, P30 AG010129, K01 AG030514]; NIA [K01AG029218]; NIH-NIBIB [T32 EB005970]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Dana Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH081755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS022343, U54NS056883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG024904, P30AG013846, P30AG010129, K01AG029218, R01AG031224, U19AG010483, K01AG030514, R01AG022381, P30AG019610] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH-NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Dana Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by NIH grants R01AG031224, R01AG22381, U54NS056883, P50NS22343, and P50MH081755 (A. M. D.); NIA K01AG029218 (LKM); NIH-NIBIB T32 EB005970 (RSD). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 2010, Alzheimers Dement, V6, P158, DOI 10.1016/j.jalz.2010.01.009; Bernick C, 2012, ARCH NEUROL; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; Brumback-Peltz C, 2011, MATURITAS, V70, P164, DOI 10.1016/j.maturitas.2011.07.008; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Caroli A, 2010, NEUROBIOL AGING, V31, P1263, DOI 10.1016/j.neurobiolaging.2010.04.024; Clarke G, 2001, HUM MOL GENET, V10, P2269, DOI 10.1093/hmg/10.20.2269; Coley N, 2011, ALZHEIMERS DEMENT, V7, P602, DOI 10.1016/j.jalz.2011.01.005; Corrada MM, 2010, ANN NEUROL, V67, P114, DOI 10.1002/ana.21915; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Desikan RS, 2012, ARCH NEUROL; Desikan RS, 2011, ANN NEUROL; DeToma AS, 2012, CHEM SOC REV, V41, P608, DOI 10.1039/c1cs15112f; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fitzmaurice GM, 2011, APPL LONGITUDINAL AN, V25; Fox NC, 2011, NEUROIMAGE, V57, P15, DOI 10.1016/j.neuroimage.2011.01.077; Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P1205, DOI 10.1097/NEN.0b013e31818fc72f; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Gold G, 2007, BRAIN, V130, P2830, DOI 10.1093/brain/awm228; Hastie T, 1990, GEN ADDITIVE MODELS, pxv; HEBERT LE, 1995, JAMA-J AM MED ASSOC, V273, P1354, DOI 10.1001/jama.273.17.1354; Holland D., 2011, HUM BRAIN MAPP; Holland D, 2011, MED IMAGE ANAL, V15, P489, DOI 10.1016/j.media.2011.02.005; Holland D, 2009, P NATL ACAD SCI USA, V106, P20954, DOI 10.1073/pnas.0906053106; Hua X, 2011, NEUROIMAGE, V57, P5, DOI 10.1016/j.neuroimage.2011.01.079; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jack CR, 2008, NEUROLOGY, V70, P1740, DOI 10.1212/01.wnl.0000281688.77598.35; Jack CR, 2012, RADIOLOGY, V263, P343, DOI 10.1148/radiol.12110433; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P474, DOI 10.1016/j.jalz.2011.04.007; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack Jr CR, 2012, ARCH NEUROL; Jellinger KA, 2010, ACTA NEUROPATHOL, V119, P421, DOI 10.1007/s00401-010-0654-5; Kennedy KM, 2009, NEUROBIOL AGING, V30, P1657, DOI 10.1016/j.neurobiolaging.2007.12.020; Khachaturian AS, 2004, ARCH GEN PSYCHIAT, V61, P518, DOI 10.1001/archpsyc.61.5.518; Kovari E, 2007, NEUROLOGY, V68, P927, DOI 10.1212/01.wnl.0000257094.10655.9a; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Lee GJ, 2012, BIOL PSYCHIAT, V71, P814, DOI 10.1016/j.biopsych.2011.12.024; Leung KK, 2012, NEUROIMAGE, V59, P3995, DOI 10.1016/j.neuroimage.2011.10.068; Lomasko T, 2009, J THEOR BIOL, V256, P104, DOI 10.1016/j.jtbi.2008.08.025; Matthews F, 2005, PLOS MED, V2, P753, DOI 10.1371/journal.pmed.0020193; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Miech RA, 2002, NEUROLOGY, V58, P209, DOI 10.1212/WNL.58.2.209; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Prohovnik I, 2006, NEUROLOGY, V66, P49, DOI 10.1212/01.wnl.0000191298.68045.50; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020; Reuter M, 2012, NEUROIMAGE; Rosner B, 2006, FUNDAMENTALS BIOSTAT, pxix; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Schuff N, 2012, NEUROBIOL AGING, V33, P845, DOI 10.1016/j.neurobiolaging.2010.07.012; Sinka L, 2010, J NEUROPATH EXP NEUR, V69, P1247, DOI 10.1097/NEN.0b013e3181ffc3b9; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Stricker NH, 2011, NEUROLOGY, V77, P713, DOI 10.1212/WNL.0b013e31822b0004; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008; van der Flier WM, 2011, LANCET NEUROL, V10, P280, DOI 10.1016/S1474-4422(10)70306-9; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Wan H, 2005, 65 US 2005; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]	71	74	75	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42325	10.1371/journal.pone.0042325	http://dx.doi.org/10.1371/journal.pone.0042325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876315	Green Published, gold			2022-12-27	WOS:000307184700043
J	Cohen, AL; Taylor, T; Farley, MM; Schaffner, W; Lesher, LJ; Gershman, KA; Bennett, NM; Reingold, A; Thomas, A; Baumbach, J; Harrison, LH; Petit, S; Beall, B; Zell, E; Moore, M				Cohen, Adam L.; Taylor, Thomas, Jr.; Farley, Monica M.; Schaffner, William; Lesher, Lindsey J.; Gershman, Kenneth A.; Bennett, Nancy M.; Reingold, Arthur; Thomas, Ann; Baumbach, Joan; Harrison, Lee H.; Petit, Susan; Beall, Bernard; Zell, Elizabeth; Moore, Matthew			An Assessment of the Screening Method to Evaluate Vaccine Effectiveness: The Case of 7-Valent Pneumococcal Conjugate Vaccine in the United States	PLOS ONE			English	Article							SURVEILLANCE; OUTBREAK; ENGLAND; PROGRAM; DISEASE	The screening method, which employs readily available data, is an inexpensive and quick means of estimating vaccine effectiveness (VE). We compared estimates of effectiveness of heptavalent pneumococcal conjugate vaccine (PCV7) against invasive pneumococcal disease (IPD) using the screening and case-control methods. Cases were children aged 19-35 months with pneumococcus isolated from normally sterile sites residing in Active Bacterial Core surveillance areas in the United States. Case-control VE was estimated for 2001-2004 by comparing the odds of vaccination among cases and community controls. Screening-method VE for 2001-2009 was estimated by comparing the proportion of cases vaccinated to National Immunization Survey-derived coverage among the general population. To evaluate the plausibility of screening-method VE findings, we estimated attack rates among vaccinated and unvaccinated persons. We identified 1,154 children with IPD. Annual population PCV7 coverage with >= 1 dose increased from 38% to 97%. Case-control VE for >= 1 dose was estimated as 75% against all-serotype IPD (annual range: 35-83%) and 91% for PCV7-type IPD (annual range: 65-100%). By the screening method, the overall VE was 86% for >= 1 dose (annual range: -240-70%) against all-serotype IPD and 94% (annual range: 62-97%) against PCV7-type IPD. As cases of PCV7-type IPD declined during 2001-2005, estimated attack rates for all-serotype IPD among vaccinated and unvaccinated individuals became less consistent than what would be expected with the estimated effectiveness of PCV7. The screening method yields estimates of VE that are highly dependent on the time period during which it is used and the choice of outcome. The method should be used cautiously to evaluate VE of PCVs.	[Cohen, Adam L.; Taylor, Thomas, Jr.; Beall, Bernard; Zell, Elizabeth; Moore, Matthew] Ctr Dis Control & Prevent, Atlanta, GA 30329 USA; [Farley, Monica M.] Emory Univ, Sch Med, Atlanta, GA USA; [Schaffner, William] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA; [Lesher, Lindsey J.] Minnesota Dept Hlth, St Paul, MN USA; [Gershman, Kenneth A.] Colorado Dept Hlth & Environm, Denver, CO USA; [Bennett, Nancy M.] Univ Rochester, Sch Med, Rochester, NY USA; [Reingold, Arthur] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Thomas, Ann] Oregon Dept Hlth, Portland, OR USA; [Baumbach, Joan] New Mexico Dept Hlth, Santa Fe, NM USA; [Harrison, Lee H.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Petit, Susan] Connecticut Dept Publ Hlth, Hartford, CT USA	Centers for Disease Control & Prevention - USA; Emory University; Vanderbilt University; Minnesota Department of Health (MHD); University of Rochester; University of California System; University of California Berkeley; New Mexico Department of Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cohen, AL (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30329 USA.	dvj1@cdc.gov			Centers for Disease Control and Prevention (CDC) Emerging Infections Program	Centers for Disease Control and Prevention (CDC) Emerging Infections Program	This work was funded by the Centers for Disease Control and Prevention (CDC) Emerging Infections Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black Carla L., 2011, Morbidity and Mortality Weekly Report, V60, P1157; Carvalho MD, 2009, J CLIN MICROBIOL, V47, P554, DOI 10.1128/JCM.01919-08; Cohen C, 2007, EMERG INFECT DIS, V13, P12; De Serres G, 2012, VACCINE, V30, P4067, DOI 10.1016/j.vaccine.2012.04.017; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; Guris D, 1997, J INFECT DIS, V176, P456, DOI 10.1086/514064; KUPPER LL, 1975, J AM STAT ASSOC, V70, P524, DOI 10.2307/2285927; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; McMorrow ML, 2009, SAMJ S AFR MED J, V99, P314; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Ramsay ME, 2003, J INFECT DIS, V188, P481, DOI 10.1086/376997; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; Seyler T, 2012, VACCINE, V30, P109, DOI 10.1016/j.vaccine.2011.11.013; Smith PJ, 2007, PEDIATRICS, V120, pE1165, DOI 10.1542/peds.2007-0037; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; US Census Bureau, US CENS BUR POP EST; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; World Health Organization, 2007, WKLY EPIDEMIOL REC, V82, P93	20	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41785	10.1371/journal.pone.0041785	http://dx.doi.org/10.1371/journal.pone.0041785			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870248	gold, Green Submitted, Green Published			2022-12-27	WOS:000307212800034
J	Eriksson, ME; Terfelt, F; Elofsson, R; Marone, F				Eriksson, Mats E.; Terfelt, Fredrik; Elofsson, Rolf; Marone, Federica			Internal Soft-Tissue Anatomy of Cambrian 'Orsten' Arthropods as Revealed by Synchrotron X-Ray Tomographic Microscopy	PLOS ONE			English	Article							CRUSTACEA; SCANDINAVIA; LABRUM	The world-famous 'Orsten' Konservat-Lagerstatte has yielded detailed information about Cambrian arthropods and their morphology. Internal organs or soft tissues have, however, rarely been reported, an obvious palaeobiological drawback. In this study, we employed synchrotron radiation X-ray tomographic microscopy (SRXTM) to study microscopic 'Orsten' arthropods from the Cambrian of Sweden: Skara minuta and two phosphatocopine species, Hesslandona sp. and Hesslandona trituberculata. This exceptionally high-resolution technique reveals internal organs or soft tissues that allow detailed comparison with equivalent structures in extant crustaceans and functional inferences to be made. The S. minuta specimen shows the digestive system and muscles that extend to the extremities. The slanting anterior portion of the head and anterior position of the mouth with a straight oesophagus suggest a primarily brushing and scraping way of feeding. The prominent head appendage muscles indicate muscle strength and good capacity for food manipulation. In the phosphatocopines the bulbous labrum is one of the most prominent morphological structures of the body. All specimens analysed reveal pairs of muscle bundles within the labrum. Based on comparisons with extant crustacean relatives, these muscles would fulfil the function of moving the labrum up and down in order to open the buccal cavity. The results of this pilot study demonstrate that there is still much to be learned about the 'Orsten' taxa.	[Eriksson, Mats E.] Lund Univ, Dept Geol, Lund, Sweden; [Terfelt, Fredrik] Lund Univ, Dept Phys, Lund, Sweden; [Elofsson, Rolf] Lund Univ, Dept Biol, Lund, Sweden; [Marone, Federica] Paul Scherrer Inst, Swiss Light Source, Villigen, Switzerland	Lund University; Lund University; Lund University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Eriksson, ME (corresponding author), Lund Univ, Dept Geol, Lund, Sweden.	mats.eriksson@geol.lu.se	Marone, Federica/J-4420-2013		Swedish Research Council; Royal Physiographic Society, Lund; Faculty of Science, Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society, Lund; Faculty of Science, Lund University	This research was financed by grants to MEE and FT from the Swedish Research Council, the Royal Physiographic Society, Lund, and the Faculty of Science, Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwmark C, 2011, METEORIT PLANET SCI, V46, P1071, DOI 10.1111/j.1945-5100.2011.01214.x; Andersson A., 1985, SVERIGES GEOLOGISKA, V56, P1; Bengtson S, 2004, SCIENCE, V306; Bitsch C, 2002, ARTHROPOD STRUCT DEV, V30, P159, DOI 10.1016/S1467-8039(01)00032-9; Chen JY, 2004, SCIENCE, V305, P218, DOI 10.1126/science.1099213; Cunningham JA, 2012, P ROY SOC B-BIOL SCI, V279, P2369, DOI 10.1098/rspb.2011.2280; Dahl E., 1956, Acta Zoologica Stockholm, V37, P123; ELOFSSON R, 1992, J CRUSTACEAN BIOL, V12, P571, DOI 10.2307/1548838; Elofsson R, 2008, ARTHROPOD STRUCT DEV, V37, P522, DOI 10.1016/j.asd.2008.05.002; Elofsson R, 2010, ARTHROPOD STRUCT DEV, V39, P242, DOI 10.1016/j.asd.2010.01.002; Eriksson ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035625; Henningsmoen G., 1957, SKRIFTER UTGITT N MN, V1957, P1; HerreraAlvarez L, 1996, J MORPHOL, V230, P199, DOI 10.1002/(SICI)1097-4687(199611)230:2<199::AID-JMOR7>3.0.CO;2-C; Hessler R. R., 1964, Mem Con Acad Sci, V16, P1; Jeppsson L, 1999, J PALEONTOL, V73, P964, DOI 10.1017/S0022336000040798; LARINK O, 1972, Z MORPHOL TIERE, V72, P341, DOI 10.1007/BF00283128; Maas A, 2005, HYDROBIOLOGIA, V538, P139, DOI 10.1007/s10750-004-4944-6; Maas Andreas, 2003, Fossils and Strata, V49, P1; Maas Andreas, 2006, Palaeoworld, V15, P266, DOI 10.1016/j.palwor.2006.10.005; Maeda H, 2011, PALAIOS, V26, P225, DOI 10.2110/palo.2010.p10-042r; Marone F, 2010, PROC SPIE, V7804, DOI 10.1117/12.859703; Martinsson A., 1974, P185; Muller K.J., 1991, Fossils and Strata, P1; MULLER KJ, 1979, LETHAIA, V12, P1, DOI 10.1111/j.1502-3931.1979.tb01234.x; Muller KJ, 1985, FOSSILS STRATA, V17, P1; Siveter DJ, 2003, SPEC PAP PALAEONTOL, P9; Stampanoni M, 2006, PROC SPIE, V6318, DOI 10.1117/12.679497; Terfelt F, 2008, NORW J GEOL, V88, P73; Terfelt F, 2011, LETHAIA, V44, P8, DOI 10.1111/j.1502-3931.2009.00211.x; Walossek D, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P185; WALOSSEK D, 1993, LETHAIA, V26, P7, DOI 10.1111/j.1502-3931.1993.tb01504.x; Walossek D, 1987, FOSSILS STRATA, V19, P1; Waloszek Dieter, 2003, Paleontological Research, V7, P71, DOI 10.2517/prpsj.7.71; WESTERGARD A. H., 1947, SVERIGES GEOL UNDERSOKN SER C, V489, P1; Westergard A. H., 1922, Sveriges geol Unders Ser Ca, V18, P1	35	19	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42582	10.1371/journal.pone.0042582	http://dx.doi.org/10.1371/journal.pone.0042582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870334	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800097
J	Madireddi, S; Schabowsky, RH; Srivastava, AK; Sharma, RK; Yolcu, ES; Shirwan, H				Madireddi, Shravan; Schabowsky, Rich-Henry; Srivastava, Abhishek K.; Sharma, Rajesh K.; Yolcu, Esma S.; Shirwan, Haval			SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4(+) T Cells into CD4(+)FoxP3(+) T Regulatory Cells by Production of IFN-gamma	PLOS ONE			English	Article							TGF-BETA; IN-VIVO; ESTABLISHED TUMORS; FOXP3 INDUCTION; 4-1BB LIGAND; RESPONSES; OX40; PROLIFERATION; EXPANSION; DEPLETION	Tumors convert conventional CD4(+) T cells into induced CD4(+)CD25(+)FoxP3(+) T regulatory (iTreg) cells that serve as an effective means of immune evasion. Therefore, the blockade of conventional CD4(+) T cell conversion into iTreg cells represents an attractive target for improving the efficacy of various immunotherapeutic approaches. Using a novel form of 4-1BBL molecule, SA-4-1BBL, we previously demonstrated that costimulation via 4-1BB receptor renders both CD4(+) and CD8(+) T effector (Teff) cells refractory to inhibition by Treg cells and increased intratumoral Teff/Treg cell ratio that correlated with therapeutic efficacy in various preclinical tumor models. Building on these studies, we herein show for the first time, to our knowledge, that signaling through 4-1BB inhibits antigen-and TGF-beta-driven conversion of naive CD4(+)FoxP3(-) T cells into iTreg cells via stimulation of IFN-gamma production by CD4(+)FoxP3(-) T cells. Importantly, treatment with SA-4-1BBL blocked the conversion of CD4(+)FoxP3(-) T cells into Treg cells by EG.7 tumors. Taken together with our previous studies, these results show that 4-1BB signaling negatively modulate Treg cells by two distinct mechanisms: i) inhibiting the conversion of CD4(+)FoxP3(-) T cells into iTreg cells and ii) endowing Teff cells refractory to inhibition by Treg cells. Given the dominant role of Treg cells in tumor immune evasion mechanisms, 4-1BB signaling represents an attractive target for favorably tipping the Teff: Treg balance toward Teff cells with important implications for cancer immunotherapy.	[Madireddi, Shravan] Univ Louisville, Dept Microbiol & Immunol, Inst Cellular Therapeut, Louisville, KY 40292 USA; Univ Louisville, James Brown Canc Ctr, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Madireddi, S (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Inst Cellular Therapeut, Louisville, KY 40292 USA.	esma.yolcu@louisville.edu; haval.shirwan@louisville.edu	Srivastava, Abhishek/M-7577-2014	MADIREDDI, SHRAVAN/0000-0002-7069-1252	NIH [2R44 AI071618-02]; Kentucky Lung Cancer Research Program; W.M. Keck Foundation; Commonwealth of Kentucky Research Challenge Trust Fund;  [R43 AI074176];  [R41 CA121665]; NATIONAL CANCER INSTITUTE [R41CA121665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI074176, R44AI071618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Lung Cancer Research Program; W.M. Keck Foundation(W.M. Keck Foundation); Commonwealth of Kentucky Research Challenge Trust Fund; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIH 2R44 AI071618-02, R43 AI074176, R41 CA121665, Kentucky Lung Cancer Research Program, the W.M. Keck Foundation, and the Commonwealth of Kentucky Research Challenge Trust Fund (HS and ESY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choi BK, 2004, J LEUKOCYTE BIOL, V75, P785, DOI 10.1189/jlb.1003491; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dawicki W, 2004, J IMMUNOL, V173, P5944, DOI 10.4049/jimmunol.173.10.5944; Duan W, 2008, J IMMUNOL, V181, P8650, DOI 10.4049/jimmunol.181.12.8650; Elpek KG, 2007, J IMMUNOL, V179, P7295, DOI 10.4049/jimmunol.179.11.7295; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Jacobs JFM, 2010, CLIN CANCER RES, V16, P5067, DOI 10.1158/1078-0432.CCR-10-1757; Klages K, 2010, CANCER RES, V70, P7788, DOI 10.1158/0008-5472.CAN-10-1736; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kwon BS, 2002, J IMMUNOL, V168, P5483, DOI 10.4049/jimmunol.168.11.5483; Lee SW, 2009, J IMMUNOL, V182, P6753, DOI 10.4049/jimmunol.0803241; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Melero I, 2008, TRENDS PHARMACOL SCI, V29, P383, DOI 10.1016/j.tips.2008.05.005; Niu LG, 2007, J IMMUNOL, V178, P4194, DOI 10.4049/jimmunol.178.7.4194; Piconese S, 2008, J EXP MED, V205, P825, DOI 10.1084/jem.20071341; Powell DJ, 2007, J IMMUNOL, V179, P4919, DOI 10.4049/jimmunol.179.7.4919; Schabowsky RH, 2009, VACCINE, V28, P512, DOI 10.1016/j.vaccine.2009.09.127; Sharma RK, 2010, VACCINE, V28, P5794, DOI 10.1016/j.vaccine.2010.06.073; Sharma RK, 2010, CANCER RES, V70, P3945, DOI 10.1158/0008-5472.CAN-09-4480; Sharma RK, 2009, CANCER RES, V69, P4319, DOI 10.1158/0008-5472.CAN-08-3141; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Teng MWL, 2010, CANCER RES, V70, P7800, DOI 10.1158/0008-5472.CAN-10-1681; Valzasina B, 2006, CANCER RES, V66, P4488, DOI 10.1158/0008-5472.CAN-05-4217; Valzasina B, 2005, BLOOD, V105, P2845, DOI 10.1182/blood-2004-07-2959; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Xiao X, 2008, J IMMUNOL, V181, P3193, DOI 10.4049/jimmunol.181.5.3193; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684; Zhang P, 2007, SCAND J IMMUNOL, V66, P435, DOI 10.1111/j.1365-3083.2007.01994.x; Zheng GX, 2004, J IMMUNOL, V173, P2428, DOI 10.4049/jimmunol.173.4.2428; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	39	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42459	10.1371/journal.pone.0042459	http://dx.doi.org/10.1371/journal.pone.0042459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870329	gold, Green Submitted, Green Published			2022-12-27	WOS:000307212800093
J	Matallana-Surget, S; Joux, F; Wattiez, R; Lebaron, P				Matallana-Surget, Sabine; Joux, Fabien; Wattiez, Ruddy; Lebaron, Philippe			Proteome Analysis of the UVB-Resistant Marine Bacterium Photobacterium angustum S14	PLOS ONE			English	Article							ESCHERICHIA-COLI; PHOSPHOTRANSFERASE SYSTEM; DEINOCOCCUS-RADIODURANS; SPHINGOPYXIS-ALASKENSIS; CELLULAR-RESPONSE; OXIDATIVE STRESS; RNA; HFQ; GENES; ULTRAMICROBACTERIUM	The proteome of the marine bacterium Photobacterium angustum S14 was exposed to UVB and analyzed by the implementation of both the post-digest ICPL labeling method and 2D-DIGE technique using exponentially growing cells. A total of 40 and 23 proteins were quantified in all replicates using either the ICPL or 2D-DIGE methods, respectively. By combining both datasets from 8 biological replicates (4 biological replicates for each proteomics technique), 55 proteins were found to respond significantly to UVB radiation in P. angustum. A total of 8 UVB biomarkers of P. angustum were quantified in all replicates using both methods. Among them, the protein found to present the highest increase in abundance (almost a 3-fold change) was RecA, which is known to play a crucial role in the so-called recombinational repair process. We also observed a high number of antioxidants, transport proteins, metabolism-related proteins, transcription/ translation regulators, chaperonins and proteases. We also discuss and compare the UVB response and global protein expression profiles obtained for two different marine bacteria with trophic lifestyles: the copiotroph P. angustum and oligotroph Sphingopyxis alaskensis.	[Matallana-Surget, Sabine; Joux, Fabien; Lebaron, Philippe] UPMC Univ Paris 06, UMR7621, Lab Oceanog Microbienne, Observ Oceanol, Banyuls Sur Mer, France; [Matallana-Surget, Sabine; Joux, Fabien; Lebaron, Philippe] CNRS, UMR7621, Lab Oceanog Microbienne, Observ Oceanol, Banyuls Sur Mer, France; [Wattiez, Ruddy] Univ Mons, Dept Prote & Microbiol, Interdisciplinary Mass Spectrometry Ctr CISMa, B-7000 Mons, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; University of Mons	Matallana-Surget, S (corresponding author), UPMC Univ Paris 06, UMR7621, Lab Oceanog Microbienne, Observ Oceanol, Banyuls Sur Mer, France.	sabine.matallana@obs-banyuls.fr	Joux, Fabien/F-8107-2010; Surget, Sabine Matallana/AAM-1004-2020	Surget, Sabine Matallana/0000-0002-6023-3215; wattiez, ruddy/0000-0003-2071-4310; Joux, Fabien/0000-0001-8089-2771	European community [FP7-KBBE-2008-226977]	European community(European Commission)	This work was supported by the European community project MAMBA (FP7-KBBE-2008-226977). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboudi M, 2008, CURR MICROBIOL, V57, P412, DOI 10.1007/s00284-008-9214-9; Basu B, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011734; [Богачев А.В. Bogachev A.V.], 2005, [Биохимия, BIOCHEMISTRY (MOSCOW), Biokhimiya], V70, P177; Booth MG, 2001, MICROB ECOL, V42, P531, DOI 10.1007/s00248-001-1009-5; Cavicchioli R, 2003, MICROB ECOL, V45, P203, DOI 10.1007/s00248-002-3008-6; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Deuerling E, 1997, MOL MICROBIOL, V23, P921, DOI 10.1046/j.1365-2958.1997.2721636.x; Eguchi M, 1996, APPL ENVIRON MICROB, V62, P1287, DOI 10.1128/AEM.62.4.1287-1294.1996; Ehling-Schulz M, 2002, MOL MICROBIOL, V46, P827, DOI 10.1046/j.1365-2958.2002.03209.x; Epp RG, 2007, PHOTOCH PHOTOBIO SCI, V6, P286, DOI 10.1039/b700021a; Fegatella F, 1999, ELECTROPHORESIS, V20, P2094, DOI 10.1002/(SICI)1522-2683(19990701)20:10<2094::AID-ELPS2094>3.0.CO;2-E; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; Gupta N, 2007, GENOME RES, V17, P1362, DOI 10.1101/gr.6427907; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; Hajnsdorf E, 2000, P NATL ACAD SCI USA, V97, P1501, DOI 10.1073/pnas.040549897; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; HECK HD, 1990, CRIT REV TOXICOL, V20, P397; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; JANOSI L, 1994, P NATL ACAD SCI USA, V91, P4249, DOI 10.1073/pnas.91.10.4249; Jolivet E, 2006, MOL MICROBIOL, V59, P338, DOI 10.1111/j.1365-2958.2005.04946.x; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Kovacs D, 2009, FEBS LETT, V583, P88, DOI 10.1016/j.febslet.2008.11.049; Kowalak JA, 1996, PROTEIN SCI, V5, P1625, DOI 10.1002/pro.5560050816; KRUEGER JH, 1984, P NATL ACAD SCI-BIOL, V81, P1499, DOI 10.1073/pnas.81.5.1499; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Lease RA, 2000, P NATL ACAD SCI USA, V97, P9919, DOI 10.1073/pnas.170281497; Lee T, 2008, RNA, V14, P514, DOI 10.1261/rna.531408; Leroy B, 2010, PROTEOMICS, V10, P2281, DOI 10.1002/pmic.200900286; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; MA TH, 1988, MUTAT RES, V196, P37, DOI 10.1016/0165-1110(88)90027-9; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Matallana-Surget S, 2009, ENVIRON MICROBIOL, V11, P2660, DOI 10.1111/j.1462-2920.2009.01992.x; Matallana-Surget S, 2009, PHOTOCH PHOTOBIO SCI, V8, P1313, DOI 10.1039/b902715g; Mitchell D. L., 1995, MOL BIOL BIOTECHNOLO, P939; MORONA R, 1984, J BACTERIOL, V159, P570, DOI 10.1128/JB.159.2.570-578.1984; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Nystrom T, 2004, ANNU REV MICROBIOL, V58, P161, DOI 10.1146/annurev.micro.58.030603.123818; Pandhal J, 2007, J PROTEOME RES, V6, P996, DOI 10.1021/pr060460c; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; POSTMA PW, 1985, MICROBIOL REV, V49, P232, DOI 10.1128/MMBR.49.3.232-269.1985; Qiu XY, 2006, J BACTERIOL, V188, P1199, DOI 10.1128/JB.188.3.1199-1204.2006; SAIER MH, 1994, MOL MICROBIOL, V13, P755; Shangari N, 2003, BIOCHEM SOC T, V31, P1390, DOI 10.1042/BST0311390; Srinivasan S, 1998, J BIOSCIENCE, V23, P501, DOI 10.1007/BF02936144; Storz G, 2004, CURR OPIN MICROBIOL, V7, P140, DOI 10.1016/j.mib.2004.02.015; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; Tatsuta T, 1998, MOL MICROBIOL, V30, P583, DOI 10.1046/j.1365-2958.1998.01091.x; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; TOMOYASU T, 1993, J BACTERIOL, V175, P1344, DOI 10.1128/JB.175.5.1344-1351.1993; Trautinger F, 1996, J PHOTOCH PHOTOBIO B, V35, P141, DOI 10.1016/S1011-1344(96)07344-7; Tsai ML, 2009, RADIAT RES, V171, P716, DOI 10.1667/RR1625.1; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Wang G, 2004, INFECT IMMUN, V72, P1391, DOI 10.1128/IAI.72.3.1391-1396.2004; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Welch TJ, 1996, J BACTERIOL, V178, P5027, DOI 10.1128/jb.178.16.5027-5031.1996; Williams T, 2011, EXTREMOPHILES HDB, P1179; Yura T, 2000, BACTERIAL STRESS RESPONSES, P3; Zhang CC, 2005, PROTEOMICS, V5, P138, DOI 10.1002/pmic.200300875	65	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42299	10.1371/journal.pone.0042299	http://dx.doi.org/10.1371/journal.pone.0042299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870314	gold, Green Published, Green Submitted			2022-12-27	WOS:000307212800077
J	Chua, JC; Douglass, JA; Gillman, A; O'Hehir, RE; Meeusen, EN				Chua, Justin C.; Douglass, Jo A.; Gillman, Andrew; O'Hehir, Robyn E.; Meeusen, Els N.			Galectin-10, a Potential Biomarker of Eosinophilic Airway Inflammation	PLOS ONE			English	Article							LEYDEN CRYSTAL PROTEIN; EXHALED NITRIC-OXIDE; ALLERGIC RHINITIS; INDUCED SPUTUM; ASTHMA; HYPERRESPONSIVENESS; EXACERBATIONS; SUBTYPES; DISEASE; COUNTS	Measurement of eosinophilic airway inflammation can assist in the diagnosis of allergic asthma and in the management of exacerbations, however its clinical implementation remains difficult. Galectin-10 has been associated with eosinophilic inflammation and has the potential to be used as a surrogate biomarker. This study aimed to assess the relationship between galectin-10 in sputum with sputum eosinophil counts, the current gold standard of eosinophil inflammation in the lung. Thirty-eight sputum samples were processed for both eosinophil counts by cytospins and semi-quantitative measurements of galectin-10 by western blots. A strong association was observed between galectin-10 levels in sputum and sputum eosinophil measurements, and they accurately determined sputum eosinophilia. The results support the potential for galectin-10 to be used as a surrogate biomarker of eosinophilic airway inflammation.	[Chua, Justin C.; Douglass, Jo A.; Gillman, Andrew; O'Hehir, Robyn E.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia; [Chua, Justin C.; Douglass, Jo A.; Gillman, Andrew; O'Hehir, Robyn E.] Monash Univ, Melbourne, Vic 3004, Australia; [Meeusen, Els N.] Monash Univ, Biotechnol Res Labs, Sch Biomed Sci, Clayton, Vic, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Monash University	Chua, JC (corresponding author), Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia.	mail@jodouglass.com	O'Hehir, Robyn E/H-3627-2011	O'Hehir, Robyn E/0000-0002-3489-7595; Douglass, Jo/0000-0002-1200-8048; Meeusen, Els/0000-0003-1239-6287; Chua, Justin/0000-0002-2399-9078	Australian Research Council	Australian Research Council(Australian Research Council)	Funding was provided by The Australian Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SJ, 2002, J BIOL CHEM, V277, P14859, DOI 10.1074/jbc.M200221200; Al-Samri M, 2010, J ALLERGY CLIN IMMUN; Berry M, 2007, THORAX, V62, P1043, DOI 10.1136/thx.2006.073429; Bryborn M, 2010, ALLERGY, V65, P220, DOI 10.1111/j.1398-9995.2009.02141.x; Carlsson MC, BIOCH BIOPHYS ACTA; Chlumsky J, 2006, J INT MED RES, V34, P129, DOI 10.1177/147323000603400202; De Re V, 2009, ANN NY ACAD SCI, V1173, P357, DOI 10.1111/j.1749-6632.2009.04627.x; Devouassoux G, 2008, ALLERGY, V63, P125, DOI 10.1111/j.1398-9995.2007.01558.x; DOR PJ, 1984, AM REV RESPIR DIS, V130, P1072; Dunphy JL, 2002, J BIOL CHEM, V277, P14916, DOI 10.1074/jbc.M200214200; Dvorak Ann M, 2005, Chem Immunol Allergy, V85, P89; Ghafouri B, 2006, J PROTEOME RES, V5, P330, DOI 10.1021/pr050341h; Global Initiative for Asthma, 2009, GLOB STRAT ASTHM MAN; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Jayaram L, 2006, EUR RESPIR J, V27, P483, DOI 10.1183/09031936.06.00137704; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Leuppi JD, 2001, EUR RESPIR J, V18, P444, DOI 10.1183/09031936.01.00058601; Lovett CJ, 2007, CLIN EXP ALLERGY, V37, P1594, DOI 10.1111/j.1365-2222.2007.02839.x; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; National Heart Lung and Blood Institute. National Asthma Education and Prevention Program, 2007, 3 NAT HEART LUNG BLO; Patil SU, 2010, ALLERGY ASTHMA PROC, V31, P259, DOI 10.2500/aap.2010.31.3350; Pavord ID, 2008, J ASTHMA, V45, P523, DOI 10.1080/02770900801978557; Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9; Pavord ID, 1997, THORAX, V52, P498, DOI 10.1136/thx.52.6.498; Petsky HL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005603.pub2; Porsbjerg C, 2009, J ASTHMA, V46, P606, DOI 10.1080/02770900903015654; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Simpson JL, 2010, RESPIRATION, V79, P147, DOI 10.1159/000245899; Smith AD, 2005, AM J RESP CRIT CARE, V172, P453, DOI 10.1164/rccm.200411-1498OC; Taylor DR, 2011, J ALLERGY CLIN IMMUN, V128, P927, DOI 10.1016/j.jaci.2011.03.051	31	43	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42549	10.1371/journal.pone.0042549	http://dx.doi.org/10.1371/journal.pone.0042549			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880030	Green Published, gold			2022-12-27	WOS:000307810000045
J	Dave, B; Landis, MD; Dobrolecki, LE; Wu, MF; Zhang, XM; Westbrook, TF; Hilsenbeck, SG; Liu, D; Lewis, MT; Tweardy, DJ; Chang, JC				Dave, Bhuvanesh; Landis, Melissa D.; Dobrolecki, Lacey E.; Wu, Meng-Fen; Zhang, Xiaomei; Westbrook, Thomas F.; Hilsenbeck, Susan G.; Liu, Dan; Lewis, Michael T.; Tweardy, David J.; Chang, Jenny C.			Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model	PLOS ONE			English	Article							STEM-CELLS; ACTIVATOR; DYNAMICS; THERAPY; TARGETS; GROWTH; ALPHA	Metastasis and disease relapse are hypothesized to result from tumor initiating cells (TICs). Previously, we have defined a CD44+/CD24-/low mammosphere-forming tumorigenic 493-gene signature in breast cancer. Stat3 was identified as a critical node in self-renewal based on an ongoing lentiviral shRNA screen being conducted in two breast cancer cell lines SUM159 and BT549. In corroborating work, targeting the SH2 domain of Stat3 with a novel small molecule decreased the percentage of cells expressing TIC markers (CD44+/CD24-/low and ALDH+) and mammosphere formation in p-Stat3 overexpressing human breast cancer xenografts in SCID-beige mice. Importantly, we observed a four-fold improvement in the 30-day recurrence-free survival relative to docetaxel alone with the addition of the Stat3 inhibitor in the chemoresistant tumor model. Thus, these findings provide a strong impetus for the development of selective Stat3 inhibitors in order to improve survival in patients with p-Stat3 overexpressing tumors.	[Dave, Bhuvanesh; Landis, Melissa D.; Dobrolecki, Lacey E.; Chang, Jenny C.] Methodist Canc Ctr, Houston, TX USA; [Tweardy, David J.] Baylor Coll Med, Dept Infect Dis, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Tweardy, David J.] Baylor Coll Med, Dept Radiol, Dept Infect Dis, Houston, TX 77030 USA; [Westbrook, Thomas F.; Liu, Dan] Baylor Coll Med, Dept Radiol, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Westbrook, Thomas F.; Liu, Dan] Baylor Coll Med, Dept Mol & Cellular Biol, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Wu, Meng-Fen; Zhang, Xiaomei; Hilsenbeck, Susan G.; Lewis, Michael T.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Wu, Meng-Fen; Zhang, Xiaomei; Hilsenbeck, Susan G.; Lewis, Michael T.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Dept Radiol, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Dave, B (corresponding author), Methodist Canc Ctr, Houston, TX USA.	jcchang@tmhs.org	Lewis, Michael T/A-9572-2009; Dave, Bhuvanesh/ABF-8334-2020; Tweardy, David/L-3929-2019; chang, jenny/G-7614-2015	Dave, Bhuvanesh/0000-0001-6741-1363; chang, jenny/0000-0002-0890-9302	Breast Cancer Research Foundation; National Cancer Institute [1 R01 CA112305-01]; Komen Promise grant [KG 081694]; US Army Medical Research and Material Command [W81XWH-04-1-0468]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA112305] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Komen Promise grant(Susan G. Komen Breast Cancer Foundation); US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the Breast Cancer Research Foundation, 1 R01 CA112305-01 from the National Cancer Institute (JCC, MTL), the Breast Cancer Research Foundation (JC), Komen Promise grant KG 081694 (JCC), and US Army Medical Research and Material Command W81XWH-04-1-0468 (JCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Huang Y, 2007, J BIOL CHEM, V282, P34958, DOI 10.1074/jbc.M704548200; Jing NJ, 2004, CANCER RES, V64, P6603, DOI 10.1158/0008-5472.CAN-03-4041; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Kim DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010290; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Redell MS, 2005, CURR PHARM DESIGN, V11, P2873, DOI 10.2174/1381612054546699; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Villalva C, 2010, INT J CANC; Wei J, 2010, MOL CANCER THER, V9, P67, DOI 10.1158/1535-7163.MCT-09-0734; Xu XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004783	22	56	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e30207	10.1371/journal.pone.0030207	http://dx.doi.org/10.1371/journal.pone.0030207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879872	Green Submitted, Green Published, gold			2022-12-27	WOS:000307810000001
J	Chen, MH; Ha, EH; Wen, TW; Su, YN; Lien, GW; Chen, CY; Chen, PC; Hsieh, WS				Chen, Mei-Huei; Ha, Eun-Hee; Wen, Ting-Wen; Su, Yi-Ning; Lien, Guang-Wen; Chen, Chia-Yang; Chen, Pau-Chung; Hsieh, Wu-Shiun			Perfluorinated Compounds in Umbilical Cord Blood and Adverse Birth Outcomes	PLOS ONE			English	Article							PERFLUOROOCTANE SULFONATE; PERFLUOROALKYL ACIDS; NEONATAL-MORTALITY; GESTATIONAL-AGE; FETAL-GROWTH; SERUM-LEVELS; CHEMICALS; EXPOSURE; WEIGHT; PREGNANCY	Background: Previous animal studies have shown that perfluorinated compounds (PFCs) have adverse impacts on birth outcomes, but the results have been inconclusive in humans. We investigated associations between prenatal exposure to perfluorooctanoic acid (PFOA), perfluorooctyl sulfonate (PFOS), perfluorononanoic acid (PFNA), and perfluoroundecanoic acid (PFUA) and birth outcomes. Methods: In total, 429 mother-infant pairs were recruited from the Taiwan Birth Panel Study (TBPS). Demographic data were obtained by interviewing mothers using a structured questionnaire and birth outcomes were extracted from medical records. Cord blood was collected for PFOA, PFOS, PFNA, and PFUA analysis by ultra-high-performance liquid chromatography/tandem mass spectrometry. Results: The geometric mean (standard deviation) levels of PFOA, PFOS, PFNA, and PFUA in cord blood plasma were 1.84 (2.23), 5.94 (1.95), 2.36(4.74), and 10.26 (3.07) ng/mL, respectively. Only PFOS levels were found to be inversely associated with gestational age, birth weight, and head circumference [per ln unit: adjusted beta (95% confidence interval, CI) = -0.37 (-0.60, -0.13) wks, -110.2 (-176.0, -44.5) gm and -0.25 (-0.46, -0.05) cm]. Additionally, the odds ratio of preterm birth, low birth weight, and small for gestational age increased with PFOS exposure [ per ln unit: adjusted odds ratio (OR) (95% CI) = 2.45 (1.47, 4.08), 2.61(0.85, 8.03) and 2.27 (1.25, 4.15)]. When PFOS levels were divided into quartiles, a dose-response relation was observed. However, PFOA, PFNA, and PFUA were not observed to have any convincing impact on birth outcomes. Conclusions: An adverse dose-dependent association was observed between prenatal PFOS exposure and birth outcomes. However, no associations were found for the other examined PFCs.	[Chen, Mei-Huei; Wen, Ting-Wen; Lien, Guang-Wen; Chen, Pau-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan; [Chen, Mei-Huei] Cardinal Tien Hosp, Yonghe Branch, Dept Pediat, New Taipei, Taiwan; [Ha, Eun-Hee] Ewha Womans Univ, Sch Med, Dept Prevent Med, Seoul, South Korea; [Su, Yi-Ning] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Su, Yi-Ning] Natl Taiwan Univ, Coll Med, Inst Clin Genom, Taipei 10764, Taiwan; [Chen, Chia-Yang] Natl Taiwan Univ, Coll Publ Hlth, Inst Environm Hlth, Taipei 10764, Taiwan; [Chen, Chia-Yang; Chen, Pau-Chung] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan; [Hsieh, Wu-Shiun] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan	National Taiwan University; Ewha Womans University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chen, MH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan.	pchen@ntu.edu.tw; hsiehws@ntu.edu.tw	Chen, Pau-Chung/H-5686-2011; Chen, Chia-Yang/AAT-6155-2021; Chen, Chia Yang/C-5466-2019	Chen, Pau-Chung/0000-0002-6242-5974; Chen, Chia-Yang/0000-0001-5301-1609; Chen, Chia Yang/0000-0001-5301-1609; HSIEH, WU-SHIUN/0000-0002-0609-3311	National Science Council, Taiwan [NSC98-2621-M-002-017, NSC98-2621-M-002-018, NSC99-2621-M-002-003, NSC99-2621-M-002-005, NSC100-2621-M-002-003, NSC100-2621-M-002-004, NSC101-2621-M-002-005]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council (NSC98-2621-M-002-017, NSC98-2621-M-002-018, NSC99-2621-M-002-003, NSC99-2621-M-002-005, NSC100-2621-M-002-003, NSC100-2621-M-002-004 and NSC101-2621-M-002-005), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BD, 2009, REPROD TOXICOL, V27, P258, DOI 10.1016/j.reprotox.2008.05.061; Apelberg BJ, 2007, ENVIRON HEALTH PERSP, V115, P1670, DOI 10.1289/ehp.10334; Apelberg BJ, 2007, ENVIRON SCI TECHNOL, V41, P3891, DOI 10.1021/es0700911; BARKER DJP, 1986, LANCET, V1, P1077; Bartell SM, 2010, ENVIRON HEALTH PERSP, V118, P222, DOI 10.1289/ehp.0901252; Begley TH, 2005, FOOD ADDIT CONTAM A, V22, P1023, DOI 10.1080/02652030500183474; Chang YC, 2012, ANAL BIOANAL CHEM, V402, P1315, DOI 10.1007/s00216-011-5519-9; Fei CY, 2008, AM J EPIDEMIOL, V168, P66, DOI 10.1093/aje/kwn095; Fei CY, 2007, ENVIRON HEALTH PERSP, V115, P1677, DOI 10.1289/ehp.10506; Grasty RC, 2003, BIRTH DEFECTS RES B, V68, P465, DOI 10.1002/bdrb.10046; Grice MM, 2007, J OCCUP ENVIRON MED, V49, P722, DOI 10.1097/JOM.0b013e3180582043; Hamm MP, 2010, J EXPO SCI ENV EPID, V20, P589, DOI 10.1038/jes.2009.57; Hsieh Wu-Shiun, 2006, Acta Paediatrica Taiwanica, V47, P25; Inoue K, 2004, ENVIRON HEALTH PERSP, V112, P1204, DOI 10.1289/ehp.6864; Kudo N, 2006, BIOL PHARM BULL, V29, P1952, DOI 10.1248/bpb.29.1952; Lau C, 2003, TOXICOL SCI, V74, P382, DOI 10.1093/toxsci/kfg122; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Lien GW, 2011, J CHROMATOGR B, V879, P641, DOI 10.1016/j.jchromb.2011.01.037; Lin AYC, 2010, CHEMOSPHERE, V80, P1167, DOI 10.1016/j.chemosphere.2010.06.018; Luebker DJ, 2005, TOXICOLOGY, V215, P149, DOI 10.1016/j.tox.2005.07.019; Monroy R, 2008, ENVIRON RES, V108, P56, DOI 10.1016/j.envres.2008.06.001; Nolan LA, 2009, REPROD TOXICOL, V27, P231, DOI 10.1016/j.reprotox.2008.11.001; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Olsen GW, 2009, REPROD TOXICOL, V27, P212, DOI 10.1016/j.reprotox.2009.02.001; Olsen GW, 2004, J OCCUP ENVIRON MED, V46, P837, DOI 10.1097/01.jom.0000135546.70469.87; Salmasi G, 2010, ACTA OBSTET GYN SCAN, V89, P423, DOI 10.3109/00016340903505748; Sinclair E, 2007, ENVIRON SCI TECHNOL, V41, P1180, DOI 10.1021/es062377w; Stein CR, 2009, AM J EPIDEMIOL, V170, P837, DOI 10.1093/aje/kwp212; U.S. Environmental Protection Agency, 2010 2015 PFOA STEW; Washino N, 2009, ENVIRON HEALTH PERSP, V117, P660, DOI 10.1289/ehp.11681; Whitworth KW, 2012, AM J EPIDEMIOL, V175, P1209, DOI 10.1093/aje/kwr459; Wolf CJ, 2008, TOXICOL SCI, V106, P162, DOI 10.1093/toxsci/kfn166; Wolf CJ, 2012, REPROD TOXICOL, V33, P546, DOI 10.1016/j.reprotox.2011.09.009; Wolf CJ, 2010, PPAR RES, V2010, DOI 10.1155/2010/282896	34	111	114	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42474	10.1371/journal.pone.0042474	http://dx.doi.org/10.1371/journal.pone.0042474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879996	gold, Green Submitted, Green Published			2022-12-27	WOS:000307284100102
J	Ding, SL; Walton, KLW; Blue, RE; MacNaughton, K; Magness, ST; Lund, PK				Ding, Shengli; Walton, Kristen L. W.; Blue, Randall Eric; MacNaughton, Kirk; Magness, Scott T.; Lund, Pauline Kay			Mucosal Healing and Fibrosis after Acute or Chronic Inflammation in Wild Type FVB-N Mice and C57BL6 Procollagen alpha 1(I)-Promoter-GFP Reporter Mice	PLOS ONE			English	Article							SODIUM-INDUCED COLITIS; INTESTINAL FIBROSIS; TRANSGENIC MICE; CROHNS-DISEASE; SUSCEPTIBILITY; EXPRESSION; ALPHA-1(I); CELLS; FIBROGENESIS; MODELS	Background: Injury and intestinal inflammation trigger wound healing responses that can restore mucosal architecture but if chronic, can promote intestinal fibrosis. Intestinal fibrosis is a major complication of Crohn's disease. The cellular and molecular basis of mucosal healing and intestinal fibrosis are not well defined and better understanding requires well characterized mouse models. Methods: FVB-N wild type mice and C57BL6 procollagen alpha 1(I)-GFP reporter mice were given one (DSS1) or two (DSS2) cycles of 3% DSS (5 days/cycle) followed by 7 days recovery. Histological scoring of inflammation and fibrosis were performed at DSS1, DSS1+3, DSS1+7, DSS2, DSS2+3, and DSS2+7. Procollagen alpha 1(I)-GFP activation was assessed in DSS and also TNBS models by whole colon GFP imaging and fluorescence microscopy. Colocalization of GFP with alpha-smooth muscle actin (alpha-SMA) or vimentin was examined. GFP mRNA levels were tested for correlation with endogenous collagen alpha 1(I) mRNA. Results: Males were more susceptible to DSS-induced disease and mortality than females. In FVB-N mice one DSS cycle induced transient mucosal inflammation and fibrosis that resolved by 7 days of recovery. Two DSS cycles induced transmural inflammation and fibrosis in a subset of FVB-N mice but overall, did not yield more consistent, severe or sustained fibrosis. In C57BL6 mice, procollagen alpha 1(I)-GFP reporter was activated at the end of DSS1 and through DSS+7 with more dramatic and transmural activation at DSS2 through DSS2+7, and in TNBS treated mice. In DSS and TNBS models GFP reporter expression localized to vimentin(+) cells and much fewer alpha-SMA(+) cells. GFP mRNA strongly correlated with collagen alpha 1(I) mRNA. Conclusions: One DSS cycle in FVB-N mice provides a model to study mucosal injury and subsequent mucosal healing. The procollagen alpha 1(I)-GFP transgenic provides a useful model to study activation of a gene encoding a major extracellular matrix protein during acute or chronic experimental intestinal inflammation and fibrosis.	[Ding, Shengli; MacNaughton, Kirk] Univ N Carolina, Dept Cell & Mol Physiol, Histol Core Facil, Chapel Hill, NC 27515 USA; [Walton, Kristen L. W.] Missouri Western State Univ, Dept Biol, St Joseph, MO USA; [Magness, Scott T.] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ding, SL (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Histol Core Facil, Chapel Hill, NC 27515 USA.	shengli_ding@med.unc.edu	, Histology Research Core Facility/ABF-6317-2021; Walton, Kristen/GMO-7132-2022	Magness, Scott/0000-0002-2746-1224	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK047769-12]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases grant R01 DK047769-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COOPER HS, 1993, LAB INVEST, V69, P238; Dave Maneesh, 2012, Gastroenterol Hepatol (N Y), V8, P29; Fiocchi C, 2011, AM J PHYSIOL-GASTR L, V300, pG677, DOI 10.1152/ajpgi.00104.2011; Grassl GA, 2008, GASTROENTEROLOGY, V134, P768, DOI 10.1053/j.gastro.2007.12.043; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Klopcic B, 2008, DIGEST DIS SCI, V53, P1553, DOI 10.1007/s10620-007-0068-y; Koon HW, 2010, AM J PATHOL, V177, P2300, DOI 10.2353/ajpath.2010.100314; Krempen K, 1999, GENE EXPRESSION, V8, P151; Lawrance IC, 2003, GASTROENTEROLOGY, V125, P1750, DOI 10.1053/j.gastro.2003.08.027; Luna J, 2011, AM J PHYSIOL-GASTR L, V300, pG703, DOI 10.1152/ajpgi.00504.2010; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; Mahavadi S, 2011, INFLAMM BOWEL DIS, V17, P711, DOI 10.1002/ibd.21437; Mahler M, 1999, GENOMICS, V55, P147, DOI 10.1006/geno.1998.5636; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pucilowska JB, 2000, AM J PHYSIOL-GASTR L, V279, pG653; Pucilowska JB, 2000, AM J PHYSIOL-GASTR L, V279, pG1307, DOI 10.1152/ajpgi.2000.279.6.G1307; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Saruta M, 2009, EUR J IMMUNOL, V39, P2195, DOI 10.1002/eji.200939216; Sasaoka T, 2011, AM J PHYSIOL-GASTR L, V300, pG568, DOI 10.1152/ajpgi.00329.2010; Strober W, 2009, CURR MOL MED, V9, P740, DOI 10.2174/156652409788970652; Suzuki K, 2011, PATHOL INT, V61, P228, DOI 10.1111/j.1440-1827.2011.02647.x; Szabo H, 2010, ALIMENT PHARM THER, V31, P189, DOI 10.1111/j.1365-2036.2009.04171.x; Velde AAT, 2006, INFLAMM BOWEL DIS, V12, P995, DOI 10.1097/01.mib.0000227817.54969.5e; Vermeire S, 2001, GASTROENTEROLOGY, V120, P834, DOI 10.1053/gast.2001.22453; Williams KL, 2001, GASTROENTEROLOGY, V120, P925, DOI 10.1053/gast.2001.22470; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yata Y, 2003, HEPATOLOGY, V37, P267, DOI 10.1053/jhep.2003.50067	30	28	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42568	10.1371/journal.pone.0042568	http://dx.doi.org/10.1371/journal.pone.0042568			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880035	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100131
J	Ebadi, H; Perkins, BA; Katzberg, HD; Lovblom, LE; Bril, V				Ebadi, Hamid; Perkins, Bruce A.; Katzberg, Hans D.; Lovblom, Leif E.; Bril, Vera			Evaluation of Proxy Tests for SFSN: Evidence for Mixed Small and Large Fiber Dysfunction	PLOS ONE			English	Article							DISTAL SYMMETRIC POLYNEUROPATHY; ELECTRODIAGNOSTIC-MEDICINE; AMERICAN-ASSOCIATION; PHYSICAL-MEDICINE; SKIN BIOPSY; NEUROPATHY; NEUROLOGY; LDIFLARE; ACADEMY; DENSITY	Background: Though intra-epidermal nerve fiber density (IENFD) is considered the gold standard for diagnosis of small fiber sensory neuropathy (SFSN), we aimed to determine if novel threshold values derived from standard tests of small or large fiber function could serve as diagnostic alternatives. Methods: Seventy-four consecutive patients with painful polyneuropathy and normal nerve conduction studies (NCS) were defined as SFSN cases or controls by distal IENFD <5.4 and >= 5.4 fibers/mm, respectively. Diagnostic performance of small fiber [cooling (CDT) and heat perception (HP) thresholds, axon reflex-mediated neurogenic vasodilatation] and large fiber function tests [vibration perception thresholds (VPT) and sural nerve conduction parameters] were determined by receiver operating-characteristic (ROC) curve analyses. Results: The 26(35%) SFSN cases had mean IENFD 3.3 +/- 1.7 fibers/mm and the 48(65%) controls 9.9 +/- 2.9 fibers/mm. Male gender (p = 0.02) and older age (p = 0.02) were associated with SFSN cases compared to controls. VPT were higher and CDT lower in SFSN cases, but the largest magnitude of differences was observed for sural nerve amplitude. It had the greatest area under the ROC curve (0.75) compared to all other tests (p<0.001 for all comparisons) and the optimal threshold value of <= 12 mu V defined SFSN cases with 80% sensitivity and 72% specificity. Conclusion: In patients presenting with polyneuropathy manifestations and normal NCS, though small fiber function tests were intuitively considered the best alternative measures to predict reduced IENFD, their diagnostic performance was poor. Instead, novel threshold values within the normal range for large fiber tests should be considered as an alternative strategy to select subjects for skin biopsy in diagnostic protocols for SFSN.	[Ebadi, Hamid; Katzberg, Hans D.; Bril, Vera] Univ Hlth Network, Dept Med, Div Neurol, Toronto, ON, Canada; [Perkins, Bruce A.; Lovblom, Leif E.] Univ Hlth Network, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Ebadi, H (corresponding author), Univ Hlth Network, Dept Med, Div Neurol, Toronto, ON, Canada.	vera.bril@utoronto.ca	Perkins, Bruce A/L-3726-2017; BRIL, vera/ABA-6509-2020	Lovblom, Leif Erik/0000-0002-6774-8924				Al-Shekhlee A, 2002, NEUROLOGIST, V8, P237, DOI 10.1097/00127893-200207000-00004; Casanova-Molla J, 2011, PAIN, V152, P410, DOI 10.1016/j.pain.2010.11.012; England JD, 2009, NEUROLOGY, V72, P177, DOI 10.1212/01.wnl.0000336345.70511.0f; England JD, 2005, NEUROLOGY, V64, P199, DOI 10.1212/01.WNL.0000149522.32823.EA; Goransson LG, 2004, NEUROLOGY, V62, P774, DOI 10.1212/01.WNL.0000113732.41127.8F; Green AQ, 2009, MUSCLE NERVE, V40, P985, DOI 10.1002/mus.21333; Kennedy WR. W-CG, 2005, PERIPHERAL NEUROPATH, V4th, P869, DOI [10.1016/B978-0-7216-9491-7.50037-5, DOI 10.1016/B978-0-7216-9491-7.50037-5]; Krishnan STM, 2009, DIABETES CARE, V32, P451, DOI 10.2337/dc08-1453; Krishnan STM, 2004, DIABETES CARE, V27, P2930, DOI 10.2337/diacare.27.12.2930; Lacomis D, 2002, MUSCLE NERVE, V26, P173, DOI 10.1002/mus.10181; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Lauria G, 1999, J NEUROL SCI, V164, P172, DOI 10.1016/S0022-510X(99)00063-5; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Lauria G, 2010, J PERIPHER NERV SYST, V15, P79, DOI 10.1111/j.1529-8027.2010.00269.x; Loseth S, 2006, EUR J NEUROL, V13, P105, DOI 10.1111/j.1468-1331.2006.01232.x; Low VA, 2006, MUSCLE NERVE, V34, P57, DOI 10.1002/mus.20551; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Perkins BA, 2001, DIABETES CARE, V24, P748, DOI 10.2337/diacare.24.4.748; Rage M, 2011, J NEUROL, V258, P1852, DOI 10.1007/s00415-011-6031-z; Wong MC, 2011, MUSCLE NERVE, V44, P902, DOI 10.1002/mus.22192; Yarnitsky D, 1997, MUSCLE NERVE, V20, P198; Zinman LH, 2004, DIABETES CARE, V27, P1674, DOI 10.2337/diacare.27.7.1674	22	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42208	10.1371/journal.pone.0042208	http://dx.doi.org/10.1371/journal.pone.0042208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870304	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100054
J	Roberts, BJ; Catterall, CP; Eby, P; Kanowski, J				Roberts, Billie J.; Catterall, Carla P.; Eby, Peggy; Kanowski, John			Long-Distance and Frequent Movements of the Flying-Fox Pteropus poliocephalus: Implications for Management	PLOS ONE			English	Article							FRUIT-BATS; HENDRA VIRUS; PTEROPODIDAE; CHIROPTERA; LANDBIRDS	Flying-foxes (Pteropodidae) are large bats capable of long-distance flight. Many species are threatened; some are considered pests. Effective conservation and management of flying-foxes are constrained by lack of knowledge of their ecology, especially of movement patterns over large spatial scales. Using satellite telemetry, we quantified long-distance movements of the grey-headed flying-fox Pteropus poliocephalus among roost sites in eastern Australia. Fourteen adult males were tracked for 2-40 weeks (mean 25 weeks). Collectively, these individuals utilised 77 roost sites in an area spanning 1,075 km by 128 km. Movement patterns varied greatly between individuals, with some travelling long distances. Five individuals travelled cumulative distances >1,000 km over the study period. Five individuals showed net displacements >300 km during one month, including one movement of 500 km within 48 hours. Seasonal movements were consistent with facultative latitudinal migration in part of the population. Flying-foxes shifted roost sites frequently: 64% of roost visits lasted <5 consecutive days, although some individuals remained at one roost for several months. Modal 2-day distances between consecutive roosts were 21-50 km (mean 45 km, range 3-166 km). Of 13 individuals tracked for >12 weeks, 10 moved >100 km in one or more weeks. Median cumulative displacement distances over 1, 10 and 30 weeks were 0 km, 260 km and 821 km, respectively. On average, over increasing time-periods, one additional roost site was visited for each additional 100 km travelled. These findings explain why culling and relocation attempts have had limited success in resolving human-bat conflicts in Australia. Flying-foxes are highly mobile between camps and regularly travel long distances. Consequently, local control actions are likely to have only temporary effects on local flying-fox populations. Developing alternative methods to manage these conflicts remains an important challenge that should be informed by a better understanding of the species' movement patterns.	[Roberts, Billie J.; Catterall, Carla P.; Kanowski, John] Griffith Univ, Sch Environm, Nathan, Qld 4111, Australia; [Roberts, Billie J.; Catterall, Carla P.; Kanowski, John] Griffith Univ, Environm Futures Ctr, Nathan, Qld 4111, Australia; [Eby, Peggy] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Kanowski, John] Australian Wildlife Conservancy, Malanda, Qld, Australia	Griffith University; Griffith University; University of New South Wales Sydney	Roberts, BJ (corresponding author), Griffith Univ, Sch Environm, Nathan, Qld 4111, Australia.	billie.roberts@griffith.edu.au	Catterall, Carla P/K-7996-2017	Catterall, Carla P/0000-0002-1914-0455	Queensland Department of Environment and Resource Management; Griffith University	Queensland Department of Environment and Resource Management; Griffith University(Griffith University)	This study was part funded by the Queensland Department of Environment and Resource Management and by a PhD scholarship awarded by Griffith University to BR. New South Wales National Parks and Wildlife Service (Grafton) provided additional in-kind support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Berthold P, 2001, AUK, V2nd; Birt P, 2005, THESIS U QUEENSLAND; Birtchnell M. J., 2008, FLOWERING ECOLOGY HO; Breed A, 2010, AUST VET J, V88, pN24; Breed AC, 2010, ECOHEALTH, V7, P204, DOI 10.1007/s10393-010-0332-z; Chan J, 2007, THESIS U NEW S WALES; Chan K, 2001, EMU, V101, P281, DOI 10.1071/MU00034; Churchill S, 2008, AUSTR BATS, V2nd; Dickman Chris, 2002, P20; Duncan AM, 1999, ACTION PLAN AUSTR BA; EBY P, 1991, WILDLIFE RES, V18, P547, DOI 10.1071/WR9910547; Eby P, 2007, FLYING FOX ROOSTS GR; Eby P., 2002, MANAGING GREY HEADED; Eby P., 2008, RANKING FEEDING HABI; EBY P, 1996, THESIS U NEW ENGLAND; Eby Peggy, 2002, P273; Epstein JH, 2009, J APPL ECOL, V46, P991, DOI 10.1111/j.1365-2664.2009.01699.x; Fleming TH, 2003, BAT ECOLOGY, P156; Fraser GC, 1996, EMERG INFECT DIS, V2, P327, DOI 10.3201/eid0204.960408; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Hall L.S., 2000, FLYING FOXES FRUIT B; Hall Leslie S., 2002, P215; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Hyne R, 2010, AUST VET J, V88, pN20; Jonsson NN, 2004, VET REC, V154, P664, DOI 10.1136/vr.154.21.664; Keith D.A., 2004, OCEAN SHORES DESERT; Kingsford RT, 2002, EMU, V102, P47, DOI 10.1071/MU01030; LUNNEY D, 2008, PTEROPUS POLIOCEPHAL; Lunney D., 1997, AUSTR EVER CHANGING, P247; Markus N, 2001, THESIS U QUEENSLAND; McKeown A, 2012, AUSTRAL ECOL, V37, P295, DOI 10.1111/j.1442-9993.2011.02276.x; McWilliam A.N., 1986, Myotis, V23-24, P201; Mickleburgh S., 1992, OLD WORLD FRUIT BATS, DOI https://doi.org/10.2305/IUCN.CH.1992.SSC-AP.6.en; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; NELSON J. E., 1965, AUSTRALIAN J ZOOL, V13, P53, DOI 10.1071/ZO9650053; Palmer C, 1999, WILDLIFE RES, V26, P823, DOI 10.1071/WR97106; PARRYJONES KA, 1992, WILDLIFE RES, V19, P331, DOI 10.1071/WR9920331; Philbey AW, 2008, AUST VET J, V86, P449, DOI 10.1111/j.1751-0813.2008.00361.x; Pierson Elizabeth D., 1992, U S Fish and Wildlife Service Biological Report, V90, P1; Ratcliffe FN, 1931, COUNCIL SCI IND RES, V53; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; Roberts BJ, 2011, BIOLOGY AND CONSERVATION OF AUSTRALASIAN BATS, P277; Roberts BJ, 2012, AUSTRAL ECOL, V37, P12, DOI 10.1111/j.1442-9993.2011.02243.x; Rogers John, 2002, P58; Sinclair EA, 1996, BIOL CONSERV, V76, P45, DOI 10.1016/0006-3207(95)00086-0; Singaravelan N, 2009, ORYX, V43, P608, DOI 10.1017/S0030605309990391; Smith CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014696; SPENCER HJ, 1991, WILDLIFE RES, V18, P463, DOI 10.1071/WR9910463; Thiriet D., 2010, AUSTRALASIAN J NATUR, V13, P161; Tidemann CR, 1999, ACTA CHIROPTEROL, V1, P151; Tidemann CR, 2004, J ZOOL, V263, P141, DOI 10.1017/S0952836904004960; Tidemann CR, 1997, AUSTR BIOL, V10, P179; Waples Kelly, 2002, P39; Webb NJ, 1996, P ROY SOC B-BIOL SCI, V263, P497, DOI 10.1098/rspb.1996.0075; West Carole, 2002, P176; Wilson DE, 1992, P INT CONS C	56	66	75	0	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42532	10.1371/journal.pone.0042532	http://dx.doi.org/10.1371/journal.pone.0042532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880021	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100122
J	Sun, S; Ke, RQ; Hughes, D; Nilsson, M; Andersson, DI				Sun, Song; Ke, Rongqin; Hughes, Diarmaid; Nilsson, Mats; Andersson, Dan I.			Genome-Wide Detection of Spontaneous Chromosomal Rearrangements in Bacteria	PLOS ONE			English	Article							ROLLING-CIRCLE AMPLIFICATION; ESCHERICHIA-COLI CHROMOSOME; PADLOCK PROBES; STRUCTURAL VARIATION; RECOMBINATION; SALMONELLA; DELETION; TRANSPOSASE; HOMOLOGIES; EVOLUTION	Genome rearrangements have important effects on bacterial phenotypes and influence the evolution of bacterial genomes. Conventional strategies for characterizing rearrangements in bacterial genomes rely on comparisons of sequenced genomes from related species. However, the spectra of spontaneous rearrangements in supposedly homogenous and clonal bacterial populations are still poorly characterized. Here we used 454 pyrosequencing technology and a 'split mapping' computational method to identify unique junction sequences caused by spontaneous genome rearrangements in chemostat cultures of Salmonella enterica Var. Typhimurium LT2. We confirmed 22 unique junction sequences with a junction microhomology more than 10 bp and this led to an estimation of 51 true junction sequences, of which 28, 12 and 11 were likely to be formed by deletion, duplication and inversion events, respectively. All experimentally confirmed rearrangements had short inverted (inversions) or direct (deletions and duplications) homologous repeat sequences at the endpoints. This study demonstrates the feasibility of genome wide characterization of spontaneous genome rearrangements in bacteria and the very high steady-state frequency (20-40%) of rearrangements in bacterial populations.	[Sun, Song; Hughes, Diarmaid; Andersson, Dan I.] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Ke, Rongqin; Nilsson, Mats] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Uppsala University; Uppsala University	Sun, S (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	dan.andersson@imbim.uu.se	Ke, Rongqin/P-2701-2019; Hughes, Diarmaid/A-9487-2014	Ke, Rongqin/0000-0002-9868-3713; Hughes, Diarmaid/0000-0002-7456-9182; Andersson, Dan/0000-0001-6640-2174	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9; ANDERSON P, 1981, P NATL ACAD SCI-BIOL, V78, P3113, DOI 10.1073/pnas.78.5.3113; Bierne H, 1997, MOL MICROBIOL, V26, P557, DOI 10.1046/j.1365-2958.1997.6011973.x; Bierne H, 1997, MOL MICROBIOL, V24, P1225, DOI 10.1046/j.1365-2958.1997.4381795.x; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Dahl F, 2004, P NATL ACAD SCI USA, V101, P4548, DOI 10.1073/pnas.0400834101; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; EGNER C, 1981, P NATL ACAD SCI-BIOL, V78, P459, DOI 10.1073/pnas.78.1.459; Henriksson S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-37; Jarvius J, 2006, NAT METHODS, V3, P725, DOI 10.1038/NMETH916; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kutsukake K, 2006, J BACTERIOL, V188, P950, DOI 10.1128/JB.188.3.950-957.2006; Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723; LOVETT ST, 1993, GENETICS, V135, P631; MAHAN MJ, 1988, GENETICS, V120, P23; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Rappleye CA, 1997, J BACTERIOL, V179, P2047, DOI 10.1128/jb.179.6.2047-2052.1997; Reams AB, 2010, GENETICS, V184, P1077, DOI 10.1534/genetics.109.111963; REBOLLO JE, 1988, P NATL ACAD SCI USA, V85, P9391, DOI 10.1073/pnas.85.24.9391; ROTH JR, 1996, ESCHERICHIA COLI SAL, P2256; Saveson CJ, 1997, GENETICS, V146, P457; SEGALL A, 1988, SCIENCE, V241, P1314, DOI 10.1126/science.3045970; SEGALL AM, 1989, GENETICS, V122, P737; SHIMIZU H, 1995, GENETICS, V140, P889; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Suyama M, 2001, TRENDS GENET, V17, P10, DOI 10.1016/S0168-9525(00)02159-4; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Wamsley HL, 2008, J CLIN MICROBIOL, V46, P2314, DOI 10.1128/JCM.02197-07; ZIEG J, 1977, J BACTERIOL, V131, P123, DOI 10.1128/JB.131.1.123-132.1977	34	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42639	10.1371/journal.pone.0042639	http://dx.doi.org/10.1371/journal.pone.0042639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880062	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100146
J	Verger, EO; Mariotti, F; Holmes, BA; Paineau, D; Huneau, JF				Verger, Eric O.; Mariotti, Francois; Holmes, Bridget A.; Paineau, Damien; Huneau, Jean-Francois			Evaluation of a Diet Quality Index Based on the Probability of Adequate Nutrient Intake (PANDiet) Using National French and US Dietary Surveys	PLOS ONE			English	Article							LOW-ENERGY-DENSITY; HEALTHY EATING INDEX-2005; UNITED-STATES; NUTRITIONAL-STATUS; ADULTS; FOOD; PATTERNS; WOMEN; ADHERENCE; POPULATION	Background: Existing diet quality indices often show theoretical and methodological limitations, especially with regard to validation. Objective: To develop a diet quality index based on the probability of adequate nutrient intake (PANDiet) and evaluate its validity using data from French and US populations. Material and Methods: The PANDiet is composed of adequacy probabilities for 24 nutrients grouped into two sub-scores. The relationship between the PANDiet score and energy intake were investigated. We evaluated the construct validity of the index by comparing scores for population sub-groups with 'a priori' differences in diet quality, according to smoking status, energy density, food intakes, plasma folate and carotenoid concentrations. French and US implementations of the PANDiet were developed and evaluated using national nutritional recommendations and dietary surveys. Results: The PANDiet was not correlated with energy for the French implementation (r = -0.02, P>0.05) and correlated at a low level for the US implementation (r = -0.11, P<0.0001). In both implementations, a higher PANDiet score (i.e. a better diet quality) was associated with not smoking, having a lower-energy-dense diet, consuming higher amounts of fruits, vegetables, fish, milk and other dairy products and lower amounts of cheese, pizza, eggs, meat and processed meat, and having higher plasma folate and carotenoid concentrations after controlling for appropriate factors (all P<0.05, carotenoid data for US not available). Conclusions: The PANDiet provides a single score that measures the adequacy of nutrient intake and reflects diet quality. This index is adaptable for use in different countries and relevant at the individual and population levels.	[Verger, Eric O.; Mariotti, Francois; Huneau, Jean-Francois] AgroParisTech, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France; [Verger, Eric O.; Mariotti, Francois; Huneau, Jean-Francois] INRA, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France; [Verger, Eric O.; Holmes, Bridget A.; Paineau, Damien] Danone Res, Dept Nutr, Palaiseau, France	AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Danone Nutricia	Verger, EO (corresponding author), AgroParisTech, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France.	eric.verger@agroparistech.fr	Verger, Eric/J-9163-2016; Mariotti, François/F-9651-2017	Verger, Eric/0000-0002-8689-8290; Mariotti, François/0000-0002-4516-3853	Danone Research; Association nationale de la recherche et de la technologie [CIFRE 474/2010]	Danone Research(Danone Nutricia); Association nationale de la recherche et de la technologie(French National Research Agency (ANR))	EOV was supported by Danone Research and a grant from the Association nationale de la recherche et de la technologie (CIFRE 474/2010). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFSSA, 2007, APP PROT CONS QUAL B; [Anonymous], APPORTS NUTR CONSEIL; Arambepola C, 2008, PUBLIC HEALTH NUTR, V11, P371, DOI 10.1017/S1368980007000377; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Bland JM, 2002, BRIT MED J, V324, P606, DOI 10.1136/bmj.324.7337.606; Castetbon K, 2009, BRIT J NUTR, V102, P733, DOI 10.1017/S0007114509274745; Commission of the European Communities, 1993, NUTR EN INT EUR COMM; Dallongeville J, 1998, J NUTR, V128, P1450; Darmon N, 2004, PUBLIC HEALTH NUTR, V7, P21, DOI 10.1079/PHN2003512; Drake I, 2011, PUBLIC HEALTH NUTR, V7, P1; EFSA Panel on Dietetic Products NaA, 2010, SCI OP DIET REF VAL; Estaquio C, 2009, J AM DIET ASSOC, V109, P1031, DOI 10.1016/j.jada.2009.03.012; Fogli-Cawley JJ, 2006, J NUTR, V136, P2908, DOI 10.1093/jn/136.11.2908; Food and Nutrition Board Institute of Medicine, 2000, DIET REF INT VIT C V; Foote JA, 2004, J NUTR, V134, P1779; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Golley RK, 2011, J NUTR, V141, P1340, DOI 10.3945/jn.110.136879; Guenther PM, 2008, J AM DIET ASSOC, V108, P1896, DOI 10.1016/j.jada.2008.08.016; Guenther PM, 2008, J AM DIET ASSOC, V108, P1854, DOI 10.1016/j.jada.2008.08.011; Hercberg S, 2005, TABLE COMPOSITION AL; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; *I MED FOOD NUTR B, 2000, DIET REF INT APPL DI; *I MED FOOD NUTR B, 2001, DIET REF INT VIT A V; Institute of Medicine, 1997, DIETARY REFERENCE IN; Institute of Medicine Food and Nutrition Board, 2004, DIET REF INT WAT POT; Institute of Medicine Food and Nutrition Board, 2010, DIET REF INT VIT D C; Institute of Medicine Food and Nutrition Board Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Panel on Micronutrients., 2002, DIET REF INT EN CARB; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Kennedy G, 2010, J NUTR, V140, p2070S, DOI 10.3945/jn.110.123612; Kourlaba G, 2009, MATURITAS, V62, P1, DOI 10.1016/j.maturitas.2008.11.021; Ledikwe JH, 2006, J AM DIET ASSOC, V106, P1172, DOI 10.1016/j.jada.2006.05.013; Ledikwe JH, 2005, J NUTR, V135, P273, DOI 10.1093/jn/135.2.273; MADDEN JP, 1972, PENN AGR EXP STA B, V78, P1; Maillot M, 2007, AM J CLIN NUTR, V86, P690; Maillot M, 2010, AM J CLIN NUTR, V91, P421, DOI 10.3945/ajcn.2009.28426; Masset G, 2009, J NUTR, V139, P1541, DOI 10.3945/jn.109.104398; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; McNaughton SA, 2008, J NUTR, V138, P86, DOI 10.1093/jn/138.1.86; Murphy MM, 2011, J AM DIET ASSOC, V112, P222; National Center for Health Statistics, 2011, 2007 2008 NAT HLTH N; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; OMS, 2018, TOP 10 CAUS DEATH; Palaniappan U, 2001, J NUTR, V131, P1952, DOI 10.1093/jn/131.7.1952; Panagiotakos D, 2009, OPEN CARDIOVASC MED, V3, P160, DOI 10.2174/1874192400903010160; Park JY, 2011, BR J NUTR, V1, P1; Pietinen P, 2008, PUBLIC HEALTH NUTR, V11, P335, DOI 10.1017/S1368980007000249; Schroder H, 2008, J NUTR, V138, P1476, DOI 10.1093/jn/138.8.1476; Shatenstein B, 2005, J AM DIET ASSOC, V105, P1251, DOI 10.1016/j.jada.2005.05.008; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; SUBAR AF, 1990, AM J PUBLIC HEALTH, V80, P1323, DOI 10.2105/AJPH.80.11.1323; Taechangam S, 2008, ASIA PAC J CLIN NUTR, V17, P365; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; Wirt A, 2009, PUBLIC HEALTH NUTR, V12, P2473, DOI 10.1017/S136898000900531X	56	73	75	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42155	10.1371/journal.pone.0042155	http://dx.doi.org/10.1371/journal.pone.0042155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870293	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100048
J	Yu, LN; Zhou, XL; Yu, J; Huang, H; Jiang, LS; Zhang, FJ; Cao, JL; Yan, M				Yu, Li-Na; Zhou, Xue-Long; Yu, Jing; Huang, Hao; Jiang, Li-Shan; Zhang, Feng-Jiang; Cao, Jun-Li; Yan, Min			PI3K Contributed to Modulation of Spinal Nociceptive Information Related to ephrinBs/EphBs	PLOS ONE			English	Article							PROTEIN-KINASE B/AKT; PHOSPHATIDYLINOSITOL 3-KINASE; NEUROPATHIC PAIN; DORSAL-HORN; CENTRAL SENSITIZATION; SYNAPTIC PLASTICITY; PATHOLOGICAL PAIN; SENSITIVE METHOD; EPH RECEPTORS; UP-REGULATION	There is accumulating evidence to implicate the importance of EphBs receptors and ephrinBs ligands were involved in modulation of spinal nociceptive information. However, the downstream mechanisms that control this process are not well understood. In the present study, we investigated whether phosphatidylinositol 3-kinase (PI3K), as the downstream effectors, participates in modulation of spinal nociceptive information related to ephrinBs/EphBs. Intrathecal injection of ephrinB1-Fc produced a dose- and time-dependent thermal and mechanical hyperalgesia, accompanied by the increase of spinal PI3K-p110 gamma, phosphorylation of AKT (p-AKT) and c-Fos expression. Pre-treatment with PI3K inhibitor wortmannin or LY294002 prevented activation of spinal AKT induced by ephrinB1-Fc. Inhibition of spinal PI3K signaling dose-dependently prevented and reversed pain behaviors and spinal c-Fos protein expression induced by intrathecal injection of ephrinB1-Fc. Inhibition of EphBs receptors by intrathecal injection of EphB1-Fc reduced formalin-induced inflammation and chronic constrictive injury-induced neuropathic pain behaviors accompanied by decreased expression of spinal PI3K,p-AKT and c-Fos protein. Furthermore, pre-treatment with PI3K inhibitor wortmannin or LY294002 prevented ephrinB1-Fc-induced ERK activation in spinal. These data demonstrated that PI3K and PI3K crosstalk to ERK signaling contributed to modulation of spinal nociceptive information related to ephrinBs/EphBs.	[Yu, Li-Na; Yu, Jing; Huang, Hao; Zhang, Feng-Jiang; Yan, Min] Zhejiang Univ, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Xue-Long; Jiang, Li-Shan; Cao, Jun-Li; Yan, Min] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China; [Zhou, Xue-Long; Jiang, Li-Shan; Cao, Jun-Li; Yan, Min] Xuzhou Med Coll, Ctr Pain Res & Treatment, Xuzhou, Jiangsu, Peoples R China	Zhejiang University; Xuzhou Medical University; Xuzhou Medical University	Yan, M (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China.	yanminnina@hotmail.com	Yu, J.Q./C-9509-2015	Yu, J.Q./0000-0002-7626-1165; Cao, Jun-Li/0000-0002-8932-4743	medicine health project of Zhejiang province [2008A088]	medicine health project of Zhejiang province	This work was supported by a grant from the medicine health project of Zhejiang province (No. 2008A088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bogen O, 2008, EUR J NEUROSCI, V28, P12, DOI 10.1111/j.1460-9568.2008.06308.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Cao JL, 2008, PAIN, V139, P617, DOI 10.1016/j.pain.2008.06.023; Carvalho TT, 2011, PHARMACOL BIOCHEM BE, V98, P188, DOI 10.1016/j.pbb.2010.12.027; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200; Cirillo G, 2010, CELL MOL NEUROBIOL, V30, P51, DOI 10.1007/s10571-009-9430-2; Coggeshall RE, 2005, PROG NEUROBIOL, V77, P299, DOI 10.1016/j.pneurobio.2005.11.002; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Guan XH, 2010, PHARMACOL BIOCHEM BE, V95, P315, DOI 10.1016/j.pbb.2010.02.007; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Haugan F, 2008, NEUROSCIENCE, V154, P1568, DOI 10.1016/j.neuroscience.2008.05.010; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Jongen JLM, 2005, EXP NEUROL, V194, P255, DOI 10.1016/j.expneurol.2005.02.019; Kim MS, 2008, TRENDS IMMUNOL, V29, P493, DOI 10.1016/j.it.2008.07.004; Kitamura T, 2008, AM J PHYSIOL-CELL PH, V294, pC189, DOI 10.1152/ajpcell.00314.2007; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kobayashi H, 2007, SPINE, V32, P1592, DOI 10.1097/BRS.0b013e318074d46a; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Liu S, 2011, CANCER RES, V71, P4392, DOI 10.1158/0008-5472.CAN-10-3870; Malik-Hall M, 2005, EUR J NEUROSCI, V21, P3387, DOI 10.1111/j.1460-9568.2005.04173.x; Melzack R, 2001, ANN NY ACAD SCI, V933, P157; Munglani R, 1996, BRIT J ANAESTH, V76, P1; Nicol GD, 2007, MOL INTERV, V7, P26, DOI 10.1124/mi.7.1.6; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Pezet S, 2008, J NEUROSCI, V28, P4261, DOI 10.1523/JNEUROSCI.5392-07.2008; Ruan JP, 2010, ANESTHESIOLOGY, V112, P1234, DOI 10.1097/ALN.0b013e3181d3e0df; Sanchez-Perez AM, 2006, NEUROCHEM INT, V49, P351, DOI 10.1016/j.neuint.2006.02.005; Song XJ, 2008, PAIN, V139, P168, DOI 10.1016/j.pain.2008.03.019; Song XJ, 2008, EUR J PAIN, V12, P1031, DOI 10.1016/j.ejpain.2008.01.011; Steinle JJ, 2003, CELL SIGNAL, V15, P1011, DOI 10.1016/S0898-6568(03)00072-X; Steinle JJ, 2002, J BIOL CHEM, V277, P43830, DOI 10.1074/jbc.M207221200; Sun R, 2007, NEUROSCIENCE, V144, P286, DOI 10.1016/j.neuroscience.2006.08.084; Sun RQ, 2006, PAIN, V120, P86, DOI 10.1016/j.pain.2005.10.017; TESSIERLAVIGNE M, 1995, CELL, V82, P345, DOI 10.1016/0092-8674(95)90421-2; Villarreal CF, 2009, LIFE SCI, V85, P822, DOI 10.1016/j.lfs.2009.10.018; Wang ZY, 2006, NEUROPHARMACOLOGY, V51, P764, DOI 10.1016/j.neuropharm.2006.05.024; Willson CA, 2003, CELL TRANSPLANT, V12, P279, DOI 10.3727/000000003108746830; Willson CA, 2002, CELL TRANSPLANT, V11, P229; Xu JT, 2007, EXP NEUROL, V206, P269, DOI 10.1016/j.expneurol.2007.05.029; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Zhang X, 2011, J NEURAL TRANSM; Zhao J, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-77	54	40	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e40930	10.1371/journal.pone.0040930	http://dx.doi.org/10.1371/journal.pone.0040930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879882	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100012
J	Joling, KJ; van Marwijk, HWJ; van der Horst, HE; Scheltens, P; van de Ven, PM; Appels, BA; van Hout, HPJ				Joling, Karlijn J.; van Marwijk, Harm W. J.; van der Horst, Henriette E.; Scheltens, Philip; van de Ven, Peter M.; Appels, Bregje A.; van Hout, Hein P. J.			Effectiveness of Family Meetings for Family Caregivers on Delaying Time to Nursing Home Placement of Dementia Patients: A Randomized Trial	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INSTITUTIONALIZATION; PEOPLE; DESIRE	Background: Interventions relieving the burden of caregiving may postpone or prevent patient institutionalization. The objective of this study was to determine whether a family meetings intervention was superior to usual care in postponing nursing home placement of patients with dementia. Methods: A randomized multicenter trial was conducted among 192 patients with a clinical diagnosis of dementia living at home at enrolment and their primary family caregiver. Dyads of caregivers and patients were randomized to the family meetings intervention (n = 96) or usual care (n = 96) condition. The intervention consisted of two individual sessions with the primary caregiver and four family counseling sessions that included family members and friends. The primary outcome measure was the time until institutionalization of the patient. Intention-to-treat as well as per protocol analyses were performed. Survival analyses were carried out to evaluate the effectiveness of the intervention. Results: During 18 months follow-up 23 of 96 relatives with dementia of caregivers in the intervention group and 18 of 96 relatives with dementia of caregivers in the usual care group were institutionalized. No significant difference between the intervention and the usual care group was found in time until institutionalization (adjusted hazard ratio (HR) 1.46, 95% confidence interval (CI) 0.78 to 2.74). The per-protocol analysis revealed no significant effect either (adjusted HR 0.57, 95% CI 0.21 to 1.57), although the number of placements among the adherers was relatively low (9.4%). A subgroup effect was found for patients' age, with a significantly higher risk of institutionalization for 'younger' patients in the intervention group compared with the usual care group (adjusted HR = 4.94, 95% CI 1.10 to 22.13). Conclusion: This family meetings intervention for primary caregivers of patients with dementia did not postpone patient institutionalization more than usual care.	[Joling, Karlijn J.; van Marwijk, Harm W. J.; van der Horst, Henriette E.; van Hout, Hein P. J.] Vrije Univ Amsterdam Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [van de Ven, Peter M.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Scheltens, Philip] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Alzheimer Ctr, Amsterdam, Netherlands; [Appels, Bregje A.] Slotervaart Hosp, Amsterdam, Netherlands; [Joling, Karlijn J.; van Marwijk, Harm W. J.; van der Horst, Henriette E.; van Hout, Hein P. J.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Slotervaart Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Joling, KJ (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Gen Practice, Amsterdam, Netherlands.	k.joling@vumc.nl	Scheltens, Philip/AAL-9631-2020; Van Marwijk, Harm/K-6306-2013	Scheltens, Philip/0000-0002-1046-6408; Van Marwijk, Harm/0000-0001-6206-485X; van Hout, Hein/0000-0002-2495-4808	Netherlands Organization for Health Research and Development (ZonMw) [62300040]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	Funding for this study was provided by the Netherlands Organization for Health Research and Development (ZonMw), grant number 62300040 (www. zonmw.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARP and National Alliance for Caregiving, 1997, FAM CAR US FIND NAT; Belle SH, 2006, ANN INTERN MED, V145, P727, DOI 10.7326/0003-4819-145-10-200611210-00005; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Dutch Institute for Healthcare Improvement, 2005, GUID DIAGN MED TREAT; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gallagher D, 2011, AM J ALZHEIMERS DIS, V26, P205, DOI 10.1177/1533317511400307; Hebert R, 2001, J GERONTOL A-BIOL, V56, pM693, DOI 10.1093/gerona/56.11.M693; Joling KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030936; Joling Karlijn J, 2008, BMC Geriatr, V8, P2, DOI 10.1186/1471-2318-8-2; LAWTON MP, 1989, GERONTOLOGIST, V29, P8, DOI 10.1093/geront/29.1.8; Luppa M, 2008, DEMENT GERIATR COGN, V26, P65, DOI 10.1159/000144027; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91; MITTELMAN MS, 1993, GERONTOLOGIST, V33, P730, DOI 10.1093/geront/33.6.730; Olazaran J, 2010, DEMENT GERIATR COGN, V30, P161, DOI 10.1159/000316119; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Spitznagel MB, 2006, J GERIATR PSYCH NEUR, V19, P16, DOI 10.1177/0891988705284713; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010	17	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42145	10.1371/journal.pone.0042145	http://dx.doi.org/10.1371/journal.pone.0042145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	984JA	22876304	gold, Green Submitted, Green Published			2022-12-27	WOS:000307184700032
J	Majesky, L; Vasut, RJ; Kitner, M; Travnicek, B				Majesky, Lubos; Vasut, Radim J.; Kitner, Miloslav; Travnicek, Bohumil			The Pattern of Genetic Variability in Apomictic Clones of Taraxacum officinale Indicates the Alternation of Asexual and Sexual Histories of Apomicts	PLOS ONE			English	Article							DANDELIONS TARAXACUM; POPULATION-STRUCTURE; RANUNCULUS-CARPATICOLA; MICROSATELLITE MARKERS; SECT. ERYTHROSPERMA; AFLP; EVOLUTION; ASTERACEAE; DIVERSITY; SECTIONS	Dandelions (genus Taraxacum) comprise a group of sexual diploids and apomictic polyploids with a complicated reticular evolution. Apomixis (clonal reproduction through seeds) in this genus is considered to be obligate, and therefore represent a good model for studying the role of asexual reproduction in microevolutionary processes of apomictic genera. In our study, a total of 187 apomictic individuals composing a set of nine microspecies (sampled across wide geographic area in Europe) were genotyped for six microsatellite loci and for 162 amplified fragment length polymorphism (AFLP) markers. Our results indicated that significant genetic similarity existed within accessions with low numbers of genotypes. Genotypic variability was high among accessions but low within accessions. Clustering methods discriminated individuals into nine groups corresponding to their phenotypes. Furthermore, two groups of apomictic genotypes were observed, which suggests that they had different asexual histories. A matrix compatibility test suggests that most of the variability within accession groups was mutational in origin. However, the presence of recombination was also detected. The accumulation of mutations in asexual clones leads to the establishment of a network of clone mates. However, this study suggests that the clones primarily originated from the hybridisation between sexual and apomicts.	[Majesky, Lubos; Vasut, Radim J.; Kitner, Miloslav; Travnicek, Bohumil] Palacky Univ, Dept Bot, Fac Sci, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc	Majesky, L (corresponding author), Palacky Univ, Dept Bot, Fac Sci, CR-77147 Olomouc, Czech Republic.	radim.vasut@upol.cz	Kitner, Miloslav/I-1223-2012; Vasut, Radim/J-8983-2012	Kitner, Miloslav/0000-0002-3762-8067; Vasut, Radim/0000-0001-6882-5509; Majesky, Lubos/0000-0002-8860-5703	Czech Science Foundation [206/09/P356]; Palacky University [IGA PrF 2010/1, 2011/3, 2012/1]; GACR [206/09/1126]; Ministry of Education, Youth and Sports of the Czech Republic [MSM 6198959215]	Czech Science Foundation(Grant Agency of the Czech Republic); Palacky University; GACR(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was funded by the Czech Science Foundation (GACR: http://www.gacr.cz/), Grant no. 206/09/P356. In addition, LM was supported by the Palacky University fundings (www.upol.cz), nos. IGA PrF 2010/1 and 2011/3 and 2012/1; RJV by GACR 206/09/1126 (www.gacr.cz) and MK by grant by the Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz), no. MSM 6198959215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asker S. E., 1992, APOMIXIS PLANTS; Battjes Johannes, 1992, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V114, P315; Bell G, 1982, MASTERPIECE NATURE E; Bendiksby M, 2011, NEW PHYTOL, V191, P1150, DOI 10.1111/j.1469-8137.2011.03753.x; Brookfield JFY, 1992, MOL ECOL, V1, P21, DOI 10.1111/j.1365-294X.1992.tb00151.x; Carman JG, 1997, BIOL J LINN SOC, V61, P51, DOI 10.1006/bijl.1996.0118; Corander J, 2006, FISH B-NOAA, V104, P550; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond EBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030314; Ehrich D, 2007, MOL ECOL, V16, P2542, DOI 10.1111/j.1365-294X.2007.03299.x; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falque M, 1998, THEOR APPL GENET, V97, P283, DOI 10.1007/s001220050897; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fehrer J, 2005, REGNUM VEG, V143, P175; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gaudeul M, 2004, HEREDITY, V92, P508, DOI 10.1038/sj.hdy.6800443; Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Heuertz M, 2004, EVOLUTION, V58, P976; Horandl E, 2006, NEW PHYTOL, V171, P525, DOI 10.1111/j.1469-8137.2006.01769.x; HUGHES J, 1988, HEREDITY, V60, P161, DOI 10.1038/hdy.1988.28; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kirschner J, 2003, PLANT SYST EVOL, V239, P231, DOI 10.1007/s00606-003-0002-5; Kirschner J, 1996, FOLIA GEOBOT PHYTOTX, V31, P415, DOI 10.1007/BF02815386; KIRSCHNER J, 1987, TAXON, V36, P608, DOI 10.2307/1221855; Kirschner J, 2011, TAXON, V60, P216, DOI 10.1002/tax.601021; Kitner M, 2012, PRESLIA, V84, P97; Kitner M, 2008, ISR J PLANT SCI, V56, P185, DOI 10.1560/IJPS.56.3.185; Kolarcik V, 2010, PLANT SYST EVOL, V290, P21, DOI 10.1007/s00606-010-0346-6; Lo EYY, 2009, MOL ECOL, V18, P1145, DOI 10.1111/j.1365-294X.2009.04091.x; Loxdale HD, 2003, BIOL J LINN SOC, V79, P3, DOI 10.1046/j.1095-8312.2003.00177.x; Mariette S, 2002, SILVAE GENET, V51, P72; Mariette S, 2001, HEREDITY, V86, P469, DOI 10.1046/j.1365-2540.2001.00852.x; Mariette S, 2002, MOL ECOL, V11, P1145, DOI 10.1046/j.1365-294X.2002.01519.x; Martonfiova L, 2006, FOLIA GEOBOT, V41, P183, DOI 10.1007/BF02806478; Martonfiova L, 2007, ACTA BIOL CRACOV BOT, V49, P47; Matzk F, 2000, PLANT J, V21, P97, DOI 10.1046/j.1365-313x.2000.00647.x; Meirmans PG, 2003, J EVOLUTION BIOL, V16, P343, DOI 10.1046/j.1420-9101.2003.00515.x; MENKEN S B J, 1989, Plant Species Biology, V4, P29, DOI 10.1111/j.1442-1984.1989.tb00045.x; Menken SBJ, 1995, EVOLUTION, V49, P1108, DOI 10.2307/2410435; Mes THM, 2002, MOL ECOL, V11, P253, DOI 10.1046/j.1365-294X.2002.01427.x; Mes THM, 1998, MOL ECOL, V7, P1719, DOI 10.1046/j.1365-294x.1998.00508.x; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Mraz P, 2007, J BIOGEOGR, V34, P2100, DOI 10.1111/j.1365-2699.2007.01765.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paule J, 2011, TAXON, V60, P721, DOI 10.1002/tax.603008; Paun O, 2006, MOL ECOL, V15, P897, DOI 10.1111/j.1365-294X.2006.02800.x; Paun O, 2006, GENETICS, V174, P387, DOI 10.1534/genetics.105.052761; Paun O, 2006, NEW PHYTOL, V171, P223, DOI 10.1111/j.1469-8137.2006.01738.x; Pavlicek A, 1999, FOLIA BIOL-PRAGUE, V45, P97; Reisch C, 2004, BOT J LINN SOC, V145, P109, DOI 10.1111/j.1095-8339.2004.00283.x; RICHARDS AJ, 1973, BOT J LINN SOC, V66, P189, DOI 10.1111/j.1095-8339.1973.tb02169.x; Richards AJ, 1996, FOLIA GEOBOT PHYTOTX, V31, P405, DOI 10.1007/BF02815385; Rogstad SH, 2002, PLANT ECOL, V161, P111, DOI 10.1023/A:1020301011283; Rohlf FJ, 1998, NTSYS PC NUMERICAL T; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; SMITH JM, 1978, EVOLUTION SEX; Symonds VV, 2010, EVOLUTION, V64, P1984, DOI [10.1111/j.1558-5646.2010.00978-x, 10.1111/j.1558-5646.2010.00978.x]; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tas ICQ, 1999, HEREDITY, V83, P707, DOI 10.1038/sj.hdy.6886190; TIBAYRENC M, 1991, P NATL ACAD SCI USA, V88, P5129, DOI 10.1073/pnas.88.12.5129; van Baarlen P, 2000, GENOME, V43, P827, DOI 10.1139/gen-43-5-827; van der Hulst RGM, 2000, MOL ECOL, V9, P1, DOI 10.1046/j.1365-294x.2000.00704.x; Van der Hulst RGM, 2003, HEREDITY, V90, P326, DOI 10.1038/sj.hdy.6800248; Van Dijk P, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P475, DOI 10.1007/978-90-481-2770-2_22; van Dijk PJ, 2008, NATURE, V451, P1063, DOI 10.1038/4511063a; van Dijk PJ, 2004, GENETICS, V166, P483, DOI 10.1534/genetics.166.1.483; van Dijk PJ, 2003, PHILOS T R SOC B, V358, P1113, DOI 10.1098/rstb.2003.1302; Vasut RJ, 2004, MOL ECOL NOTES, V4, P645, DOI 10.1111/j.1471-8286.2004.00760.x; Vasut RJ, 2003, PRESLIA, V75, P311; Vijverberg K, 2004, THEOR APPL GENET, V108, P725, DOI 10.1007/s00122-003-1474-y; Vijverberg K, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-154; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Welch DBM, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P259, DOI 10.1007/978-90-481-2770-2_13; Whitton J, 2008, INT J PLANT SCI, V169, P169, DOI 10.1086/523369; Wilkinson M., 2001, PICA 4 0 SOFTWARE DO; Wittzell H, 1999, MOL ECOL, V8, P2023, DOI 10.1046/j.1365-294x.1999.00807.x; Zaveska Drabkova L, 2009, PLANT SYST EVOL, V278, P67, DOI 10.1007/s00606-008-0134-8	87	48	50	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41868	10.1371/journal.pone.0041868	http://dx.doi.org/10.1371/journal.pone.0041868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870257	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800040
J	Gunnaiah, R; Kushalappa, AC; Duggavathi, R; Fox, S; Somers, DJ				Gunnaiah, Raghavendra; Kushalappa, Ajjamada C.; Duggavathi, Raj; Fox, Stephen; Somers, Daryl J.			Integrated Metabolo-Proteomic Approach to Decipher the Mechanisms by Which Wheat QTL (Fhb1) Contributes to Resistance against Fusarium graminearum	PLOS ONE			English	Article							HEAD BLIGHT RESISTANCE; QUANTITATIVE TRAIT LOCUS; MYCOTOXIN DEOXYNIVALENOL; TRANSCRIPTOME ANALYSIS; PEROXIDASE-ACTIVITY; IDENTIFICATION; BARLEY; LIGNIN; GENE; INFECTION	Background: Resistance in plants to pathogen attack can be qualitative or quantitative. For the latter, hundreds of quantitative trait loci (QTLs) have been identified, but the mechanisms of resistance are largely unknown. Integrated nontarget metabolomics and proteomics, using high resolution hybrid mass spectrometry, were applied to identify the mechanisms of resistance governed by the fusarium head blight resistance locus, Fhb1, in the near isogenic lines derived from wheat genotype Nyubai. Findings: The metabolomic and proteomic profiles were compared between the near isogenic lines (NIL) with resistant and susceptible alleles of Fhb1 upon F. graminearum or mock-inoculation. The resistance-related metabolites and proteins identified were mapped to metabolic pathways. Metabolites of the shunt phenylpropanoid pathway such as hydroxycinnamic acid amides, phenolic glucosides and flavonoids were induced only in the resistant NIL, or induced at higher abundances in resistant than in susceptible NIL, following pathogen inoculation. The identities of these metabolites were confirmed, with fragmentation patterns, using the high resolution LC-LTQ-Orbitrap. Concurrently, the enzymes of phenylpropanoid biosynthesis such as cinnamyl alcohol dehydrogenase, caffeoyl-CoA O-methyltransferase, caffeic acid O-methyltransferase, flavonoid O-methyltransferase, agmatine coumaroyltransferase and peroxidase were also up-regulated. Increased cell wall thickening due to deposition of hydroxycinnamic acid amides and flavonoids was confirmed by histochemical localization of the metabolites using confocal microscopy. Conclusion: The present study demonstrates that the resistance in Fhb1 derived from the wheat genotype Nyubai is mainly associated with cell wall thickening due to deposition of hydroxycinnamic acid amides, phenolic glucosides and flavonoids, but not with the conversion of deoxynivalenol to less toxic deoxynivalenol 3-O-glucoside.	[Gunnaiah, Raghavendra; Kushalappa, Ajjamada C.] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada; [Duggavathi, Raj] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada; [Fox, Stephen] Agr & Agri Food Canada, Winnipeg, MB, Canada; [Somers, Daryl J.] Vineland Res & Innovat Ctr, Vineland Stn, ON, Canada	McGill University; McGill University; Agriculture & Agri Food Canada	Gunnaiah, R (corresponding author), McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada.	ajjamada.kushalappa@mcgill.ca	Duggavathi, Raj/GSJ-3503-2022	Gunnaiah, Raghavendra/0000-0001-8479-3164	Natural Sciences and Engineering Research Council of Canada; Indian Council of Agricultural Research, New Delhi, India	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Indian Council of Agricultural Research, New Delhi, India(Indian Council of Agricultural Research (ICAR))	This project was funded by the Natural Sciences and Engineering Research Council of Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mr. Raghavendra Gunnaiah would like to thank the Indian Council of Agricultural Research, New Delhi, India for the ICAR-International Ph.D. fellowship.	Aldini G, 2011, J CHROMATOGR A, V1218, P2856, DOI 10.1016/j.chroma.2011.02.065; Alemanno L, 2003, ANN BOT-LONDON, V92, P613, DOI 10.1093/aob/mcg177; [Anonymous], 2004, SAS V 9 2; Bai GH, 1999, PHYTOPATHOLOGY, V89, P343, DOI 10.1094/PHYTO.1999.89.4.343; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Ballini E, 2008, MOL PLANT MICROBE IN, V21, P859, DOI 10.1094/MPMI-21-7-0859; Bassard JE, 2010, PHYTOCHEMISTRY, V71, P1808, DOI 10.1016/j.phytochem.2010.08.003; Bhuiyan NH, 2007, PLANT MOL BIOL, V64, P305, DOI 10.1007/s11103-007-9155-x; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bollina V, 2011, PLANT MOL BIOL, V77, P355, DOI 10.1007/s11103-011-9815-8; Bollina V, 2010, MOL PLANT PATHOL, V11, P769, DOI 10.1111/j.1364-3703.2010.00643.x; Brown NA, 2010, FUNGAL BIOL-UK, V114, P555, DOI 10.1016/j.funbio.2010.04.006; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Cerretani L, 2010, EUR J LIPID SCI TECH, V112, P1150, DOI 10.1002/ejlt.201000356; Chen LiFeng, 1997, Acta Phytopathologica Sinica, V27, P209; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Cloutier P, 2009, METHODS, V48, P381, DOI 10.1016/j.ymeth.2009.05.005; Cuthbert PA, 2006, THEOR APPL GENET, V112, P1465, DOI 10.1007/s00122-006-0249-7; Danan S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-16; DHARMAWARDHANA DP, 1995, PLANT PHYSIOL, V107, P331, DOI 10.1104/pp.107.2.331; Ding LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019008; Edreva AM, 2007, RUSS J PLANT PHYSL+, V54, P287, DOI 10.1134/S1021443707030016; Facchini PJ, 2002, CAN J BOT, V80, P577, DOI [10.1139/B02-065, 10.1139/b02-065]; Gang DR, 1999, J BIOL CHEM, V274, P7516, DOI 10.1074/jbc.274.11.7516; Gardiner SA, 2010, MOL PLANT MICROBE IN, V23, P962, DOI 10.1094/MPMI-23-7-0962; Geddes J, 2008, PROTEOMICS, V8, P545, DOI 10.1002/pmic.200700115; Grabber JH, 1998, J AGR FOOD CHEM, V46, P2609, DOI 10.1021/jf9800099; Hamzehzarghani H, 2008, CAN J PLANT PATHOL, V30, P24, DOI 10.1080/07060660809507493; Hamzehzarghani H, 2005, PHYSIOL MOL PLANT P, V66, P119, DOI 10.1016/j.pmpp.2005.05.005; Ishihara A, 2008, PLANT J, V54, P481, DOI 10.1111/j.1365-313X.2008.03441.x; Jia HY, 2009, MOL PLANT MICROBE IN, V22, P1366, DOI 10.1094/MPMI-22-11-1366; Kuhl C, 2009, LC MS PEAK ANNOTATIO; Kumaraswamy GK, 2012, PLANT PATHOL, V61, P509, DOI 10.1111/j.1365-3059.2011.02528.x; Kumaraswamy GK, 2011, EUR J PLANT PATHOL, V130, P29, DOI 10.1007/s10658-010-9729-3; Kumaraswamy KG, 2011, J CHEM ECOL, V37, P846, DOI 10.1007/s10886-011-9989-1; Lemmens M, 2005, MOL PLANT MICROBE IN, V18, P1318, DOI 10.1094/MPMI-18-1318; Li L, 2002, P NATL ACAD SCI USA, V99, P6416, DOI 10.1073/pnas.072072599; Lim EK, 2005, FEBS LETT, V579, P2802, DOI 10.1016/j.febslet.2005.04.016; Lloyd AJ, 2011, PLANT J, V67, P852, DOI 10.1111/j.1365-313X.2011.04639.x; MATERN U, 1995, CAN J BOT, V73, pS511, DOI 10.1139/b95-290; Matsuda F, 2009, PLANT J, V57, P555, DOI 10.1111/j.1365-313X.2008.03705.x; McCartney CA, 2007, MOL BREEDING, V20, P209, DOI 10.1007/s11032-007-9084-z; McLusky SR, 1999, PLANT J, V17, P523, DOI 10.1046/j.1365-313X.1999.00403.x; Menden B, 2007, PHYTOCHEMISTRY, V68, P513, DOI 10.1016/j.phytochem.2006.11.011; Mesterhazy A, 1995, PLANT BREEDING, V114, P377, DOI 10.1111/j.1439-0523.1995.tb00816.x; MILLER JD, 1985, PHYTOPATHOL Z, V113, P359; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Qi X, 1998, THEOR APPL GENET, V96, P1205, DOI 10.1007/s001220050858; SCHROEDER HW, 1963, PHYTOPATHOLOGY, V53, P831; Somers DJ, 2005, THEOR APPL GENET, V111, P1623, DOI 10.1007/s00122-005-0094-0; Somers DJ, 2003, GENOME, V46, P555, DOI 10.1139/G03-033; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Suzuki S, 2010, J WOOD SCI, V56, P71, DOI 10.1007/s10086-009-1059-8; Tautenhahn R, 2011, ANAL CHEM, V83, P696, DOI 10.1021/ac102980g; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Tohge T, 2010, NAT PROTOC, V5, P1210, DOI 10.1038/nprot.2010.82; Walter S, 2010, NEW PHYTOL, V185, P54, DOI 10.1111/j.1469-8137.2009.03041.x; Wang Y, 2005, PROTEOMICS, V5, P4496, DOI 10.1002/pmic.200401317; Wei S, 2010, PLANT GROWTH REGUL, V61, P243, DOI 10.1007/s10725-010-9468-7; Xue YJ, 2008, J AGR FOOD CHEM, V56, P9676, DOI 10.1021/jf802001v; Yang F, 2010, PROTEOMICS, V10, P3748, DOI 10.1002/pmic.201000243; Young ND, 1996, ANNU REV PHYTOPATHOL, V34, P479, DOI 10.1146/annurev.phyto.34.1.479; Zhang CY, 2008, J AGR FOOD CHEM, V56, P8268, DOI 10.1021/jf801830z; Zhou WC, 2005, GENOME, V48, P770, DOI 10.1139/g05-041	69	180	188	7	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40695	10.1371/journal.pone.0040695	http://dx.doi.org/10.1371/journal.pone.0040695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22866179	Green Submitted, Green Published, gold			2022-12-27	WOS:000306366400048
J	Fearnley, LG; Nielsen, LK				Fearnley, Liam G.; Nielsen, Lars K.			PATHLOGIC-S: A Scalable Boolean Framework for Modelling Cellular Signalling	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; ACTIVATION; PATHWAYS; RECEPTOR; NETWORKS	Curated databases of signal transduction have grown to describe several thousand reactions, and efficient use of these data requires the development of modelling tools to elucidate and explore system properties. We present PATHLOGIC-S, a Boolean specification for a signalling model, with its associated GPL-licensed implementation using integer programming techniques. The PATHLOGIC-S specification has been designed to function on current desktop workstations, and is capable of providing analyses on some of the largest currently available datasets through use of Boolean modelling techniques to generate predictions of stable and semi-stable network states from data in community file formats. PATHLOGIC-S also addresses major problems associated with the presence and modelling of inhibition in Boolean systems, and reduces logical incoherence due to common inhibitory mechanisms in signalling systems. We apply this approach to signal transduction networks including Reactome and two pathways from the Panther Pathways database, and present the results of computations on each along with a discussion of execution time. A software implementation of the framework and model is freely available under a GPL license.	[Fearnley, Liam G.; Nielsen, Lars K.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia	University of Queensland	Fearnley, LG (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.	lars.nielsen@uq.edu.au	Nielsen, Lars K/A-5519-2011	Nielsen, Lars K/0000-0001-8191-3511	Department of Industry, Innovation, Science, Research and Tertiary Education of the Australian Government; Australian Research Council [DP110103384]	Department of Industry, Innovation, Science, Research and Tertiary Education of the Australian Government(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Research Council(Australian Research Council)	LGF was funded by an Australian Postgraduate Award from the Department of Industry, Innovation, Science, Research and Tertiary Education of the Australian Government, and through Australian Research Council Discovery Grant DP110103384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; [Anonymous], 2011, BIOPAX BIOL PATHW EX; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Berkelaar M, 2010, LP SOLV VERS 5 5 2 0; Bertsimas D, 2005, ATHENA SCI, VI-X, P1; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Chen WW, 2010, GENE DEV, V24, P1861, DOI 10.1101/gad.1945410; Dasika MS, 2006, BIOPHYS J, V91, P382, DOI 10.1529/biophysj.105.069724; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fliss AE, 1999, J BIOL CHEM, V274, P34045, DOI 10.1074/jbc.274.48.34045; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Gosling J, 2005, JAVATMLANGUAGE SPECI; Graves JD, 2004, IMMUNOL REV, V197, P129, DOI 10.1111/j.0105-2896.2004.0110.x; Handorf T, 2012, BIOINFORMATICS, V28, P557, DOI 10.1093/bioinformatics/btr697; Harlin H, 2002, J IMMUNOL, V169, P2451, DOI 10.4049/jimmunol.169.5.2451; Haus UU, 2009, J COMPUT BIOL, V16, P725, DOI 10.1089/cmb.2008.0163; Haus UU, 2008, J SATISF BOOLEAN MOD, V6, P13; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Himsolt M, 1996, A8 U FLOR; Hyduke DR, 2010, NAT REV GENET, V11, P297, DOI 10.1038/nrg2750; Joshi-Tope G, 2003, COLD SPRING HARB SYM, V68, P237, DOI 10.1101/sqb.2003.68.237; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Matthews L, 2007, BIOINFORMATICS PRIME, DOI [10.1038/pid.2007.3, DOI 10.1038/PID.2007.3]; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Nielsen LK, 2011, NAT CHEM BIOL, V7, P407, DOI 10.1038/nchembio.601; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Rivas FV, 2001, J IMMUNOL, V167, P3123, DOI 10.4049/jimmunol.167.6.3123; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Tarjan Robert, 1971, P 12 ANN S SWITCH AU, P114, DOI [DOI 10.1109/SWAT.1971.10, 10.1109/SWAT.1971.10]; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Zhang YQ, 2004, MOL CELL BIOL, V24, P1044, DOI 10.1128/MCB.24.3.1044-1057.2004	38	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41977	10.1371/journal.pone.0041977	http://dx.doi.org/10.1371/journal.pone.0041977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879903	Green Published, Green Submitted, gold			2022-12-27	WOS:000307437900018
J	Milanesi, A; Lee, JW; Li, ZH; Da Sacco, S; Villani, V; Cervantes, V; Perin, L; Yu, JS				Milanesi, Anna; Lee, Jang-Won; Li, Zhenhua; Da Sacco, Stefano; Villani, Valentina; Cervantes, Vanessa; Perin, Laura; Yu, John S.			beta-Cell Regeneration Mediated by Human Bone Marrow Mesenchymal Stem Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INSULIN-PRODUCING CELLS; PANCREATIC-ISLETS; STROMAL CELLS; IN-VIVO; FACTOR-A; DIFFERENTIATION; EXPRESSION; PDX1; TRANSPLANTATION	Bone marrow mesenchymal stem cells (BMSCs) have been shown to ameliorate diabetes in animal models. The mechanism, however, remains largely unknown. An unanswered question is whether BMSCs are able to differentiate into beta-cells in vivo, or whether BMSCs are able to mediate recovery and/or regeneration of endogenous beta-cells. Here we examined these questions by testing the ability of hBMSCs genetically modified to transiently express vascular endothelial growth factor (VEGF) or pancreatic-duodenal homeobox 1 (PDX1) to reverse diabetes and whether these cells were differentiated into beta-cells or mediated recovery through alternative mechanisms. Human BMSCs expressing VEGF and PDX1 reversed hyperglycemia in more than half of the diabetic mice and induced overall improved survival and weight maintenance in all mice. Recovery was sustained only in the mice treated with hBMSCs-VEGF. However, de novo beta-cell differentiation from human cells was observed in mice in both cases, treated with either hBMSCs-VEGF or hBMSCs-PDX1, confirmed by detectable level of serum human insulin. Sustained reversion of diabetes mediated by hBMSCs-VEGF was secondary to endogenous beta-cell regeneration and correlated with activation of the insulin/IGF receptor signaling pathway involved in maintaining beta-cell mass and function. Our study demonstrated the possible benefit of hBMSCs for the treatment of insulin-dependent diabetes and gives new insight into the mechanism of beta-cell recovery after injury mediated by hBMSC therapy.	[Milanesi, Anna] Cedars Sinai Med Ctr, Div Endocrinol, Los Angeles, CA 90048 USA; [Milanesi, Anna] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Lee, Jang-Won; Li, Zhenhua; Cervantes, Vanessa; Yu, John S.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Da Sacco, Stefano; Villani, Valentina; Perin, Laura] Univ So Calif, Dept Urol, Childrens Hosp Los Angeles, Los Angeles, CA USA	Cedars Sinai Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Cedars Sinai Medical Center; Children's Hospital Los Angeles; University of Southern California	Milanesi, A (corresponding author), Cedars Sinai Med Ctr, Div Endocrinol, Los Angeles, CA 90048 USA.	john.yu@cshs.org	Da Sacco, Stefano/G-6346-2011; Villani, Valentina/ABB-8016-2020	Da Sacco, Stefano/0000-0001-9654-6822; Yu, John/0000-0003-1230-8494	Endocrine Fellow Foundation; Cedars-Sinai Clinical Scholar Program	Endocrine Fellow Foundation; Cedars-Sinai Clinical Scholar Program	Funding source: Endocrine Fellow Foundation, and Cedars-Sinai Clinical Scholar Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Assmann A, 2009, PEDIATR DIABETES, V10, P14, DOI 10.1111/j.1399-5448.2008.00468.x; Banerjee M, 2005, BIOCHEM BIOPH RES CO, V328, P318, DOI 10.1016/j.bbrc.2004.12.176; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Chae HY, 2005, EXP MOL MED, V37, P513, DOI 10.1038/emm.2005.64; Chen LB, 2004, WORLD J GASTROENTERO, V10, P3016; CHRISTOFORI G, 1995, MOL ENDOCRINOL, V9, P1760, DOI 10.1210/me.9.12.1760; Duffy GP, 2009, TISSUE ENG PT A, V15, P2459, DOI [10.1089/ten.tea.2008.0341, 10.1089/ten.TEA.2008.0341]; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Ezquer F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016566; Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Folli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028050; Forte A, 2008, J CELL PHYSIOL, V217, P789, DOI 10.1002/jcp.21559; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924; Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200; Gu YY, 2011, DIABETES, V60, P827, DOI 10.2337/db10-1194; Hasegawa Y, 2007, ENDOCRINOLOGY, V148, P2006, DOI 10.1210/en.2006-1351; Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Issbrucker K, 2002, FASEB J, V16, P262, DOI 10.1096/fj.02-0329fje; Iwashita N, 2007, DIABETOLOGIA, V50, P380, DOI 10.1007/s00125-006-0512-0; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Kabos P, 2002, EXP NEUROL, V178, P288, DOI 10.1006/exnr.2002.8039; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Lin H, 2008, J CELL PHYSIOL, V216, P458, DOI 10.1002/jcp.21414; Malek A, 2010, CLIN EXP METASTAS, V27, P261, DOI 10.1007/s10585-010-9324-1; Matsumoto R, 2005, ARTERIOSCL THROM VAS, V25, P1168, DOI 10.1161/01.ATV.0000165696.25680.ce; Matsuoka T, 2010, DIABETES, V59, P1709, DOI 10.2337/db08-0693; Milanesi A, 2011, J ENDOCRINOL, V209, P193, DOI 10.1530/JOE-10-0344; Nakayama S, 2009, DIABETOLOGIA, V52, P115, DOI 10.1007/s00125-008-1172-z; Narang AS, 2006, PHARM RES, V23, P1970, DOI 10.1007/s11095-006-9065-7; Nicholson JM, 2010, EXP BIOL MED, V235, P189, DOI 10.1258/ebm.2009.009316; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Sakata N, 2010, TRANSPLANTATION, V89, P686, DOI 10.1097/TP.0b013e3181cb3e8d; Alvarez SS, 2006, MICROSURG, V26, P539, DOI 10.1002/micr.20283; Tamama K, 2008, STEM CELLS DEV, V17, P897, DOI 10.1089/scd.2007.0155; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Urban VS, 2008, STEM CELLS, V26, P244, DOI 10.1634/stemcells.2007-0267; Wang QH, 2009, ISLETS, V1, P95, DOI 10.4161/isl.1.2.9263; Yue WM, 2008, STEM CELLS DEV, V17, P785, DOI 10.1089/scd.2007.0243; Zeng ZH, 2007, J NEUROSCI RES, V85, P310, DOI 10.1002/jnr.21131; Zhao M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002666	54	42	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42177	10.1371/journal.pone.0042177	http://dx.doi.org/10.1371/journal.pone.0042177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879915	gold, Green Submitted, Green Published			2022-12-27	WOS:000307437900023
J	Fan, L; Xiao, HP; Hu, ZY; Ernst, JD				Fan, Lin; Xiao, He-ping; Hu, Zhong-yi; Ernst, Joel D.			Variation of Mycobacterium tuberculosis Antigen-Specific IFN-gamma and IL-17 Responses in Healthy Tuberculin Skin Test (TST)-Positive Human Subjects	PLOS ONE			English	Article							T-CELL RESPONSES; IMMUNE-RESPONSE; LUNG; VACCINATION; GRANULOMA; INFECTION; CAVITARY; SPECTRUM; IL-23	Objective: To determine the variation of IFN-gamma and IL-17 responses to M. tuberculosis antigens in healthy TST+ humans. Methods: We isolated peripheral blood mononuclear cells from 21 TST+ healthy adults, stimulated them with phytohemagglutinin (PHA), PPD, Ag85B, ESAT-6, and live M. bovis BCG, and assayed IFN-gamma and IL-17 secretion by ELISA in supernatants after 24 or 72 hours of incubation respectively. Results: As in other studies, we found a wide range of IFN-gamma responses to M. tuberculosis antigens; the variation significantly exceeded that observed in the same donors to the polyclonal T cell stimulus, phytohemagglutinin (PHA). In addition, we assayed IL-17 secretion in response to the same stimuli, and found less subject-to-subject variation. Analysis of the ratio of IFN-gamma to IL-17 secretion on a subject-to-subject basis also revealed a wide range, with the majority of results distributed in a narrow range, and a minority with extreme results all of which were greater than that in the majority of subjects. The data suggest that study of exceptional responses to M. tuberculosis antigens may reveal immunologic correlates with specific outcomes of M. tuberculosis infection. Conclusion: Variation of IFN gamma and IFN-gamma/IL-17 responses to mycobacterial antigens exceeds that of responses to the polyclonal stimulus, PHA, in TST positive healthy humans. This indicates a quantitative spectrum of human immune responses to infection with M. tuberculosis. Since the outcome of human infection with M. tuberculosis varies greatly, systematic study of multiple immune responses to multiple antigens is likely to reveal correlations between selected immune responses and the outcomes of infection.	[Fan, Lin; Ernst, Joel D.] NYU, Sch Med, Div Infect Dis, New York, NY 10003 USA; [Fan, Lin; Xiao, He-ping; Hu, Zhong-yi] Tongji Univ, Sch Med, TB Ctr Diag & Treatment, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China	New York University; Tongji University	Fan, L (corresponding author), NYU, Sch Med, Div Infect Dis, New York, NY 10003 USA.	shhuzy@163.com; joel.ernst@med.nyu.edu		Ernst, Joel/0000-0001-9951-6207	NIH [R01 AI090928]; NIH/NCRR [1UL1RR029893-0109]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090928] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01 AI090928 and NIH/NCRR 1UL1RR029893-0109. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Barry S, 2009, TUBERCULOSIS, V89, P48, DOI 10.1016/j.tube.2008.07.002; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; D'Agostino RB., 2004, INTRO APPL BIOSTATIS; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gideon HP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001237; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Mazzarella G, 2003, CLIN EXP IMMUNOL, V132, P283, DOI 10.1046/j.1365-2249.2003.02121.x; MUKADI Y, 1993, LANCET, V342, P143, DOI 10.1016/0140-6736(93)91346-N; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332	27	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42716	10.1371/journal.pone.0042716	http://dx.doi.org/10.1371/journal.pone.0042716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880090	Green Published, Green Submitted, gold			2022-12-27	WOS:000307810000063
J	Perina, D; Korolija, M; Mikoc, A; Roller, M; Plese, B; Imesek, M; Morrow, C; Batel, R; Cetkovic, H				Perina, Drago; Korolija, Marina; Mikoc, Andreja; Roller, Masa; Plese, Bruna; Imesek, Mirna; Morrow, Christine; Batel, Renato; Cetkovic, Helena			Structural and Functional Characterization of Ribosomal Protein Gene Introns in Sponges	PLOS ONE			English	Article							SMALL NUCLEOLAR RNAS; EXTRARIBOSOMAL FUNCTIONS; SUBERITES-DOMUNCULA; ANGSTROM RESOLUTION; NONCODING RNAS; EVOLUTION; SNORNAS; GENOME; ASSOCIATION; CONGRUENCE	Ribosomal protein genes (RPGs) are a powerful tool for studying intron evolution. They exist in all three domains of life and are much conserved. Accumulating genomic data suggest that RPG introns in many organisms abound with non-protein-coding-RNAs (ncRNAs). These ancient ncRNAs are small nucleolar RNAs (snoRNAs) essential for ribosome assembly. They are also mobile genetic elements and therefore probably important in diversification and enrichment of transcriptomes through various mechanisms such as intron/exon gain/loss. snoRNAs in basal metazoans are poorly characterized. We examined 449 RPG introns, in total, from four demosponges: Amphimedon queenslandica, Suberites domuncula, Suberites ficus and Suberites pagurorum and showed that RPG introns from A. queenslandica share position conservancy and some structural similarity with "higher'' metazoans. Moreover, our study indicates that mobile element insertions play an important role in the evolution of their size. In four sponges 51 snoRNAs were identified. The analysis showed discrepancies between the snoRNA pools of orthologous RPG introns between S. domuncula and A. queenslandica. Furthermore, these two sponges show as much conservancy of RPG intron positions between each other as between themselves and human. Sponges from the Suberites genus show consistency in RPG intron position conservation. However, significant differences in some of the orthologous RPG introns of closely related sponges were observed. This indicates that RPG introns are dynamic even on these shorter evolutionary time scales.	[Perina, Drago; Mikoc, Andreja; Plese, Bruna; Imesek, Mirna; Cetkovic, Helena] Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia; [Korolija, Marina] Rudjer Boskovic Inst, Dept Mol Med, Zagreb, Croatia; [Roller, Masa] Univ Zagreb, Fac Sci, Dept Mol Biol, Zagreb 41000, Croatia; [Morrow, Christine] Queens Univ, Sch Biol Sci, Belfast, Antrim, North Ireland; [Batel, Renato] Rudjer Boskovic Inst, Ctr Marine Res, Rovinj, Croatia	Rudjer Boskovic Institute; Rudjer Boskovic Institute; University of Zagreb; Queens University Belfast; Rudjer Boskovic Institute	Perina, D (corresponding author), Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia.	cetkovic@irb.hr	Roller, Maša/F-4532-2011; Plese, Bruna/L-8289-2016	Plese, Bruna/0000-0001-6690-3876; Halasz, Mirna/0000-0003-1715-1625; Morrow, Christine/0000-0001-5686-8747; Roller, Masa/0000-0001-5667-3317	Croatian Ministry of Science, Education and Sports [098-0982913-2874]	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	This work was funded by the Croatian Ministry of Science, Education and Sports grants 098-0982913-2874 (H. Cetkovic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bompfunewerer AF, 2005, THEOR BIOSCI, V123, P301, DOI 10.1016/j.thbio.2005.01.002; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; d'Orval BC, 2001, NUCLEIC ACIDS RES, V29, P4518, DOI 10.1093/nar/29.22.4518; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Gardner Paul P., 2010, Journal of Biology (London), V8, P4, DOI 10.1186/jbiol211; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gilbert D, 2009, BIOINFORMATICS, V25, P2171, DOI 10.1093/bioinformatics/btp389; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Harcet M, 2010, MOL BIOL EVOL, V27, P2747, DOI 10.1093/molbev/msq174; Hertel J, 2009, NUCLEIC ACIDS RES, V37, P1602, DOI 10.1093/nar/gkn1084; Hoeppner MP, 2009, GENOME BIOL EVOL, V1, P420, DOI 10.1093/gbe/evp045; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kressler D., 2009, BIOCHIM BIOPHYS ACTA, V1803, P673; Lafontaine DLJ, 1998, TRENDS BIOCHEM SCI, V23, P383, DOI 10.1016/S0968-0004(98)01260-2; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Long MY, 1999, MOL BIOL EVOL, V16, P1528, DOI 10.1093/oxfordjournals.molbev.a026065; Luo YP, 2007, NUCLEIC ACIDS RES, V35, P559, DOI 10.1093/nar/gkl1086; Marais G, 2005, GENETICS, V170, P481, DOI 10.1534/genetics.104.037333; Morrow CC, 2012, MOL PHYLOGENET EVOL, V62, P174, DOI 10.1016/j.ympev.2011.09.016; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Perina D, 2006, GENE, V366, P275, DOI 10.1016/j.gene.2005.08.015; Perina D, 2011, NAUNYN SCHMIEDEBERGS; Perina D, 2011, GENOMICS, V98, P56, DOI 10.1016/j.ygeno.2011.03.009; Perina D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-87; Perina D, 2009, FOOD TECHNOL BIOTECH, V47, P269; Perry RP, 2007, GENE, V401, P1, DOI 10.1016/j.gene.2007.07.007; Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233; QU LH, 1995, NUCLEIC ACIDS RES, V23, P2669, DOI 10.1093/nar/23.14.2669; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schmitz J, 2008, GENOME RES, V18, P1005, DOI 10.1101/gr.7177908; Scott MS, 2011, BIOCHIMIE; Sela N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r59; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Weber MJ, 2006, PLOS GENET, V2, P1984, DOI 10.1371/journal.pgen.0020205; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P5112, DOI 10.1093/nar/gkl672; Yoshihama M, 2002, GENOME RES, V12, P379, DOI 10.1101/gr.214202; Yoshihama M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000141; Yoshihama M, 2006, PLOS GENET, V2, P237, DOI 10.1371/journal.pgen.0020025; Zemann A, 2006, NUCLEIC ACIDS RES, V34, P2676, DOI 10.1093/nar/gkl359	53	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42523	10.1371/journal.pone.0042523	http://dx.doi.org/10.1371/journal.pone.0042523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880015	Green Submitted, Green Published, gold			2022-12-27	WOS:000307810000039
J	Reilly, J; Westbury, C; Kean, J; Peelle, JE				Reilly, Jamie; Westbury, Chris; Kean, Jacob; Peelle, Jonathan E.			Arbitrary Symbolism in Natural Language Revisited: When Word Forms Carry Meaning	PLOS ONE			English	Article							LEXICAL ACCESS; GRAMMATICAL CLASS; PHONOTACTIC PROBABILITY; INDIVIDUAL-DIFFERENCES; CONTEXT AVAILABILITY; CONCRETE WORDS; IMAGEABILITY; SPEECH; SOUND; RECOGNITION	Cognitive science has a rich history of interest in the ways that languages represent abstract and concrete concepts (e. g., idea vs. dog). Until recently, this focus has centered largely on aspects of word meaning and semantic representation. However, recent corpora analyses have demonstrated that abstract and concrete words are also marked by phonological, orthographic, and morphological differences. These regularities in sound-meaning correspondence potentially allow listeners to infer certain aspects of semantics directly from word form. We investigated this relationship between form and meaning in a series of four experiments. In Experiments 1-2 we examined the role of metalinguistic knowledge in semantic decision by asking participants to make semantic judgments for aurally presented nonwords selectively varied by specific acoustic and phonetic parameters. Participants consistently associated increased word length and diminished wordlikeness with abstract concepts. In Experiment 3, participants completed a semantic decision task (i.e., abstract or concrete) for real words varied by length and concreteness. Participants were more likely to misclassify longer, inflected words (e. g., "apartment'') as abstract and shorter uninflected abstract words (e.g., "fate'') as concrete. In Experiment 4, we used a multiple regression to predict trial level naming data from a large corpus of nouns which revealed significant interaction effects between concreteness and word form. Together these results provide converging evidence for the hypothesis that listeners map sound to meaning through a non-arbitrary process using prior knowledge about statistical regularities in the surface forms of words.	[Reilly, Jamie] Univ Florida, Dept Speech Language & Hearing Sci, Gainesville, FL 32611 USA; [Westbury, Chris] Univ Alberta, Dept Phys, Edmonton, AB, Canada; [Kean, Jacob] Indiana Univ, Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Peelle, Jonathan E.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Peelle, Jonathan E.] Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 19104 USA	State University System of Florida; University of Florida; University of Alberta; Indiana University System; Indiana University-Purdue University Indianapolis; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Reilly, J (corresponding author), Univ Florida, Dept Speech Language & Hearing Sci, Gainesville, FL 32611 USA.	jjreilly@phhp.ufl.edu	Peelle, Jonathan/AAA-8299-2020	Peelle, Jonathan/0000-0001-9194-854X; Kean, Jacob/0000-0002-8577-0586	National Institutes of Health/National Institute on Deafness and Other Communication Disorders [NIH/NIDCD K23 DC010197]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC010197] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a grant from the National Institutes of Health/National Institute on Deafness and Other Communication Disorders (NIH/NIDCD K23 DC010197). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson DJ, 2010, J EXP PSYCHOL LEARN, V36, P17, DOI 10.1037/a0017679; Albright A, 2003, COGNITION, V90, P119, DOI 10.1016/S0010-0277(03)00146-X; Baayen R. H, 1995, CELEX LEXICAL DATABA; Balota DA, 2004, J EXP PSYCHOL GEN, V133, P283, DOI 10.1037/0096-3445.133.2.283; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Barca L, 2002, BEHAV RES METH INS C, V34, P424, DOI 10.3758/BF03195471; Barnes J, 2006, ARCH NEUROL-CHICAGO, V63, P1434, DOI 10.1001/archneur.63.10.1434; Berndt RS, 2002, J NEUROLINGUIST, V15, P353, DOI 10.1016/S0911-6044(01)00030-6; Binder JR, 2005, J COGNITIVE NEUROSCI, V17, P905, DOI 10.1162/0898929054021102; Boulenger V, 2007, COGNITION, V103, P131, DOI 10.1016/j.cognition.2006.03.001; BREEDIN SD, 1994, COGNITIVE NEUROPSYCH, V11, P617, DOI 10.1080/02643299408251987; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Cassidy KW, 2001, PSYCHON B REV, V8, P519; Chomsky Noam, 1968, SOUND PATTERN ENGLIS; Christiansen MH, 2009, DEVELOPMENTAL SCI, V12, P388, DOI 10.1111/j.1467-7687.2009.00824.x; Cipolotti L, 1995, J Int Neuropsychol Soc, V1, P104; Clark JM, 2004, BEHAV RES METH INS C, V36, P371, DOI 10.3758/BF03195584; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; COLTHEART V, 1988, BRIT J PSYCHOL, V79, P1, DOI 10.1111/j.2044-8295.1988.tb02270.x; Cortese MJ, 1997, PSYCHON B REV, V4, P226, DOI 10.3758/BF03209397; Cowan N, 1997, PSYCHOL SCI, V8, P290, DOI 10.1111/j.1467-9280.1997.tb00440.x; Crutch SJ, 2006, NEUROCASE, V12, P151, DOI 10.1080/13554790600598832; Crutch SJ, 2005, BRAIN, V128, P615, DOI 10.1093/brain/awh349; Crutch SJ, 2003, NEUROCASE, V9, P465, DOI 10.1076/neur.9.6.465.29373; CUTLER A, 1981, COGNITION, V10, P65, DOI 10.1016/0010-0277(81)90026-3; Davis MH, 2007, HEARING RES, V229, P132, DOI 10.1016/j.heares.2007.01.014; DEGROOT AMB, 1989, J EXP PSYCHOL LEARN, V15, P824, DOI 10.1037/0278-7393.15.5.824; DELL GS, 1992, COGNITION, V42, P287, DOI 10.1016/0010-0277(92)90046-K; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Dikker S, 2010, PSYCHOL SCI, V21, P629, DOI 10.1177/0956797610367751; Farmer TA, 2006, P NATL ACAD SCI USA, V103, P12203, DOI 10.1073/pnas.0602173103; FRANKLIN S, 1994, COGNITIVE NEUROPSYCH, V11, P1, DOI 10.1080/02643299408251964; FRANKLIN S, 1995, COGNITIVE NEUROPSYCH, V12, P549, DOI 10.1080/02643299508252007; Frisch SA, 2000, J MEM LANG, V42, P481, DOI 10.1006/jmla.1999.2692; Gleitman L. R., 1992, CURR DIR PSYCHOL SCI, V1, P31, DOI [10.1111/1467-8721.ep10767853H&aring, DOI 10.1111/1467-8721.EP10767853H&ARING]; JUSCZYK PW, 1994, J MEM LANG, V33, P630, DOI 10.1006/jmla.1994.1030; KELLY MH, 1992, PSYCHOL REV, V99, P349, DOI 10.1037/0033-295X.99.2.349; Kounios J, 2003, COGNITIVE BRAIN RES, V17, P484, DOI 10.1016/S0926-6410(03)00164-2; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; KROLL JF, 1986, J EXP PSYCHOL LEARN, V12, P92, DOI 10.1037/0278-7393.12.1.92; Langenmayr A, 2001, PERCEPT MOTOR SKILL, V93, P843, DOI 10.2466/PMS.93.7.843-850; Lederer A., 1995, NAMES THINGS YOUNG C, P277; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Lidz Jeffrey, 2004, WEAVING LEXICON, P603; Locke J., 1685, ESSAY HUMAN UNDERSTA; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; MarslenWilson W, 1996, J EXP PSYCHOL HUMAN, V22, P1376, DOI 10.1037/0096-1523.22.6.1376; Monaghan P, 2005, COGNITION, V96, P143, DOI 10.1016/j.cognition.2004.09.001; Monaghan P, 2011, J EXP PSYCHOL GEN, V140, P325, DOI 10.1037/a0022924; Monaghan P, 2010, J CHILD LANG, V37, P545, DOI 10.1017/S0305000909990511; Nuckolls JB, 1999, ANNU REV ANTHROPOL, V28, P225, DOI 10.1146/annurev.anthro.28.1.225; Nygaard LC, 2009, COGNITION, V112, P181, DOI 10.1016/j.cognition.2009.04.001; PAIVIO A, 1994, J EXP PSYCHOL LEARN, V20, P1196, DOI 10.1037/0278-7393.20.5.1196; PAIVIO A, 1991, CAN J PSYCHOL, V45, P255, DOI 10.1037/h0084295; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; Paivio A., 1985, MENTAL REPRESENTATIO; Paivio Allan, 1995, P977; Papagno C, 2009, NEUROPSYCHOLOGIA, V47, P1138, DOI 10.1016/j.neuropsychologia.2009.01.019; Pexman PM, 2007, J COGNITIVE NEUROSCI, V19, P1407, DOI 10.1162/jocn.2007.19.8.1407; Piantadosi ST, 2011, P NATL ACAD SCI USA, V108, pE109, DOI 10.1073/pnas.1103550108; Piantadosi ST, 2011, P NATL ACAD SCI USA, V108, P3526, DOI 10.1073/pnas.1012551108; Pinker S., 1987, MECH LANGUAGE ACQUIS, P399; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; Rastle K, 2002, Q J EXP PSYCHOL-A, V55, P1339, DOI 10.1080/02724980244000099; Rastle K, 2002, J EXP PSYCHOL HUMAN, V28, P307, DOI 10.1037//0096-1523.28.2.307; Reali F, 2005, COGNITIVE SCI, V29, P1007, DOI 10.1207/s15516709cog0000_28; Regier T, 2005, COGNITIVE SCI, V29, P819, DOI 10.1207/s15516709cog0000_31; Reilly J., 2005, DISS ABSTR INT B; Reilly J., 2006, BRAIN LANG, V99, P218; Reilly J, 2011, P NATL ACAD SCI USA, DOI [10.1073/pnas.1103550108, DOI 10.1073/PNAS.1103550108]; Reilly J, 2007, APHASIOLOGY, V21, P558, DOI 10.1080/02687030701191986; Reilly J, 2007, COGNITIVE SCI, V31, P157, DOI 10.1080/03640210709336988; Sadoski M, 1997, J EDUC PSYCHOL, V89, P518; Sadoski M, 2001, IMAGERY TEXT DUAL CO, P236; Saffran JR, 2003, CURR DIR PSYCHOL SCI, V12, P110, DOI 10.1111/1467-8721.01243; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 2003, DEV PSYCHOL, V39, P484, DOI 10.1037/0012-1649.39.3.484; Saussure F, 1907, COURS LINGUISTIQUE G; SCHWANENFLUGEL PJ, 1989, READ RES QUART, V24, P114, DOI 10.2307/748013; SCHWANENFLUGEL PJ, 1983, J EXP PSYCHOL LEARN, V9, P82, DOI 10.1037/0278-7393.9.1.82; SCHWANENFLUGEL PJ, 1992, MEM COGNITION, V20, P96, DOI 10.3758/BF03208259; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Shaoul C, 2010, BEHAV RES METHODS, V42, P393, DOI 10.3758/BRM.42.2.393; Shibahara N, 2003, Q J EXP PSYCHOL-A, V56, P263, DOI 10.1080/02724980244000369; Shukla M, 2011, P NATL ACAD SCI USA, V108, P6038, DOI 10.1073/pnas.1017617108; Sommers M., 2011, WASHINGTON U SPEECH; Spieler DH, 1997, PSYCHOL SCI, V8, P411, DOI 10.1111/j.1467-9280.1997.tb00453.x; Storkel HL, 2006, J SPEECH LANG HEAR R, V49, P1175, DOI 10.1044/1092-4388(2006/085); Strain E, 2002, J EXP PSYCHOL LEARN, V28, P207, DOI 10.1037//0278-7393.28.1.207; STRAIN E, 1995, J EXP PSYCHOL LEARN, V21, P1140, DOI 10.1037/0278-7393.21.5.1140; Strain E, 1999, CAN J EXP PSYCHOL, V53, P347, DOI 10.1037/h0087322; Thiessen ED, 2003, DEV PSYCHOL, V39, P706, DOI 10.1037/0012-1649.39.4.706; Thiessen ED, 2007, LANG LEARN DEV, V3, P73, DOI 10.1080/15475440709337001; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; Vitevitch MS, 2004, BEHAV RES METH INS C, V36, P481, DOI 10.3758/BF03195594; Walker I, 1999, J EXP PSYCHOL LEARN, V25, P1256, DOI 10.1037/0278-7393.25.5.1256; Westbury C, 2006, J NEUROLINGUIST, V19, P124, DOI 10.1016/j.jneuroling.2005.09.002; Westbury C., 2011, APPL NATURAL LANGUAG, P230; Westbury C, 2009, MENT LEX, V4, P115, DOI 10.1075/ml.4.1.05wes; Wise RJS, 2000, NEUROPSYCHOLOGIA, V38, P985, DOI 10.1016/S0028-3932(99)00152-9; Woollams AM, 2005, J EXP PSYCHOL LEARN, V31, P878, DOI 10.1037/0278-7393.31.5.878; Yang CD, 2004, TRENDS COGN SCI, V8, P451, DOI 10.1016/j.tics.2004.08.006; Yap MJ, 2012, J EXP PSYCHOL HUMAN, V38, P53, DOI 10.1037/a0024177; Yap MJ, 2009, J MEM LANG, V60, P502, DOI 10.1016/j.jml.2009.02.001; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	106	35	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42286	10.1371/journal.pone.0042286	http://dx.doi.org/10.1371/journal.pone.0042286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992WD	22879931	Green Published, Green Submitted, gold			2022-12-27	WOS:000307810000026
J	Tiemann, I; Rehkamper, G				Tiemann, Inga; Rehkaemper, Gerd			Evolutionary Pets: Offspring Numbers Reveal Speciation Process in Domesticated Chickens	PLOS ONE			English	Article							GALLUS-GALLUS; ISOLATING MECHANISMS; SEXUAL SELECTION; FOWL; HYBRIDIZATION; PREFERENCES; JUNGLEFOWL; HOMOGAMY; PIGEONS; CHOICE	Since Darwin, the nature of the relationship between evolution and domestication has been debated. Evolution offers different mechanisms of selection that lead to adaptation and may end in the origin of new species as defined by the biological species concept. Domestication has given rise to numerous breeds in almost every domesticated species, including chickens. At the same time, so-called artificial selection seems to exclude mechanisms of sexual selection by the animals themselves. We want to forward the question to the animal itself: With whom do you reproduce successfully? This study focused on the sexual behavior of the domestic chicken Gallus gallus f.dom., particularly the White Crested Polish breed. Experiments on mate choice and the observation of fertilization and hatching rates of mixed-breeding groups revealed breed-specific preferences. In breeding groups containing White Crested Polish and a comparative breed, more purebred chicks hatched than hybrids (number of eggs collected: 1059). Mating was possible in equal shares, but in relation to the number of eggs collected, purebred offspring (62.75%+/-67.10%, M+/-SE) hatched to a greater extend compared to hybrid offspring (28.75%+/-15.32%, M+/-SE). These data demonstrate that the mechanism of sexual selection is still present in domestic chicken breeds, which includes the alteration of gene frequencies typical for domestication and evolutionary speciation. Due to selection and mate choice we state that breeding in principle can generate new species. Therefore, we see domestication as an evolutionary process that integrates human interests of animal breeding with innate mate choice by the animal.	[Tiemann, Inga] Poultry Res Ctr, Bruno Durigen Inst, Rommerskirchen, Germany; [Tiemann, Inga; Rehkaemper, Gerd] Univ Dusseldorf, Inst Anat, Res Grp Comparat Neurobiol & Evolutionary Res, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Tiemann, I (corresponding author), Poultry Res Ctr, Bruno Durigen Inst, Rommerskirchen, Germany.	tiemanni@uni-duesseldorf.de	Tiemann, Inga/AAF-8365-2021	Tiemann, Inga/0000-0002-3607-4453	German Research Foundation [RE 635/6 2]	German Research Foundation(German Research Foundation (DFG))	The project was supported by the German Research Foundation, RE 635/6 2 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, SEXUAL SELECTION; [Anonymous], 1963, ANIMAL SPECIES EVOLU; BATESON P, 1978, NATURE, V273, P659, DOI 10.1038/273659a0; Bateson P., 1983, MATE CHOICE; Birkhead TR, 1992, SPERM COMPETITION BI; Bleed P, 2006, EVOL ANTHROPOL, V15, P8, DOI 10.1002/evan.20084; Bolhuis JJ, 1999, BEHAV BRAIN RES, V98, P245, DOI 10.1016/S0166-4328(98)00090-4; BROTHWELL D, 1979, J ARCHAEOL SCI, V6, P291, DOI 10.1016/0305-4403(79)90007-4; CLAYTON NS, 1990, PHILOS T R SOC B, V330, P351, DOI 10.1098/rstb.1990.0205; Cooke F., 1983, P279; Coyne J.A., 2004, SPECIATION; Crawford R.D, 1990, POULTRY BREEDING GEN; d'Udine B., 1983, P311; Darwin C, 1859, ORIGIN SPECIES MEANS; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Dytham C, 2003, CHOOSING USING STAT; Fisher A. E., 1957, Behaviour, V10, P309; Fisher R.A., 1930, GEN THEORY NATURAL S; Frahm HD, 1998, BRAIN BEHAV EVOLUT, V52, P292, DOI 10.1159/000006574; Freeman S., 2007, EVOLUTIONARY ANAL; FUMIHITO A, 1994, P NATL ACAD SCI USA, V91, P12505, DOI 10.1073/pnas.91.26.12505; Gleason JM, 1998, EVOLUTION, V52, P1093, DOI [10.2307/2411239, 10.1111/j.1558-5646.1998.tb01836.x]; Gulick JT, 1890, NATURE, V42, P28; Hartl :D. L, 2000, PRIMER POPULATION GE; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; Hauffe HC, 2004, CYTOGENET GENOME RES, V105, P395, DOI 10.1159/000078212; Herre W., 1990, HAUSTIERE ZOOLOGISCH, V2nd ed.; Holveck MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023974; Kirk RE, 1995, EXPT DESIGN; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lijtmaer DA, 2003, EVOLUTION, V57, P1411, DOI 10.1111/j.0014-3820.2003.tb00348.x; LILL A, 1968, Behaviour, V30, P127; LILL A, 1968, BEHAVIOUR, V30, P107, DOI 10.1163/156853967X00280; LILL A, 1965, BEHAVIOUR, V25, P16, DOI 10.1163/156853965X00101; MAYNARDSMITH J, 1980, BEHAV ECOL SOCIOBIOL, V7, P247; MOREJOHN GV, 1968, EVOLUTION, V22, P576, DOI 10.1111/j.1558-5646.1968.tb03993.x; Noor MAF, 2002, TRENDS ECOL EVOL, V17, P153, DOI 10.1016/S0169-5347(02)02452-7; PARKER GA, 1972, J THEOR BIOL, V36, P529, DOI 10.1016/0022-5193(72)90007-0; Price E.O., 2002, ANIMAL DOMESTICATION; Price T, 2008, SPECIATION BIRDS; Price TD, 2002, EVOLUTION, V56, P2083; Provine W. B., 1986, SEWALL WRIGHT EVOLUT; Pryke SR, 2007, J EVOLUTION BIOL, V20, P1512, DOI 10.1111/j.1420-9101.2007.01332.x; Rehkamper G, 2008, BRAIN BEHAV EVOLUT, V71, P115, DOI 10.1159/000111458; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; SAMBRAUS HH, 1980, ARCH GEFLUGELKD, V44, P200; Sawai H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010639; Schutz F., 1965, Zeitschrift fuer Tierpsychologie, V22, P50; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; SMITH JM, 1978, EVOLUTION SEX; ten Cate C, 2006, CURR BIOL, V16, P1128, DOI 10.1016/j.cub.2006.03.068; TENCATE C, 1988, EVOLUTION, V42, P1355, DOI 10.1111/j.1558-5646.1988.tb04196.x; Tiemann I, 2009, POULTRY SCI, V88, P1948, DOI 10.3382/ps.2008-00250; Tiemann I, 2008, BRAIN RES BULL, V76, P300, DOI 10.1016/j.brainresbull.2008.03.013; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Turner GF, 1999, REV FISH BIOL FISHER, V9, P281, DOI 10.1023/A:1008903228512; Verzijden MN, 2007, BIOL LETTERS, V3, P134, DOI 10.1098/rsbl.2006.0601; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5; Westneat D.F., 2010, EVOLUTIONARY BEHAV E; Williams D.M., 1983, P297; WRIGHT S, 1978, J ANIM SCI, V46, P1192, DOI 10.2527/jas1978.4651192x; Wright S., 1978, EVOLUTION GENETICS P; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	63	4	4	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e41453	10.1371/journal.pone.0041453	http://dx.doi.org/10.1371/journal.pone.0041453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879889	Green Submitted, Green Published, gold			2022-12-27	WOS:000307810000007
J	Agampodi, S; Agampodi, T; Wickramasinghe, N; Fernando, S; Chathurani, U; Adhikari, W; Dharshika, I; Nugegoda, D; Dharmaratne, S; Newlands, D				Agampodi, Suneth; Agampodi, Thilini; Wickramasinghe, Nuwan; Fernando, Santhushya; Chathurani, Umanga; Adhikari, Wathsala; Dharshika, Ishani; Nugegoda, Dhanaseela; Dharmaratne, Samath; Newlands, David			Productivity Cost Due to Maternal Ill Health in Sri Lanka	PLOS ONE			English	Article							NAUSEA; PREGNANCY; QUALITY; ILLNESS	Background: The global impact of maternal ill health on economic productivity is estimated to be over 15 billion USD per year. Global data on productivity cost associated with maternal ill health are limited to estimations based on secondary data. Purpose of our study was to determine the productivity cost due to maternal ill health during pregnancy in Sri Lanka. Methods and Findings: We studied 466 pregnant women, aged 24 to 36 weeks, residing in Anuradhapura, Sri Lanka. A two stage cluster sampling procedure was used in a cross sectional design and all pregnant women were interviewed at clinic centers, using the culturally adapted Immpact tool kit for productivity cost assessment. Of the 466 pregnant women studied, 421 (90.3%) reported at least one ill health condition during the pregnancy period, and 353 (83.8%) of them had conditions affecting their daily life. Total incapacitation requiring another person to carry out all their routine activities was reported by 122 (26.1%) of the women. In this study sample, during the last episode of ill health, total number of days lost due to absenteeism was 3,356 (32.9% of total loss) and the days lost due to presenteeism was 6,832.8 (67.1% of the total loss). Of the 353 women with ill health conditions affecting their daily life, 280 (60%) had coping strategies to recover loss of productivity. Of the coping strategies used to recover productivity loss during maternal ill health, 76.8% (n = 215) was an intra-household adaptation, and 22.8% (n = 64) was through social networks. Loss of productivity was 28.9 days per episode of maternal ill health. The mean productivity cost due to last episode of ill health in this sample was Rs. 8,444.26 (95% CI-Rs.6888.74-Rs.9999.78). Conclusions: Maternal ill health has a major impact on household productivity and economy. The major impact is due to, generally ignored minor ailments during pregnancy.	[Agampodi, Suneth; Agampodi, Thilini; Wickramasinghe, Nuwan; Fernando, Santhushya; Chathurani, Umanga; Adhikari, Wathsala; Dharshika, Ishani; Nugegoda, Dhanaseela] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Community Med, Saliyapura, Sri Lanka; [Dharmaratne, Samath] Univ Peradeniya, Fac Med, Dept Community Med, Peradeniya, Sri Lanka; [Newlands, David] Univ Aberdeen, Dept Econ, Aberdeen AB9 1FX, Scotland	Rajarata University of Sri Lanka; University of Peradeniya; University of Aberdeen	Agampodi, S (corresponding author), Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Community Med, Saliyapura, Sri Lanka.	sunethagampodi@yahoo.com	Wickramasinghe, Nuwan Darshana/I-3578-2019; Agampodi, Thilini/AAN-5396-2021; Agampodi, Suneth/G-3320-2012	Wickramasinghe, Nuwan Darshana/0000-0001-6025-6022; Agampodi, Thilini/0000-0002-7977-6578; Agampodi, Suneth/0000-0001-7810-1774	Maternal Health Task Force of Engender Health [GMH-106-01]	Maternal Health Task Force of Engender Health	This study was funded by the Maternal Health Task Force (http://maternalhealthtaskforce.org/) of Engender Health (Grant GMH-106-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard CL, 2002, AM J OBSTET GYNECOL, V186, pS220, DOI 10.1067/mob.2002.122605; Bamigboye AA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001066.pub2; Chou FH, 2008, INT J NURS STUD, V45, P1185, DOI 10.1016/j.ijnurstu.2007.08.004; FORTNEY JA, 1987, STUD FAMILY PLANN, V18, P109, DOI 10.2307/1966702; Gill K, 2007, WOM DEL C LOND, P1; Gill SK, 2009, CAN J GASTROENTEROL, V23, P270, DOI 10.1155/2009/678514; Islam MK, 2006, CS20061015; Koken G, 2008, J PSYCHOSOM OBST GYN, V29, P91, DOI 10.1080/01674820701733697; Lacasse A, 2008, BJOG-INT J OBSTET GY, V115, P1484, DOI 10.1111/j.1471-0528.2008.01891.x; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Matthews A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007575.pub2; OBRIEN B, 1992, BIRTH-ISS PERINAT C, V19, P138, DOI 10.1111/j.1523-536X.1992.tb00671.x; Padma GR, 2004, MATERNAL MORBIDITY R; Piwko C, 2005, VALUE HEALTH, V8, P303, DOI 10.1016/S1098-3015(10)62780-5; Piwko C, 2007, CURR MED RES OPIN, V23, P833, DOI 10.1185/030079907X178739; Rizzo JA, 1998, MED CARE, V36, P1471, DOI 10.1097/00005650-199810000-00006; Schultz AB, 2009, PHARMACOECONOMICS, V27, P365, DOI 10.2165/00019053-200927050-00002; Sumathipala A., 2000, INT J METH PSYCH RES, V9, P87, DOI DOI 10.1002/MPR.83; Swallow B L, 2004, J Obstet Gynaecol, V24, P28; University of Aberdeen, 2007, EC COSTS CONS PROD C; World Health Organization, 2008, GLOB BURD DIS 2004 U; Young G L, 2002, Cochrane Database Syst Rev, pCD000121	22	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42333	10.1371/journal.pone.0042333	http://dx.doi.org/10.1371/journal.pone.0042333			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22879943	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100070
J	Arroyo-Villa, I; Bautista-Caro, MB; Balsa, A; Aguado-Acin, P; Nuno, L; Bonilla-Hernan, MG; Puig-Kroer, A; Martin-Mola, E; Miranda-Carus, ME				Arroyo-Villa, Irene; Bautista-Caro, Maria-Belen; Balsa, Alejandro; Aguado-Acin, Pilar; Nuno, Laura; Bonilla-Hernan, Maria-Gema; Puig-Kroeger, Amaya; Martin-Mola, Emilio; Miranda-Carus, Maria-Eugenia			Frequency of Th17 CD4+T Cells in Early Rheumatoid Arthritis: A Marker of Anti-CCP Seropositivity	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; T-HELPER-CELLS; BONE EROSION; JOINT INFLAMMATION; INTERLEUKIN-17; DISEASE; IL-17; LYMPHOCYTES; RESPONSES	Objective: To examine the frequency and phenotype of Th17 cells in the peripheral blood of early RA (eRA) patients. Methods: CD4+ T cells were isolated from the peripheral blood of 33 eRA patients, 20 established RA patients and 53 healthy controls (HC), and from the synovial fluid of 20 established RA patients (RASF), by ficoll-hypaque gradient and magnetical negative selection. After polyclonal stimulation, the frequency of Th17 and Th1 cells was determined by flow cytometry and concentrations of IL-17, IFN-gamma, TNF-alpha and IL-10 were measured by ELISA in cell-free supernatants. Results: When all of our eRA patients were analyzed together, a significantly lower percentage of circulating Th17 cells and a lower CD4-derived IL-17 secretion were observed in comparison with HC. However, after stratifying by anti-CCP antibody status, circulating Th17 cells were decreased in anti-CCP(+) but not in anti-CCP(-)-eRA. All Th17 cells were CD45RO+CD45RA-and CCR6+. Dual Th17/Th1 cells were also exclusively decreased in anti-CCP(+)-eRA. Circulating Th17 and Th17/Th1 cells were negatively correlated with anti-CCP titres. When anti-CCP(+)-eRA patients were retested one year after initiating treatment with oral methotrexate, their circulating Th17 frequency was no longer different from HC. Of note, the percentage of circulating Th1 cells and the secretion of CD4-derived IFN-gamma, TNF-alpha and IL-10 were not different between eRA patients and HC. In established RA patients, circulating Th17 and T17/Th1 cell frequencies were comparable to HC. In RASF, both Th17 and Th1 cells were increased when compared with blood of eRA patients, established RA patients and HC. Conclusion: Decreased circulating Th17 levels in eRA seem to be a marker of anti-CCP seropositivity, and return to levels observed in healthy controls after treatment with methotrexate.	[Arroyo-Villa, Irene; Bautista-Caro, Maria-Belen; Balsa, Alejandro; Aguado-Acin, Pilar; Nuno, Laura; Bonilla-Hernan, Maria-Gema; Martin-Mola, Emilio; Miranda-Carus, Maria-Eugenia] Hosp Univ La Paz IdiPaz, Dept Rheumatol, Madrid, Spain; [Puig-Kroeger, Amaya] Hosp Gen Univ Gregorio Maranon, Lab Inmunooncol, Madrid, Spain	Hospital Universitario La Paz; General University Gregorio Maranon Hospital	Arroyo-Villa, I (corresponding author), Hosp Univ La Paz IdiPaz, Dept Rheumatol, Madrid, Spain.	mmiranda.hulp@salud.madrid.org	Balsa, Alejandro/ABF-6456-2020; Miranda-Carus, Maria-Eugenia/S-7403-2019; Puig, Amaya/B-6164-2015	Puig, Amaya/0000-0003-2943-9757	Ministerio de Ciencia e Innovacion [SAF 2009-07100]; RETICS Program (RIER) from "Instituto de Salud Carlos III" (ISCIII) [RD08/0075]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); RETICS Program (RIER) from "Instituto de Salud Carlos III" (ISCIII)	This work was supported by Ministerio de Ciencia e Innovacion grant SAF 2009-07100, (http://www.idi.mineco.gob.es/portal/site/MICINN) and by RETICS Program, RD08/0075 (RIER) from "Instituto de Salud Carlos III" (ISCIII) (http://www.isciii.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Aerts NE, 2010, RHEUMATOLOGY, V49, P2264, DOI 10.1093/rheumatology/keq224; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Balsa A, 2004, J RHEUMATOL, V31, P40; Buckland Jenny, 2011, Nat Rev Rheumatol, V7, P311, DOI 10.1038/nrrheum.2011.69; Bush KA, 2002, ARTHRITIS RHEUM-US, V46, P802, DOI 10.1002/art.10173; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Daha NA, 2011, NAT REV RHEUMATOL, V7, P203, DOI 10.1038/nrrheum.2011.28; Davis LS, 2001, ARTHRITIS RES, V3, P54, DOI 10.1186/ar140; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; Firestein GS, 2005, ARTHRITIS RES THER, V7, P157, DOI 10.1186/ar1780; Fox DA, 1997, ARTHRITIS RHEUM, V40, P598, DOI 10.1002/art.1780400403; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Genovese MC, 2011, ARTHRITIS RHEUM-US, V63, pS1017; Genovese MC, 2011, ARTHRITIS RHEUM-US, V63, pS149; Gullick NJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012516; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Ito Y, 2009, ARTHRITIS RHEUM-US, V60, P2294, DOI 10.1002/art.24687; KONTTINEN YT, 1990, CLIN RHEUMATOL, V9, P325, DOI 10.1007/BF02114392; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2003, J IMMUNOL, V170, P2655, DOI 10.4049/jimmunol.170.5.2655; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nistala K, 2008, ARTHRITIS RHEUM-US, V58, P875, DOI 10.1002/art.23291; Notley CA, 2008, J EXP MED, V205, P2491, DOI 10.1084/jem.20072707; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Plater-Zyberk C, 2009, ANN RHEUM DIS, V68, P721, DOI 10.1136/ard.2007.085431; Pollinger B, 2011, J IMMUNOL, V186, P2602, DOI 10.4049/jimmunol.1003370; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; Sarkar S, 2010, RHEUM DIS CLIN N AM, V36, P345, DOI 10.1016/j.rdc.2010.02.006; Shahrara S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2477; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Stamp LK, 2009, J RHEUMATOL, V36, P2403, DOI 10.3899/jrheum.081304; Suurmond J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3466; Syversen SW, 2010, ANN RHEUM DIS, V69, P345, DOI 10.1136/ard.2009.113092; van Hamburg JP, 2011, ARTHRITIS RHEUM-US, V63, P73, DOI 10.1002/art.30093; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	40	35	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42189	10.1371/journal.pone.0042189	http://dx.doi.org/10.1371/journal.pone.0042189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870298	gold, Green Submitted, Green Published			2022-12-27	WOS:000307284100051
J	Magosso, E; Cuppini, C; Ursino, M				Magosso, Elisa; Cuppini, Cristiano; Ursino, Mauro			A Neural Network Model of Ventriloquism Effect and Aftereffect	PLOS ONE			English	Article							AUDITORY SPATIAL PERCEPTION; CROSS-MODAL BIAS; MULTISENSORY INTEGRATION; MACAQUE MONKEY; SUPERIOR COLLICULUS; BAYESIAN-INFERENCE; POPULATION CODES; MOTOR CORTEX; LOCALIZATION; PLASTICITY	Presenting simultaneous but spatially discrepant visual and auditory stimuli induces a perceptual translocation of the sound towards the visual input, the ventriloquism effect. General explanation is that vision tends to dominate over audition because of its higher spatial reliability. The underlying neural mechanisms remain unclear. We address this question via a biologically inspired neural network. The model contains two layers of unimodal visual and auditory neurons, with visual neurons having higher spatial resolution than auditory ones. Neurons within each layer communicate via lateral intra-layer synapses; neurons across layers are connected via inter-layer connections. The network accounts for the ventriloquism effect, ascribing it to a positive feedback between the visual and auditory neurons, triggered by residual auditory activity at the position of the visual stimulus. Main results are: i) the less localized stimulus is strongly biased toward the most localized stimulus and not vice versa; ii) amount of the ventriloquism effect changes with visual-auditory spatial disparity; iii) ventriloquism is a robust behavior of the network with respect to parameter value changes. Moreover, the model implements Hebbian rules for potentiation and depression of lateral synapses, to explain ventriloquism aftereffect (that is, the enduring sound shift after exposure to spatially disparate audio-visual stimuli). By adaptively changing the weights of lateral synapses during cross-modal stimulation, the model produces post-adaptive shifts of auditory localization that agree with in-vivo observations. The model demonstrates that two unimodal layers reciprocally interconnected may explain ventriloquism effect and aftereffect, even without the presence of any convergent multimodal area. The proposed study may provide advancement in understanding neural architecture and mechanisms at the basis of visual-auditory integration in the spatial realm.	[Magosso, Elisa; Cuppini, Cristiano; Ursino, Mauro] Univ Bologna, Dept Elect Comp Sci & Syst, Bologna, Italy	University of Bologna	Magosso, E (corresponding author), Univ Bologna, Dept Elect Comp Sci & Syst, Bologna, Italy.	elisa.magosso@unibo.it	Ursino, Mauro/AAE-7389-2020; Cuppini, Cristiano/K-7814-2018	Ursino, Mauro/0000-0002-0911-0308; Cuppini, Cristiano/0000-0002-6529-2599; Magosso, Elisa/0000-0002-4673-2974				Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; [Anonymous], 1998, NEURAL NETWORKS BRAI; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BERTELSON P, 1981, PERCEPT PSYCHOPHYS, V29, P578, DOI 10.3758/BF03207374; Bertelson P, 2006, PERCEPT PSYCHOPHYS, V68, P428, DOI 10.3758/BF03193687; Bertini C, 2010, EUR J NEUROSCI, V31, P1791, DOI 10.1111/j.1460-9568.2010.07200.x; Bolognini N, 2007, PERCEPTION, V36, P1477, DOI 10.1068/p5846; Bonath B, 2007, CURR BIOL, V17, P1697, DOI 10.1016/j.cub.2007.08.050; Bruns P, 2011, EXP BRAIN RES, V209, P333, DOI 10.1007/s00221-011-2543-0; Burr D, 2006, PROG BRAIN RES, V155, P243, DOI 10.1016/S0079-6123(06)55014-9; CRICK F, 1989, NATURE, V337, P129, DOI 10.1038/337129a0; Cuppini C, 2011, EXP BRAIN RES, V213, P341, DOI 10.1007/s00221-011-2714-z; Cuppini C, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00006; Dayan P, 2001, PLASTICITY LEARNING, P153; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Frissen I, 2005, ACTA PSYCHOL, V118, P93, DOI 10.1016/j.actpsy.2004.10.004; Frissen I, 2003, ACTA PSYCHOL, V113, P315, DOI 10.1016/S0001-6918(03)00043-X; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GEORGOPOULOS AP, 1993, SCIENCE, V260, P47, DOI 10.1126/science.8465199; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Hairston WD, 2003, J COGNITIVE NEUROSCI, V15, P20, DOI 10.1162/089892903321107792; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Lewald J, 2002, LEARN MEMORY, V9, P268, DOI 10.1101/lm.51402; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Magosso E, 2008, NEURAL NETWORKS, V21, P817, DOI 10.1016/j.neunet.2008.06.003; Magosso E, 2010, IEEE T INF TECHNOL B, V14, P598, DOI 10.1109/TITB.2010.2040750; Magosso E, 2010, NEUROPSYCHOLOGIA, V48, P812, DOI 10.1016/j.neuropsychologia.2009.09.037; Magosso E, 2010, NEURAL COMPUT, V22, P190, DOI 10.1162/neco.2009.01-08-694; Martuzzi R, 2007, CEREB CORTEX, V17, P1672, DOI 10.1093/cercor/bhl077; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; Passamonti C, 2009, EUR J NEUROSCI, V30, P1141, DOI 10.1111/j.1460-9568.2009.06910.x; RADEAU M, 1987, PSYCHOL RES-PSYCH FO, V49, P17, DOI 10.1007/BF00309198; RADEAU M, 1977, PERCEPT PSYCHOPHYS, V22, P137, DOI 10.3758/BF03198746; RAJAN R, 1990, J NEUROPHYSIOL, V64, P888, DOI 10.1152/jn.1990.64.3.888; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Recanzone GH, 1998, P NATL ACAD SCI USA, V95, P869, DOI 10.1073/pnas.95.3.869; Recanzone GH, 2008, ANNU REV PSYCHOL, V59, P119, DOI 10.1146/annurev.psych.59.103006.093544; Recanzone GH, 2009, HEARING RES, V258, P89, DOI 10.1016/j.heares.2009.04.009; Rolls ET, 2002, COMPUTATIONAL NEUROS; Sato Y, 2007, NEURAL COMPUT, V19, P3335, DOI 10.1162/neco.2007.19.12.3335; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Stein BE., 1993, MERGING SENSES; TREVES A, 1993, NETWORK-COMP NEURAL, V4, P259, DOI 10.1088/0954-898X/4/3/002; Ursino M, 2009, J COMPUT NEUROSCI, V26, P55, DOI 10.1007/s10827-008-0096-4; van Ooyen A, 2011, NAT REV NEUROSCI, V12, P311, DOI 10.1038/nrn3031; VOGELS R, 1990, J NEUROSCI, V10, P3543; Wallace MT, 2004, EXP BRAIN RES, V158, P252, DOI 10.1007/s00221-004-1899-9; Weisswange TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021575; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Witten IB, 2005, NEURON, V48, P489, DOI 10.1016/j.neuron.2005.10.020; Witten IB, 2008, J NEUROPHYSIOL, V100, P1067, DOI 10.1152/jn.00013.2008; Woods TM, 2006, J NEUROPHYSIOL, V96, P3323, DOI 10.1152/jn.00392.2006; Woods TM, 2004, CURR BIOL, V14, P1559, DOI 10.1016/j.cub.2004.08.059; Wozny DR, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00075	58	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42503	10.1371/journal.pone.0042503	http://dx.doi.org/10.1371/journal.pone.0042503			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880007	gold, Green Submitted, Green Published			2022-12-27	WOS:000307284100112
J	Singh, RR; Jefferies, AJ; Lankadeva, YR; Lombardo, P; Schneider-Kolsky, M; Hilliard, L; Denton, KM; Moritz, KM				Singh, Reetu R.; Jefferies, Andrew J.; Lankadeva, Yugeesh R.; Lombardo, Paul; Schneider-Kolsky, Michal; Hilliard, Lucinda; Denton, Kate M.; Moritz, Karen M.			Increased Cardiovascular and Renal Risk Is Associated with Low Nephron Endowment in Aged Females: An Ovine Model of Fetal Unilateral Nephrectomy	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; NITRIC-OXIDE SYSTEM; BLOOD-PRESSURE; PRENATAL DEXAMETHASONE; ANGIOTENSIN-II; MALE SHEEP; FUNCTIONAL RESERVE; ARTERIAL-PRESSURE; HYPERTENSIVE-RATS; SEXUAL-DIMORPHISM	Previously we have shown that ovariectomised (OVX) female sheep have reduced renal function and elevated blood pressure from 6 months of age following fetal uninephrectomy (uni-x) at 100 days of gestation (term = 150 days). In the current study we examined if in intact female sheep the onset of decline in renal function and elevation in blood pressure was prevented. Studies were performed at 1 year, 2 and 5 years of age. Following fetal uni-x at 100 days, intact female sheep had similar to 30% reduction in glomerular filtration rate (GFR) at 1 year, which did not exacerbate with age (P-treatment = 0.0001, P-age = 0.7). In contrast renal blood flow was similar between the treatment groups at 1 year of age but had declined in the uni-x animals at 5 years of age (P-treatment (x) (age) = 0.046). Interestingly, intact uni-x sheep did not develop elevations in arterial pressure until 2 years of age. Furthermore, uni-x animals had a similar capacity to respond to a cardiac challenge at 1 year and 2 years of age, however, cardiac functional reserve was significantly reduced compared to sham group at 5 years of age. Uni-x animals exhibited an increase in left ventricular dimensions at 5 years of age compared to the sham animals and compared to 2 years of age (P-treatment <0.001, P-treatment (x age) <0.001). In conclusion, the onset of renal dysfunction preceded the onset of hypertension in intact female uni-x sheep. Furthermore, this study showed that the intact females are protected from the impact of a reduced nephron endowment on cardiovascular health early in life as opposed to our findings in young male sheep and OVX uni-x female sheep. However, with ageing this protection is lost as evidenced by presence of left ventricular hypertrophy and impaired cardiac function in 5 year old uni-x female sheep.	[Singh, Reetu R.; Jefferies, Andrew J.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Singh, Reetu R.; Lankadeva, Yugeesh R.; Hilliard, Lucinda; Denton, Kate M.] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia; [Lombardo, Paul; Schneider-Kolsky, Michal] Monash Univ, Dept Med Imaging & Radiat Sci, Clayton, Vic 3800, Australia; [Singh, Reetu R.; Moritz, Karen M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia	Monash University; Monash University; Monash University; University of Queensland	Singh, RR (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia.	r.singh7@uq.edu.au	Lankadeva, Yugeesh/R-9253-2019; Moritz, Karen/G-2508-2015; Denton, Kate/AAG-2423-2019	Lankadeva, Yugeesh/0000-0002-3589-9111; Moritz, Karen/0000-0002-8085-0034; Lombardo, Paul/0000-0003-2519-3358; Schneider, Michal/0000-0002-5521-3455; Krause, Lucinda/0000-0002-8634-6568; Denton, Kate/0000-0002-5929-4387	National Heart Foundation Grant [G 05M 2110]; Monash University Research Fund; Australian Postgraduate Award; Monash University, Faculty of Medicine, Nursing and Health Sciences Bridging Post-Doctoral Fellowship; National Health and Medical Research Council (NHMRC)	National Heart Foundation Grant(National Heart Foundation of Australia); Monash University Research Fund(Monash University); Australian Postgraduate Award(Australian Government); Monash University, Faculty of Medicine, Nursing and Health Sciences Bridging Post-Doctoral Fellowship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported by a National Heart Foundation Grant (G 05M 2110) and Monash University Research Fund. RS was supported by an Australian Postgraduate Award and Monash University, Faculty of Medicine, Nursing and Health Sciences Bridging Post-Doctoral Fellowship. KM was supported by an National Health and Medical Research Council (NHMRC) Career Development Award and by an (NHMRC) Senior Research Fellowship and KD was supported by an NHMRC Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2002, AM J PHYSIOL-RENAL, V283, pF236, DOI 10.1152/ajprenal.00336.2001; Alexander BT, 2006, AM J PHYSIOL-REG I, V290, pR1, DOI 10.1152/ajpregu.00417.2005; [Anonymous], 2011, BAS INF SHEEP, P1; Bagby SP, 2007, J NUTR, V137, P1066, DOI 10.1093/jn/137.4.1066; Baylis C, 2005, EXP GERONTOL, V40, P271, DOI 10.1016/j.exger.2005.01.008; BAYLIS C, 1994, J CLIN INVEST, V94, P1823, DOI 10.1172/JCI117531; Baylis C, 2009, NAT REV NEPHROL, V5, P384, DOI 10.1038/nrneph.2009.90; Bensley JG, 2010, EUR HEART J, V31, P2058, DOI 10.1093/eurheartj/ehq104; Berg UB, 2006, NEPHROL DIAL TRANSPL, V21, P2577, DOI 10.1093/ndt/gfl227; Blantz RC, 2002, KIDNEY INT, V61, P782, DOI 10.1046/j.1523-1755.2002.00220.x; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Brenner BM, 1997, KIDNEY INT, pS124; Celsi G, 1998, PEDIATR RES, V44, P317, DOI 10.1203/00006450-199809000-00009; Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56; Dalshaug GB, 2000, AM J PHYSIOL-HEART C, V282, pH1359; Dodic M, 2001, CIRC RES, V89, P623, DOI 10.1161/hh1901.097086; Dodic M, 2002, HYPERTENSION, V40, P729, DOI 10.1161/01.HYP.0000036455.62159.7E; Dodic M, 1998, CLIN SCI, V94, P149, DOI 10.1042/cs0940149; Douglas-Denton R, 2002, J AM SOC NEPHROL, V13, P406, DOI 10.1681/ASN.V132406; Epstein M, 1996, J AM SOC NEPHROL, V7, P1106; Fliser D, 1997, KIDNEY INT, V51, P1196, DOI 10.1038/ki.1997.163; Fontanet HL, 1996, AM J CARDIOL, V78, P1029, DOI 10.1016/S0002-9149(96)00592-9; Gades MD, 1998, KIDNEY INT, V53, P130, DOI 10.1046/j.1523-1755.1998.00746.x; Gava AL, 2011, BRAZ J MED BIOL RES, V44, P905, DOI 10.1590/S0100-879X2011000900012; Gibson KJ, 1999, CLIN EXP PHARMACOL P, V26, P765, DOI 10.1046/j.1440-1681.1999.03127.x; Gray SP, 2010, J AM SOC NEPHROL, V21, P1891, DOI 10.1681/ASN.2010040368; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Hamilton CA, 2006, AM J HYPERTENS, V19, P859, DOI 10.1016/j.amjhyper.2006.01.008; Hilliard LM, 2011, HYPERTENSION, V57, P275, DOI 10.1161/HYPERTENSIONAHA.110.166827; Huang A, 2004, MICROCIRCULATION, V11, P9, DOI 10.1080/10739680490266162; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Huxley VH, 2007, ADV PHYSIOL EDUC, V31, P17, DOI 10.1152/advan.00099.2006; Jonker SS, 2007, J APPL PHYSIOL, V102, P1130, DOI 10.1152/japplphysiol.00937.2006; Kett MM, 2011, AM J PHYSL REGUL INT; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; Mahmoodzadeh S, 2010, CARDIOVASC RES, V85, P719, DOI 10.1093/cvr/cvp350; Mitchell Kenneth D., 1995, P1437; Moritz KM, 2005, KIDNEY INT, V67, P822, DOI 10.1111/j.1523-1755.2005.00147.x; Moritz KM, 2002, HYPERTENSION, V39, P1071, DOI 10.1161/01.HYP.0000019131.77075.54; Mulatero P, 2007, CLIN ENDOCRINOL, V67, P324, DOI 10.1111/j.1365-2265.2007.02898.x; Nielsen CB, 2003, J AM SOC NEPHROL, V14, P3102, DOI 10.1097/01.ASN.0000096262.18679.25; Ojeda NB, 2007, HYPERTENSION, V50, P679, DOI 10.1161/HYPERTENSIONAHA.107.091785; Okuniewski R, 1998, CLIN SCI, V95, P445, DOI 10.1042/CS19970303; OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8; Ortiz LA, 2003, HYPERTENSION, V41, P328, DOI 10.1161/01.HYP.0000049763.51269.51; Ortiz LA, 2001, KIDNEY INT, V59, P1663, DOI 10.1046/j.1523-1755.2001.0590051663.x; PecinsThompson M, 1997, AM J PHYSIOL-REG I, V272, pR377, DOI 10.1152/ajpregu.1997.272.1.R377; Reckelhoff JF, 2008, GENDER MED, V5, pS1, DOI 10.1016/j.genm.2008.03.001; Rumball CWH, 2008, PLACENTA, V29, P89, DOI 10.1016/j.placenta.2007.09.004; Sampson AK, 2008, HYPERTENSION, V52, P666, DOI 10.1161/HYPERTENSIONAHA.108.114058; Schreuder MF, 2008, J PAEDIATR CHILD H, V44, P363, DOI 10.1111/j.1440-1754.2008.01315.x; Silbiger SR, 2011, KIDNEY INT, V79, P382, DOI 10.1038/ki.2010.474; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; Singh RR, 2011, AM J PHYSIOL-RENAL, V301, pF1168, DOI 10.1152/ajprenal.00463.2011; Singh RR, 2011, AM J PHYSIOL-RENAL, V301, pF319, DOI 10.1152/ajprenal.00139.2011; Singh RR, 2010, CLIN SCI, V118, P669, DOI 10.1042/CS20090479; Singh RR, 2009, J HYPERTENS, V27, P386, DOI 10.1097/HJH.0b013e32831bc778; Stefanelli CB, 2004, MOL GENET METAB, V83, P188, DOI 10.1016/j.ymgme.2004.04.013; Stier CT, 2003, AM J PHYSIOL-ENDOC M, V285, pE232, DOI 10.1152/ajpendo.00029.2003; THOMAS GB, 1988, AUST J BIOL SCI, V41, P303, DOI 10.1071/BI9880303; Wintour EM, 2003, J PHYSIOL-LONDON, V549, P929, DOI 10.1113/jphysiol.2003.042408; Witt H, 2008, J MOL MED, V86, P1013, DOI 10.1007/s00109-008-0385-4; Wlodek ME, 2007, J AM SOC NEPHROL, V18, P1688, DOI 10.1681/ASN.2007010015; Woods LL, 2005, AM J PHYSIOL-REG I, V289, pR955, DOI 10.1152/ajpregu.00455.2004; Woods LL, 2001, PEDIATR RES, V49, P460, DOI 10.1203/00006450-200104000-00005; Yamaleyeva LM, 2007, AM J PHYSIOL-HEART C, V293, pH2064, DOI 10.1152/ajpheart.00427.2007	67	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42400	10.1371/journal.pone.0042400	http://dx.doi.org/10.1371/journal.pone.0042400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879965	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100079
J	Cummings, DO; Buhl, J; Lee, RW; Simpson, SJ; Holmes, SP				Cummings, David O.; Buhl, Jerome; Lee, Raymond W.; Simpson, Stephen J.; Holmes, Sebastian P.			Estimating Niche Width Using Stable Isotopes in the Face of Habitat Variability: A Modelling Case Study in the Marine Environment	PLOS ONE			English	Article							TROPHIC POSITION; SERIOLA-DUMERILI; MIXING MODELS; FOOD-WEB; DIET; DELTA-C-13; MIGRATION; PREY; SEA; INFORMATION	Distributions of stable isotopes have been used to infer an organism's trophic niche width, the 'isotopic niche', and examine resource partitioning. Spatial variation in the isotopic composition of prey may however confound the interpretation of isotopic signatures especially when foragers exploit resources across numerous locations. In this study the isotopic compositions from marine assemblages are modelled to determine the role of variation in the signature of prey items and the effect of dietary breadth and foraging strategies on predator signatures. Outputs from the models reveal that isotopic niche widths can be greater for populations of dietary specialists rather than for generalists, which contravenes what is generally accepted in the literature. When a range of different mixing models are applied to determine if the conversion from delta to p-space can be used to improve model accuracy, predator signature variation is increased rather than model precision. Furthermore the mixing models applied failed to correctly identify dietary specialists and/or to accurately estimate diet contributions that may identify resource partitioning. The results presented illustrate the need to collect sufficiently large sample sizes, in excess of what is collected under most current studies, across the complete distribution of a species and its prey, before attempts to use stable isotopes to make inferences about niche width can be made.	[Cummings, David O.; Buhl, Jerome; Simpson, Stephen J.; Holmes, Sebastian P.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Lee, Raymond W.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Holmes, Sebastian P.] Univ Western Sydney, Sch Nat Sci, Penrith, NSW 1797, Australia; [Cummings, David O.] Cardno NSW ACT Pty Ltd, Cardno Ecol Lab, St Leonards, NSW, Australia	University of Sydney; Washington State University; Western Sydney University	Cummings, DO (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	davidocummings@hotmail.com	Buhl, Jerome/AAE-1687-2020	Buhl, Jerome/0000-0002-7506-6835; Holmes, Sebastian/0000-0003-2101-376X; Simpson, Stephen J./0000-0003-0256-7687	Australian Research Council (ARC) [ARC LP0775183]; ARC	Australian Research Council (ARC)(Australian Research Council); ARC(Australian Research Council)	This research was funded by the Australian Research Council (ARC) linkage grant ARC LP0775183 and constitutes a portion of the Ph.D. thesis of DOC. SJS was funded by an ARC Laureate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andaloro F, 1997, CAH BIOL MAR, V38, P91; Araujo MS, 2007, OECOLOGIA, V152, P643, DOI 10.1007/s00442-007-0687-1; Aurioles-Gamboa D, 2009, J MAMMAL, V90, P1410, DOI 10.1644/08-MAMM-A-209R2.1; Barnes C, 2008, OECOLOGIA, V155, P227, DOI 10.1007/s00442-007-0904-y; Barreiros JP, 2003, CYBIUM, V27, P37; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Behmer ST, 2003, ANIM BEHAV, V66, P665, DOI 10.1006/anbe.2003.2243; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; Burke CM, 2009, J ZOOL, V278, P354, DOI 10.1111/j.1469-7998.2009.00584.x; Burton RK, 1999, OECOLOGIA, V119, P578, DOI 10.1007/s004420050822; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chen G, 2011, LIMNOLOGY, V12, P151, DOI 10.1007/s10201-010-0332-2; Cherel Y, 2008, MAR ECOL PROG SER, V366, P281, DOI 10.3354/meps07587; Costa GC, 2009, ECOLOGY, V90, P2014, DOI 10.1890/08-1150.1; Cummings DO, 2011, J EXP MAR BIOL ECOL, V409, P186, DOI 10.1016/j.jembe.2011.08.021; Cummings DO, 2010, MAR ECOL PROG SER, V419, P211, DOI 10.3354/meps08827; Darimont CT, 2007, BIOL J LINN SOC, V90, P125, DOI 10.1111/j.1095-8312.2007.00716.x; Doi H, 2010, LIMNOLOGY, V11, P185, DOI 10.1007/s10201-009-0297-1; Erhardt EB, 2010, SISUS STABLE ISOTOPE; Feranec RS, 2000, PALAEOGEOGR PALAEOCL, V162, P155, DOI 10.1016/S0031-0182(00)00110-3; Flaherty EA, 2010, OIKOS, V119, P1409, DOI 10.1111/j.1600-0706.2010.18259.x; Flaherty EA, 2010, J MAMMAL, V91, P79, DOI 10.1644/09-MAMM-A-014R.1; Frederich B, 2009, ICHTHYOL RES, V56, P10, DOI 10.1007/s10228-008-0053-2; Gillanders BM, 2001, MAR FRESHWATER RES, V52, P179, DOI 10.1071/MF99153; Gross A, 2009, ESTUAR COAST SHELF S, V84, P367, DOI 10.1016/j.ecss.2009.05.017; Hammerschlag-Peyer CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027104; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; KREBS JR, 1974, ANIM BEHAV, V22, P953, DOI 10.1016/0003-3472(74)90018-9; Kristensen DK, 2010, ESTUAR COAST SHELF S, V87, P583, DOI 10.1016/j.ecss.2010.02.016; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lubetkin SC, 2004, J APPL ECOL, V41, P996, DOI 10.1111/j.0021-8901.2004.00957.x; MATALLANAS J, 1995, J MAR BIOL ASSOC UK, V75, P257, DOI 10.1017/S0025315400015356; Matthews B, 2004, OECOLOGIA, V140, P361, DOI 10.1007/s00442-004-1579-2; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mooney KA, 2005, ECOLOGY, V86, P1225, DOI 10.1890/04-0938; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; OBRIEN RG, 1981, PSYCHOL BULL, V89, P570, DOI 10.1037/0033-2909.89.3.570; Olsson K, 2009, FRESHWATER BIOL, V54, P1731, DOI 10.1111/j.1365-2427.2009.02221.x; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; Quinn GP, 2003, EXPT DESIGN DATA ANA; RAU GH, 1982, DEEP-SEA RES, V29, P1035, DOI 10.1016/0198-0149(82)90026-7; Raubenheimer D, 2003, J EXP BIOL, V206, P1669, DOI 10.1242/jeb.00336; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Semmens BX, 2009, ECOL LETT, V12, pE6, DOI 10.1111/j.1461-0248.2009.01283.x; Simpson SJ, 2010, TRENDS ECOL EVOL, V25, P53, DOI 10.1016/j.tree.2009.06.012; SOULE M, 1970, American Naturalist, V104, P85, DOI 10.1086/282642; TANAKA S, 1972, B JPN SOC SCI FISH, V38, P93; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 1998, T AM FISH SOC, V127, P729, DOI 10.1577/1548-8659(1998)127<0729:AOSITT>2.0.CO;2; Willson JD, 2010, OIKOS, V119, P1161, DOI 10.1111/j.1600-0706.2009.17939.x; Wilson RM, 2009, ESTUAR COAST, V32, P999, DOI 10.1007/s12237-009-9183-7; Woo KJ, 2008, J ANIM ECOL, V77, P1082, DOI 10.1111/j.1365-2656.2008.01429.x; Yohannes E, 2008, OECOLOGIA, V158, P299, DOI 10.1007/s00442-008-1138-3; ZOHARY T, 1994, LIMNOL OCEANOGR, V39, P1030, DOI 10.4319/lo.1994.39.5.1030	65	27	28	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e40539	10.1371/journal.pone.0040539	http://dx.doi.org/10.1371/journal.pone.0040539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876280	Green Submitted, Green Published, gold			2022-12-27	WOS:000307184700008
J	Hashimoto, S				Hashimoto, Shoji			A New Estimation of Global Soil Greenhouse Gas Fluxes Using a Simple Data-Oriented Model	PLOS ONE			English	Article							ATMOSPHERIC METHANE; INTERANNUAL VARIABILITY; TERRESTRIAL ECOSYSTEMS; NITROUS-OXIDE; FOREST SOILS; EMISSIONS; N2O; RESPIRATION; TEMPERATURE; UNCERTAINTIES	Soil greenhouse gas fluxes (particularly CO2, CH4, and N2O) play important roles in climate change. However, despite the importance of these soil greenhouse gases, the number of reports on global soil greenhouse gas fluxes is limited. Here, new estimates are presented for global soil CO2 emission (total soil respiration), CH4 uptake, and N2O emission fluxes, using a simple data-oriented model. The estimated global fluxes for CO2 emission, CH4 uptake, and N2O emission were 78 Pg C yr(-1) (Monte Carlo 95% confidence interval, 64-95 Pg C yr(-1)), 18 Tg C yr(-1) (11-23 Tg C yr(-1)), and 4.4 Tg N yr(-1) (1.4-11.1 Tg N yr(-1)), respectively. Tropical regions were the largest contributor of all of the gases, particularly the CO2 and N2O fluxes. The soil CO2 and N2O fluxes had more pronounced seasonal patterns than the soil CH4 flux. The collected estimates, including both the previous and the present estimates, demonstrate that the means of the best estimates from each study were 79 Pg C yr(-1) (291 Pg CO2 yr(-1); coefficient of variation, CV = 13%, N = 6) for CO2, 21 Tg C yr(-1) (29 Tg CH4 yr(-1); CV = 24%, N = 24) for CH4, and 7.8 Tg N yr(-1) (12.2 Tg N2O yr(-1); CV = 38%, N = 11) for N2O. For N2O, the mean of the estimates that was calculated by excluding the earliest two estimates was 6.6 Tg N yr(-1) (10.4 Tg N2O yr(-1); CV = 22%, N = 9). The reported estimates vary and have large degrees of uncertainty but their overall magnitudes are in general agreement. To further minimize the uncertainty of soil greenhouse gas flux estimates, it is necessary to build global databases and identify key processes in describing global soil greenhouse gas fluxes.	Forestry & Forest Prod Res Inst, Dept Forest Site Environm, Tsukuba, Ibaraki 305, Japan	Forestry & Forest Products Research Institute - Japan	Hashimoto, S (corresponding author), Forestry & Forest Prod Res Inst, Dept Forest Site Environm, 1 Matsunosato, Tsukuba, Ibaraki 305, Japan.	shojih@ffpri.affrc.go.jp	Hashimoto, Shoji/C-5785-2011	Hashimoto, Shoji/0000-0003-3022-7495	Forestry and Forest Products Research Institute, Japan; Japan Society for the Promotion of Science KAKENHI [24510025]	Forestry and Forest Products Research Institute, Japan; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Forestry and Forest Products Research Institute, Japan. Also, this work was supported by a grant from the Japan Society for the Promotion of Science KAKENHI (grant number 24510025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASELMANN I, 1989, J ATMOS CHEM, V8, P307, DOI 10.1007/BF00052709; Banin A, 1984, Adv Space Res, V4, P207, DOI 10.1016/0273-1177(84)90564-7; BANIN A, 1986, SCI TOTAL ENVIRON, V55, P27, DOI 10.1016/0048-9697(86)90166-X; Batjes N., 2005, ISRIC WISE GLOBAL DA; Batjes N. H., 1995, HOMOGENIZED SOIL DAT; Bond-Lamberty B, 2010, BIOGEOSCIENCES, V7, P1915, DOI 10.5194/bg-7-1915-2010; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; BORN M, 1990, Tellus Series B Chemical and Physical Meteorology, V42, P2, DOI 10.1034/j.1600-0889.1990.00002.x; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; BOUWMAN AF, 1993, GLOBAL BIOGEOCHEM CY, V7, P557, DOI 10.1029/93GB01186; BOUWMAN AF, 1995, J GEOPHYS RES-ATMOS, V100, P2785, DOI 10.1029/94JD02946; BOWDEN WB, 1986, BIOGEOCHEMISTRY, V2, P249, DOI 10.1007/BF02180161; Chapuis-Lardy L, 2007, GLOBAL CHANGE BIOL, V13, P1, DOI 10.1111/j.1365-2486.2006.01280.x; Curry CL, 2009, BIOGEOSCIENCES, V6, P2355, DOI 10.5194/bg-6-2355-2009; Curry CL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002818; Del Grosso SJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P999, DOI 10.1029/1999GB001226; DORR H, 1993, CHEMOSPHERE, V26, P697, DOI 10.1016/0045-6535(93)90454-D; Dutaur L, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002734; [FAO IFA], 2001, GLOB EST GAS EM NH4; FUNG I, 1991, J GEOPHYS RES-ATMOS, V96, P13033, DOI 10.1029/91JD01247; GLOBALVIEW-CH4, 2009, COOP ATM DAT INT PRO; Hashimoto S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00116; Hashimoto S, 2011, ECOL MODEL, V222, P1283, DOI 10.1016/j.ecolmodel.2011.01.013; Hein R, 1997, GLOBAL BIOGEOCHEM CY, V11, P43, DOI 10.1029/96GB03043; Hirsch AI, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002443; IPCC, 2007, CLIM CHANG 2007 PHYS; Ito A, 2012, BIOGEOSCIENCES, V9, P759, DOI 10.5194/bg-9-759-2012; KING GM, 1994, NATURE, V370, P282, DOI 10.1038/370282a0; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; KREILEMAN GJJ, 1994, WATER AIR SOIL POLL, V76, P231, DOI 10.1007/BF00478341; Lelieveld J, 1998, TELLUS B, V50, P128, DOI 10.1034/j.1600-0889.1998.t01-1-00002.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Morishita T, 2007, SOIL SCI PLANT NUTR, V53, P678, DOI 10.1111/j.1747-0765.2007.00181.x; Mosier AR, 1998, CLIMATIC CHANGE, V40, P39, DOI 10.1023/A:1005338731269; Nevison CD, 1996, CLIMATIC CHANGE, V32, P327, DOI 10.1007/BF00142468; Olivier JGJ, 1998, ENVIRON POLLUT, V102, P135, DOI 10.1016/S0269-7491(98)80026-2; Potter CS, 1996, J GEOPHYS RES-ATMOS, V101, P1361, DOI 10.1029/95JD02028; Potter CS, 1996, CHEMOSPHERE, V32, P2219, DOI 10.1016/0045-6535(96)00119-1; Potter CS, 1998, GLOBAL BIOGEOCHEM CY, V12, P621, DOI 10.1029/98GB02425; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Ridgwell AJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P59, DOI 10.1029/1998GB900004; SAXTON KE, 1986, SOIL SCI SOC AM J, V50, P1031, DOI 10.2136/sssaj1986.03615995005000040039x; SCHLESINGER WH, 1977, ANNU REV ECOL SYST, V8, P51, DOI 10.1146/annurev.es.08.110177.000411; SCHMIDT J, 1988, J ATMOS CHEM, V6, P95, DOI 10.1007/BF00048334; Seiler W., 1987, GEOPHYSIOLOGY AMAZON, P133; Smith KA, 2000, GLOBAL CHANGE BIOL, V6, P791, DOI 10.1046/j.1365-2486.2000.00356.x; Spahni R, 2011, BIOGEOSCIENCES, V8, P1643, DOI 10.5194/bg-8-1643-2011; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Thornton PE, 2000, AGR FOREST METEOROL, V104, P255, DOI 10.1016/S0168-1923(00)00170-2; Wang JS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002180	52	34	37	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41962	10.1371/journal.pone.0041962	http://dx.doi.org/10.1371/journal.pone.0041962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876295	Green Published, Green Submitted, gold			2022-12-27	WOS:000307184700023
J	Stevens, JR; Nicholas, G				Stevens, John R.; Nicholas, Gabriel			Assessing Numerical Dependence in Gene Expression Summaries with the Jackknife Expression Difference	PLOS ONE			English	Article							PREFERRED ANALYSIS-METHODS; MODEL	Statistical methods to test for differential expression traditionally assume that each gene's expression summaries are independent across arrays. When certain preprocessing methods are used to obtain those summaries, this assumption is not necessarily true. In general, the erroneous assumption of dependence results in a loss of statistical power. We introduce a diagnostic measure of numerical dependence for gene expression summaries from any preprocessing method and discuss the relative performance of several common preprocessing methods with respect to this measure. Some common preprocessing methods introduce non-trivial levels of numerical dependence. The issue of (between-array) dependence has received little if any attention in the literature, and researchers working with gene expression data should not take such properties for granted, or they risk unnecessarily losing statistical power.	[Stevens, John R.] Utah State Univ, Ctr Integrated Biosyst, Dept Math & Stat, Logan, UT 84322 USA; [Nicholas, Gabriel] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA	Utah System of Higher Education; Utah State University; University of Wisconsin System; University of Wisconsin Madison	Stevens, JR (corresponding author), Utah State Univ, Ctr Integrated Biosyst, Dept Math & Stat, Logan, UT 84322 USA.	john.r.stevens@usu.edu			Utah Agricultural Experiment Station (UAES), Utah State University; UAES [W1112/W2112]; College of Science at Utah State University	Utah Agricultural Experiment Station (UAES), Utah State University; UAES; College of Science at Utah State University	This research was supported by the Utah Agricultural Experiment Station (UAES), Utah State University, and approved as journal paper number 8430. This UAES funding was in association with the Multistate Research Project W1112/W2112, Reproductive Performance in Domestic Ruminants. This work was also supported by start-up funding from the College of Science at Utah State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, 2001, AFF MICR SUIT US GUI; Affymetrix, 2005, TECHN NOT GUID PROB; Affymetrix, 2002, STAT ALG DESCR DOC; Affymetrix, 2000, LAT SQUAR DAT EXPR A; Auer PL, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1627; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; BOLSTAD B, 2005, BIOINFORMATICS COMPU; Bolstad BM, 2004, THESIS U CALIFORNIA; CARR DB, 1987, J AM STAT ASSOC, V82, P424, DOI 10.2307/2289444; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; Craig BA, 2003, J AGRIC BIOL ENVIR S, V8, P1, DOI 10.1198/1085711031256; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hevel JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-376; Hoy M, 2004, COMPSTAT 2004: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P261; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li C., 2003, ANAL GENE EXPRESSION; Liu X, 2007, BMC BIOINFORMATICS, V8; Liu XJ, 2005, BIOINFORMATICS, V21, P3637, DOI 10.1093/bioinformatics/bti583; Liu XJ, 2006, BIOINFORMATICS, V22, P2107, DOI 10.1093/bioinformatics/btl361; Lockhart DJ, 1996, NATURE BIOTECHNOLOGY, V14; Nicholas G, 2007, THESIS UTAH STAT U; Qiu X, 2005, STAT APPL GENET MOL, V4; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rey W., 1983, INTRO ROBUST QUASI R; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Seber G.A., 1977, LINEAR REGRESSION AN; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stevens JR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-281; Therneau TM, 2008, CANCER INFORM, V6, P423; Tukey JW, 1977, EXPLORATORY DATA ANA; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zhu DX, 2007, BIOINFORMATICS, V23, P2298, DOI 10.1093/bioinformatics/btm328; Zhu QQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-285	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e39570	10.1371/journal.pone.0039570	http://dx.doi.org/10.1371/journal.pone.0039570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876276	Green Published, gold, Green Submitted			2022-12-27	WOS:000307184700004
J	van Hoorn, F; Campian, ME; Spijkerboer, A; Blom, MT; Planken, RN; van Rossum, AC; de Bakker, JMT; Wilde, AAM; Groenink, M; Tan, HL				van Hoorn, Frans; Campian, Maria E.; Spijkerboer, Anje; Blom, Marieke T.; Planken, R. Nils; van Rossum, Albert C.; de Bakker, Jacques M. T.; Wilde, Arthur A. M.; Groenink, Maarten; Tan, Hanno L.			SCN5A Mutations in Brugada Syndrome Are Associated with Increased Cardiac Dimensions and Reduced Contractility	PLOS ONE			English	Article							ST-SEGMENT ELEVATION; SICK SINUS SYNDROME; CONDUCTION DISEASE; LONG-QT; FAILURE; ABNORMALITIES; CONTRIBUTES; ACTIVATION; MECHANISM; DELAY	Background: The cardiac sodium channel (Na(v)1.5) controls cardiac excitability. Accordingly, SCN5A mutations that result in loss-of-function of Na(v)1.5 are associated with various inherited arrhythmia syndromes that revolve around reduced cardiac excitability, most notably Brugada syndrome (BrS). Experimental studies have indicated that Na(v)1.5 interacts with the cytoskeleton and may also be involved in maintaining structural integrity of the heart. We aimed to determine whether clinical evidence may be obtained that Na(v)1.5 is involved in maintaining cardiac structural integrity. Methods: Using cardiac magnetic resonance (CMR) imaging, we compared right ventricular (RV) and left ventricular (LV) dimensions and ejection fractions between 40 BrS patients with SCN5A mutations (SCN5a-mut-positive) and 98 BrS patients without SCN5A mutations (SCN5a-mut-negative). We also studied 18 age/sex-matched healthy volunteers. Results: SCN5a-mut-positive patients had significantly larger end-diastolic and end-systolic RV and LV volumes, and lower LV ejection fractions, than SCN5a-mut-negative patients or volunteers. Conclusions: Loss-of-function SCN5A mutations are associated with dilatation and impairment in contractile function of both ventricles that can be detected by CMR analysis.	[van Hoorn, Frans; Spijkerboer, Anje; Planken, R. Nils; Groenink, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Campian, Maria E.; Blom, Marieke T.; de Bakker, Jacques M. T.; Wilde, Arthur A. M.; Tan, Hanno L.] Univ Amsterdam, Acad Med Ctr, Dept Heart Failure, Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [van Rossum, Albert C.] Vrije Univ Amsterdam, Med Ctr, Cardiol, Amsterdam, Netherlands; [Wilde, Arthur A. M.; Groenink, Maarten; Tan, Hanno L.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Hoorn, F (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.l.tan@amc.nl	Planken, RN/GMX-0438-2022	Blom, Marieke Tabo/0000-0002-8088-1105; van Rossum, Albert C./0000-0003-1714-4652; Planken, R. Nils/0000-0003-3940-4670	Netherlands Organization for Scientific Research (NWO) [ZonMW Vici 918.86.616]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Dr. Tan was supported by the Netherlands Organization for Scientific Research (NWO, grant ZonMW Vici 918.86.616). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 2010, J MOL CELL CARDIOL, V48, P2, DOI 10.1016/j.yjmcc.2009.08.025; Alfakih K, 2003, J MAGN RESON IMAGING, V18, P25, DOI 10.1002/jmri.10329; Amin AS, 2010, PFLUG ARCH EUR J PHY, V460, P223, DOI 10.1007/s00424-009-0761-0; Antzelevitch C, 2005, HEART RHYTHM, V2, P429, DOI 10.1016/jhrthm.2005.01.005; Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Bezzina C, 1999, CIRC RES, V85, P1206; Bezzina CR, 2003, CIRC RES, V92, P159, DOI 10.1161/01.RES.0000052672.97759.36; CASE MT, 1984, TOXICOL APPL PHARM, V73, P232, DOI 10.1016/0041-008X(84)90328-4; Casini S, 2010, CARDIOVASC RES, V85, P691, DOI 10.1093/cvr/cvp352; Catalano O, 2009, EUR HEART J, V30, P2241, DOI 10.1093/eurheartj/ehp252; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; Fahmi AI, 2001, J PHYSIOL-LONDON, V537, P693; Frustaci A, 2005, CIRCULATION, V112, P3680, DOI 10.1161/CIRCULATIONAHA.105.520999; Gavillet B, 2006, CIRC RES, V99, P407, DOI 10.1161/01.RES.0000237466.13252.5e; Groenewegen WA, 2003, CIRC RES, V92, P14, DOI 10.1161/01.RES.0000050585.07097.D7; Hardziyenka M, 2011, EUROPACE, V13, P1753, DOI 10.1093/europace/eur189; Hoogendijk MG, 2010, HEART RHYTHM, V7, P238, DOI 10.1016/j.hrthm.2009.10.007; London B, 2007, CIRCULATION, V116, P2260, DOI 10.1161/CIRCULATIONAHA.107.703330; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; Nademanee K, 2011, CIRCULATION, V123, P1270, DOI 10.1161/CIRCULATIONAHA.110.972612; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Papavassiliu T, 2004, J CARDIOVASC ELECTR, V15, P1133, DOI 10.1046/j.1540-8167.2004.03681.x; Papavassiliu T, 2010, HEART RHYTHM, V7, P1790, DOI 10.1016/j.hrthm.2010.09.004; Postema PG, 2010, J AM COLL CARDIOL, V55, P789, DOI 10.1016/j.jacc.2009.11.033; Postema PG, 2008, CIRC-ARRHYTHMIA ELEC, V1, P379, DOI 10.1161/CIRCEP.108.790543; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Remme CA, 2006, CIRCULATION, V114, P2584, DOI 10.1161/CIRCULATIONAHA.106.653949; Royer A, 2005, CIRCULATION, V111, P1738, DOI 10.1161/01.CIR.0000160853.19867.61; Smits JPP, 2005, J MOL CELL CARDIOL, V38, P969, DOI 10.1016/j.yjmcc.2005.02.024; Takagi M, 2003, HEART, V89, P169, DOI 10.1136/heart.89.2.169; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Tukkie R, 2004, CIRCULATION, V109, P1272, DOI 10.1161/01.CIR.0000118467.53182.D1; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Wang DW, 2002, CIRCULATION, V105, P341, DOI 10.1161/hc0302.102592; Watanabe H, 2008, J CLIN INVEST, V118, P2260, DOI [10.1172/JC133891, 10.1172/JCI33891]; Wilde AAM, 2002, CIRCULATION, V106, P2514, DOI 10.1161/01.CIR.0000034169.45752.4A; Zumhagen S, 2009, CIRC-ARRHYTHMIA ELEC, V2, P16, DOI 10.1161/CIRCEP.107.737882	39	55	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42037	10.1371/journal.pone.0042037	http://dx.doi.org/10.1371/journal.pone.0042037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876298	gold, Green Published, Green Submitted			2022-12-27	WOS:000307184700026
J	Li, FX; Jo, MS; Curry, TE; Liu, J				Li, Feixue; Jo, Misung; Curry, Thomas E., Jr.; Liu, Jing			Hormonal Induction of Polo-Like Kinases (Plks) and Impact of Plk2 on Cell Cycle Progression in the Rat Ovary	PLOS ONE			English	Article							PROTEIN-SERINE/THREONINE KINASE; FOLLICLE-STIMULATING-HORMONE; GRANULOSA-CELLS; LUTEINIZING-HORMONE; GENE-EXPRESSION; PROLIFERATION; GONADOTROPIN; FAMILY; GROWTH; FERTILIZATION	The highly conserved polo-like kinases (Plks) are potent regulators of multiple functions in the cell cycle before and during mitotic cell division. We investigated the expression pattern of Plk genes and their potential role(s) in the rat ovary during the periovulatory period. Plk2 and Plk3 were highly induced both in intact ovaries and granulosa cells in vivo after treatment with the luteinizing hormone (LH) agonist, human chorionic gonadotropin (hCG). In vitro, hCG stimulated the expression of Plk2 in granulosa cells, but not Plk3. This induction of Plk2 expression was mimicked by both forskolin and phorbol 12 myristate 13-acetate (PMA). Moreover, Plk2 expression was reduced by inhibitors of prostaglandin synthesis or the EGF pathway, but not by progesterone receptor antagonist (RU486) treatment. At the promoter level, mutation of the Sp1 binding sequence abolished the transcriptional activity of the Plk2 gene. ChIP assays also revealed the interaction of endogenous Sp1 protein in the Plk2 promoter region. Functionally, the over-expression of Plk2 and Plk3 arrested granulosa cells at the G0/G1 phase of the cell cycle. In contrast, the knockdown of Plk2 expression in granulosa cells decreased the number of cells in the G0/G1 stage of the cell cycle, but increased granulosa cell viability. In summary, hCG induced Plk2 and Plk3 expression in the rat ovary. Prostaglandins and the EGF signaling pathway are involved in regulating Plk2 expression. The transcription factor Sp1 is important for Plk2 transcriptional up-regulation. Our findings suggest that the increase in Plk2 and Plk3 expression contributes to the cell cycle arrest of granulosa cells which is important for the luteinization of granulosa cells during the periovulatory period.	[Li, Feixue] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Jo, Misung; Curry, Thomas E., Jr.] Univ Kentucky, Albert B Chandler Med Ctr, Dept Obstet & Gynecol, Lexington, KY 40536 USA; [Liu, Jing] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Hangzhou Normal University; University of Kentucky; Zhejiang University	Liu, J (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	jliue@zju.edu.cn	Jing, Liu/K-8655-2014; Li, Feixue/M-2126-2014	Jing, Liu/0000-0001-8892-036X; 	National Natural Science Foundation of China [21007056, 31100845]; Scientific Research Foundation of Hangzhou Normal University [2011QPL15]; National Institutes of Health grants [HD057446]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057446] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Hangzhou Normal University; National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The present study was supported by the National Natural Science Foundation of China (21007056 to J.L., and 31100845 to F.L.), Scientific Research Foundation of Hangzhou Normal University (2011QPL15 to F.L.), and National Institutes of Health grants (HD057446 to M.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliston TN, 1997, MOL ENDOCRINOL, V11, P1934, DOI 10.1210/me.11.13.1934; Andrysik Z, 2010, NUCLEIC ACIDS RES, V38, P2931, DOI 10.1093/nar/gkq011; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bin OY, 1999, ONCOGENE, V18, P6029, DOI 10.1038/sj.onc.1202983; Burns TF, 2003, MOL CELL BIOL, V23, P5556, DOI 10.1128/MCB.23.16.5556-5571.2003; Davie JR, 2008, ADV ENZYME REGUL, V48, P189, DOI 10.1016/j.advenzreg.2007.11.016; de Carcer G, 2011, MOL CELL BIOL, V31, P1225, DOI 10.1128/MCB.00607-10; DONOHUE PJ, 1995, J BIOL CHEM, V270, P10351, DOI 10.1074/jbc.270.17.10351; Espey LL, 2000, ENDOCRINOLOGY, V141, P2385, DOI 10.1210/en.141.7.2385; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; Jo M, 2006, MOL ENDOCRINOL, V20, P2156, DOI 10.1210/me.2005-0512; Karn T, 1997, ONCOL REP, V4, P505; LAKE RJ, 1993, MOL CELL BIOL, V13, P7793, DOI 10.1128/MCB.13.12.7793; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Li F, 2012, BIOL REPROD; Li FX, 2011, MOL ENDOCRINOL, V25, P445, DOI 10.1210/me.2010-0250; Li FX, 2009, ENDOCRINOLOGY, V150, P3894, DOI 10.1210/en.2008-1650; Li FX, 2009, ENDOCRINOLOGY, V150, P3903, DOI 10.1210/en.2008-1141; Liu J, 2011, TOXICOLOGY, V290, P42, DOI 10.1016/j.tox.2011.08.016; Liu J, 2011, TOXICOLOGY, V282, P47, DOI 10.1016/j.tox.2011.01.007; Liu J, 2010, MOL ENDOCRINOL, V24, P1203, DOI 10.1210/me.2009-0325; Liu J, 2009, MOL ENDOCRINOL, V23, P1014, DOI 10.1210/me.2008-0451; Liu J, 2009, ENDOCRINOLOGY, V150, P3291, DOI 10.1210/en.2008-1527; Liu Z, 1997, MOL ENDOCRINOL, V11, P127, DOI 10.1210/me.11.2.127; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; Matthew EM, 2009, CELL CYCLE, V8, P4168, DOI 10.4161/cc.8.24.10800; Richards Joanne S, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-02062-9_1; Richards JS, 2005, MOL CELL ENDOCRINOL, V234, P75, DOI 10.1016/j.mce.2005.01.004; Rosario CO, 2010, P NATL ACAD SCI USA, V107, P6888, DOI 10.1073/pnas.0910941107; Roshak AK, 2000, CELL SIGNAL, V12, P405, DOI 10.1016/S0898-6568(00)00080-2; Russell DL, 2003, MOL ENDOCRINOL, V17, P520, DOI 10.1210/me.2002-0066; Seo YM, 2009, LIFE SCI, V85, P153, DOI 10.1016/j.lfs.2009.05.005; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Sriraman V, 2003, MOL ENDOCRINOL, V17, P436, DOI 10.1210/me.2002-0252; SUNKEL CE, 1988, J CELL SCI, V89, P25; Syed N, 2006, BLOOD, V107, P250, DOI 10.1182/blood-2005-03-1194; Tong C, 2002, BIOL REPROD, V67, P546, DOI 10.1095/biolreprod67.2.546; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002	40	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41844	10.1371/journal.pone.0041844	http://dx.doi.org/10.1371/journal.pone.0041844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870256	Green Published, gold			2022-12-27	WOS:000307212800039
J	Ryvkin, A; Ashkenazy, H; Smelyanski, L; Kaplan, G; Penn, O; Weiss-Ottolenghi, Y; Privman, E; Ngam, PB; Woodward, JE; May, GD; Bell, C; Pupko, T; Gershoni, JM				Ryvkin, Arie; Ashkenazy, Haim; Smelyanski, Larisa; Kaplan, Gilad; Penn, Osnat; Weiss-Ottolenghi, Yael; Privman, Eyal; Ngam, Peter B.; Woodward, James E.; May, Gregory D.; Bell, Callum; Pupko, Tal; Gershoni, Jonathan M.			Deep Panning: Steps towards Probing the IgOme	PLOS ONE			English	Article							LONG-TERM PERSISTENCE; B-CELL EPITOPES; PHAGE DISPLAY; PEPTIDE LIBRARIES; PROTEIN; GENERATION; ANTIBODIES; REPERTOIRE; DIVERSITY; BACTERIOPHAGE	Background: Polyclonal serum consists of vast collections of antibodies, products of differentiated B-cells. The spectrum of antibody specificities is dynamic and varies with age, physiology, and exposure to pathological insults. The complete repertoire of antibody specificities in blood, the IgOme, is therefore an extraordinarily rich source of information-a molecular record of previous encounters as well as a status report of current immune activity. The ability to profile antibody specificities of polyclonal serum at exceptionally high resolution has been an important and serious challenge which can now be overcome. Methodology/Principal Findings: Here we illustrate the application of Deep Panning, a method that combines the flexibility of combinatorial phage display of random peptides with the power of high-throughput deep sequencing. Deep Panning is first applied to evaluate the quality and diversity of naive random peptide libraries. The production of very large data sets, hundreds of thousands of peptides, has revealed unexpected properties of combinatorial random peptide libraries and indicates correctives to ensure the quality of the libraries generated. Next, Deep Panning is used to analyze a model monoclonal antibody in addition to allowing one to follow the dynamics of biopanning and peptide selection. Finally Deep Panning is applied to profile polyclonal sera derived from HIV infected individuals. Conclusions/Significance: The ability to generate and characterize hundreds of thousands of affinity-selected peptides creates an effective means towards the interrogation of the IgOme and understanding of the humoral response to disease. Deep Panning should open the door to new possibilities for serological diagnostics, vaccine design and the discovery of the correlates of immunity to emerging infectious agents.	[Ryvkin, Arie; Ashkenazy, Haim; Smelyanski, Larisa; Kaplan, Gilad; Penn, Osnat; Weiss-Ottolenghi, Yael; Privman, Eyal; Pupko, Tal; Gershoni, Jonathan M.] Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Ngam, Peter B.; Woodward, James E.; May, Gregory D.; Bell, Callum] Natl Ctr Genome Resources, Santa Fe, NM USA	Tel Aviv University; National Center for Genome Resources (NCGR)	Ryvkin, A (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	gershoni@tauex.tau.ac.il	Pupko, Tal/HGF-1353-2022; Ashkenazy, Haim/AAX-6285-2021	Kaplan, Gilad/0000-0003-1374-305X; Pupko, Tal/0000-0001-9463-2575; Ashkenazy, Haim/0000-0002-5079-4684	The United States - Israel Binational Agricultural Research and Development Fund (BARD) [IS-4287-10]; Marian Gertner Institute for Nanomedical Systems Fellowship; Edmond J. Safra Center for Bioinformatics at Tel-Aviv University; Jakov, Miriana, and Jorge Saia Doctoral Fellowship	The United States - Israel Binational Agricultural Research and Development Fund (BARD)(US-Israel Binational Science Foundation); Marian Gertner Institute for Nanomedical Systems Fellowship; Edmond J. Safra Center for Bioinformatics at Tel-Aviv University; Jakov, Miriana, and Jorge Saia Doctoral Fellowship	This research was supported by the The United States - Israel Binational Agricultural Research and Development Fund (BARD) [Research Grant No. IS-4287-10 to TP and JMG]. AR is the recipient of the Marian Gertner Institute for Nanomedical Systems Fellowship. This study was supported in part by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel-Aviv University to HA and OP. GK is the recipient of the Jakov, Miriana, and Jorge Saia Doctoral Fellowship. We thank the Frankel Foundation for generous support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Borggren M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020135; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Bublil EM, 2007, PROTEINS, V68, P294, DOI 10.1002/prot.21387; Butler JE, 2009, DEV COMP IMMUNOL, V33, P321, DOI 10.1016/j.dci.2008.06.015; Cawthraw SA, 2002, CLIN EXP IMMUNOL, V130, P101, DOI 10.1046/j.1365-2249.2002.01966.x; COHEN D, 1994, EUR J EPIDEMIOL, V10, P267, DOI 10.1007/BF01719348; Denisova G, 1996, AIDS RES HUM RETROV, V12, P901, DOI 10.1089/aid.1996.12.901; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; Di Niro R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq052; Dias-Neto E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008338; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Dunn-Walters DK, 2010, CURR OPIN IMMUNOL, V22, P514, DOI 10.1016/j.coi.2010.04.009; Enshell-Seijffers D, 2001, Nucleic Acids Res, V29, pE50, DOI 10.1093/nar/29.10.e50; Ernst A, 2010, MOL BIOSYST, V6, P1782, DOI 10.1039/c0mb00061b; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Freund NT, 2009, CURR PROTOC IMMUNOL; Georgieva Y, 2011, MOLECULES, V16, P1667, DOI 10.3390/molecules16021667; Gibson KL, 2009, AGING CELL, V8, P18, DOI 10.1111/j.1474-9726.2008.00443.x; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; GREENWOOD J, 1991, J MOL BIOL, V220, P821, DOI 10.1016/0022-2836(91)90354-9; Hofer T, 2006, IMMUNOL REV, V211, P295, DOI 10.1111/j.0105-2896.2006.00380.x; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; IANNOLO G, 1995, J MOL BIOL, V248, P835, DOI 10.1006/jmbi.1995.0264; Irving MB, 2001, CURR OPIN CHEM BIOL, V5, P314, DOI 10.1016/S1367-5931(00)00208-8; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; KRETZSCHMAR T, 1995, GENE, V155, P61, DOI 10.1016/0378-1119(94)00897-2; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Lynch RM, 2012, J VIROLOGY; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; Overbaugh J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007039; PAIGE CJ, 1989, FASEB J, V3, P1818, DOI 10.1096/fasebj.3.7.2497040; Ravn U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq789; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SMITH GP, 1993, GENE, V128, P1, DOI 10.1016/0378-1119(93)90145-S; Smith-Norowitz TA, 2011, INT J MED SCI, V8, P239, DOI 10.7150/ijms.8.239; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; 't Hoen PAC, 2012, ANAL BIOCHEM, V421, P622, DOI 10.1016/j.ab.2011.11.005; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3	51	38	41	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41469	10.1371/journal.pone.0041469	http://dx.doi.org/10.1371/journal.pone.0041469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870226	Green Submitted, gold, Green Published			2022-12-27	WOS:000307212800022
J	Van Belleghem, SM; Roelofs, D; Van Houdt, J; Hendrickx, F				Van Belleghem, Steven M.; Roelofs, Dick; Van Houdt, Jeroen; Hendrickx, Frederik			De novo Transcriptome Assembly and SNP Discovery in the Wing Polymorphic Salt Marsh Beetle Pogonus chalceus (Coleoptera, Carabidae)	PLOS ONE			English	Article							HABITAT PERSISTENCE; JUVENILE-HORMONE; GENOME SEQUENCE; GENE-EXPRESSION; PEA APHID; EVOLUTION; DISPERSAL; DIMORPHISM; ADAPTATION; DIFFERENTIATION	Background: The salt marsh beetle Pogonus chalceus represents a unique opportunity to understand and study the origin and evolution of dispersal polymorphisms as remarkable inter-population divergence in dispersal related traits (e. g. wing development, body size and metabolism) has been shown to persist in face of strong homogenizing gene flow. Sequencing and assembling the transcriptome of P. chalceus is a first step in developing large scale genetic information that will allow us to further study the recurrent phenotypic evolution in dispersal traits in these natural populations. Methodology/Results: We used the Illumina HiSeq2000 to sequence 37 Gbases of the transcriptome and performed de novo transcriptome assembly with the Trinity short read assembler. This resulted in 65,766 contigs, clustering into 39,393 unique transcripts (unigenes). A subset of 12,987 show similarity (BLAST) to known proteins in the NCBI database and 7,589 are assigned Gene Ontology (GO). Using homology searches we identified all reported genes involved in wing development, juvenile- and ecdysteroid hormone pathways in Tribolium castaneum. About half (56.7%) of the unique assembled genes are shared among three life stages (third-instar larva, pupa, and imago). We identified 38,141 single nucleotide polymorphisms (SNPs) in these unigenes. Of these SNPs, 26,823 (70.3%) were found in a predicted open reading frame (ORF) and 6,998 (18.3%) were nonsynonymous. Conclusions: The assembled transcriptome and SNP data are essential genomic resources for further study of the developmental pathways, genetic mechanisms and metabolic consequences of adaptive divergence in dispersal power in natural populations.	[Van Belleghem, Steven M.; Hendrickx, Frederik] Univ Ghent, Dept Biol, Terr Ecol Unit, B-9000 Ghent, Belgium; [Van Belleghem, Steven M.; Hendrickx, Frederik] Royal Belgian Inst Nat Sci, Dept Entomol, Brussels, Belgium; [Roelofs, Dick] Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands; [Van Houdt, Jeroen] Lab Cytogenet & Genome Res, Louvain, Belgium	Ghent University; Royal Belgian Institute of Natural Sciences; Vrije Universiteit Amsterdam	Van Belleghem, SM (corresponding author), Univ Ghent, Dept Biol, Terr Ecol Unit, B-9000 Ghent, Belgium.	Steven.VanBelleghem@UGent.be	Van Belleghem, Steven/J-2270-2019; Hendrickx, Frederik/F-3149-2013	Van Belleghem, Steven/0000-0001-9399-1007; Roelofs, Dick/0000-0003-3954-3590	FWO-Flanders; Belgian Science Policy [MO/36/025]; Ghent University; Hercules Foundation; Flemish Government - department EWI	FWO-Flanders(FWO); Belgian Science Policy(Belgian Federal Science Policy Office); Ghent University(Ghent University); Hercules Foundation; Flemish Government - department EWI	Funding was received from the FWO-Flanders (PhD grant to Steven Van Belleghem) and the Belgian Science Policy (MO/36/025) and partly conducted within the framework of the Interuniversity Attraction Poles programme IAP (SPEEDY) - Belgian Science Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Janine Marien, affiliated to the Vrije Universiteit Amsterdam, for her help in preparation of the samples. This work was carried out using the Stevin Supercomputer Infrastructure at Ghent University, funded by Ghent University, the Hercules Foundation and the Flemish Government - department EWI and we are grateful to the ICT Department of Ghent University for assistance with our computations. Sequencing was performed by the Genomics Core of the University Hospital of Leuven, Belgium.	Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020714; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brisson JA, 2010, INSECT MOL BIOL, V19, P63, DOI 10.1111/j.1365-2583.2009.00935.x; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Den Boer P. J., 1968, Acta Biotheoretica, V18, P165; den Boer P. J., 1970, Oecologia, V4, P1, DOI 10.1007/BF00390612; DENBOER PJ, 1980, ENTOMOL GEN, V6, P107; Denno RF, 1996, ECOL MONOGR, V66, P389, DOI 10.2307/2963487; DESENDER K, 1988, ANN SOC ROY ZOOL BEL, V118, P78; DESENDER K, 1987, ACTA PHYTOPATHOL HUN, V22, P85; DESENDER K, 1985, Biologisch Jaarboek, V53, P89; Desender K, 1998, OECOLOGIA, V114, P503, DOI 10.1007/s004420050474; Dhuyvetter H, 2004, MOL ECOL, V13, P1065, DOI 10.1111/j.1365-294X.2004.02134.x; Dhuyvetter H, 2007, EVOLUTION, V61, P184, DOI 10.1111/j.1558-5646.2007.00015.x; Doebeli M, 1997, EVOLUTION, V51, P1730, DOI 10.1111/j.1558-5646.1997.tb05097.x; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Emlen DJ, 1999, J INSECT PHYSIOL, V45, P45, DOI 10.1016/S0022-1910(98)00096-1; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gustavson E, 1996, GENETICS, V142, P893; Hendrickx F, 2009, GLOBAL ECOL BIOGEOGR, V18, P607, DOI 10.1111/j.1466-8238.2009.00473.x; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Holt RD, 1996, AM NAT, V148, P709, DOI 10.1086/285949; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Ishikawa A, 2012, INSECT MOL BIOL, V21, P49, DOI 10.1111/j.1365-2583.2011.01111.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Rouzic A, 2008, TRENDS ECOL EVOL, V23, P33, DOI 10.1016/j.tree.2007.09.014; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mathias A, 2001, EVOLUTION, V55, P246; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Michel AP, 2010, P NATL ACAD SCI USA, V107, P9724, DOI 10.1073/pnas.1000939107; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; MITTAPALLI O, 2010, PLOS ONE, V5; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; ODUM WE, 1988, ANNU REV ECOL SYST, V19, P147, DOI 10.1146/annurev.es.19.110188.001051; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Poelchau MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-619; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; ROFF DA, 1986, EVOLUTION, V40, P1009, DOI 10.1111/j.1558-5646.1986.tb00568.x; ROFF DA, 1994, AM NAT, V144, P772, DOI 10.1086/285706; Roff DA, 2007, BIOSCIENCE, V57, P155, DOI 10.1641/B570210; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; SERRANO J, 1981, GENETICA, V57, P119, DOI 10.1007/BF00131237; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Shigenobu S, 2010, INSECT MOL BIOL, V19, P47, DOI 10.1111/j.1365-2583.2009.00944.x; Sloan DB, 2012, MOL ECOL RESOUR, V12, P333, DOI 10.1111/j.1755-0998.2011.03079.x; Song HJ, 2010, SYST ENTOMOL, V35, P429, DOI 10.1111/j.1365-3113.2009.00517.x; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Stevens VM, 2012, ECOL LETT, V15, P74, DOI 10.1111/j.1461-0248.2011.01709.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; Theodorides K, 2002, INSECT MOL BIOL, V11, P467, DOI 10.1046/j.1365-2583.2002.00355.x; Turin H, 2000, NEDERLANDSE LOOPKEVE; Van Dyck H, 1999, TRENDS ECOL EVOL, V14, P172, DOI 10.1016/S0169-5347(99)01610-9; VANSTRAALEN NM, 2006, INTRO ECOLOGICAL GEN; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Weatherbee SD, 1999, CURR BIOL, V9, P109, DOI 10.1016/S0960-9822(99)80064-5; Weihe U, 2005, INSECT DEV MORPHOGEN, P730; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6; Xue J, 2011, PLOS ONE, V5; Zera AJ, 2003, INTEGR COMP BIOL, V43, P607, DOI 10.1093/icb/43.5.607; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zera AJ, 2007, EVOL DEV, V9, P499, DOI 10.1111/j.1525-142X.2007.00181.x	87	45	48	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42605	10.1371/journal.pone.0042605	http://dx.doi.org/10.1371/journal.pone.0042605			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870338	Green Published, gold			2022-12-27	WOS:000307212800101
J	Oba, S; Noda, M; Waki, K; Nanri, A; Kato, M; Takahashi, Y; Poudel-Tandukar, K; Matsushita, Y; Inoue, M; Mizoue, T; Tsugane, S				Oba, Shino; Noda, Mitsuhiko; Waki, Kayo; Nanri, Akiko; Kato, Masayuki; Takahashi, Yoshihiko; Poudel-Tandukar, Kalpana; Matsushita, Yumi; Inoue, Manami; Mizoue, Tetsaya; Tsugane, Shoichiro		Japan Public Hlth Ctr Based Prospe	Smoking Cessation Increases Short-Term Risk of Type 2 Diabetes Irrespective of Weight Gain: The Japan Public Health Center-Based Prospective Study	PLOS ONE			English	Article							MIDDLE-AGED JAPANESE; SELF-REPORTED HEIGHT; BETA-CELL FUNCTION; BODY-WEIGHT; FOLLOW-UP; COHORT-I; ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; PLASMA-INSULIN; POPULATION	Objective: The effect of smoking cessation on the risk of diabetes has been reported previously. However, it is unknown whether the association is influenced by weight gain and other potential risk factors. Methods: The Japan Public Health Center-Based Prospective Study established in 1990 for Cohort I and in 1993 for Cohort II provided data, and 25,875 men and 33,959 women were analyzed. The response rate to the baseline questionnaire was 80.9%, and 68.4% of the respondents participated both the 5- and 10-year follow-up surveys. Smoking cessation was noted during the initial five years and the development of diabetes was reported in the subsequent five years. Results: An increased risk was observed among individuals who newly quit smoking compared with never smokers among men (odds ratio (OR) = 1.42, 95% CI = 1.03-1.94) and women (OR = 2.84, CI = 1.53-5.29). The risk of developing diabetes among male new quitters who gained 3 kg or more during the 5-year follow-up did not substantially differ from the risk among male never smokers with less than 3 kg of weight gain or no weight gain, while an increased risk was observed among male new quitters with less or no weight gain (OR = 1.46, 95% CI 1.00-2.14). An insignificant increased risk was observed among male new quitters with a family history of diabetes compared with male never smokers with a family history of diabetes. The risk was more than twice as high for male new quitters who used to smoke 25 or more cigarettes per day compared with never smokers (OR = 2.15, 95% CI: 1.34-3.47). Discussion: An increased risk of diabetes was implied among individuals who quit smoking. However, the increased risk was not implied among those who gained weight over the 5-years of follow-up. Those who had major risk factors for diabetes or who smoked heavier had a higher risk.	[Oba, Shino] Natl Inst Publ Hlth, Dept Hlth Promot, Saitama, Japan; [Noda, Mitsuhiko; Takahashi, Yoshihiko] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet & Metab Med, Tokyo, Japan; [Waki, Kayo] Tokyo Univ Hosp, Dept Ubiquitous Hlth Informat, Tokyo 113, Japan; [Waki, Kayo; Takahashi, Yoshihiko] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Nanri, Akiko; Mizoue, Tetsaya] Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Dept Epidemiol & Prevent, Tokyo, Japan; [Kato, Masayuki] Japan Fdn Promot Int Med Res Cooperat, Tokyo, Japan; [Poudel-Tandukar, Kalpana] Waseda Univ, Waseda Inst Adv Study, Tokyo, Japan; [Matsushita, Yumi] Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Dept Clin Res Coordinat, Tokyo, Japan; [Inoue, Manami; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 104, Japan	National Institute of Public Health - Japan; National Center for Global Health & Medicine - Japan; University of Tokyo; University of Tokyo; National Center for Global Health & Medicine - Japan; Waseda University; National Center for Global Health & Medicine - Japan; National Cancer Center - Japan	Oba, S (corresponding author), Natl Inst Publ Hlth, Dept Hlth Promot, Saitama, Japan.	oba@niph.go.jp	Waki, Kayo/AAS-9523-2021; Oba, Shino/AAC-5473-2021; Noda, Mitsuhiko/W-3905-2019; Tsugane, Shoichiro/A-2424-2015; wang, YA XING/K-9671-2016	Oba, Shino/0000-0002-7388-5861; Noda, Mitsuhiko/0000-0003-0413-4631; Tsugane, Shoichiro/0000-0003-4105-2774; wang, YA XING/0000-0003-2749-7793; Waki, Kayo/0000-0003-0046-2523	Ministry of Health, Labour and Welfare of Japan [19shi-2, H19-016]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Grants-in-Aid for Cancer Research (19shi-2) and a Health Sciences Research Grant (Research on Comprehensive Research on Cardiovascular Diseases H19-016) from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335; Black E, 2005, DIABETIC MED, V22, P1199, DOI 10.1111/j.1464-5491.2005.01615.x; Bolton-Smith C, 2000, J EPIDEMIOL COMMUN H, V54, P143, DOI 10.1136/jech.54.2.143; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Daniel M, 2004, DIABETIC MED, V21, P188, DOI 10.1046/j.1464-5491.2003.01064.x; Drivsholm T, 2005, DIABETOLOGIA, V48, P210, DOI 10.1007/s00125-004-1625-y; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hur NW, 2007, EUR J CARDIOV PREV R, V14, P244, DOI 10.1097/01.hjr.0000239474.41379.79; Inoue M, 2008, ANN EPIDEMIOL, V18, P522, DOI 10.1016/j.annepidem.2008.03.008; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; Ministry of Health and Welfare, 1988, KOK EIYO GENJ; Ministry of Health Labour and Welfare in Japan, 2010, NAT HLTH NUTR SURV J; Mizoue T, 1998, INT J EPIDEMIOL, V27, P984, DOI 10.1093/ije/27.6.984; MOFFATT RJ, 1991, METABOLISM, V40, P465, DOI 10.1016/0026-0495(91)90225-L; Nanri A, 2010, J EPIDEMIOL COMMUNIT; Ostgren CJ, 2000, DIABETIC MED, V17, P445, DOI 10.1046/j.1464-5491.2000.00294.x; PYORALA K, 1985, ACTA MED SCAND, P38; Ronnemaa T, 1996, DIABETES CARE, V19, P1229, DOI 10.2337/diacare.19.11.1229; Sakurai Y, 1997, DIABETES CARE, V20, P978, DOI 10.2337/diacare.20.6.978; Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427; STAMFORD BA, 1986, AM J CLIN NUTR, V43, P486, DOI 10.1093/ajcn/43.4.486; Tsugane S, 1999, AM J EPIDEMIOL, V150, P1201, DOI 10.1093/oxfordjournals.aje.a009946; Tsugane S, 2001, J Epidemiol, V11, pS24; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj.ijo.0801961; Wada K, 2005, INT J OBESITY, V29, P1093, DOI 10.1038/sj.ijo.0803012; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005; Zhang LX, 2011, DIABETES CARE, V34, P892, DOI 10.2337/dc10-2087	29	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e17061	10.1371/journal.pone.0017061	http://dx.doi.org/10.1371/journal.pone.0017061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22879858	Green Published, gold			2022-12-27	WOS:000302733900001
J	Dechorgnat, J; Patrit, O; Krapp, A; Fagard, M; Daniel-Vedele, F				Dechorgnat, Julie; Patrit, Oriane; Krapp, Anne; Fagard, Mathilde; Daniel-Vedele, Francoise			Characterization of the Nrt2.6 Gene in Arabidopsis thaliana: A Link with Plant Response to Biotic and Abiotic Stress	PLOS ONE			English	Article							AFFINITY NITRATE TRANSPORTER; NITRIC-OXIDE; DEFENSE RESPONSES; NITROGEN; EXPRESSION; IDENTIFICATION; RESISTANCE; ATNRT2.1; CLONING; ROOTS	The high affinity nitrate transport system in Arabidopsis thaliana involves one gene and potentially seven genes from the NRT1 and NRT2 family, respectively. Among them, NRT2.1, NRT2.2, NRT2.4 and NRT2.7 proteins have been shown to transport nitrate and are localized on the plasmalemma or the tonoplast membranes. NRT2.1, NRT2.2 and NRT2.4 play a role in nitrate uptake from soil solution by root cells while NRT2.7 is responsible for nitrate loading in the seed vacuole. We have undertaken the functional characterization of a third member of the family, the NRT2.6 gene. NRT2.6 was weakly expressed in most plant organs and its expression was higher in vegetative organs than in reproductive organs. Contrary to other NRT2 members, NRT2.6 expression was not induced by limiting but rather by high nitrogen levels, and no nitrate-related phenotype was found in the nrt2.6-1 mutant. Consistently, the over-expression of the gene failed to complement the nitrate uptake defect of an nrt2.1-nrt2.2 double mutant. The NRT2.6 expression is induced after inoculation of Arabidopsis thaliana by the phytopathogenic bacterium Erwinia amylovora. Interestingly, plants with a decreased NRT2.6 expression showed a lower tolerance to pathogen attack. A correlation was found between NRT2.6 expression and ROS species accumulation in response to infection by E. amylovora and treatment with the redox-active herbicide methyl viologen, suggesting a probable link between NRT2.6 activity and the production of ROS in response to biotic and abiotic stress.	[Dechorgnat, Julie; Krapp, Anne; Daniel-Vedele, Francoise] Saclay Plant Sci, AgroParisTech, INRA, Inst Jean Pierre Bourgin,UMR 1318, Versailles, France; [Patrit, Oriane] AgroParisTech, UMR217, Lab Interact Plantes Pathogenes, Paris, France; [Fagard, Mathilde] INRA, UMR217, Lab Interact Plantes Pathogenes, Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE	Dechorgnat, J (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Urrbrae, Australia.	fancoise.vedele@versailles.inra.fr	Fagard, Mathilde/K-7998-2012; Krapp, Anne/E-8372-2013	Krapp, Anne/0000-0003-2034-5615	French Ministry; French ANR (Agence Nationale pour la Recherche) [ANR08-Blan-008]; doctoral school, ABIES (Agriculture, Alimentation, Environnement et Sante)	French Ministry; French ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); doctoral school, ABIES (Agriculture, Alimentation, Environnement et Sante)	J Dechorgnat was funded by the French Ministry and the doctoral school, ABIES (Agriculture, Alimentation, Environnement et Sante). This project was supported by a French ANR (Agence Nationale pour la Recherche, http://www.agence-nationale-recherche.fr/) program (Nitrapool, ANR08-Blan-008). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Besson-Bard A, 2008, J EXP BOT, V59, P3407, DOI 10.1093/jxb/ern189; Besson-Bard A, 2008, ANNU REV PLANT BIOL, V59, P21, DOI 10.1146/annurev.arplant.59.032607.092830; Bonasera JM, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-23; Camanes G, 2012, PLANT PHYSIOL, V158, P1054, DOI 10.1104/pp.111.184424; Chardon F, 2010, J EXP BOT, V61, P2293, DOI 10.1093/jxb/erq059; Chopin F, 2007, PLANT PHYSIOL BIOCH, V45, P630, DOI 10.1016/j.plaphy.2007.04.007; Chopin F, 2007, PLANT CELL, V19, P1590, DOI 10.1105/tpc.107.050542; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DANIELVEDELE F, 1993, MOL GEN GENET, V240, P365, DOI 10.1007/BF00280388; Dechorgnat J, 2011, J EXP BOT, V62, P1349, DOI 10.1093/jxb/erq409; Deeken R, 2006, PLANT CELL, V18, P3617, DOI 10.1105/tpc.106.044743; Degrave A, 2008, MOL PLANT MICROBE IN, V21, P1076, DOI 10.1094/MPMI-21-8-1076; Divol F, 2007, PLANT CELL ENVIRON, V30, P187, DOI 10.1111/j.1365-3040.2006.01618.x; DODGE AD, 1994, CAUSES PHOTOOXIDATIV, P219; ESTELLE MA, 1987, MOL GEN GENET, V206, P200, DOI 10.1007/BF00333575; Fan SC, 2009, PLANT CELL, V21, P2750, DOI 10.1105/tpc.109.067603; Filleur S, 1999, PLANTA, V207, P461, DOI 10.1007/s004250050505; Filleur S, 2001, FEBS LETT, V489, P220, DOI 10.1016/S0014-5793(01)02096-8; Glass ADM, 1995, NITROGEN NUTR HIGHER, P21; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Gupta KJ, 2011, TRENDS PLANT SCI, V16, P160, DOI 10.1016/j.tplants.2010.11.007; HUBER DM, 1974, ANNU REV PHYTOPATHOL, V12, P139, DOI 10.1146/annurev.py.12.090174.001035; Ischiropoulos H, 1999, METHOD ENZYMOL, V301, P367; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jouannic S, 2011, ANN BOT-LONDON, V108, P1477, DOI 10.1093/aob/mcr019; Kiba T, 2012, PLANT CELL, V24, P245, DOI 10.1105/tpc.111.092221; Krapp A, 1998, PLANT J, V14, P723, DOI 10.1046/j.1365-313x.1998.00181.x; Lejay L, 2008, PLANT PHYSIOL, V146, P2036, DOI 10.1104/pp.107.114710; Li WB, 2007, PLANT PHYSIOL, V143, P425, DOI 10.1104/pp.106.091223; Lin SH, 2008, PLANT CELL, V20, P2514, DOI 10.1105/tpc.108.060244; Liu GS, 2010, PLANT CELL, V22, P3845, DOI 10.1105/tpc.110.079392; Lu M, 2001, PLANT CELL, V13, P437, DOI 10.1105/tpc.13.2.437; Mantelin S, 2006, PLANTA, V223, P591, DOI 10.1007/s00425-005-0106-y; Merigout P, 2008, PLANT PHYSIOL, V147, P1225, DOI 10.1104/pp.108.119339; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Modolo LV, 2006, PLANT SCI, V171, P34, DOI 10.1016/j.plantsci.2006.02.010; Moreau M, 2012, MOL PLANT MICROBE IN, V25, P421, DOI 10.1094/MPMI-05-11-0111; Nazoa P, 2003, PLANT MOL BIOL, V52, P689, DOI 10.1023/A:1024899808018; Okamoto M, 2003, PLANT CELL PHYSIOL, V44, P304, DOI 10.1093/pcp/pcg036; Oliveira HC, 2009, PLANT SCI, V176, P105, DOI 10.1016/j.plantsci.2008.09.017; Orsel M, 2002, PLANT PHYSIOL, V129, P886, DOI 10.1104/pp.005280; Orsel M, 2006, PLANT PHYSIOL, V142, P1304, DOI 10.1104/pp.106.085209; PAULIN J-P, 1973, Annales de Phytopathologie, V5, P389; Rockel P, 2002, J EXP BOT, V53, P103, DOI 10.1093/jexbot/53.366.103; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; Segonzac C, 2007, PLANT CELL, V19, P3760, DOI 10.1105/tpc.106.048173; Snoeijers SS, 2000, EUR J PLANT PATHOL, V106, P493, DOI 10.1023/A:1008720704105; Song W, 1996, PLANT PHYSIOL, V110, P171, DOI 10.1104/pp.110.1.171; Tissier AF, 1999, PLANT CELL, V11, P1841, DOI 10.1105/tpc.11.10.1841; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Venisse JS, 2002, MOL PLANT MICROBE IN, V15, P1204, DOI 10.1094/MPMI.2002.15.12.1204; Vidmar JJ, 2000, PLANT PHYSIOL, V123, P307, DOI 10.1104/pp.123.1.307; Wirth J, 2007, J BIOL CHEM, V282, P23541, DOI 10.1074/jbc.M700901200; Yong ZH, 2010, PLANT J, V63, P739, DOI 10.1111/j.1365-313X.2010.04278.x; Zeier J, 2004, PLANT PHYSIOL, V136, P2875, DOI 10.1104/pp.104.042499; Zhang C, 2004, MOL PLANT MICROBE IN, V17, P357, DOI 10.1094/MPMI.2004.17.4.357	61	50	51	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42491	10.1371/journal.pone.0042491	http://dx.doi.org/10.1371/journal.pone.0042491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880003	Green Submitted, Green Published, gold			2022-12-27	WOS:000307437900042
J	Fricke, K; Koban, I; Tresp, H; Jablonowski, L; Schroder, K; Kramer, A; Weltmann, KD; von Woedtke, T; Kocher, T				Fricke, Katja; Koban, Ina; Tresp, Helena; Jablonowski, Lukasz; Schroeder, Karsten; Kramer, Axel; Weltmann, Klaus-Dieter; von Woedtke, Thomas; Kocher, Thomas			Atmospheric Pressure Plasma: A High-Performance Tool for the Efficient Removal of Biofilms	PLOS ONE			English	Article							CANDIDA-ALBICANS; NONTHERMAL PLASMA; IN-VITRO; EMISSION-SPECTROSCOPY; INACTIVATION; DECONTAMINATION	Introduction: The medical use of non-thermal physical plasmas is intensively investigated for sterilization and surface modification of biomedical materials. A further promising application is the removal or etching of organic substances, e. g., biofilms, from surfaces, because remnants of biofilms after conventional cleaning procedures are capable to entertain inflammatory processes in the adjacent tissues. In general, contamination of surfaces by micro-organisms is a major source of problems in health care. Especially biofilms are the most common type of microbial growth in the human body and therefore, the complete removal of pathogens is mandatory for the prevention of inflammatory infiltrate. Physical plasmas offer a huge potential to inactivate micro-organisms and to remove organic materials through plasma-generated highly reactive agents. Method: In this study a Candida albicans biofilm, formed on polystyrene (PS) wafers, as a prototypic biofilm was used to verify the etching capability of the atmospheric pressure plasma jet operating with two different process gases (argon and argon/oxygen mixture). The capability of plasma-assisted biofilm removal was assessed by microscopic imaging. Results: The Candida albicans biofilm, with a thickness of 10 to 20 mm, was removed within 300 s plasma treatment when oxygen was added to the argon gas discharge, whereas argon plasma alone was practically not sufficient in biofilm removal. The impact of plasma etching on biofilms is localized due to the limited presence of reactive plasma species validated by optical emission spectroscopy.	[Fricke, Katja; Tresp, Helena; Schroeder, Karsten; Weltmann, Klaus-Dieter; von Woedtke, Thomas] INP Greifswald, Leibniz Inst Plasma Sci & Technol eV, Greifswald, Germany; [Koban, Ina; Jablonowski, Lukasz; Kocher, Thomas] Ernst Moritz Arndt Univ Greifswald, Sch Dent, Unit Periodontol, Greifswald, Germany; [Tresp, Helena] Ctr Innovat Competence Plasmatis, Greifswald, Germany; [Kramer, Axel] Ernst Moritz Arndt Univ Greifswald, Inst Hyg & Environm Med, Greifswald, Germany	Leibniz Institut fur Plasmaforschung und Technologie; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Fricke, K (corresponding author), INP Greifswald, Leibniz Inst Plasma Sci & Technol eV, Greifswald, Germany.	k.fricke@inp-greifswald.de	von Woedtke, Thomas/U-3604-2018	von Woedtke, Thomas/0000-0002-1097-4832; Fricke, Katja/0000-0001-6050-7725	Bundesministerium fur Bildung und Forschung (BMBF) - Federal Ministry of Education and Research [13N9779, 13N11188]	Bundesministerium fur Bildung und Forschung (BMBF) - Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from Bundesministerium fur Bildung und Forschung (BMBF) - Federal Ministry of Education and Research, grant no. 13N9779 and 13N11188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0; Baxter HC, 2005, J GEN VIROL, V86, P2393, DOI 10.1099/vir.0.81016-0; Boudam MK, 2006, J PHYS D APPL PHYS, V39, P3494, DOI 10.1088/0022-3727/39/16/S07; Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130, DOI 10.1128/MMBR.62.1.130-180.1998; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Ehlbeck J, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/1/013002; Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0; Fricke K, 2011, PLASMA PROCESS POLYM, V8, P51, DOI 10.1002/ppap.201000093; Gaunt LF, 2006, IEEE T PLASMA SCI, V34, P1257, DOI 10.1109/TPS.2006.878381; Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09; He M, 2007, MYCOPATHOLOGIA, V163, P137, DOI 10.1007/s11046-007-0097-2; Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026; Joaquin JC, 2009, MICROBIOL-SGM, V155, P724, DOI 10.1099/mic.0.021501-0; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; Koban I, 2011, J CLIN PERIODONTOL, V38, P956, DOI 10.1111/j.1600-051X.2011.01740.x; Koban I, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/073039; Kudrle V, 2010, J PHYS D, V43, P13; Lloyd G, 2010, PLASMA PROCESS POLYM, V7, P194, DOI 10.1002/ppap.200900097; Machala Z, 2007, J MOL SPECTROSC, V243, P194, DOI 10.1016/j.jms.2007.03.001; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Melzer A., 2008, LOW TEMPERATURE PLAS, V2nd ed., P129; Moreau M, 2008, BIOTECHNOL ADV, V26, P610, DOI 10.1016/j.biotechadv.2008.08.001; Navratil Z, 2006, CZECH J PHYS, V56, pB944, DOI 10.1007/s10582-006-0308-y; Otto C, 2011, FOOD ENG REV, V3, P171, DOI 10.1007/s12393-011-9038-4; Pompl R, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115023; Ramage Gordon, 2001, Revista Iberoamericana de Micologia, V18, P163; Rossi F, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115017; Rossi F, 2006, PLASMA PROCESS POLYM, V3, P431, DOI 10.1002/ppap.200600011; Rupf S, 2011, PLOS ONE, V6, P9; Rupf S, 2010, J MED MICROBIOL, V59, P206, DOI 10.1099/jmm.0.013714-0; Schroder K, 2001, CONTRIB PLASM PHYS, V41, P562, DOI 10.1002/1521-3986(200111)41:6<562::AID-CTPP562>3.0.CO;2-Y; Schulz-von der Gathen V, 2008, J PHYS D, V41, P6; Sureshkumar A, 2010, INT J PHARMACEUT, V396, P17, DOI 10.1016/j.ijpharm.2010.05.045; von Keudell A, 2010, PLASMA PROCESS POLYM, V7, P327, DOI 10.1002/ppap.200900121; Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067; Weltmann KD, 2011, IEEE T PLASMA SCI, V39, P1015, DOI 10.1109/TPS.2011.2112674; Whittaker AG, 2004, J HOSP INFECT, V56, P37, DOI 10.1016/j.jhin.2003.09.019	38	126	130	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42539	10.1371/journal.pone.0042539	http://dx.doi.org/10.1371/journal.pone.0042539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880025	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000043
J	Nolasco, S; Bellido, J; Goncalves, J; Tavares, A; Zabala, JC; Soares, H				Nolasco, Sofia; Bellido, Javier; Goncalves, Joao; Tavares, Alexandra; Carlos Zabala, Juan; Soares, Helena			The Expression of Tubulin Cofactor A (TBCA) Is Regulated by a Noncoding Antisense Tbca RNA during Testis Maturation	PLOS ONE			English	Article							MAMMALIAN-CELLS; BETA-TUBULIN; ENDOGENOUS SIRNAS; INTERFERING RNAS; GENE-EXPRESSION; MOUSE OOCYTES; TRANSCRIPTS; PSEUDOGENES; IDENTIFICATION; RETROPOSITION	Background: Recently, long noncoding RNAs have emerged as pivotal molecules for the regulation of coding genes' expression. These molecules might result from antisense transcription of functional genes originating natural antisense transcripts (NATs) or from transcriptional active pseudogenes. TBCA interacts with beta-tubulin and is involved in the folding and dimerization of new tubulin heterodimers, the building blocks of microtubules. Methodology/Principal Findings: We found that the mouse genome contains two structurally distinct Tbca genes located in chromosomes 13 (Tbca13) and 16 (Tbca16). Interestingly, the two Tbca genes albeit ubiquitously expressed, present differential expression during mouse testis maturation. In fact, as testis maturation progresses Tbca13 mRNA levels increase progressively, while Tbca16 mRNA levels decrease. This suggests a regulatory mechanism between the two genes and prompted us to investigate the presence of the two proteins. However, using tandem mass spectrometry we were unable to identify the TBCA16 protein in testis extracts even in those corresponding to the maturation step with the highest levels of Tbca16 transcripts. These puzzling results led us to re-analyze the expression of Tbca16. We then detected that Tbca16 transcription produces sense and natural antisense transcripts. Strikingly, the specific depletion by RNAi of these transcripts leads to an increase of Tbca13 transcript levels in a mouse spermatocyte cell line. Conclusions/Significance: Our results demonstrate that Tbca13 mRNA levels are post-transcriptionally regulated by the sense and natural antisense Tbca16 mRNA levels. We propose that this regulatory mechanism operates during spermatogenesis, a process that involves microtubule rearrangements, the assembly of specific microtubule structures and requires critical TBCA levels.	[Goncalves, Joao; Tavares, Alexandra; Soares, Helena] Univ Lisbon, Fac Ciencias, Dept Quim & Bioquim, Ctr Quim & Bioquim, Lisbon, Portugal; [Nolasco, Sofia; Bellido, Javier; Carlos Zabala, Juan] Univ Cantabria, IFIMAV, Fac Med, Dept Biol Mol, E-39005 Santander, Spain; [Nolasco, Sofia; Goncalves, Joao; Tavares, Alexandra; Soares, Helena] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Soares, Helena] Escola Super Tecnol Saude Lisboa, Lisbon, Portugal	Universidade de Lisboa; Universidad de Cantabria; Instituto Gulbenkian de Ciencia; Universidade de Lisboa	Nolasco, S (corresponding author), Fac Med Vet, Ctr Invest Interdisciplinar Sanidade Anim, Lisbon, Portugal.	mhsoares@fc.ul.pt	Nolasco, Sofia/J-3353-2013; Gonçalves, João/P-4778-2017; Soares, Helena/G-3065-2010; Zabala, Juan Carlos/K-5163-2014; Goncalves, Joao/B-2013-2008	Nolasco, Sofia/0000-0003-2168-0511; Gonçalves, João/0000-0001-5329-0986; Soares, Helena/0000-0001-6180-7041; Zabala, Juan Carlos/0000-0003-2679-5473; Tavares, Alexandra/0000-0002-5332-3386; Goncalves, Joao/0000-0002-1245-3715	Fundacao para a Ciencia e a Tecnologia (FCT) [QUI-LVT-612]; Consolider-Ingenio Spanish Ministry of Education and Science Centrosome-3D [BFU2007-64882, BFU2010-18948]; Instituto de Formacion e Investigacion Marques de Valdecilla;  [POCTI/CTM/61622/2004];  [PTDC/CVT/105470/2008];  [FCT-SFRH/BPD/20681/2004];  [FCT-SFRH/BD/24532/2005]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Consolider-Ingenio Spanish Ministry of Education and Science Centrosome-3D; Instituto de Formacion e Investigacion Marques de Valdecilla; ; ; ; 	This work was partly supported by POCTI/CTM/61622/2004, PTDC/CVT/105470/2008 and funds from unit key QUI-LVT-612 given by Fundacao para a Ciencia e a Tecnologia (FCT); by BFU2007-64882 and BFU2010-18948 and Consolider-Ingenio Spanish Ministry of Education and Science Centrosome-3D and the Instituto de Formacion e Investigacion Marques de Valdecilla. Fellowships were given to S.N. (FCT-SFRH/BPD/20681/2004) and to J.G. (FCT-SFRH/BD/24532/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Beiter T, 2009, CELL MOL LIFE SCI, V66, P94, DOI 10.1007/s00018-008-8381-y; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Caley DP, 2010, THESCIENTIFICWORLDJO, V10, P90, DOI 10.1100/tsw.2010.7; D'Errico Ilenia, 2004, Briefings in Functional Genomics & Proteomics, V3, P157, DOI 10.1093/bfgp/3.2.157; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fanarraga ML, 1999, CELL MOTIL CYTOSKEL, V43, P243, DOI 10.1002/(SICI)1097-0169(1999)43:3<243::AID-CM7>3.0.CO;2-0; FARRELL CM, 1995, J BIOL CHEM, V270, P3400, DOI 10.1074/jbc.270.7.3400; Ge XJ, 2006, BIOINFORMATICS, V22, P2475, DOI 10.1093/bioinformatics/btl429; Guo XY, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000449; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; HOFMANN MC, 1994, P NATL ACAD SCI USA, V91, P5533, DOI 10.1073/pnas.91.12.5533; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Korneev SA, 2008, RNA, V14, P2030, DOI 10.1261/rna.1084308; Kortazar D, 2007, EXP CELL RES, V313, P425, DOI 10.1016/j.yexcr.2006.09.002; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Llosa M, 1996, FEBS LETT, V397, P283, DOI 10.1016/S0014-5793(96)01198-2; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; Maestre J, 1995, EMBO J, V14, P6333, DOI 10.1002/j.1460-2075.1995.tb00324.x; Malecova B, 2010, CURR OPIN MOL THER, V12, P214; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Meadus W. J., 2003, Biological Procedures Online, V5, P20, DOI 10.1251/bpo43; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; MUNROE SH, 1991, J BIOL CHEM, V266, P22083; Nolasco S, 2005, FEBS LETT, V579, P3515, DOI 10.1016/j.febslet.2005.05.022; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Okada Y, 2008, HUM MOL GENET, V17, P1631, DOI 10.1093/hmg/ddn051; Pavlicek A, 2006, TRENDS GENET, V22, P69, DOI 10.1016/j.tig.2005.11.005; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Rogozin IB, 2002, TRENDS GENET, V18, P228, DOI 10.1016/S0168-9525(02)02649-5; Rosok O, 2004, NAT BIOTECHNOL, V22, P104, DOI 10.1038/nbt925; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Su WY, 2010, BIOCHEM BIOPH RES CO, V396, P177, DOI 10.1016/j.bbrc.2010.04.147; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Vanhee-Brossollet C, 1998, GENE, V211, P1, DOI 10.1016/S0378-1119(98)00093-6; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Werner A, 2009, RNA BIOL, V6, P43, DOI 10.4161/rna.6.1.7568; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhang ZD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r26; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307	55	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42536	10.1371/journal.pone.0042536	http://dx.doi.org/10.1371/journal.pone.0042536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880023	Green Published, gold			2022-12-27	WOS:000307810000042
J	Yanovsky, Y; Schubring, SR; Yao, QL; Zhao, Y; Li, S; May, A; Haas, HL; Lin, JS; Sergeeva, OA				Yanovsky, Yevgenij; Schubring, Stephan R.; Yao, Quiaoling; Zhao, Yan; Li, Sha; May, Andrea; Haas, Helmut L.; Lin, Jian-Sheng; Sergeeva, Olga A.			Waking Action of Ursodeoxycholic Acid (UDCA) Involves Histamine and GABA(A) Receptor Block	PLOS ONE			English	Article							BILE-ACIDS; TAUROURSODEOXYCHOLIC ACID; POSTERIOR HYPOTHALAMUS; BILIARY ENRICHMENT; NERVOUS-SYSTEM; NEURONS; SLEEP; MODULATION; APOPTOSIS; SUBUNIT	Since ancient times ursodeoxycholic acid (UDCA), a constituent of bile, is used against gallstone formation and cholestasis. A neuroprotective action of UDCA was demonstrated recently in models of Alzheimer's disease and retinal degeneration. The mechanisms of UDCA action in the nervous system are poorly understood. We show now that UDCA promotes wakefulness during the active period of the day, lacking this activity in histamine-deficient mice. In cultured hypothalamic neurons UDCA did not affect firing rate but synchronized the firing, an effect abolished by the GABA(A)R antagonist gabazine. In histaminergic neurons recorded in slices UDCA reduced amplitude and duration of spontaneous and evoked IPSCs. In acutely isolated histaminergic neurons UDCA inhibited GABA-evoked currents and sIPSCs starting at 10 mu M (IC50 = 70 mu M) and did not affect NMDA- and AMPA-receptor mediated currents at 100 mu M. Recombinant GABA(A) receptors composed of alpha 1, beta 1-3 and gamma 2L subunits expressed in HEK293 cells displayed a sensitivity to UDCA similar to that of native GABA(A) receptors. The mutation alpha 1V256S, known to reduce the inhibitory action of pregnenolone sulphate, reduced the potency of UDCA. The mutation alpha 1Q241L, which abolishes GABA(A)R potentiation by several neurosteroids, had no effect on GABA(A)R inhibition by UDCA. In conclusion, UDCA enhances alertness through disinhibition, at least partially of the histaminergic system via GABA(A) receptors.	[Yanovsky, Yevgenij; Schubring, Stephan R.; Li, Sha; May, Andrea; Haas, Helmut L.; Sergeeva, Olga A.] Univ Dusseldorf, Dept Neurophysiol, Fac Med, D-40225 Dusseldorf, Germany; [Yao, Quiaoling; Zhao, Yan; Li, Sha; Lin, Jian-Sheng] Univ Lyon 1, INSERM, U1028, Lyon Neurosci Res Ctr,Fac Med,CNRS,UMR 5292, F-69365 Lyon, France	Heinrich Heine University Dusseldorf; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet	Yanovsky, Y (corresponding author), Univ Dusseldorf, Dept Neurophysiol, Fac Med, D-40225 Dusseldorf, Germany.	olga.sergeeva@uni-duesseldorf.de	Lin, Jian-Sheng/G-4395-2013; Sergeeva, Olga/AAE-1869-2019	Lin, Jian-Sheng/0000-0002-2004-6079; 	Deutsche Forschungsgemeinschaft [DFG SE 1767, SFB 575/3, INSERM U628]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft DFG SE 1767, SFB 575/3 and 8 to OAS, INSERM U628 to J-SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk G, 2001, J PHYSIOL-LONDON, V532, P673, DOI 10.1111/j.1469-7793.2001.0673e.x; Akk G, 2008, MOL PHARMACOL, V74, P614, DOI 10.1124/mol.108.048520; Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; Bergasa NV, 2008, CLIN LIVER DIS, V12, P219, DOI 10.1016/j.cld.2007.11.009; Boatright JH, 2006, MOL VIS, V12, P1706; Cauli O, 2009, GASTROENTEROLOGY, V136, P1359, DOI 10.1053/j.gastro.2008.12.057; Chepkova AN, 2008, NEUROPHARMACOLOGY, V55, P139, DOI 10.1016/j.neuropharm.2008.05.001; Dalpiaz A, 2012, MOL PHARMACEUT, V9, P957, DOI 10.1021/mp200565g; Festi D, 2007, CURR CLIN PHARMACOL, V2, P155, DOI 10.2174/157488407780598171; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hatton GI, 2001, J NEUROSCI, V21, P2974, DOI 10.1523/JNEUROSCI.21-09-02974.2001; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Jimenez-Anguiano A, 2009, WORLD J GASTROENTERO, V15, P5176, DOI 10.3748/wjg.15.5176; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keene CD, 2002, P NATL ACAD SCI USA, V99, P10671, DOI 10.1073/pnas.162362299; Keitel V, 2008, WORLD J GASTROENTERO, V14, P5620, DOI 10.3748/wjg.14.5620; Lin JS, 2011, CELL MOL LIFE SCI, V68, P2499, DOI 10.1007/s00018-011-0631-8; LIN JS, 1989, BRAIN RES, V479, P225, DOI 10.1016/0006-8993(89)91623-5; Lu JW, 2007, J PHYSIOL-LONDON, V582, P553, DOI 10.1113/jphysiol.2007.127613; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Nobilis M, 2001, J PHARMACEUT BIOMED, V24, P937, DOI 10.1016/S0731-7085(00)00563-X; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Oveson BC, 2011, J NEUROCHEM, V116, P144, DOI 10.1111/j.1471-4159.2010.07092.x; Parmentier R, 2009, J NEUROSCI, V29, P4471, DOI 10.1523/JNEUROSCI.2976-08.2009; Perret P, 1999, J BIOL CHEM, V274, P25350, DOI 10.1074/jbc.274.36.25350; Ramalho RM, 2008, TRENDS MOL MED, V14, P54, DOI 10.1016/j.molmed.2007.12.001; Roda E, 2002, DIGEST LIVER DIS, V34, P523, DOI 10.1016/S1590-8658(02)80112-8; Rost D, 2004, HEPATOLOGY, V40, P693, DOI 10.1002/hep.20370; Saras A, 2008, J BIOL CHEM, V283, P10470, DOI 10.1074/jbc.M709993200; Schubring SR, 2012, NEUROSCI LETT, V506, P322, DOI 10.1016/j.neulet.2011.11.036; Sergeeva OA, 2005, J NEUROSCI, V25, P88, DOI 10.1523/JNEUROSCI.3209-04.2005; Sergeeva OA, 2006, EUR J NEUROSCI, V24, P1413, DOI 10.1111/j.1460-9568.2006.05027.x; Sergeeva OA, 2010, J BIOL CHEM, V285, P23985, DOI 10.1074/jbc.M110.103309; Shen WX, 2000, J NEUROSCI, V20, P3571, DOI 10.1523/JNEUROSCI.20-10-03571.2000; Sola S, 2005, HEPATOLOGY, V42, P925, DOI 10.1002/hep.20870; Sola S, 2006, MOL ENDOCRINOL, V20, P2292, DOI 10.1210/me.2006-0063; Vorobjev VS, 1996, J NEUROSCI METH, V68, P303, DOI 10.1016/0165-0270(96)00097-0; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Woo SJ, 2010, J OCUL PHARMACOL TH, V26, P223, DOI 10.1089/jop.2010.0012; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Yanovsky Y, 2012, PFLUG ARCH EUR J PHY, V463, P187, DOI 10.1007/s00424-011-0988-4; Yanovsky Y, 2011, J PHYSIOL-LONDON, V589, P1349, DOI 10.1113/jphysiol.2010.203257	44	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42512	10.1371/journal.pone.0042512	http://dx.doi.org/10.1371/journal.pone.0042512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880010	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000037
J	Patti, F; Nicoletti, A; Leone, C; Messina, S; D'Amico, E; Lo Fermo, S; Paradisi, V; Bruno, E; Quattrocchi, G; Veroux, P; Di Pino, L; Costanzo, L; Zappia, M				Patti, Francesco; Nicoletti, Alessandra; Leone, Carmela; Messina, Silvia; D'Amico, Emanuele; Lo Fermo, Salvatore; Paradisi, Vincenza; Bruno, Elisa; Quattrocchi, Graziella; Veroux, Pierfrancesco; Di Pino, Luigi; Costanzo, Luca; Zappia, Mario			Multiple Sclerosis and CCSVI: A Population-Based Case Control Study	PLOS ONE			English	Article							CEREBROSPINAL VENOUS INSUFFICIENCY; DIAGNOSTIC-CRITERIA; WHITE-MATTER; HEMODYNAMICS; DOPPLER; GUIDELINES; CATANIA	Background: Chronic cerebrospinal venous insufficiency (CCSVI) has been associated to multiple sclerosis (MS). Objective: To evaluate the possible association between CCSVI and MS, using a population-based control design. Methods: A random cohort of 148 incident MS patients were enrolled in the study. We have also studied 20 patients with clinically isolated syndrome (CIS), 40 patients with other neurological diseases (OND), and 172 healthy controls. Transcranial (TCC) and Echo Color Doppler (ECD) were carried out in 380 subjects. A subject was considered CCSVI positive if >= 2 venous hemodynamic criteria were fulfilled. Results: CCSVI was present in 28 (18.9%) of the MS patients, in 2 (10%) of CIS patients, in 11 (6.4%) of the controls, and in 2 (5%) of the OND patients. A significant association between MS and CCSVI was found with an odds ratio of 3.41 (95% confidence interval 1.63-7.13; p=0.001). CCSVI was significantly more frequent among MS subjects with a disease duration longer than 144 months (26.1% versus 12.6% of patients with duration shorter than 144 months; p=0.03) and among patients with secondary progressive (SP) and primary progressive (PP) forms (30.2% and 29.4, respectively) than in patients with relapsing remitting (RR) MS (14.3%). A stronger association was found considering SP and PP forms (age adjusted OR=4.7; 95% CI 1.83-12.0, p=0.001); the association was weaker with the RR patients (age adjusted OR=2.58; 95% CI 1.12-5.92; p=0.02) or not significant in CIS group (age adjusted OR=2.04; 95% CI 0.40-10.3; p=0.4). Conclusions: A higher frequency of CCSVI has been found in MS patients; it was more evident in patients with advanced MS, suggesting that CCSVI could be related to MS disability.	[Patti, Francesco; Nicoletti, Alessandra; Leone, Carmela; Messina, Silvia; D'Amico, Emanuele; Lo Fermo, Salvatore; Bruno, Elisa; Quattrocchi, Graziella; Zappia, Mario] Univ Catania, Sect Neurosci, Dept DANA GF Ingrassia, Catania, Italy; [Paradisi, Vincenza] Catania Municipal Sect, FIMG, Catania, Italy; [Veroux, Pierfrancesco] Univ Catania, Dept Vasc Surg, Catania, Italy; [Di Pino, Luigi; Costanzo, Luca] Univ Catania, Dept Cardiol, Catania, Italy	University of Catania; University of Catania; University of Catania	Patti, F (corresponding author), Univ Catania, Sect Neurosci, Dept DANA GF Ingrassia, Catania, Italy.	mzappia@unict.it	Nicoletti, Alessandra/K-4486-2018; veroux, pierfrancesco/K-5195-2018; D'Amico, Emanuele/N-5568-2019; Messina, Silvia/ABC-8780-2020; Bruno, Elisa/P-4317-2018; D'Amico, Emanuele/C-3752-2011; Zappia, Mario/AAB-7800-2019	Nicoletti, Alessandra/0000-0001-6757-340X; D'Amico, Emanuele/0000-0001-7494-9057; Bruno, Elisa/0000-0001-8166-1190; D'Amico, Emanuele/0000-0001-7494-9057; patti, francesco/0000-0002-6923-0846; Di Pino, luigi/0000-0003-4442-7199	Pfizer; FISM; Bayer Schering; Biogen Idec; Merck Serono; Novartis; Sanofi Aventis; TEVA; Lilly; AIFA; MIUR	Pfizer(Pfizer); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Bayer Schering(Bayer AG); Biogen Idec(Biogen); Merck Serono(Merck & Company); Novartis(Novartis); Sanofi Aventis(Sanofi-Aventis); TEVA(Teva Pharmaceutical Industries); Lilly(Eli Lilly); AIFA; MIUR(Ministry of Education, Universities and Research (MIUR))	The authors have read the journal's policy and have the following conflicts: Dr. F. Patti has received honoraria for speaking activities by Bayer Schering, Biogen Idec, Merck Serono, Novartis and Sanofi Aventis; he also served as advisory board member the following companies: Bayer Schering, Biogen Idec, Merck Serono, Novartis; he was also funded by Pfizer and FISM for epidemiological studies; finally he received grants for congress participation from Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi Aventis and TEVA. Prof. A. Nicoletti reports no competing interests. Dr. C. Leone received partial grants for congress participation from Bayer Schering and Biogen Idec. Dr. S. Messina received grants for congress participation from Bayer Schering and Merck Serono. Dr. E. D'Amico received grants for congress participation from Sanofi Aventis. Dr. S. Lo Fermo received honoraria for speaking activities from Biogen Idec, Merck Serono; he also received grants for congress participation from Bayer Schering, Biogen Idec, Merck Serono and Sanofi Aventis. Dr. V. Paradisi reports no competing interests. Dr. E. Bruno reports no competing interests. Dr. G. Quattrocchi reports no competing interests. Prof. P. F. Veroux reports no competing interests. Prof. L. Di Pino reports no competing interests. Dr. L. Costanzo reports no competing interests. Prof. M. Zappia received speaking honoraria from Biogen Idec, Merck Serono, Lilly, Sanofi Aventis; he also received grants for congress participation from the following companies: Bayer Schering, Biogen Idec, Merck Serono, Lilly, Novartis, and Sanofi Aventis; he was also funded by AIFA and MIUR. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adams CWM, 1989, COLOUR ATLAS MULTIPL, P184; Al-Omari MH, 2010, INT ANGIOL, V29, P115; Baracchini C, 2011, ANN NEUROL, V69, P90, DOI 10.1002/ana.22228; Bastianello S, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-132; Charcot, 1868, GAZETTE HOSP PARIS, V41, P554; De Keyser J, 2008, J CEREBR BLOOD F MET, V28, P1645, DOI 10.1038/jcbfm.2008.72; Diaconu C, 2011, MULT SCLER J, V17, pS50; Doepp F, 2011, NEUROLOGY, V77, P1745, DOI 10.1212/WNL.0b013e318236f0ea; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; Dolic K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028062; Ertl-Wagner B, 2011, MSJ, DOI 0.1177/1352458511432742; FOG T, 1965, ACTA NEUROL SCAND, VS 41, P3; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Krogias C, 2010, NERVENARZT, V81, P740, DOI 10.1007/s00115-010-2972-1; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Laupacis A, 2011, CMAJ, V183, P1203; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Menegatti E, 2010, INT ANGIOL, V29, P121; MENEGHINI F, 1992, J CLIN EPIDEMIOL, V45, P319, DOI 10.1016/0895-4356(92)90033-J; Nicoletti A, 2005, NEUROLOGY, V65, P1259, DOI 10.1212/01.wnl.0000180628.38786.85; Nicoletti A, 2011, MULT SCLER J, V17, P273, DOI 10.1177/1352458510386995; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Santiago O, 2010, EUR J CLIN MICROBIOL, V29, P857, DOI 10.1007/s10096-010-0940-0; SCHELLING F, 1986, MED HYPOTHESES, V21, P141, DOI 10.1016/0306-9877(86)90003-4; Simka M, 2010, INT ANGIOL, V29, P109; STATA Corp, STATA STAT SOFTW REL; Stolz E, 1989, STROKE, V90, P1070; Sundstrom P, 2010, ANN NEUROL, V68, P255, DOI 10.1002/ana.22132; Tan IL, 2000, AM J NEURORADIOL, V21, P1039; Tsivgoulis G, 2011, NEUROLOGY, V77, P1241, DOI 10.1212/WNL.0b013e318230a149; Varga AW, 2009, J NEUROL SCI, V282, P28, DOI 10.1016/j.jns.2008.12.036; Wattjes MP, 2011, J NEUROL NEUROSUR PS, V82, P429, DOI 10.1136/jnnp.2010.223479; Wuerfel J, 2007, J NEUROL SCI, V259, P16, DOI 10.1016/j.jns.2007.02.011; Yamout B, 2010, MULT SCLER, V16, P1341, DOI 10.1177/1352458510385268; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2007, CURR NEUROVASC RES, V4, P252, DOI 10.2174/156720207782446298; Zamboni P, 2006, J ROY SOC MED, V99, P589, DOI 10.1258/jrsm.99.11.589; Zamboni P, 2009, J NEUROL SCI, V282, P21, DOI 10.1016/j.jns.2008.11.027; Zivadinov R, 2011, NEUROLOGY, V77, P138, DOI 10.1212/WNL.0b013e318212a901; Zivadinov R, 2011, RADIOLOGY, V258, P562, DOI 10.1148/radiol.10101387	41	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41227	10.1371/journal.pone.0041227	http://dx.doi.org/10.1371/journal.pone.0041227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870210	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100014
J	Buczkowski, G; Richmond, DS				Buczkowski, Grzegorz; Richmond, Douglas S.			The Effect of Urbanization on Ant Abundance and Diversity: A Temporal Examination of Factors Affecting Biodiversity	PLOS ONE			English	Article							ODOROUS HOUSE ANT; TAPINOMA-SESSILE; BIOTIC HOMOGENIZATION; HYMENOPTERA-FORMICIDAE; URBAN-ENVIRONMENT; SPECIES RICHNESS; UNITED-STATES; COMMUNITIES; HABITAT; CONSERVATION	Numerous studies have examined the effect of urbanization on species richness and most studies implicate urbanization as the major cause of biodiversity loss. However, no study has identified an explicit connection between urbanization and biodiversity loss as the impact of urbanization is typically inferred indirectly by comparing species diversity along urban-rural gradients at a single time point. A different approach is to focus on the temporal rather than the spatial aspect and perform "before and after" studies where species diversity is cataloged over time in the same sites. The current study examined changes in ant abundance and diversity associated with the conversion of natural habitats into urban habitats. Ant abundance and diversity were tracked in forested sites that became urbanized through construction and were examined at 3 time points - before, during, and after construction. On average, 4.3 +/- 1.2 unique species were detected in undisturbed plots prior to construction. Ant diversity decreased to 0.7 +/- 0.8 species in plots undergoing construction and 1.5 +/- 1.1 species in plots 1 year after construction was completed. With regard to species richness, urbanization resulted in the permanent loss of 17 of the 20 species initially present in the study plots. Recovery was slow and only 3 species were present right after construction was completed and 4 species were present 1 year after construction was completed. The second objective examined ant fauna recovery in developed residential lots based on time since construction, neighboring habitat quality, pesticide inputs, and the presence of invasive ants. Ant diversity was positively correlated with factors that promoted ecological recovery and negatively correlated with factors that promoted ecological degradation. Taken together, these results address a critical gap in our knowledge by characterizing the short-and long-term the effects of urbanization on the loss of ant biodiversity.	[Buczkowski, Grzegorz; Richmond, Douglas S.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Buczkowski, G (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	gbuczkow@purdue.edu			Purdue University	Purdue University	Grzegorz Buczkowski was supported by the Industrial Affiliates Program at Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LW, 1994, URBAN WILDLIFE HABIT; ALBERTI M, 2001, AVIAN ECOLOGY URBANI, P68; Alonso Leeanne E., 2000, P1; Andersen AN, 2002, J APPL ECOL, V39, P8, DOI 10.1046/j.1365-2664.2002.00704.x; Angilletta MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000258; Buczkowski G, 2006, INSECT SOC, V53, P282, DOI 10.1007/s00040-006-0870-0; Buczkowski G, 2012, INSECT SOC, V59, P241, DOI 10.1007/s00040-011-0211-9; Buczkowski G, 2008, ECOL ENTOMOL, V33, P780, DOI 10.1111/j.1365-2311.2008.01034.x; Buczkowski G, 2012, MYRMECOL NEWS, V16, P61; Buczkowski G, 2011, ECOL ENTOMOL, V36, P62, DOI 10.1111/j.1365-2311.2010.01245.x; Buczkowski G, 2010, BIOL INVASIONS, V12, P3343, DOI 10.1007/s10530-010-9727-6; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Clarke Kevin M., 2008, Urban Ecosystems, V11, P317, DOI 10.1007/s11252-008-0065-8; Coovert GA., 2005, ANTS OHIO HYMENOPTER; Cover, 2007, ANTS N AM GUIDE GENE, P145; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; Dauber J, 2006, CONSERV BIOL, V20, P1150, DOI 10.1111/j.1523-1739.2006.00373.x; Gibb H, 2002, BIOL CONSERV, V106, P91, DOI 10.1016/S0006-3207(01)00232-4; Grimm NB, 2000, BIOSCIENCE, V50, P571, DOI 10.1641/0006-3568(2000)050[0571:IATLTO]2.0.CO;2; Hahs AK, 2006, LANDSCAPE URBAN PLAN, V78, P435, DOI 10.1016/j.landurbplan.2005.12.005; Holway DA, 2006, BIOL CONSERV, V127, P319, DOI 10.1016/j.biocon.2005.05.016; Kremen C, 1993, ECOGRAPHY, V27, P57; Lassau SA, 2004, BIOL CONSERV, V106, P91; Lessard JP, 2005, CAN ENTOMOL, V137, P215, DOI 10.4039/N04-055; Marzluff John M., 2001, P19; MCDONNELL MJ, 1990, ECOLOGY, V71, P1232, DOI 10.2307/1938259; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; McIntyre NE, 2001, LANDSCAPE URBAN PLAN, V52, P257, DOI 10.1016/S0169-2046(00)00122-5; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; McKinney ML, 2004, GLOBAL ECOL BIOGEOGR, V13, P47, DOI 10.1111/j.1466-882X.2004.00059.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; McKinney ML, 2001, BIOTIC HOMOGENIZATION, P1; Meissner HE, 2001, J ECON ENTOMOL, V94, P1526, DOI 10.1603/0022-0493-94.6.1526; Menke SB, 2011, URBAN ECOSYST, V14, P135, DOI 10.1007/s11252-010-0150-7; Menke SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009194; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; PASSERA L, 1994, WESTV STUD, P23; Pecarevic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013222; Peck DC, 2009, PEDOBIOLOGIA, V52, P287, DOI 10.1016/j.pedobi.2008.10.003; Philpott SM, 2006, BIODIVERS CONSERV, V15, P139, DOI 10.1007/s10531-004-4247-2; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; Rahel FJ, 2000, SCIENCE, V288, P854, DOI 10.1126/science.288.5467.854; Rooney TP, 2004, CONSERV BIOL, V18, P787, DOI 10.1111/j.1523-1739.2004.00515.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanford MP, 2009, CONSERV BIOL, V23, P131, DOI 10.1111/j.1523-1739.2008.01040.x; SAS Institute, 2008, SAS STAT GUID PERS C; Scharf ME, 2004, J ECON ENTOMOL, V97, P601, DOI 10.1603/0022-0493-97.2.601; Steiner FM, 2008, DIVERS DISTRIB, V14, P538, DOI 10.1111/j.1472-4642.2008.00472.x; Stringer Lloyd D., 2009, Urban Ecosystems, V12, P503, DOI 10.1007/s11252-009-0100-4; Thompson Bill, 2007, Urban Ecosystems, V10, P43, DOI 10.1007/s11252-006-0013-4; THOMPSON CR, 1990, WESTV STUD, P51; Toennisson TA, 2011, ENVIRON ENTOMOL, V40, P1397, DOI 10.1603/EN11110; Underwood EC, 2006, BIOL CONSERV, V132, P166, DOI 10.1016/j.biocon.2006.03.022; Uno Shinsuke, 2010, Urban Ecosystems, V13, P425, DOI 10.1007/s11252-010-0136-5; Vitousek P., 2007, SCIENCE, V277, P494; Wang CL, 2001, ENVIRON ENTOMOL, V30, P842, DOI 10.1603/0046-225X-30.5.842; WILSON EDWARD O., 1955, BULL MUS COMP ZOOL HARVARD UNIV, V113, P1; Wilson JM, 2006, MANAGING GRASSLANDS, P51; Yasuda M, 2009, LANDSCAPE URBAN PLAN, V92, P276, DOI 10.1016/j.landurbplan.2009.05.008; Zipperer WC, 2000, ECOL APPL, V10, P685, DOI 10.2307/2641038	62	71	89	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41729	10.1371/journal.pone.0041729	http://dx.doi.org/10.1371/journal.pone.0041729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876291	Green Published, Green Submitted, gold			2022-12-27	WOS:000307184700019
J	Fukushi, M; Yamashita, M; Miyoshi-Akiyama, T; Kubo, S; Yamamoto, K; Kudo, K				Fukushi, Masaya; Yamashita, Makoto; Miyoshi-Akiyama, Tohru; Kubo, Shuku; Yamamoto, Kenji; Kudo, Koichiro			Laninamivir Octanoate and Artificial Surfactant Combination Therapy Significantly Increases Survival of Mice Infected with Lethal Influenza H1N1 Virus	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISTRESS; NEURAMINIDASE INHIBITOR LANINAMIVIR; B-IMMOBILIZED FIBER; ACUTE LUNG INJURY; PROTEIN-D; A H1N1; PULMONARY SURFACTANT; DIRECT HEMOPERFUSION; CLINICAL-TRIAL; IN-VIVO	Background: Patients with influenza virus infection can develop severe pneumonia and acute respiratory distress syndrome (ARDS) which have a high mortality. Influenza virus infection is treated worldwide mainly by neuraminidase inhibitors (NAIs). However, monotherapy with NAIs is insufficient for severe pneumonia secondary to influenza virus infection. We previously demonstrated that mice infected with a lethal dose of influenza virus develop diffuse alveolar damage (DAD) with alveolar collapse similar to that seen in ARDS in humans. Additionally, pulmonary surfactant proteins were gradually increased in mouse serum, suggesting a decrease in pulmonary surfactant in the lung. Therefore, the present study examined whether combination therapy of NAI with exogenous artificial surfactant affects mortality of influenza virus-infected mice. Methodology/Principal Findings: BALB/c mice were inoculated with several viral doses of influenza A/Puerto Rico/8/34 (PR8) virus (H1N1). The mice were additionally administered exogenous artificial surfactant in the presence or absence of a new NAI, laninamivir octanoate. Mouse survival, body weight and general condition were observed for up to 20 days after inoculation. Viral titer and cytokine/chemokine levels in the lungs, lung weight, pathological analysis, and blood O-2 and CO2 pressures were evaluated. Infected mice treated with combination therapy of laninamivir octanoate with artificial surfactant showed a significantly higher survival rate compared with those that received laninamivir octanoate monotherapy (p = 0.003). However, virus titer, lung weight and cytokine/chemokine responses were not different between the groups. Histopathological examination, a hydrostatic lung test and blood gas analysis showed positive results in the combination therapy group. Conclusions/Significance: Combination therapy of laninamivir octanoate with artificial surfactant reduces lethality in mice infected with influenza virus, and eventually suppresses DAD formation and preserves lung function. This combination could be effective for prevention of severe pneumonia secondary to influenza virus infection in humans, which is not improved by NAI monotherapy.	[Fukushi, Masaya; Kudo, Koichiro] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan; [Fukushi, Masaya; Yamamoto, Kenji] Natl Ctr Global Hlth & Med, Res Inst, Deputy Director Gen Lab, Tokyo, Japan; [Fukushi, Masaya] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Virol, Hiroshima, Japan; [Yamashita, Makoto; Kubo, Shuku] Daiichi Sankyo Co Ltd, Biol Res Labs, Tokyo, Japan; [Miyoshi-Akiyama, Tohru] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Hiroshima University; Daiichi Sankyo Company Limited; National Center for Global Health & Medicine - Japan	Fukushi, M (corresponding author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan.	mfukushi@hiroshima-u.ac.jp	YAMAMOTO, Kenji/I-1758-2013		Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan	The Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHBAUGH DG, 1967, LANCET, V2, P319; Baudouin SV, 2004, NEW ENGL J MED, V351, P853, DOI 10.1056/NEJMp048172; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Confalonieri Marco, 2010, Ther Adv Respir Dis, V4, P233, DOI 10.1177/1753465810376951; Crouch E, 2011, J BIOL CHEM, V286, P40681, DOI 10.1074/jbc.M111.300673; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Eisner MD, 2003, THORAX, V58, P983, DOI 10.1136/thorax.58.11.983; Esteban A, 2004, ANN INTERN MED, V141, P440, DOI 10.7326/0003-4819-141-6-200409210-00009; Fukushi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021207; Gingrich JR, 1996, CANCER RES, V56, P4096; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; Gunther A, 2001, RESPIR RES, V2, P353, DOI 10.1186/rr86; Hartl D, 2006, EUR J CLIN INVEST, V36, P423, DOI 10.1111/j.1365-2362.2006.01648.x; Hasleton P. S., 1996, SPENCERS PATHOLOGY L; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hillaire MLB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025005; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860, DOI 10.1164/ajrccm.152.6.8520747; Hui DS, 2010, CHEST, V137, P916, DOI 10.1378/chest.09-2344; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Inoue T., 2010, Kawasaki Medical Journal, V36, P295; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Iwasaki T, 1999, ARCH VIROL, V144, P675, DOI 10.1007/s007050050535; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Katzenstein A., 2006, SURG PATHOLOGY NONNE; Kesecioglu J, 2009, AM J RESP CRIT CARE, V180, P989, DOI 10.1164/rccm.200812-1955OC; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Kiso M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000786; Kliegman RM, 2020, NELSON TXB PEDIAT; Koyama K, 2010, XENOBIOTICA, V40, P207, DOI 10.3109/00498250903447691; Koyama K, 2009, ANTIMICROB AGENTS CH, V53, P4845, DOI 10.1128/AAC.00731-09; Kubo S, 2010, ANTIMICROB AGENTS CH, V54, P1256, DOI 10.1128/AAC.01311-09; Lucattelli M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-83; Martin R.J, 2011, FANAROFF MARTINS NEO, V9th; Matthay MA, 2010, AM J RESP CRIT CARE, V181, P1027, DOI 10.1164/rccm.201001-0074UP; Murata M, 2010, EXP LUNG RES, V36, P463, DOI 10.3109/01902141003746371; Nakajima N, 2012, MODERN PATHOL, V25, P1, DOI 10.1038/modpathol.2011.125; Namendys-Silva SA, 2010, INTENS CARE MED, V36, P1102, DOI 10.1007/s00134-010-1865-x; Namendys-Silva SA, 2010, INTENS CARE MED, V36, P1097, DOI 10.1007/s00134-010-1814-8; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; OKUNO Y, 1994, J VIROL, V68, P517, DOI 10.1128/JVI.68.1.517-520.1994; Orgeig S, 2010, RESP PHYSIOL NEUROBI, V173, pS43, DOI 10.1016/j.resp.2010.04.023; Ottolini M, 2003, PEDIATR PULM, V36, P290, DOI 10.1002/ppul.10320; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8183; Safronetz D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002426; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Skokic F, 2010, PEDIATR INFECT DIS J, V29, P387, DOI [10.1097/INF.0b013e3181cf2eaa, 10.1097/INF.0b013e3181ce8e81]; Sugaya N, 2010, ANTIMICROB AGENTS CH, V54, P2575, DOI 10.1128/AAC.01755-09; THURLBECK W, 1995, PATHOLOGY LUNG; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Turner DA, 2011, RESP CARE, V56, P941, DOI 10.4187/respcare.01066; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Watanabe A, 2010, CLIN INFECT DIS, V51, P1167, DOI 10.1086/656802; White MR, 2005, AM J PHYSIOL-LUNG C, V288, pL831, DOI 10.1152/ajplung.00365.2004; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yamashita Makoto, 2010, Antiviral Chemistry & Chemotherapy, V21, P71, DOI 10.3851/IMP1688; Yamashita M, 2009, ANTIMICROB AGENTS CH, V53, P186, DOI 10.1128/AAC.00333-08; Yatera K, 2011, INTERNAL MED, V50, P601, DOI 10.2169/internalmedicine.50.4604; Yokoyama T, 2010, J CLIN APHERESIS, V25, P350, DOI 10.1002/jca.20252; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	65	18	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42419	10.1371/journal.pone.0042419	http://dx.doi.org/10.1371/journal.pone.0042419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22879974	Green Published, Green Submitted, gold			2022-12-27	WOS:000307212800090
J	Lague, MN; Romieu-Mourez, R; Bonneil, E; Boyer, A; Pouletty, N; Mes-Masson, AM; Thibault, P; Nadeau, ME; Boerboom, D				Lague, Marie-Noelle; Romieu-Mourez, Raphaelle; Bonneil, Eric; Boyer, Alexandre; Pouletty, Nicolas; Mes-Masson, Anne-Marie; Thibault, Pierre; Nadeau, Marie-Eve; Boerboom, Derek			Proteomic Profiling of a Mouse Model for Ovarian Granulosa Cell Tumor Identifies VCP as a Highly Sensitive Serum Tumor Marker in Several Human Cancers	PLOS ONE			English	Article							VALOSIN-CONTAINING PROTEIN; INCREASED EXPRESSION; ELEVATED EXPRESSION; DISEASE RECURRENCE; P97; PROGNOSIS; CARCINOMA; PROGRESSION; PROSTATE; HORMONE	The initial aim of this study was to identify novel serum diagnostic markers for the human ovarian granulosa cell tumor (GCT), a tumor that represents up to 5% of all ovarian cancers. To circumvent the paucity of human tissues available for analyses, we used the Ctnnb1(tm1Mmt/+); Pten(tm1Hwu/tmiHwu); Amhr2(tm3(cre)Bhr/+) transgenic mouse model, which features the constitutive activation of CTNNB1 signaling combined with the loss of Pten in granulosa cells and develops GCTs that mimic aggressive forms of the human disease. Proteomic profiling by mass spectrometry showed that vinculin, enolase 1, several heat shock proteins, and valosin containing protein (VCP) were more abundantly secreted by cultured mouse GCT cells compared to primary cultured GC. Among these proteins, only VCP was present in significantly increased levels in the preoperative serum of GCT cancer patients compared to normal subjects. To determine the specificity of VCP, serum levels were also measured in ovarian carcinoma, non-Hodgkin's lymphoma and breast, colon, pancreatic, lung, and prostate cancer patients. Increased serum VCP levels were observed in the majority of cancer cases, with the exception of patients with lung or prostate cancer. Moreover, serum VCP levels were increased in some GCT, ovarian carcinoma, breast cancer, and colon cancer patients who did not otherwise display increased levels of widely used serum tumor markers for their cancer type (e. g. inhibin A, inhibin B, CA125, CEA, or CA15.3). These results demonstrate the potential use of VCP as highly sensitive serum marker for GCT as well as several other human cancers.	[Lague, Marie-Noelle; Boyer, Alexandre; Boerboom, Derek] Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, Montreal, PQ, Canada; [Romieu-Mourez, Raphaelle] Lady Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ, Canada; [Romieu-Mourez, Raphaelle] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Bonneil, Eric; Thibault, Pierre] Univ Montreal, Inst Rech Canc & Immunol, Montreal, PQ, Canada; [Pouletty, Nicolas] Univ Montreal, Fac Med Vet, Dept Pathol & Microbiol, Montreal, PQ, Canada; [Mes-Masson, Anne-Marie] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada; [Mes-Masson, Anne-Marie] Inst Canc Montreal, Montreal, PQ, Canada; [Nadeau, Marie-Eve] Univ Montreal, Fac Med Vet, Dept Sci Clin, Montreal, PQ, Canada	Universite de Montreal; Lady Davis Institute; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Lague, MN (corresponding author), Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, Montreal, PQ, Canada.	derek.boerboom@umontreal.ca		Mes-Masson, Anne-Marie/0000-0002-6498-266X; Thibault, Pierre/0000-0001-5993-0331	Canadian Institutes of Health Research [MOP-102508]; Canada Research Chair in Ovarian Molecular Biology and Functional Genomics; National Institutes of Health NICHD (SCCPRR) [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Ovarian Molecular Biology and Functional Genomics(Canada Research Chairs); National Institutes of Health NICHD (SCCPRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported by operating grant MOP-102508 from the Canadian Institutes of Health Research and the Canada Research Chair in Ovarian Molecular Biology and Functional Genomics. The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by the National Institutes of Health NICHD (SCCPRR) Grant U54-HD28934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaiya A, 2005, J PROTEOME RES, V4, P1213, DOI 10.1021/pr050149f; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Boerboom D, 2005, CANCER RES, V65, P9206, DOI 10.1158/0008-5472.CAN-05-1024; CARLSON KJ, 1994, ANN INTERN MED, V121, P124, DOI 10.7326/0003-4819-121-2-199407150-00009; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Fry WHD, 2011, MOL CELL BIOL, V31, P3009, DOI 10.1128/MCB.05105-11; Geerts I, 2009, INT J GYNECOL CANCER, V19, P847, DOI 10.1111/IGC.0b013e3181a702d1; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Lague MN, 2008, CARCINOGENESIS, V29, P2062, DOI 10.1093/carcin/bgn186; Mullany LK, 2011, ONCOGENE, V30, P3522, DOI 10.1038/onc.2011.70; Perkins GL, 2003, AM FAM PHYSICIAN, V68, P1075; Pitteri SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007916; Sturgeon CM, 2008, CLIN CHEM, V54, pE11, DOI 10.1373/clinchem.2008.105601; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wei BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007670; Weihl CC, 2011, J CLIN INVEST, V121, P4627, DOI 10.1172/JCI61126; Yamamoto S, 2005, ANN SURG ONCOL, V12, P925, DOI 10.1245/ASO.2005.07.002; Yamamoto S, 2004, ONCOLOGY-BASEL, V66, P468, DOI 10.1159/000079501; Yamamoto S, 2004, CLIN CANCER RES, V10, P5558, DOI 10.1158/1078-0432.CCR-0723-03; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yamamoto S, 2004, CLIN CANCER RES, V10, P651, DOI 10.1158/1078-0432.CCR-1576-03; Yamamoto S, 2004, ANN SURG ONCOL, V11, P165, DOI 10.1245/ASO.2004.05.012; Yamamoto S, 2003, J CLIN ONCOL, V21, P447, DOI 10.1200/JCO.2003.06.068; ZELEZNIK AJ, 1974, ENDOCRINOLOGY, V95, P818, DOI 10.1210/endo-95-3-818	26	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42470	10.1371/journal.pone.0042470	http://dx.doi.org/10.1371/journal.pone.0042470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870330	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800094
J	Miao, YY; Dong, LD; Chen, J; Hu, XC; Yang, XL; Wang, ZF				Miao, Yanying; Dong, Ling-Dan; Chen, Jie; Hu, Xiao-Chen; Yang, Xiong-Li; Wang, Zhongfeng			Involvement of Calpain/p35-p25/Cdk5/NMDAR Signaling Pathway in Glutamate-Induced Neurotoxicity in Cultured Rat Retinal Neurons	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; GANGLION-CELL DEATH; EXPERIMENTAL GLAUCOMA; NMDA RECEPTORS; NEURITE OUTGROWTH; DOWN-REGULATION; CDK5 ACTIVITY; UP-REGULATION; IN-VITRO; CALPAIN	We investigated possible involvement of a calpain/p35-p25/cyclin-dependent kinase 5 (Cdk5) signaling pathway in modifying NMDA receptors (NMDARs) in glutamate-induced injury of cultured rat retinal neurons. Glutamate treatment decreased cell viability and induced cell apoptosis, which was accompanied by an increase in Cdk5 and p-Cdk5(T15) protein levels. The Cdk5 inhibitor roscovitine rescued the cell viability and inhibited the cell apoptosis. In addition, the protein levels of both calpain 2 and calpain-specific alpha-spectrin breakdown products (SBDPs), which are both Ca2+-dependent, were elevated in glutamate-induced cell injury. The protein levels of Cdk5, p-Cdk5(T15), calpain 2 and SBDPs tended to decline with glutamate treatments of more than 9 h. Furthermore, the elevation of SBDPs was attenuated by either D-APV, a NMDAR antagonist, or CNQX, a non-NMDAR antagonist, but was hardly changed by the inhibitors of intracellular calcium stores dantrolene and xestospongin. Moreover, the Cdk5 co-activator p35 was significantly up-regulated, whereas its cleaved product p25 expression showed a transient increase. Glutamate treatment for less than 9 h also considerably enhanced the ratio of the Cdk5-phosphorylated NMDAR subunit NR2A at Ser1232 site (p-NR2A(S1232)) and NR2A (p-NR2A(S1232)/NR2A), and caused a translocation of p-NR2A(S1232) from the cytosol to the plasma membrane. The enhanced p-NR2A(S1232) was inhibited by roscovitine, but augmented by over-expression of Cdk5. Calcium imaging experiments further showed that intracellular Ca2+ concentrations ([Ca2+](i)) of retinal cells were steadily increased following glutamate treatments of 2 h, 6 h and 9 h. All these results suggest that the activation of the calpain/p35-p25/Cdk5 signaling pathway may contribute to glutamate neurotoxicity in the retina by up-regulating p-NR2A(S1232) expression.	[Miao, Yanying] Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200433, Peoples R China; Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Miao, YY (corresponding author), Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200433, Peoples R China.	yymiao@fudan.edu.cn; zfwang@fudan.edu.cn	Chen, Jie/J-4852-2015	Chen, Jie/0000-0003-0906-0416	National Program of Basic Research; Ministry of Science and Technology of China [2011CB504602]; Natural Science Foundation of China [30900427, 31070966, 30930034]; Key Research Program of Science and Technology Commissions of Shanghai Municipality [11JC1401200]; Research Fund for the Doctoral Program of Higher Education of China [20110071110031]; SRF for ROCS, SEM	National Program of Basic Research(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of Science and Technology Commissions of Shanghai Municipality; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by grants from the National Program of Basic Research sponsored by the Ministry of Science and Technology of China (2011CB504602), the Natural Science Foundation of China (30900427; 31070966; 30930034), the Key Research Program of Science and Technology Commissions of Shanghai Municipality (11JC1401200), Research Fund for the Doctoral Program of Higher Education of China (20110071110031), and SRF for ROCS, SEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Barisic Karmela, 2003, Acta Pharmaceutica (Zagreb), V53, P151; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; Berliocchi L, 2005, PHILOS T R SOC B, V360, P2255, DOI 10.1098/rstb.2005.1765; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Bu BT, 2002, J NEUROSCI, V22, P6515; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Calzada JI, 2002, NEUROCHEM RES, V27, P79, DOI 10.1023/A:1014854606309; Casson RJ, 2006, CLIN EXP OPHTHALMOL, V34, P54, DOI 10.1111/j.1442-9071.2006.01146.x; Caudle WM, 2009, EXP NEUROL, V220, P230, DOI 10.1016/j.expneurol.2009.09.027; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen J, 2011, NEUROBIOL DIS, V43, P455, DOI 10.1016/j.nbd.2011.04.019; Chen Jie, 2010, Shengli Xuebao, V62, P295; Cheng Q, 2003, MOL CELL NEUROSCI, V24, P632, DOI 10.1016/S1044-7431(03)00220-3; Cheung ZH, 2008, J NEUROSCI, V28, P4872, DOI 10.1523/JNEUROSCI.0689-08.2008; Chiu K, 2005, BRAIN RES, V1046, P207, DOI 10.1016/j.brainres.2005.04.016; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Das A, 2006, BRAIN RES, V1084, P146, DOI 10.1016/j.brainres.2006.02.051; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dingledine R, 1999, PHARMACOL REV, V51, P7; Franklin JL, 2011, ANTIOXID REDOX SIGN, V14, P1437, DOI 10.1089/ars.2010.3596; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; GREENAMYRE JT, 1994, NEUROLOGY, V44, P7; Guan JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025735; Guo L, 2006, INVEST OPHTH VIS SCI, V47, P626, DOI 10.1167/iovs.05-0754; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Hosokawa T, 2006, J NEUROSCI RES, V84, P747, DOI 10.1002/jnr.20975; Huang W, 2010, INVEST OPHTH VIS SCI, V51, P3049, DOI 10.1167/iovs.09-4364; Humbert S, 2000, J CELL SCI, V113, P975; Ikiz B, 2008, NEURON, V60, P731, DOI 10.1016/j.neuron.2008.11.020; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; Kerokoski P, 2002, MOL BRAIN RES, V106, P50, DOI 10.1016/S0169-328X(02)00409-6; Kerokoski P, 2004, NEUROSCI LETT, V368, P181, DOI 10.1016/j.neulet.2004.07.007; Kerrison JB, 2007, METH MOL B, V356, P427; Ko J, 2001, J NEUROSCI, V21, P6758; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Kusari J, 2007, INVEST OPHTH VIS SCI, V48, P5152, DOI 10.1167/iovs.07-0427; Lagreze WA, 1998, INVEST OPHTH VIS SCI, V39, P1063; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Lefevre K, 2002, J COMP NEUROL, V447, P72, DOI 10.1002/cne.10215; Li BS, 2003, J BIOL CHEM, V278, P35702, DOI 10.1074/jbc.M302004200; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Li FQ, 2010, J NEUROSCI, V30, P10351, DOI 10.1523/JNEUROSCI.2112-10.2010; Lipton S A, 2001, Prog Brain Res, V131, P712; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; LUCAS DR, 1957, ARCH OPHTHALMOL-CHIC, V58, P193; Luo XM, 2001, INVEST OPHTH VIS SCI, V42, P1096; Luo XG, 2009, CELL MOL NEUROBIOL, V29, P1143, DOI 10.1007/s10571-009-9407-1; McKernan DP, 2007, INVEST OPHTH VIS SCI, V48, P5420, DOI 10.1167/iovs.07-0287; Miao YY, 2010, J NEUROSCI RES, V88, P102, DOI 10.1002/jnr.22188; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nguyen MD, 2003, J NEUROSCI, V23, P2131; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nucci C, 2005, NEUROTOXICOLOGY, V26, P935, DOI 10.1016/j.neuro.2005.06.002; Ohshima T, 2002, J NEUROSCI, V22, P4036, DOI 10.1523/JNEUROSCI.22-10-04036.2002; Oka T, 2006, J NEUROSCI RES, V83, P1342, DOI 10.1002/jnr.20827; Paquet-Durand F, 2007, J NEUROSCI RES, V85, P693, DOI 10.1002/jnr.21151; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118; Rothman Steven M., 1995, Trends in Neurosciences, V18, P57, DOI 10.1016/0166-2236(95)93869-Y; Russo R, 2008, J NEUROCHEM, V107, P1347, DOI 10.1111/j.1471-4159.2008.05694.x; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Seki M, 2008, PROG BRAIN RES, V173, P495, DOI 10.1016/S0079-6123(08)01134-5; Sharma AK, 2004, J BIOL CHEM, V279, P35564, DOI 10.1074/jbc.M401037200; Shen Y, 2006, MOL NEUROBIOL, V34, P163, DOI 10.1385/MN:34:3:163; Skaper SD, 2001, ANN NY ACAD SCI, V939, P11; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Sukharev SA, 1997, CELL DEATH DIFFER, V4, P457, DOI 10.1038/sj.cdd.4400263; Tamada Y, 2005, BRAIN RES, V1050, P148, DOI 10.1016/j.brainres.2005.05.048; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Ullian EM, 2004, MOL CELL NEUROSCI, V26, P544, DOI 10.1016/j.mcn.2004.05.002; Wang CX, 2006, CELL DEATH DIFFER, V13, P1203, DOI 10.1038/sj.cdd.4401804; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Wang Y, 2007, J NEUROCHEM, V103, P439, DOI 10.1111/j.1471-4159.2007.04746.x; WoldeMussie E, 2002, J GLAUCOMA, V11, P474, DOI 10.1097/00061198-200212000-00003; Yang XF, 2011, NEUROSCIENCE, V173, P19, DOI 10.1016/j.neuroscience.2010.11.028; YOSHIMURA N, 1983, J BIOL CHEM, V258, P8883; Zhao PW, 2008, EUR J NEUROSCI, V27, P572, DOI 10.1111/j.1460-9568.2008.06041.x; Zhao WJ, 2010, J PHYSIOL-LONDON, V588, P2605, DOI 10.1113/jphysiol.2010.187641; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	95	43	50	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42318	10.1371/journal.pone.0042318	http://dx.doi.org/10.1371/journal.pone.0042318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870316	gold, Green Published, Green Submitted			2022-12-27	WOS:000307212800079
J	Ioannidis, NE; Lopera, O; Santos, M; Torne, JM; Kotzabasis, K				Ioannidis, Nikolaos E.; Lopera, Oriol; Santos, Mireya; Torne, Josep M.; Kotzabasis, Kiriakos			Role of Plastid Transglutaminase in LHCII Polyamination and Thylakoid Electron and Proton Flow	PLOS ONE			English	Article							CROSS-LINKING ENZYMES; PHOTOSYSTEM-II; IN-VIVO; PHOTOSYNTHETIC APPARATUS; ENERGY-DISSIPATION; XANTHOPHYLL CYCLE; ANTENNA PROTEINS; FLUORESCENCE; STRESS; PHOTOPROTECTION	Transglutaminases function as biological glues in animal cells, plant cells and microbes. In energy producing organelles such as chloroplasts the presence of transglutaminases was recently confirmed. Furthermore, a plastidial transglutaminase has been cloned from maize and the first plants overexpressing tgz are available (Nicotiana tabacum TGZ OE). Our hypothesis is that the overexpression of plastidal transglutaminase will alter photosynthesis via increased polyamination of the antenna of photosystem II. We have used standard analytical tools to separate the antenna from photosystem II in wild type and modified plants, 6 specific antibodies against LHCbs to confirm their presence and sensitive HPLC method to quantify the polyamination level of these proteins. We report that bound spermidine and spermine were significantly increased (similar to 80%) in overexpressors. Moreover, we used recent advances in in vivo probing to study simultaneously the proton and electron circuit of thylakoids. Under physiological conditions overexpressors show a 3-fold higher sensitivity of the antenna down regulation loop (qE) to the elicitor (luminal protons) which is estimated as the Delta pH component of thylakoidal proton motive force. In addition, photosystem (hyper-PSII alpha) with an exceptionally high antenna (large absorption cross section), accumulate in transglutaminase over expressers doubling the rate constant of light energy utilization (K alpha) and promoting thylakoid membrane stacking. Polyamination of antenna proteins is a previously unrecognized mechanism for the modulation of the size (antenna absorption cross section) and sensitivity of photosystem II to down regulation. Future research will reveal which peptides and which residues of the antenna are responsible for such effects.	[Ioannidis, Nikolaos E.; Kotzabasis, Kiriakos] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [Ioannidis, Nikolaos E.; Lopera, Oriol; Santos, Mireya; Torne, Josep M.] CRAG CSIC IRTA UAB UB, Ctr Res Agr Genom, Dept Mol Genet, Barcelona, Spain	University of Crete; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA	Ioannidis, NE (corresponding author), Univ Crete, Dept Biol, Voutes Univ Campus, Iraklion, Crete, Greece.	kotzab@biology.uoc.gr	Kotzabasis, Kiriakos/AAP-1448-2021	Kotzabasis, Kiriakos/0000-0002-1002-6365	Greek Scholarship Foundation (IKY); Spanish projects MEC (Ministerio de Educacion y Ciencia) [BFU2006-15115-01/BMC, BFU2009-08575]	Greek Scholarship Foundation (IKY); Spanish projects MEC (Ministerio de Educacion y Ciencia)	N.E.I. acknowledges Greek Scholarship Foundation (IKY) for a post doctoral research fellowship. This study was supported by the Spanish projects MEC (Ministerio de Educacion y Ciencia) BFU2006-15115-01/BMC and BFU2009-08575. The authors would also like to thank the Spanish Ministry of Science and Innovation, Consolider-Ingenio 2010 Programme, CSD2007-00036 "CRAG'' (Centre for Research in Agricultural Genomics) and the Xarxa de Referencia en Biotecnologia de la Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avenson TJ, 2005, P NATL ACAD SCI USA, V102, P9709, DOI 10.1073/pnas.0503952102; Avenson TJ, 2004, P NATL ACAD SCI USA, V101, P5530, DOI 10.1073/pnas.0401269101; BAKER GM, 1981, BIOCHEMISTRY-US, V20, P2307, DOI 10.1021/bi00511a037; Bernet E, 1999, PLANT PHYSIOL BIOCH, V37, P899, DOI 10.1016/S0981-9428(99)00104-7; Bernet E, 1997, THESIS U BARCELONA B; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Campos A, 2010, PLANT BIOLOGY, V12, P708, DOI 10.1111/j.1438-8677.2009.00280.x; Carvajal P, 2011, BIOTECHNOL PROGR, V27, P232, DOI 10.1002/btpr.538; Carvajal-Vallejos PK, 2007, BIOTECHNOL LETT, V29, P1255, DOI 10.1007/s10529-007-9377-7; Cruz JA, 2001, BIOCHEMISTRY-US, V40, P1226, DOI 10.1021/bi0018741; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; DELDUCA S, 1994, PLANTA, V193, P283, DOI 10.1007/BF00192542; Della Mea M, 2004, PLANTA, V219, P754, DOI 10.1007/s00425-004-1278-6; Dilley RA, 2004, PHOTOSYNTH RES, V80, P245, DOI 10.1023/B:PRES.0000030436.32486.aa; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Hamdani S, 2011, J PHOTOCH PHOTOBIO B, V104, P314, DOI 10.1016/j.jphotobiol.2011.02.007; HIND G, 1974, P NATL ACAD SCI USA, V71, P1484, DOI 10.1073/pnas.71.4.1484; Huber CG, 2001, J BIOL CHEM, V276, P45755, DOI 10.1074/jbc.M106700200; Ioannidis NE, 2007, BBA-BIOENERGETICS, V1767, P1372, DOI 10.1016/j.bbabio.2007.10.002; Ioannidis NE, 2006, BBA-BIOENERGETICS, V1757, P821, DOI 10.1016/j.bbabio.2006.05.034; Ioannidis NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029864; Ioannidis NE, 2011, PHOTOSYNTH RES, V107, P169, DOI 10.1007/s11120-010-9617-x; Ioannidis NE, 2009, BBA-BIOENERGETICS, V1787, P1215, DOI 10.1016/j.bbabio.2009.05.014; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; JUNGE W, 1968, Z NATURFORSCH PT B, VB 23, P244, DOI 10.1515/znb-1968-0222; Kanazawa A, 2002, P NATL ACAD SCI USA, V99, P12789, DOI 10.1073/pnas.182427499; Kereiche S, 2010, FEBS LETT, V584, P759, DOI 10.1016/j.febslet.2009.12.031; KOTZABASIS K, 1993, ANAL BIOCHEM, V214, P484, DOI 10.1006/abio.1993.1526; KOTZABASIS K, 1993, PHOTOSYNTH RES, V38, P83, DOI 10.1007/BF00015064; Kramer DM, 2011, PLANT PHYSIOL, V155, P70, DOI 10.1104/pp.110.166652; Kramer DM, 2003, TRENDS PLANT SCI, V8, P27, DOI 10.1016/S1360-1385(02)00010-9; Kramer DM, 1998, PHOTOSYNTH RES, V56, P103, DOI 10.1023/A:1005968211506; Labate MTV, 2004, PLANT MOL BIOL, V55, P701, DOI 10.1007/s11103-004-1963-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASZLO JA, 1984, BIOCHIM BIOPHYS ACTA, V764, P160, DOI 10.1016/0005-2728(84)90025-2; LASZLO JA, 1984, J BIOENERG BIOMEMBR, V16, P37, DOI 10.1007/BF00744144; Livingston AK, 2010, PLANT CELL, V22, P221, DOI 10.1105/tpc.109.071084; Logothetis K, 2004, J PLANT PHYSIOL, V161, P715, DOI 10.1078/0176-1617-00942; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Navakoudis E, 2007, BBA-BIOENERGETICS, V1767, P261, DOI 10.1016/j.bbabio.2007.02.008; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Ortigosa SM, 2010, PLANTA, V232, P593, DOI 10.1007/s00425-010-1185-y; Pan XW, 2011, NAT STRUCT MOL BIOL, V18, P309, DOI 10.1038/nsmb.2008; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Pinto-Marijuan M, 2007, PHYSIOL PLANTARUM, V131, P159, DOI 10.1111/j.1399-3054.2007.00939.x; Santos M, 2007, MODERN RES ED TOPICS, P212; Serafini-Fracassini D, 2008, ANN BOT-LONDON, V102, P145, DOI 10.1093/aob/mcn075; Sfichi-Duke L, 2008, PLANTA, V228, P341, DOI 10.1007/s00425-008-0741-1; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Takizawa K, 2007, BBA-BIOENERGETICS, V1767, P1233, DOI 10.1016/j.bbabio.2007.07.006; Torne JM, 2003, Patent, Patent No. [1535992, EP1535992]; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsiavos T, 2012, BBA-BIOENERGETICS, V1817, P735, DOI 10.1016/j.bbabio.2012.01.007; Villalobos E, 2004, GENE, V336, P93, DOI 10.1016/j.gene.2004.03.025; Villalobos E, 2001, PROTOPLASMA, V216, P155, DOI 10.1007/BF02673867; Villalobos E, 2007, THESIS U BARCELONA S; Villar-Pique A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013625; Wehner A, 2006, J BIOL CHEM, V281, P21924, DOI 10.1074/jbc.M602915200	62	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41979	10.1371/journal.pone.0041979	http://dx.doi.org/10.1371/journal.pone.0041979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22870182	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200141
J	Samanta, S; Anderson, K; Moran, S; Hawke, D; Gorenstein, D; Fornage, M				Samanta, Susmita; Anderson, Kurtis; Moran, Sean; Hawke, David; Gorenstein, David; Fornage, Myriam			Characterization of a Human 12/15-Lipoxygenase Promoter Variant Associated with Atherosclerosis Identifies Vimentin as a Promoter Binding Protein	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEINS; CORONARY-ARTERY-DISEASE; IN-VITRO; CELLS; EXPRESSION; LDL; MACROPHAGES; PLAQUES; DNA; TRANSCRIPTION	Background: Sequence variation in the human 12/15 lipoxygenase (ALOX15) has been associated with atherosclerotic disease. We functionally characterized an ALOX15 promoter polymorphism, rs2255888, previously associated with carotid plaque burden. Methodology/Principal Findings: We demonstrate specific in vitro and in vivo binding of the cytoskeletal protein, vimentin, to the ALOX15 promoter. We show that the two promoter haplotypes carrying alternate alleles at rs2255888 exhibit significant differences in promoter activity by luciferase reporter assay in two cell lines. Differences in in-vitro vimentin-binding to and formation of DNA secondary structures in the polymorphic promoter sequence are also detected by electrophoretic mobility shift assay and biophysical analysis, respectively. We show regulation of ALOX15 protein by vimentin. Conclusions/Significance: This study suggests that vimentin binds the ALOX15 promoter and regulates its promoter activity and protein expression. Sequence variation that results in changes in DNA conformation and vimentin binding to the promoter may be relevant to ALOX15 gene regulation.	[Samanta, Susmita; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Res Ctr Human Genet, Brown Fdn Inst Mol Med, Houston, TX USA; [Anderson, Kurtis; Gorenstein, David] Univ Texas Hlth Sci Ctr Houston, Ctr Prote & Syst Biol, Brown Fdn Inst Mol Med, Houston, TX USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Sch Publ Hlth, Houston, TX USA; [Anderson, Kurtis] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Moran, Sean] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Hawke, David] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Medical Branch Galveston; Rice University; University of Texas System; UTMD Anderson Cancer Center	Samanta, S (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	Susmita.Samanta@bcm.edu		Hawke, David/0000-0002-6102-7843	National Heart Lung and Blood Institute [HL084099]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084099] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grant HL084099 from the National Heart Lung and Blood Institute to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco-Colio LM, 2006, CARDIOVASC RES, V72, P18, DOI 10.1016/j.cardiores.2006.05.017; DARTSCH PC, 1989, ATHEROSCLEROSIS, V80, P149, DOI 10.1016/0021-9150(89)90023-3; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Funk CD, 2001, TRENDS CARDIOVAS MED, V11, P116; Hartig R, 1998, J CELL SCI, V111, P3573; Heidenthal AK, 2000, BIOCHEM BIOPH RES CO, V267, P49, DOI 10.1006/bbrc.1999.1940; Hersberger M, 2009, ATHEROSCLEROSIS, V205, P192, DOI 10.1016/j.atherosclerosis.2008.11.017; Holwell TA, 1999, J LIPID RES, V40, P1440; Jiang WG, 2006, PROSTAG LEUKOTR ESS, V74, P235, DOI 10.1016/j.plefa.2006.01.009; Kang JH, 2006, PROTEOMICS, V6, P1261, DOI 10.1002/pmic.200500290; Kayama Y, 2009, J EXP MED, V206, P1565, DOI 10.1084/jem.20082596; Kuhn H, 2005, MOL NUTR FOOD RES, V49, P1014, DOI 10.1002/mnfr.200500131; Lian N, 2009, J BIOL CHEM, V284, P30518, DOI 10.1074/jbc.M109.052373; McCaskie PA, 2008, HUM GENET, V123, P445, DOI 10.1007/s00439-008-0496-6; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni134; Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6; Mergui X, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-473; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Nagatoishi S, 2007, ANAL CHIM ACTA, V581, P125, DOI 10.1016/j.aca.2006.08.010; Nakatani Y, 2000, J BIOL CHEM, V275, P1161, DOI 10.1074/jbc.275.2.1161; OSBORN M, 1987, VIRCHOWS ARCH A, V411, P449, DOI 10.1007/BF00735226; Poduri A, 2012, MOL CELL BIOCHEM, V360, P181, DOI 10.1007/s11010-011-1055-3; Qin Z, 2011, J MOL MODEL, V17, P37, DOI 10.1007/s00894-010-0696-6; Qin Z, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425101; Reimann I, 2002, J MOL BIOL, V315, P965, DOI 10.1006/jmbi.2001.5315; RIUS C, 1990, EXP CELL RES, V188, P129, DOI 10.1016/0014-4827(90)90287-K; RIUS C, 1992, J CELL SCI, V101, P395; Rogers KR, 1996, J STRUCT BIOL, V117, P55, DOI 10.1006/jsbi.1996.0069; Schurmann K, 2011, J BIOL CHEM, V286, P23920, DOI 10.1074/jbc.M110.211821; SHOEMAN RL, 1988, J BIOL CHEM, V263, P18744; Takahashi Y, 2005, ANTIOXID REDOX SIGN, V7, P425, DOI 10.1089/ars.2005.7.425; Tolstonog GV, 2005, DNA CELL BIOL, V24, P85, DOI 10.1089/dna.2005.24.85; TRAUB P, 1994, INT REV CYTOL, V154, P1, DOI 10.1016/S0074-7696(08)62198-1; Tuntiwechapikul W, 2006, BIOORG MED CHEM LETT, V16, P4120, DOI 10.1016/j.bmcl.2006.04.078; Vivanco F, 2008, BIOMARK INSIGHTS, V3, P101; Wang Q, 2000, BIOCHEMISTRY-US, V39, P6645, DOI 10.1021/bi000199s; Weibel GL, 2009, ARTERIOSCL THROM VAS, V29, P837, DOI 10.1161/ATVBAHA.109.186163; Wittwer J, 2006, HUM MUTAT, V27, P78, DOI 10.1002/humu.20273; Xu B, 2004, MOL CELL BIOL, V24, P9198, DOI 10.1128/MCB.24.20.9198-9206.2004; Zhang K, 2010, HEART VESSELS, V25, P368, DOI 10.1007/s00380-009-1223-5; Zuo X, 2009, ONCOGENE, V28, P1496, DOI 10.1038/onc.2008.494	41	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42417	10.1371/journal.pone.0042417	http://dx.doi.org/10.1371/journal.pone.0042417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879973	Green Submitted, gold, Green Published			2022-12-27	WOS:000307437900038
J	Schallenberg, S; Petzold, C; Tsai, PY; Sparwasser, T; Kretschmer, K				Schallenberg, Sonja; Petzold, Cathleen; Tsai, Pei-Yun; Sparwasser, Tim; Kretschmer, Karsten			Vagaries of Fluorochrome Reporter Gene Expression in Foxp3(+) Regulatory T Cells	PLOS ONE			English	Article							FOREIGN ANTIGEN; DENDRITIC CELLS; TARGET GENES; IN-VIVO; DIFFERENTIATION; TOLERANCE; AUTOIMMUNITY; THYMOCYTES; INDUCTION; ABSENCE	CD4(+)CD25(+) regulatory T (Treg) cell lineage commitment and expression of the transcription factor Foxp3 can be induced at the CD4(+)CD8(+) double-positive (DP) and CD4(+)CD8(?) single-positive stages of thymic development, as well as in postthymic CD4(+) T cells in peripheral lymphoid tissues. The availability of transgenic mice with Foxp3-dependent fluorochrome reporter gene expression has greatly facilitated studies on the intra-and extrathymic generation of murine Foxp3(+) Treg cells. Here, we performed a comparative analysis of thymic Treg cell development and peripheral compartments of mature Treg cells in various transgenic strains with gene targeted and bacterial artificial chromosome (BAC)-driven Foxp3-fluorochrome expression. These studies revealed a relative deficiency of Foxp3(+) DP thymocytes selectively in mice with targeted insertion of the fluorochrome reporter gene coding sequence into the endogenous Foxp3 gene. While Foxp3 BAC-driven fluorochrome expression in ex vivo CD4(+) T cells was found to faithfully reflect Foxp3 protein expression, we provide evidence that Foxp3 BAC transgenesis can result in sizable populations of Foxp3(+) Treg cells that lack fluorochrome reporter expression. This could be attributed to both timely delayed up-regulation of BAC expression in developing Treg cells and the accumulation of peripheral Foxp3(+) Treg cells with continuous transcriptional inactivity of the Foxp3 BAC transgene.	[Schallenberg, Sonja; Petzold, Cathleen; Tsai, Pei-Yun; Kretschmer, Karsten] Tech Univ Dresden, CRTD DFG Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany; [Sparwasser, Tim] TWINCORE Ctr Expt & Clin Infect Res, Inst Infect Immunol, Hannover, Germany	Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center for Infection Research	Schallenberg, S (corresponding author), Tech Univ Dresden, CRTD DFG Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany.	Karsten.Kretschmer@crt-dresden.de	Tsai, Pei-Yun/L-9386-2013; Sparwasser, Tim/AAF-7085-2019; Kretschmer, Karsten/E-8174-2010; Sparwasser, Tim D/AAA-4306-2022; Schallenberg, Sonja/F-6220-2012	Sparwasser, Tim/0000-0001-5645-902X; Kretschmer, Karsten/0000-0001-6770-4078; 	German Federal Ministry of education and Research (BMBF) [FKZ 01GI1102]; Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus); DFG, Center for Regenerative Therapies Dresden, Cluster of Excellence [FZT 111]	German Federal Ministry of education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus); DFG, Center for Regenerative Therapies Dresden, Cluster of Excellence(German Research Foundation (DFG))	This work was supported by a grant from the German Federal Ministry of education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.); by the Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) funded by the BMBF (FKZ 01GI1102); and by the FZT 111 (DFG, Center for Regenerative Therapies Dresden, Cluster of Excellence). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kretschmer K, 2006, NAT PROTOC, V1, P653, DOI 10.1038/nprot.2006.105; Kretschmer K, 2006, IMMUNOL REV, V212, P163, DOI 10.1111/j.0105-2896.2006.00411.x; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lee HM, 2009, J IMMUNOL, V183, P2261, DOI 10.4049/jimmunol.0901304; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Petzold Cathleen, 2010, Rev Diabet Stud, V7, P47, DOI 10.1900/RDS.2010.7.47; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Schallenberg S, 2010, J EXP MED, V207, P1393, DOI 10.1084/jem.20100045; Sparwasser T, 2007, IMMUNOLOGY, V121, P308, DOI 10.1111/j.1365-2567.2007.02605.x; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stern JNH, 2010, P NATL ACAD SCI USA, V107, P17280, DOI 10.1073/pnas.1010263107; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Verginis P, 2008, P NATL ACAD SCI USA, V105, P3479, DOI 10.1073/pnas.0800149105; Verhagen J, 2010, J IMMUNOL, V185, P7129, DOI 10.4049/jimmunol.1090105; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wirnsberger G, 2009, P NATL ACAD SCI USA, V106, P10278, DOI 10.1073/pnas.0901877106; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	40	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e41971	10.1371/journal.pone.0041971	http://dx.doi.org/10.1371/journal.pone.0041971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879902	Green Submitted, gold, Green Published			2022-12-27	WOS:000307810000012
J	Treacy, O; Ryan, AE; Heinzl, T; O'Flynn, L; Cregg, M; Wilk, M; Odoardi, F; Lohan, P; O'Brien, T; Nosov, M; Ritter, T				Treacy, Oliver; Ryan, Aideen E.; Heinzl, Teresa; O'Flynn, Lisa; Cregg, Marese; Wilk, Mieszko; Odoardi, Francesca; Lohan, Paul; O'Brien, Timothy; Nosov, Mikhail; Ritter, Thomas			Adenoviral Transduction of Mesenchymal Stem Cells: In Vitro Responses and In Vivo Immune Responses after Cell Transplantation	PLOS ONE			English	Article							FUNCTIONAL CHEMOKINE RECEPTORS; MEDIATED GENE-TRANSFER; STROMAL CELLS; DENDRITIC CELLS; ENGRAFTMENT; MIGRATION; THERAPY; VECTORS; MODULATION; EXPRESSION	Adult mesenchymal stem cells (MSCs) are non-hematopoietic cells with multi-lineage potential which makes them attractive targets for regenerative medicine applications. However, to date, therapeutic success of MSC-therapy is limited and the genetic modification of MSCs using viral vectors is one option to improve their therapeutic potential. Ex-vivo genetic modification of MSCs using recombinant adenovirus (Ad) could be promising to reduce undesired immune responses as Ad will be removed before cell/tissue transplantation. In this regard, we investigated whether Ad-modification of MSCs alters their immunological properties in vitro and in vivo. We found that Ad-transduction of MSCs does not lead to up-regulation of major histocompatibility complex class I and II and co-stimulatory molecules CD80 and CD86. Moreover, Ad-transduction caused no significant changes in terms of pro-inflammatory cytokine expression, chemokine and chemokine receptor and Toll-like receptor expression. In addition, Ad-modification of MSCs had no affect on their ability to suppress T cell proliferation in vitro. In vivo injection of Ad-transduced MSCs did not change the frequency of various immune cell populations (antigen presenting cells, T helper and cytotoxic T cells, natural killer and natural killer T cells) neither in the blood nor in tissues. Our results indicate that Ad-modification has no major influence on the immunological properties of MSCs and therefore can be considered as a suitable gene vector for therapeutic applications of MSCs.	[Treacy, Oliver; Ryan, Aideen E.; Heinzl, Teresa; O'Flynn, Lisa; Cregg, Marese; Wilk, Mieszko; Lohan, Paul; O'Brien, Timothy; Nosov, Mikhail; Ritter, Thomas] Natl Univ Ireland, Regenerat Med Inst, Sch Med, Coll Med Nursing & Hlth Sci, Galway, Ireland; [Odoardi, Francesca] Univ Med, Dept Neuroimmunol, Inst Multiple Sclerosis Res, Gottingen, Germany	Ollscoil na Gaillimhe-University of Galway	Treacy, O (corresponding author), Natl Univ Ireland, Regenerat Med Inst, Sch Med, Coll Med Nursing & Hlth Sci, Galway, Ireland.	thomas.ritter@nuigalway.ie	O'Brien, Timothy/N-7112-2014; Treacy, Oliver/AAQ-3679-2020; Ryan, Aideen/H-3909-2019	O'Brien, Timothy/0000-0001-9028-5481; Ryan, Aideen/0000-0002-5831-6783; Wilk, Mieszko/0000-0002-7947-633X; Ritter, Thomas/0000-0001-7709-8489; Treacy, Oliver/0000-0003-3898-9806	Science Foundation Ireland [07/IN.1/B925, 09/SRC/B1794]; Health Research Board [RP/2007/60]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board	This material is based upon works supported by the Science Foundation Ireland (www.sfi.ie) under Grant No. [07/IN.1/B925 and 09/SRC/B1794] and by the Health Research Board (www.hrb.ie) under Grant No. [RP/2007/60]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Basner-Tschakarjan E, 2006, J GENE MED, V8, P1300, DOI 10.1002/jgm.964; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Brandao JG, 2003, VACCINE, V21, P2268, DOI 10.1016/S0264-410X(03)00050-1; Cerullo V, 2007, MOL THER, V15, P378, DOI 10.1038/sj.mt.6300031; Chamberlain G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002934; Chen DM, 2003, AM J TRANSPLANT, V3, P1216, DOI 10.1046/j.1600-6143.2003.00207.x; Chuang CK, 2009, MOL THER, V17, P889, DOI 10.1038/mt.2009.30; DelaRosa O, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/865601; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Duffy GP, 2010, TISSUE ENG PT A, V16, P2755, DOI 10.1089/ten.tea.2009.0623; Edelstein ML, 2007, J GENE MED, V9, P833, DOI 10.1002/jgm.1100; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Griffin M, 2010, DISCOV MED, V9, P219; Hodgkinson CP, 2010, HUM GENE THER, V21, P1513, DOI 10.1089/hum.2010.165; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030; Ip JE, 2007, MOL BIOL CELL, V18, P2873, DOI 10.1091/mbc.E07-02-0166; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; KOLLS J, 1994, P NATL ACAD SCI USA, V91, P215, DOI 10.1073/pnas.91.1.215; Kumar S, 2008, GENE THER, V15, P711, DOI 10.1038/gt.2008.35; Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; McMahon JM, 2006, STEM CELLS DEV, V15, P87, DOI 10.1089/scd.2006.15.87; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rasmusson I, 2006, EXP CELL RES, V312, P2169, DOI 10.1016/j.yexcr.2006.03.019; Ritter T, 1999, EXP EYE RES, V69, P563, DOI 10.1006/exer.1999.0731; Rooney GE, 2008, TISSUE ENG PT A, V14, P681, DOI 10.1089/tea.2007.0260; Schu S, 2011, J CELL MOL MED; Shujia J, 2008, CARDIOVASC RES, V77, P525, DOI 10.1093/cvr/cvm077; Tan PH, 2005, BLOOD, V105, P3824, DOI 10.1182/blood-2004-10-3880; Tang JM, 2010, MOL CELL BIOCHEM, V339, P107, DOI 10.1007/s11010-009-0374-0; Zhang N, 2003, AM J TRANSPLANT, V3, P1230, DOI 10.1046/j.1600-6143.2003.00215.x	38	30	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42662	10.1371/journal.pone.0042662	http://dx.doi.org/10.1371/journal.pone.0042662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880073	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000058
J	Atkinson, J; Pipitone, RN; Sorokowska, A; Sorokowski, P; Mberira, M; Bartels, A; Gallup, GG				Atkinson, Jeremy; Pipitone, R. Nathan; Sorokowska, Agnieszka; Sorokowski, Piotr; Mberira, Mara; Bartels, Astrid; Gallup, Gordon G., Jr.			Voice and Handgrip Strength Predict Reproductive Success in a Group of Indigenous African Females	PLOS ONE			English	Article							BONE-MINERAL DENSITY; FORMANT FREQUENCIES INFLUENCE; ANDROGEN-DEPRIVATION THERAPY; LEAN BODY-MASS; MUSCLE STRENGTH; GRIP STRENGTH; SEXUAL-BEHAVIOR; COGNITIVE IMPAIRMENT; GENETIC INFLUENCES; MENS VOICES	Evolutionary accounts of human traits are often based on proxies for genetic fitness (e.g., number of sex partners, facial attractiveness). Instead of using proxies, actual differences in reproductive success is a more direct measure of Darwinian fitness. Certain voice acoustics such as fundamental frequency and measures of health such as handgrip strength correlate with proxies of fitness, yet there are few studies showing the relation of these traits to reproduction. Here, we explore whether the fundamental frequency of the voice and handgrip strength account for differences in actual reproduction among a population of natural fertility humans. Our results show that both fundamental frequency and handgrip strength predict several measures of reproductive success among a group of indigenous Namibian females, particularly amongst the elderly, with weight also predicting reproductive outcomes among males. These findings demonstrate that both hormonally regulated and phenotypic quality markers can be used as measures of Darwinian fitness among humans living under conditions that resemble the evolutionary environment of Homo sapiens. We also argue that these findings provide support for the Grandmother Hypothesis.	[Atkinson, Jeremy; Gallup, Gordon G., Jr.] SUNY Albany, Dept Psychol, Albany, NY 12222 USA; [Pipitone, R. Nathan] Adams State Univ, Dept Psychol, Alamosa, CO USA; [Sorokowska, Agnieszka; Sorokowski, Piotr] Univ Wroclaw, Inst Psychol, PL-50138 Wroclaw, Poland; [Mberira, Mara] Univ Namibia, Fac Humanities & Social Sci, Windhoek, Namibia; [Bartels, Astrid] Tech Univ Berlin, Inst Sprache & Kommunikat, Berlin, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Wroclaw; University of Namibia; Technical University of Berlin	Atkinson, J (corresponding author), SUNY Albany, Dept Psychol, 1400 Washington Ave, Albany, NY 12222 USA.	ja391266@albany.edu; npipitone@adams.edu		Sorokowska, Agnieszka/0000-0003-3999-8851; Sorokowski, Piotr/0000-0001-9225-9965	University of Wroclaw [2900/W/IPS/08]	University of Wroclaw	Two of the authors (PS and AS) received a grant (2900/W/IPS/08) in the amount of $2,200 USD from the University of Wroclaw. This money was primarily used for travel and was not enough to cover experimental costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol J, 1999, J VOICE, V13, P424, DOI 10.1016/S0892-1997(99)80048-4; Ala-Fossi SL, 1998, MATURITAS, V29, P239, DOI 10.1016/S0378-5122(98)00034-6; Alibhai SMH, 2010, J CLIN ONCOL, V28, P5038, DOI 10.1200/JCO.2010.29.8091; Alonso LC, 2002, BEST PRACT RES CL EN, V16, P13, DOI 10.1053/beem.2002.0177; Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; Arden NK, 1997, J BONE MINER RES, V12, P2076, DOI 10.1359/jbmr.1997.12.12.2076; Asikainen TM, 2006, PHYS THER, V86, P912, DOI 10.1093/ptj/86.7.912; Auyeung TW, 2008, NEUROEPIDEMIOLOGY, V31, P167, DOI 10.1159/000154929; BEVIER WC, 1989, J BONE MINER RES, V4, P421; Bhasin S, 1997, J CLIN ENDOCR METAB, V82, P407, DOI 10.1210/jc.82.2.407; Boersma P, 2021, PRAAT DOING PHONETIC; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Boyle PA, 2008, J AM GERIATR SOC, V58, P248; Buchman AS, 2007, NEUROEPIDEMIOLOGY, V29, P66, DOI 10.1159/000109498; Collins SA, 2003, ANIM BEHAV, V65, P997, DOI 10.1006/anbe.2003.2123; Collins SA, 2000, ANIM BEHAV, V60, P773, DOI 10.1006/anbe.2000.1523; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; Deary IJ, 2006, NEUROLOGY, V67, P1195, DOI 10.1212/01.wnl.0000238520.06958.6a; Evans S, 2006, BIOL PSYCHOL, V72, P160, DOI 10.1016/j.biopsycho.2005.09.003; Evans S, 2008, PHYSIOL BEHAV, V93, P783, DOI 10.1016/j.physbeh.2007.11.033; Feinberg DR, 2008, PERCEPTION, V37, P615, DOI 10.1068/p5514; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; Feinberg DR, 2005, EVOL HUM BEHAV, V26, P398, DOI 10.1016/j.evolhumbehav.2005.04.001; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fink B, 2006, AM J HUM BIOL, V18, P776, DOI 10.1002/ajhb.20549; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Foo LH, 2009, J NUTR, V139, P1002, DOI 10.3945/jn.108.102053; Frederick DA, 2007, PERS SOC PSYCHOL B, V33, P1167, DOI 10.1177/0146167207303022; Frederiksen H, 2002, GENET EPIDEMIOL, V23, P110, DOI 10.1002/gepi.1127; Gallup AC, 2007, EVOL HUM BEHAV, V28, P423, DOI 10.1016/j.evolhumbehav.2007.07.001; Gallup AC, 2010, EVOL PSYCHOL-US, V8, P229, DOI 10.1177/147470491000800207; Gallup GG, 2010, REV GEN PSYCHOL, V14, P240, DOI 10.1037/a0020451; Geliebter A, 1997, AM J CLIN NUTR, V66, P557, DOI 10.1093/ajcn/66.3.557; Gettler LT, 2010, AM J PHYS ANTHROPOL, V142, P590, DOI 10.1002/ajpa.21282; Giampaoli S, 1999, AGE AGEING, V28, P283, DOI 10.1093/ageing/28.3.283; Gibson MA, 2005, EVOL HUM BEHAV, V26, P469, DOI 10.1016/j.evolhumbehav.2005.03.004; GRIGGS RC, 1989, J APPL PHYSIOL, V66, P498, DOI 10.1152/jappl.1989.66.1.498; Hansen L, 1999, J APPL PHYSIOL, V87, P1141, DOI 10.1152/jappl.1999.87.3.1141; Harries M, 1998, J LARYNGOL OTOL, V112, P451, DOI 10.1017/S0022215100140757; Hawkes K, 1997, CURR ANTHROPOL, V38, P551, DOI 10.1086/204646; Hawkes K, 2003, AM J HUM BIOL, V15, P380, DOI 10.1002/ajhb.10156; Hawkes K, 2004, NATURE, V428, P128, DOI 10.1038/428128a; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; Hawkes K, 1989, COMP SOCIOECOLOGY BE, P341; Hodges-Simeon CR, 2011, ARCH SEX BEHAV, V40, P551, DOI 10.1007/s10508-010-9625-0; Hodges-Simeon CR, 2010, HUM NATURE-INT BIOS, V21, P406, DOI 10.1007/s12110-010-9101-5; Hughes S, 1997, J AM GERIATR SOC, V45, P905, DOI 10.1111/j.1532-5415.1997.tb02957.x; Hughes SM, 2004, EVOL HUM BEHAV, V25, P295, DOI 10.1016/j.evolhumbehav.2004.06.001; Hughes SM, 2002, EVOL HUM BEHAV, V23, P173, DOI 10.1016/S1090-5138(01)00099-X; Hughes SM, 2003, EVOL HUM BEHAV, V24, P173, DOI 10.1016/S1090-5138(02)00149-6; Jones BC, 2008, BIOL LETTERS, V4, P192, DOI 10.1098/rsbl.2007.0626; KALLMAN DA, 1990, J GERONTOL, V45, pM82, DOI 10.1093/geronj/45.3.M82; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Kaya A, 2005, ARCH MED RES, V36, P603, DOI 10.1016/j.arcmed.2005.03.026; KRITZSILVERSTEIN D, 1994, J BONE MINER RES, V9, P45, DOI 10.1002/jbmr.5650090107; Kuh D, 2006, J GERONTOL A-BIOL, V61, P702, DOI 10.1093/gerona/61.7.702; LAUKKANEN P, 1995, AGE AGEING, V24, P468, DOI 10.1093/ageing/24.6.468; Malan JS, 2004, PEOPLES OF NAMIBIA; Maltais ML, 2009, J MUSCULOSKEL NEURON, V9, P186; Marlowe F, 2010, HADZA HUNTER GATHERN; Monden CWS, 2009, AM J HUM BIOL, V21, P305, DOI 10.1002/ajhb.20860; Nettle D, 2002, HUM NATURE-INT BIOS, V13, P473, DOI 10.1007/s12110-002-1004-7; Nettle D, 2002, P ROY SOC B-BIOL SCI, V269, P1919, DOI 10.1098/rspb.2002.2111; Norman K, CLIN NUTR IN PRESS; Orsatti FL, 2008, MATURITAS, V59, P394, DOI 10.1016/j.maturitas.2008.04.002; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; PREISINGER E, 1995, MATURITAS, V21, P57, DOI 10.1016/0378-5122(94)00857-4; Puig-Domingo M, 2008, AGING CLIN EXP RES, V20, P439; Puts DA, 2012, J SEX RES, V49, P227, DOI 10.1080/00224499.2012.658924; Puts DA, 2012, P ROY SOC B-BIOL SCI, V279, P601, DOI 10.1098/rspb.2011.0829; Puts DA, 2011, PERS INDIV DIFFER, V50, P111, DOI 10.1016/j.paid.2010.09.011; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; RANTANEN T, 1994, AGE AGEING, V23, P132, DOI 10.1093/ageing/23.2.132; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; Rantanen T, 1998, J APPL PHYSIOL, V85, P2047, DOI 10.1152/jappl.1998.85.6.2047; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Rantanen T, 2003, SCAND J MED SCI SPOR, V13, P3, DOI 10.1034/j.1600-0838.2003.00298.x; RANTANEN T, 1993, EUR J APPL PHYSIOL O, V66, P514, DOI 10.1007/BF00634301; Rantanen Taina, 2002, Aging Clin Exp Res, V14, P10; REED T, 1991, ANN HUM BIOL, V18, P425, DOI 10.1080/03014469100001722; Ridgway CL, 2009, MED SCI SPORT EXER, V41, P1212, DOI 10.1249/MSS.0b013e31819794ab; Rogers SD, 2008, J AGING PHYS ACTIV, V16, P61, DOI 10.1123/japa.16.1.61; Scelza BA, 2011, BIOL LETTERS, V7, P889, DOI 10.1098/rsbl.2011.0478; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Sear R, 2006, HUM NATURE-INT BIOS, V17, P405, DOI 10.1007/s12110-006-1003-1; Sear R, 2009, BIOL LETTERS, V5, P606, DOI 10.1098/rsbl.2009.0342; Sell A, 2010, P ROY SOC B-BIOL SCI, V277, P3509, DOI 10.1098/rspb.2010.0769; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Shoup ML, 2008, EVOL PSYCHOL-US, V6, P469; SINAKI M, 1974, ARCH PHYS MED REHAB, V55, P508; Soyupek F, 2008, UROL ONCOL-SEMIN ORI, V26, P141, DOI 10.1016/j.urolonc.2006.12.014; Taekema DG, 2010, AGE AGEING, V39, P331, DOI 10.1093/ageing/afq022; Tiainen K, 2004, J APPL PHYSIOL, V96, P173, DOI 10.1152/japplphysiol.00200.2003; Vianna LC, 2007, J STRENGTH COND RES, V21, P1310; Vukovic J., 2010, J EVOLUTIONARY PSYCH, V8, P217, DOI [10.1556/JEP.8.2010.3.2, DOI 10.1556/JEP.8.2010.3.2]; Wang C, 2004, J CLIN ENDOCR METAB, V89, P2085, DOI 10.1210/jc.2003-032006; Willcox BJ, 2006, JAMA-J AM MED ASSOC, V296, P2343, DOI 10.1001/jama.296.19.2343; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; WINDSOR JA, 1988, BRIT J SURG, V75, P880, DOI 10.1002/bjs.1800750917; Young RW, 2003, J ANAT, V202, P165, DOI 10.1046/j.1469-7580.2003.00144.x	102	30	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41811	10.1371/journal.pone.0041811	http://dx.doi.org/10.1371/journal.pone.0041811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22870251	Green Submitted, gold, Green Published			2022-12-27	WOS:000307284100032
J	Corrado, C; Flugy, AM; Taverna, S; Raimondo, S; Guggino, G; Karmali, R; De Leo, G; Alessandro, R				Corrado, Chiara; Flugy, Anna Maria; Taverna, Simona; Raimondo, Stefania; Guggino, Giuliana; Karmali, Rashida; De Leo, Giacomo; Alessandro, Riccardo			Carboxyamidotriazole-Orotate Inhibits the Growth of Imatinib-Resistant Chronic Myeloid Leukaemia Cells and Modulates Exosomes-Stimulated Angiogenesis	PLOS ONE			English	Article							BCR-ABL; MICROVESICLES	The Bcr/Abl kinase has been targeted for the treatment of chronic myelogenous leukaemia (CML) by imatinib mesylate. While imatinib has been extremely effective for chronic phase CML, blast crisis CML are often resistant. New therapeutic options are therefore needed for this fatal disease. Although more common in solid tumors, increased microvessel density was also reported in chronic myelogenous leukaemia and was associated with a significant increase of angiogenic factors, suggesting that vascularity in hematologic malignancies is a controlled process and may play a role in the leukaemogenic process thus representing an alternative therapeutic target. Carboxyamidotriazole-orotate (CTO) is the orotate salt form of carboxyamidotriazole (CAI), an orally bioavailable signal transduction inhibitor that in vitro has been shown to possess antileukaemic activities. CTO, which has a reduced toxicity, increased oral bioavailability and stronger efficacy when compared to the parental compound, was tested in this study for its ability to affect imatinib-resistant CML tumor growth in a xenograft model. The active cross talk between endothelial cells and leukemic cells in the bone marrow involving exosomes plays an important role in modulating the process of neovascularization in CML. We have thus investigated the effects of CTO on exosome-stimulated angiogenesis. Our results indicate that CTO may be effective in targeting both cancer cell growth and the tumor microenvironment, thus suggesting a potential therapeutic utility for CTO in leukaemia patients.	[Corrado, Chiara; Flugy, Anna Maria; Taverna, Simona; Raimondo, Stefania; Guggino, Giuliana; De Leo, Giacomo; Alessandro, Riccardo] Univ Palermo, Dipartimento Biopatol & Biotecnol Med & Forensi, Sez Biol & Genet, I-90133 Palermo, Italy; [Karmali, Rashida] Tact Therapeut Inc, New York, NY USA	University of Palermo	Corrado, C (corresponding author), Univ Palermo, Dipartimento Biopatol & Biotecnol Med & Forensi, Sez Biol & Genet, I-90133 Palermo, Italy.	riccardo.alessandro@unipa.it	Taverna, Simona/AAE-7135-2020; RAIMONDO, Stefania/J-7997-2016	RAIMONDO, Stefania/0000-0001-5413-1303; GUGGINO, Giuliana/0000-0003-2479-6958	Tactical Therapeutics Inc, New York, United States of America; University of Palermo; Ministero per l'Universita e per la Ricerca Scientifica e Tecnologica; Tactical Therapeutics	Tactical Therapeutics Inc, New York, United States of America; University of Palermo; Ministero per l'Universita e per la Ricerca Scientifica e Tecnologica; Tactical Therapeutics	This work was supported by Tactical Therapeutics Inc, New York, United States of America; University of Palermo (International Cooperation) to RA; ex 60% Ministero per l'Universita e per la Ricerca Scientifica e Tecnologica to RA, AF and to GDL. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RA received a grant research from Tactical Therapeutics that owns the anticancer drug (CTO) studied in the research. However, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Alessandro R, 2008, J CELL PHYSIOL, V215, P111, DOI 10.1002/jcp.21290; Anderson HC, 2010, LAB INVEST; Corrado C, 2011, CANCER LETT, V300, P205, DOI 10.1016/j.canlet.2010.10.007; D'Asaro M, 2010, J IMMUNOL, V184, P3260, DOI 10.4049/jimmunol.0903454; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Grover G.J., 2007, CANC THER, V5, P437; Hood JL, 2009, LAB INVEST, V89, P1317, DOI 10.1038/labinvest.2009.94; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Hussain MM, 2003, J CLIN ONCOL, V21, P4356, DOI 10.1200/JCO.2003.04.136; Jabbour E, 2011, CANCER-AM CANCER SOC, V117, P1800, DOI 10.1002/cncr.25717; Johnson EA, 2008, LUNG CANCER, V60, P200, DOI 10.1016/j.lungcan.2007.10.003; KOHN EC, 1995, P NATL ACAD SCI USA, V92, P1307, DOI 10.1073/pnas.92.5.1307; Kvasnicka HM, 2004, BLOOD, V103, P3549, DOI 10.1182/blood-2003-08-2734; MINE M, 2011, ANGIOGENESIS; Muller MC, 2009, BLOOD, V114, P4944, DOI 10.1182/blood-2009-04-214221; Naka K, 2010, CANCER SCI, V101, P1577, DOI 10.1111/j.1349-7006.2010.01584.x; Negaard HFS, 2009, LEUKEMIA, V23, P162, DOI 10.1038/leu.2008.255; Patel-Hett S, 2011, INT J DEV BIOL, V55, P353, DOI 10.1387/ijdb.103213sp; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Rodriguez Luis G., 2004, V294, P23; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Schmidt T, 2011, HEMATOL-AM SOC HEMAT, P1, DOI 10.1182/asheducation-2011.1.1; Sonoyama J, 2002, J BIOL CHEM, V277, P8076, DOI 10.1074/jbc.M111501200; Taverna S., 2011, INT J CANC; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wysoczynski M, 2009, INT J CANCER, V125, P1595, DOI 10.1002/ijc.24479; Zhang H, 2008, LEUKEMIA, V22, P1191, DOI 10.1038/leu.2008.74; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	31	39	44	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42310	10.1371/journal.pone.0042310	http://dx.doi.org/10.1371/journal.pone.0042310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879938	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100065
J	Jacquemyn, H; Deja, A; De Hert, K; Bailarote, BC; Lievens, B				Jacquemyn, Hans; Deja, Agnieszka; De Hert, Koen; Bailarote, Bruno Cachapa; Lievens, Bart			Variation in Mycorrhizal Associations with Tulasnelloid Fungi among Populations of Five Dactylorhiza Species	PLOS ONE			English	Article							MYCOHETEROTROPHIC ORCHIDS; DIVERSITY; SPECIFICITY; RARITY; IDENTIFICATION; CONSERVATION; GERMINATION; SEQUENCES; SYMBIOSIS; INSIGHTS	Background: Orchid species rely on mycorrhizal symbioses with fungi to complete their life cycle. Although there is mounting evidence that orchids can associate with several fungi from different clades or families, less is known about the actual geographic distribution of these fungi and how they are distributed across different orchid species within a genus. Methodology/Principal Findings: We investigated among-population variation in mycorrhizal associations in five species of the genus Dactylorhiza (D. fuchsii, D. incarnata, D. maculata, D. majalis and D. praetermissa) using culture-independent detection and identification techniques enabling simultaneous detection of multiple fungi in a single individual. Mycorrhizal specificity, determined as the number of fungal operational taxonomic units (OTUs), and phylogenetic diversity of fungi were compared between species, whereas discriminant analysis was used to compare mycorrhizal spectra across populations and species. Based on a 95% cut-off value in internal transcribed spacer (ITS) sequence similarity, a total of ten OTUs was identified belonging to three different clades within the Tulasnellaceae. Most OTUs were found in two or more Dactylorhiza species, and some of them were common and widespread, occurring in more than 50% of all sampled populations. Each orchid species associated with at least five different OTUs, whereas most individuals also associated with two or more fungal OTUs at the same time. Phylogenetic diversity, corrected for species richness, was not significantly different between species, confirming the generality of the observed orchid mycorrhizal associations. Conclusions/Significance: We found that the investigated species of the genus Dactylorhiza associated with a wide range of fungal OTUs from the Tulasnellaceae, some of which were widespread and common. These findings challenge the idea that orchid rarity is related to mycorrhizal specificity and fungal distribution.	[Jacquemyn, Hans; Deja, Agnieszka; De Hert, Koen; Bailarote, Bruno Cachapa] Katholieke Univ Leuven, Dept Biol, Div Plant Ecol & Systemat, Heverlee, Belgium; [Lievens, Bart] Scientia Terrae Res Inst, St Katelijne Waver, Belgium; [Lievens, Bart] KU Leuven Assoc, Dept Microbial & Mol Syst, CIMB,Lessius Univ Coll, Lab Proc Microbial Ecol & Bioinspirat Management, St Katelijne Waver, Belgium	KU Leuven; KU Leuven	Jacquemyn, H (corresponding author), Katholieke Univ Leuven, Dept Biol, Div Plant Ecol & Systemat, Heverlee, Belgium.	hans.jacquemyn@bio.kuleuven.be	Jacquemyn, Hans/AAC-4875-2019; Lievens, Bart/B-3339-2019	Jacquemyn, Hans/0000-0001-9600-5794; 	European Research Council (ERC) [260601 - MYCASOR]	European Research Council (ERC)(European Research Council (ERC)European Commission)	This research was funded by the European Research Council (ERC starting grant 260601 - MYCASOR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie JC, 2006, CAN J BOT, V84, P1462, DOI 10.1139/B06-101; Bidartondo MI, 2008, MOL ECOL, V17, P3707, DOI 10.1111/j.1365-294X.2008.03848.x; Bidartondo MI, 2004, P ROY SOC B-BIOL SCI, V271, P1799, DOI 10.1098/rspb.2004.2807; Bidartondo MI, 2003, P ROY SOC B-BIOL SCI, V270, P835, DOI 10.1098/rspb.2002.2299; Bonnardeaux Y, 2007, MYCOL RES, V111, P51, DOI 10.1016/j.mycres.2006.11.006; Dearnaley JDW, 2012, FUNGAL ASS, VIX, P207, DOI DOI 10.1007/978-3-642-30826-0_12; Dearnaley JDW, 2007, MYCORRHIZA, V17, P475, DOI 10.1007/s00572-007-0138-1; Devos N, 2006, MOL PHYLOGENET EVOL, V38, P767, DOI 10.1016/j.ympev.2005.11.013; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gebauer G, 2003, NEW PHYTOL, V160, P209, DOI 10.1046/j.1469-8137.2003.00872.x; Girlanda M, 2006, MOL ECOL, V15, P491, DOI 10.1111/j.1365-294X.2005.02770.x; Girlanda M, 2011, AM J BOT, V98, P1148, DOI 10.3732/ajb.1000486; Govaerts R., 2011, WORLD CHECKLIST ORCH; Gura-Tsujita Y, 2008, AM J BOT, V95, P93, DOI 10.3732/ajb.95.1.93; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jacquemyn H, 2005, BIOL CONSERV, V121, P257, DOI 10.1016/j.biocon.2004.05.002; Jacquemyn H, 2011, NEW PHYTOL, V192, P518, DOI 10.1111/j.1469-8137.2011.03796.x; Jacquemyn H, 2010, MOL ECOL, V19, P4086, DOI 10.1111/j.1365-294X.2010.04785.x; Julou T, 2005, NEW PHYTOL, V166, P639, DOI 10.1111/j.1469-8137.2005.01364.x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kristiansen KA, 2001, MOL ECOL, V10, P2089, DOI 10.1046/j.0962-1083.2001.01324.x; Kull T, 2006, BIOL CONSERV, V129, P31, DOI 10.1016/j.biocon.2005.09.046; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leake JR, 2010, NEW PHYTOL, V185, P601, DOI 10.1111/j.1469-8137.2009.03153.x; Liebel HT, 2010, AM J BOT, V97, P903, DOI 10.3732/ajb.0900354; Lievens B, 2003, FEMS MICROBIOL LETT, V223, P113, DOI 10.1016/S0378-1097(03)00352-5; Lievens B, 2010, J MICROBIOL METH, V80, P76, DOI 10.1016/j.mimet.2009.11.004; Martos F, 2009, NEW PHYTOL, V184, P668, DOI 10.1111/j.1469-8137.2009.02987.x; McCormick MK, 2004, NEW PHYTOL, V163, P425, DOI 10.1111/j.1469-8137.2004.01114.x; McCormick MK, 2006, ECOLOGY, V87, P903, DOI 10.1890/0012-9658(2006)87[903:OFAMMT]2.0.CO;2; McKendrick SL, 2002, NEW PHYTOL, V154, P233, DOI 10.1046/j.1469-8137.2002.00372.x; Otero JT, 2006, TRENDS ECOL EVOL, V21, P64, DOI 10.1016/j.tree.2005.11.016; Phillips RD, 2011, J ECOL, V99, P858, DOI 10.1111/j.1365-2745.2011.01797.x; Rasmussen HN, 2009, OIKOS, V118, P334, DOI 10.1111/j.1600-0706.2008.17116.x; Rasmussen HN, 1995, TERRESTRIAL ORCHIDS; Roche SA, 2010, AM J BOT, V97, P1313, DOI 10.3732/ajb.1000049; Roy M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-51; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shefferson RP, 2008, AM J BOT, V95, P156, DOI 10.3732/ajb.95.2.156; Shefferson RP, 2007, EVOLUTION, V61, P1380, DOI 10.1111/j.1558-5646.2007.00112.x; Shefferson RP, 2005, MOL ECOL, V14, P613, DOI 10.1111/j.1365-294X.2005.02424.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stark C, 2009, MYCOL RES, V113, P952, DOI 10.1016/j.mycres.2009.05.002; Suarez JP, 2006, MYCOL RES, V110, P1257, DOI 10.1016/j.mycres.2006.08.004; Swarts ND, 2010, MOL ECOL, V19, P3226, DOI 10.1111/j.1365-294X.2010.04736.x; Swarts ND, 2009, ANN BOT-LONDON, V104, P543, DOI 10.1093/aob/mcp025; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Taylor DL, 2008, NEW PHYTOL, V177, P1020, DOI 10.1111/j.1469-8137.2007.02320.x; Taylor DL, 1997, P NATL ACAD SCI USA, V94, P4510, DOI 10.1073/pnas.94.9.4510; Waterman RJ, 2008, J EXP BOT, V59, P1085, DOI 10.1093/jxb/erm366; Waterman RJ, 2011, AM NAT, V177, pE54, DOI 10.1086/657955; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zettler LW, 2012, AM MIDL NAT, V166, P29	55	49	54	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42212	10.1371/journal.pone.0042212	http://dx.doi.org/10.1371/journal.pone.0042212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870305	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100055
J	Pardoux, R; Sauge-Merle, S; Lemaire, D; Delangle, P; Guilloreau, L; Adriano, JM; Berthomieu, C				Pardoux, Romain; Sauge-Merle, Sandrine; Lemaire, David; Delangle, Pascale; Guilloreau, Luc; Adriano, Jean-Marc; Berthomieu, Catherine			Modulating Uranium Binding Affinity in Engineered Calmodulin EF-Hand Peptides: Effect of Phosphorylation	PLOS ONE			English	Article							PROTEIN-KINASE CK2; AQUEOUS-SOLUTION; AMINO-ACIDS; URANYL-ION; GAS-PHASE; SPECTROSCOPY; COORDINATION; COMPLEXES; CALCIUM; SPECTRA	To improve our understanding of uranium toxicity, the determinants of uranyl affinity in proteins must be better characterized. In this work, we analyzed the contribution of a phosphoryl group on uranium binding affinity in a protein binding site, using the site 1 EF-hand motif of calmodulin. The recombinant domain 1 of calmodulin from A. thaliana was engineered to impair metal binding at site 2 and was used as a structured template. Threonine at position 9 of the loop was phosphorylated in vitro, using the recombinant catalytic subunit of protein kinase CK2. Hence, the T9TKE12 sequence was substituted by the CK2 recognition sequence TAAE. A tyrosine was introduced at position 7, so that uranyl and calcium binding affinities could be determined by following tyrosine fluorescence. Phosphorylation was characterized by ESI-MS spectrometry, and the phosphorylated peptide was purified to homogeneity using ion-exchange chromatography. The binding constants for uranyl were determined by competition experiments with iminodiacetate. At pH 6, phosphorylation increased the affinity for uranyl by a factor of similar to 5, from K-d = 25 +/- 6 nM to K-d = 5 +/- 1 nM. The phosphorylated peptide exhibited a much larger affinity at pH 7, with a dissociation constant in the subnanomolar range (K-d = 0.25 +/- 0.06 nM). FTIR analyses showed that the phosphothreonine side chain is partly protonated at pH 6, while it is fully deprotonated at pH 7. Moreover, formation of the uranyl-peptide complex at pH 7 resulted in significant frequency shifts of the v(as)(P-O) and v(s)(P-O) IR modes of phosphothreonine, supporting its direct interaction with uranyl. Accordingly, a bathochromic shift in v(as)(UO2)(2+) vibration (from 923 cm(-1) to 908 cm(-1)) was observed upon uranyl coordination to the phosphorylated peptide. Together, our data demonstrate that the phosphoryl group plays a determining role in uranyl binding affinity to proteins at physiological pH.	[Pardoux, Romain; Sauge-Merle, Sandrine; Lemaire, David; Guilloreau, Luc; Berthomieu, Catherine] CEA, DSV IBEB, Lab Interact Prot Met, St Paul Les Durance, France; [Pardoux, Romain; Sauge-Merle, Sandrine; Lemaire, David; Guilloreau, Luc; Adriano, Jean-Marc; Berthomieu, Catherine] CNRS, UMR Biol Vegetale & Microbiol Environm, St Paul Les Durance, France; [Pardoux, Romain; Sauge-Merle, Sandrine; Lemaire, David; Guilloreau, Luc; Adriano, Jean-Marc; Berthomieu, Catherine] Univ Aix Marseille, St Paul Les Durance, France; [Delangle, Pascale] CEA, INAC, Serv Chim Inorgan & Biol, UMR E CEA UJF 3, Grenoble, France; [Adriano, Jean-Marc] CEA, DSV IBEB, Lab Bioenerget & Biotechnol Bacteries & Microalg, Grenoble, France	CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Pardoux, R (corresponding author), CEA, DSV IBEB, Lab Interact Prot Met, St Paul Les Durance, France.	catherine.berthomieu@cea.fr	Berthomieu, Catherine/AAX-9559-2021	Berthomieu, Catherine/0000-0001-8784-5396; Sauge-Merle, Sandrine/0000-0003-2721-3885; Lemaire, David/0000-0001-6874-3685	"Toxicologie'' program of the Commissariat a l'energie atomique et aux energies alternatives (CEA) (CalUMo); CEA international program IRTELIS	"Toxicologie'' program of the Commissariat a l'energie atomique et aux energies alternatives (CEA) (CalUMo); CEA international program IRTELIS	This work was funded in part by the "Toxicologie'' program of the Commissariat a l'energie atomique et aux energies alternatives (CEA) (CalUMo). RP acknowledges a PhD grant from the CEA international program IRTELIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananyev GM, 1999, BIOCHEMISTRY-US, V38, P7200, DOI 10.1021/bi990023u; Ansoborlo E, 2006, BIOCHIMIE, V88, P1605, DOI 10.1016/j.biochi.2006.06.011; Averseng O, 2010, ANAL CHEM, V82, P9797, DOI 10.1021/ac102578y; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Barkleit A, 2011, DALTON T, V40, P9868, DOI 10.1039/c1dt10546a; Binstead R. A., 2003, SPECFIT GLOBAL ANAL; Blake RC, 2004, BIOCONJUGATE CHEM, V15, P1125, DOI 10.1021/bc049889p; Brugge Doug, 2005, Reviews on Environmental Health, V20, P177; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Correia CF, 2008, J AM CHEM SOC, V130, P3359, DOI 10.1021/ja073868z; Dedieu A, 2009, J CHROMATOGR A, V1216, P5365, DOI 10.1016/j.chroma.2009.05.023; Deng H, 1998, J PHYS CHEM B, V102, P3617, DOI 10.1021/jp973314q; Duff MR, 2006, ANGEW CHEM INT EDIT, V45, P137, DOI 10.1002/anie.200502344; Hartsock WJ, 2007, CHEM RES TOXICOL, V20, P784, DOI 10.1021/tx600347k; Hillson NJ, 2007, APPL ENVIRON MICROB, V73, P7615, DOI 10.1128/AEM.01566-07; HOFFMANN R, 1994, INT J PEPT PROT RES, V44, P193; Huang H, 2005, INORG CHEM, V44, P813, DOI 10.1021/ic049528l; Jiang J, 2003, INORG CHEM, V42, P1233, DOI 10.1021/ic020460o; KAKIHANA M, 1987, J PHYS CHEM-US, V91, P6128, DOI 10.1021/j100308a015; Koban A, 2007, J INORG BIOCHEM, V101, P750, DOI 10.1016/j.jinorgbio.2007.01.001; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Le Clainche L, 2006, ENVIRON CHEM LETT, V4, P45, DOI 10.1007/s10311-005-0033-y; Le Clainche L, 2003, J BIOL INORG CHEM, V8, P334, DOI 10.1007/s00775-002-0419-2; Li B, 2010, J INORG BIOCHEM, V104, P718, DOI 10.1016/j.jinorgbio.2010.03.004; Liu JW, 2007, P NATL ACAD SCI USA, V104, P2056, DOI 10.1073/pnas.0607875104; MARCHIORI F, 1988, BIOCHIM BIOPHYS ACTA, V971, P332; Marin O, 1997, BIOCHEMISTRY-US, V36, P7192, DOI 10.1021/bi962885q; MCGLYNN SP, 1961, J CHEM PHYS, V35, P105, DOI 10.1063/1.1731876; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Melton SJ, 2009, ENVIRON SCI TECHNOL, V43, P6703, DOI 10.1021/es9007239; Merroun ML, 2005, APPL ENVIRON MICROB, V71, P5532, DOI 10.1128/AEM.71.9.5532-5543.2005; Michon J, 2010, J FLUORESC, V20, P581, DOI 10.1007/s10895-009-0587-3; Montavon G, 2009, J INORG BIOCHEM, V103, P1609, DOI 10.1016/j.jinorgbio.2009.08.010; Muller K, 2008, INORG CHEM, V47, P10127, DOI 10.1021/ic8005103; Muller K, 2009, J PHYS CHEM A, V113, P6626, DOI 10.1021/jp9008948; Pible O, 2006, BIOCHIMIE, V88, P1631, DOI 10.1016/j.biochi.2006.05.015; Pible O, 2010, PROTEIN SCI, V19, P2219, DOI 10.1002/pro.501; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Pollmann K, 2006, BIOTECHNOL ADV, V24, P58, DOI 10.1016/j.biotechadv.2005.06.002; Quadroni M, 1998, BIOCHEMISTRY-US, V37, P6523, DOI 10.1021/bi972930+; Quiles F, 2000, VIB SPECTROSC, V23, P231, DOI 10.1016/S0924-2031(00)00067-9; Reisser-Rubrecht L, 2008, CHEM RES TOXICOL, V21, P349, DOI 10.1021/tx700215e; Sawicki M, 2005, CHEM-EUR J, V11, P3689, DOI 10.1002/chem.200401056; Scapolan S, 1998, RADIAT PROT DOSIM, V79, P505, DOI 10.1093/oxfordjournals.rpd.a032462; Scuderi D, 2009, CHEMPHYSCHEM, V10, P1630, DOI 10.1002/cphc.200800856; Taylor David M., 1997, Reviews on Environmental Health, V12, P147; Van Horn JD, 2006, COORDIN CHEM REV, V250, P765, DOI 10.1016/j.ccr.2005.09.010; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; Vidaud C, 2007, BIOCHEMISTRY-US, V46, P2215, DOI 10.1021/bi061945h; Wegner SV, 2009, ANGEW CHEM INT EDIT, V48, P2339, DOI 10.1002/anie.200805262; Xie Y, 2005, ANAL BIOCHEM, V343, P223, DOI 10.1016/j.ab.2005.05.038; Ye YM, 2005, J AM CHEM SOC, V127, P3743, DOI 10.1021/ja042786x	52	50	53	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41922	10.1371/journal.pone.0041922	http://dx.doi.org/10.1371/journal.pone.0041922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870263	gold, Green Submitted, Green Published			2022-12-27	WOS:000307284100037
J	Rangiani, A; Cao, ZG; Sun, Y; Lu, YB; Gao, T; Yuan, BZ; Rodgers, A; Qin, CL; Kuro-o, M; Feng, JQ				Rangiani, Afsaneh; Cao, Zhengguo; Sun, Yao; Lu, Yongbo; Gao, Tian; Yuan, Baozhi; Rodgers, Anika; Qin, Chunlin; Kuro-o, Makoto; Feng, Jian Q.			Protective Roles of DMP1 in High Phosphate Homeostasis	PLOS ONE			English	Article							MATRIX PROTEIN-1 DMP1; SOFT-TISSUE CALCIFICATION; CHRONIC KIDNEY-DISEASE; HYPOPHOSPHATEMIC RICKETS; COMPUTED-TOMOGRAPHY; DMP1-DEFICIENT MICE; PATHOGENIC ROLE; DEFICIENT MICE; MOUSE MODEL; IN-VIVO	Purpose: Dmp1 (dentin matrix protein1) null mice (Dmp1(-/-)) display hypophosphatemic rickets with a sharp increase in fibroblast growth factor 23 (FGF23). Disruption of Klotho (the obligatory co-receptor of FGF23) results in hyperphosphatemia with ectopic calcifications formed in blood vessels and kidneys. To determine the role of DMP1 in both a hyperphosphatemic environment and within the ectopic calcifications, we created Dmp1/Klotho compound deficient (Dmp1(-/-)kl/kl) mice. Procedures: A combination of TUNEL, immunohistochemistry, TRAP, von Kossa, micro CT, bone histomorphometry, serum biochemistry and Scanning Electron Microscopy techniques were used to analyze the changes in blood vessels, kidney and bone for wild type control, Dmp1(-/-), Klotho deficient (kl/kl) and Dmp1(-/-)kl/kl animals. Findings: Interestingly, Dmp1(-/-)kl/kl mice show a dramatic improvement of rickets and an identical serum biochemical phenotype to kl/kl mice (extremely high FGF23, hyperphosphatemia and reduced parathyroid hormone (PTH) levels). Unexpectedly, Dmp1(-/-)kl/kl mice presented elevated levels of apoptosis in osteocytes, endothelial and vascular smooth muscle cells in small and large blood vessels, and within the kidney as well as dramatic increase in ectopic calcification in all these tissues, as compared to kl/kl. Conclusion: These findings suggest that DMP1 has an anti-apoptotic role in hyperphosphatemia. Discovering this novel protective role of DMP1 may have clinical relevance in protecting the cells from apoptosis in high-phosphate environments as observed in chronic kidney disease (CKD).	[Rangiani, Afsaneh; Cao, Zhengguo; Sun, Yao; Lu, Yongbo; Gao, Tian; Rodgers, Anika; Qin, Chunlin; Feng, Jian Q.] Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dallas, TX USA; [Yuan, Baozhi] Univ Wisconsin, Madison, WI USA; [Yuan, Baozhi] GRECC, Madison, WI USA; [Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Cao, Zhengguo] Wuhan Univ, Dept Periodontol, Sch & Hosp Stomatol,Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China; [Cao, Zhengguo] Wuhan Univ, Dept Periodontol, Sch & Hosp Stomatol,Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Wuhan University; Wuhan University	Rangiani, A (corresponding author), Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dallas, TX USA.	arangiani@bcd.tamhsc.edu		Lu, Yongbo/0000-0003-3692-1736; Cao, Zhengguo/0000-0002-4261-9034	NIH [DE018486, DE005092]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018486, R01DE005092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE005092] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was partly supported by NIH Grant DE018486 (to JQF) and DE005092 (to CQ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XY, 2003, J BIOL CHEM, V278, P9843, DOI 10.1074/jbc.M210490200; Brownstein CA, 2010, ENDOCRINOLOGY, V151, P492, DOI 10.1210/en.2009-0564; Di Marco GS, 2008, AM J PHYSIOL-RENAL, V294, pF1381, DOI 10.1152/ajprenal.00003.2008; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Foster Brian L., 2008, Birth Defects Research, V84, P281, DOI 10.1002/bdrc.20136; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Kestenbaum B, 2007, SEMIN DIALYSIS, V20, P286, DOI 10.1111/j.1525-139X.2007.00303.x; Kuro-o M, 2010, MECH AGEING DEV, V131, P270, DOI 10.1016/j.mad.2010.02.008; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Liu SG, 2008, AM J PHYSIOL-ENDOC M, V295, pE254, DOI 10.1152/ajpendo.90201.2008; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; Lu YB, 2011, J BONE MINER RES, V26, P331, DOI 10.1002/jbmr.226; Lv K, 2010, INT J BIOL SCI, V6, P537; Maciejewska I, 2009, J HISTOCHEM CYTOCHEM, V57, P155, DOI 10.1369/jhc.2008.952630; Maekawa Y, 2011, GERIATR GERONTOL INT; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Mathew S, 2008, J AM SOC NEPHROL, V19, P1092, DOI 10.1681/ASN.2007070760; Meleti Z, 2000, BONE, V27, P359, DOI 10.1016/S8756-3282(00)00346-X; Memon F, 2008, KIDNEY INT, V74, P566, DOI 10.1038/ki.2008.218; Moe SM, 2004, CIRC RES, V95, P560, DOI 10.1161/01.RES.0000141775.67189.98; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; O'Rourke RA, 2000, J AM COLL CARDIOL, V36, P326, DOI 10.1016/S0735-1097(00)00831-7; Ogbureke KUE, 2005, KIDNEY INT, V68, P155, DOI 10.1111/j.1523-1755.2005.00389.x; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Prasad M, 2011, J HISTOCHEM CYTOCHEM, V59, P1009, DOI 10.1369/0022155411423406; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; Sabbagh Y, 2005, P NATL ACAD SCI USA, V102, P9637, DOI 10.1073/pnas.0502249102; Schiavi SC, 2004, KIDNEY INT, V65, P1, DOI 10.1111/j.1523-1755.2004.00355.x; Schlieper G, 2010, J AM SOC NEPHROL, V21, P689, DOI 10.1681/ASN.2009080829; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shroff RC, 2010, J AM SOC NEPHROL, V21, P103, DOI 10.1681/ASN.2009060640; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Sitara D, 2006, AM J PATHOL, V169, P2161, DOI 10.2353/ajpath.2006.060329; Takeda E, 2004, J CELL MOL MED, V8, P191, DOI 10.1111/j.1582-4934.2004.tb00274.x; Terasawa M, 2004, J BONE MINER METAB, V22, P430, DOI 10.1007/s00774-004-0504-4; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; Yamashita T, 2000, J ENDOCRINOL, V164, P239, DOI 10.1677/joe.0.1640239; Ye L, 2008, J DENT RES, V87, P624, DOI 10.1177/154405910808700708; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Zhang R, 2011, J BONE MINER RES, V26, P1047, DOI 10.1002/jbmr.294	51	18	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42329	10.1371/journal.pone.0042329	http://dx.doi.org/10.1371/journal.pone.0042329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879941	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100068
J	Sutterby, SR; Bedwell, JS				Sutterby, Scott R.; Bedwell, Jeffrey S.			Lack of Neuropsychological Deficits in Generalized Social Phobia	PLOS ONE			English	Article							POSTEVENT RUMINATION; COGNITIVE FUNCTION; JUDGMENTAL BIASES; ANXIETY; PERFORMANCE; DISORDER; FACES; INDIVIDUALS; SPECIFICITY; DEPRESSION	There are relatively few existing studies examining neuropsychological functioning in social phobia (SP), which collectively yield mixed results. Interpretation of results is further complicated by a number of methodological inconsistencies across studies, including the examination of neuropsychological domains in relative isolation from one another. The present study utilized a broader collection of neuropsychological tests to assess nine domains of functioning in 25 individuals diagnosed with generalized SP and 25 nonpsychiatric controls (NC). A mixed ANOVA revealed neither a significant group by domain interaction, nor a significant main effect of group. Furthermore, no significant group differences emerged between the SP and NC groups within each specific neuropsychological domain. These findings suggest that underlying neuropsychological deficits are not likely to account for the information processing biases observed in the empirical literature, and appear to be consistent with current theoretical models which argue for the specificity of these biases to social information.	[Sutterby, Scott R.; Bedwell, Jeffrey S.] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Sutterby, SR (corresponding author), Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA.	jeffrey.bedwell@ucf.edu		Bedwell, Jeffrey/0000-0002-1205-5792				Abbott MJ, 2004, J ABNORM PSYCHOL, V113, P136, DOI 10.1037/0021-843X.113.1.136; Airaksinen E, 2005, J PSYCHIAT RES, V39, P207, DOI 10.1016/j.jpsychires.2004.06.001; Amir N, 2005, BIOL PSYCHIAT, V57, P975, DOI 10.1016/j.biopsych.2005.01.044; Amir N, 1998, J ABNORM PSYCHOL, V107, P285, DOI 10.1037/0021-843X.107.2.285; AMIR N, 1998, BEHAV RES THER, V36, P945, DOI DOI 10.1016/S0005-7967(98)00060-6; ASMUNDSON GJG, 1994, ANXIETY, V1, P201; Brown T. A., 1994, ANXIETY DISORDERS IN; BUCKELEW SP, 1986, PERCEPT MOTOR SKILL, V63, P711, DOI 10.2466/pms.1986.63.2.711; Campbell DW, 2009, DEPRESS ANXIETY, V26, P419, DOI 10.1002/da.20474; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Cohen LJ, 1996, J NEUROPSYCH CLIN N, V8, P82; Constans JI, 1999, BEHAV RES THER, V37, P643, DOI 10.1016/S0005-7967(98)00180-6; Foa EB, 2000, J ANXIETY DISORD, V14, P501, DOI 10.1016/S0887-6185(00)00036-0; Graver CJ, 2007, BEHAV RES THER, V45, P1193, DOI 10.1016/j.brat.2006.08.002; Hackmann A, 2000, BEHAV RES THER, V38, P601, DOI 10.1016/S0005-7967(99)00161-8; Hackmann A., 1998, BEHAV COGN PSYCHOTH, V26, P3, DOI [10.1017/S1352465898000022, DOI 10.1017/S1352465898000022]; Hofmann SG, 2003, COGNITIVE THER RES, V27, P131, DOI 10.1023/A:1023507624356; Hollander E, 1996, NEUROPSY NEUROPSY BE, V9, P182; Kolassa IT, 2009, COGNITION EMOTION, V23, P69, DOI 10.1080/02699930801940461; Leininger S, 2012, ARCH CLIN NEUROPSYCH, V27, P318, DOI 10.1093/arclin/acs035; Lundh LG, 1996, BEHAV RES THER, V34, P787, DOI 10.1016/0005-7967(96)00035-6; MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3; Meyers J.E., 1996, REY COMPLEX FIGURE T; Mialet J, 1996, EUR PSYCHIAT, V11, P334; Mogg K, 2002, BEHAV RES THER, V40, P1403, DOI 10.1016/S0005-7967(02)00017-7; O'Toole MS, 2011, NORD J PSYCHIAT, V65, P147, DOI 10.3109/08039488.2011.565801; Perini SJ, 2006, COGNITIVE THER RES, V30, P645, DOI 10.1007/s10608-006-9023-z; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Roberson-Nay R, 2007, PSYCHOL ASSESSMENT, V19, P133, DOI 10.1037/1040-3590.19.1.133; Sachs G, 2004, PSYCHIAT RES-NEUROIM, V131, P249, DOI 10.1016/j.pscychresns.2004.05.005; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stopa L, 2000, BEHAV RES THER, V38, P273, DOI 10.1016/S0005-7967(99)00043-1; TURNER SM, 1992, BEHAV THER, V23, P389, DOI 10.1016/S0005-7894(05)80165-0; Vassilopoulos SP, 2005, ANXIETY STRESS COPIN, V18, P321, DOI 10.1080/10615800500258149; Voncken MJ, 2007, PSYCHOL PSYCHOTHER-T, V80, P443, DOI 10.1348/147608306X161890; Voncken MJ, 2003, BEHAV RES THER, V41, P1481, DOI 10.1016/S0005-7967(03)00143-8; Wechsler D, 1997, ADM SCORING GUIDE WA, V3; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wolfson D., 1985, HALSTED REITAN NEURO; [No title captured], DOI DOI 10.1016/S0887-6177(97)00013-9	40	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42675	10.1371/journal.pone.0042675	http://dx.doi.org/10.1371/journal.pone.0042675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22880078	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100154
J	Wang, RX; Sun, XJ; Wang, CY; Hu, PZ; Chu, CY; Liu, SR; Zhau, HE; Chung, LWK				Wang, Ruoxiang; Sun, Xiaojuan; Wang, Christopher Y.; Hu, Peizhen; Chu, Chia-Yi; Liu, Shurong; Zhau, Haiyen E.; Chung, Leland W. K.			Spontaneous Cancer-Stromal Cell Fusion as a Mechanism of Prostate Cancer Androgen-Independent Progression	PLOS ONE			English	Article							MITOTIC CATASTROPHE; BONE FIBROBLASTS; SARCOMA-CELLS; GROWTH-INVIVO; METASTASIS; HYBRIDS; CHROMOSOME; DIFFERENTIATION; CHECKPOINT; ANEUPLOIDY	We have previously shown that human prostate cancer cells are capable of acquiring malignant attributes through interaction with stromal cells in the tumor microenvironment, while the interacting stromal cells can also become affected with both phenotypic and genotypic alterations. This study used a co-culture model to investigate the mechanism underlying the co-evolution of cancer and stromal cells. Red fluorescent androgen-dependent LNCaP prostate cancer cells were cultured with a matched pair of normal and cancer-associated prostate myofibroblast cells to simulate cancer-stromal interaction, and cellular changes in the co-culture were documented by tracking the red fluorescence. We found frequent spontaneous fusions between cancer and stromal cells throughout the co-culture. In colony formation assays assessing the fate of the hybrid cells, most of the cancer-stromal fusion hybrids remained growth-arrested and eventually perished. However, some of the hybrids survived to form colonies from the co-culture with cancer-associated stromal cells. These derivative clones showed genomic alterations together with androgen-independent phenotype. The results from this study reveal that prostate cancer cells are fusogenic, and cancer-stromal interaction can lead to spontaneous fusion between the two cell types. While a cancer-stromal fusion strategy may allow the stromal compartment to annihilate invading cancer cells, certain cancer-stromal hybrids with increased survival capability may escape annihilation to form a derivative cancer cell population with an altered genotype and increased malignancy. Cancer-stromal fusion thus lays a foundation for an incessant co-evolution between cancer and the cancer-associated stromal cells in the tumor microenvironment.	[Wang, Ruoxiang; Hu, Peizhen; Zhau, Haiyen E.; Chung, Leland W. K.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Wang, Ruoxiang; Sun, Xiaojuan; Wang, Christopher Y.; Chu, Chia-Yi; Liu, Shurong] Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA	Cedars Sinai Medical Center; Emory University	Wang, RX (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.	ruoxiang.wang@cshs.org			NCI/NIH (National Cancer Institute of the National Institutes of Health of the United States.) [R21CA112330, CA132388]; DoD [PC040578]; NCI/NIH [CA98912-02]; NATIONAL CANCER INSTITUTE [P01CA098912, P20CA132388, R21CA112330] Funding Source: NIH RePORTER	NCI/NIH (National Cancer Institute of the National Institutes of Health of the United States.); DoD(United States Department of Defense); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by research grants R21CA112330 and CA132388 from NCI/NIH (National Cancer Institute of the National Institutes of Health of the United States.), and PC040578 from DoD to Ruoxiang Wang; and NCI/NIH grant CA98912-02 to Leland W. K. Chung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichel O., 1911, ZELLVERSCHMELZUNG QU; Arnold JT, 2002, ENDOCR-RELAT CANCER, V9, P61, DOI 10.1677/erc.0.0090061; BARSKI G, 1961, J NATL CANCER I, V26, P1269; BARSKI G, 1962, J NATL CANCER I, V28, P801; Bjerregaard B, 2006, CELL MOL LIFE SCI, V63, P1906, DOI 10.1007/s00018-006-6201-9; Busund LTR, 2002, INT J CANCER, V98, P573, DOI 10.1002/ijc.10249; Canman CE, 2001, CURR BIOL, V11, pR121, DOI 10.1016/S0960-9822(01)00057-4; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Castedo M, 2004, ONCOGENE, V23, P4353, DOI 10.1038/sj.onc.1207573; Chakraborty AK, 2000, CANCER RES, V60, P2512; Chaudhary KS, 1999, ENVIRON HEALTH PERSP, V107, P49, DOI 10.2307/3434471; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; CHUNG LWK, 1993, SEMIN CANCER BIOL, V4, P183; Chung LWK, 2005, J UROLOGY, V173, P10, DOI 10.1097/01.ju.0000141582.15218.10; CHUNG LWK, 1991, CANCER SURV, V11, P91; ENG B, 1994, J FORENSIC SCI, V39, P1356; GLEAVE M, 1991, CANCER RES, V51, P3753; GLEAVE ME, 1992, J UROLOGY, V147, P1151, DOI 10.1016/S0022-5347(17)37506-7; Hasegawa T, 2000, J VET MED SCI, V62, P1109, DOI 10.1292/jvms.62.1109; KING KL, 1995, J CELL BIOCHEM, V58, P175, DOI 10.1002/jcb.240580206; Larsson LI, 2008, HISTOCHEM CELL BIOL, V129, P551, DOI 10.1007/s00418-008-0411-1; Larsson LI, 2007, THESCIENTIFICWORLDJO, V7, P1193, DOI 10.1100/tsw.2007.212; LIEBER MM, 1992, J CELL BIOCHEM, P44; Mortensen K, 2004, CELL MOL LIFE SCI, V61, P2125, DOI 10.1007/s00018-004-4200-2; Murillo H, 2006, GENE CHROMOSOME CANC, V45, P702, DOI 10.1002/gcc.20333; Navarro D, 2002, J STEROID BIOCHEM, V81, P191, DOI 10.1016/S0960-0760(02)00064-X; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Pawelek JM, 2005, LANCET ONCOL, V6, P988, DOI 10.1016/S1470-2045(05)70466-6; Pawelek JM, 2000, MELANOMA RES, V10, P507, DOI 10.1097/00008390-200012000-00001; PETERS J M, 1989, Henry Ford Hospital Medical Journal, V37, P8; Podbilewicz Benjamin, 2006, WormBook, P1; Rachkovsky M, 1998, CLIN EXP METASTAS, V16, P299; Rhee HW, 2001, IN VITRO CELL DEV-AN, V37, P127; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; STONE JF, 1995, MUTAT RES-DNAGING G, V338, P107, DOI 10.1016/0921-8734(95)00016-Y; Sun XJ, 2010, IN VITRO CELL DEV-AN, V46, P538, DOI 10.1007/s11626-010-9309-z; Sung SY, 2008, CANCER RES, V68, P9996, DOI 10.1158/0008-5472.CAN-08-2492; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; THALMANN GN, 1994, CANCER RES, V54, P2577; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; Verma RS, 1999, CANCER INVEST, V17, P441, DOI 10.3109/07357909909021436; WAKELING WF, 1994, CELL BIOL INT, V18, P207, DOI 10.1006/cbir.1994.1063; Wang RX, 2004, CANCER RES, V64, P1589, DOI 10.1158/0008-5472.CAN-03-3331; WIENER F, 1974, P NATL ACAD SCI USA, V71, P148, DOI 10.1073/pnas.71.1.148; WIENER F, 1974, J NATL CANCER I, V52, P1779, DOI 10.1093/jnci/52.6.1779; Wong AK, 2008, ARCH PATHOL LAB MED, V132, P1329, DOI 10.1043/1543-2165(2008)132[1329:LOTYCA]2.0.CO;2; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319	49	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42653	10.1371/journal.pone.0042653	http://dx.doi.org/10.1371/journal.pone.0042653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880071	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100152
J	Maxwell, EE; Fernandez, MS; Schoch, RR				Maxwell, Erin E.; Fernandez, Marta S.; Schoch, Rainer R.			First Diagnostic Marine Reptile Remains from the Aalenian (Middle Jurassic): A New Ichthyosaur from Southwestern Germany	PLOS ONE			English	Article							GENUS; STENOPTERYGIUS; TENUIROSTRIS; BAJOCIAN; BASIN	Background: The Middle Jurassic was a critical time in the evolutionary history of ichthyosaurs. During this time interval, the diverse, well-studied faunas of the Lower Jurassic were entirely replaced by ophthalmosaurids, a new group that arose sometime prior to the Aalenian-Bajocian boundary and by the latest middle Jurassic comprised the only surviving group of ichthyosaurs. Thus, the Middle Jurassic Aalenian-Bathonian interval (176-165 million years ago) comprises the time frame during which ophthalmosaurids not only originated but also achieved taxonomic dominance. However, diagnostic ichthyosaur remains have been described previously from only a single locality from this interval, from the Bajocian of Argentina. Methodology/Principal Findings: In this paper, we describe a new species of ichthyosaur based on a partial articulated specimen from the Middle Jurassic of southwestern Germany. This specimen was recovered from the Opalinuston Formation (early Aalenian) and is referable to Stenopterygius aaleniensis sp. nov. reflecting features of the skull and forefin. The genus Stenopterygius is diverse and abundant in the Lower Jurassic of Europe, but its presence has not previously been confirmed in younger (Middle Jurassic) rocks from the northern hemisphere. Conclusions/Significance: This specimen represents the only diagnostic ichthyosaur remains reported from the Aalenian. It bears numerous similarities in size and in morphology to the Lower Jurassic species of the genus Stenopterygius and provides additional evidence that the major ecological changes hypothesized to have occurred at the end of the Toarcian took place sometime after this point and most likely did not occur suddenly. There is currently no evidence for the presence of ophthalmosaurids in the northern hemisphere during the Aalenian-Bathonian interval.	[Maxwell, Erin E.; Schoch, Rainer R.] Staatliches Museum Nat Kunde, Stuttgart, Germany; [Maxwell, Erin E.] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Berlin, Germany; [Fernandez, Marta S.] Museo La Plata, Dept Paleontol Vertebrados, La Plata, Buenos Aires, Argentina	Leibniz Institut fur Evolutions und Biodiversitatsforschung; National University of La Plata; Museo La Plata	Maxwell, EE (corresponding author), Staatliches Museum Nat Kunde, Stuttgart, Germany.	emaxwell@ualberta.ca		Maxwell, Erin/0000-0002-6032-6251; Fernandez, Marta/0000-0001-6935-7575	Natural Sciences and Engineering Research Council of Canada; Alexander von Humboldt postdoctoral fellowships; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina;  [PIP 0426]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alexander von Humboldt postdoctoral fellowships; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); 	This project was funded through Natural Sciences and Engineering Research Council of Canada and Alexander von Humboldt postdoctoral fellowships to EM, and PIP 0426, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina, to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews C.W, 1910, DESCRIPTIVE CATALOGU; Arkhangel'skii M.S., 2002, IZV VYSSH UCHEBN ZAV, P14; Arnaud M., 1976, Bulletin du Museum d'Histoire Naturelle de Marseille, V36, P17; Bardet Nathalie, 1994, Historical Biology, V7, P313; Benson RBJ, 2010, P ROY SOC B-BIOL SCI, V277, P829, DOI 10.1098/rspb.2009.1845; Buchholtz EA, 2001, J VERTEBR PALEONTOL, V21, P61, DOI 10.1671/0272-4634(2001)021[0061:SSIJI]2.0.CO;2; Cabrera xC., 1939, Notas del Museo de La Plata Paleontologia, V4, P485; Caine H, 2011, PALAEONTOLOGY, V54, P1069, DOI 10.1111/j.1475-4983.2011.01093.x; Druckenmiller PS, 2010, CAN J EARTH SCI, V47, P1037, DOI 10.1139/E10-028; Fernandez Marta, 1994, Ameghiniana, V31, P291; Fernandez MS, 2005, J VERTEBR PALEONTOL, V25, P330, DOI 10.1671/0272-4634(2005)025[0330:IEPICI]2.0.CO;2; Fernandez MS, 1999, J PALEONTOL, V73, P677, DOI 10.1017/S0022336000032492; Fernandez MS, 2003, J VERTEBR PALEONTOL, V23, P691, DOI 10.1671/1864; Fernandez MS, 2007, PATAGONIAN MESOZOIC, P271; Fischer V, 2012, WILEY BLACKWELL  SEP, V7; Fischer V, 2011, J VERTEBR PALEONTOL, V31, P1010, DOI 10.1080/02724634.2011.595464; Fischer V, 2011, NEUES JAHRB GEOL P-A, V261, P111, DOI 10.1127/0077-7749/2011/0155; Fraas E.E., 1891, ICHTHYOSAURIER SUDDE; Geyer M., 2011, GEOLOGIE BADEN WURTT; Godefroit Pascal, 1994, Memoires pour Servir a l'Explication des Cartes Geologiques et Minieres de la Belgique, V39, P1; Godefroit Pascal, 1994, Revue de Paleobiologie Volume Special, V7, P67; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hegele A., 1995, KLASSISCHE FUNDSTELL, V3, P92; JOHNSON R, 1977, CAN J EARTH SCI, V14, P1916, DOI 10.1139/e77-162; Johnson R., 1979, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V159, P41; Kirton A.M., 1983, THESIS NEWSCASTLE UP; Lingham-Soliar T, 2003, NEUES JAHRB GEOL P-A, V228, P421; Maddison WP, 2019, MESQUITE MODULAR SYS; Maisch MW, 2006, GEOBIOS-LYON, V39, P491, DOI 10.1016/j.geobios.2005.04.005; Maisch Michael W., 2004, Palaeontologische Zeitschrift, V78, P161; Maisch Michael W., 2008, Palaeodiversity, P227; Maisch Michael W., 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V298, P1; Maisch Michael W., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V209, P401; Maisch MW, 2003, J VERTEBR PALEONTOL, V23, P116, DOI 10.1671/0272-4634(2003)23[116:TCOOTI]2.0.CO;2; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Maxwell EE, 2006, PALAEONTOLOGY, V49, P1043, DOI 10.1111/j.1475-4983.2006.00589.x; Maxwell EE, 2012, J PALEONTOL, V86, P105, DOI 10.1666/11-038.1; Mazin J.M., 1988, B SOC LINNEENNE NORM, V112, P121; MCGOWAN C, 1976, CAN J EARTH SCI, V13, P668, DOI 10.1139/e76-070; McGowan C., 1973, B BRIT MUS NAT HIST, V24, P1; MCGOWAN C., 2003, HDB PALEOHERPETOLOGY; Motani R, 2005, J VERTEBR PALEONTOL, V25, P338, DOI 10.1671/0272-4634(2005)025[0338:TSRCOI]2.0.CO;2; Motani R, 1999, J VERTEBR PALEONTOL, V19, P473, DOI 10.1080/02724634.1999.10011160; Ogg J.G., 2008, CONCISE GEOLOGIC TIM; Ohmert W, 1993, GEOLOGISCHE BLATTER, V43, P143; PHILLIPS J., 1871, GEOLOGY OXFORD VALLE; QUENSTEDT F.A., 1856, JURA; Sander P. Martin, 1993, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1993, P631; Storrs Glenn W., 2000, P187; Vincent P, 2007, NEUES JAHRB GEOL P-A, V243, P363, DOI 10.1127/0077-7749/2007/0243-0363; Von Huene F, 1922, MONOGRAPHIEN GEOLOGI	51	46	48	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41692	10.1371/journal.pone.0041692	http://dx.doi.org/10.1371/journal.pone.0041692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870244	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800031
J	Sidorchuk, A; Hemmingsson, T; Romelsjo, A; Allebeck, P				Sidorchuk, Anna; Hemmingsson, Tomas; Romelsjo, Anders; Allebeck, Peter			Alcohol Use in Adolescence and Risk of Disability Pension: A 39 Year Follow-up of a Population-Based Conscription Survey	PLOS ONE			English	Article							SOCIAL-CLASS DIFFERENCES; SICKNESS ABSENCE; YOUNG MEN; DRUG-USE; SELF-MEDICATION; PREDICTORS; CONSUMPTION; HEALTH; TRANSITION; MORTALITY	Background: The role of alcohol consumption for disability pension (DP) is controversial and systematic reviews have not established causality. We aimed to assess the role of adolescent alcohol use for future DP. We wanted to find out whether an increased risk mainly would affect DP occurring early or late in life as well as whether the level of alcohol consumption and patterns of drinking contribute differently in DP receiving. Methodology/Principal Findings: The study is a 39-year follow-up of 49 321 Swedish men born in 1949-1951 and conscripted for compulsory military service in 1969-1970. As study exposures (i) "risk use" of alcohol composed of measures related to pattern of drinking, and (ii) the level of consumption based on self-reported volume and frequency of drinking had been used. Information on DP was obtained from social insurance databases through 2008. "Risk use" of alcohol was associated with both "early DP" and "late DP", i. e. granted below and above the approximate age of 40 years, with crude hazard ratio (HR) of 2.89 (95% confidence intervals (CI) 2.47-3.38) and HR of 1.87 (95% CI: 1.74-2.02), respectively. After adjustment for covariates, HR was reduced to 1.32 (95% CI: 1.09-1.59) and 1.14 (95% CI: 1.05-1.25), respectively. Similar patterns were seen for moderate (101-250 g 100% alcohol/week) and high (>250 g) consumption, though the risk disappeared when fully adjusted. Conclusions/Significance: Alcohol use in adolescence, particularly measured as "risk use", is associated with increased risk of future DP. The association is stronger for "early DP", but remains significant even for DP granted in older ages. Therefore, pattern of drinking in adolescent should be considered an important marker for future reduced work capacity.	[Sidorchuk, Anna; Romelsjo, Anders; Allebeck, Peter] Karolinska Inst, Dept Publ Hlth Sci, Div Social Med, Stockholm, Sweden; [Sidorchuk, Anna] N Western State Med Univ, Dept Epidemiol Parasitol & Desinfectol, St Petersburg, Russia; [Hemmingsson, Tomas] Karolinska Inst, Dept Publ Hlth Sci, Div Occupat & Environm Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Sidorchuk, A (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Social Med, Stockholm, Sweden.	Anna.Sidorchuk@ki.se		Hemmingsson, Tomas/0000-0001-6156-3964	Swedish Council for Working Life and Social Research [FAS 2009-1611, 2009-1718]; The Alcohol Research Council of the Swedish Alcohol Retailing Monopoly [SRA 2011-0058]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); The Alcohol Research Council of the Swedish Alcohol Retailing Monopoly	This work was funded by research grants from the Swedish Council for Working Life and Social Research (FAS 2009-1611 to PA, 2009-1718 to TH; http://www.fas.se) and The Alcohol Research Council of the Swedish Alcohol Retailing Monopoly (SRA 2011-0058 to AS; http://www.can.se/sv/SRA). The founders had no role in study design, collection and analysis, decision to publish or preparation of the manuscript.	Ahola K, 2011, J AFFECT DISORDERS, V134, P365, DOI 10.1016/j.jad.2011.05.028; Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P12, DOI 10.1080/14034950410021808; Alexanderson Kristina, 2004, Scand J Public Health Suppl, V63, P256; Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P36, DOI 10.1080/14034950410021835; ALLEBECK P, 1988, BRIT MED J, V297, P176, DOI 10.1136/bmj.297.6642.176; ANDREASSON S, 1988, BRIT MED J, V296, P1021, DOI 10.1136/bmj.296.6628.1021; ANDREASSON S, 1993, AM J PUBLIC HEALTH, V83, P845, DOI 10.2105/AJPH.83.6.845; ANDREASSON S, 1992, ALCOHOL CLIN EXP RES, V16, P708, DOI 10.1111/j.1530-0277.1992.tb00666.x; [Anonymous], 2009, INT DAT LAB MARK RES, P1; [Anonymous], 2010, SOC INS FIG 2020; [Anonymous], 2011, ALC WORK PROD; BENSON G, 1985, ACTA PSYCHIAT SCAND, V71, P9, DOI 10.1111/j.1600-0447.1985.tb05045.x; Carrigan MH, 2003, ADDICT BEHAV, V28, P269, DOI 10.1016/S0306-4603(01)00235-0; Duncan SC, 1998, J BEHAV MED, V21, P375, DOI 10.1023/A:1018730814379; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fergusson DM, 2009, ARCH GEN PSYCHIAT, V66, P260, DOI 10.1001/archgenpsychiatry.2008.543; Fillmore KM, 2007, ANN EPIDEMIOL, V17, pS16, DOI 10.1016/j.annepidem.2007.01.005; Flay BR, 1998, PREV MED, V27, pA9, DOI 10.1006/pmed.1998.0380; Gravseth HM, 2008, EUR J PUBLIC HEALTH, V18, P650, DOI 10.1093/eurpub/ckn055; Hallfors DD, 2005, AM J PREV MED, V29, P163, DOI 10.1016/j.amepre.2005.06.002; Hansen ABG, 2011, SCAND J PUBLIC HEALT, V39, P128, DOI 10.1177/1403494810393556; Hemmingsson T, 1998, SOC SCI MED, V47, P1399, DOI 10.1016/S0277-9536(98)00258-5; Hensing G, 2010, SOU, P47; Hensing Gunnel, 2004, Scand J Public Health Suppl, V63, P152; Holmberg SAC, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-66; Jackson KM, 2002, ADDICTION, V97, P517, DOI 10.1046/j.1360-0443.2002.00082.x; Jensen MK, 2003, ADDICTION, V98, P355, DOI 10.1046/j.1360-0443.2003.00304.x; Johansson E, 2009, EUR J PUBLIC HEALTH, V19, P19, DOI 10.1093/eurpub/ckn116; Kleinjan M, 2013, ADDICT BIOL, V18, P1003, DOI 10.1111/j.1369-1600.2011.00422.x; Laaksonen M, 2009, OCCUP ENVIRON MED, V66, P840, DOI 10.1136/oem.2008.039248; Larsson D, 2002, SCAND J PUBLIC HEALT, V30, P259, DOI 10.1080/14034940210133997; Lash, 2008, MODERN EPIDEMIOLOGY, P345; LEIFMAN H, 1995, SOC SCI MED, V41, P113, DOI 10.1016/0277-9536(94)00298-8; Lundin A, 2010, J EPIDEMIOL COMMUN H, V64, P22, DOI 10.1136/jech.2008.079269; Mansson N.O, 1994, EUR J PUBLIC HEALTH, V4, P22; Mansson NO, 1999, ANN EPIDEMIOL, V9, P341, DOI 10.1016/S1047-2797(99)00014-9; Mason WA, 2009, SUBST USE MISUSE, V44, P1142, DOI 10.1080/10826080802495211; Norstrom T, 2006, ADDICTION, V101, P1421, DOI 10.1111/j.1360-0443.2006.01446.x; Norstrom T, 2009, EUR J PUBLIC HEALTH, V19, P383, DOI 10.1093/eurpub/ckp044; Organisation for economic Co-operation and development, 2010, SICKN DIS WORK BREAK; Pietikainen S, 2011, J OCCUP ENVIRON MED, V53, P488, DOI 10.1097/JOM.0b013e31821576dd; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Ropponen A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-678; RYDELIUS PA, 1983, ACTA PSYCHIAT SCAND, V68, P368, DOI 10.1111/j.1600-0447.1983.tb07019.x; Salonsalmi A, 2009, SCAND J PUBLIC HEALT, V37, P846, DOI 10.1177/1403494809350519; Sartor CE, 2008, ADDICT BEHAV, V33, P235, DOI 10.1016/j.addbeh.2007.09.002; Sjolund S, 2012, ADDICTION, V107, P89, DOI 10.1111/j.1360-0443.2011.03544.x; Skogen JC, 2012, ADDICTION, V107, P98, DOI 10.1111/j.1360-0443.2011.03551.x; Stenbacka M, 2000, ADDICTION, V95, P1573, DOI 10.1046/j.1360-0443.2000.9510157311.x; Stockwell T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2276; Tomlinson KL, 2012, ADDICT BEHAV, V37, P179, DOI 10.1016/j.addbeh.2011.09.016; Tucker JS, 2006, J ADOLESCENT HEALTH, V39, P488, DOI 10.1016/j.jadohealth.2006.03.012; Upmark M, 1999, J EPIDEMIOL COMMUN H, V53, P223, DOI 10.1136/jech.53.4.223; Upmark M, 1997, EUR J PUBLIC HEALTH, V7, P20, DOI 10.1093/eurpub/7.1.20; Upmark M, 2002, SCAND J PUBLIC HEALT, V30, P191, DOI 10.1080/14034940210133861; Upmark M, 1999, SOC PSYCH PSYCH EPID, V34, P533, DOI 10.1007/s001270050172; Upmark M, 2001, SCAND J PUBLIC HEALT, V29, P96, DOI 10.1177/14034948010290020601; Upmark M, 1999, THESIS KAROLINSKA I; Vaillant G.E., 1995, WISDOM EGO; Wagner FA, 2005, DRUG ALCOHOL DEPEN, V77, P93, DOI 10.1016/j.drugalcdep.2004.06.009; Wagner FA, 2002, AM J EPIDEMIOL, V155, P918, DOI 10.1093/aje/155.10.918; World Health Organization, 2011, GLOB STAT REP ALC HL	63	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42083	10.1371/journal.pone.0042083	http://dx.doi.org/10.1371/journal.pone.0042083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	984SU	22870284	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800057
J	Gong, R; Wang, YP; Ying, TL; Dimitrov, DS				Gong, Rui; Wang, Yanping; Ying, Tianlei; Dimitrov, Dimiter S.			Bispecific Engineered Antibody Domains (Nanoantibodies) That Interact Noncompetitively with an HIV-1 Neutralizing Epitope and FcRn	PLOS ONE			English	Article							INTERNATIONAL IMMUNOGENETICS DATABASE; BINDING-SITE; CH2 DOMAINS; HUMAN IGG1; THERAPEUTIC ANTIBODIES; MOLECULAR RECOGNITION; INCREASED-STABILITY; PROTEIN SCAFFOLDS; CRYSTAL-STRUCTURE; RECEPTOR	Libraries based on an isolated human immunoglobulin G1 (IgG1) constant domain 2 (CH2) have been previously diversified by random mutagenesis. However, native isolated CH2 is not very stable and the generation of many mutations could lead to an increase in immunogenicity. Recently, we demonstrated that engineering an additional disulfide bond and removing seven N-terminal residues results in an engineered antibody domain (eAd) (m01s) with highly increased stability and enhanced binding to human neonatal Fc receptor (FcRn) (Gong et al, JBC, 2009 and 2011). We and others have also previously shown that grafting of the heavy chain complementarity region 3 (CDR-H3 (H3)) onto cognate positions of the variable domain leads to highly diversified libraries from which a number of binders to various antigens have been selected. However, grafting of H3s to non-cognate positions in constant domains results in additional residues at the junctions of H3s and the CH2 framework. Here we describe a new method based on multi-step PCR that allows the precise replacement of loop FG (no changes in its flanking sequences) by human H3s from another library. Using this method and limited mutagenesis of loops BC and DE we generated an eAd phage-displayed library. Panning of this library against an HIV-1 gp41 MPER peptide resulted in selection of a binder, m2a1, which neutralized HIV-1 isolates from different clades with modest activity and retained the m01s capability of binding to FcRn. This result provides a proof of concept that CH2-based antigen binders that also mimic to certain extent other functions of full-size antibodies (binding to FcRn) can be generated; we have previously hypothesized that such binders can be made and coined the term nanoantibodies (nAbs). Further studies in animal models and in humans will show how useful nAbs could be as therapeutics and diagnostics.	[Gong, Rui; Wang, Yanping; Ying, Tianlei; Dimitrov, Dimiter S.] NIH, Prot Interact Grp, Frederick Natl Lab Canc Res, Frederick, MD USA; [Wang, Yanping] SAIC Frederick Inc, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Gong, R (corresponding author), NIH, Prot Interact Grp, Frederick Natl Lab Canc Res, Frederick, MD USA.	gongr@mail.nih.gov	应, 天雷/P-5396-2019	应, 天雷/0000-0002-9597-2843	National Institutes of Health (NIH); NIH, National Cancer Institute (NCI), Center for Cancer Research; NCI, NIH [N01-CO-12400]; U.S. Government; NATIONAL CANCER INSTITUTE [ZIABC011155] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Cancer Institute (NCI), Center for Cancer Research; NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Government; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural AIDS Targeted Antiviral Program (IATAP), National Institutes of Health (NIH) to DSD, and by the Intramural Research Program of the NIH, National Cancer Institute (NCI), Center for Cancer Research. This project has been funded in whole or in part with federal funds from the NCI, NIH, under contract N01-CO-12400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SAIC-Frederick, Inc. is a wholly owned subsidiary of Science Applications International Corporation and operates exclusively under a single, long-term contract to the National Cancer Institute, part of the U.S. National Institutes of Health. All funding is derived from the U.S. Government. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Caravella J, 2010, CURR OPIN CHEM BIOL, V14, P520, DOI 10.1016/j.cbpa.2010.06.175; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen WZ, 2008, P NATL ACAD SCI USA, V105, P17121, DOI 10.1073/pnas.0805297105; Chen WZ, 2008, J MOL BIOL, V382, P779, DOI 10.1016/j.jmb.2008.07.054; Chen WZ, 2010, MOL IMMUNOL, V47, P912, DOI 10.1016/j.molimm.2009.09.039; Chen Weizao, 2009, V525, P81, DOI 10.1007/978-1-59745-554-1_4; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Dimitrov Dimiter S., 2009, V525, P1, DOI 10.1007/978-1-59745-554-1_1; Dimitrov DS, 2009, MABS, V1, P26, DOI 10.4161/mabs.1.1.7480; Feige MJ, 2004, J MOL BIOL, V344, P107, DOI 10.1016/j.jmb.2004.09.033; Feng Y, 2011, PROTEIN EXPRES PURIF, V79, P66, DOI 10.1016/j.pep.2011.03.012; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Gehlsen KR, 2012, MABS-AUSTIN, V4, P466, DOI 10.4161/mabs.20652; Gill DS, 2006, CURR OPIN BIOTECH, V17, P653, DOI 10.1016/j.copbio.2006.10.003; Gong R, 2012, BIODRUGS, V26, P143, DOI 10.2165/11631400-000000000-00000; Gong R, 2011, J BIOL CHEM, V286, P27288, DOI 10.1074/jbc.M111.254219; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lefranc Marie-Paule, 2005, In Silico Biology, V5, P45; Lefranc Marie-Paule, 2004, In Silico Biology, V4, P17; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Lefranc MP, 2003, NUCLEIC ACIDS RES, V31, P307, DOI 10.1093/nar/gkg085; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Mezo AR, 2010, J BIOL CHEM, V285, P27694, DOI 10.1074/jbc.M110.120667; Nicely NI, 2010, NAT STRUCT MOL BIOL, V17, P1492, DOI 10.1038/nsmb.1944; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Regan L, 2003, P NATL ACAD SCI USA, V100, P3553, DOI 10.1073/pnas.0830651100; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Ruiz M, 2000, NUCLEIC ACIDS RES, V28, P219, DOI 10.1093/nar/28.1.219; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Skerra A, 2000, J MOL RECOGNIT, V13, P167, DOI 10.1002/1099-1352(200007/08)13:4<167::AID-JMR502>3.3.CO;2-0; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; von Minckwitz G, 2005, BREAST CANCER RES, V7, pR617, DOI 10.1186/bcr1264; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V387, P387, DOI 10.1016/j.bbrc.2009.07.044; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182; Zhang MY, 2004, J MOL BIOL, V335, P209, DOI 10.1016/j.jmb.2003.09.055; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11	54	20	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42288	10.1371/journal.pone.0042288	http://dx.doi.org/10.1371/journal.pone.0042288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879932	Green Published, Green Submitted, gold			2022-12-27	WOS:000307437900027
J	Canducci, F; Saita, D; Foglieni, C; Piscopiello, MR; Chiesa, R; Colombo, A; Cianflone, D; Maseri, A; Clementi, M; Burioni, R				Canducci, Filippo; Saita, Diego; Foglieni, Chiara; Piscopiello, Maria Rosaria; Chiesa, Roberto; Colombo, Antonio; Cianflone, Domenico; Maseri, Attilio; Clementi, Massimo; Burioni, Roberto			Cross-Reacting Antibacterial Auto-Antibodies Are Produced within Coronary Atherosclerotic Plaques of Acute Coronary Syndrome Patients	PLOS ONE			English	Article							CELLS; INFECTION; INFLAMMATION; PROTEIN; RISK; DIFFERENTIATE; MECHANISMS; EXPRESSION; GENERATION; MICROBIOTA	Coronary atherosclerosis, the main condition predisposing to acute myocardial infarction, has an inflammatory component caused by stimuli that are yet unknown. We molecularly investigated the nature of the immune response within human coronary lesion in four coronary plaques obtained by endoluminal atherectomy from four patients. We constructed phage-display libraries containing the IgG1/kappa antibody fragments produced by B-lymphocytes present in each plaque. By immunoaffinity, we selected from these libraries a monoclonal antibody, arbitrarily named Fab7816, able to react both with coronary and carotid atherosclerotic tissue samples. We also demonstrated by confocal microscopy that this monoclonal antibody recognized human transgelin type 1, a cytoskeleton protein involved in atherogenesis, and that it co-localized with fibrocyte-like cells transgelin+, CD68+, CD45+ in human sections of coronary and carotid plaques. In vitro fibrocytes obtained by differentiating CD14+ cells isolated from peripheral blood mononuclear cells also interacted with Fab7816, thus supporting the hypothesis of a specific recognition of fibrocytes into the atherosclerotic lesions. Interestingly, the same antibody, cross-reacted with the outer membrane proteins of Proteus mirabilis and Klebsiella pneumoniae (and possibly with homologous proteins of other enterobacteriaceae present in the microbiota). From all the other three libraries, we were able to clone, by immunoaffinity selection, human monoclonal antibodies cross-reacting with bacterial outer membrane proteins and with transgelin. These findings demonstrated that in human atherosclerotic plaques a local cross-reactive immune response takes place.	[Canducci, Filippo; Saita, Diego; Clementi, Massimo; Burioni, Roberto] Univ Milan, Osped San Raffaele, Lab Microbiol & Virol, I-20127 Milan, Italy; [Canducci, Filippo; Saita, Diego; Foglieni, Chiara; Piscopiello, Maria Rosaria; Chiesa, Roberto; Colombo, Antonio; Cianflone, Domenico; Clementi, Massimo; Burioni, Roberto] Univ Vita Salute San Raffaele, Milan, Italy; [Foglieni, Chiara; Cianflone, Domenico] Univ Milan, Osped San Raffaele, Clin Cardiovasc Biol Ctr, I-20127 Milan, Italy; [Piscopiello, Maria Rosaria] Univ Milan, Osped San Raffaele, Ist Neurol Sperimentale, I-20127 Milan, Italy; [Chiesa, Roberto] Univ Milan, Osped San Raffaele, Div Vasc Surg, I-20127 Milan, Italy; [Colombo, Antonio] Univ Milan, Osped San Raffaele, Intervent Cardiol Unit, Dept Cardiothorac & Vasc Dis, I-20127 Milan, Italy; [Maseri, Attilio] ONLUS, Heart Care Fdn, Florence, Italy	University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Canducci, F (corresponding author), Univ Milan, Osped San Raffaele, Lab Microbiol & Virol, Via Prinetti 29, I-20127 Milan, Italy.	Canducci.filippo@hsr.it; Burioni.roberto@hsr.it	Roberto, Chiesa/AAV-6476-2021; Clementi, Massimo/F-6646-2013; Colombo, Antonio/N-2960-2015; Foglieni, Chiara/O-2339-2015; Burioni, Roberto/F-2396-2012	Colombo, Antonio/0000-0002-2940-2455; Foglieni, Chiara/0000-0002-5155-6426; Canducci, Filippo/0000-0002-5637-6205; Clementi, Massimo/0000-0002-7461-5898; Grandi, Alessandro/0000-0002-2770-8266	Bracco Imaging SpA; Young Investigators Grant of the Italian Ministry of Health [GR08-41]	Bracco Imaging SpA; Young Investigators Grant of the Italian Ministry of Health	This work was partially supported by a grant from Bracco Imaging SpA, and by the Young Investigators Grant GR08-41 of the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Angiolillo DJ, 2003, J AM COLL CARDIOL, V41, P546, DOI 10.1016/S0735-1097(02)02899-1; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Binder CJ, 2010, J CLIN IMMUNOL, V30, pS56, DOI 10.1007/s10875-010-9396-3; Blankenberg S, 2001, CIRCULATION, V103, P2915, DOI 10.1161/01.CIR.103.24.2915; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Burioni R, 1998, J IMMUNOL METHODS, V217, P195, DOI 10.1016/S0022-1759(98)00102-1; Burioni R, 1998, HEPATOLOGY, V28, P810, DOI 10.1002/hep.510280331; Burioni R, 2010, VIROLOGY, V399, P144, DOI 10.1016/j.virol.2009.12.014; Burioni R, 2009, J IMMUNOL, V183, P2537, DOI 10.4049/jimmunol.0901076; Camoretti-Mercado B, 1998, GENOMICS, V49, P452, DOI 10.1006/geno.1998.5267; Clayton TC, 2008, EUR HEART J, V29, P96, DOI 10.1093/eurheartj/ehm516; Curnow SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009730; De Palma R, 2006, CIRCULATION, V113, P640, DOI 10.1161/CIRCULATIONAHA.105.537712; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Espinola-Klein C, 2007, ATHEROSCLEROSIS, V195, pE126, DOI 10.1016/j.atherosclerosis.2007.01.021; Feil S, 2004, CIRC RES, V94, P863, DOI 10.1161/01.RES.0000126417.38728.F6; Ford PJ, 2006, ORAL MICROBIOL IMMUN, V21, P206, DOI 10.1111/j.1399-302X.2006.00276.x; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Grau AJ, 2010, NAT REV NEUROL, V6, P681, DOI 10.1038/nrneurol.2010.163; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Honda T, 2005, ORAL MICROBIOL IMMUN, V20, P82, DOI 10.1111/j.1399-302X.2004.00193.x; Houtkamp MA, 2001, J PATHOL, V193, P263, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH774>3.0.CO;2-N; Iwata H, 2010, CIRCULATION, V122, P2048, DOI 10.1161/CIRCULATIONAHA.110.965202; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Knip M, 2010, NEW ENGL J MED, V363, P1900, DOI 10.1056/NEJMoa1004809; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Liuzzo G, 1999, J AM COLL CARDIOL, V34, P1696, DOI 10.1016/S0735-1097(99)00432-5; Mandal K, 2005, HANDB EXP PHARM, V170, P723; Paju S, 2007, ATHEROSCLEROSIS, V193, P193, DOI 10.1016/j.atherosclerosis.2006.06.015; Rao J, 2008, MICROBIOL-SGM, V154, P654, DOI 10.1099/mic.0.2007/011429-0; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Rupprecht HJ, 2001, CIRCULATION, V104, P25, DOI 10.1161/hc2601.091703; Shen JB, 2010, CIRC RES, V106, P1351, DOI 10.1161/CIRCRESAHA.109.213900; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Stassen FR, 2008, PHARMACOL REP, V60, P85; Stow NW, 2010, OTOLARYNG CLIN N AM, V43, P489, DOI 10.1016/j.otc.2010.02.008; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; Vidakovics MLAP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000724; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Watanabe M, 2007, J ATHEROSCLER THROMB, V14, P325, DOI 10.5551/jat.E489; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538	46	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42283	10.1371/journal.pone.0042283	http://dx.doi.org/10.1371/journal.pone.0042283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879930	Green Submitted, gold, Green Published			2022-12-27	WOS:000307810000025
J	Fekete, A; Kenesi, E; Hunyadi-Gulyas, E; Durgo, H; Berko, B; Dunai, ZA; Bauer, PI				Fekete, Anna; Kenesi, Erzsebet; Hunyadi-Gulyas, Eva; Durgo, Hajnalka; Berko, Barbara; Dunai, Zsuzsanna A.; Bauer, Pal I.			The Guanine-Quadruplex Structure in the Human c-myc Gene's Promoter Is Converted into B-DNA Form by the Human Poly(ADP-Ribose)Polymerase-1	PLOS ONE			English	Article							TOPOISOMERASE-I; TRANSCRIPTIONAL CONTROL; POLYMERASE; IDENTIFICATION; BINDING; PROTEIN; NUCLEOLIN; PARP-1; POLY(ADP-RIBOSYL)ATION; ACTIVATION	The important regulatory role of the guanine-quadruplex (GQ) structure, present in the nuclease hypersensitive element (NHE) III1 region of the human c-myc (h c-myc) gene's promoter, in the regulation of the transcription of that gene has been documented. Here we present evidences, that the human nuclear poly(ADP-ribose)polymerase-1 (h PARP-1) protein participates in the regulation of the h c-myc gene expression through its interaction with this GQ structure, characterized by binding assays, fluorescence energy transfer (FRET) experiments and by affinity pull-down experiments in vitro, and by chromatin immunoprecipitation (ChIP)-qPCR analysis and h c-myc-promoter-luciferase reporter determinations in vivo. We surmise that h PARP-1 binds to the GQ structure and participates in the conversion of that structure into the transcriptionally more active B-DNA form. The first Zn-finger structure present in h PARP-1 participates in this interaction. PARP-1 might be a new member of the group of proteins participating in the regulation of transcription through their interactions with GQ structures present in the promoters of different genes.	[Fekete, Anna; Kenesi, Erzsebet; Berko, Barbara; Bauer, Pal I.] Semmelweis Univ, Dept Med Biochem, H-1085 Budapest, Hungary; [Hunyadi-Gulyas, Eva; Durgo, Hajnalka] Hungarian Acad Sci, Biol Res Ctr, Lab Prote, H-6701 Szeged, Hungary; [Dunai, Zsuzsanna A.] Natl Inst Oncol, Dept Pathogenet, Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Hungarian Biological Research Center; National Institute of Oncology Hungary	Fekete, A (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary.	bauer.pal@med.semmelweis-univ.hu		Hunyadi-Gulyas, Eva/0000-0003-2089-1499	Hungarian Medical Research Council [ETT 071/07/2009]	Hungarian Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant of Hungarian Medical Research Council, [ETT 071/07/2009] to PIB (http://www.ett.hu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas P, 2008, J CELL BIOCHEM, V103, P1013, DOI 10.1002/jcb.21474; Arora A, 2008, J PHYS CHEM B, V112, P8151, DOI 10.1021/jp711608y; Balakrishnan L, 2010, J BIOL CHEM, V285, P38861, DOI 10.1074/jbc.M110.165191; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Bauer PI, 2000, INT J MOL MED, V5, P533; BAUER PI, 1990, BIOCHEM J, V270, P17, DOI 10.1042/bj2700017; Bauer PI, 2001, FEBS LETT, V506, P239, DOI 10.1016/S0014-5793(01)02919-2; Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Brown RV, 2011, J BIOL CHEM, V286, P41018, DOI 10.1074/jbc.M111.274720; BUKI KG, 1995, J BIOL CHEM, V270, P3370, DOI 10.1074/jbc.270.7.3370; Cogoi S, 2010, J BIOL CHEM, V285, P22003, DOI 10.1074/jbc.M110.101923; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; FERRO AM, 1984, J BIOL CHEM, V259, P547; Freyer MW, 2007, BIOPHYS J, V92, P2007, DOI 10.1529/biophysj.106.097246; Gonzalez V, 2010, BIOCHEMISTRY-US, V49, P9706, DOI 10.1021/bi100509s; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Halder K, 2005, BIOCHEM BIOPH RES CO, V327, P49, DOI 10.1016/j.bbrc.2004.11.137; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Huppert JL, 2010, FEBS J, V277, P3452, DOI 10.1111/j.1742-4658.2010.07758.x; IKAI K, 1983, J HISTOCHEM CYTOCHEM, V31, P1261, DOI 10.1177/31.11.6311893; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; IQBAL MA, 1987, NUCLEIC ACIDS RES, V15, P87, DOI 10.1093/nar/15.1.87; JI L, 1995, J BIOL CHEM, V270, P13392, DOI 10.1074/jbc.270.22.13392; Ju BG, 2006, CELL CYCLE, V5, P2557, DOI 10.4161/cc.5.22.3497; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kim MY, 2002, J AM CHEM SOC, V124, P2098, DOI 10.1021/ja017308q; Kodym R, 2005, BIOCHEM BIOPH RES CO, V333, P411, DOI 10.1016/j.bbrc.2005.05.136; Kotova E, 2010, P NATL ACAD SCI USA, V107, P6406, DOI 10.1073/pnas.0914152107; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kun E, 2006, INT J MOL MED, V17, P293; Kun E, 2008, FEBS LETT, V582, P2709, DOI 10.1016/j.febslet.2008.06.052; Kun E, 2008, BIOCHEM BIOPH RES CO, V366, P568, DOI 10.1016/j.bbrc.2007.12.004; Kun E, 2011, INT J MOL MED, V27, P181, DOI 10.3892/ijmm.2010.567; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Langelier MF, 2011, J BIOL CHEM, V286, P10690, DOI 10.1074/jbc.M110.202507; Lis JT, 2006, CELL, V125, P1225, DOI 10.1016/j.cell.2006.06.016; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Mathad RI, 2011, NUCLEIC ACIDS RES, V39, P9023, DOI 10.1093/nar/gkr612; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mikami-Terao Y, 2008, CANCER LETT, V261, P226, DOI 10.1016/j.canlet.2007.11.017; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ogino H., 2007, BMC GENOMICS, V8; Ostrowski J, 2003, NUCLEIC ACIDS RES, V31, P3954, DOI 10.1093/nar/gkg452; Romera C, 2011, BIOCHIMIE, V93, P1310, DOI 10.1016/j.biochi.2011.06.008; Saenz L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-171; SASTRY SS, 1990, BIOCHEM BIOPH RES CO, V167, P842, DOI 10.1016/0006-291X(90)92102-6; Sedoris KC, 2011, MOL CANCER THER, V11, P66; SHIMA H, 1989, P NATL ACAD SCI USA, V86, P7442, DOI 10.1073/pnas.86.19.7442; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Soldatenkov VA, 2008, ACS CHEM BIOL, V3, P214, DOI 10.1021/cb700234f; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; Szego A, 2010, VIRUS GENES, V40, P267, DOI 10.1007/s11262-009-0432-4; Uribe DJ, 2011, BIOCHEMISTRY-US, V50, P3796, DOI 10.1021/bi101633b; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang XC, 2007, BIOTECHNOL LETT, V29, P1599, DOI 10.1007/s10529-007-9425-3; Yoon J, 2010, B KOREAN CHEM SOC, V31, P1025, DOI 10.5012/bkcs.2010.31.04.1025; Zhang HJ, 2009, SPECTROCHIM ACTA A, V74, P243, DOI 10.1016/j.saa.2009.06.018; Zhong N, 1999, AM J MED GENET, V84, P268, DOI 10.1002/(SICI)1096-8628(19990528)84:3<268::AID-AJMG20>3.0.CO;2-#; Zupan K, 2005, BIOCHEMISTRY-US, V44, P15000, DOI 10.1021/bi0510227	67	23	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42690	10.1371/journal.pone.0042690	http://dx.doi.org/10.1371/journal.pone.0042690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880082	gold, Green Published, Green Submitted			2022-12-27	WOS:000307810000061
J	Lim, J; Maher, GJ; Turner, GDH; Dudka-Ruszkowska, W; Taylor, S; Meyts, ERD; Goriely, A; Wilkie, AOM				Lim, Jasmine; Maher, Geoffrey J.; Turner, Gareth D. H.; Dudka-Ruszkowska, Wioleta; Taylor, Stephen; Meyts, Ewa Rajpert-De; Goriely, Anne; Wilkie, Andrew O. M.			Selfish Spermatogonial Selection: Evidence from an Immunohistochemical Screen in Testes of Elderly Men	PLOS ONE			English	Article							HUMAN SEMINIFEROUS TUBULES; SPERMATOCYTIC SEMINOMA; STEM-CELLS; BREAST-CANCER; GERM-LINE; CANCER/TESTIS ANTIGENS; MUTATION FREQUENCY; TESTICULAR-TUMORS; FGFR2 MUTATIONS; GROWTH-FACTORS	The dominant congenital disorders Apert syndrome, achondroplasia and multiple endocrine neoplasia-caused by specific missense mutations in the FGFR2, FGFR3 and RET proteins respectively-represent classical examples of paternal age-effect mutation, a class that arises at particularly high frequencies in the sperm of older men. Previous analyses of DNA from randomly selected cadaveric testes showed that the levels of the corresponding FGFR2, FGFR3 and RET mutations exhibit very uneven spatial distributions, with localised hotspots surrounded by large mutation-negative areas. These studies imply that normal testes are mosaic for clusters of mutant cells: these clusters are predicted to have altered growth and signalling properties leading to their clonal expansion (selfish spermatogonial selection), but DNA extraction eliminates the possibility to study such processes at a tissue level. Using a panel of antibodies optimised for the detection of spermatocytic seminoma, a rare tumour of spermatogonial origin, we demonstrate that putative clonal events are frequent within normal testes of elderly men (mean age: 73.3 yrs) and can be classed into two broad categories. We found numerous small (less than 200 cells) cellular aggregations with distinct immunohistochemical characteristics, localised to a portion of the seminiferous tubule, which are of uncertain significance. However more infrequently we identified additional regions where entire seminiferous tubules had a circumferentially altered immunohistochemical appearance that extended through multiple serial sections that were physically contiguous (up to 1 mm in length), and exhibited enhanced staining for antibodies both to FGFR3 and a marker of downstream signal activation, pAKT. These findings support the concept that populations of spermatogonia in individual seminiferous tubules in the testes of older men are clonal mosaics with regard to their signalling properties and activation, thus fulfilling one of the specific predictions of selfish spermatogonial selection.	[Lim, Jasmine; Maher, Geoffrey J.; Dudka-Ruszkowska, Wioleta; Goriely, Anne; Wilkie, Andrew O. M.] Univ Oxford, Weatherall Inst Mol Med, Clin Genet Grp, Oxford, England; [Turner, Gareth D. H.] Univ Oxford Hosp NHS Trust, NIHR Biomed Res Ctr, Dept Cellular Pathol, Oxford, England; [Taylor, Stephen] Univ Oxford, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford, England; [Meyts, Ewa Rajpert-De] Rigshosp, Copenhagen Univ Hosp, Univ Dept Growth & Reprod, DK-2100 Copenhagen, Denmark	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; Rigshospitalet; University of Copenhagen	Lim, J (corresponding author), Univ Malaya, Kuala Lumpur, Malaysia.	andrew.wilkie@imm.ox.ac.uk	JASMINE, LIM/F-7404-2015; Goriely, Anne/AAR-1133-2020; Wilkie, Andrew/AAC-3820-2020; Rajpert-De Meyts, Ewa/H-6526-2019	JASMINE, LIM/0000-0002-7501-1834; Wilkie, Andrew/0000-0002-2972-5481; Rajpert-De Meyts, Ewa/0000-0002-5946-7559; Goriely, Anne/0000-0001-9229-7216; Dudka, Wioleta/0000-0002-7637-6480	Wellcome Trust [091182]; National Institute for Health Research Biomedical Research Centre Programme, Oxford; Danish Cancer Society [DP08147]; Malaysian Ministry of Higher Education Fellowship; NIHR Biomedical Research Centre Programme	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Biomedical Research Centre Programme, Oxford(National Institute for Health Research (NIHR)); Danish Cancer Society(Danish Cancer Society); Malaysian Ministry of Higher Education Fellowship; NIHR Biomedical Research Centre Programme(National Institute for Health Research (NIHR))	This work was funded by the Wellcome Trust (091182 to AG and AOMW); the National Institute for Health Research Biomedical Research Centre Programme, Oxford (GDHT); and the Danish Cancer Society (DP08147 to ERDM). JL was funded by a Malaysian Ministry of Higher Education Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Giulio Spagnoli (University of Basel, Basel, Switzerland) and Ad Geurts van Kessel (Department of Human Genetics, University Hospital, Nijmegen, The Netherlands) for the MAGEA4 and SSX antibodies, respectively. For sourcing samples used in this study, we thank Mark Sullivan, David Cranston, Helen Hemsworth, Gemma Crane, Ian Roberts, and Freddie Hamdy, as well as Divija Jatavallabhula, Linda Godfrey and the Oxford Radcliffe Biobank, which is supported by the NIHR Biomedical Research Centre Programme. We are grateful to Russell Leek and Graham Steers for assistance with digital microscopy.	Al-Saad S, 2009, ANTICANCER RES, V29, P4175; Amann RP, 2008, J ANDROL, V29, P469, DOI 10.2164/jandrol.107.004655; Aubry F, 2001, CANCER, V92, P2778, DOI 10.1002/1097-0142(20011201)92:11<2778::AID-CNCR10125>3.0.CO;2-S; BEHRE HM, 1989, INT J ANDROL, V12, P395, DOI 10.1111/j.1365-2605.1989.tb01328.x; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; BERGMANN M, 1989, CELL TISSUE RES, V256, P183; CARLSON KM, 1994, AM J HUM GENET, V55, P1076; Chang H, 2005, BLOOD, V106, P353, DOI 10.1182/blood-2005-01-0033; Choi SK, 2008, P NATL ACAD SCI USA, V105, P10143, DOI 10.1073/pnas.0801267105; Choi SK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002420; CLERMONT Y, 1963, AM J ANAT, V112, P35, DOI 10.1002/aja.1001120103; Crow JF, 2006, J RADIAT RES, V47, pB75, DOI 10.1269/jrr.47.B75; dos Santos NR, 2000, CANCER RES, V60, P1654; EBLE JN, 1994, HUM PATHOL, V25, P1035, DOI 10.1016/0046-8177(94)90062-0; GERDES J, 1984, J IMMUNOL, V133, P1710; Giudicelli MD, 2008, FERTIL STERIL, V89, P1651, DOI 10.1016/j.fertnstert.2007.04.037; Glass J, 2005, GRAYS ANATOMY ANATOM, P1304; Gori S, 2009, ANN ONCOL, V20, P648, DOI 10.1093/annonc/mdn681; Goriely A, 2005, P NATL ACAD SCI USA, V102, P6051, DOI 10.1073/pnas.0500267102; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; Goriely A, 2011, 12 INT C HUM GEN ICH, P44; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; Goriely A, 2009, NAT GENET, V41, P1247, DOI 10.1038/ng.470; HOLSTEIN AF, 1984, CELL TISSUE RES, V236, P35, DOI 10.1007/BF00216510; JOHNSEN S G, 1970, Hormones (Basel), V1, P2, DOI 10.1159/000178170; JOHNSON L, 1986, J ANDROL, V7, P331; Johnston CL, 1995, J BIOL CHEM, V270, P30643, DOI 10.1074/jbc.270.51.30643; Khnykin D, 2006, J PATHOL, V208, P431, DOI 10.1002/path.1900; Kimura T, 2008, DEVELOPMENT, V135, P869, DOI 10.1242/dev.013474; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Krege S, 2008, EUR UROL, V53, P478, DOI 10.1016/j.eururo.2007.12.024; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Landry C, 2000, INT J CANCER, V86, P835, DOI 10.1002/(SICI)1097-0215(20000615)86:6<835::AID-IJC12>3.0.CO;2-N; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Lim J, 2011, J PATHOL, V224, P473, DOI 10.1002/path.2919; LINDNER SG, 1982, ANDROLOGIA, V14, P352; Marcar L, 2010, CANCER RES, V70, P10362, DOI 10.1158/0008-5472.CAN-10-1341; Martinez-Torrecuadrada JL, 2008, MOL CANCER THER, V7, P862, DOI 10.1158/1535-7163.MCT-07-0394; McLachlan RI, 2007, HUM REPROD, V22, P2, DOI 10.1093/humrep/del279; Meyts ERD, 2007, INT J ANDROL, V30, P192, DOI 10.1111/j.1365-2605.2007.00810.x; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; MULLER J, 1987, INT J ANDROL, V10, P147, DOI 10.1111/j.1365-2605.1987.tb00176.x; NISTAL M, 1987, J ANDROL, V8, P64; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; PANIAGUA R, 1991, J ELECTRON MICR TECH, V19, P241, DOI 10.1002/jemt.1060190209; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Pop OT, 2011, ROM J MORPHOL EMBRYO, V52, P241; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Qin J, 2007, PLOS BIOL, V5, P1912, DOI 10.1371/journal.pbio.0050224; Ren ZP, 1996, ONCOGENE, V12, P765; Ren ZP, 1997, AM J PATHOL, V150, P1791; Rimoldi D, 2000, INT J CANCER, V86, P749; Sato Y, 2008, FERTIL STERIL, V90, P1310, DOI 10.1016/j.fertnstert.2007.10.019; Sol-Church K, 2006, HUM MUTAT, V27, P736, DOI 10.1002/humu.20381; Stoop H, 2001, LAB INVEST, V81, P919, DOI 10.1038/labinvest.3780302; TAN K H, 1991, SMJ Singapore Medical Journal, V32, P41; Tan PH, 2005, MODERN PATHOL, V18, P374, DOI 10.1038/modpathol.3800254; Tartaglia M, 2004, AM J HUM GENET, V75, P492, DOI 10.1086/423493; Tiemann-Boege I, 2002, P NATL ACAD SCI USA, V99, P14952, DOI 10.1073/pnas.232568699; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Ventela ST, 2012, STEM CELLS; Waheeb R, 2011, INT J ANDROL, V34, pE296, DOI 10.1111/j.1365-2605.2011.01199.x; Wilkin DJ, 1998, AM J HUM GENET, V63, P711, DOI 10.1086/302000; Yoon SR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000558; Zhu XG, 2010, AM J PATHOL, V176, P2333, DOI 10.2353/ajpath.2010.091049	66	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42382	10.1371/journal.pone.0042382	http://dx.doi.org/10.1371/journal.pone.0042382			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879958	Green Published, gold			2022-12-27	WOS:000307810000030
J	Liang, J; Zhou, N; Teng, F; Zou, CY; Xue, Y; Yang, MQ; Song, HD; Qi, L				Liang, Jun; Zhou, Na; Teng, Fei; Zou, Caiyan; Xue, Ying; Yang, Manqing; Song, Huaidong; Qi, Lu			Hemoglobin A1c Levels and Aortic Arterial Stiffness: The Cardiometabolic Risk in Chinese (CRC) Study	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; GLYCATED HEMOGLOBIN; CARDIOVASCULAR EVENTS; GLUCOSE-INTOLERANCE; PRESSURE; METABOLISM; MORTALITY; DISEASE; MARKER; INDEX	Objective: The American Diabetes Association (ADA) recently published new clinical guidelines in which hemoglobin A1c (HbA1c) was recommended as a diagnostic test for diabetes. The present study was to investigate the association between HbA1c and cardiovascular risk, and compare the associations with fasting glucose and 2-hour oral glucose tolerance test (2 h OGTT). Research Design and Methods: The study samples are from a community-based health examination survey in central China. Carotid-to-femoral pulse wave velocity (cfPWV) and HbA1c were measured in 5,098 men and women. Results: After adjustment for age, sex, and BMI, the levels of HbA1c were significantly associated with an increasing trend of cfPWV in a dose-dependent fashion (P for trend, < 0.0001). The associations remained significant after further adjustment for blood pressure, heart rate, and lipids (P = 0.004), and the difference in cfPWV between the highest and the lowest quintiles of HbA1c was 0.31 m/s. Fasting glucose and 2 h OGTT were not associated with cfPWV in the multivariate analyses. HbA1c showed additive effects with fasting glucose or 2 h OGTT on cfPWV. In addition, age and blood pressure significantly modified the associations between HbA1c and cfPWV (P for interactions,0.0001 for age; and = 0.019 for blood pressure). The associations were stronger in subjects who were older (>= 60 y; P for trend = 0.004) and had higher blood pressure (>= 120 [systolic blood pressure]/80 mmHg [diastolic blood pressure]; P for trend = 0.028) than those who were younger and had lower blood pressure (P for trend >0.05). Conclusions: HbA1c was related to high cfPWV, independent of conventional cardiovascular risk factors. Senior age and high blood pressure might amplify the adverse effects of HbA1c on cardiovascular risk.	[Liang, Jun; Zhou, Na; Teng, Fei; Zou, Caiyan; Xue, Ying; Yang, Manqing] Southeast Univ, Affiliated Hosp, Xuzhou Clin Sch,Xuzhou Med Coll, Dept Endocrinol,Cent Hosp Xuzhou, Xuzhou, Jiangsu, Peoples R China; [Liang, Jun; Qi, Lu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Qi, Lu] Harvard Univ, Sch Med, Boston, MA USA; [Song, Huaidong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp,State Key Lab Med Genom, Mol Med Ctr,Shanghai Inst Endocrinol, Shanghai 200030, Peoples R China	Southeast University - China; Xuzhou Medical University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Shanghai Jiao Tong University	Liang, J (corresponding author), Southeast Univ, Affiliated Hosp, Xuzhou Clin Sch,Xuzhou Med Coll, Dept Endocrinol,Cent Hosp Xuzhou, Xuzhou, Jiangsu, Peoples R China.	mwlj521@163.com; nhlqi@channing.harvard.edu						Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Benetos A, 2002, AM J HYPERTENS, V15, P1101, DOI 10.1016/S0895-7061(02)03029-7; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Cameron JD, 2007, CLIN EXP PHARMACOL P, V34, P677, DOI 10.1111/j.1440-1681.2007.04659.x; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; Chen YH, 2009, ENDOCRINE, V36, P262, DOI 10.1007/s12020-009-9221-z; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Davies MJ, 2000, DIABETIC MED, V17, P433, DOI 10.1046/j.1464-5491.2000.00246.x; Duprez Daniel A, 2007, Curr Atheroscler Rep, V9, P139, DOI 10.1007/s11883-007-0010-y; Gavin JR, 1997, DIABETES CARE, V20, P1183; Lapolla A, 2011, NUTR METAB CARDIOVAS, V21, P467, DOI 10.1016/j.numecd.2011.02.006; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Matsumae T, 2008, HYPERTENS RES, V31, P1365, DOI 10.1291/hypres.31.1365; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Meaume S, 2001, ARTERIOSCL THROM VAS, V21, P2046, DOI 10.1161/hq1201.100226; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Mostafa SA, 2010, POSTGRAD MED J, V86, P656, DOI 10.1136/pgmj.2009.091215; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Park S, 1996, DIABETES CARE, V19, P450, DOI 10.2337/diacare.19.5.450; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Shirwany NA, 2010, ACTA PHARMACOL SIN, V31, P1267, DOI 10.1038/aps.2010.123; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Szczepanska-Sadowska E, 2010, J PHYSIOL PHARMACOL, V61, P509; Tomiyama H, 2006, HYPERTENSION, V47, P180, DOI 10.1161/01.HYP.0000198539.34501.1a; Wang XX, 2005, J HYPERTENS, V23, P1565, DOI 10.1097/01.hjh.0000173778.85233.1b; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; Wendt Thoralf, 2002, Curr Atheroscler Rep, V4, P228, DOI 10.1007/s11883-002-0024-4; Wildman RP, 2005, HYPERTENSION, V45, P187, DOI 10.1161/01.HYP.0000152200.10578.5d; Wilkinson IB, 2002, J AM COLL CARDIOL, V39, P1005, DOI 10.1016/S0735-1097(02)01723-0; Winlove CP, 1996, DIABETOLOGIA, V39, P1131, DOI 10.1007/BF02658498	31	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e38485	10.1371/journal.pone.0038485	http://dx.doi.org/10.1371/journal.pone.0038485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870185	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100001
J	Hung, YP; Tsai, PJ; Hung, KH; Liu, HC; Lee, CI; Lin, HJ; Wu, YH; Wu, JJ; Ko, WC				Hung, Yuan-Pin; Tsai, Pei-Jane; Hung, Kuei-Hsiang; Liu, Hsiu-Chuan; Lee, Chih-I; Lin, Hsiao-Ju; Wu, Yi-Hui; Wu, Jiunn-Jong; Ko, Wen-Chien			Impact of Toxigenic Clostridium difficile Colonization and Infection among Hospitalized Adults at a District Hospital in Southern Taiwan	PLOS ONE			English	Article							RISK-FACTORS; HEMATOLOGICAL MALIGNANCY; NOSOCOMIAL ACQUISITION; DIARRHEA; PREVALENCE; PCR; COHORT; EPIDEMIOLOGY; ADMISSION; RESIDENTS	Background: The impact of toxigenic Clostridium difficile colonization (tCDC) in hospitalized patients is not clear. Aim: To study the significance of tCDC in hospitalized patients. Methods: A prospective study in the medical wards of a regional hospital was performed from January to June 2011. Fecal samples collected from patients at the time of admission were tested for tcdB by real-time polymerase chain reaction (PCR) and cultured for C. difficile. The patients were followed up weekly or when they developed diarrhea during hospitalization. If C. difficile was isolated, tcdA and tcdB would be tested by multiplex PCR. The primary outcome was the development of C. difficile-associated diarrhea (CDAD). Findings: Of 168 patients enrolled, females predominated (87, 51.8%), and the mean patient age was 75.4 years old. Approximately 70% of the patients were nursing home residents, and one third had a recent hospitalization within the prior three months. Twenty-eight (16.7%) patients had tCDC, including 16 (9.5%) patients with tCDC at the time of admission and 12 (7.2%) with tCDC during the follow-up period. With regard to the medications taken during hospitalization, the patients were more likely to have tCDC if they had received more than one class of antibiotics than if they had received monotherapy (odds ratio [OR] 6.67, 95% confidence interval [CI] 1.41-31.56, P = 0.01), particularly if they received a glycopeptide in combination with a cephalosporin or penicillin or a cephalosporin and a carbapenem. More patients with tCDC developed CDAD than those without tCDC (17.9%, 5/28 vs. 1.4%, 2/140, P = 0.002). Overall 7 (4.2%) of the 168 patients developed CDAD, and crude mortality rate of those with and without tCDC was similar (21.4%, 6/28 vs. 19.4%, 27/140, P = 0.79). Conclusion: Recent use of glycopeptides and beta-lactam antibiotics is associated with toxigenic C. difficile colonization, which is a risk factor for developing C. difficile-associated diarrhea.	[Hung, Yuan-Pin; Lee, Chih-I; Lin, Hsiao-Ju] Tainan Hosp, Dept Hlth, Dept Internal Med, Tainan, Taiwan; [Liu, Hsiu-Chuan] Tainan Hosp, Dept Hlth, Dept Expt & Diag, Tainan, Taiwan; [Hung, Yuan-Pin; Lin, Hsiao-Ju; Wu, Yi-Hui; Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Hung, Yuan-Pin] Natl Hlth Res Inst, Grad Inst Clin Med, Tainan, Taiwan; [Tsai, Pei-Jane; Hung, Kuei-Hsiang; Wu, Jiunn-Jong] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Ctr Infect Control, Tainan 70428, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Hung, YP (corresponding author), Tainan Hosp, Dept Hlth, Dept Internal Med, Tainan, Taiwan.	jjwu@mail.ncku.edu.tw; winston3415@gmail.com	Ko, Wen-Chien/ABG-4316-2020; hong, hesse/EUM-0179-2022; Tsai, Pei-Jane/G-3563-2011; Wu, Jiunn-Jong/E-6075-2011	Ko, Wen-Chien/0000-0001-7497-149X; hong, hesse/0000-0003-1006-705X; 	National Science Council, Taiwan [NSC 99-2628-B-006-014-MY3]; Department of Health, Executive Yuan, Taiwan [DOH100-TD-B-111-002]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taiwan	This work was supported by the grants from the National Science Council, Taiwan (NSC 99-2628-B-006-014-MY3) and Department of Health, Executive Yuan, Taiwan (DOH100-TD-B-111-002) for the consumables in the real-time PCR and multiplex PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolopoulou E, 2011, EUR J ONCOL NURS, V15, P404, DOI 10.1016/j.ejon.2010.11.002; Arvand M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030183; BARTLETT JG, 1992, CLIN INFECT DIS, V15, P573, DOI 10.1093/clind/15.4.573; Bidet P, 2000, J CLIN MICROBIOL, V38, P2484, DOI 10.1128/JCM.38.7.2484-2487.2000; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Chang VT, 2000, CLIN INFECT DIS, V31, P717, DOI 10.1086/314030; Chopra T, 2011, CLIN TRANSPLANT, V25, pE82, DOI 10.1111/j.1399-0012.2010.01331.x; Chopra T, 2010, EXPERT REV ANTI-INFE, V8, P1113, DOI [10.1586/eri.10.95, 10.1586/ERI.10.95]; Chung CH, 2010, J MICROBIOL IMMUNOL, V43, P119, DOI 10.1016/S1684-1182(10)60019-9; CLABOTS CR, 1992, J INFECT DIS, V166, P561, DOI 10.1093/infdis/166.3.561; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Hornbuckle K, 1998, ANN ONCOL, V9, P307, DOI 10.1023/A:1008295500932; Hutin Y, 1997, CLIN INFECT DIS, V24, P920, DOI 10.1093/clinids/24.5.920; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kent KC, 1998, ANN SURG, V227, P296, DOI 10.1097/00000658-199802000-00021; Knetsch CW, 2011, J CLIN MICROBIOL, V49, P227, DOI 10.1128/JCM.01743-10; Kvach EJ, 2010, J CLIN MICROBIOL, V48, P109, DOI 10.1128/JCM.01630-09; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Lawrence SJ, 2007, INFECT CONT HOSP EP, V28, P123, DOI 10.1086/511793; Lin YC, 2011, ANTIMICROB AGENTS CH; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Marciniak C, 2006, ARCH PHYS MED REHAB, V87, P1086, DOI 10.1016/j.apmr.2006.03.020; MCFARLAND LV, 1990, J INFECT DIS, V162, P678, DOI 10.1093/infdis/162.3.678; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; McGowan AP, 2011, J HOSP INFECT, V77, P11, DOI 10.1016/j.jhin.2010.09.017; Pant Chaitanya, 2011, J La State Med Soc, V163, P91; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Persson S, 2008, CLIN MICROBIOL INFEC, V14, P1057, DOI 10.1111/j.1469-0691.2008.02092.x; RAMPLING A, 1985, J CLIN PATHOL, V38, P445, DOI 10.1136/jcp.38.4.445; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; RUDENSKY B, 1993, POSTGRAD MED J, V69, P45, DOI 10.1136/pgmj.69.807.45; Sakai C, 1993, Gan To Kagaku Ryoho, V20, P2413; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Schaier M, 2004, NEPHROL DIAL TRANSPL, V19, P2432, DOI 10.1093/ndt/gfh428; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Spencer RC, 1998, J ANTIMICROB CHEMOTH, V41, P21, DOI 10.1093/jac/41.suppl_3.21; Thomas C, 2003, J ANTIMICROB CHEMOTH, V51, P1339, DOI 10.1093/jac/dkg254; WALKER KJ, 1993, J AM GERIATR SOC, V41, P940, DOI 10.1111/j.1532-5415.1993.tb06759.x; Winkeljohn D, 2011, CLIN J ONCOL NURS, V15, P215, DOI 10.1188/11.CJON.215-217	39	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42415	10.1371/journal.pone.0042415	http://dx.doi.org/10.1371/journal.pone.0042415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876321	Green Published, Green Submitted, gold			2022-12-27	WOS:000307184700049
J	Kengne, AP; Czernichow, S; Hamer, M; Batty, GD; Stamatakis, E				Kengne, Andre Pascal; Czernichow, Sebastien; Hamer, Mark; Batty, G. David; Stamatakis, Emmanuel			Anaemia, Haemoglobin Level and Cause-Specific Mortality in People with and without Diabetes	PLOS ONE			English	Article							ERYTHROPOIESIS-STIMULATING AGENTS; CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; RISK-FACTOR; METAANALYSIS; ASSOCIATION; HEMATOCRIT; EQUIVALENT	Background: Both anaemia and cardiovascular disease (CVD) are common in people with diabetes. While individually both characteristics are known to raise mortality risk, their combined influence has yet to be quantified. In this pooling project, we examined the combined impact of baseline haemoglobin levels and existing CVD on all-cause and CVD mortality in people with diabetes. We draw comparison of these effects with those apparent in diabetes-free individuals. Methods/Principal Findings: A combined analyses of 7 UK population-based cohorts resulted in 26,480 study members. There were 946 participants with physician-diagnosed diabetes, 2227 with anaemia [haemoglobin<13 g/dl (men) or <12 (women)], 2592 with existing CVD (stroke, ischaemic heart disease), and 21,396 with none of the conditions. Across diabetes and anaemia subgroups, and using diabetes-free, non-anaemic participants as the referent group, the adjusted hazard ratios (HR) were 1.46 (95% CI: 1.30-1.63) for anaemia, 1.67 (1.45-1.92) for diabetes, and 2.10 (1.55-2.85) for diabetes and anaemia combined. Across combined diabetes, anaemia and CVD subgroups, and compared with non-anaemic, diabetes-free and CVD-free participants, HR (95% CI) for all-cause mortality were 1.49 (1.32-1.69) anaemia, 1.60 (1.46-1.76) for existing CVD, and 1.66 (1.39-1.97) for diabetes alone. Equivalents were 2.13 (1.48-3.07) for anaemia and diabetes, 2.68 (2.14-3.36) for diabetes and existing CVD, and 3.25 (1.88-5.62) for the three combined. Patterns were similar for CVD mortality. Conclusions/Significance: Individually, anaemia and CVD confer similar mortality risks in people with diabetes, and are excessively fatal in combination. Screening for anaemia would identify vulnerable diabetic patients whose outcomes can potentially be improved.	[Kengne, Andre Pascal] S African MRC, Natl Collaborat Res Programme Cardiovasc & Metab, Cape Town, South Africa; [Kengne, Andre Pascal] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Kengne, Andre Pascal] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Kengne, Andre Pascal] George Inst Global Hlth, Cardiovasc Div, Sydney, NSW, Australia; [Czernichow, Sebastien] Ambroise Pare Hosp AP HP, Dept Nutr, Boulogne, France; [Czernichow, Sebastien] Univ Versailles St Quentin, Dept Nutr, Boulogne, France; [Hamer, Mark; Batty, G. David; Stamatakis, Emmanuel] UCL, Dept Epidemiol & Publ Hlth, London, England	South African Medical Research Council; University of Cape Town; Utrecht University; Utrecht University Medical Center; George Institute for Global Health; University of Sydney; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London	Kengne, AP (corresponding author), S African MRC, Natl Collaborat Res Programme Cardiovasc & Metab, Cape Town, South Africa.	andre.kengne@mrc.ac.za	Batty, GD/Y-4401-2018; Hamer, Mark/AAJ-6814-2021; Stamatakis, Emmanuel/C-4958-2009; Hamer, Mark/C-1602-2008; Kengne, Andre Pascal/ABB-3696-2020	Batty, GD/0000-0003-1822-5753; Hamer, Mark/0000-0002-8726-7992; Stamatakis, Emmanuel/0000-0001-7323-3225; Hamer, Mark/0000-0002-8726-7992; Kengne, Andre Pascal/0000-0002-5183-131X	Wellcome Trust; UK MRC; Chief Scientist Office at Scottish Government Health Directorates	Wellcome Trust(Wellcome TrustEuropean Commission); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office at Scottish Government Health Directorates	GD Batty is supported by a Wellcome Trust Career Development Fellowship. The Medical Research Council (MRC) Social and Public Health Sciences Unit receives funding from the UK MRC and the Chief Scientist Office at the Scottish Government Health Directorates. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Falluji N, 2002, AM HEART J, V144, P636, DOI 10.1067/mhj.2002.124351; Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Bhatia V, 2006, DIABETES CARE, V29, P2289, DOI 10.2337/dc06-0637; Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; Bulugahapitiya U, 2009, DIABETIC MED, V26, P142, DOI 10.1111/j.1464-5491.2008.02640.x; Chonchol M, 2008, AM HEART J, V155, P494, DOI 10.1016/j.ahj.2007.10.031; Collett, 2003, MODELLING SURVIVAL D; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; Davis MD, 1998, INVEST OPHTH VIS SCI, V39, P233; Deray G, 2004, AM J NEPHROL, V24, P522, DOI 10.1159/000081058; Dong W, 1997, SCOTTISH HLTH SURVEY; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Erens B, 1999, HLTH SURVEY ENGLAND; Fishbane Steven, 2008, Heart Fail Clin, V4, P401, DOI 10.1016/j.hfc.2008.03.005; Gonzalez-Clemente JM, 2007, REV ESP CARDIOL, V60, P1167, DOI 10.1157/13111789; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Kengne AP, 2012, DIABETES CARE, V35, P396, DOI 10.2337/dc11-1588; Lipsic E, 2005, INT J CARDIOL, V100, P289, DOI 10.1016/j.ijcard.2004.10.043; McFarlane Samy I, 2006, Curr Diab Rep, V6, P213, DOI 10.1007/s11892-006-0037-4; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Pereira AA, 2003, KIDNEY INT, V64, pS32, DOI 10.1046/j.1523-1755.64.s87.6.x; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Qiao Q, 1997, J CLIN EPIDEMIOL, V50, P153, DOI 10.1016/S0895-4356(96)00335-6; Redondo-Bermejo B, 2007, REV ESP CARDIOL, V60, P597, DOI 10.1157/13107116; Sarnak MJ, 2002, J AM COLL CARDIOL, V40, P27, DOI 10.1016/S0735-1097(02)01938-1; Shaw A., 2000, SCOTTISH HLTH SURVEY; Tong PCY, 2006, DIABETES CARE, V29, P2439, DOI 10.2337/dc06-0887; Unger EF, 2010, NEW ENGL J MED, V362, P189, DOI 10.1056/NEJMp0912328; van der Meer P, 2009, HEART, V95, P1309, DOI 10.1136/hrt.2008.161091; Vlagopoulos PT, 2005, J AM SOC NEPHROL, V16, P3403, DOI 10.1681/ASN.2005030226; *WHO, 1972, WHO TECHN REP SER, V503; Zoppini G, 2010, ATHEROSCLEROSIS, V210, P575, DOI 10.1016/j.atherosclerosis.2009.12.008	35	25	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41875	10.1371/journal.pone.0041875	http://dx.doi.org/10.1371/journal.pone.0041875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876293	Green Published, gold, Green Submitted			2022-12-27	WOS:000307184700021
J	Cohen, L; Cole, SW; Sood, AK; Prinsloo, S; Kirschbaum, C; Arevalo, JMG; Jennings, NB; Scott, S; Vence, L; Wei, Q; Kentor, D; Radvanyi, L; Tannir, N; Jonasch, E; Tamboli, P; Pisters, L				Cohen, Lorenzo; Cole, Steven W.; Sood, Anil K.; Prinsloo, Sarah; Kirschbaum, Clemens; Arevalo, Jesusa M. G.; Jennings, Nicholas B.; Scott, Shellie; Vence, Luis; Wei, Qi; Kentor, Diane; Radvanyi, Laszlo; Tannir, Nizar; Jonasch, Eric; Tamboli, Pheroze; Pisters, Louis			Depressive Symptoms and Cortisol Rhythmicity Predict Survival in Patients with Renal Cell Carcinoma: Role of Inflammatory Signaling	PLOS ONE			English	Article							BREAST-CANCER; PROSTATE-CANCER; TUMOR-GROWTH; EXPRESSION; STRESS; REPRODUCIBILITY; ANGIOGENESIS; VALIDATION; SYSTEM; COHORT	Purpose: Evidence has supported the association between psychological factors and cancer biology; however, findings are equivocal on the role of psychosocial factors in cancer progression. This study generates a hypothesis of mechanistic variables by examining the clinical effects of psychosocial factors and cortisol dysregulation in patients with metastatic renal cell carcinoma (RCC) and examines associated activation of transcription control pathways. Methods: Patients with metastatic RCC (n = 217) were prospectively enrolled in this study. Patients completed questionnaires (Centers for Epidemiologic Studies - Depression; SF-36 Health Status Survey; Duke Social Support Index; Coping Operations Preference Enquiry; organized and non-organized religious activity; and intrinsic religiosity), and provided blood and saliva samples. Cortisol levels and whole genome transcriptional profiling were assessed to identify potential alterations in circadian rhythms and genomic pathways. Results: Separate Cox regression models, controlling for disease risk category, revealed that CES-D scores (p = 0.05, HR = 1.5, 95% CI for HR: 1.00-2.23) and cortisol slope (p = 0.002; HR = 1.9; 95% CI for HR: 1.27-2.97) were significantly associated with decreased survival. Only cortisol slope and risk category remained significant in the complete model. Functional genomic analyses linked depressive symptoms to increased expression of pro-inflammatory and pro-metastatic genes in circulating leukocytes. 116 transcripts were found to be upregulated by an average of 50% or more in high CES-D patients, and 57 transcripts downregulated by at least 50%. These changes were also found in the tumor in a subset of patients. Conclusion: These findings identify depressive symptoms as a key predictor of survival in renal cell carcinoma patients with potential links to dysregulation of cortisol and inflammatory biology.	[Cohen, Lorenzo; Prinsloo, Sarah; Wei, Qi] Univ Texas MD Anderson Canc Ctr, Dept Gen Oncol, Houston, TX 77030 USA; [Cohen, Lorenzo; Prinsloo, Sarah; Wei, Qi] Univ Texas MD Anderson Canc Ctr, Integrat Med Program, Houston, TX 77030 USA; [Cole, Steven W.; Arevalo, Jesusa M. G.] Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA; [Sood, Anil K.; Jennings, Nicholas B.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Sood, Anil K.; Jennings, Nicholas B.] Univ Texas MD Anderson Canc Ctr, Canc Biol Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Kirschbaum, Clemens] Tech Univ Dresden, D-01062 Dresden, Germany; [Scott, Shellie; Pisters, Louis] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Vence, Luis; Kentor, Diane; Radvanyi, Laszlo] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Tannir, Nizar; Jonasch, Eric] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Tamboli, Pheroze] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Technische Universitat Dresden; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Cohen, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gen Oncol, Houston, TX 77030 USA.	lcohen@mdanderson.org	Kirschbaum, Clemens/AAB-1752-2020	Prinsloo, Sarah/0000-0003-3078-4558	Dana Foundation; Mary and David Wolff Family Foundation; National Institutes of Health [CA116778, CA110793, CA109298]; MD Anderson Cancer Center Support Grant [NCI CA16672]; NATIONAL CANCER INSTITUTE [R01CA116778, R01CA110793, P30CA016672, R01CA109298] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K01AT008485] Funding Source: NIH RePORTER	Dana Foundation; Mary and David Wolff Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by The Dana Foundation, The Mary and David Wolff Family Foundation, National Institutes of Health (CA116778, CA110793, CA109298) and the MD Anderson Cancer Center Support Grant (NCI CA16672) for the Immune Monitoring Core Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti L, 2004, INT J CANCER, V111, P653, DOI 10.1002/ijc.20287; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Barton BE, 2005, EXPERT OPIN THER TAR, V9, P737, DOI 10.1517/14728222.9.4.737; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Chen L, 2008, AM J MED GENET B, V147B, P814, DOI 10.1002/ajmg.b.30686; Classen C, 2001, ARCH GEN PSYCHIAT, V58, P494, DOI 10.1001/archpsyc.58.5.494; Cohen L, 2001, PSYCHOSOM MED, V63, P951, DOI 10.1097/00006842-200111000-00014; Cole SW, 2010, P NATL ACAD SCI USA, V107, P5681, DOI 10.1073/pnas.0911515107; Cole SW, 2005, BIOINFORMATICS, V21, P803, DOI 10.1093/bioinformatics/bti038; Cole SW, 2003, BIOINFORMATICS, V19, P1808, DOI 10.1093/bioinformatics/btg242; Fetzer, 1999, MULTIDIMENSIONAL MEA; Filipski E, 2002, J NATL CANCER I, V94, P690; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; HOGE DR, 1972, J SCI STUD RELIG, V11, P369; Irwin MR, 2011, NAT REV IMMUNOL, V11, P625, DOI 10.1038/nri3042; Jehn CF, 2006, CANCER-AM CANCER SOC, V107, P2723, DOI 10.1002/cncr.22294; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; KOENIG HG, 1993, PSYCHOSOMATICS, V34, P61, DOI 10.1016/S0033-3182(93)71928-3; Leonard B, 2000, World J Biol Psychiatry, V1, P17, DOI 10.3109/15622970009150562; LEVY SM, 1991, BEHAV MED, V17, P67, DOI 10.1080/08964289.1991.9935161; Lieberman MA, 2003, CANCER, V97, P920, DOI 10.1002/cncr.11145; Lin YG, 2007, CLIN CANCER RES, V13, P3423, DOI 10.1158/1078-0432.CCR-06-3072; Lutgendorf SK, 1999, J GERONTOL A-BIOL, V54, pM434, DOI 10.1093/gerona/54.9.M434; Lutgendorf SK, 2008, CLIN CANCER RES, V14, P6839, DOI 10.1158/1078-0432.CCR-08-0230; Martikainen P, 2003, J EPIDEMIOL COMMUN H, V57, P718, DOI 10.1136/jech.57.9.718; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mekhail TM, 2005, J CLIN ONCOL, V23, P832, DOI 10.1200/JCO.2005.05.179; Metcalfe C, 2007, EUR J CANCER, V43, P1060, DOI 10.1016/j.ejca.2007.01.027; Pachana NA, 2008, AGE AGEING, V37, P666, DOI 10.1093/ageing/afn205; Perczek RE, 2002, CANCER-AM CANCER SOC, V94, P2923, DOI 10.1002/cncr.10564; Plotsky PM, 1998, PSYCHIAT CLIN N AM, V21, P293, DOI 10.1016/S0193-953X(05)70006-X; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reiche EMV, 2006, INT REV PSYCHIATR, V17, P515, DOI 10.1080/02646830500382102; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Reinertsen KV, 2011, BRAIN BEHAV IMMUN, V25, P1376, DOI 10.1016/j.bbi.2011.04.001; Satin JR, 2009, CANCER-AM CANCER SOC, V115, P5349, DOI 10.1002/cncr.24561; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Spiegel D, 2003, BIOL PSYCHIAT, V54, P269, DOI 10.1016/S0006-3223(03)00566-3; Stommel M, 2002, CANCER-AM CANCER SOC, V94, P2719, DOI 10.1002/cncr.10533; Sun M, 2011, EUR UROL; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Ware J., 1993, SF 36 HLTH SURVEY MA; Witten D, 2007, COMPARISON FOLD CHAN	49	98	100	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42324	10.1371/journal.pone.0042324	http://dx.doi.org/10.1371/journal.pone.0042324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870317	Green Submitted, gold, Green Published			2022-12-27	WOS:000307212800080
J	Corney, DPA; Tang, HLL; Clark, JY; Hu, Y; Jin, J				Corney, David P. A.; Tang, H. Lilian; Clark, Jonathan Y.; Hu, Yin; Jin, Jing			Automating Digital Leaf Measurement: The Tooth, the Whole Tooth, and Nothing but the Tooth	PLOS ONE			English	Article							ACER-RUBRUM; SEED PLANTS; CLIMATE; LEAVES; SHAPE; SIZE; IDENTIFICATION; SENSITIVITY	Many species of plants produce leaves with distinct teeth around their margins. The presence and nature of these teeth can often help botanists to identify species. Moreover, it has long been known that more species native to colder regions have teeth than species native to warmer regions. It has therefore been suggested that fossilized remains of leaves can be used as a proxy for ancient climate reconstruction. Similar studies on living plants can help our understanding of the relationships. The required analysis of leaves typically involves considerable manual effort, which in practice limits the number of leaves that are analyzed, potentially reducing the power of the results. In this work, we describe a novel algorithm to automate the marginal tooth analysis of leaves found in digital images. We demonstrate our methods on a large set of images of whole herbarium specimens collected from Tilia trees (also known as lime, linden or basswood). We chose the genus Tilia as its constituent species have toothed leaves of varied size and shape. In a previous study we extracted c: 1600 leaves automatically from a set of c: 1100 images. Our new algorithm locates teeth on the margins of such leaves and extracts features such as each tooth's area, perimeter and internal angles, as well as counting them. We evaluate an implementation of our algorithm's performance against a manually analyzed subset of the images. We found that the algorithm achieves an accuracy of 85% for counting teeth and 75% for estimating tooth area. We also demonstrate that the automatically extracted features are sufficient to identify different species of Tilia using a simple linear discriminant analysis, and that the features relating to teeth are the most useful.	[Corney, David P. A.; Tang, H. Lilian; Clark, Jonathan Y.; Hu, Yin; Jin, Jing] Univ Surrey, Dept Comp, Guildford GU2 5XH, Surrey, England	University of Surrey	Corney, DPA (corresponding author), Univ Surrey, Dept Comp, Guildford GU2 5XH, Surrey, England.	David.Corney.1@city.ac.uk	Corney, David/C-1601-2008	Corney, David/0000-0002-0651-9028	Leverhulme Trust, MORPHIDAS: the Morphological Herbarium Image Data Analysis research project [F/00 242/H]	Leverhulme Trust, MORPHIDAS: the Morphological Herbarium Image Data Analysis research project	This work was partly funded by the Leverhulme Trust (grant F/00 242/H) as part of MORPHIDAS: the Morphological Herbarium Image Data Analysis research project, and the authors express their gratitude to them. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 1106 US GEOL SURV; Bailey IW, 1916, AM J BOT, V3, P24, DOI 10.2307/2435109; Bailey IW, 1915, SCIENCE, V41, P831, DOI 10.1126/science.41.1066.831; Belhumeur PN, 2008, LECT NOTES COMPUT SC, V5305, P116, DOI 10.1007/978-3-540-88693-8_9; Bylesjo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-82; Clark J. Y., 2012, 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), P343, DOI 10.1109/CIBCB.2012.6217250; Clark JY, 2009, BOT J LINN SOC, V159, P300, DOI 10.1111/j.1095-8339.2008.00891.x; Cope JS, 2012, EXPERT SYST APPL, V39, P7562, DOI 10.1016/j.eswa.2012.01.073; Corney DPA, 2012, TAXON, V61, P231, DOI 10.1002/tax.611016; Feild TS, 2005, PLANT CELL ENVIRON, V28, P1179, DOI 10.1111/j.1365-3040.2005.01354.x; Govaerts R, 2001, TAXON, V50, P1085, DOI 10.2307/1224723; Green WA, 2006, PALAEONTOL ELECTRON, V9; Huff PM, 2003, PALAIOS, V18, P266, DOI 10.1669/0883-1351(2003)018<0266:DFFPEF>2.0.CO;2; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; Pigott C.D., 1997, EUROPEAN GARDEN FLOR, V5, P205; Pigott CD, 2012, LIME TREES IN PRESS; Royer DL, 2008, NEW PHYTOL, V179, P808, DOI 10.1111/j.1469-8137.2008.02496.x; Royer DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007653; Royer DL, 2006, INT J PLANT SCI, V167, P11, DOI 10.1086/497995; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; Scotland RW, 2003, TAXON, V52, P101, DOI 10.2307/3647306; Thiers B, 2019, INDEX HERBARIORUM GL; Viscosi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025630; Wilf P, 1997, PALEOBIOLOGY, V23, P373, DOI 10.1017/S0094837300019746; Wolfe JA, 1993, US GEOL SURVEY B, V2040	26	28	28	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42112	10.1371/journal.pone.0042112	http://dx.doi.org/10.1371/journal.pone.0042112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870286	Green Published, Green Submitted, gold			2022-12-27	WOS:000307212800059
J	Oh, TJ; Kim, MY; Park, KS; Cho, YM				Oh, Tae Jung; Kim, Min Young; Park, Kyong Soo; Cho, Young Min			Effects of Chemosignals from Sad Tears and Postprandial Plasma on Appetite and Food Intake in Humans	PLOS ONE			English	Article							MENSTRUAL SYNCHRONY; BRAIN; RECOGNITION; GLUCAGON; RECEPTOR; SYSTEMS; OBESITY	Chemosignals from human body fluids may modulate biological functions in humans. The objective of this study was to examine whether chemosignals from human sad tears and postprandial plasma modulate appetite. We obtained fasting and postprandial plasma from male participants and sad tears and saline, which was trickled below the eyelids, from female volunteers. These samples were then randomly distributed to male participants to sniff with a band-aid containing 100 mu l of each fluid on four consecutive days in a double-blind fashion. We checked appetite by a visual analogue scale (VAS) and food intake by measuring the consumption of a test meal. In addition, the serum levels of total testosterone and LH were measured. Twenty men (mean age 26.3 +/- 4.6 years) were enrolled in this study. They could not discriminate between the smell of fasting and postprandial plasma and the smell of sad tears and trickled saline. Appetite and the amount of food intake were not different between the groups. Although the VAS ratings of appetite correlated with the food intake upon sniffing fasting plasma, postprandial plasma, and trickled saline, there was no such correlation upon sniffing sad tears. In addition, the decrease in serum testosterone levels from the baseline was greater with sad tears than with the trickled saline (228.6 +/- 3.3% vs. -14.0 +/- 5.2%; P = 0.019). These data suggest that chemosignals from human sad tears and postprandial plasma do not appear to reduce appetite and food intake. However, further studies are necessary to examine whether sad tears may alter the appetite-eating behavior relation.	[Oh, Tae Jung; Kim, Min Young; Park, Kyong Soo; Cho, Young Min] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Seoul National University (SNU)	Oh, TJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	ymchomd@snu.ac.kr	Cho, Young Min/J-5669-2012; Oh, Tae Jung/K-8863-2018; Park, Kyong Soo/C-2265-2008	Oh, Tae Jung/0000-0002-5078-6123; Park, Kyong Soo/0000-0003-3597-342X	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0009127]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) that was funded by the Ministry of Education, Science and Technology (2011-0009127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks WA, 2004, J PHARMACOL EXP THER, V309, P469, DOI 10.1124/jpet.103.063222; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; Blundell J, 2010, OBES REV, V11, P251, DOI 10.1111/j.1467-789X.2010.00714.x; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Doving KB, 1998, J EXP BIOL, V201, P2913; Eckel RH, 2008, NEW ENGL J MED, V358, P1941, DOI 10.1056/NEJMcp0801652; Field BCT, 2010, NAT REV ENDOCRINOL, V6, P444, DOI 10.1038/nrendo.2010.93; Gelstein S, 2011, SCIENCE, V331, P226, DOI 10.1126/science.1198331; Grouzmann E, 2002, FASEB J, V16, P1132, DOI 10.1096/fj.01-0939fje; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Jacob S, 2000, HORM BEHAV, V37, P57, DOI 10.1006/hbeh.1999.1559; Jones D, 2011, NAT REV DRUG DISCOV, V10, P5, DOI 10.1038/nrd3353; KAITZ M, 1987, DEV PSYCHOBIOL, V20, P587, DOI 10.1002/dev.420200604; Keller M, 2010, VITAM HORM, V83, P331, DOI 10.1016/S0083-6729(10)83014-6; Kennett GA, 2010, PHARMACOL BIOCHEM BE, V97, P63, DOI 10.1016/j.pbb.2010.07.020; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Lam CKL, 2009, PHYSIOLOGY, V24, P159, DOI 10.1152/physiol.00003.2009; Lehman MN, 2010, ENDOCRINOLOGY, V151, P3479, DOI 10.1210/en.2010-0022; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Macht M, 2008, APPETITE, V50, P1, DOI 10.1016/j.appet.2007.07.002; MCCLINTOCK MK, 1971, NATURE, V229, P244, DOI 10.1038/229244a0; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Stubbs RJ, 2000, BRIT J NUTR, V84, P405, DOI 10.1017/S0007114500001719; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Van der Ploeg LHT, 2002, P NATL ACAD SCI USA, V99, P11381, DOI 10.1073/pnas.172378699; Varendi H, 2001, ACTA PAEDIATR, V90, P372, DOI 10.1080/080352501750126131; WELLER L, 1993, NEUROSCI BIOBEHAV R, V17, P427, DOI 10.1016/S0149-7634(05)80118-6; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; Yanovski SZ, 2002, NEW ENGL J MED, V346, P591, DOI 10.1056/NEJMra012586; ZARBIN MA, 1983, J NEUROSCI, V3, P877; Zivkovic AM, 2009, METABOLOMICS, V5, P209, DOI 10.1007/s11306-008-0136-0	33	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42352	10.1371/journal.pone.0042352	http://dx.doi.org/10.1371/journal.pone.0042352			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870321	gold, Green Published, Green Submitted			2022-12-27	WOS:000307212800084
J	Duenas, M; Santos, M; Aranda, JF; Bielza, C; Martinez-Cruz, AB; Lorz, C; Taron, M; Ciruelos, EM; Rodriguez-Peralto, JL; Martin, M; Larranaga, P; Dahabreh, J; Stathopoulos, GP; Rosell, R; Paramio, JM; Garcia-Escudero, R				Duenas, Marta; Santos, Mirentxu; Aranda, Juan F.; Bielza, Concha; Martinez-Cruz, Ana B.; Lorz, Corina; Taron, Miquel; Ciruelos, Eva M.; Rodriguez-Peralto, Jose L.; Martin, Miguel; Larranaga, Pedro; Dahabreh, Jubrail; Stathopoulos, George P.; Rosell, Rafael; Paramio, Jesus M.; Garcia-Escudero, Ramon			Mouse p53-Deficient Cancer Models as Platforms for Obtaining Genomic Predictors of Human Cancer Clinical Outcomes	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURES; ESTROGEN-RECEPTOR-ALPHA; HUMAN BREAST; LUNG-CANCER; MOLECULAR SUBTYPES; P53; IDENTIFICATION; MAMMARY; SENSITIVITY; METASTASIS	Mutations in the TP53 gene are very common in human cancers, and are associated with poor clinical outcome. Transgenic mouse models lacking the Trp53 gene or that express mutant Trp53 transgenes produce tumours with malignant features in many organs. We previously showed the transcriptome of a p53-deficient mouse skin carcinoma model to be similar to those of human cancers with TP53 mutations and associated with poor clinical outcomes. This report shows that much of the 682-gene signature of this murine skin carcinoma transcriptome is also present in breast and lung cancer mouse models in which p53 is inhibited. Further, we report validated gene-expression-based tests for predicting the clinical outcome of human breast and lung adenocarcinoma. It was found that human patients with cancer could be stratified based on the similarity of their transcriptome with the mouse skin carcinoma 682-gene signature. The results also provide new targets for the treatment of p53-defective tumours.	[Duenas, Marta; Santos, Mirentxu; Aranda, Juan F.; Martinez-Cruz, Ana B.; Lorz, Corina; Paramio, Jesus M.; Garcia-Escudero, Ramon] CIEMAT, Mol Oncol Unit, E-28040 Madrid, Spain; [Bielza, Concha; Larranaga, Pedro] Univ Politecn Madrid, Dept Inteligencia Artificial, Madrid, Spain; [Taron, Miquel; Rosell, Rafael] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain; [Ciruelos, Eva M.] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid, Spain; [Rodriguez-Peralto, Jose L.] Hosp Univ 12 Octubre, Dept Pathol, Madrid, Spain; [Rodriguez-Peralto, Jose L.] Univ Complutense Madrid, Inst Invest Hosp Octubre I 12 12, Madrid, Spain; [Martin, Miguel] Univ Complutense Madrid, Hosp Gen Gregorio Maranon, Madrid, Spain; [Dahabreh, Jubrail] Athens Med Ctr, Dept Surg, Athens, Greece; [Stathopoulos, George P.] Errikos Dunant Hosp, Dept Oncol, Athens, Greece	Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Universidad Politecnica de Madrid; Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Complutense University of Madrid; General University Gregorio Maranon Hospital; Henry Dunant Hospital	Duenas, M (corresponding author), CIEMAT, Mol Oncol Unit, E-28040 Madrid, Spain.	jesusm.paramio@ciemat.es; ramon.garcia@ciemat.es	Paramio, Jesus M/M-8482-2014; Santos, Mirentxu/AAA-1727-2020; Martin, Miguel/V-6589-2019; Bielza, Concha/F-9277-2013; Lorz, Corina/E-3651-2016; Martin, Miguel/AAJ-9242-2020; Garcia-Escudero, Ramon/A-2735-2012; Aranda, Juan Francisco/S-6388-2018; Larranaga, Pedro/F-9293-2013	Paramio, Jesus M/0000-0001-7520-3177; Bielza, Concha/0000-0001-7109-2668; Lorz, Corina/0000-0001-8214-9076; Martin, Miguel/0000-0001-9237-3231; Garcia-Escudero, Ramon/0000-0001-5640-6542; Aranda, Juan Francisco/0000-0002-5598-2465; Larranaga, Pedro/0000-0003-0652-9872; Rodriguez-Peralto, Jose Luis/0000-0002-6578-7153; Duenas, Marta/0000-0003-0857-9726; Ciruelos, Eva/0000-0002-2796-1042	CAM [Oncocycle S2006/BIO-0232]; MICINN [ISCIII-RETIC RD06/0020, SAF2008-00121]; Fundacion Sandra Ibarra	CAM; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Sandra Ibarra	Oncocycle S2006/BIO-0232 (CAM), ISCIII-RETIC RD06/0020 (MICINN), and SAF2008-00121 (MICINN). J.M.P. was the recipient of a grant from the Fundacion Sandra Ibarra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMUNDADOTTIR LT, 1995, CELL GROWTH DIFFER, V6, P737; Andrechek ER, 2009, P NATL ACAD SCI USA, V106, P16387, DOI 10.1073/pnas.0901250106; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bornachea O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00434; Calvo A, 2008, ONCOGENE, V27, P5373, DOI 10.1038/onc.2008.155; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chen R, 2007, NAT METHODS, V4, P879, DOI 10.1038/nmeth1107-879; Coutant C, 2011, CLIN CANCER RES, V17, P2591, DOI 10.1158/1078-0432.CCR-10-1045; Dar AA, 2008, CANCER RES, V68, P8998, DOI 10.1158/0008-5472.CAN-08-2658; Deeb KK, 2007, CANCER RES, V67, P8065, DOI 10.1158/0008-5472.CAN-07-1515; Degenhardt Y, 2010, MOL CANCER THER, V9, P2079, DOI 10.1158/1535-7163.MCT-10-0095; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Eilon T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-231; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Garcia-Escudero R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-193; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gibbons DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005401; Greshock J, 2010, CANCER RES, V70, P3677, DOI 10.1158/0008-5472.CAN-09-3788; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Hurd C, 1999, ONCOGENE, V18, P1067, DOI 10.1038/sj.onc.1202398; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Mandinova A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001366; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; Neale G, 2008, CLIN CANCER RES, V14, P4572, DOI 10.1158/1078-0432.CCR-07-5090; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Regales L, 2009, J CLIN INVEST, V119, P3000, DOI 10.1172/JCI38746; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Sayeed A, 2007, CANCER RES, V67, P7746, DOI 10.1158/0008-5472.CAN-06-3724; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schoenherr RM, 2011, PROTEOM CLIN APPL, V5, P179, DOI 10.1002/prca.201000037; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shirley SH, 2009, CANCER RES, V69, P3405, DOI 10.1158/0008-5472.CAN-08-3628; SILVEY SD, 1959, ANN MATH STAT, V30, P389, DOI 10.1214/aoms/1177706259; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Toussaint J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-424; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yu CL, 1997, BIOCHEM BIOPH RES CO, V239, P617, DOI 10.1006/bbrc.1997.7522; Yu X, 2012, CANCER CELL, V21, P614, DOI 10.1016/j.ccr.2012.03.042; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2; Zhou YM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-59; Zhu M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r77	70	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42494	10.1371/journal.pone.0042494	http://dx.doi.org/10.1371/journal.pone.0042494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880004	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000307437900043
J	Hidalgo, J; Seoane, LF; Cortes, JM; Munoz, MA				Hidalgo, Jorge; Seoane, Luis F.; Cortes, Jesus M.; Munoz, Miguel A.			Stochastic Amplification of Fluctuations in Cortical Up-States	PLOS ONE			English	Article							SLOW-WAVE SLEEP; NETWORK MECHANISMS; NEURONAL NETWORKS; DYNAMIC SYNAPSES; CEREBRAL-CORTEX; IN-VITRO; OSCILLATIONS; POPULATION; HZ; TRANSITIONS	Cortical neurons are bistable; as a consequence their local field potentials can fluctuate between quiescent and active states, generating slow 0.5-2 Hz oscillations which are widely known as transitions between Up and Down States. Despite a large number of studies on Up-Down transitions, deciphering its nature, mechanisms and function are still today challenging tasks. In this paper we focus on recent experimental evidence, showing that a class of spontaneous oscillations can emerge within the Up states. In particular, a non-trivial peak around 20 Hz appears in their associated power-spectra, what produces an enhancement of the activity power for higher frequencies ( in the 30{90 Hz band). Moreover, this rhythm within Ups seems to be an emergent or collective phenomenon given that individual neurons do not lock to it as they remain mostly unsynchronized. Remarkably, similar oscillations ( and the concomitant peak in the spectrum) do not appear in the Down states. Here we shed light on these findings by using different computational models for the dynamics of cortical networks in presence of different levels of physiological complexity. Our conclusion, supported by both theory and simulations, is that the collective phenomenon of "stochastic amplification of fluctuations'' - previously described in other contexts such as Ecology and Epidemiology - explains in an elegant and parsimonious manner, beyond model-dependent details, this extra-rhythm emerging only in the Up states but not in the Downs.	[Hidalgo, Jorge; Munoz, Miguel A.] Univ Granada, Dept Electromagnetism & Fis Mat, Granada, Spain; [Hidalgo, Jorge; Munoz, Miguel A.] Univ Granada, Inst Fis Teor & Computac Carlos 1, Granada, Spain; [Seoane, Luis F.] Tech Univ Berlin, Bernstein Ctr Computat Neurosci, Berlin, Germany; [Seoane, Luis F.] UPF CSIC, Inst Biol Evolutiva, Barcelona, Spain; [Cortes, Jesus M.] Univ Granada, Dept Ciencias Computac & Inteligencia Artificial, Granada, Spain	University of Granada; University of Granada; Technical University of Berlin; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Granada	Hidalgo, J (corresponding author), Univ Granada, Dept Electromagnetism & Fis Mat, Granada, Spain.	mamunoz@onsager.ugr.es	Munoz, Miguel A/J-9627-2012; Cortes, Jesus/D-9949-2012; MUÑOZ, MIGUEL A/M-4099-2015; , Ivan/D-6804-2012	Munoz, Miguel A/0000-0002-0529-6221; Cortes, Jesus/0000-0002-9059-8194; MUÑOZ, MIGUEL A/0000-0003-0152-9080; Hidalgo, Jorge/0000-0001-7433-5602; , Ivan/0000-0002-3108-058X	Spanish MICINN-FEDER [FIS2009-08451]; Junta de Andalucia Proyecto de Excelencia [P09FQM-4682]; Fundacion P. Barrie de la Maza;  [01GQ1001A]	Spanish MICINN-FEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia Proyecto de Excelencia(Junta de Andalucia); Fundacion P. Barrie de la Maza; 	Funding provided by Spanish MICINN-FEDER under project FIS2009-08451 and Junta de Andalucia Proyecto de Excelencia P09FQM-4682. L.S. acknowledges the financial support of Fundacion P. Barrie de la Maza and funding grant 01GQ1001A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2007, J R SOC INTERFACE, V4, P575, DOI 10.1098/rsif.2006.0192; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Brunel N, 2008, CHAOS, V18, DOI 10.1063/1.2779858; Buzsaki G., 2006, RHYTHMS BRAIN; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Compte A, 2008, J NEUROSCI, V28, P13828, DOI 10.1523/JNEUROSCI.2684-08.2008; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Fujisawa S, 2006, CEREB CORTEX, V16, P639, DOI 10.1093/cercor/bhj010; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Kandel E., 2000, PRINCIPLES NEURAL SC; Kang K, 2010, J COMPUT NEUROSCI, V29, P495, DOI 10.1007/s10827-009-0190-2; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Mattia M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.052903; Mattia M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051917; McCarthy MM, 2011, P NATL ACAD SCI USA, V108, P11620, DOI 10.1073/pnas.1107748108; McCormick DA, 2005, CURR BIOL, V15, pR294, DOI 10.1016/j.cub.2005.04.009; McKane AJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.218102; Mejias JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013651; Millman D, 2010, NAT PHYS, V6, P801, DOI 10.1038/NPHYS1757; Mukovski M, 2007, CEREB CORTEX, V17, P400, DOI 10.1093/cercor/bhj157; NISBET RM, 1976, NATURE, V263, P319, DOI 10.1038/263319a0; Pantic L, 2002, NEURAL COMPUT, V14, P2903, DOI 10.1162/089976602760805331; Pargaa N, 2007, FRONT NEUROSCI-SWITZ, V1, P57, DOI 10.3389/neuro.01.1.1.004.2007; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Spiridon M, 1999, NETWORK-COMP NEURAL, V10, P257, DOI 10.1088/0954-898X/10/3/304; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Wallace E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014804; Wilson Charles, 2008, Scholarpedia J, V3, P1410; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686	39	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e40710	10.1371/journal.pone.0040710	http://dx.doi.org/10.1371/journal.pone.0040710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879879	Green Published, Green Submitted, gold			2022-12-27	WOS:000307437900003
J	Peuser, V; Remes, B; Klug, G				Peuser, Verena; Remes, Bernhard; Klug, Gabriele			Role of the Irr Protein in the Regulation of Iron Metabolism in Rhodobacter sphaeroides	PLOS ONE			English	Article							DEPENDENT GENE-EXPRESSION; OXIDATIVE STRESS-RESPONSE; HYDROGEN-PEROXIDE; SINGLET OXYGEN; DESULFOVIBRIO-VULGARIS; HEME-BIOSYNTHESIS; ESCHERICHIA-COLI; FUR; RUBRERYTHRIN; RIRA	In Rhizobia the Irr protein is an important regulator for iron-dependent gene expression. We studied the role of the Irr homolog RSP_3179 in the photosynthetic alpha-proteobacterium Rhodobacter sphaeroides. While Irr had little effect on growth under iron-limiting or non-limiting conditions its deletion resulted in increased resistance to hydrogen peroxide and singlet oxygen. This correlates with an elevated expression of katE for catalase in the Irr mutant compared to the wild type under non-stress conditions. Transcriptome studies revealed that Irr affects the expression of genes for iron metabolism, but also has some influence on genes involved in stress response, citric acid cycle, oxidative phosphorylation, transport, and photosynthesis. Most genes showed higher expression levels in the wild type than in the mutant under normal growth conditions indicating an activator function of Irr. Irr was however not required to activate genes of the iron metabolism in response to iron limitation, which showed even stronger induction in the absence of Irr. This was also true for genes mbfA and ccpA, which were verified as direct targets for Irr. Our results suggest that in R. sphaeroides Irr diminishes the strong induction of genes for iron metabolism under iron starvation.	[Peuser, Verena; Remes, Bernhard; Klug, Gabriele] Univ Giessen, Inst Mikrobiol & Mol Biol, Giessen, Germany	Justus Liebig University Giessen	Peuser, V (corresponding author), Univ Giessen, Inst Mikrobiol & Mol Biol, Giessen, Germany.	Gabriele.Klug@mikro.bio.uni-giessen.de	Klug, Gabriele/K-5322-2014	Klug, Gabriele/0000-0002-3527-5093; Gluschak, Verena/0000-0001-8612-954X	Deutsche Forschungsgemeinschaft [Kl563/25]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (Kl563/25) (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony JR, 2005, P NATL ACAD SCI USA, V102, P6502, DOI 10.1073/pnas.0502225102; Berghoff BA, 2009, MOL MICROBIOL, V74, P1497, DOI 10.1111/j.1365-2958.2009.06949.x; Chao TC, 2004, J BACTERIOL, V186, P3609, DOI 10.1128/JB.186.11.3609-3620.2004; Diaz-Mireles E, 2004, MICROBIOL-SGM, V150, P1447, DOI 10.1099/mic.0.26961-0; Drews G, 1983, MIKROBIOLOGISCHES PR; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Elsen S, 2004, MICROBIOL MOL BIOL R, V68, P263, DOI 10.1128/MMBR.68.2.263-279.2004; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Glaeser J, 2005, MICROBIOL-SGM, V151, P1927, DOI 10.1099/mic.0.27789-0; Glaeser J, 2007, J PROTEOME RES, V6, P2460, DOI 10.1021/pr060624p; Gomelsky L, 2003, MICROBIOL-SGM, V149, P377, DOI 10.1099/mic.0.25972-0; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Hibbing ME, 2011, J BACTERIOL, V193, P3461, DOI 10.1128/JB.00317-11; JANZON L, 1986, FEMS MICROBIOL LETT, V33, P193; Jean D, 2004, MICROBIOL-SGM, V150, P1649, DOI 10.1099/mic.0.27017-0; LEGALL J, 1988, BIOCHEMISTRY-US, V27, P1636, DOI 10.1021/bi00405a037; Li KY, 2003, ARCH MICROBIOL, V180, P484, DOI 10.1007/s00203-003-0620-x; Li M, 2003, J BIOL INORG CHEM, V8, P149, DOI 10.1007/s00775-002-0400-0; Lumppio HL, 2001, J BACTERIOL, V183, P101, DOI 10.1128/JB.183.1.101-108.2001; Martinez M, 2005, MICROBIOL-SGM, V151, P3427, DOI 10.1099/mic.0.28213-0; Martinez M, 2006, MICROBIOL-SGM, V152, P2591, DOI 10.1099/mic.0.28782-0; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Nuss AM, 2009, J BACTERIOL, V191, P220, DOI 10.1128/JB.00925-08; Peuser V, 2011, ENV MICROBIOL REP, V3, P397, DOI 10.1111/j.1758-2229.2011.00245.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Platero R, 2004, APPL ENVIRON MICROB, V70, P4349, DOI 10.1128/AEM.70.7.4349-4355.2004; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rodionov DA, 2006, PLOS COMPUT BIOL, V2, P1568, DOI 10.1371/journal.pcbi.0020163; Rudolph G, 2006, J BACTERIOL, V188, P733, DOI 10.1128/JB.188.2.733-744.2006; Sangwan I, 2008, J BACTERIOL, V190, P5172, DOI 10.1128/JB.00495-08; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Singleton C, 2010, J BIOL CHEM, V285, P16023, DOI 10.1074/jbc.M109.067215; Small SK, 2009, J BACTERIOL, V191, P1361, DOI 10.1128/JB.01571-08; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sztukowska M, 2002, MOL MICROBIOL, V44, P479, DOI 10.1046/j.1365-2958.2002.02892.x; Todd JD, 2002, MICROBIOL-SGM, V148, P4059, DOI 10.1099/00221287-148-12-4059; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Viguier C, 2005, FEMS MICROBIOL LETT, V246, P235, DOI 10.1016/j.femsle.2005.04.012; VONGABAIN A, 1983, P NATL ACAD SCI-BIOL, V80, P653; Weinberg MV, 2004, J BACTERIOL, V186, P7888, DOI 10.1128/JB.186.23.7888-7895.2004; Wexler M, 2003, MICROBIOL-SGM, V149, P1357, DOI 10.1099/mic.0.26130-0; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Yang J, 2006, MOL MICROBIOL, V60, P209, DOI 10.1111/j.1365-2958.2006.05087.x; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200; Zeilstra-Ryalls JH, 2004, CELL MOL LIFE SCI, V61, P417, DOI 10.1007/s00018-003-3242-1; Zeller T, 2005, J BACTERIOL, V187, P7232, DOI 10.1128/JB.187.21.7232-7242.2005; Zeller T, 2004, MICROBIOL-SGM, V150, P3451, DOI 10.1099/mic.0.27308-0; Zeller T, 2007, J BACTERIOL, V189, P3784, DOI 10.1128/JB.01795-06	54	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42231	10.1371/journal.pone.0042231	http://dx.doi.org/10.1371/journal.pone.0042231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879920	Green Published, gold, Green Submitted			2022-12-27	WOS:000307437900026
J	Schauble, S; Klement, K; Marthandan, S; Munch, S; Heiland, I; Schuster, S; Hemmerich, P; Diekmann, S				Schaeuble, Sascha; Klement, Karolin; Marthandan, Shiva; Muench, Sandra; Heiland, Ines; Schuster, Stefan; Hemmerich, Peter; Diekmann, Stephan			Quantitative Model of Cell Cycle Arrest and Cellular Senescence in Primary Human Fibroblasts	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; INDUCED PREMATURE SENESCENCE; HUMAN-DIPLOID FIBROBLASTS; DNA-DAMAGE; REPLICATIVE SENESCENCE; LIFE-SPAN; IN-VIVO; INTRACLONAL VARIATION; STOCHASTIC MECHANISM; CHECKPOINT RESPONSE	Primary human fibroblasts in tissue culture undergo a limited number of cell divisions before entering a non-replicative "senescent'' state. At early population doublings (PD), fibroblasts are proliferation-competent displaying exponential growth. During further cell passaging, an increasing number of cells become cell cycle arrested and finally senescent. This transition from proliferating to senescent cells is driven by a number of endogenous and exogenous stress factors. Here, we have developed a new quantitative model for the stepwise transition from proliferating human fibroblasts (P) via reversibly cell cycle arrested (C) to irreversibly arrested senescent cells (S). In this model, the transition from P to C and to S is driven by a stress function gamma and a cellular stress response function F which describes the time-delayed cellular response to experimentally induced irradiation stress. The application of this model based on senescence marker quantification at the single-cell level allowed to discriminate between the cellular states P, C, and S and delivers the transition rates between the P, C and S states for different human fibroblast cell types. Model-derived quantification unexpectedly revealed significant differences in the stress response of different fibroblast cell lines. Evaluating marker specificity, we found that SA-beta-Gal is a good quantitative marker for cellular senescence in WI-38 and BJ cells, however much less so in MRC-5 cells. Furthermore we found that WI-38 cells are more sensitive to stress than BJ and MRC-5 cells. Thus, the explicit separation of stress induction from the cellular stress response, and the differentiation between three cellular states P, C and S allows for the first time to quantitatively assess the response of primary human fibroblasts towards endogenous and exogenous stress during cellular ageing.	[Schaeuble, Sascha] Univ Jena, Res Grp Theoret Syst Biol, Jena, Germany; [Schaeuble, Sascha; Heiland, Ines; Schuster, Stefan] Univ Jena, Dept Bioinformat, Jena, Germany; [Klement, Karolin; Marthandan, Shiva; Muench, Sandra; Hemmerich, Peter; Diekmann, Stephan] FLI, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Schauble, S (corresponding author), Univ Jena, Res Grp Theoret Syst Biol, Jena, Germany.	diekmann@fli-leibniz.de	Heiland, Ines/B-9212-2014; Schäuble, Sascha/AAF-7809-2021	Heiland, Ines/0000-0002-9124-5112; 	Bundesministerium fuer Bildung und Forschung (BMBF) [0315581D]	Bundesministerium fuer Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from Bundesministerium fuer Bildung und Forschung (BMBF) (grant no. 0315581D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Benanti JA, 2004, MOL CELL BIOL, V24, P2842, DOI 10.1128/MCB.24.7.2842-2852.2004; Campisi J, 2009, J GERONTOL A-BIOL, V64, P164, DOI 10.1093/gerona/gln073; Chaturvedi V, 1999, J BIOL CHEM, V274, P23358, DOI 10.1074/jbc.274.33.23358; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cosme-Blanco W, 2008, EXP CELL RES, V314, P1973, DOI 10.1016/j.yexcr.2008.03.011; Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010; Csikasz-Nagy A, 2006, BIOPHYS J, V90, P4361, DOI 10.1529/biophysj.106.081240; Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; FARAGHER RGA, 1993, P NATL ACAD SCI USA, V90, P12030, DOI 10.1073/pnas.90.24.12030; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259; Golubev A, 2003, J THEOR BIOL, V225, P153, DOI 10.1016/S0022-5193(03)00229-7; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Havelka AM, 2007, MINI-REV MED CHEM, V7, P1035, DOI 10.2174/138955707782110196; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hwang ES, 2002, MECH AGEING DEV, V123, P1681, DOI 10.1016/S0047-6374(02)00102-1; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; KILL IR, 1994, J CELL SCI, V107, P571; Kim CS, 2007, MOL CELLS, V24, P424; Klement K, 2012, MECH AGEING IN PRESS; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Krizhanovsky V, 2008, COLD SH Q B, V73, P513, DOI 10.1101/sqb.2008.73.048; Kronschnabl M, 2003, J GEN VIROL, V84, P61, DOI 10.1099/vir.0.18703-0; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; LUDWIG D, 1978, J ANIM ECOL, V47, P315, DOI 10.2307/3939; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Marcotte R, 2004, MECH AGEING DEV, V125, P777, DOI 10.1016/j.mad.2004.07.007; Maslov AY, 2009, BBA-GEN SUBJECTS, V1790, P963, DOI 10.1016/j.bbagen.2009.03.020; Munch S, 2011, THESIS F SCHILLER U; Nakamura AJ, 2009, AGING-US, V1, P212, DOI 10.18632/aging.100019; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; PENNINGDEVRIES FWT, 1975, ANN BOT-LONDON, V39, P77; PIRT SJ, 1965, PROC R SOC SER B-BIO, V163, P224, DOI 10.1098/rspb.1965.0069; Portugal RD, 2008, BIOSYSTEMS, V91, P262, DOI 10.1016/j.biosystems.2007.10.003; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rubelj I, 1999, J THEOR BIOL, V197, P425, DOI 10.1006/jtbi.1998.0886; Seluanov A, 2008, AGING CELL, V7, P813, DOI 10.1111/j.1474-9726.2008.00431.x; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Shin JS, 2006, PATHOLOGY, V38, P103, DOI 10.1080/00313020600580468; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; SMITH JR, 1980, SCIENCE, V207, P82; Sozou PD, 2001, J THEOR BIOL, V213, P573, DOI 10.1006/jtbi.2001.2432; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tan Z, 1999, J THEOR BIOL, V198, P259, DOI 10.1006/jtbi.1999.0914; THORNLEY JH, 1970, NATURE, V227, P304, DOI 10.1038/227304b0; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; Toussaint O, 2002, BIOGERONTOLOGY, V3, P13, DOI 10.1023/A:1015226524335; Toussaint O, 2011, J CELL PHYSIOL, V226, P315, DOI 10.1002/jcp.22416; Tyson JJ, 2008, CURR BIOL, V18, pR759, DOI 10.1016/j.cub.2008.07.001; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Zhao W, 2004, CELL RES, V14, P60, DOI 10.1038/sj.cr.7290203	78	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42150	10.1371/journal.pone.0042150	http://dx.doi.org/10.1371/journal.pone.0042150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879912	gold, Green Published, Green Submitted			2022-12-27	WOS:000307437900022
J	Toriseva, M; Laato, M; Carpen, O; Ruohonen, ST; Savontaus, E; Inada, M; Krane, SM; Kahari, VM				Toriseva, Mervi; Laato, Matti; Carpen, Olli; Ruohonen, Suvi T.; Savontaus, Eriika; Inada, Masaki; Krane, Stephen M.; Kahari, Veli-Matti			MMP-13 Regulates Growth of Wound Granulation Tissue and Modulates Gene Expression Signatures Involved in Inflammation, Proteolysis, and Cell Viability	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE; COLLAGENASE-3 MMP-13; NEUROPEPTIDE-Y; HUMAN SKIN; 3-DIMENSIONAL COLLAGEN; KERATINOCYTE MIGRATION; ENDOTHELIAL-CELLS; FACTOR-BETA; ANGIOGENESIS; REPAIR	Proteinases play a pivotal role in wound healing by regulating cell-matrix interactions and availability of bioactive molecules. The role of matrix metalloproteinase-13 (MMP-13) in granulation tissue growth was studied in subcutaneously implanted viscose cellulose sponge in MMP-13 knockout (Mmp13(-/-)) and wild type (WT) mice. The tissue samples were harvested at time points day 7, 14 and 21 and subjected to histological analysis and gene expression profiling. Granulation tissue growth was significantly reduced (42%) at day 21 in Mmp13(-/-) mice. Granulation tissue in Mmp13(-/-) mice showed delayed organization of myofibroblasts, increased microvascular density at day 14, and virtual absence of large vessels at day 21. Gene expression profiling identified differentially expressed genes in Mmp13(-/-) mouse granulation tissue involved in biological functions including inflammatory response, angiogenesis, cellular movement, cellular growth and proliferation and proteolysis. Among genes linked to angiogenesis, Adamts4 and Npy were significantly upregulated in early granulation tissue in Mmp13(-/-) mice, and a set of genes involved in leukocyte motility including Il6 were systematically downregulated at day 14. The expression of Pdgfd was downregulated in Mmp13(-/-) granulation tissue in all time points. The expression of matrix metalloproteinases Mmp2, Mmp3, Mmp9 was also significantly downregulated in granulation tissue of Mmp13(-/-) mice compared to WT mice. Mmp13(-/-) mouse skin fibroblasts displayed altered cell morphology and impaired ability to contract collagen gel and decreased production of MMP-2. These results provide evidence for an important role for MMP-13 in wound healing by coordinating cellular activities important in the growth and maturation of granulation tissue, including myofibroblast function, inflammation, angiogenesis, and proteolysis.	[Toriseva, Mervi; Kahari, Veli-Matti] Univ Turku, Dept Dermatol, Turku, Finland; [Toriseva, Mervi; Kahari, Veli-Matti] Univ Turku, MediCity Res Lab, Turku, Finland; [Laato, Matti] Turku Univ Hosp, Dept Surg, FIN-20520 Turku, Finland; [Carpen, Olli] Univ Turku, Dept Pathol, Turku, Finland; [Ruohonen, Suvi T.; Savontaus, Eriika] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Inada, Masaki] Tokyo Univ Agr & Technol, Fac Engn, Dept Life Sci & Biotechnol, Tokyo, Japan; [Krane, Stephen M.] Harvard Univ, Sch Med, Dept Med, Ctr Immunol & Inflammatory Dis, Boston, MA USA; [Krane, Stephen M.] Massachusetts Gen Hosp, Boston, MA 02114 USA	University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; Tokyo University of Agriculture & Technology; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Toriseva, M (corresponding author), Univ Turku, Dept Dermatol, Turku, Finland.	veli-matti.kahari@utu.fi	Kahari, Veli-Matti/T-4925-2019; Kähäri, Veli-Matti/E-5144-2011; inada, masaki/D-1581-2013	Kahari, Veli-Matti/0000-0003-2421-9368; Kähäri, Veli-Matti/0000-0003-2421-9368; inada, masaki/0000-0002-5066-8506; Toriseva, Mervi/0000-0003-3024-6282; Savontaus, Eriika/0000-0003-3421-0367	Academy of Finland [137687]; Turku University Hospital [13336]; Sigrid Juselius Foundation; Cancer Research Foundation of Finland; Orion-Farmos Research Foundation; K. Albin Johansson's Foundation; Southwestern Finnish Cancer Foundation; Maud Kuistila's Memory Foundation; Paulo Foundation; Finnish Cultural Foundation; U.S. National Institutes of Health; Cancer Foundation Finland sr [110087, 100104] Funding Source: researchfish	Academy of Finland(Academy of Finland); Turku University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Research Foundation of Finland; Orion-Farmos Research Foundation; K. Albin Johansson's Foundation; Southwestern Finnish Cancer Foundation; Maud Kuistila's Memory Foundation; Paulo Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Foundation Finland sr	The study has been supported by grants from the Academy of Finland (project 137687), Turku University Hospital (project 13336), the Sigrid Juselius Foundation, the Cancer Research Foundation of Finland, and by personal grants (to M. Toriseva) from Orion-Farmos Research Foundation, K. Albin Johansson's Foundation, Southwestern Finnish Cancer Foundation, Maud Kuistila's Memory Foundation, Paulo Foundation and Finnish Cultural Foundation. Generation of the Mmp13<SUP>-/-</SUP> mice and backcrossing into WT mice was supported by grants from the U.S. National Institutes of Health to S. M. Krane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN MS, 1994, BRIT J DERMATOL, V131, P634, DOI 10.1111/j.1365-2133.1994.tb04974.x; Ahokas K, 2005, J INVEST DERMATOL, V124, P849, DOI 10.1111/j.0022-202X.2005.23640.x; Ala-aho R, 2000, ONCOGENE, V19, P248, DOI 10.1038/sj.onc.1203306; Chen L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-471; Cole J, 2001, WOUND REPAIR REGEN, V9, P360, DOI 10.1046/j.1524-475x.2001.00360.x; Ding SL, 2003, BLOOD, V101, P4816, DOI 10.1182/blood-2002-06-1731; Ekstrand AJ, 2003, P NATL ACAD SCI USA, V100, P6033, DOI 10.1073/pnas.1135965100; Endo H, 2011, PATHOBIOLOGY, V78, P239, DOI 10.1159/000328841; Farshchian M, 2011, AM J PATHOL, V179, P1110, DOI 10.1016/j.ajpath.2011.05.012; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; GACK S, 1995, CELL GROWTH DIFFER, V6, P759; Giangreco A, 2009, DEVELOPMENT, V136, P3505, DOI 10.1242/dev.038232; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hartenstein B, 2006, J INVEST DERMATOL, V126, P486, DOI 10.1038/sj.jid.5700084; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hieta N, 2003, J INVEST DERMATOL, V121, P997, DOI 10.1046/j.1523-1747.2003.12533.x; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Inkinen K, 2000, APMIS, V108, P318, DOI 10.1034/j.1600-0463.2000.d01-63.x; INOUE M, 1995, J INVEST DERMATOL, V104, P479, DOI 10.1111/1523-1747.ep12605917; Jeon SH, 2007, J LEUKOCYTE BIOL, V81, P557, DOI 10.1189/jlb.0806517; Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E; Johansson N, 1997, AM J PATHOL, V151, P499; Kahn J, 2000, AM J PATHOL, V156, P1887, DOI 10.1016/S0002-9440(10)65062-6; Kato T, 2001, FEBS LETT, V508, P187, DOI 10.1016/S0014-5793(01)02897-6; Koulu M, 2004, ANN MED, V36, P232, DOI 10.1080/07853890410031236; LAATO M, 1987, BIOCHEM J, V247, P385, DOI 10.1042/bj2470385; Lecomte J, 2011, CELL MOL LIFE SCI, V68, P677, DOI 10.1007/s00018-010-0476-6; Lederle W, 2010, CARCINOGENESIS, V31, P1175, DOI 10.1093/carcin/bgp248; Lee NV, 2006, EMBO J, V25, P5270, DOI 10.1038/sj.emboj.7601400; Lohi J, 2001, J BIOL CHEM, V276, P10134, DOI 10.1074/jbc.M001599200; Lund LR, 1999, EMBO J, V18, P4645, DOI 10.1093/emboj/18.17.4645; Madlener M, 1998, EXP CELL RES, V242, P201, DOI 10.1006/excr.1998.4049; Mauch C, 2010, J INVEST DERMATOL, V130, P2120, DOI 10.1038/jid.2010.60; Mirastschijski U, 2002, HUM PATHOL, V33, P355, DOI 10.1053/hupa.2002.32221; Mirastschijski U, 2010, WOUND REPAIR REGEN, V18, P223, DOI 10.1111/j.1524-475X.2010.00574.x; Mohan R, 2000, J BIOL CHEM, V275, P10405, DOI 10.1074/jbc.275.14.10405; Movafagh S, 2006, FASEB J, V20, P1924, DOI 10.1096/fj.05-4770fje; Nikkola J, 2002, INT J CANCER, V97, P432, DOI 10.1002/ijc.1636; Nowacki S, 2008, ONCOGENE, V27, P3329, DOI 10.1038/sj.onc.1210996; Nwomeh BC, 1999, J SURG RES, V81, P189, DOI 10.1006/jsre.1998.5495; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; Pins GD, 2000, J INVEST DERMATOL, V114, P647, DOI 10.1046/j.1523-1747.2000.00858.x; Ravanti L, 2001, FASEB J, V15, P1098, DOI 10.1096/fj.00-0588fje; Ravanti L, 1999, J BIOL CHEM, V274, P37292, DOI 10.1074/jbc.274.52.37292; Roy S, 2008, PHYSIOL GENOMICS, V34, P162, DOI 10.1152/physiolgenomics.00045.2008; Salter RC, 2011, INT J BIOCHEM CELL B, V43, P805, DOI 10.1016/j.biocel.2011.02.005; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Stokes A, 2010, CLIN CANCER RES, V16, P2022, DOI 10.1158/1078-0432.CCR-09-2525; Tommila M, 2011, J MOL CELL BIOL, V3, P190, DOI 10.1093/jmcb/mjq036; Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4; Toriseva MJ, 2007, J INVEST DERMATOL, V127, P49, DOI 10.1038/sj.jid.5700500; Uutela M, 2004, BLOOD, V104, P3198, DOI 10.1182/blood-2004-04-1485; Vaalamo M, 1997, J INVEST DERMATOL, V109, P96, DOI 10.1111/1523-1747.ep12276722; Vaalamo M, 1996, BRIT J DERMATOL, V135, P52; Veit G, 2011, J BIOL CHEM, V286, P27804, DOI 10.1074/jbc.M111.220046; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803; Wu NJ, 2003, J INVEST DERMATOL, V121, P926, DOI 10.1046/j.1523-1747.2003.12497.x; Xin H, 2003, ONCOGENE, V22, P4775, DOI 10.1038/sj.onc.1206780; Zigrino P, 2009, J INVEST DERMATOL, V129, P2686, DOI 10.1038/jid.2009.130	65	66	67	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42596	10.1371/journal.pone.0042596	http://dx.doi.org/10.1371/journal.pone.0042596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880047	Green Published, Green Submitted, gold			2022-12-27	WOS:000307437900045
J	Holtta, M; Zetterberg, H; Mirgorodskaya, E; Mattsson, N; Blennow, K; Gobom, J				Holtta, Mikko; Zetterberg, Henrik; Mirgorodskaya, Ekaterina; Mattsson, Niklas; Blennow, Kaj; Gobom, Johan			Peptidome Analysis of Cerebrospinal Fluid by LC-MALDI MS	PLOS ONE			English	Article							SCLEROSIS-RELATED PROTEINS; ALZHEIMERS-DISEASE; MASS-SPECTROMETRY; MULTIPLE-SCLEROSIS; SERUM PEPTIDOME; FRONTOTEMPORAL DEMENTIA; PROTEOMIC ANALYSIS; IDENTIFICATION; BIOMARKERS; WEIGHT	We report on the analysis of endogenous peptides in cerebrospinal fluid (CSF) by mass spectrometry. A method was developed for preparation of peptide extracts from CSF. Analysis of the extracts by offline LC-MALDI MS resulted in the detection of 3,000-4,000 peptide-like features. Out of these, 730 peptides were identified by MS/MS. The majority of these peptides have not been previously reported in CSF. The identified peptides were found to originate from 104 proteins, of which several have been reported to be involved in different disorders of the central nervous system. These results support the notion that CSF peptidomics may be viable complement to proteomics in the search of biomarkers of CNS disorders.	[Holtta, Mikko; Zetterberg, Henrik; Mattsson, Niklas; Blennow, Kaj; Gobom, Johan] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Clin Neurochem Lab,Dept Psychiat & Neurochem, Gothenburg, Sweden; [Mirgorodskaya, Ekaterina] Univ Gothenburg, Dept Occupat & Environm Med, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Holtta, M (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Clin Neurochem Lab,Dept Psychiat & Neurochem, Gothenburg, Sweden.	johan.gobom@neuro.gu.se	Mattsson-Carlgren, Niklas/H-7597-2019	Mattsson-Carlgren, Niklas/0000-0002-8885-7724; Holtta, Mikko/0000-0001-6024-3686				Andreasson U, 2007, BIOMARK MED, V1, P59, DOI 10.2217/17520363.1.1.59; Bartolomucci A, 2011, ENDOCR REV, V32, P755, DOI 10.1210/er.2010-0027; Benarroch EE, 2009, NEUROLOGY, V72, P1016, DOI 10.1212/01.wnl.0000345258.18071.54; Berger T, 2000, ADV RES NEURODEGENER, V8, P351; Berven FS, 2007, PROTEOM CLIN APPL, V1, P699, DOI 10.1002/prca.200700126; BLENNOW K, 1993, EUR NEUROL, V33, P129, DOI 10.1159/000116919; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Capellari S, 2011, ACTA NEUROPATHOL, V121, P21, DOI 10.1007/s00401-010-0760-4; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Flechsig E, 2004, CURR MOL MED, V4, P337, DOI 10.2174/1566524043360645; Gu CG, 1999, ANAL CHIM ACTA, V397, P247, DOI 10.1016/S0003-2670(99)00409-2; Harrington MG, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-10; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; Huang HL, 2005, ELECTROPHORESIS, V26, P2843, DOI 10.1002/elps.200500167; Huang JTJ, 2006, PLOS MED, V3, P2145, DOI 10.1371/journal.pmed.0030428; Huhmer AF, 2006, DIS MARKERS, V22, P3; Jahn H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026540; Jing Z, 2005, NEUROBIOL AGING, V26, P207, DOI 10.1016/j.neurobiolaging.2004.03.012; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Jurado R., 1990, CEREBROSPINAL FLUID; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Liotta LA, 2006, J CLIN INVEST, V116, P26, DOI 10.1172/JCI27467; Lopez MF, 2005, CLIN CHEM, V51, P1946, DOI 10.1373/clinchem.2005.053090; Maccarrone G, 2004, ELECTROPHORESIS, V25, P2402, DOI 10.1002/elps.200305909; Mattsson N, 2007, J NEUROCHEM, V103, P1932, DOI 10.1111/j.1471-4159.2007.04985.x; Mattsson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031084; Pan S, 2007, PROTEOMICS, V7, P469, DOI 10.1002/pmic.200600756; Portelius E, 2006, J PROTEOME RES, V5, P1010, DOI 10.1021/pr050475v; Portelius E, 2011, NEUROBIOL AGING, V32, P1090, DOI 10.1016/j.neurobiolaging.2009.06.002; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Ruetschi U, 2005, EXP NEUROL, V196, P273, DOI 10.1016/j.expneurol.2005.08.002; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Shores KS, 2007, J PROTEOME RES, V6, P3739, DOI 10.1021/pr070293w; Sickmann A, 2000, ELECTROPHORESIS, V21, P2721, DOI 10.1002/1522-2683(20000701)21:13<2721::AID-ELPS2721>3.0.CO;2-3; Simonsen AH, 2007, DEMENT GERIATR COGN, V24, P434, DOI 10.1159/000110576; Stark M, 2001, J CHROMATOGR B, V754, P357, DOI 10.1016/S0378-4347(00)00628-9; Stoop MP, 2008, PROTEOMICS, V8, P1576, DOI 10.1002/pmic.200700446; Stoop MP, 2009, J PROTEOME RES, V8, P1404, DOI 10.1021/pr8010155; Takeda K, 2004, FASEB J, V18, P1755, DOI 10.1096/fj.03-1070fje; Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Villanueva J, 2006, MOL CELL PROTEOMICS, V5, P1840, DOI 10.1074/mcp.M600229-MCP200; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; Wenner BR, 2004, J PROTEOME RES, V3, P97, DOI 10.1021/pr034070r; Xu J, 2006, INT REV NEUROBIOL, V73, P29, DOI 10.1016/S0074-7742(06)73002-1; Yanagida K, 2009, EMBO MOL MED, V1, P223, DOI 10.1002/emmm.200900026; YU W, 1993, ANAL CHEM, V65, P3015, DOI 10.1021/ac00069a014; Yuan XL, 2005, J MASS SPECTROM, V40, P176, DOI 10.1002/jms.737; Yuan XL, 2005, PROTEOMICS, V5, P541, DOI 10.1002/pmic.200400934; Zhang J, 2005, J ALZHEIMERS DIS, V8, P377; Zougman A, 2008, J PROTEOME RES, V7, P386, DOI 10.1021/pr070501k	53	51	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42555	10.1371/journal.pone.0042555	http://dx.doi.org/10.1371/journal.pone.0042555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880031	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000046
J	Vasileiadis, S; Puglisi, E; Arena, M; Cappa, F; Cocconcelli, PS; Trevisan, M				Vasileiadis, Sotirios; Puglisi, Edoardo; Arena, Maria; Cappa, Fabrizio; Cocconcelli, Pier S.; Trevisan, Marco			Soil Bacterial Diversity Screening Using Single 16S rRNA Gene V Regions Coupled with Multi-Million Read Generating Sequencing Technologies	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; ECOSYSTEMS; POLYMERASE	The novel multi-million read generating sequencing technologies are very promising for resolving the immense soil 16S rRNA gene bacterial diversity. Yet they have a limited maximum sequence length screening ability, restricting studies in screening DNA stretches of single 16S rRNA gene hypervariable (V) regions. The aim of the present study was to assess the effects of properties of four consecutive V regions (V3-6) on commonly applied analytical methodologies in bacterial ecology studies. Using an in silico approach, the performance of each V region was compared with the complete 16S rRNA gene stretch. We assessed related properties of the soil derived bacterial sequence collection of the Ribosomal Database Project (RDP) database and concomitantly performed simulations based on published datasets. Results indicate that overall the most prominent V region for soil bacterial diversity studies was V3, even though it was outperformed in some of the tests. Despite its high performance during most tests, V4 was less conserved along flanking sites, thus reducing its ability for bacterial diversity coverage. V5 performed well in the non-redundant RDP database based analysis. However V5 did not resemble the full-length 16S rRNA gene sequence results as well as V3 and V4 did when the natural sequence frequency and occurrence approximation was considered in the virtual experiment. Although, the highly conserved flanking sequence regions of V6 provide the ability to amplify partial 16S rRNA gene sequences from very diverse owners, it was demonstrated that V6 was the least informative compared to the rest examined V regions. Our results indicate that environment specific database exploration and theoretical assessment of the experimental approach are strongly suggested in 16S rRNA gene based bacterial diversity studies.	[Vasileiadis, Sotirios; Arena, Maria; Trevisan, Marco] Univ Cattolica Sacro Cuore, Inst Agr & Environm Chem, Fac Agr Sci, Piacenza, Italy; [Puglisi, Edoardo; Cappa, Fabrizio; Cocconcelli, Pier S.] Inst Microbiol, Piacenza, Italy	Catholic University of the Sacred Heart	Vasileiadis, S (corresponding author), Univ Cattolica Sacro Cuore, Inst Agr & Environm Chem, Fac Agr Sci, Piacenza, Italy.	marco.trevisan@unicatt.it	Vasileiadis, Sotirios/G-4119-2014; COCCONCELLI, Pier Sandro/ABB-5485-2020; Puglisi, Edoardo/O-3876-2019; Puglisi, Edoardo/I-8720-2012	Vasileiadis, Sotirios/0000-0002-2048-8192; COCCONCELLI, Pier Sandro/0000-0003-2212-7611; Puglisi, Edoardo/0000-0001-5051-0971; Puglisi, Edoardo/0000-0001-5051-0971; Cappa, Fabrizio/0000-0003-3814-4766	Cariplo Foundation	Cariplo Foundation(Fondazione Cariplo)	The performance of this study was financially supported by the Cariplo Foundation (URL http://www.fondazionecariplo.it/portal/sv1.do;jsessionid = 91C459E9C6037A2A296CE7B629CC3A17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Degnan PH, 2011, ISME J; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Meyer M, 2010, ILLUMINA SEQUENCING; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Roux S, 2011, FEMS MICROBIOL ECOL, V78, P617, DOI 10.1111/j.1574-6941.2011.01190.x; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255	34	83	94	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42671	10.1371/journal.pone.0042671	http://dx.doi.org/10.1371/journal.pone.0042671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880076	Green Submitted, Green Published, gold			2022-12-27	WOS:000307810000060
J	Zhou, Q; Bett, GCL; Rasmusson, RL				Zhou, Qinlian; Bett, Glenna C. L.; Rasmusson, Randall L.			Markov Models of Use-Dependence and Reverse Use-Dependence during the Mouse Cardiac Action Potential	PLOS ONE			English	Article							OUTWARD POTASSIUM CURRENT; HUMAN ATRIAL MYOCYTES; LONG QT; K+ CURRENTS; HUMAN HEART; INACTIVATION; CHANNELS; BLOCK; PROLONGATION; DRUGS	The fast component of the cardiac transient outward current, I-Ktof, is blocked by a number of drugs. The major molecular bases of I-Ktof are Kv4.2/Kv4.3 voltage-gated potassium channels. Drugs with similar potencies but different blocking mechanisms have differing effects on action potential duration (APD). We used in silico analysis to determine the effect of I-Ktof-blocking drugs with different blocking mechanisms on mouse ventricular myocytes. We used our existing mouse model of the action potential, and developed 4 new Markov formulations for I-Ktof, I-Ktos, I-Kur, I-Ks. We compared effects of theoretical I-Ktof-specific channel blockers: (1) a closed state, and (2) an open channel blocker. At concentrations lower or close to IC50, the drug which bound to the open state always had a much greater effect on APD than the drug which bound to the closed state. At concentrations much higher than IC50, both mechanisms had similar effects at very low pacing rates. However, an open state binding drug had a greater effect on APD at faster pacing rates, particularly around 10 Hz. In summary, our data indicate that drug effects on APD are strongly dependent not only on IC50, but also on the drug binding state.	[Zhou, Qinlian; Bett, Glenna C. L.; Rasmusson, Randall L.] SUNY Buffalo, Ctr Cellular & Syst Elect, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zhou, Q (corresponding author), SUNY Buffalo, Ctr Cellular & Syst Elect, Buffalo, NY USA.	rr32@buffalo.edu	Bett, Glenna/I-8074-2012	Bett, Glenna/0000-0003-2405-6562	NIH [HL062465, HL088058, HL093631]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062465, R21HL093631, R21HL088058] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the following grants from the NIH: HL062465, HL088058 (RR) and HL093631 (GB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUS ZS, 1991, AM J PHYSIOL, V261, pC310, DOI 10.1152/ajpcell.1991.261.2.C310; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bett GCL, 2004, J PHYSIOL-LONDON, V556, P109, DOI 10.1113/jphysiol.2003.055012; Bett GCL, 2011, BIOPHYS J, V100, P11, DOI 10.1016/j.bpj.2010.11.011; Bondarenko VE, 2004, AM J PHYSIOL-HEART C, V287, pH1378, DOI 10.1152/ajpheart.00185.2003; Bondarenko VE, 2007, AM J PHYSIOL-HEART C, V293, pH1816, DOI 10.1152/ajpheart.00471.2007; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Burashnikov A, 2011, PHARMACOL THERAPEUT, V132, P300, DOI 10.1016/j.pharmthera.2011.08.002; CAMPBELL DL, 1993, J GEN PHYSIOL, V101, P571, DOI 10.1085/jgp.101.4.571; CAMPBELL DL, 1993, J GEN PHYSIOL, V101, P603, DOI 10.1085/jgp.101.4.603; Das MK, 2010, J CARDIOVASC PHARM, V55, P438, DOI 10.1097/FJC.0b013e3181d64dde; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Ehrlich JR, 2007, CURR VASC PHARMACOL, V5, P185; Feng JL, 1998, AM J PHYSIOL-HEART C, V275, pH1717, DOI 10.1152/ajpheart.1998.275.5.H1717; Fiset C, 1997, J PHYSIOL-LONDON, V504, P557, DOI 10.1111/j.1469-7793.1997.557bd.x; Gilmour RF, 2002, J CARDIOVASC ELECTR, V13, P1150, DOI 10.1046/j.1540-8167.2002.01150.x; Ich, 2002, SAF PHARM STUD ASS P; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Knollmann BC, 2000, J PHYSIOL-LONDON, V525, P483, DOI 10.1111/j.1469-7793.2000.t01-1-00483.x; Knollmann BC, 2007, AM J PHYSIOL-HEART C, V292, pH614, DOI 10.1152/ajpheart.01085.2005; Liu SG, 1997, AM J PHYSIOL-HEART C, V272, pH2013, DOI 10.1152/ajpheart.1997.272.4.H2013; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; McEwen DP, 2009, MOL INTERV, V9, P79, DOI 10.1124/mi.9.2.7; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Moreno JD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002588; Rasmusson RL, 1998, CIRC RES, V82, P739, DOI 10.1161/01.RES.82.7.739; Ravens U, 2011, CARDIOVASC RES, V89, P776, DOI 10.1093/cvr/cvq398; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Riera Andres Ricardo Perez, 2008, Cardiol J, V15, P209; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; ROGERS WJ, 1992, NEW ENGL J MED, V327, P227; Rudy Y, 2008, CIRCULATION, V118, P1202, DOI 10.1161/CIRCULATIONAHA.108.772715; Silva J, 2005, CIRCULATION, V112, P1384, DOI 10.1161/CIRCULATIONAHA.105.543306; SNYDERS DJ, 1992, MOL PHARMACOL, V41, P322; SNYDERS DJ, 1995, CIRC RES, V77, P575, DOI 10.1161/01.RES.77.3.575; SNYDERS DJ, 1993, J GEN PHYSIOL, V101, P513, DOI 10.1085/jgp.101.4.513; Wang L, 1997, CIRC RES, V81, P120, DOI 10.1161/01.RES.81.1.120; Wang SM, 2005, BIOPHYS J, V89, P3026, DOI 10.1529/biophysj.105.059378; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Xu HD, 1999, CIRC RES, V85, P623, DOI 10.1161/01.RES.85.7.623	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42295	10.1371/journal.pone.0042295	http://dx.doi.org/10.1371/journal.pone.0042295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879935	gold, Green Submitted, Green Published			2022-12-27	WOS:000307810000027
J	Mangieri, RA; Cofresi, RU; Gonzales, RA				Mangieri, Regina A.; Cofresi, Roberto U.; Gonzales, Rueben A.			Ethanol Seeking by Long Evans Rats Is Not Always a Goal-Directed Behavior	PLOS ONE			English	Article							ACCUMBAL DOPAMINE CONCENTRATION; NUCLEUS-ACCUMBENS; BASAL GANGLIA; 10-PERCENT SUCROSE; COCAINE SEEKING; DEVALUATION; EXPOSURE; PARALLEL	Background: Two parallel and interacting processes are said to underlie animal behavior, whereby learning and performance of a behavior is at first via conscious and deliberate (goal-directed) processes, but after initial acquisition, the behavior can become automatic and stimulus-elicited (habitual). With respect to instrumental behaviors, animal learning studies suggest that the duration of training and the action-outcome contingency are two factors involved in the emergence of habitual seeking of "natural" reinforcers (e. g., sweet solutions, food or sucrose pellets). To rigorously test whether behaviors reinforced by abused substances such as ethanol, in particular, similarly become habitual was the primary aim of this study. Methodology/Principal Findings: Male Long Evans rats underwent extended or limited operant lever press training with 10% sucrose/10% ethanol (10S10E) reinforcement (variable interval (VI) or (VR) ratio schedule of reinforcement), or with 10% sucrose (10S) reinforcement (VI schedule only). Once training and pretesting were complete, the impact of outcome devaluation on operant behavior was evaluated after lithium chloride injections were paired with the reinforcer, or unpaired 24 hours later. After limited, but not extended instrumental training, lever pressing by groups trained under VR with 10S10E and under VI with 10S was sensitive to outcome devaluation. In contrast, responding by both the extended and limited training 10S10E VI groups was not sensitive to ethanol devaluation during the test for habitual behavior. Conclusions/Significance: Operant behavior by rats trained to self-administer an ethanol-sucrose solution showed variable sensitivity to a change in the value of ethanol, with relative insensitivity developing sooner in animals that received time-variable ethanol reinforcement during training sessions. One important implication, with respect to substance abuse in humans, is that initial learning about the relationship between instrumental actions and the opportunity to consume ethanol-containing drinks can influence the time course for the development or expression of habitual ethanol seeking behavior.	[Mangieri, Regina A.; Cofresi, Roberto U.; Gonzales, Rueben A.] Univ Texas Austin, Coll Pharm, Dept Pharmacol & Toxicol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Mangieri, RA (corresponding author), Univ Texas Austin, Coll Pharm, Dept Pharmacol & Toxicol, Austin, TX 78712 USA.	reginamangieri@austin.utexas.edu	Mangieri, Regina/N-1602-2019	Mangieri, Regina/0000-0002-4499-6183; Cofresi Bonilla, Roberto Ulises/0000-0003-1131-6142	National Institute on Alcohol and Alcohol Abuse [T32AA007471, F32AA018252, R37AA011852]; National Science Foundation [HRD-0703584]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007471, R37AA011852, F32AA018252] Funding Source: NIH RePORTER	National Institute on Alcohol and Alcohol Abuse; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Research support was provided by awards T32AA007471, F32AA018252, and R37AA011852 from the National Institute on Alcohol and Alcohol Abuse (http://www.niaaa.nih.gov) and HRD-0703584 from the National Science Foundation (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CD, 1982, Q J EXP PSYCHOL-B, V34, P77, DOI 10.1080/14640748208400878; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Belin D, 2009, BEHAV BRAIN RES, V199, P89, DOI 10.1016/j.bbr.2008.09.027; Carrillo J, 2008, ALCOHOL, V42, P171, DOI 10.1016/j.alcohol.2008.01.005; Carrillo J, 2011, ALCOHOL, V45, P559, DOI 10.1016/j.alcohol.2011.01.003; Corbit LH, 2012, BIOL PSYCHIAT; DeRusso AL, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00017; Dickinson A, 2002, Q J EXP PSYCHOL-B, V55, P331, DOI 10.1080/0272499024400016; DICKINSON A, 1983, Q J EXP PSYCHOL-B, V35, P35, DOI 10.1080/14640748308400912; Donahoe JW, 2000, J EXP ANAL BEHAV, V74, P331, DOI 10.1901/jeab.2000.74-331; Doyon WM, 2006, NEUROPHARMACOLOGY, V51, P487, DOI 10.1016/j.neuropharm.2006.04.005; Doyon WM, 2005, J NEUROCHEM, V93, P1469, DOI 10.1111/j.1471-4159.2005.03137.x; Doyon WM, 2004, ALCOHOL, V34, P261, DOI 10.1016/j.alcohol.2004.10.004; Doyon WM, 2003, ALCOHOL CLIN EXP RES, V27, P1573, DOI 10.1097/01.ALC.0000089959.66222.B8; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hogarth L, 2011, J EXP PSYCHOL-ANIM B, V37, P261, DOI 10.1037/a0022913; Howard EC, 2009, ALCOHOL CLIN EXP RES, V33, P1355, DOI 10.1111/j.1530-0277.2009.00965.x; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Jonkman S, 2010, BEHAV PROCESS, V83, P276, DOI 10.1016/j.beproc.2009.12.017; Miles FJ, 2003, BEHAV NEUROSCI, V117, P927, DOI 10.1037/0735-7044.117.5.927; Ostlund SB, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00019; Redgrave P, 2011, NEUROSCIENCE, V198, P138, DOI 10.1016/j.neuroscience.2011.07.060; Rescorla RA, 1996, ANIM LEARN BEHAV, V24, P450, DOI 10.3758/BF03199016; RESCORLA RA, 1995, Q J EXP PSYCHOL-B, V48, P252; Roberts AJ, 1999, ALCOHOL CLIN EXP RES, V23, P1151, DOI 10.1097/00000374-199907000-00003; Robinson DL, 2009, ALCOHOL CLIN EXP RES, V33, P1187, DOI 10.1111/j.1530-0277.2009.00942.x; Root DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007170; Samson HH, 1999, PSYCHOPHARMACOLOGY, V147, P274, DOI 10.1007/s002130051167; Samson HH, 2004, ALCOHOL, V32, P203, DOI 10.1016/j.alcohol.2004.02.002; Seger CA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00066; Shahan TA, 2004, BEHAV PHARMACOL, V15, P279, DOI 10.1097/01.fbp.0000135706.93950.1a; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; Wang LP, 2011, NEURON, V72, P1055, DOI 10.1016/j.neuron.2011.10.019; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Zapata A, 2010, J NEUROSCI, V30, P15457, DOI 10.1523/JNEUROSCI.4072-10.2010	38	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42886	10.1371/journal.pone.0042886	http://dx.doi.org/10.1371/journal.pone.0042886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870342	gold, Green Submitted, Green Published			2022-12-27	WOS:000307284100178
J	Motsch, N; Alles, J; Imig, J; Zhu, JY; Barth, S; Reineke, T; Tinguely, M; Cogliatti, S; Dueck, A; Meister, G; Renner, C; Grasser, FA				Motsch, Natalie; Alles, Julia; Imig, Jochen; Zhu, Jiayun; Barth, Stephanie; Reineke, Tanja; Tinguely, Marianne; Cogliatti, Sergio; Dueck, Anne; Meister, Gunter; Renner, Christoph; Graesser, Friedrich A.			MicroRNA Profiling of Epstein-Barr Virus-Associated NK/T-Cell Lymphomas by Deep Sequencing	PLOS ONE			English	Article							BCL-6 PROTEIN EXPRESSION; GENE; IDENTIFICATION; ESTABLISHMENT; INTERLEUKIN-1; SYSTEM; TARGET; LINES; SITES; TUMOR	The Epstein-Barr virus (EBV) is an oncogenic human Herpes virus involved in the pathogenesis of nasal NK/T-cell lymphoma. EBV encodes microRNAs (miRNAs) and induces changes in the host cellular miRNA profile. MiRNAs are short non-coding RNAs of about 19-25 nt length that regulate gene expression by post-transcriptional mechanisms and are frequently deregulated in human malignancies including cancer. The microRNA profiles of EBV-positive NK/T-cell lymphoma, noninfected T-cell lymphoma and normal thymus were established by deep sequencing of small RNA libraries. The comparison of the EBV-positive NK/T-cell vs. EBV-negative T-cell lymphoma revealed 15 up-und 16 down-regulated miRNAs. In contrast, the majority of miRNAs was repressed in the lymphomas compared to normal tissue. We also identified 10 novel miRNAs from known precursors and two so far unknown miRNAs. The sequencing results were confirmed for selected miRNAs by quantitative Real-Time PCR (qRT-PCR). We show that the proinflammatory cytokine interleukin 1 alpha (IL1A) is a target for miR-142-3p and the oncogenic BCL6 for miR-205. MiR-142-3p is down-regulated in the EBV-positive vs. EBV-negative lymphomas. MiR-205 was undetectable in EBV-negative lymphoma and strongly down-regulated in EBV-positive NK/T-cell lymphoma as compared to thymus. The targets were confirmed by reporter assays and by down-regulation of the proteins by ectopic expression of the cognate miRNAs. Taken together, our findings demonstrate the relevance of deregulated miRNAs for the post-transcriptional gene regulation in nasal NK/T-cell lymphomas.	[Motsch, Natalie; Alles, Julia; Imig, Jochen; Barth, Stephanie; Graesser, Friedrich A.] Univ Saarland, Univ Hosp, Dept Virol, Inst Microbiol & Hyg, D-6650 Homburg, Germany; [Zhu, Jiayun; Meister, Gunter] Max Planck Inst Biochem, CIPSM, Lab RNA Biol, D-82152 Martinsried, Germany; [Reineke, Tanja; Tinguely, Marianne] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Cogliatti, Sergio] Kantonsspital, Inst Pathol, St Gallen, Switzerland; [Dueck, Anne; Meister, Gunter] Univ Regensburg, Regensburg, Germany; [Renner, Christoph] Univ Zurich Hosp, Dept Internal Med Oncol, Div Oncol, CH-8091 Zurich, Switzerland	Saarland University; Universitatsklinikum des Saarlandes; Max Planck Society; University of Zurich; University Zurich Hospital; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Regensburg; University of Zurich; University Zurich Hospital	Motsch, N (corresponding author), Univ Saarland, Univ Hosp, Dept Virol, Inst Microbiol & Hyg, D-6650 Homburg, Germany.	graesser@uks.eu		Imig, Jochen/0000-0003-0385-1081	Deutsche Krebshilfe [107166]; German Bundesministerium fur Bildung und Forschung [01GS0801/4, 01GS0801/5]; Max-Planck-Society; Bavarian Ministry for Education and Science	Deutsche Krebshilfe(Deutsche Krebshilfe); German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Bavarian Ministry for Education and Science	This research was supported by grant 107166 from the Deutsche Krebshilfe to G. Meister and F. Grasser; S. Barth was supported by the German Bundesministerium fur Bildung und Forschung through grant NGFN-Plus #01GS0801/4 to F. Grasser. The contribution from the Meister lab was partially supported by the Max-Planck-Society, a grant from the German Bundesministerium fur Bildung und Forschung through grant NGFN-Plus #01GS0801/5 (to G. Meister) and the Bavarian Ministry for Education and Science (BayGene to G. Meister). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aozasa K, 2008, INT J HEMATOL, V87, P110, DOI 10.1007/s12185-008-0021-7; Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Baron BW, 2002, P NATL ACAD SCI USA, V99, P2860, DOI 10.1073/pnas.042702599; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Carbone A, 1997, BLOOD, V90, P2445; Charoudeh HN, 2010, BLOOD, V116, P183, DOI 10.1182/blood-2009-10-247130; Cicatiello L, 2010, AM J PATHOL, V176, P2113, DOI 10.2353/ajpath.2010.090837; Cosmopoulos K, 2009, J VIROL, V83, P2357, DOI 10.1128/JVI.02104-08; Delecluse HJ, 2007, J CLIN PATHOL, V60, P1358, DOI 10.1136/jcp.2006.044586; DENNY CT, 1986, NATURE, V320, P549, DOI 10.1038/320549a0; Feng M, 2010, CELL CYCLE, V9, P213, DOI 10.4161/cc.9.2.10502; Gao CP, 2010, CANCER-AM CANCER SOC, V116, P41, DOI 10.1002/cncr.24743; Godshalk SE, 2008, CELL CYCLE, V7, P3595, DOI 10.4161/cc.7.22.7120; GONG JH, 1994, LEUKEMIA, V8, P652; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Habig M, 2006, ARCH VIROL, V151, P1961, DOI 10.1007/s00705-006-0768-1; Harabuchi Y, 2009, INT J CLIN ONCOL, V14, P181, DOI 10.1007/s10147-009-0882-7; Hinuma Y, 1967, J Virol, V1, P1045; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Huang Y, 2011, BLOOD, V115, P1226; Huang YT, 1999, CANCER RES, V59, P1599; Hutzinger R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000547; Iliopoulos D, 2009, CANCER RES, V69, P3278, DOI 10.1158/0008-5472.CAN-09-0155; Imig J, 2011, NUCLEIC ACIDS RES, V39, P1880, DOI 10.1093/nar/gkq1043; Jun SM, 2008, BR J HAEMATOL; Kagami Y, 1998, BRIT J HAEMATOL, V103, P669, DOI 10.1046/j.1365-2141.1998.01029.x; Kerl K, 2001, LAB INVEST, V81, P1693, DOI 10.1038/labinvest.3780382; Kim DN, 2007, J VIROL, V81, P1033, DOI 10.1128/JVI.02271-06; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lenoir G M, 1985, IARC Sci Publ, P309; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Meister G, 2007, CELL, V131, P25, DOI 10.1016/j.cell.2007.09.021; Meneses-Garcia Abelardo, 2008, World J Surg Oncol, V6, P114, DOI 10.1186/1477-7819-6-114; Ng SB, 2011, BLOOD, V118, P4919, DOI 10.1182/blood-2011-07-364224; O'Leary Hilary M, 2009, Curr Hematol Malig Rep, V4, P227, DOI 10.1007/s11899-009-0030-5; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Papadopoulou V, 2010, BIOCHEM J, V427, P541, DOI 10.1042/BJ20091578; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Rickinson AB, 2007, FIELDS VIROLOGY, V2, P2655; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Spizzo R, 2009, CELL, V137, P586, DOI 10.1016/j.cell.2009.04.040; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; SUNG SSJ, 1991, J CLIN INVEST, V88, P1915, DOI 10.1172/JCI115515; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Tsuchiyama J, 1998, BLOOD, V92, P1374, DOI 10.1182/blood.V92.4.1374.416a33_1374_1383; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Zhang Y, 2006, BRIT J CANCER, V94, P599, DOI 10.1038/sj.bjc.6602968; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08	59	51	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42193	10.1371/journal.pone.0042193	http://dx.doi.org/10.1371/journal.pone.0042193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870299	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000307284100052
J	Pham, NT; Jewell, WT; Morin, D; Jones, AD; Buckpitt, AR				Pham, Nathalie T.; Jewell, William T.; Morin, Dexter; Jones, A. Daniel; Buckpitt, Alan R.			Characterization of Model Peptide Adducts with Reactive Metabolites of Naphthalene by Mass Spectrometry	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; COVALENT BINDING; PROTEIN TARGETS; IN-VIVO; LIVER; 1,4-NAPHTHOQUINONE; HEMOGLOBIN; LYSINE; MICE; 1,2-NAPHTHOQUINONE	Naphthalene is a volatile polycyclic aromatic hydrocarbon generated during combustion and is a ubiquitous chemical in the environment. Short term exposures of rodents to air concentrations less than the current OSHA standard yielded necrotic lesions in the airways and nasal epithelium of the mouse, and in the nasal epithelium of the rat. The cytotoxic effects of naphthalene have been correlated with the formation of covalent protein adducts after the generation of reactive metabolites, but there is little information about the specific sites of adduction or on the amino acid targets of these metabolites. To better understand the chemical species produced when naphthalene metabolites react with proteins and peptides, we studied the formation and structure of the resulting adducts from the incubation of model peptides with naphthalene epoxide, naphthalene diol epoxide, 1,2-naphthoquinone, and 1,4-naphthoquinone using high resolution mass spectrometry. Identification of the binding sites, relative rates of depletion of the unadducted peptide, and selectivity of binding to amino acid residues were determined. Adduction occurred on the cysteine, lysine, and histidine residues, and on the N-terminus. Monoadduct formation occurred in 39 of the 48 reactions. In reactions with the naphthoquinones, diadducts were observed, and in one case, a triadduct was detected. The results from this model peptide study will assist in data interpretation from ongoing work to detect peptide adducts in vivo as markers of biologic effect.	[Pham, Nathalie T.; Morin, Dexter; Buckpitt, Alan R.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Jewell, William T.] Univ Calif Davis, Mol Struct Facil, Davis, CA 95616 USA; [Jones, A. Daniel] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Jones, A. Daniel] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	University of California System; University of California Davis; University of California System; University of California Davis; Michigan State University; Michigan State University	Pham, NT (corresponding author), Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA.	natpham@ucdavis.edu	Jones, Arthur D/C-2670-2013	Jones, A. Daniel/0000-0002-7408-6690	National Institutes of Environmental Health [ES 04311, ES 04699]; Floyd and Mary Schwall Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004311, P42ES004699] Funding Source: NIH RePORTER	National Institutes of Environmental Health; Floyd and Mary Schwall Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Environmental Health [Grant ES 04311, ES 04699]. NP was supported by a fellowship from the Floyd and Mary Schwall Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAMBAL RB, 1995, CHEM RES TOXICOL, V8, P729, DOI 10.1021/tx00047a013; Booth ED, 2004, CHEM-BIOL INTERACT, V147, P213, DOI 10.1016/j.cbi.2004.01.002; Britto PJ, 2002, J BIOL CHEM, V277, P29018, DOI 10.1074/jbc.M204263200; Chao YCE, 2006, ENVIRON HEALTH PERSP, V114, P182, DOI 10.1289/ehp.8288; CHO M, 1994, J PHARMACOL EXP THER, V269, P881; COLES B, 1985, DRUG METAB REV, V15, P1307, DOI 10.3109/03602538409029962; Dennehy MK, 2006, CHEM RES TOXICOL, V19, P20, DOI 10.1021/tx050312l; DeStefano-Shields C, 2010, ENVIRON HEALTH PERSP, V118, P647, DOI 10.1289/ehp.0901333; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Hanzlik RP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-95; Hettick JM, 2011, ANAL BIOCHEM, V414, P232, DOI 10.1016/j.ab.2011.03.035; Humphreys WG, 2011, CHEM-BIOL INTERACT, V192, P56, DOI 10.1016/j.cbi.2011.01.005; Ikehata K, 2008, CHEM RES TOXICOL, V21, P1432, DOI 10.1021/tx800093k; Jagr M, 2007, CHEM RES TOXICOL, V20, P1442, DOI 10.1021/tx700057t; Kristiansson MH, 2003, BIOMARKERS, V8, P343, DOI 10.1080/13547500310001607836; Liebler DC, 2008, CHEM RES TOXICOL, V21, P117, DOI 10.1021/tx700235t; Lin CY, 2006, PROTEOMICS, V6, P972, DOI 10.1002/pmic.200500170; Liu J, 2005, CHEM RES TOXICOL, V18, P1485, DOI 10.1021/tx0501738; LoPachin RM, 2009, CHEM RES TOXICOL, V22, P1499, DOI 10.1021/tx900147g; MILLER MG, 1986, BIOCHEM PHARMACOL, V35, P1177, DOI 10.1016/0006-2952(86)90157-7; National Toxicology Program, 2000, 500 NTP; Obach RS, 2008, CHEM RES TOXICOL, V21, P1814, DOI 10.1021/tx800161s; Pham N, 2012, CHEM BIOL INTERACTIO; Pham N, 2011, TOXICOLOGIST, V120; Preuss R, 2003, INT ARCH OCC ENV HEA, V76, P556, DOI 10.1007/s00420-003-0458-1; ROBERTS SA, 1990, TOXICOL APPL PHARM, V105, P195, DOI 10.1016/0041-008X(90)90181-S; Stamper BD, 2011, CHEM RES TOXICOL, V24, P549, DOI 10.1021/tx1004198; Tang W, 2010, DRUG METAB REV, V42, P225, DOI 10.3109/03602530903401658; TSANG WS, 1982, J ORG CHEM, V47, P5339, DOI 10.1021/jo00148a021; TSURUDA LS, 1995, DRUG METAB DISPOS, V23, P129; TSURUDA LS, 1995, ARCH TOXICOL, V69, P362, DOI 10.1007/s002040050185; Waidyanatha S, 2002, CHEM-BIOL INTERACT, V141, P189, DOI 10.1016/S0009-2797(02)00048-0; Waidyanatha S, 2008, CHEM-BIOL INTERACT, V172, P105, DOI 10.1016/j.cbi.2008.01.004; YAGI H, 1975, J AM CHEM SOC, V97, P3185, DOI 10.1021/ja00844a044; ZHANG MJ, 1993, J BIOL CHEM, V268, P22420; Zheng J, 1997, CHEM RES TOXICOL, V10, P1008, DOI 10.1021/tx970061j	36	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42053	10.1371/journal.pone.0042053	http://dx.doi.org/10.1371/journal.pone.0042053			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870282	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100044
J	Smith, CR; Mutti, NS; Jasper, WC; Naidu, A; Smith, CD; Gadau, J				Smith, Chris R.; Mutti, Navdeep S.; Jasper, W. Cameron; Naidu, Agni; Smith, Christopher D.; Gadau, Juergen			Patterns of DNA Methylation in Development, Division of Labor and Hybridization in an Ant with Genetic Caste Determination	PLOS ONE			English	Article							RED HARVESTER ANT; HYBRID ORIGIN; DRAFT GENOME; EVOLUTION; WIDESPREAD; INSECT; SYSTEM; AMPLIFICATION; METHYLOME; FREQUENCY	Background: DNA methylation is a common regulator of gene expression, including acting as a regulator of developmental events and behavioral changes in adults. Using the unique system of genetic caste determination in Pogonomyrmex barbatus, we were able to document changes in DNA methylation during development, and also across both ancient and contemporary hybridization events. Methodology/Principal Findings: Sodium bisulfite sequencing demonstrated in vivo methylation of symmetric CG dinucleotides in P. barbatus. We also found methylation of non-CpG sequences. This validated two bioinformatics methods for predicting gene methylation, the bias in observed to expected ratio of CpG dinucleotides and the density of CpG/TpG single nucleotide polymorphisms (SNP). Frequencies of genomic DNA methylation were determined for different developmental stages and castes using ms-AFLP assays. The genetic caste determination system (GCD) is probably the product of an ancestral hybridization event between P. barbatus and P. rugosus. Two lineages obligately co-occur within a GCD population, and queens are derived from intra-lineage matings whereas workers are produced from inter-lineage matings. Relative DNA methylation levels of queens and workers from GCD lineages (contemporary hybrids) were not significantly different until adulthood. Virgin queens had significantly higher relative levels of DNA methylation compared to workers. Worker DNA methylation did not vary among developmental stages within each lineage, but was significantly different between the currently hybridizing lineages. Finally, workers of the two genetic caste determination lineages had half as many methylated cytosines as workers from the putative parental species, which have environmental caste determination. Conclusions/Significance: These results suggest that DNA methylation may be a conserved regulatory mechanism moderating division of labor in both bees and ants. Current and historic hybridization appear to have altered genomic methylation levels suggesting a possible link between changes in overall DNA methylation and the origin and regulation of genetic caste determination in P. barbatus.	[Smith, Chris R.; Mutti, Navdeep S.; Gadau, Juergen] Earlham Coll, Dept Biol, Richmond, IN 47374 USA; [Smith, Chris R.] Arizona State Univ, Sch Life Sci, Ctr Social Dynam & Complex, Tempe, AZ USA; [Jasper, W. Cameron; Naidu, Agni; Smith, Christopher D.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	Earlham College; Arizona State University; Arizona State University-Tempe; California State University System; San Francisco State University	Smith, CR (corresponding author), Earlham Coll, Dept Biol, Richmond, IN 47374 USA.	crsmith.ant@gmail.com		Smith, Chris/0000-0003-4667-9509	Arizona State University; National Science Foundation [IOS-0920732]; Division Of Integrative Organismal Systems [0920732] Funding Source: National Science Foundation	Arizona State University; National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded primarily by a Post-doctoral Interdisciplinary Research in the Life Sciences (PIRLS) grant from Arizona State University to C. R. Smith and N. S. Mutti. Additional funding was provided by a grant from the National Science Foundation (IOS-0920732) to J. Gadau and C. R. Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Kirk E., 2008, Myrmecological News, V11, P119; Anderson KE, 2006, ECOLOGY, V87, P2171, DOI 10.1890/0012-9658(2006)87[2171:DAEOGC]2.0.CO;2; Anderson KE, 2009, EVOLUTION, V63, P2142, DOI 10.1111/j.1558-5646.2009.00696.x; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Cahan SH, 2004, CURR BIOL, V14, P2277, DOI 10.1016/j.cub.2004.12.027; Cahan SH, 2003, NATURE, V424, P306, DOI 10.1038/nature01744; Cahan SH, 2002, P ROY SOC B-BIOL SCI, V269, P1871, DOI 10.1098/rspb.2002.2061; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; EVANS JD, 1993, MOL ECOL, V2, P393, DOI 10.1111/j.1365-294X.1993.tb00032.x; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Field LM, 2004, INSECT MOL BIOL, V13, P109, DOI 10.1111/j.0962-1075.2004.00470.x; Flores KB, 2011, J EXP BIOL, V214, P3155, DOI 10.1242/jeb.059741; Foitzik S, 1997, INSECT SOC, V44, P219, DOI 10.1007/s000400050043; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foret S, 2012, P NATL ACAD SCI USA, V109, P4968, DOI 10.1073/pnas.1202392109; Gadau J, 2012, TRENDS GENET, V28, P14, DOI 10.1016/j.tig.2011.08.005; Glastad KM, 2011, INSECT MOL BIOL, V20, P553, DOI 10.1111/j.1365-2583.2011.01092.x; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hahn DA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P100, DOI 10.1086/380214; Hunt BG, 2011, P NATL ACAD SCI USA, V108, P15936, DOI 10.1073/pnas.1104825108; Julian GE, 2002, P NATL ACAD SCI USA, V99, P8157, DOI 10.1073/pnas.112222099; Kim SH, 2006, PLOS GENET, V2, P1527, DOI 10.1371/journal.pgen.0020163; Krauss V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007223; Kronforst MR, 2008, CURR BIOL, V18, pR287, DOI 10.1016/j.cub.2008.02.015; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Lewis S.E., 2002, GENOME BIOL, V3; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lockett GA, 2012, GENES BRAIN BEHAV, V11, P235, DOI 10.1111/j.1601-183X.2011.00751.x; Lu HL, 2009, FEBS J, V276, P3110, DOI 10.1111/j.1742-4658.2009.07029.x; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Park J, 2011, MOL BIOL EVOL, V28, P3345, DOI 10.1093/molbev/msr168; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Schutt S, 2003, GENETICS, V165, P223; Schwander T, 2008, EVOLUTION, V62, P1635, DOI 10.1111/j.1558-5646.2008.00387.x; Schwander T, 2008, CURR BIOL, V18, P265, DOI 10.1016/j.cub.2008.01.024; Schwander T, 2007, MOL ECOL, V16, P367, DOI 10.1111/j.1365-294X.2006.03124.x; Sha K, 2008, ANNU REV GENOM HUM G, V9, P197, DOI 10.1146/annurev.genom.122007.110031; Sirvio A, 2011, EVOLUTION, V65, P869, DOI 10.1111/j.1558-5646.2010.01170.x; Smith CR, 2008, AM NAT, V172, P497, DOI 10.1086/590961; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CR, 2010, FUNCT ECOL, V24, P122, DOI 10.1111/j.1365-2435.2009.01604.x; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Volny VP, 2002, P NATL ACAD SCI USA, V99, P6108, DOI 10.1073/pnas.092066699; Volny VP, 2002, MOL ECOL NOTES, V2, P302, DOI 10.1046/j.1471-8286.2002.00243.x; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064; Yi SV, 2009, EPIGENETICS-US, V4, P551, DOI 10.4161/epi.4.8.10345; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhao Y, 2008, MOL BIOL+, V42, P169, DOI 10.1134/S0026893308020015; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	58	47	48	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42433	10.1371/journal.pone.0042433	http://dx.doi.org/10.1371/journal.pone.0042433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879983	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100093
J	Wei, CY; Kumar, S; Kim, IK; Gupta, S				Wei, Chuanyu; Kumar, Sandeep; Kim, Il-Kwon; Gupta, Sudhiranjan			Thymosin Beta 4 Protects Cardiomyocytes from Oxidative Stress by Targeting Anti-Oxidative Enzymes and Anti-Apoptotic Genes	PLOS ONE			English	Article							NF-KAPPA-B; HEART-FAILURE; CARDIAC REPAIR; MITOCHONDRIAL DYSFUNCTION; EPITHELIAL-CELLS; COMPLEX-I; OXYGEN; ACTIVATION; DEATH; OVEREXPRESSION	Background: Thymosin beta-4 (T beta 4) is a ubiquitous protein with many properties relating to cell proliferation and differentiation that promotes wound healing and modulates inflammatory mediators. The mechanism by which T beta 4 modulates cardiac protection under oxidative stress is not known. The purpose of this study is to dissect the cardioprotective mechanism of T beta 4 on H2O2 induced cardiac damage. Methods: Rat neonatal cardiomyocytes with or without T beta 4 pretreatment were exposed to H2O2 and expression of antioxidant, apoptotic, and anti-inflammatory genes was evaluated by quantitative real-time PCR and western blotting. ROS levels were estimated by DCF-DA using fluorescent microscopy and fluorimetry. Selected antioxidant, anti-inflammatory and antiapoptotic genes were silenced by siRNA transfections in neonatal cardiomyocytes and effect of T beta 4 on H2O2-induced cardiac damage was evaluated. Results: Pre-treatment of T beta 4 resulted in reduction of the intracellular ROS levels induced by H2O2 in cardiomyocytes. T beta 4 pretreatment also resulted in an increase in the expression of antiapoptotic proteins and reduction of Bax/BCl2 ratio in the cardiomyocytes. Pretreatment with T beta 4 resulted in stimulating the expression of antioxidant enzymes copper/zinc SOD and catalase in cardiomyocytes at both transcription and translation levels. T beta 4 treatment resulted in the increased expression of anti-apoptotic and anti-inflammatory genes. Silencing of Cu/Zn SOD and catalase gene resulted in apoptotic cell death in the cardiomyocytes which was prevented by treatment with T beta 4. Conclusion: This is the first report that demonstrates the effect of T beta 4 on cardiomyocytes and its capability to selectively upregulate anti-oxidative enzymes, anti-inflammatory genes, and antiapoptotic enzymes in the neonatal cardiomyocytes thus preventing cell death thereby protecting the myocardium. T beta 4 treatment resulted in decreased oxidative stress and inflammation in the myocardium under oxidative stress.	[Wei, Chuanyu; Kumar, Sandeep; Kim, Il-Kwon; Gupta, Sudhiranjan] Texas A & M Hlth Sci Ctr, Coll Med, Dept Med, Div Mol Cardiol,Cent Texas Vet Hlth Care Syst, Temple, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Wei, CY (corresponding author), Texas A & M Hlth Sci Ctr, Coll Med, Dept Med, Div Mol Cardiol,Cent Texas Vet Hlth Care Syst, Temple, TX USA.	sgupta@medicine.tamhsc.edu	Kumar, Sandeep/AAX-4612-2021; wei, chuanyu/H-3150-2016	Kumar, Sandeep/0000-0003-3440-3628; 	Texas A & M Health Science Center, College of Medicine; American Heart Association-National Scientist Development Grant [0835227N]	Texas A & M Health Science Center, College of Medicine; American Heart Association-National Scientist Development Grant(American Heart Association)	This study was partly supported by start-up funds from the Texas A & M Health Science Center, College of Medicine, by an American Heart Association-National Scientist Development Grant (0835227N) to S. Gupta. The authors acknowledge the Central Texas Veterans Affairs Health Care System for providing the research facility to complete this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Afanas'ev I, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/293769; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Chen ZY, 1998, J MOL CELL CARDIOL, V30, P2281, DOI 10.1006/jmcc.1998.0789; CRAWFORD DR, 1994, ENVIRON HEALTH PERSP, V102, P25, DOI 10.2307/3432208; Crockford D, 2010, ANN NY ACAD SCI, V1194, P179, DOI 10.1111/j.1749-6632.2010.05492.x; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; DHALLA AK, 1994, AM J PHYSIOL, V266, pH1280, DOI 10.1152/ajpheart.1994.266.4.H1280; Dube KN, 2012, CURR PHARM DESIGN, V18, P799; Ferrari R, 2004, CURR PHARM DESIGN, V10, P1699, DOI 10.2174/1381612043384718; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Gupta S, 2002, J CELL BIOL, V159, P1019, DOI 10.1083/jcb.200207149; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Hall G, 2006, J MOL CELL CARDIOL, V41, P580, DOI 10.1016/j.yjmcc.2006.07.006; Han H, 2004, AM J PHYSIOL-HEART C, V286, pH2169, DOI 10.1152/ajpheart.00199.2003; Higuchi Y, 2006, AM J PHYSIOL-HEART C, V290, pH590, DOI 10.1152/ajpheart.00379.2005; Ho JHC, 2008, BRIT J OPHTHALMOL, V92, P992, DOI 10.1136/bjo.2007.136747; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Kratsios P, 2010, CIRC RES, V106, P133, DOI 10.1161/CIRCRESAHA.109.202200; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026912; Kumar S, 2011, FREE RADICAL BIO MED, V50, P206, DOI 10.1016/j.freeradbiomed.2010.10.711; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Murphy MP, 1998, GEN PHARMACOL, V31, P179, DOI 10.1016/S0306-3623(97)00418-7; Nelson M, 2007, INT J BIOCHEM CELL B, V39, P879, DOI 10.1016/j.biocel.2006.10.004; Oliveira-Marques V, 2009, ANTIOXID REDOX SIGN, V11, P2223, DOI [10.1089/ars.2009.2601, 10.1089/ARS.2009.2601]; Pashkow FJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/514623; Pendergrass KD, 2011, CIRC-HEART FAIL, V4, P98, DOI 10.1161/CIRCHEARTFAILURE.110.957712; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Sadoshima J, 2006, ANTIOXID REDOX SIGN, V8, P1621, DOI 10.1089/ars.2006.8.1621; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Shrivastava S, 2010, ANN NY ACAD SCI, V1194, P87, DOI 10.1111/j.1749-6632.2010.05468.x; Smart N, 2010, ANN NY ACAD SCI, V1194, P97, DOI 10.1111/j.1749-6632.2010.05478.x; Sopko N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020184; Sosne G, 2004, INVEST OPHTH VIS SCI, V45, P1095, DOI 10.1167/iovs.03-1002; Sosne G, 2006, EXP EYE RES, V83, P502, DOI 10.1016/j.exer.2006.02.001; Stanley WC, 2000, CARDIOVASC RES, V45, P805, DOI 10.1016/S0008-6363(99)00419-8; Tsutsui H, 2001, INTERNAL MED, V40, P1177, DOI 10.2169/internalmedicine.40.1177; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012; Zhou SX, 2009, J CARDIOVASC PHARM, V54, P154, DOI 10.1097/FJC.0b013e3181af6d7f	47	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42586	10.1371/journal.pone.0042586	http://dx.doi.org/10.1371/journal.pone.0042586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880044	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100137
J	Lee, JJ; Kim, YM; Jeong, J; Bae, DS; Lee, KJ				Lee, Jae-Jin; Kim, Young Mee; Jeong, Jaeho; Bae, Duk Soo; Lee, Kong-Joo			Ubiquitin-Associated (UBA) Domain in Human Fas Associated Factor 1 Inhibits Tumor Formation by Promoting Hsp70 Degradation	PLOS ONE			English	Article							NF-KAPPA-B; POSTTRANSLATIONAL MODIFICATIONS; LIGASE ACTIVITY; PAGETS-DISEASE; PROTEINS; PROTEASOME; BINDING; IDENTIFICATION; SUPPRESSOR; APOPTOSIS	Human Fas associated factor 1 (hFAF1) is a pro-apoptotic scaffolding protein containing ubiquitin-associating (UBA), ubiquitin like 1 and 2 (UBL1, UBL2), and ubiquitin regulatory X (UBX) domains. hFAF1 interacts with polyubiquitinated proteins via its N-terminal UBA domain and with valosin containing protein (VCP) via its C-terminal UBX domain. Overexpression of hFAF1 or its N-terminal UBA domain significantly increases cell death by increasing the degradation of polyubiquitinated proteins. In this study, we investigated whether hFAF1, whose expression level is reduced in cervical cancer, plays a role in tumor formation. We found that HeLa cells overexpressing full-length hFAF1 or the hFAF1 UBA domain alone, significantly suppressed the anchorage independent tumor growth in soft agar colony formation, increased cell death, and activated JNK and caspase 3. Employing UBA-specific tandem immunoprecipitation, we identified moieties specifically interacting with UBA domain of hFAF1, and found that polyubiquitinated Hsp70s are recruited to UBA domain. We also demonstrated that hFAF1 overexpression promotes Hsp70 degradation via the proteasome. We further found that mutating the UBA domain (I41N), as well as knocking down hFAF1 with specific RNAi, abolishs its ability to increase the proteasomal degradation of Hsp70. These findings suggest that hFAF1 inhibits tumor formation by increasing the degradation of Hsp70 mediated via its UBA domain.	[Lee, Jae-Jin; Kim, Young Mee; Jeong, Jaeho; Lee, Kong-Joo] Ewha Womans Univ, Coll Pharm, Ctr Cell Signaling, Div Life & Pharmaceut Sci,Dept Bioinspired Sci, Seoul, South Korea; [Bae, Duk Soo] Sungkyunkwan Univ, Dept Obstet & Gynecol, Samsung Med Ctr, Seoul, South Korea	Ewha Womans University; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, JJ (corresponding author), Ewha Womans Univ, Coll Pharm, Ctr Cell Signaling, Div Life & Pharmaceut Sci,Dept Bioinspired Sci, Seoul, South Korea.	kjl@ewha.ac.kr		Lee, Kong-Joo/0000-0001-7972-6020	Center for Cell Signaling Research and Drug Discovery Research (CCS & DDR) at Ewha Womans University from National Core Research Center (NCRC) [R15-2006-020]; WCU (World Class University) [R31-2008-000-10010-0]; Brain Korea 21 project	Center for Cell Signaling Research and Drug Discovery Research (CCS & DDR) at Ewha Womans University from National Core Research Center (NCRC); WCU (World Class University); Brain Korea 21 project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported through the Center for Cell Signaling Research and Drug Discovery Research (CCS & DDR, R15-2006-020) at Ewha Womans University from the National Core Research Center (NCRC) program and by WCU (World Class University) project R31-2008-000-10010-0). Lee JJ and Kim YM were supported by the Brain Korea 21 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Bjorling-Poulsen M, 2003, INT J ONCOL, V23, P1015; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; CHU KT, 1995, P NATL ACAD SCI USA, V92, P11894, DOI 10.1073/pnas.92.25.11894; Ciani B, 2003, J BIOL CHEM, V278, P37409, DOI 10.1074/jbc.M307416200; Daniel DC, 2002, MICROSC RES TECHNIQ, V59, P68, DOI 10.1002/jemt.10178; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hidalgo A, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-77; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kim HJ, 2005, J BIOL CHEM, V280, P8125, DOI 10.1074/jbc.M406297200; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017; Liu M, 2008, J BIOL CHEM, V283, P35783, DOI 10.1074/jbc.M806860200; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Na S, 2008, MOL CELL PROTEOMICS, V7, P2452, DOI 10.1074/mcp.M800101-MCP200; Park MY, 2007, J BIOL CHEM, V282, P27572, DOI 10.1074/jbc.C700106200; Park MY, 2004, J BIOL CHEM, V279, P2544, DOI 10.1074/jbc.M304565200; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Ryu SW, 2003, J BIOL CHEM, V278, P24003, DOI 10.1074/jbc.M302200200; Ryu SW, 2001, BIOCHEM BIOPH RES CO, V286, P1027, DOI 10.1006/bbrc.2001.5505; Saracco SA, 2009, PLANT J, V59, P344, DOI 10.1111/j.1365-313X.2009.03862.x; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Song J, 2009, PROTEIN SCI, V18, P2265, DOI 10.1002/pro.237; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Yip KHM, 2006, AM J PATHOL, V169, P503, DOI 10.2353/ajpath.2006.050960	38	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e40361	10.1371/journal.pone.0040361	http://dx.doi.org/10.1371/journal.pone.0040361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876279	Green Published, gold, Green Submitted			2022-12-27	WOS:000307184700007
J	Shepherd, LD; Worthy, TH; Tennyson, AJD; Scofield, RP; Ramstad, KM; Lambert, DM				Shepherd, Lara D.; Worthy, Trevor H.; Tennyson, Alan J. D.; Scofield, R. Paul; Ramstad, Kristina M.; Lambert, David M.			Ancient DNA Analyses Reveal Contrasting Phylogeographic Patterns amongst Kiwi (Apteryx spp.) and a Recently Extinct Lineage of Spotted Kiwi	PLOS ONE			English	Article							QUATERNARY FOSSIL FAUNAS; NEW-ZEALAND; SOUTH-ISLAND; HYBRIDIZATION; CONSERVATION; CANTERBURY; DIVERGENCE; HISTORY; MAXIMUM; CAVES	The little spotted kiwi (Apteryx owenii) is a flightless ratite formerly found throughout New Zealand but now greatly reduced in distribution. Previous phylogeographic studies of the related brown kiwi (A. mantelli, A. rowi and A. australis), with which little spotted kiwi was once sympatric, revealed extremely high levels of genetic structuring, with mitochondrial DNA haplotypes often restricted to populations. We surveyed genetic variation throughout the present and pre-human range of little spotted kiwi by obtaining mitochondrial DNA sequences from contemporary and ancient samples. Little spotted kiwi and great spotted kiwi (A. haastii) formed a monophyletic clade sister to brown kiwi. Ancient samples of little spotted kiwi from the northern North Island, where it is now extinct, formed a lineage that was distinct from remaining little spotted kiwi and great spotted kiwi lineages, potentially indicating unrecognized taxonomic diversity. Overall, little spotted kiwi exhibited much lower levels of genetic diversity and structuring than brown kiwi, particularly through the South Island. Our results also indicate that little spotted kiwi (or at least hybrids involving this species) survived on the South Island mainland until more recently than previously thought.	[Shepherd, Lara D.; Lambert, David M.] Massey Univ, Allan Wilson Ctr, Auckland, New Zealand; [Shepherd, Lara D.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Shepherd, Lara D.; Tennyson, Alan J. D.] Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand; [Worthy, Trevor H.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Scofield, R. Paul] Canterbury Museum, Christchurch, New Zealand; [Ramstad, Kristina M.] Victoria Univ Wellington, Sch Biol Sci, Allan Wilson Ctr, Wellington, New Zealand; [Lambert, David M.] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [Lambert, David M.] Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia	Massey University; Massey University; University of New South Wales Sydney; Victoria University Wellington; Griffith University; Griffith University	Shepherd, LD (corresponding author), Massey Univ, Allan Wilson Ctr, Auckland, New Zealand.	Lara.Shepherd@tepapa.govt.nz	Ramstad, Kristina/AAC-1103-2019; Scofield, R. Paul/A-4271-2011; Ramstad, Kristina/AAV-7517-2021; Worthy, Trevor/B-3781-2012; Ramstad, Kristina/G-3728-2014	Scofield, R. Paul/0000-0002-7510-6980; Ramstad, Kristina/0000-0002-4979-6543; Worthy, Trevor/0000-0001-7047-4680; Shepherd, Lara/0000-0002-7136-0017; Lambert, David/0000-0002-5821-3637	Massey University Doctoral Scholarship; New Zealand Federation of University Women; Marsden Fund grant [MAU302]	Massey University Doctoral Scholarship; New Zealand Federation of University Women; Marsden Fund grant(Royal Society of New ZealandMarsden Fund (NZ))	L.D.S. acknowledges financial support from a Massey University Doctoral Scholarship and the New Zealand Federation of University Women. This research was supported by a Marsden Fund grant (MAU302) to D. M. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; BAKER AJ, 1995, P NATL ACAD SCI USA, V92, P8254, DOI 10.1073/pnas.92.18.8254; Barrell DJA, 2005, 20057 I GEOL NUCL SC; Basse B, 2003, NEW ZEAL J ECOL, V27, P95; Boessenkool S, 2009, P ROY SOC B-BIOL SCI, V276, P815, DOI 10.1098/rspb.2008.1246; Brochu CA, 2004, EVOLUTION, V58, P1375; Buller WL, 1888, HIST BIRDS NZ, V2; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; Burbidge ML, 2003, CONSERV GENET, V4, P167, DOI 10.1023/A:1023386506067; Butler D, 1991, KIWI RECOVERY PLAN; Colbourne R. M., 2005, DEP CONSERVATION RES, V208; Drost F, 2007, QUATERNARY SCI REV, V26, P2505, DOI 10.1016/j.quascirev.2007.06.005; Drummond AJ, 2010, GENEIOUS V5 3; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; Fleming C.A., 1986, Notornis, V33, P245; Forbes Y, 2009, THESIS AUCKLAND U TE; Garcia-Moreno J, 2004, J AVIAN BIOL, V35, P465, DOI 10.1111/j.0908-8857.2004.03316.x; Gardner RC, 2004, BIOL J LINN SOC, V83, P399, DOI 10.1111/j.1095-8312.2004.00398.x; Gibb J. G., 1986, R SOC NZ B, V24, P377; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HEATHER BD, 2000, FIELD GUIDE BIRDS NZ; Herbert J., 2002, SOME EARLY 1990S STU, P11; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Holzapfel S, 2008, KIWI APTERYX SPP REC; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Hutching G., 2004, BACK BRINK FIGHT SAV; Jolly Jim N., 2002, New Zealand Department of Conservation Science & Research Internal Report, V191, P57; Jolly JN, 1992, GREAT SPOTTED UNPUB; Jolly JN, 1990, KIWIS, P86; Jolly JN, 1983, 2 NZ WILDL SERV; Lambert DM, 1993, MORPHOLOGICAL RESEMB, P63; Leschen RAB, 2008, MOL ECOL, V17, P1256, DOI 10.1111/j.1365-294X.2007.03630.x; Lovette IJ, 2004, AUK, V121, P1, DOI 10.1642/0004-8038(2004)121[0001:MDAMSF]2.0.CO;2; Marsh S, 2005, KIWI HUNTER; Marske KA, 2009, MOL ECOL, V18, P5126, DOI 10.1111/j.1365-294X.2009.04418.x; MATHEWS G. M., 1935, BULL BRIT ORNITH CLUB, V55, P179; McGlone MS, 2010, TERRA AUSTRALIS, V32, P49; MCGLONE MS, 1985, NEW ZEAL J BOT, V23, P723, DOI 10.1080/0028825X.1985.10434240; McLennan J, 2002, SOME EARLY 1990S STU, P35; MCLENNAN JA, 1987, NEW ZEAL J ECOL, V10, P97; McLennan JA, 1990, MONOGRAPH APTERYGIDA, P72; Millar CD, 2008, TRENDS ECOL EVOL, V23, P386, DOI 10.1016/j.tree.2008.04.002; Miskelly Colin M., 2008, Notornis, V55, P117; Morgan-Richards M, 2009, J ROY SOC NEW ZEAL, V39, P15, DOI 10.1080/03014220909510561; Newnham RM, 2004, PALAEOGEOGR PALAEOCL, V207, P165, DOI 10.1016/j.palaeo.2004.02.007; PEAT N, 1990, INCREDIBLE KIWI; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramstad KM, 2010, CONSERV GENET RESOUR, V2, P333, DOI 10.1007/s12686-010-9233-2; Reid B, 1975, BIOGEOGRAPHY ECOLOGY, P301; Reischek A, 1930, YESTERDAYS MAORILAND; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Robertson H., 2004, SCI CONSERVATION, V241; Rothschild W, 1899, NOVITATES ZOOLOGICAE, V6, P361; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shepherd LD, 2008, MOL ECOL, V17, P2174, DOI 10.1111/j.1365-294X.2008.03749.x; Shepherd LD, 2007, MOL ECOL, V16, P4536, DOI 10.1111/j.1365-294X.2007.03451.x; Shepherd LD, 2011, MOL ECOL, V20, P1389, DOI 10.1111/j.1365-294X.2011.05017.x; Shepherd LD, 2006, MOL ECOL NOTES, V6, P227, DOI 10.1111/j.1471-8286.2005.01201.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taborsky B, 1999, J AVIAN BIOL, V30, P143, DOI 10.2307/3677123; Tennyson Alan J. D., 2003, Records of the Auckland Museum, V40, P55; Trewick Steven A., 2011, Insects, V2, P297, DOI 10.3390/insects2030297; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; WILKINSON AS, 1952, KAPITI BIRD SANCTUAR; Wilson K. J., 2004, FLIGHT HUIA ECOLOGY; Worthy T. H., 1998, Records of the Canterbury Museum, V12, P49; Worthy TH, 1997, J ROY SOC NEW ZEAL, V27, P67, DOI 10.1080/03014223.1997.9517528; WORTHY TH, 1994, J ROY SOC NEW ZEAL, V24, P297, DOI 10.1080/03014223.1994.9517474; Worthy TH, 1998, J ROY SOC NEW ZEAL, V28, P537, DOI 10.1080/03014223.1998.9517575; WORTHY TH, 1995, J ROY SOC NEW ZEAL, V25, P333, DOI 10.1080/03014223.1995.9517494; Worthy TH, 1998, J ROYAL SOC NZ, V28, P42; WORTHY TH, 2002, LOST WORLD MOA; Worthy Trevor H., 2002, Tuhinga Records of the Museum of New Zealand Te Papa Tongarewa, V13, P1	77	32	35	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42384	10.1371/journal.pone.0042384	http://dx.doi.org/10.1371/journal.pone.0042384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876319	Green Published, gold, Green Submitted			2022-12-27	WOS:000307184700047
J	Valles, I; Pajares, MJ; Segura, V; Guruceaga, E; Gomez-Roman, J; Blanco, D; Tamura, A; Montuenga, LM; Pio, R				Valles, Inaki; Pajares, Maria J.; Segura, Victor; Guruceaga, Elisabet; Gomez-Roman, Javier; Blanco, David; Tamura, Akiko; Montuenga, Luis M.; Pio, Ruben			Identification of Novel Deregulated RNA Metabolism-Related Genes in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; NUCLEAR RIBONUCLEOPROTEIN A2/B1; TUMOR-SUPPRESSOR GENE; MESSENGER-RNA; LONG ARM; EXPRESSION PROFILES; PROSTATE-CANCER; DIFFERENTIAL EXPRESSION; SPLICING MACHINERY; MALIGNANT GLIOMAS	Lung cancer is a leading cause of cancer death worldwide. Several alterations in RNA metabolism have been found in lung cancer cells; this suggests that RNA metabolism-related molecules are involved in the development of this pathology. In this study, we searched for RNA metabolism-related genes that exhibit different expression levels between normal and tumor lung tissues. We identified eight genes differentially expressed in lung adenocarcinoma microarray datasets. Of these, seven were up-regulated whereas one was down-regulated. Interestingly, most of these genes had not previously been associated with lung cancer. These genes play diverse roles in mRNA metabolism: three are associated with the spliceosome (ASCL3L1, SNRPB and SNRPE), whereas others participate in RNA-related processes such as translation (MARS and MRPL3), mRNA stability (PCBPC1), mRNA transport (RAE), or mRNA editing (ADAR2, also known as ADARB1). Moreover, we found a high incidence of loss of heterozygosity at chromosome 21q22.3, where the ADAR2 locus is located, in NSCLC cell lines and primary tissues, suggesting that the downregulation of ADAR2 in lung cancer is associated with specific genetic losses. Finally, in a series of adenocarcinoma patients, the expression of five of the deregulated genes (ADAR2, MARS, RAE, SNRPB and SNRPE) correlated with prognosis. Taken together, these results support the hypothesis that changes in RNA metabolism are involved in the pathogenesis of lung cancer, and identify new potential targets for the treatment of this disease.	[Valles, Inaki; Pajares, Maria J.; Blanco, David; Montuenga, Luis M.; Pio, Ruben] Ctr Appl Med Res, Div Oncol, Pamplona, Spain; [Pajares, Maria J.; Blanco, David; Montuenga, Luis M.] Univ Navarra, Sch Med, Dept Histol & Pathol, E-31080 Pamplona, Spain; [Segura, Victor; Guruceaga, Elisabet] Ctr Appl Med Res, Genom & Bioinformat Unit, Pamplona, Spain; [Gomez-Roman, Javier] Univ Cantabria, Dept Pathol, Marques de Valdecilla Univ Hosp, Sch Med, E-39005 Santander, Spain; [Tamura, Akiko] Univ Navarra Clin, Dept Thorac Surg, Pamplona, Spain; [Pio, Ruben] Univ Navarra, Sch Sci, Dept Biochem, E-31080 Pamplona, Spain	University of Navarra; University of Navarra; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; University of Navarra; University of Navarra	Valles, I (corresponding author), Ctr Appl Med Res, Div Oncol, Pamplona, Spain.	lmontuenga@unav.es; rpio@unav.es	Montuenga, Luis M/AAF-7783-2020; José Javier, Gómez-Román/AAC-8156-2021; Pio, Ruben/F-5353-2017; Segura, Victor/E-4531-2010; Guruceaga, Elizabeth/B-1796-2008	Montuenga, Luis M/0000-0002-8739-1387; José Javier, Gómez-Román/0000-0002-2849-9435; Pio, Ruben/0000-0002-6831-6111; Segura, Victor/0000-0002-7740-6290; Guruceaga, Elizabeth/0000-0003-0547-681X	UTE project CIMA; Spanish Government [ISCIII452RTICC RD06/0020/0066, PI02/1116, PI10/00166]; European Regional Development Fund (ERDF) "Una manera de hacer Europa"	UTE project CIMA; Spanish Government(Spanish GovernmentEuropean Commission); European Regional Development Fund (ERDF) "Una manera de hacer Europa"(European Commission)	This work has been supported by "UTE project CIMA"; Spanish Government (ISCIII452RTICC RD06/0020/0066, PI02/1116 and PI10/00166), European Regional Development Fund (ERDF) "Una manera de hacer Europa". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2011, CANCER CELL, V20, P420, DOI 10.1016/j.ccr.2011.10.004; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Castano Z, 2008, INT J CANCER, V122, P1512, DOI 10.1002/ijc.23236; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chen R, 2011, J INT MED RES, V39, P533, DOI 10.1177/147323001103900222; CLIBY W, 1993, CANCER RES, V53, P2393; Comtesse N, 2007, INT J CANCER, V120, P2538, DOI 10.1002/ijc.22585; Cuende J, 2008, ONCOGENE, V27, P3339, DOI 10.1038/sj.onc.1210987; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; Ebert B, 2011, NEW ENGL J MED, V365, P2534, DOI 10.1056/NEJMe1111584; Ezponda T, 2010, CLIN CANCER RES, V16, P4113, DOI 10.1158/1078-0432.CCR-10-0076; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Flanagan JM, 2009, MOL CANCER THER, V8, P249, DOI 10.1158/1535-7163.MCT-08-0636; Galeano F, 2010, INT J CANCER, V127, P127, DOI 10.1002/ijc.25022; Goehe RW, 2010, J CLIN INVEST, V120, P3923, DOI 10.1172/JCI43552; Groeger AM, 2004, HISTOPATHOLOGY, V44, P54, DOI 10.1111/j.1365-2559.2004.01750.x; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Inamura K, 2005, ONCOGENE, V24, P7105, DOI 10.1038/sj.onc.1208858; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Jeganathan KB, 2006, CELL CYCLE, V5, P366, DOI 10.4161/cc.5.4.2483; Jia D, 2011, HEPATOLOGY; Karczmarek-Borowska B, 2006, LUNG CANCER, V51, P61, DOI 10.1016/j.lungcan.2005.08.010; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Katzenellenbogen RA, 2010, J VIROL, V84, P12934, DOI 10.1128/JVI.01377-10; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Kohno T, 1998, GENE CHROMOSOME CANC, V21, P236, DOI 10.1002/(SICI)1098-2264(199803)21:3<236::AID-GCC8>3.0.CO;2-0; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Kuo WP, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P415; KUSHNER JP, 1976, P SOC EXP BIOL MED, V153, P273; Langer W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-676; Lee EB, 2003, ANN THORAC SURG, V75, P1597, DOI 10.1016/S0003-4975(02)04902-0; Li Z, 2008, J CELL MOL MED, V12, P2427, DOI 10.1111/j.1582-4934.2008.00244.x; Liu YF, 2007, ONCOL REP, V18, P943; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Martinez HD, 2008, J BIOL CHEM, V283, P29938, DOI 10.1074/jbc.M800534200; Mayama T, 2000, INT J ONCOL, V17, P245; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Misquitta-Ali CM, 2011, MOL CELL BIOL, V31, P138, DOI 10.1128/MCB.00709-10; Miura K, 2011, CANCER SCI, V102, P309, DOI 10.1111/j.1349-7006.2010.01797.x; Ohgaki K, 1998, GENE CHROMOSOME CANC, V23, P244, DOI 10.1002/(SICI)1098-2264(199811)23:3<244::AID-GCC6>3.3.CO;2-#; OU JH, 1987, NUCLEIC ACIDS RES, V15, P8919, DOI 10.1093/nar/15.21.8919; Pacher M, 2007, CARCINOGENESIS, V28, P49, DOI 10.1093/carcin/bgl091; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Park SW, 2010, GUT LIVER, V4, P430, DOI 10.5009/gnl.2010.4.3.430; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Peebles KA, 2007, MOL CARCINOGEN, V46, P887, DOI 10.1002/mc.20321; Petersen S, 2000, BRIT J CANCER, V82, P65; Pino I, 2003, LUNG CANCER-J IASLC, V41, P131, DOI 10.1016/S0169-5002(03)00193-4; Pio R, 2004, CANCER RES, V64, P4171, DOI 10.1158/0008-5472.CAN-03-2982; Pio R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-352; Pio R, 2009, J THORAC ONCOL, V4, P674, DOI 10.1097/JTO.0b013e3181a520dc; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Riemenschneider MJ, 2003, INT J CANCER, V104, P752, DOI 10.1002/ijc.11023; Sakata K, 1997, GENE CHROMOSOME CANC, V18, P318, DOI 10.1002/(SICI)1098-2264(199704)18:4<318::AID-GCC12>3.3.CO;2-#; SATO S, 1994, CANCER RES, V54, P5652; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shultz JC, 2011, MOL CANCER RES, V9, P889, DOI 10.1158/1541-7786.MCR-11-0061; Sueoka E, 2005, LUNG CANCER, V48, P77, DOI 10.1016/j.lungcan.2004.10.007; Takashima N, 2006, ONCOL REP, V15, P667; Tockman MS, 1997, CLIN CANCER RES, V3, P2237; Travis WD., 2004, TRAVIS WB WHO CLASSI; Tseng RC, 2005, INT J CANCER, V117, P241, DOI 10.1002/ijc.21178; van Alphen RJ, 2009, BRIT J CANCER, V100, P228, DOI 10.1038/sj.bjc.6604801; van Duin M, 2005, GENE CHROMOSOME CANC, V44, P438, DOI 10.1002/gcc.20259; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang XS, 2010, HUM MOL GENET, V19, P2886, DOI 10.1093/hmg/ddq174; Wong RW, 2006, P NATL ACAD SCI USA, V103, P19783, DOI 10.1073/pnas.0609582104; Wong RW, 2010, CELL CYCLE, V9, P198, DOI 10.4161/cc.9.1.10431; Xi LQ, 2008, NUCLEIC ACIDS RES, V36, P6535, DOI 10.1093/nar/gkn697; Yamamoto N, 1999, ONCOL REP, V6, P1223; Yap YL, 2005, NUCLEIC ACIDS RES, V33, P409, DOI 10.1093/nar/gki188; Yi YJ, 2009, MOL CYTOGENET, V2, DOI 10.1186/1755-8166-2-18; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zerbe LK, 2004, MOL CARCINOGEN, V41, P187, DOI 10.1002/mc.20053	77	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42086	10.1371/journal.pone.0042086	http://dx.doi.org/10.1371/journal.pone.0042086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876301	gold, Green Published, Green Submitted			2022-12-27	WOS:000307184700029
J	Idei, M; Osada, K; Sato, S; Toyoda, K; Nagumo, T; Mann, DG				Idei, Masahiko; Osada, Keigo; Sato, Shinya; Toyoda, Kensuke; Nagumo, Tamotsu; Mann, David G.			Gametogenesis and Auxospore Development in Actinocyclus (Bacillariophyta)	PLOS ONE			English	Article							CENTRIC DIATOM; FINE-STRUCTURE; ENTWICKLUNGSGESCHICHTLICHE UNTERSUCHUNGEN; CYCLOTELLA-MENEGHINIANA; SPECIES IDENTIFICATION; ZENTRISCHEN DIATOMEEN; SEXUAL REPRODUCTION; LIFE-HISTORY; INITIAL CELL; EVOLUTION	cGametogenesis and auxospore development have been studied in detail in surprisingly few centric diatoms. We studied the development of sperm, eggs and auxospores in Actinocyclus sp., a radially symmetrical freshwater diatom collected from Japan, using LM and electron microscopy of living cultures and thin sections. Actinocyclus represents a deep branch of the 'radial centric' diatoms and should therefore contribute useful insights into the evolution of sexual reproduction in diatoms. Spermatogenesis was examined by LM and SEM and involved the formation of two spermatogonia (sperm mother-cells) in each spermatogonangium through an equal mitotic division. The spermatogonia produced a reduced 'lid' valve, resembling a large flat scale with irregular radial thickenings. Sperm formation was merogenous, producing four sperm per spermatogonium, which were released by dehiscence of the 'lid' valve. The sperm were spindle-shaped with numerous surface globules and, as usual for diatoms, the single anterior flagellum bore mastigonemes. One egg cell was produced per oogonium. Immature eggs produced a thin layer of circular silica scales before fertilization, while the eggs were still contained within the oogonium. Sperm were attracted in large numbers to each egg and were apparently able to contact the egg surface via a gap formed between the long hypotheca and shorter epitheca of the oogonium and a small underlying hole in the scale-case. Auxospores expanded isodiametrically and many new scales were added to its envelope during expansion. Finally, new slightly-domed initial valves were produced at right angles to the oogonium axis, after a strong contraction of the cell away from the auxospore wall. At different stages, Golgi bodies were associated with chloroplasts or mitochondria, contrasting with the constancy of Golgi-ER-mitochondrion (G-ER-M) units in some other centric diatoms, which has been suggested to have phylogenetic significance. Electron-dense bodies in the vacuole of Actinocyclus are probably acidocalcisomes containing polyphosphate.	[Idei, Masahiko] Bunkyo Univ, Dept Biol, Saitama, Japan; [Osada, Keigo] Nippon Dent Univ, Dept Biol, Sch Life Dent Niigata, Niigata, Japan; [Sato, Shinya; Mann, David G.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Toyoda, Kensuke] Keio Univ, Dept Biol, Tokyo, Kanagawa 108, Japan; [Nagumo, Tamotsu] Nippon Dent Univ Tokyo, Dept Biol, Tokyo, Japan	Nippon Dental University; Keio University; Nippon Dental University	Idei, M (corresponding author), Bunkyo Univ, Dept Biol, Saitama, Japan.	idei@koshigaya.bunkyo.ac.jp	Toyoda, Kensuke/AAB-7875-2021; Mann, David G/I-9018-2014	Mann, David G/0000-0003-0522-6802				Bergon P, 1907, B SOC BOT FRANCE 4, V7, P327; Chepurnov VA, 2004, INT REV CYTOL, V237, P91; Chepurnov VA, 2006, J PHYCOL, V42, P845, DOI 10.1111/j.1529-8817.2006.00244.x; CRAWFORD R M, 1974, British Phycological Journal, V9, P9; DAWSON PA, 1973, J PHYCOL, V9, P165, DOI 10.1111/j.0022-3646.1973.00165.x; Diaz J, 2008, SCIENCE, V320, P652, DOI 10.1126/science.1151751; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; DREBES G, 1966, HELGOLAND WISS MEER, V13, P101, DOI 10.1007/BF01612659; Drebes G., 1977, BIOL DIATOMS, P250; DREBES G., 1974, MARINES PHYTOPLANKTO; DREBES G, 1977, NOVA HEDWIGIA S, V54, P167; Drebes G, 1972, NOVA HEDWIGIA S, V39, P95; Drum RW, 1966, DIATOMEEN ELEKTRONEN, V6; EHRLICH A, 1982, BRIT PHYCOL J, V17, P205, DOI 10.1080/00071618200650221; FRITSCH F.E., 1935, STRUCTURE REPROD ALG, V1; Geitler L, 1952, OSTERR BOT Z, V99, P507; GEITLER L, 1963, BER DEUT BOT GES, V75, P393; GEITLER LOTHAR, 1932, ARCH PROTISTENK, V78, P1; Guillou L, 1999, J PHYCOL, V35, P368, DOI 10.1046/j.1529-8817.1999.3520368.x; Hamsher SE, 2011, PROTIST, V162, P405, DOI 10.1016/j.protis.2010.09.005; Hasle G.R., 1983, BACILLARIA, V6, P9; HEATH IB, 1971, Z ZELLFORSCH MIK ANA, V112, P371; HEATH IB, 1972, J PHYCOL, V8, P51, DOI 10.1111/j.1529-8817.1972.tb04001.x; Heinzerling O., 1908, BIBL BOT, V69, P1; HOFKER J., 1928, ANN PROTISTOL, V1, P167; HOOPS HJ, 1979, PHYCOLOGIA, V18, P424, DOI 10.2216/i0031-8884-18-4-424.1; Hoppenrath M., 2009, SCHWEIZERBART SCHE V; Hori T, 1993, ILLUSTRATED ATLAS LI, V3; Ichinomiya M, 2011, J PHYCOL, V47, P144, DOI 10.1111/j.1529-8817.2010.00926.x; IDEI M, 1992, BOT MAG TOKYO, V105, P649, DOI 10.1007/BF02489438; Jensen KG, 2003, PHYCOLOGIA, V42, P98, DOI 10.2216/i0031-8884-42-1-98.1; Kaczmarska I, 2000, NOVA HEDWIGIA, V71, P337; Kaczmarska I, 2007, PHYCOLOGIA, V46, P726, DOI 10.2216/07-04.1; Koester JA, 2007, EUR J PHYCOL, V42, P351, DOI 10.1080/09670260701562100; KUROIWA T, 1980, CELL STRUCT FUNCT, V5, P195, DOI 10.1247/csf.5.195; Mann DG, 2010, CRYPTOGAMIE ALGOL, V31, P557; Mann DG, 1984, P 7 INT DIAT S PHIL, V982, P47; Manton I., 1966, J ROY MICROSC SOC, V85, P119, DOI DOI 10.1111/J.1365-2818.1966.TB02174.X; Martin-Jezequel V, 2000, J PHYCOL, V36, P821, DOI 10.1046/j.1529-8817.2000.00019.x; Medeiros LCS, 2011, J EUKARYOT MICROBIOL, V58, P416, DOI 10.1111/j.1550-7408.2011.00565.x; Medlin LK, 2004, PHYCOLOGIA, V43, P245, DOI 10.2216/i0031-8884-43-3-245.1; Migita S., 1967, B JPN SOC SCI FISH, V33, P392, DOI [10.2331/suisan.33.392, DOI 10.2331/SUISAN.33.392)]; Mizuno M., 1977, B JAP SOC PHYCOL, V25, P149; Mizuno M, 2008, PHYCOL RES, V56, P156, DOI 10.1111/j.1440-1835.2008.00497.x; OTT D W, 1974, British Phycological Journal, V9, P111; Pickett-Heaps J., 1990, PROGR PHYCOLOGICAL R, V7, P1; PICKETTHEAPS JD, 1988, J PHYCOL, V24, P35; PICKETTHEAPS JD, 1986, J PHYCOL, V22, P334, DOI 10.1111/j.1529-8817.1986.tb00032.x; REIMANN B, 1960, NOVA HEDWIGIA, V2, P349; Round F. E., 1990, DIATOMS BIOL MORPHOL; ROUND FE, 1981, PROC R SOC SER B-BIO, V211, P237, DOI 10.1098/rspb.1981.0004; Ruiz FA, 2004, MICROSC MICROANAL, V10, P563, DOI 10.1017/S1431927604040875; Schmid A. M.-M., 2000, ORIGIN EARLY EVOLUTI, P13; SCHMID AMM, 1979, PROTOPLASMA, V100, P267, DOI 10.1007/BF01279316; Schmid AMM, 1995, PROCEEDINGS OF THE THIRTEENTH INTERNATIONAL DIATOM SYMPOSIUM, P139; SCHMID AMM, 1988, PLANT SYST EVOL, V158, P211; SCHMID AMM, 1989, PLANT SYST EVOL, V164, P239, DOI 10.1007/BF00940440; Schmid AMM, 2001, EUR J PHYCOL, V36, P307, DOI 10.1080/09670260110001735468; Schmid Anna-Maria M., 1994, Diatom Research, V9, P371; SCHULTZ ME, 1968, J PHYCOL, V4, P85, DOI 10.1111/j.1529-8817.1968.tb04681.x; Shimizu K, 2001, CHEM BIOL, V8, P1051, DOI 10.1016/S1074-5521(01)00072-2; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; STOERMER EF, 1965, AM J BOT, V52, P1067, DOI 10.2307/2440138; STOSCH HAV, 1973, HELGOLAND WISS MEER, V25, P384, DOI 10.1007/BF01611205; Subrahmanyan R., 1946, JOUR INDIAN BOT SOC, V25, P61; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Toyoda Kensuke, 2010, Plankton & Benthos Research, V5, P56; Trobajo R, 2010, EUR J PHYCOL, V45, P413, DOI 10.1080/09670262.2010.498586; von Stosch H. A., 1982, BACILLARIA, V5, P127; VON STOSCH HANS A., 1964, HELGOLANDER WISSENSCHAFTLICHE MEERESUNTERSUCH, V11, P209; VONSTOSCH HA, 1950, NATURE, V165, P531, DOI 10.1038/165531a0; VONSTOSCH HA, 1956, ARCH MIKROBIOL, V23, P327; VONSTOSCH HA, 1951, ARCH MIKROBIOL, V16, P101; VONSTOSCH HA, 1958, ARCH MIKROBIOL, V31, P274; Went FW, 1925, NEDERLANDSCH KRUIDKU, V1924, P75	76	21	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41890	10.1371/journal.pone.0041890	http://dx.doi.org/10.1371/journal.pone.0041890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870259	gold, Green Published, Green Submitted			2022-12-27	WOS:000307212800041
J	Smidt, MP; von Oerthel, L; Hoekstra, EJ; Schellevis, RD; Hoekman, MFM				Smidt, Marten P.; von Oerthel, Lars; Hoekstra, Elisa J.; Schellevis, Raymond D.; Hoekman, Marco F. M.			Spatial and Temporal Lineage Analysis of a Pitx3-Driven Cre-Recombinase Knock-In Mouse Model	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GABAERGIC NEURON DIFFERENTIATION; DIENCEPHALIC DOPAMINE NEURONS; SUBSTANTIA-NIGRA; GENE-EXPRESSION; ELEGANS UNC-30; PITX3; MICE; IDENTIFICATION; PROGENITORS	Development and function of mesodiencephalic dopaminergic (mdDA) neurons has received a lot of scientific interest since these neurons are critically involved in neurological diseases as Parkinson and psychiatric diseases as schizophrenia, depression and attention deficit hyperactivity disorder (ADHD). The understanding of the molecular processes that lead to normal development and function of mdDA neurons has provided insight in the pathology and provided critical information on new treatment paradigms. In order to be able to study specific genetic ablation in mdDA neurons a new tools was developed that drives Cre-recombinase under the control of the Pitx3 locus. The Pitx3 gene is well known for its specific expression in mdDA neurons and is present at the onset of terminal differentiation. Analysis of newly generated Pitx3-Cre knock-in mice shows that Cre expression, measured through the activation of eYfp by removal of a "Stop'' signal (LoxP-Stop-LoxP-eYfp reporter mouse), is present at the onset of terminal differentiation and mimics closely the native Pitx3 expression domain. In conclusion, we present here a new Cre-driver mouse model to be used in the restricted ablation of interesting genes in mdDA neurons in order to improve our understanding of the underlying molecular programming.	[Smidt, Marten P.; von Oerthel, Lars; Hoekstra, Elisa J.; Hoekman, Marco F. M.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Smidt, Marten P.; Hoekstra, Elisa J.; Schellevis, Raymond D.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands	University of Amsterdam; Utrecht University; Utrecht University Medical Center	Smidt, MP (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	m.p.smidt@uva.nl		Smidt, Marten/0000-0002-8815-747X	VICI-grant [865.09.002]	VICI-grant	This work was supported by a VICI-grant (no. 865.09.002 to M.P. Smidt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Chung S, 2011, P NATL ACAD SCI USA, V108, P9703, DOI 10.1073/pnas.1016443108; Coulon V, 2007, J BIOL CHEM, V282, P33192, DOI 10.1074/jbc.M706119200; Ferrari D, 2006, EUR J NEUROSCI, V24, P1885, DOI 10.1111/j.1460-9568.2006.05093.x; Gelman DM, 2003, GENESIS, V36, P196, DOI 10.1002/gene.10217; Jacobs FMJ, 2007, DEVELOPMENT, V134, P2673, DOI 10.1242/dev.02865; Jacobs FMJ, 2011, DEVELOPMENT, V138, P5213, DOI 10.1242/dev.071704; Jacobs FMJ, 2009, DEVELOPMENT, V136, P2363, DOI 10.1242/dev.037556; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Maxwell SL, 2005, J ANAT, V207, P209, DOI 10.1111/j.1469-7580.2005.00453.x; Semina EV, 1997, HUM MOL GENET, V6, P2109, DOI 10.1093/hmg/6.12.2109; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Smidt MP, 2004, CELL TISSUE RES, V318, P35, DOI 10.1007/s00441-004-0943-1; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Smits SM, 2006, PROG NEUROBIOL, V78, P1, DOI 10.1016/j.pneurobio.2005.12.003; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Westmoreland JJ, 2001, J NEUROSCI, V21, P6810, DOI 10.1523/JNEUROSCI.21-17-06810.2001; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x; Zhou WB, 2009, STEM CELLS, V27, P2952, DOI 10.1002/stem.216; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	23	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42641	10.1371/journal.pone.0042641	http://dx.doi.org/10.1371/journal.pone.0042641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870339	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800102
J	Starkey, MR; Kim, RY; Beckett, EL; Schilter, HC; Shim, D; Essilfie, AT; Nguyen, DH; Beagley, KW; Mattes, J; Mackay, CR; Horvat, JC; Hansbro, PM				Starkey, Malcolm R.; Kim, Richard Y.; Beckett, Emma L.; Schilter, Heidi C.; Shim, Doris; Essilfie, Ama-Tawiah; Nguyen, Duc H.; Beagley, Kenneth W.; Mattes, Joerg; Mackay, Charles R.; Horvat, Jay C.; Hansbro, Philip M.			Chlamydia muridarum Lung Infection in Infants Alters Hematopoietic Cells to Promote Allergic Airway Disease in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; IFN-GAMMA; STREPTOCOCCUS-PNEUMONIAE; PROTECTIVE IMMUNITY; ASTHMA; THERAPY; INFLAMMATION; INDUCTION; TWAR	Background: Viral and bacterial respiratory tract infections in early-life are linked to the development of allergic airway inflammation and asthma. However, the mechanisms involved are not well understood. We have previously shown that neonatal and infant, but not adult, chlamydial lung infections in mice permanently alter inflammatory phenotype and physiology to increase the severity of allergic airway disease by increasing lung interleukin (IL)-13 expression, mucus hypersecretion and airway hyper-responsiveness. This occurred through different mechanisms with infection at different ages. Neonatal infection suppressed inflammatory responses but enhanced systemic dendritic cell: T-cell IL-13 release and induced permanent alterations in lung structure (i.e., increased the size of alveoli). Infant infection enhanced inflammatory responses but had no effect on lung structure. Here we investigated the role of hematopoietic cells in these processes using bone marrow chimera studies. Methodology/Principal Findings: Neonatal (<24-hours-old), infant (3-weeks-old) and adult (6-weeks-old) mice were infected with C. muridarum. Nine weeks after infection bone marrow was collected and transferred into recipient age-matched irradiated naive mice. Allergic airway disease was induced (8 weeks after adoptive transfer) by sensitization and challenge with ovalbumin. Reconstitution of irradiated naive mice with bone marrow from mice infected as neonates resulted in the suppression of the hallmark features of allergic airway disease including mucus hyper-secretion and airway hyper-responsiveness, which was associated with decreased IL-13 levels in the lung. In stark contrast, reconstitution with bone marrow from mice infected as infants increased the severity of allergic airway disease by increasing T helper type-2 cell cytokine release (IL-5 and IL-13), mucus hyper-secretion, airway hyper-responsiveness and IL-13 levels in the lung. Reconstitution with bone marrow from infected adult mice had no effects. Conclusions: These results suggest that an infant chlamydial lung infection results in long lasting alterations in hematopoietic cells that increases the severity of allergic airway disease in later-life.	[Starkey, Malcolm R.; Kim, Richard Y.; Beckett, Emma L.; Essilfie, Ama-Tawiah; Nguyen, Duc H.; Mattes, Joerg; Horvat, Jay C.; Hansbro, Philip M.] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia; [Starkey, Malcolm R.; Kim, Richard Y.; Beckett, Emma L.; Essilfie, Ama-Tawiah; Nguyen, Duc H.; Mattes, Joerg; Horvat, Jay C.; Hansbro, Philip M.] Hunter Med Res Inst, Callaghan, NSW, Australia; [Schilter, Heidi C.; Shim, Doris] Garvan Inst Med Res, Program Immunol, Sydney, NSW, Australia; [Beagley, Kenneth W.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Australia; [Mattes, Joerg] Univ Newcastle, Fac Hlth, Sch Med & Publ Hlth, Expt & Translat Resp Grp, Callaghan, NSW 2308, Australia; [Mackay, Charles R.] Monash Univ, Fac Med Nursing & Hlth Serv, Clayton, Vic, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Garvan Institute of Medical Research; Queensland University of Technology (QUT); University of Newcastle; Monash University	Starkey, MR (corresponding author), Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia.	Philip.Hansbro@newcastle.edu.au	MATTES, JOERG/M-5179-2019; Hansbro, Phil/G-7486-2013; Beckett, Emma/AAU-8537-2021; Beagley, Kenneth/J-1129-2012; Mackay, Charles R/A-9673-2008	Hansbro, Phil/0000-0002-4741-3035; Beckett, Emma/0000-0002-8888-3789; Beagley, Kenneth/0000-0003-3112-6557; Mackay, Charles R/0000-0002-6338-7340; Schilter, Heidi/0000-0003-3709-1631; Horvat, Jay/0000-0002-8526-0631; Essilfie, Ama-Tawiah/0000-0003-0443-9005; Kim, Richard/0000-0002-8709-5270; Starkey, Malcolm/0000-0002-7359-7464	National Health and Medical Research Council of Australia (NHMRC) [569219]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by National Health and Medical Research Council of Australia (NHMRC) grant #569219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Beagley KW, 2009, CRIT REV IMMUNOL, V29, P275, DOI 10.1615/CritRevImmunol.v29.i4.10; Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Blasi F, 2004, EUR RESPIR J, V24, P171, DOI 10.1183/09031936.04.00135703; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Essilfie AT, 2012, THORAX; GRAYSTON JT, 1992, CLIN INFECT DIS, V15, P757, DOI 10.1093/clind/15.5.757; Hansbro NG, 2008, PHARMACOL THERAPEUT, V117, P313, DOI 10.1016/j.pharmthera.2007.11.002; Hansbro PM, 2011, BRIT J PHARMACOL, V163, P81, DOI 10.1111/j.1476-5381.2011.01219.x; Hansbro PM, 2004, PHARMACOL THERAPEUT, V101, P193, DOI 10.1016/j.pharmthera.2003.10.007; Hansbro PM, 2012, J DEV ORIGI IN PRESS; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Horvat JC, 2010, J IMMUNOL, V184, P4159, DOI 10.4049/jimmunol.0902287; Horvat JC, 2010, J ALLERGY CLIN IMMUN, V125, P617, DOI 10.1016/j.jaci.2009.10.018; Jupelli M, 2008, J IMMUNOL, V180, P4148, DOI 10.4049/jimmunol.180.6.4148; Jupelli M, 2011, LAB INVEST, V91, P1530, DOI 10.1038/labinvest.2011.103; Kaiko GE, 2008, J IMMUNOL, V180, P2225, DOI 10.4049/jimmunol.180.4.2225; Kaiko GE, 2008, IMMUNOLOGY, V123, P326, DOI 10.1111/j.1365-2567.2007.02719.x; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Patel KK, 2010, PEDIATR INFECT DIS J, V29, P1093, DOI 10.1097/INF.0b013e3181eaebdc; Preston JA, 2011, EUR RESPIR J, V37, P53, DOI 10.1183/09031936.00049510; Preston JA, 2007, VACCINE, V25, P8154, DOI 10.1016/j.vaccine.2007.09.034; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; SAETTA M, 1994, EUR RESPIR J, V7, P1505, DOI 10.1183/09031936.94.07081505; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; Skelding KA, 2006, VACCINE, V24, P355, DOI 10.1016/j.vaccine.2005.07.104; Thorburn AN, 2010, THORAX, V65, P1053, DOI 10.1136/thx.2009.131508; Thorburn AN, 2010, AM J RESP CELL MOL, V43, P511, DOI 10.1165/rcmb.2009-0342TR; Thorburn AN, 2009, EXPERT OPIN BIOL TH, V9, P621, DOI [10.1517/14712590902916999, 10.1517/14712590902916999 ]; Thorburn AN, 2012, J IMMUNOL IN PRESS, V188; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Vila-Corcoles A, 2009, RESP MED, V103, P309, DOI 10.1016/j.rmed.2008.08.006; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x	38	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42588	10.1371/journal.pone.0042588	http://dx.doi.org/10.1371/journal.pone.0042588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870337	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800100
J	Walter, WJ; Beranek, V; Fischermeier, E; Diez, S				Walter, Wilhelm J.; Beranek, Vaclav; Fischermeier, Elisabeth; Diez, Stefan			Tubulin Acetylation Alone Does Not Affect Kinesin-1 Velocity and Run Length In Vitro	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; MOTOR DOMAIN; TRANSPORT; MICROTUBULES; BINDING; ACETYLTRANSFERASE; PROCESSIVITY; DEACETYLASE; MICROSCOPY; MOLECULES	Kinesin-1 plays a major role in anterograde transport of intracellular cargo along microtubules. Currently, there is an ongoing debate of whether alpha-tubulin K40 acetylation directly enhances the velocity of kinesin-1 and its affinity to the microtubule track. We compared motor motility on microtubules reconstituted from acetylated and deacetylated tubulin. For both, single- and multi-motor in vitro motility assays, we demonstrate that tubulin acetylation alone does not affect kinesin-1 velocity and run length.	[Walter, Wilhelm J.; Beranek, Vaclav; Fischermeier, Elisabeth; Diez, Stefan] Tech Univ Dresden, CUBE Ctr Mol Bioengn B, D-01062 Dresden, Germany; [Diez, Stefan] Max Planck Insitute Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Max Planck Society	Walter, WJ (corresponding author), Tech Univ Dresden, CUBE Ctr Mol Bioengn B, D-01062 Dresden, Germany.	diez@bcube-dresden.de	Diez, Stefan/E-8172-2010	Diez, Stefan/0000-0002-0750-8515	Volkswagen Foundation [I/84 087-090]; Deutsche Forschungsgemeinschaft (DFG Heisenberg Program); Max-Planck-Society; Technische Universitat Dresden; European Research Council (ERC) [242933]	Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft (DFG Heisenberg Program)(German Research Foundation (DFG)); Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Technische Universitat Dresden; European Research Council (ERC)(European Research Council (ERC))	This work has been supported by funding from the Volkswagen Foundation (grant I/84 087-090), the Deutsche Forschungsgemeinschaft (DFG Heisenberg Program), the Max-Planck-Society, the Technische Universitat Dresden and the European Research Council (ERC starting grant 242933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; [Anonymous], FREE STAT SOFTWARE; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; CAMBRAYDEAKIN MA, 1987, CELL MOTIL CYTOSKEL, V8, P284, DOI 10.1002/cm.970080309; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Kawaguchi K, 2000, BIOCHEM BIOPH RES CO, V272, P895, DOI 10.1006/bbrc.2000.2856; Kerssemakers J, 2006, P NATL ACAD SCI USA, V103, P15812, DOI 10.1073/pnas.0510400103; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; MacDonald ME, 2003, NEUROMOL MED, V4, P7, DOI 10.1385/NMM:4:1-2:7; Mashanov GI, 2004, J BIOL CHEM, V279, P15274, DOI 10.1074/jbc.M312140200; McVicker DP, 2011, J BIOL CHEM, V286, P42873, DOI 10.1074/jbc.M111.292987; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nitzsche B, 2010, METHOD CELL BIOL, V95, P247, DOI 10.1016/S0091-679X(10)95014-0; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Press W. H., 1992, ART SCI COMPUTING; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rogers KR, 2001, EMBO J, V20, P5101, DOI 10.1093/emboj/20.18.5101; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032	30	65	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42218	10.1371/journal.pone.0042218	http://dx.doi.org/10.1371/journal.pone.0042218			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870307	gold, Green Submitted, Green Published			2022-12-27	WOS:000307212800070
J	Aristieta, A; Azkona, G; Sagarduy, A; Miguelez, C; Ruiz-Ortega, JA; Sanchez-Pernaute, R; Ugedo, L				Aristieta, Asier; Azkona, Garikoitz; Sagarduy, Ainhoa; Miguelez, Cristina; Angel Ruiz-Ortega, Jose; Sanchez-Pernaute, Rosario; Ugedo, Luisa			The Role of the Subthalamic Nucleus in L-DOPA Induced Dyskinesia in 6-Hydroxydopamine Lesioned Rats	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; ABNORMAL INVOLUNTARY MOVEMENTS; HIGH-FREQUENCY STIMULATION; PARKINSONS-DISEASE; NEURONAL-ACTIVITY; BASAL GANGLIA; RECEPTOR ANTAGONIST; SUBSTANTIA-NIGRA; RODENT MODEL; MGLUR5 ANTAGONIST	L-DOPA is the most effective treatment for Parkinson's disease (PD), but prolonged use leads to disabling motor complications including dyskinesia. Strong evidence supports a role of the subthalamic nucleus (STN) in the pathophysiology of PD whereas its role in dyskinesia is a matter of controversy. Here, we investigated the involvement of STN in dyskinesia, using single-unit extracellular recording, behavioural and molecular approaches in hemi-parkinsonian rats rendered dyskinetic by chronic L-DOPA administration. Our results show that chronic L-DOPA treatment does not modify the abnormal STN activity induced by the 6-hydroxydopamine lesion of the nigrostriatal pathway in this model. Likewise, we observed a loss of STN responsiveness to a single L-DOPA dose both in lesioned and sham animals that received daily L-DOPA treatment. We did not find any correlation between the abnormal involuntary movement (AIM) scores and the electrophysiological parameters of STN neurons recorded 24 h or 20-120 min after the last L-DOPA injection, except for the axial subscores. Nonetheless, unilateral chemical ablation of the STN with ibotenic acid resulted in a reduction in global AIM scores and peak-severity of dyskinesia. In addition, STN lesion decreased the anti-dyskinetogenic effect of buspirone in a reciprocal manner. Striatal protein expression was altered in dyskinetic animals with increases in Delta FosB, phosphoDARPP-32, dopamine receptor (DR) D3 and DRD2/DRD1 ratio. The STN lesion attenuated the striatal molecular changes and normalized the DRD2/DRD1 ratio. Taken together, our results show that the STN plays a role, if modest, in the physiopathology of dyskinesias.	[Aristieta, Asier; Sagarduy, Ainhoa; Miguelez, Cristina; Angel Ruiz-Ortega, Jose; Ugedo, Luisa] Univ Basque Country, Dept Pharmacol, Fac Med & Dent, Leioa, Spain; [Azkona, Garikoitz; Sanchez-Pernaute, Rosario] Fdn Inbiomed, Lab Stem Cells & Neural Repair, San Sebastian, Spain	University of Basque Country	Aristieta, A (corresponding author), Univ Basque Country, Dept Pharmacol, Fac Med & Dent, Leioa, Spain.	rpernaute@inbiomed.org; LuisaUgedoluisa.ugedo@ehu.es	Azkona, Garikoitz/AAE-6205-2020; Azkona, Garikoitz/A-4789-2013; Ruiz-Ortega, Jose Angel/F-2465-2016; Sanchez-Pernaute, Rosario/AAZ-9566-2021; Ugedo, Luisa/H-4244-2015; Sanchez-Pernaute, Rosario/ABD-8661-2021; Miguelez, Cristina/I-6213-2015	Azkona, Garikoitz/0000-0002-5312-1207; Azkona, Garikoitz/0000-0002-5312-1207; Ruiz-Ortega, Jose Angel/0000-0003-2246-4378; Sanchez-Pernaute, Rosario/0000-0003-1144-9025; Ugedo, Luisa/0000-0001-5993-0606; Miguelez, Cristina/0000-0001-6624-2932	Spanish Ministry of Science [SAF 2009-08664]; department of Industry of the Basque Government [S-PE10UN24]; Kutxa Obra social; University of the Basque Country	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); department of Industry of the Basque Government; Kutxa Obra social; University of the Basque Country	This study was supported by grants from the Spanish Ministry of Science SAF 2009-08664 (LU), the department of Industry of the Basque Government S-PE10UN24 (LU and RSP) and Kutxa Obra social (RSP). AA and AS have a fellowship from the University of the Basque Country. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aguirre JA, 2005, BRAIN RES, V1033, P216, DOI 10.1016/j.brainres.2004.11.040; Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andersson M, 1999, NEUROBIOL DIS, V6, P461, DOI 10.1006/nbdi.1999.0259; Apetauerova D, 2006, MOVEMENT DISORD, V21, P1277, DOI 10.1002/mds.20896; Armentero MT, 2006, NEUROBIOL DIS, V22, P1, DOI 10.1016/j.nbd.2005.09.010; Azkona G, 2010, GENES BRAIN BEHAV, V9, P160, DOI 10.1111/j.1601-183X.2009.00538.x; Battaglia G, 2004, J NEUROSCI, V24, P828, DOI 10.1523/JNEUROSCI.3831-03.2004; BENAZZOUZ A, 1993, EUR J NEUROSCI, V5, P382, DOI 10.1111/j.1460-9568.1993.tb00505.x; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; BONIFATI V, 1994, CLIN NEUROPHARMACOL, V17, P73, DOI 10.1097/00002826-199402000-00008; BOUTHENET ML, 1987, NEUROSCIENCE, V20, P117, DOI 10.1016/0306-4522(87)90008-X; BOYSON SJ, 1986, J NEUROSCI, V6, P3177; Breit S, 2007, EXP NEUROL, V205, P36, DOI 10.1016/j.expneurol.2006.12.016; Breysse N, 2002, J NEUROSCI, V22, P5669; BROWN LL, 1979, SCIENCE, V206, P1416, DOI 10.1126/science.505015; BURBAUD P, 1995, EXP BRAIN RES, V105, P48; CANTERAS NS, 1990, BRAIN RES, V513, P43, DOI 10.1016/0006-8993(90)91087-W; Capus L, 2001, NEUROL SCI, V22, P57, DOI 10.1007/s100720170045; Carlsson T, 2005, BRAIN, V128, P559, DOI 10.1093/brain/awh374; Cenci MA, 1998, EUR J NEUROSCI, V10, P2694, DOI 10.1046/j.1460-9568.1998.t01-1-00285.x; Cenci MA, 2007, CURR PROTOC NEUROSCI; Cesaro P, 2003, MALADIE PARKINSON; Dekundy A, 2007, BEHAV BRAIN RES, V179, P76, DOI 10.1016/j.bbr.2007.01.013; Eskow KL, 2007, PHARMACOL BIOCHEM BE, V87, P306, DOI 10.1016/j.pbb.2007.05.002; Flores G, 1999, NEUROSCIENCE, V91, P549, DOI 10.1016/S0306-4522(98)00633-2; Gerlach M, 2011, J NEURAL TRANSM, V118, P1727, DOI 10.1007/s00702-010-0570-9; Gill SS, 1997, LANCET, V350, P1224, DOI 10.1016/S0140-6736(05)63455-1; Gilmour TP, 2011, EXP NEUROL, V228, P53, DOI 10.1016/j.expneurol.2010.12.001; Guridi J, 2008, NEUROSURGERY, V62, P311, DOI 10.1227/01.neu.0000315998.58022.55; Murer MG, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00051; Hassani OK, 1996, NEUROSCIENCE, V72, P105, DOI 10.1016/0306-4522(95)00535-8; Hilker R, 2002, J NEURAL TRANSM, V109, P1257, DOI 10.1007/s00702-002-0696-5; HOLLERMAN JR, 1992, BRAIN RES, V590, P291, DOI 10.1016/0006-8993(92)91108-Q; JOHNSON AE, 1994, NEUROREPORT, V5, P1836, DOI 10.1097/00001756-199409080-00038; Johnston TH, 2010, J PHARMACOL EXP THER, V333, P865, DOI 10.1124/jpet.110.166629; Kaneoke Y, 1996, J NEUROSCI METH, V68, P211, DOI 10.1016/0165-0270(96)00081-7; Katayama Y, 2006, STEREOT FUNCT NEUROS, V84, P176, DOI 10.1159/000094957; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; KITA H, 1987, J COMP NEUROL, V260, P435, DOI 10.1002/cne.902600309; Kobylecki C, 2011, MOVEMENT DISORD, V26, P2354, DOI 10.1002/mds.23867; Kreiss DS, 1997, J NEUROSCI, V17, P6807; Kumar R, 2009, NEUROPHARMACOLOGY, V56, P956, DOI 10.1016/j.neuropharm.2009.01.019; Lacombe E, 2007, EUR J NEUROSCI, V26, P1670, DOI 10.1111/j.1460-9568.2007.05747.x; Levandis G, 2008, NEUROBIOL DIS, V29, P161, DOI 10.1016/j.nbd.2007.08.011; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Lindgren HS, 2010, J NEUROCHEM, V112, P1465, DOI 10.1111/j.1471-4159.2009.06556.x; de Maturana RL, 2010, CNS NEUROL DISORD-DR, V9, P601, DOI 10.2174/187152710793361531; Lozano AM, 2000, ANN NEUROL, V47, pS141; Lundblad M, 2003, J NEUROCHEM, V84, P1398, DOI 10.1046/j.1471-4159.2003.01632.x; Lundblad M, 2002, EUR J NEUROSCI, V15, P120, DOI 10.1046/j.0953-816x.2001.01843.x; Magill PJ, 2001, NEUROSCIENCE, V106, P313, DOI 10.1016/S0306-4522(01)00281-0; Marin C, 2001, SYNAPSE, V42, P40, DOI 10.1002/syn.1097; Mela F, 2007, J NEUROCHEM, V101, P483, DOI 10.1111/j.1471-4159.2007.04456.x; Miguelez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024679; MITCHELL IJ, 1989, NEUROSCIENCE, V32, P213, DOI 10.1016/0306-4522(89)90120-6; Morera-Herreras T, 2008, NEUROSCIENCE, V151, P817, DOI 10.1016/j.neuroscience.2007.11.016; Morera-Herreras T, 2011, PSYCHOPHARMACOLOGY, V214, P379, DOI 10.1007/s00213-010-2043-0; Morera-Herreras T, 2010, SYNAPSE, V64, P20, DOI 10.1002/syn.20701; Morin N, 2010, NEUROPHARMACOLOGY, V58, P981, DOI 10.1016/j.neuropharm.2009.12.024; Munoz A, 2008, BRAIN, V131, P3380, DOI 10.1093/brain/awn235; Ni ZG, 2001, EUR J NEUROSCI, V14, P373, DOI 10.1046/j.0953-816x.2001.01644.x; Ni ZG, 2001, BRAIN RES, V899, P142, DOI 10.1016/S0006-8993(01)02219-3; Nimura T, 2005, J NEUROSURG, V103, P968, DOI 10.3171/jns.2005.103.6.0968; Nishikawa Y, 2010, NEUROL MED-CHIR, V50, P257, DOI 10.2176/nmc.50.257; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS2, DOI 10.1016/S1471-1931(00)00031-8; Obeso JA, 2008, MOVEMENT DISORD, V23, pS548, DOI 10.1002/mds.22062; Oueslati A, 2007, J NEUROSCI, V27, P2377, DOI 10.1523/JNEUROSCI.2949-06.2007; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Piallat B, 1999, J NEURAL TRANSM-SUPP, P71; RINVIK E, 1993, J CHEM NEUROANAT, V6, P19, DOI 10.1016/0891-0618(93)90004-N; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Russmann H, 2004, NEUROLOGY, V63, P153, DOI 10.1212/01.WNL.0000131910.72829.9D; Rylander D, 2010, ANN NEUROL, V68, P619, DOI 10.1002/ana.22097; Rylander D, 2009, J PHARMACOL EXP THER, V330, P227, DOI 10.1124/jpet.108.150425; Sanchez-Pernaute R, 2008, NEUROIMAGE, V42, P248, DOI 10.1016/j.neuroimage.2008.04.170; Sanchez-Pernaute R, 2007, NEUROBIOL DIS, V27, P220, DOI 10.1016/j.nbd.2007.04.016; Shimo Y, 2009, EUR J NEUROSCI, V29, P104, DOI 10.1111/j.1460-9568.2008.06565.x; Shin E, 2012, NEUROBIOL DIS, V47, P393, DOI 10.1016/j.nbd.2012.03.038; Strafella AP, 2003, NEUROREPORT, V14, P1287, DOI 10.1097/00001756-200307010-00020; Thobois S, 2003, J NEUROL, V250, P1219, DOI 10.1007/s00415-003-0188-z; Vernon AC, 2007, J NEUROCHEM, V103, P1075, DOI 10.1111/j.1471-4159.2007.04860.x; Vila M, 2000, EUR J NEUROSCI, V12, P337, DOI 10.1046/j.1460-9568.2000.00901.x; Visanji NP, 2009, NEUROBIOL DIS, V35, P184, DOI 10.1016/j.nbd.2008.11.010; Wallace BA, 2007, BRAIN, V130, P2129, DOI 10.1093/brain/awm137; Wichmann T, 2011, NEUROSCIENCE, V198, P232, DOI 10.1016/j.neuroscience.2011.06.048; Zheng Z, 2010, STEREOT FUNCT NEUROS, V88, P29, DOI 10.1159/000260077; Zhu ZT, 2002, BRAIN RES, V945, P31, DOI 10.1016/S0006-8993(02)02543-X	89	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42652	10.1371/journal.pone.0042652	http://dx.doi.org/10.1371/journal.pone.0042652			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880070	Green Published, gold			2022-12-27	WOS:000307810000056
J	Kihira, S; Yu, EJ; Cunningham, J; Cram, EJ; Lee, M				Kihira, Shingo; Yu, Eun Jeong; Cunningham, Jessica; Cram, Erin J.; Lee, Myeongwoo			A Novel Mutation in beta Integrin Reveals an Integrin-Mediated Interaction between the Extracellular Matrix and cki-1/p27(KIP1)	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; LINKED KINASE ILK; F-BOX PROTEIN; CAENORHABDITIS-ELEGANS; C-ELEGANS; CYTOPLASMIC DOMAIN; DEVELOPMENTAL REGULATION; PROSTATE CARCINOMA; ADHESION COMPLEXES; SPLICE VARIANTS	The cell-extracellular matrix (ECM) interaction plays an essential role in maintaining tissue shapes and regulates cell behaviors such as cell adhesion, differentiation and proliferation. The mechanism by which the ECM influences the cell cycle in vivo is poorly understood. Here we demonstrate that the beta integrin PAT-3 regulates the localization and expression of CKI-1, a C. elegans homologue of the cyclin dependent kinase inhibitor p27(KIP1). In nematodes expressing wild type PAT-3, CKI-1::GFP localizes primarily to nucleoli in hypodermal cells, whereas in animals expressing mutant pat-3 with a defective splice junction, CKI-1::GFP appears clumped and disorganized in nucleoplasm. RNAi analysis links cell adhesion genes to the regulation of CKI-1. RNAi of unc-52/perlecan, ina-1/alpha integrin, pat-4/ILK, and unc-97/PINCH resulted in abnormal CKI-1::GFP localization. Additional RNAi experiments revealed that the SCF E3 ubiquitin-ligase complex genes, skpt-1/SKP2, cul-1/CUL1 and lin-23/F-box, are required for the proper localization and expression of CKI-1, suggesting that integrin signaling and SCF E3 ligase work together to regulate the cellular distribution of CKI-1. These data also suggest that integrin plays a major role in maintaining proper CKI-1/p27(KIP1) levels in the cell. Perturbed integrin signaling may lead to the inhibition of SCF ligase activity, mislocalization and elevation of CKI-1/p27(KIP1). These results suggest that adhesion signaling is crucial for cell cycle regulation in vivo.	[Kihira, Shingo; Yu, Eun Jeong; Cunningham, Jessica; Lee, Myeongwoo] Baylor Univ, Dept Biol, Waco, TX 76798 USA; [Cram, Erin J.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Baylor University; Northeastern University	Kihira, S (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.	myeongwoo_lee@baylor.edu		lee, myeongwoo/0000-0003-2652-3646; Kihira, Shingo/0000-0003-1001-8741	National Institutes of Health [GM077156]; University Research Council (URC) at Baylor University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM077156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Research Council (URC) at Baylor University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.K. was a business fellow at Baylor University. M. L. was funded by the National Institutes of Health (GM077156) and the University Research Council (URC) at Baylor University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTRUDA F, 1990, GENE, V95, P261, DOI 10.1016/0378-1119(90)90369-3; Ambros V, 1999, DEVELOPMENT, V126, P1947; Armulik A, 2002, FRONT BIOSCI-LANDMRK, V7, pD219, DOI 10.2741/armulik; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BALZAC F, 1993, J CELL BIOL, V121, P171, DOI 10.1083/jcb.121.1.171; BALZAC F, 1994, J CELL BIOL, V127, P557, DOI 10.1083/jcb.127.2.557; Baudoin C, 1996, CELL ADHES COMMUN, V4, P1, DOI 10.3109/15419069609010759; Baum PD, 1997, NEURON, V19, P51, DOI 10.1016/S0896-6273(00)80347-5; Belkin AM, 1997, J CELL BIOL, V139, P1583, DOI 10.1083/jcb.139.6.1583; Boxem M, 2001, DEVELOPMENT, V128, P4349; BRENNER S, 1974, GENETICS, V77, P71; Buck SH, 2009, CELL CYCLE, V8, P2613, DOI 10.4161/cc.8.16.9354; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Carrano AC, 2001, J CELL BIOL, V153, P1381, DOI 10.1083/jcb.153.7.1381; Chen NS, 2005, NUCLEIC ACIDS RES, V33, pD383, DOI 10.1093/nar/gki066; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; Cruet-Hennequart S, 2003, ONCOGENE, V22, P1688, DOI 10.1038/sj.onc.1206347; Del Pizzo JJ, 1999, AM J PATHOL, V155, P1129, DOI 10.1016/S0002-9440(10)65216-9; Dello SAWG, 2007, WORLD J SURG, V31, P2215, DOI 10.1007/s00268-007-9197-x; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Donati G, 2012, CANCER RES, V72, P1602, DOI 10.1158/0008-5472.CAN-11-3992; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fornaro M, 2001, CANCER METAST REV, V20, P321, DOI 10.1023/A:1015547830323; Fornaro M, 1996, AM J PATHOL, V149, P765; Fornaro M, 1999, J CLIN INVEST, V103, P321, DOI 10.1172/JCI4585; Fornaro M, 1998, AM J PATHOL, V153, P1079, DOI 10.1016/S0002-9440(10)65652-0; Fornaro M, 1997, MATRIX BIOL, V16, P185, DOI 10.1016/S0945-053X(97)90007-X; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Frank DJ, 1998, J CELL BIOL, V140, P1321, DOI 10.1083/jcb.140.6.1321; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grashoff C, 2003, EMBO REP, V4, P432, DOI 10.1038/sj.embor.embor801; Griffith OL, 2005, GENOMICS, V86, P476, DOI 10.1016/j.ygeno.2005.06.009; Guo YP, 1997, CLIN CANCER RES, V3, P2269; Hebeisen M, 2008, DEVELOPMENT, V135, P1259, DOI 10.1242/dev.014969; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; HEDGECOCK EM, 1995, GENETICS, V141, P989; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Hong Y, 1998, DEVELOPMENT, V125, P3585; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jonason JH, 2007, CELL CYCLE, V6, P951, DOI 10.4161/cc.6.8.4104; Kamai T, 2001, BRIT J CANCER, V84, P1242, DOI 10.1054/bjoc.2000.1736; Kim Y, 2007, MOL CELL BIOL, V27, P1394, DOI 10.1128/MCB.00736-06; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kostic I, 2003, DEV BIOL, V263, P242, DOI 10.1016/S0012-1606(03)00452-4; Kostic I, 2002, DEVELOPMENT, V129, P2155; LANGUINO LR, 1992, J BIOL CHEM, V267, P7116; Lee M, 2005, BBA-GEN SUBJECTS, V1723, P248, DOI 10.1016/j.bbagen.2005.01.003; Lee M, 2001, J BIOL CHEM, V276, P36404, DOI 10.1074/jbc.M105795200; Lin XY, 2003, CURR BIOL, V13, P922, DOI 10.1016/S0960-9822(03)00372-5; Lo SJ, 2006, CELL RES, V16, P530, DOI 10.1038/sj.cr.7310070; Lyapina SA, 1998, P NATL ACAD SCI USA, V95, P7451, DOI 10.1073/pnas.95.13.7451; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MEREDITH J, 1995, SCIENCE, V269, P1570, DOI 10.1126/science.7545312; Merz DC, 2003, DEV BIOL, V256, P173, DOI 10.1016/S0012-1606(03)00014-9; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Moerman Donald G, 2006, WormBook, P1; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Moro L, 2004, J BIOL CHEM, V279, P1692, DOI 10.1074/jbc.M307857200; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; Pleasance ED, 2003, GENOME RES, V13, P1203, DOI 10.1101/gr.873003; Qadota H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/864749; ROGALSKI TM, 1995, GENETICS, V139, P159; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; SIBLEY MH, 1994, EMBO J, V13, P3278, DOI 10.1002/j.1460-2075.1994.tb06629.x; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Timmons L, 2003, MOL BIOL CELL, V14, P2972, DOI 10.1091/mbc.E03-01-0858; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Walker JL, 2005, CANCER METAST REV, V24, P383, DOI 10.1007/s10555-005-5130-7; Wang XX, 2008, J BIOL CHEM, V283, P21113, DOI 10.1074/jbc.M801270200; Wang-Rodriguez J, 2002, CANCER-AM CANCER SOC, V95, P1387, DOI 10.1002/cncr.10878; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Wood WB, 1988, NEMATODE CAENORHABDI; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Xu XJ, 2006, EXP CELL RES, V312, P1475, DOI 10.1016/j.yexcr.2006.01.006; Xu XJ, 2010, DEV DYNAM, V239, P763, DOI 10.1002/dvdy.22205; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	89	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42425	10.1371/journal.pone.0042425	http://dx.doi.org/10.1371/journal.pone.0042425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879977	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000033
J	Songane, M; Kleinnijenhuis, J; Alisjahbana, B; Sahiratmadja, E; Parwati, I; Oosting, M; Plantinga, TS; Joosten, LAB; Netea, MG; Ottenhoff, THM; van de Vosse, E; van Crevel, R				Songane, Mario; Kleinnijenhuis, Johanneke; Alisjahbana, Bachti; Sahiratmadja, Edhyana; Parwati, Ida; Oosting, Marije; Plantinga, Theo S.; Joosten, Leo A. B.; Netea, Mihai G.; Ottenhoff, Tom H. M.; van de Vosse, Esther; van Crevel, Reinout			Polymorphisms in Autophagy Genes and Susceptibility to Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; HUMAN MACROPHAGES; HUMAN MONOCYTES/MACROPHAGES; INTRACELLULAR MYCOBACTERIA; CONTAINING PHAGOSOMES; CROHNS-DISEASE; P2X(7) GENE; ASSOCIATION; RECEPTOR	Recent data suggest that autophagy is important for intracellular killing of Mycobacterium tuberculosis, and polymorphisms in the autophagy gene IRGM have been linked with susceptibility to tuberculosis (TB) among African-Americans, and with TB caused by particular M. tuberculosis genotypes in Ghana. We compared 22 polymorphisms of 14 autophagy genes between 1022 Indonesian TB patients and 952 matched controls, and between patients infected with different M. tuberculosis genotypes, as determined by spoligotyping. The same autophagy polymorphisms were studied in correlation with ex-vivo production of TNF, IL-1 beta, IL-6, IL-8, IFN-gamma and IL-17 in healthy volunteers. No association was found between TB and polymorphisms in the genes ATG10, ATG16L2, ATG2B, ATG5, ATG9B, IRGM, LAMP1, LAMP3, P2RX7, WIPI1, MTOR and ATG4C. Associations were found between polymorphisms in LAMP1 (p = 0.02) and MTOR (p = 0.02) and infection with the successful M. tuberculosis Beijing genotype. The polymorphisms examined were not associated with M. tuberculosis induced cytokines, except for a polymorphism in ATG10, which was linked with IL-8 production (p = 0.04). All associations found lost statistical significance after correction for multiple testing. This first examination of a broad set of polymorphisms in autophagy genes fails to show a clear association with TB, with M. tuberculosis Beijing genotype infection or with ex-vivo pro-inflammatory cytokine production.	[Songane, Mario; Kleinnijenhuis, Johanneke; Oosting, Marije; Plantinga, Theo S.; Joosten, Leo A. B.; Netea, Mihai G.; van Crevel, Reinout] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [Songane, Mario; Kleinnijenhuis, Johanneke; Oosting, Marije; Plantinga, Theo S.; Joosten, Leo A. B.; Netea, Mihai G.; van Crevel, Reinout] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun N4i, NL-6525 ED Nijmegen, Netherlands; [Alisjahbana, Bachti] Padjadjaran State Univ, Fac Med, Dept Internal Med, Bandung, Indonesia; [Alisjahbana, Bachti; Sahiratmadja, Edhyana] Padjadjaran State Univ, Fac Med, Hlth Res Unit, Bandung, Indonesia; [Sahiratmadja, Edhyana] Padjadjaran State Univ, Fac Med, Dept Biochem, Bandung, Indonesia; [Parwati, Ida] Padjadjaran State Univ, Fac Med, Dept Clin Pathol, Bandung, Indonesia; [Ottenhoff, Tom H. M.; van de Vosse, Esther] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Universitas Padjadjaran; Universitas Padjadjaran; Universitas Padjadjaran; Universitas Padjadjaran; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Songane, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands.	r.vancrevel@aig.umcn.nl	Oosting, Marije/H-7437-2015; van de Vosse, Esther/HDO-0723-2022; van de Vosse, Esther/B-7285-2009; kleinnijenhuis, johanneke/G-7978-2016; Netea, Mihai/N-5155-2014; Kleinnijenhuis, Johanneke/P-6309-2015; van Crevel, reinout/A-6636-2010; Plantinga, Theo S./A-6895-2015; Joosten, Leo AB/H-3138-2015	van de Vosse, Esther/0000-0001-5199-3426; van Crevel, reinout/0000-0002-6233-6410; Plantinga, Theo S./0000-0003-4990-6084; Joosten, Leo AB/0000-0001-6166-9830; Sahiratmadja, Edhyana/0000-0001-9092-5848; Parwati, Ida/0000-0002-9700-589X	Netherlands Organization of Scientific Research; Royal Netherlands Academy of Arts and Sciences (KNAW) [KNAW99MED01]; Netherlands Organization for Scientific Research-Netherlands Foundation for the Advancement of Tropical Research (NWOWOTRO)	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Royal Netherlands Academy of Arts and Sciences (KNAW); Netherlands Organization for Scientific Research-Netherlands Foundation for the Advancement of Tropical Research (NWOWOTRO)	R.v.C. was supported by a Vidi grant from the Netherlands Organization of Scientific Research. M.G.N. was supported by a Vici grant from the Netherlands Organization of Scientific Research. This study was supported by the Royal Netherlands Academy of Arts and Sciences (KNAW; KNAW99MED01) and the Netherlands Organization for Scientific Research-Netherlands Foundation for the Advancement of Tropical Research (NWOWOTRO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisjahbana B, 2006, INT J TUBERC LUNG D, V10, P696; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Binker MG, 2007, CELL MICROBIOL, V9, P2153, DOI 10.1111/j.1462-5822.2007.00946.x; Biswas D, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-35; Bornman L, 2004, J INFECT DIS, V190, P1631, DOI 10.1086/424462; Che NY, 2010, CLIN CHIM ACTA, V411, P1645, DOI 10.1016/j.cca.2010.06.009; Cheng JF, 2010, WORLD J GASTROENTERO, V16, P1258, DOI 10.3748/wjg.v16.i10.1258; Crisan TO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018666; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Fernando SL, 2005, J INFECT DIS, V192, P149, DOI 10.1086/430622; Fernando SL, 2007, AM J RESP CRIT CARE, V175, P360, DOI 10.1164/rccm.200607-970OC; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; GOREN MB, 1976, P NATL ACAD SCI USA, V73, P2510, DOI 10.1073/pnas.73.7.2510; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hoal-van Helden EG, 1999, PEDIATR RES, V45, P459, DOI 10.1203/00006450-199904010-00002; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; King KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016317; Kleinnijenhuis J, 2011, IMMUNOLOGY, V134, P341, DOI 10.1111/j.1365-2567.2011.03494.x; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Lacher M, 2009, ACTA PAEDIATR, V98, P1835, DOI 10.1111/j.1651-2227.2009.01438.x; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Li CM, 2002, J INFECT DIS, V186, P1458, DOI 10.1086/344351; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Moon CM, 2012, INFLAMM BOWEL DIS; Myers AJ, 2005, INFECT IMMUN, V73, P3192, DOI 10.1128/IAI.73.5.3192-3195.2005; Parwati I, 2008, J CLIN MICROBIOL, V46, P3639, DOI 10.1128/JCM.00605-08; Plantinga TS, 2011, GUT, V60, P1229, DOI 10.1136/gut.2010.228908; Png E, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-5; Roth DE, 2004, J INFECT DIS, V190, P920, DOI 10.1086/423212; Sahiratmadja E, 2007, TUBERCULOSIS, V87, P303, DOI 10.1016/j.tube.2007.02.001; Sehgal R, 2012, DIS COLON RECTUM, V55, P115, DOI 10.1097/DCR.0b013e31823ccea8; Selvaraj P., 1999, Tubercle and Lung Disease, V79, P221, DOI 10.1054/tuld.1999.0204; Shepard EM, 2005, HUM BIOL, V77, P825, DOI 10.1353/hub.2006.0019; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Stober CB, 2001, J IMMUNOL, V166, P6276, DOI 10.4049/jimmunol.166.10.6276; van Crevel R, 2001, EMERG INFECT DIS, V7, P880; van Crevel R, 2009, J INFECT DIS, V200, P1671, DOI 10.1086/648477; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004	49	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e41618	10.1371/journal.pone.0041618	http://dx.doi.org/10.1371/journal.pone.0041618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879892	Green Published, Green Submitted, gold			2022-12-27	WOS:000307810000008
J	Zamostna, B; Novak, J; Vopalensky, V; Masek, T; Burysek, L; Pospisek, M				Zamostna, Blanka; Novak, Josef; Vopalensky, Vaclav; Masek, Tomas; Burysek, Ladislav; Pospisek, Martin			N-Terminal Domain of Nuclear IL-1 alpha Shows Structural Similarity to the C-Terminal Domain of Snf1 and Binds to the HAT/Core Module of the SAGA Complex	PLOS ONE			English	Article							HISTONE ACETYLTRANSFERASE COMPLEXES; ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; IN-VIVO; NUCLEOSOME ACETYLATION; ALZHEIMERS-DISEASE; ADA-COMPLEX; YEAST SAGA; INTERLEUKIN-1-ALPHA; TRANSCRIPTION	Interleukin-1 alpha (IL-1 alpha) is a proinflammatory cytokine and a key player in host immune responses in higher eukaryotes. IL-1 alpha has pleiotropic effects on a wide range of cell types, and it has been extensively studied for its ability to contribute to various autoimmune and inflammation-linked disorders, including rheumatoid arthritis, Alzheimer's disease, systemic sclerosis and cardiovascular disorders. Interestingly, a significant proportion of IL-1 alpha is translocated to the cell nucleus, in which it interacts with histone acetyltransferase complexes. Despite the importance of IL-1 alpha, little is known regarding its binding targets and functions in the nucleus. We took advantage of the histone acetyltransferase (HAT) complexes being evolutionarily conserved from yeast to humans and the yeast SAGA complex serving as an epitome of the eukaryotic HAT complexes. Using gene knock-out technique and co-immunoprecipitation of the IL-1 alpha precursor with TAP-tagged subunits of the yeast HAT complexes, we mapped the IL-1 alpha-binding site to the HAT/Core module of the SAGA complex. We also predicted the 3-D structure of the IL-1 alpha N-terminal domain, and by employing structure similarity searches, we found a similar structure in the C-terminal regulatory region of the catalytic subunit of the AMP-activated/Snf1 protein kinases, which interact with HAT complexes both in mammals and yeast, respectively. This finding is further supported with the ability of the IL-1 alpha precursor to partially rescue growth defects of snf1 Delta yeast strains on media containing 3-Amino-1,2,4-triazole (3-AT), a competitive inhibitor of His3. Finally, the careful evaluation of our data together with other published data in the field allows us to hypothesize a new function for the ADA complex in SAGA complex assembly.	[Zamostna, Blanka; Novak, Josef; Vopalensky, Vaclav; Masek, Tomas; Pospisek, Martin] Charles Univ Prague, Dept Genet & Microbiol, Fac Sci, Prague, Czech Republic; [Burysek, Ladislav] Protean Sro, Dobra Voda, Czech Republic	Charles University Prague	Zamostna, B (corresponding author), Charles Univ Prague, Dept Genet & Microbiol, Fac Sci, Prague, Czech Republic.	martin@natur.cuni.cz	Pospisek, Martin/A-9100-2008; Zamostna, Blanka/AAK-6526-2020; Vopalensky, Vaclav/Q-6418-2017; Burýšek, Ladislav/M-7369-2019; Masek, Tomas/Q-4636-2017	Vopalensky, Vaclav/0000-0002-4858-4645; Novak, Josef/0000-0002-9764-6195; Masek, Tomas/0000-0001-8732-0565; Pospisek, Martin/0000-0002-9490-8911	Ministry of Health of the Czech Republic, IGA [NS/9819]; Ministry of Education, Youth and Sports of the Czech Republic [MSM0021620858]; Charles University [SVV-2012-265202]	Ministry of Health of the Czech Republic, IGA; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University	This project was supported by the Ministry of Health of the Czech Republic, IGA (grant NS/9819) and also partially supported by the Ministry of Education, Youth and Sports of the Czech Republic (grant MSM0021620858) and by the Charles University institutional grant SVV-2012-265202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Balasubramanian R, 2002, J BIOL CHEM, V277, P7989, DOI 10.1074/jbc.M110849200; Belotserkovskaya R, 2000, MOL CELL BIOL, V20, P634, DOI 10.1128/MCB.20.2.634-647.2000; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Buryskova M, 2004, J BIOL CHEM, V279, P4017, DOI 10.1074/jbc.M306342200; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Eberharter A, 1999, MOL CELL BIOL, V19, P6621; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; GAO G, 1995, BBA-MOL CELL RES, V1266, P73, DOI 10.1016/0167-4889(94)00222-Z; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Grant PA, 1998, TRENDS CELL BIOL, V8, P193, DOI 10.1016/S0962-8924(98)01263-X; Grant PA, 1998, MOL CELL, V2, P863, DOI 10.1016/S1097-2765(00)80300-7; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Gueldener Ullrich, 1996, Nucleic Acids Research, V24, P2519; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horiuchi J, 1997, MOL CELL BIOL, V17, P3220, DOI 10.1128/MCB.17.6.3220; HORIUCHI J, 1995, MOL CELL BIOL, V15, P1203; Hu B, 2003, P NATL ACAD SCI USA, V100, P10008, DOI 10.1073/pnas.1737765100; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; KAWAGUCHI Y, 1994, CLIN EXP IMMUNOL, V97, P445; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Liu Y, 2005, MOL CELL BIOL, V25, P10566, DOI 10.1128/MCB.25.23.10566-10579.2005; Liu Y, 2010, GENETICS, V184, P91, DOI 10.1534/genetics.109.110957; Marcus GA, 1996, MOL CELL BIOL, V16, P3197; Mohibullah N, 2008, GENE DEV, V22, P2994, DOI 10.1101/gad.1724408; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G; Orlova M, 2006, EUKARYOT CELL, V5, P1831, DOI 10.1128/EC.00110-06; Orlova M, 2010, EUKARYOT CELL, V9, P208, DOI 10.1128/EC.00216-09; Pollock AS, 2003, FASEB J, V17, P203, DOI 10.1096/fj.02-0602com; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Rainero I, 2004, NEUROBIOL AGING, V25, P1293, DOI 10.1016/j.neurobiolaging.2004.02.011; Saleh A, 1998, J BIOL CHEM, V273, P26559, DOI 10.1074/jbc.273.41.26559; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Slovackova J, 2010, CELL CYCLE, V9, P2141, DOI 10.4161/cc.9.11.11808; Smardova J, 2005, DIFFERENTIATION, V73, P261, DOI 10.1111/j.1432-0436.2005.00028.x; Sterner DE, 2002, P NATL ACAD SCI USA, V99, P11622, DOI 10.1073/pnas.182021199; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Vicenova B, 2009, PHYSIOL RES, V58, P481, DOI 10.33549/physiolres.931673; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Wang LA, 1997, MOL CELL BIOL, V17, P519, DOI 10.1128/MCB.17.1.519; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; WESSENDORF JHM, 1993, J BIOL CHEM, V268, P22100; Wilson M, 2011, J PETROL, V52, P1, DOI 10.1093/petrology/egq092; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005; Wu PYJ, 2002, MOL CELL BIOL, V22, P5367, DOI 10.1128/MCB.22.15.5367-5379.2002; Yin HL, 2001, CYTOKINE, V15, P122, DOI 10.1006/cyto.2001.0891; Yousef AF, 2008, INT J CANCER, V122, P942, DOI 10.1002/ijc.23174	65	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e41801	10.1371/journal.pone.0041801	http://dx.doi.org/10.1371/journal.pone.0041801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879895	gold, Green Published, Green Submitted			2022-12-27	WOS:000307810000010
J	Balakrishnan, SK; Witcher, M; Berggren, TW; Emerson, BM				Balakrishnan, Sri Kripa; Witcher, Michael; Berggren, Travis W.; Emerson, Beverly M.			Functional and Molecular Characterization of the Role of CTCF in Human Embryonic Stem Cell Biology	PLOS ONE			English	Article							ENHANCER-BLOCKING ACTIVITY; TRANSCRIPTIONAL NETWORK; PROTEIN CTCF; ES CELLS; HUMAN GENOME; H19 GENE; CHROMATIN; BINDING; INSULATOR; PLURIPOTENCY	The CCCTC-binding factor CTCF is the only known vertebrate insulator protein and has been shown to regulate important developmental processes such as imprinting, X-chromosome inactivation and genomic architecture. In this study, we examined the role of CTCF in human embryonic stem cell (hESC) biology. We demonstrate that CTCF associates with several important pluripotency genes, including NANOG, SOX2, cMYC and LIN28 and is critical for hESC proliferation. CTCF depletion impacts expression of pluripotency genes and accelerates loss of pluripotency upon BMP4 induced differentiation, but does not result in spontaneous differentiation. We find that CTCF associates with the distal ends and internal sites of the coregulated 160 kb NANOG-DPPA3-GDF3 locus. Each of these sites can function as a CTCF-dependent enhancer-blocking insulator in heterologous assays. In hESCs, CTCF exists in multisubunit protein complexes and can be poly(ADP) ribosylated. Known CTCF cofactors, such as Cohesin, differentially co-localize in the vicinity of specific CTCF binding sites within the NANOG locus. Importantly, the association of some cofactors and protein PARlation selectively changes upon differentiation although CTCF binding remains constant. Understanding how unique cofactors may impart specialized functions to CTCF at specific genomic locations will further illuminate its role in stem cell biology.	[Balakrishnan, Sri Kripa; Witcher, Michael; Emerson, Beverly M.] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Berggren, Travis W.] Salk Inst Biol Studies, Stem Cell Core, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Balakrishnan, SK (corresponding author), Salk Inst Biol Studies, Regulatory Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	emerson@salk.edu			California Institute of Regenerative Medicine SEED grant [RS1-00195]	California Institute of Regenerative Medicine SEED grant	This work was supported by a California Institute of Regenerative Medicine SEED grant (RS1-00195) to BME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Gombert WM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006109; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; NG YK, 1994, DEVELOPMENT, V120, P3257; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Recillas-Targa F, 1999, P NATL ACAD SCI USA, V96, P14354, DOI 10.1073/pnas.96.25.14354; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tutter AV, 2009, J BIOL CHEM, V284, P3709, DOI 10.1074/jbc.M805677200; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Xiao TJ, 2011, MOL CELL BIOL, V31, P2174, DOI 10.1128/MCB.05093-11; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2	50	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42424	10.1371/journal.pone.0042424	http://dx.doi.org/10.1371/journal.pone.0042424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879976	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100087
J	Chen, B; Tardell, C; Higgins, B; Packman, K; Boylan, JF; Niu, HF				Chen, Brenden; Tardell, Christine; Higgins, Brian; Packman, Kathryn; Boylan, John F.; Niu, Huifeng			BRAFV600E Negatively Regulates the AKT Pathway in Melanoma Cell Lines	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; MAPK PATHWAY; CANCER-CELLS; BRAF GENE; INHIBITION; MEK; RAF; ACTIVATION; PHOSPHORYLATION; MUTATION	Cross-feedback activation of MAPK and AKT pathways is implicated as a resistance mechanism for cancer therapeutic agents targeting either RAF/MEK or PI3K/AKT/mTOR. It is thus important to have a better understanding of the molecular resistance mechanisms to improve patient survival benefit from these agents. Here we show that BRAFV600E is a negative regulator of the AKT pathway. Expression of BRAFV600E in NIH3T3 cells significantly suppresses MEK inhibitor (RG7167) or mTORC1 inhibitor (rapamycin) induced AKT phosphorylation (pAKT) and downstream signal activation. Treatment-induced pAKT elevation is found in BRAF wild type melanoma cells but not in a subset of melanoma cell lines harboring BRAFV600E. Knock-down of BRAFV600E in these melanoma cells elevates basal pAKT and downstream signals, whereas knock-down of CRAF, MEK1/2 or ERK1/2 or treatment with a BRAF inhibitor have no impact on pAKT. Mechanistically, we show that BRAFV600E interacts with rictor complex (mTORC2) and regulates pAKT through mTORC2. BRAFV600E is identified in mTORC2 after immunoprecipitation of rictor. Knock-down of rictor abrogates BRAFV600E depletion induced pAKT. Knockdown of BRAFV600E enhances cellular enzyme activity of mTORC2. Aberrant activation of AKT pathway by PTEN loss appears to override the negative impact of BRAFV600E on pAKT. Taken together, our findings suggest that in a subset of BRAFV600E melanoma cells, BRAFV600E negatively regulates AKT pathway in a rictor-dependent, MEK/ERK and BRAF kinase-independent manner. Our study reveals a novel molecular mechanism underlying the regulation of feedback loops between the MAPK and AKT pathways.	[Chen, Brenden; Tardell, Christine; Higgins, Brian; Packman, Kathryn; Boylan, John F.; Niu, Huifeng] Hoffmann La Roche Inc, Discovery Oncol, Nutley, NJ USA	Roche Holding	Chen, B (corresponding author), Hoffmann La Roche Inc, Discovery Oncol, Nutley, NJ USA.	huifeng.niu@roche.com			Roche Postdoc Fellowship Program	Roche Postdoc Fellowship Program	This work was partly supported by Roche Postdoc Fellowship Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Buck E, 2008, CANCER RES, V68, P8322, DOI 10.1158/0008-5472.CAN-07-6720; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Corcoran RB, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001148; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Easty DJ, 2011, PIGM CELL MELANOMA R, V24, P446, DOI 10.1111/j.1755-148X.2011.00836.x; Eblen ST, 2004, MOL CELL BIOL, V24, P2308, DOI 10.1128/MCB.24.6.2308-2317.2004; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Esteve-Puig R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004771; Falchook GS, 2011, ASCO M; Guldberg P, 1999, ONCOGENE, V18, P1777, DOI 10.1038/sj.onc.1202486; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Karbowniczek M, 2008, J INVEST DERMATOL, V128, P980, DOI 10.1038/sj.jid.5701074; Kirkwood JM, 2012, CLIN CANCER RES, V18, P555, DOI 10.1158/1078-0432.CCR-11-1491; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee L, 2009, CLIN CANCER RES, V15, P7368, DOI 10.1158/1078-0432.CCR-09-1696; Little AS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001752; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Maddodi N, 2010, J INVEST DERMATOL, V130, P1657, DOI 10.1038/jid.2010.26; McCubrey JA, 2008, CURR OPIN INVEST DR, V9, P614; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mielgo A, 2011, NAT MED, V17, P1641, DOI 10.1038/nm.2464; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Slipicevic A, 2005, AM J CLIN PATHOL, V124, P528, DOI 10.1309/YT58WWMTA6YR1PRV; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Steelman LS, 2008, EXPERT OPIN THER TAR, V12, P1139, DOI [10.1517/14728222.12.9.1139, 10.1517/14728222.12.9.1139 ]; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wang HS, 2011, CANCER RES, V71, P5535, DOI 10.1158/0008-5472.CAN-10-4351; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	42	50	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42598	10.1371/journal.pone.0042598	http://dx.doi.org/10.1371/journal.pone.0042598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880048	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100138
J	Cunha, TF; Bacurau, AVN; Moreira, JBN; Paixao, NA; Campos, JC; Ferreira, JCB; Leal, ML; Negrao, CE; Moriscot, AS; Wisloff, U; Brum, PC				Cunha, Telma F.; Bacurau, Aline V. N.; Moreira, Jose B. N.; Paixao, Nathalie A.; Campos, Juliane C.; Ferreira, Julio C. B.; Leal, Marcelo L.; Negrao, Carlos E.; Moriscot, Anselmo S.; Wisloff, Ulrik; Brum, Patricia C.			Exercise Training Prevents Oxidative Stress and Ubiquitin-Proteasome System Overactivity and Reverse Skeletal Muscle Atrophy in Heart Failure	PLOS ONE			English	Article							CARDIAC-FUNCTION; GENETIC MODEL; PROTEIN EXPRESSION; SATELLITE CELLS; HYPERACTIVITY; MICE; DYSFUNCTION; ANTIOXIDANT; IMPROVES; PATHWAY	Background: Heart failure (HF) is known to lead to skeletal muscle atrophy and dysfunction. However, intracellular mechanisms underlying HF-induced myopathy are not fully understood. We hypothesized that HF would increase oxidative stress and ubiquitin-proteasome system (UPS) activation in skeletal muscle of sympathetic hyperactivity mouse model. We also tested the hypothesis that aerobic exercise training (AET) would reestablish UPS activation in mice and human HF. Methods/Principal Findings: Time-course evaluation of plantaris muscle cross-sectional area, lipid hydroperoxidation, protein carbonylation and chymotrypsin-like proteasome activity was performed in a mouse model of sympathetic hyperactivity-induced HF. At the 7th month of age, HF mice displayed skeletal muscle atrophy, increased oxidative stress and UPS overactivation. Moderate-intensity AET restored lipid hydroperoxides and carbonylated protein levels paralleled by reduced E3 ligases mRNA levels, and reestablished chymotrypsin-like proteasome activity and plantaris trophicity. In human HF (patients randomized to sedentary or moderate-intensity AET protocol), skeletal muscle chymotrypsin-like proteasome activity was also increased and AET restored it to healthy control subjects' levels. Conclusions: Collectively, our data provide evidence that AET effectively counteracts redox imbalance and UPS overactivation, preventing skeletal myopathy and exercise intolerance in sympathetic hyperactivity-induced HF in mice. Of particular interest, AET attenuates skeletal muscle proteasome activity paralleled by improved aerobic capacity in HF patients, which is not achieved by drug treatment itself. Altogether these findings strengthen the clinical relevance of AET in the treatment of HF.	[Cunha, Telma F.; Bacurau, Aline V. N.; Moreira, Jose B. N.; Paixao, Nathalie A.; Campos, Juliane C.; Ferreira, Julio C. B.; Negrao, Carlos E.; Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Leal, Marcelo L.; Moriscot, Anselmo S.] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil; [Negrao, Carlos E.] Univ Sao Paulo, Heart Inst InCor, Sao Paulo, Brazil; [Wisloff, Ulrik] Norwegian Univ Sci & Technol, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Norwegian University of Science & Technology (NTNU)	Cunha, TF (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil.	pcbrum@usp.br	Moriscot, Anselmo S./C-4506-2012; Cunha, Telma F/I-5222-2016; Ferreira, Julio/L-4687-2019; Campos, Juliane/G-5997-2014; Wisloff, Ulrik/K-2899-2012; Bacurau, Aline Villa Nova/AAK-7446-2021; Ferreira, Julio Cesar Batista/I-3177-2012; Brum, Patricia C/E-6605-2011; Moreira, Jose/G-1556-2014; Negrao, Carlos E/C-4281-2012; Bacurau, Aline/F-3293-2012; Ferreira, Julio Cesar Batista/AEU-0494-2022	Moriscot, Anselmo S./0000-0003-3098-4613; Campos, Juliane/0000-0003-0075-7209; Bacurau, Aline Villa Nova/0000-0002-5129-5115; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Brum, Patricia C/0000-0002-4750-6506; Bacurau, Aline/0000-0002-5129-5115; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Wisloff, Ulrik/0000-0002-7211-3587; Negrao, Carlos Eduardo/0000-0003-4652-1226	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/61523-7, 2006/58460-4]; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) [473251/2009-4, 301519/2008-0, 301867/2010-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP #2006/61523-7) and Conselho Nacional de Pesquisa e Desenvolvimento (CNPq #473251/2009-4). PCB and CEN hold scholarships from CNPq (#301519/2008-0 and #301867/2010-0]. TFC held a scholarship from FAPESP (#2006/58460-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Attaix Didier, 2008, Curr Opin Support Palliat Care, V2, P262, DOI 10.1097/SPC.0b013e3283196ac2; Bacurau AVN, 2009, J APPL PHYSIOL, V106, P1631, DOI 10.1152/japplphysiol.91067.2008; Bartholomeu JB, 2008, J MOL CELL CARDIOL, V45, P240, DOI 10.1016/j.yjmcc.2008.05.011; Barton-Davis ER, 1999, ACTA PHYSIOL SCAND, V167, P301; Batista ML, 2010, CYTOKINE, V49, P102, DOI 10.1016/j.cyto.2009.10.007; Beehler BC, 2006, EXP BIOL MED, V231, P335; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brum PC, 2002, AM J PHYSIOL-HEART C, V283, pH1838, DOI 10.1152/ajpheart.01063.2001; Bueno CR, 2010, J APPL PHYSIOL, V109, P702, DOI 10.1152/japplphysiol.00281.2010; Choksi KB, 2008, FREE RADICAL BIO MED, V45, P826, DOI 10.1016/j.freeradbiomed.2008.06.006; CHOPRA M, 1992, J CARDIOVASC PHARM, V19, P330, DOI 10.1097/00005344-199203000-00005; Coirault C, 2007, AM J PHYSIOL-HEART C, V292, pH1009, DOI 10.1152/ajpheart.00438.2006; Dalla-Libera L, 2005, BASIC APPL MYOL, V15, P6; Ferreira JCB, 2008, AM J PHYSIOL-REG I, V294, pR26, DOI 10.1152/ajpregu.00424.2007; Ferreira JCB, 2007, CLIN EXP PHARMACOL P, V34, P760, DOI 10.1111/j.1440-1681.2007.04635.x; Ferreira JCB, 2011, LIFE SCI, V88, P578, DOI 10.1016/j.lfs.2011.01.009; Feuerstein G, 1998, Adv Pharmacol, V42, P611; Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012; Gielen S, 2005, EUR J CARDIOV PREV R, V12, P393, DOI 10.1097/01.hjr.0000174824.94892.43; Gielen S, 2003, J AM COLL CARDIOL, V42, P861, DOI 10.1016/S0735-1097(03)00848-9; Gielen S, 2012, CIRCULATION, V125, P2716, DOI 10.1161/CIRCULATIONAHA.111.047381; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gomes-Marcondes MCC, 2002, CANCER LETT, V180, P69, DOI 10.1016/S0304-3835(02)00006-X; Goncalves DAP, 2012, AM J PHYSIOL-ENDOC M, V302, pE123, DOI 10.1152/ajpendo.00188.2011; Goncalves DAP, 2009, ENDOCRINOLOGY, V150, P5395, DOI 10.1210/en.2009-0428; Guarnier FA, 2010, MUSCLE NERVE, V42, P950, DOI 10.1002/mus.21798; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; JahngenHodge J, 1997, J BIOL CHEM, V272, P28218, DOI 10.1074/jbc.272.45.28218; Jamart C, 2011, MUSCLE NERVE, V43, P708, DOI 10.1002/mus.21949; Kuwahara H, 2010, FREE RADICAL BIO MED, V48, P1252, DOI 10.1016/j.freeradbiomed.2010.02.011; Laughlin MH, 2008, J PHYSIOL PHARMACOL, V59, P71; Li YF, 2011, BBA-GENE REGUL MECH, V1809, P141, DOI 10.1016/j.bbagrm.2010.09.001; MANCINI DM, 1992, CIRCULATION, V85, P1364, DOI 10.1161/01.CIR.85.4.1364; Matsuo T, 2005, HEART VESSELS, V20, P8, DOI 10.1007/s00380-004-0793-5; Medeiros A, 2008, J APPL PHYSIOL, V104, P103, DOI 10.1152/japplphysiol.00493.2007; Moylan JS, 2007, MUSCLE NERVE, V35, P411, DOI 10.1002/mus.20743; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; MURRAY D, 1987, ANESTHESIOLOGY, V67, P211, DOI 10.1097/00000542-198708000-00010; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Negrao CE, 2008, HEART FAIL REV, V13, P51, DOI 10.1007/s10741-007-9057-7; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; Nowis D, 2010, AM J PATHOL, V176, P2658, DOI 10.2353/ajpath.2010.090690; Ohta Y, 2011, AM J PHYSIOL-HEART C, V300, pH1637, DOI 10.1152/ajpheart.01185.2009; Oliveira RSF, 2009, J PHYSIOL-LONDON, V587, P3899, DOI 10.1113/jphysiol.2009.173948; Pellegrino MA, 2011, J PHYSIOL-LONDON, V589, P2147, DOI 10.1113/jphysiol.2010.203232; Pereira MG, 2009, EUR J APPL PHYSIOL, V105, P843, DOI 10.1007/s00421-008-0967-4; Renault V, 2002, EXP GERONTOL, V37, P1229, DOI 10.1016/S0531-5565(02)00129-8; Rolim NPL, 2007, PHYSIOL GENOMICS, V29, P246, DOI 10.1152/physiolgenomics.00188.2006; Schulze PC, 2005, CIRC RES, V97, P418, DOI 10.1161/01.RES.0000179580.72375.c2; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Toth MJ, 2011, J APPL PHYSIOL, V110, P892, DOI 10.1152/japplphysiol.00545.2010; Tsutsui H, 2011, J CLIN BIOCHEM NUTR, V48, P68, DOI 10.3164/jcbn.11-012FR; van Hees HWH, 2008, AM J PHYSIOL-LUNG C, V294, pL1260, DOI 10.1152/ajplung.00035.2008; Vescovo G, 2001, ACTA PHYSIOL SCAND, V171, P305, DOI 10.1046/j.1365-201x.2001.00832.x; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P1, DOI 10.1007/s13539-010-0002-6; Willis MS, 2010, CIRC RES, V106, P463, DOI 10.1161/CIRCRESAHA.109.208801; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200	61	100	105	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41701	10.1371/journal.pone.0041701	http://dx.doi.org/10.1371/journal.pone.0041701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870245	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100030
J	Hao, JL; Madigan, MC; Khatri, A; Power, CA; Hung, TT; Beretov, J; Chang, L; Xiao, WW; Cozzi, PJ; Graham, PH; Kearsley, JH; Li, Y				Hao, Jingli; Madigan, Michele C.; Khatri, Aparajita; Power, Carl A.; Hung, Tzong-Tyng; Beretov, Julia; Chang, Lei; Xiao, Weiwei; Cozzi, Paul J.; Graham, Peter H.; Kearsley, John H.; Li, Yong			In Vitro and In Vivo Prostate Cancer Metastasis and Chemoresistance Can Be Modulated by Expression of either CD44 or CD147	PLOS ONE			English	Article							DRUG-RESISTANCE; MONOCARBOXYLATE TRANSPORTERS; MULTIDRUG-RESISTANCE; CELL-LINE; HYALURONAN-CD44 INTERACTION; P-GLYCOPROTEIN; OVARIAN-CANCER; INVASION; EMMPRIN; GROWTH	CD44 and CD147 are associated with cancer metastasis and progression. Our purpose in the study was to investigate the effects of down-regulation of CD44 or CD147 on the metastatic ability of prostate cancer (CaP) cells, their docetaxel (DTX) responsiveness and potential mechanisms involved in vitro and in vivo. CD44 and CD147 were knocked down (KD) in PC-3M-luc CaP cells using short hairpin RNA (shRNA). Expression of CD44, CD147, MRP2 (multi-drug resistance protein-2) and MCT4 (monocarboxylate tranporter-4) was evaluated using immunofluorescence and Western blotting. The DTX dose-response and proliferation was measured by MTT and colony assays, respectively. The invasive potential was assessed using a matrigel chamber assay. Signal transduction proteins in PI3K/Akt and MAPK/Erk pathways were assessed by Western blotting. An in vivo subcutaneous (s.c.) xenograft model was established to assess CaP tumorigenecity, lymph node metastases and DTX response. Our results indicated that KD of CD44 or CD147 decreased MCT4 and MRP2 expression, reduced CaP proliferation and invasive potential and enhanced DTX sensitivity; and KD of CD44 or CD147 down-regulated p-Akt and p-Erk, the main signal modulators associated with cell growth and survival. In vivo, CD44 or CD147-KD PC-3M-luc xenografts displayed suppressed tumor growth with increased DTX responsiveness compared to control xenografts. Both CD44 and CD147 enhance metastatic capacity and chemoresistance of CaP cells, potentially mediated by activation of the PI3K and MAPK pathways. Selective targeting of CD44/CD147 alone or combined with DTX may limit CaP metastasis and increase chemosensitivity, with promise for future CaP treatment.	[Hao, Jingli; Beretov, Julia; Chang, Lei; Xiao, Weiwei; Cozzi, Paul J.; Graham, Peter H.; Kearsley, John H.; Li, Yong] Univ New S Wales, St George Clin Sch, Kensington, NSW 2033, Australia; [Hao, Jingli; Beretov, Julia; Chang, Lei; Xiao, Weiwei; Graham, Peter H.; Kearsley, John H.; Li, Yong] St George Hosp, Canc Care Ctr, Kogarah, NSW, Australia; [Madigan, Michele C.] Univ New S Wales, Sch Optometry & Vis Sci, Kensington, NSW 2033, Australia; [Madigan, Michele C.] Univ Sydney, Sydney Med Sch, Save Sight Inst, Sydney, NSW 2006, Australia; [Khatri, Aparajita; Hung, Tzong-Tyng] Univ New S Wales, Prince Wales Clin Sch, Kensington, NSW 2033, Australia; [Power, Carl A.; Hung, Tzong-Tyng] Univ New S Wales, Biol Resources Imaging Lab, Kensington, NSW 2033, Australia; [Beretov, Julia] St George Hosp, Dept Anat Pathol, Kogarah, NSW, Australia; [Cozzi, Paul J.] St George Hosp, Dept Surg, Kogarah, NSW, Australia	University of New South Wales Sydney; St George Hospital; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; St George Hospital; St George Hospital	Hao, JL (corresponding author), Univ New S Wales, St George Clin Sch, POB 1, Kensington, NSW 2033, Australia.	y.li@unsw.edu.au		Li, Yong/0000-0002-8910-9787; Hung, Tzong/0000-0002-2904-2664; Xiao, WeiWei/0000-0002-9922-640X; Beretov, Julia/0000-0001-5582-0020	National Health & Medical Research Council (NHMRC); St George Medical Research Foundation; Urology Research Fund; St George Hospital Trust Fund	National Health & Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia); St George Medical Research Foundation; Urology Research Fund; St George Hospital Trust Fund	This work was supported by National Health & Medical Research Council (NH&MRC) (YL), St George Medical Research Foundation (YL), Urology Research Fund (PJC) and St George Hospital Trust Fund (PHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2007, ONCOGENE, V26, P836, DOI 10.1038/sj.onc.1209849; Benitez A, 2011, CANCER RES, V71, P4085, DOI 10.1158/0008-5472.CAN-10-4610; Bougatef F, 2009, BLOOD, V114, P5547, DOI 10.1182/blood-2009-04-217380; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Calabro F, 2007, EUR UROL, V51, P17, DOI 10.1016/j.eururo.2006.08.013; Chang SS, 2009, BJU INT, V103, P8, DOI 10.1111/j.1464-410X.2008.08256.x; Chen H, 2009, BRIT J CANCER, V101, P432, DOI 10.1038/sj.bjc.6605185; Chen HC, 2010, INTEGR SER INFORM SY, V21, P147, DOI 10.1007/978-1-4419-1278-7_10; Cozzi PJ, 2005, CLIN EXP METASTAS, V22, P565, DOI 10.1007/s10585-005-5376-z; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Gao AC, 1998, CANCER RES, V58, P2350; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gilg AG, 2008, CLIN CANCER RES, V14, P1804, DOI 10.1158/1078-0432.CCR-07-1228; GLEAVE M, 1991, CANCER RES, V51, P3753; Hao J, 2010, BRIT J CANCER, V103, P1008, DOI 10.1038/sj.bjc.6605839; Hao JL, 2010, CURR CANCER DRUG TAR, V10, P287, DOI 10.2174/156800910791190193; Ide H, 2010, JPN J CLIN ONCOL, V40, P79, DOI 10.1093/jjco/hyp126; Izumi H, 2011, CANCER SCI, V102, P1007, DOI 10.1111/j.1349-7006.2011.01908.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Klein CA, 2002, NAT BIOTECHNOL, V20, P387, DOI 10.1038/nbt0402-387; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Lee JT, 2004, CANCER RES, V64, P8397, DOI 10.1158/0008-5472.CAN-04-1612; Li Y, 2002, BRIT J CANCER, V86, P1197, DOI 10.1038/sj/bjc/6600179; Ma JJ, 2009, ARCH GYNECOL OBSTET, V279, P149, DOI 10.1007/s00404-008-0690-8; Madigan MC, 2008, CANCER IMMUNOL IMMUN, V57, P1367, DOI 10.1007/s00262-008-0473-x; Marieb EA, 2004, CANCER RES, V64, P1229, DOI 10.1158/0008-5472.CAN-03-2832; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Mesiano S, 1998, AM J PATHOL, V153, P1249, DOI 10.1016/S0002-9440(10)65669-6; Miletti-Gonzalez KE, 2005, CANCER RES, V65, P6660, DOI 10.1158/0008-5472.CAN-04-3478; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Nishida N, 2004, CANCER, V101, P364; Omara-Opyene AL, 2004, LAB INVEST, V84, P894, DOI 10.1038/labinvest.3700112; Pertega-Gomes N, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-312; Petrylak DP, 2005, UROLOGY, V65, P8, DOI 10.1016/j.urology.2005.04.020; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Rudrabhatla SR, 2006, J INVEST DERMATOL, V126, P1378, DOI 10.1038/sj.jid.5700255; Schneiderhan W, 2009, GUT, V58, P1391, DOI 10.1136/gut.2009.181412; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Slomiany MG, 2009, CLIN CANCER RES, V15, P7593, DOI 10.1158/1078-0432.CCR-09-2317; Slomiany MG, 2009, CANCER RES, V69, P4992, DOI 10.1158/0008-5472.CAN-09-0143; Slomiany MG, 2009, CANCER RES, V69, P1293, DOI 10.1158/0008-5472.CAN-08-2491; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024405; Wang L, 2011, CANCER LETT, V300, P122, DOI 10.1016/j.canlet.2010.09.013; Wang LG, 2006, CANCER BIOL THER, V5, P608, DOI 10.4161/cbt.5.6.2661; Wang WJ, 2008, CHEMOTHERAPY, V54, P291, DOI 10.1159/000151225; WARE JL, 1982, J UROLOGY, V128, P1064, DOI 10.1016/S0022-5347(17)53345-5; Wegiel B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007953; Yamasaki M, 2011, BRIT J CANCER, V104, P707, DOI 10.1038/sj.bjc.6606071; Yan L, 2005, THROMB HAEMOSTASIS, V93, P199, DOI 10.1160/TH04-08-0536; Yang K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-16; Zhong WD, 2012, INT J CANCER, V130, P300, DOI 10.1002/ijc.25982; Zhu HN, 2012, PROSTATE, V72, P72, DOI 10.1002/pros.21408	62	69	75	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e40716	10.1371/journal.pone.0040716	http://dx.doi.org/10.1371/journal.pone.0040716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870202	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100010
J	Proenca-Modena, JL; Valera, FCP; Jacob, MG; Buzatto, GP; Saturno, TH; Lopes, L; Souza, JM; Paula, FE; Silva, ML; Carenzi, LR; Tamashiro, E; Arruda, E; Anselmo-Lima, WT				Proenca-Modena, Jose Luiz; Pereira Valera, Fabiana Cardoso; Jacob, Marcos Gerhardinger; Buzatto, Guilherme Pietrucci; Saturno, Tamara Honorato; Lopes, Lucia; Souza, Jamila Mendonca; Paula, Flavia Escremim; Silva, Maria Lucia; Carenzi, Lucas Rodrigues; Tamashiro, Edwin; Arruda, Eurico; Anselmo-Lima, Wilma Terezinha			High Rates of Detection of Respiratory Viruses in Tonsillar Tissues from Children with Chronic Adenotonsillar Disease	PLOS ONE			English	Article							RECURRENT TONSILLITIS; HUMAN BOCAVIRUS; HYPERTROPHY; LYMPHOCYTES; PREVALENCE; APOPTOSIS; RNA; DNA	Chronic tonsillar diseases are an important health problem, leading to large numbers of surgical procedures worldwide. Little is known about pathogenesis of these diseases. In order to investigate the role of respiratory viruses in chronic adenotonsillar diseases, we developed a cross-sectional study to determine the rates of viral detections of common respiratory viruses detected by TaqMan real time PCR (qPCR) in nasopharyngeal secretions, tonsillar tissues and peripheral blood from 121 children with chronic tonsillar diseases, without symptoms of acute respiratory infections. At least one respiratory virus was detected in 97.5% of patients. The viral co-infection rate was 69.5%. The most frequently detected viruses were human adenovirus in 47.1%, human enterovirus in 40.5%, human rhinovirus in 38%, human bocavirus in 29.8%, human metapneumovirus in 17.4% and human respiratory syncytial virus in 15.7%. Results of qPCR varied widely between sample sites: human adenovirus, human bocavirus and human enterovirus were predominantly detected in tissues, while human rhinovirus was more frequently detected in secretions. Rates of virus detection were remarkably high in tonsil tissues: over 85% in adenoids and close to 70% in palatine tonsils. In addition, overall virus detection rates were higher in more hypertrophic than in smaller adenoids (p = 0.05), and in the particular case of human enteroviruses, they were detected more frequently (p = 0.05) in larger palatine tonsils than in smaller ones. While persistence/latency of DNA viruses in tonsillar tissues has been documented, such is not the case of RNA viruses. Respiratory viruses are highly prevalent in adenoids and palatine tonsils of patients with chronic tonsillar diseases, and persistence of these viruses in tonsils may stimulate chronic inflammation and play a role in the pathogenesis of these diseases.	[Proenca-Modena, Jose Luiz; Paula, Flavia Escremim; Silva, Maria Lucia; Arruda, Eurico] Univ Sao Paulo, Dept Cell Biol, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Pereira Valera, Fabiana Cardoso; Buzatto, Guilherme Pietrucci; Carenzi, Lucas Rodrigues; Tamashiro, Edwin; Anselmo-Lima, Wilma Terezinha] Univ Sao Paulo, Dept Ophthalmol Otorhinolaryngol & Head & Neck Su, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Proenca-Modena, Jose Luiz; Jacob, Marcos Gerhardinger; Saturno, Tamara Honorato; Lopes, Lucia; Souza, Jamila Mendonca; Paula, Flavia Escremim; Silva, Maria Lucia; Arruda, Eurico] Univ Sao Paulo, Virol Res Ctr, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Proenca-Modena, JL (corresponding author), Univ Sao Paulo, Dept Cell Biol, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.	wtalima@fmrp.usp.br	Arruda, Eurico/E-4101-2012; Valera, Fabiana Cardoso Pereira/D-3787-2012; Proenca-Modena, Jose Luiz/C-8231-2014; Tamashiro, Edwin/C-5062-2012	Valera, Fabiana Cardoso Pereira/0000-0002-6605-5317; Proenca-Modena, Jose Luiz/0000-0002-4996-3153; Tamashiro, Edwin/0000-0002-3153-6292	FAPESP-Sao Paulo Research Foundation [2009/51818-8]; National Research Counsel (CNPq)	FAPESP-Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research Counsel (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by FAPESP-Sao Paulo Research Foundation (Grant No. 2009/51818-8). EA, WTAL and FCPV are recipients of longstanding research scholarships from the National Research Counsel (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Anlar B, 2002, J PAEDIATR CHILD H, V38, P424, DOI 10.1046/j.1440-1754.2002.t01-1-00029.x; Chen RW, 2005, J CLIN MICROBIOL, V43, P1408, DOI 10.1128/JCM.43.3.1408-1410.2005; Endo LH, 2001, INT J PEDIATR OTORHI, V58, P9, DOI 10.1016/S0165-5876(00)00446-8; Erdag TK, 2005, INT J PEDIATR OTORHI, V69, P1321, DOI 10.1016/j.ijporl.2005.05.005; Frankel SS, 1997, AM J PATHOL, V151, P89; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Kurnatowski P, 2008, J LARYNGOL OTOL, V122, P931, DOI 10.1017/S0022215107001235; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Lopez-Gonzalez MA, 1999, EUR J PEDIATR, V158, P469, DOI 10.1007/s004310051122; Lu XY, 2008, EMERG INFECT DIS, V14, P1332, DOI 10.3201/eid1408.080300; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Meerhoff TJ, 2010, EUR J CLIN MICROBIOL, V29, P365, DOI 10.1007/s10096-009-0865-7; Nave H, 2001, ANAT EMBRYOL, V204, P367, DOI 10.1007/s004290100210; PORTER JDH, 1991, J HOSP INFECT, V18, P201, DOI 10.1016/0195-6701(91)90144-W; Proenca-Modena JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021083; Roush KS, 2001, AM J CLIN PATHOL, V116, P648, DOI 10.1309/Y2HH-B1CK-0F5L-U7B8; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; Stenfors LE, 2003, INT J PEDIATR OTORHI, V67, P1075, DOI 10.1016/S0165-5876(03)00194-0; Suvilehto J, 2006, J CLIN VIROL, V35, P292, DOI 10.1016/j.jcv.2005.08.009; SZALATY H., 1959, ARCH IMMUNOL I TERAP DOSWIADCZALNEJ, V7, P615; Vicente D, 2007, EMERG INFECT DIS, V13, P636, DOI 10.3201/eid1304.061501; Winther B, 2009, ARCH OTOLARYNGOL, V135, P1239, DOI 10.1001/archoto.2009.186; Zhang PC, 2003, CLIN OTOLARYNGOL, V28, P235, DOI 10.1046/j.1365-2273.2003.00697.x; Zhang YG, 2010, J VIROL, V84, P8799, DOI 10.1128/JVI.00562-10	25	63	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42136	10.1371/journal.pone.0042136	http://dx.doi.org/10.1371/journal.pone.0042136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870291	gold, Green Submitted, Green Published			2022-12-27	WOS:000307284100047
J	Lai, A; Simonetti, FR; Zehender, G; De Luca, A; Micheli, V; Meraviglia, P; Corsi, P; Bagnarelli, P; Almi, P; Zoncada, A; Paolucci, S; Gonnelli, A; Colao, G; Tacconi, D; Franzetti, M; Ciccozzi, M; Zazzi, M; Balotta, C				Lai, Alessia; Simonetti, Francesco R.; Zehender, Gianguglielmo; De Luca, Andrea; Micheli, Valeria; Meraviglia, Paola; Corsi, Paola; Bagnarelli, Patrizia; Almi, Paolo; Zoncada, Alessia; Paolucci, Stefania; Gonnelli, Angela; Colao, Grazia; Tacconi, Danilo; Franzetti, Marco; Ciccozzi, Massimo; Zazzi, Maurizio; Balotta, Claudia			HIV-1 Subtype F1 Epidemiological Networks among Italian Heterosexual Males Are Associated with Introduction Events from South America	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NON-B SUBTYPES; DRUG-RESISTANCE; PREVALENCE; TRANSMISSION; DIVERSITY; STRAINS	About 40% of the Italian HIV-1 epidemic due to non-B variants is sustained by F1 clade, which circulates at high prevalence in South America and Eastern Europe. Aim of this study was to define clade F1 origin, population dynamics and epidemiological networks through phylogenetic approaches. We analyzed pol sequences of 343 patients carrying F1 subtype stored in the ARCA database from 1998 to 2009. Citizenship of patients was as follows: 72.6% Italians, 9.3% South Americans and 7.3% Rumanians. Heterosexuals, Homo-bisexuals, Intravenous Drug Users accounted for 58.1%, 24.0% and 8.8% of patients, respectively. Phylogenetic analysis indicated that 70% of sequences clustered in 27 transmission networks. Two distinct groups were identified; the first clade, encompassing 56 sequences, included all Rumanian patients. The second group involved the remaining clusters and included 10 South American Homo-bisexuals in 9 distinct clusters. Heterosexual modality of infection was significantly associated with the probability to be detected in transmission networks. Heterosexuals were prevalent either among Italians (67.2%) or Rumanians (50%); by contrast, Homo-bisexuals accounted for 71.4% of South Americans. Among patients with resistant strains the proportion of clustering sequences was 57.1%, involving 14 clusters (51.8%). Resistance in clusters tended to be higher in South Americans (28.6%) compared to Italian (17.7%) and Rumanian patients (14.3%). A striking proportion of epidemiological networks could be identified in heterosexuals carrying F1 subtype residing in Italy. Italian Heterosexual males predominated within epidemiological clusters while foreign patients were mainly Heterosexual Rumanians, both males and females, and South American Homo-bisexuals. Tree topology suggested that F1 variant from South America gave rise to the Italian F1 epidemic through multiple introduction events. The contact tracing also revealed an unexpected burden of resistance in epidemiological clusters underlying the need of public interventions to limit the spread of non-B subtypes and transmitted drug resistance.	[Lai, Alessia; Simonetti, Francesco R.; Zehender, Gianguglielmo; Franzetti, Marco; Balotta, Claudia] Univ Milan, L Sacco Hosp, Dept Biomed & Clin Sci, Infect Dis & Immunopathol Sect, Milan, Italy; [De Luca, Andrea] Univ Siena, Infect Dis Unit 2, I-53100 Siena, Italy; [Micheli, Valeria] L Sacco Hosp Vialba, Microbiol Lab, Milan, Italy; [Meraviglia, Paola] L Sacco Hosp Vialba, Div Infect Dis 2, Milan, Italy; [Corsi, Paola] Unita Operat Complessa Infect Dis Careggi, Florence, Italy; [Bagnarelli, Patrizia] Univ Politecn Marche, Virol Lab, Microbiol Sect, Dept Biomed Sci, Ancona, Italy; [Almi, Paolo; Gonnelli, Angela] Azienda Osped Univ Senese, Unita Operat Complessa Infect Dis & Hepatol, Siena, Italy; [Zoncada, Alessia] Infect Dis Sect, Cremona, Italy; [Paolucci, Stefania] Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Colao, Grazia] Sect Virol Careggi, Florence, Italy; [Tacconi, Danilo] Infect Dis Sect, Arezzo, Italy; [Ciccozzi, Massimo] Italian Inst Hlth, Dept Infect, Epidemiol Unit, Rome, Italy; [Zazzi, Maurizio] Univ Siena, Dept Biotechnol, Microbiol Sect, I-53100 Siena, Italy	University of Milan; Luigi Sacco Hospital; University of Siena; University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; Marche Polytechnic University; University of Siena; University Hospital of Siena; IRCCS Fondazione San Matteo; University of Siena	Lai, A (corresponding author), Univ Milan, L Sacco Hosp, Dept Biomed & Clin Sci, Infect Dis & Immunopathol Sect, Milan, Italy.	alessia.lai@unimi.it	Paolucci, Stefania/J-4055-2018; LAI, ALESSIA/AAR-1300-2021; Micheli, Valeria/G-4927-2018; Bagnarelli, Patrizia/AAL-2750-2020; Ciccozzi, Massimo/AAC-3271-2022; CICCOZZI, MASSIMO/C-6484-2016; Zazzi, Maurizio/K-3422-2018; De Luca, Andrea/G-8810-2011; Balotta, Claudia/L-7295-2017	Paolucci, Stefania/0000-0001-8447-8586; LAI, ALESSIA/0000-0002-3174-5721; Micheli, Valeria/0000-0001-5629-3875; Bagnarelli, Patrizia/0000-0001-5231-9660; Ciccozzi, Massimo/0000-0003-3866-9239; CICCOZZI, MASSIMO/0000-0003-3866-9239; Zazzi, Maurizio/0000-0002-0344-6281; De Luca, Andrea/0000-0002-9561-9193; meraviglia, paola/0000-0002-3356-7199; Balotta, Claudia/0000-0002-1107-9119; Simonetti, Francesco Roberto/0000-0002-4165-660X	Ministry of Health, Rome, Italy [40H63, 40H64]; VI AIDS Research Program of the Ministry of Health, Rome, Italy [30G.58]; Italian PRIN [200887SYZ5]; Anti-HIV Drug Resistance Network (CHAIN) [223131]	Ministry of Health, Rome, Italy(Ministry of Health, Italy); VI AIDS Research Program of the Ministry of Health, Rome, Italy; Italian PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Anti-HIV Drug Resistance Network (CHAIN)	This work was supported by grants from the Ministry of Health, Rome, Italy (grant 40H63 and grant 40H64) to CB; from the VI AIDS Research Program of the Ministry of Health, Rome, Italy (grant 30G.58), the Italian PRIN 2008 (grant 200887SYZ5) and Anti-HIV Drug Resistance Network (CHAIN) (grant agreement 223131) to MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldanti F, 2008, J MED VIROL, V80, P947, DOI 10.1002/jmv.21163; Balotta C, 2001, J ACQ IMMUN DEF SYND, V27, P499, DOI 10.1097/00126334-200108150-00012; Callegaro A, 2011, INFECT GENET EVOL, V11, P624, DOI 10.1016/j.meegid.2011.01.019; Chaix ML, 2003, AIDS, V17, P2635, DOI 10.1097/00002030-200312050-00011; Ciccozzi M, 2010, NEW MICROBIOL, V33, P179; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DUMITRESCU O, 1994, J INFECT DIS, V169, P281, DOI 10.1093/infdis/169.2.281; Franzetti M, 2012, J ANTIMICROB CHEMOTH, V67, P1250, DOI 10.1093/jac/dks013; Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07; Guimaraes ML, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-39; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Lai A, 2010, HIV MED, V11, P593, DOI 10.1111/j.1468-1293.2010.00832.x; Lai A, 2011, AIDS RES HU IN PRESS; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lospitao E, 2005, HIV MED, V6, P313, DOI 10.1111/j.1468-1293.2005.00313.x; Montano SM, 2005, JAIDS-J ACQ IMM DEF, V40, P57, DOI 10.1097/01.qai.0000159667.72584.8b; Niama FR, 2006, INFECT GENET EVOL, V6, P337, DOI 10.1016/j.meegid.2005.12.001; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Riva C, 2010, AIDS RES HUM RETROV, V26, P41, DOI 10.1089/aid.2009.0057; Snoeck J, 2004, JAIDS-J ACQ IMM DEF, V35, P279, DOI 10.1097/00126334-200403010-00009; Suligoi B., 2009, NOTIZIARIO I SUPERIO, V22, P3; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; Zaccarelli M, 2004, SEX TRANSM INFECT, V80, P541, DOI 10.1136/sti.2004.010769	25	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42223	10.1371/journal.pone.0042223	http://dx.doi.org/10.1371/journal.pone.0042223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876310	gold, Green Published, Green Submitted			2022-12-27	WOS:000307184700038
J	Mountrakis, G; Zhuang, W				Mountrakis, Giorgos; Zhuang, Wei			Integrating Local and Global Error Statistics for Multi-Scale RBF Network Training: An Assessment on Remote Sensing Data	PLOS ONE			English	Article							FUNCTION NEURAL-NETWORKS; RESOLUTION SATELLITE IMAGERY; RADIAL BASIS FUNCTIONS; IMPERVIOUS SURFACES; LASER ALTIMETER; CLASSIFICATION; ALGORITHM; SYSTEM; CLASSIFIERS; LIDAR	Background: This study discusses the theoretical underpinnings of a novel multi-scale radial basis function (MSRBF) neural network along with its application to classification and regression tasks in remote sensing. The novelty of the proposed MSRBF network relies on the integration of both local and global error statistics in the node selection process. Methodology and Principal Findings: The method was tested on a binary classification task, detection of impervious surfaces using a Landsat satellite image, and a regression problem, simulation of waveform LiDAR data. In the classification scenario, results indicate that the MSRBF is superior to existing radial basis function and back propagation neural networks in terms of obtained classification accuracy and training-testing consistency, especially for smaller datasets. The latter is especially important as reference data acquisition is always an issue in remote sensing applications. In the regression case, MSRBF provided improved accuracy and consistency when contrasted with a multi kernel RBF network. Conclusion and Significance: Results highlight the potential of a novel training methodology that is not restricted to a specific algorithmic type, therefore significantly advancing machine learning algorithms for classification and regression tasks. The MSRBF is expected to find numerous applications within and outside the remote sensing field.	[Mountrakis, Giorgos; Zhuang, Wei] SUNY Coll Environm Sci & Forestry, Dept Environm Resources Engn, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Mountrakis, G (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm Resources Engn, Syracuse, NY 13210 USA.	gmountrakis@esf.edu	Beckley, Matthew/D-4547-2013; Mountrakis, Giorgos/I-9612-2014	Mountrakis, Giorgos/0000-0001-5958-8134	NASA [NNX09AK16G, NNX08AR11G]	NASA(National Aeronautics & Space Administration (NASA))	This work was supported NASA's Biodiversity and New Investigator Progams (awards NNX09AK16G, NNX08AR11G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson PM, 1997, INT J REMOTE SENS, V18, P699, DOI 10.1080/014311697217224; Bauer M. E., 2004, ASPRS ANN C P DENV C; BENEDIKTSSON JA, 1990, IEEE T GEOSCI REMOTE, V28, P540, DOI 10.1109/TGRS.1990.572944; Bhattacharya D, 1997, IEEE T GEOSCI REMOTE, V35, P699, DOI 10.1109/36.581990; Bhattacharya D, 1996, P IEEE INT S CIRCUIT, V3, P309; BILLINGS SA, 1989, INT J CONTROL, V49, P2157, DOI 10.1080/00207178908559767; Billings SA, 2007, NEURAL NETWORKS, V20, P1081, DOI 10.1016/j.neunet.2007.09.017; Blair JB, 1999, ISPRS J PHOTOGRAMM, V54, P115, DOI 10.1016/S0924-2716(99)00002-7; Bruzzone L., 2002, Information Fusion, V3, P289, DOI 10.1016/S1566-2535(02)00091-X; Bruzzone L, 2004, PATTERN RECOGN LETT, V25, P1491, DOI 10.1016/j.patrec.2004.06.002; Bruzzone L, 2004, IEEE T GEOSCI REMOTE, V42, P1321, DOI 10.1109/TGRS.2004.826821; Bruzzone L, 2003, INT J REMOTE SENS, V24, P1709, DOI 10.1080/01431160210144714; Bruzzone L, 1999, IEEE T GEOSCI REMOTE, V37, P1179, DOI 10.1109/36.752239; Bruzzone L, 2002, IEEE T GEOSCI REMOTE, V40, P1984, DOI 10.1109/TGRS.2002.803794; Bruzzone L, 2001, P SPIE INT SOC OPTIC, V4541, P223; CHEN S, 1989, INT J CONTROL, V50, P1873, DOI 10.1080/00207178908953472; CHEN S, 1991, IEEE T NEURAL NETWOR, V2, P302, DOI 10.1109/72.80341; Constantinopoulos C, 2006, IEEE T NEURAL NETWOR, V17, P966, DOI 10.1109/TNN.2006.875982; Dell'Acqua F, 2003, IEEE T GEOSCI REMOTE, V41, P853, DOI 10.1109/TGRS.2003.811077; Ferrari S, 2004, IEEE T NEURAL NETWOR, V15, P178, DOI 10.1109/TNN.2003.811355; Fischer MM, 1997, GEOGRAPHICAL SYSTEMS, V4, P195; Foody GM, 2007, INT J REMOTE SENS, V28, P1733, DOI 10.1080/01431160600962566; Foody G.M., 2001, J GEOGR SYST, V3, P217; Foody GM, 2004, INT J REMOTE SENS, V25, P3091, DOI 10.1080/01431160310001648019; Fu XJ, 2003, IEEE T SYST MAN CY B, V33, P399, DOI 10.1109/TSMCB.2003.810911; Gamba P, 2003, INT J REMOTE SENS, V24, P827, DOI 10.1080/01431160210154001; Grebby S, 2010, REMOTE SENS ENVIRON, V114, P713, DOI 10.1016/j.rse.2009.11.006; Harding DJ, 2001, REMOTE SENS ENVIRON, V76, P283, DOI 10.1016/S0034-4257(00)00210-8; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Hyde P, 2005, REMOTE SENS ENVIRON, V96, P427, DOI 10.1016/j.rse.2005.03.005; Jena B, 2010, IEEE GEOSCI REMOTE S, V7, P567, DOI 10.1109/LGRS.2010.2041632; Joughin I, 1999, SCIENCE, V286, P283, DOI 10.1126/science.286.5438.283; Kalra R, 2005, MAR STRUCT, V18, P289, DOI 10.1016/j.marstruc.2005.09.003; Kalra R, 2005, OCEAN ENG, V32, P1917, DOI 10.1016/j.oceaneng.2005.01.007; Karayiannis NB, 2006, IEEE T NEURAL NETWOR, V17, P1222, DOI 10.1109/TNN.2006.877538; Keramitsoglou I, 2005, INT J REMOTE SENS, V26, P1861, DOI 10.1080/01431160512331326594; Keramitsoglou I, 2006, ISPRS J PHOTOGRAMM, V60, P225, DOI 10.1016/j.isprsjprs.2006.01.002; Le Gia QT, 2012, APPL COMPUT HARMON A, V32, P401, DOI 10.1016/j.acha.2011.07.007; Lee S, 2006, IEEE T GEOSCI REMOTE, V44, P1642, DOI 10.1109/TGRS.2006.869984; Li Q, 2011, PROC SPIE, V8286, DOI 10.1117/12.913031; Lu DS, 2004, PHOTOGRAMM ENG REM S, V70, P1053, DOI 10.14358/PERS.70.9.1053; Luo H, 2005, P SPIE INT SOC OPTIC; Luo L, 2010, REMOTE SENS ENVIRON, V114, P1220, DOI 10.1016/j.rse.2010.01.008; McCauley S, 2004, INT J REMOTE SENS, V25, P1077, DOI 10.1080/0143116031000115102; Means JE, 1999, REMOTE SENS ENVIRON, V67, P298, DOI 10.1016/S0034-4257(98)00091-1; Mountrakis G, 2011, REMOTE SENSING ENV; Mountrakis G, 2009, MULTISCALE RADIAL BA; Mountrakis G, 2009, PHOTOGRAMM ENG REM S, V75, P831, DOI 10.14358/PERS.75.7.831; Perry DA, 2008, FOREST ECOSYSTEMS; Rollet R, 1998, INT J REMOTE SENS, V19, P3003, DOI 10.1080/014311698214398; ROY A, 1995, NEURAL NETWORKS, V8, P179, DOI 10.1016/0893-6080(94)00064-S; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; SHIOTANI S, 1995, NEUROCOMPUTING, V9, P111, DOI 10.1016/0925-2312(94)00061-V; Sing JK, 2009, NEURAL COMPUT APPL, V18, P979, DOI 10.1007/s00521-009-0242-6; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Suresh S, 2008, NEUROCOMPUTING, V71, P1345, DOI 10.1016/j.neucom.2007.06.003; Swatantran A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028922; Wei HL, 2007, ADV SPACE RES, V40, P1863, DOI 10.1016/j.asr.2007.02.080; Weng Q., 2011, REMOTE SENSING ENV; Weng QH, 2008, IEEE T GEOSCI REMOTE, V46, P2397, DOI 10.1109/TGRS.2008.917601; Weng QH, 2009, INT J REMOTE SENS, V30, P4807, DOI 10.1080/01431160802665926; Weng QH, 2009, INT J REMOTE SENS, V30, P2547, DOI 10.1080/01431160802552777; West D.C., 1981, FOREST SUCCESSION CO, DOI 10.1007/978-1-4612-5950-3; Xiao RR, 1998, IEEE T GEOSCI REMOTE, V36, P716, DOI 10.1109/36.673664; Xie N, 2003, IEEE T GEOSCI REMOTE, V41, P1491, DOI 10.1109/TGRS.2003.811690; Yang LM, 2003, CAN J REMOTE SENS, V29, P230, DOI 10.5589/m02-098; Yang XJ, 2006, IEEE GEOSCI REMOTE S, V3, P6, DOI 10.1109/LGRS.2005.853929	67	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e40093	10.1371/journal.pone.0040093	http://dx.doi.org/10.1371/journal.pone.0040093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876278	gold, Green Submitted, Green Published			2022-12-27	WOS:000307184700006
J	Prole, DL; Taylor, CW				Prole, David L.; Taylor, Colin W.			Identification and Analysis of Cation Channel Homologues in Human Pathogenic Fungi	PLOS ONE			English	Article							K-ATP CHANNELS; ANTIFUNGAL ANTIBIOTIC CLOTRIMAZOLE; RECTIFYING POTASSIUM CHANNEL; RECEPTOR POTENTIAL CHANNELS; 2 PORE DOMAINS; NEUROSPORA-CRASSA; PLASMA-MEMBRANE; ION CHANNELS; CANDIDA-ALBICANS; CA2+ CHANNEL	Fungi are major causes of human, animal and plant disease. Human fungal infections can be fatal, but there are limited options for therapy, and resistance to commonly used anti-fungal drugs is widespread. The genomes of many fungi have recently been sequenced, allowing identification of proteins that may become targets for novel therapies. We examined the genomes of human fungal pathogens for genes encoding homologues of cation channels, which are prominent drug targets. Many of the fungal genomes examined contain genes encoding homologues of potassium (K+), calcium (Ca2+) and transient receptor potential (Trp) channels, but not sodium (Na+) channels or ligand-gated channels. Some fungal genomes contain multiple genes encoding homologues of K+ and Trp channel subunits, and genes encoding novel homologues of voltage-gated K-v channel subunits are found in Cryptococcus spp. Only a single gene encoding a homologue of a plasma membrane Ca2+ channel was identified in the genome of each pathogenic fungus examined. These homologues are similar to the Cch1 Ca2+ channel of Saccharomyces cerevisiae. The genomes of Aspergillus spp. and Cryptococcus spp., but not those of S. cerevisiae or the other pathogenic fungi examined, also encode homologues of the mitochondrial Ca2+ uniporter (MCU). In contrast to humans, which express many K+, Ca2+ and Trp channels, the genomes of pathogenic fungi encode only very small numbers of K+, Ca2+ and Trp channel homologues. Furthermore, the sequences of fungal K+, Ca2+, Trp and MCU channels differ from those of human channels in regions that suggest differences in regulation and susceptibility to drugs.	[Prole, David L.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	Prole, DL (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	dp350@cam.ac.uk	; Taylor, Colin/G-2447-2010	Prole, David/0000-0003-2782-6665; Taylor, Colin/0000-0001-7771-1044	St. John's College, Cambridge; Wellcome Trust [085295]	St. John's College, Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a Meres senior research associateship from St. John's College, Cambridge (to DLP), and by the Wellcome Trust (grant number 085295, to CWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, CHEST, V135, P805, DOI 10.1378/chest.08-2586; Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; Aide MA, 2009, J BRAS PNEUMOL, V35, P1145, DOI 10.1590/S1806-37132009001100013; Akiyoshi DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000261; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; ALVAREZ J, 1992, J BIOL CHEM, V267, P11789; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; [Anonymous], 2012, OR MULT SEQ PROJ FUN; Baev D, 2003, INFECT IMMUN, V71, P3251, DOI 10.1128/IAI.71.6.3251-3260.2003; Bao L, 2011, AM J PHYSIOL-HEART C, V300, pH262, DOI 10.1152/ajpheart.00857.2010; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BELDE PJM, 1993, FEBS LETT, V323, P113, DOI 10.1016/0014-5793(93)81460-H; Bencina M, 2009, FUNGAL GENET BIOL, V46, pS93, DOI 10.1016/j.fgb.2008.07.019; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bertl A, 2003, MOL MICROBIOL, V47, P767, DOI 10.1046/j.1365-2958.2003.03335.x; Bertl A, 1998, J MEMBRANE BIOL, V162, P67, DOI 10.1007/s002329900343; Binder U, 2010, EUKARYOT CELL, V9, P1374, DOI 10.1128/EC.00050-10; Borchers AT, 2010, AUTOIMMUN REV, V10, P94, DOI 10.1016/j.autrev.2010.08.010; Bormann J, 2009, MICROBIOL-SGM, V155, P3922, DOI 10.1099/mic.0.030825-0; Brand A, 2009, MOL MICROBIOL, V71, P1155, DOI 10.1111/j.1365-2958.2008.06592.x; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; Cai XJ, 2012, PURINERG SIGNAL, V8, P11, DOI 10.1007/s11302-011-9261-8; Cai XJ, 2012, MOL BIOL EVOL, V29, P91, DOI 10.1093/molbev/msr149; CALVERT CM, 1995, J BIOL CHEM, V270, P7272, DOI 10.1074/jbc.270.13.7272; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Cavinder B, 2011, EUKARYOT CELL, V10, P832, DOI 10.1128/EC.00235-10; Chaturvedi V, 2011, TRENDS MICROBIOL, V19, P564, DOI 10.1016/j.tim.2011.07.010; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019257; Cibulsky SM, 2000, J GEN PHYSIOL, V116, P349, DOI 10.1085/jgp.116.3.349; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CORNELIUS G, 1989, BIOCHEM BIOPH RES CO, V162, P852, DOI 10.1016/0006-291X(89)92388-7; Cunningham KW, 2011, CELL CALCIUM, V50, P129, DOI 10.1016/j.ceca.2011.01.010; de Deus A, 2009, J BRAS PNEUMOL, V35, P920, DOI 10.1590/S1806-37132009000900014; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Didier ES, 2011, CURR OPIN INFECT DIS, V24, P490, DOI 10.1097/QCO.0b013e32834aa152; Docampo R, 2012, TRENDS PARASITOL, V28, P31, DOI 10.1016/j.pt.2011.10.007; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; ERMOLAYEVA E, 1995, APPL ENVIRON MICROB, V61, P3385, DOI 10.1128/AEM.61.9.3385-3390.1995; Faguy David M, 2011, Radiol Technol, V82, P321; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Gajdanowicz P, 2011, P NATL ACAD SCI USA, V108, P864, DOI 10.1073/pnas.1009777108; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Geng XH, 2003, DIABETES, V52, P767, DOI 10.2337/diabetes.52.3.767; Gobert A, 2007, P NATL ACAD SCI USA, V104, P10726, DOI 10.1073/pnas.0702595104; Goldstein SAN, 1998, J MOL MED-JMM, V76, P13, DOI 10.1007/s109-1998-8100-0; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Gullo A, 2009, DRUGS, V69, P65, DOI 10.2165/11315530-000000000-00000; Hallstrom TC, 2000, J BIOL CHEM, V275, P37347, DOI 10.1074/jbc.M007338200; Havlickova B, 2008, MYCOSES, V51, P2, DOI 10.1111/j.1439-0507.2008.01606.x; Haynes WJ, 2008, FEBS LETT, V582, P1514, DOI 10.1016/j.febslet.2008.03.046; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Hill K, 2004, N-S ARCH PHARMACOL, V370, P227, DOI 10.1007/s00210-004-0981-y; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hong MP, 2010, J BIOL CHEM, V285, P10951, DOI 10.1074/jbc.M109.056218; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Inoue I, 1996, J DERMATOL SCI, V12, P156, DOI 10.1016/0923-1811(95)00475-0; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kaczorowski GJ, 2008, J GEN PHYSIOL, V131, P399, DOI 10.1085/jgp.200709946; Kaur R, 2004, ANTIMICROB AGENTS CH, V48, P1600, DOI 10.1128/AAC.48.5.1600-1613.2004; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kiselyov K, 2011, CELL CALCIUM, V50, P288, DOI 10.1016/j.ceca.2011.04.009; Kozubowski L, 2009, CELL MICROBIOL, V11, P370, DOI 10.1111/j.1462-5822.2008.01273.x; Kozubowski L, 2012, FEMS MICROBIOL REV, V36, P78, DOI 10.1111/j.1574-6976.2011.00286.x; Kraus R, 1996, J BIOL CHEM, V271, P20113, DOI 10.1074/jbc.271.33.20113; Kronstad JW, 2011, NAT REV MICROBIOL, V9, P193, DOI 10.1038/nrmicro2522; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; LaPlante JM, 2002, FEBS LETT, V532, P183, DOI 10.1016/S0014-5793(02)03670-0; Lesage F, 1996, J BIOL CHEM, V271, P4183; Lew RR, 2009, MICROBIOL-SGM, V155, P903, DOI 10.1099/mic.0.023507-0; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Liu M, 2006, EUKARYOT CELL, V5, P1788, DOI 10.1128/EC.00158-06; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Loukin SH, 1999, BIOPHYS J, V77, P3060, DOI 10.1016/S0006-3495(99)77137-7; Loukin SH, 2005, J GEN PHYSIOL, V125, P521, DOI 10.1085/jgp.200509261; Loukin SH, 2002, P NATL ACAD SCI USA, V99, P1926, DOI 10.1073/pnas.042538599; Lupetti A, 2004, J ANTIMICROB CHEMOTH, V54, P603, DOI 10.1093/jac/dkh385; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Maresova L, 2006, FEMS YEAST RES, V6, P1039, DOI 10.1111/j.1567-1364.2006.00140.x; Marr KA, 2002, INFECT DIS CLIN N AM, V16, P875, DOI 10.1016/S0891-5520(02)00035-1; Martin DC, 2011, J BIOL CHEM, V286, P10744, DOI 10.1074/jbc.M110.177451; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MAZZANTI M, 1990, NATURE, V343, P764, DOI 10.1038/343764a0; McDonough SI, 2002, J GEN PHYSIOL, V119, P313, DOI 10.1085/jgp.20028560; Meseguer V, 2008, J NEUROSCI, V28, P576, DOI 10.1523/JNEUROSCI.4772-07.2008; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Miller C., 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-4-reviews0004.REVIEWS0004, DOI 10.1186/GB-2000-1-4-REVIEWS0004.REVIEWS0004, 10.1186/gb-2000-1-4-reviews0004, DOI 10.1186/GB-2000-1-4-REVIEWS0004]; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Ng KE, 2010, J MEMBRANE BIOL, V234, P137, DOI 10.1007/s00232-010-9241-x; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nosanchuk JD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00021; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Patterson Karen, 2010, Proc Am Thorac Soc, V7, P237, DOI 10.1513/pats.200908-086AL; Peiter E, 2005, FEBS LETT, V579, P5697, DOI 10.1016/j.febslet.2005.09.058; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Peterson BZ, 1996, J BIOL CHEM, V271, P5293, DOI 10.1074/jbc.271.10.5293; Peyretaillade E, 2011, RES MICROBIOL, V162, P598, DOI 10.1016/j.resmic.2011.03.004; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Prole DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032264; Prole DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026218; Quesada I, 2002, P NATL ACAD SCI USA, V99, P9544, DOI 10.1073/pnas.142039299; Remillard CV, 2004, AM J PHYSIOL-LUNG C, V286, pL49, DOI 10.1152/ajplung.00041.2003; Roberts SK, 2003, EUKARYOT CELL, V2, P181, DOI 10.1128/EC.2.1.181-190.2003; Rodrigues AAG, 2000, CURR MICROBIOL, V40, P145, DOI 10.1007/s002849910030; Roller A, 2005, PFLUG ARCH EUR J PHY, V451, P362, DOI 10.1007/s00424-005-1418-2; SALKOFF L, 1995, NEURON, V15, P489, DOI 10.1016/0896-6273(95)90137-X; Sanglard D, 2001, ANTIMICROB AGENTS CH, V45, P1174, DOI 10.1128/AAC.45.4.1174-1183.2001; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; Sesti F, 2003, NAT NEUROSCI, V6, P353, DOI 10.1038/nn1028; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Silverman-Gavrila LB, 2002, J CELL SCI, V115, P5013, DOI 10.1242/jcs.00180; SLAYMAN CL, 1962, SCIENCE, V136, P876, DOI 10.1126/science.136.3519.876; SLAYMAN CL, 1965, J GEN PHYSIOL, V49, P69, DOI 10.1085/jgp.49.1.69; SLAYMAN CL, 1976, BIOCHIM BIOPHYS ACTA, V426, P732, DOI 10.1016/0005-2736(76)90138-3; STRIESSNIG J, 1990, P NATL ACAD SCI USA, V87, P9108, DOI 10.1073/pnas.87.23.9108; Su ZW, 2011, J GEN PHYSIOL, V138, P627, DOI 10.1085/jgp.201110693; Su ZW, 2009, J MEMBRANE BIOL, V227, P141, DOI 10.1007/s00232-009-9153-9; Szewczyk A, 2009, IUBMB LIFE, V61, P134, DOI 10.1002/iub.155; Taylor CW, 2009, BIOCHEMISTRY-US, V48, P12062, DOI 10.1021/bi901739t; Thomas GP, 1999, BRIT J PHARMACOL, V126, P1531, DOI 10.1038/sj.bjp.0702475; Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527; Tian M, 2006, BRIT J PHARMACOL, V147, P289, DOI 10.1038/sj.bjp.0706590; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; URIBE S, 1992, CELL CALCIUM, V13, P211, DOI 10.1016/0143-4160(92)90009-H; VACATA V, 1981, BIOCHIM BIOPHYS ACTA, V643, P265, DOI 10.1016/0005-2736(81)90241-8; VanderHeyden N, 2000, FEMS MICROBIOL LETT, V183, P327, DOI 10.1111/j.1574-6968.2000.tb08979.x; Verret F, 2010, NEW PHYTOL, V187, P23, DOI 10.1111/j.1469-8137.2010.03271.x; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Wheeler GL, 2008, TRENDS PLANT SCI, V13, P506, DOI 10.1016/j.tplants.2008.06.004; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu T, 2011, ANTIMICROB AGENTS CH, V55, P1611, DOI 10.1128/AAC.01022-10; Yamashita M, 2006, FEBS J, V273, P3585, DOI 10.1111/j.1742-4658.2006.05365.x; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Zhang Yong-Qiang, 2010, Virulence, V1, P551, DOI 10.4161/viru.1.6.13802; ZHOU XL, 1995, FEBS LETT, V373, P170, DOI 10.1016/0014-5793(95)01035-D	155	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42404	10.1371/journal.pone.0042404	http://dx.doi.org/10.1371/journal.pone.0042404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876320	Green Submitted, Green Published, gold			2022-12-27	WOS:000307184700048
J	Xu, Q; Xiong, GJ; Li, PB; He, F; Huang, Y; Wang, KB; Li, ZH; Hua, JP				Xu, Qin; Xiong, Guanjun; Li, Pengbo; He, Fei; Huang, Yi; Wang, Kunbo; Li, Zhaohu; Hua, Jinping			Analysis of Complete Nucleotide Sequences of 12 Gossypium Chloroplast Genomes: Origin and Evolution of Allotetraploids	PLOS ONE			English	Article							DISTINCT PLASTID GENOMES; PHYLOGENETIC-RELATIONSHIPS; SUBSECTION OENOTHERA; SUBSTITUTION RATES; COTTON; DIVERGENCE; NUCLEAR; GENE; DIVERSIFICATION; POLYPLOIDY	Background: Cotton (Gossypium spp.) is a model system for the analysis of polyploidization. Although ascertaining the donor species of allotetraploid cotton has been intensively studied, sequence comparison of Gossypium chloroplast genomes is still of interest to understand the mechanisms underlining the evolution of Gossypium allotetraploids, while it is generally accepted that the parents were A-and D-genome containing species. Here we performed a comparative analysis of 13 Gossypium chloroplast genomes, twelve of which are presented here for the first time. Methodology/Principal Findings: The size of 12 chloroplast genomes under study varied from 159,959 bp to 160,433 bp. The chromosomes were highly similar having >98% sequence identity. They encoded the same set of 112 unique genes which occurred in a uniform order with only slightly different boundary junctions. Divergence due to indels as well as substitutions was examined separately for genome, coding and noncoding sequences. The genome divergence was estimated as 0.374% to 0.583% between allotetraploid species and A-genome, and 0.159% to 0.454% within allotetraploids. Forty protein-coding genes were completely identical at the protein level, and 20 intergenic sequences were completely conserved. The 9 allotetraploids shared 5 insertions and 9 deletions in whole genome, and 7-bp substitutions in protein-coding genes. The phylogenetic tree confirmed a close relationship between allotetraploids and the ancestor of A-genome, and the allotetraploids were divided into four separate groups. Progenitor allotetraploid cotton originated 0.43-0.68 million years ago (MYA). Conclusion: Despite high degree of conservation between the Gossypium chloroplast genomes, sequence variations among species could still be detected. Gossypium chloroplast genomes preferred for 5-bp indels and 1-3-bp indels are mainly attributed to the SSR polymorphisms. This study supports that the common ancestor of diploid A-genome species in Gossypium is the maternal source of extant allotetraploid species and allotetraploids have a monophyletic origin. G. hirsutum AD1 lineages have experienced more sequence variations than other allotetraploids in intergenic regions. The available complete nucleotide sequences of 12 Gossypium chloroplast genomes should facilitate studies to uncover the molecular mechanisms of compartmental co-evolution and speciation of Gossypium allotetraploids.	[Xu, Qin; Xiong, Guanjun; Li, Pengbo; Li, Zhaohu; Hua, Jinping] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Li, Pengbo] Shanxi Acad Agr Sci, Inst Cotton, Yuncheng, Peoples R China; [He, Fei] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Huang, Yi] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China; [Wang, Kunbo] Chinese Acad Agr Sci, Cotton Res Inst, Anyang, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shanxi Agricultural University; China Agricultural University; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Xu, Q (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	jinping_hua@cau.edu.cn	FEI, HE/C-5912-2015; Hua, Jinping/L-3221-2019; li, zh/HII-5698-2022	FEI, HE/0000-0002-1165-3248; 	Training Program Foundation for the New Century Excellent Talents in University [NCET-06-0106]; National Natural Science Foundation of China [31171591]	Training Program Foundation for the New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Training Program Foundation for the New Century Excellent Talents in University (NCET-06-0106) and National Natural Science Foundation of China (Grant No. 31171591) to J. Hua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; BALDAUF SL, 1990, NATURE, V344, P262, DOI 10.1038/344262a0; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Britten RJ, 2003, P NATL ACAD SCI USA, V100, P4661, DOI 10.1073/pnas.0330964100; Brubaker CL, 1999, GENOME, V42, P184, DOI 10.1139/gen-42-2-184; Chan CX, 2011, PLANT PHYSIOL, V155, P1552, DOI 10.1104/pp.111.173500; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Chen JQ, 2009, MOL BIOL EVOL, V26, P1523, DOI 10.1093/molbev/msp063; Cronn RC, 1999, P NATL ACAD SCI USA, V96, P14406, DOI 10.1073/pnas.96.25.14406; Cronn RC, 2002, AM J BOT, V89, P707, DOI 10.3732/ajb.89.4.707; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; Flagel LE, 2010, NEW PHYTOL, V186, P184, DOI 10.1111/j.1469-8137.2009.03107.x; Fryxell P.A, 1979, NATURAL HIST COTTON; Gaut BS, 1998, EVOL BIOL, V30, P93; Gong X, 1991, CHINESE SCI BULL, V36, P467; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Greiner S, 2008, MOL BIOL EVOL, V25, P2019, DOI 10.1093/molbev/msn149; Greiner S, 2008, NUCLEIC ACIDS RES, V36, P2366, DOI 10.1093/nar/gkn081; Greiner S, 2011, MOL ECOL, V20, P671, DOI 10.1111/j.1365-294X.2010.04984.x; Grover CE, 2004, GENOME RES, V14, P1474, DOI 10.1101/gr.2673204; Grover CE, 2008, MOL BIOL EVOL, V25, P1415, DOI 10.1093/molbev/msn085; Grover CE, 2007, PLANT J, V50, P995, DOI 10.1111/j.1365-313X.2007.03102.x; GU X, 1995, J MOL EVOL, V40, P464, DOI 10.1007/BF00164032; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Guisinger MM, 2008, P NATL ACAD SCI USA, V105, P18424, DOI 10.1073/pnas.0806759105; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Ibrahim RIH, 2006, GENES GENET SYST, V81, P311, DOI 10.1266/ggs.81.311; Jansen RK, 2011, MOL BIOL EVOL, V28, P835, DOI 10.1093/molbev/msq261; Lee SB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-61; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; Leseberg CH, 2009, J MOL EVOL, V69, P311, DOI 10.1007/s00239-009-9275-9; LI WH, 1987, NATURE, V326, P93, DOI 10.1038/326093a0; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Matsuoka Y, 2002, MOL BIOL EVOL, V19, P2084, DOI 10.1093/oxfordjournals.molbev.a004033; McCluskey K, 2011, G3-GENES GENOM GENET, V1, P303, DOI 10.1534/g3.111.000307; Muse SV, 2000, PLANT MOL BIOL, V42, P25, DOI 10.1023/A:1006319803002; Ogihara Y, 2002, MOL GENET GENOMICS, V266, P740, DOI 10.1007/s00438-001-0606-9; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; Seelanan T, 1997, SYST BOT, V22, P259, DOI 10.2307/2419457; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Small RL, 1998, AM J BOT, V85, P1301, DOI 10.2307/2446640; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Stoletzki N, 2011, MOL BIOL EVOL, V28, P1371, DOI 10.1093/molbev/msq320; Sugiura C, 2003, NUCLEIC ACIDS RES, V31, P5324, DOI 10.1093/nar/gkg726; TAJIMA F, 1993, GENETICS, V135, P599; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turmel M, 2009, MOL BIOL EVOL, V26, P2317, DOI 10.1093/molbev/msp138; Turmel M, 2009, MOL BIOL EVOL, V26, P631, DOI 10.1093/molbev/msn285; Vallender EJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-168; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; WENDEL JF, 1994, PLANT SYST EVOL, V192, P49, DOI 10.1007/BF00985907; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Wendel JF, 2010, PHYSIOLOGY OF COTTON, P1, DOI 10.1007/978-90-481-3195-2_1; Wu FH, 2009, TREE PHYSIOL, V29, P847, DOI 10.1093/treephys/tpp015; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yamane K, 2006, DNA RES, V13, P197, DOI 10.1093/dnares/dsl012; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	69	54	57	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e37128	10.1371/journal.pone.0037128	http://dx.doi.org/10.1371/journal.pone.0037128			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876273	Green Published, Green Submitted, gold			2022-12-27	WOS:000307184700001
J	Cohen, JM; Fagin, AP; Hariton, E; Niska, JR; Pierce, MW; Kuriyama, A; Whelan, JS; Jackson, JL; Dimitrakoff, JD				Cohen, Jeffrey M.; Fagin, Adam P.; Hariton, Eduardo; Niska, Joshua R.; Pierce, Michael W.; Kuriyama, Akira; Whelan, Julia S.; Jackson, Jeffrey L.; Dimitrakoff, Jordan D.			Therapeutic Intervention for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS): A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PLACEBO-CONTROLLED MULTICENTER; SYNDROME CATEGORY IIIA; DOUBLE-BLIND; TERAZOSIN THERAPY; CLINICAL-TRIALS; MEN; SYMPTOMS; TAMSULOSIN; LEVOFLOXACIN; FINASTERIDE	Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has been treated with several different interventions with limited success. This meta-analysis aims to review all trials reporting on therapeutic intervention for CP/CPPS using the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI). Methods: We searched Medline, PubMed, the Cochrane Pain, Palliative & Supportive Care Trials, the Cochrane Register of Controlled Trials, CINAHL, ClinicalTrials.gov, and the NIDDK website between 1947 and December 31, 2011 without language or study type restrictions. All RCTs for CP/CPPS lasting at least 6 weeks, with a minimum of 10 participants per arm, and using the NIH-CPSI score, the criterion standard for CP/CPPS, as an outcome measure were included. Data was extracted from each study by two independent reviewers. Gillbraith and I-squared plots were used for heterogeneity testing and Eggers and Peters methods for publication bias. Quality was assessed using a component approach and meta-regression was used to analyze sources of heterogeneity. Results: Mepartricin, percutaneous tibial nerve stimulation (PTNS), and triple therapy comprised of doxazosin + ibuprofen + thiocolchicoside (DIT) resulted in clinically and statistically significant reduction in NIH-CPSI total score. The same agents and aerobic exercise resulted in clinically and statistically significant NIH-CPSI pain domain score reduction. Acupuncture, DIT, and PTNS were found to produce statistically and clinically significant reductions in the NIH-CPSI voiding domain. A statistically significant placebo effect was found for all outcomes and time analysis showed that efficacy of all treatments increased over time. Alpha-blockers, antibiotics, and combinations of the two failed to show statistically or clinically significant NIH-CPSI reductions. Conclusion: Results from this meta-analysis reflect our current inability to effectively manage CP/CPPS. Clinicians and researchers must consider placebo effect and treatment efficacy over time and design studies creatively so we can more fully elucidate the etiology and role of therapeutic intervention in CP/CPPS.	[Cohen, Jeffrey M.; Hariton, Eduardo; Niska, Joshua R.; Pierce, Michael W.; Whelan, Julia S.; Dimitrakoff, Jordan D.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Dimitrakoff, Jordan D.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Fagin, Adam P.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Jackson, Jeffrey L.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Kuriyama, Akira] Kurashiki Cent Hosp, Okayama, Japan	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard School of Dental Medicine; Medical College of Wisconsin; Kurashiki Central Hospital	Cohen, JM (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.	jordan.dimitrakoff@gmail.com	Jackson, Jeffrey/AAA-3519-2019; Dimitrakov, Jordan D/A-9115-2008	Niska, Joshua/0000-0001-5751-2806; Jackson, Jeffrey/0000-0002-9820-5834; Whelan, Julia/0000-0002-4014-1954; Dimitrakoff, Jordan/0000-0001-6827-1382				Alexander RB, 2004, ANN INTERN MED, V141, P581, DOI 10.7326/0003-4819-141-8-200410190-00005; Anothaisintawee T, 2011, JAMA-J AM MED ASSOC, V305, P78, DOI 10.1001/jama.2010.1913; Cheah PY, 2003, J UROLOGY, V169, P592, DOI 10.1016/S0022-5347(05)63960-2; 정연환, 2006, Investigative and Clinical Urology, V47, P1191; Collins MM, 2000, ANN INTERN MED, V133, P367, DOI 10.7326/0003-4819-133-5-200009050-00013; De Rose AF, 2004, UROLOGY, V63, P13, DOI 10.1016/j.urology.2003.08.006; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engeler D, 2012, GUIDELINES CHRONIC P; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Giubilei G, 2007, J UROLOGY, V177, P159, DOI 10.1016/j.juro.2006.08.107; Higgins J.P.T., 2021, COCHRANE HDB SYSTEMA, V6.2 ed; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; 차우헌, 2009, Investigative and Clinical Urology, V50, P148; Jackson JL, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5222; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jeong CW, 2008, UROL INT, V80, P157, DOI 10.1159/000112606; Kabay S, 2009, UROL INT, V83, P33, DOI 10.1159/000224865; Kaplan SA, 2004, J UROLOGY, V171, P284, DOI 10.1097/01.ju.0000101487.83730.80; Kaptchuk TJ, 2001, J CLIN EPIDEMIOL, V54, P541, DOI 10.1016/S0895-4356(00)00347-4; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Kusek J, 2008, STRATEGIES IMPROVING, P248; Lee CB, 2006, WORLD J UROL, V24, P55, DOI 10.1007/s00345-005-0039-x; Lee SWH, 2008, UROLOGY, V71, P79, DOI 10.1016/j.urology.2007.08.043; Li Bo, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P251; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; Mehik A, 2003, UROLOGY, V62, P425, DOI 10.1016/S0090-4295(03)00466-7; Moher David, 2009, Open Med, V3, pe123; Morgia G, 2010, UROL INT, V84, P400, DOI 10.1159/000302716; Nickel JC, 2011, J UROLOGY, V186, P125, DOI 10.1016/j.juro.2011.03.028; Nickel JC, 2008, NEW ENGL J MED, V359, P2663, DOI 10.1056/NEJMoa0803240; Nickel JC, 2005, J UROLOGY, V173, P1252, DOI 10.1097/01.ju.0000159198.83103.01; Nickel JC, 2004, BJU INT, V93, P991, DOI 10.1111/j.1464-410X.2003.04766.x; Nickel JC, 2004, J UROLOGY, V171, P1594, DOI 10.1097/01.ju.0000117811.40279.19; Nickel JC, 2003, UROLOGY, V62, P614, DOI 10.1016/S0090-4295(03)00583-1; Nickel JC, 2003, J UROLOGY, V169, P1401, DOI 10.1097/01.ju.0000054983.45096.16; Nickel JC, 2002, BJU INT, V90, P678, DOI 10.1046/j.1464-410X.2002.03007.x; Nickel JC, 2001, J UROLOGY, V165, P842, DOI 10.1016/S0022-5347(05)66541-X; Paick JS, 2006, PROSTATE CANCER P D, V9, P261, DOI 10.1038/sj.pcan.4500881; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pontari MA, 2010, ARCH INTERN MED, V170, P1586, DOI 10.1001/archinternmed.2010.319; Propert KJ, 2002, UROLOGY, V59, P870, DOI 10.1016/S0090-4295(02)01601-1; Sharp S, 1998, STATA TECH B, V7, DOI DOI 10.1002/SIM.1187/FULL); Shen Shu-lin, 2006, Zhonghua Nan Ke Xue, V12, P851; Shoskes DA, 2009, UROLOGY, V73, P538, DOI 10.1016/j.urology.2008.09.074; Sivkov A. V., 2005, Urologiya (Moscow), P47; [谭育红 Tan Yuhong], 2009, [中国男科学杂志, Chinese Journal of Andrology], V23, P44; Tugcu V, 2007, EUR UROL, V51, P1113, DOI 10.1016/j.eururo.2006.09.036; Turner JA, 2004, J UROLOGY, V172, P538, DOI 10.1097/01.ju.0000132797.63480.44; Wagenlehner FME, 2009, EUR UROL, V56, P544, DOI 10.1016/j.eururo.2009.05.046; Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319; Ye ZQ, 2008, J INT MED RES, V36, P244, DOI 10.1177/147323000803600205; Youn CW, 2008, KOREAN J UROL, V49, P72, DOI 10.4111/kju.2008.49.1.72; Zeng Xiaoyong, 2004, Zhonghua Nan Ke Xue, V10, P278; Zhao WP, 2009, BRAZ J MED BIOL RES, V42, P963, DOI 10.1590/S0100-879X2009005000021; Zhou ZS, 2008, UROLOGY, V71, P1091, DOI 10.1016/j.urology.2008.02.041; Ziaee Amir M., 2006, Int. braz j urol., V32, P181, DOI 10.1590/S1677-55382006000200008; Zimmermann R, 2009, EUR UROL, V56, P418, DOI 10.1016/j.eururo.2009.03.043	61	68	80	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41941	10.1371/journal.pone.0041941	http://dx.doi.org/10.1371/journal.pone.0041941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870266	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800045
J	Gallo, ND; Jeffery, WR				Gallo, Natalya D.; Jeffery, William R.			Evolution of Space Dependent Growth in the Teleost Astyanax mexicanus	PLOS ONE			English	Article							JUVENILE RAINBOW-TROUT; CAVE FISH; REGRESSIVE EVOLUTION; EYE DEGENERATION; STOCKING DENSITY; STRESS-RESPONSE; CORTISOL; COMPENSATION; CONSEQUENCES; POPULATIONS	The relationship between growth rate and environmental space is an unresolved issue in teleosts. While it is known from aquaculture studies that stocking density has a negative relationship to growth, the underlying mechanisms have not been elucidated, primarily because the growth rate of populations rather than individual fish were the subject of all previous studies. Here we investigate this problem in the teleost Astyanax mexicanus, which consists of a sighted surface-dwelling form (surface fish) and several blind cave-dwelling (cavefish) forms. Surface fish and cavefish are distinguished by living in spatially contrasting environments and therefore are excellent models to study the effects of environmental size on growth. Multiple controlled growth experiments with individual fish raised in confined or unconfined spaces showed that environmental size has a major impact on growth rate in surface fish, a trait we have termed space dependent growth (SDG). In contrast, SDG has regressed to different degrees in the Pachon and Tinaja populations of cavefish. Mating experiments between surface and Pachon cavefish show that SDG is inherited as a dominant trait and is controlled by multiple genetic factors. Despite its regression in blind cavefish, SDG is not affected when sighted surface fish are raised in darkness, indicating that vision is not required to perceive and react to environmental space. Analysis of plasma cortisol levels showed that an elevation above basal levels occurred soon after surface fish were exposed to confined space. This initial cortisol peak was absent in Pachon cavefish, suggesting that the effects of confined space on growth may be mediated partly through a stress response. We conclude that Astyanax reacts to confined spaces by exhibiting SDG, which has a genetic component and shows evolutionary regression during adaptation of cavefish to confined environments.	[Gallo, Natalya D.; Jeffery, William R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Gallo, ND (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	Jeffery@umd.edu	Gallo, Natalya/V-7734-2019		National Science Foundation [IBN-052384]; National Institutes of Health [R01-EYE014619]; Udall Fellowship; NATIONAL EYE INSTITUTE [R01EY014619] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Udall Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Science Foundation (IBN-052384) and National Institutes of Health (R01-EYE014619) grants to WRJ supported the research. NDG acknowledges support by a Udall Fellowship while conducting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad TA, 2000, AQUAC RES, V31, P603, DOI 10.1046/j.1365-2109.2000.00479.x; BARTON BA, 1987, DIS AQUAT ORGAN, V2, P173; Bernier NJ, 2001, COMP BIOCHEM PHYS B, V129, P639, DOI 10.1016/S1096-4959(01)00360-8; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Borowsky R, 2002, J HERED, V93, P19, DOI 10.1093/jhered/93.1.19; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; Costas B, 2008, AQUAC RES, V39, P1, DOI 10.1111/j.1365-2109.2007.01845.x; Dorn LD, 2007, ANN CLIN BIOCHEM, V44, P281, DOI 10.1258/000456307780480954; Duboue ER, 2011, CURR BIOL, V21, P671, DOI 10.1016/j.cub.2011.03.020; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Gregory TR, 1999, PHYSIOL BIOCHEM ZOOL, V72, P286, DOI 10.1086/316673; Herrera M, 2009, AQUAC RES, V40, P790, DOI 10.1111/j.1365-2109.2008.02162.x; Hofmann HA, 1999, P NATL ACAD SCI USA, V96, P14171, DOI 10.1073/pnas.96.24.14171; Huang WB, 1997, AQUAC RES, V28, P165; Iguchi K, 2003, AQUACULTURE, V220, P515, DOI 10.1016/S0044-8486(02)00626-9; Jeffery WR, 2009, ANNU REV GENET, V43, P25, DOI 10.1146/annurev-genet-102108-134216; Jeffery WR, 2005, J HERED, V96, P185, DOI 10.1093/jhered/esi028; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; Jeffery WR, 2000, DEV GENES EVOL, V210, P223, DOI 10.1007/s004270050308; JOBLING M, 1986, J FISH BIOL, V28, P379, DOI 10.1111/j.1095-8649.1986.tb05174.x; Langecker T.G., 1991, Ichthyological Exploration of Freshwaters, V2, P209; Menuet A, 2007, DEVELOPMENT, V134, P845, DOI 10.1242/dev.02780; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; MITCHELL RW, 1977, SPEC PUBL MUS TEXAS, V12, P1; Montgomery JC, 2001, ENVIRON BIOL FISH, V62, P87, DOI 10.1023/A:1011873111454; Pankhurst NW, 2000, GEN COMP ENDOCR, V117, P225, DOI 10.1006/gcen.1999.7401; Porter ML, 2007, ACTA CARSOLOGICA, V36, P173; Protas M, WIRES DEV B IN PRESS; Protas M, 2008, EVOL DEV, V10, P196, DOI 10.1111/j.1525-142X.2008.00227.x; Ruane NM, 2003, AQUACULTURE, V218, P685, DOI 10.1016/S0044-8486(02)00422-2; SCHEMMEL CHRISTIAN, 1967, Z MORPHOL TIERE, V61, P255, DOI 10.1007/BF00400988; SIDDIQUI A Q, 1989, Aquaculture and Fisheries Management, V20, P49, DOI 10.1111/j.1365-2109.1989.tb00440.x; Strecker U, 2003, MOL ECOL, V12, P699, DOI 10.1046/j.1365-294X.2003.01753.x; SUMPTER JP, 1986, GEN COMP ENDOCR, V62, P377, DOI 10.1016/0016-6480(86)90047-X; TEYKE T, 1990, BRAIN BEHAV EVOLUT, V35, P23, DOI 10.1159/000115853; Varatharasan N, 2009, DEV DYNAM, V238, P3056, DOI 10.1002/dvdy.22144; Wilkens H, 1988, EVOL BIOL, V23, P271, DOI [10.1007/978-1-4613-1043-3_8, DOI 10.1007/978-1-4613-1043-3_]; Yamamoto Y, 2003, EVOL DEV, V5, P435, DOI 10.1046/j.1525-142X.2003.03050.x; Yamamoto Y, 2009, DEV BIOL, V330, P200, DOI 10.1016/j.ydbio.2009.03.003; Yoshizawa M, 2012, EVOLUTION, V66, P2975, DOI 10.1111/j.1558-5646.2012.01651.x; Yoshizawa Masato, 2011, Communicative & Integrative Biology, V4, P89, DOI 10.4161/cib.4.1.14118; Yoshizawa M, 2010, CURR BIOL, V20, P1631, DOI 10.1016/j.cub.2010.07.017	43	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41443	10.1371/journal.pone.0041443	http://dx.doi.org/10.1371/journal.pone.0041443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870223	Green Published, Green Submitted, gold			2022-12-27	WOS:000307212800020
J	Heinrichsen, ET; Haddad, GG				Heinrichsen, Erilynn T.; Haddad, Gabriel G.			Role of High-Fat Diet in Stress Response of Drosophila	PLOS ONE			English	Article							INTERMITTENT HYPOXIA; INSULIN-RESISTANCE; CONSTANT HYPOXIA; O-2 DEPRIVATION; COLD STRESS; OBESITY; MELANOGASTER; TOLERANCE; INSECTS; METABOLISM	Obesity is associated with many diseases, one of the most common being obstructive sleep apnea (OSA), which in turn leads to blood gas disturbances, including intermittent hypoxia (IH). Obesity, OSA and IH are associated with metabolic changes, and while much mammalian work has been done, mechanisms underlying the response to IH, the role of obesity and the interaction of obesity and hypoxia remain unknown. As a model organism, Drosophila offers tremendous power to study a specific phenotype and, at a subsequent stage, to uncover and study fundamental mechanisms, given the conservation of molecular pathways. Herein, we characterize the phenotype of Drosophila on a high-fat diet in normoxia, IH and constant hypoxia (CH) using triglyceride and glucose levels, response to stress and lifespan. We found that female flies on a high-fat diet show increased triglyceride levels (p<0.001) and a shortened lifespan in normoxia, IH and CH. Furthermore, flies on a high-fat diet in normoxia and CH show diminished tolerance to stress, with decreased survival after exposure to extreme cold or anoxia (p<0.001). Of interest, IH seems to rescue this decreased cold tolerance, as flies on a high-fat diet almost completely recovered from cold stress following IH. We conclude that the cross talk between hypoxia and a high-fat diet can be either deleterious or compensatory, depending on the nature of the hypoxic treatment.	[Heinrichsen, Erilynn T.; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA; [Heinrichsen, Erilynn T.; Haddad, Gabriel G.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Rady Childrens Hosp, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Heinrichsen, ET (corresponding author), Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA.	ghaddad@ucsd.edu			National Institutes of Health (NIH) [PO1 HL098053]; National Institute of General Medical Sciences [T32 GM008666]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524, T32GM008666] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institutes of Health (NIH) grant PO1 HL098053 and in part by the UCSD Genetics Training Program through an institutional training grant from the National Institute of General Medical Sciences, T32 GM008666. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurora RN, 2007, SLEEP MED CLIN, V2, P237, DOI 10.1016/j.jsmc.2007.03.006; Azad P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005371; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Bross TG, 2005, AGING CELL, V4, P309, DOI 10.1111/j.1474-9726.2005.00181.x; BURTON V, 1988, MOL CELL BIOL, V8, P3550, DOI 10.1128/MCB.8.8.3550; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Chen QF, 2002, J BIOL CHEM, V277, P3274, DOI 10.1074/jbc.M109479200; Clark MS, 2008, J COMP PHYSIOL B, V178, P917, DOI 10.1007/s00360-008-0286-4; Colinet H, 2010, INSECT BIOCHEM MOLEC, V40, P425, DOI 10.1016/j.ibmb.2010.03.002; Colinet H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010925; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Douglas RM, 2007, AM J PHYSIOL-REG I, V292, pR1254, DOI 10.1152/ajpregu.00404.2006; Farahani R, 2008, PEDIATR PULM, V43, P20, DOI 10.1002/ppul.20729; Feala JD, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-91; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Huang H, 2007, PHYSIOL GENOMICS, V29, P260, DOI 10.1152/physiolgenomics.00166.2006; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Johnson TE, 1996, J GERONTOL A-BIOL, V51, pB392, DOI 10.1093/gerona/51A.6.B392; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kanaan A, 2006, AM J PHYSIOL-REG I, V290, pR1105, DOI 10.1152/ajpregu.00535.2005; Li JG, 2005, CIRC RES, V97, P698, DOI 10.1161/01.RES.0000183879.60089.a9; MacMillan HA, 2011, J INSECT PHYSIOL, V57, P12, DOI 10.1016/j.jinsphys.2010.10.004; O'Brien PE, 2002, AM J SURG, V184, p4S, DOI 10.1016/S0002-9610(02)01172-8; Oltmanns KM, 2004, AM J RESP CRIT CARE, V169, P1231, DOI 10.1164/rccm.200308-1200OC; Polotsky VY, 2003, J PHYSIOL-LONDON, V552, P253, DOI 10.1113/jphysiol.2003.048173; Prabhakar NR, 2001, AM J PHYSIOL-LUNG C, V281, pL524, DOI 10.1152/ajplung.2001.281.3.L524; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; Row BW, 2003, AM J RESP CRIT CARE, V167, P1548, DOI 10.1164/rccm.200209-1050OC; Shuldiner AR, 2001, NEW ENGL J MED, V345, P1345, DOI 10.1056/NEJM200111013451814; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221	39	41	43	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42587	10.1371/journal.pone.0042587	http://dx.doi.org/10.1371/journal.pone.0042587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870336	Green Published, Green Submitted, gold			2022-12-27	WOS:000307212800099
J	Van, VQ; Baba, N; Rubio, M; Wakahara, K; Panzini, B; Richard, C; Soucy, G; Franchimont, D; Fortin, G; Torres, ACM; Cabon, L; Susin, S; Sarfati, M				Vu Quang Van; Baba, Nobuyasu; Rubio, Manuel; Wakahara, Keiko; Panzini, Benoit; Richard, Carole; Soucy, Genevieve; Franchimont, Denis; Fortin, Genevieve; Torres, Ana Carolina Martinez; Cabon, Lauriane; Susin, Santos; Sarfati, Marika			CD47(Low) Status on CD4 Effectors Is Necessary for the Contraction/Resolution of the Immune Response in Humans and Mice	PLOS ONE			English	Article							INTEGRIN-ASSOCIATED PROTEIN; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; MEMBRANE-SPANNING DOMAINS; RED-BLOOD-CELLS; MEMORY T-CELLS; APOPTOTIC CELLS; LIGAND-BINDING; DENDRITIC CELL; SIRP-ALPHA; THROMBOSPONDIN	How do effector CD4 T cells escape cell death during the contraction of the immune response (IR) remain largely unknown. CD47, through interactions with thrombospondin-1 (TSP-1) and SIRP-alpha, is implicated in cell death and phagocytosis of malignant cells. Here, we reported a reduction in SIRP-alpha-Fc binding to effector memory T cells (T-EM) and in vitro TCR-activated human CD4 T cells that was linked to TSP-1/CD47-induced cell death. The reduced SIRP-alpha-Fc binding (CD47(low) status) was not detected when CD4 T cells were stained with two anti-CD47 mAbs, which recognize distinct epitopes. In contrast, increased SIRP-alpha-Fc binding (CD47(high) status) marked central memory T cells (T-CM) as well as activated CD4 T cells exposed to IL-2, and correlated with resistance to TSP-1/CD47-mediated killing. Auto aggressive CD4 effectors, which accumulated in lymph nodes and at mucosal sites of patients with Crohn's disease, displayed a CD47(high) status despite a high level of TSP-1 release in colonic tissues. In mice, CD47 (CD47(low) status) was required on antigen (Ag)-specific CD4 effectors for the contraction of the IR in vivo, as significantly lower numbers of Ag-specific CD47(+/+) CD4 T cells were recovered when compared to Ag-specific CD47(-/-) CD4 T cells. In conclusion, we demonstrate that a transient change in the status of CD47, i.e. from CD47(high) to CD47(low), on CD4 effectors regulates the decision-making process that leads to CD47-mediated cell death and contraction of the IR while maintenance of a CD47(high) status on tissue-destructive CD4 effectors prevents the resolution of the inflammatory response.	[Vu Quang Van; Baba, Nobuyasu; Rubio, Manuel; Wakahara, Keiko; Sarfati, Marika] Univ Montreal, Notre Dame Hosp, Immunoregulat Lab, CRCHUM, Montreal, PQ H3C 3J7, Canada; [Panzini, Benoit] Univ Montreal, Notre Dame Hosp, Dept Gastroenterol, CHUM, Montreal, PQ H3C 3J7, Canada; [Richard, Carole] Univ Montreal, Notre Dame Hosp, Dept Digest Tract Surg, CHUM, Montreal, PQ H3C 3J7, Canada; [Soucy, Genevieve] Univ Montreal, Notre Dame Hosp, Dept Pathol, CHUM, Montreal, PQ H3C 3J7, Canada; [Franchimont, Denis] Univ Libre Bruxelles, Dept Gastroenterol, Erasme Hosp, Brussels, Belgium; [Fortin, Genevieve] McGill Univ, Res Inst, McGill Univ Hlth Ctr, Montreal, PQ, Canada; [Torres, Ana Carolina Martinez; Cabon, Lauriane; Susin, Santos] Ctr Rech Cordeliers, INSERM U872, Mort Cellulaire Programmee & Physiopathol Cellule, Equipe 19, Paris, France; [Torres, Ana Carolina Martinez; Cabon, Lauriane; Susin, Santos] Sorbonne Univ, Univ Paris 06, UMRS 872, Paris, France; [Torres, Ana Carolina Martinez; Cabon, Lauriane; Susin, Santos] Univ Paris 05, Paris, France	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite Libre de Bruxelles; Vrije Universiteit Brussel; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Van, VQ (corresponding author), Univ Montreal, Notre Dame Hosp, Immunoregulat Lab, CRCHUM, Montreal, PQ H3C 3J7, Canada.	m.sarfati@umontreal.ca	Martínez-Torres, Ana Carolina/C-1845-2015; WAKAHARA, Keiko/I-7324-2014; Torres, Ana C Martinez/AAV-8106-2021; Susin, Santos A/Q-6754-2017; Martinez-Torres, Ana Carolina/GLQ-6047-2022; Baba, Nobuyasu/AAF-8593-2019	Martínez-Torres, Ana Carolina/0000-0002-6183-0089; Susin, Santos A/0000-0002-3366-1628; Martinez-Torres, Ana Carolina/0000-0002-6183-0089; Baba, Nobuyasu/0000-0001-9945-080X	Canadian Institutes of Health Research - CIHR [MOP-102562]; Crohn's and Colitis Foundation of Canada	Canadian Institutes of Health Research - CIHR(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Foundation of Canada	This work was supported by Canadian Institutes of Health Research - CIHR (no MOP-102562) and Crohn's and Colitis Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Avice MN, 2001, J IMMUNOL, V167, P2459, DOI 10.4049/jimmunol.167.5.2459; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Bouguermouh S, 2008, J IMMUNOL, V180, P8073, DOI 10.4049/jimmunol.180.12.8073; Bras M, 2007, MOL CELL BIOL, V27, P7073, DOI 10.1128/MCB.02116-06; Brittain JE, 2001, BLOOD, V97, P2159, DOI 10.1182/blood.V97.7.2159; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Burger P, 2012, BLOOD; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Choi Y, 1999, CLIN IMMUNOL, V93, P34, DOI 10.1006/clim.1999.4767; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Floquet N, 2008, ARCH BIOCHEM BIOPHYS, V478, P103, DOI 10.1016/j.abb.2008.07.015; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gerlach C, 2011, ANN NY ACAD SCI, V1217, P139, DOI 10.1111/j.1749-6632.2010.05830.x; Green JM, 1999, J CELL BIOL, V146, P673, DOI 10.1083/jcb.146.3.673; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kameyama K, 2010, EUR J IMMUNOL; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Krysko DV, 2006, APOPTOSIS, V11, P1709, DOI 10.1007/s10495-006-9527-8; Lamy L, 2003, J BIOL CHEM, V278, P23915, DOI 10.1074/jbc.M301869200; Lamy L, 2007, J IMMUNOL, V178, P5930, DOI 10.4049/jimmunol.178.9.5930; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Li SS, 2006, BLOOD, V108, P3112, DOI 10.1182/blood-2006-04-016832; LINDBERG FP, 1993, J CELL BIOL, V123, P485, DOI 10.1083/jcb.123.2.485; Manna PP, 2005, J BIOL CHEM, V280, P29637, DOI 10.1074/jbc.M500922200; Mateo V, 1999, NAT MED, V5, P1277, DOI 10.1038/15233; Mateo W, 2002, BLOOD, V100, P2882, DOI 10.1182/blood-2001-12-0217; Nagata S, 1998, J HUM GENET, V43, P2, DOI 10.1007/s100380050029; Nussbaum AK, 2004, J IMMUNOL, V173, P6611, DOI 10.4049/jimmunol.173.11.6611; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Osborne LC, 2010, CYTOKINE, V50, P105, DOI 10.1016/j.cyto.2009.09.008; Pettersen RD, 1999, J IMMUNOL, V162, P7031; Ramaswamy M, 2010, CELL DEATH DIFFER; Raymond M, 2012, J IMMUNOLOGY; Raymond M, 2009, J ALLERGY CLIN IMMUN, V124, P1333, DOI 10.1016/j.jaci.2009.07.021; Rebres RA, 2001, J BIOL CHEM, V276, P34607, DOI 10.1074/jbc.M106107200; Rebres RA, 2001, J BIOL CHEM, V276, P7672, DOI 10.1074/jbc.M008858200; REN Y, 1995, J IMMUNOL, V154, P2366; ROSALES C, 1992, J IMMUNOL, V149, P2759; Sarfati M, 2008, CURR DRUG TARGETS, V9, P842, DOI 10.2174/138945008785909310; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Subramanian S, 2007, J BIOL CHEM, V282, P1805, DOI 10.1074/jbc.M603923200; Tada K, 2003, J IMMUNOL, V171, P5718, DOI 10.4049/jimmunol.171.11.5718; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Van VQ, 2008, J IMMUNOL, V181, P5204, DOI 10.4049/jimmunol.181.8.5204; Wang H, 2007, P NATL ACAD SCI USA, V104, P13744, DOI 10.1073/pnas.0702881104; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365	53	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41972	10.1371/journal.pone.0041972	http://dx.doi.org/10.1371/journal.pone.0041972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870271	Green Published, Green Submitted, gold			2022-12-27	WOS:000307212800047
J	Wu, XH; Zhang, QF; Wang, XJ; Zhu, JY; Xu, KF; Okada, H; Wang, RN; Woo, M				Wu, Xiaohong; Zhang, Qinfeng; Wang, Xiaojing; Zhu, Jiayu; Xu, Kuangfeng; Okada, Hitoshi; Wang, Rennian; Woo, Minna			Survivin Is Required for Beta-Cell Mass Expansion in the Pancreatic Duct-Ligated Mouse Model	PLOS ONE			English	Article							DEVELOPMENTALLY-REGULATED EXPRESSION; FOXM1 TRANSCRIPTION FACTOR; ANTI-APOPTOSIS GENE; DIFFERENTIATION; CANCER; GROWTH; MICE; PROLIFERATION; MAINTENANCE; PROGENITORS	Aims/Hypothesis: Pancreatic beta-cell mass expands through adulthood under certain conditions. The related molecular mechanisms are elusive. This study was designed to determine whether surviving (also known as Birc5), which is transiently expressed perinatally in islets, was required for beta-cell mass expansion in the pancreatic duct-ligated mouse model. Methods: Mice with beta cell-specific deletion of survivin (RIPCre(+) survivin(fl/fl)) and their control littermates (RIPCre(+) survivin(+/+)) were examined to determine the essential role of survivin in partial pancreatic duct ligation (PDL)-induced beta-cell proliferation, function and survival. Results: Resurgence of survivin expression occurred as early as day 3 post-PDL. By day 7 post-PDL, control mice showed significant expansion of beta-cell mass and increase in beta-cell proliferation and islet number in the ligated tail of the pancreas. However, mice deficient in beta-cell survivin showed a defect in beta-cell mass expansion and proliferation with a marked attenuation in the increase of total islet number, largely due to an impairment in the increase in number of larger islets while sparing the increase in number of small islets in the ligated tail of pancreas, resulting in insufficient insulin secretion and glucose intolerance. Importantly however, beta cell neogenesis and apoptosis were not affected by the absence of survivin in beta cells after PDL. Conclusions/Interpretation: Our results indicate that survivin is essential for beta-cell mass expansion after PDL. Survivin appears to exhibit a preferential requirement for proliferation of preexisting beta cells.	[Wu, Xiaohong; Zhang, Qinfeng; Wang, Xiaojing; Zhu, Jiayu; Xu, Kuangfeng] Nanjing Med Univ, Dept Endocrinol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Okada, Hitoshi] Ontario Canc Inst, Div Signaling Biol, Toronto, ON M4X 1K9, Canada; [Wang, Rennian] Univ Western Ontario, Dept Physiol & Pharmacol, Childrens Hlth Res Inst, London, ON, Canada; [Woo, Minna] Toronto Gen Res Inst, Toronto, ON, Canada; [Woo, Minna] Univ Toronto, Dept Med & Med Biophys, Toronto, ON, Canada; [Woo, Minna] St Michaels Hosp, Div Endocrinol, Toronto, ON M5B 1W8, Canada; [Woo, Minna] St Michaels Hosp, Keenan Res Ctr, Li KaShing Knowledge Inst, Toronto, ON M5B 1W8, Canada	Nanjing Medical University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Wu, XH (corresponding author), Nanjing Med Univ, Dept Endocrinol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	drxhwu@njmu.edu.cn	Wang, Rennian/N-3879-2015	Wu, Xiaohong/0000-0001-5984-3342	National Natural Science Foundation of China [30971404/C140406, 81070621/H0704]; Scientific Research Foundation for the Returned Overseas Chinese Scholars; State Human Resource Ministry; State Education Ministry; International Science and Technology Cooperation Plan - the Key National and Regional Research and Development Cooperation Projects [BZ2011042]; Jiangsu Government Scholarship for Overseas Studies; Canadian Institutes of Health Research [MOP-201188, MOP-191501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Human Resource Ministry; State Education Ministry; International Science and Technology Cooperation Plan - the Key National and Regional Research and Development Cooperation Projects; Jiangsu Government Scholarship for Overseas Studies; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants to X. Wu from the National Natural Science Foundation of China (30971404/C140406 and 81070621/H0704), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Human Resource Ministry and State Education Ministry, International Science and Technology Cooperation Plan - the Key National and Regional Research and Development Cooperation Projects (BZ2011042) and the Jiangsu Government Scholarship for Overseas Studies. MW was supported by grants from the Canadian Institutes of Health Research (MOP-201188 and MOP-191501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Adida C, 1998, AM J PATHOL, V152, P43; Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Amrani A, 1998, ENDOCRINOLOGY, V139, P1115, DOI 10.1210/en.139.3.1115; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; EFRAT S, 1991, ENDOCRINOLOGY, V128, P897, DOI 10.1210/endo-128-2-897; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Geisler JG, 2002, DIABETES, V51, P2158, DOI 10.2337/diabetes.51.7.2158; Gianani R, 2010, DIABETOLOGIA, V53, P690, DOI 10.1007/s00125-009-1642-y; Hasel C, 2005, LAB INVEST, V85, P1263, DOI 10.1038/labinvest.3700323; Jiang Y, 2008, DIABETES, V57, P2718, DOI 10.2337/db08-0170; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Liggins C, 2003, PEDIATR DEVEL PATHOL, V6, P392, DOI 10.1007/s10024-003-2014-0; Misfeldt AA, 2008, DIABETES, V57, P3069, DOI 10.2337/db08-0878; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Nguyen KTT, 2006, MOL CELL BIOL, V26, P4511, DOI 10.1128/MCB.00238-06; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Wang LY, 2010, DIABETES, V59, P3117, DOI 10.2337/db09-1805; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; Wu X, 2009, DIABETOLOGIA, V52, P2130, DOI 10.1007/s00125-009-1469-6; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang HJ, 2006, MOL ENDOCRINOL, V20, P1853, DOI 10.1210/me.2006-0056; Zwerts F, 2007, BLOOD, V109, P4742, DOI 10.1182/blood-2006-06-028068	36	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41976	10.1371/journal.pone.0041976	http://dx.doi.org/10.1371/journal.pone.0041976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870272	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800048
J	Anteby, M; Garip, F; Martorana, PV; Lozanoff, S				Anteby, Michel; Garip, Filiz; Martorana, Paul V.; Lozanoff, Scott			Individuals' Decision to Co-Donate or Donate Alone: An Archival Study of Married Whole Body Donors in Hawaii	PLOS ONE			English	Article								Background: Human cadavers are crucial to numerous aspects of health care, including initial and continuing training of medical doctors and advancement of medical research. Concerns have periodically been raised about the limited number of whole body donations. Little is known, however, about a unique form of donation, namely co-donations or instances when married individuals decide to register at the same time as their spouse as whole body donors. Our study aims to determine the extent of whole body co-donation and individual factors that might influence co-donation. Methods and Findings: We reviewed all records of registrants to the University of Hawaii Medical School's whole body donation program from 1967 through 2006 to identify married registrants. We then examined the 806 married individuals' characteristics to understand their decision to register alone or with their spouse. We found that married individuals who registered at the same time as their spouse accounted for 38.2 percent of married registrants. Sex differences provided an initial lens to understand co-donation. Wives were more likely to co-donate than to register alone (p = 0.002). Moreover, registrants' main occupational background had a significant effect on co-donations (p = 0.001). Married registrants (regardless of sex) in female-gendered occupations were more likely to co-donate than to donate alone (p = 0.014). Female-gendered occupations were defined as ones in which women represented more than 55 percent of the workforce (e. g., preschool teachers). Thus, variations in donors' occupational backgrounds explained co-donation above and beyond sex differences. Conclusions: Efforts to secure whole body donations have historically focused on individual donations regardless of donors' marital status. More attention needs to be paid, however, to co-donations since they represent a non-trivial number of total donations. Also, targeted outreach efforts to male and female members of female-gendered occupations might prove a successful way to increase donations through co-donations.	[Anteby, Michel] Harvard Univ, Sch Business, Org Behav Area, Boston, MA 02163 USA; [Garip, Filiz] Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA; [Martorana, Paul V.] Wagner Coll, Dept Business Adm, New York, NY USA; [Lozanoff, Scott] Univ Hawaii, Dept Anat Biochem & Physiol, Honolulu, HI 96822 USA	Harvard University; Harvard University; University of Hawaii System	Anteby, M (corresponding author), Harvard Univ, Sch Business, Org Behav Area, Boston, MA 02163 USA.	manteby@hbs.edu	Anteby, Michel/O-7597-2015	Anteby, Michel/0000-0002-2629-2529	Harvard University; University of Hawaii	Harvard University; University of Hawaii	Funding came from Harvard University and the University of Hawaii. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barman E, 2007, AM J SOCIOL, V112, P1416, DOI 10.1086/511802; Baumel J J, 1968, Nebr State Med J, V53, P90; Becker GS, 2007, J ECON PERSPECT, V21, P3, DOI 10.1257/jep.21.3.3; Boulware LE, 2004, CLIN ANAT, V17, P570, DOI 10.1002/ca.10225; Bureau of the Labor Statistics, 2009, CURR POP SURV 1987; Dasgupta N, 2004, JAMA-J AM MED ASSOC, V291, P122, DOI 10.1001/jama.291.1.122; Dluzen D E, 1996, Clin Anat, V9, P183, DOI 10.1002/(SICI)1098-2353(1996)9:3<183::AID-CA10>3.0.CO;2-N; Fox R. C., 1992, SPARE PARTS ORGAN RE; Healy K., 2006, LAST BEST GIFTS ALTR, DOI DOI 10.7208/CHICAGO/9780226322384.001.0001; Labrash Steven, 2007, Hawaii Med J, V66, P74; Lagwinski M, 1998, CLIN ANAT, V11, P253, DOI 10.1002/(SICI)1098-2353(1998)11:4<253::AID-CA6>3.3.CO;2-E; Madoff R., 2010, IMMORTALITY LAW RISI; Piliavin J. A., 1991, GIVING BLOOD DEV ALT; PILIAVIN JA, 1990, TRANSFUSION, V30, P444, DOI 10.1046/j.1537-2995.1990.30590296381.x; PILIAVIN JA, 1990, ANNU REV SOCIOL, V16, P27, DOI 10.1146/annurev.so.16.080190.000331; Richardson R, 1995, LANCET, V346, P27; SANNER M, 1994, JAMA-J AM MED ASSOC, V271, P284, DOI 10.1001/jama.271.4.284; Tabachnick B. G., 2006, USING MULTIVARIATE S; U.S. Department of Labor, 2007, MAY 2006 STAT OCC EM; Williams ChristineL., 1995, STILL MANS WORLD MEN	20	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42673	10.1371/journal.pone.0042673	http://dx.doi.org/10.1371/journal.pone.0042673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880077	gold, Green Published			2022-12-27	WOS:000307437900049
J	Cook, DC; Liu, S; Edwards, J; Villalta, ON; Aurambout, JP; Kriticos, DJ; Drenth, A; De Barro, PJ				Cook, David C.; Liu, Shuang; Edwards, Jacqueline; Villalta, Oscar N.; Aurambout, Jean-Philippe; Kriticos, Darren J.; Drenth, Andre; De Barro, Paul J.			Predicting the Benefits of Banana Bunchy Top Virus Exclusion from Commercial Plantations in Australia	PLOS ONE			English	Article							DISEASE; SPREAD; ERADICATION	Benefit cost analysis is a tried and tested analytical framework that can clearly communicate likely net changes in producer welfare from investment decisions to diverse stakeholder audiences. However, in a plant biosecurity context, it is often difficult to predict policy benefits over time due to complex biophysical interactions between invasive species, their hosts, and the environment. In this paper, we demonstrate how a break-even style benefit cost analysis remains highly relevant to biosecurity decision-makers using the example of banana bunchy top virus, a plant pathogen targeted for eradication from banana growing regions of Australia. We develop an analytical approach using a stratified diffusion spread model to simulate the likely benefits of exclusion of this virus from commercial banana plantations over time relative to a nil management scenario in which no surveillance or containment activities take place. Using Monte Carlo simulation to generate a range of possible future incursion scenarios, we predict the exclusion benefits of the disease will avoid Aus$15.9-27.0 million in annual losses for the banana industry. For these exclusion benefits to be reduced to zero would require a bunchy top re-establishment event in commercial banana plantations three years in every four. Sensitivity analysis indicates that exclusion benefits can be greatly enhanced through improvements in disease surveillance and incursion response.	[Cook, David C.] Dept Agr & Food, Bunbury, WA, Australia; [Cook, David C.; Liu, Shuang; Edwards, Jacqueline; Villalta, Oscar N.; Aurambout, Jean-Philippe; Kriticos, Darren J.; De Barro, Paul J.] Cooperat Res Ctr Natl Plant Biosecur, Bruce, ACT, Australia; [Cook, David C.] Univ Western Australia, Crawley, WA, Australia; [Cook, David C.; Liu, Shuang] Australian Ctr Biosecur & Environm Econ, Canberra, ACT, Australia; [Liu, Shuang; Kriticos, Darren J.] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Edwards, Jacqueline; Villalta, Oscar N.] Dept Primary Ind, Knoxfield, Vic, Australia; [Aurambout, Jean-Philippe] Dept Primary Ind, Parkville, Vic, Australia; [Kriticos, Darren J.] Charles Sturt Univ, Barton, ACT, Australia; [Kriticos, Darren J.] Univ Minnesota, Minneapolis, MN USA; [Drenth, Andre] Univ Queensland, Dutton Pk, Qld, Australia; [De Barro, Paul J.] CSIRO Ecosyst Sci, Dutton Pk, Qld, Australia	Government of Western Australia; Department of Agriculture & Food - Western Australia; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Charles Sturt University; University of Minnesota System; University of Minnesota Twin Cities; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Cook, DC (corresponding author), Dept Agr & Food, Bunbury, WA, Australia.	david.cook@agric.wa.gov.au	Drenth, Andre/A-4915-2008; Liu, Shuang/C-1951-2008; Cook, David C/C-1064-2009; De Barro, Paul J/C-1724-2008; Kriticos, Darren J/A-4170-2008	Drenth, Andre/0000-0002-8510-1534; Liu, Shuang/0000-0002-8749-3607; Cook, David C/0000-0002-2954-7697; Kriticos, Darren J/0000-0003-2599-8105; Edwards, Jacqueline/0000-0003-0310-7236	Cooperative Research Centre for National Plant Biosecurity under Australian Government [CRC10162]	Cooperative Research Centre for National Plant Biosecurity under Australian Government	This research was supported by the Cooperative Research Centre for National Plant Biosecurity (Project No. CRC10162), established and supported under the Australian Government's Cooperative Research Centres Program (http://www.crcplantbiosecurity.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS A.B.o.S., 2013, AGR COMM; ANDOW DA, 1990, LANDSCAPE ECOL, V4, P177, DOI 10.1007/BF00132860; [Anonymous], 1966, BANANAS; Biosecurity Australia, 2001, GUID IMP RISK AN; Boardman A, 2006, COST BENEFIT ANAL CO; Carrasco LR, 2012, ECOL ECON, V76, P95, DOI 10.1016/j.ecolecon.2012.02.009; COOK D, 2003, PRIORITISING EXOTIC; Cook D, 2010, POTENTIAL METHODS TO; Cook D. C., 2011, AUSTR J AGR RESOURCE, V55, P1; Cook DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026084; DALE JL, 1987, ADV VIRUS RES, V33, P301, DOI 10.1016/S0065-3527(08)60321-8; *DEP FIN, 1991, HDB COST BEN AN; DWYER G, 1992, ECOLOGY, V73, P479, DOI 10.2307/1940754; FAO, 2010, FAOSTAT DAT; FISH S, 1970, ANNU REV PHYTOPATHOL, V8, P13, DOI 10.1146/annurev.py.08.090170.000305; Fisher R A, 1937, ANN EUGEN, V7, P353, DOI DOI 10.1111/J.1469-1809.1937.TB02153.X; Henderson J, 2006, AUSTRALAS PLANT PATH, V35, P181, DOI 10.1071/AP06017; Hengeveld B., 1989, DYNAMICS BIOL INVASI; Heslop-Harrison JS, 2007, ANN BOT-LONDON, V100, P1073, DOI 10.1093/aob/mcm191; Hinchy M. D., 1991, COST BENEFIT ANAL QU; HOLMES EE, 1993, AM NAT, V142, P779, DOI 10.1086/285572; Hooks CRR, 2008, ANN APPL BIOL, V153, P1, DOI 10.1111/j.1744-7348.2008.00233.x; Lewis M., 1997, SPATIAL ECOLOGY ROLE, P46; MAGEE CJP, 1927, COUNCIL SCI IND RES, V30, P1; McCann K, 2000, THEOR POPUL BIOL, V57, P97, DOI 10.1006/tpbi.1999.1444; MOODY ME, 1988, J APPL ECOL, V25, P1009, DOI 10.2307/2403762; MORAN P. A. P., 1984, INTRO PROBABILITY TH; Okubo A., 2002, DIFFUSION ECOLOGICAL; Perrings C, 1998, ENVIRON RESOUR ECON, V11, P503, DOI 10.1023/A:1008255614276; Peterson R., 2005, Infomusa, V14, P7; Ploetz R., 2000, Pesticide Outlook, V11, P19, DOI 10.1039/b006308h; Sapoukhina N, 2010, ECOL MODEL, V221, P2793, DOI 10.1016/j.ecolmodel.2010.08.020; Shigesada N., 1997, BIOL INVASIONS THEOR; Sosnowski MR, 2009, PLANT PATHOL, V58, P621, DOI 10.1111/j.1365-3059.2009.02042.x; Thomas JE, 1996, DEV DETECTION METHOD; Ulubasoglu M, 2011, PRICE AFFECTS DEMAND; Wilby, 2005, NEW AGENDA BIOSECURI; Wittwer G, 2005, AUST J AGR RESOUR EC, V49, P75, DOI 10.1111/j.1467-8489.2005.00276.x	38	13	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42391	10.1371/journal.pone.0042391	http://dx.doi.org/10.1371/journal.pone.0042391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879960	Green Published, gold			2022-12-27	WOS:000307437900036
J	Mahan, VL; Zurakowski, D; Otterbein, LE; Pigula, FA				Mahan, Vicki L.; Zurakowski, David; Otterbein, Leo E.; Pigula, Frank A.			Inhaled Carbon Monoxide Provides Cerebral Cytoprotection in Pigs	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; HYPOTHERMIC CARDIOPULMONARY BYPASS; HEME OXYGENASE-1; LIVER-TRANSPLANTATION; LACTATE METABOLISM; CIRCULATORY ARREST; SIGNALING PATHWAY; BRAIN ISCHEMIA; UP-REGULATION; BLOOD-FLOW	Carbon monoxide (CO) at low concentrations imparts protective effects in numerous preclinical small animal models of brain injury. Evidence of protection in large animal models of cerebral injury, however, has not been tested. Neurologic deficits following open heart surgery are likely related in part to ischemia reperfusion injury that occurs during cardiopulmonary bypass surgery. Using a model of deep hypothermic circulatory arrest (DHCA) in piglets, we evaluated the effects of CO to reduce cerebral injury. DHCA and cardiopulmonary bypass (CPB) induced significant alterations in metabolic demands, including a decrease in the oxygen/glucose index (OGI), an increase in lactate/glucose index (LGI) and a rise in cerebral blood pressure that ultimately resulted in increased cell death in the neocortex and hippocampus that was completely abrogated in piglets preconditioned with a low, safe dose of CO. Moreover CO-treated animals maintained normal, pre-CPB OGI and LGI and corresponding cerebral sinus pressures with no change in systemic hemodynamics or metabolic intermediates. Collectively, our data demonstrate that inhaled CO may be beneficial in preventing cerebral injury resulting from DHCA and offer important therapeutic options in newborns undergoing DHCA for open heart surgery.	[Mahan, Vicki L.; Otterbein, Leo E.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Zurakowski, David; Pigula, Frank A.] Boston Childrens Hosp, Dept Pediat Cardiothorac Surg, Boston, MA USA; [Mahan, Vicki L.; Otterbein, Leo E.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Mahan, VL (corresponding author), Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA.	vmahan@bidmc.harvard.edu			Julie Henry Fund at the Transplant Center of the BIDMC (Beth Israel Deaconess Medical Center); National Institutes of Health [5R01GM088666, R56AI092272]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI092272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088666] Funding Source: NIH RePORTER	Julie Henry Fund at the Transplant Center of the BIDMC (Beth Israel Deaconess Medical Center); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to the Julie Henry Fund at the Transplant Center of the BIDMC (Beth Israel Deaconess Medical Center) for their support. LEO is supported by National Institutes of Health grants 5R01GM088666 and R56AI092272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amara M, 2011, LIVER TRANSPLANT, V17, P610, DOI 10.1002/lt.22272; Andreani P, 2010, HPB, V12, P439, DOI 10.1111/j.1477-2574.2010.00194.x; Bach FH, 2002, WIEN KLIN WOCHENSCHR, V114, P1; Bauer M, 2008, INTENS CARE MED, V34, P640, DOI 10.1007/s00134-008-1010-2; Bouma HR, 2010, TRANSPLANTATION, V90, P353, DOI 10.1097/TP.0b013e3181e7a3aa; Bouzier AK, 1998, DEV NEUROSCI-BASEL, V20, P331, DOI 10.1159/000017328; Cakir T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-48; Daley ML, 2007, J NEUROTRAUM, V24, P559, DOI 10.1089/neu.2006.0129; Dallas ML, 2011, FASEB J, V25, P1519, DOI 10.1096/fj.10-173450; Deshane J, 2005, ACTA BIOCHIM POL, V52, P273; Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079; Donahue MJ, 2009, J CEREBR BLOOD F MET, V29, P176, DOI 10.1038/jcbfm.2008.109; Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hanto DW, 2010, AM J TRANSPLANT, V10, P2421, DOI 10.1111/j.1600-6143.2010.03289.x; Kanoria S, 2007, TRANSPLANTATION, V84, P445, DOI 10.1097/01.tp.0000228235.55419.e8; Katori M, 2002, TRANSPL IMMUNOL, V9, P227, DOI 10.1016/S0966-3274(02)00043-6; Khaladj N, 2006, EUR J CARDIO-THORAC, V30, P492, DOI 10.1016/j.ejcts.2006.05.031; Lango Romuald, 2010, Anestezjol Intens Ter, V42, P206; Leffler CW, 2006, J APPL PHYSIOL, V100, P1065, DOI 10.1152/japplphysiol.00793.2005; Li QH, 2011, BASIC RES CARDIOL, V106, P1367, DOI 10.1007/s00395-011-0208-6; Li QF, 2008, ACTA BIOCH BIOPH SIN, V40, P803, DOI 10.1111/j.1745-7270.2008.00461.x; Li Y, 2010, TRANSL STROKE RES, V1, P184, DOI 10.1007/s12975-010-0016-6; MEZROW CK, 1995, J THORAC CARDIOV SUR, V109, P959, DOI 10.1016/S0022-5223(95)70322-5; Mo L, 2012, INT J MOL MED, V30, P314, DOI 10.3892/ijmm.2012.1002; Montalvo-Jave Eduardo Esteban, 2011, Cir Cir, V79, P132; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Moxon-Lester L, 2007, BRAIN RES, V1179, P79, DOI 10.1016/j.brainres.2007.08.037; Nie J, 2011, J SURG RES, V168, P281, DOI 10.1016/j.jss.2009.10.020; Occhipinti R, 2009, J NEUROPHYSIOL, V101, P2528, DOI 10.1152/jn.90377.2008; Otterbein LE, 2009, RESP CARE, V54, P925, DOI 10.4187/002013209793800394; Pae HO, 2008, RECENT PATENTS INFLA, V2, P159, DOI 10.2174/187221308786241929; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Pigula FA, 2001, J THORAC CARDIOV SUR, V121, P366, DOI 10.1067/mtc.2001.112207; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; Raza A, LIVER TRANSPLANTATIO, V16, P588; Rieger A, 1997, NEUROSURGERY, V41, P462, DOI 10.1097/00006123-199708000-00027; Romanoski CE, 2011, CIRC RES, V109, pE27, DOI 10.1161/CIRCRESAHA.111.241869; Rox PT, 1986, P NATL ACAD SCI USA, V83, P1140; RUDOLPH AM, 1967, CIRC RES, V21, P163, DOI 10.1161/01.RES.21.2.163; Saeki I, 2011, PEDIATR SURG INT, V27, P857, DOI 10.1007/s00383-010-2810-3; Schridde U, 2008, CEREB CORTEX, V18, P1814, DOI 10.1093/cercor/bhm208; Schurr A, 2007, NEUROSCIENCE, V147, P613, DOI 10.1016/j.neuroscience.2007.05.002; Siesjo BK, 1978, BRAIN ENERGY METABOL, P101; Simon T, 2011, IMMUNOTHERAPY-UK, V3, P15, DOI [10.2217/IMT.11.43, 10.2217/imt.11.43]; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Soares MP, 2007, FRONT BIOSCI, V12, P4932, DOI 10.2741/2439; Song XY, 2012, INT J BIOL SCI, V8, P707, DOI 10.7150/ijbs.4231; Stein AB, 2005, J MOL CELL CARDIOL, V38, P127, DOI 10.1016/j.yjmcc.2004.10.006; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; Strauch JT, 2003, EUR J CARDIO-THORAC, V24, P807, DOI 10.1016/S1010-7940(03)00517-7; Tapuria N, 2008, J SURG RES, V150, P304, DOI 10.1016/j.jss.2007.12.747; Tsuchihashi Sei-ichiro, 2004, Ann Transplant, V9, P84; van der Woude FJ, 2004, J INVEST MED, V52, P323, DOI 10.1136/jim-52-05-32; Varga J, 2011, EUR SURG RES, V46, P207, DOI 10.1159/000327396; Vega C, 2006, J NEUROCHEM, V97, P872, DOI 10.1111/j.1471-4159.2006.03790.x; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Wang B, 2011, STROKE, V42, P2605, DOI 10.1161/STROKEAHA.110.607101; Wang Z, 2011, PEDIATR TRANSPLANT, V15, P65, DOI 10.1111/j.1399-3046.2010.01362.x; Weerateerangkul P, 2011, MED SCI MONITOR, V17, pRA44, DOI 10.12659/MSM.881385; Won SJ, 2012, J CEREBR BLOOD F MET, V32, P1086, DOI 10.1038/jcbfm.2012.30; Yan S, 2010, HEPATOB PANCREAT DIS, V9, P346; Zapletal C, 2010, MICROVASC RES, V80, P365, DOI 10.1016/j.mvr.2010.05.005; Zeynalov E, 2009, NEUROTOX RES, V15, P133, DOI 10.1007/s12640-009-9014-4; Zeynalov E, 2009, NEUROBIOL DIS, V35, P264, DOI 10.1016/j.nbd.2009.05.010; Zimmermann A, 2007, AM J PHYSIOL-HEART C, V293, pH2501, DOI 10.1152/ajpheart.00354.2007	69	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41982	10.1371/journal.pone.0041982	http://dx.doi.org/10.1371/journal.pone.0041982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879904	Green Submitted, gold, Green Published			2022-12-27	WOS:000307437900019
J	Sanseverino, AM; Bastviken, D; Sundh, I; Pickova, J; Enrich-Prast, A				Sanseverino, Angela M.; Bastviken, David; Sundh, Ingvar; Pickova, Jana; Enrich-Prast, Alex			Methane Carbon Supports Aquatic Food Webs to the Fish Level	PLOS ONE			English	Article							PHOSPHOLIPID FATTY-ACIDS; STABLE-ISOTOPES; OXIDIZING BACTERIA; LIPID EXTRACTION; BIOGENIC METHANE; PETIT SAUT; GEN-NOV; LAKE; RIVER; COMMUNITY	Large amounts of the greenhouse gas methane (CH4) are produced by anaerobic mineralization of organic matter in lakes. In spite of extensive freshwater CH4 emissions, most of the CH4 is typically oxidized by methane oxidizing bacteria (MOB) before it can reach the lake surface and be emitted to the atmosphere. In turn, it has been shown that the CH4-derived biomass of MOB can provide the energy and carbon for zooplankton and macroinvertebrates. In this study, we demonstrate the presence of specific fatty acids synthesized by MOB in fish tissues having low carbon stable isotope ratios. Fish species, zooplankton, macroinvertebrates and the water hyacinth Eichhornia crassipes were collected from a shallow lake in Brazil and analyzed for fatty acids (FA) and carbon stable isotope ratios (delta C-13). The fatty acids 16:1 omega 8c, 16:1 omega 8t, 16:1 omega 6c, 16:1 omega 5t, 18:1 omega 8c and 18:1 omega 8t were used as signature for MOB. The delta C-13 ratios varied from -27.7 parts per thousand to -42.0 parts per thousand and the contribution of MOB FA ranged from 0.05% to 0.84% of total FA. Organisms with higher total content of MOB FAs presented lower delta C-13 values (i.e. they were more depleted in C-13), while organisms with lower content of MOB signature FAs showed higher delta C-13 values. An UPGMA cluster analysis was carried out to distinguish grouping of organisms in relation to their MOB FA contents. This combination of stable isotope and fatty acid tracers provides new evidence that assimilation of methane-derived carbon can be an important carbon source for the whole aquatic food web, up to the fish level.	[Sanseverino, Angela M.; Enrich-Prast, Alex] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Sanseverino, Angela M.; Bastviken, David; Enrich-Prast, Alex] Linkoping Univ, Dept Themat Studies Water & Environm Studies, Linkoping, Sweden; [Sundh, Ingvar] Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, S-75007 Uppsala, Sweden; [Pickova, Jana] Swedish Univ Agr Sci, Dept Food Sci, Uppsala BioCtr, Uppsala, Sweden	Universidade Federal do Rio de Janeiro; Linkoping University; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Sanseverino, AM (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.	angelamsanseverino@gmail.com	Prast, Alex Enrich/AAL-4722-2021; Sanseverino, Angela/G-2809-2012; Enrich-Prast, Alex/H-5391-2012	Prast, Alex Enrich/0000-0003-3561-0936; Sanseverino, Angela/0000-0001-7133-257X; pickova, jana/0000-0002-3406-3435; Bastviken, David/0000-0003-0038-2152	Coordination for the Improvement of Higher Education Personnel CAPES; Brazilian Science Council CNPq; Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State FAPERJ; Swedish Research Council VR	Coordination for the Improvement of Higher Education Personnel CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Science Council CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Swedish Research Council VR(Swedish Research Council)	Financial support was contributed by Coordination for the Improvement of Higher Education Personnel CAPES (http://www.capes.gov.br), the Brazilian Science Council CNPq (http://www.cnpq.br), and Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State FAPERJ (http://www.faperj.br) to AEP and AMS and by the Swedish Research Council VR (http://www.vr.se) to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht MP, 2003, STUD NEOTROP FAUNA E, V38, P33, DOI 10.1076/snfe.38.1.33.14033; AMARAL JA, 1995, FEMS MICROBIOL LETT, V126, P215, DOI 10.1111/j.1574-6968.1995.tb07421.x; APPELQVIST LA, 1968, ARK KEMI, V28, P551; Arcifa M. S., 2000, Revista Brasileira de Biologia, V60, P591, DOI 10.1590/S0034-71082000000400008; Arrington DA, 2006, J FISH BIOL, V68, P1347, DOI 10.1111/j.0022-1112.2006.00996.x; Bastviken D, 2003, ECOLOGY, V84, P969, DOI 10.1890/0012-9658(2003)084[0969:MAASOC]2.0.CO;2; Bastviken D., 2009, ENCY INLAND WATERS, P783, DOI [10.1016/b978-012370626-3.00117-4, DOI 10.1016/B978-012370626-3.00117-4]; Bastviken D, 2010, ENVIRON SCI TECHNOL, V44, P5450, DOI 10.1021/es1005048; Bodelier PLE, 2009, ISME J, V3, P606, DOI 10.1038/ismej.2009.6; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Borjesson G, 2004, FEMS MICROBIOL ECOL, V48, P305, DOI 10.1016/j.femsec.2004.02.006; Bowman J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P266, DOI 10.1007/0-387-30745-1_15; BOWMAN JP, 1993, INT J SYST BACTERIOL, V43, P735, DOI 10.1099/00207713-43-4-735; BUNN SE, 1993, OECOLOGIA, V96, P85, DOI 10.1007/BF00318034; Calheiros DF, 2003, THESIS U SAO PAULO B; Chowdhury TR, 2011, NATURE PRECEDINGS; Coffman W.P., 1996, P635; Cole JJ, 2011, P NATL ACAD SCI USA, V108, P1975, DOI 10.1073/pnas.1012807108; Conrad R, 2011, BIOGEOSCIENCES, V8, P795, DOI 10.5194/bg-8-795-2011; Correa CE, 2011, NEOTROP ICHTHYOL, V9, P637, DOI 10.1590/S1679-62252011000300017; Correa SB, 2005, THESIS U FLORIDA; de Oliveira ERN, 2003, BRAZ ARCH BIOL TECHN, V46, P105, DOI 10.1590/S1516-89132003000100015; Deines P, 2007, ENVIRON MICROBIOL, V9, P1126, DOI 10.1111/j.1462-2920.2006.01235.x; Dumestre JF, 1999, HYDROBIOLOGIA, V400, P75, DOI 10.1023/A:1003707129170; Dumestre JF, 2002, AQUAT MICROB ECOL, V26, P209, DOI 10.3354/ame026209; ESTEVES KE, 1995, ENVIRON BIOL FISH, V42, P375, DOI 10.1007/BF00001468; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Goedkoop W, 1998, FRESHWATER BIOL, V40, P135, DOI 10.1046/j.1365-2427.1998.00339.x; Grey J, 2000, OECOLOGIA, V123, P232, DOI 10.1007/s004420051010; Grey J, 2004, FRESHWATER BIOL, V49, P681, DOI 10.1111/j.1365-2427.2004.01217.x; Grey J, 2004, LIMNOL OCEANOGR, V49, P239, DOI 10.4319/lo.2004.49.1.0239; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Harrod C, 2006, ARCH HYDROBIOL, V167, P281, DOI 10.1127/0003-9136/2006/0167-0281; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; Jones RI, 1998, P ROY SOC B-BIOL SCI, V265, P105, DOI 10.1098/rspb.1998.0270; Jones RI, 2008, ECOLOGY, V89, P857, DOI 10.1890/06-2010.1; Jones RI, 2011, FRESHWATER BIOL, V56, P213, DOI 10.1111/j.1365-2427.2010.02494.x; Junk W.J., 1993, WETL ECOL MANAG, V2, P231, DOI [10.1007/BF00188157, DOI 10.1007/BF00188157]; Kankaala P, 2006, LIMNOL OCEANOGR, V51, P2821, DOI 10.4319/lo.2006.51.6.2821; KING GM, 1992, ADV MICROB ECOL, V12, P431; Kip N, 2010, NAT GEOSCI, V3, P617, DOI 10.1038/NGEO939; Kiyashko SI, 2004, COMP BIOCHEM PHYS B, V139, P705, DOI 10.1016/j.cbpc.2004.08.013; Kiyashko SI, 2001, AQUAT MICROB ECOL, V24, P203, DOI 10.3354/ame024203; Lopes CA, 2009, BRAZ J BIOL, V69, P573, DOI 10.1590/S1519-69842009000300012; Merritt R.W., 1996, INTRO AQUATIC INSECT; Molineri C, 2010, AQUAT INSECT, V32, P265, DOI 10.1080/01650424.2010.533131; NICHOLS PD, 1986, J MICROBIOL METH, V5, P49, DOI 10.1016/0167-7012(86)90023-0; Op den Camp HJM, 2009, ENV MICROBIOL REP, V1, P293, DOI 10.1111/j.1758-2229.2009.00022.x; Pereira PR, 2007, NEOTROP ICHTHYOL, V5, P399, DOI 10.1590/S1679-62252007000300019; Pereira R.A.C., 1998, EMBRAPA BOL PESQ, V12, P1; Peretti D, 2008, BRAZ J BIOL, V68, P671, DOI 10.1590/S1519-69842008000300027; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Raghoebarsing AA, 2005, NATURE, V436, P1153, DOI 10.1038/nature03802; RAU G, 1978, SCIENCE, V201, P901, DOI 10.1126/science.201.4359.901; Ravinet M, 2010, OIKOS, V119, P409, DOI 10.1111/j.1600-0706.2009.17859.x; Resende E. K., 2000, EMBRAPA BOL PESQ, V16, P1; Saether O.A., 1997, AQUATIC INSECTS N EU, P149; SAZIMA I, 1986, J FISH BIOL, V29, P53, DOI 10.1111/j.1095-8649.1986.tb04926.x; Sohngen NL, 1906, ZENTRALBL BAKTERIOL, V15, P513; Steger K, 2011, LIMNOL OCEANOGR, V56, P725, DOI 10.4319/lo.2011.56.2.0725; SUMMONS RE, 1994, GEOCHIM COSMOCHIM AC, V58, P2853, DOI 10.1016/0016-7037(94)90119-8; Sundh I, 2005, APPL ENVIRON MICROB, V71, P6746, DOI 10.1128/AEM.71.11.6746-6752.2005; Taipale S, 2009, FRESHWATER BIOL, V54, P90, DOI 10.1111/j.1365-2427.2008.02094.x; Trattner S, 2008, LIPIDS, V43, P999, DOI 10.1007/s11745-008-3229-7; Trimmer M, 2009, LIMNOL OCEANOGR, V54, P1541, DOI 10.4319/lo.2009.54.5.1541; Vari R. P., 1992, SMITHSONIAN CONTRIBU, V529, P1, DOI DOI 10.5479/SI.00810282.529; Virtue P, 1996, J MICROBIOL METH, V25, P177, DOI 10.1016/0167-7012(95)00095-X; Wantzen KM, 2002, AQUAT SCI, V64, P239, DOI 10.1007/PL00013196; Wise MG, 2001, INT J SYST EVOL MICR, V51, P611, DOI 10.1099/00207713-51-2-611	70	56	58	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42723	10.1371/journal.pone.0042723	http://dx.doi.org/10.1371/journal.pone.0042723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880091	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000307437900051
J	Schulz-Mirbach, T; Metscher, B; Ladich, F				Schulz-Mirbach, Tanja; Metscher, Brian; Ladich, Friedrich			Relationship between Swim Bladder Morphology and Hearing Abilities-A Case Study on Asian and African Cichlids	PLOS ONE			English	Article							INNER-EAR; AMBIENT NOISE; ACOUSTIC COMMUNICATION; AUDITORY-SENSITIVITY; SOUND PRODUCTION; FISHES; BUTTERFLYFISHES; THRESHOLDS; AUDIOGRAMS; DIVERSITY	Background: Several teleost species have evolved anterior extensions of the swim bladder which come close to or directly contact the inner ears. A few comparative studies have shown that these morphological specializations may enhance hearing abilities. This study investigates the diversity of swim bladder morphology in four Asian and African cichlid species and analyzes how this diversity affects their hearing sensitivity. Methodology/Principal Findings: We studied swim bladder morphology by dissections and by making 3D reconstructions from high-resolution microCT scans. The auditory sensitivity was determined in terms of sound pressure levels (SPL) and particle acceleration levels (PAL) using the auditory evoked potential (AEP) recording technique. The swim bladders in Hemichromis guttatus and Steatocranus tinanti lacked anterior extensions and the swim bladder was considerably small in the latter species. In contrast, Paratilapia polleni and especially Etroplus maculatus possessed anterior extensions bringing the swim bladder close to the inner ears. All species were able to detect frequencies up to 3 kHz (SPL) except S. tinanti which only responded to frequencies up to 0.7 kHz. P. polleni and E. maculatus showed significantly higher auditory sensitivities at 0.5 and 1 kHz than the two species lacking anterior swim bladder extensions. The highest auditory sensitivities were found in E. maculatus, which possessed the most intimate swim bladder-inner ear relationship (maximum sensitivity 66 dB re 1 mu Pa at 0.5 kHz). Conclusions: Our results indicate that anterior swim bladder extensions seem to improve mean absolute auditory sensitivities by 21-42 dB (SPLs) and 21-36 dB (PALs) between 0.5 and 1 kHz. Besides anterior extensions, the size of the swim bladder appears to be an important factor for extending the detectable frequency range (up to 3 kHz).	[Schulz-Mirbach, Tanja; Ladich, Friedrich] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Metscher, Brian] Univ Vienna, Dept Theoret Biol, Vienna, Austria	University of Vienna; University of Vienna	Schulz-Mirbach, T (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	tanja.schulz-mirbach@univie.ac.at	Metscher, Brian/I-1238-2019	Metscher, Brian/0000-0002-6514-4406	German Academic Exchange Service (DAAD) [D/10/51727]; Austrian Science Fund (FWF) [22319]; Austrian Science Fund (FWF) [P 22319] Funding Source: researchfish	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Financial support came from the German Academic Exchange Service (DAAD) (Postdoctoral fellowship D/10/51727 to TSM) and the Austrian Science Fund (FWF grant 22319 to FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1966, BIOL REV, V41, P141, DOI 10.1111/j.1469-185X.1966.tb01542.x; Amoser S, 2005, J EXP BIOL, V208, P3533, DOI 10.1242/jeb.01809; Blaxter JHS, 1981, HEARING SOUND COMMUN, P39; Braun Christopher B., 2008, V32, P99; Casper BM, 2006, ENVIRON BIOL FISH, V76, P101, DOI 10.1007/s10641-006-9012-9; COOMBS S, 1979, J COMP PHYSIOL, V132, P203, DOI 10.1007/BF00614491; Corwin J.T., 1981, HEARING SOUND COMMUN, P81; Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482; Dehadrai P. V., 1959, Proceedings of the National Institute of Sciences of India, V25B, P254; Deng XH, 2011, DEEP-SEA RES PT I, V58, P27, DOI 10.1016/j.dsr.2010.11.001; Fay R. R., 1988, HEARING VERTEBRATES; FINE ML, 1995, MAR BIOL, V123, P401, DOI 10.1007/BF00349218; Hawkins A.D., 1993, Fish and Fisheries Series, V7, P129; Horodysky AZ, 2008, J EXP BIOL, V211, P1504, DOI 10.1242/jeb.016196; *ISO, 1983, 1683 ISO; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Ladich F, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P321; Ladich F, 2003, HEARING RES, V182, P119, DOI 10.1016/S0378-5955(03)00188-6; Ladich F, 2004, SPR HDB AUD, V22, P95, DOI 10.1007/978-1-4419-8957-4_4; Ladich F, 2000, PHILOS T ROY SOC B, V355, P1285, DOI 10.1098/rstb.2000.0685; Ladich Friedrich, 2006, P3; Lechner W, 2008, J EXP BIOL, V211, P1681, DOI 10.1242/jeb.016436; Longrie N, 2009, J EXP BIOL, V212, P3395, DOI 10.1242/jeb.032946; Lugli M, 2003, J COMP PHYSIOL A, V189, P309, DOI 10.1007/s00359-003-0404-4; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; MYRBERG AA, 1980, J COMP PHYSIOL, V140, P135, DOI 10.1007/BF00606305; NELSON EDWARD M., 1955, FIELDIANA ZOOL, V37, P121; Papes S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026479; Parmentier E, 2011, J EXP BIOL, V214, P2697, DOI 10.1242/jeb.058750; Parmentier E, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-12; PAULIN CD, 1988, COPEIA, P450, DOI 10.2307/1445886; Popper AN, 2005, MAR FRESHWATER RES, V56, P497, DOI 10.1071/MF04267; Popper AN, 2000, FISH RES, V46, P15, DOI 10.1016/S0165-7836(00)00129-6; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; Ramcharitar J, 2001, BRAIN BEHAV EVOLUT, V58, P152, DOI 10.1159/000047269; Ramcharitar JU, 2006, J ACOUST SOC AM, V119, P439, DOI 10.1121/1.2139068; Ramcharitar JU, 2004, J COMP NEUROL, V475, P531, DOI 10.1002/cne.20192; Ripley Jennifer L., 2002, Bioacoustics, V12, P238; SCHELLART NAM, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P295; Schwarzer J, 2012, J EVOLUTION BIOL, V25, P138, DOI 10.1111/j.1420-9101.2011.02409.x; Smith ME, 2004, J EXP BIOL, V207, P3591, DOI 10.1242/jeb.01188; Sparks JS, 2008, B AM MUS NAT HIST, P5; Tavolga W. N., 1963, Bulletin of the American Museum of Natural History, V126, P177; Webb JF, 2010, J FISH BIOL, V77, P1406, DOI 10.1111/j.1095-8649.2010.02765.x; Webb JF, 2006, J MORPHOL, V267, P1338, DOI 10.1002/jmor.10480; Wysocki LE, 2005, JARO-J ASSOC RES OTO, V6, P28, DOI 10.1007/s10162-004-4043-4; Wysocki LE, 2005, HEARING RES, V201, P27, DOI 10.1016/j.heares.2004.08.015; Wysocki LE, 2002, HEARING RES, V169, P36, DOI 10.1016/S0378-5955(02)00336-2; Wysocki LE, 2007, J ACOUST SOC AM, V121, P2559, DOI 10.1121/1.2713661; Wysocki LE, 2009, J ACOUST SOC AM, V126, P2100, DOI 10.1121/1.3203562; YAN HY, 1992, J COMP PHYSIOL A, V171, P105; Yan HY, 2000, J COMP PHYSIOL A, V187, P371, DOI DOI 10.1007/S003590050443	52	47	47	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42292	10.1371/journal.pone.0042292	http://dx.doi.org/10.1371/journal.pone.0042292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879934	Green Published, gold, Green Submitted			2022-12-27	WOS:000307437900028
J	Wichroski, MJ; Fang, J; Eggers, BJ; Rose, RE; Mazzucco, CE; Pokornowski, KA; Baldick, CJ; Anthony, MN; Dowling, CJ; Barber, LE; Leet, JE; Beno, BR; Gerritz, SW; Agler, ML; Cockett, MI; Tenney, DJ				Wichroski, Michael J.; Fang, Jie; Eggers, Betsy J.; Rose, Ronald E.; Mazzucco, Charles E.; Pokornowski, Kevin A.; Baldick, Carl J.; Anthony, Monique N.; Dowling, Craig J.; Barber, Lauren E.; Leet, John E.; Beno, Brett R.; Gerritz, Samuel W.; Agler, Michele L.; Cockett, Mark I.; Tenney, Daniel J.			High-Throughput Screening and Rapid Inhibitor Triage Using an Infectious Chimeric Hepatitis C Virus	PLOS ONE			English	Article							SIGNAL PEPTIDE PEPTIDASE; CELL-CULTURE SYSTEMS; CORE PROTEIN; INTRAMEMBRANE PROTEOLYSIS; POTENT INHIBITORS; IN-VIVO; CLEAVAGE; MEMBRANE; PARTICLES; PROMOTES	The recent development of a Hepatitis C virus (HCV) infectious virus cell culture model system has facilitated the development of whole-virus screening assays which can be used to interrogate the entire virus life cycle. Here, we describe the development of an HCV growth assay capable of identifying inhibitors against all stages of the virus life cycle with assay throughput suitable for rapid screening of large-scale chemical libraries. Novel features include, 1) the use of an efficiently-spreading, full-length, intergenotypic chimeric reporter virus with genotype 1 structural proteins, 2) a homogenous assay format compatible with miniaturization and automated liquid-handling, and 3) flexible assay end-points using either chemiluminescence (high-throughput screening) or Cellomics ArrayScan (TM) technology (high-content screening). The assay was validated using known HCV antivirals and through a large-scale, high-throughput screening campaign that identified novel and selective entry, replication and late-stage inhibitors. Selection and characterization of resistant viruses provided information regarding inhibitor target and mechanism. Leveraging results from this robust whole-virus assay represents a critical first step towards identifying inhibitors of novel targets to broaden the spectrum of antivirals for the treatment of HCV.	[Wichroski, Michael J.; Fang, Jie; Eggers, Betsy J.; Rose, Ronald E.; Mazzucco, Charles E.; Pokornowski, Kevin A.; Baldick, Carl J.; Anthony, Monique N.; Dowling, Craig J.; Barber, Lauren E.; Leet, John E.; Beno, Brett R.; Gerritz, Samuel W.; Agler, Michele L.; Cockett, Mark I.; Tenney, Daniel J.] Bristol Myers Squibb Res & Dev, Wallingford, CT USA	Bristol-Myers Squibb	Wichroski, MJ (corresponding author), Bristol Myers Squibb Res & Dev, Wallingford, CT USA.	michael.wichroski@bms.com		Gerritz, Samuel/0000-0002-8378-0393				Ai LS, 2009, J VIROL, V83, P9923, DOI 10.1128/JVI.00066-09; Ait-Goughoulte M, 2006, J GEN VIROL, V87, P855, DOI 10.1099/vir.0.81664-0; Baldick CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001086; Chockalingam K, 2010, P NATL ACAD SCI USA, V107, P3764, DOI 10.1073/pnas.0915117107; Dev KK, 2006, EUR J PHARMACOL, V540, P10, DOI 10.1016/j.ejphar.2006.04.011; Gastaminza P, 2010, P NATL ACAD SCI USA, V107, P291, DOI 10.1073/pnas.0912966107; Gentzsch J, 2011, ANTIVIR RES, V89, P136, DOI 10.1016/j.antiviral.2010.12.005; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Gottwein JM, 2011, J VIROL, V85, P8913, DOI 10.1128/JVI.00049-11; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Hope RG, 2006, J GEN VIROL, V87, P623, DOI 10.1099/vir.0.81371-0; Horscroft Nigel, 2005, Antiviral Chemistry & Chemotherapy, V16, P1; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; Jensen TB, 2008, J INFECT DIS, V198, P1756, DOI 10.1086/593021; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Kota S, 2009, J GEN VIROL, V90, P1319, DOI 10.1099/vir.0.008565-0; Kota S, 2009, ASSAY DRUG DEV TECHN; Laakso MM, 2007, PLOS PATHOG, V3, P1118, DOI 10.1371/journal.ppat.0030117; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Ma HC, 2007, J BIOMED SCI, V14, P31, DOI 10.1007/s11373-006-9127-1; Majeau N, 2005, J GEN VIROL, V86, P3055, DOI 10.1099/vir.0.81174-0; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Mittapalli GK, 2011, BIOORG MED CHEM LETT; Ni F, 2011, BIOORG MED CHEM LETT, V21, P2198, DOI 10.1016/j.bmcl.2011.03.014; Nolan KM, 2009, J VIROL, V83, P3798, DOI 10.1128/JVI.01751-08; Nyanguile O, 2010, J VIROL, V84, P2923, DOI 10.1128/JVI.01980-09; O'Boyle DR, 2005, ANTIMICROB AGENTS CH, V49, P1346, DOI 10.1128/AAC.49.4.1346-1353.2005; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; Pene V, 2009, J VIRAL HEPATITIS, V16, P705, DOI 10.1111/j.1365-2893.2009.01118.x; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105; Seeff L B, 1997, Clin Liver Dis, V1, P587, DOI 10.1016/S1089-3261(05)70323-8; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; SIMONETTI RG, 1992, ANN INTERN MED, V116, P97, DOI 10.7326/0003-4819-116-2-97; Strosberg AD, 2010, VIRUSES-BASEL, V2, P1734, DOI 10.3390/v2081734; Vauloup-Fellous C, 2006, J BIOL CHEM, V281, P27679, DOI 10.1074/jbc.M602587200; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Yi MinKyung, 2009, V510, P337, DOI 10.1007/978-1-59745-394-3_25; Yu XM, 2009, ANTIMICROB AGENTS CH, V53, P4311, DOI 10.1128/AAC.00495-09; Zeuzem S, 2008, NAT CLIN PRACT GASTR, V5, P610, DOI 10.1038/ncpgasthep1274; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	47	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42609	10.1371/journal.pone.0042609	http://dx.doi.org/10.1371/journal.pone.0042609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880053	Green Submitted, gold, Green Published			2022-12-27	WOS:000307810000051
J	Cabal, B; Cafini, F; Esteban-Tejeda, L; Alou, L; Bartolome, JF; Sevillano, D; Lopez-Piriz, R; Torrecillas, R; Moya, JS				Cabal, Belen; Cafini, Fabio; Esteban-Tejeda, Leticia; Alou, Luis; Bartolome, Jose F.; Sevillano, David; Lopez-Piriz, Roberto; Torrecillas, Ramon; Serafin Moya, Jose			Inhibitory Effect on In Vitro Streptococcus oralis Biofilm of a Soda-Lime Glass Containing Silver Nanoparticles Coating on Titanium Alloy	PLOS ONE			English	Article							6 BACTERIA; IMPLANTS	This paper reports the effect of soda-lime-glass-nAg coating on the viability of an in vitro biofilm of Streptococcus oralis. Three strains (ATCC 35037 and two clinical isolates from periodontitis patients) were grown on coated with glass, glass containing silver nanoparticles, and uncoated titanium alloy disks. Two different methods were used to quantify biofilm formation abilities: crystal violet staining and determination of viable counts. The influence of the surface morphology on the cell attachment was studied. The surface morphology was characterized by scanning electron microscopy (SEM) and using a profilometer. SEM was also used to study the formation and the development of biofilm on the coated and uncoated disks. At least a >99.7% inocula reduction of biofilm respect to titanium disks and also to glass coated disks was observed in the glass-nAg coated disks for all the studied strains. A quantitative evaluation of the release of silver was conducted in vitro to test whether and to what extend the biocidal agent (silver) could leach from the coating. These findings suggest that the biofilm formation of S. oralis strains is highly inhibited by the glass-nAg and may be useful for materials which require durable antibacterial effect on their surfaces, as it is the case of dental implants.	[Cabal, Belen; Lopez-Piriz, Roberto; Torrecillas, Ramon] Univ Oviedo Principado Asturias, Spanish Natl Res Council, Nanomat & Nanotechnol Res Ctr, Llanera, Spain; [Cabal, Belen; Esteban-Tejeda, Leticia; Bartolome, Jose F.; Serafin Moya, Jose] CSIC, Inst Mat Sci Madrid, Dept Biomat & Bioinspired Mat, Madrid, Spain; [Cafini, Fabio; Alou, Luis; Sevillano, David] Univ Complutense Madrid, Sch Med, Dept Microbiol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion en Nanomateriales y Nanotecnologia (CINN); University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); Complutense University of Madrid	Cabal, B (corresponding author), Univ Oviedo Principado Asturias, Spanish Natl Res Council, Nanomat & Nanotechnol Res Ctr, Parque Tecnol Asturias, Llanera, Spain.	b.cabal@cinn.es	Torrecillas, Ramón/G-7851-2011; Cafini, Fabio/AAA-7938-2020; Cabal, Belén/G-2694-2019; Sevillano, David/G-5661-2010; Moya, Jose/I-5841-2013; Bartolomé, José/B-1977-2010; López-Píriz, Roberto/W-8146-2019; Alou, Luis/B-8170-2011	Torrecillas, Ramón/0000-0003-3856-0217; Cafini, Fabio/0000-0002-5442-1674; Cabal, Belén/0000-0002-4102-3810; Bartolomé, José/0000-0002-7515-4202; López-Píriz, Roberto/0000-0003-2431-6950; Alou, Luis/0000-0002-0859-008X; Sevillano Fernandez, David/0000-0003-0212-2194	Spanish Ministry of Science and Innovation [MAT2009-14542-C02-01]; CSIC JAE-Doc Program	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC JAE-Doc Program	This work was supported by the Spanish Ministry of Science and Innovation under the project MAT2009-14542-C02-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors thank Juan Ramon Maestre for the supply of the S. oralis strains. B. Cabal thanks the CSIC JAE-Doc Program for a postdoctoral contract.	Ahmed AA, 2011, J BIOMED MATER RES A, V98A, P132, DOI 10.1002/jbm.a.33101; Burgers R, 2010, CLIN ORAL IMPLAN RES, V21, P156, DOI 10.1111/j.1600-0501.2009.01815.x; da Silva AC, 2008, J AM CERAM SOC, V91, P1300; Das K, 2008, J BIOMED MATER RES B, V87B, P455, DOI 10.1002/jbm.b.31125; Davey ME, 2006, PERIODONTOL 2000, V42, P13, DOI 10.1111/j.1600-0757.2006.00052.x; Esteban-Tejeda L, 2012, J EUR CERAM SOC, V32, P2723, DOI 10.1016/j.jeurceramsoc.2012.02.053; Fang M, 2006, INT J ANTIMICROB AG, V27, P513, DOI 10.1016/j.ijantimicag.2006.01.008; Filoche S, 2010, J DENT RES, V89, P8, DOI 10.1177/0022034509351812; Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Maestre JR, 2007, REV ESP QUIM, V20, P61; Moya JS, 2011, ADV ENG MATER, V13, pB256, DOI 10.1002/adem.201080133; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Quirynen M, 2002, CLIN ORAL IMPLAN RES, V13, P1, DOI 10.1034/j.1600-0501.2002.130101.x; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Sanchez MC, 2011, J PERIODONTAL RES, V46, P252, DOI 10.1111/j.1600-0765.2010.01341.x; Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; Wecke J, 2000, FEMS MICROBIOL LETT, V191, P95, DOI 10.1016/S0378-1097(00)00376-1	21	27	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42393	10.1371/journal.pone.0042393	http://dx.doi.org/10.1371/journal.pone.0042393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879961	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100077
J	Chambers, D; Wilson, P; Thompson, C; Harden, M				Chambers, Duncan; Wilson, Paul; Thompson, Carl; Harden, Melissa			Social Network Analysis in Healthcare Settings: A Systematic Scoping Review	PLOS ONE			English	Review							OPINION LEADERS; DIFFUSION; KNOWLEDGE; WORK; PATTERNS; ADOPTION; PRACTITIONERS; COMMUNICATION; INFORMATION; INNOVATIONS	Background: Social network analysis (SNA) has been widely used across a range of disciplines but is most commonly applied to help improve the effectiveness and efficiency of decision making processes in commercial organisations. We are utilising SNA to inform the development and implementation of tailored behaviour-change interventions to improve the uptake of evidence into practice in the English National Health Service. To inform this work, we conducted a systematic scoping review to identify and evaluate the use of SNA as part of an intervention to support the implementation of change in healthcare settings. Methods and Findings: We searched ten bibliographic databases to October 2011. We also searched reference lists, hand searched selected journals and websites, and contacted experts in the field. To be eligible for the review, studies had to describe and report the results of an SNA performed with healthcare professionals (e. g. doctors, nurses, pharmacists, radiographers etc.) and others involved in their professional social networks. We included 52 completed studies, reported in 62 publications. Almost all of the studies were limited to cross sectional descriptions of networks; only one involved using the results of the SNA as part of an intervention to change practice. Conclusions: We found very little evidence for the potential of SNA being realised in healthcare settings. However, it seems unlikely that networks are less important in healthcare than other settings. Future research should seek to go beyond the merely descriptive to implement and evaluate SNA-based interventions.	[Chambers, Duncan; Wilson, Paul; Harden, Melissa] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Thompson, Carl] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK	Chambers, D (corresponding author), Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England.	duncan.chambers@york.ac.uk		Thompson, Carl/0000-0002-9369-1204; Chambers, Duncan/0000-0002-0154-0469	National Institute for Health Research (NIHR)	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This work was done as part of the Translating Research into Practice in Leeds and Bradford project funded by the National Institute for Health Research (NIHR) as part of the Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Leeds, York, and Bradford. The views expressed in this article are those of the authors and not necessarily those of the NIHR or the CLAHRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JG, 1985, SOCIOL QUART, V26, P49, DOI 10.1111/j.1533-8525.1985.tb00215.x; Anderson JG, 2002, COMPUT BIOL MED, V32, P179, DOI 10.1016/S0010-4825(02)00014-8; Anderson JG., 1990, CLIN SOCIOLOGICAL RE, V8, P116; Anderson JG, 1987, USE IMPACT COMPUTERS, P185; Ankem K, 2003, J MED LIBR ASSOC, V91, P450; Barrera D, 2009, EUR SOCIOL REV, V25, P709, DOI 10.1093/esr/jcn078; Baumgart Andre, 2009, Qual Manag Health Care, V18, P305, DOI 10.1097/QMH.0b013e3181bee2c6; Benham-Hutchins M, 2008, AMIA ANN S P NOV 6, V6, P875; Benham-Hutchins MM, 2010, INT J MED INFORM, V79, P252, DOI 10.1016/j.ijmedinf.2009.12.005; Benham-Hutchins MM, 2008, INFLUENCE INFORM TEC; Boyer L, 2010, INT J HEALTH CARE Q, V23, P460, DOI 10.1108/09526861011050501; Bradley F., 2011, INT J PHARM PRACT S2, P26; Bradley F, 2010, INT J PHARM PRACT S1, V4, P3; Chung KSK, 2010, COMPUT HUM BEHAV, V26, P562, DOI 10.1016/j.chb.2009.12.008; Chung KSK, 2007, SIGMIS CPR 2007: PROCEEDINGS OF THE 2007 ACM SIGMIS CPR CONFERENCE GLOBAL INFORMATION TECHNOLOGY WORKFORCE, P159; COLEMAN J, 1957, SOCIOMETRY, V20, P253, DOI 10.2307/2785979; Cott C, 1997, SOC SCI MED, V45, P1411, DOI 10.1016/S0277-9536(97)00066-X; Creswick N, 2010, INT J MED INFORM, V79, pE116, DOI 10.1016/j.ijmedinf.2008.08.005; Creswick N, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-247; Creswick N, 2007, STUD HEALTH TECHNOL, V130, P217; Cross R., 2004, HIDDEN POWER SOCIAL; Cunningham FC, 2010, SOCIAL PROFESSIONAL; Curran J, 2006, STUD HEALTH TECHNOL, V124, P941; Curran Janet A, 2007, Health Informatics J, V13, P255, DOI 10.1177/1460458207079834; Currie G, 2011, KNOWLEDGE BROKERING; Fattore G, 2009, HEALTH POLICY, V92, P141, DOI 10.1016/j.healthpol.2009.03.005; Foy R, 2011, BMJ QUAL SAF, V20, P453, DOI 10.1136/bmjqs.2010.047993; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grimshaw JM, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-3; Hanbury A, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-37; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; Harris JK, 2007, PUBLIC HEALTH REP, V122, P488, DOI 10.1177/003335490712200410; Heiligers PJM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-204; Hiscott RD, 1989, CONNECTIONS, VXII, P24; Iyengar R, 2011, MARKET SCI, V30, P195, DOI 10.1287/mksc.1100.0566; Jippes E, 2010, SOC SCI MED, V70, P1509, DOI 10.1016/j.socscimed.2009.12.035; Keating NL, 2007, J GEN INTERN MED, V22, P794, DOI 10.1007/s11606-007-0190-8; Kravitz RL, 2003, SOC SCI MED, V57, P2423, DOI 10.1016/S0277-9536(03)00137-0; Lewis JM, 2006, SOC SCI MED, V62, P2125, DOI 10.1016/j.socscimed.2005.10.004; Lower T, 2010, AUST J PRIM HEALTH, V16, P47, DOI 10.1071/PY09043; Lurie SJ, 2009, ACAD MED, V84, P1029, DOI 10.1097/ACM.0b013e3181ad16d3; MacPhee M, 2000, J NURS ADMIN, V30, P190, DOI 10.1097/00005110-200004000-00010; MacPhee M, 2002, J NURS ADMIN, V32, P264, DOI 10.1097/00005110-200205000-00006; Arino JM, 2009, ATEN PRIM, V41, P670, DOI 10.1016/j.aprim.2009.03.012; Mascia D, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-172; Mascia D, 2011, SOC SCI MED, V72, P798, DOI 10.1016/j.socscimed.2010.12.011; Menchik DA, 2010, J HEALTH SOC BEHAV, V51, P137, DOI 10.1177/0022146510372231; Myers DJ, 2010, AM J IND MED, V53, P514, DOI 10.1002/ajim.20805; Nair HS, 2010, J MARKETING RES, V47, P883, DOI 10.1509/jmkr.47.5.883; O'Malley AJ, 2008, HEALTH SERV OUTCOME, V8, P222, DOI 10.1007/s10742-008-0041-z; Pappas James M, 2003, Hosp Top, V81, P15; Pappas JM, 2004, HEALTH CARE MANAGE R, V29, P8, DOI 10.1097/00004010-200401000-00003; Landim FLP, 2010, SAUDE SOC, V19, P828, DOI 10.1590/S0104-12902010000400010; Quinlan E, 2010, J INTERPROF CARE, V24, P565, DOI 10.3109/13561820903520385; Rangachari P, 2008, HEALTH CARE MANAGE R, V33, P253, DOI 10.1097/01.HMR.0000324910.26896.91; Rangachari Pavani, 2010, Qual Manag Health Care, V19, P330, DOI 10.1097/QMH.0b013e3181fa36a4; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Sales AE, 2010, IMPLEMENTATION SCI, V5; Samarth Chandrika N, 2009, J Healthc Inf Manag, V23, P20; Scott J, 2005, ANN FAM MED, V3, P443, DOI 10.1370/afm.344; Sykes TA, 2011, J AM MED INFORM ASSN, V18, P125, DOI 10.1136/jamia.2010.009316; Tagliaventi MR, 2006, HUM RELAT, V59, P291, DOI 10.1177/0018726706064175; Valente TW, 2007, HEALTH EDUC BEHAV, V34, P881, DOI 10.1177/1090198106297855; Valente TW, 1996, SOC NETWORKS, V18, P69, DOI 10.1016/0378-8733(95)00256-1; van Beek APA, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-140; Vanderveen KA, 2007, ANN SURG ONCOL, V14, P1662, DOI 10.1245/s10434-006-9336-x; Walton JM, 2010, MED EDUC, V44, P550, DOI 10.1111/j.1365-2923.2010.03626.x; Ward V, 2010, ROLE INFORMAL NETWOR; Waring J, 2011, KNOWLEDGE SHARING BO; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wensing C, 2010, IMPLEMENTATION SCI, V5; Wensing M, 2011, IMPLEMENTATION SCI, V6; West E, 1999, SOC SCI MED, V48, P633, DOI 10.1016/S0277-9536(98)00361-X; West E, 2005, CAN J NURS RES, V37, P132; WINICK C, 1961, SOCIOMETRY, V24, P384, DOI 10.2307/2785920; Zappa P, 2011, QUAL QUANT, V45, P1109, DOI 10.1007/s11135-011-9494-1; Zheng Kai, 2007, AMIA Annu Symp Proc, P1175; Zheng K, 2010, J AM MED INFORM ASSN, V17, P328, DOI 10.1136/jamia.2009.000877	78	142	143	2	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41911	10.1371/journal.pone.0041911	http://dx.doi.org/10.1371/journal.pone.0041911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22870261	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100036
J	Dinkla, S; Novotny, VMJ; Joosten, I; Bosman, GJCGM				Dinkla, Sip; Novotny, Vera M. J.; Joosten, Irma; Bosman, Giel J. C. G. M.			Storage-Induced Changes in Erythrocyte Membrane Proteins Promote Recognition by Autoantibodies	PLOS ONE			English	Article							AUTOIMMUNE HEMOLYTIC-ANEMIA; BLOOD-BANK CONDITIONS; IN-VIVO; AGED ERYTHROCYTES; RED-CELLS; TRANSFUSION; INFLAMMATION; VESICLES; BAND-3; SILVER	Physiological erythrocyte removal is associated with a selective increase in expression of neoantigens on erythrocytes and their vesicles, and subsequent autologous antibody binding and phagocytosis. Chronic erythrocyte transfusion often leads to immunization and the formation of alloantibodies and autoantibodies. We investigated whether erythrocyte storage leads to the increased expression of non-physiological antigens. Immunoprecipitations were performed with erythrocytes and vesicles from blood bank erythrocyte concentrates of increasing storage periods, using patient plasma containing erythrocyte autoantibodies. Immunoprecipitate composition was identified using proteomics. Patient plasma antibody binding increased with erythrocyte storage time, while the opposite was observed for healthy volunteer plasma, showing that pathology-associated antigenicity changes during erythrocyte storage. Several membrane proteins were identified as candidate antigens. The protein complexes that were precipitated by the patient antibodies in erythrocytes were different from the ones in the vesicles formed during erythrocyte storage, indicating that the storage-associated vesicles have a different immunization potential. Soluble immune mediators including complement factors were present in the patient plasma immunoprecipitates, but not in the allogeneic control immunoprecipitates. The results support the theory that disturbed erythrocyte aging during storage of erythrocyte concentrates contributes to transfusion-induced alloantibody and autoantibody formation.	[Dinkla, Sip; Joosten, Irma] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, Dept Lab Med,Lab Med Immunol, NL-6525 ED Nijmegen, Netherlands; [Novotny, Vera M. J.] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands; [Bosman, Giel J. C. G. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Dinkla, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, Dept Lab Med,Lab Med Immunol, NL-6525 ED Nijmegen, Netherlands.	G.Bosman@ncmls.ru.nl	Joosten, Irma/N-4418-2013; Bosman, G.J.C.G.M./L-4221-2015	Joosten, Irma/0000-0003-2950-4977; 				Antonelou MH, 2010, TRANSFUSION, V50, P376, DOI 10.1111/j.1537-2995.2009.02449.x; BARKER RN, 1992, BRIT J HAEMATOL, V82, P126, DOI 10.1111/j.1365-2141.1992.tb04604.x; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Bosman GJCGM, 2008, TRANSFUSION MED, V18, P335, DOI 10.1111/j.1365-3148.2008.00892.x; Bosman GJCGM, 2008, TRANSFUSION, V48, P827, DOI 10.1111/j.1537-2995.2007.01630.x; BOSMAN GJCGM, 1993, NEUROBIOL AGING, V14, P223, DOI 10.1016/0197-4580(93)90004-U; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUCE LJ, 1995, BLOOD, V85, P541; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Couper KN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000744; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Facchiano A, 2009, AMINO ACIDS, V36, P599, DOI 10.1007/s00726-008-0124-8; Fossati-Jimack L, 2002, J AUTOIMMUN, V18, P17, DOI 10.1006/jaut.2001.0563; Galletti J, 2008, J IMMUNOL, V181, P3674, DOI 10.4049/jimmunol.181.5.3674; Grove H, 2009, ELECTROPHORESIS, V30, P1856, DOI 10.1002/elps.200800568; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Kriebardis AG, 2008, TRANSFUSION, V48, P1943, DOI 10.1111/j.1537-2995.2008.01794.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang KS, 2005, CELL PHYSIOL BIOCHEM, V15, P195, DOI 10.1159/000086406; LEDDY JP, 1993, J CLIN INVEST, V91, P1672, DOI 10.1172/JCI116376; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; Luten M, 2008, TRANSFUSION, V48, P1478, DOI 10.1111/j.1537-2995.2008.01734.x; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Messana I, 2000, TRANSFUSION, V40, P353, DOI 10.1046/j.1537-2995.2000.40030353.x; Racanelli V, 2011, AUTOIMMUN REV, V10, P503, DOI 10.1016/j.autrev.2011.03.001; Salzer U, 2008, TRANSFUSION, V48, P451, DOI 10.1111/j.1537-2995.2007.01549.x; Sawasdee N, 2010, BIOCHEM BIOPH RES CO, V401, P85, DOI 10.1016/j.bbrc.2010.09.015; Shen CR, 2003, BLOOD, V102, P3800, DOI 10.1182/blood-2002-07-2125; Stolz A, 2010, BBA-MOL CELL RES, V1803, P694, DOI 10.1016/j.bbamcr.2010.02.005; van den Akker E, 2010, BLOOD CELL MOL DIS, V45, P1, DOI 10.1016/j.bcmd.2010.02.019; Vlaar APJ, 2010, ANESTHESIOLOGY, V113, P92, DOI 10.1097/ALN.0b013e3181de6f25; Willekens FLA, 2003, BLOOD, V101, P747, DOI 10.1182/blood-2002-02-0500; Willekens FLA, 2008, BRIT J HAEMATOL, V141, P549, DOI 10.1111/j.1365-2141.2008.07055.x; Xiong ZY, 2011, TRANSFUSION, V51, P610, DOI 10.1111/j.1537-2995.2010.02861.x; Young PP, 2004, TRANSFUSION, V44, P67, DOI 10.1046/j.0041-1132.2003.00589.x	37	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42250	10.1371/journal.pone.0042250	http://dx.doi.org/10.1371/journal.pone.0042250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879923	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100059
J	Edqvist, PHD; Niklasson, M; Vidal-Sanz, M; Hallbook, F; Forsberg-Nilsson, K				Edqvist, Per-Henrik D.; Niklasson, Mia; Vidal-Sanz, Manuel; Hallbook, Finn; Forsberg-Nilsson, Karin			Platelet-Derived Growth Factor Over-Expression in Retinal Progenitors Results in Abnormal Retinal Vessel Formation	PLOS ONE			English	Article							PERSISTENT FETAL VASCULATURE; OVEREXPRESSING PDGF-B; PRECURSOR CELLS APCS; DEVELOPING MOUSE EYE; OPTIC-NERVE; GLIAL-CELLS; IN-VIVO; MICE; DIFFERENTIATION; ASTROCYTES	Platelet-derived growth factor (PDGF) plays an important role in development of the central nervous system, including the retina. Excessive PDGF signaling is associated with proliferative retinal disorders. We reported previously that transgenic mice in which PDGF-B was over-expressed under control of the nestin enhancer, nes/tk-PdgfB-lacZ, exhibited enhanced apoptosis in the developing corpus striatum. These animals display enlarged lateral ventricles after birth as well as behavioral aberrations as adults. Here, we report that in contrast to the relatively mild central nervous system phenotype, development of the retina is severely disturbed in nes/tk-PdgfB-lacZ mice. In transgenic retinas all nuclear layers were disorganized and photoreceptor segments failed to develop properly. Since astrocyte precursor cells did not populate the retina, retinal vascular progenitors could not form a network of vessels. With time, randomly distributed vessels resembling capillaries formed, but there were no large trunk vessels and the intraocular pressure was reduced. In addition, we observed a delayed regression of the hyaloid vasculature. The prolonged presence of this structure may contribute to the other abnormalities observed in the retina, including the defective lamination.	[Edqvist, Per-Henrik D.; Niklasson, Mia; Forsberg-Nilsson, Karin] Dept Immunol Genet & Pathol, Uppsala, Sweden; [Edqvist, Per-Henrik D.; Niklasson, Mia; Forsberg-Nilsson, Karin] Sci Life Lab, Uppsala, Sweden; [Hallbook, Finn] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Vidal-Sanz, Manuel] Univ Murcia, Dept Ophthalmol, Murcia, Spain	Uppsala University; University of Murcia	Edqvist, PHD (corresponding author), Dept Immunol Genet & Pathol, Uppsala, Sweden.	karin.nilsson@igp.uu.se	Forsberg-Nilsson, Karin/D-9604-2019; Vidal-Sanz, Manuel/J-6989-2016	Forsberg-Nilsson, Karin/0000-0003-0692-6245; Vidal-Sanz, Manuel/0000-0002-9216-1615; Hallbook, Finn/0000-0001-7552-187X	Swedish Cancer Society [070079]; Swedish Research Council [319-2008-2557]; Swedish Childhood Cancer Foundation [PROJ07/017]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission)	This study was supported by grants to KFN from the Swedish Cancer Society (www.cancerfonden.se Grant 070079), Swedish Research Council (www.vr.se 319-2008-2557) and Swedish Childhood Cancer Foundation (www.barncancerfonden.se PROJ07/017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrakis G, 2000, OPHTHALMOLOGY, V107, P1068, DOI 10.1016/S0161-6420(00)00100-7; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Chan-Ling T, 2009, GLIA, V57, P39, DOI 10.1002/glia.20733; Chang B, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-18; Chu Y, 2001, FASEB J, V15, P2013, DOI 10.1096/fj.00-0868fje; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Forsberg-Nilsson K, 2003, GLIA, V41, P276, DOI 10.1002/glia.10191; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Fruttiger M, 2000, CURR BIOL, V10, P1283, DOI 10.1016/S0960-9822(00)00757-0; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Goldberg MF, 1997, AM J OPHTHALMOL, V124, P587, DOI 10.1016/S0002-9394(14)70899-2; Guidry C, 2003, INVEST OPHTH VIS SCI, V44, P1355, DOI 10.1167/iovs.02-0046; Hackett SF, 2002, J CELL PHYSIOL, V192, P182, DOI 10.1002/jcp.10128; Homsi Jade, 2007, Cancer Control, V14, P285; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Johansson CB, 2002, J NEUROSCI RES, V69, P784, DOI 10.1002/jnr.10376; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Lindsey JD, 2005, J GLAUCOMA, V14, P318, DOI 10.1097/01.ijg.0000169411.09258.f6; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P2001; MUDHAR HS, 1993, DEVELOPMENT, V118, P539; Niklasson M, 2010, EXP CELL RES, V316, P2779, DOI 10.1016/j.yexcr.2010.07.009; Peichl L, 1998, NATO ADV SCI I A-LIF, V299, P147; Pequignot MO, 2003, DEV DYNAM, V228, P231, DOI 10.1002/dvdy.10376; Reichel MB, 1998, CELL DEATH DIFFER, V5, P156, DOI 10.1038/sj.cdd.4400326; Reneker LW, 1996, INVEST OPHTH VIS SCI, V37, P2455; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Savinova OV, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-12; Seo MS, 2000, AM J PATHOL, V157, P995, DOI 10.1016/S0002-9440(10)64612-3; Silva RLA, 2005, EMBO J, V24, P2803, DOI 10.1038/sj.emboj.7600751; Thornton JD, 2007, INVEST OPHTH VIS SCI, V48, P491, DOI 10.1167/iovs.06-0765; Vinores SA, 2003, DEV BRAIN RES, V140, P169, DOI 10.1016/S0165-3806(02)00581-3; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; Xue LP, 2006, NEUROSCIENCE, V139, P723, DOI 10.1016/j.neuroscience.2005.12.032; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; Zhang JM, 2008, INVEST OPHTH VIS SCI, V49, P5561, DOI 10.1167/iovs.08-2226	41	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42488	10.1371/journal.pone.0042488	http://dx.doi.org/10.1371/journal.pone.0042488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880002	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100109
J	Formella, I; Scott, EK; Burne, THJ; Harms, LR; Liu, PY; Turner, KM; Cui, X; Eyles, DW				Formella, Isabel; Scott, Ethan K.; Burne, Tom H. J.; Harms, Lauren R.; Liu, Pei-Yun; Turner, Karly M.; Cui, Xiaoying; Eyles, Darryl W.			Transient Knockdown of Tyrosine Hydroxylase during Development Has Persistent Effects on Behaviour in Adult Zebrafish (Danio rerio)	PLOS ONE			English	Article							DOPAMINE-RECEPTOR GENES; D DEFICIENCY ALTERS; LARVAL ZEBRAFISH; CATECHOLAMINERGIC SYSTEMS; LOCUS-COERULEUS; SCHIZOPHRENIA; BRAIN; EXPRESSION; NEURONS; ANXIETY	Abnormal dopamine (DA) signaling is often suggested as causative in schizophrenia. The other prominent hypothesis for this disorder, largely driven by epidemiological data, is that certain adverse events during the early stages of brain development increase an individual's risk of developing schizophrenia later in life. However, the clinical and preclinical literature consistently implicates behavioural, cognitive, and pharmacological abnormalities, implying that DA signaling is abnormal in the adult brain. How can we reconcile these two major hypotheses underlying much of the clinical and basic research into schizophrenia? In this study we have transiently knocked down tyrosine hydroxylase (TH, the rate limiting enzyme in DA synthesis) gene expression in the early stages of brain development in zebrafish using morpholinos. We show that by adulthood, TH and DA levels have returned to normal and basic DA-mediated behaviours, such as locomotion, are also normal. However, when they were exposed to a novel environment the levels of freezing and immediate positioning in deeper zones were significantly reduced in these adult fish. The neurochemistry underlying these behaviours is complex, and the exact mechanisms for these abnormal behaviours remains unknown. This study demonstrates that early transient alterations in DA ontogeny can produce persistent alterations in adult brain function and suggests that the zebrafish may be a promising model animal for future studies directed at clarifying the basic neurodevelopmental mechanisms behind complex psychiatric disease.	[Formella, Isabel; Scott, Ethan K.; Burne, Tom H. J.; Harms, Lauren R.; Liu, Pei-Yun; Turner, Karly M.; Cui, Xiaoying; Eyles, Darryl W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Scott, Ethan K.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Burne, Tom H. J.; Eyles, Darryl W.] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Queensland Centre for Mental Health Research	Formella, I (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	eyles@uq.edu.au	Burne, Thomas H/C-5656-2009; Harms, Lauren R/J-8698-2012; Turner, Karly/F-4607-2012; Eyles, Darryl W/X-3386-2018	Burne, Thomas H/0000-0003-3502-9789; Turner, Karly/0000-0003-3714-5118; Eyles, Darryl W/0000-0002-5023-7095; Scott, Ethan/0000-0003-3150-9216; Harms, Lauren/0000-0003-2268-8654	National Health and Medical Research Council, Australia; Queensland Centre for Mental Health Research, Australia	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Queensland Centre for Mental Health Research, Australia	This study was supported by the National Health and Medical Research Council, Australia, and the Queensland Centre for Mental Health Research, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcellos LJG, 2007, AQUACULTURE, V272, P774, DOI 10.1016/j.aquaculture.2007.09.002; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Blaser R, 2006, BEHAV RES METHODS, V38, P456, DOI 10.3758/BF03192800; Blaser RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036931; Blin M, 2008, MOL CELL NEUROSCI, V39, P592, DOI 10.1016/j.mcn.2008.08.006; Boehmler W, 2007, GENES BRAIN BEHAV, V6, P155, DOI 10.1111/j.1601-183X.2006.00243.x; Boehmler W, 2004, DEV DYNAM, V230, P481, DOI 10.1002/dvdy.20075; Burne T, 2011, MOL PSYCHIATR, V16, P7, DOI 10.1038/mp.2010.35; Cachat J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017597; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Cachat J, 2010, BEHAV BRAIN RES, V208, P371, DOI 10.1016/j.bbr.2009.12.004; Candy J, 2005, BBA-GENE STRUCT EXPR, V1727, P35, DOI 10.1016/j.bbaexp.2004.11.005; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; Cui XY, 2010, NEUROSCI LETT, V486, P220, DOI 10.1016/j.neulet.2010.09.057; Eastwood SL, 2004, INT REV NEUROBIOL, V59, P47; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Eyles D, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.6; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Filippi A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-135; Filippi A, 2010, J COMP NEUROL, V518, P423, DOI 10.1002/cne.22213; Giacomini NJ, 2006, NEUROTOXICOL TERATOL, V28, P245, DOI 10.1016/j.ntt.2006.01.013; Hermanson E, 2003, EXP CELL RES, V288, P324, DOI 10.1016/S0014-4827(03)00216-7; Holland LZ, 2008, BRAIN BEHAV EVOLUT, V72, P91, DOI 10.1159/000151470; Holzschuh J, 2003, J NEUROSCI, V23, P5507; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Kandel ER., 2012, PRINCIPLES NEURAL SC, V5; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; Kastenhuber E, 2010, J COMP NEUROL, V518, P439, DOI 10.1002/cne.22214; Kesby JP, 2009, NEUROSCI LETT, V461, P155, DOI 10.1016/j.neulet.2009.05.070; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lange M, 2012, MOL PSYCHIATR, V17, P946, DOI 10.1038/mp.2012.29; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; LEWIS SW, 1987, J PSYCHIAT RES, V21, P413, DOI 10.1016/0022-3956(87)90088-4; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; Lopez-Patino MA, 2008, PHYSIOL BEHAV, V93, P160, DOI 10.1016/j.physbeh.2007.08.013; Ma PM, 2003, J COMP NEUROL, V460, P13, DOI 10.1002/cne.10544; MA PM, 1994, J COMP NEUROL, V344, P242, DOI 10.1002/cne.903440206; MA PM, 1994, J COMP NEUROL, V344, P256, DOI 10.1002/cne.903440207; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Maximino C, 2010, BEHAV BRAIN RES, V210, P1, DOI 10.1016/j.bbr.2010.01.031; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Meyer U, 2008, NEUROSCIENCE, V154, P701, DOI 10.1016/j.neuroscience.2008.04.031; Mirnics K, 2001, AM J PSYCHIAT, V158, P1384, DOI 10.1176/appi.ajp.158.9.1384; Murray RM, 2008, EUR NEUROPSYCHOPHARM, V18, pS129, DOI 10.1016/j.euroneuro.2008.04.002; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Rosemberg DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019397; Ruediger T, 2007, ADV EXP MED BIOL, V621, P104, DOI 10.1007/978-0-387-76715-4_8; Sackerman James, 2010, Int J Comp Psychol, V23, P43; Schweitzer J, 2009, ADV EXP MED BIOL, V651, P1; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Souza BR, 2011, J NEUROSCI, V31, P5512, DOI 10.1523/JNEUROSCI.5548-10.2011; Speedie N, 2008, BEHAV BRAIN RES, V188, P168, DOI 10.1016/j.bbr.2007.10.031; Stewart A, 2012, NEUROPHARMACOLOGY, V62, P135, DOI 10.1016/j.neuropharm.2011.07.037; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023; Yamamoto K, 2010, MOL CELL NEUROSCI, V43, P394, DOI 10.1016/j.mcn.2010.01.006	62	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42482	10.1371/journal.pone.0042482	http://dx.doi.org/10.1371/journal.pone.0042482			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879998	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100104
J	Qurei, L; Seto, D; Salah, Z; Azzeh, M				Qurei, Lina; Seto, Donald; Salah, Zaidoun; Azzeh, Maysa			A Molecular Epidemiology Survey of Respiratory Adenoviruses Circulating in Children Residing in Southern Palestine	PLOS ONE			English	Article							COMPUTATIONAL ANALYSIS; TRACT INFECTIONS; BUENOS-AIRES; 2 STRAINS; OUTBREAK; DISEASE; PNEUMONIA; TYPE-3; IDENTIFICATION; SEROTYPES	A molecular epidemiology survey was performed in order to establish and document the respiratory adenovirus pathogen profiles among children in Southern Palestine. Three hundred and thirty-eight hospitalized pediatric cases with adenovirus-associated respiratory tract infections were analyzed. Forty four cases out of the 338 were evaluated in more detail for the adenoviruses types present. All of the children resided in Southern Palestine, that is, in city, village and refugee camp environments within the districts of Hebron and Bethlehem. Human adenoviruses circulated throughout 2005-2010, with major outbreaks occurring in the spring months. A larger percent of the children diagnosed with adenoviral infections were male infants. DNA sequence analysis of the hexon genes from 44 samples revealed that several distinct adenovirus types circulated in the region; these were HAdV-C1, HAdV-C2, HAdV-B3 and HAdV-C5. However, not all of these types were detected within each year. This is the first study ever conducted in Palestine of the genetic epidemiology of respiratory adenovirus infections.	[Qurei, Lina; Salah, Zaidoun; Azzeh, Maysa] Al Quds Univ, Virol Res Lab, Med Res Ctr, E Jerusalem Abu Dies, Israel; [Seto, Donald] George Mason Univ, Sch Syst Biol, Manassas, VA USA	George Mason University	Qurei, L (corresponding author), Al Quds Univ, Virol Res Lab, Med Res Ctr, E Jerusalem Abu Dies, Israel.	mazzeh@med.alquds.edu			Virology Laboratory at the Medical Research Center	Virology Laboratory at the Medical Research Center	Support for this work came, in part, from the internal resources of the Virology Laboratory at the Medical Research Center. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Jamil J, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-46; Barrero PR, 2012, J CLIN VIROL, V53, P145, DOI 10.1016/j.jcv.2011.11.001; BRANDT CD, 1969, AM J EPIDEMIOL, V90, P484, DOI 10.1093/oxfordjournals.aje.a121094; Carballal Guadalupe, 2002, BMC Pediatr, V2, P6, DOI 10.1186/1471-2431-2-6; Chang SY, 2008, J MED VIROL, V80, P102, DOI 10.1002/jmv.21045; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Chmielewicz B, 2005, J MED VIROL, V77, P232, DOI 10.1002/jmv.20441; Cohen S, 1999, ANN NY ACAD SCI, V896, P246, DOI 10.1111/j.1749-6632.1999.tb08119.x; Cooper RJ, 2000, EPIDEMIOL INFECT, V125, P333, DOI 10.1017/S0950268899004550; De Jong JC, 1999, J CLIN MICROBIOL, V37, P3940, DOI 10.1128/JCM.37.12.3940-3945.1999; DENNY FW, 1995, AM J RESP CRIT CARE, V152, pS4, DOI 10.1164/ajrccm/152.4_Pt_2.S4; Esposito DH, 2010, J INFECT DIS, V202, P214, DOI 10.1086/653498; Franz A, 2010, J CLIN VIROL, V48, P239, DOI 10.1016/j.jcv.2010.05.007; FU WY, 1989, CHINESE MED J-PEKING, V102, P857; Ghanaiem H, 2011, PEDIATR INFECT DIS J, V30, P948, DOI 10.1097/INF.0b013e31822702fe; Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188; Harley D, 2001, Commun Dis Intell, V25, P9; HEMMING VG, 1994, J PEDIATR-US, V124, pS13, DOI 10.1016/S0022-3476(94)70185-7; HILLEMAN MR, 1954, P SOC EXP BIOL MED, V85, P183, DOI 10.3181/00379727-85-20825; Hsieh WY, 2009, J MICROBIOL IMMUNOL, V42, P371; Ishiko H, 2009, J CLIN MICROBIOL, V47, P2678, DOI 10.1128/JCM.r00313-09; JOHANSSON ME, 1993, J VIROL METHODS, V42, P193, DOI 10.1016/0166-0934(93)90032-M; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; KAJON AE, 1992, J MED VIROL, V36, P292, DOI 10.1002/jmv.1890360411; Kandel R, 2010, INFECT CONT HOSP EP, V31, P755, DOI 10.1086/653612; Landry ML, 2009, J MED VIROL, V81, P1380, DOI 10.1002/jmv.21539; Lautenbach Ebbing, 2010, LDI Issue Brief, V16, P1; Lee J, 2010, J MED VIROL, V82, P624, DOI 10.1002/jmv.21701; Lessa FC, 2009, J INFECT DIS, V200, P1759, DOI 10.1086/647987; Liu EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024491; Louie JK, 2008, CLIN INFECT DIS, V46, P421, DOI 10.1086/525261; Lu X, 2006, ARCH VIROL, V151, P1587, DOI 10.1007/s00705-005-0722-7; Mandelboim M, 2011, J CLIN MICROBIOL, V49, P597, DOI 10.1128/JCM.00979-10; MANTYJAR.R, 1966, ANN MED EXP BIOL FEN, VS 44, P7; Metzgar D, 2005, J CLIN MICROBIOL, V43, P5743, DOI 10.1128/JCM.43.11.5743-5752.2005; Mitchell LS, 2000, PEDIATR INFECT DIS J, V19, P996, DOI 10.1097/00006454-200010000-00011; Mizuta K, 2006, MICROBIOL IMMUNOL, V50, P553, DOI 10.1111/j.1348-0421.2006.tb03826.x; Munoz FM, 1998, CLIN INFECT DIS, V27, P1194, DOI 10.1086/514978; Palomino MA, 2000, PEDIATR INFECT DIS J, V19, P527, DOI 10.1097/00006454-200006000-00007; Palomino MA, 2004, PEDIATR INFECT DIS J, V23, P337, DOI 10.1097/00006454-200404000-00012; Pavia AT, 2011, CLIN INFECT DIS, V52, pS284, DOI 10.1093/cid/cir043; PIEDRA PA, 1962, INFECT IMMUNOCOMPOMI, P662; PINTO A, 1992, ARCH PATHOL LAB MED, V116, P95; Rebelo-De-Andrade H, 2010, J CLIN MICROBIOL, V48, P1391, DOI 10.1128/JCM.02019-09; Robinson CM, 2011, VIROLOGY, V409, P141, DOI 10.1016/j.virol.2010.10.020; Rocholl C, 2004, PEDIATRICS, V113, pE51, DOI 10.1542/peds.113.1.e51; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; RUUSKANEN O, 1992, EUR J CLIN MICROBIOL, V11, P217, DOI 10.1007/BF02098083; Ryan MAK, 2002, CLIN INFECT DIS, V34, P577, DOI 10.1086/338471; SCHMITZ H, 1983, AM J EPIDEMIOL, V117, P455, DOI 10.1093/oxfordjournals.aje.a113563; Selvaraju SB, 2011, J CLIN VIROL, V51, P126, DOI 10.1016/j.jcv.2011.02.014; Seto D, 2011, J VIROL, V85, P5701, DOI 10.1128/JVI.00354-11; Shiley KT, 2010, INFECT CONT HOSP EP, V31, P1177, DOI 10.1086/656596; SINGHNAZ N, 1993, PEDIATR INFECT DIS J, V12, P922, DOI 10.1097/00006454-199311000-00006; VANDERVEEN J, 1969, J HYG-CAMB, V67, P255, DOI 10.1017/S0022172400041668; Walsh MP, 2011, J CLIN MICROBIOL, V49, P3482, DOI 10.1128/JCM.00156-11; Walsh MP, 2010, J CLIN MICROBIOL, V48, P991, DOI 10.1128/JCM.01694-09; Walsh MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005635; Wold WSM, 2007, FIELDS VIROLOGY, P2396; Wu E, 1990, Rev Chil Pediatr, V61, P177; Yeung R, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-11; Zhang QW, 2006, J GEN VIROL, V87, P1531, DOI 10.1099/vir.0.81515-0; Zheng X, 2008, J CLIN MICROBIOL, V46, P317, DOI 10.1128/JCM.01585-07; Zhu Z, 2009, J CLIN MICROBIOL, V47, P697, DOI 10.1128/JCM.01769-08	64	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42732	10.1371/journal.pone.0042732	http://dx.doi.org/10.1371/journal.pone.0042732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880092	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100163
J	Richards, CH; Roxburgh, CSD; MacMillan, MT; Isswiasi, S; Robertson, EG; Guthrie, GK; Horgan, PG; McMillan, DC				Richards, Colin H.; Roxburgh, Campbell S. D.; MacMillan, Mark T.; Isswiasi, Sanad; Robertson, Ewen G.; Guthrie, Graeme K.; Horgan, Paul G.; McMillan, Donald C.			The Relationships between Body Composition and the Systemic Inflammatory Response in Patients with Primary Operable Colorectal Cancer	PLOS ONE			English	Article							WEIGHT-LOSS; PROGNOSTIC SCORE; CURATIVE RESECTION; MASS DEPLETION; CHEMOTHERAPY; SURVIVAL; TUMOR; LUNG; COMPLICATIONS; DISEASE	Background: Weight loss is recognised as a marker of poor prognosis in patients with cancer but the aetiology of cancer cachexia remains unclear. The aim of the present study was to examine the relationships between CT measured parameters of body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. Patient and Methods: 174 patients with primary operable colorectal cancer who underwent resection with curative intent (2003-2010). Image analysis of CT scans was used to measure total fat index (cm(2)/m(2)), subcutaneous fat index (cm(2)/m(2)), visceral fat index (cm(2)/m(2)) and skeletal muscle index (cm(2)/m(2)). Systemic inflammatory response was measured by serum white cell count (WCC), neutrophil: lymphocyte ratio (NLR) and the Glasgow Prognostic Score (mGPS). Results: There were no relationships between any parameter of body composition and serum WCC or NLR. There was a significant relationship between low skeletal muscle index and an elevated systemic inflammatory response, as measured by the mGPS (p = 0.001). This was confirmed by linear relationships between skeletal muscle index and both C-reactive protein (r = -0.21, p = 0.005) and albumin (r = 0.31, p<0.001). There was no association between skeletal muscle index and tumour stage. Conclusions: The present study highlights a direct relationship between low levels of skeletal muscle and the presence of a systemic inflammatory response in patients with primary operable colorectal cancer.	[Richards, Colin H.; Roxburgh, Campbell S. D.; MacMillan, Mark T.; Isswiasi, Sanad; Guthrie, Graeme K.; Horgan, Paul G.; McMillan, Donald C.] Glasgow Royal Infirm, Univ Dept Surg, Glasgow G4 0SF, Lanark, Scotland; [Robertson, Ewen G.] Glasgow Royal Infirm, Univ Dept Radiol, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow; University of Glasgow	Richards, CH (corresponding author), Glasgow Royal Infirm, Univ Dept Surg, Glasgow G4 0SF, Lanark, Scotland.	colinrichards@nhs.net	peng-cheng, chen/K-8100-2013	peng-cheng, chen/0000-0001-9763-6459; McMillan, Donald/0000-0003-4260-5334				Andreyev HJN, 1998, EUR J CANCER, V34, P503, DOI 10.1016/S0959-8049(97)10090-9; Argiles JM, 2005, INT J BIOCHEM CELL B, V37, P2036, DOI 10.1016/j.biocel.2005.03.014; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bosanquet N, 2004, LANCET ONCOL, V5, P568, DOI 10.1016/S1470-2045(04)01569-4; Brown DJF, 2007, J CLIN PATHOL, V60, P705, DOI 10.1136/jcp.2005.033217; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fleming IDCJ, 1997, AJCC; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Khalid U, 2007, SUPPORT CARE CANCER, V15, P39, DOI 10.1007/s00520-006-0091-0; Kotler DP, 2000, ANN INTERN MED, V133, P622, DOI 10.7326/0003-4819-133-8-200010170-00015; Maltoni M, 2005, J CLIN ONCOL, V23, P6240, DOI 10.1200/JCO.2005.06.866; McMillan DC, 1998, NUTR CANCER, V31, P101, DOI 10.1080/01635589809514687; McMillan DC, 2008, P NUTR SOC, V67, P257, DOI 10.1017/S0029665108007131; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Moyes LH, 2009, BRIT J CANCER, V100, P1236, DOI 10.1038/sj.bjc.6604997; O'Gorman P, 2000, NUTR CANCER, V37, P36, DOI 10.1207/S15327914NC3701_4; Peng PD, 2011, HPB, V13, P439, DOI 10.1111/j.1477-2574.2011.00301.x; PERRY GS, 1995, EPIDEMIOLOGY, V6, P61, DOI 10.1097/00001648-199501000-00012; Pichard C, 2004, AM J CLIN NUTR, V79, P613; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2007, CLIN CANCER RES, V13, P3264, DOI 10.1158/1078-0432.CCR-06-3067; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Richards CH, 2011, ANN SURG, V254, P83, DOI 10.1097/SLA.0b013e31821fd469; Ross PJ, 2004, BRIT J CANCER, V90, P1905, DOI 10.1038/sj.bjc.6601781; Roxburgh CSD, 2010, COLORECTAL DIS, V12, P987, DOI 10.1111/j.1463-1318.2009.01961.x; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI 10.2217/FON.09.136; Saijo Y, 2004, DIABETES OBES METAB, V6, P249, DOI 10.1111/j.1462-8902.2003.0342.x; STUNKARD AJ, 1981, AM J CLIN NUTR, V34, P1593, DOI 10.1093/ajcn/34.8.1593; Thibault R, 2012, CLIN NUTR; Thibault R, 2012, ANN NUTR METAB, V60, P6, DOI 10.1159/000334879; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; van Vledder MG, 2012, BRIT J SURG, V99, P550, DOI 10.1002/bjs.7823; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329	37	117	118	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41883	10.1371/journal.pone.0041883	http://dx.doi.org/10.1371/journal.pone.0041883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870258	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100035
J	Thean, LF; Li, HH; Teo, YY; Koh, WP; Yuan, JM; Teoh, ML; Koh, PK; Tang, CL; Cheah, PY				Thean, Lai Fun; Li, Hui Hua; Teo, Yik Ying; Koh, Woon-Puay; Yuan, Jian-Min; Teoh, Mei Lin; Koh, Poh Koon; Tang, Choong Leong; Cheah, Peh Yean			Association of Caucasian-Identified Variants with Colorectal Cancer Risk in Singapore Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISM; MIXED POLYPOSIS SYNDROME; SUSCEPTIBILITY LOCI; C-MYC; 8Q24; SCAN; POPULATION; 8Q23.3; 18Q21	Background: Genome-wide association studies (GWAS) in Caucasians have identified fourteen index single nucleotide polymorphisms (iSNPs) that influence colorectal cancer (CRC) risk. Methods: We investigated the role of eleven iSNPs or surrogate SNPs (sSNPs), in high linkage disequilibrium (LD, r(2)>= 0.8) and within 100 kb vicinity of iSNPs, in 2,000 age-and gender-matched Singapore Chinese (SCH) cases and controls. Results: Only iSNP rs6983267 at 8q24.21 and sSNPs rs6695584, rs11986063, rs3087967, rs2059254, and rs7226855 at 1q41, 8q23.3, 11q23.1, 16q22.1 and 18q21.1 respectively showed evidence of association with CRC risk, with odds ratios (OR) ranging from 1.13 to 1.40. sSNP rs827401 at 10p14 was associated with rectal cancer risk (OR = 0.74, 95% CI 0.63-0.88) but not disease prognosis (OR = 0.91, 95% CI 0.69-1.20). Interestingly, sSNP rs3087967 at 11q23.1 was associated with CRC risk in men (OR = 1.34, 95% CI 1.14-1.58) but not women (OR = 1.07, 95% CI: 0.88-1.29), suggesting a gender-specific role. Half of the Caucasian-identified variants, including the recently fine-mapped BMP pathway loci, BMP4, GREM1, BMP2 and LAMA 5, did not show any evidence for association with CRC in SCH (OR similar to 1; p-value >0.1). Comparing the results of this study with that of the Northern and Hong Kong Chinese, only variants at chromosomes 8q24.21, 10p14, 11q23.1 and 18q21.1 were replicated in at least two out of the three Chinese studies. Conclusions: The contrasting results between Caucasians and Chinese could be due to different LD patterns and allelic frequencies or genetic heterogeneity. The results suggest that additional common variants contributing to CRC predisposition remained to be identified.	[Thean, Lai Fun; Koh, Poh Koon; Tang, Choong Leong; Cheah, Peh Yean] Singapore Gen Hosp, Dept Colorectal Surg, Singapore 0316, Singapore; [Li, Hui Hua] Singapore Gen Hosp, Dept Clin Res, Singapore 0316, Singapore; [Teo, Yik Ying; Koh, Woon-Puay; Cheah, Peh Yean] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Inst Canc, Pittsburgh, PA USA; [Teoh, Mei Lin] Singapore Gen Hosp, Hlth Screening Unit, Singapore 0316, Singapore; [Cheah, Peh Yean] Natl Univ Singapore, Grad Sch Med, Duke Natl Univ Singapore, Singapore 117548, Singapore	Singapore General Hospital; Singapore General Hospital; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Singapore General Hospital; National University of Singapore	Thean, LF (corresponding author), Singapore Gen Hosp, Dept Colorectal Surg, Singapore 0316, Singapore.	cheah.peh.yean@sgh.com.sg		Yuan, Jian-Min/0000-0002-4620-3108	National Medical Research Council of Singapore [NMRC/1193/2008]; National Institutes of Health [R01-CA55069, R35-CA53890, R01-CA80205, R01-CA98497, R01-CA144034]; NATIONAL CANCER INSTITUTE [R01CA098497, R01CA055069, R35CA053890, R01CA080205, R01CA144034] Funding Source: NIH RePORTER	National Medical Research Council of Singapore(National Medical Research Council, Singapore); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded in part by a grant from the National Medical Research Council of Singapore (NMRC/1193/2008) to PYC and grants from the National Institutes of Health (grant numbers R01-CA55069, R35-CA53890, R01-CA80205, R01-CA98497 and R01-CA144034) to WPK and JMY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Cao X, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.034827; Carvajal-Carmona LG, 2011, HUM MOL GENET, V20, P2879, DOI 10.1093/hmg/ddr190; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chia KS, 2000, 5 SING CANC REG; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; Ho JW, 2011, BRIT J CANCER, V104, P369, DOI 10.1038/sj.bjc.6605977; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Jaeger EEM, 2003, AM J HUM GENET, V72, P1261, DOI 10.1086/375144; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Lubbe SJ, 2012, CARCINOGENESIS, V33, P108, DOI 10.1093/carcin/bgr243; Matsuo K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-379; Niittymaki I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-23; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pittman AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001126; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Schafmayer C, 2009, INT J CANCER, V124, P75, DOI 10.1002/ijc.23872; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; von Holst S, 2010, BRIT J CANCER, V103, P575, DOI 10.1038/sj.bjc.6605774; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Xing JL, 2011, EUR J CANCER, V47, P1699, DOI 10.1016/j.ejca.2011.02.004; Xiong F, 2010, CANCER EPIDEM BIOMAR, V19, P1855, DOI 10.1158/1055-9965.EPI-10-0210; Xu S, 2009, AM J HUM GENET, V85, P1; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	28	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42407	10.1371/journal.pone.0042407	http://dx.doi.org/10.1371/journal.pone.0042407			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879968	Green Published, Green Accepted, gold			2022-12-27	WOS:000307284100082
J	Verger, P; Flicoteaux, R; Schwarzinger, M; Sagaon-Teyssier, L; Peretti-Watel, P; Launay, O; Sebbah, R; Moatti, JP				Verger, Pierre; Flicoteaux, Remi; Schwarzinger, Michael; Sagaon-Teyssier, Luis; Peretti-Watel, Patrick; Launay, Odile; Sebbah, Remy; Moatti, Jean-Paul			Pandemic Influenza (A/H1N1) Vaccine Uptake among French Private General Practitioners: A Cross Sectional Study in 2010	PLOS ONE			English	Article							HEALTH-CARE WORKERS; H1N1 INFLUENZA; WILLINGNESS; ACCEPTANCE; ATTITUDES; SELECTION; FRANCE	Background: In July, 2009, French health authorities, like those in many other countries, decided to embark on a mass vaccination campaign against the pandemic A(H1N1) influenza. Private general practitioners (GPs) were not involved in this campaign. We studied GPs' pandemic vaccine (pvaccine) uptake, quantified the relative contribution of its potential explanatory factors and studied whether their own vaccination choice was correlated with their recommendations to patients about pvaccination. Methodology/Principal Findings: In this cross-sectional telephone survey, professional investigators interviewed an existing panel of randomly selected private GPs (N = 1431; response rate at inclusion in the panel: 36.8%; participation rate in the survey: 100%). The main outcome variable was GPs' own pvaccine uptake. We used an averaging multi-model approach to quantify the relative contribution of factors associated with their vaccination. The pvaccine uptake rate was 61% (95% CI = 58.3-63.3). Four independent factors contributed the most to this rate (partial Nagelkerke's R-2): history of previous vaccination against seasonal influenza (14.5%), perception of risks and efficacy of the pvaccine (10.8%), opinions regarding the organization of the vaccination campaign (7.1%), and perception of the pandemic's severity (5.2%). Overall, 71.3% (95% CI = 69.0-73.6) of the participants recommended pvaccination to young adults at risk and 40.1% (95% CI = 37.6-42.7) to other young adults. GPs' own pvaccination was strongly predictive of their recommendation to both young adults at risk (OR = 9.6; 95% CI = 7.2-12.6) and those not at risk (OR = 8.5; 95% CI = 6.4-11.4). Conclusions/Significance: These results suggest that around 60% of French private GPs followed French authorities' recommendations about vaccination of health care professionals against the A(H1N1) influenza. They pinpoint priority levers for improving preparedness for future influenza pandemics. Besides encouraging GPs' own uptake of regular vaccination against seasonal influenza, providing GPs with clear information about the risks and efficacy of any new pvaccine and involving them in the organization of any future vaccine campaign may improve their pvaccine uptake.	[Verger, Pierre; Sagaon-Teyssier, Luis; Peretti-Watel, Patrick; Moatti, Jean-Paul] INSERM, Sci Econ & Sociales Sante & Traitement Informat M, Marseilles, France; [Verger, Pierre; Sagaon-Teyssier, Luis; Peretti-Watel, Patrick; Moatti, Jean-Paul] Aix Marseille Univ, UMR S912, Inst Rech & Dev, Marseilles, France; [Verger, Pierre; Sagaon-Teyssier, Luis; Peretti-Watel, Patrick; Moatti, Jean-Paul] Observ Reg Sante Provence Alpes Cote dAzur, Marseilles, France; [Flicoteaux, Remi] Hop St Louis, AP HP, Dept Biostat & Informat Med, Paris, France; [Schwarzinger, Michael] INSERM, Act Themat & Incitat Programme AVENIR U738, Paris, France; [Schwarzinger, Michael] Univ Paris Diderot, UMR S738, Paris, France; [Launay, Odile] INSERM, Ctr Invest Clin BT505, Paris, France; [Sebbah, Remy] Union Reg Profess Sante, Marseilles, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Verger, P (corresponding author), INSERM, Sci Econ & Sociales Sante & Traitement Informat M, Marseilles, France.	pierre.verger@inserm.fr	Schwarzinger, Michael/F-7367-2011; Peretti-Watel, Patrick/P-4535-2017	Schwarzinger, Michael/0000-0002-0573-6856; Sagaon-Teyssier, Luis/0000-0001-7318-6596	Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques - Ministere du travail, des relations sociales, de la famille, de la solidarite et de la ville/Ministere de la Sante et des Sports; Observatoire Regional de la Sante Provence-Alpes-Cote d'Azur	Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques - Ministere du travail, des relations sociales, de la famille, de la solidarite et de la ville/Ministere de la Sante et des Sports; Observatoire Regional de la Sante Provence-Alpes-Cote d'Azur	The French Regional Panel of General Practices received funding from the Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques - Ministere du travail, des relations sociales, de la famille, de la solidarite et de la ville/Ministere de la Sante et des Sports as part of the 2010-2012 contract with the Observatoire Regional de la Sante Provence-Alpes-Cote d'Azur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkuwari MG, 2011, VACCINE, V29, P2206, DOI 10.1016/j.vaccine.2010.08.093; Barriere J, 2010, VACCINE, V28, P7030, DOI 10.1016/j.vaccine.2010.08.021; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Bone A, 2010, VACCINE, V28, P8157, DOI 10.1016/j.vaccine.2010.09.096; Brien S, 2012, VACCINE, V30, P1255, DOI 10.1016/j.vaccine.2011.12.089; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chan M, 2009, WORDL NOW START 2009; Chor JSY, 2011, VACCINE, V29, P7364, DOI 10.1016/j.vaccine.2011.07.079; Chor JSY, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3391; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Dube Eve, 2010, BMC Res Notes, V3, P102, DOI 10.1186/1756-0500-3-102; Esteves-Jaramillo A, 2009, ARCH MED RES, V40, P705, DOI 10.1016/j.arcmed.2010.01.004; Fantino B, 2004, Sante Publique, V16, P551; Gautier A, 2011, 2009 HLTH BAROMETER; HANNOUN C, 1989, EUR J EPIDEMIOL, V5, P285, DOI 10.1007/BF00144828; HCSP, 2010, B EP HEBD, V14-15; Henrich N, 2009, Emerg Health Threats J, V2, pe8, DOI 10.3134/ehtj.09.008; Inoue Yusuke, 2011, Environmental Health and Preventive Medicine, V16, P320, DOI 10.1007/s12199-010-0202-x; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Joyce CM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-50; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kraut A, 2011, VACCINE, V29, P8357, DOI 10.1016/j.vaccine.2011.08.084; La Torre G, 2009, EUROSURVEILLANCE, V14, P7; Lavoue J, 2009, ANN OCCUP HYG, V53, P173, DOI 10.1093/annhyg/men085; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Maltezou HC, 2010, J INFECTION, V61, P252, DOI 10.1016/j.jinf.2010.06.004; Michiels B, 2006, VACCINE, V24, P3145, DOI 10.1016/j.vaccine.2006.01.040; Opstelten W, 2010, VACCINE, V28, P6164, DOI 10.1016/j.vaccine.2010.07.031; Poland GA, 2010, VACCINE, V28, pD3, DOI 10.1016/j.vaccine.2010.08.024; POTTHOFF RF, 1994, AM J EPIDEMIOL, V139, P967, DOI 10.1093/oxfordjournals.aje.a116946; Rachiotis G, 2010, EUROSURVEILLANCE, V15, P8; Raude Jocelyn, 2010, PLoS Curr, V2, pRRN1188, DOI 10.1371/currents.RRN1188; Savas E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-281; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; Schwarzinger M, 2010, VACCINE, V28, P2743, DOI 10.1016/j.vaccine.2010.01.027; Seale H, 2011, VACCINE, V29, P1605, DOI 10.1016/j.vaccine.2010.12.077; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Sicart D, 2008, 127 MIN SANT JEUN SP, P127; Thoon KC, 2010, ANN ACAD MED SINGAP, V39, P307; Torun SD, 2010, VACCINE, V28, P5703, DOI 10.1016/j.vaccine.2010.06.049; Turkheimer FE, 2003, J CEREBR BLOOD F MET, V23, P490, DOI 10.1097/01.WCB.0000050065.57184.BB; Viallefont V, 2001, STAT MED, V20, P3215, DOI 10.1002/sim.976.abs; Woo TM, 2010, J PEDIATR HEALTH CAR, V24, P258, DOI 10.1016/j.pedhc.2010.05.001; Wright DB, 2010, LEGAL CRIMINOL PSYCH, V15, P195, DOI 10.1348/135532508X400347; Yassi A, 1994, Can J Infect Control, V9, P103	45	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41837	10.1371/journal.pone.0041837	http://dx.doi.org/10.1371/journal.pone.0041837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879896	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100034
J	Wu, YC; Zhu, MF; Robertson, DM				Wu, Yu-Chieh; Zhu, Meifang; Robertson, Danielle M.			Novel Nuclear Localization and Potential Function of Insulin-Like Growth Factor-1 Receptor/Insulin Receptor Hybrid in Corneal Epithelial Cells	PLOS ONE			English	Article							PATHWAY MEDIATES ACTIVATION; FGFR1 SIGNALING INFS; LARGE GENE LISTS; TUMOR-CELLS; DIABETES-MELLITUS; IGF-1 RECEPTOR; ANGIOTENSIN-II; PROTEIN-KINASE; TYPE-1; DIFFERENTIATION	Background: Type I insulin-like growth factor receptor (IGF-1R) and insulin receptor (INSR) are highly homologous molecules, which can heterodimerize to form an IGF-1R/INSR hybrid (Hybrid-R). The presence and biological significance of the Hybrid-R in human corneal epithelium has not yet been established. In addition, while nuclear localization of IGF-1R was recently reported in cancer cells and human corneal epithelial cells, the function and profile of nuclear IGF-1R is unknown. In this study, we characterized the nuclear localization and function of the Hybrid-R and the role of IGF-1/IGF-1R and Hybrid-R signaling in the human corneal epithelium. Methodology/Principle Findings: IGF-1-mediated signaling and cell growth were examined in a human telomerized corneal epithelial (hTCEpi) cell line using co-immunoprecipitation, immunoblotting and cell proliferation assays. The presence of Hybrid-R in hTCEpi and primary cultured human corneal epithelial cells was confirmed by immunofluorescence and reciprocal immunoprecipitation of whole cell lysates. We found that IGF-1 stimulated Akt and promoted cell growth through IGF-1R activation, which was independent of the Hybrid-R. The presence of Hybrid-R, but not IGF-1R/IGF-1R, was detected in nuclear extracts. Knockdown of INSR by small interfering RNA resulted in depletion of the INSR/INSR and preferential formation of Hybrid-R. Chromatin-immunoprecipitation sequencing assay with anti-IGF-1R or anti-INSR was subsequently performed to identify potential genomic targets responsible for critical homeostatic regulatory pathways. Conclusion/Significance: In contrast to previous reports on nuclear localized IGF-1R, this is the first report identifying the nuclear localization of Hybrid-R in an epithelial cell line. The identification of a nuclear Hybrid-R and novel genomic targets suggests that IGF-1R traffics to the nucleus as an IGF-1R/INSR heterotetrameric complex to regulate corneal epithelial homeostatic pathways. The development of novel therapeutic strategies designed to target the IGF-1/IGF-1R pathway must take into account the modulatory roles IGF-1R/INSR play in the epithelial cell nucleus.	[Wu, Yu-Chieh; Zhu, Meifang; Robertson, Danielle M.] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Wu, YC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA.	Danielle.Robertson@utsouthwestern.edu			National Institutes of Health [R01 EY018219, P30 EY020799]; OneSight Research Foundation; Research to Prevent Blindness Career Development Award; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY018219, P30EY020799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OneSight Research Foundation; Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grant R01 EY018219 (DMR), P30 EY020799; OneSight Research Foundation (DMR); a Research to Prevent Blindness Career Development Award (DMR); and an unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkader H, 2011, CLIN EXP OPHTHALMOL, V39, P259, DOI 10.1111/j.1442-9071.2010.02435.x; Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Annenkov A, 2009, MOL NEUROBIOL, V40, P195, DOI 10.1007/s12035-009-8081-0; Belfiore A, 2007, CURR PHARM DESIGN, V13, P671, DOI 10.2174/138161207780249173; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Deng H, 2011, BIOCHEM BIOPH RES CO, V404, P667, DOI 10.1016/j.bbrc.2010.12.038; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dunn SE, 1998, CANCER RES, V58, P3353; Federici M, 1996, J CLIN INVEST, V98, P2887, DOI 10.1172/JCI119117; Federici M, 1997, MOL CELL ENDOCRINOL, V135, P41, DOI 10.1016/S0303-7207(97)00185-8; Feng X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-139; FORSAYETH JR, 1987, J BIOL CHEM, V262, P4134; GAROFALO RS, 1992, J BIOL CHEM, V267, P11470; Hailey J, 2002, MOL CANCER THER, V1, P1349; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Lawlor MA, 2001, J CELL SCI, V114, P2903; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; MOXHAM CP, 1989, J BIOL CHEM, V264, P13238; Myers JM, 2003, J CELL BIOCHEM, V88, P1273, DOI 10.1002/jcb.10476; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; Peng H, 2002, J NEUROCHEM, V81, P506, DOI 10.1046/j.1471-4159.2002.00833.x; Peng H, 2001, MOL BIOL CELL, V12, P449, DOI 10.1091/mbc.12.2.449; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; RADULESCU RT, 1995, MED HYPOTHESES, V45, P107, DOI 10.1016/0306-9877(95)90055-1; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Robertson DM, 2012, EXP EYE RES, V94, P179, DOI 10.1016/j.exer.2011.12.006; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Rocha EM, 2002, INVEST OPHTH VIS SCI, V43, P963; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Sesti G, 2001, DIABETES-METAB RES, V17, P363, DOI 10.1002/dmrr.225; SOOS MA, 1990, BIOCHEM J, V270, P383, DOI 10.1042/bj2700383; Sprynski AC, 2010, LEUKEMIA, V24, P1940, DOI 10.1038/leu.2010.192; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Xu YR, 2009, J CELL BIOCHEM, V107, P873, DOI 10.1002/jcb.22195; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	43	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42483	10.1371/journal.pone.0042483	http://dx.doi.org/10.1371/journal.pone.0042483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879999	gold, Green Submitted, Green Published			2022-12-27	WOS:000307284100105
J	Yuan, WG; Li, DL; Xu, LD; Cai, YG; Chen, S; Liu, YH; Xu, FY; Fu, ZK; Pang, D; Li, DJ				Yuan Weiguang; Li Dalin; Xu Lidan; Cai Yonggang; Chen Shuang; Liu Yanhong; Xu Fengyan; Fu Zhenkun; Pang Da; Li Dianjun			Association of OX40L Polymorphisms with Sporadic Breast Cancer in Northeast Chinese Han Population	PLOS ONE			English	Article							T-CELLS; TNFSF4; LIGAND; GENE; EXPRESSION; IMMUNITY; SEX; DIFFERENTIATION; SUSCEPTIBILITY; PROLIFERATION	OX40L is an important costimulatory molecule that plays a crucial role in the regulation of T-cell-mediated immunity. The interaction of OX40-OX40L is involved in the pathogenesis of multiple autoimmune and inflammatory diseases such as systemic lupus erythematosus (SLE), carotid artery disease and cancer. The genetic variants of OX40L can increase the risk of SLE, atherosclerosis, systemic sclerosis and show gender-specific effects in some studies. Accordingly, we performed a case-control study including 557 breast cancer patients and 580 age- and sex-matched healthy controls to investigate whether single nucleotide polymorphisms (SNPs) in the OX40L gene are associated with sporadic breast cancer susceptibility and progression in Chinese Han women. Seven SNPs of OX40L (rs6661173, rs1234313, rs3850641, rs1234315, rs12039904, rs844648 and rs10912580) were genotyped with the method of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The results indicated that rs3850641G allele could increase the susceptibility to breast cancer (P=0.009662), even in the validation study (P=0.0001515). A significant association between rs3850641 and breast cancer risk was observed under the additive model and dominant model (P=0.01042 and 0.01942, respectively). The haplotype analysis showed that haplotype A(rs844648)A(rs10912580) was significantly associated with breast cancer, even after 10,000 permutations for haplotypes in block only (P=0.0003). In clinicopathologic features analysis, the association between rs1234315 and C-erbB2 status was significant (P=0.02541). Our data primarily indicates that rs3850641 of OX40L gene contributes to sporadic breast carcinogenesis in a northeast Chinese Han population.	[Yuan Weiguang; Cai Yonggang; Chen Shuang; Xu Fengyan; Fu Zhenkun; Li Dianjun] Harbin Med Univ, Dept Immunol, Harbin, Peoples R China; [Yuan Weiguang; Pang Da; Li Dianjun] Harbin Med Univ, Inst Canc Prevent & Treatment, Dept Tumor Cell Biol, Harbin, Peoples R China; [Li Dalin; Pang Da] Harbin Med Univ, Affiliated Hosp 3, Dept Surg, Harbin, Peoples R China; [Xu Lidan] Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China; [Liu Yanhong] Harbin Med Univ, Hosp 2, Dept Lab Med, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Yuan, WG (corresponding author), Harbin Med Univ, Dept Immunol, Harbin, Peoples R China.	pangdasir@163.com; dianjunli@163.com			National Natural Science Foundation of China [31070780]; Foundation of Health Department, Heilongjiang Province [2011-153]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Health Department, Heilongjiang Province	This research was supported by the National Natural Science Foundation of China (No. 31070780) to Li Dianjun and by the Foundation of Health Department, Heilongjiang Province (No. 2011-153) to Yuan Weiguang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ali SA, 2004, VACCINE, V22, P3585, DOI 10.1016/j.vaccine.2004.03.041; Bossini-Castillo L, 2011, ANN RHEUM DIS, V70, P638, DOI 10.1136/ard.2010.141838; Chang YK, 2009, GENES IMMUN, V10, P414, DOI 10.1038/gene.2009.16; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Delgado-Vega AM, 2009, GENES IMMUN, V10, P248, DOI 10.1038/gene.2008.95; Duan W, 2008, J IMMUNOL, V181, P8650, DOI 10.4049/jimmunol.181.12.8650; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Gough MJ, 2008, CANCER RES, V68, P5206, DOI 10.1158/0008-5472.CAN-07-6484; Gourh P, 2010, ANN RHEUM DIS, V69, P550, DOI 10.1136/ard.2009.116434; Graham DSC, 2008, NAT GENET, V40, P83, DOI 10.1038/ng.2007.47; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Imura A, 1996, J EXP MED, V183, P2185, DOI 10.1084/jem.183.5.2185; Ito T, 2006, P NATL ACAD SCI USA, V103, P13138, DOI 10.1073/pnas.0603107103; Kashiwakura J, 2004, J IMMUNOL, V173, P5247, DOI 10.4049/jimmunol.173.8.5247; Lin PY, 2010, J IMMUNOL, V185, P2747, DOI 10.4049/jimmunol.1000496; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Malarstig A, 2008, CLIN CHEM, V54, P833, DOI 10.1373/clinchem.2007.096479; Mashimo Y, 2008, J HYPERTENS, V26, P902, DOI 10.1097/HJH.0b013e3282f6a65e; Morris A, 2001, BREAST CANCER RES TR, V67, P71, DOI 10.1023/A:1010649303056; Murata K, 2000, J EXP MED, V191, P365, DOI 10.1084/jem.191.2.365; Ohshima Y, 1997, J IMMUNOL, V159, P3838; Pedroza-Gonzalez A, 2011, J EXP MED, V208, P479, DOI 10.1084/jem.20102131; Rakha EA, 2007, J CLIN ONCOL, V25, P4772, DOI 10.1200/JCO.2007.12.2747; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Ria M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017652; Shukla PC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1601; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smirnov DA, 2008, AM J HUM GENET, V83, P243, DOI 10.1016/j.ajhg.2008.07.003; Soerjomataram I, 2008, BREAST CANCER RES TR, V107, P309, DOI 10.1007/s10549-007-9556-1; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; Stuber E, 1996, J EXP MED, V183, P979, DOI 10.1084/jem.183.3.979; Takeda I, 2004, J IMMUNOL, V172, P3580, DOI 10.4049/jimmunol.172.6.3580; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524; Weinberg AD, 2000, J IMMUNOL, V164, P2160, DOI 10.4049/jimmunol.164.4.2160; Yamaguchi S, 2006, INT J MOL MED, V18, P871; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	38	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41277	10.1371/journal.pone.0041277	http://dx.doi.org/10.1371/journal.pone.0041277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870213	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100015
J	Cong, RG; Brady, M				Cong, Rong-Gang; Brady, Mark			How to Design a Targeted Agricultural Subsidy System: Efficiency or Equity?	PLOS ONE			English	Article							POLICIES	In this paper we appraise current agricultural subsidy policy in the EU. Several sources of its inefficiency are identified: it is inefficient for supporting farmers' incomes or guaranteeing food security, and irrational transfer payments decoupled from actual performance that may be negative for environmental protection, social cohesion, etc. Based on a simplified economic model, we prove that there is "reverse redistribution" in the current tax-subsidy system, which cannot be avoided. To find a possible way to distribute subsidies more efficiently and equitably, several alternative subsidy systems (the pure loan, the harvest tax and the income contingent loan) are presented and examined.	[Cong, Rong-Gang; Brady, Mark] Lund Univ, Ctr Environm & Climate Res CEC, Lund, Sweden; [Brady, Mark] Swedish Univ Agr Sci, Dept Econ, AgriFood Econ Ctr, Lund, Sweden	Lund University; Swedish University of Agricultural Sciences	Cong, RG (corresponding author), Lund Univ, Ctr Environm & Climate Res CEC, Lund, Sweden.	cascong@126.com	Brady, Mark/J-6313-2014; Cong, Rong-Gang/F-5489-2012; cong, ronggang/AAJ-4639-2021; Cong, Rong-Gang/C-3691-2017	Brady, Mark/0000-0001-9773-9722; Cong, Rong-Gang/0000-0003-3506-2095; Cong, Rong-Gang/0000-0003-3506-2095	Biodiversity and Ecosystem services in a Changing Climate - BECC; SAPES	Biodiversity and Ecosystem services in a Changing Climate - BECC; SAPES	This research is funded by "Biodiversity and Ecosystem services in a Changing Climate - BECC" and SAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents are the responsibility of the authors and do not necessarily reflect the views of Centre for Environmental and Climate Research (CEC), Lund University.	Ahmed AU, 2001, 119 INT FOOD POL RES; Akalpler E, 2006, THESIS U EC BUSINESS; Andersson FCA, 2004, 2004 SLI SWED I FOOD, P1; Beard N, 2001, FOOD POLICY, V26, P121, DOI 10.1016/S0306-9192(00)00041-5; BRADY M., 2009, EUROP POL ANAL, V11, P1; Brady M, 2009, J AGR ECON, V60, P563, DOI 10.1111/j.1477-9552.2009.00216.x; Chapman B, 1997, ECON J, V107, P738, DOI 10.1111/1468-0297.00189; Chapman B., 2006, HDB EC ED; Cong RG, 2010, ENERGY, V35, P3921, DOI 10.1016/j.energy.2010.06.013; Dunne W, 2002, 2002 INT C AUG 28 31; EC, 2008, HLTH CHECK CAP REF I; EU, 2009, GEN BUDG AGR RUR DEV; Garcia-Penalosa C, 2000, OXFORD ECON PAP, V52, P702, DOI 10.1093/oep/52.4.702; Happe K, 2006, ECOL SOC, V11; Hennessy DA, 1998, AM J AGR ECON, V80, P46, DOI 10.2307/3180267; JOSLING TE, 1974, J AGR ECON, V25, P229, DOI 10.1111/j.1477-9552.1974.tb00547.x; Magnani E, 2000, ECOL ECON, V32, P431, DOI 10.1016/S0921-8009(99)00115-9; REVELL B, 2003, DECOUPLING UK AGR WH; Shah A, 2006, ECOL ECON, V59, P237, DOI 10.1016/j.ecolecon.2005.12.019; Uthes S., 2008, Journal of Farm Management, V13, P219; Vandenberghe V, 2008, EUR J POLIT ECON, V24, P364, DOI 10.1016/j.ejpoleco.2007.09.005; Zahrnt V, 2009, 08 ECIPE	22	18	18	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41225	10.1371/journal.pone.0041225	http://dx.doi.org/10.1371/journal.pone.0041225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	984JA	22876283	Green Submitted, Green Published, gold			2022-12-27	WOS:000307184700011
J	Henesy, MB; Britain, AL; Zhu, B; Amable, L; Honkanen, RE; Corbin, JD; Francis, SH; Rich, TC				Henesy, Michelle B.; Britain, Andrea L.; Zhu, Bing; Amable, Lauren; Honkanen, Richard E.; Corbin, Jackie D.; Francis, Sharron H.; Rich, Thomas C.			Calcineurin Regulates Homologous Desensitization of Natriuretic Peptide Receptor-A and Inhibits ANP-Induced Testosterone Production in MA-10 Cells	PLOS ONE			English	Article							PARTICULATE GUANYLATE-CYCLASE; SALAMANDER ROD PHOTORESPONSE; VASCULAR SMOOTH-MUSCLE; MOUSE LEYDIG-CELLS; CYCLIC-GMP; RAT TESTIS; PROTEIN PHOSPHATASES; NUCLEAR FACTOR; CAMP SIGNALS; PHOSPHORYLATION	Receptor desensitization is a ubiquitous regulatory mechanism that defines the activatable pool of receptors, and thus, the ability of cells to respond to environmental stimuli. In recent years, the molecular mechanisms controlling the desensitization of a variety of receptors have been established. However, little is known about the molecular mechanisms that underlie desensitization of natriuretic peptide receptors, including natriuretic peptide receptor-A (NPR-A). Here we report that calcineurin (protein phosphatase 2B, PP2B, PPP3C) regulates homologous desensitization of NPR-A in murine Leydig tumor (MA-10) cells. We demonstrate that both pharmacological inhibition of calcineurin activity and siRNA-mediated suppression of calcineurin expression potentiate atrial natriuretic peptide (ANP)-induced cGMP synthesis. Treatment of MA-10 cells with inhibitors of other phosphoprotein phosphatases had little or no effect on ANP-induced cGMP accumulation. In addition, overexpression of calcineurin blunts ANP-induced cGMP synthesis. We also present data indicating that the inhibition of calcineurin potentiates ANP-induced testosterone production. To better understand the contribution of calcineurin in the regulation of NPR-A activity, we examined the kinetics of ANP-induced cGMP signals. We observed transient ANP-induced cGMP signals, even in the presence of phosphodiesterase inhibitors. Inhibition of both calcineurin and phosphodiesterase dramatically slowed the decay in the response. These observations are consistent with a model in which calcineurin mediated dephosphorylation and desensitization of NPR-A is associated with significant inhibition of cGMP synthesis. PDE activity hydrolyzes cGMP, thus lowering intracellular cGMP toward the basal level. Taken together, these data suggest that calcineurin plays a previously unrecognized role in the desensitization of NPR-A and, thereby, inhibits ANP-mediated increases in testosterone production.	[Henesy, Michelle B.; Britain, Andrea L.; Zhu, Bing; Rich, Thomas C.] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA; [Zhu, Bing; Rich, Thomas C.] Univ S Alabama, Coll Med, Ctr Lung Biol, Mobile, AL 36688 USA; [Amable, Lauren; Honkanen, Richard E.] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Corbin, Jackie D.; Francis, Sharron H.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	University of South Alabama; University of South Alabama; University of South Alabama; Vanderbilt University	Henesy, MB (corresponding author), Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA.	trich@jaguar1.usouthal.edu			National Institutes of Health [R01HL094455, P01H066299, R01DK40029]; American Heart Association [0715101B, 0335084N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R01HL094455, P01H066299, and R01DK40029, and American Heart Association grants 0715101B and 0335084N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey SE, 2002, J BIOL CHEM, V277, P42423, DOI 10.1074/jbc.M206686200; Saraiva KLA, 2009, INT J EXP PATHOL, V90, P454, DOI 10.1111/j.1365-2613.2009.00660.x; Antos LK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1756, DOI 10.1152/ajpendo.00321.2007; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Bonness K, 2006, MOL CANCER THER, V5, P2727, DOI 10.1158/1535-7163.MCT-06-0273; Bryan PM, 2002, J BIOL CHEM, V277, P16041, DOI 10.1074/jbc.M110626200; Cheng AY, 2000, J BIOL CHEM, V275, P1846, DOI 10.1074/jbc.275.3.1846; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Corbin JD, 2000, EUR J BIOCHEM, V267, P2760, DOI 10.1046/j.1432-1327.2000.01297.x; DEBOLD AJ, 1982, CAN J PHYSIOL PHARM, V60, P324, DOI 10.1139/y82-045; DUFAU ML, 1988, ANNU REV PHYSIOL, V50, P483, DOI 10.1146/annurev.ph.50.030188.002411; El-Gehani F, 2001, BIOL REPROD, V65, P595, DOI 10.1095/biolreprod65.2.595; FORESTA C, 1987, ARCH ANDROLOGY, V19, P253, DOI 10.3109/01485018708986825; FORESTA C, 1993, ACTA ENDOCRINOL-COP, V128, P274, DOI 10.1530/acta.0.1280274; Fortin Y, 2006, CAN J PHYSIOL PHARM, V84, P539, DOI 10.1139/Y05-163; Francis SH, 2002, J BIOL CHEM, V277, P47581, DOI 10.1074/jbc.M206088200; Francis Sharron H., 2009, V191, P367, DOI 10.1007/978-3-540-68964-5_16; GARBERS DL, 1993, ADV SEC MESS PHOSPH, V28, P91; Golden TA, 2003, METHOD ENZYMOL, V366, P372; Gross KL, 2004, IN VITRO CELL DEV-AN, V40, P57; HALL PF, 1981, ENDOCRINOLOGY, V109, P1677, DOI 10.1210/endo-109-5-1677; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Kapasi AA, 1996, HYPERTENSION, V28, P847, DOI 10.1161/01.HYP.28.5.847; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; KUNO T, 1986, J BIOL CHEM, V261, P5817; Lucas KA, 2000, PHARMACOL REV, V52, P375; Middendorff R, 2000, ANDROLOGIA, V32, P55; MOGER WH, 1983, BIOL REPROD, V28, P528, DOI 10.1095/biolreprod28.3.528; MUKHOPADHYAY AK, 1986, FEBS LETT, V202, P111, DOI 10.1016/0014-5793(86)80659-7; Muller D, 2004, ENDOCRINOLOGY, V145, P1392, DOI 10.1210/en.2003-0706; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; PANDEY KN, 1986, BIOCHEM BIOPH RES CO, V138, P399, DOI 10.1016/0006-291X(86)90295-0; PANDEY KN, 1990, J BIOL CHEM, V265, P12342; Pereira VM, 2008, PEPTIDES, V29, P2024, DOI 10.1016/j.peptides.2008.08.005; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Potter LR, 2005, FRONT BIOSCI-LANDMRK, V10, P1205, DOI 10.2741/1613; Potter LR, 1999, METHODS, V19, P506, DOI 10.1006/meth.1999.0893; Potter LR, 1998, MOL CELL BIOL, V18, P2164, DOI 10.1128/MCB.18.4.2164; Potthast R, 2005, PEPTIDES, V26, P1001, DOI 10.1016/j.peptides.2004.08.033; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Rich TC, 2007, AM J PHYSIOL-CELL PH, V292, pC319, DOI 10.1152/ajpcell.00121.2006; Scipioni A, 2005, HISTOCHEM CELL BIOL, V124, P401, DOI 10.1007/s00418-005-0057-1; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; Terada H, 2003, J NEUROCHEM, V87, P1145, DOI 10.1046/j.1471-4159.2003.02098.x; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tremblay J, 2002, MOL CELL BIOCHEM, V230, P31, DOI 10.1023/A:1014260204524; Tsai LCL, 2011, CURR OPIN PHARMACOL, V11, P670, DOI 10.1016/j.coph.2011.09.003; WALDMAN SA, 1984, J BIOL CHEM, V259, P4332; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; WINQUIST RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7661, DOI 10.1073/pnas.81.23.7661; Wyatt TA, 1998, AM J PHYSIOL-HEART C, V274, pH448, DOI 10.1152/ajpheart.1998.274.2.H448; Xin WK, 2008, J GEN PHYSIOL, V131, P349, DOI 10.1085/jgp.200709881; Zuo Z, 1998, J BIOL CHEM, V273, P12250, DOI 10.1074/jbc.273.20.12250	57	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41711	10.1371/journal.pone.0041711	http://dx.doi.org/10.1371/journal.pone.0041711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876290	Green Published, Green Submitted, gold			2022-12-27	WOS:000307184700018
J	Lee, P; Taghavi, F; Yan, P; Ewart, P; Ashley, EA; Loew, LM; Kohl, P; Bollensdorff, C; Woods, CE				Lee, Peter; Taghavi, Fouad; Yan, Ping; Ewart, Paul; Ashley, Euan A.; Loew, Leslie M.; Kohl, Peter; Bollensdorff, Christian; Woods, Christopher E.			In Situ Optical Mapping of Voltage and Calcium in the Heart	PLOS ONE			English	Article							ENDOCARDIAL VISUALIZATION CATHETER; RABBIT HEARTS; CARDIAC-CELLS; ABLATION; SYSTEM; IMPLANTATION; MOTION; MODEL; VITRO; DYES	Electroanatomic mapping the interrelation of intracardiac electrical activation with anatomic locations has become an important tool for clinical assessment of complex arrhythmias. Optical mapping of cardiac electrophysiology combines high spatiotemporal resolution of anatomy and physiological function with fast and simultaneous data acquisition. If applied to the clinical setting, this could improve both diagnostic potential and therapeutic efficacy of clinical arrhythmia interventions. The aim of this study was to explore this utility in vivo using a rat model. To this aim, we present a single-camera imaging and multiple light-emitting-diode illumination system that reduces economic and technical implementation hurdles to cardiac optical mapping. Combined with a red-shifted calcium dye and a new near-infrared voltage-sensitive dye, both suitable for use in blood-perfused tissue, we demonstrate the feasibility of in vivo multi-parametric imaging of the mammalian heart. Our approach combines recording of electrophysiologically-relevant parameters with observation of structural substrates and is adaptable, in principle, to trans-catheter percutaneous approaches.	[Lee, Peter; Ewart, Paul] Univ Oxford, Dept Phys, Oxford, England; [Taghavi, Fouad] Papworth Hosptial, Div Cardiothorac Surg, Cambridge, England; [Yan, Ping; Loew, Leslie M.] Univ Connecticut, Ctr Hlth, Richard D Berlin Ctr Cell Anal & Modeling, Farmington, CT USA; [Ashley, Euan A.; Woods, Christopher E.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Kohl, Peter; Bollensdorff, Christian] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Kohl, Peter] Univ Oxford, Dept Comp Sci, Oxford, England	University of Oxford; Papworth Hospital; University of Connecticut; Stanford University; Imperial College London; University of Oxford	Lee, P (corresponding author), Univ Oxford, Dept Phys, Oxford, England.	c.bollensdorff@imperial.ac.uk; cwoods1@stanford.edu	Bollensdorff, Christian/AAQ-6961-2020	Bollensdorff, Christian/0000-0002-6333-4791; Yan, Ping/0000-0001-6472-150X; Loew, Leslie/0000-0002-1851-4646; Kohl, Peter/0000-0003-0416-6270	Clarendon Fund Scholarship; Papsworth Hospital National Health Service Foundation Trust [175-2009-MD398]; National Institutes of Health (NIH) [OD004613]; National Institute of Biomedical Imaging and Bioengineering [R01EB001963NIH]; British Heart Foundation; NIH [HL094274-01A2]; BBSRC [BB/I012117/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I012117/1] Funding Source: researchfish; British Heart Foundation [FS/12/17/29532, PG/09/031/27221] Funding Source: researchfish	Clarendon Fund Scholarship; Papsworth Hospital National Health Service Foundation Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); British Heart Foundation(British Heart Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported by the Clarendon Fund Scholarship (to PL), Papsworth Hospital National Health Service Foundation Trust (Gledhill Fellowship Reference 175-2009-MD398 to FT), National Institutes of Health (NIH) New Investigator DP2 award (OD004613 to EAA), National Institute of Biomedical Imaging and Bioengineering (R01EB001963NIH to PY and LML), and the British Heart Foundation (to PK and CB), and NIH T32 award (HL094274-01A2 to CEW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anh DJ, 2008, PACE, V31, P78, DOI 10.1111/j.1540-8159.2007.00928.x; Anh DJ, 2006, HEART RHYTHM, V3, P875, DOI 10.1016/j.hrthm.2006.04.029; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bhakta Deepak, 2008, Indian Pacing Electrophysiol J, V8, P32; Cribier A, 2009, HERZ, V34, P347, DOI 10.1007/s00059-009-3264-z; Dillon SM, 1998, IEEE ENG MED BIOL, V17, P95, DOI 10.1109/51.646226; Ding CH, 2010, PACE, V33, P687, DOI [10.1111/J.1540-8159.2010.02704.x, 10.1111/j.1540-8159.2010.02704.x]; Efimov IR, 2004, CIRC RES, V95, P21, DOI 10.1161/01.RES.0000130529.18016.35; Entcheva E, 2004, IEEE T BIO-MED ENG, V51, P333, DOI 10.1109/TBME.2003.820376; Eversull CS, 2009, J CARDIOVASC TRANSL, V2, P198, DOI 10.1007/s12265-009-9094-9; Fedorov VV, 2007, HEART RHYTHM, V4, P619, DOI 10.1016/j.hrthm.2006.12.047; Gepstein L, 1997, CIRCULATION, V95, P1611; Gerstenfeld EP, 2010, J INTERV CARD ELECTR, V29, P1, DOI 10.1007/s10840-010-9501-9; Gunzinger R, 2007, BASIC RES CARDIOL, V102, P508, DOI 10.1007/s00395-007-0668-x; Hameedullah I, 2009, HEART RHYTHM, V6, P1249, DOI 10.1016/j.hrthm.2009.04.032; Herron TJ, 2012, CIRC RES, V110, P609, DOI 10.1161/CIRCRESAHA.111.247494; Irani AR, 2009, J INTERV CARD ELECTR, V25, P107, DOI 10.1007/s10840-008-9338-7; Kong W, 2003, J CARDIOVASC ELECTR, V14, P76, DOI 10.1046/j.1540-8167.2003.02077.x; LaPage MJ, 2011, CURR OPIN CARDIOL, V26, P79, DOI 10.1097/HCO.0b013e3283437d48; Lee P, 2011, HEART RHYTHM, V8, P1482, DOI 10.1016/j.hrthm.2011.03.061; Matiukas A, 2007, HEART RHYTHM, V4, P1441, DOI 10.1016/j.hrthm.2007.07.012; Metzner A, 2011, HEART RHYTHM, V8, P988, DOI 10.1016/j.hrthm.2011.02.030; Phillips KP, 2008, J CARDIOVASC ELECTR, V19, P14, DOI 10.1111/j.1540-8167.2007.00964.x; Qian YW, 2001, CIRCULATION, V104, P2082, DOI 10.1161/hc4201.097136; Rohde GK, 2005, IEEE T BIO-MED ENG, V52, P338, DOI 10.1109/TBME.2004.840464; Salama Guy, 2009, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1217s49; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; Waggoner A S, 2001, Curr Protoc Cytom, VChapter 2, DOI 10.1002/0471142956.cy0204s15	28	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42562	10.1371/journal.pone.0042562	http://dx.doi.org/10.1371/journal.pone.0042562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876327	gold, Green Published			2022-12-27	WOS:000307184700055
J	Taulet, N; Delorme-Walker, VD; DerMardirossian, C				Taulet, Nicolas; Delorme-Walker, Violaine D.; DerMardirossian, Celine			Reactive Oxygen Species Regulate Protrusion Efficiency by Controlling Actin Dynamics	PLOS ONE			English	Article							FLUORESCENT SPECKLE MICROSCOPY; VASCULAR SMOOTH-MUSCLE; CELL-MIGRATION; ARP2/3 COMPLEX; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; FILAMENT TURNOVER; ENDOTHELIAL-CELLS; XANTHINE-OXIDASE; COFILIN ACTIVITY	Productive protrusions allowing motile cells to sense and migrate toward a chemotactic gradient of reactive oxygen species (ROS) require a tight control of the actin cytoskeleton. However, the mechanisms of how ROS affect cell protrusion and actin dynamics are not well elucidated yet. We show here that ROS induce the formation of a persistent protrusion. In migrating epithelial cells, protrusion of the leading edge requires the precise regulation of the lamellipodium and lamella F-actin networks. Using fluorescent speckle microscopy, we showed that, upon ROS stimulation, the F-actin retrograde flow is enhanced in the lamellipodium. This event coincides with an increase of cofilin activity, free barbed ends formation, Arp2/3 recruitment, and ERK activity at the cell edge. In addition, we observed an acceleration of the F-actin flow in the lamella of ROS-stimulated cells, which correlates with an enhancement of the cell contractility. Thus, this study demonstrates that ROS modulate both the lamellipodium and the lamella networks to control protrusion efficiency.	[Taulet, Nicolas; Delorme-Walker, Violaine D.; DerMardirossian, Celine] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Taulet, N (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	dmceline@scripps.edu	DerMardirossian, Celine/P-1020-2015		National Institutes of Health [HL48008]; Fondation pour la Recherche Medicale (FRM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a National Institutes of Health grant (HL48008) to GMB and CDM. NT was supported in part by a postdoctoral fellowship from Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSTEIN RS, 1975, NATURE, V256, P597, DOI 10.1038/256597a0; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Alexandrova AY, 2006, EXP CELL RES, V312, P2066, DOI 10.1016/j.yexcr.2006.03.004; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Blanc A, 2004, ANTIOXID REDOX SIGN, V6, P353, DOI 10.1089/152308604322899422; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Chew TL, 1998, J MUSCLE RES CELL M, V19, P839, DOI 10.1023/A:1005417926585; DalleDonne I, 1995, BIOPHYS J, V69, P2710, DOI 10.1016/S0006-3495(95)80142-6; Danuser G, 2006, ANNU REV BIOPH BIOM, V35, P361, DOI 10.1146/annurev.biophys.35.040405.102114; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Delorme-Walker VD, 2011, J CELL BIOL, V193, P1289, DOI 10.1083/jcb.201010059; DesMarais V, 2004, J CELL SCI, V117, P3499, DOI 10.1242/jcs.01211; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; FAGGIONI R, 1994, J LAB CLIN MED, V123, P394; Fiaschi T, 2006, J BIOL CHEM, V281, P22983, DOI 10.1074/jbc.M603040200; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Giandomenico AR, 1997, FREE RADICAL BIO MED, V23, P426, DOI 10.1016/S0891-5849(97)00113-5; Gianni D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000370; Gottlieb RA, 2003, ARCH BIOCHEM BIOPHYS, V420, P262, DOI 10.1016/j.abb.2003.07.004; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Ikeda S, 2005, ARTERIOSCL THROM VAS, V25, P2295, DOI 10.1161/01.ATV.0000187472.55437.af; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; JAESCHKE H, 1989, BIOCHEM BIOPH RES CO, V160, P140, DOI 10.1016/0006-291X(89)91632-X; Jernigan NL, 2008, AM J PHYSIOL-LUNG C, V295, pL515, DOI 10.1152/ajplung.00355.2007; Jin LM, 2004, AM J PHYSIOL-HEART C, V287, pH1495, DOI 10.1152/ajpheart.01006.2003; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Klemke M, 2008, IMMUNITY, V29, P404, DOI 10.1016/j.immuni.2008.06.016; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Lee CK, 2006, PROTEOMICS, V6, P6455, DOI 10.1002/pmic.200600124; Mehdi MZ, 2005, ANTIOXID REDOX SIGN, V7, P1014, DOI 10.1089/ars.2005.7.1014; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Moldovan L, 2000, CIRC RES, V86, P549, DOI 10.1161/01.RES.86.5.549; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Munnamalai V, 2009, J NEUROCHEM, V108, P644, DOI 10.1111/j.1471-4159.2008.05787.x; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Ponti A, 2005, BIOPHYS J, V89, P3456, DOI 10.1529/biophysj.104.058701; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ponti A, 2003, BIOPHYS J, V84, P3336, DOI 10.1016/S0006-3495(03)70058-7; Sadok A, 2008, BBA-MOL CELL RES, V1783, P23, DOI 10.1016/j.bbamcr.2007.10.010; Sadok A, 2009, MOL CELL BIOL, V29, P3915, DOI 10.1128/MCB.01199-08; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; San Martin A, 2008, CIRC RES, V102, P432, DOI 10.1161/CIRCRESAHA.107.158923; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2; Waterman-Storer C, 2002, CURR PROTOC CELL BIO; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632	71	45	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41342	10.1371/journal.pone.0041342	http://dx.doi.org/10.1371/journal.pone.0041342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876286	Green Published, Green Submitted, gold			2022-12-27	WOS:000307184700014
J	Bexfield, NH; Watson, PJ; Aguirre-Hernandez, J; Sargan, DR; Tiley, L; Heeney, JL; Kennedy, LJ				Bexfield, Nicholas H.; Watson, Penny J.; Aguirre-Hernandez, Jesus; Sargan, David R.; Tiley, Laurence; Heeney, Jonathan L.; Kennedy, Lorna J.			DLA Class II Alleles and Haplotypes Are Associated with Risk for and Protection from Chronic Hepatitis in the English Springer Spaniel	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CHRONIC ACTIVE HEPATITIS; CHRONIC LIVER-DISEASE; C VIRUS; NOMENCLATURE COMMITTEE; PEPTIDE PRESENTATION; INFECTIOUS-DISEASES; DOBERMAN HEPATITIS; SYSTEM DLA; 1ST REPORT	Chronic hepatitis (CH) is common in dogs in the United Kingdom. An increased prevalence of the disease is seen in the English Springer spaniel (ESS), and this breed suffer from a severe form with young to middle aged female dogs being predisposed. The disease shares histological features with those of human viral hepatitis, although the specific aetiological agent has not yet been identified. The aim of the current study was to investigate whether dog leucocyte antigen (DLA) class II alleles and haplotypes are associated with susceptibility/resistance to CH in the ESS. Sequence-based genotyping of the polymorphic exon 2 from DLA-DRB1, -DQA1 and -DQB1 class II loci were performed in 66 ESSs with CH and 84 healthy controls. There was a significant difference in the distribution of the protective alleles DRB1*00501 (3.0% vs. 12.0%, odds ratio [OR] = 0.23, 95% confidence interval [CI] = 0.06-0.74) and DQB1*00501 (3.8% vs. 12.0%, OR = 0.29, 95% CI = 0.09-0.85) between cases and controls. The haplotype DLA-DRB1*00501/DQA1*00301/DQB1*00501 was present in 11.9% of controls and 3.0% of cases and was significantly associated with protection against disease development (OR = 0.26, 95% CI = 0.08-0.80). There was a significant difference in the distribution of the risk alleles DRB1*00601 (14.4% vs. 6.5%, OR = 2.40, 95% CI = 1.10-5.63) and DQB1*00701 (14.4% vs. 6.5%, OR = 2.40, 95% CI = 1.10-5.63) between cases and controls. A risk haplotype (DLA-DRB1*00601/DQA1*005011/DQB1*00701) was present in 14.4% of cases and 6.5% of controls and conferred an elevated risk of developing CH with an OR of 3.13 (95% CI = 1.20-8.26). These results demonstrate that DLA class II is significantly associated with risk and protection from developing CH in ESSs.	[Bexfield, Nicholas H.; Watson, Penny J.; Aguirre-Hernandez, Jesus; Sargan, David R.; Tiley, Laurence; Heeney, Jonathan L.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Kennedy, Lorna J.] Univ Manchester, Ctr Integrated Genom Med Res, Manchester, Lancs, England	University of Cambridge; University of Manchester	Bexfield, NH (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	nb289@cam.ac.uk	Aguirre-Hernandez, Jesus/M-7955-2018; Kennedy, Lorna/AAK-8767-2020	Aguirre-Hernandez, Jesus/0000-0002-2715-6422; Kennedy, Lorna/0000-0002-3087-4548; Sargan, David Richard/0000-0001-9897-2489; Watson, Penelope Jayne/0000-0002-7241-9412; Heeney, Jonathan/0000-0003-2702-1621; Bexfield, Nicholas/0000-0001-6830-8296	Wellcome Trust [WT088619MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by funding from the Wellcome Trust (grant number WT088619MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Hernandez J, 2010, TISSUE ANTIGENS, V76, P476, DOI 10.1111/j.1399-0039.2010.01554.x; ALMARRI A, 1994, LANCET, V344, P1194, DOI 10.1016/S0140-6736(94)90510-X; ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; ANDERSSON M, 1992, J SMALL ANIM PRACT, V33, P389, DOI 10.1111/j.1748-5827.1992.tb01182.x; Bateman AC, 2007, HISTOPATHOLOGY, V51, P585, DOI 10.1111/j.1365-2559.2007.02765.x; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Bexfield NH, 2011, VET REC, V169, P415, DOI 10.1136/vr.d4665; Bexfield NH, 2012, VET J, DOI [10.1016/j.tvjl.2011.1011.1024, DOI 10.1016/J.TVJL.2011.1011.1024]; Bexfield N, 2011, VET J, V190, P191, DOI 10.1016/j.tvjl.2010.10.014; BISHOP L, 1979, AM J VET RES, V40, P839; Boomkens SY, 2005, VET MICROBIOL, V108, P49, DOI 10.1016/j.vetmic.2005.03.003; BROWN JH, 1988, NATURE, V332, P845, DOI 10.1038/332845a0; BUNCH SE, 1993, VET CLIN N AM-SMALL, V23, P659, DOI 10.1016/S0195-5616(93)50311-X; Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6; Clements DN, 2010, J HERED, V101, P54, DOI 10.1093/jhered/esp088; DIENES HP, 1987, HEPATOLOGY, V7, P1317, DOI 10.1002/hep.1840070623; Donaldson PT, 2004, GUT, V53, P599, DOI 10.1136/gut.2003.031732; DONALDSON PT, 1991, HEPATOLOGY, V13, P701, DOI 10.1016/0270-9139(91)92567-R; Dyggve H, 2011, TISSUE ANTIGENS, V77, P30, DOI 10.1111/j.1399-0039.2010.01575.x; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; FRANCO A, 1988, HEPATOLOGY, V8, P449, DOI 10.1002/hep.1840080302; Frodsham AJ, 2004, HUM MOL GENET, V13, pR187, DOI 10.1093/hmg/ddh225; FUJISAWA T, 1995, DIABETOLOGIA, V38, P1493; Gao J, 1999, J VIROL, V73, P1411, DOI 10.1128/JVI.73.2.1411-1418.1999; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GOCKE DJ, 1967, J CLIN INVEST, V46, P1506, DOI 10.1172/JCI105642; GUARDIOLA J, 1993, CRIT REV IMMUNOL, V13, P247; HANKE T, 1994, REV MED VIROL, V4, P47, DOI 10.1002/rmv.1980040109; Herkel J, 2003, HEPATOLOGY, V37, P1079, DOI 10.1053/jhep.2003.50191; Ishak KG, 2000, AM J CLIN PATHOL, V113, P40, DOI 10.1309/42D6-W7PL-FX0A-LBXF; It V, 2010, TISSUE ANTIGENS, V76, P67, DOI 10.1111/j.1399-0039.2010.01463.x; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kennedy LJ, 2007, TISSUE ANTIGENS, V69, P292, DOI 10.1111/j.1399-0039.2006.00781.x; Kennedy LJ, 2007, TISSUE ANTIGENS, V69, P272, DOI 10.1111/j.1399-0039.2006.00779.x; Kennedy LJ, 2007, TISSUE ANTIGENS, V69, P269, DOI 10.1111/j.1399-0039.2006.00778.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P502, DOI 10.1111/j.1399-0039.2006.00715.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P467, DOI 10.1111/j.1399-0039.2006.00716.x; Kennedy LJ, 1999, TISSUE ANTIGENS, V54, P312, DOI 10.1034/j.1399-0039.1999.540319.x; Kennedy LJ, 1998, IMMUNOGENETICS, V48, P296, DOI 10.1007/s002510050435; Kennedy LJ, 2002, TISSUE ANTIGENS, V60, P43, DOI 10.1034/j.1399-0039.2002.600106.x; Kennedy LJ, 2002, TISSUE ANTIGENS, V59, P194, DOI 10.1034/j.1399-0039.2002.590303.x; Kennedy LJ, 2000, ANIM GENET, V31, P52, DOI 10.1046/j.1365-2052.2000.00492.x; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Kuniholm MH, 2010, HEPATOLOGY, V51, P1514, DOI 10.1002/hep.23515; Kuzushita N, 1998, HEPATOLOGY, V27, P240, DOI 10.1002/hep.510270136; Mieli-Vergani G, 2011, NAT REV GASTRO HEPAT, V8, P320, DOI 10.1038/nrgastro.2011.69; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Poldervaart JH, 2009, J VET INTERN MED, V23, P72, DOI 10.1111/j.1939-1676.2008.0215.x; SEVELIUS E, 1994, J COMP PATHOL, V111, P401, DOI 10.1016/S0021-9975(05)80098-2; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Shawcroft A., 2010, BSAVA 53rd Annual Congress 2010, Scientific Proceedings, Veterinary Programme, Birmingham, UK, 8-11 April 2010, P458; Speeti M, 2003, VET IMMUNOL IMMUNOP, V96, P1, DOI 10.1016/S0165-2427(03)00134-X; STEEL CM, 1988, LANCET, V1, P1185; STROMBECK DR, 1988, J AM VET MED ASSOC, V193, P1109; Thio CL, 2003, J VIROL, V77, P12083, DOI 10.1128/JVI.77.22.12083-12087.2003; Thurairajah PH, 2008, J INFECT DIS, V198, P1749, DOI 10.1086/593337; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; van den Ingh T. S. G. A. M., 2006, WSAVA STANDARDS CLIN, P85; Venkataraman GM, 2007, TISSUE ANTIGENS, V70, P53, DOI 10.1111/j.1399-0039.2007.00839.x; Watson PJ, 2010, J SMALL ANIM PRACT, V51, P566, DOI 10.1111/j.1748-5827.2010.00996.x; Watson PJ, 2004, VET J, V167, P228, DOI 10.1016/S1090-0233(03)00118-7; WEISS DJ, 1995, J VET INTERN MED, V9, P267, DOI 10.1111/j.1939-1676.1995.tb01078.x; Wilbe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012332; Wilbe M, 2009, IMMUNOGENETICS, V61, P557, DOI 10.1007/s00251-009-0387-6; Zavaglia C, 1998, J HEPATOL, V28, P1, DOI 10.1016/S0168-8278(98)80195-5	66	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42584	10.1371/journal.pone.0042584	http://dx.doi.org/10.1371/journal.pone.0042584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870335	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800098
J	Chen, YF; Pottala, JV; Weltman, NY; Ge, XJ; Savinova, OV; Gerdes, AM				Chen, Yue-Feng; Pottala, James V.; Weltman, Nathan Y.; Ge, Xijin; Savinova, Olga V.; Gerdes, A. Martin			Regulation of Gene Expression with Thyroid Hormone in Rats with Myocardial Infarction	PLOS ONE			English	Article							NF-KAPPA-B; ILLUMINA MICROARRAY; CARDIAC MYOCYTE; HEART; ANGIOGENESIS; MODEL; BIOINFORMATICS; ANGIOPOIETIN-2; HYPERTROPHY; APOPTOSIS	Introduction: The expression of hundreds of genes is altered in response to left ventricular (LV) remodeling following large transmural myocardial infarction (MI). Thyroid hormone (TH) improves LV remodeling and cardiac performance after MI. However, the molecular basis is unknown. Methods: MI was produced by ligation of the left anterior descending coronary artery in female SD rats. Rats were divided into the following groups: (1) Sham MI, (2) MI, and (3) MI+T4 treatment (T4 pellet 3.3 mg, 60 days release, implanted subcutaneously immediately following MI). Four weeks after surgery, total RNA was isolated from LV non-infarcted areas for microarray analysis using the Illumina RatRef-12 Expression BeadChip Platform. Results: Signals were detected in 13,188 genes (out of 22,523), of which the expression of 154 genes were decreased and the expression of 200 genes were increased in MI rats compared with Sham MI rats (false discovery rate (FDR) < 0.05). Compared to MI rats, T4 treatment decreased expression of 27 genes and increased expression of 28 genes. In particular, 6 genes down- regulated by MI and 12 genes up-regulated by MI were reversed by T4. Most of the 55 genes altered by T4 treatment are in the category of molecular function under binding (24) and biological processes which includes immune system process (9), multi-organism process (5) and biological regulation (19) nonexclusively. Conclusions: These results suggest that altered expression of genes for molecular function and biological process may be involved in the beneficial effects of thyroid hormone treatment following MI in rats.	[Chen, Yue-Feng; Gerdes, A. Martin] New York Inst Technol, New York Coll Osteopath Med, Dept Biomed Sci, Old Westbury, NY 11568 USA; [Pottala, James V.; Weltman, Nathan Y.; Savinova, Olga V.] Univ S Dakota, Sioux Falls, SD USA; [Ge, Xijin] S Dakota State Univ, Dept Math & Stat, Brookings, SD 57007 USA	New York Institute Technology; University of South Dakota; South Dakota State University	Chen, YF (corresponding author), New York Inst Technol, New York Coll Osteopath Med, Dept Biomed Sci, Old Westbury, NY 11568 USA.	ychen33@nyit.edu	Ge, Xijin/AAP-6237-2021; Ge, Steven/ABF-1186-2021	Ge, Steven/0000-0001-7406-3782; Chen, Yuefeng/0000-0002-5925-2291	National Institutes of Health (NIH) [RO1 HL093160-01A1, RO1 HL103671-01A1]; American Heart Association (AHA) MWA Fall 09 Postdoctoral Fellowship [10POST2650057]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103671, R01HL093160] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA) MWA Fall 09 Postdoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health (NIH) RO1 HL093160-01A1 and RO1 HL103671-01A1, as well as American Heart Association (AHA) MWA Fall 09 Postdoctoral Fellowship 10POST2650057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson C, 2004, J PHARMACOL EXP THER, V311, P164, DOI 10.1124/jpet.104.069153; Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; BREISCH EA, 1989, BASIC RES CARDIOL, V84, P345, DOI 10.1007/BF02650869; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Chen YF, 2008, J MOL CELL CARDIOL, V44, P180, DOI 10.1016/j.yjmcc.2007.09.009; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; De K, 2004, J ENDOCRINOL, V182, P303, DOI 10.1677/joe.0.1820303; Deacon DC, 2010, DEVELOPMENT, V137, P1887, DOI 10.1242/dev.050526; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Forini F, 2011, J CELL MOL MED, V15, P514, DOI 10.1111/j.1582-4934.2010.01014.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GERDES AM, 1986, ANAT RECORD, V215, P420, DOI 10.1002/ar.1092150414; Henderson KK, 2009, CIRC-HEART FAIL, V2, P243, DOI 10.1161/CIRCHEARTFAILURE.108.810747; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kahaly GJ, 2005, ENDOCR REV, V26, P704, DOI 10.1210/er.2003-0033; Kalofoutis C, 2010, MOL CELL BIOCHEM, V345, P161, DOI 10.1007/s11010-010-0569-4; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu GY, 2009, J APPL GENET, V50, P47, DOI 10.1007/BF03195651; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Misra A, 2003, CIRCULATION, V108, P3075, DOI 10.1161/01.CIR.0000108929.93074.0B; Ojamaa K, 2000, AM J PHYSIOL-ENDOC M, V279, pE1319, DOI 10.1152/ajpendo.2000.279.6.E1319; Ojamaa K, 2010, VASC PHARMACOL, V52, P113, DOI 10.1016/j.vph.2009.11.008; Pantos C, 2008, BASIC RES CARDIOL, V103, P308, DOI 10.1007/s00395-008-0697-0; Perkins ND, 1997, INT J BIOCHEM CELL B, V29, P1433, DOI 10.1016/S1357-2725(97)00088-5; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Sandhu R, 2004, CARDIOVASC RES, V64, P115, DOI 10.1016/j.cardiores.2004.05.013; Sasaki H, 2001, J MOL CELL CARDIOL, V33, P283, DOI 10.1006/jmcc.2000.1299; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stanton LW, 2000, CIRC RES, V86, P939, DOI 10.1161/01.RES.86.9.939; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tuo QH, 2008, AM J PHYSIOL-HEART C, V294, pH2547, DOI 10.1152/ajpheart.01250.2007; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; ZIMMER HG, 1990, J MOL CELL CARDIOL, V22, P1231, DOI 10.1016/0022-2828(90)90060-F	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40161	10.1371/journal.pone.0040161	http://dx.doi.org/10.1371/journal.pone.0040161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870193	gold, Green Published			2022-12-27	WOS:000307212800004
J	Chong-Seng, KM; Mannering, TD; Pratchett, MS; Bellwood, DR; Graham, NAJ				Chong-Seng, Karen M.; Mannering, Thomas D.; Pratchett, Morgan S.; Bellwood, David R.; Graham, Nicholas A. J.			The Influence of Coral Reef Benthic Condition on Associated Fish Assemblages	PLOS ONE			English	Article							GREAT-BARRIER-REEF; MARINE PROTECTED AREAS; PHASE-SHIFTS; CLIMATE-CHANGE; RESILIENCE; HERBIVORY; DEGRADATION; DECLINE; IMPACTS; STATES	Accumulative disturbances can erode a coral reef's resilience, often leading to replacement of scleractinian corals by macroalgae or other non-coral organisms. These degraded reef systems have been mostly described based on changes in the composition of the reef benthos, and there is little understanding of how such changes are influenced by, and in turn influence, other components of the reef ecosystem. This study investigated the spatial variation in benthic communities on fringing reefs around the inner Seychelles islands. Specifically, relationships between benthic composition and the underlying substrata, as well as the associated fish assemblages were assessed. High variability in benthic composition was found among reefs, with a gradient from high coral cover (up to 58%) and high structural complexity to high macroalgae cover (up to 95%) and low structural complexity at the extremes. This gradient was associated with declining species richness of fishes, reduced diversity of fish functional groups, and lower abundance of corallivorous fishes. There were no reciprocal increases in herbivorous fish abundances, and relationships with other fish functional groups and total fish abundance were weak. Reefs grouping at the extremes of complex coral habitats or low-complexity macroalgal habitats displayed markedly different fish communities, with only two species of benthic invertebrate feeding fishes in greater abundance in the macroalgal habitat. These results have negative implications for the continuation of many coral reef ecosystem processes and services if more reefs shift to extreme degraded conditions dominated by macroalgae.	[Chong-Seng, Karen M.; Mannering, Thomas D.; Pratchett, Morgan S.; Bellwood, David R.; Graham, Nicholas A. J.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Mannering, Thomas D.; Bellwood, David R.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Chong-Seng, KM (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	karen.chongseng@my.jcu.edu.au	Pratchett, Morgan/AAW-5179-2020; Graham, Nicholas AJ/C-8360-2014; Pratchett, Morgan S/A-9256-2010	Pratchett, Morgan/0000-0002-1862-8459; Graham, Nicholas AJ/0000-0002-0304-7467; Pratchett, Morgan S/0000-0002-1862-8459; Chong-Seng, Karen/0000-0001-9178-5891	Australian Research Council; Seychelles Fishing Authority; Western Indian Ocean Marine Science Association Marine Research Grant	Australian Research Council(Australian Research Council); Seychelles Fishing Authority; Western Indian Ocean Marine Science Association Marine Research Grant	This study was funded by the Australian Research Council, the Seychelles Fishing Authority, and a Western Indian Ocean Marine Science Association Marine Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamada S., 2008, STATUS CORAL REEFS W, V2008, P105; Arthur R, 2006, CORAL REEFS, V25, P427, DOI 10.1007/s00338-006-0127-4; Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2006, GLOBAL CHANGE BIOL, V12, P1587, DOI 10.1111/j.1365-2486.2006.01204.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2012, OECOLOGIA, DOI [10.1007/s00442-00012-02306-z, DOI 10.1007/S00442-00012-02306-Z]; Brown Barbara E., 1997, P354; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Connell SD, 2011, J EXP MAR BIOL ECOL, V400, P296, DOI 10.1016/j.jembe.2011.02.031; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Daw TM, 2011, ENVIRON CONSERV, V38, P75, DOI 10.1017/S0376892910000901; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Doak DF, 2008, ECOLOGY, V89, P952, DOI 10.1890/07-0965.1; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Duckworth AR, 2011, J EXP MAR BIOL ECOL, V402, P49, DOI 10.1016/j.jembe.2011.03.017; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Fox HE, 2004, MAR ECOL PROG SER, V269, P131, DOI 10.3354/meps269131; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Garpe KC, 2003, HYDROBIOLOGIA, V498, P191, DOI 10.1023/A:1026217201408; Goreau T.J., 1998, CORAL RECOVERY BLEAC; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Grandcourt EM, 2003, FISH RES, V60, P539, DOI 10.1016/S0165-7836(02)00173-X; GRANDCOURT EM, 1999, POPULATION BIOL SELE; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Halford A. R., 1994, VISUAL CENSUS SURVEY; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Johansson CL, 2010, MAR ECOL PROG SER, V414, P65, DOI 10.3354/meps08730; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Lecchini D, 2012, ENVIRON BIOL FISH, V94, P421, DOI 10.1007/s10641-011-9958-0; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Littler MM, 2007, AQUAT CONSERV, V17, P195, DOI 10.1002/aqc.790; Maina J., 2011, SPATIAL BEHAV ARTISA; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mumby PJ, 2008, CONSERV BIOL, V22, P941, DOI 10.1111/j.1523-1739.2008.00933.x; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Nogueira C, 2009, AUSTRAL ECOL, V34, P83, DOI 10.1111/j.1442-9993.2008.01887.x; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; O'Neill RV., 1998, J AQUATIC ECOSYSTEM, V6, P181, DOI [10.1023/A:1009996332614, DOI 10.1023/A:1009996332614]; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Payet R, 2006, AMBIO, V35, P182, DOI 10.1579/0044-7447(2006)35[182:CCITSI]2.0.CO;2; Petraitis PS, 2009, OECOLOGIA, V161, P139, DOI 10.1007/s00442-009-1350-9; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett Morgan S., 2011, Diversity, V3, P424, DOI 10.3390/d3030424; Pratchett MS, 2005, MAR BIOL, V148, P373, DOI 10.1007/s00227-005-0084-4; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Shafer CS, 2000, ENVIRON MANAGE, V26, P73, DOI 10.1007/s002670010072; Stoddart DR, 1984, BIOGEOGRAPHY ECOLOGY; Syms C, 2001, OECOLOGIA, V127, P560, DOI 10.1007/s004420000617; TAYLOR JD, 1968, PHILOS T ROY SOC B, V254, P129, DOI 10.1098/rstb.1968.0015; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661; Uyarra MC, 2005, ENVIRON CONSERV, V32, P11, DOI 10.1017/S0376892904001808; Victor S, 2008, ESTUAR COAST SHELF S, V77, P175, DOI 10.1016/j.ecss.2007.09.009; WALKER BH, 1993, AMBIO, V22, P80; WESTOBY M, 1989, J RANGE MANAGE, V42, P266, DOI 10.2307/3899492; Williams ID, 2000, ENVIRON CONSERV, V27, P382, DOI 10.1017/S0376892900000436; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wilson SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015185; Wilson SK, 2012, CONSERV BIO IN PRESS; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; Wootton JT, 2002, J SEA RES, V48, P157, DOI 10.1016/S1385-1101(02)00149-1; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	84	72	73	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42167	10.1371/journal.pone.0042167	http://dx.doi.org/10.1371/journal.pone.0042167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870294	Green Published, gold, Green Accepted			2022-12-27	WOS:000307212800064
J	Park, E; Schoner, G; Scholz, JP				Park, Eunse; Schoener, Gregor; Scholz, John P.			Functional Synergies Underlying Control of Upright Posture during Changes in Head Orientation	PLOS ONE			English	Article							QUIET STANCE; COORDINATION; MOVEMENTS; SWAY; FEEDBACK; INFORMATION; ADJUSTMENTS; PERCEPTION; POSITION; BALANCE	Background: Studies of human upright posture typically have stressed the need to control ankle and hip joints to achieve postural stability. Recent studies, however, suggest that postural stability involves multi degree-of-freedom (DOF) coordination, especially when performing supra-postural tasks. This study investigated kinematic synergies related to control of the body's position in space (two, four and six DOF models) and changes in the head's orientation (six DOF model). Methodology/Principal Findings: Subjects either tracked a vertically moving target with a head-mounted laser pointer or fixated a stationary point during 4-min trials. Uncontrolled manifold (UCM) analysis was performed across tracking cycles at each point in time to determine the structure of joint configuration variance related to postural stability or tracking consistency. The effect of simulated removal of covariance among joints on that structure was investigated to further determine the role of multijoint coordination. Results indicated that cervical joint motion was poorly coordinated with other joints to stabilize the position of the body center of mass (CM). However, cervical joints were coordinated in a flexible manner with more caudal joints to achieve consistent changes in head orientation. Conclusions/Significance: An understanding of multijoint coordination requires reference to the stability/control of important performance variables. The nature of that coordination differs depending on the reference variable. Stability of upright posture primarily involved multijoint coordination of lower extremity and lower trunk joints. Consistent changes in the orientation of the head, however, required flexible coordination of those joints with motion of the cervical spine. A two-segment model of postural control was unable to account for the observed stability of the CM position during the tracking task, further supporting the need to consider multijoint coordination to understand postural stability.	[Park, Eunse; Scholz, John P.] Univ Delaware, Biomech & Movement Sci Program, Newark, DE 19716 USA; [Schoener, Gregor] Ruhr Univ Bochum, Inst Neuroinformat, Bochum, Germany; [Scholz, John P.] Univ Delaware, Phys Therapy Dept, Newark, DE USA	University of Delaware; Ruhr University Bochum; University of Delaware	Park, E (corresponding author), Univ Delaware, Biomech & Movement Sci Program, Newark, DE 19716 USA.	jpscholz@udel.edu	Scḧoner, Gregor/U-4885-2019; Schöner, Gregor/AAU-1050-2020	Schöner, Gregor/0000-0002-4776-9998	National Science Foundation [0957920]; Deutsche Forschungsgemeinschaft; Division Of Behavioral and Cognitive Sci [0957920] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by a National Science Foundation Grant 0957920 to John Scholz (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5686) and Deutsche Forschungsgemeinschaft grant to Gregor Schoner (http://www.dfg.de/en/index.jsp) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov AV, 2005, BIOL CYBERN, V93, P309, DOI [10.1007/s00422-005-0004-1, 10.1007/s00422-005-0004-l]; Ariff G, 2002, J NEUROSCI, V22, P7721; Bardy BG, 1999, J EXP PSYCHOL HUMAN, V25, P1284, DOI 10.1037/0096-1523.25.5.1284; Bove M, 2009, NEUROSCIENCE, V164, P1601, DOI 10.1016/j.neuroscience.2009.09.053; Corriveau H, 2004, ARCH GERONTOL GERIAT, V39, P163, DOI 10.1016/j.archger.2004.03.001; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.071; Danna-dos-Santos A, 2008, EXP BRAIN RES, V189, P171, DOI 10.1007/s00221-008-1413-x; Dempster W.T., 1955, SPACE REQUIREMENTS S; Dyde RT, 2008, J VISION, V8, DOI 10.1167/8.14.5; Feldman AG, 2009, EXP BRAIN RES, V194, P39, DOI 10.1007/s00221-008-1667-3; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; Freitas SMSF, 2006, J NEUROPHYSIOL, V95, P636, DOI 10.1152/jn.00482.2005; Gera G, 2010, MOTOR CONTROL, V14, P83, DOI 10.1123/mcj.14.1.83; Gielen CCAM, 2009, CORTEX, V45, P340, DOI 10.1016/j.cortex.2008.02.009; HORAK FB, 1990, EXP BRAIN RES, V82, P167; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; Hsu WL, 2011, MOTOR ABUNDANCE SUPP; Jeka J, 2004, J NEUROPHYSIOL, V92, P2368, DOI 10.1152/jn.00983.2003; Jeka J, 1998, J NEUROPHYSIOL, V79, P1661, DOI 10.1152/jn.1998.79.4.1661; Jeka J, 2000, EXP BRAIN RES, V134, P107, DOI 10.1007/s002210000412; Kiemel T, 2006, J NEUROPHYSIOL, V95, P1410, DOI 10.1152/jn.01144.2004; Kiemel T, 2011, J NEUROSCI, V31, P15144, DOI 10.1523/JNEUROSCI.1013-11.2011; Krishnamoorthy V, 2005, EXP BRAIN RES, V164, P1, DOI 10.1007/s00221-004-2205-6; Krishnamoorthy V, 2005, J PHYSIOL-LONDON, V565, P675, DOI 10.1113/jphysiol.2005.084772; Krishnamoorthy V, 2003, BIOL CYBERN, V89, P152, DOI 10.1007/s00422-003-0419-5; Kuo AD, 1998, EXP BRAIN RES, V122, P185, DOI 10.1007/s002210050506; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Latash Mark L., 2005, Neural Plasticity, V12, P119, DOI 10.1155/NP.2005.119; Latash ML, 2012, EXP BRAIN RES, V217, P1, DOI 10.1007/s00221-012-3000-4; Latash ML, 2005, NEURAL PLAST, V12, P263; Loram ID, 2002, J PHYSIOL-LONDON, V540, P1111, DOI 10.1113/jphysiol.2001.013077; Loram ID, 2011, J PHYSL, V589, P302; Martin TA, 2002, J NEUROPHYSIOL, V88, P1685, DOI 10.1152/jn.2002.88.4.1685; MCCOLLUM G, 1989, J MOTOR BEHAV, V21, P225; McCollum G, 1996, J THEOR BIOL, V180, P257, DOI 10.1006/jtbi.1996.0101; Muller H, 2004, J EXP PSYCHOL HUMAN, V30, P212, DOI 10.1037/0096-1523.30.1.212; NASHNER LM, 1985, BEHAV BRAIN SCI, V8, P135, DOI 10.1017/S0140525X00020008; Nashner LM, 1989, PROG BRAIN RES, V80, P395; Oullier O, 2004, MOTOR CONTROL, V8, P174, DOI 10.1123/mcj.8.2.174; Oullier O, 2002, HUM MOVEMENT SCI, V21, P147, DOI 10.1016/S0167-9457(02)00093-3; Park S, 2004, EXP BRAIN RES, V154, P417, DOI 10.1007/s00221-003-1674-3; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Reimann H, 2011, 41 ANN M SOC NEUR WA; Reina GA, 2003, HUM MOVEMENT SCI, V22, P137, DOI 10.1016/S0167-9457(02)00156-2; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Scholz JP, 2007, EXP BRAIN RES, V180, P163, DOI 10.1007/s00221-006-0848-1; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Shiratori T, 2007, EXP BRAIN RES, V178, P206, DOI 10.1007/s00221-006-0725-y; SUZUKI Y, 2011, STABILITY DOUBLE INV, P7450; Vedula S, 2008, IEEE ENG MED BIO, P4523, DOI 10.1109/IEMBS.2008.4650218; Verrel J, 2010, EXP BRAIN RES, V207, P13, DOI 10.1007/s00221-010-2424-y; Vuillerme N, 2005, NEUROSCI LETT, V378, P135, DOI 10.1016/j.neulet.2004.12.024; Wexler M, 2003, PSYCHOL SCI, V14, P340, DOI 10.1111/1467-9280.14491; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Winter DA, 2001, J NEUROPHYSIOL, V85, P2630, DOI 10.1152/jn.2001.85.6.2630; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Winter DA, 2003, J ELECTROMYOGR KINES, V13, P49, DOI 10.1016/S1050-6411(02)00085-8; Yen JT, 2010, J R SOC INTERFACE, V7, P801, DOI 10.1098/rsif.2009.0296	58	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41583	10.1371/journal.pone.0041583	http://dx.doi.org/10.1371/journal.pone.0041583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	984SU	22870233	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800027
J	Exeter, HJ; Folkersen, L; Palmen, J; Franco-Cereceda, A; Cooper, JA; Kalea, AZ; van't Hooft, F; Eriksson, P; Humphries, SE; Talmud, PJ				Exeter, Holly J.; Folkersen, Lasse; Palmen, Jutta; Franco-Cereceda, Anders; Cooper, Jackie A.; Kalea, Anastasia Z.; van't Hooft, Ferdinand; Eriksson, Per; Humphries, Steve E.; Talmud, Philippa J.			Functional Analysis of Two PLA2G2A Variants Associated with Secretory Phospholipase A2-IIA Levels	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; BINDING-PROTEINS; EPIC-NORFOLK; SERUM-LEVELS; HEALTHY-MEN; A(2); LIPOPROTEIN; RISK; EVENTS; WOMEN	Background: Secretory phospholipase A2 group IIA (sPLA2-IIA) has been identified as a biomarker of atherosclerosis in observational and animal studies. The protein is encoded by the PLA2G2A gene and the aim of this study was to test the functionality of two PLA2G2A non-coding SNPs, rs11573156 C>G and rs3767221 T>G where the rare alleles have been previously associated with higher and lower sPLA2-IIA levels respectively. Methodology/Principal Findings: Luciferase assays, electrophoretic mobility shift assays (EMSA), and RNA expression by RT-PCR were used to examine allelic differences. For rs3767221 the G allele showed similar to 55% lower luciferase activity compared to the T allele (T = 62.1 (95% CI 59.1 to 65.1) G = 27.8 (95% CI 25.0 to 30.6), p = 1.22x10(-35), and stronger EMSA binding of a nuclear protein compared to the T-allele. For rs11573156 C>G there were no luciferase or EMSA allelic differences seen. In lymphocyte cell RNA, from individuals of known rs11573156 genotype, there was no allelic RNA expression difference for exons 5 and 6, but G allele carriers (n = 7) showed a trend to lower exon 1-2 expression compared to CC individuals. To take this further, in the ASAP study (n = 223), an rs11573156 proxy (r(2) = 0.91) showed similar to 25% higher liver expression of PLA2G2A (1.67x10(-17)) associated with the G allele. However, considering exon specific expression, the association was greatly reduced for exon 2 (4.5x10(-5)) compared to exons 3-6 (10(-10) to 10(-20)), suggesting rs11573156 G allele-specific exon 2 skipping. Conclusion: Both SNPs are functional and provide useful tools for Mendelian Randomisation to determine whether the relationship between sPLA2-IIA and coronary heart disease is causal.	[Exeter, Holly J.; Palmen, Jutta; Cooper, Jackie A.; Kalea, Anastasia Z.; Humphries, Steve E.; Talmud, Philippa J.] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London, England; [Folkersen, Lasse; van't Hooft, Ferdinand; Eriksson, Per] Karolinska Inst, Dept Med Solna, Atherosclerosis Res Unit, Stockholm, Sweden; [Franco-Cereceda, Anders] Karolinska Inst, Dept Mol Med & Surg, Cardiothorac Surg Unit, Stockholm, Sweden	University of London; University College London; Karolinska Institutet; Karolinska Institutet	Exeter, HJ (corresponding author), UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London, England.	h.exeter@ucl.ac.uk; p.talmud@ucl.ac.uk	Kalea, Anastasia Z./G-4053-2010	Talmud, Philippa/0000-0002-5560-1933; Eriksson, Per/0000-0002-5635-2692; Kalea, Anastasia Z./0000-0001-5775-3984; Folkersen, Lasse/0000-0003-0708-9530; Humphries, Stephen E/0000-0002-8221-6547	British Heart Foundation [FS08/048/25628, RG008/014]; Swedish Research Council; Swedish Heart-Lung foundation; Fredrik Lundberg; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung foundation(Swedish Heart-Lung Foundation); Fredrik Lundberg; British Heart Foundation(British Heart Foundation)	This work was supported by a British Heart Foundation PhD studentship FS08/048/25628 supporting HJE. The ASAP study was supported by the Swedish Research Council, the Swedish Heart-Lung foundation, and a donation by Fredrik Lundberg. SEH and PJT are supported by the British Heart Foundation RG008/014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boekholdt SM, 2005, ARTERIOSCL THROM VAS, V25, P839, DOI 10.1161/01.ATV.0000157933.19424.b7; Fan QS, 1997, MOL CELL BIOL, V17, P4238, DOI 10.1128/MCB.17.8.4238; Folkersen L, 2010, CIRC-CARDIOVASC GENE, V3, P365, DOI 10.1161/CIRCGENETICS.110.948935; Folkersen L, 2009, BIOINFORMATICS, V25, P1978, DOI 10.1093/bioinformatics/btp279; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Henderson WR, 2011, J BIOL CHEM, V286, P28049, DOI 10.1074/jbc.M111.235812; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hingorani A, 2005, LANCET, V366, P1906, DOI 10.1016/S0140-6736(05)67767-7; Hurt-Camejo E, 2000, CURR OPIN LIPIDOL, V11, P465, DOI 10.1097/00041433-200010000-00004; Jonsson-Rylander AC, 2008, CURR ATHEROSCLER REP, V10, P252, DOI 10.1007/s11883-008-0039-6; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Leonarduzzi G, 2011, FREE RADIC BIOL MED; Lu M, 2006, AM J PHYSIOL-CELL PH, V290, pC1477, DOI 10.1152/ajpcell.00374.2005; Mallat Z, 2005, J AM COLL CARDIOL, V46, P1249, DOI 10.1016/j.jacc.2005.06.056; Mallat Z, 2007, ARTERIOSCL THROM VAS, V27, P1177, DOI 10.1161/ATVBAHA.107.139352; Mallat Z, 2010, CIRCULATION, V122, P2183, DOI 10.1161/CIRCULATIONAHA.110.936393; Oorni K, 2009, CURR OPIN LIPIDOL, V20, P421, DOI 10.1097/MOL.0b013e32832fa14d; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; PRUZANSKI W, 1988, J RHEUMATOL, V15, P1351; Smith AJP, 2009, J MOL BIOL, V385, P714, DOI 10.1016/j.jmb.2008.11.035; Touqui Lhousseine, 2001, Current Molecular Medicine (Hilversum), V1, P739, DOI 10.2174/1566524013363258; Trousson A, 2009, J NEUROCHEM, V109, P945, DOI 10.1111/j.1471-4159.2009.06009.x; Tsai NP, 2009, BIOCHEM J, V424, P411, DOI 10.1042/BJ20090915; Webb NR, 2003, ARTERIOSCL THROM VAS, V23, P263, DOI 10.1161/01.ATV.0000051701.90972.E5; Wootton PTE, 2006, HUM MOL GENET, V15, P355, DOI 10.1093/hmg/ddi453	25	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41139	10.1371/journal.pone.0041139	http://dx.doi.org/10.1371/journal.pone.0041139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22879865	Green Published, gold, Green Submitted			2022-12-27	WOS:000306507000073
J	Auzmendi, J; Do Porto, DF; Pallavicini, C; Moffatt, L				Auzmendi, Jeronimo; Fernandez Do Porto, Dario; Pallavicini, Carla; Moffatt, Luciano			Achieving Maximal Speed of Solution Exchange for Patch Clamp Experiments	PLOS ONE			English	Article							LASER-PULSE PHOTOLYSIS; ACETYLCHOLINE-RECEPTOR KINETICS; CHANNEL-OPENING KINETICS; GATED ION CHANNELS; END-PLATE; CONFORMATIONAL-CHANGE; MACROSCOPIC CURRENTS; GLYCINE RECEPTORS; GABA(A) RECEPTORS; AMPA RECEPTOR	Background: Resolving the kinetics of agonist binding events separately from the subsequent channel gating processes requires the ability of applying and removing the agonist before channel gating occurs. No reported system has yet achieved pulses shorter than 100 m mu, necessary to study nicotinic ACh receptor or AMPA receptor activation. Methodology/Principal Findings: Solution exchange systems deliver short agonist pulses by moving a sharp interface between a control and an experimental solution across a channel preparation. We achieved shorter pulses by means of an exchange system that combines a faster flow velocity, narrower partition between the two streams, and increased velocity and bandwidth of the movement of the interface. The measured response of the entire system was fed back to optimize the voltage signal applied to the piezoelectric actuator overcoming the spurious oscillations arising from the mechanical resonances when a high bandwidth driving function was applied. Optimization was accomplished by analyzing the transfer function of the solution exchange system. When driven by optimized command pulses the enhanced system provided pulses lasting 26 +/- 1 mu s and exchanging 93 +/- 1% of the solution, as measured in the open tip of a patch pipette. Conclusions/Significance: Pulses of this duration open the experimental study of the molecular events that occur between the agonist binding and the opening of the channel.	[Auzmendi, Jeronimo; Fernandez Do Porto, Dario; Pallavicini, Carla; Moffatt, Luciano] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Quim Fis Mat Medio Ambiente & Energia, Buenos Aires, DF, Argentina	University of Buenos Aires	Auzmendi, J (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Quim Fis Mat Medio Ambiente & Energia, Buenos Aires, DF, Argentina.	lmoffatt@qi.fcen.uba.ar	Moffatt, Luciano/E-9805-2012	Auzmendi, Jeronimo/0000-0002-4819-2713; Moffatt, Luciano/0000-0003-4994-4304; Fernandez Do Porto, Dario Augusto/0000-0002-3622-4052	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1902/2006]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 1902/2006 to L. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auzmendi JA, 2010, J NEUROSCI METH, V185, P280, DOI 10.1016/j.jneumeth.2009.10.002; BARTOL TM, 1991, BIOPHYS J, V59, P1290, DOI 10.1016/S0006-3495(91)82344-X; Botzolakis EJ, 2009, J NEUROSCI METH, V177, P294, DOI 10.1016/j.jneumeth.2008.10.014; Breitinger HG, 2001, NEUROSCIENTIST, V7, P95, DOI 10.1177/107385840100700204; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Chakrapani S, 2005, P NATL ACAD SCI USA, V102, P87, DOI 10.1073/pnas.0406777102; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; COLQUHOUN D, 1981, NATURE, V294, P464, DOI 10.1038/294464a0; Colquhoun D, 2004, TRENDS NEUROSCI, V27, P337, DOI 10.1016/j.tins.2004.04.010; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; DIONNE VE, 1982, BIOPHYS J, V39, P253, DOI 10.1016/S0006-3495(82)84515-3; Elenes S, 2009, J GEN PHYSIOL, V133, P151, DOI 10.1085/jgp.200810089; FRANKE C, 1992, J PHYSIOL-LONDON, V451, P145, DOI 10.1113/jphysiol.1992.sp019158; Freche D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025122; Gingrich KJ, 2009, J GEN PHYSIOL, V133, P171, DOI 10.1085/jgp.200810081; Grewer C, 1999, BIOPHYS J, V77, P727, DOI 10.1016/S0006-3495(99)76927-4; Hamill OP, 1995, PATCH CLAMP TECHNIQU, P75; Jonas Peter, 1995, P231; Komal P, 2011, J NEUROSCI METH, V198, P246, DOI 10.1016/j.jneumeth.2011.04.024; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; LEIBOWITZ MD, 1984, BIOPHYS J, V45, P153, DOI 10.1016/S0006-3495(84)84144-2; Li G, 2003, BIOCHEMISTRY-US, V42, P12358, DOI 10.1021/bi0347961; Li HY, 2002, BIOCHEMISTRY-US, V41, P4753, DOI 10.1021/bi0118916; Li XS, 2000, J NEUROSCI, V20, P899, DOI 10.1523/JNEUROSCI.20-03-00899.2000; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; MACONOCHIE DJ, 1989, PFLUG ARCH EUR J PHY, V414, P589, DOI 10.1007/BF00580996; MACONOCHIE DJ, 1995, J GEN PHYSIOL, V106, P113, DOI 10.1085/jgp.106.1.113; MACONOCHIE DJ, 1994, NEURON, V12, P61, DOI 10.1016/0896-6273(94)90152-X; MATSUBARA N, 1992, BIOCHEMISTRY-US, V31, P5507, DOI 10.1021/bi00139a012; Milescu LS, 2005, BIOPHYS J, V88, P2494, DOI 10.1529/biophysj.104.053256; Moffatt L, 2007, BIOPHYS J, V93, P74, DOI 10.1529/biophysj.106.101212; Moffatt L, 2007, J GEN PHYSIOL, V130, P183, DOI 10.1085/jgp.200709779; Robert A, 2003, J NEUROSCI, V23, P847; Sachs F, 1999, BIOPHYS J, V77, P682, DOI 10.1016/S0006-3495(99)76923-7; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Sigworth FJ, 1983, SINGLE CHANNEL RECOR, P3; Sivilotti LG, 2010, J PHYSIOL-LONDON, V588, P45, DOI 10.1113/jphysiol.2009.178525; Stiles JR, 1999, BIOPHYS J, V77, P1177, DOI 10.1016/S0006-3495(99)76969-9; Stilson S, 2001, IEEE T BIO-MED ENG, V48, P806, DOI 10.1109/10.930905; Willenbring D, 2011, BIOPHYS J, V101, P1905, DOI 10.1016/j.bpj.2011.09.026	41	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42275	10.1371/journal.pone.0042275	http://dx.doi.org/10.1371/journal.pone.0042275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879927	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100060
J	Chen, TT; Hedman, L; Mattila, PS; Jartti, L; Jartti, T; Ruuskanen, O; Soderlund-Venermo, M; Hedman, K				Chen, Tingting; Hedman, Lea; Mattila, Petri S.; Jartti, Laura; Jartti, Tuomas; Ruuskanen, Olli; Soderlund-Venermo, Maria; Hedman, Klaus			Biotin IgM Antibodies in Human Blood: A Previously Unknown Factor Eliciting False Results in Biotinylation-Based Immunoassays	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; MONOREACTIVE HIGH-AFFINITY; BINDING IMMUNOGLOBULIN-G; B-CELL REPERTOIRE; EGG-WHITE POWDER; RHEUMATOID-FACTOR; AUTOANTIBODIES; DEFICIENCY; SERA; QUANTITATION	Biotin is an essential vitamin that binds streptavidin or avidin with high affinity and specificity. As biotin is a small molecule that can be linked to proteins without affecting their biological activity, biotinylation is applied widely in biochemical assays. In our laboratory, IgM enzyme immuno assays (EIAs) of mu-capture format have been set up against many viruses, using as antigen biotinylated virus like particles (VLPs) detected by horseradish peroxidase-conjugated streptavidin. We recently encountered one serum sample reacting with the biotinylated VLP but not with the unbiotinylated one, suggesting in human sera the occurrence of biotin-reactive antibodies. In the present study, we search the general population (612 serum samples from adults and 678 from children) for IgM antibodies reactive with biotin and develop an indirect EIA for quantification of their levels and assessment of their seroprevalence. These IgM antibodies were present in 3% adults regardless of age, but were rarely found in children. The adverse effects of the biotin IgM on biotinylation-based immunoassays were assessed, including four inhouse and one commercial virus IgM EIAs, showing that biotin IgM do cause false positivities. The biotin can not bind IgM and streptavidin or avidin simultaneously, suggesting that these biotin-interactive compounds compete for the common binding site. In competitive inhibition assays, the affinities of biotin IgM antibodies ranged from 2.1x10(-3) to 1.7x10(-4) mol/L. This is the first report on biotin antibodies found in humans, providing new information on biotinylation-based immunoassays as well as new insights into the biomedical effects of vitamins.	[Chen, Tingting; Hedman, Lea; Soderlund-Venermo, Maria; Hedman, Klaus] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Mattila, Petri S.] Univ Helsinki, Dept Otorhinolaryngol, Helsinki, Finland; [Jartti, Laura] Turku City Hosp, Dept Geriatr, Turku, Finland; [Jartti, Tuomas; Ruuskanen, Olli] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland; [Hedman, Klaus] Univ Helsinki, Cent Hosp, Dept Virol & Immunol, Lab Div, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Turku; University of Turku; University of Helsinki; Helsinki University Central Hospital	Chen, TT (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	klaus.hedman@helsinki.fi	Chen, Tingting/I-8274-2019; Söderlund-Venermo, Maria/AAX-2112-2020; Hedman, Klaus/D-5379-2009	Chen, Tingting/0000-0002-2227-3208; Mattila, Petri/0000-0003-1911-1811; Hedman, Klaus/0000-0003-1779-7960	Helsinki University Central Hospital Research and Education Fund; Sigrid Juselius Foundation; Medical Society of Finland; Academy of Finland [1122539]; Orion-Farmos Research Foundation Grant	Helsinki University Central Hospital Research and Education Fund; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medical Society of Finland; Academy of Finland(Academy of Finland); Orion-Farmos Research Foundation Grant	This study was supported by the Helsinki University Central Hospital Research and Education Fund, the Sigrid Juselius Foundation, the Medical Society of Finland, the Academy of Finland (project 1122539), and the Orion-Farmos Research Foundation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AILUS K, 1991, CLIN CHEM, V37, P1766; BALNAVE D, 1977, AM J CLIN NUTR, V30, P1408, DOI 10.1093/ajcn/30.9.1408; Bobrovnik SA, 2003, J BIOCHEM BIOPH METH, V57, P213, DOI 10.1016/S0165-022X(03)00145-3; Bratthauer GL, 2010, METHODS MOL BIOL, V588, P257, DOI 10.1007/978-1-59745-324-0_26; BURASTERO SE, 1988, J EXP MED, V168, P1979, DOI 10.1084/jem.168.6.1979; Carvalho JF, 2007, ANN NY ACAD SCI, V1109, P550, DOI 10.1196/annals.1398.061; CASALI P, 1989, ANNU REV IMMUNOL, V7, P513, DOI 10.1146/annurev.immunol.7.1.513; Chatterjee NS, 1999, AM J PHYSIOL-CELL PH, V277, pC605, DOI 10.1152/ajpcell.1999.277.4.C605; Chen TT, 2011, J INFECT DIS, V204, P1523, DOI 10.1093/infdis/jir614; Chen TT, 2011, J CLIN VIROL, V50, P125, DOI 10.1016/j.jcv.2010.10.015; DAKSHINAMURTI K, 1990, METHOD ENZYMOL, V184, P93; DEVEY ME, 1989, CLIN EXP IMMUNOL, V77, P191; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; GRIER RE, 1990, CLIN CHIM ACTA, V186, P397, DOI 10.1016/0009-8981(90)90326-N; Hedman L, 2010, J CLIN VIROL, V48, P44, DOI 10.1016/j.jcv.2010.02.003; HOFMANN K, 1980, P NATL ACAD SCI-BIOL, V77, P4666, DOI 10.1073/pnas.77.8.4666; Kaikkonen L, 1999, J CLIN MICROBIOL, V37, P3952, DOI 10.1128/JCM.37.12.3952-3956.1999; Korpilahde T, 2003, ANN RHEUM DIS, V62, P353, DOI 10.1136/ard.62.4.353; Lahtinen A, 2011, EMERG INFECT DIS, V17, P79, DOI 10.3201/eid1701.100750; McMahon RJ, 2002, ANNU REV NUTR, V22, P221, DOI 10.1146/annurev.nutr.22.121101.112819; Mock DM, 1999, J NUTR, V129, p498S, DOI 10.1093/jn/129.2.498S; MOCK DM, 1995, J NUTR, V125, P941; Muratsugu M, 2003, BIOL PHARM BULL, V26, P1605, DOI 10.1248/bpb.26.1605; Muratsugu M, 2008, BIOL PHARM BULL, V31, P507, DOI 10.1248/bpb.31.507; NAKAMURA M, 1988, J IMMUNOL, V141, P4165; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; Pengo P, 2010, J MOL RECOGNIT, V23, P551, DOI 10.1002/jmr.1095; PETERS JM, 1967, BRIT J NUTR, V21, P801, DOI 10.1079/BJN19670082; PETERS JM, 1969, FOOD COSMET TOXICOL, V7, P197, DOI 10.1016/S0015-6264(69)80323-8; Shils ME, 2006, MODERN NUTR HLTH DIS, V10th; Shim CN, 2012, MOD RHEUMATOL, V22, P885, DOI 10.1007/s10165-012-0603-3; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; SUTTON A, 1985, J IMMUNOL METHODS, V82, P215, DOI 10.1016/0022-1759(85)90353-9; SYDENSTRICKER V. P., 1942, SCIENCE, V95, P176, DOI 10.1126/science.95.2459.176; TERNYNCK T, 1986, IMMUNOL REV, V94, P99; Wolf B, 2010, MOL GENET METAB, V100, P6, DOI 10.1016/j.ymgme.2010.01.003; Zempleni J, 1999, J NUTR BIOCHEM, V10, P128, DOI 10.1016/S0955-2863(98)00095-3	39	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42376	10.1371/journal.pone.0042376	http://dx.doi.org/10.1371/journal.pone.0042376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879954	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100074
J	Guo, K				Guo, Kun			Holistic Gaze Strategy to Categorize Facial Expression of Varying Intensities	PLOS ONE			English	Article							FACES; RECOGNITION; INFORMATION; DURATION; EMOTION	Using faces representing exaggerated emotional expressions, recent behaviour and eye-tracking studies have suggested a dominant role of individual facial features in transmitting diagnostic cues for decoding facial expressions. Considering that in everyday life we frequently view low-intensity expressive faces in which local facial cues are more ambiguous, we probably need to combine expressive cues from more than one facial feature to reliably decode naturalistic facial affects. In this study we applied a morphing technique to systematically vary intensities of six basic facial expressions of emotion, and employed a self-paced expression categorization task to measure participants' categorization performance and associated gaze patterns. The analysis of pooled data from all expressions showed that increasing expression intensity would improve categorization accuracy, shorten reaction time and reduce number of fixations directed at faces. The proportion of fixations and viewing time directed at internal facial features (eyes, nose and mouth region), however, was not affected by varying levels of intensity. Further comparison between individual facial expressions revealed that although proportional gaze allocation at individual facial features was quantitatively modulated by the viewed expressions, the overall gaze distribution in face viewing was qualitatively similar across different facial expressions and different intensities. It seems that we adopt a holistic viewing strategy to extract expressive cues from all internal facial features in processing of naturalistic facial expressions.	Lincoln Univ, Sch Psychol, Lincoln, England	University of Lincoln	Guo, K (corresponding author), Lincoln Univ, Sch Psychol, Lincoln, England.	kguo@lincoln.ac.uk		Guo, Kun/0000-0001-6765-1957	State Key Laboratory of Cognitive Neuroscience and Learning, P.R. China; Leverhulme Trust [RF/2/RFG/2009/0152]	State Key Laboratory of Cognitive Neuroscience and Learning, P.R. China; Leverhulme Trust(Leverhulme Trust)	This research was partly supported by Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, P.R. China; The Leverhulme Trust Grant (RF/2/RFG/2009/0152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; Barton JJS, 2006, PERCEPTION, V35, P1089, DOI 10.1068/p5547; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Calvo MG, 2008, BEHAV RES METHODS, V40, P109, DOI 10.3758/BRM.40.1.109; Clark US, 2010, NEUROPSYCHOLOGIA, V48, P1901, DOI 10.1016/j.neuropsychologia.2010.03.006; Du SC, 2011, J VISION, V11, DOI 10.1167/11.13.24; Eisenbarth H, 2011, EMOTION, V11, P860, DOI 10.1037/a0022758; Ekman P., 2002, FACIAL ACTION CODING; Ekman P., 1976, PICTURES FACIAL AFFE; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; Guo K, 2003, EXP BRAIN RES, V150, P363, DOI 10.1007/s00221-003-1429-1; Guo K, 2006, EXP BRAIN RES, V171, P91, DOI 10.1007/s00221-005-0248-y; Guo K, 2007, EXP BRAIN RES, V181, P673, DOI 10.1007/s00221-007-1038-5; Guo K, 2010, PERCEPTION, V39, P533, DOI 10.1068/p6517; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; Herba CM, 2006, J CHILD PSYCHOL PSYC, V47, P1098, DOI 10.1111/j.1469-7610.2006.01652.x; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; KIROUAC G, 1985, J NONVERBAL BEHAV, V9, P3, DOI 10.1007/BF00987555; Kohler CG, 2004, PSYCHIAT RES, V128, P235, DOI 10.1016/j.psychres.2004.07.003; Lundqvist D., 1998, KAROLINSKA DIRECTED; Palermo R, 2004, BEHAV RES METH INS C, V36, P634, DOI 10.3758/BF03206544; Rutishauser U, 2011, CURR BIOL, V21, P1654, DOI 10.1016/j.cub.2011.08.035; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Sullivan S, 2007, J GERONTOL B-PSYCHOL, V62, pP53, DOI 10.1093/geronb/62.1.P53; Vassallo S, 2009, J VISION, V9, DOI 10.1167/9.3.11	27	56	57	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42585	10.1371/journal.pone.0042585	http://dx.doi.org/10.1371/journal.pone.0042585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22880043	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000307284100136
J	Hinkley, LBN; Marco, EJ; Findlay, AM; Honma, S; Jeremy, RJ; Strominger, Z; Bukshpun, P; Wakahiro, M; Brown, WS; Paul, LK; Barkovich, AJ; Mukherjee, P; Nagarajan, SS; Sherr, EH				Hinkley, Leighton B. N.; Marco, Elysa J.; Findlay, Anne M.; Honma, Susanne; Jeremy, Rita J.; Strominger, Zoe; Bukshpun, Polina; Wakahiro, Mari; Brown, Warren S.; Paul, Lynn K.; Barkovich, A. James; Mukherjee, Pratik; Nagarajan, Srikantan S.; Sherr, Elliott H.			The Role of Corpus Callosum Development in Functional Connectivity and Cognitive Processing	PLOS ONE			English	Article							SORTING TEST-PERFORMANCE; INTERHEMISPHERIC-TRANSFER; BRAIN REORGANIZATION; SPATIAL ATTENTION; EARLY CALLOSOTOMY; EEG COHERENCE; FRONTAL-LOBE; AGENESIS; ABNORMALITIES; CHILDREN	The corpus callosum is hypothesized to play a fundamental role in integrating information and mediating complex behaviors. Here, we demonstrate that lack of normal callosal development can lead to deficits in functional connectivity that are related to impairments in specific cognitive domains. We examined resting-state functional connectivity in individuals with agenesis of the corpus callosum (AgCC) and matched controls using magnetoencephalographic imaging (MEG-I) of coherence in the alpha (8-12 Hz), beta (12-30 Hz) and gamma (30-55 Hz) bands. Global connectivity (GC) was defined as synchronization between a region and the rest of the brain. In AgCC individuals, alpha band GC was significantly reduced in the dorsolateral pre-frontal (DLPFC), posterior parietal (PPC) and parieto-occipital cortices (PO). No significant differences in GC were seen in either the beta or gamma bands. We also explored the hypothesis that, in AgCC, this regional reduction in functional connectivity is explained primarily by a specific reduction in interhemispheric connectivity. However, our data suggest that reduced connectivity in these regions is driven by faulty coupling in both inter-and intrahemispheric-connectivity. We also assessed whether the degree of connectivity correlated with behavioral performance, focusing on cognitive measures known to be impaired in AgCC individuals. Neuropsychological measures of verbal processing speed were significantly correlated with resting-state functional connectivity of the left medial and superior temporal lobe in AgCC participants. Connectivity of DLPFC correlated strongly with performance on the Tower of London in the AgCC cohort. These findings indicate that the abnormal callosal development produces salient but selective (alpha band only) resting-state functional connectivity disruptions that correlate with cognitive impairment. Understanding the relationship between impoverished functional connectivity and cognition is a key step in identifying the neural mechanisms of language and executive dysfunction in common neurodevelopmental and psychiatric disorders where disruptions of callosal development are consistently identified.	[Hinkley, Leighton B. N.; Findlay, Anne M.; Honma, Susanne; Barkovich, A. James; Mukherjee, Pratik; Nagarajan, Srikantan S.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Marco, Elysa J.; Strominger, Zoe; Bukshpun, Polina; Wakahiro, Mari; Barkovich, A. James; Sherr, Elliott H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Marco, Elysa J.; Jeremy, Rita J.; Barkovich, A. James; Sherr, Elliott H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Brown, Warren S.; Paul, Lynn K.] Fuller Theol Seminary, Travis Res Inst, Pasadena, CA 91101 USA; [Paul, Lynn K.] CALTECH, Dept Neurosci, Pasadena, CA 91125 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; California Institute of Technology	Hinkley, LBN (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	sri@radiology.ucsf.edu; sherre@neuropeds.ucsf.edu		Paul, Lynn/0000-0002-3128-8313; Mukherjee, Pratik/0000-0001-7473-7409	National Institutes of Health (NIH) [R01 DC004855, DC006435, DC010145, NS067962, NS64060]; National Science Foundation [BCS-0926196]; NIH grant [K23 MH083890, K02 NS052192, KL2 RR024130]; Sandler Program for Breakthrough Biomedical Research; Simons Foundation; Dystonia Medical Research Foundation; National Institutes of Health/National Center for Research Resources (NIH/NCRR) UCSF-Clinical and Translational Science Institute (CTSI) [UL1 RR024131]; National Alliance for Research on Schizophrenia and Depression; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130, UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH083890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS052192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004855, R01DC006435, R01DC010145] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Program for Breakthrough Biomedical Research; Simons Foundation; Dystonia Medical Research Foundation; National Institutes of Health/National Center for Research Resources (NIH/NCRR) UCSF-Clinical and Translational Science Institute (CTSI); National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by National Institutes of Health (NIH) grants R01 DC004855, DC006435, DC010145, NS067962, NS64060, and by National Science Foundation grant BCS-0926196 to SSN, NIH grant K23 MH083890 to EJM, K02 NS052192 to EHS, KL2 RR024130 to EJM, EHS), the Sandler Program for Breakthrough Biomedical Research (EHS), the Simons Foundation (LKP), National Alliance for Research on Schizophrenia and Depression (LKP) and the Dystonia Medical Research Foundation (LBNH). This project was supported by the National Institutes of Health/National Center for Research Resources (NIH/NCRR) UCSF-Clinical and Translational Science Institute (CTSI) grant no. UL1 RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adcock RA, 2009, SCHIZOPHRENIA BULL, V35, P1132, DOI 10.1093/schbul/sbp068; ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Badaruddin DH, 2007, CHILD PSYCHIAT HUM D, V38, P287, DOI 10.1007/s10578-007-0065-6; Banich MT, 2000, DEV NEUROPSYCHOL, V18, P1, DOI 10.1207/S15326942DN1801_1; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Bigler E D, 1988, Arch Clin Neuropsychol, V3, P189, DOI 10.1016/0887-6177(88)90063-7; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Braun U, 2011, NEUROIMAGE IN PRESS; Brown WS, 1999, NEUROPSYCHOLOGIA, V37, P1165, DOI 10.1016/S0028-3932(99)00011-1; Brown WS, 2005, NEUROPSYCHOLOGIA, V43, P906, DOI 10.1016/j.neuropsychologia.2004.09.008; Brown WS, 2005, BRAIN LANG, V93, P135, DOI 10.1016/j.bandl.2004.09.003; Brown WS, 1998, CORTEX, V34, P677, DOI 10.1016/S0010-9452(08)70772-X; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Cantero JL, 2002, NEUROPHYSIOL CLIN, V32, P54, DOI 10.1016/S0987-7053(01)00289-1; Dalal SS, 2008, NEUROIMAGE, V40, P1686, DOI 10.1016/j.neuroimage.2008.01.023; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; DAVID AS, 1993, J NEUROL NEUROSUR PS, V56, P85, DOI 10.1136/jnnp.56.1.85; DEGREEF G, 1992, AM J NEURORADIOL, V13, P835; Delis DC, 2001, DELIS KAPLAN EXECUTI; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; DREWE E A, 1974, Cortex, V10, P159; FISCHER M, 1992, ARCH NEUROL-CHICAGO, V49, P271, DOI 10.1001/archneur.1992.00530270085023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Guggisberg AG, 2008, ANN NEUROL, V63, P193, DOI 10.1002/ana.21224; Hardan AY, 2009, PSYCHIAT RES-NEUROIM, V174, P57, DOI 10.1016/j.pscychresns.2009.03.005; Harrell KM, 2010, INT M AUT RES PHIL P; Hetts SW, 2006, AM J ROENTGENOL, V187, P1343, DOI 10.2214/AJR.05.0146; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hillebrand A, 2003, NEUROIMAGE, V20, P2302, DOI 10.1016/j.neuroimage.2003.07.031; Hines RJ, 2002, NEUROPSYCHOLOGIA, V40, P1804, DOI 10.1016/S0028-3932(02)00032-5; Hinkley LBN, 2010, FRONT HUM NEUROSCI, V11, P3; Hinkley LBN, 2011, BIOL PSYCHIAT, V70, P1134, DOI 10.1016/j.biopsych.2011.06.029; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Hutchinson AD, 2009, EXP BRAIN RES, V192, P455, DOI 10.1007/s00221-008-1604-5; HYND GW, 1991, J LEARN DISABIL, V24, P141, DOI 10.1177/002221949102400302; Imamura T, 1994, Behav Neurol, V7, P43, DOI 10.3233/BEN-1994-7201; Jeeves M A, 1965, Proc Aust Assoc Neurol, V3, P41; JEEVES MA, 1964, NEUROPSYCHOLOGIA, V2, P247, DOI 10.1016/0028-3932(64)90009-0; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Keary CJ, 2009, J AUTISM DEV DISORD, V39, P834, DOI 10.1007/s10803-009-0689-4; Knyazeva M, 1997, BEHAV BRAIN RES, V89, P243, DOI 10.1016/S0166-4328(97)00070-3; KOEDA T, 1993, DEV MED CHILD NEUROL, V35, P65; Koeda T, 1995, ELECTROEN CLIN NEURO, V95, P397, DOI 10.1016/0013-4694(95)00171-9; Kounios J, 2008, NEUROPSYCHOLOGIA, V46, P281, DOI 10.1016/j.neuropsychologia.2007.07.013; KUKS JBM, 1987, ELECTROEN CLIN NEURO, V66, P8, DOI 10.1016/0013-4694(87)90132-5; LASSONDE M, 1991, NEUROPSYCHOLOGIA, V29, P481, DOI 10.1016/0028-3932(91)90006-T; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Leon-Carrion J, 2009, CLIN NEUROPHYSIOL, V120, P1039, DOI 10.1016/j.clinph.2009.01.021; Lessard N, 2002, BRAIN, V125, P1039, DOI 10.1093/brain/awf096; LEWIS SW, 1988, PSYCHOL MED, V18, P341, DOI 10.1017/S0033291700007881; Luders E, 2007, NEUROIMAGE, V37, P1457, DOI 10.1016/j.neuroimage.2007.06.028; Luders E, 2011, NEUROIMAGE, V54, P1823, DOI 10.1016/j.neuroimage.2010.09.083; Marco EJ, 2011, PROCESSING IN PRESS; Mazoyer B, 2009, BRAIN RES BULL, V80, P133, DOI 10.1016/j.brainresbull.2009.06.021; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; McKenzie A, 2003, AM J PHYS MED REHAB, V82, P737, DOI 10.1097/01.PHM.0000087458.32122.14; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Nachev P, 2006, CORTEX, V42, P766, DOI 10.1016/S0010-9452(08)70415-5; NAGASE Y, 1994, CLIN ELECTROENCEPHAL, V25, P36, DOI 10.1177/155005949402500110; Nakata Y, 2009, AM J NEURORADIOL, V30, P1142, DOI 10.3174/ajnr.A1527; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niedermeyer E., 1999, ELECTROENCEPHALOGRAP; NIELSEN T, 1993, EUR NEUROL, V33, P173, DOI 10.1159/000116928; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez P.L., 1995, NEOCORTICAL DYNAMICS; NUNEZ PL, 1981, IEEE T BIO-MED ENG, V28, P271, DOI 10.1109/TBME.1981.324700; Nunez PL, 1996, EEG CL N SU, P37; Osbun N, 2011, AM J MED GENET A, V155A, P1865, DOI 10.1002/ajmg.a.34081; Paul, 2000, COGNITIVE NEUROPSYCH, V5, P135, DOI DOI 10.1080/135468000395781; Paul LK, 2004, ARCH CLIN NEUROPSYCH, V19, P215, DOI 10.1016/S0887-6177(03)00024-6; Paul LK, 2003, BRAIN LANG, V85, P313, DOI 10.1016/S0093-934X(03)00062-2; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; Penke L, 2010, J NEUROSCI, V30, P7569, DOI 10.1523/JNEUROSCI.1553-10.2010; PETERS M, 1988, CAN J PSYCHOL, V42, P313, DOI 10.1037/h0084195; PETRIDES M, 1985, NEUROPSYCHOLOGIA, V23, P601, DOI 10.1016/0028-3932(85)90062-4; Quigley M, 2003, AM J NEURORADIOL, V24, P208; Quigley M, 2001, AM J NEURORADIOL, V22, P294; Raffi M, 2005, J NEUROSCI, V25, P5171, DOI 10.1523/JNEUROSCI.5201-04.2005; Raichle ME, 2009, J NEUROSCI, V29, P12729, DOI 10.1523/JNEUROSCI.4366-09.2009; Robinson S.E., 1999, RECENT ADV BIOMAGNET, P302; SANDERS RJ, 1989, BRAIN LANG, V37, P59, DOI 10.1016/0093-934X(89)90101-6; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shen YP, 2010, PEDIATRICS, V125, pE727, DOI 10.1542/peds.2009-1684; Sherr EH, 2003, CURR OPIN PEDIATR, V15, P567, DOI 10.1097/00008480-200312000-00004; SOLURSH LP, 1965, J NERV MENT DIS, V141, P180, DOI 10.1097/00005053-196508000-00005; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; SWAYZE VW, 1990, ARCH NEUROL-CHICAGO, V47, P805, DOI 10.1001/archneur.1990.00530070103018; Symington SH, 2010, SOC NEUROSCI-UK, V5, P296, DOI 10.1080/17470910903462419; Tibbo P, 1998, BIOL PSYCHIAT, V44, P405, DOI 10.1016/S0006-3223(98)00096-1; TOMASCH J, 1954, ANAT REC, V119, P119, DOI 10.1002/ar.1091190109; Tovar-Moll F, 2007, CEREB CORTEX, V17, P531, DOI 10.1093/cercor/bhj178; Turk AA, 2010, NEUROPSYCHOLOGIA, V48, P43, DOI 10.1016/j.neuropsychologia.2009.08.009; van Eimeren L, 2008, NEUROREPORT, V19, P1117, DOI 10.1097/WNR.0b013e328307f5c1; Voineskos A. N., 2010, NEUROBIOLOGY AGING; Wahl M, 2009, AM J NEURORADIOL, V30, P282, DOI 10.3174/ajnr.A1361; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1997, WECHSLER ADULT INTEL; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30; Wolf RC, 2008, EUR PSYCHIAT, V23, P541, DOI 10.1016/j.eurpsy.2008.02.002; Zahr NM, 2009, NEUROIMAGE, V44, P1050, DOI 10.1016/j.neuroimage.2008.09.046	106	102	105	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e39804	10.1371/journal.pone.0039804	http://dx.doi.org/10.1371/journal.pone.0039804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870191	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000307284100005
J	Jiao, J; Hindoyan, A; Wang, SY; Tran, LM; Goldstein, AS; Lawson, D; Chen, DH; Li, YF; Guo, CY; Zhang, BH; Fazli, L; Gleave, M; Witte, ON; Garraway, IP; Wu, H				Jiao, Jing; Hindoyan, Antreas; Wang, Shunyou; Tran, Linh M.; Goldstein, Andrew S.; Lawson, Devon; Chen, Donghui; Li, Yunfeng; Guo, Changyong; Zhang, Baohui; Fazli, Ladan; Gleave, Martin; Witte, Owen N.; Garraway, Isla P.; Wu, Hong			Identification of CD166 as a Surface Marker for Enriching Prostate Stem/Progenitor and Cancer Initiating Cells	PLOS ONE			English	Article							EPITHELIAL STEM-CELLS; ADHESION MOLECULE; MOUSE PROSTATE; PROGENITOR CELLS; BASAL-CELLS; IN-VITRO; MURINE; PTEN; EXPRESSION; SURVIVAL	New therapies for late stage and castration resistant prostate cancer (CRPC) depend on defining unique properties and pathways of cell sub-populations capable of sustaining the net growth of the cancer. One of the best enrichment schemes for isolating the putative stem/ progenitor cell from the murine prostate gland is Lin(-);Sca1(+);CD49f(hi) (LSChi), which results in a more than 10-fold enrichment for in vitro sphere-forming activity. We have shown previously that the LSChi subpopulation is both necessary and sufficient for cancer initiation in the Pten-null prostate cancer model. To further improve this enrichment scheme, we searched for cell surface molecules upregulated upon castration of murine prostate and identified CD166 as a candidate gene. CD166 encodes a cell surface molecule that can further enrich sphere-forming activity of WT LSChi and Pten null LSChi. Importantly, CD166 could enrich sphere-forming ability of benign primary human prostate cells in vitro and induce the formation of tubule-like structures in vivo. CD166 expression is upregulated in human prostate cancers, especially CRPC samples. Although genetic deletion of murine CD166 in the Pten null prostate cancer model does not interfere with sphere formation or block prostate cancer progression and CRPC development, the presence of CD166 on prostate stem/ progenitors and castration resistant sub-populations suggest that it is a cell surface molecule with the potential for targeted delivery of human prostate cancer therapeutics.	[Jiao, Jing; Hindoyan, Antreas; Wang, Shunyou; Tran, Linh M.; Lawson, Devon; Li, Yunfeng; Witte, Owen N.; Wu, Hong] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; [Jiao, Jing; Hindoyan, Antreas; Tran, Linh M.; Li, Yunfeng; Witte, Owen N.; Wu, Hong] Univ Calif Los Angeles, Inst Mol Med, Los Angeles, CA USA; [Goldstein, Andrew S.; Chen, Donghui; Witte, Owen N.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA; [Goldstein, Andrew S.; Chen, Donghui; Witte, Owen N.] Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90024 USA; [Guo, Changyong; Zhang, Baohui; Garraway, Isla P.] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA USA; [Fazli, Ladan; Gleave, Martin] Vancouver Prostate Ctr, Vancouver, BC, Canada; [Fazli, Ladan; Gleave, Martin] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Witte, Owen N.; Wu, Hong] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of British Columbia; University of California System; University of California Los Angeles	Jiao, J (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA.	igarraway@mednet.ucla.edu; hwu@mednet.ucla.edu	Witte, Otto/P-4127-2018; Jiao, Jing/F-5354-2015	Witte, Otto/0000-0003-2101-4105; Goldstein, Andrew/0000-0003-0434-9149; Gleave, Martin/0000-0003-4235-0167	Prostate Cancer Foundation; Jean Perkins Foundation; Department of Defense; National Institutes of Health [R01 CA107166, RO1 CA121110]; NATIONAL CANCER INSTITUTE [R01CA121110, R01CA107166] Funding Source: NIH RePORTER	Prostate Cancer Foundation; Jean Perkins Foundation; Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported in part by an award from the Prostate Cancer Foundation (to OW, IPG and HW), Jean Perkins Foundation and Department of Defense (to IPG) and a grant from the National Institutes of Health (R01 CA107166 and RO1 CA121110 to HW). ONW is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Kheir WG, 2010, STEM CELLS, V28, P2129, DOI 10.1002/stem.538; Burger PE, 2009, STEM CELLS, V27, P2220, DOI 10.1002/stem.135; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; De Marzo AM, 2010, NAT REV UROL, V7, P650, DOI 10.1038/nrurol.2010.188; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Goldstein AS, 2011, NAT PROTOC, V6, P656, DOI 10.1038/nprot.2011.317; Goldstein AS, 2010, MOL ONCOL, V4, P385, DOI 10.1016/j.molonc.2010.06.009; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Hart LS, 2008, J CLIN ONCOL, V26, P2901, DOI 10.1200/JCO.2008.16.9573; Ishigami S, 2011, J SURG ONCOL, V103, P57, DOI 10.1002/jso.21756; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kahlert C, 2009, BRIT J CANCER, V101, P457, DOI 10.1038/sj.bjc.6605136; King JA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-266; Korsten H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005662; Kristiansen G, 2005, J PATHOL, V205, P359, DOI 10.1002/path.1676; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Liao CP, 2010, CANCER RES, V70, P7294, DOI 10.1158/0008-5472.CAN-09-3982; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001237; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Lunter PC, 2005, CANCER RES, V65, P8801, DOI 10.1158/0008-5472.CAN-05-0378; Maitland NJ, 2005, BJU INT, V96, P1219, DOI 10.1111/j.1464-410X.2005.05744.x; McMenamin ME, 1999, CANCER RES, V59, P4291; Mezzanzanica D, 2008, CLIN CANCER RES, V14, P1726, DOI 10.1158/1078-0432.CCR-07-0428; Moscatelli D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001445; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Narita S, 2008, CLIN CANCER RES, V14, P5769, DOI 10.1158/1078-0432.CCR-07-4282; Ofori-Acquah SF, 2008, TRANSL RES, V151, P122, DOI 10.1016/j.trsl.2007.09.006; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Roth A, 2007, MOL CANCER THER, V6, P2737, DOI 10.1158/1535-7163.MCT-07-0140; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Sato C, 2002, J BIOL CHEM, V277, P45299, DOI 10.1074/jbc.M206046200; Sawhney M, 2009, INT J CANCER, V124, P2098, DOI 10.1002/ijc.24192; Swart GWM, 2002, EUR J CELL BIOL, V81, P313, DOI 10.1078/0171-9335-00256; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Taylor RA, 2010, ENDOCR-RELAT CANCER, V17, pR273, DOI 10.1677/ERC-10-0145; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; van Kempen LCLT, 2001, J BIOL CHEM, V276, P25783, DOI 10.1074/jbc.M011272200; van Kempen LCLT, 2000, AM J PATHOL, V156, P769, DOI 10.1016/S0002-9440(10)64943-7; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang CH, 2011, NANOMED-NANOTECHNOL, V7, P69, DOI 10.1016/j.nano.2010.06.010; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Wang ZA, 2011, ONCOGENE, V30, P1261, DOI 10.1038/onc.2010.530; Weichert W, 2004, J CLIN PATHOL, V57, P1160, DOI 10.1136/jcp.2004.016238; Weiner JA, 2004, MOL CELL NEUROSCI, V27, P59, DOI 10.1016/j.mcn.2004.06.005; Wiiger MT, 2010, CANCER IMMUNOL IMMUN, V59, P1665, DOI 10.1007/s00262-010-0892-3; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355	59	73	79	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42564	10.1371/journal.pone.0042564	http://dx.doi.org/10.1371/journal.pone.0042564			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880034	Green Published, gold			2022-12-27	WOS:000307284100130
J	Kohn, C; Schleifenbaum, J; Szijarto, IA; Marko, L; Dubrovska, G; Huang, Y; Gollasch, M				Koehn, Carolin; Schleifenbaum, Johanna; Szijarto, Istvan Andras; Marko, Lajos; Dubrovska, Galyna; Huang, Yu; Gollasch, Maik			Differential Effects of Cystathionine-gamma-lyase-Dependent Vasodilatory H2S in Periadventitial Vasoregulation of Rat and Mouse Aortas	PLOS ONE			English	Article							PERIVASCULAR ADIPOSE-TISSUE; SPONTANEOUSLY HYPERTENSIVE-RATS; SMOOTH-MUSCLE-CELLS; HYDROGEN-SULFIDE; VASCULAR FUNCTION; ARTERIAL TONE; MICE; VASORELAXANT; INFLAMMATION; ENDOTHELIUM	Background: Hydrogen sulfide (H2S) is a potent vasodilator. However, the complex mechanisms of vasoregulation by H2S are not fully understood. We tested the hypotheses that (1) H2S exerts vasodilatory effects by opening KCNQ-type voltage-dependent (K-v) K+ channels and (2) that H2S-producing cystathionine-gamma-lyase (CSE) in perivascular adipose tissue plays a major role in this pathway. Methodology/Principal Findings: Wire myography of rat and mouse aortas was used. NaHS and 5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione (ADTOH) were used as H2S donors. KCNQ-type K-v channels were blocked by XE991. 4-Propargylglycine (PPG) and beta-cyano-l-alanine (BCA), or 2-(aminooxy)-acetic acid (AOAA) were used as inhibitors of CSE or cystathionine-beta-synthase (CBS), respectively. NaHS and ADTOH produced strong vasorelaxation in rat and mouse aortas, which were abolished by KCNQ channel inhibition with XE991. Perivascular adipose tissue (PVAT) exerted an anticontractile effect in these arteries. CSE inhibition by PPG and BCA reduced this effect in aortas from rats but not from mice. CBS inhibition with AOAA did not inhibit the anticontractile effects of PVAT. XE991, however, almost completely suppressed the anticontractile effects of PVAT in both species. Exogenous l-cysteine, substrate for the endogenous production of H2S, induced vasorelaxation only at concentrations >5 mmol/l, an effect unchanged by CSE inhibition. Conclusions/Signficance: Our results demonstrate potent vasorelaxant effects of H2S donors in large arteries of both rats and mice, in which XE991-sensitive KCNQ-type channel opening play a pivotal role. CSE-H2S seems to modulate the effect of adipocyte-derived relaxing factor in rat but not in mouse aorta. The present study provides novel insight into the interaction of CSE-H2S and perivascular adipose tissue. Furthermore, with additional technical advances, a future clinical approach targeting vascular H2S/KCNQ pathways to influence states of vascular dysfunction may be possible.	[Koehn, Carolin; Schleifenbaum, Johanna; Szijarto, Istvan Andras; Marko, Lajos; Dubrovska, Galyna; Gollasch, Maik] Charite Campus Virchow Klinikum, Med Clin Nephrol & Internal Intens Care, Berlin, Germany; [Koehn, Carolin; Schleifenbaum, Johanna; Szijarto, Istvan Andras; Marko, Lajos; Dubrovska, Galyna; Gollasch, Maik] Max Delbruck Ctr Mol Med, ECRC, Berlin, Germany; [Huang, Yu] Chinese Univ Hong Kong, Inst Vasc Med, Li Ka Shing Inst Hlth Sci, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Chinese University of Hong Kong	Kohn, C (corresponding author), Charite Campus Virchow Klinikum, Med Clin Nephrol & Internal Intens Care, Berlin, Germany.	maik.gollasch@charite.de	Huang, Yu/K-2866-2017	Huang, Yu/0000-0002-1277-6784; Schleifenbaum, Johanna/0000-0002-3195-1517; Marko, Lajos/0000-0003-1888-5575; Szijarto, Istvan/0000-0002-0796-9450	Deutsche Forschungsgemeinschaft (DFG); Deutsche Akademische Austauschdienst (Germany/Hong Kong Joint Research Scheme)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Akademische Austauschdienst (Germany/Hong Kong Joint Research Scheme)	This study has been supported by the Deutsche Forschungsgemeinschaft (DFG) and Deutsche Akademische Austauschdienst (Germany/Hong Kong Joint Research Scheme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Magableh MR, 2011, N-S ARCH PHARMACOL, V383, P403, DOI 10.1007/s00210-011-0608-z; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Dubrovska G, 2004, AM J PHYSIOL-HEART C, V286, pH1107, DOI 10.1152/ajpheart.00656.2003; Fang LP, 2009, J HYPERTENS, V27, P2174, DOI 10.1097/HJH.0b013e328330a900; Feng XJ, 2009, BIOCHEM BIOPH RES CO, V380, P153, DOI 10.1016/j.bbrc.2009.01.059; Fesus G, 2007, CARDIOVASC RES, V75, P719, DOI 10.1016/j.cardiores.2007.05.025; Galvez B, 2006, ARTERIOSCL THROM VAS, V26, P1297, DOI 10.1161/01.ATV.0000220381.40739.dd; Galvez-Prieto B, 2008, HYPERTENS RES, V31, P1415, DOI 10.1291/hypres.31.1415; Gao YJ, 2007, BRIT J PHARMACOL, V151, P323, DOI 10.1038/sj.bjp.0707228; Gao YJ, 2005, J THORAC CARDIOV SUR, V130, P1130, DOI 10.1016/j.jtcvs.2005.05.028; Giustarini D, 2010, FREE RADICAL BIO MED, V48, P1263, DOI 10.1016/j.freeradbiomed.2010.02.014; Givvimani S, 2011, J APPL PHYSIOL, V110, P1093, DOI 10.1152/japplphysiol.01064.2010; Gollasch M, 2004, TRENDS PHARMACOL SCI, V25, P647, DOI 10.1016/j.tips.2004.10.005; Gollasch M, 2012, BRIT J PHARMACOL, V165, P633, DOI 10.1111/j.1476-5381.2011.01430.x; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Jin Hong-fang, 2008, Zhonghua Xinxueguanbing Zazhi, V36, P541; Ketonen J, 2010, CIRC J, V74, P1479, DOI 10.1253/circj.CJ-09-0661; Kiss L, 2008, LIFE SCI, V83, P589, DOI 10.1016/j.lfs.2008.08.006; Koenitzer JR, 2007, AM J PHYSIOL-HEART C, V292, pH1953, DOI 10.1152/ajpheart.01193.2006; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Lee RMKW, 2009, CAN J PHYSIOL PHARM, V87, P944, DOI [10.1139/Y09-088, 10.1139/y09-088]; Lee SW, 2007, BIOCHEM BIOPH RES CO, V358, P1142, DOI 10.1016/j.bbrc.2007.05.063; Lee YC, 2011, CIRCULATION, V124, P1160, DOI 10.1161/CIRCULATIONAHA.111.027375; Liang GH, 2011, AM J PHYSIOL-HEART C, V300, pH2088, DOI 10.1152/ajpheart.01290.2010; Lim JJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1261, DOI 10.1152/ajpcell.00195.2008; Lohn M, 2002, FASEB J, V16, P1057, DOI 10.1096/fj.02-0024com; Lu M, 2010, J AM SOC NEPHROL, V21, P993, DOI 10.1681/ASN.2009090949; Monjok EM, 2008, EXP EYE RES, V87, P612, DOI 10.1016/j.exer.2008.09.011; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Schleifenbaum J, 2010, J HYPERTENS, V28, P1875, DOI 10.1097/HJH.0b013e32833c20d5; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; SOLTIS EE, 1991, CLIN EXP HYPERTENS A, V13, P277, DOI 10.3109/10641969109042063; Sun Yan, 2009, Zhonghua Xinxueguanbing Zazhi, V37, P161, DOI 10.3760/cma.j.issn.0253-3758.2009.02.018; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Szabo C, 2011, BRIT J PHARMACOL, V164, P853, DOI 10.1111/j.1476-5381.2010.01191.x; Szasz T, 2012, CLIN SCI, V122, P1, DOI 10.1042/CS20110151; Verlohren S, 2004, HYPERTENSION, V44, P271, DOI 10.1161/01.HYP.0000140058.28994.ec; Wagner CA, 2009, J NEPHROL, V22, P173; Webb GD, 2008, J PHARMACOL EXP THER, V324, P876, DOI 10.1124/jpet.107.133538; Withers SB, 2011, ARTERIOSCL THROM VAS, V31, P908, DOI 10.1161/ATVBAHA.110.221705; Wojcicka G, 2011, PHARMACOL RES, V63, P68, DOI 10.1016/j.phrs.2010.10.011; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao Jing, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P449	45	72	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41951	10.1371/journal.pone.0041951	http://dx.doi.org/10.1371/journal.pone.0041951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870268	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100039
J	Li, HZ; Mani, S; Cao, W; Yang, GD; Lai, C; Wu, LY; Wang, R				Li, Hongzhu; Mani, Sarathi; Cao, Wei; Yang, Guangdong; Lai, Christopher; Wu, Lingyun; Wang, Rui			Interaction of Hydrogen Sulfide and Estrogen on the Proliferation of Vascular Smooth Muscle Cells	PLOS ONE			English	Article							H2S; APOPTOSIS; BETA; VASORELAXANT; MECHANISMS; ESTRADIOL; P38	Hydrogen sulfide (H2S) can be endogenously generated from cystathionine gamma-lyase (CSE) in cardiovascular system, offering a cardiovascular protection. It is also known that the lower risk of cardiovascular diseases in female is partially attributed to the protective effect of estrogen. The current study explores the interaction of H2S and estrogen on smooth muscle cell (SMC) growth. In the present study, we found that the proliferation of cultured vascular SMCs isolated from wildtype mice (WT-SMCs) was inhibited, but that from CSE gene knockout mice (CSE-KO-SMCs) increased, by estrogen treatments. The expression of estrogen receptor alpha (ER alpha), but not ER beta, was significantly decreased in CSE-KO-SMCs compared with that in WT-SMCs. Exogenously applied H2S markedly increased ER alpha but not ER beta expression. In addition, the inhibition of ER activation and knockdown of ER alpha expression in WT-SMCs or the overexpression of ER alpha in CSE-KO-SMCs reversed the respective effects of estrogen on cell proliferation. The expression of cyclin D1 was reduced in WT-SMCs but increased in CSE-KO-SMCs after estrogen treatments, which was reversed by knockdown of ER alpha in WT-SMCs or overexpression of ER alpha in CSE-KO-SMCs, respectively. The overexpression of cyclin D1 in WT-SMCs or knockdown of cyclin D1 expression in CSE-KO-SMCs reversed the effects of estrogen on cell proliferation. These results suggest that H2S mediates estrogen-inhibited proliferation of SMCs via selective activation of ER alpha/cyclin D1 pathways.	[Li, Hongzhu; Mani, Sarathi; Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Li, Hongzhu; Wang, Rui] Harbin Med Univ, Dept Pathophysiol, Harbin, Peoples R China; [Cao, Wei; Wu, Lingyun] Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada; [Yang, Guangdong] Lakehead Univ, Sch Kinesiol, Thunder Bay, ON P7B 5E1, Canada; [Lai, Christopher] Lakehead Univ, No Ontario Sch Med, Thunder Bay, ON P7B 5E1, Canada	Lakehead University; Harbin Medical University; Lakehead University; Lakehead University; Lakehead University; Northern Ontario School of Medicine	Li, HZ (corresponding author), Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada.	rwang@lakeheadu.ca	Wang, Rui/C-7824-2012; Yang, Guangdong/G-4129-2011	Wang, Rui/0000-0003-3825-3620; MANI, SARATHI/0000-0001-8383-4788	Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada (HSFC); HSFC	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada); HSFC(Heart & Stroke Foundation of Canada)	This study was supported by a Discovery Grant from Natural Sciences and Engineering Research Council of Canada. SM was supported by a research fellowship award from Heart and Stroke Foundation of Canada (HSFC). GY was supported by a New Investigator Award from HSFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal JF, 2004, EUR J ENDOCRINOL, V150, P113, DOI 10.1530/eje.0.1500113; Cao QH, 2010, ANTIOXID REDOX SIGN, V12, P1101, DOI 10.1089/ars.2009.2915; Cheng B, 2009, INT J CARDIOL, V134, P356, DOI 10.1016/j.ijcard.2008.02.017; Geraldes P, 2002, ARTERIOSCL THROM VAS, V22, P1585, DOI 10.1161/01.ATV.0000035393.11854.6A; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hodges YK, 2000, CIRCULATION, V101, P1792, DOI 10.1161/01.CIR.101.15.1792; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Li HZ, 2008, BASIC CLIN PHARMACOL, V102, P329, DOI 10.1111/j.1742-7843.2007.00177.x; Li HZ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-18; Lu Y, 2002, LIFE SCI, V71, P1465, DOI 10.1016/S0024-3205(02)01922-7; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Pace P, 1997, J BIOL CHEM, V272, P25832, DOI 10.1074/jbc.272.41.25832; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Stamatiou R, 2011, STEROIDS, V76, P400, DOI 10.1016/j.steroids.2010.12.010; Takahashi K, 2003, J ENDOCRINOL, V178, P319, DOI 10.1677/joe.0.1780319; Waladali W, 2009, WORLD J UROL, V27, P241, DOI 10.1007/s00345-008-0333-5; Wang R, 2003, ANTIOXID REDOX SIGN, V5, P493, DOI 10.1089/152308603768295249; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2011, CURR OPIN NEPHROL HY, V20, P107, DOI 10.1097/MNH.0b013e3283430651; Wang R, 2009, KIDNEY INT, V76, P700, DOI 10.1038/ki.2009.221; WARENYCIA MW, 1989, BIOCHEM PHARMACOL, V38, P973, DOI 10.1016/0006-2952(89)90288-8; Watanabe T, 2003, CARDIOVASC RES, V59, P734, DOI 10.1016/S0008-6363(03)00496-6; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279; Yang G, 2006, FASEB J, V20, P553, DOI 10.1096/fj.05-4712fje; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Yang GD, 2004, J BIOL CHEM, V279, P49199, DOI 10.1074/jbc.M408997200; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	31	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41614	10.1371/journal.pone.0041614	http://dx.doi.org/10.1371/journal.pone.0041614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870237	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100024
J	Maddi, A; Dettman, A; Fu, C; Seiler, S; Free, SJ				Maddi, Abhiram; Dettman, Anne; Fu, Ci; Seiler, Stephan; Free, Stephen J.			WSC-1 and HAM-7 Are MAK-1 MAP Kinase Pathway Sensors Required for Cell Wall Integrity and Hyphal Fusion in Neurospora crassa	PLOS ONE			English	Article							FILAMENTOUS FUNGUS; SACCHAROMYCES-CEREVISIAE; GENOME SEQUENCE; PROTEIN-KINASES; STRESS SENSORS; GROWTH; IDENTIFICATION; BIOSYNTHESIS; BIOGENESIS; BEHAVIOR	A large number of cell wall proteins are encoded in the Neurospora crassa genome. Strains carrying gene deletions of 65 predicted cell wall proteins were characterized. Deletion mutations in two of these genes (wsc-1 and ham-7) have easily identified morphological and inhibitor-based defects. Their phenotypic characterization indicates that HAM-7 and WSC-1 function during cell-to-cell hyphal fusion and in cell wall integrity maintenance, respectively. wsc-1 encodes a transmembrane protein with extensive homology to the yeast Wsc family of sensor proteins. In N. crassa, WSC-1 (and its homolog WSC-2) activates the cell wall integrity MAK-1 MAP kinase pathway. The GPI-anchored cell wall protein HAM-7 is required for cell-to-cell fusion and the sexual stages of the N. crassa life cycle. Like WSC-1, HAM-7 is required for activating MAK-1. A Delta wsc-1; Delta ham-7 double mutant fully phenocopies mutants lacking components of the MAK-1 MAP kinase cascade. The data identify WSC-1 and HAM-7 as the major cell wall sensors that regulate two distinct MAK-1-dependent cellular activities, cell wall integrity and hyphal anastomosis, respectively.	[Maddi, Abhiram; Fu, Ci; Free, Stephen J.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Maddi, Abhiram] SUNY Buffalo, Sch Dent Med, Dept Periodont & Endodont, Buffalo, NY 14260 USA; [Dettman, Anne; Seiler, Stephan] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & Genet, Gottingen, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Gottingen	Maddi, A (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	sseiler@gwdg.de; free@buffalo.edu	Maddi, Abhiram/B-3895-2018; Maddi, Abhiram/L-1696-2019	Maddi, Abhiram/0000-0001-9565-408X; Maddi, Abhiram/0000-0001-9565-408X	National Institutes of Health [R01 GM078589]; Deutsche Forschungsgesellschaft [SE1054/4-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants R01 GM078589 from the National Institutes of Health (to SF) and SE1054/4-1 from the Deutsche Forschungsgesellschaft (to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldabbous MS, 2010, MICROBIOL-SGM, V156, P2621, DOI 10.1099/mic.0.040147-0; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Bowman SM, 2006, EUKARYOT CELL, V5, P587, DOI 10.1128/EC.5.3.587-600.2006; Bowman SM, 2005, MYCOLOGIA, V97, P872, DOI 10.3852/mycologia.97.4.872; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; Dichtl K, 2012, MOL MICROBIOL, V83, P506, DOI 10.1111/j.1365-2958.2011.07946.x; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Dupres V, 2009, NAT CHEM BIOL, V5, P857, DOI 10.1038/nchembio.220; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Fleissner A, 2005, EUKARYOT CELL, V4, P920, DOI 10.1128/EC.4.5.920-930.2005; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; Fleissner Andre, 2008, V475, P21, DOI 10.1007/978-1-59745-250-2_2; Fu C, 2011, EUKARYOT CELL, V10, P1100, DOI 10.1128/EC.05003-11; Futagami T, 2011, EUKARYOT CELL, V10, P1504, DOI 10.1128/EC.05080-11; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Gastebois A, 2009, FUTURE MICROBIOL, V4, P583, DOI 10.2217/FMB.09.29; Goryachev AB, 2012, BIOESSAYS, V34, P259, DOI 10.1002/bies.201100135; Heinisch JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011104; Khatun R, 2011, FUNGAL GENET BIOL, V48, P465, DOI 10.1016/j.fgb.2010.11.002; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Kothe GO, 1998, GENETICS, V149, P117; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Leeder AC, 2011, NAT REV MICROBIOL, V9, P440, DOI 10.1038/nrmicro2580; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Li D, 2005, GENETICS, V170, P1091, DOI 10.1534/genetics.104.036772; Maddi A, 2010, EUKARYOT CELL, V9, P1766, DOI 10.1128/EC.00134-10; Maddi A, 2009, FUNGAL GENET BIOL, V46, P768, DOI 10.1016/j.fgb.2009.06.005; Maerz S, 2008, GENETICS, V179, P1313, DOI 10.1534/genetics.108.089425; Maerz S, 2012, MOL CELL BIOL, V32, P2083, DOI 10.1128/MCB.06263-11; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; Maerz S, 2009, MOL MICROBIOL, V74, P707, DOI 10.1111/j.1365-2958.2009.06896.x; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Pandey A, 2004, EUKARYOT CELL, V3, P348, DOI 10.1128/EC.3.2.348-358.2004; Park G, 2008, EUKARYOT CELL, V7, P2113, DOI 10.1128/EC.00466-07; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Read Nick D., 2012, Fungal Biology Reviews, V26, P1, DOI 10.1016/j.fbr.2012.02.003; Richthammer C, 2012, MOL MICROBI IN PRESS; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Roca MG, 2012, FUNGAL BIOL-UK, V116, P379, DOI 10.1016/j.funbio.2011.12.007; Rodicio R, 2010, YEAST, V27, P531, DOI 10.1002/yea.1785; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Selker EU, 1999, CELL, V97, P157, DOI 10.1016/S0092-8674(00)80725-4; Simonin AR, 2010, FUNGAL GENET BIOL, V47, P855, DOI 10.1016/j.fgb.2010.06.010; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Vogt N, 2008, MOL BIOL CELL, V19, P4554, DOI 10.1091/mbc.E07-12-1266; Xiang QJ, 2002, GENETICS, V160, P169	53	45	46	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42374	10.1371/journal.pone.0042374	http://dx.doi.org/10.1371/journal.pone.0042374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879952	gold, Green Published			2022-12-27	WOS:000307284100073
J	Mazurek, J; Ignatowicz, L; Kallenius, G; Svenson, SB; Pawlowski, A; Hamasur, B				Mazurek, Jolanta; Ignatowicz, Lech; Kallenius, Gunilla; Svenson, Stefan B.; Pawlowski, Andrzej; Hamasur, Beston			Divergent Effects of Mycobacterial Cell Wall Glycolipids on Maturation and Function of Human Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; BACILLUS-CALMETTE-GUERIN; HUMAN ALVEOLAR MACROPHAGES; TUBERCULOSIS H37RV; MANNOSYLATED LIPOARABINOMANNANS; CYTOKINE PRODUCTION; DC-SIGN; ACTIVATION; STRAINS; ALPHA	Background: Mycobacterium tuberculosis (Mtb) is able to evade the immune defenses and may persist for years, decades and even lifelong in the infected host. Mtb cell wall components may contribute to such persistence by modulating several pivotal types of immune cells. Dendritic cells (DCs) are the most potent antigen-presenting cells and hence play a crucial role in the initial immune response to infections by connecting the innate with the adaptive immune system. Principal Findings: We investigated the effects of two of the major mycobacterial cell wall-associated types of glycolipids, mannose-capped lipoarabinomannan (ManLAM) and phosphatidylinositol mannosides (PIMs) purified from the Mtb strains H37Rv and Mycobacterium bovis, on the maturation and cytokine profiles of immature human monocyte-derived DCs. ManLAM from Mtb H37Rv stimulated the release of pro-inflammatory cytokines TNF, IL-12, and IL-6 and expression of costimulatory (CD80, CD86) and antigen-presenting molecules (MHC class II). ManLAM from M. bovis also induced TNF, IL-12 and IL-6 but at significantly lower levels. Importantly, while ManLAM was found to augment LPS-induced DC maturation and pro-inflammatory cytokine production, addition of PIMs from both Mtb H37Rv and M. bovis strongly reduced this stimulatory effect. Conclusions: These results indicate that the mycobacterial cell wall contains macromolecules of glycolipid nature which are able to induce strong and divergent effects on human DCs; i.e while ManLAM is immune-stimulatory, PIMs act as powerful inhibitors of DC cytokine responses. Thus PIMs may be important Mtb-associated virulence factors contributing to the pathogenesis of tuberculosis disease. These findings may also aid in the understanding of some earlier conflicting reports on the immunomodulatory effects exerted by different ManLAM preparations.	[Mazurek, Jolanta; Ignatowicz, Lech] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Kallenius, Gunilla; Svenson, Stefan B.; Pawlowski, Andrzej; Hamasur, Beston] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital	Mazurek, J (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	beston.hamasur@ki.se	Källenius, Gunilla/AGZ-3956-2022	Pawlowski, Andrzej/0000-0003-4555-6048; Mazurek, Jolanta/0000-0001-5023-0398	European Commission [MEST-CT-2005-020872]; Swedish Research Council [K2007-58X-13027, K2010-79X-21374-01-3]	European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by European Commission Grant MEST-CT-2005-020872 (to J.M. and A.P), and by Swedish Research Council Grants K2007-58X-13027 (to G.K.) and K2010-79X-21374-01-3 (to A.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LB, 1993, INFECT IMMUN, V61, P4173, DOI 10.1128/IAI.61.10.4173-4181.1993; Andersen CS, 2009, J IMMUNOL, V182, P424, DOI 10.4049/jimmunol.182.1.424; BARNES PF, 1992, J IMMUNOL, V149, P541; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; BRADBURY MG, 1993, CLIN EXP IMMUNOL, V94, P57; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; CHATTERJEE D, 1992, INFECT IMMUN, V60, P1249, DOI 10.1128/IAI.60.3.1249-1253.1992; Chatterjee D, 1997, CURR OPIN CHEM BIOL, V1, P579, DOI 10.1016/S1367-5931(97)80055-5; Dahl KE, 1996, INFECT IMMUN, V64, P399, DOI 10.1128/IAI.64.2.399-405.1996; Dao DN, 2004, INFECT IMMUN, V72, P2067, DOI 10.1128/IAI.72.4.2067-2074.2004; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; Doz E, 2009, J BIOL CHEM, V284, P23187, DOI 10.1074/jbc.M109.037846; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dulphy N, 2007, CELL MICROBIOL, V9, P1412, DOI 10.1111/j.1462-5822.2006.00881.x; Engele M, 2002, J IMMUNOL, V168, P1328, DOI 10.4049/jimmunol.168.3.1328; Gagliardi MC, 2007, CELL MICROBIOL, V9, P2081, DOI 10.1111/j.1462-5822.2007.00940.x; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geurtsen J, 2009, J IMMUNOL, V183, P5221, DOI 10.4049/jimmunol.0900768; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Gilleron M, 2000, J BIOL CHEM, V275, P677, DOI 10.1074/jbc.275.1.677; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Guerin ME, 2010, J BIOL CHEM, V285, P33577, DOI 10.1074/jbc.R110.168328; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hamasur B, 1999, FEMS IMMUNOL MED MIC, V24, P11, DOI 10.1111/j.1574-695X.1999.tb01259.x; Henderson RA, 1997, J IMMUNOL, V159, P635; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hetland G, 1998, CLIN DIAGN LAB IMMUN, V5, P211, DOI 10.1128/CDLI.5.2.211-218.1998; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Holt PG, 2000, J AEROSOL MED, V13, P361, DOI 10.1089/jam.2000.13.361; Hope JC, 2004, VET IMMUNOL IMMUNOP, V100, P187, DOI 10.1016/j.vetimm.2004.04.007; HUNTER SW, 1990, J BIOL CHEM, V265, P9272; Jang S, 2004, J IMMUNOL, V173, P3392, DOI 10.4049/jimmunol.173.5.3392; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; KHOO KH, 1995, J BIOL CHEM, V270, P12380, DOI 10.1074/jbc.270.21.12380; Kim KD, 1999, IMMUNOLOGY, V97, P626; Majumder N, 2008, MICROBES INFECT, V10, P349, DOI 10.1016/j.micinf.2007.12.013; MALEFYT RD, 1991, J EXP MED, V174, P1209; Marshall BG, 2000, EUR RESPIR J, V15, P764, DOI 10.1034/j.1399-3003.2000.15d22.x; Mazurek J, 2012, EUR J IMMUNOL, V42, P1192, DOI 10.1002/eji.201142049; Mohagheghpour N, 2000, INFECT IMMUN, V68, P5824, DOI 10.1128/IAI.68.10.5824-5829.2000; MOLLOY A, 1990, P NATL ACAD SCI USA, V87, P973, DOI 10.1073/pnas.87.3.973; MORENO C, 1989, CLIN EXP IMMUNOL, V76, P240; MORENO C, 1988, CLIN EXP IMMUNOL, V74, P206; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Nigou J, 1997, J BIOL CHEM, V272, P23094, DOI 10.1074/jbc.272.37.23094; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; Nigou J, 2008, J IMMUNOL, V180, P6696, DOI 10.4049/jimmunol.180.10.6696; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; PRINZIS S, 1993, J GEN MICROBIOL, V139, P2649, DOI 10.1099/00221287-139-11-2649; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; ROACH TIA, 1993, J IMMUNOL, V150, P1886; Sandegren L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016647; SIBLEY LD, 1990, CLIN EXP IMMUNOL, V80, P141; Takimoto H, 2006, CLIN EXP IMMUNOL, V144, P134, DOI 10.1111/j.1365-2249.2006.03043.x; Thurnher M, 1997, INT J CANCER, V70, P128; Torrelles JB, 2008, J BIOL CHEM, V283, P31417, DOI 10.1074/jbc.M806350200; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Torrelles JB, 2011, J BIOL CHEM, V286, P35438, DOI 10.1074/jbc.M111.232587; Vignal C, 2003, J IMMUNOL, V171, P2014, DOI 10.4049/jimmunol.171.4.2014; Wu TT, 2011, CELL IMMUNOL, V272, P94, DOI 10.1016/j.cellimm.2011.09.001; Yoshida A, 1997, INFECT IMMUN, V65, P1953, DOI 10.1128/IAI.65.5.1953-1955.1997	71	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42515	10.1371/journal.pone.0042515	http://dx.doi.org/10.1371/journal.pone.0042515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880012	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100115
J	Peng, RH; Tian, YS; Xiong, AS; Zhao, W; Fu, XY; Han, HJ; Chen, C; Jin, XF; Yao, QH				Peng, Ri-He; Tian, Yong-Sheng; Xiong, Ai-Sheng; Zhao, Wei; Fu, Xiao-Yan; Han, Hong-Juan; Chen, Chen; Jin, Xiao-Fen; Yao, Quan-Hong			A Novel 5-Enolpyruvylshikimate-3-Phosphate Synthase from Rahnella aquatilis with Significantly Reduced Glyphosate Sensitivity	PLOS ONE			English	Article							3-PHOSPHATE SYNTHASE; 5-ENOPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE; SHIKIMATE 3-PHOSPHATE; HERBICIDE GLYPHOSATE; CATALYTIC RESIDUES; STRUCTURAL BASIS; HIGH TOLERANCE; RESISTANCE; GENE; AROA	The 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS; EC 2.5.1.19) is a key enzyme in the shikimate pathway for the production of aromatic amino acids and chorismate-derived secondary metabolites in plants, fungi, and microorganisms. It is also the target of the broad-spectrum herbicide glyphosate. Natural glyphosate resistance is generally thought to occur within microorganisms in a strong selective pressure condition. Rahnella aquatilis strain GR20, an antagonist against pathogenic agrobacterial strains of grape crown gall, was isolated from the rhizosphere of grape in glyphosate-contaminated vineyards. A novel gene encoding EPSPS was identified from the isolated bacterium by complementation of an Escherichia coli auxotrophic aroA mutant. The EPSPS, named AroA(R.aquatilis), was expressed and purified from E. coli, and key kinetic values were determined. The full-length enzyme exhibited higher tolerance to glyphosate than the E. coli EPSPS (AroA(E.coli)), while retaining high affinity for the substrate phosphoenolpyruvate. Transgenic plants of AroA(R.aquatilis) were also observed to be more resistant to glyphosate at a concentration of 5 mM than that of AroA(E.coli). To probe the sites contributing to increased tolerance to glyphosate, mutant R. aquatilis EPSPS enzymes were produced with the c-strand of subdomain 3 and the f-strand of subdomain 5 (Thr38Lys, Arg40Val, Arg222Gln, Ser224Val, Ile225Val, and Gln226Lys) substituted by the corresponding region of the E. coli EPSPS. The mutant enzyme exhibited greater sensitivity to glyphosate than the wild type R. aquatilis EPSPS with little change of affinity for its first substrate, shikimate-3-phosphate (S3P) and phosphoenolpyruvate (PEP). The effect of the residues on subdomain 5 on glyphosate resistance was more obvious.	[Peng, Ri-He; Tian, Yong-Sheng; Xiong, Ai-Sheng; Zhao, Wei; Fu, Xiao-Yan; Han, Hong-Juan; Chen, Chen; Jin, Xiao-Fen; Yao, Quan-Hong] Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai Key Lab Agr Genet & Breeding, Shanghai, Peoples R China	Shanghai Academy of Agricultural Sciences	Peng, RH (corresponding author), Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai Key Lab Agr Genet & Breeding, Shanghai, Peoples R China.	yaoquanhong_sh@yahoo.com.cn		Xiong, Ai-Sheng/0000-0002-7900-5001	Key Project Fund of the Shanghai Municipal Committee of Agriculture [2009-6-4, 2011-1-8]; International Scientific and Technological Cooperation [2010DFA62320, 11230705900]; National Natural Science Foundation [31071486]	Key Project Fund of the Shanghai Municipal Committee of Agriculture; International Scientific and Technological Cooperation; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The research was supported by the Key Project Fund of the Shanghai Municipal Committee of Agriculture (No. 2009-6-4) and The Key Project Fund of the Shanghai Municipal Committee of Agriculture (No. 2011-1-8) and International Scientific and Technological Cooperation (2010DFA62320, 11230705900) and National Natural Science Foundation (31071486). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel F, 1997, SHORT PROTOCOLS MOL; Baerson SR, 2002, PLANT PHYSIOL, V129, P1265, DOI 10.1104/pp.001560; Berti PJ, 2009, BIOCHEMISTRY-US, V48, P3699, DOI 10.1021/bi802251s; Chen F, 2007, PLANT DIS, V91, P957, DOI 10.1094/PDIS-91-8-0957; Dill GM, 2008, PEST MANAG SCI, V64, P326, DOI 10.1002/ps.1501; Eschenburg S, 2002, PLANTA, V216, P129, DOI 10.1007/s00425-002-0908-0; Farmer JJ, 1986, BERGEYS MANUAL SYSTE, V1, P506; Franz JE, 1997, AM CHEM SOC MONOGRAP, V189; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; Funke T, 2009, J BIOL CHEM, V284, P9854, DOI 10.1074/jbc.M809771200; He M, 2003, BIOSCI BIOTECH BIOCH, V67, P1405, DOI 10.1271/bbb.67.1405; He M, 2001, BBA-GEN SUBJECTS, V1568, P1, DOI 10.1016/S0304-4165(01)00181-7; Healy-Fried ML, 2007, J BIOL CHEM, V282, P32949, DOI 10.1074/jbc.M705624200; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Kahrizi D, 2007, PLANT CELL REP, V26, P95, DOI 10.1007/s00299-006-0208-4; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li L, 2009, J BIOTECHNOL, V144, P330, DOI 10.1016/j.jbiotec.2009.09.014; Marzabadi MR, 1996, BIOCHEMISTRY-US, V35, P4199, DOI 10.1021/bi9521349; McDowell LM, 1996, J MOL BIOL, V256, P160, DOI 10.1006/jmbi.1996.0074; Mizyed S, 2003, BIOCHEMISTRY-US, V42, P6986, DOI 10.1021/bi027217l; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; OPHEL K, 1990, INT J SYST BACTERIOL, V40, P236, DOI 10.1099/00207713-40-3-236; PADGETTE SR, 1991, J BIOL CHEM, V266, P22364; Peng RH, 2006, APPL MICROBIOL BIOT, V73, P234, DOI 10.1007/s00253-006-0583-3; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; STALLINGS WC, 1991, P NATL ACAD SCI USA, V88, P5046, DOI 10.1073/pnas.88.11.5046; Stauffer ME, 2001, FEBS LETT, V499, P182, DOI 10.1016/S0014-5793(01)02555-8; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Sun YC, 2005, APPL ENVIRON MICROB, V71, P4771, DOI 10.1128/AEM.71.8.4771-4776.2005; Tian YS, 2012, APPL MICROBIOL BIOT, V93, P241, DOI 10.1007/s00253-011-3443-8; Tian YS, 2011, APPL ENVIRON MICROB, V77, P8409, DOI 10.1128/AEM.05271-11; Tian YS, 2010, APPL ENVIRON MICROB, V76, P6001, DOI 10.1128/AEM.00770-10; Wang HY, 2003, J PLANT RES, V116, P455, DOI 10.1007/s10265-003-0120-8; Xie X. M., 1993, Acta Phytopathologica Sinica, V23, P137; Xue Y, 2009, J PLANT PHYSIOL, V166, P844, DOI 10.1016/j.jplph.2008.11.013; [No title captured], Patent No. 6040497	36	19	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e39579	10.1371/journal.pone.0039579	http://dx.doi.org/10.1371/journal.pone.0039579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870190	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100004
J	Walters, K; Rait, G; Griffin, M; Buszewicz, M; Nazareth, I				Walters, Kate; Rait, Greta; Griffin, Mark; Buszewicz, Marta; Nazareth, Irwin			Recent Trends in the Incidence of Anxiety Diagnoses and Symptoms in Primary Care	PLOS ONE			English	Article							GENERALIZED ANXIETY; PROSPECTIVE COHORT; MENTAL-DISORDERS; PREVALENCE; DEPRESSION; MORBIDITY; DATABASE; AGE	Background: Anxiety is common, with significant morbidity, but little is known about presentations and recording of anxiety diagnoses and symptoms in primary care. This study aimed to determine trends in incidence and sociodemographic variation in General Practitioner (GP) recorded diagnoses of anxiety, mixed anxiety/depression, panic and anxiety symptoms. Methodology/Principal Findings: Annual incidence rates of anxiety diagnoses and symptoms were calculated from 361 UK general practices contributing to The Health Improvement Network (THIN) database between 1998 and 2008, adjusted for year of diagnosis, gender, age, and deprivation. Incidence of GP recorded anxiety diagnosis fell from 7.9 to 4.9/1000PYAR from 1998 to 2008, while incidence of anxiety symptoms rose from 3.9 to 5.8/1000PYAR. Incidence of mixed anxiety/depression fell from 4.0 to 2.2/1000PYAR, and incidence of panic disorder fell from 0.9/1000PYAR in 1998 to 0.5/1000PYAR in 2008. All these entries were approximately twice as common in women and more common in deprived areas. GP-recorded anxiety diagnoses, symptoms and mixed anxiety/depression were commonest aged 45-64 years, whilst panic disorder/attacks were more common in those 16-44 years. GPs predominately use broad non-specific codes to record anxiety problems in the UK. Conclusions/Significance: GP recording of anxiety diagnoses has fallen whilst recording of anxiety symptoms has increased over time. The incidence of GP recorded diagnoses of anxiety diagnoses was lower than in screened populations in primary care. The reasons for this apparent under-recording and whether it represents under-detection in those being seen, a reluctance to report anxiety to their GP, or a reluctance amongst GPs to label people with anxiety requires investigation.	[Walters, Kate; Rait, Greta; Griffin, Mark; Buszewicz, Marta; Nazareth, Irwin] UCL, Dept Primary Care & Populat Hlth, London, England	University of London; University College London	Walters, K (corresponding author), UCL, Dept Primary Care & Populat Hlth, London, England.	k.walters@ucl.ac.uk		Rait, Greta/0000-0002-7216-7294; Nazareth, Irwin/0000-0003-2146-9628; Walters, Kate/0000-0003-2173-2430	MRC [G106/1053] Funding Source: UKRI; Medical Research Council [G106/1053] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bijl RV, 2002, SOC PSYCH PSYCH EPID, V37, P372, DOI 10.1007/s00127-002-0566-3; Bourke Alison, 2004, Inform Prim Care, V12, P171; Brugha T, 2009, ADULT PSYCHIAT MORBI; Clark DM, 2009, BEHAV RES THER, V47, P910, DOI 10.1016/j.brat.2009.07.010; EATON WW, 1989, ACTA PSYCHIAT SCAND, V79, P163, DOI 10.1111/j.1600-0447.1989.tb08584.x; Grant BF, 2009, MOL PSYCHIATR, V14, P1051, DOI 10.1038/mp.2008.41; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Hickie I, 2007, BRIT MED J, V335, P328; Jameson JP, 2010, PSYCHIAT SERV, V61, P624, DOI 10.1176/ps.2010.61.6.624; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P93; King M, 2011, PSYCHOL MED, V41, P1625, DOI 10.1017/S0033291710002400; King M, 2008, BRIT J PSYCHIAT, V192, P362, DOI 10.1192/bjp.bp.107.039966; Kosidou K, 2010, ACTA PSYCHIAT SCAND, V122, P47, DOI 10.1111/j.1600-0447.2009.01487.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lawton-Smith M, 2008, COST MENTAL HLTH CAR; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; Martin-Merino E, 2010, FAM PRACT, V27, P9, DOI 10.1093/fampra/cmp071; MURPHY JM, 1988, AM J PUBLIC HEALTH, V78, P534, DOI 10.2105/AJPH.78.5.534; Office for National Statistics, 2001, CENS 2001; Rait G, 2009, BRIT J PSYCHIAT, V195, P520, DOI 10.1192/bjp.bp.108.058636; Richards DA, 2009, BRIT J CLIN PSYCHOL, V48, P377, DOI 10.1348/014466509X405178; Rollman BL, 2005, J GEN INTERN MED, V20, P623, DOI 10.1007/s11606-005-0108-2; Somers JM, 2006, CAN J PSYCHIAT, V51, P100, DOI 10.1177/070674370605100206; Spiers N, 2011, BRIT J PSYCHIAT, V198, P479, DOI 10.1192/bjp.bp.110.084269; Stein MB, 2005, MED CARE, V43, P1164, DOI 10.1097/01.mlr.0000185750.18119.fd; Townsend P., 1986, INEQUALITIES HLTH NO; Walters K, 2011, BRIT J PSYCHIAT, V198, P472, DOI 10.1192/bjp.bp.110.085092; Wittchen HU, 2002, J CLIN PSYCHIAT, V63, P24	29	46	47	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41670	10.1371/journal.pone.0041670	http://dx.doi.org/10.1371/journal.pone.0041670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22870242	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100029
J	Gates, TA; Prieto-Marquez, A; Zanno, LE				Gates, Terry A.; Prieto-Marquez, Albert; Zanno, Lindsay E.			Mountain Building Triggered Late Cretaceous North American Megaherbivore Dinosaur Radiation	PLOS ONE			English	Article							KAIPAROWITS FORMATION; HADROSAURIAN DINOSAUR; PARK FORMATION; SOUTHERN UTAH; BIOGEOGRAPHY; DIVERSITY; HISTORY; DYNAMICS; PLANT; ORNITHISCHIA	Prior studies of Mesozoic biodiversity document a diversity peak for dinosaur species in the Campanian stage of the Late Cretaceous, yet have failed to provide explicit causal mechanisms. We provide evidence that a marked increase in North American dinosaur biodiversity can be attributed to dynamic orogenic episodes within the Western Interior Basin (WIB). Detailed fossil occurrences document an association between the shift from Sevier-style, latitudinally arrayed basins to smaller Laramide-style, longitudinally arrayed basins and a well substantiated decreased geographic range/increased taxonomic diversity of megaherbivorous dinosaur species. Dispersal-vicariance analysis demonstrates that the nearly identical biogeographic histories of the megaherbivorous dinosaur clades Ceratopsidae and Hadrosauridae are attributable to rapid diversification events within restricted basins and that isolation events are contemporaneous with known tectonic activity in the region. SYMMETREE analysis indicates that megaherbivorous dinosaur clades exhibited significant variation in diversification rates throughout the Late Cretaceous. Phylogenetic divergence estimates of fossil clades offer a new lower boundary on Laramide surficial deformation that precedes estimates based on sedimentological data alone.	[Gates, Terry A.] Ohio Univ, Coll Osteopath Med, Athens, OH 45701 USA; [Gates, Terry A.; Zanno, Lindsay E.] N Carolina State Univ, Raleigh, NC 27695 USA; [Prieto-Marquez, Albert] Bayer Staatssammlung Palaontol & Geol, Munich, Germany; [Zanno, Lindsay E.] N Carolina Museum Nat, Nat Res Ctr, Raleigh, NC USA	University System of Ohio; Ohio University; University of North Carolina; North Carolina State University	Gates, TA (corresponding author), Ohio Univ, Coll Osteopath Med, Athens, OH 45701 USA.	terryagates@gmail.com	Prieto-Marquez, Albert/AAA-1470-2019	Prieto-Marquez, Albert/0000-0002-4836-4052	Alexander von Humboldt Foundation; National Science Foundation [EAR0959029]; Ministry of Education and Science of Spain [CGL2005-07878-C02-01]; North Carolina State University	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Science Foundation(National Science Foundation (NSF)); Ministry of Education and Science of Spain(Spanish Government); North Carolina State University	The Alexander von Humboldt Foundation, the National Science Foundation (grant #EAR0959029 presented to G. Erickson and M. Norell), the Ministry of Education and Science of Spain (CGL2005-07878-C02-01 grant presented to A. Galobart), and North Carolina State University provided funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2009, P NATL ACAD SCI USA, V106, P9749, DOI 10.1073/pnas.0811421106; Badgley C, 2010, ECOGRAPHY, V33, P220, DOI 10.1111/j.1600-0587.2010.06282.x; Barrett PM, 2009, P ROY SOC B-BIOL SCI, V276, P2667, DOI 10.1098/rspb.2009.0352; Bell PR, 2011, CRETACEOUS RES, V32, P30, DOI 10.1016/j.cretres.2010.10.002; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Butler RJ, 2011, P ROY SOC B-BIOL SCI, V278, P1165, DOI 10.1098/rspb.2010.1754; Campione N, 2010, J VERTEBRATE PALE S3, V30, p69A; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Carr TD, 2011, NATURWISSENSCHAFTEN, V98, P241, DOI 10.1007/s00114-011-0762-7; Cather SM., 2004, GEOLOGY NEW MEXICO G, P203; CERVENY PF, 1993, TECTONICS, V12, P77, DOI 10.1029/92TC01567; Chan KMA, 2005, BIOINFORMATICS, V21, P1709, DOI 10.1093/bioinformatics/bti175; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; CRACRAFT J, 1985, ANN MO BOT GARD, V72, P794, DOI 10.2307/2399222; Crisci J. V., 2003, HIST BIOGEOGRAPHY IN; Crowley PD, 2002, GEOLOGY, V30, P27, DOI 10.1130/0091-7613(2002)030<0027:LEOTBM>2.0.CO;2; DECELLES PG, 1986, GEOL SOC AM BULL, V97, P911, DOI 10.1130/0016-7606(1986)97<911:SIATPN>2.0.CO;2; Dickinson W.R., 1978, LARAMIDE FOLDING ASS, V151, P355, DOI DOI 10.1130/MEM151-P355; Dickinson W.R., 1989, GEOLOGIC EVOLUTION A, V17, P447; DODSON P, 1990, P NATL ACAD SCI USA, V87, P7608, DOI 10.1073/pnas.87.19.7608; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; Evans DC, 2009, CAN J EARTH SCI, V46, P791, DOI 10.1139/E09-050; Fastovsky DE, 2004, GEOLOGY, V32, P877, DOI 10.1130/G20695.1; Finarelli JA, 2010, P ROY SOC B-BIOL SCI, V277, P2721, DOI 10.1098/rspb.2010.0348; Gates TA, 2010, PALAEOGEOGR PALAEOCL, V291, P371, DOI 10.1016/j.palaeo.2010.03.008; Gates TA, ADV LATE CR IN PRESS; Gates T, 2009, J VERTEBR PALEONTOL, V29, p103A; Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Gates TA, 2011, J VERTEBR PALEONTOL, V31, P798, DOI 10.1080/02724634.2011.577854; Holdridge LR, 1967, LIFE ZONE ECOLOGY; Horner J.R., 1989, Montana Geological Society Field Conference Guidebook, V1, P153; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 1992, MUSEUM ROCKIES OCCAS, V2, P1; Horton BK, 2004, GEOLOGY, V32, P637, DOI 10.1130/G20407.1; Hunt Adrian P., 2003, New Mexico Geological Society Field Conference Guidebook, V54, P383; Jacques-Ayala C, 1999, REV MEXICANA CIENCIA, V16, P97; Jinnah ZA, 2009, CRETACEOUS RES, V30, P287, DOI 10.1016/j.cretres.2008.07.012; Johnson KR, 2002, GEOL S AM S, P503; Kirkland James I., 2006, BULLETIN OF THE NEW MEXICO MUSEUM OF NATURAL HISTORY AND SCIENCE, P299; Lawton T.F., 1986, PALEOTECTONICS SEDIM, V41, P423; Lawton T.F., 1983, LATE CRETACEOUS FLUV; Lawton TF, 2011, J SEDIMENT RES, V81, P495, DOI 10.2110/jsr.2011.45; Lawton TF, 2008, SEDIMENT BASIN WORLD, V5, P429, DOI 10.1016/S1874-5997(08)00012-9; Lieberman BS, 1996, PALEOBIOLOGY, V22, P66, DOI 10.1017/S009483730001602X; Liu LJ, 2010, GEOLOGY, V38, P663, DOI 10.1130/G30624.1; Lomolino M. V., 2005, BIOGEOGRAPHY; Longrich NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032623; Lucas SG, 1990, CRETACEOUS RES, V11, P1; Lucas Spencer G., 2006, BULLETIN OF THE NEW MEXICO MUSEUM OF NATURAL HISTORY AND SCIENCE, P293; Mallon JC, 2012, PALAEOGEOGR PALAEOCL, V350, P124, DOI 10.1016/j.palaeo.2012.06.024; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; McMillan NJ, 2000, NEW MEX GEOL SOC GUI, P149; Mederos S., 2005, ROCKY MOUNTAIN GEOLO, V40, P167, DOI [10.2113/40.2.167, DOI 10.2113/40.2.167]; MILLER AI, 1995, GEOLOGY, V23, P305, DOI 10.1130/0091-7613(1995)023<0305:AOOAWT>2.3.CO;2; NEILSON RP, 1986, SCIENCE, V232, P27, DOI 10.1126/science.232.4746.27; NORELL MA, 1993, AM J SCI, V293A, P407, DOI 10.2475/ajs.293.A.407; OSTROM JH, 1961, J PALEONTOL, V35, P575; Perry Jr W. J., 1988, INTERACTION ROCKY MO, V171, P267, DOI [10.1130/MEM171-p267, DOI 10.1130/MEM171-P267]; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Prieto-Marquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038207; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P503, DOI 10.1111/j.1096-3642.2010.00642.x; RENNE PR, 1991, GEOPHYS RES LETT, V18, P459, DOI 10.1029/91GL00464; Roberts EM, 2005, CRETACEOUS RES, V26, P307, DOI 10.1016/j.cretres.2005.01.002; Roberts EM, 2007, SEDIMENT GEOL, V197, P207, DOI 10.1016/j.sedgeo.2006.10.001; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; RONQUIST F, 1996, DIVA VERSION 1 1 COM; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rowe RJ, 2010, GLOBAL CHANGE BIOL, V16, P2930, DOI 10.1111/j.1365-2486.2009.02150.x; Ryan MJ, 2005, LIFE O PAST, P312; Sampson Scott D., 2010, P405; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; SMITH T, 1989, VEGETATIO, V83, P49, DOI 10.1007/BF00031680; Sullivan RM, 1999, NEW SKULL PARASAUROL; Upchurch P, 2002, P ROY SOC B-BIOL SCI, V269, P613, DOI 10.1098/rspb.2001.1921; URBAN DL, 1987, BIOSCIENCE, V37, P119, DOI 10.2307/1310366; Vavrek MJ, 2010, P NATL ACAD SCI USA, V107, P8265, DOI 10.1073/pnas.0913645107; Wagner JR, 2001, THESIS TEXAS TU; Wang SC, 2006, P NATL ACAD SCI USA, V103, P13601, DOI 10.1073/pnas.0606028103; Williams ST, 2008, EVOLUTION, V62, P1618, DOI 10.1111/j.1558-5646.2008.00399.x; WOLFE JA, 1987, PALAEOGEOGR PALAEOCL, V61, P33, DOI 10.1016/0031-0182(87)90040-X; Zanno LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024487	88	58	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42135	10.1371/journal.pone.0042135	http://dx.doi.org/10.1371/journal.pone.0042135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876302	Green Submitted, Green Published, gold			2022-12-27	WOS:000307184700030
J	Kent, JS; Hong, SL; Bolbecker, AR; Klaunig, MJ; Forsyth, JK; O'Donnell, BF; Hetrick, WP				Kent, Jerillyn S.; Hong, S. Lee; Bolbecker, Amanda R.; Klaunig, Mallory J.; Forsyth, Jennifer K.; O'Donnell, Brian F.; Hetrick, William P.			Motor Deficits in Schizophrenia Quantified by Nonlinear Analysis of Postural Sway	PLOS ONE			English	Article							NEUROLOGICAL SOFT SIGNS; 1ST-EPISODE SCHIZOPHRENIA; CEREBELLAR DYSFUNCTION; NAIVE SCHIZOPHRENIA; CHAOS THEORY; HIGH-RISK; ABNORMALITIES; VOLUME; PROPRIOCEPTION; COMPLEXITY	Motor dysfunction is a consistently reported but understudied aspect of schizophrenia. Postural sway area was examined in individuals with schizophrenia under four conditions with different amounts of visual and proprioceptive feedback: eyes open or closed and feet together or shoulder width apart. The nonlinear complexity of postural sway was assessed by detrended fluctuation analysis (DFA). The schizophrenia group (n = 27) exhibited greater sway area compared to controls (n = 37). Participants with schizophrenia showed increased sway area following the removal of visual input, while this pattern was absent in controls. Examination of DFA revealed decreased complexity of postural sway and abnormal changes in complexity upon removal of visual input in individuals with schizophrenia. Additionally, less complex postural sway was associated with increased symptom severity in participants with schizophrenia. Given the critical involvement of the cerebellum and related circuits in postural stability and sensorimotor integration, these results are consistent with growing evidence of motor, cerebellar, and sensory integration dysfunction in the disorder, and with theoretical models that implicate cerebellar deficits and more general disconnection of function in schizophrenia.	[Kent, Jerillyn S.; Bolbecker, Amanda R.; O'Donnell, Brian F.; Hetrick, William P.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Hong, S. Lee] Ohio Univ, Dept Biomed Sci, Athens, OH 45701 USA; [Bolbecker, Amanda R.; O'Donnell, Brian F.; Hetrick, William P.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN USA; [Klaunig, Mallory J.] Univ Munich, Dept Cognit Neurosci, Munich, Germany; [Forsyth, Jennifer K.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [O'Donnell, Brian F.; Hetrick, William P.] Larue D Carter Mem Hosp, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; University System of Ohio; Ohio University; Indiana University System; Indiana University Bloomington; University of Munich; University of California System; University of California Los Angeles	Kent, JS (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	whetrick@indiana.edu	Hong, S./B-2390-2008	Hong, S./0000-0001-6044-2482	National Institute of Mental Health (NIMH) [R01 MH074983]; National Science Foundation (NSF); NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH091774, R01MH074983] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health (NIMH) grant R01 MH074983 to WPH. JSK was supported by an National Science Foundation (NSF) Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AJ, 2009, SCHIZOPHR RES, V109, P24, DOI 10.1016/j.schres.2009.01.016; Andersen BB, 2004, BRAIN RES, V1007, P10, DOI 10.1016/j.brainres.2004.01.058; Andreasen NC, 1999, ARCH GEN PSYCHIAT, V56, P781, DOI 10.1001/archpsyc.56.9.781; Andreasen NC, 1998, SCHIZOPHRENIA BULL, V24, P203, DOI 10.1093/oxfordjournals.schbul.a033321; Atkins M., 1997, PSYCHIATR BULL, V21, P224, DOI DOI 10.1192/PB.21.4.224; Avila MT, 2002, AM J PSYCHIAT, V159, P1490, DOI 10.1176/appi.ajp.159.9.1490; BARNES TRE, 1989, BRIT J PSYCHIAT, V154, P672, DOI 10.1192/bjp.154.5.672; Bolbecker AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019824; Bolbecker AR, 2009, SCHIZOPHR RES, V111, P182, DOI 10.1016/j.schres.2009.03.016; Bombin I, 2005, SCHIZOPHRENIA BULL, V31, P962, DOI 10.1093/schbul/sbi028; Bottmer C, 2005, PSYCHIAT RES-NEUROIM, V140, P239, DOI 10.1016/j.pscychresns.2005.02.011; Carroll CA, 2009, BRAIN COGNITION, V71, P345, DOI 10.1016/j.bandc.2009.06.009; Dazzan P, 2002, BRIT J PSYCHIAT, V181, pS50, DOI 10.1192/bjp.181.43.s50; Fitzpatrick LE, 2008, NEUROSCI BIOBEHAV R, V32, P466, DOI 10.1016/j.neubiorev.2007.08.004; Friedrich M, 2008, EXP BRAIN RES, V186, P305, DOI 10.1007/s00221-007-1233-4; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Gebber Gerard L, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P4615; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Guy W, 1976, ABNORMAL INVOLUNTARY; Ho BC, 2004, BIOL PSYCHIAT, V55, P1146, DOI 10.1016/j.biopsych.2004.02.020; HORAK FB, 1990, EXP BRAIN RES, V82, P167; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Konczak J, 2009, J MOTOR BEHAV, V41, P543, DOI 10.3200/35-09-002; Kraepelin E., 1919, GERMAN EDITION TXB P, P282; Kurtz MM, 2005, SCHIZOPHR RES, V74, P15, DOI 10.1016/j.schres.2004.07.005; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Manzoni D, 2005, CEREBELLUM, V4, P178, DOI 10.1080/14734220500193493; Marvel CL, 2004, SCHIZOPHR RES, V68, P363, DOI 10.1016/j.schres.2003.09.003; Meyer M, 2003, EUR J APPL PHYSIOL, V90, P305, DOI 10.1007/s00421-003-0915-2; Mills NP, 2005, AM J PSYCHIAT, V162, P1530, DOI 10.1176/appi.ajp.162.8.1530; Mittal VA, 2008, ARCH GEN PSYCHIAT, V65, P165, DOI 10.1001/archgenpsychiatry.2007.23; Mittal VA, 2010, SCHIZOPHR RES, V123, P68, DOI 10.1016/j.schres.2010.08.002; Mittal VA, 2010, BIOL PSYCHIAT, V68, P93, DOI 10.1016/j.biopsych.2010.01.021; NAKAGAWA H, 1993, ACTA OTO-LARYNGOL, P112; ODENRICK P, 1984, HUM NEUROBIOL, V3, P241; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; Pappa S, 2009, PSYCHOL MED, V39, P1065, DOI 10.1017/S0033291708004716; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PRIETO TE, 1992, IEEE ENG MED BIOL, V11, P25, DOI 10.1109/51.256953; Putzhammer A, 2005, PSYCHIAT CLIN NEUROS, V59, P303, DOI 10.1111/j.1440-1819.2005.01375.x; Rasser PE, 2010, NEUROIMAGE, V53, P1175, DOI 10.1016/j.neuroimage.2010.07.018; Sears LL, 2000, BIOL PSYCHIAT, V48, P204, DOI 10.1016/S0006-3223(00)00247-X; SIMPSON GM, 1970, ACTA PSYCHIAT SCAND, P11; SPITZER R. L., 1994, STRUCTURED CLIN INTE; Sullivan EV, 2004, AM J PSYCHIAT, V161, P751, DOI 10.1176/appi.ajp.161.4.751; Sullivan EV, 2000, ARCH GEN PSYCHIAT, V57, P894, DOI 10.1001/archpsyc.57.9.894; Varambally S, 2006, ACTA PSYCHIAT SCAND, V114, P352, DOI 10.1111/j.1600-0447.2006.00837.x; Walker E, 1999, DEV PSYCHOPATHOL, V11, P509, DOI 10.1017/S0954579499002187; WALKER EF, 1994, SCHIZOPHRENIA BULL, V20, P441, DOI 10.1093/schbul/20.3.441; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Yazici AH, 2002, SCHIZOPHR RES, V58, P241, DOI 10.1016/S0920-9964(01)00338-3	52	49	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41808	10.1371/journal.pone.0041808	http://dx.doi.org/10.1371/journal.pone.0041808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870250	gold, Green Submitted, Green Published			2022-12-27	WOS:000307212800035
J	Ockinger, E; Van Dyck, H				Ockinger, Erik; Van Dyck, Hans			Landscape Structure Shapes Habitat Finding Ability in a Butterfly	PLOS ONE			English	Article							LEVEL PERCEPTUAL ABILITIES; LIFE-HISTORY TRAITS; FRAGMENTATION; CONNECTIVITY; MOVEMENTS; BEHAVIOR; RANGE; ORIENTATION; DISPERSAL; EVOLUTION	Land-use intensification and habitat fragmentation is predicted to impact on the search strategies animals use to find habitat. We compared the habitat finding ability between populations of the speckled wood butterfly (Pararge aegeria L.) from landscapes that differ in degree of habitat fragmentation. Naive butterflies reared under standardized laboratory conditions but originating from either fragmented agricultural landscapes or more continuous forested landscapes were released in the field, at fixed distances from a target habitat patch, and their flight paths were recorded. Butterflies originating from fragmented agricultural landscapes were better able to find a woodlot habitat from a distance compared to conspecifics from continuous forested landscapes. To manipulate the access to olfactory information, a subset of individuals from both landscape types were included in an antennae removal experiment. This confirmed the longer perceptual range for butterflies from agricultural landscapes and indicated the significance of both visual and olfactory information for orientation towards habitat. Our results are consistent with selection for increased perceptual range in fragmented landscapes to reduce dispersal costs. An increased perceptual range will alter the functional connectivity and thereby the chances for population persistence for the same level of structural connectivity in a fragmented landscape.	[Ockinger, Erik] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Ockinger, Erik; Van Dyck, Hans] Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, B-3000 Louvain, Belgium	Swedish University of Agricultural Sciences; Universite Catholique Louvain	Ockinger, E (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	hans.vandyck@uclouvain.be	Öckinger, Erik/F-4154-2010	Öckinger, Erik/0000-0001-7517-4505	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); UCL-Academie Louvain (ARC) [10/15-031]; FNRS (FRFC) [2.4595.07]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); UCL-Academie Louvain (ARC); FNRS (FRFC)(Fonds de la Recherche Scientifique - FNRS)	This study was funded by grants from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) to EO and from UCL-Academie Louvain (ARC-grant no. 10/15-031) and FNRS (FRFC grant 2.4595.07) to HVD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2003, J CHEM ECOL, V29, P2319, DOI 10.1023/A:1026278531806; [Anonymous], 2006, SAS MIXED MODELS; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; Batschelet E, 1981, CIRCULAR STAT BIOL; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Forero-Medina G, 2009, J TROP ECOL, V25, P53, DOI 10.1017/S0266467408005543; Gibbs M, 2010, OECOLOGIA, V163, P341, DOI 10.1007/s00442-010-1613-5; Gibbs M, 2009, BEHAV ECOL SOCIOBIOL, V64, P1, DOI 10.1007/s00265-009-0849-8; Goodwin BJ, 1999, OIKOS, V84, P160, DOI 10.2307/3546877; Hein S, 2005, ECOL ENTOMOL, V30, P225, DOI 10.1111/j.0307-6946.2005.00680.x; Hildebrand JG, 1996, J COMP PHYSIOL A, V178, P5, DOI 10.1007/BF00189586; Hill JK, 2001, ECOL LETT, V4, P313, DOI 10.1046/j.1461-0248.2001.00222.x; Karlsson B, 2005, P ROY SOC B-BIOL SCI, V272, P1257, DOI 10.1098/rspb.2005.3074; Kovach WL, 2009, ORIANA CIRCULAR STAT; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Merckx T, 2006, FUNCT ECOL, V20, P436, DOI 10.1111/j.1365-2435.2006.01124.x; Merckx T, 2003, P ROY SOC B-BIOL SCI, V270, P1815, DOI 10.1098/rspb.2003.2459; Merckx T, 2007, ANIM BEHAV, V74, P1029, DOI 10.1016/j.anbehav.2006.12.020; Merlin C, 2009, SCIENCE, V325, P1700, DOI 10.1126/science.1176221; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Olden JD, 2004, J ANIM ECOL, V73, P1190, DOI 10.1111/j.0021-8790.2004.00889.x; Omura H, 2009, CHEMOECOLOGY, V19, P227, DOI 10.1007/s00049-009-0024-8; Palmer SCF, 2011, METHODS ECOL EVOL, V2, P258, DOI 10.1111/j.2041-210X.2010.00073.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Schooley RL, 2003, OIKOS, V102, P559, DOI 10.1034/j.1600-0706.2003.12490.x; Stavenga DG, 2006, ARTHROPOD STRUCT DEV, V35, P307, DOI 10.1016/j.asd.2006.08.011; Thomas CD, 2000, P ROY SOC B-BIOL SCI, V267, P139, DOI 10.1098/rspb.2000.0978; Travis JMJ, 2012, METHODS ECOL EVOL, V3, P628, DOI 10.1111/j.2041-210X.2012.00193.x; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; Vandewoestijne S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013810; Vuilleumier S, 2006, OIKOS, V113, P139, DOI 10.1111/j.0030-1299.2006.14405.x; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035; Zollner PA, 1997, OIKOS, V80, P51, DOI 10.2307/3546515; Zollner PA, 2000, LANDSCAPE ECOL, V15, P523, DOI 10.1023/A:1008154532512	36	22	23	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41517	10.1371/journal.pone.0041517	http://dx.doi.org/10.1371/journal.pone.0041517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870227	Green Submitted, gold, Green Published			2022-12-27	WOS:000307212800023
J	Pristera, A; Baker, MD; Okuse, K				Pristera, Alessandro; Baker, Mark D.; Okuse, Kenji			Association between Tetrodotoxin Resistant Channels and Lipid Rafts Regulates Sensory Neuron Excitability	PLOS ONE			English	Article							MECHANOSENSITIVE ION CHANNELS; MEMBRANE-PROTEIN FUNCTION; PRIMARY AFFERENT NEURONS; GATED SODIUM-CHANNELS; DRG NEURONS; ANNEXIN-II; IN-VITRO; PAIN; DOMAINS; AXONS	Voltage-gated sodium channels (VGSCs) play a key role in the initiation and propagation of action potentials in neurons. Na(V)1.8 is a tetrodotoxin (TTX) resistant VGSC expressed in nociceptors, peripheral small-diameter neurons able to detect noxious stimuli. Na(V)1.8 underlies the vast majority of sodium currents during action potentials. Many studies have highlighted a key role for Na(V)1.8 in inflammatory and chronic pain models. Lipid rafts are microdomains of the plasma membrane highly enriched in cholesterol and sphingolipids. Lipid rafts tune the spatial and temporal organisation of proteins and lipids on the plasma membrane. They are thought to act as platforms on the membrane where proteins and lipids can be trafficked, compartmentalised and functionally clustered. In the present study we investigated Na(V)1.8 sub-cellular localisation and explored the idea that it is associated with lipid rafts in nociceptors. We found that Na(V)1.8 is distributed in clusters along the axons of DRG neurons in vitro and ex vivo. We also demonstrated, by biochemical and imaging studies, that Na(V)1.8 is associated with lipid rafts along the sciatic nerve ex vivo and in DRG neurons in vitro. Moreover, treatments with methyl-beta-cyclodextrin (M beta CD) and 7-ketocholesterol (7KC) led to the dissociation between rafts and Na(V)1.8. By calcium imaging we demonstrated that the lack of association between rafts and Na(V)1.8 correlated with impaired neuronal excitability, highlighted by a reduction in the number of neurons able to conduct mechanically- and chemically-evoked depolarisations. These findings reveal the sub-cellular localisation of Na(V)1.8 in nociceptors and highlight the importance of the association between Na(V)1.8 and lipid rafts in the control of nociceptor excitability.	[Pristera, Alessandro; Okuse, Kenji] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Cell & Mol Biol, London, England; [Baker, Mark D.] Univ London, Blizard Inst, Neurosci & Trauma Ctr, Barts, England; [Baker, Mark D.] London Sch Med & Dent, London, England	Imperial College London; University of London; University of London; Queen Mary University London	Pristera, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Cell & Mol Biol, London, England.	k.okuse@imperial.ac.uk			Wellcome Trust; Wellcome Trust UK [080958/Z/06/Z, 083259/C/07/Z]	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust UK(Wellcome Trust)	This work was supported by the Wellcome Trust. AP and KO are members of the Wellcome Trust London Pain Consortium.; This work was supported by the Wellcome Trust UK (080958/Z/06/Z and 083259/C/07/Z), and AP and KO are members of London Pain Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Alfalah M, 1999, CURR BIOL, V9, P593, DOI 10.1016/S0960-9822(99)80263-2; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Basbaum AI, 1999, CURR BIOL, V9, pR429, DOI 10.1016/S0960-9822(99)80273-5; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Black JA, 2002, EXP EYE RES, V75, P193, DOI 10.1006/exer.2002.2014; Botto L, 2007, J NEUROSCI RES, V85, P443, DOI 10.1002/jnr.21111; Brackenbury WJ, 2008, J NEUROSCI, V28, P3246, DOI 10.1523/JNEUROSCI.5446-07.2008; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown RE, 1998, J CELL SCI, V111, P1; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Cheng CM, 2010, NAT PROTOC, V5, P714, DOI 10.1038/nprot.2010.15; Cho HW, 2002, J NEUROSCI, V22, P1238, DOI 10.1523/JNEUROSCI.22-04-01238.2002; Coskun U, 2010, FEBS LETT, V584, P1685, DOI 10.1016/j.febslet.2009.12.043; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cusdin FS, 2008, TRAFFIC, V9, P17, DOI 10.1111/j.1600-0854.2007.00673.x; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Drew LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000515; Drew LJ, 2009, EMBO J, V28, P1378, DOI 10.1038/emboj.2009.105; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; ENGLAND JD, 1990, P NATL ACAD SCI USA, V87, P6777, DOI 10.1073/pnas.87.17.6777; Fang X, 2002, J NEUROSCI, V22, P7425; Fitzgerald EM, 1999, J PHYSIOL-LONDON, V516, P433, DOI 10.1111/j.1469-7793.1999.0433v.x; Gaus K, 2004, FASEB J, V18, P574, DOI 10.1096/fj.03-0486fje; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Gold MS, 2003, J NEUROSCI, V23, P158; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Golub T, 2004, CURR OPIN NEUROBIOL, V14, P542, DOI 10.1016/j.conb.2004.08.003; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hartmann AM, 2009, J NEUROCHEM, V111, P321, DOI 10.1111/j.1471-4159.2009.06343.x; Hering H, 2003, J NEUROSCI, V23, P3262; Hille B, 2001, ION CHANNELS EXCITAB, Vxviii, P814; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Jin L, 2006, BIOPHYS J, V90, P2563, DOI 10.1529/biophysj.105.072884; Jin L, 2005, BIOPHYS J, V89, pL4, DOI 10.1529/biophysj.105.064816; KANDEL ER, 2000, PRINCIPLES NEURAL SC, pR41; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Massey JB, 2005, BIOCHEMISTRY-US, V44, P10423, DOI 10.1021/bi0506425; Matthews EA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-5; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; MEIRI H, 1985, BRAIN RES, V359, P326, DOI 10.1016/0006-8993(85)91444-1; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Morenilla-Palao C, 2009, J BIOL CHEM, V284, P9215, DOI 10.1074/jbc.M807228200; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Okuse K, 2007, INT J BIOCHEM CELL B, V39, P490, DOI 10.1016/j.biocel.2006.11.016; Oldfield S, 2009, MOL PHARMACOL, V76, P1279, DOI 10.1124/mol.109.058008; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Persson AK, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-84; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Pristera A, 2011, NEUROSCIENTIST; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rentero C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002262; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rescher U, 2008, PFLUG ARCH EUR J PHY, V455, P575, DOI 10.1007/s00424-007-0313-4; Rook MB, 2012, CARDIOVASC RES, V93, P12, DOI 10.1093/cvr/cvr252; Rush AM, 2005, EUR J NEUROSCI, V22, P39, DOI 10.1111/j.1460-9568.2005.04186.x; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; Shao D, 2009, MOL CELL NEUROSCI, V42, P219, DOI 10.1016/j.mcn.2009.07.003; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Sivilotti L, 1997, FEBS LETT, V409, P49, DOI 10.1016/S0014-5793(97)00479-1; SMITH KJ, 1982, J NEUROL SCI, V54, P13, DOI 10.1016/0022-510X(82)90215-5; Swanwick RS, 2010, NEUROSCI LETT, V486, P78, DOI 10.1016/j.neulet.2010.08.074; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; Usoskin D, 2010, P NATL ACAD SCI USA, V107, P16336, DOI 10.1073/pnas.0914705107; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023; Waxman Stephen G., 1995; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207	94	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40079	10.1371/journal.pone.0040079	http://dx.doi.org/10.1371/journal.pone.0040079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870192	Green Published, gold			2022-12-27	WOS:000307212800003
J	Schmidt, CM; Hood, WR				Schmidt, Christina M.; Hood, Wendy R.			Calcium Availability Influences Litter Size and Sex Ratio in White-Footed Mice (Peromyscus leucopus)	PLOS ONE			English	Article							COLUMBIAN GROUND-SQUIRRELS; BIG BROWN BATS; MATERNAL DIET; BONE METABOLISM; LIFE-HISTORY; OOCYTE ACTIVATION; BODY-COMPOSITION; SKELETAL MASS; PREGNANCY; LACTATION	The production of offspring typically requires investment of resources derived from both the environment and maternal somatic reserves. As such, the availability of either of these types of resources has the potential to limit the degree to which resources are allocated to reproduction. Theory and empirical studies have argued that mothers modify reproductive performance relative to exogenous resource availability and maternal condition by adjusting size, number or sex of offspring produced. These relationships have classically been defined relative to availability of energy sources; however, in vertebrates, calcium also plays a critical role in offspring production, as a considerable amount of calcium is required to support the development of offspring skeleton(s). We tested whether the availability of calcium influences reproductive output by providing female white-footed mice with a low-calcium or standard diet from reproductive maturity to senescence. We then compared maternal skeletal condition and reproductive output, based on offspring mass, offspring number and litter sex ratio, between dietary treatments. Mothers on the low-calcium diet exhibited diminished skeletal condition at senescence and produced smaller and strongly female-biased litters. We show that skeletal condition and calcium intake can influence sex ratio and reproductive output following general theoretical models of resource partitioning during reproduction.	[Schmidt, Christina M.; Hood, Wendy R.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	Auburn University System; Auburn University	Schmidt, CM (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	ossavolatus@gmail.com	Schmidt, Christina/A-7711-2013	Schmidt, Christina/0000-0003-4627-8326; Hood, Wendy/0000-0002-8398-3908	American Society of Mammalogists; Society for Integrative and Comparative Biology; Auburn University College of Science and Mathematics	American Society of Mammalogists; Society for Integrative and Comparative Biology; Auburn University College of Science and Mathematics	The project was funded by grants-in-aid of research from the American Society of Mammalogists (http://www.mammalsociety.org) and the Society for Integrative and Comparative Biology (http://www.sicb.org) awarded to CMS as well as through start up funding provided to WRH from the Auburn University College of Science and Mathematics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; BIRD E, 1986, PHYSIOL BEHAV, V36, P307, DOI 10.1016/0031-9384(86)90021-1; Boelter MDD, 1943, J NUTR, V26, P105, DOI 10.1093/jn/26.2.105; Booher CM, 2008, J ZOOL, V274, P38, DOI 10.1111/j.1469-7998.2007.00354.x; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Bowman B. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P347; Bowman BM, 1999, BONE, V25, P553, DOI 10.1016/S8756-3282(99)00204-5; Cameron EZ, 2007, BIOL LETTERS, V3, P395, DOI 10.1098/rsbl.2007.0089; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Charnov EL, 2007, AM NAT, V170, pE129, DOI 10.1086/522840; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; CLUTTONBROCK TH, 1986, Q REV BIOL, V61, P339, DOI 10.1086/415033; COLE FR, 1978, J MAMMAL, V59, P809, DOI 10.2307/1380145; Cooper C, 2009, ADV EXP MED BIOL, V646, P31, DOI 10.1007/978-1-4020-9173-5_3; CURREY JD, 1984, PHILOS T ROY SOC B, V304, P509, DOI 10.1098/rstb.1984.0042; CURREY JD, 1969, J BIOMECH, V2, P1, DOI 10.1016/0021-9290(69)90036-0; CUTHBERTSON KSR, 1981, NATURE, V294, P754, DOI 10.1038/294754a0; Dama MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016296; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; DOBSON FS, 1985, CAN J ZOOL, V63, P2105, DOI 10.1139/z85-309; DOBSON FS, 1995, ECOLOGY, V76, P851, DOI 10.2307/1939350; Ducibella T, 2002, DEV BIOL, V250, P280, DOI 10.1006/dbio.2002.0788; GOUNDIE TR, 1986, J MAMMAL, V67, P53, DOI 10.2307/1381001; Graveland J, 1996, OECOLOGIA, V105, P351, DOI 10.1007/BF00328738; GRUBER HE, 1994, BONE, V15, P167, DOI 10.1016/8756-3282(94)90704-8; Hanover JA, 2009, J BIOL CHEM, V284, P12593, DOI 10.1074/jbc.R800076200; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; Heytens E, 2008, REPROD BIOMED ONLINE, V17, P764, DOI 10.1016/S1472-6483(10)60403-8; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Hood WR, 2006, J COMP PHYSIOL B, V176, P807, DOI 10.1007/s00360-006-0102-y; Johnson LE, 2002, J NUTR, V132, P2270, DOI 10.1093/jn/132.8.2270; Jones G, 2000, EUR J CLIN NUTR, V54, P749, DOI 10.1038/sj.ejcn.1601082; Kalkwarf HJ, 2002, ENDOCRINE, V17, P49, DOI 10.1385/ENDO:17:1:49; Keech MA, 2000, J WILDLIFE MANAGE, V64, P450, DOI 10.2307/3803243; KOJOLA I, 1989, EVOLUTION, V43, P1331, DOI [10.2307/2409370, 10.1111/j.1558-5646.1989.tb02582.x]; Koo WWK, 1999, OBSTET GYNECOL, V94, P577, DOI 10.1016/S0029-7844(99)00371-3; Kovacs CS, 2005, J MAMMARY GLAND BIOL, V10, P105, DOI 10.1007/s10911-005-5394-0; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Liesegang A, 2007, J ANIM PHYSIOL AN N, V91, P217, DOI 10.1111/j.1439-0396.2007.00695.x; Miller SC, 2005, BIOL REPROD, V73, P156, DOI 10.1095/biolreprod.105.039610; MIYAZAKI S, 1993, DEV BIOL, V158, P62, DOI 10.1006/dbio.1993.1168; Oftedal O.T., 1984, Symposia of the Zoological Society of London, P33; ONO KA, 1987, BEHAV ECOL SOCIOBIOL, V21, P109, DOI 10.1007/BF02395438; Ott SM, 1999, J BONE MINER RES, V14, P1779, DOI 10.1359/jbmr.1999.14.10.1779; Patten MA, 2007, J AVIAN BIOL, V38, P637, DOI 10.1111/j.2007.0908-8857.04203.x; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; Prentice A, 2000, ANNU REV NUTR, V20, P249, DOI 10.1146/annurev.nutr.20.1.249; Prentice A, 2006, P NUTR SOC, V65, P348, DOI 10.1079/PNS2006519; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; RAMAN L, 1978, AM J CLIN NUTR, V31, P466, DOI 10.1093/ajcn/31.3.466; Reid IR, 2010, ARCH BIOCHEM BIOPHYS, V503, P20, DOI 10.1016/j.abb.2010.06.027; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100; Schmidt CM, 2011, EFFECTS DIETARY SKEL; Skibiel AL, 2009, ECOL MONOGR, V79, P325, DOI 10.1890/08-0718.1; SKOGLAND T, 1986, OIKOS, V46, P417, DOI 10.2307/3565843; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Spiller C, 2009, BIOL CELL, V101, P587, DOI 10.1042/BC20090021; STUDIER EH, 1995, J MAMMAL, V76, P32, DOI 10.2307/1382312; TERMAN CR, 1967, J MAMMAL, V48, P589, DOI 10.2307/1377582; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; WAUTERS LA, 1995, BEHAV ECOL SOCIOBIOL, V37, P189, DOI 10.1007/s002650050180; Wysolmerski JJ, 2010, ANN NY ACAD SCI, V1192, P161, DOI 10.1111/j.1749-6632.2009.05249.x; Yin J, 2010, EUR J CLIN NUTR, V64, P131, DOI 10.1038/ejcn.2009.117; Zeni S, 2003, CALCIFIED TISSUE INT, V73, P594, DOI 10.1007/s00223-002-1093-7	66	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41402	10.1371/journal.pone.0041402	http://dx.doi.org/10.1371/journal.pone.0041402			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870218	Green Published, Green Submitted			2022-12-27	WOS:000307212800018
J	Schuck-Paim, C; Viboud, C; Simonsen, L; Miller, MA; Moura, FEA; Fernandes, RM; Carvalho, ML; Alonso, WJ				Schuck-Paim, Cynthia; Viboud, Cecile; Simonsen, Lone; Miller, Mark A.; Moura, Fernanda E. A.; Fernandes, Roberto M.; Carvalho, Marcia L.; Alonso, Wladimir J.			Were Equatorial Regions Less Affected by the 2009 Influenza Pandemic? The Brazilian Experience	PLOS ONE			English	Article							UNITED-STATES; A H1N1; MORTALITY; SEASONALITY; BURDEN; WINTER	Although it is in the Tropics where nearly half of the world population lives and infectious disease burden is highest, little is known about the impact of influenza pandemics in this area. We investigated the mortality impact of the 2009 influenza pandemic relative to mortality rates from various outcomes in pre-pandemic years throughout a wide range of latitudes encompassing the entire tropical, and part of the subtropical, zone of the Southern Hemisphere (+5 degrees N to -35 degrees S) by focusing on a country with relatively uniform health care, disease surveillance, immunization and mitigation policies: Brazil. To this end, we analyzed laboratory-confirmed deaths and vital statistics mortality beyond pre-pandemic levels for each Brazilian state. Pneumonia, influenza and respiratory mortality were significantly higher during the pandemic, affecting predominantly adults aged 25 to 65 years. Overall, there were 2,273 and 2,787 additional P&I- and respiratory deaths during the pandemic, corresponding to a 5.2% and 2.7% increase, respectively, over average pre-pandemic annual mortality. However, there was a marked spatial structure in mortality that was independent of socio-demographic indicators and inversely related with income: mortality was progressively lower towards equatorial regions, where low or no difference from pre-pandemic mortality levels was identified. Additionally, the onset of pandemic-associated mortality was progressively delayed in equatorial states. Unexpectedly, there was no additional mortality from circulatory causes. Comparing disease burden reliably across regions is critical in those areas marked by competing health priorities and limited resources. Our results suggest, however, that tropical regions of the Southern Hemisphere may have been disproportionally less affected by the pandemic, and that climate may have played a key role in this regard. These findings have a direct bearing on global estimates of pandemic burden and the assessment of the role of immunological, socioeconomic and environmental drivers of the transmissibility and severity of this pandemic.	[Schuck-Paim, Cynthia; Alonso, Wladimir J.] Origem Sci, Sao Paulo, Brazil; [Viboud, Cecile; Miller, Mark A.; Alonso, Wladimir J.] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Simonsen, Lone] George Washington Univ, Sch Publ Hlth, Washington, DC USA; [Simonsen, Lone] George Washington Univ, Hlth Serv, Washington, DC USA; [Moura, Fernanda E. A.] Univ Fed Ceara, Virol Lab, Dept Pathol & Med, Fortaleza, Ceara, Brazil; [Carvalho, Marcia L.] Brazilian Minist Hlth, Hlth Surveillance Secretariat, Brasilia, DF, Brazil	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); George Washington University; George Washington University; Universidade Federal do Ceara	Schuck-Paim, C (corresponding author), Origem Sci, Sao Paulo, Brazil.	alonsow@mail.nih.gov	Simonsen, Lone/K-4531-2014; Moura, Fernanda/I-2739-2013; Schuck-Paim, Cynthia/AGG-9729-2022; Schuck-Paim, Cynthia/G-5503-2013; Alonso, Wladimir J./N-9223-2017	Simonsen, Lone/0000-0003-1535-8526; Schuck-Paim, Cynthia/0000-0002-9760-7786; Alonso, Wladimir J./0000-0001-7038-0801	research program of the Fogarty International Center (National Institutes of Health); International Influenza Unit, Office of Global Affairs, United States Department of Health and Human Services; Research and Policy for Infectious Disease Dynamics program; Fogarty International Center (National Institutes of Health); Department of Homeland Security Science and Technology Directorate (United States of America); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (Brazil)	research program of the Fogarty International Center (National Institutes of Health); International Influenza Unit, Office of Global Affairs, United States Department of Health and Human Services; Research and Policy for Infectious Disease Dynamics program; Fogarty International Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Department of Homeland Security Science and Technology Directorate (United States of America)(United States Department of Homeland Security (DHS)); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (Brazil)	This work was supported by the research program of the Fogarty International Center (National Institutes of Health) and the International Influenza Unit, Office of Global Affairs, United States Department of Health and Human Services. Funding support for Lone Simonsen came from the Research and Policy for Infectious Disease Dynamics program, jointly supported by the Fogarty International Center (National Institutes of Health) and the Department of Homeland Security Science and Technology Directorate (United States of America). FEAM was supported by Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Azzoni C, 2000, 122 IDB; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Blyth CC, 2010, EUROSURVEILLANCE, V15, P11; Brazilian Ministry of Health, 2010, INF TECN OP; Charu V, 2011, CLIN INFECT DIS, V53, P985, DOI 10.1093/cid/cir644; Chowell G, 2009, NEW ENGL J MED; Chowell G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021287; Chowell G, 2010, P ROY SOC B-BIOL SCI, V277, P1857, DOI 10.1098/rspb.2009.1897; DATASUS, 2011, VIT STAT BRAZ; Dawood F, 2012, LANCET INFECT DIS, V3099, P70121; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Libster R, 2009, NEW ENGL J MED; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; Nzussouo NT, 2012, J INFECT DI IN PRESS; Oliveira WK, 2009, EUROSURVEILLANCE, V14, P16; Opatowski L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002225; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; van den Wijngaard CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031197; van Kerkhove M, 2011, INFLUENZA OTHER RESP, V5; Van Kerkhove M, 2011, INFLUENZA OTHER RESP, V20; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wilson N, 2009, EUROSURVEILLANCE, V14; World Health Organization, 2009, SIT UPD PAND H1N1; World Health Organization, 2007, SER ICD 10 INT STAT; World Health Organization, 2009, WORLD NOW START 2009; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216	33	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41918	10.1371/journal.pone.0041918	http://dx.doi.org/10.1371/journal.pone.0041918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870262	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800043
J	Wong, AMK; Chang, WH; Ke, PC; Huang, CK; Tsai, TH; Chang, HT; Shieh, WY; Chan, HL; Chen, CK; Pei, YC				Wong, Alice M. K.; Chang, Wei-Han; Ke, Pei-Chih; Huang, Chun-Kai; Tsai, Tsai-Hsuan; Chang, Hsien-Tsung; Shieh, Wann-Yun; Chan, Hsiao-Lung; Chen, Chih-Kuang; Pei, Yu-Cheng			Technology Acceptance for an Intelligent Comprehensive Interactive Care (ICIC) System for Care of the Elderly: A Survey-Questionnaire Study	PLOS ONE			English	Article							NONLINEAR STRUCTURAL SYSTEMS; TIME-DELAY; USER ACCEPTANCE; STABILITY CONDITIONS; ROBUSTNESS DESIGN; FUZZY-SYSTEMS; INTERNET; ADOPTION; MODELS	The key components of caring for the elderly are diet, living, transportation, education, and safety issues, and telemedical systems can offer great assistance. Through the integration of personal to community information technology platforms, we have developed a new Intelligent Comprehensive Interactive Care (ICIC) system to provide comprehensive services for elderly care. The ICIC system consists of six items, including medical care (physiological measuring system, Medication Reminder, and Dr. Ubiquitous), diet, living, transportation, education (Intelligent Watch), entertainment (Sharetouch), and safety (Fall Detection). In this study, we specifically evaluated the users' intention of using the Medication Reminder, Dr. Ubiquitous, Sharetouch, and Intelligent Watch using a modified technological acceptance model (TAM). A total of 121 elderly subjects (48 males and 73 females) were recruited. The modified TAM questionnaires were collected after they had used these products. For most of the ICIC units, the elderly subjects revealed great willingness and/or satisfaction in using this system. The elderly users of the Intelligent Watch showed the greatest willingness and satisfaction, while the elderly users of Dr. Ubiquitous revealed fair willingness in the dimension of perceived ease of use. The old-old age group revealed greater satisfaction in the dimension of result demonstrability for the users of the Medication Reminder as compared to the young-old and oldest-old age groups. The women revealed greater satisfaction in the dimension of perceived ease of use for the users of Dr. Ubiquitous as compared to the men. There were no statistically significant differences in terms of gender, age, and education level in the other dimensions. The modified TAM showed its effectiveness in evaluating the acceptance and characteristics of technologic products for the elderly user. The ICIC system offers a user-friendly solution in telemedical care and improves the quality of care for the elderly.	[Wong, Alice M. K.; Chang, Wei-Han; Ke, Pei-Chih; Huang, Chun-Kai; Chen, Chih-Kuang; Pei, Yu-Cheng] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Tao Yuan, Taiwan; [Wong, Alice M. K.; Tsai, Tsai-Hsuan; Chang, Hsien-Tsung; Shieh, Wann-Yun; Chan, Hsiao-Lung] Chang Gung Univ, Grad Inst Rehabil Sci, Tao Yuan, Taiwan; [Pei, Yu-Cheng] Chang Gung Univ, Hlth Aging Res Ctr, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Wong, AMK (corresponding author), Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Tao Yuan, Taiwan.	albert.ckchen@gmail.com; yspeii@adm.cgmh.org.tw	Chang, Hsien-Tsung/E-7511-2012; Wong, Alice M. K./ABI-1000-2020	Chang, Hsien-Tsung/0000-0003-4987-5943; Wong, Alice M. K./0000-0003-3586-1292; Shieh, Wann-Yun/0000-0003-4325-3553; Pei, Yu-Cheng/0000-0001-5986-0046	Ministry of Economic Affairs of Taiwan, Republic of China	Ministry of Economic Affairs of Taiwan, Republic of China(Ministry of Economic Affairs, Taiwan)	This research work was supported by the research grant of the Ministry of Economic Affairs of Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DA, 1992, MIS QUART, V16, P227, DOI 10.2307/249577; Aubert BA, 2001, SOC SCI MED, V53, P879, DOI 10.1016/S0277-9536(00)00388-9; Chang HS, 2010, HABITAT INT, V34, P210, DOI 10.1016/j.habitatint.2009.09.005; Chang PL, 2004, ST HEAL T, V107, P1421; Chen CY, 2010, J VIB CONTROL, V16, P147, DOI 10.1177/1077546309339424; Chen CW, 2006, ADV ENG SOFTW, V37, P624, DOI 10.1016/j.advengsoft.2005.12.002; Chen CW, 2011, APPL SOFT COMPUT, V11, P2735, DOI 10.1016/j.asoc.2010.11.004; Chen CW, 2010, J VIB CONTROL, V16, P1651, DOI 10.1177/1077546309104185; Chen CW, 2009, MATH COMPUT SIMULAT, V80, P402, DOI 10.1016/j.matcom.2009.08.001; Chen CW, 2009, INT J UNCERTAIN FUZZ, V17, P705, DOI 10.1142/S0218488509006224; Chen CW, 2009, EXPERT SYST APPL, V36, P4765, DOI 10.1016/j.eswa.2008.06.062; Chen CW, 2006, INT J ARTIF INTELL T, V15, P163, DOI 10.1142/S0218213006002618; Chen CW, 2004, MATH COMPUT SIMULAT, V66, P523, DOI 10.1016/j.matcom.2004.04.001; Chen CW, 2010, MATH PROBLEMS ENG; Chen K., 2009, J POPULATION STUDIES, V39, P59; Chen PC, 2011, J VIB CONTROL, V17, P163, DOI 10.1177/1077546309352826; Cheng-Wu C, 2007, INT J ARTIFICIAL INT, V16, P8; DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; DAVIS FD, 1992, J APPL SOC PSYCHOL, V22, P1111, DOI 10.1111/j.1559-1816.1992.tb00945.x; Dickinson A, 2005, INTERACT COMPUT, V17, P621, DOI 10.1016/j.intcom.2005.09.003; Dyck JL, 1996, COMPUT HUM BEHAV, V12, P107, DOI 10.1016/0747-5632(95)00022-4; GILLY MC, 1985, J CONSUM RES, V12, P353, DOI 10.1086/208521; Hsiao FH, 2005, INT J UNCERTAIN FUZZ, V13, P281, DOI 10.1142/S0218488505003461; Hsiao FH, 2005, IEEE T FUZZY SYST, V13, P152, DOI 10.1109/TFUZZ.2004.836067; Hsiao FH, 2005, J CHIN INST ENG, V28, P175, DOI 10.1080/02533839.2005.9670984; Hsu C. L., 2008, J TAIWAN OCCUPATIONA, V4, P104; Huang CH, 2009, J DESIGN RES, V3, P121; Jen WY, 2010, TELEMED J E-HEALTH, V16, P41, DOI 10.1089/tmj.2009.0093; Juznic P, 2006, NEW LIB WORLD, V107, P332, DOI 10.1108/03074800610677308; Lee MKO, 2005, INFORM MANAGE-AMSTER, V42, P1095, DOI 10.1016/j.im.2003.10.007; Lin ML, 2011, J VIB CONTROL, V17, P1930, DOI 10.1177/1077546310385737; Lin ML, 2010, ENG COMPUTATION, V27, P5, DOI 10.1108/02644401011008504; Marcellini F, 2000, Z GERONTOL GERIATR, V33, P169, DOI 10.1007/s003910070057; Mathur A, 1999, J MARKETING MANAGEME, V9, P21; Petersen RC, 2010, NEUROLOGY, V75, P889, DOI 10.1212/WNL.0b013e3181f11d85; Phang CW, 2006, IEEE T ENG MANAGE, V53, P555, DOI 10.1109/TEM.2006.883710; Ryu MH, 2009, COMPUT HUM BEHAV, V25, P619, DOI 10.1016/j.chb.2008.08.013; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Venkatesh V., 2000, INFORM SYST RES, V11, P265, DOI DOI 10.1287/isre.11.4.342.11872; Yeh K, 2008, APPL MATH COMPUT, V205, P568, DOI 10.1016/j.amc.2008.05.104; Yeh K, 2010, MATH PROBL ENG, V2010, DOI 10.1155/2010/734340	42	16	16	8	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40591	10.1371/journal.pone.0040591	http://dx.doi.org/10.1371/journal.pone.0040591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	984SU	22870200	Green Published, gold			2022-12-27	WOS:000307212800008
J	Di Lullo, G; Ieva, F; Longhi, R; Paganoni, AM; Protti, MP				Di Lullo, Giulia; Ieva, Francesca; Longhi, Renato; Paganoni, Anna Maria; Protti, Maria Pia			Estimating Point and Interval Frequency of Antigen-Specific CD4(+) T Cells Based on Short In Vitro Expansion and Improved Poisson Distribution Analysis	PLOS ONE			English	Article							CLASS-II TETRAMERS; GRADE CERVICAL LESIONS; IMMUNE-RESPONSES; MEMORY; VIRUS; IMMUNOTHERAPY; REPERTOIRE; VACCINES; SUBSETS; ROLES	Background: Knowledge of antigen-specific CD4(+) T cells frequencies is pivotal to the choice of the antigen to be used in anti-viral and anti-tumor vaccination procedures and for monitoring of immune responses. Methods that employ small cell numbers from patient samples, are easy to perform and do not require complex techniques/instrumentations and therefore standardization are desirable. Methodology/Principal Findings: Purified blood CD4(+) T cells from healthy donors were cultured with autologous antigen presenting cells in several replicate wells in equal numbers in the absence (un-stimulated wells) or in the presence of synthetic peptides corresponding to viral antigens promiscuous HLA-DR epitopes (antigen-stimulated wells). At day 7 of culture low dose IL-2 was added and at day 14 IFN-gamma and IL-5 release in the supernatant was measured. A statistical analysis approach, based on Poisson distribution, was then implemented to calculate the frequency of viral-specific CD4(+) T cells. We first determined a patient-specific exceptionality threshold of cytokine release in the un-stimulated wells and then, based on this threshold, we counted the inactive/active wells within the antigen-stimulated wells. This number, along with the number of cells per well, allowed the point and interval estimates of frequencies. A ready-to-use Excel worksheet template with automatic calculations for frequencies estimate was developed and is provided as a supplemental file (Table S9). Conclusions/Significance: We report a simple experimental procedure combining short term in vitro cell culture with statistical analysis to calculate the frequency of antigen-specific CD4(+) T cells. The detailed experimental procedure along with the Excel applicative are a valuable tool for monitoring immune responses in the clinical practice.	[Di Lullo, Giulia; Protti, Maria Pia] Ist Sci San Raffaele, Tumor Immunol Unit, I-20132 Milan, Italy; [Di Lullo, Giulia; Protti, Maria Pia] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Ieva, Francesca; Paganoni, Anna Maria] Politecn Milan, Dipartimento Matemat, Laboratorty Modeling & Sci Comp MOX, I-20133 Milan, Italy; [Longhi, Renato] CNR, Ist Chim Riconoscimento Mol, I-20133 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Polytechnic University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Di Lullo, G (corresponding author), Ist Sci San Raffaele, Tumor Immunol Unit, I-20132 Milan, Italy.	m.protti@hsr.it	Di Lullo, Giulia/G-4800-2016; Paganoni, Anna Maria/N-9885-2016; Protti, Maria Pia/J-7899-2016	Di Lullo, Giulia/0000-0002-9358-920X; Paganoni, Anna Maria/0000-0002-8253-3630; Protti, Maria Pia/0000-0001-9079-2336; Ieva, Francesca/0000-0003-0165-1983	AIRC (Associazione Italiana per la Ricerca sul Cancro) [IG-4510, IG-11353]; Special Program Molecular Clinical Oncology AIRC 5 per mille [9965]; Italian Ministry of Health	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Special Program Molecular Clinical Oncology AIRC 5 per mille(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by: AIRC (Associazione Italiana per la Ricerca sul Cancro, IG-4510, IG-11353), Special Program Molecular Clinical Oncology AIRC 5 per mille (9965), and the Italian Ministry of Health (Programma Straordinario Ricerca Oncologica). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Cecconi V, 2008, CYTOM PART A, V73A, P1010, DOI 10.1002/cyto.a.20603; Cecconi V, 2010, EUR J IMMUNOL, V40, P1603, DOI 10.1002/eji.200940123; Curnis F, 2004, CANCER RES, V64, P565, DOI 10.1158/0008-5472.CAN-03-1753; Danke NA, 2003, J IMMUNOL, V171, P3163, DOI 10.4049/jimmunol.171.6.3163; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Heller KN, 2007, BLOOD, V109, P1138, DOI 10.1182/blood-2006-05-023663; Hoos A, 2011, NAT BIOTECHNOL, V29, P867, DOI 10.1038/nbt.2000; Jovanovic BD, 1997, AM STAT, V51, P137, DOI 10.2307/2685405; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kwok WW, 2012, J IMMUNOL, V188, P2537, DOI 10.4049/jimmunol.1102190; Letsch A, 2003, METHODS, V31, P143, DOI 10.1016/S1046-2023(03)00124-5; Lucas M, 2004, J VIROL, V78, P7284, DOI 10.1128/JVI.78.13.7284-7287.2004; Lyerly HK, 2003, SEMIN ONCOL, V30, P9, DOI 10.1016/S0093-7754(03)00230-6; Maino VC, 1998, CYTOMETRY, V34, P207, DOI 10.1002/(SICI)1097-0320(19981015)34:5<207::AID-CYTO1>3.0.CO;2-J; Marturano J, 2008, CANCER RES, V68, P1555, DOI 10.1158/0008-5472.CAN-07-5233; MAZZOCCHI A, 1994, INT J CANCER, V58, P330, DOI 10.1002/ijc.2910580304; Nepom GT, 2012, J IMMUNOL, V188, P2477, DOI 10.4049/jimmunol.1102398; Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; Pardoll D, 2012, J EXP MED, V209, P201, DOI 10.1084/jem.20112275; Seresini S, 2007, J IMMUNOL, V179, P7176, DOI 10.4049/jimmunol.179.10.7176; Seresini S, 2010, IMMUNOLOGY, V131, P89, DOI 10.1111/j.1365-2567.2010.03277.x; Siota M, 2011, EXPERT REV VACCINES, V10, P299, DOI [10.1586/ERV.10.169, 10.1586/erv.10.169]; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Tassi E, 2008, J IMMUNOL, V181, P6595, DOI 10.4049/jimmunol.181.9.6595; van der Burg SH, 2011, PROBABILITY RANDOM P, V3; van der Burg SH, 2008, EXPERT REV VACCINES, V7, P1, DOI 10.1586/14760584.7.1.1; van der Burg SH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002785; Whitmire JK, 2011, VIROLOGY, V411, P216, DOI 10.1016/j.virol.2010.12.015; Whitmire JK, 2000, PHILOS T R SOC B, V355, P373, DOI 10.1098/rstb.2000.0577	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42340	10.1371/journal.pone.0042340	http://dx.doi.org/10.1371/journal.pone.0042340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879946	Green Submitted, Green Published, gold			2022-12-27	WOS:000307437900030
J	Vey, G; Moreno-Hagelsieb, G				Vey, Gregory; Moreno-Hagelsieb, Gabriel			Metagenomic Annotation Networks: Construction and Applications	PLOS ONE			English	Article							GUT MICROBIOME; FUNCTIONAL MODULES; ESCHERICHIA-COLI; SEQUENCE; DATABASE; GENOMES; ENZYMES; MODELS	The derivation and comparison of biological interaction networks are vital for understanding the functional capacity and hierarchical organization of integrated microbial communities. In the current work we present metagenomic annotation networks as a novel taxonomy-free approach for understanding the functional architecture of metagenomes. Specifically, metagenomic operon predictions are exploited to derive functional interactions that are translated and categorized according to their associated functional annotations. The result is a collection of discrete networks of weighted annotation linkages. These networks are subsequently examined for the occurrence of annotation modules that portray the functional and organizational characteristics of various microbial communities. A variety of network perspectives and annotation categories are applied to recover a diverse range of modules with different degrees of annotative cohesiveness. Applications to biocatalyst discovery and human health issues are discussed, as well as the limitations of the current implementation.	[Vey, Gregory] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Moreno-Hagelsieb, Gabriel] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON N2L 3C5, Canada	University of Waterloo; Wilfrid Laurier University	Vey, G (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	gmoreno@wlu.ca		Vey, Gregory/0000-0003-1574-1373; Moreno-Hagelsieb, Gabriel/0000-0002-2457-4450	NSERC Strategic Grant; NSERC Discovery Grant	NSERC Strategic Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	GV was supported by an NSERC Strategic Grant; GM-H's research was supported by a NSERC Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2000, GENOME RES, V10, P1074, DOI 10.1101/gr.10.8.1074; Candela M, 2010, INT J FOOD MICROBIOL, V140, P93, DOI 10.1016/j.ijfoodmicro.2010.04.017; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; CHEN GJ, 1989, APPL ENVIRON MICROB, V55, P2658, DOI 10.1128/AEM.55.10.2658-2663.1989; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Ferrer M, 2005, CURR OPIN BIOTECH, V16, P588, DOI 10.1016/j.copbio.2005.09.001; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Hsu JT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-281; Janga SC, 2011, METAB ENG, V13, P1, DOI 10.1016/j.ymben.2010.07.001; Kaddurah-Daouk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025482; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kidd P, 2005, ALTERN MED REV, V10, P193; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Konietzny SGA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-141; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li LL, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-23; Liu Bo, 2011, BMC Proc, V5 Suppl 2, pS9, DOI 10.1186/1753-6561-5-S2-S9; Lykidis A, 2007, J BACTERIOL, V189, P2477, DOI 10.1128/JB.01899-06; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moreno-Hagelsieb Gabriel, 2002, Bioinformatics, V18 Suppl 1, pS329; Nataf Y, 2009, J BACTERIOL, V191, P203, DOI 10.1128/JB.01190-08; Peregrin-Alvarez JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000523; Pignatelli M, 2008, BIOINFORMATICS, V24, P2124, DOI 10.1093/bioinformatics/btn355; Rende D, 2011, MOL BIOSYST, V7, P2205, DOI 10.1039/c1mb05064h; Salgado H, 2000, P NATL ACAD SCI USA, V97, P6652, DOI 10.1073/pnas.110147297; Selengut JD, 2007, NUCLEIC ACIDS RES, V35, pD260, DOI 10.1093/nar/gkl1043; Sun MGF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-235; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vey G, 2010, MOL BIOSYST, V6, P1247, DOI 10.1039/b919263h; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667	37	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41283	10.1371/journal.pone.0041283	http://dx.doi.org/10.1371/journal.pone.0041283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879885	Green Published, gold, Green Submitted			2022-12-27	WOS:000307437900008
J	Brim, H; Lee, E; Abu-Asab, MS; Chaouchi, M; Razjouyan, H; Namin, H; Goel, A; Schaffer, AA; Ashktorab, H				Brim, Hassan; Lee, Edward; Abu-Asab, Mones S.; Chaouchi, Mohamed; Razjouyan, Hadi; Namin, Hassanzadeh; Goel, Ajay; Schaeffer, Alejandro A.; Ashktorab, Hassan			Genomic Aberrations in an African American Colorectal Cancer Cohort Reveals a MSI-Specific Profile and Chromosome X Amplification in Male Patients	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; SPORADIC COLON-CANCER; MICROSATELLITE INSTABILITY; HUMAN BREAST; EXPRESSION; CARCINOMAS; DISTINCT; HYPERMETHYLATION; HYBRIDIZATION; ABNORMALITIES	Objective: DNA aberrations that cause colorectal cancer (CRC) occur in multiple steps that involve microsatellite instability (MSI) and chromosomal instability (CIN). Herein, we studied CRCs from AA patients for their CIN and MSI status. Experimental Design: Array CGH was performed on 30 AA colon tumors. The MSI status was established. The CGH data from AA were compared to published lists of 41 TSG and oncogenes in Caucasians and 68 cancer genes, proposed via systematic sequencing for somatic mutations in colon and breast tumors. The patient-by-patient CGH profiles were organized into a maximum parsimony cladogram to give insights into the tumors' aberrations lineage. Results: The CGH analysis revealed that CIN was independent of age, gender, stage or location. However, both the number and nature of aberrations seem to depend on the MSI status. MSI-H tumors clustered together in the cladogram. The chromosomes with the highest rates of CGH aberrations were 3, 5, 7, 8, 20 and X. Chromosome X was primarily amplified in male patients. A comparison with Caucasians revealed an overall similar aberration profile with few exceptions for the following genes; THRB, RAF1, LPL, DCC, XIST, PCNT, STS and genes on the 20q12-q13 cytoband. Among the 68 CAN genes, all showed some level of alteration in our cohort. Conclusion: Chromosome X amplification in male patients with CRC merits follow-up. The observed CIN may play a distinctive role in CRC in AAs. The clustering of MSI-H tumors in global CGH data analysis suggests that chromosomal aberrations are not random.	[Brim, Hassan; Lee, Edward; Razjouyan, Hadi; Namin, Hassanzadeh; Ashktorab, Hassan] Howard Univ, Dept Med, Washington, DC 20059 USA; [Brim, Hassan; Lee, Edward; Razjouyan, Hadi; Namin, Hassanzadeh; Ashktorab, Hassan] Howard Univ, Coll Med, Ctr Canc, Dept Pathol, Washington, DC USA; [Abu-Asab, Mones S.] NCI, NIH, DHHS, Bethesda, MD 20892 USA; [Chaouchi, Mohamed] Georgetown Univ, Sch Med, Dept Physiol & Biophys, Washington, DC 20007 USA; [Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX USA; [Goel, Ajay] Baylor Univ, Med Ctr, Sammons Canc Ctr, Dallas, TX USA; [Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, DHHS, Bethesda, MD 20892 USA	Howard University; Howard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center; National Institutes of Health (NIH) - USA	Brim, H (corresponding author), Howard Univ, Dept Med, Washington, DC 20059 USA.	hbrim@howard.edu; hashktorab@howard.edu	Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019; Ashktorab, hassan/AAJ-2908-2020	Abu-Asab, Mones/0000-0002-4047-1232; Goel, Ajay/0000-0003-1396-6341	National Cancer Institute (NCI), National Institutes of Health; National Institutes of Health, National Cancer Institute and National Library of Medicine; Research Centers in Minority Institutions (RCMI);  [CA102681]; NATIONAL CANCER INSTITUTE [R01CA102681] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003048] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	National Cancer Institute (NCI), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Cancer Institute and National Library of Medicine; Research Centers in Minority Institutions (RCMI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by Grant #CA102681, funded by the National Cancer Institute (NCI), National Institutes of Health, by the Intramural Research Program of the National Institutes of Health, National Cancer Institute and National Library of Medicine, and by Research Centers in Minority Institutions (RCMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Abu-Asab MS, 2011, OMICS, V15, P105, DOI 10.1089/omi.2010.0023; Arnold CN, 2004, CANCER BIOL THER, V3, P960, DOI 10.4161/cbt.3.10.1113; Arthold S, 2011, HUM GENET; Ashktorab H, 2005, INT J CANCER, V116, P914, DOI 10.1002/ijc.21062; Ashktorab H, 2003, CLIN CANCER RES, V9, P1112; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Babaei-Jadidi R, 2011, J EXP MED, V208, P295, DOI 10.1084/jem.20100830; BARDI G, 1995, GENE CHROMOSOME CANC, V12, P97, DOI 10.1002/gcc.2870120204; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; BOMME L, 1994, GENE CHROMOSOME CANC, V10, P190, DOI 10.1002/gcc.2870100307; Brim H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-68; Cacev T, 2005, GUT, V54, P1129, DOI 10.1136/gut.2004.053348; Camps J, 2006, CARCINOGENESIS, V27, P419, DOI 10.1093/carcin/bgi244; Carethers JM, 2011, GASTROENTEROLOGY; Chen G, 2010, PATHOL RES PRACT, V206, P631, DOI 10.1016/j.prp.2010.05.011; Chura JC, 2009, MOL CELL ENDOCRINOL, V301, P51, DOI 10.1016/j.mce.2008.07.015; Copelli SB, 2001, ONCOL REP, V8, P923; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941; Goel A, 2003, CANCER RES, V63, P1608; He QJ, 2003, CANCER GENET CYTOGEN, V144, P112, DOI 10.1016/S0165-4608(02)00959-7; Hitchins MP, 2007, CANCER RES, V67, P9107, DOI 10.1158/0008-5472.CAN-07-0869; Hu Q, 2011, MOL CELL BIOL; Hutter CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-670; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jian BX, 2009, CELL CYCLE, V8, P3770, DOI 10.4161/cc.8.22.10066; Kelly KM, 2007, AM J HEALTH BEHAV, V31, P502, DOI 10.5993/AJHB.31.5.6; Kibreab A, 2009, GASTEREOENTROLOGY, P136; Kratz CP, 2002, BLOOD, V99, P372, DOI 10.1182/blood.V99.1.372; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lu CX, 2011, AM J CANCER RES, V1, P1; Maliekal TT, 2003, ONCOGENE, V22, P4889, DOI 10.1038/sj.onc.1206806; Markowitz S, 2000, J CLIN ONCOL, V18, p75S; MULERIS M, 1995, GENE CHROMOSOME CANC, V14, P223, DOI 10.1002/gcc.2870140312; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Rmali KA, 2005, WORLD J GASTROENTERO, V11, P1283, DOI 10.3748/wjg.v11.i9.1283; Salhab M, 2008, BREAST CANCER RES TR, V109, P35, DOI 10.1007/s10549-007-9622-8; Shin SK, 2007, GASTROENTEROLOGY, V133, P1849, DOI 10.1053/j.gastro.2007.08.074; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tang RP, 2004, CARCINOGENESIS, V25, P841, DOI 10.1093/carcin/bgh074; Thean LF, 2010, GENE CHROMOSOME CANC, V49, P99, DOI 10.1002/gcc.20724; Tominaga E, 2010, GYNECOL ONCOL, V118, P160, DOI 10.1016/j.ygyno.2010.03.010; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Unotoro J, 2006, J INT MED RES, V34, P397, DOI 10.1177/147323000603400409; Wang ZH, 2004, CANCER RES, V64, P2998, DOI 10.1158/0008-5472.CAN-04-0587; Will O, 2007, GASTROENTEROLOGY, V132, P527, DOI 10.1053/j.gastro.2006.11.043; Wilson CH, 2010, ONCOGENE, V29, P4567, DOI 10.1038/onc.2010.202; Wong JCT, 2011, CLIN CANCER RES, V17, P4167, DOI 10.1158/1078-0432.CCR-10-1224; Yu J, 2010, CLIN CANCER RES, V16, P2275, DOI 10.1158/1078-0432.CCR-09-2000; Zhao C, 2003, CANCER, V98, P18, DOI 10.1002/cncr.11482	55	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e40392	10.1371/journal.pone.0040392	http://dx.doi.org/10.1371/journal.pone.0040392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879877	Green Submitted, Green Published, gold			2022-12-27	WOS:000307810000004
J	Leen, WG; Willemsen, MA; Wevers, RA; Verbeek, MM				Leen, Wilhelmina G.; Willemsen, Michel A.; Wevers, Ron A.; Verbeek, Marcel M.			Cerebrospinal Fluid Glucose and Lactate: Age-Specific Reference Values and Implications for Clinical Practice	PLOS ONE			English	Article							PROTEIN-CONCENTRATION; BACTERIAL-MENINGITIS; CHILDREN; GLUT1; DEFICIENCY; DISORDERS; MUTATIONS; INFANTS; RATIO	Cerebrospinal fluid (CSF) analysis is an important tool in the diagnostic work-up of many neurological disorders, but reference ranges for CSF glucose, CSF/plasma glucose ratio and CSF lactate based on studies with large numbers of CSF samples are not available. Our aim was to define age-specific reference values. In 1993 The Nijmegen Observational CSF Study was started. Results of all CSF samples that were analyzed between 1993 and 2008 at our laboratory were systematically collected and stored in our computerized database. After exclusion of CSF samples with an unknown or elevated erythrocyte count, an elevated leucocyte count, elevated concentrations of bilirubin, free hemoglobin, or total protein 9,036 CSF samples were further studied for CSF glucose (n = 8,871), CSF/plasma glucose ratio (n = 4,516) and CSF lactate values (n = 7,614). CSF glucose, CSF/plasma glucose ratio and CSF lactate were age-, but not sex dependent. Age-specific reference ranges were defined as 5-95th percentile ranges. CSF glucose 5th percentile values ranged from 1.8 to 2.9 mmol/L and 95th percentile values from 3.8 to 5.6 mmol/L. CSF/plasma glucose ratio 5th percentile values ranged from 0.41 to 0.53 and 95th percentile values from 0.82 to 1.19. CSF lactate 5th percentile values ranged from 0.88 to 1.41 mmol/L and 95th percentile values from 2.00 to 2.71 mmol/L. Reference ranges for all three parameters were widest in neonates and narrowest in toddlers, with lower and upper limits increasing with age. These reference values allow a reliable interpretation of CSF results in everyday clinical practice. Furthermore, hypoglycemia was associated with an increased CSF/plasma glucose ratio, whereas hyperglycemia did not affect the CSF/plasma glucose ratio.	[Leen, Wilhelmina G.; Verbeek, Marcel M.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, Nijmegen, Netherlands; [Willemsen, Michel A.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Neurol, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Wevers, Ron A.; Verbeek, Marcel M.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Leen, WG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, Nijmegen, Netherlands.	w.leen@neuro.umcn.nl	Wevers, Ron A./H-8116-2014; Verbeek, Marcel M/D-1971-2010; Willemsen, Michel A.A.P./H-8119-2014	Wevers, Ron A./0000-0003-2278-9746; Verbeek, Marcel M/0000-0003-4635-7876; 	Netherlands Organization for Scientific Research (NWO) [92003529]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	W. G. Leen was supported by The Netherlands Organization for Scientific Research (Project number 92003529; NWO; www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 1996, PEDIATR INFECT DIS J, V15, P298, DOI 10.1097/00006454-199604000-00004; Barros LF, 2007, GLIA, V55, P1222, DOI 10.1002/glia.20375; Benoist JF, 2003, CLIN CHEM, V49, P487, DOI 10.1373/49.3.487; Biou D, 2000, CLIN CHEM, V46, P399; BONADIO WA, 1992, PEDIATR INFECT DIS J, V11, P589, DOI 10.1097/00006454-199207000-00015; Bruna J, 2009, CANCER-AM CANCER SOC, V115, P381, DOI 10.1002/cncr.24041; CALABRESE VP, 1991, EPILEPSIA, V32, P816, DOI 10.1111/j.1528-1157.1991.tb05538.x; CAMERON PD, 1993, J INFECTION, V26, P245, DOI 10.1016/0163-4453(93)95253-F; Chow SL, 2005, ARCH DIS CHILD, V90, P1188, DOI 10.1136/adc.2005.075317; Dohnal L, 2010, Prague Med Rep, V111, P42; Fernandez F, 1986, Pediatr Neurol, V2, P39, DOI 10.1016/0887-8994(86)90038-X; Fishman RA., 1992, CEREBROSPINAL FLUID; FISHMAN ROBERT A., 1963, TRANS AMER NEUROL ASSOC, V88, P114; HEMACHANDRA AH, 1999, PEDIAT REV, V20, P16, DOI DOI 10.1542/PIR.20-7-E16; Hoffmann GF, 1998, NEUROPEDIATRICS, V29, P59, DOI 10.1055/s-2007-973538; Holbrook I, 2007, ANN CLIN BIOCHEM, V44, P443, DOI 10.1258/000456307781646085; Hume R, 2005, EARLY HUM DEV, V81, P95, DOI 10.1016/j.earlhumdev.2004.10.005; KENNEDY C, 1957, J CLIN INVEST, V36, P1130, DOI 10.1172/JCI103509; LAMERS KJB, 1987, CLIN CHIM ACTA, V167, P135, DOI 10.1016/0009-8981(87)90366-4; Leen WG, 2010, BRAIN, V133, P655, DOI 10.1093/brain/awp336; Mullen SA, 2010, NEUROLOGY, V75, P432, DOI 10.1212/WNL.0b013e3181eb58b4; POWERS WJ, 1981, AM J MED, V71, P217, DOI 10.1016/0002-9343(81)90108-X; Shah SS, 2011, J HOSP MED, V6, P22, DOI 10.1002/jhm.711; Smith S V, 1994, Clin Lab Sci, V7, P32; Straus SE, 2006, JAMA-J AM MED ASSOC, V296, P2012, DOI 10.1001/jama.296.16.2012; Suls A, 2008, BRAIN, V131, P1831, DOI 10.1093/brain/awn113; Vamosi B, 1983, Arch Psychiatr Nervenkr (1970), V232, P521; Weber YG, 2008, J CLIN INVEST, V118, P2157, DOI 10.1172/JCI34438; Willemsen MAAP, 2001, ANN NEUROL, V49, P685, DOI 10.1002/ana.1044.abs; Wong M, 2000, ARCH PEDIAT ADOL MED, V154, P827, DOI 10.1001/archpedi.154.8.827	30	83	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42745	10.1371/journal.pone.0042745	http://dx.doi.org/10.1371/journal.pone.0042745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880096	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000066
J	Qu, ZP; Adelson, DL				Qu, Zhipeng; Adelson, David L.			Bovine ncRNAs Are Abundant, Primarily Intergenic, Conserved and Associated with Regulatory Genes	PLOS ONE			English	Article							NONCODING RNAS; SEQUENCE; EXPRESSION; REVEALS; GENOME; TRANSCRIPTS; IDENTIFICATION; COMPLEXITY; ENRICHMENT; EVOLUTION	It is apparent that non-coding transcripts are a common feature of higher organisms and encode uncharacterized layers of genetic regulation and information. We used public bovine EST data from many developmental stages and tissues, and developed a pipeline for the genome wide identification and annotation of non-coding RNAs (ncRNAs). We have predicted 23,060 bovine ncRNAs, 99% of which are un-annotated, based on known ncRNA databases. Intergenic transcripts accounted for the majority (57%) of the predicted ncRNAs and the occurrence of ncRNAs and genes were only moderately correlated (r = 0.55, p-value<2.2e-16). Many of these intergenic non-coding RNAs mapped close to the 3' or 5' end of thousands of genes and many of these were transcribed from the opposite strand with respect to the closest gene, particularly regulatory-related genes. Conservation analyses showed that these ncRNAs were evolutionarily conserved, and many intergenic ncRNAs proximate to genes contained sequence-specific motifs. Correlation analysis of expression between these intergenic ncRNAs and protein-coding genes using RNA-seq data from a variety of tissues showed significant correlations with many transcripts. These results support the hypothesis that ncRNAs are common, transcribed in a regulated fashion and have regulatory functions.	[Qu, Zhipeng; Adelson, David L.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide	Qu, ZP (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	david.adelson@adelaide.edu.au	Adelson, David L/E-5506-2011	Adelson, David L/0000-0003-2404-5636; Qu, Zhipeng/0000-0002-6841-0773	University of Adelaide; China Scholarship Council (CSC)	University of Adelaide; China Scholarship Council (CSC)(China Scholarship Council)	This study was funded by the University of Adelaide. ZQ thanks the China Scholarship Council (CSC) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson DL, 2009, P NATL ACAD SCI USA, V106, P12855, DOI 10.1073/pnas.0901282106; Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Askarian-Amiri ME, 2011, RNA, V17, P878, DOI 10.1261/rna.2528811; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carninci P, 2006, TRENDS GENET, V22, P501, DOI 10.1016/j.tig.2006.07.003; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Freyhult EK, 2007, GENOME RES, V17, P117, DOI 10.1101/gr.5890907; Frith MC, 2005, EUR J HUM GENET, V13, P894, DOI 10.1038/sj.ejhg.5201459; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones Sam, 2005, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1205s9; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Gustincich S, 2006, J PHYSIOL-LONDON, V575, P321, DOI 10.1113/jphysiol.2006.115568; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Hancock JM, 2005, TRENDS GENET, V21, P591, DOI 10.1016/j.tig.2005.08.008; Harhay GP, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r102; He SM, 2008, NUCLEIC ACIDS RES, V36, pD170, DOI 10.1093/nar/gkm1011; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Khachane AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010316; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Li JT, 2008, NUCLEIC ACIDS RES, V36, P4833, DOI 10.1093/nar/gkn470; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Mourier T, 2009, BRIEF FUNCT GENOMIC; Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Rearick D, 2011, NUCL ACIDS RES; Reiner R, 2006, GENE DEV, V20, P1621, DOI 10.1101/gad.386706; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Seemann SE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-316; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith CD, 2007, GENE, V389, P1, DOI 10.1016/j.gene.2006.09.011; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xue CH, 2008, CELL RES, V18, P695, DOI 10.1038/cr.2008.59	57	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42638	10.1371/journal.pone.0042638	http://dx.doi.org/10.1371/journal.pone.0042638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880061	gold, Green Published, Green Submitted			2022-12-27	WOS:000307810000054
J	Torrent, M; Nogues, MV; Andreu, D; Boix, E				Torrent, Marc; Victoria Nogues, M.; Andreu, David; Boix, Ester			The "CPC Clip Motif": A Conserved Structural Signature for Heparin-Binding Proteins	PLOS ONE			English	Article							C-CHEMOKINE LYMPHOTACTIN; X-RAY-STRUCTURE; GLYCOSAMINOGLYCAN INTERACTIONS; ALZHEIMERS-DISEASE; SULFATE; DOMAIN; IDENTIFICATION; RECOGNITION; PRECURSOR; GROWTH	Glycosaminoglycans (GAGs) are essential molecules that regulate diverse biological processes including cell adhesion, differentiation, signaling and growth, by interaction with a wide variety of proteins. However, despite the efforts committed to understand the molecular nature of the interactions in protein-GAG complexes, the answer to this question remains elusive. In the present study the interphases of 20 heparin-binding proteins have been analyzed searching for a conserved structural pattern. We have found that a structural motif encompassing one polar and two cationic residues (which has been named the CPC clip motif) is conserved among all the proteins deposited in the PDB. The distances between the alpha carbons and the side chain center of gravity of the residues composing this motif are also conserved. Furthermore, this pattern can be found in other proteins suggested to bind heparin for which no structural information is available. Hence we propose that the CPC clip motif, working like a staple, is a primary contributor to the attachment of heparin and other sulfated GAGs to heparin-binding proteins.	[Torrent, Marc; Victoria Nogues, M.; Boix, Ester] Univ Autonoma Barcelona, Biosci Fac, Dept Biochem & Mol Biol, Cerdanyola Del Valles, Spain; [Torrent, Marc; Andreu, David] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain	Autonomous University of Barcelona; Pompeu Fabra University	Torrent, M (corresponding author), Univ Autonoma Barcelona, Biosci Fac, Dept Biochem & Mol Biol, Cerdanyola Del Valles, Spain.	marc.torrent@uab.cat	Burgas, Marc Torrent/A-5171-2010; Andreu, David/I-4359-2014; Nogues, M. Victoria/H-6100-2015; Boix, Ester/B-9038-2012	Burgas, Marc Torrent/0000-0001-6567-3474; Andreu, David/0000-0002-6317-6666; Nogues, M. Victoria/0000-0002-7104-0961; Boix, Ester/0000-0003-1790-2142	Alianza Cuatro Universidades (Spain); European Union [HEALTH-F3-2008-223414]; Spanish Ministry of Science and Innovation [BIO2008-04487-CO3-02, BFU2009-09371]; Generalitat de Catalunya [SGR2009-494, SGR2009-795]	Alianza Cuatro Universidades (Spain); European Union(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	MT is the recipient of a postdoctoral grant from Alianza Cuatro Universidades (Spain). Work supported by the European Union (HEALTH-F3-2008-223414), the Spanish Ministry of Science and Innovation (BIO2008-04487-CO3-02, BFU2009-09371, FEDER funds) and the Generalitat de Catalunya (SGR2009-494, SGR2009-795). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga T, 2010, J NEUROSCI RES, V88, P2303, DOI 10.1002/jnr.22393; BAE JH, 1994, BIOCHEM J, V301, P121, DOI 10.1042/bj3010121; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Casu B, 2004, CURR PHARM DESIGN, V10, P939, DOI 10.2174/1381612043452794; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hoover DM, 2000, J BIOL CHEM, V275, P23187, DOI 10.1074/jbc.M002584200; IUIS/WHO, 2001, J LEUKOC BIOL, V70, P465; Valle-Delgado JJ, 2010, FASEB J, V24, P4250, DOI 10.1096/fj.09-153551; Kisilevsky R, 2007, AMYLOID, V14, P21, DOI 10.1080/13506120601116419; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; Kovensky J, 2009, CURR MED CHEM, V16, P2338, DOI 10.2174/092986709788453096; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuloglu ES, 2001, BIOCHEMISTRY-US, V40, P12486, DOI 10.1021/bi011106p; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Liu DF, 2002, SEMIN THROMB HEMOST, V28, P67, DOI 10.1055/s-2002-20565; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Madsen D, 2002, J APPL CRYSTALLOGR, V35, P137, DOI 10.1107/S0021889802000602; Mulloy B, 2001, CURR OPIN STRUC BIOL, V11, P623, DOI 10.1016/S0959-440X(00)00257-8; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Peplow PV, 2005, THROMB HAEMOSTASIS, V94, P4, DOI 10.1160/TH04-12-0812; Peterson FC, 2004, J BIOL CHEM, V279, P12598, DOI 10.1074/jbc.M311633200; Raghuraman A, 2006, J MED CHEM, V49, P3553, DOI 10.1021/jm060092o; Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020; Rider CC, 1997, GLYCOCONJUGATE J, V14, P639, DOI 10.1023/A:1018596728605; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Shaw JP, 2004, STRUCTURE, V12, P2081, DOI 10.1016/j.str.2004.08.014; SMALL DH, 1994, J NEUROSCI, V14, P2117; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; Tuinstra RL, 2008, P NATL ACAD SCI USA, V105, P5057, DOI 10.1073/pnas.0709518105; Volkman BF, 2009, METHOD ENZYMOL, V461, P51, DOI 10.1016/S0076-6879(09)05403-2; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Weber C, 2006, TRENDS IMMUNOL, V27, P268, DOI 10.1016/j.it.2006.04.002; Yoshida T, 1998, J BIOL CHEM, V273, P16551, DOI 10.1074/jbc.273.26.16551; Young E, 2008, THROMB RES, V122, P743, DOI 10.1016/j.thromres.2006.10.026	40	31	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42692	10.1371/journal.pone.0042692	http://dx.doi.org/10.1371/journal.pone.0042692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880084	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000062
J	Angenieux, C; Waharte, F; Gidon, A; Signorino-Gelo, F; Wurtz, V; Hojeij, R; Proamer, F; Gachet, C; Van Dorsselaer, A; Hanau, D; Salamero, J; de la Salle, H				Angenieux, Catherine; Waharte, Francois; Gidon, Alexandre; Signorino-Gelo, Francois; Wurtz, Virginie; Hojeij, Rim; Proamer, Fabienne; Gachet, Christian; Van Dorsselaer, Alain; Hanau, Daniel; Salamero, Jean; de la Salle, Henri			Lysosomal-Associated Transmembrane Protein 5 (LAPTM5) Is a Molecular Partner of CD1e	PLOS ONE			English	Article							HEMATOPOIETIC-CELLS; MEMBRANE-PROTEIN; DENDRITIC CELLS; EXPRESSION; PATHWAY; DIFFERENTIATION; ACTIVATION; MELANOMA; COMPLEX	The CD1e protein participates in the presentation of lipid antigens in dendritic cells. Its transmembrane precursor is transported to lysosomes where it is cleaved into an active soluble form. In the presence of bafilomycin, which inhibits vacuolar ATPase and consequently the acidification of endosomal compartments, CD1e associates with a 27 kD protein. In this work, we identified this molecular partner as LAPTM5. The latter protein and CD1e colocalize in trans-Golgi and late endosomal compartments. The quantity of LAPTM5/CD1e complexes increases when the cells are treated with bafilomycin, probably due to the protection of LAPTM5 from lysosomal proteases. Moreover, we could demonstrate that LAPTM5/CD1e association occurs under physiological conditions. Although LAPTM5 was previously shown to act as a platform recruiting ubiquitin ligases and facilitating the transport of receptors to lysosomes, we found no evidence that LATPM5 controls either CD1e ubiquitination or the generation of soluble lysosomal CD1e proteins. Notwithstanding these last observations, the interaction of LAPTM5 with CD1e and their colocalization in antigen processing compartments both suggest that LAPTM5 might influence the role of CD1e in the presentation of lipid antigens.	[Angenieux, Catherine; Signorino-Gelo, Francois; Hojeij, Rim; Proamer, Fabienne; Hanau, Daniel; de la Salle, Henri] Inst Natl Sante & Rech Med, Unite Mixte Rech S725, Strasbourg, France; [Angenieux, Catherine; Signorino-Gelo, Francois; Wurtz, Virginie; Hojeij, Rim; Proamer, Fabienne; Gachet, Christian; Hanau, Daniel; de la Salle, Henri] Etab Francais Sang Alsace, Strasbourg, France; [Angenieux, Catherine; Signorino-Gelo, Francois; Wurtz, Virginie; Hojeij, Rim; Proamer, Fabienne; Gachet, Christian; Van Dorsselaer, Alain; Hanau, Daniel; de la Salle, Henri] Univ Strasbourg, Strasbourg, France; [Waharte, Francois; Salamero, Jean] Inst Curie, CNRS, Cell & Tissue Imaging Facil, Unite Mixte Rech 144,Sect Rech, F-75231 Paris, France; [Wurtz, Virginie; Gachet, Christian] Inst Natl Sante & Rech Med, Unite Mixte Rech S949, Strasbourg, France; [Van Dorsselaer, Alain] Ctr Natl Rech Sci, Unite Mixte Rech 7178, F-67037 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Angenieux, C (corresponding author), Inst Natl Sante & Rech Med, Unite Mixte Rech S725, Strasbourg, France.	henri.delasalle@efs-alsace.fr	De La Salle, Henri/H-9353-2016; Gachet, Christian/H-9156-2016; Gidon, Alexandre/ABC-1477-2020; El-Daher, Francois/AAJ-8976-2021	De La Salle, Henri/0000-0001-5136-0776; salamero, jean/0000-0002-2610-5826; El-Daher, Francois/0000-0002-6676-3970; Gidon, Alexandre/0000-0001-9722-1253	Etablissement Franeais du Sang (EFS)-Alsace; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-05-MIME-006, ANR-MICAD-08-Biot-015-01]; Fondation pour la Recherche Medicale; EU [NMP4-SL-2009-228980]; Research and Technology Ministry grant	Etablissement Franeais du Sang (EFS)-Alsace; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); EU(European Commission); Research and Technology Ministry grant	This work was supported by the Etablissement Franeais du Sang (EFS)-Alsace, the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique and grants from the Agence Nationale de la Recherche (ANR-05-MIME-006; ANR-MICAD-08-Biot-015-01), the Fondation pour la Recherche Medicale (Call Grand Equipement 2008) and the EU funded CAMINEMS project (NMP4-SL-2009-228980). A. G. was a recipient of a Research and Technology Ministry grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra CN, 1996, GENOMICS, V35, P328, DOI 10.1006/geno.1996.0364; Angenieux C, 2005, TRAFFIC, V6, P286, DOI 10.1111/j.1600-0854.2005.00272.x; Angenieux C, 2000, J BIOL CHEM, V275, P37757, DOI 10.1074/jbc.M007082200; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; Facciotti F, 2011, P NATL ACAD SCI USA, V108, P14228, DOI 10.1073/pnas.1108809108; Felio K, 2009, J EXP MED, V206, P2497, DOI 10.1084/jem.20090898; GUARINI L, 1989, CANCER IMMUNOL IMMUN, V30, P262, DOI 10.1007/BF01744892; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Inoue J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007099; Ishihara T, 2011, J BIOL CHEM, V286, P44086, DOI 10.1074/jbc.M111.251694; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; MACKENSEN A, 1993, CANCER RES, V53, P3569; Maitre B, 2008, TRAFFIC, V9, P431, DOI 10.1111/j.1600-0854.2008.00707.x; Maitre B, 2009, BIOCHEM J, V419, P661, DOI 10.1042/BJ20082204; MARTIN LH, 1986, P NATL ACAD SCI USA, V83, P9154, DOI 10.1073/pnas.83.23.9154; Origasa M, 2001, MOL BRAIN RES, V88, P1, DOI 10.1016/S0169-328X(01)00005-5; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x; Sirven A, 2001, MOL THER, V3, P438, DOI 10.1006/mthe.2001.0282; Yudin D, 2009, J CELL SCI, V122, P587, DOI 10.1242/jcs.015289; Zhu YJ, 2001, P NATL ACAD SCI USA, V98, P10380, DOI 10.1073/pnas.181347498	24	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42634	10.1371/journal.pone.0042634	http://dx.doi.org/10.1371/journal.pone.0042634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880058	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100145
J	Keefer, MC; Gilmour, J; Hayes, P; Gill, D; Kopycinski, J; Cheeseman, H; Cashin-Cox, M; Naarding, M; Clark, L; Fernandez, N; Bunce, CA; Hay, CM; Welsh, S; Komaroff, W; Hachaambwa, L; Tarragona-Fiol, T; Sayeed, E; Zachariah, D; Ackland, J; Loughran, K; Barin, B; Cormier, E; Cox, JH; Fast, P; Excler, JL				Keefer, Michael C.; Gilmour, Jill; Hayes, Peter; Gill, Dilbinder; Kopycinski, Jakub; Cheeseman, Hannah; Cashin-Cox, Michelle; Naarding, Marloes; Clark, Lorna; Fernandez, Natalia; Bunce, Catherine A.; Hay, Christine M.; Welsh, Sabrina; Komaroff, Wendy; Hachaambwa, Lottie; Tarragona-Fiol, Tony; Sayeed, Eddy; Zachariah, Devika; Ackland, James; Loughran, Kelley; Barin, Burc; Cormier, Emmanuel; Cox, Josephine H.; Fast, Patricia; Excler, Jean-Louis			A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD8(+) T-CELLS; CELLULAR IMMUNE-RESPONSES; NEUTRALIZING ANTIBODIES; QUALITY-ASSURANCE; RATIONAL DESIGN; RHESUS-MONKEYS; EFFICACY TRIAL; AIDS VACCINE; INFECTION	Background: We conducted a phase I, randomized, double-blind, placebo-controlled trial to assess the safety and immunogenicity of escalating doses of two recombinant replication defective adenovirus serotype 35 (Ad35) vectors containing gag, reverse transcriptase, integrase and nef (Ad35-GRIN) and env (Ad35-ENV), both derived from HIV-1 subtype A isolates. The trial enrolled 56 healthy HIV-uninfected adults. Methods: Ad35-GRIN/ENV (Ad35-GRIN and Ad35-ENV mixed in the same vial in equal proportions) or Ad35-GRIN was administered intramuscularly at 0 and 6 months. Participants were randomized to receive either vaccine or placebo (10/4 per group, respectively) within one of four dosage groups: Ad35-GRIN/ENV 2x10(9) (A), 2x10(10) (B), 2x10(11) (C), or Ad35-GRIN 1610 10 (D) viral particles. Results: No vaccine-related serious adverse event was reported. Reactogenicity events reported were dose-dependent, mostly mild or moderate, some severe in Group C volunteers, all transient and resolving spontaneously. IFN-gamma ELISPOT responses to any vaccine antigen were detected in 50, 56, 70 and 90% after the first vaccination, and in 75, 100, 88 and 86% of Groups A-D vaccine recipients after the second vaccination, respectively. The median spot forming cells (SFC) per 10(6) PBMC to any antigen was 78-139 across Groups A-C and 158-174 in Group D, after each of the vaccinations with a maximum of 2991 SFC. Four to five HIV proteins were commonly recognized across all the groups and over multiple timepoints. CD4+ and CD8+ T-cell responses were polyfunctional. Env antibodies were detected in all Group A-C vaccinees and Gag antibodies in most vaccinees after the second immunization. Ad35 neutralizing titers remained low after the second vaccination. Conclusion/Significance: Ad35-GRIN/ENV reactogenicity was dose-related. HIV-specific cellular and humoral responses were seen in the majority of volunteers immunized with Ad35-GRIN/ENV or Ad35-GRIN and increased after the second vaccination. T-cell responses were broad and polyfunctional.	[Keefer, Michael C.; Bunce, Catherine A.; Hay, Christine M.; Hachaambwa, Lottie] Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA; [Gilmour, Jill; Hayes, Peter; Gill, Dilbinder; Kopycinski, Jakub; Cheeseman, Hannah; Cashin-Cox, Michelle; Naarding, Marloes; Clark, Lorna; Fernandez, Natalia; Tarragona-Fiol, Tony; Cormier, Emmanuel; Cox, Josephine H.] Univ London Imperial Coll Sci Technol & Med, IAVI Human Immunol Lab, London, England; [Welsh, Sabrina; Komaroff, Wendy; Sayeed, Eddy; Zachariah, Devika; Fast, Patricia; Excler, Jean-Louis] IAVI, New York, NY USA; [Ackland, James] Global BioSolut, Melbourne, Vic, Australia; [Loughran, Kelley; Barin, Burc] EMMES Corp, Rockville, MD USA	University of Rochester; Imperial College London; International AIDS Vaccine Initiative; International AIDS Vaccine Initiative; Emmes Corporation	Keefer, MC (corresponding author), Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA.	Michael_Keefer@URMC.Rochester.edu		Cheeseman, Hannah/0000-0001-9044-1341; Cashin-Cox, Michelle/0000-0002-7501-9203; Cox, Josephine/0000-0003-1301-7373	International AIDS Vaccine Initiative; United States Agency for International Development (USAID) [GPO-A-00-06-00006-00]	International AIDS Vaccine Initiative; United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study was funded by the International AIDS Vaccine Initiative and its donors, including the generous support of the American people through the United States Agency for International Development (USAID; USAID Cooperative Agreement Number GPO-A-00-06-00006-00). The contents of this manuscript are the responsibility of IAVI and do not necessarily reflect the views of USAID or the US government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Boaz MJ, 2009, CLIN VACCINE IMMUNOL, V16, P147, DOI 10.1128/CVI.00326-08; Bockl K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034723; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Cox JH, 2005, AIDS RES HUM RETROV, V21, P68, DOI 10.1089/aid.2005.21.68; D'Souza MP, 2010, AIDS, V24, P803, DOI 10.1097/QAD.0b013e3283379712; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Engram JC, 2009, J IMMUNOL, V183, P706, DOI 10.4049/jimmunol.0803746; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Fioretti D, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/174378; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; Girard MP, 2011, VACCINE, V29, P6191, DOI [10.1016/j.vaccine.2011.08.031, 10.1016/j.vaccine.2011.06.085]; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Gupta SB, 2007, J INFECT DIS, V195, P546, DOI 10.1086/510909; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Haynes BF, 2008, J ALLERGY CLIN IMMUN, V122, P3, DOI 10.1016/j.jaci.2008.03.036; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hel Z, 2006, J IMMUNOL, V176, P85, DOI 10.4049/jimmunol.176.1.85; Hutnick NA, 2011, CURR OPIN VIROL, V1, P233, DOI 10.1016/j.coviro.2011.08.003; Jaimes MC, 2011, J IMMUNOL METHODS, V363, P143, DOI 10.1016/j.jim.2010.08.004; Jaoko W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012873; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Koff WC, 2010, NATURE, V464, P161, DOI 10.1038/464161a; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Li FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020479; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Nabel GJ, 2011, PHILOS T R SOC B, V366, P2759, DOI 10.1098/rstb.2011.0096; Ni SH, 2005, HUM GENE THER, V16, P664, DOI 10.1089/hum.2005.16.664; Perfetto SP, 2006, NAT PROTOC, V1, P1522, DOI 10.1038/nprot.2006.250; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reyes-Sandoval A, 2012, MOL THER, V20, P1633, DOI 10.1038/mt.2012.25; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Sarzotti-Kelsoe M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000067; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Stiles T, 2010, GOOD CLIN LAB PRACTI, P1; Toapanta FR, 2007, CURR HIV RES, V5, P199, DOI 10.2174/157016207780077057; UNAIDS, 2011, GLOB HIV AIDS RESP E; Vaccari M, 2008, J VIROL, V82, P9629, DOI 10.1128/JVI.00893-08; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008617; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	64	61	65	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41936	10.1371/journal.pone.0041936	http://dx.doi.org/10.1371/journal.pone.0041936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870265	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100038
J	Miura, K; Namba, N; Fujiwara, M; Ohata, Y; Ishida, H; Kitaoka, T; Kubota, T; Hirai, H; Higuchi, C; Tsumaki, N; Yoshikawa, H; Sakai, N; Michigami, T; Ozono, K				Miura, Kohji; Namba, Noriyuki; Fujiwara, Makoto; Ohata, Yasuhisa; Ishida, Hidekazu; Kitaoka, Taichi; Kubota, Takuo; Hirai, Haruhiko; Higuchi, Chikahisa; Tsumaki, Noriyuki; Yoshikawa, Hideki; Sakai, Norio; Michigami, Toshimi; Ozono, Keiichi			An Overgrowth Disorder Associated with Excessive Production of cGMP Due to a Gain-of-Function Mutation of the Natriuretic Peptide Receptor 2 Gene	PLOS ONE			English	Article							CYCLASE-B RECEPTOR; ENDOCHONDRAL OSSIFICATION; OVEREXPRESSION; MOUSE; TRANSLOCATION; CARTILAGE; DWARFISM; PATHWAY; ROLES; NPPC	We describe a three-generation family with tall stature, scoliosis and macrodactyly of the great toes and a heterozygous p.Val883Met mutation in Npr2, the gene that encodes the CNP receptor NPR2 (natriuretic peptide receptor 2). When expressed in HEK293A cells, the mutant Npr2 cDNA generated intracellular cGMP (cyclic guanosine monophosphate) in the absence of CNP ligand. In the presence of CNP, cGMP production was greater in cells that had been transfected with the mutant Npr2 cDNA compared to wild-type cDNA. Transgenic mice in which the mutant Npr2 was expressed in chondrocytes driven by the promoter and intronic enhancer of the Col11a2 gene exhibited an enhanced production of cGMP in cartilage, leading to a similar phenotype to that observed in the patients. In addition, blood cGMP concentrations were elevated in the patients. These results indicate that p.Val883Met is a constitutive active gain-of-function mutation and elevated levels of cGMP in growth plates lead to the elongation of long bones. Our findings reveal a critical role for NPR2 in skeletal growth in both humans and mice, and may provide a potential target for prevention and treatment of diseases caused by impaired production of cGMP.	[Miura, Kohji; Namba, Noriyuki; Fujiwara, Makoto; Ohata, Yasuhisa; Ishida, Hidekazu; Kitaoka, Taichi; Kubota, Takuo; Hirai, Haruhiko; Sakai, Norio; Ozono, Keiichi] Osaka Univ, Dept Pediat, Grad Sch Med, Suita, Osaka, Japan; [Higuchi, Chikahisa; Yoshikawa, Hideki] Osaka Univ, Dept Orthoped, Grad Sch Med, Suita, Osaka, Japan; [Tsumaki, Noriyuki] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Michigami, Toshimi] Osaka Med Ctr, Dept Bone & Mineral Res, Izumi, Osaka, Japan; [Michigami, Toshimi] Res Inst Maternal & Child Hlth, Izumi, Osaka, Japan	Osaka University; Osaka University; Kyoto University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Miura, K (corresponding author), Osaka Univ, Dept Pediat, Grad Sch Med, Suita, Osaka, Japan.	keioz@ped.med.osaka-u.ac.jp	Michigami, Toshimi/AAU-2326-2021; Ohata, Yasuhisa/AAJ-4615-2020	Ohata, Yasuhisa/0000-0001-6084-6620; Tsumaki, Noriyuki/0000-0002-0520-3654	Ministry of Health, Labour and Welfare of Japan [KH20Q007a-1]; Grants-in-Aid for Scientific Research [23591227] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid from the Ministry of Health, Labour and Welfare of Japan [KH20Q007a-1]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; Bocciardi R, 2007, HUM MUTAT, V28, P724, DOI 10.1002/humu.20511; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Hachiya R, 2007, J CLIN ENDOCR METAB, V92, P4009, DOI 10.1210/jc.2007-1101; Lucas KA, 2000, PHARMACOL REV, V52, P375; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; Mittendorf J, 2009, CHEMMEDCHEM, V4, P853, DOI 10.1002/cmdc.200900014; Moncla A, 2007, HUM MUTAT, V28, P1183, DOI 10.1002/humu.20611; Pejchalova K, 2007, MOL GENET METAB, V92, P210, DOI 10.1016/j.ymgme.2007.06.014; Philippe P, 1989, ANAL CHEM, V61, P447; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Potter LR, 2001, J BIOL CHEM, V276, P6057, DOI 10.1074/jbc.R000033200; Schulz S, 2005, PEPTIDES, V26, P1024, DOI 10.1016/j.peptides.2004.08.027; Tamura N, 2004, P NATL ACAD SCI USA, V101, P17300, DOI 10.1073/pnas.0407894101; Teixeira CC, 2008, DEV BIOL, V319, P171, DOI 10.1016/j.ydbio.2008.04.031; Tesmer John J. G., 2008, Journal of Biology (London), V7, DOI 10.1186/jbiol96; Toydemir RM, 2006, AM J HUM GENET, V79, P935, DOI 10.1086/508433; Tsuji T, 2005, J BIOL CHEM, V280, P14288, DOI 10.1074/jbc.C500024200; Tsumaki N, 1996, J CELL BIOL, V134, P1573, DOI 10.1083/jcb.134.6.1573; Wedel BJ, 2001, ANNU REV PHYSIOL, V63, P215, DOI 10.1146/annurev.physiol.63.1.215; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Yasoda A, 1998, J BIOL CHEM, V273, P11695, DOI 10.1074/jbc.273.19.11695; Zhang MJ, 2010, SCIENCE, V330, P366, DOI 10.1126/science.1193573	23	80	82	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42180	10.1371/journal.pone.0042180	http://dx.doi.org/10.1371/journal.pone.0042180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870295	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100049
J	Ozden, I; Dombeck, DA; Hoogland, TM; Tank, DW; Wang, SSH				Ozden, Ilker; Dombeck, Daniel A.; Hoogland, Tycho M.; Tank, David W.; Wang, Samuel S-H.			Widespread State-Dependent Shifts in Cerebellar Activity in Locomoting Mice	PLOS ONE			English	Article							SINGLE OLIVOCEREBELLAR AXONS; HIPPOCAMPAL PLACE CELLS; COMPLEX SPIKE ACTIVITY; CLIMBING FIBER INPUT; NEURAL ACTIVITY; GRANULE CELLS; CELLULAR RESOLUTION; ANTERIOR LOBE; IN-VIVO; FUNCTIONAL-ORGANIZATION	Excitatory drive enters the cerebellum via mossy fibers, which activate granule cells, and climbing fibers, which activate Purkinje cell dendrites. Until now, the coordinated regulation of these pathways has gone unmonitored in spatially resolved neuronal ensembles, especially in awake animals. We imaged cerebellar activity using functional two-photon microscopy and extracellular recording in awake mice locomoting on an air-cushioned spherical treadmill. We recorded from putative granule cells, molecular layer interneurons, and Purkinje cell dendrites in zone A of lobule IV/V, representing sensation and movement from trunk and limbs. Locomotion was associated with widespread increased activity in granule cells and interneurons, consistent with an increase in mossy fiber drive. At the same time, dendrites of different Purkinje cells showed increased co-activation, reflecting increased synchrony of climbing fiber activity. In resting animals, aversive stimuli triggered increased activity in granule cells and interneurons, as well as increased Purkinje cell co-activation that was strongest for neighboring dendrites and decreased smoothly as a function of mediolateral distance. In contrast with anesthetized recordings, no 1-10 Hz oscillations in climbing fiber activity were evident. Once locomotion began, responses to external stimuli in all three cell types were strongly suppressed. Thus climbing and mossy fiber representations can shift together within a fraction of a second, reflecting in turn either movement-associated activity or external stimuli.	[Ozden, Ilker; Dombeck, Daniel A.; Hoogland, Tycho M.; Tank, David W.; Wang, Samuel S-H.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Ozden, Ilker; Dombeck, Daniel A.; Hoogland, Tycho M.; Tank, David W.; Wang, Samuel S-H.] Princeton Univ, Inst Neurosci, Princeton, NJ 08544 USA; [Dombeck, Daniel A.; Tank, David W.] Princeton Univ, Lewis Sigler Ctr Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Ozden, I (corresponding author), Brown Univ, Sch Engn, Providence, RI 02912 USA.	sswang@princeton.edu	Ozden, Ilker/AAJ-3856-2020	Dombeck, Daniel/0000-0003-2576-5918; Hoogland, T.M./0000-0002-7444-9279	National Institute of Health [NS045193, NS068148]; Autism Speaks postdoctoral award; Robert Leet and Clara Guthrie Patterson Trust; W.M. Keck Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068148, R01NS045193] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks postdoctoral award; Robert Leet and Clara Guthrie Patterson Trust; W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by (1) National Institute of Health grants NS045193 (SW) and NS068148 (DT, SW) http://www.nih.gov (2) Autism Speaks postdoctoral award (IO) http://autismspeaks.org (3) Robert Leet and Clara Guthrie Patterson Trust (DD) https://www.bankofamerica.com/philanthropic/foundation.action?fnId = 106 (4) W.M. Keck Foundation Distinguished Young Investigator (SW). http://wmkeck.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ALLEN GI, 1974, PHYSIOL REV, V54, P957, DOI 10.1152/physrev.1974.54.4.957; Apps R, 1999, PROG NEUROBIOL, V57, P537, DOI 10.1016/S0301-0082(98)00068-9; Apps R, 2000, PROG BRAIN RES, V124, P201; APPS R, 1995, J PHYSIOL-LONDON, V483, P687, DOI 10.1113/jphysiol.1995.sp020614; Arenz A, 2008, SCIENCE, V321, P977, DOI 10.1126/science.1158391; ARMSTRONG DL, 1987, BRAIN RES BULL, V19, P699, DOI 10.1016/0361-9230(87)90057-8; BELL CC, 1972, J NEUROPHYSIOL, V35, P155, DOI 10.1152/jn.1972.35.2.155; Bell CC, 2008, ANNU REV NEUROSCI, V31, P1, DOI 10.1146/annurev.neuro.30.051606.094225; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Bloedel JR, 1998, ANAT REC, V253, P118; BLOEDEL JR, 1984, J PHYSIOL-LONDON, V352, P129, DOI 10.1113/jphysiol.1984.sp015282; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; Brown IE, 2001, J COMP NEUROL, V429, P59, DOI 10.1002/1096-9861(20000101)429:1<59::AID-CNE5>3.0.CO;2-3; BUISSERETDELMAS C, 1993, PROG NEUROBIOL, V40, P63, DOI 10.1016/0301-0082(93)90048-W; CADDY KWT, 1979, PHILOS T ROY SOC B, V287, P167, DOI 10.1098/rstb.1979.0055; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; CHAPMAN CE, 1994, CAN J PHYSIOL PHARM, V72, P558, DOI 10.1139/y94-080; Collman FC, 2010, THESIS PRINCETON U, Vvii; Courtemanche R, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.006.2009; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; Devor A, 2002, J NEUROPHYSIOL, V87, P3048, DOI 10.1152/jn.2002.87.6.3048; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; ECCLES JC, 1968, EXP BRAIN RES, V6, P171, DOI 10.1007/BF00235123; ECCLES JC, 1971, EXP BRAIN RES, V13, P15, DOI 10.1007/BF00236428; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Gall D, 2005, J NEUROSCI, V25, P4813, DOI 10.1523/JNEUROSCI.0410-05.2005; GELLMAN R, 1985, J NEUROPHYSIOL, V54, P40, DOI 10.1152/jn.1985.54.1.40; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Hartmann MJ, 2001, J NEUROSCI, V21, P3549, DOI 10.1523/JNEUROSCI.21-10-03549.2001; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Hoebeek FE, 2010, P NATL ACAD SCI USA, V107, P8410, DOI 10.1073/pnas.0907118107; Horn KM, 1996, J NEUROPHYSIOL, V76, P4140, DOI 10.1152/jn.1996.76.6.4140; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; JACOBS BL, 1993, TRENDS NEUROSCI, V16, P346, DOI 10.1016/0166-2236(93)90090-9; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jorntell H, 2000, J PHYSIOL-LONDON, V522, P297, DOI 10.1111/j.1469-7793.2000.00297.x; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; KEATING JG, 1995, J NEUROPHYSIOL, V73, P1329, DOI 10.1152/jn.1995.73.4.1329; Lang EJ, 1999, J NEUROSCI, V19, P2728; LIDIERTH M, 1990, J PHYSIOL-LONDON, V430, P453, DOI 10.1113/jphysiol.1990.sp018301; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P241, DOI 10.1113/jphysiol.1988.sp017288; LLINAS R, 1989, EUR J NEUROSCI, V1, P587, DOI 10.1111/j.1460-9568.1989.tb00365.x; Llinas RR, 2009, NEUROSCIENCE, V162, P797, DOI 10.1016/j.neuroscience.2009.04.045; Long MA, 2002, J NEUROSCI, V22, P10898; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Miri A, 2011, J NEUROPHYSIOL, V105, P964, DOI 10.1152/jn.00702.2010; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Ozden I, 2008, J NEUROPHYSIOL, V100, P495, DOI 10.1152/jn.01310.2007; Ozden I, 2009, J NEUROSCI, V29, P10463, DOI 10.1523/JNEUROSCI.0967-09.2009; Palay SL, 1974, CEREBELLAR CORTEX CY, Vxii; Pardoe J, 2004, J NEUROSCI, V24, P2656, DOI 10.1523/JNEUROSCI.1659-03.2004; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; Pijpers A, 2006, J NEUROSCI, V26, P12067, DOI 10.1523/JNEUROSCI.2905-06.2006; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; PROCHAZKA A, 1989, PROG NEUROBIOL, V33, P281, DOI 10.1016/0301-0082(89)90004-X; PROVINI L, 1968, EXP BRAIN RES, V6, P216; Pugh JR, 2008, J NEUROSCI, V28, P10549, DOI 10.1523/JNEUROSCI.2061-08.2008; Ranade SP, 2009, J NEUROPHYSIOL, V102, P3026, DOI 10.1152/jn.00507.2009; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; Sawtell NB, 2010, NEURON, V66, P573, DOI 10.1016/j.neuron.2010.04.018; Schultz SR, 2009, J NEUROSCI, V29, P8005, DOI 10.1523/JNEUROSCI.4919-08.2009; SHAMBES GM, 1978, BRAIN BEHAV EVOLUT, V15, P94, DOI 10.1159/000123774; Sugihara I, 2001, J NEUROSCI, V21, P7715, DOI 10.1523/JNEUROSCI.21-19-07715.2001; Sugihara I, 1999, J COMP NEUROL, V414, P131; Sullivan MR, 2005, J NEUROPHYSIOL, V94, P1636, DOI 10.1152/jn.01013.2004; Szapiro G, 2007, NAT NEUROSCI, V10, P735, DOI 10.1038/nn1907; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Wise AK, 2010, J PHYSIOL-LONDON, V588, P2373, DOI 10.1113/jphysiol.2010.189704; WYLIE DR, 1995, J NEUROSCI, V15, P2875	78	72	72	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42650	10.1371/journal.pone.0042650	http://dx.doi.org/10.1371/journal.pone.0042650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880068	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100151
J	Terazono, H; Kim, H; Hayashi, M; Hattori, A; Nomura, F; Kaneko, T; Yasuda, K				Terazono, Hideyuki; Kim, Hyonchol; Hayashi, Masahito; Hattori, Akihiro; Nomura, Fumimasa; Kaneko, Tomoyuki; Yasuda, Kenji			A Non-Destructive Culturing and Cell Sorting Method for Cardiomyocytes and Neurons Using a Double Alginate Layer	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MICROENCAPSULATION; SCAFFOLDS; DELIVERY; BEHAVIOR; SAFETY; REPAIR; MOUSE; LINES	A non-destructive method of collecting cultured cells after identifying their in situ functional characteristics is proposed. In this method, cells are cultivated on an alginate layer in a culture dish and released by spot application of a calcium chelate buffer that locally melts the alginate layer and enables the collection of cultured cells at the single-cell level. Primary hippocampal neurons, beating human embryonic stem (hES) cell-derived cardiomyocytes, and beating hES cell-derived cardiomyocyte clusters cultivated on an alginate layer were successfully released and collected with a micropipette. The collected cells were recultured while maintaining their physiological function, including beating, and elongated neurites. These results suggest that the proposed method may eventually facilitate the transplantation of ES- or iPS-derived cardiomyocytes and neurons differentiated in culture.	[Terazono, Hideyuki; Kim, Hyonchol; Hayashi, Masahito; Yasuda, Kenji] Kanagawa Acad Sci & Technol, On Chip Cell Project, Kawasaki, Kanagawa, Japan; [Hattori, Akihiro; Nomura, Fumimasa; Kaneko, Tomoyuki; Yasuda, Kenji] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Biomed Informat, Div Biosyst, Tokyo, Japan	Kanagawa Academy Science & Technology; Tokyo Medical & Dental University (TMDU)	Terazono, H (corresponding author), Kanagawa Acad Sci & Technol, On Chip Cell Project, Kawasaki, Kanagawa, Japan.	yasuda.bmi@tmd.ac.jp	Kim, Hyonchol/R-9922-2017; Yasuda, Kenji/L-6520-2016	Kim, Hyonchol/0000-0002-1786-648X; Terazono, Hideyuki/0000-0002-2657-4454; Yasuda, Kenji/0000-0002-1433-4509	Kanagawa Academy of Science and Technology	Kanagawa Academy of Science and Technology	This research was supported by Kanagawa Academy of Science and Technology's own research budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Comisar WA, 2007, BIOMATERIALS, V28, P4409, DOI 10.1016/j.biomaterials.2007.06.018; Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006; Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8; Fujie T, 2009, ADV FUNCT MATER, V19, P2560, DOI 10.1002/adfm.200900103; Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2; GOOSEN MFA, 1985, BIOTECHNOL BIOENG, V27, P146, DOI 10.1002/bit.260270207; Heise M, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-47; Ide T, 2006, BIOMATERIALS, V27, P607, DOI 10.1016/j.biomaterials.2005.06.005; Kaneko T, 2007, ANALYST, V132, P892, DOI 10.1039/b704961g; Liang HM, 2010, CELL PHYSIOL BIOCHEM, V25, P459, DOI 10.1159/000303051; Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakamura M, 2008, J IMAGING SCI TECHN, V52, DOI 10.2352/J.ImagingSci.Technol.(2008)52:6(060201); Pouton CW, 2005, ADV DRUG DELIVER REV, V57, P1918, DOI 10.1016/j.addr.2005.08.003; Raikwar SP, 2011, TRANSPLANTATION, V91, P11, DOI 10.1097/TP.0b013e3181fdd98b; Sams AV, 2009, DRUG METAB REV, V41, P123; Selden C, 1999, ANN NY ACAD SCI, V875, P353, DOI 10.1111/j.1749-6632.1999.tb08517.x; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Tostoes RM, 2011, BIOTECHNOL BIOENG, V108, P41, DOI 10.1002/bit.22920; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Yan YN, 2005, J BIOACT COMPAT POL, V20, P259, DOI 10.1177/0883911505053658; Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052; Yang J, 2006, J DRUG TARGET, V14, P471, DOI 10.1080/10611860600847997; Yohn DC, 2008, J NEUROSCI, V28, P12409, DOI 10.1523/JNEUROSCI.1761-08.2008; Yokoo N, 2009, BIOCHEM BIOPH RES CO, V387, P482, DOI 10.1016/j.bbrc.2009.07.052; Yoshida Y, 2011, J MOL CELL CARDIOL, V50, P327, DOI 10.1016/j.yjmcc.2010.10.026	27	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42485	10.1371/journal.pone.0042485	http://dx.doi.org/10.1371/journal.pone.0042485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870332	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100106
J	Yoshida, T; Ishikawa, M; Niitsu, T; Nakazato, M; Watanabe, H; Shiraishi, T; Shiina, A; Hashimoto, T; Kanahara, N; Hasegawa, T; Enohara, M; Kimura, A; Iyo, M; Hashimoto, K				Yoshida, Taisuke; Ishikawa, Masatomo; Niitsu, Tomihisa; Nakazato, Michiko; Watanabe, Hiroyuki; Shiraishi, Tetsuya; Shiina, Akihiro; Hashimoto, Tasuku; Kanahara, Nobuhisa; Hasegawa, Tadashi; Enohara, Masayo; Kimura, Atsushi; Iyo, Masaomi; Hashimoto, Kenji			Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder	PLOS ONE			English	Article							MOOD DISORDERS; SCHIZOPHRENIA; COGNITION; METALLOPROTEINASES; RELIABILITY; IMPAIRMENT; BATTERY; ANXIETY; SCALE	Background: Meta-analyses have identified serum levels of brain-derived neurotrophic factor (BDNF) as a potential biomarker for major depressive disorder (MDD). However, at the time, commercially available human ELISA kits are unable to distinguish between proBDNF (precursor of BDNF) and mature BDNF because of limited BDNF antibody specificity. In this study, we examined whether serum levels of proBDNF, mature BDNF, and matrix metalloproteinase-9 (MMP-9), which converts proBDNF to mature BDNF, are altered in patients with MDD. Methodology/Principal Findings: Sixty-nine patients with MDD and 78 age-and gender-matched healthy subjects were enrolled. Patients were evaluated using 17 items on the Structured Interview Guide for the Hamilton Depression Rating Scale. Cognitive impairment was evaluated using the CogState battery. Serum levels of proBDNF, mature BDNF, and MMP-9 were measured using ELISA kits. Serum levels of mature BDNF in patients with MDD were significantly lower than those of normal controls. In contrast, there was no difference in the serum levels of proBDNF and MMP-9 between patients and normal controls. While neither proBDNF nor mature BDNF serum levels was associated with clinical variables, there were significant correlations between MMP-9 serum levels and the severity of depression, quality of life scores, and social function scores in patients. Conclusions/Significance: These findings suggest that mature BDNF may serve as a biomarker for MDD, and that MMP-9 may play a role in the pathophysiology of MDD. Further studies using larger sample sizes will be needed to investigate these results.	[Yoshida, Taisuke; Ishikawa, Masatomo; Iyo, Masaomi; Hashimoto, Kenji] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan; [Yoshida, Taisuke; Ishikawa, Masatomo; Watanabe, Hiroyuki; Shiraishi, Tetsuya; Shiina, Akihiro; Hashimoto, Tasuku; Kanahara, Nobuhisa; Hasegawa, Tadashi; Enohara, Masayo; Kimura, Atsushi; Iyo, Masaomi] Chiba Univ, Dept Psychiat, Grad Sch Med, Chiba, Japan; [Niitsu, Tomihisa; Nakazato, Michiko] Chiba Univ, Res Ctr Child Mental Dev, Grad Sch Med, Chiba, Japan	Chiba University; Chiba University; Chiba University	Yoshida, T (corresponding author), Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	Comprehensive Research on Disability, Health and Welfare Research Grant, Japan; Health and Labor Sciences Research Grant, Japan; Japan Foundation for Neuroscience and Mental Health, Japan	Comprehensive Research on Disability, Health and Welfare Research Grant, Japan; Health and Labor Sciences Research Grant, Japan; Japan Foundation for Neuroscience and Mental Health, Japan	This study was supported by a grant (to KH) from Comprehensive Research on Disability, Health and Welfare, Health and Labor Sciences Research Grants, Japan, and a grant (to TY) from Japan Foundation for Neuroscience and Mental Health, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altar CA, 1999, TRENDS PHARMACOL SCI, V20, P59, DOI 10.1016/S0165-6147(99)01309-7; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Bosc M, 2000, COMPR PSYCHIAT, V41, P63, DOI 10.1016/S0010-440X(00)90133-0; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Hashimoto K, 2007, BIOESSAYS, V29, P116, DOI 10.1002/bies.20534; Hashimoto Kenji, 2012, Clin Psychopharmacol Neurosci, V10, P59, DOI 10.9758/cpn.2012.10.1.59; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Hasselbalch BJ, 2011, J AFFECT DISORDERS, V134, P20, DOI 10.1016/j.jad.2010.11.011; Hindmarch I, 2010, HUM PSYCHOPHARM CLIN, V25, P193, DOI 10.1002/hup.1106; Hwang JJ, 2005, J BIOL CHEM, V280, P11995, DOI 10.1074/jbc.M403172200; Johannsen A, 2007, J PERIODONTAL RES, V42, P546, DOI 10.1111/j.1600-0765.2007.00980.x; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Marazziti D, 2010, EUR J PHARMACOL, V626, P83, DOI 10.1016/j.ejphar.2009.08.046; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Mizoguchi H, 2011, J NEUROSCI, V31, P12963, DOI 10.1523/JNEUROSCI.3118-11.2011; Molendijk ML, 2011, MOL PSYCHIATR, V16, P1088, DOI 10.1038/mp.2010.98; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Pietrzak RH, 2009, J CLIN EXP NEUROPSYC, V31, P848, DOI 10.1080/13803390802592458; Porter RJ, 2003, BRIT J PSYCHIAT, V182, P214, DOI 10.1192/bjp.182.3.214; RYBAKOWSKI JK, 2009, CARDIOVASC PSYCHIAT; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Ueda N, 2011, PSYCHIAT CLIN NEUROS, V65, P624, DOI 10.1111/j.1440-1819.2011.02274.x; Yoshida T., 2012, OPEN CLIN CHEM J, V5, P7, DOI [10.2174/1874241601205010007, DOI 10.2174/1874241601205010007]; Yoshida T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020469	33	187	191	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42676	10.1371/journal.pone.0042676	http://dx.doi.org/10.1371/journal.pone.0042676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880079	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100155
J	Lu, TP; Lee, CY; Tsai, MH; Chiu, YC; Hsiao, CK; Lai, LC; Chuang, EY				Lu, Tzu-Pin; Lee, Chien-Yueh; Tsai, Mong-Hsun; Chiu, Yu-Chiao; Hsiao, Chuhsing Kate; Lai, Liang-Chuan; Chuang, Eric Y.			miRSystem: An Integrated System for Characterizing Enriched Functions and Pathways of MicroRNA Targets	PLOS ONE			English	Article							MULTIPLE-MYELOMA; GENE-EXPRESSION; CANCER-CELLS; IDENTIFICATION; REGULATORS; THROMBOSIS; CARCINOMA; APOPTOSIS; MIRNAS	Background: Many prediction tools for microRNA (miRNA) targets have been developed, but inconsistent predictions were observed across multiple algorithms, which can make further analysis difficult. Moreover, the nomenclature of human miRNAs changes rapidly. To address these issues, we developed a web-based system, miRSystem, for converting queried miRNAs to the latest annotation and predicting the function of miRNA by integrating miRNA target gene prediction and function/pathway analyses. Results: First, queried miRNA IDs were converted to the latest annotated version to prevent potential conflicts resulting from multiple aliases. Next, by combining seven algorithms and two validated databases, potential gene targets of miRNAs and their functions were predicted based on the consistency across independent algorithms and observed/expected ratios. Lastly, five pathway databases were included to characterize the enriched pathways of target genes through bootstrap approaches. Based on the enriched pathways of target genes, the functions of queried miRNAs could be predicted. Conclusions: MiRSystem is a user-friendly tool for predicting the target genes and their associated pathways for many miRNAs simultaneously. The web server and the documentation are freely available at http://mirsystem.cgm.ntu.edu.tw/.	[Lu, Tzu-Pin; Chuang, Eric Y.] Natl Taiwan Univ, YongLin Biomed Engn Ctr, Taipei 10764, Taiwan; [Lu, Tzu-Pin; Tsai, Mong-Hsun; Hsiao, Chuhsing Kate; Lai, Liang-Chuan; Chuang, Eric Y.] Natl Taiwan Univ, Ctr Genom Med, Bioinformat & Biostat Core, Taipei 10764, Taiwan; [Lee, Chien-Yueh; Chiu, Yu-Chiao; Chuang, Eric Y.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Lee, Chien-Yueh; Chiu, Yu-Chiao; Chuang, Eric Y.] Natl Taiwan Univ, Dept Elect Engn, Taipei 10764, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Hsiao, Chuhsing Kate] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan; [Lai, Liang-Chuan] Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Lu, TP (corresponding author), Natl Taiwan Univ, YongLin Biomed Engn Ctr, Taipei 10764, Taiwan.	llai@ntu.edu.tw; chuangey@ntu.edu.tw	Lai, Liang-Chuan/B-4768-2009; Lu, Tzupin/ABC-2195-2021	Lai, Liang-Chuan/0000-0002-3913-5338; Lu, Tzupin/0000-0003-3697-0386; Lee, Chien-Yueh/0000-0002-4304-974X; TSAI, MONG-HSUN/0000-0001-8777-5818; hsiao, chuhsing kate/0000-0003-4905-8484; Chiu, Yu-Chiao/0000-0003-1647-8634	National Science Council, Taiwan [NSC100-2314-B-002-054-]; National Taiwan University, Taiwan [99R81811]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University, Taiwan(National Taiwan University)	This research was supported in part by NSC100-2314-B-002-054- from National Science Council, Taiwan and 99R81811 by National Taiwan University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang-Berthelsen CH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-97; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bommert K, 2006, EUR J CANCER, V42, P1574, DOI 10.1016/j.ejca.2005.12.026; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Ciucci A, 2006, MOL PHARMACOL, V70, P1812, DOI 10.1124/mol.106.025759; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Enright AJ, 2004, GENOME BIOL, V5; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gutierrez NC, 2010, LEUKEMIA, V24, P629, DOI 10.1038/leu.2009.274; Harris A, 2010, AM J TRANSPLANT, V10, P713, DOI 10.1111/j.1600-6143.2010.03032.x; Harrison Claire N, 2005, Hematology Am Soc Hematol Educ Program, P409; Havelange V, 2010, AM J HEMATOL, V85, P935, DOI 10.1002/ajh.21863; Hsu DF, 2010, LECT NOTES ARTIF INT, V6334, P42, DOI 10.1007/978-3-642-15314-3_5; Hsu DF, 2006, COMBINATORIAL FUSION, P32; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jundt F, 2004, BLOOD, V103, P3511, DOI 10.1182/blood-2003-07-2254; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kristinsson SY, 2010, HEMATOL-AM SOC HEMAT, P437, DOI 10.1182/asheducation-2010.1.437; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; Ma SM, 2010, INT J RADIAT BIOL, V86, P517, DOI 10.3109/09553001003734592; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McCullough DF, 2010, BIOCHEM SOC T, V38, P1565, DOI 10.1042/BST0381565; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Neufeld G, 2005, FRONT BIOSCI-LANDMRK, V10, P751, DOI 10.2741/1569; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Port JD, 2010, J CARDIOVASC PHARM, V56, P444, DOI 10.1097/FJC.0b013e3181f605b6; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Roy AM, 2005, MOL CANCER THER, V4, P81; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schwarzer R, 2008, LEUKEMIA, V22, P2273, DOI 10.1038/leu.2008.138; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Wagner DD, 2003, ARTERIOSCL THROM VAS, V23, P2131, DOI 10.1161/01.ATV.0000095974.95122.EC; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang JM, 2005, J CHEM INF MODEL, V45, P1134, DOI 10.1021/ci050034w; Zangari M, 2007, EXPERT REV ANTICANC, V7, P307, DOI 10.1586/14737140.7.3.307	49	209	214	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42390	10.1371/journal.pone.0042390	http://dx.doi.org/10.1371/journal.pone.0042390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870325	Green Published, Green Submitted, gold			2022-12-27	WOS:000307212800088
J	McCrone, P; Sharpe, M; Chalder, T; Knapp, M; Johnson, AL; Goldsmith, KA; White, PD				McCrone, Paul; Sharpe, Michael; Chalder, Trudie; Knapp, Martin; Johnson, Anthony L.; Goldsmith, Kimberley A.; White, Peter D.			Adaptive Pacing, Cognitive Behaviour Therapy, Graded Exercise, and Specialist Medical Care for Chronic Fatigue Syndrome: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							SELF-REPORT	Background: The PACE trial compared the effectiveness of adding adaptive pacing therapy (APT), cognitive behaviour therapy (CBT), or graded exercise therapy (GET), to specialist medical care (SMC) for patients with chronic fatigue syndrome. This paper reports the relative cost-effectiveness of these treatments in terms of quality adjusted life years (QALYs) and improvements in fatigue and physical function. Methods: Resource use was measured and costs calculated. Healthcare and societal costs (healthcare plus lost production and unpaid informal care) were combined with QALYs gained, and changes in fatigue and disability; incremental cost-effectiveness ratios (ICERs) were computed. Results: SMC patients had significantly lower healthcare costs than those receiving APT, CBT and GET. If society is willing to value a QALY at 30,000 pound there is a 62.7% likelihood that CBT is the most cost-effective therapy, a 26.8% likelihood that GET is most cost effective, 2.6% that APT is most cost-effective and 7.9% that SMC alone is most cost-effective. Compared to SMC alone, the incremental healthcare cost per QALY was pound 18,374 for CBT, pound 23,615 for GET and pound 55,235 for APT. From a societal perspective CBT has a 59.5% likelihood of being the most cost-effective, GET 34.8%, APT 0.2% and SMC alone 5.5%. CBT and GET dominated SMC, while APT had a cost per QALY of pound 127,047. ICERs using reductions in fatigue and disability as outcomes largely mirrored these findings. Conclusions: Comparing the four treatments using a health care perspective, CBT had the greatest probability of being the most cost-effective followed by GET. APT had a lower probability of being the most cost-effective option than SMC alone. The relative cost-effectiveness was even greater from a societal perspective as additional cost savings due to reduced need for informal care were likely.	[McCrone, Paul; Knapp, Martin] Kings Coll London, Ctr Econ Mental & Phys Hlth, Hlth Serv & Populat Res Dept, Inst Psychiat, London WC2R 2LS, England; [Sharpe, Michael] Univ Oxford, Univ Dept Psychiat, Oxford, England; [Chalder, Trudie] Kings Coll London, Acad Dept Psychol Med, London WC2R 2LS, England; [Knapp, Martin] London Sch Econ, Personal Social Serv Res Unit, London WC2A 2AE, England; [Johnson, Anthony L.] Inst Publ Hlth, MRC Biostat Unit, Cambridge, England; [Johnson, Anthony L.] MRC Clin Trials Unit, London, England; [Goldsmith, Kimberley A.] Kings Coll London, Dept Biostat, Inst Psychiat, London WC2R 2LS, England; [White, Peter D.] Queen Mary Univ London, Ctr Psychiat, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England	University of London; King's College London; University of Oxford; University of London; King's College London; University of London; London School Economics & Political Science; MRC Biostatistics Unit; University of Cambridge; Medical Research Council Clinical Trials Unit; University of London; King's College London; University of London; Queen Mary University London	McCrone, P (corresponding author), Kings Coll London, Ctr Econ Mental & Phys Hlth, Hlth Serv & Populat Res Dept, Inst Psychiat, London WC2R 2LS, England.	paul.mccrone@kcl.ac.uk	Goldsmith, Kimberley/B-9107-2011; Chalder, Trudie/A-5717-2011	Goldsmith, Kimberley/0000-0002-0620-7868; Chalder, Trudie/0000-0003-0775-1045; sharpe, michael/0000-0002-6474-9980; Knapp, Martin/0000-0003-1427-0215; McCrone, Paul/0000-0001-7001-4502; White, Peter/0000-0002-8193-5355	United Kingdom Medical Research Council, Department of Health for England, Department for Work and Pensions; Scottish Chief Scientist Office; MRC [G0200434] Funding Source: UKRI; Medical Research Council [G0200434] Funding Source: researchfish	United Kingdom Medical Research Council, Department of Health for England, Department for Work and Pensions; Scottish Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work supported by United Kingdom Medical Research Council, Department of Health for England, Department for Work and Pensions, and Scottish Chief Scientist Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber JA, 1998, BRIT MED J, V317, P1195, DOI 10.1136/bmj.317.7167.1195; Beecham J., 2001, MEASURING MENTAL HLT, P200; Briggs AH, 2001, INT J TECHNOL ASSESS, V17, P69, DOI 10.1017/S0266462301104071; CALSYN RJ, 1993, EVALUATION REV, V17, P353, DOI 10.1177/0193841X9301700306; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chisholm D, 2001, BRIT J GEN PRACT, V51, P15; Collin SM, 2011, BMC HLTH SERV RES, V11; Curtis L., 2010, UNIT COSTS HLTH SOCI; Department of Health, 2011, NHS REF COSTS 2009 2; Dolan P, 1995, SOCIAL TARIFF EUROQO; Goldberg RW, 2002, PSYCHIATR SERV, V53, P879, DOI 10.1176/appi.ps.53.7.879; KOOPMANSCHAP MA, 1992, SOC SCI MED, V34, P1005, DOI 10.1016/0277-9536(92)90131-9; Koopmanschap MA, 2008, PHARMACOECONOMICS, V26, P269, DOI 10.2165/00019053-200826040-00001; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; McCrone P, 2004, PSYCHOL MED, V34, P991, DOI 10.1017/S0033291704001928; McCrone P, 2003, PSYCHOL MED, V33, P253, DOI 10.1017/S0033291702006980; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; National Institute for Health and Clinical Excellence, 2007, CLIN GUID CG53 CHRON; NHS Information Centre Prescribing Support Unit (PSU), 2011, PRESCR COST AN ENGL; Office for National Statistics, 2010, ANN SURV HOURS EARN; Patel A, 2005, FAM PRACT, V22, P323, DOI 10.1093/fampra/cmi027; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Severens JL, 2004, QJM-INT J MED, V97, P153, DOI 10.1093/qjmed/hch029; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	26	57	57	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40808	10.1371/journal.pone.0040808	http://dx.doi.org/10.1371/journal.pone.0040808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	984SU	22870204	Green Published, gold			2022-12-27	WOS:000307212800010
J	Mulvihill, MS; Kwon, YW; Lee, S; Fang, LT; Choi, H; Ray, R; Kang, HC; Mao, JH; Jablons, D; Kim, IJ				Mulvihill, Michael S.; Kwon, Yong-Won; Lee, Sharon; Fang, Li Tai; Choi, Helen; Ray, Roshni; Kang, Hio Chung; Mao, Jian-Hua; Jablons, David; Kim, Il-Jin			Gremlin is Overexpressed in Lung Adenocarcinoma and Increases Cell Growth and Proliferation in Normal Lung Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; ANTAGONIST GREMLIN; GENE-EXPRESSION; DRM/GREMLIN; CANCER; IDENTIFICATION; CARCINOMAS; ONCOGENES; OUTGROWTH; PCR	Background: Gremlin, a member of the Dan family of BMP antagonists, is a glycosylated extracellular protein. Previously Gremlin has been shown to play a role in dorsal-ventral patterning, in tissue remodeling, and recently in angiogenesis. Evidence has previously been presented showing both over-and under-expression of Gremlin in different tumor tissues. Here, we sought to quantify expression of Gremlin in cancers of the lung and performed in vitro experiments to check whether Gremlin promotes cell growth and proliferation. Methodology/Principal Findings: Expression of Gremlin in 161 matched tumor and normal lung cancer specimens is quantified by quantitative real-time PCR and protein level is measured by immunohistochemistry. GREM1 was transfected into lung fibroblast and epithelial cell lines to assess the impact of overexpression of Gremlin in vitro. Results: Lung adenocarcinoma but not squamous cell carcinoma shows a significant increase in Gremlin expression by mRNA and protein level. Lung fibroblast and epithelial cell lines transfected with GREM1 show significantly increased cell proliferation. Conclusions/Significance: Our data suggest that Gremlin acts in an oncogenic manner in lung adenocarcinoma and could hold promise as a new diagnostic marker or potential therapeutic target in lung AD or general thoracic malignancies.	[Mulvihill, Michael S.; Lee, Sharon; Fang, Li Tai; Choi, Helen; Ray, Roshni; Jablons, David; Kim, Il-Jin] Univ Calif San Francisco, Dept Surg, Thorac Oncol Lab, San Francisco, CA 94143 USA; [Choi, Helen; Kang, Hio Chung; Jablons, David; Kim, Il-Jin] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [Kwon, Yong-Won; Mao, Jian-Hua] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mulvihill, MS (corresponding author), Univ Calif San Francisco, Dept Surg, Thorac Oncol Lab, San Francisco, CA 94143 USA.	David.Jablons@ucsfmedctr.org; kimij@cc.ucsf.edu	Mao, Jian-Hua/EIZ-8595-2022; Fang, Li Tai/ABA-6638-2021	Mao, Jian-Hua/0000-0001-9320-6021; Fang, Li Tai/0000-0003-3201-5162; Ricchetti, Roshni/0000-0002-1969-1046; Mulvihill, Michael/0000-0002-8122-1483	Barbara Isackson Lung Cancer Research Fund; The Eileen D. Ludwig Endowed Fund for Thoracic Oncology Research	Barbara Isackson Lung Cancer Research Fund; The Eileen D. Ludwig Endowed Fund for Thoracic Oncology Research	This work was supported by the Barbara Isackson Lung Cancer Research Fund, and The Eileen D. Ludwig Endowed Fund for Thoracic Oncology Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; Buckley S, 2004, AM J PHYSIOL-LUNG C, V286, pL81, DOI 10.1152/ajplung.00160.2003; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Chen B, 2002, BIOCHEM BIOPH RES CO, V295, P1135, DOI 10.1016/S0006-291X(02)00828-8; Costello CM, 2008, AM J PHYSIOL-LUNG C, V295, pL272, DOI 10.1152/ajplung.00358.2007; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Howlader NNA, 2010, SEER CANC STAT REV 1; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kelsey CR, 2009, CANCER-AM CANCER SOC, V115, P5218, DOI 10.1002/cncr.24625; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Langenfeld EM, 2006, ONCOGENE, V25, P685, DOI 10.1038/sj.onc.1209110; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; Lu MM, 2001, DEV DYNAM, V222, P667, DOI 10.1002/dvdy.1231; Merino R, 1999, DEVELOPMENT, V126, P5515; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930; Namkoong H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-74; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi W, 2001, AM J PHYSIOL-LUNG C, V280, pL1030, DOI 10.1152/ajplung.2001.280.5.L1030; Singh A, 2010, CYTOKINE GROWTH F R, V21, P299, DOI 10.1016/j.cytogfr.2010.06.003; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stabile H, 2007, BLOOD, V109, P1834, DOI 10.1182/blood-2006-06-032276; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Topol LZ, 2000, CYTOGENET CELL GENET, V89, P79, DOI 10.1159/000015568; Topol LZ, 1997, MOL CELL BIOL, V17, P4801, DOI 10.1128/MCB.17.8.4801; Wang DJ, 2011, ONCOL REP; Weaver M, 1999, DEVELOPMENT, V126, P4005; WEINBERG RA, 1994, CA-CANCER J CLIN, V44, P160, DOI 10.3322/canjclin.44.3.160; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	40	36	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42264	10.1371/journal.pone.0042264	http://dx.doi.org/10.1371/journal.pone.0042264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870311	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800074
J	Zhang, TW; Hu, SN; Zhang, GY; Pan, LL; Zhang, XW; Al-Mssallem, IS; Yu, J				Zhang, Tongwu; Hu, Songnian; Zhang, Guangyu; Pan, Linlin; Zhang, Xiaowei; Al-Mssallem, Ibrahim S.; Yu, Jun			The Organelle Genomes of Hassawi Rice (Oryza sativa L.) and Its Hybrid in Saudi Arabia: Genome Variation, Rearrangement, and Origins	PLOS ONE			English	Article							TRANSFER-RNA GENES; MITOCHONDRIAL GENOMES; SEQUENCE; RECOMBINATION; EVOLUTION; FREQUENCY	Hassawi rice (Oryza sativa L.) is a landrace adapted to the climate of Saudi Arabia, characterized by its strong resistance to soil salinity and drought. Using high quality sequencing reads extracted from raw data of a whole genome sequencing project, we assembled both chloroplast (cp) and mitochondrial (mt) genomes of the wild-type Hassawi rice (Hassawi-1) and its dwarf hybrid (Hassawi-2). We discovered 16 InDels (insertions and deletions) but no SNP (single nucleotide polymorphism) is present between the two Hassawi cp genomes. We identified 48 InDels and 26 SNPs in the two Hassawi mt genomes and a new type of sequence variation, termed reverse complementary variation (RCV) in the rice cp genomes. There are two and four RCVs identified in Hassawi-1 when compared to 93-11 (indica) and Nipponbare (japonica), respectively. Microsatellite sequence analysis showed there are more SSRs in the genic regions of both cp and mt genomes in the Hassawi rice than in the other rice varieties. There are also large repeats in the Hassawi mt genomes, with the longest length of 96,168 bp and 96,165 bp in Hassawi-1 and Hassawi-2, respectively. We believe that frequent DNA rearrangement in the Hassawi mt and cp genomes indicate ongoing dynamic processes to reach genetic stability under strong environmental pressures. Based on sequence variation analysis and the breeding history, we suggest that both Hassawi-1 and Hassawi-2 originated from the Indonesian variety Peta since genetic diversity between the two Hassawi cultivars is very low albeit an unknown historic origin of the wild-type Hassawi rice.	[Zhang, Tongwu; Hu, Songnian; Zhang, Guangyu; Pan, Linlin; Zhang, Xiaowei; Al-Mssallem, Ibrahim S.; Yu, Jun] King Abdulaziz City Sci & Technol, JCGR, Riyadh, Saudi Arabia; [Zhang, Tongwu; Hu, Songnian; Zhang, Guangyu; Pan, Linlin; Zhang, Xiaowei; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Zhang, Tongwu; Hu, Songnian; Yu, Jun] Zhejiang Univ, Coll Life Sci, James D Watson Inst Genome Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Al-Mssallem, Ibrahim S.] King Faisal Univ, Coll Agr & Food Sci, Dept Biotechnol, Al Hssa, Hofuf, Saudi Arabia	King Abdulaziz City for Science & Technology; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Zhejiang University; King Faisal University	Zhang, TW (corresponding author), King Abdulaziz City Sci & Technol, JCGR, Riyadh, Saudi Arabia.	zhangxw@big.ac.cn; imssallem@kacst.edu.sa; junyu@big.ac.cn	Zhang, Tongwu/M-4975-2015; Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111	Joint Center of Excellence for Genomics, King Abdulaziz City for Science and Technology (KACST); Chinese Academy of Sciences	Joint Center of Excellence for Genomics, King Abdulaziz City for Science and Technology (KACST); Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors thank the Joint Center of Excellence for Genomics, King Abdulaziz City for Science and Technology (KACST) and Chinese Academy of Sciences. KASCT had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mssallem IS, 1997, ARAB GULF J SCI RES, V15, P633; Al-Mssallem MQ, 2011, EUR J CLIN NUTR, V65, P627, DOI 10.1038/ejcn.2011.4; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Bajaj S, 2005, PLANT BIOTECHNOL J, V3, P275, DOI 10.1111/j.1467-7652.2005.00130.x; Barker GLA, 2009, PLANT BIOTECHNOL J, V7, P318, DOI 10.1111/j.1467-7652.2009.00412.x; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Fujii S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-209; Gawel N.J., 1991, PLANT MOL BIOL REP, V9, P262, DOI [10.1007/BF02672076, DOI 10.1007/BF02672076]; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Greiner S, 2011, MOL ECOL, V20, P671, DOI 10.1111/j.1365-294X.2010.04984.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Imelfort M, 2009, PLANT BIOTECHNOL J, V7, P312, DOI 10.1111/j.1467-7652.2009.00406.x; Kato A, 2000, DNA SEQUENCE, V11, P395, DOI 10.3109/10425170009033990; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Liu HT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-163; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mackenzie S, 1999, PLANT CELL, V11, P571, DOI 10.1105/tpc.11.4.571; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; Nishikawa T, 2005, THEOR APPL GENET, V110, P696, DOI 10.1007/s00122-004-1895-2; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Rajendrakumar P, 2007, BIOINFORMATICS, V23, P1, DOI 10.1093/bioinformatics/btl547; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Wang XY, 2002, SCI CHINA SER C, V45, P504, DOI 10.1360/02yc9055; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu X, 2011, NAT BIOTECH; Xue JY, 2010, CURR GENET, V56, P53, DOI 10.1007/s00294-009-0279-1; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Young HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023980; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531; Zhang TW, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-38	40	18	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42041	10.1371/journal.pone.0042041	http://dx.doi.org/10.1371/journal.pone.0042041			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22870184	Green Submitted, gold, Green Published			2022-12-27	WOS:000307045600055
J	Ranasinghe, JA; Stein, ED; Miller, PE; Weisberg, SB				Ranasinghe, J. Ananda; Stein, Eric D.; Miller, Peter E.; Weisberg, Stephen B.			Performance of Two Southern California Benthic Community Condition Indices Using Species Abundance and Presence-Only Data: Relevance to DNA Barcoding	PLOS ONE			English	Article							MARINE BIOTIC INDEX; CHESAPEAKE BAY; ESTUARINE; QUALITY; AMBI	DNA barcoding, as it is currently employed, enhances use of marine benthic macrofauna as environmental condition indicators by improving the speed and accuracy of the underlying taxonomic identifications. The next generation of barcoding applications, processing bulk environmental samples, will likely only provide presence information. However, macrofauna indices presently used to interpret these data are based on species abundances. To assess the importance of this difference, we evaluated the performance of the Southern California Benthic Response Index (BRI) and the AZTI Marine Biotic Index (AMBI) when species abundance data were removed from their calculation. Presence only versions of these two indices were created by eliminating abundance weighting while preserving species identity. Associations between the presence and abundance BRI, and the presence and abundance AMBI were highly significant, with correlation coefficients of 0.99 and 0.81, respectively. The presence versions validated almost equally to the abundance-based indices when applied to the spatial and the temporal monitoring data used to validate the original indices. Simulations in which taxa were systematically removed from calculation of the indices were also conducted to assess how large the barcode library must be for the indices to be effective. Correlation between the BRI-P and BRI remained above 0.9 with only 370 species in the library and reducing the number of species to 450 had almost no effect on correlation between the presence and abundance versions of the AMBI.	[Ranasinghe, J. Ananda; Stein, Eric D.; Weisberg, Stephen B.] So Calif Coastal Water Res Project, Costa Mesa, CA USA; [Miller, Peter E.] Univ Guelph, Canadian Ctr DNA Barcoding, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	Southern California Coastal Water Research Project; University of Guelph	Ranasinghe, JA (corresponding author), So Calif Coastal Water Res Project, Costa Mesa, CA USA.	AnandaR@sccwrp.org	Weisberg, Stephen B/B-2477-2008; Stein, Eric D./A-9362-2008	Weisberg, Stephen B/0000-0002-0655-9425; Stein, Eric D./0000-0002-4729-809X	Southern California Coastal Water Research Project	Southern California Coastal Water Research Project	No external funding. This work was supported by Southern California Coastal Water Research Project internal funds only. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden RW, 2002, ENVIRONMETRICS, V13, P473, DOI 10.1002/env.548; Bevilacqua S, 2009, MAR POLLUT BULL, V58, P1850, DOI 10.1016/j.marpolbul.2009.07.018; Borisenko AV, 2009, MOL ECOL RESOUR, V9, P27, DOI 10.1111/j.1755-0998.2009.02629.x; Borja A, 2008, ECOL INDIC, V8, P395, DOI 10.1016/j.ecolind.2007.05.003; Borja A, 2009, MAR POLLUT BULL, V59, P1, DOI 10.1016/j.marpolbul.2008.11.006; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; County Sanitation Districts of Orange County (CSDOC), 1991, COUNT SAN DISTR OR C; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Dauvin JC, 2009, MAR POLLUT BULL, V59, P38, DOI 10.1016/j.marpolbul.2008.11.008; Dethier MN, 2005, ESTUAR COAST SHELF S, V62, P253, DOI 10.1016/j.ecss.2004.08.021; Diaz RJ, 2004, J ENVIRON MANAGE, V73, P165, DOI 10.1016/j.jenvman.2004.06.004; FERRARO SP, 1995, ENVIRON TOXICOL CHEM, V14, P1031, DOI 10.1002/etc.5620140614; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; Pinto R, 2009, ECOL INDIC, V9, P1, DOI 10.1016/j.ecolind.2008.01.005; Ranasinghe JA, 2003, ENVIRON MONIT ASSESS, V81, P199, DOI 10.1023/A:1021333209477; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Smith RW, 2001, ECOL APPL, V11, P1073, DOI 10.1890/1051-0761(2001)011[1073:BRIFAI]2.0.CO;2; Stoeckle MY, 2008, SCI AM, V299, P82; Stull Janet K., 1995, Bulletin Southern California Academy of Sciences, V94, P21; STULL JK, 1986, MAR BIOL, V91, P539, DOI 10.1007/BF00392606; Teixeira H, 2012, ECOL INDIC, V12, P84, DOI 10.1016/j.ecolind.2011.05.025; Thompson B, 2012, ECOL INDIC, V12, P167, DOI 10.1016/j.ecolind.2011.03.020; Warwick RM, 2010, MAR POLLUT BULL, V60, P554, DOI 10.1016/j.marpolbul.2009.11.009; Weisberg SB, 1997, ESTUARIES, V20, P149, DOI 10.2307/1352728	29	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e40875	10.1371/journal.pone.0040875	http://dx.doi.org/10.1371/journal.pone.0040875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879881	Green Published, gold			2022-12-27	WOS:000307437900005
J	Hough, C; Radu, M; Dore, JJE				Hough, Chris; Radu, Maria; Dore, Jules J. E.			TGF-Beta Induced Erk Phosphorylation of Smad Linker Region Regulates Smad Signaling	PLOS ONE			English	Article							MYC PROTEIN STABILITY; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; MAP KINASE; SERINE 338; P21-ACTIVATED KINASE-2; II RECEPTOR; CROSS-TALK; ACTIVATION; RAS	The Transforming Growth Factor-Beta (TGF-beta) family is involved in regulating a variety of cellular processes such as apoptosis, differentiation, and proliferation. TGF-beta binding to a Serine/Threonine kinase receptor complex causes the recruitment and subsequent activation of transcription factors known as smad2 and smad3. These proteins subsequently translocate into the nucleus to negatively or positively regulate gene expression. In this study, we define a second signaling pathway leading to TGF-beta receptor activation of Extracellular Signal Regulated Kinase (Erk) in a cell-type dependent manner. TGF-beta induced Erk activation was found in phenotypically normal mesenchymal cells, but not normal epithelial cells. By activating phosphotidylinositol 3-kinase (PI3K), TGF-beta stimulates p21-activated kinase2 (Pak2) to phosphorylate c-Raf, ultimately resulting in Erk activation. Activation of Erk was necessary for TGF-beta induced fibroblast replication. In addition, Erk phosphorylated the linker region of nuclear localized smads, resulting in increased half-life of C-terminal phospho-smad 2 and 3 and increased duration of smad target gene transcription. Together, these data show that in mesenchymal cell types the TGF-beta/PI3K/Pak2/Raf/MEK/Erk pathway regulates smad signaling, is critical for TGF-beta-induced growth and is part of an integrated signaling web containing multiple interacting pathways rather than discrete smad/non-smad pathways.	[Hough, Chris; Dore, Jules J. E.] Mem Univ Newfoundland, St John, NF, Canada; [Radu, Maria] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	Memorial University Newfoundland; Fox Chase Cancer Center	Hough, C (corresponding author), Mem Univ Newfoundland, St John, NF, Canada.	jdore@mun.ca			Canadian Institutes of Health Research/Regional Partnership Program [ROP-62277, ROP-82355]	Canadian Institutes of Health Research/Regional Partnership Program(Canadian Institutes of Health Research (CIHR))	This work was supported by funding through the Canadian Institutes of Health Research/Regional Partnership Program, ROP-62277 and ROP-82355. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Blanchette F, 2001, J BIOL CHEM, V276, P33986, DOI 10.1074/jbc.M100093200; Burch ML, 2010, CELL MOL LIFE SCI, V67, P2077, DOI 10.1007/s00018-010-0315-9; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Chen CM, 2004, BLOOD, V104, P73, DOI 10.1182/blood-2003-04-1340; Cohen-Solal KA, 2011, PIGM CELL MELANOMA R, V24, P512, DOI 10.1111/j.1755-148X.2011.00858.x; Coles LC, 2002, ONCOGENE, V21, P2236, DOI 10.1038/sj.onc.1205302; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Grimm OH, 2002, NAT CELL BIOL, V4, P519, DOI 10.1038/ncb812; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Inman Gareth J, 2005, Biochem J, V386, pe1; Jakobi R, 2001, J BIOL CHEM, V276, P16624, DOI 10.1074/jbc.M007753200; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; Liu YD, 2007, J BIOL CHEM, V282, P8594, DOI 10.1074/jbc.M610230200; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Lo RS, 2001, EMBO J, V20, P128, DOI 10.1093/emboj/20.1.128; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; MANNE V, 1995, DRUG DEVELOP RES, V34, P121, DOI 10.1002/ddr.430340205; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Mucsi I, 1996, J BIOL CHEM, V271, P16567, DOI 10.1074/jbc.271.28.16567; Park ER, 2007, CELL SIGNAL, V19, P1488, DOI 10.1016/j.cellsig.2007.01.018; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Suzuki K, 2007, CANCER RES, V67, P3673, DOI 10.1158/0008-5472.CAN-06-3211; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; WHARTON W, 1982, P NATL ACAD SCI-BIOL, V79, P5567, DOI 10.1073/pnas.79.18.5567; Wilkes MC, 2009, DEV CELL, V16, P433, DOI 10.1016/j.devcel.2009.01.009; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; Yue JB, 1999, ONCOGENE, V18, P2033, DOI 10.1038/sj.onc.1202521; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	52	106	111	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42513	10.1371/journal.pone.0042513	http://dx.doi.org/10.1371/journal.pone.0042513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880011	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000307810000038
J	Bode, N; Massey, C; Gonzalez-Alegre, P				Bode, Nicole; Massey, Cory; Gonzalez-Alegre, Pedro			DYT1 Knock-In Mice Are Not Sensitized against Mitochondrial Complex-II Inhibition	PLOS ONE			English	Article							EARLY-ONSET DYSTONIA; PC12 CELLS; TORSION DYSTONIA; TRANSGENIC MICE; STRESS; EXPRESSION; TOXICITY; PROTEIN; MOUSE; MODEL	DYT1 is caused by a partly penetrant dominant mutation in TOR1A that leads to a glutamic acid deletion (Delta E) in torsinA. Identifying environmental factors that modulate disease pathogenesis and penetrance could help design therapeutic strategies for dystonia. Several cell-based studies suggest that expression of torsinA(Delta E) increases the susceptibility of neuronal cells to challenges to their oxidative/energy metabolism. Based on those reports, we hypothesized that mice expressing torsinA(Delta E) would be more susceptible than control littermates to the effects of oxidative stress and ATP deficits caused by disruption of the mitochondrial respiratory chain in neurons. To test this hypothesis, we administered 20 or 50 mg/kg/day of the irreversible complex-II inhibitor 3-nitropropionic acid (3-NP) intraperitoneally for 15 consecutive days to young heterozygote DYT1 knock-in (KI) mice and wild type littermates. Repeated phenotypic assessments were performed at baseline, during and after the injections. Animals were then sacrificed and their brains processed for protein analysis. The administration of 20 mg/kg 3-NP led to increased levels of torsinA in the striatum, the main target of 3-NP, but did not cause motor dysfunction in DYT1 KI or control mice. The administration of 50 mg/kg/day of 3-NP caused the death of similar to 40% of wild type animals. Interestingly, DYT1 KI animals showed significantly reduced mortality. Surviving animals exhibited abnormal motor behavior during and right after the injection period, but recovered by 4 weeks postinjection independent of genotype. In contrast to the findings reported in cultured cells, these studies suggest the DYT1 mutation does not sensitize central neurons against the toxic effects of oxidative stress and energy deficits.	[Bode, Nicole; Gonzalez-Alegre, Pedro] Univ Iowa, Dept Neurol, Roy J & Lucille Carver Coll Med, Iowa City, IA 52242 USA; [Massey, Cory; Gonzalez-Alegre, Pedro] Univ Iowa, Grad Program Neurosci, Iowa City, IA USA	University of Iowa; University of Iowa	Bode, N (corresponding author), Univ Iowa, Dept Neurol, Roy J & Lucille Carver Coll Med, Iowa City, IA 52242 USA.	pedro-gonzalez-alegre@uiowa.edu		Massey, Cory/0000-0003-1625-7292	Bachmann-Strauss Dystonia & Parkinson Foundation, Inc	Bachmann-Strauss Dystonia & Parkinson Foundation, Inc	This work was funded by Bachmann-Strauss Dystonia & Parkinson Foundation, Inc (http://www.dystonia-parkinsons.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexi T, 1998, NEUROREPORT, V9, pR57, DOI 10.1097/00001756-199808030-00001; Bao L, 2010, J NEUROCHEM, V114, P1781, DOI 10.1111/j.1471-4159.2010.06890.x; Bragg DC, 2011, NEUROBIOL DIS, V42, P136, DOI 10.1016/j.nbd.2010.11.015; Bressman SB, 2000, NEUROLOGY, V54, P1746, DOI 10.1212/WNL.54.9.1746; Calabrese V, 2001, NEUROCHEM RES, V26, P739, DOI 10.1023/A:1010955807739; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Chen XP, 2010, NEUROCHEM RES, V35, P1214, DOI 10.1007/s11064-010-0177-4; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Fahn S, 1998, Adv Neurol, V78, P1; Gabrielson KL, 2001, AM J PATHOL, V159, P1507, DOI 10.1016/S0002-9440(10)62536-9; Gonzalez-Alegre P, 2007, SEMIN NEUROL, V27, P151, DOI 10.1055/s-2007-971170; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Granata A, 2010, EUR J NEUROL, V17, P81, DOI 10.1111/j.1468-1331.2010.03057.x; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Hewett J, 2010, J NEUROCHEM, V113, P228, DOI 10.1111/j.1471-4159.2010.06590.x; Hickey MA, 2000, J NEUROCHEM, V75, P2163, DOI 10.1046/j.1471-4159.2000.0752163.x; Jungwirth M, 2010, HUM MOL GENET, V19, P888, DOI 10.1093/hmg/ddp557; Kim CE, 2010, P NATL ACAD SCI USA, V107, P9861, DOI 10.1073/pnas.0912877107; Kuner R, 2004, NEUROSCI LETT, V355, P126, DOI 10.1016/j.neulet.2003.10.069; Kuner R, 2003, NEUROSCI LETT, V350, P153, DOI 10.1016/S0304-3940(03)00904-2; Li XB, 2008, GOSPOD SUROWCAMI MIN, V24, P225; Martin JN, 2011, GENE THER, V18, P666, DOI 10.1038/gt.2011.10; Martin JN, 2009, NEUROSCIENCE; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Page ME, 2010, NEUROBIOL DIS, V39, P318, DOI 10.1016/j.nbd.2010.04.016; Rice ME, 2011, NEUROSCIENTIST, V17, P389, DOI 10.1177/1073858411404531; Risch NJ, 2007, AM J HUM GENET, V80, P1188, DOI 10.1086/518427; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Sharma N, 2005, J NEUROSCI, V25, P5351, DOI 10.1523/JNEUROSCI.0855-05.2005; Shashidharan P, 2004, J NEUROCHEM, V88, P1019, DOI 10.1046/j.1471-4159.2003.02233.x; Tassone A, 2011, INT REV NEUROBIOL, V98, P551, DOI 10.1016/B978-0-12-381328-2.00020-1; Ulug AM, 2011, P NATL ACAD SCI USA, V108, P6638, DOI 10.1073/pnas.1016445108; Zhao Y, 2008, NEUROSCIENCE, V155, P439, DOI 10.1016/j.neuroscience.2008.04.053; Zhao Y, 2008, EXP NEUROL, V210, P719, DOI 10.1016/j.expneurol.2007.12.027; Zhu L, 2008, MOL BIOL CELL, V19, P3599, DOI 10.1091/mbc.E08-01-0015; Zhu L, 2010, J BIOL CHEM, V285, P37271, DOI 10.1074/jbc.M110.123471	36	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42644	10.1371/journal.pone.0042644	http://dx.doi.org/10.1371/journal.pone.0042644			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880064	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100148
J	Guo, YT; Chen, X; Zhang, HT; Li, ND; Yang, X; Cheng, WB; Zhao, KX				Guo, Yatu; Chen, Xia; Zhang, Hongtuan; Li, Ningdong; Yang, Xiong; Cheng, Wenbo; Zhao, Kanxing			Association of OPA1 Polymorphisms with NTG and HTG: A Meta-Analysis	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NORMAL-TENSION GLAUCOMA; DOMINANT OPTIC ATROPHY; RISK-FACTOR; REPLICATION VALIDITY; GENETIC ASSOCIATION; LOCUS; REGION; MAPS; SUSCEPTIBILITY	Background: Genetic polymorphisms of the Optic atrophy 1 gene have been implicated in altering the risk of primary open angle glaucoma (POAG), especially the susceptibility to normal tension glaucoma (NTG), but the results remain controversial. Methods: Multiple electronic databases (up to January 20, 2012) were searched independently by two investigators. A meta-analysis was performed on the association between Optic atrophy 1 polymorphisms (rs 166850 and rs 10451941) and normal tension glaucoma (NTG)/high tension glaucoma (HTG). Summary odds ratios (ORs) and 95% confidence intervals (CI) were estimated. Results: Seven studies of 713 cases and 964 controls for NTG and five studies of 1200 cases and 971 controls for HTG on IVS8+4C>T (rs 166850) and IVS8+32T>C (rs10451941) were identified. There were significant associations between the OPA1 rs10451941 polymorphism and NTG susceptibility for all genetic models(C vs. T OR = 1.26, 95% CI 1.09-1.47, p = 0.002; CC vs. TT: OR = 1.52, 95% CI 1.04-2.20, p = 0.029; CC vs. CT+TT: OR = 1.64, 95% CI 1.16-2.33, p = 0.005; CC+CT vs. TT: OR = 1.21, 95% CI 1.02-1.44, p = 0.032). However, no evidence of associations was detected between the OPA1 IVS8+32C>T polymorphism and POAG susceptibility to HTG. Similarly, clear associations between the rs 166850 variant and NTG were observed in allelic and dominant models (T vs. C OR = 1.52, 95% CI 1.16-1.99, p = 0.002; TT+TC vs. CC OR = 1.50, 95% CI 1.13-2.01, p = 0.006) but not to HTG. In subgroup analyses by ethnicity, we detected an association between both OPA1 polymorphisms and risk for NTG in Caucasians but not in Asians. By contrast, no significant findings were noted between OPA1 variants for HTG, either in Caucasians or in Asians. Conclusions: Both the IVS8+4C>T and IVS8+32T>C variants may affect individual susceptibility to NTG. Moreover, stratified analyses for NTG detecting the effects of both OPA1 polymorphisms seemed to vary with ethnicity. Further investigations are needed to validate the association.	[Guo, Yatu; Cheng, Wenbo] Tianjin Med Univ, Tianjin, Peoples R China; [Guo, Yatu; Chen, Xia; Li, Ningdong; Zhao, Kanxing] Tianjin Eye Hosp, Tianjin Eye Inst, Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin, Peoples R China; [Zhang, Hongtuan; Yang, Xiong] Tianjin Med Univ, Hosp 2, Tianjin, Peoples R China; [Guo, Yatu] Johns Hopkins Univ, Krieger Mind Brain Inst, Baltimore, MD USA; [Cheng, Wenbo] Peoples Hosp Changzhi, Dept Ophthalmol, Changzhi, Shanxi, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Johns Hopkins University	Guo, YT (corresponding author), Tianjin Med Univ, Tianjin, Peoples R China.	zhaokanxing@yahoo.com.cn			Chinese National Natural Science Foundation [30730099]; Tianjin Medical University	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Tianjin Medical University	This work was supported by major And key Programs of the Chinese National Natural Science Foundation (30730099) [http://www.nsfc.gov.cn/Portal0/default152.htm], 'Project 211' -The Innovation Fund For Graduate Students of Tianjin Medical University [http://gs.tmu.cn/xyxw/2010/100128.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Anderson DR, 2008, OPHTHALMOLOGY, V115, P590, DOI 10.1016/j.ophtha.2007.08.017; Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8; Aung T, 2002, HUM GENET, V110, P513, DOI 10.1007/s00439-002-0711-9; Aung T, 2002, HUM GENET, V110, P52, DOI 10.1007/s00439-001-0645-7; Baird PN, 2005, HUM GENET, V117, P249, DOI 10.1007/s00439-005-1296-x; Bergen A A B, 2004, Ned Tijdschr Geneeskd, V148, P1343; Blanco-Marchite C, 2011, INVEST OPHTH VIS SCI, V52, P8467, DOI 10.1167/iovs.11-7489; Bourne RRA, 2003, BRIT J OPHTHALMOL, V87, P1069, DOI 10.1136/bjo.87.9.1069; Bron A, 2008, J FR OPHTALMOL, V31, P435, DOI 10.1016/S0181-5512(08)71443-8; Buono Lawrence M, 2002, Curr Opin Ophthalmol, V13, P362, DOI 10.1097/00055735-200212000-00004; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Cedrone C, 2008, PROG BRAIN RES, V173, P3, DOI 10.1016/S0079-6123(08)01101-1; Charliat G, 1994, Ophthalmic Epidemiol, V1, P131, DOI 10.3109/09286589409047221; Chen Xiang-yu, 2011, Zhonghua Yan Ke Za Zhi, V47, P949; Chihara E, 1997, OPHTHALMOLOGICA, V211, P66, DOI 10.1159/000310760; Coleman A L, 2001, Minerva Med, V92, P365; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Fan BJ, 2010, INVEST OPHTH VIS SCI, V51, P4110, DOI 10.1167/iovs.09-4974; Fan BJ, 2006, CLIN BIOCHEM, V39, P249, DOI 10.1016/j.clinbiochem.2005.11.001; Fan BJ, 2004, CHINESE MED J-PEKING, V117, P706; Fernandez-Martinez L, 2011, EUR J HUM GENET, V19, P445, DOI 10.1038/ejhg.2010.217; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Foster Paul J, 2002, Semin Ophthalmol, V17, P50; Gemenetzi M, 2012, EYE, V26, P355, DOI 10.1038/eye.2011.309; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Junemann AGM, 2005, AM J OPHTHALMOL, V139, P721, DOI 10.1016/j.ajo.2004.09.081; Juronen E, 2000, EXP EYE RES, V71, P447, DOI 10.1006/exer.2000.0899; Kim E, 2010, CURR OPIN OPHTHALMOL, V21, P100, DOI 10.1097/ICU.0b013e3283360b1e; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Kountouras J, 2008, CLIN EXP OPHTHALMOL, V36, P296, DOI 10.1111/j.1442-9071.2008.01729.x; Lenaers G, 2009, INT J BIOCHEM CELL B, V41, P1866, DOI 10.1016/j.biocel.2009.04.013; Libby RT, 2005, ANNU REV GENOM HUM G, V6, P15, DOI 10.1146/annurev.genom.6.080604.162209; LIU YP, 2007, J JISHOU UNIV, V28, P1; Mabuchi F, 2007, AM J OPHTHALMOL, V143, P125, DOI 10.1016/j.ajo.2006.09.028; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Munafo MR, 2004, NICOTINE TOB RES, V6, P381, DOI 10.1080/14622200410001676369; Olichon A, 2006, BBA-MOL CELL RES, V1763, P500, DOI 10.1016/j.bbamcr.2006.04.003; Ozcura F, 2007, MED HYPOTHESES, V69, P233, DOI 10.1016/j.mehy.2006.11.030; Pasutto F, 2008, INVEST OPHTH VIS SCI, V49, P270, DOI 10.1167/iovs.07-0500; Pawlikowska Patrycja, 2007, Postepy Biochem, V53, P53; Peng PH, 2011, CURR EYE RES, V36, P733, DOI 10.3109/02713683.2011.584009; Powell B, 2003, MOL VIS, V9, P460; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rocha AV, 2011, MOL VIS, V17, P1679; Rouland JF, 2005, DRUG AGING, V22, P315, DOI 10.2165/00002512-200522040-00004; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; Sowka Joseph, 2005, Optometry, V76, P600, DOI 10.1016/j.optm.2005.08.020; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; Sugiyama Kazuhisa, 2011, Nippon Ganka Gakkai Zasshi, V115, P79; Suriyapperuma SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P86, DOI 10.1001/archopht.125.1.86; Thiselton DL, 2002, INVEST OPHTH VIS SCI, V43, P1715; Trifan OC, 1998, AM J OPHTHALMOL, V126, P17, DOI 10.1016/S0002-9394(98)00073-7; Turkoski BB, 2012, ORTHOP NURS, V31, P37, DOI 10.1097/NOR.0b013e31824196a8; Van Bergen NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021347; Votruba M, 1998, HUM GENET, V102, P79, DOI 10.1007/s004390050657; Wen Wen, 2010, Zhonghua Yan Ke Za Zhi, V46, P566; Wirtz MK, 1999, ARCH OPHTHALMOL-CHIC, V117, P237; Wolf C, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-91; Woo SJ, 2004, J GLAUCOMA, V13, P492, DOI 10.1097/01.ijg.0000137870.25779.40; Yao WL, 2006, MOL VIS, V12, P649; Yu-Wai-Man P, 2010, J MED GENET, V47, P120, DOI 10.1136/jmg.2009.067512; Yuki K, 2009, BIOL TRACE ELEM RES, V132, P1, DOI 10.1007/s12011-009-8376-z; Zanon-Moreno V, 2009, MOL VIS, V15, P2953	65	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42387	10.1371/journal.pone.0042387	http://dx.doi.org/10.1371/journal.pone.0042387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879959	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100076
J	Rizzetto, L; Buschow, SI; Beltrame, L; Figdor, CG; Schierer, S; Schuler, G; Cavalieri, D				Rizzetto, Lisa; Buschow, Sonja I.; Beltrame, Luca; Figdor, Carl G.; Schierer, Stephan; Schuler, Gerold; Cavalieri, Duccio			The Modular Nature of Dendritic Cell Responses to Commensal and Pathogenic Fungi	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BETA-GLUCAN RECEPTOR; C-TYPE LECTINS; IMMUNE-RESPONSES; DC-SIGN; ASPERGILLUS-FUMIGATUS; RECOGNITION; DECTIN-1; MYCOBACTERIA; INNATE	The type of adaptive immune response following host-fungi interaction is largely determined at the level of the antigen-presenting cells, and in particular by dendritic cells (DCs). The extent to which transcriptional regulatory events determine the decision making process in DCs is still an open question. By applying the highly structured DC-ATLAS pathways to analyze DC responses, we classified the various stimuli by revealing the modular nature of the different transcriptional programs governing the recognition of either pathogenic or commensal fungi. Through comparison of the network parts affected by DC stimulation with fungal cells and purified single agonists, we could determine the contribution of each receptor during the recognition process. We observed that initial recognition of a fungus creates a temporal window during which the simultaneous recruitment of cell surface receptors can intensify, complement and sustain the DC activation process. The breakdown of the response to whole live cells, through the purified components, showed how the response to invading fungi uses a set of specific modules. We find that at the start of fungal recognition, DCs rapidly initiate the activation process. Ligand recognition is further enhanced by over-expression of the receptor genes, with a significant correspondence between gene expression and protein levels and function. Then a marked decrease in the receptor levels follows, suggesting that at this moment the DC commits to a specific fate. Overall our pathway based studies show that the temporal window of the fungal recognition process depends on the availability of ligands and is different for pathogens and commensals. Modular analysis of receptor and signalling-adaptor expression changes, in the early phase of pathogen recognition, is a valuable tool for rapid and efficient dissection of the pathogen derived components that determine the phenotype of the DC and thereby the type of immune response initiated.	[Rizzetto, Lisa; Cavalieri, Duccio] Univ Florence, Dept Preclin & Clin Pharmacol, Florence, Italy; [Buschow, Sonja I.; Figdor, Carl G.] Mario Negri Res Inst, Dept Oncol, Translat Genom Unit, Milan, Italy; [Beltrame, Luca] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands; [Schierer, Stephan; Schuler, Gerold] Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany; [Cavalieri, Duccio] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, TN, Italy	University of Florence; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Radboud University Nijmegen; University of Erlangen Nuremberg; Fondazione Edmund Mach	Rizzetto, L (corresponding author), Univ Florence, Dept Preclin & Clin Pharmacol, Florence, Italy.		Figdor, Carl G/A-4232-2010; Rizzetto, Lisa/C-7304-2016; Buschow, Sonja/AAD-3567-2020; Beltrame, Luca/AAB-1998-2020; CAVALIERI, DUCCIO/T-3097-2017; Buschow, Sonja I/F-3777-2010	Figdor, Carl G/0000-0002-2366-9212; Rizzetto, Lisa/0000-0002-2170-9276; Beltrame, Luca/0000-0003-3631-6544; CAVALIERI, DUCCIO/0000-0001-6426-5719; Buschow, Sonja/0000-0002-7907-8315	European Community [242220]; Cariplo Foundation [2010-0744]	European Community(European Commission); Cariplo Foundation(Fondazione Cariplo)	This work was supported by funding from the European Community's Project FP6 DC-THERA EU LSHB-CT-2004-512074 and Project FP7, SYBARIS (Grant Agreement 242220). LB was supported by a grant of the Cariplo Foundation (Grant Number 2010-0744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Beltrame L, 2011, BIOINFORMATICS, V27, P2127, DOI 10.1093/bioinformatics/btr339; Beltrame L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004128; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; Buschow SI, 2010, J PROTEOME RES, V9, P1727, DOI 10.1021/pr9008546; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Cavalieri Duccio, 2010, Immunome Res, V6, P10, DOI 10.1186/1745-7580-6-10; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Mezger M, 2008, ANTIMICROB AGENTS CH, V52, P2644, DOI 10.1128/AAC.01618-07; Netea MG, 2010, TRENDS IMMUNOL, V31, P346, DOI 10.1016/j.it.2010.06.007; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Rizzetto L, 2010, IMMUNOBIOLOGY, V215, P762, DOI 10.1016/j.imbio.2010.05.009; Rizzetto L, 2010, J IMMUNOL, V184, P4258, DOI 10.4049/jimmunol.0902972; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schorey JS, 2008, CURR DRUG TARGETS, V9, P123, DOI 10.2174/138945008783502430; Serrano-Gomez D, 2004, J IMMUNOL, V173, P5635, DOI 10.4049/jimmunol.173.9.5635; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Tada H, 2002, MICROBIOL IMMUNOL, V46, P503, DOI 10.1111/j.1348-0421.2002.tb02727.x; Tam JM, 2012, INTEGR BIOL-UK, V4, P220, DOI 10.1039/c2ib00089j; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; van Kooyk Y, 2008, BIOCHEM SOC T, V36, P1478, DOI 10.1042/BST0361478; van Vliet SJ, 2008, IMMUNOL CELL BIOL, V86, P580, DOI 10.1038/icb.2008.55; Weiss DS, 2007, ANN NY ACAD SCI, V1105, P219, DOI 10.1196/annals.1409.005; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406	40	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42430	10.1371/journal.pone.0042430	http://dx.doi.org/10.1371/journal.pone.0042430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879980	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100091
J	Li, L; Liu, B; Haversen, L; Lu, E; Magnusson, LU; Stahlman, M; Boren, J; Bergstrom, G; Levin, MC; Hulten, LM				Li, Lu; Liu, Bo; Haversen, Liliana; Lu, Emma; Magnusson, Lisa U.; Stahlman, Marcus; Boren, Jan; Bergstrom, Goran; Levin, Malin C.; Hulten, Lillemor Mattsson			The Importance of GLUT3 for De Novo Lipogenesis in Hypoxia-Induced Lipid Loading of Human Macrophages	PLOS ONE			English	Article							GLUCOSE; INFLAMMATION; EXPRESSION; LIVER	Atherosclerotic lesions are characterized by lipid-loaded macrophages (foam cells) and hypoxic regions. Although it is well established that foam cells are produced by uptake of cholesterol from oxidized LDL, we previously showed that hypoxia also promotes foam cell formation even in the absence of exogenous lipids. The hypoxia-induced lipid accumulation results from increased triglyceride biosynthesis but the exact mechanism is unknown. Our aim was to investigate the importance of glucose in promoting hypoxia-induced de novo lipid synthesis in human macrophages. In the absence of exogenous lipids, extracellular glucose promoted the accumulation of Oil Red O-stained lipid droplets in human monocyte-derived macrophages in a concentration-dependent manner. Lipid droplet accumulation was higher in macrophages exposed to hypoxia at all assessed concentrations of glucose. Importantly, triglyceride synthesis from glucose was increased in hypoxic macrophages. GLUT3 was highly expressed in macrophage-rich and hypoxic regions of human carotid atherosclerotic plaques and in macrophages isolated from these plaques. In human monocyte-derived macrophages, hypoxia increased expression of both GLUT3 mRNA and protein, and knockdown of GLUT3 with siRNA significantly reduced both glucose uptake and lipid droplet accumulation. In conclusion, we have shown that hypoxia-induced increases in glucose uptake through GLUT3 are important for lipid synthesis in macrophages, and may contribute to foam cell formation in hypoxic regions of atherosclerotic lesions.	[Li, Lu; Liu, Bo; Haversen, Liliana; Lu, Emma; Magnusson, Lisa U.; Stahlman, Marcus; Boren, Jan; Bergstrom, Goran; Levin, Malin C.; Hulten, Lillemor Mattsson] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden	University of Gothenburg	Li, L (corresponding author), Univ Gothenburg, Inst Med, Sahlgrenska Acad, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden.	lillemor.mattsson@wlab.gu.se	StÃhlman, Marcus/M-4597-2019	Bergstrom, Goran/0000-0003-4289-5722; Henricsson, Marcus/0000-0002-4202-0339; Levin, Malin/0000-0003-1069-5275	Swedish Research Council; Novo Nordisk Fonden [NNF11OC1014864] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding was provided by the Swedish Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; ANDERSSON M, 1994, J LIPID RES, V35, P535; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Bostrom P, 2006, ARTERIOSCL THROM VAS, V26, P1871, DOI 10.1161/01.ATV.0000229665.78997.0b; Brusselmans K, 2005, J BIOL CHEM, V280, P5636, DOI 10.1074/jbc.M408177200; Folco EJ, 2011, J AM COLL CARDIOL, V58, P603, DOI 10.1016/j.jacc.2011.03.044; FROST SC, 1985, J BIOL CHEM, V260, P2646; Fu YC, 2004, BLOOD CELL MOL DIS, V32, P182, DOI 10.1016/j.bcmd.2003.09.002; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Homan R, 1998, J CHROMATOGR B, V708, P21, DOI 10.1016/S0378-4347(97)00651-8; HOROWICZ P, 1962, J NEUROCHEM, V9, P407, DOI 10.1111/j.1471-4159.1962.tb09468.x; HOWARD CF, 1972, ATHEROSCLEROSIS, V15, P359, DOI 10.1016/0021-9150(72)90025-1; Hulten LM, 2009, CURR OPIN LIPIDOL, V20, P409, DOI 10.1097/MOL.0b013e3283307be8; Kanter JE, 2007, CIRC RES, V100, P769, DOI 10.1161/01.RES.0000259589.34348.74; Kim TN, 2010, CIRC-CARDIOVASC IMAG, V3, P142, DOI 10.1161/CIRCIMAGING.109.888909; Magnusson B, 2006, ARTERIOSCLER THROMB; Martin S, 2006, NAT REV MOL CELL BIO; MATTSSON L, 1991, ATHEROSCLEROSIS, V89, P25, DOI 10.1016/0021-9150(91)90004-M; Na TY, 2011, ARTERIOSCL THROM VAS, V31, P2949, DOI 10.1161/ATVBAHA.111.235788; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Oorni K, 2006, CURR OPIN LIPIDOL, V17, P534; Parathath S, 2011, CIRC RES, V109, P1141, DOI 10.1161/CIRCRESAHA.111.246363; Rudd JHF, 2002, CIRCULATION, V105, P2708, DOI 10.1161/01.CIR.0000020548.60110.76; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Yu J, 2012, BRAIN RES, V1430, P18, DOI 10.1016/j.brainres.2011.10.046	25	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42360	10.1371/journal.pone.0042360	http://dx.doi.org/10.1371/journal.pone.0042360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876317	Green Published, gold, Green Submitted			2022-12-27	WOS:000307184700045
J	Chang, WW; Tsai, FC; Tsai, TY; Chang, CH; Jenq, CC; Chang, MY; Tian, YC; Hung, CC; Fang, JT; Yang, CW; Chen, YC				Chang, Wei-Wen; Tsai, Feng-Chun; Tsai, Tsung-Yu; Chang, Chih-Hsiang; Jenq, Chang-Chyi; Chang, Ming-Yang; Tian, Ya-Chung; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Chen, Yung-Chang			Predictors of Mortality in Patients Successfully Weaned from Extracorporeal Membrane Oxygenation	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; FAILURE ASSESSMENT SCORE; HEART-FAILURE; CARDIAC-SURGERY; PROGNOSIS; CLASSIFICATION; DIALYSIS; DISEASE; SYSTEM; IMPACT	Purpose: Extracorporeal membrane oxygenation (ECMO) has been utilized for critically ill patients, such as those with life-threatening respiratory failure or post-cardiotomy cardiogenic shock. This study compares the predictive value of Acute Physiology, Age, and Chronic Health Evaluation II (APACHE II), Sequential Organ Failure Assessment (SOFA), and Organ System Failure (OSF) obtained on the first day of ECMO removal, and the Acute Kidney Injury Network (AKIN) stages obtained at 48 hours post-ECMO removal (AKIN(48-hour)) in terms of hospital mortality for critically ill patients. Methods: This study reviewed the medical records of 119 critically ill patients successfully weaned from ECMO at the specialized intensive care unit of a tertiary-care university hospital between July 2006 and October 2010. Demographic, clinical, and laboratory data were collected retrospectively as survival predictors. Results: Overall mortality rate was 26%. The most common condition requiring ECMO support was cardiogenic shock. By using the areas under the receiver operating characteristic (AUROC) curve, the Sequential Organ Failure Assessment (SOFA) score displayed good discriminative power (AUROC 0.805 +/- 0.055, p<0.001). Furthermore, multiple logistic regression analysis indicated that daily urine output on the second day of ECMO removal (UO24-48 hour), mean arterial pressure (MAP), and SOFA score on the day of ECMO removal were independent predictors of hospital mortality. Finally, cumulative survival rates at 6-month follow-up differed significantly (p<0.001) for a SOFA score <= 13 relative to those for a SOFA score>13. Conclusions: Following successful ECMO weaning, the SOFA score proved a reproducible evaluation tool with good prognostic abilities.	[Chang, Wei-Wen; Tsai, Tsung-Yu; Chang, Chih-Hsiang; Jenq, Chang-Chyi; Chang, Ming-Yang; Tian, Ya-Chung; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Chen, Yung-Chang] Chang Gung Mem Hosp, Dept Nephrol, Taipei 10591, Taiwan; [Tsai, Feng-Chun] Chang Gung Mem Hosp, Div Cardiovasc Surg, Taipei 10591, Taiwan; [Tsai, Feng-Chun; Jenq, Chang-Chyi; Chang, Ming-Yang; Tian, Ya-Chung; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Chen, Yung-Chang] Chang Gung Univ, Coll Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chang, WW (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	cyc2356@adm.cgmh.org.tw	Chang, Jason Chih-Hsiang/P-8662-2017; Chang, Ming-Yang/AGH-5397-2022	Chang, Jason Chih-Hsiang/0000-0002-7342-335X; Chang, Ming-Yang/0000-0001-8899-0376				Belohlavek J, 2011, J CARDIOVASC SURG, V52, P445; Cadnapaphornchai MA, 2001, CARDIOLOGY, V96, P122, DOI 10.1159/000047396; Ceriani R, 2003, CHEST, V123, P1229, DOI 10.1378/chest.123.4.1229; Chen YS, 2003, J AM COLL CARDIOL, V41, P197, DOI 10.1016/S0735-1097(02)02716-X; Chen YC, 2011, ANN THORAC SURG, V91, P137, DOI 10.1016/j.athoracsur.2010.08.063; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1985, ANN SURG, V202, P685, DOI 10.1097/00000658-198512000-00004; Lin CY, 2007, ANN THORAC SURG, V84, P1256, DOI 10.1016/j.athoracsur.2007.05.045; Lin CY, 2006, NEPHROL DIAL TRANSPL, V21, P2867, DOI 10.1093/ndt/gfl326; Mariscalco G, 2011, ANN THORAC SURG, V92, P1539, DOI 10.1016/j.athoracsur.2011.04.123; Mehta RH, 2006, CIRCULATION, V114, P2208, DOI 10.1161/CIRCULATIONAHA.106.635573; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Metra M, 2008, EUR J HEART FAIL, V10, P188, DOI 10.1016/j.ejheart.2008.01.011; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wu MY, 2008, RESUSCITATION, V79, P54, DOI 10.1016/j.resuscitation.2008.05.002	17	62	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42687	10.1371/journal.pone.0042687	http://dx.doi.org/10.1371/journal.pone.0042687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870340	gold, Green Submitted, Green Published			2022-12-27	WOS:000307212800103
J	Kadowaki, T; Ohtani, T; Odawara, M				Kadowaki, Takashi; Ohtani, Tetsuya; Odawara, Masato			Potential Formula for the Calculation of Starting and Incremental Insulin Glargine Doses: ALOHA Subanalysis	PLOS ONE			English	Article							TYPE-2; EFFICACY; THERAPY	Background: Pragmatic methods for dose optimization are required for the successful basal management in daily clinical practice. To derive a useful formula for calculating recommended glargine doses, we analyzed data from the Add-on Lantus (R) to Oral Hypoglycemic Agents (ALOHA) study, a 24-week observation of Japanese type 2 diabetes patients. Methodology/Principal Findings: The patients who initiated insulin glargine in basal-supported oral therapy (BOT) regimen (n = 3506) were analyzed. The correlations between average changes in glargine dose and HbA1c were calculated, and its regression formula was estimated from grouped data categorized by baseline HbA1c levels. Starting doses of the background-subgroup achieving the HbA1c target with a last-observed dose above the average were compared to an assumed optimal starting dose of 0.15 U/kg/day. The difference in regression lines between background-subgroups was examined. A formula for determining the optimal starting and titration doses was thereby derived. The correlation coefficient between changes in dose and HbA1c was -0.9043. The estimated regression line formula was -0.964 x change in HbA1c+2.000. A starting dose of 0.15 U/kg/day was applicable to all background-subgroups except for patients with retinopathy (0.120 U/kg/day) and/or with eGFR<60 mL/min/1.73 m(2) (0.114 U/kg/day). Additionally, women (0.135 U/kg/day) and patients with sulfonylureas (0.132 U/kg/day) received a slightly decreased starting dose. Conclusions/Significance: We suggest a simplified and pragmatic dose calculation formula for type 2 diabetes patients starting glargine BOT optimal daily dose at 24 weeks = starting dose (0.15 x weight) + incremental dose (baseline HbA1c - target HbA1c+2). This formula should be further validated using other samples in a prospective follow-up, especially since several patient groups required lower starting doses.	[Kadowaki, Takashi] Univ Tokyo, Dept Diabet & Metab Dis, Grad Sch Med, Tokyo, Japan; [Ohtani, Tetsuya] Sanofi Aventis KK, Tokyo, Japan; [Odawara, Masato] Tokyo Med Univ, Dept Diabetol Metab & Endocrinol, Tokyo, Japan	University of Tokyo; Sanofi-Aventis; Tokyo Medical University	Kadowaki, T (corresponding author), Univ Tokyo, Dept Diabet & Metab Dis, Grad Sch Med, Tokyo, Japan.	kadowaki-3im@h.u-tokyo.ac.jp		Naito, Yusuke/0000-0001-8033-6708	sanofi-aventis K.K.	sanofi-aventis K.K.(Sanofi-Aventis)	This study was sponsored by sanofi-aventis K.K. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday LA, 2006, DESIGNING CONDUCTING; Barnett A, 2007, CLIN THER, V29, P987, DOI 10.1016/j.clinthera.2007.06.018; Fritsche A, 2003, ANN INTERN MED, V138, P952, DOI 10.7326/0003-4819-138-12-200306170-00006; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Gordon J, 2010, INT J CLIN PRACT, V64, P1609, DOI 10.1111/j.1742-1241.2010.02520.x; Holman R R, 1985, Diabet Med, V2, P45; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Mayfield JA, 2004, AM FAM PHYSICIAN, V70, P489; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Ohtani T., 2011, SHINYAKU TO RINSHO, V60, P458; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schreiber SA, 2008, DIABETES TECHNOL THE, V10, P121, DOI 10.1089/dia.2007.0265; Wright A, 2002, DIABETES CARE, V25, P330, DOI 10.2337/diacare.25.2.330	13	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41358	10.1371/journal.pone.0041358	http://dx.doi.org/10.1371/journal.pone.0041358			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870214	Green Published, gold			2022-12-27	WOS:000307212800016
J	Lopez, MJ; Fernandez, E; Gorini, G; Moshammer, H; Polanska, K; Clancy, L; Dautzenberg, B; Delrieu, A; Invernizzi, G; Munoz, G; Precioso, J; Ruprecht, A; Stansty, P; Hanke, W; Nebot, M				Lopez, Maria J.; Fernandez, Esteve; Gorini, Giuseppe; Moshammer, Hanns; Polanska, Kinga; Clancy, Luke; Dautzenberg, Bertrand; Delrieu, Agnes; Invernizzi, Giovanni; Munoz, Gloria; Precioso, Jose; Ruprecht, Ario; Stansty, Peter; Hanke, Wojciech; Nebot, Manel			Exposure to Secondhand Smoke in Terraces and Other Outdoor Areas of Hospitality Venues in Eight European Countries	PLOS ONE			English	Article							2ND-HAND SMOKE; PUBLIC SPACES; IMPACT; BARS; LAW; RESTAURANTS; WORKERS; HEALTH	Background: Outdoor secondhand smoke (SHS) concentrations are usually lower than indoor concentrations, yet some studies have shown that outdoor SHS levels could be comparable to indoor levels under specific conditions. The main objectives of this study were to assess levels of SHS exposure in terraces and other outdoor areas of hospitality venues and to evaluate their potential displacement to adjacent indoor areas. Methods: Nicotine and respirable particles (PM2.5) were measured in outdoor and indoor areas of hospitality venues of 8 European countries. Hospitality venues of the study included night bars, restaurants and bars. The fieldwork was carried out between March 2009 and March 2011. Results: We gathered 170 nicotine and 142 PM2.5 measurements during the study. The median indoor SHS concentration was significantly higher in venues where smoking was allowed (nicotine 3.69 mu g/m3, PM2.5: 120.51 mu g/m3) than in those where smoking was banned (nicotine: 0.48 mu g/m3, PM2.5: 36.90 mu g/m3). The median outdoor nicotine concentration was higher in places where indoor smoking was banned (1.56 mg/m3) than in venues where smoking was allowed (0.31 mg/m3). Among the different types of outdoor areas, the highest median outdoor SHS levels (nicotine: 4.23 mu g/m3, PM2.5: 43.64 mu g/m3) were found in the semi-closed outdoor areas of venues where indoor smoking was banned. Conclusions: Banning indoor smoking seems to displace SHS exposure to adjacent outdoor areas. Furthermore, indoor settings where smoking is banned but which have a semi-closed outdoor area have higher levels of SHS than those with open outdoor areas, possibly indicating that SHS also drifts from outdoors to indoors. Current legislation restricting indoor SHS levels seems to be insufficient to protect hospitality workers - and patrons - from SHS exposure. Tobacco-free legislation should take these results into account and consider restrictions in the terraces of some hospitality venues to ensure effective protection.	[Lopez, Maria J.; Munoz, Gloria; Nebot, Manel] Publ Hlth Agcy Barcelona, Barcelona, Spain; [Lopez, Maria J.; Munoz, Gloria; Nebot, Manel] Consorcio Invest Biomed Red Especializado Epidemi, Barcelona, Spain; [Lopez, Maria J.; Nebot, Manel] Inst Invest Biomed St Pau, Barcelona, Spain; [Fernandez, Esteve] ICO, Canc Control & Prevent Programme, Tobacco Control Unit, Lhospitalet De Llobregat, Spain; [Fernandez, Esteve] Inst Invest Biomed Bellvitge, Canc Control & Prevent Grp, Lhospitalet De Llobregat, Spain; [Fernandez, Esteve] Univ Barcelona, Sch Med, Dept Clin Sci, Lhospitalet De Llobregat, Spain; [Gorini, Giuseppe] Canc Prevent & Res Inst, Environm & Occupat Epidemiol Unit, Florence, Italy; [Moshammer, Hanns] Med Univ Vienna, Inst Environm Hlth, Vienna, Austria; [Polanska, Kinga; Hanke, Wojciech] Nofer Inst Occupat Med, Dept Environm Epidemiol, Lodz, Poland; [Clancy, Luke] Digital Depot, Tobacco Free Res Inst, Dublin, Ireland; [Dautzenberg, Bertrand; Delrieu, Agnes] Off Francais Prevent Tabagisme, Paris, France; [Precioso, Jose] Univ Minho, Braga, Portugal; [Ruprecht, Ario] Italian Coll Gen Practitioners, Fdn Ist Ric & Cura Carattere Sci IRCCS, Environm Tobacco Smoke Res Lab, SIMG,Ist Nazl Tumori,Tobacco Control Unit, Milan, Italy; [Stansty, Peter] Obcianske Zdruzenie Stop Smoking NGO, Stop Fajceniu, Bratislava, Slovakia; [Nebot, Manel] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain	Public Health Agency of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Medical University of Vienna; Nofer Institute of Occupational Medicine; Universidade do Minho; Fondazione IRCCS Istituto Nazionale Tumori Milan; Pompeu Fabra University	Lopez, MJ (corresponding author), Publ Hlth Agcy Barcelona, Barcelona, Spain.	mjlopez@aspb.cat	Lopez, Maria/HHC-3659-2022; clancy, luke/ABA-1826-2020; Clancy, Luke/O-6597-2019; Fernandez, Esteve/A-9750-2008; Gorini, Giuseppe/O-9560-2017; Polanska, Kinga/F-7599-2010; DAUTZENBERG, Bertrand/F-4104-2017	Clancy, Luke/0000-0003-2407-2263; Fernandez, Esteve/0000-0003-4239-723X; Gorini, Giuseppe/0000-0002-1413-5948; Lopez Medina, Maria Jose/0000-0003-4402-2239; DAUTZENBERG, Bertrand/0000-0001-6937-8907; Hanke, Wojciech/0000-0001-7162-2569; Polanska, Kinga/0000-0002-3212-2307; Precioso, Jose/0000-0002-7889-8290	Executive Agency for Health and Consumers; DG SANCO; European Commission [2007313]	Executive Agency for Health and Consumers; DG SANCO; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Executive Agency for Health and Consumers, DG SANCO, European Commission, grant number 2007313. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwright S, 2005, BMJ-BRIT MED J, V331, P1117, DOI 10.1136/bmj.38636.499225.55; Apsley A, 2012, TOB CONTROL IN PRESS; Brennan E, 2010, NICOTINE TOB RES, V12, P271, DOI 10.1093/ntr/ntp204; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Cameron M, 2010, TOB CONTROL, V19, P19, DOI 10.1136/tc.2009.030544; Chapman S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2804; Fernandez E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004244; Gorini G, 2008, INDOOR AIR, V18, P328, DOI 10.1111/j.1600-0668.2008.00534.x; Hall JC, 2009, J OCCUP ENVIRON HYG, V6, P698, DOI 10.1080/15459620903249893; HAMMOND SK, 1993, SAMPLING ANAL AIRBOR, P319; IARC, 2009, IARC HDB CANC PREVEN; Kaufman P, 2011, TOB CONTROL, V20, P212, DOI 10.1136/tc.2010.041277; Kennedy RD, 2010, TOB CONTROL, V19, P165, DOI 10.1136/tc.2009.031872; Klepeis NE, 2007, J AIR WASTE MANAGE, V57, P522, DOI 10.3155/1047-3289.57.5.522; Lopez MJ, 2008, ENVIRON HEALTH PERSP, V116, P1469, DOI 10.1289/ehp.11374; Lopez MJ, 2012, TOB CONTROL, V21, P407, DOI 10.1136/tc.2010.042275; Nebot M, 2009, ENVIRON HEALTH PERSP, V117, P344, DOI 10.1289/ehp.11845; Repace J., 2005, MEASUREMENTS OUTDOOR; Ruprecht AA, 2011, EPIDEMIOLOGY, V22, pS206, DOI 10.1097/01.ede.0000392314.24613.c6; Stafford J, 2010, HEALTH PROMOT J AUST, V21, P99, DOI 10.1071/HE10099; Sureda X, 2011, TOB CONTROL; Thomson G, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2806; Thomson G, 2009, NICOTINE TOB RES, V11, P584, DOI 10.1093/ntr/ntp046; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; World Health Organization, 2009, WHO REP GLOB TOB EP; WorldHealthOrganization, 2000, AIR QUAL GUID EUR, Vsecond	26	51	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42130	10.1371/journal.pone.0042130	http://dx.doi.org/10.1371/journal.pone.0042130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870289	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800062
J	Gao, ZX; Luo, W; Liu, H; Zeng, C; Liu, XL; Yi, SJ; Wang, WM				Gao, Zexia; Luo, Wei; Liu, Hong; Zeng, Cong; Liu, Xiaolian; Yi, Shaokui; Wang, Weimin			Transcriptome Analysis and SSR/SNP Markers Information of the Blunt Snout Bream (Megalobrama amblycephala)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CANDIDATE GENES; SNP DISCOVERY; REVEALS; POLYMORPHISMS; GENERATION; SPECIATION; POPULATION; EVOLUTION; SELECTION	Background: Blunt snout bream (Megalobrama amblycephala) is an herbivorous freshwater fish species native to China and has been recognized as a main aquaculture species in the Chinese freshwater polyculture system with high economic value. Right now, only limited EST resources were available for M. amblycephala. Recent advances in large-scale RNA sequencing provide a fast, cost-effective, and reliable approach to generate large expression datasets for functional genomic analysis, which is especially suitable for non-model species with un-sequenced genomes. Methodology and Principal Findings: Using 454 pyrosequencing, a total of 1,409,706 high quality reads (total length 577 Mbp) were generated from the normalized cDNA of pooled M. amblycephala individuals. These sequences were assembled into 26,802 contigs and 73,675 singletons. After BLAST searches against the NCBI non-redundant (NR) and UniProt databases with an arbitrary expectation value of E-10, over 40,000 unigenes were functionally annotated and classified using the FunCat functional annotation scheme. A comparative genomics approach revealed a substantial proportion of genes expressed in M. amblycephala tanscriptome to be shared across the genomes of zebrafish, medaka, tetraodon, fugu, stickleback, human, mouse, and chicken, and identified a substantial number of potentially novel M. amblycephala genes. A total number of 4,952 SSRs were found and 116 polymorphic loci have been characterized. A significant number of SNPs (25,697) and indels (23,287) were identified based on specific filter criteria in the M. amblycephala. Conclusions: This study is the first comprehensive transcriptome analysis for a fish species belonging to the genus Megalobrama. These large EST resources are expected to be valuable for the development of molecular markers, construction of gene-based linkage map, and large-scale expression analysis of M. amblycephala, as well as comparative genome analysis for the genus Megalobrama fish species. The identified SSR and SNP markers will greatly benefit its breeding program and whole genome association studies.	[Gao, Zexia; Luo, Wei; Liu, Hong; Zeng, Cong; Liu, Xiaolian; Yi, Shaokui; Wang, Weimin] Huazhong Agr Univ, Key Lab Freshwater Anim Breeding, Key Lab Agr Anim Genet Breeding & Reprod, Coll Fisheries,Minist Agr,Minist Educ, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Gao, ZX (corresponding author), Huazhong Agr Univ, Key Lab Freshwater Anim Breeding, Key Lab Agr Anim Genet Breeding & Reprod, Coll Fisheries,Minist Agr,Minist Educ, Wuhan, Peoples R China.	wangwm@mail.hzau.edu.cn	YI, Shaokui/GZH-2932-2022; Yi, Shaokui/I-5726-2019; Zeng, Cong/J-4933-2014	YI, Shaokui/0000-0003-2325-0179; Zeng, Cong/0000-0003-1003-9382	Modern Agroindustry Technology Research System entitled "Staple Freshwater Fishery Industry Technology System" [CARS-46-05]; Fundamental Research Funds for the Central Universities [2011PY023, 2011PY043, 52902-0900202146]	Modern Agroindustry Technology Research System entitled "Staple Freshwater Fishery Industry Technology System"; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the grants from Modern Agroindustry Technology Research System entitled "Staple Freshwater Fishery Industry Technology System" (No. CARS-46-05), Fundamental Research Funds for the Central Universities (No. 2011PY023, 2011PY043 and 52902-0900202146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2007, ANIM GENET, V38, P491, DOI 10.1111/j.1365-2052.2007.01642.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016368; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Becker D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008689; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Brooks SA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000909; *CAFS, 2001, FISH STAT DAT; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Du ZQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004837; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Elmer KR, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04488.x; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Ke H W, 1965, ACTA HYDROBIOL SIN, V5, P282; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Kim ES, 2009, ANIM GENET, V40, P300, DOI 10.1111/j.1365-2052.2008.01832.x; Klmer KR, 2010, MOL ECOL S1, V19, P197; Li HH, 2008, FRESHW FISHERIES, V38, P63; LI SF, 1993, AQUACULTURE, V111, P117, DOI 10.1016/0044-8486(93)90030-3; Li SF, 1996, J FISHERIES CHINA, V3, P1; Li Shao-wu, 2006, Journal of Fishery Sciences of China, V13, P187; Li WT, 2007, MOL ECOL NOTES, V7, P771, DOI 10.1111/j.1471-8286.2007.01689.x; Li Y, 2010, THESIS HUAZHONG AGR, DOI DOI 10.1093/bioinformatics/bts460; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Lu FH, 2012, MOL BIOL REP, V39, P3327, DOI 10.1007/s11033-011-1102-x; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meuwissen THE, 2001, GENETICS, V157, P1819; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Perez-Enciso M, 2010, ANIM GENET, V41, P561, DOI 10.1111/j.1365-2052.2010.02057.x; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roeding F, 2009, MOL PHYLOGENET EVOL, V53, P826, DOI 10.1016/j.ympev.2009.08.014; Rokas A, 2009, TRENDS ECOL EVOL, V24, P192, DOI 10.1016/j.tree.2008.11.004; Rozen S, 2000, Methods Mol Biol, V132, P365; Schwarz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-633; THURSTON MI, 2005, MSATFINDER DETECTION; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang WM, 2009, SCI FISH FARMING, V4, P44; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Xu W, 2008, J HYDROECOL, V1, P7; ZHANG D, 2001, J CHINA 3 GORGES U, V3, P282	53	200	224	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42637	10.1371/journal.pone.0042637	http://dx.doi.org/10.1371/journal.pone.0042637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880060	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000053
J	Mittelstadt, ML; Patel, RC				Mittelstadt, Megan L.; Patel, Rekha C.			AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon beta	PLOS ONE			English	Article							NF-KAPPA-B; REGULATORY FACTOR-I; GENE-EXPRESSION; DOWN-REGULATION; GELATINASE-B; IFN-GAMMA; MMP-9; PTEN; STAT-1-ALPHA; ACETYLATION	Matrix metalloproteinase-9 (MMP-9) is a 92 kDa zinc-dependant endopeptidase that degrades components of the extracellular matrix. Increased expression of MMP-9 is implicated in many pathological conditions including metastatic cancer, multiple sclerosis, and atherosclerosis. Although it has been widely noted that interferon-beta (IFN beta) downregulates both the basal and phorbol 12-myristate 13-acetate (PMA)-induced MMP-9 expression at the transcriptional level, the molecular mechanism of this repression is poorly understood. In the present study we identify a novel mechanism for repression of MMP-9 transcription by IFN beta in HT1080 fibrosarcoma cells. Using reporter assays with promoter deletion constructs we show that IFNb's inhibitory effects require a region of the promoter between -154 and -72, which contains an AP-1 binding site. Chromatin immunoprecipitation (ChIP) studies indicate that IFN beta increases histone deacetylase (HDAC)-1 recruitment to the MMP-9 promoter and reduces histone H3 acetylation, in addition to reduced NF-kappa B recruitment. ChIP analysis shows that IFN beta induced HDAC1 recruitment to the MMP-9 promoter and IFNb mediated transcriptional repression is lost when the AP-1 binding site is inactivated by a point mutation. Altogether, our results establish that the repression of MMP-9 transcription in response to IFN beta occurs by the recruitment of HDAC1 via the proximal AP-1 binding site.	[Mittelstadt, Megan L.; Patel, Rekha C.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Mittelstadt, ML (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	patelr@biol.sc.edu	Patel, Rekha/M-7123-2015	Patel, Rekha/0000-0001-9434-4880	University of South Carolina Research Opportunity Pilot Grant	University of South Carolina Research Opportunity Pilot Grant	This work was supported by University of South Carolina Research Opportunity Pilot Grant to RCP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Fantini D, 2008, FREE RADICAL RES, V42, P20, DOI 10.1080/10715760701765616; Galewska Z, 2008, CLIN CHEM LAB MED, V46, P517, DOI 10.1515/CCLM.2008.083; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; Han YJ, 2009, FERTIL STERIL, V91, P2324, DOI 10.1016/j.fertnstert.2008.03.047; Hartung HP, 2000, J NEUROIMMUNOL, V107, P140, DOI 10.1016/S0165-5728(00)00225-3; Hartung HP, 2000, LANCET, V356, P1114, DOI 10.1016/S0140-6736(05)74558-X; Hebbar PB, 2008, J BIOL CHEM, V283, P4595, DOI 10.1074/jbc.M709121200; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Ikenoue T, 2008, CANCER RES, V68, P6908, DOI 10.1158/0008-5472.CAN-08-1107; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kim LK, 2007, PLOS BIOL, V5, P2064, DOI 10.1371/journal.pbio.0050238; Kim T, 2005, NAT IMMUNOL, V6, P211, DOI 10.1038/ni1159; Ma ZD, 2004, J BIOL CHEM, V279, P46326, DOI 10.1074/jbc.M405438200; Ma ZD, 2005, J LEUKOCYTE BIOL, V78, P515, DOI 10.1189/jlb.0205112; Ma ZD, 2001, J IMMUNOL, V167, P5150, DOI 10.4049/jimmunol.167.9.5150; Nozell S, 2004, J BIOL CHEM, V279, P38577, DOI 10.1074/jbc.M403738200; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Rani MRS, 2005, J INTERF CYTOK RES, V25, P788, DOI 10.1089/jir.2005.25.788; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Sanceau J, 2002, J BIOL CHEM, V277, P35766, DOI 10.1074/jbc.M202959200; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Yan CH, 2003, J BIOL CHEM, V278, P2309, DOI 10.1074/jbc.M210369200; Yao XH, 2008, AM J PHYSIOL-REG I, V294, pR1797, DOI 10.1152/ajpregu.00804.2007; Zhao XY, 2007, FEBS J, V274, P6456, DOI 10.1111/j.1742-4658.2007.06163.x; Zhao ZD, 2003, J IMMUNOL, V170, P5674, DOI 10.4049/jimmunol.170.11.5674	29	49	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42152	10.1371/journal.pone.0042152	http://dx.doi.org/10.1371/journal.pone.0042152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879913	Green Published, Green Submitted, gold			2022-12-27	WOS:000307810000018
J	Qin, XH; Li, JP; Zhang, Y; Ma, W; Fan, FF; Wang, BY; Xing, HX; Tang, GF; Wang, XB; Xu, X; Xu, XP; Huo, Y				Qin, Xianhui; Li, Jianping; Zhang, Yan; Ma, Wei; Fan, Fangfang; Wang, Binyan; Xing, Houxun; Tang, Genfu; Wang, Xiaobin; Xu, Xin; Xu, Xiping; Huo, Yong			Prevalence and Associated Factors of Diabetes and Impaired Fasting Glucose in Chinese Hypertensive Adults Aged 45 to 75 Years	PLOS ONE			English	Article							RISK-FACTORS; METABOLIC SYNDROME; POPULATION; DISEASE; METAANALYSIS; MELLITUS; C677T; MEN; POLYMORPHISMS; HOMOCYSTEINE	Objective: This study examined the prevalence of impaired fasting glucose (IFG) and diabetes and their associated factors in 17,184 Chinese hypertensive adults aged 45-75 years. Methods: A cross-sectional investigation was carried out in a rural area of Lianyungang, China. Previously undiagnosed diabetes [fasting plasma glucose (FPG) >= 7.0mmol/l] and IFG (6.1-6.9mmol/l) were defined based on FPG concentration. Previously diagnosed diabetes was determined on the basis of self-report. Total diabetes included both previously diagnosed diabetes and previously undiagnosed diabetes. Results: The prevalence of previously diagnosed diabetes, undiagnosed diabetes, and IFG were 3.4%, 9.8%, and 14.1%, respectively. About 74.2% of the participants with diabetes had not previously been diagnosed. In the multivariable logistic-regression model, older age, men, antihypertensive treatment, obesity (BMI >= 25kg/m(2)), abdominal obesity (waist circumference >= 90cm for men and >= 80cm for women), non-current smoking, a family history of diabetes, higher heart rate, lower physical activity levels, and inland residence (versus coastal) were significantly associated with both total diabetes and previously undiagnosed diabetes. Furthermore, methylene-tetrahydrofolate reductase (MTHFR) 677 TT genotype was an independent associated factor for total diabetes, and current alcohol drinking was an independent associated factor for previously undiagnosed diabetes. At the same time, older age, men, abdominal obesity, non-current smoking, current alcohol drinking, a family history of diabetes, higher heart rate, and inland residence (versus coastal) were important independent associated factors for IFG. Conclusion: In conclusion, we found a high prevalence of diabetes in Chinese hypertensive adults. Furthermore, about three out of every four diabetic adults were undiagnosed. Our results suggest that population-level measures aimed at the prevention, identification (even if only based on the FPG evaluation), and treatment of diabetes should be urgently taken to overcome the diabetes epidemic in Chinese hypertensive adults.	[Qin, Xianhui; Wang, Binyan] Anhui Med Univ, Inst Biomed, Hefei, Peoples R China; [Li, Jianping; Zhang, Yan; Ma, Wei; Fan, Fangfang; Huo, Yong] Peking Univ, Hosp 1, Dept Cardiol, Beijing 100871, Peoples R China; [Xing, Houxun] Lianyungang Ctr Adv Res Cardiovasc Dis, Lianyungang, Peoples R China; [Tang, Genfu] Anhui Med Univ, Sch Hlth Adm, Hefei, Peoples R China; [Wang, Xiaobin] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Early Life Origins Dis, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Xu, Xin; Xu, Xiping] So Med Univ, Inst Nephrol, Guangzhou, Guangdong, Peoples R China	Anhui Medical University; Peking University; Anhui Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Southern Medical University - China	Qin, XH (corresponding author), Anhui Med Univ, Inst Biomed, Hefei, Peoples R China.	xipingxu18@gmail.com; huoyong@263.net.cn	Xu, Xin/A-1687-2016; Fan, Fang/GRO-2696-2022; fan, fang/GQY-9173-2022	Xu, Xin/0000-0002-6324-5211; Qin, Xianhui/0000-0001-7812-7982	Ministry of Science and Technology of the People's Republic of China [2012zx09101-105]; Major State Basic Research Development Program of China (973 program) [2012CB517703]; Department of Development and Reform, Shenzhen [(2010)1744]; Department of Science, Industry, Trade and Information Technology, Shenzhen	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); Department of Development and Reform, Shenzhen; Department of Science, Industry, Trade and Information Technology, Shenzhen	The study was supported by The Ministry of Science and Technology of the People's Republic of China (2012zx09101-105); The Major State Basic Research Development Program of China (973 program, No.2012CB517703); Department of Development and Reform, Shenzhen (2010)1744; Department of Science, Industry, Trade and Information Technology, Shenzhen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belalcazar LM, 2010, DIABETES CARE, V33, P197, DOI 10.2337/dc09-1235; Benes P, 2001, MOL GENET METAB, V73, P188, DOI 10.1006/mgme.2001.3188; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Chang YH, 2011, CLIN BIOCHEM, V44, P1370, DOI 10.1016/j.clinbiochem.2011.09.020; Department of Noncommunicable Disease Surveillance, 1999, DEF DIAGN CLASS DI 1; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Feng Y, 2006, OBESITY, V14, P2089, DOI 10.1038/oby.2006.244; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6; Iimura O, 1996, Hypertens Res, V19 Suppl 1, pS1, DOI 10.1291/hypres.19.SupplementI_S1; International Diabetes Federation, IDF CONS WORLDW DEF; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Movva S, 2011, GENET TEST MOL BIOMA, V15, P257, DOI 10.1089/gtmb.2010.0118; Mozaffarian D, 2007, LANCET, V370, P667, DOI 10.1016/S0140-6736(07)61343-9; Njolstad I, 1998, AM J EPIDEMIOL, V147, P49; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Pedersen MH, 2010, J PEDIATR-US, V157, P395, DOI 10.1016/j.jpeds.2010.04.001; Qian XQ, 2007, EUR J HUM GENET, V15, P1239, DOI 10.1038/sj.ejhg.5201914; Qin XH, 2012, PHARMACOGENET GENOM, V22, P421, DOI 10.1097/FPC.0b013e32834ac5e8; Qin XH, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-2; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shi ZM, 2010, NEW ENGL J MED, V362, P2425, DOI 10.1056/NEJMc1004671; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Sun ZQ, 2009, ACTA CARDIOL, V64, P351, DOI 10.2143/AC.64.3.2038021; *WHO W PAC REG INT, 2000, AS PAC PERSP RED OB; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang SC, 2009, OBESITY, V17, P1581, DOI 10.1038/oby.2009.125; Zhang XL, 2010, INT J EPIDEMIOL, V39, P900, DOI 10.1093/ije/dyq068	31	30	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42538	10.1371/journal.pone.0042538	http://dx.doi.org/10.1371/journal.pone.0042538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880024	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100124
J	Tang, YT; Ho, G; Li, YX; Hall, MA; Hills, RL; Black, SC; Liang, Y; Demarest, KT				Tang, Yuting; Ho, George; Li, Yaxin; Hall, Meghan A.; Hills, Robert L.; Black, Shawn C.; Liang, Yin; Demarest, Keith T.			Beneficial Metabolic Effects of CB1R Anti-Sense Oligonucleotide Treatment in Diet-Induced Obese AKR/J Mice	PLOS ONE			English	Article							RECEPTOR ANTAGONIST SR141716; ENDOCANNABINOID SYSTEM; CANNABINOID RECEPTOR; ADIPOSE-TISSUE; INSULIN SENSITIVITY; GLUCOSE-UPTAKE; RIMONABANT; EXPRESSION; CB2; STEATOSIS	An increasing amount of evidence supports pleiotropic metabolic roles of the cannibinoid-1 receptor (CB1R) in peripheral tissues such as adipose, liver, skeletal muscle and pancreas. To further understand the metabolic consequences of specific blockade of CB1R function in peripheral tissues, we performed a 10-week-study with an anti-sense oligonucleotide directed against the CB1R in diet-induced obese (DIO) AKR/J mice. DIO AKR/J mice were treated with CB1R ASO Isis-414930 (6.25, 12.5 and 25 mg/kg/week) or control ASO Isis-141923 (25 mg/kg/week) via intraperitoneal injection for 10 weeks. At the end of the treatment, CB1R mRNA from the 25 mg/kg/week CB1R ASO group in the epididymal fat and kidney was decreased by 81% and 63%, respectively. Body weight gain was decreased in a dose-dependent fashion, significantly different in the 25 mg/kg/week CB1R ASO group (46.1 +/- 1.0 g vs veh, 51.2 +/- 0.9 g, p<0.05). Body fat mass was reduced in parallel with attenuated body weight gain. CB1R ASO treatment led to decreased fed glucose level (at week 8, 25 mg/kg/week group, 145 +/- 4 mg/dL vs veh, 195 +/- 10 mg/dL, p<0.05). Moreover, CB1R ASO treatment dose-dependently improved glucose excursion during an oral glucose tolerance test, whereas control ASO exerted no effect. Liver steatosis was also decreased upon CB1R ASO treatment. At the end of the study, plasma insulin and leptin levels were significantly reduced by 25 mg/kg/week CB1R ASO treatment. SREBP1 mRNA expression was decreased in both epididymal fat and liver. G6PC and fatty acid translocase/CD36 mRNA levels were also reduced in the liver. In summary, CB1R ASO treatment in DIO AKR/J mice led to improved insulin sensitivity and glucose homeostasis. The beneficial effects of CB1R ASO treatment strongly support the notion that selective inhibition of the peripheral CB1R, without blockade of central CB1R, may serve as an effective approach for treating type II diabetes, obesity and the metabolic syndrome.	[Tang, Yuting; Ho, George; Li, Yaxin; Hall, Meghan A.; Hills, Robert L.; Black, Shawn C.; Liang, Yin; Demarest, Keith T.] Janssen Pharmaceut Co, Cardiovasc & Metab Therapeut Area, Johnson & Johnson, Spring House, PA USA	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson USA	Tang, YT (corresponding author), Janssen Pharmaceut Co, Cardiovasc & Metab Therapeut Area, Johnson & Johnson, Spring House, PA USA.	ytang69@yahoo.com			Janssen Pharmaceutical Companies of Johnson and Johnson	Janssen Pharmaceutical Companies of Johnson and Johnson	The study was funded by Janssen Pharmaceutical Companies of Johnson and Johnson. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo J, 2010, DIABETOLOGIA, V53, P2629, DOI 10.1007/s00125-010-1894-6; Baldassano S, 2008, EUR J PHARMACOL, V582, P132, DOI 10.1016/j.ejphar.2007.12.016; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Bermudez-Silva FJ, 2008, DIABETOLOGIA, V51, P476, DOI 10.1007/s00125-007-0890-y; Bermudez-Silva FJ, 2010, PHARMACOL BIOCHEM BE, V95, P375, DOI 10.1016/j.pbb.2010.03.012; Bermudez-Silva FJ, 2009, BEST PRACT RES CL EN, V23, P87, DOI 10.1016/j.beem.2008.10.012; Bermudez-Silva FJ, 2007, EUR J PHARMACOL, V565, P207, DOI 10.1016/j.ejphar.2007.02.066; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Chang LC, 2009, J FORMOS MED ASSOC, V108, P353, DOI 10.1016/S0929-6646(09)60079-6; Cigolini M, 1999, ATHEROSCLEROSIS, V143, P81, DOI 10.1016/S0021-9150(98)00281-0; Corbille AG, 2007, J NEUROSCI, V27, P6937, DOI 10.1523/JNEUROSCI.3936-06.2007; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cote M, 2005, J CLIN ENDOCR METAB, V90, P1434, DOI 10.1210/jc.2004-1711; Crespillo A, 2011, BIOCHEM J, V433, P175, DOI 10.1042/BJ20100751; Croci T, 1998, BRIT J PHARMACOL, V125, P1393, DOI 10.1038/sj.bjp.0702190; De Gottardi A, 2010, LIVER INT, V30, P1482, DOI 10.1111/j.1478-3231.2010.02298.x; Despres JP, 2009, CURR PHARM DESIGN, V15, P553, DOI 10.2174/138161209787315666; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Esposito I, 2008, MOL PHARMACOL, V74, P1678, DOI 10.1124/mol.108.049205; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Friedman SL, 2008, CELL METAB, V7, P187, DOI 10.1016/j.cmet.2008.02.002; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Getty-Kaushik L, 2009, OBESITY, V17, P1856, DOI 10.1038/oby.2009.234; Gomez R, 2002, J NEUROSCI, V22, P9612; Ishac EJN, 1996, BRIT J PHARMACOL, V118, P2023, DOI 10.1111/j.1476-5381.1996.tb15639.x; Janero DR, 2009, EXPERT OPIN EMERG DR, V14, P43, DOI [10.1517/14728210902736568 , 10.1517/14728210902736568]; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Jiang LS, 2009, CARDIOVASC RES, V81, P805, DOI 10.1093/cvr/cvn344; Jourdan T, 2010, DIABETES, V59, P926, DOI 10.2337/db09-1482; Jumpertz R, 2011, J CLIN ENDOCR METAB, V96, P787, DOI 10.1210/jc.2010-2028; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; Liu YL, 2005, INT J OBESITY, V29, P183, DOI 10.1038/sj.ijo.0802847; Lobo SM, 2012, CYTOKINE IN PRESS; Marsenic O, 2009, AM J KIDNEY DIS, V53, P875, DOI 10.1053/j.ajkd.2008.12.031; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Mendez-Sanchez N, 2007, LIVER INT, V27, P215, DOI 10.1111/j.1478-3231.2006.01401.x; Migrenne S, 2009, AM J PHYSIOL-REG I, V296, pR929, DOI 10.1152/ajpregu.90824.2008; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Moezi L, 2006, BRIT J PHARMACOL, V149, P898, DOI 10.1038/sj.bjp.0706928; Nakata M, 2008, REGUL PEPTIDES, V145, P49, DOI 10.1016/j.regpep.2007.08.009; Osei-Hyiaman D, 2005, NEUROENDOCRINOLOGY, V81, P273, DOI 10.1159/000087925; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pagano C, 2007, J CLIN ENDOCR METAB, V92, P4810, DOI 10.1210/jc.2007-0768; Quarta C, 2010, CELL METAB, V11, P273, DOI 10.1016/j.cmet.2010.02.015; Scheen AJ, 2009, CURR PROTEIN PEPT SC, V10, P56, DOI 10.2174/138920309787315149; Silvestri C, 2011, REV ENDOCR METAB DIS, V12, P153, DOI 10.1007/s11154-011-9167-3; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; Stumvoll M, 1998, AM J PHYSIOL-ENDOC M, V274, pE817, DOI 10.1152/ajpendo.1998.274.5.E817; Svizenska I, 2008, PHARMACOL BIOCHEM BE, V90, P501, DOI 10.1016/j.pbb.2008.05.010; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Vemuri VK, 2008, PHYSIOL BEHAV, V93, P671, DOI 10.1016/j.physbeh.2007.11.012; Verty ANA, 2009, OBESITY, V17, P254, DOI 10.1038/oby.2008.509; Wang Q, 2011, OBESITY, V19, P505, DOI 10.1038/oby.2010.213; Watanabe T, 2009, J BIOL CHEM, V284, P1803, DOI 10.1074/jbc.M807120200; Wijesekara N, 2010, J BIOL CHEM, V285, P33623, DOI 10.1074/jbc.M109.085084; Xu XD, 2006, CANCER GENET CYTOGEN, V171, P31, DOI 10.1016/j.cancergencyto.2006.06.014	68	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42134	10.1371/journal.pone.0042134	http://dx.doi.org/10.1371/journal.pone.0042134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870290	Green Published, gold			2022-12-27	WOS:000307284100046
J	Zheng, LL; Li, YX; Ding, J; Guo, XK; Feng, KY; Wang, YJ; Hu, LL; Cai, YD; Hao, P; Chou, KC				Zheng, Lu-Lu; Li, Yi-Xue; Ding, Juan; Guo, Xiao-Kui; Feng, Kai-Yan; Wang, Ya-Jun; Hu, Le-Le; Cai, Yu-Dong; Hao, Pei; Chou, Kuo-Chen			A Comparison of Computational Methods for Identifying Virulence Factors	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN-PROTEIN INTERACTIONS; ANTIBIOTIC-RESISTANCE GENES; ESCHERICHIA-COLI; DATABASE; PREDICTION; PATHOGENICITY; SEQUENCE; NEIGHBORS; SELECTION	Bacterial pathogens continue to threaten public health worldwide today. Identification of bacterial virulence factors can help to find novel drug/vaccine targets against pathogenicity. It can also help to reveal the mechanisms of the related diseases at the molecular level. With the explosive growth in protein sequences generated in the postgenomic age, it is highly desired to develop computational methods for rapidly and effectively identifying virulence factors according to their sequence information alone. In this study, based on the protein-protein interaction networks from the STRING database, a novel network-based method was proposed for identifying the virulence factors in the proteomes of UPEC 536, UPEC CFT073, P. aeruginosa PAO1, L. pneumophila Philadelphia 1, C. jejuni NCTC 11168 and M. tuberculosis H37Rv. Evaluated on the same benchmark datasets derived from the aforementioned species, the identification accuracies achieved by the network-based method were around 0.9, significantly higher than those by the sequence-based methods such as BLAST, feature selection and VirulentPred. Further analysis showed that the functional associations such as the gene neighborhood and co-occurrence were the primary associations between these virulence factors in the STRING database. The high success rates indicate that the network-based method is quite promising. The novel approach holds high potential for identifying virulence factors in many other various organisms as well because it can be easily extended to identify the virulence factors in many other bacterial species, as long as the relevant significant statistical data are available for them.	[Zheng, Lu-Lu; Li, Yi-Xue] Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Hubei, Peoples R China; [Zheng, Lu-Lu; Li, Yi-Xue; Feng, Kai-Yan; Wang, Ya-Jun; Hao, Pei] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Hu, Le-Le; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Hu, Le-Le] Shanghai Univ, Coll Sci, Dept Chem, Shanghai, Peoples R China; [Li, Yi-Xue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Hao, Pei] Chinese Acad Sci, Inst Pasteur Shanghai, Pathogen Diagnost Ctr, Shanghai, Peoples R China; [Wang, Ya-Jun] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China; [Guo, Xiao-Kui] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Med Microbiol & Parasitol, Shanghai 200030, Peoples R China; [Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA; [Ding, Juan] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA USA	Huazhong University of Science & Technology; Chinese Academy of Sciences; Shanghai University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Shanghai Jiao Tong University; Shanghai Jiao Tong University; Harvard University; Harvard Medical School; Schepens Eye Research Institute	Zheng, LL (corresponding author), Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Hubei, Peoples R China.	cai_yud@yahoo.com.cn; phao@sibs.ac.cn	Ding, Juan/L-5149-2013; zheng, lu/GXH-7035-2022; Chou, Kuo-Chen/A-8340-2009	cai, yudong/0000-0001-5664-7979; Guo, Xiao-Kui/0000-0002-1595-9965; Hao, Pei/0000-0002-1498-7059	National Basic Research Program of China [2011CB510102, 2011CB510101, 2012CB517905]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087]; SA-SIBS Scholarship Program	National Basic Research Program of China(National Basic Research Program of China); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); SA-SIBS Scholarship Program	This work was supported by the National Basic Research Program of China (2011CB510102, 2011CB510101, and 2012CB517905) and Innovation Program of Shanghai Municipal Education Commission (12ZZ087). The author PH gratefully acknowledges the support of SA-SIBS Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Brouwers L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022187; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Dyer MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012089; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Falkow S, 2004, NAT REV MICROBIOL, V2, P67, DOI 10.1038/nrmicro799; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-62; Gu JY, 2009, J BACTERIOL, V191, P6262, DOI 10.1128/JB.00475-09; Gulig PA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-512; Hawkins Troy, 2007, J Bioinform Comput Biol, V5, P1, DOI 10.1142/S0219720007002503; He QY, 2008, NUCLEIC ACIDS RES, V36, pD293, DOI 10.1093/nar/gkm832; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Korves T, 2009, TRENDS MICROBIOL, V17, P279, DOI 10.1016/j.tim.2009.04.002; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Liu GM, 2008, GENOME INFORM SER, V21, P138; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Sachdeva G, 2005, BIOINFORMATICS, V21, P483, DOI 10.1093/bioinformatics/bti028; Saha Sudipto, 2006, Genomics Proteomics & Bioinformatics, V4, P42, DOI 10.1016/S1672-0229(06)60015-6; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stanley P, 1998, MICROBIOL MOL BIOL R, V62, P309, DOI 10.1128/MMBR.62.2.309-333.1998; Sui SJH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008094; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; The UC, 2011, NUCLEIC ACIDS RES, V39, pD214; Tsai C.-T., 2009, INT J BIOL LIFE SCI, V5, P80; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Winnenburg R, 2008, NUCLEIC ACIDS RES, V36, pD572, DOI 10.1093/nar/gkm858; Wu HJ, 2008, CURR OPIN CHEM BIOL, V12, P93, DOI 10.1016/j.cbpa.2008.01.023; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou HF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S20	58	29	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42517	10.1371/journal.pone.0042517	http://dx.doi.org/10.1371/journal.pone.0042517			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880014	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100117
J	Blaho, M; Egri, A; Bahidszki, L; Kriska, G; Hegedus, R; Akesson, S; Horvath, G				Blaho, Miklos; Egri, Adam; Bahidszki, Lea; Kriska, Gyorgy; Hegedus, Ramon; Akesson, Susanne; Horvath, Gabor			Spottier Targets Are Less Attractive to Tabanid Flies: On the Tabanid-Repellency of Spotty Fur Patterns	PLOS ONE			English	Article							POLARIZATION VISION; WATER; ADVANTAGE; INSECTS; DIPTERA; HORSE; TRAP	During blood-sucking, female members of the family Tabanidae transmit pathogens of serious diseases and annoy their host animals so strongly that they cannot graze, thus the health of the hosts is drastically reduced. Consequently, a tabanid-resistant coat with appropriate brightness, colour and pattern is advantageous for the host. Spotty coats are widespread among mammals, especially in cattle (Bos primigenius). In field experiments we studied the influence of the size and number of spots on the attractiveness of test surfaces to tabanids that are attracted to linearly polarized light. We measured the reflection-polarization characteristics of living cattle, spotty cattle coats and the used test surfaces. We show here that the smaller and the more numerous the spots, the less attractive the target (host) is to tabanids. We demonstrate that the attractiveness of spotty patterns to tabanids is also reduced if the target exhibits spottiness only in the angle of polarization pattern, while being homogeneous grey with a constant high degree of polarization. Tabanid flies respond strongly to linearly polarized light, and we show that bright and dark parts of cattle coats reflect light with different degrees and angles of polarization that in combination with dark spots on a bright coat surface disrupt the attractiveness to tabanids. This could be one of the possible evolutionary benefits that explains why spotty coat patterns are so widespread in mammals, especially in ungulates, many species of which are tabanid hosts.	[Blaho, Miklos; Egri, Adam; Bahidszki, Lea; Horvath, Gabor] Eotvos Lorand Univ, Inst Phys, Dept Biol Phys, Environm Opt Lab, Budapest, Hungary; [Kriska, Gyorgy] Eotvos Lorand Univ, Inst Biol, Grp Methodol Biol Teaching, Budapest, Hungary; [Kriska, Gyorgy] Hungarian Acad Sci, Ctr Ecol Res, Danube Res Inst, Vacratot, Hungary; [Hegedus, Ramon] Univ Girona, Comp Vis & Robot Grp, Girona, Spain; [Akesson, Susanne] Lund Univ, Ctr Anim Movement Res, Dept Biol, Lund, Sweden	Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Universitat de Girona; Lund University	Blaho, M (corresponding author), Eotvos Lorand Univ, Inst Phys, Dept Biol Phys, Environm Opt Lab, Budapest, Hungary.	susanne.akesson@biol.lu.se	Kriska, György/B-5723-2019; Akesson, Susanne/F-3175-2015	Akesson, Susanne/0000-0001-9039-2180; Kriska, Gyorgy/0000-0003-4271-3167	Hungarian Science Foundation [OTKA K-68462]; European Commission; Swedish Research Council [349-2007-8690]; Centre for Animal Movement Research (CAnMove); Lund University;  [TabaNOid 232366]	Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Animal Movement Research (CAnMove); Lund University; 	This work was supported by the grant OTKA K-68462 from the Hungarian Science Foundation, and the grant TabaNOid 232366 funded by the European Commission under the 7th Framework Programme received by G. Horvath and G. Kriska. Gabor Horvath thanks the German Alexander von Humboldt Foundation for an equipment donation. Susanne Akesson is supported by a project grant from the Swedish Research Council and the Centre for Animal Movement Research (CAnMove) financed by a Linnaeus grant (349-2007-8690) from the Swedish Research Council and Lund University. Ramon Hegedus is a Marie Curie IEF fellow and is grateful for the support of the European Commission. The authors are grateful to Dr. Robert Farkas and Monika Gyurkovszky (Department of Parasitology and Zoology, Faculty of Veterinary Science, Szent Istvan University, Budapest) for the taxonomical determination of the captured tabanids. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN SA, 1991, CAN J ZOOL, V69, P369, DOI 10.1139/z91-057; Allen WL, 2011, P ROY SOC B-BIOL SCI, V278, P1373, DOI 10.1098/rspb.2010.1734; Andersson Malte, 1994; Caro T, 2009, PHILOS T R SOC B, V364, P537, DOI 10.1098/rstb.2008.0221; CLARKE CA, 1966, PROC R SOC SER B-BIO, V165, P424, DOI 10.1098/rspb.1966.0075; CLAYTON DH, 1991, PARASITOL TODAY, V7, P329, DOI 10.1016/0169-4758(91)90211-6; Egri A, 2012, NATURWISSENSCHAFTEN, V99, P407, DOI 10.1007/s00114-012-0916-2; Egri A, 2012, J EXP BIOL, V215, P736, DOI 10.1242/jeb.065540; FINCH VA, 1984, J AGR SCI-CAMBRIDGE, V102, P141, DOI 10.1017/S0021859600041575; FOIL LD, 1989, PARASITOL TODAY, V5, P88, DOI 10.1016/0169-4758(89)90009-4; GODFREY D, 1987, BIOL J LINN SOC, V32, P427, DOI 10.1111/j.1095-8312.1987.tb00442.x; Grant BS, 1999, EVOLUTION, V53, P980; Hall MJR, 1998, MED VET ENTOMOL, V12, P241, DOI 10.1046/j.1365-2915.1998.00107.x; Horvath G, 1997, J EXP BIOL, V200, P1155; Horvath G, 2004, POLARIZED LIGHT ANIM, P447; Horvath G, 2008, NATURWISSENSCHAFTEN, V95, P1093, DOI 10.1007/s00114-008-0425-5; Horvath G, 2010, P ROY SOC B-BIOL SCI, V277, P1643, DOI 10.1098/rspb.2009.2202; Kriska G, 2009, J INSECT PHYSIOL, V55, P1167, DOI 10.1016/j.jinsphys.2009.08.013; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Lerner A, 2008, J EXP BIOL, V211, P3536, DOI 10.1242/jeb.022277; Majer J, 1987, FAUNA HUNGARIAE, V14, P1; Mihok S, 2012, MED VET ENTOMOL, V26, P282, DOI 10.1111/j.1365-2915.2011.00999.x; Mihok S, 2002, B ENTOMOL RES, V92, P385, DOI 10.1079/BER2002186; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Ortolani Alessia, 1996, P132; SCHWIND R, 1995, J COMP PHYSIOL A, V177, P439; SCHWIND R, 1991, J COMP PHYSIOL A, V169, P531; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; WALSBERG GE, 1983, BIOSCIENCE, V33, P88, DOI 10.2307/1309169; Wildermuth H, 1998, NATURWISSENSCHAFTEN, V85, P297, DOI 10.1007/s001140050504	30	30	31	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41138	10.1371/journal.pone.0041138	http://dx.doi.org/10.1371/journal.pone.0041138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876282	Green Published, Green Submitted, gold			2022-12-27	WOS:000307184700010
J	Li, RM; Song, DS; Zhu, ZB; Xu, HH; Liu, SW				Li, Runming; Song, Deshou; Zhu, Zhibo; Xu, Hanhong; Liu, Shuwen			An Induced Pocket for the Binding of Potent Fusion Inhibitor CL-385319 with H5N1 Influenza Virus Hemagglutinin	PLOS ONE			English	Article							ENERGY SIMULATIONS REVEAL; AIM TOPOLOGICAL ANALYSIS; VIRAL MEMBRANE-FUSION; A VIRUS; CONFORMATIONAL-CHANGE; ELECTRONIC DENSITY; GENERALIZED BORN; RECEPTOR-BINDING; PEPTIDE MUTANTS; HYDROGEN-BONDS	The influenza glycoprotein hemagglutinin (HA) plays crucial roles in the early stage of virus infection, including receptor binding and membrane fusion. Therefore, HA is a potential target for developing anti-influenza drugs. Recently, we characterized a novel inhibitor of highly pathogenic H5N1 influenza virus, CL-385319, which specifically inhibits HA-mediated viral entry. Studies presented here identified the critical binding residues for CL-385319, which clustered in the stem region of the HA trimer by site-directed mutagenesis. Extensive computational simulations, including molecular docking, molecular dynamics simulations, molecular mechanics generalized Born surface area (MM_GBSA) calculations, charge density and Laplacian calculations, have been carried out to uncover the detailed molecular mechanism that underlies the binding of CL-385319 to H5N1 influenza virus HA. It was found that the recognition and binding of CL-385319 to HA proceeds by a process of "induced fit" whereby the binding pocket is formed during their interaction. Occupation of this pocket by CL-385319 stabilizes the neutral pH structure of hemagglutinin, thus inhibiting the conformational rearrangements required for membrane fusion. This "induced fit" pocket may be a target for structure-based design of more potent influenza fusion inhibitors.	[Li, Runming; Zhu, Zhibo; Liu, Shuwen] So Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Song, Deshou; Xu, Hanhong] S China Agr Univ, Key Lab Nat Pesticides & Chem Biol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; South China Agricultural University	Li, RM (corresponding author), So Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.	liusw@smu.edu.cn		Liu, Shuwen/0000-0001-6346-5006; Xu, Han-Hong/0000-0001-7841-2396	Natural Science Foundation of China [30772602]; foundation from Key Laboratory of Prevention and Control of Emerging Infectious Diseases of Guangdong Higher Education Institutes [KLB09007]; Guangdong Pearl River Scholar Funded Scheme	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); foundation from Key Laboratory of Prevention and Control of Emerging Infectious Diseases of Guangdong Higher Education Institutes; Guangdong Pearl River Scholar Funded Scheme	This work was supported by the Natural Science Foundation of China (30772602), the foundation from Key Laboratory of Prevention and Control of Emerging Infectious Diseases of Guangdong Higher Education Institutes (KLB09007) and the Guangdong Pearl River Scholar Funded Scheme to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; Bader R. F. W., 1990, ATOMS MOL QUANTUM TH; Biegler-Konig F., 2002, AIM 2000 VERSION 2 0; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Cross KJ, 2001, EMBO J, V20, P4432, DOI 10.1093/emboj/20.16.4432; Das P, 2009, J COMPUT CHEM, V30, P1654, DOI 10.1002/jcc.21274; Epand RM, 2001, BIOCHEMISTRY-US, V40, P8800, DOI 10.1021/bi0107187; Feig M, 2004, J CHEM PHYS, V120, P903, DOI 10.1063/1.1631258; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; Frisch M.J., 2009, GAUSSIAN 09 REVIS D0; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Ilyushina NA, 2007, J GEN VIROL, V88, P1266, DOI 10.1099/vir.0.82256-0; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kim CS, 2011, J BIOL CHEM, V286, P13226, DOI 10.1074/jbc.M110.181297; KOCH U, 1995, J PHYS CHEM-US, V99, P9747, DOI 10.1021/j100024a016; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Liu SW, 2011, EUR J PHARMACOL, V660, P460, DOI 10.1016/j.ejphar.2011.04.013; Louit G, 2003, PHYSCHEMCOMM, V6, P1, DOI 10.1039/b210911e; Louit G, 2002, PHYSCHEMCOMM, V5, P94, DOI 10.1039/b204736e; Luo GX, 1997, J VIROL, V71, P4062, DOI 10.1128/JVI.71.5.4062-4070.1997; Luo GX, 1996, VIROLOGY, V226, P66, DOI 10.1006/viro.1996.0628; LYBRAND TP, 1986, P NATL ACAD SCI USA, V83, P833, DOI 10.1073/pnas.83.4.833; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Plotch SJ, 1999, J VIROL, V73, P140, DOI 10.1128/JVI.73.1.140-151.1999; Popelier PLA, 1998, J PHYS CHEM A, V102, P1873, DOI 10.1021/jp9805048; Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Reed ML, 2010, J VIROL, V84, P1527, DOI 10.1128/JVI.02069-09; Reed ML, 2009, J VIROL, V83, P3568, DOI 10.1128/JVI.02238-08; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; STEINHAUER DA, 1995, J VIROL, V69, P6643, DOI 10.1128/JVI.69.11.6643-6651.1995; Steinhauer DA, 1996, P NATL ACAD SCI USA, V93, P12873, DOI 10.1073/pnas.93.23.12873; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; WEIS WI, 1990, EMBO J, V9, P17, DOI 10.1002/j.1460-2075.1990.tb08075.x; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Xia Z, 2012, BIOPHYS J, V102, P1453, DOI 10.1016/j.bpj.2012.01.043; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10; Yoshimoto J, 1999, ARCH VIROL, V144, P865, DOI 10.1007/s007050050552; Zhou RH, 2008, J PHYS CHEM B, V112, P15813, DOI 10.1021/jp805529z	48	10	11	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41956	10.1371/journal.pone.0041956	http://dx.doi.org/10.1371/journal.pone.0041956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876294	Green Published, Green Submitted			2022-12-27	WOS:000307184700022
J	Li, YQ; Low, HQ; Foo, JN; Darabi, H; Einarsdottir, K; Humphreys, K; Spurdle, A; Easton, DF; Thompson, DJ; Dunning, AM; Pharoah, PDP; Czene, K; Chia, KS; Hall, P; Liu, JJ				Li, Yuqing; Low, Hui-Qi; Foo, Jia Nee; Darabi, Hatef; Einarsdottir, Kristjana; Humphreys, Keith; Spurdle, Amanda; Easton, Douglas F.; Thompson, Deborah J.; Dunning, Alison M.; Pharoah, Paul D. P.; Czene, Kamila; Chia, Kee Seng; Hall, Per; Liu, Jianjun		ANECS Grp	Genetic Variants in ER Cofactor Genes and Endometrial Cancer Risk	PLOS ONE			English	Article							NUCLEAR RECEPTOR COREGULATORS; GENOME-WIDE ASSOCIATION; ESTROGEN; COACTIVATOR; EXPRESSION	Given that the transcriptional regulatory activity of estrogen receptor (ER) is modulated by its biochemical cofactors, genetic variation within the ER cofactor genes may alter cellular response to estrogen exposure and consequently modify the risk for endometrial cancer. We genotyped 685 tagging SNPs within 60 ER cofactor genes in 564 endometrial cancer cases and 1,510 controls from Sweden, and tested their associations with the risk of endometrial cancer. We investigated the associations of individual SNPs by using a trend test as well as multiple SNPs within a gene or gene complex by using multi-variant association analysis. No significant association was observed for any individual SNPs or genes, but a marginal association of the cumulative genetic variation of the NCOA2 complex as a whole (NCOA2, CARM1, CREBBP, PRMT1 and EP300) with endometrial cancer risk was observed (P-adjusted = 0.033). However, the association failed to be replicated in an independent European dataset of 1265 cases and 5190 controls (P = 0.71). The results indicate that common genetic variants within ER cofactor genes are unlikely to play a significant role in endometrial cancer risk in European population.	[Li, Yuqing; Low, Hui-Qi; Foo, Jia Nee; Liu, Jianjun] Genome Inst Singapore, Singapore, Singapore; [Darabi, Hatef; Humphreys, Keith; Czene, Kamila; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Einarsdottir, Kristjana] Univ Western Australia, Telethon Inst Child Hlth Res, Nedlands, WA 6009, Australia; [Spurdle, Amanda] Queensland Inst Med Res, Div Genet & Populat Hlth, Brisbane, Qld 4006, Australia; [ANECS Grp] Queensland Inst Med Res, Australian Natl Endometrial Canc Study ANECS Grp, Brisbane, Qld 4006, Australia; [Easton, Douglas F.; Thompson, Deborah J.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Dunning, Alison M.; Pharoah, Paul D. P.] Univ Cambridge, Dept Oncol, Cambridge, England; [Chia, Kee Seng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet; Telethon Kids Institute; University of Western Australia; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Cambridge; University of Cambridge; National University of Singapore	Li, YQ (corresponding author), Genome Inst Singapore, Singapore, Singapore.	liuj3@gis.a-star.edu.sg	Einarsdóttir, Kristjana/E-8337-2011; Spurdle, Amanda B/A-4978-2011; Pharoah, Paul/V-6658-2019; Nicklin, James L/F-8035-2013; Foo, Jia Nee/D-6069-2014; Liu, Jianjun/AAK-4989-2020	Einarsdóttir, Kristjana/0000-0003-4931-7650; Spurdle, Amanda B/0000-0003-1337-7897; Pharoah, Paul/0000-0001-8494-732X; Nicklin, James L/0000-0001-5857-3723; Foo, Jia Nee/0000-0001-9899-2308; Liu, Jianjun/0000-0002-3255-3019; Czene, Kamila/0000-0002-3233-5695; Dunning, Alison Margaret/0000-0001-6651-7166	American Cancer Society; National Institutes of Health; Department of Defense; Swedish Cancer Society; Swedish Research Council; Agency for Science, Technology and Research of Singapore (A*STAR); National Health and Medical Research Council of Australia [339435]; Cancer Council Queensland [4196615]; Cancer Council Tasmania [403031, 457636]; Cancer Research UK [C490/A10124]; National Health and Medical Research Council [552402]; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02, 085475]; Cancer Research UK [11022, 10118] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; MRC [G0000934] Funding Source: UKRI	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Agency for Science, Technology and Research of Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Research UK(Cancer Research UK); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This discovery dataset was supported by funding from American Cancer Society, National Institutes of Health, Department of Defense, Swedish Cancer Society, Swedish Research Council and the Agency for Science, Technology and Research of Singapore (A*STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The validation dataset was funded as follows: ANECS recruitment was supported by project grants from the National Health and Medical Research Council of Australia (ID#339435), The Cancer Council Queensland (ID#4196615) and Cancer Council Tasmania (ID#403031 and ID#457636). SEARCH recruitment was funded by a programme grant from Cancer Research UK [C490/A10124]. Case genotyping was supported by the National Health and Medical Research Council (ID#552402). Control data was generated by the Wellcome Trust Case Control Consortium (WTCCC)2, and a full list of the investigators who contributed to the generation of the data is available from the WTCCC website. The authors acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. Funding for this project was provided by the Wellcome Trust under award 085475. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Arafa M, 2010, PATHOLOGY, V42, P613, DOI 10.3109/00313025.2010.520307; Balmer NN, 2006, MODERN PATHOL, V19, P1593, DOI 10.1038/modpathol.3800696; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Einarsdottir K, 2007, HUM MOL GENET, V16, P154, DOI 10.1093/hmg/ddl451; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; KEY TJA, 1988, BRIT J CANCER, V57, P205, DOI 10.1038/bjc.1988.44; Lee YH, 2005, P NATL ACAD SCI USA, V102, P3611, DOI 10.1073/pnas.0407159102; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Li YQ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2817; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Low YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001012; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; O'Malley BW, 2006, SCIENCE, V313, P1749, DOI 10.1126/science.1132509; Olson SH, 2007, AM J EPIDEMIOL, V165, P235, DOI 10.1093/aje/kwk015; ONATE SA, 1995, SCIENCE, V270, P1354; Pathirage N, 2006, FERTIL STERIL, V86, P469, DOI 10.1016/j.fertnstert.2005.12.057; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rose PG, 1996, NEW ENGL J MED, V335, P640, DOI 10.1056/NEJM199608293350907; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Setiawan VW, 2009, CANCER EPIDEM BIOMAR, V18, P242, DOI 10.1158/1055-9965.EPI-08-0689; Spurdle AB, 2011, NAT GENET, V43, P451, DOI 10.1038/ng.812; Tyrer J, 2006, GENET EPIDEMIOL, V30, P636, DOI 10.1002/gepi.20175; Weiderpass E, 1999, LANCET, V353, P1824, DOI 10.1016/S0140-6736(98)10233-7	32	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42445	10.1371/journal.pone.0042445	http://dx.doi.org/10.1371/journal.pone.0042445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876322	Green Submitted, Green Published, gold			2022-12-27	WOS:000307184700050
J	Ramsberg, J; Asseburg, C; Henriksson, M				Ramsberg, Joakim; Asseburg, Christian; Henriksson, Martin			Effectiveness and Cost-Effectiveness of Antidepressants in Primary Care: A Multiple Treatment Comparison Meta-Analysis and Cost-Effectiveness Model	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; ASTERISK-D REPORT; SUICIDE; REMISSION; TRIALS	Objective: To determine effectiveness and cost-effectiveness over a one-year time horizon of pharmacological first line treatment in primary care for patients with moderate to severe depression. Design: A multiple treatment comparison meta-analysis was employed to determine the relative efficacy in terms of remission of 10 antidepressants (citalopram, duloxetine escitalopram, fluoxetine, fluvoxamine mirtazapine, paroxetine, reboxetine, sertraline and venlafaxine). The estimated remission rates were then applied in a decision-analytic model in order to estimate costs and quality of life with different treatments at one year. Data Sources: Meta-analyses of remission rates from randomised controlled trials, and cost and quality-of-life data from published sources. Results: The most favourable pharmacological treatment in terms of remission was escitalopram with an 8- to 12-week probability of remission of 0.47. Despite a high acquisition cost, this clinical effectiveness translated into escitalopram being both more effective and having a lower total cost than all other comparators from a societal perspective. From a healthcare perspective, the cost per QALY of escitalopram was (sic)3732 compared with venlafaxine. Conclusion: Of the investigated antidepressants, escitalopram has the highest probability of remission and is the most effective and cost-effective pharmacological treatment in a primary care setting, when evaluated over a one year time-horizon. Small differences in remission rates may be important when assessing costs and cost-effectiveness of antidepressants.	[Ramsberg, Joakim] Karolinska Inst, Dept Learning Informat Management & Eth, Med Management Ctr, Stockholm, Sweden; [Asseburg, Christian] ESiOR Oy, Kuopio, Finland; [Henriksson, Martin] AstraZeneca Nord, Sodertalje, Sweden	Karolinska Institutet; AstraZeneca	Ramsberg, J (corresponding author), Karolinska Inst, Dept Learning Informat Management & Eth, Med Management Ctr, Stockholm, Sweden.	Joakim.ramsberg@vardanalys.se	Ramsberg, Joakim/G-7255-2011; Asseburg, Christian/AAK-2903-2020; Henriksson, Martin/HDN-3507-2022; Ramsberg, Joakim/HGC-3605-2022	Asseburg, Christian/0000-0001-7196-3363; Henriksson, Martin/0000-0003-1699-3185; Ramsberg, Joakim/0000-0002-2578-832X	Innovus; AstraZeneca	Innovus; AstraZeneca(AstraZeneca)	No external funding was received. In 2008 TLV reviewed the reimbursement status of antidepressants in Sweden and that review was the starting point of the current study, but TLV has not funded the production of the current analyses and manuscript. No external funding has been received from any organization. In particular, neither Innovus nor AstraZeneca Nordic (where two of the authors are employees) have in any way funded the study. The work has been carried out in the authors' free time without any involvement from these organizations.	Barbui C, 2007, CLIN EVID; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Claxton K, 2008, PHARMACOECONOMICS, V26, P781, DOI 10.2165/00019053-200826090-00008; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Gilchrist G, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-28; GUZE SB, 1970, BRIT J PSYCHIAT, V117, P437, DOI 10.1192/bjp.117.539.437; Hansen RA, 2005, ANN INTERN MED, V143, P415, DOI 10.7326/0003-4819-143-6-200509200-00006; Keller MB, 2003, JAMA-J AM MED ASSOC, V289, P3152, DOI 10.1001/jama.289.23.3152; Kennedy SH, 2001, CAN J PSYCHIAT, V46, p38S; Khan A, 2001, INT J NEUROPSYCHOPH, V4, P113, DOI 10.1017/S1461145701002322; Lothgren M, 2004, PRIMARY CARE PSYCHIA, V9, P153, DOI 10.1185/135525705X20375; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Machado M, 2006, CURR MED RES OPIN, V22, P1825, DOI 10.1185/030079906X132415; McGrath PJ, 2006, AM J PSYCHIAT, V163, P1531, DOI 10.1176/appi.ajp.163.9.1531; Melander Hans, 2009, Lakartidningen, V106, P1030; Nasjonalt Kunnskapssenter for Helsetjenesten, 2007, EFF SIKK SSRI ANDR N; National Board of Health and Welfare, 2010, NAT RIKTL VARD DEPR; NICE, 2010, DEPR NICE GUID TREAT; Nierenberg AA, 2001, J CLIN PSYCHIAT, V62, P27; Nierenberg AA, 2006, AM J PSYCHIAT, V163, P1519, DOI 10.1176/appi.ajp.163.9.1519; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Omori IM, 2008, J PSYCHOPHARMACOL; RUNESON B, 1994, ACTA PSYCHIAT SCAND, V90, P222, DOI 10.1111/j.1600-0447.1994.tb01581.x; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; SBU, 2004, BEH DEPR, V1; Sobocki P, 2006, INT J CLIN PRACT, V60, P791, DOI 10.1111/j.1742-1241.2006.00997.x; Sobocki P, 2006, J MENT HEALTH POLICY, V9, P87; Sutton A, 2008, PHARMACOECONOMICS, V26, P753, DOI 10.2165/00019053-200826090-00006; von Knorring L, 2006, EUR PSYCHIAT, V21, P349, DOI 10.1016/j.eurpsy.2006.04.005; Wulsin LR, 1999, PSYCHOSOM MED, V61, P6, DOI 10.1097/00006842-199901000-00003	30	39	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42003	10.1371/journal.pone.0042003	http://dx.doi.org/10.1371/journal.pone.0042003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876296	Green Published, gold, Green Submitted			2022-12-27	WOS:000307184700024
J	Houser, D; Montinari, N; Piovesan, M				Houser, Daniel; Montinari, Natalia; Piovesan, Marco			Private and Public Decisions in Social Dilemmas: Evidence from Children's Behavior	PLOS ONE			English	Article							GAMES	Are selfish impulses less likely to be pursued when decisions are publicly observable? Is the presence of peers a potential solution to social dilemmas? In this paper we report data on the self-control decisions of children aged 6 to 11 who participated in games that require one to resist a selfish impulse for several minutes in order to benefit others. In Public Condition children make decisions in public view of the group of other participants, while in Private Condition they have the possibility to decide privately. We find that children aged 9 and higher are better able to resist selfish impulses in public environments. Younger children, however, display no such effect. Further, we find self-control substantially impacted by group size. When decisions are public, self-control is better in larger groups, while in private condition the opposite holds.	[Houser, Daniel] George Mason Univ, Interdisciplinary Ctr Econ Sci, Fairfax, VA 22030 USA; [Montinari, Natalia] Max Planck Inst Econ, Jena, Germany; [Piovesan, Marco] Univ Copenhagen, Inst Food & Resource Econ, Copenhagen, Denmark	George Mason University; Max Planck Society; University of Copenhagen	Houser, D (corresponding author), George Mason Univ, Interdisciplinary Ctr Econ Sci, Fairfax, VA 22030 USA.	dhouser@gmu.edu		Houser, Daniel/0000-0003-3583-8201; Montinari, Natalia/0000-0002-3718-9367; Piovesan, Marco/0000-0002-5721-3053	Harvard Business School, Division of Research and Faculty Development	Harvard Business School, Division of Research and Faculty Development	Harvard Business School, Division of Research and Faculty Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister RF, 1996, PSYCHOL INQ, V7, P1, DOI 10.1207/s15327965pli0701_1; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Bucciol A., 2010, INT REV EC, V57, P259, DOI DOI 10.1007/S12232-010-0103-8; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; FERGUSON TJ, 1991, CHILD DEV, V62, P827, DOI 10.2307/1131180; Gummerum M, 2010, J ECON PSYCHOL, V31, P25, DOI 10.1016/j.joep.2009.09.002; Guroglu B, 2009, ANN NY ACAD SCI, V1167, P197, DOI 10.1111/j.1749-6632.2009.04502.x; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Hoffman E, 1996, AM ECON REV, V86, P653; Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028; MISCHEL W, 1962, J ABNORM PSYCHOL, V64, P425, DOI 10.1037/h0045046; O'Donoghue T, 2007, HEAT MOMENT MODELLIN; Ostrom E., 1994, RULES GAMES COMMON P; Pan XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018050; Seeley EA, 2003, SELF IDENTITY, V2, P103, DOI 10.1080/15298860309034; Sheldon OJ, 2011, J EXP SOC PSYCHOL, V47, P403, DOI 10.1016/j.jesp.2010.11.003; Takagishi H, 2010, J EXP CHILD PSYCHOL, V105, P130, DOI 10.1016/j.jecp.2009.09.005; Xiao E, 2011, J PUBLIC ECON, V95, P1006, DOI 10.1016/j.jpubeco.2010.11.021	19	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41568	10.1371/journal.pone.0041568	http://dx.doi.org/10.1371/journal.pone.0041568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	984SU	22870230	Green Published, gold			2022-12-27	WOS:000307212800024
J	Rawlinson, KA; Stella, JS				Rawlinson, Kate A.; Stella, Jessica S.			Discovery of the Corallivorous Polyclad Flatworm, Amakusaplana acroporae, on the Great Barrier Reef, Australia - the First Report from the Wild	PLOS ONE			English	Article							CORAL-REEFS; BAND DISEASE; STONY CORALS; PREDATORS; DIVERSITY; HEALTH	The role of corallivory is becoming increasingly recognised as an important factor in coral health at a time when coral reefs around the world face a number of other stressors. The polyclad flatworm, Amakusaplana acroporae, is a voracious predator of Indo-Pacific acroporid corals in captivity, and its inadvertent introduction into aquaria has lead to the death of entire coral colonies. While this flatworm has been a pest to the coral aquaculture community for over a decade, it has only been found in aquaria and has never been described from the wild. Understanding its biology and ecology in its natural environment is crucial for identifying viable biological controls for more successful rearing of Acropora colonies in aquaria, and for our understanding of what biotic interactions are important to coral growth and fitness on reefs. Using morphological, histological and molecular techniques we determine that a polyclad found on Acropora valida from Lizard Island, Australia is A. acroporae. The presence of extracellular Symbiodinium in the gut and parenchyma and spirocysts in the gut indicates that it is a corallivore in the wild. The examination of a size-range of individuals shows maturation of the sexual apparatus and increases in the number of eyes with increased body length. Conservative estimates of abundance show that A. acroporae occurred on 7 of the 10 coral colonies collected, with an average of 2.6 +/- 0.65 (mean +/- SE) animals per colony. This represents the first report of A. acroporae in the wild, and sets the stage for future studies of A. acroporae ecology and life history in its natural habitat.	[Rawlinson, Kate A.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Stella, Jessica S.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Stella, Jessica S.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Stella, Jessica S.] CSIRO, Climate Adaptat Flagship, Hobart, Tas, Australia	Dalhousie University; James Cook University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Rawlinson, KA (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	k.rawlinson@dal.ca			Yugilbar Foundation; Lizard Island Research Station - a facility of the Australian Museum; Great Barrier Reef Marine Park Authority Science for Management Award; Natural Sciences and Engineering Research Council of Canada [A5056]	Yugilbar Foundation; Lizard Island Research Station - a facility of the Australian Museum; Great Barrier Reef Marine Park Authority Science for Management Award; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Animal collection and field work was funded by the Yugilbar Foundation and Lizard Island Research Station - a facility of the Australian Museum and the Great Barrier Reef Marine Park Authority Science for Management Award awarded to J.S. Stella. Morphological and molecular analysis was funded by the Natural Sciences and Engineering Research Council of Canada grant (A5056) awarded to B. K. Hall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Bouchet P, 2002, BIOL J LINN SOC, V75, P421, DOI 10.1046/j.1095-8312.2002.00052.x; CASTRO P, 1988, SYMBIOSIS, V5, P161; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; FAUBEL A, 1984, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V81, P189; Faubel A, 1983, MITTEILUNGEN HAMBURG, V80, P189; Haapkyla J, 2007, J MAR BIOL ASSOC UK, V87, P403, DOI 10.1017/S0025315407055828; Haapkyla J, 2009, DIS AQUAT ORGAN, V87, P105, DOI 10.3354/dao02160; Holleman JJ, 1998, HYDROBIOLOGIA, V383, P61, DOI 10.1023/A:1003488905205; JOKIEL PL, 1974, PAC SCI, V28, P361; Kato K., 1940, Japanese Journal of Zoology, V8, P537; Kato K., 1937, Japanese Journal of Zoology, V7, P347; Laidlaw FF, 1906, P ZOOL SOC LOND, V1906, P705; Lang A, 1884, FAUNA FLORA GOLFES N, P688; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Nosratpour F, 2008, ADV CORAL HUSBANDRY, P37; ORMOND R F G, 1976, Marine Behaviour and Physiology, V4, P93; Ostman C, 2000, SCI MAR, V64, P31; PATTON WK, 1994, B MAR SCI, V55, P193; POULTER JL, 1975, PAC SCI, V29, P317; Prudhoe S, 1985, MONOGRAPH POLYCLAD T; Rawlinson KA, 2011, CORAL REEFS, V30, P693, DOI 10.1007/s00338-011-0745-3; Richards Z, 2008, ACROPORA VALIDA IUCN; Rinkevich B, 2005, ENVIRON SCI TECHNOL, V39, P4333, DOI 10.1021/es0482583; ROBERTSON R, 1970, PAC SCI, V24, P43; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; Stella JS, 2010, CORAL REEFS, V29, P957, DOI 10.1007/s00338-010-0648-8; Stella JS, 2011, OCEANOGR MAR BIOL, V49, P43; Stewart HL, 2006, CORAL REEFS, V25, P609, DOI 10.1007/s00338-006-0132-7; Sussman M, 2003, ENVIRON MICROBIOL, V5, P250, DOI 10.1046/j.1462-2920.2003.00424.x; Sweet M, 2012, J MAR BIOL ASSOC UK, V92, P791, DOI 10.1017/S0025315411001688; TURNER SJ, 1994, CORAL REEFS, V13, P41, DOI 10.1007/BF00426434; WALLACE CC, 1994, ANNU REV ECOL SYST, V25, P237, DOI 10.1146/annurev.es.25.110194.001321; WINSOR L, 1990, Memoirs of the Queensland Museum, V28, P785	36	15	15	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42240	10.1371/journal.pone.0042240	http://dx.doi.org/10.1371/journal.pone.0042240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870308	Green Accepted, Green Published, gold			2022-12-27	WOS:000307212800071
J	Brons, S; van Beusichem, ME; Bronkhorst, EM; Draaisma, J; Berge, SJ; Maal, TJ; Kuijpers-Jagtman, AM				Brons, Sander; van Beusichem, Machteld E.; Bronkhorst, Ewald M.; Draaisma, Jos; Berge, Stefaan J.; Maal, Thomas J.; Kuijpers-Jagtman, Anne Marie			Methods to Quantify Soft-Tissue Based Facial Growth and Treatment Outcomes in Children: A Systematic Review	PLOS ONE			English	Article							UNILATERAL CLEFT-LIP; EARLY CRANIOFACIAL MORPHOLOGY; RAPID MAXILLARY EXPANSION; PROFILE CHANGES; CEPHALOMETRIC ANALYSIS; PALATE; RELIABILITY; QUALITY; DISTRACTION; ADVANCEMENT	Context: Technological advancements have led craniofacial researchers and clinicians into the era of three-dimensional digital imaging for quantitative evaluation of craniofacial growth and treatment outcomes. Objective: To give an overview of soft-tissue based methods for quantitative longitudinal assessment of facial dimensions in children until six years of age and to assess the reliability of these methods in studies with good methodological quality. Data Source: PubMed, EMBASE, Cochrane Library, Web of Science, Scopus and CINAHL were searched. A hand search was performed to check for additional relevant studies. Study Selection: Primary publications on facial growth and treatment outcomes in children younger than six years of age were included. Data Extraction: Independent data extraction by two observers. A quality assessment instrument was used to determine the methodological quality. Methods, used in studies with good methodological quality, were assessed for reliability expressed as the magnitude of the measurement error and the correlation coefficient between repeated measurements. Results: In total, 47 studies were included describing 4 methods: 2D x-ray cephalometry; 2D photography; anthropometry; 3D imaging techniques (surface laser scanning, stereophotogrammetry and cone beam computed tomography). In general the measurement error was below 1 mm and 1 degrees and correlation coefficients range from 0.65 to 1.0. Conclusion: Various methods have shown to be reliable. However, at present stereophotogrammetry seems to be the best 3D method for quantitative longitudinal assessment of facial dimensions in children until six years of age due to its millisecond fast image capture, archival capabilities, high resolution and no exposure to ionizing radiation.	[Brons, Sander; van Beusichem, Machteld E.; Kuijpers-Jagtman, Anne Marie] Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands; [Bronkhorst, Ewald M.] Radboud Univ Nijmegen, Med Ctr, Dept Prevent & Curat Dent, NL-6525 ED Nijmegen, Netherlands; [Draaisma, Jos] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Med, NL-6525 ED Nijmegen, Netherlands; [Berge, Stefaan J.; Maal, Thomas J.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Brons, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands.	orthodontics@dent.umcn.nl	Bergé, S.J./H-8011-2014; Brons, Sander/I-2714-2018; Bronkhorst, Ewald/L-4230-2015; Berge, Stefaan/AAP-3708-2020; Draaisma, J.M.T./L-4283-2015; Bronkhorst, Ewald/AAR-2250-2020; Maal, Thomas JJ/L-4497-2015; Kuijpers-Jagtman, Anne Marie/A-9413-2008	Brons, Sander/0000-0001-5263-4804; Bronkhorst, Ewald/0000-0003-0953-8053; Maal, Thomas JJ/0000-0002-1702-4733; Kuijpers-Jagtman, Anne Marie/0000-0001-8172-0090; Draaisma, Jos/0000-0003-4829-6173	Dutch Technology Foundation [10315]	Dutch Technology Foundation(Technologiestichting STW)	This work was supported by a grant from the Dutch Technology Foundation to STW (grant no. 10315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlBarakati SF, 2012, DENTOMAXILLOFAC RAD, V41, P11, DOI 10.1259/dmfr/37010910; Aldridge K, 2005, AM J MED GENET A, V138A, P247, DOI 10.1002/ajmg.a.30959; Altug-Atac AT, 2008, PLAST RECONSTR SURG, V121, P1751, DOI 10.1097/PRS.0b013e31816aa003; Aynechi N, 2011, ANGLE ORTHOD, V81, P245, DOI 10.2319/041810-210.1; Ayoub A, 2003, CLEFT PALATE-CRAN J, V40, P523, DOI 10.1597/02-067; Bartzela TN, 2011, INT J ORAL MAX SURG, V40, P782, DOI 10.1016/j.ijom.2011.02.029; Bennun RD, 1999, PLAST RECONSTR SURG, V104, P616, DOI 10.1097/00006534-199909030-00002; BISHARA SE, 1985, AM J ORTHOD DENTOFAC, V88, P466, DOI 10.1016/S0002-9416(85)80046-4; Bishara SE, 1997, ANGLE ORTHOD, V67, P55; Bishara SE, 1998, AM J ORTHOD DENTOFAC, V114, P698, DOI 10.1016/S0889-5406(98)70203-3; BISHARA SE, 1984, AM J ORTHOD DENTOFAC, V85, P238, DOI 10.1016/0002-9416(84)90063-0; BISHARA SE, 1985, AM J ORTHOD DENTOFAC, V88, P209, DOI 10.1016/S0002-9416(85)90216-7; Boluyt N, 2008, ARCH PEDIAT ADOL MED, V162, P111, DOI 10.1001/archpediatrics.2007.40; Bongaarts CAM, 2009, CLEFT PALATE-CRAN J, V46, P654, DOI 10.1597/08-034.1; Broadbent BH, 1931, ANGLE ORTHOD, V1, P45, DOI [10.1043/0003-3219(1981)051<0093:ANXTAI>2.0.CO;2, DOI 10.1043/0003-3219(1981)051<0093:ANXTAI>2.0.CO;2, DOI 10.1043/0003-3219(1931)001<0045:ANXTAI>2.0.CO;2]; Castelo PM, 2010, ANN ANAT, V192, P23, DOI 10.1016/j.aanat.2009.10.002; Cevidanes LHS, 2011, ORAL SURG ORAL MED O, V111, P757, DOI 10.1016/j.tripleo.2011.02.002; Chien-Jung B, 2005, CLEFT PALATE-CRAN J, V42, P658, DOI 10.1597/04-126.1; Clark HD, 1999, CONTROL CLIN TRIALS, V20, P448, DOI 10.1016/S0197-2456(99)00026-4; COCCARO P J, 1965, Cleft Palate J, V45, P1; Cole TJ, 2011, ANN HUM BIOL, V38, P7, DOI 10.3109/03014460.2011.544139; Cruz AAV, 2008, J CRANIOFAC SURG, V19, P106, DOI 10.1097/scs.0b013e31815c94e1; Daskalogiannakis J, 2006, CLEFT PALATE-CRAN J, V43, P471; Davis JP, 2010, FORENSIC SCI INT, V200, P165, DOI 10.1016/j.forsciint.2010.04.012; de Menezes M, 2010, J ORAL MAXIL SURG, V68, P2129, DOI 10.1016/j.joms.2009.09.036; Djordjevic J, 2011, EUR J ORTHOD; Drew SJ, 2000, J ORAL MAXIL SURG, V58, P969, DOI 10.1053/joms.2000.8798; El-Beialy AR, 2011, AM J ORTHOD DENTOFAC, V140, P157, DOI 10.1016/j.ajodo.2010.03.030; Ezzat CF, 2007, CLEFT PALATE-CRAN J, V44, P8, DOI 10.1597/06-009; FARKAS LG, 1980, PLAST RECONSTR SURG, V66, P346, DOI 10.1097/00006534-198066030-00004; Ferring V, 2008, AM J ORTHOD DENTOFAC, V134, P472, DOI 10.1016/j.ajodo.2007.03.027; Gordon JM, 2009, ANGLE ORTHOD, V79, P1000, DOI 10.2319/082108-441.1; GRABER LW, 1977, AM J ORTHOD DENTOFAC, V72, P23, DOI 10.1016/0002-9416(77)90122-1; Hajeer M Y, 2004, J Orthod, V31, P62, DOI 10.1179/146531204225011346; HANADA K, 1975, AM J ORTHOD DENTOFAC, V67, P363, DOI 10.1016/0002-9416(75)90019-6; Hansen M, 1997, PLAST RECONSTR SURG, V100, P1387, DOI 10.1097/00006534-199711000-00002; Heimer MV, 2008, EUR J ORTHODONT, V30, P580, DOI 10.1093/ejo/cjn035; Hermann NV, 2004, CLEFT PALATE-CRAN J, V41, P424, DOI 10.1597/03-056.1; Hermann NV, 2003, CLEFT PALATE-CRAN J, V40, P373, DOI 10.1597/1545-1569(2003)040<0373:CMAGCI>2.0.CO;2; Hermann NV, 2003, CLEFT PALATE-CRAN J, V40, P131, DOI 10.1597/1545-1569(2003)040<0131:ECMAGI>2.0.CO;2; Hermann NV, 2002, CLEFT PALATE-CRAN J, V39, P604, DOI 10.1597/1545-1569(2002)039<0604:ECMAGI>2.0.CO;2; Hermann NV, 1999, J CRAN GENET DEV BIO, V19, P135; Hodges JS, 2004, J EVID-BASED DENT PR, V4, P24; Hoefert CS, 2010, J OROFAC ORTHOP, V71, P136, DOI 10.1007/s00056-010-9931-0; HOLDAWAY RA, 1983, AM J ORTHOD DENTOFAC, V84, P1, DOI 10.1016/0002-9416(83)90144-6; Hood C A, 2003, Int J Paediatr Dent, V13, P404, DOI 10.1046/j.1365-263X.2003.00496.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kau CH, 2011, AM J ORTHOD DENTOFAC, V139, pE285, DOI 10.1016/j.ajodo.2009.03.054; Ko EW, 2004, CLEFT PALATE-CRAN J, V41, P5, DOI 10.1597/02-132; Ko EWC, 2000, J ORAL MAXIL SURG, V58, P959, DOI 10.1053/joms.2000.8735; Kohout MP, 1998, PLAST RECONSTR SURG, V102, P1339, DOI 10.1097/00006534-199810000-00004; Lagravere MO, 2005, ANGLE ORTHOD, V75, P1046; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liou EJW, 2007, PLAST RECONSTR SURG, V119, P642, DOI 10.1097/01.prs.0000239600.79638.6f; Littlefield TR, 2004, J CRANIOFAC SURG, V15, P175, DOI 10.1097/00001665-200401000-00042; Maal TJJ, 2010, J ORAL MAXIL SURG, V68, P2391, DOI 10.1016/j.joms.2009.10.017; Nada RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016520; Nollet PJPM, 2008, INT J ORAL MAX SURG, V37, P123, DOI 10.1016/j.ijom.2007.09.168; Padwa BL, 1999, PLAST RECONSTR SURG, V104, P1261, DOI 10.1097/00006534-199910000-00004; POSEN JM, 1967, AMER J ORTHODONTICS, V53, P746, DOI 10.1016/0002-9416(67)90119-4; Primozic J, 2009, EUR J ORTHODONT, V31, P352, DOI 10.1093/ejo/cjp041; RAS F, 1995, CLEFT PALATE-CRAN J, V32, P463, DOI 10.1597/1545-1569(1995)032<0463:LSOTDC>2.3.CO;2; Ridgway EB, 2011, J CRANIOFAC SURG, V22, P455, DOI 10.1097/SCS.0b013e3182077d93; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; SADOWSKY C, 1973, ANGLE ORTHOD, V43, P233; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Schuler G, 2007, ANTHROPOL ANZ, V65, P203, DOI 10.1127/anthranz/65/2007/203; Schwenzer-Zimmerer K, 2008, J CRANIO MAXILL SURG, V36, P431, DOI 10.1016/j.jcms.2008.05.003; Seidenstricker-Kink LM, 2008, CLEFT PALATE-CRAN J, V45, P511, DOI 10.1597/07-001.1; SEMB G, 1991, CLEFT PALATE-CRAN J, V28, P22, DOI 10.1597/1545-1569(1991)028<0022:ASOFGI>2.3.CO;2; SEMB G, 1991, CLEFT PALATE-CRAN J, V28, P1, DOI 10.1597/1545-1569(1991)028<0001:ASOFGI>2.3.CO;2; Singh GD, 2005, CLEFT PALATE-CRAN J, V42, P403, DOI 10.1597/04-063.1; SMAHEL Z, 1995, J CRAN GENET DEV BIO, V15, P72; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Subtelny JD, 1959, AM J ORTHOD DENTOFAC, V45, P481, DOI [10.1016/0002-9416(59)90014-4, DOI 10.1016/0002-9416(59)90014-4]; Sultana R, 2000, PLAST RECONSTR SURG, V106, P563, DOI 10.1097/00006534-200009030-00006; Swennen GRJ, 2004, J CRANIOFAC SURG, V15, P399, DOI 10.1097/00001665-200405000-00010; Toma AM, 2008, ORTHOD CRANIOFAC RES, V11, P180, DOI 10.1111/j.1601-6343.2008.00428.x; van Loon B, 2010, INT J ORAL MAX SURG, V39, P534, DOI 10.1016/j.ijom.2010.03.022; van Loon B, 2011, RHINOLOGY, V49, P121, DOI 10.4193/Rhino10.056; VanderWoude DL, 1997, PLAST RECONSTR SURG, V100, P567, DOI 10.1097/00006534-199709000-00001; Wong JY, 2008, CLEFT PALATE-CRAN J, V45, P232, DOI 10.1597/06-175; Yang XX, 2009, J CRANIOFAC SURG, V20, P718, DOI 10.1097/SCS.0b013e3181a2de32; Zettergren-Wijk L, 2006, EUR J ORTHODONT, V28, P319, DOI 10.1093/ejo/cji119	85	35	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e41898	10.1371/journal.pone.0041898	http://dx.doi.org/10.1371/journal.pone.0041898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879898	Green Published, Green Submitted, gold			2022-12-27	WOS:000307810000011
J	Hui, SK; Sharkey, L; Kidder, LS; Zhang, Y; Fairchild, G; Coghill, K; Xian, CJ; Yee, D				Hui, Susanta K.; Sharkey, Leslie; Kidder, Louis S.; Zhang, Yan; Fairchild, Greg; Coghill, Kayti; Xian, Cory J.; Yee, Douglas			The Influence of Therapeutic Radiation on the Patterns of Bone Marrow in Ovary-Intact and Ovariectomized Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ACUTE HEMATOLOGIC TOXICITY; TOTAL-BODY IRRADIATION; LONG-TERM BONE; STROMAL CELLS; FRACTURE RISK; FAT; OSTEOPOROSIS; OSTEOBLASTOGENESIS; MICROENVIRONMENT	Background: The functional components of bone marrow (i.e., the hematopoietic and stromal populations) and the adjacent bone have traditionally been evaluated incompletely as distinct entities rather than the integrated system. We perturbed this system in vivo using a medically relevant radiation model in the presence or absence of ovarian function to understand integrated tissue interaction. Methodology/Principal Findings: Ovary-intact and ovariectomized mice underwent either no radiation or single fractional 16 Gy radiation to the caudal skeleton (I +/- R, OVX +/- R). Marrow fat, hematopoietic cellularity, and cancellous bone volume fraction (BV/TV %) were assessed. Ovariectomy alone did not significantly reduce marrow cellularity in non-irradiated mice (OVX-R vs. I-R, p = 0.8445) after 30 days; however it impaired the hematopoietic recovery of marrow following radiation exposure (OVX+R vs. I+R, p = 0.0092). The combination of radiation and OVX dramatically increases marrow fat compared to either factor alone (p = 0.0062). The synergistic effect was also apparent in the reduction of hematopoietic marrow cellularity (p = 0.0661); however it was absent in BV/TV% changes (p = 0.2520). The expected inverse relationship between marrow adiposity vs. hematopoietic cellularity and bone volume was observed. Interestingly compared with OVX mice, intact mice demonstrated double the reduction in hematopoietic cellularity and a tenfold greater degree of bone loss for a given unit of expansion in marrow fat. Conclusions/Significance: Ovariectomy prior to delivery of a clinically-relevant focal radiation exposure in mice, exacerbated post-radiation adipose accumulation in the marrow space but blunted bone loss and hematopoietic suppression. In the normally coupled homeostatic relationship between the bone and marrow domains, OVX appears to alter feedback mechanisms. Confirmation of this non-linear phenomenon (presumably due to differential radiosensitivity) and demonstration of the mechanism of action is needed to provide strategies to diminish the effect of radiation on exposed tissues.	[Hui, Susanta K.; Fairchild, Greg; Coghill, Kayti] Univ Minnesota, Sch Med, Dept Therapeut Radiol, Minneapolis, MN 55455 USA; [Sharkey, Leslie] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Hui, Susanta K.; Sharkey, Leslie; Kidder, Louis S.; Zhang, Yan; Yee, Douglas] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Yee, Douglas] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Xian, Cory J.] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst, Adelaide, SA 5001, Australia	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of South Australia	Hui, SK (corresponding author), Univ Minnesota, Sch Med, Dept Therapeut Radiol, Minneapolis, MN 55455 USA.	huixx019@umn.edu	Xian, Cory/D-2646-2009	Xian, Cory/0000-0002-8467-2845; Yee, Douglas/0000-0002-3387-4009	National Institutes of Health [1R01CA154491-01, 1R03AR055333-01A1, 1K12-HD055887-01]; PHS Cancer Center [P30 CA77398]; Minnesota Medical Foundation (MMF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055887] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA077398, R01CA154491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS Cancer Center; Minnesota Medical Foundation (MMF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health grants (1R01CA154491-01, 1R03AR055333-01A1 and 1K12-HD055887-01). This work was also supported by PHS Cancer Center Support Grant P30 CA77398 and the Minnesota Medical Foundation (MMF). Susanta K. Hui is a scholar of the BIRCWH (Building Interdisciplinary Careers in Women's Health) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanei CM, 2012, STEM CELLS DEV, V21, P1604, DOI 10.1089/scd.2011.0390; Abdallah BM, 2012, BONE, V50, P540, DOI 10.1016/j.bone.2011.06.030; Ali Khalil, 2010, AM J OBSTET GYNECOLO, V203; Baxter NN, 2005, JAMA-J AM MED ASSOC, V294, P2587, DOI 10.1001/jama.294.20.2587; Benayahu D, 2000, J CELL BIOCHEM, V79, P407, DOI 10.1002/1097-4644(20001201)79:3<407::AID-JCB60>3.0.CO;2-8; Bernardo ME, 2012, BONE MARROW TRANSPL, V47, P323, DOI 10.1038/bmt.2011.102; Bianco P, 2011, ENDOCRINOLOGY, V152, P2957, DOI 10.1210/en.2011-0217; Blake GM, 2009, BONE, V44, P495, DOI 10.1016/j.bone.2008.11.003; BOYCE RW, 1990, J BONE MINER RES, V5, P947; Chen Z, 2005, ARCH INTERN MED, V165, P552, DOI 10.1001/archinte.165.5.552; Clavin NW, 2008, PLAST RECONSTR SURG, V122, P739, DOI 10.1097/PRS.0b013e318180edaa; Despars G, 2011, EXP HEMATOL, V39, P809, DOI 10.1016/j.exphem.2011.04.008; Elmore SA, 2006, TOXICOL PATHOL, V34, P666, DOI 10.1080/01926230600939971; Fowler JF, 2006, PHYS MED BIOL, V51, pR263, DOI 10.1088/0031-9155/51/13/R16; Greenberger JS, 2009, SEMIN RADIAT ONCOL, V19, P133, DOI 10.1016/j.semradonc.2008.11.006; Greenberger JS, 1996, LEUKEMIA, V10, P514; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; Hui SK, 2012, CALCIFIED TISSUE INT, V90, P40, DOI 10.1007/s00223-011-9547-4; Imai Y, 2009, ANN NY ACAD SCI, V1173, pE31, DOI 10.1111/j.1749-6632.2009.04954.x; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; Kim YY, 2010, MOL CELLS, V29, P277, DOI 10.1007/s10059-010-0027-x; Li JY, 2011, P NATL ACAD SCI USA, V108, P768, DOI 10.1073/pnas.1013492108; Liu SB, 2011, CELL BIOCHEM BIOPHYS, V61, P539, DOI 10.1007/s12013-011-9236-y; Ma J, 2007, HAEMATOLOGICA, V92, P889, DOI 10.3324/haematol.11106; MARTIN RB, 1991, BONE, V12, P123, DOI 10.1016/8756-3282(91)90011-7; Mell LK, 2008, INT J RADIAT ONCOL, V70, P1431, DOI 10.1016/j.ijrobp.2007.08.074; MEUNIER P, 1971, CLIN ORTHOP RELAT R, P147, DOI 10.1097/00003086-197110000-00021; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; Rodriguez JP, 2008, CURR STEM CELL RES T, V3, P208, DOI 10.2174/157488808785740325; Rodriguez JP, 2000, J CELL BIOCHEM, V79, P557, DOI 10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H; Rose BS, 2012, INT J RADIAT ONCOL, V83, P1185, DOI 10.1016/j.ijrobp.2011.09.048; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Tong XQ, 1998, ACTA RADIOL, V39, P620, DOI 10.3109/02841859809175486; Travlos GS, 2006, TOXICOL PATHOL, V34, P566, DOI 10.1080/01926230600964706; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; Tyagi AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021216; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Zhang H, 2011, CURR MOL MED, V11, P489, DOI 10.2174/156652411796268704; Zhu L, 2009, INT J EXP PATHOL, V90, P512, DOI 10.1111/j.1365-2613.2009.00661.x	43	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42668	10.1371/journal.pone.0042668	http://dx.doi.org/10.1371/journal.pone.0042668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880075	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000307810000059
J	Attar, CH; Finckh, B; Buchel, C				Attar, Catherine Hindi; Finckh, Barbara; Buechel, Christian			The Influence of Serotonin on Fear Learning	PLOS ONE			English	Article							ACUTE TRYPTOPHAN DEPLETION; ORBITOFRONTAL CORTEX; 5-HTTLPR GENOTYPE; REWARD VALUE; PREDICTION; PAIN; AMYGDALA; NEURONS; CHLOROPHENYLALANINE; ACQUISITION	Learning of associations between aversive stimuli and predictive cues is the basis of Pavlovian fear conditioning and is driven by a mismatch between expectation and outcome. To investigate whether serotonin modulates the formation of such aversive cue-outcome associations, we used functional magnetic resonance imaging (fMRI) and dietary tryptophan depletion to reduce brain serotonin (5-HT) levels in healthy human subjects. In a Pavlovian fear conditioning paradigm, 5-HT depleted subjects compared to a non-depleted control group exhibited attenuated autonomic responses to cues indicating the upcoming of an aversive event. These results were closely paralleled by reduced aversive learning signals in the amygdala and the orbitofrontal cortex, two prominent structures of the neural fear circuit. In agreement with current theories of serotonin as a motivational opponent system to dopamine in fear learning, our data provide first empirical evidence for a role of serotonin in representing formally derived learning signals for aversive events.	[Attar, Catherine Hindi; Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Finckh, Barbara] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Attar, CH (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	c.hindi-attar@uke.uni-hamburg.de			DFG, German Research Foundation	DFG, German Research Foundation(German Research Foundation (DFG))	This work was supported by the DFG, German Research Foundation (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Blair KS, 2008, PSYCHOPHARMACOLOGY, V196, P29, DOI 10.1007/s00213-007-0920-y; BRODY JF, 1970, PSYCHOPHARMACOLOGIA, V17, P14, DOI 10.1007/BF00402088; Bromberg-Martin ES, 2010, J NEUROSCI, V30, P6262, DOI 10.1523/JNEUROSCI.0015-10.2010; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Carr GV, 2011, PSYCHOPHARMACOLOGY, V213, P265, DOI [10.1007/s00213-010-1832-9, 10.1007/s00213-010-2097-z]; Clarke HF, 2007, CEREB CORTEX, V17, P18, DOI 10.1093/cercor/bhj120; Clarke HF, 2008, J NEUROSCI, V28, P10972, DOI 10.1523/JNEUROSCI.1521-08.2008; Clarke HF, 2005, J NEUROSCI, V25, P532, DOI 10.1523/JNEUROSCI.3690-04.2005; Cools R, 2008, NEUROPSYCHOPHARMACOL, V33, P2291, DOI 10.1038/sj.npp.1301598; Cools R, 2011, NEUROPSYCHOPHARMACOL, V36, P98, DOI 10.1038/npp.2010.121; Crockett MJ, 2012, MOL PSYCHIATR, V17, P121, DOI 10.1038/mp.2011.106; Crockett MJ, 2009, J NEUROSCI, V29, P11993, DOI 10.1523/JNEUROSCI.2513-09.2009; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dayan P, 2009, ANNU REV NEUROSCI, V32, P95, DOI 10.1146/annurev.neuro.051508.135607; Evers EAT, 2005, NEUROPSYCHOPHARMACOL, V30, P1138, DOI 10.1038/sj.npp.1300663; Finger EC, 2007, NEUROPSYCHOPHARMACOL, V32, P206, DOI 10.1038/sj.npp.1301182; Freedman LJ, 2001, NEUROSCIENCE, V104, P1067, DOI 10.1016/S0306-4522(01)00157-9; Glascher J, 2005, NEURON, V47, P295, DOI 10.1016/j.neuron.2005.06.008; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Knight DC, 2003, P NATL ACAD SCI USA, V100, P15280, DOI 10.1073/pnas.2535780100; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Miyazaki K, 2011, J NEUROSCI, V31, P469, DOI 10.1523/JNEUROSCI.3714-10.2011; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; Nakamura K, 2008, J NEUROSCI, V28, P5331, DOI 10.1523/JNEUROSCI.0021-08.2008; Nemeroff CB, 2009, CLIN CHEM, V55, P1578, DOI 10.1373/clinchem.2009.123752; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Robinson OJ, 2012, PSYCHOPHARMACOLOGY, V219, P599, DOI 10.1007/s00213-011-2410-5; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schweimer JV, 2010, NEUROSCIENCE, V171, P1209, DOI 10.1016/j.neuroscience.2010.09.058; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; Seymour B, 2012, J NEUROSCI, V32, P5833, DOI 10.1523/JNEUROSCI.0053-12.2012; SOUBRIE P, 1986, BEHAV BRAIN SCI, V9, P319, DOI 10.1017/S0140525X00022871; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; TENEN SS, 1967, PSYCHOPHARMACOLOGIA, V10, P204, DOI 10.1007/BF00401382; van Donkelaar EL, 2011, MOL PSYCHIATR, V16, P695, DOI 10.1038/mp.2011.9; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; Walker SC, 2009, CEREB CORTEX, V19, P889, DOI 10.1093/cercor/bhn136; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; YOUNG SN, 1985, PSYCHOPHARMACOLOGY, V87, P173, DOI 10.1007/BF00431803	46	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42397	10.1371/journal.pone.0042397	http://dx.doi.org/10.1371/journal.pone.0042397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879964	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100078
J	Desgent, S; Duss, S; Sanon, NT; Lema, P; Levesque, M; Hebert, D; Rebillard, RM; Bibeau, K; Brochu, M; Carmant, L				Desgent, Sebastien; Duss, Sandra; Sanon, Nathalie T.; Lema, Pablo; Levesque, Maxime; Hebert, David; Rebillard, Rose-Marie; Bibeau, Karine; Brochu, Michele; Carmant, Lionel			Early-Life Stress Is Associated with Gender-Based Vulnerability to Epileptogenesis in Rat Pups	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; PROLONGED FEBRILE SEIZURES; METHYL-D-ASPARTATE; LONG-TERM; PRENATAL STRESS; IMMATURE RAT; CEREBRAL MICROGYRIA; RECURRENT SEIZURES; PYRAMIDAL NEURONS; BRAIN-DEVELOPMENT	During development, the risk of developing mesial temporal lobe epilepsy (MTLE) increases when the developing brain is exposed to more than one insult in early life. Early life insults include abnormalities of cortical development, hypoxic-ischemic injury and prolonged febrile seizures. To study epileptogenesis, we have developed a two-hit model of MTLE characterized by two early-life insults: a freeze lesion-induced cortical malformation at post-natal day 1 (P1), and a prolonged hyperthermic seizure (HS) at P10. As early life stressors lead to sexual dimorphism in both acute response and long-term outcome, we hypothesized that our model could lead to gender-based differences in acute stress response and long-term risk of developing MTLE. Male and female pups underwent a freeze-lesion induced cortical microgyrus at P1 and were exposed to HS at P10. Animals were monitored by video-EEG from P90 to P120. Pre and post-procedure plasma corticosterone levels were used to measure stress response at P1 and P10. To confirm the role of sex steroids, androgenized female pups received daily testosterone injections to the mother pre-natally and post-natally for nine days while undergoing both insults. We demonstrated that after both insults females did not develop MTLE while all males did. This correlated with a rise in corticosterone levels at P1 following the lesion in males only. Interestingly, all androgenized females showed a similar rise in corticosterone at P1, and also developed MTLE. Moreover, we found that the cortical lesion significantly decreased the latency to generalized convulsion during hyperthermia at P10 in both genders. The cortical dysplasia volumes at adulthood were also similar between male and female individuals. Our data demonstrate sexual dimorphism in long-term vulnerability to develop epilepsy in the lesion + hyperthermia animal model of MTLE and suggest that the response to early-life stress at P1 contributes significantly to epileptogenesis in a gender-specific manner.	[Desgent, Sebastien; Duss, Sandra; Sanon, Nathalie T.; Lema, Pablo; Levesque, Maxime; Hebert, David; Rebillard, Rose-Marie; Bibeau, Karine; Brochu, Michele; Carmant, Lionel] Univ Montreal, Ctr Rech, Ctr Hosp Univ St Justine, Montreal, PQ, Canada; [Desgent, Sebastien; Brochu, Michele; Carmant, Lionel] Univ Montreal, Dept Physiol, Fac Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Desgent, S (corresponding author), Univ Montreal, Ctr Rech, Ctr Hosp Univ St Justine, Montreal, PQ, Canada.	sebastien.desgent@umontreal.ca; lionel.carmant@umontreal.ca			Epilepsy Canada,Toronto (Ontario) Canada; SAVOY epilepsy foundation, Saint-Jean-sur-Richelieu (Quebec) Canada; Foundation of the CHU Sainte-Justine Hospital; foundation of the stars, Montreal (Quebec) Canada; Steriade-SAVOY foundation; foundation of the stars scholarship, Montreal (Quebec) Canada	Epilepsy Canada,Toronto (Ontario) Canada; SAVOY epilepsy foundation, Saint-Jean-sur-Richelieu (Quebec) Canada; Foundation of the CHU Sainte-Justine Hospital; foundation of the stars, Montreal (Quebec) Canada; Steriade-SAVOY foundation; foundation of the stars scholarship, Montreal (Quebec) Canada	S. Desgent was supported by postdoctoral research awards from: Epilepsy Canada,Toronto (Ontario) Canada; the SAVOY epilepsy foundation, Saint-Jean-sur-Richelieu (Quebec) Canada and the Foundation of the CHU Sainte-Justine Hospital and the foundation of the stars, Montreal (Quebec) Canada. Fondation Savoy Epilepsy to LC. ML obtained the Steriade-SAVOY foundation award, Saint-Jean-sur-Richelieu (Quebec) Canada and the Foundation of the CHU Sainte-Justine Hospital and the foundation of the stars scholarship, Montreal (Quebec) Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali I, 2011, PSYCHOPHARMACOLOGY, V214, P155, DOI 10.1007/s00213-010-2125-z; BARAM TZ, 1991, DEV BRAIN RES, V61, P97, DOI 10.1016/0165-3806(91)90118-3; Baram TZ, 1997, DEV BRAIN RES, V98, P265, DOI 10.1016/S0165-3806(96)00190-3; Briellmann RS, 2000, NEUROLOGY, V55, P1479, DOI 10.1212/WNL.55.10.1479; Burnham W McIntyre, 2006, Adv Neurol, V97, P351; Carmant L, 2007, M S-MED SCI, V23, P929, DOI 10.1051/medsci/20072311929; Carrer HF, 2003, J NEUROSCI, V23, P6338; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Dube C, 2000, ANN NEUROL, V47, P336, DOI 10.1002/1531-8249(200003)47:3<336::AID-ANA9>3.0.CO;2-W; Dube CM, 2010, J NEUROSCI, V30, P7484, DOI 10.1523/JNEUROSCI.0551-10.2010; Dube CM, 2009, BRAIN DEV-JPN, V31, P366, DOI 10.1016/j.braindev.2008.11.010; DVORAK K, 1977, ACTA NEUROPATHOL, V38, P203; Edwards HE, 2002, HORM BEHAV, V42, P437, DOI 10.1006/hbeh.2002.1839; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Frye CA, 1999, DEV PSYCHOBIOL, V34, P227; Galanopoulou AS, 2008, EPILEPSY RES, V80, P99, DOI 10.1016/j.eplepsyres.2008.04.013; Galanopoulou AS, 2008, J NEUROSCI, V28, P1557, DOI 10.1523/JNEUROSCI.5180-07.2008; Galanopoulou AS, 2003, EXP NEUROL, V183, P628, DOI 10.1016/S0014-4886(03)00213-9; GALLAGHER BB, 1984, EPILEPSIA, V25, P683, DOI 10.1111/j.1528-1157.1984.tb03477.x; Gibbs S, 2011, NEUROBIOL DIS, V43, P312, DOI 10.1016/j.nbd.2011.02.013; Gibbs SA, 2008, NEUROBIOL DIS, V32, P176, DOI 10.1016/j.nbd.2008.07.005; Giorgi FS, 2007, NEUROBIOL DIS, V25, P73, DOI 10.1016/j.nbd.2006.08.009; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hamed SA, 2008, NEUROLOGIST, V14, P157, DOI 10.1097/NRL.0b013e3181618ada; Heida JG, 2005, EPILEPSIA, V46, P1906, DOI 10.1111/j.1528-1167.2005.00294.x; Herman AE, 1997, CEREB CORTEX, V7, P453, DOI 10.1093/cercor/7.5.453; Huang LT, 2002, EPILEPSIA, V43, P1141, DOI 10.1046/j.1528-1157.2002.14602.x; Janszky J, 2004, J NEUROL NEUROSUR PS, V75, P773, DOI 10.1136/jnnp.2003.020941; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Joels M, 2009, EPILEPSIA, V50, P586, DOI 10.1111/j.1528-1167.2008.01902.x; Jones NC, 2009, BEHAV BRAIN RES, V203, P81, DOI 10.1016/j.bbr.2009.04.023; Karst H, 1999, EUR J NEUROSCI, V11, P889, DOI 10.1046/j.1460-9568.1999.00495.x; Koe AS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.024.2009; Kumar G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024033; Lai Ming-Chi, 2008, Pediatr Neonatol, V49, P19, DOI 10.1016/S1875-9572(08)60006-6; Li J, 2009, J AUTISM DEV DISORD, V39, P1047, DOI 10.1007/s10803-009-0717-4; Liu MY, 2009, RESTOR NEUROL NEUROS, V27, P163, DOI 10.3233/RNN-2009-0467; McEwen BS, 2001, HUM PSYCHOPHARM CLIN, V16, pS7, DOI 10.1002/hup.266; Mejias-Aponte CA, 2002, BRAIN RES, V944, P210, DOI 10.1016/S0006-8993(02)02691-4; Mouton P.R., 2002, PRINCIPLES PRACTICES, Vx; Mouton PR, 2011, UNBIAISED STEREOLOGY; Nunez JL, 2008, EXP NEUROL, V210, P699, DOI 10.1016/j.expneurol.2008.01.001; Ouardouz M, 2010, EUR J NEUROSCI, V31, P1252, DOI 10.1111/j.1460-9568.2010.07159.x; Paxinos G, 2009, COMPACT; Peternel S, 2009, PROG NEURO-PSYCHOPH, V33, P456, DOI 10.1016/j.pnpbp.2009.01.005; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Roselli CE, 1998, ENDOCRINOLOGY, V139, P3193, DOI 10.1210/en.139.7.3193; ROSEN GD, 1992, J NEUROPATH EXP NEUR, V51, P601, DOI 10.1097/00005072-199211000-00005; Rosen GD, 1999, CEREB CORTEX, V9, P27, DOI 10.1093/cercor/9.1.27; ROSEN JB, 1994, NEUROSCI LETT, V174, P113, DOI 10.1016/0304-3940(94)90132-5; Rudick CN, 2001, J NEUROSCI, V21, P6532, DOI 10.1523/JNEUROSCI.21-17-06532.2001; Saberi M, 2001, EPILEPSY RES, V46, P45, DOI 10.1016/S0920-1211(01)00257-1; Salzberg M, 2007, EPILEPSIA, V48, P2079, DOI 10.1111/j.1528-1167.2007.01246.x; Sanon N, 2012, ATYPICAL FEBRILE SEI, V1, P9; Sawyer NT, 2010, J CLIN NEUROPHYSIOL, V27, P445, DOI 10.1097/WNP.0b013e3181fe0573; Scantlebury MH, 2005, ANN NEUROL, V58, P41, DOI 10.1002/ana.20512; Scantlebury MH, 2004, EPILEPSIA, V45, P592, DOI 10.1111/j.0013-9580.2004.51503.x; Scantlebury MH, 2010, EPILEPSY RES, V89, P27, DOI 10.1016/j.eplepsyres.2009.11.002; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Weinstock M, 2007, NEUROCHEM RES, V32, P1730, DOI 10.1007/s11064-007-9339-4; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zamani MR, 2004, NEUROSCIENCE, V129, P243, DOI 10.1016/j.neuroscience.2004.06.082	64	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42622	10.1371/journal.pone.0042622	http://dx.doi.org/10.1371/journal.pone.0042622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880055	Green Submitted, gold, Green Published			2022-12-27	WOS:000307284100144
J	Gross, H; Hennard, C; Masouris, I; Cassel, C; Barth, S; Stober-Grasser, U; Mamiani, A; Moritz, B; Ostareck, D; Ostareck-Lederer, A; Neuenkirchen, N; Fischer, U; Deng, W; Leonhardt, H; Noessner, E; Kremmer, E; Grasser, FA				Gross, Henrik; Hennard, Christine; Masouris, Ilias; Cassel, Christian; Barth, Stephanie; Stober-Graesser, Ute; Mamiani, Alfredo; Moritz, Bodo; Ostareck, Dirk; Ostareck-Lederer, Antje; Neuenkirchen, Nils; Fischer, Utz; Deng, Wen; Leonhardt, Heinrich; Noessner, Elfriede; Kremmer, Elisabeth; Graesser, Friedrich A.			Binding of the Heterogeneous Ribonucleoprotein K (hnRNP K) to the Epstein-Barr Virus Nuclear Antigen 2 (EBNA2) Enhances Viral LMP2A Expression	PLOS ONE			English	Article							PROTEIN ARGININE METHYLTRANSFERASE; MOTOR-NEURON PROTEIN; RNA-POLYMERASE-II; MESSENGER-RNA; C-MYC; GENE-EXPRESSION; SPLICING FACTOR; DOWN-REGULATION; LIVING CELLS; SM PROTEINS	The Epstein-Barr Virus (EBV) -encoded EBNA2 protein, which is essential for the in vitro transformation of B-lymphocytes, interferes with cellular processes by binding to proteins via conserved sequence motifs. Its Arginine-Glycine (RG) repeat element contains either symmetrically or asymmetrically di-methylated arginine residues (SDMA and ADMA, respectively). EBNA2 binds via its SDMA-modified RG-repeat to the survival motor neurons protein (SMN) and via the ADMA-RG-repeat to the NP9 protein of the human endogenous retrovirus K (HERV-K (HML-2) Type 1). The hypothesis of this work was that the methylated RG-repeat mimics an epitope shared with cellular proteins that is used for interaction with target structures. With monoclonal antibodies against the modified RG-repeat, we indeed identified cellular homologues that apparently have the same surface structure as methylated EBNA2. With the SDMA-specific antibodies, we precipitated the Sm protein D3 (SmD3) which, like EBNA2, binds via its SDMA-modified RG-repeat to SMN. With the ADMA-specific antibodies, we precipitated the heterogeneous ribonucleoprotein K (hnRNP K). Specific binding of the ADMA-antibody to hnRNP K was demonstrated using E. coli expressed/ADMA-methylated hnRNP K. In addition, we show that EBNA2 and hnRNP K form a complex in EBV-infected B-cells. Finally, hnRNP K, when co-expressed with EBNA2, strongly enhances viral latent membrane protein 2A (LMP2A) expression by an unknown mechanism as we did not detect a direct association of hnRNP K with DNA-bound EBNA2 in gel shift experiments. Our data support the notion that the methylated surface of EBNA2 mimics the surface structure of cellular proteins to interfere with or co-opt their functional properties.	[Gross, Henrik; Cassel, Christian; Barth, Stephanie; Stober-Graesser, Ute; Mamiani, Alfredo; Graesser, Friedrich A.] Univ Saarland, Inst Virol, Sch Med, D-6650 Homburg, Germany; [Hennard, Christine; Masouris, Ilias; Noessner, Elfriede; Kremmer, Elisabeth] German Res Ctr Environm Hlth, Inst Mol Immunol, Helmholtz Zentrum Munchen, Munich, Germany; [Moritz, Bodo] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Halle, Saale, Germany; [Ostareck, Dirk; Ostareck-Lederer, Antje] Rhein Westfal TH Aachen, Expt Res Unit, Dept Intens Care & Intermediate Care, Univ Hosp Aachen, Aachen, Germany; [Neuenkirchen, Nils; Fischer, Utz] Univ Wurzburg, Dept Biochem, Bioctr, Wurzburg, Germany; [Deng, Wen; Leonhardt, Heinrich] Univ Munich, Dept Biol, Ctr Integrated Prot Sci Munich, Planegg Martinsried, Germany	Saarland University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Martin Luther University Halle Wittenberg; RWTH Aachen University; RWTH Aachen University Hospital; University of Wurzburg; University of Munich	Gross, H (corresponding author), Univ Saarland, Inst Virol, Sch Med, D-6650 Homburg, Germany.	graesser@uks.eu	Fischer, Utz/AAT-8422-2020; Fischer, Utz/A-4090-2016; Leonhardt, Heinrich/B-2791-2014; Deng, Wen/GQH-3160-2022	Fischer, Utz/0000-0002-1465-6591; Fischer, Utz/0000-0002-1465-6591; Deng, Wen/0000-0003-3062-7843; Ostareck-Lederer, Antje/0000-0003-0733-7071; Ostareck, Dirk/0000-0001-9406-7190	Deutsche Forschungsgemeinschaft [KR2218/2-1, OS290/3-2, GR950/12-1]; BioImaging Network Munich; Chinese Scholarship Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BioImaging Network Munich; Chinese Scholarship Council(China Scholarship Council)	This work was supported by Deutsche Forschungsgemeinschaft through grant KR2218/2-1 to EK, OS290/3-2 to AO-L and DHO and GR950/12-1 to FG and the BioImaging Network Munich to HL. WD was supported by the Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph D, 2007, MOL CELL BIOL, V27, P1758, DOI 10.1128/MCB.02014-06; ALFIERI C, 1991, VIROLOGY, V181, P595, DOI 10.1016/0042-6822(91)90893-G; Barth S, 2003, J VIROL, V77, P5008, DOI 10.1128/JVI.77.8.5008-5013.2003; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; BENBASSAT H, 1977, INT J CANCER, V19, P27, DOI 10.1002/ijc.2910190105; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bornkamm GW, 2001, PHILOS T R SOC B, V356, P437, DOI 10.1098/rstb.2000.0781; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Cancian L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002164; Chan JYH, 2009, FEBS LETT, V583, P281, DOI 10.1016/j.febslet.2008.12.025; COHEN JI, 1991, J VIROL, V65, P2545, DOI 10.1128/JVI.65.5.2545-2554.1991; Cook JR, 2006, BIOCHEM BIOPH RES CO, V342, P472, DOI 10.1016/j.bbrc.2006.01.167; Crawford DH, 2001, PHILOS T R SOC B, V356, P461, DOI 10.1098/rstb.2000.0783; Dambacher S, 2012, NUCLEUS, V3; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Forsman A, 2008, J PROTEOME RES, V7, P2309, DOI 10.1021/pr700769e; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Fuentes-Panana EM, 2000, J VIROL, V74, P8166, DOI 10.1128/JVI.74.17.8166-8175.2000; Garcia-Jurado G, 2011, HYBRIDOMA, V30, P53, DOI 10.1089/hyb.2010.0081; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; GRASSER FA, 1991, J VIROL, V65, P3779; Gross H, 2011, INT J CANCER, V129, P1105, DOI 10.1002/ijc.25760; Gross H, 2010, VIROLOGY, V397, P299, DOI 10.1016/j.virol.2009.11.023; Grundhoff AT, 1999, J BIOL CHEM, V274, P19136, DOI 10.1074/jbc.274.27.19136; HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657; Hennard C, 2006, J PATHOL, V209, P430, DOI 10.1002/path.1996; Hsieh TY, 1998, J BIOL CHEM, V273, P17651, DOI 10.1074/jbc.273.28.17651; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kaiser C, 1999, J VIROL, V73, P4481, DOI 10.1128/JVI.73.5.4481-4484.1999; Kieff E, 2007, FIELDS VIROLOGY, P2603; KREMMER E, 1995, VIROLOGY, V208, P336, DOI 10.1006/viro.1995.1157; Lau JS, 2000, J CELL BIOCHEM, V79, P395, DOI 10.1002/1097-4644(20001201)79:3<395::AID-JCB50>3.0.CO;2-M; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee Jeongbok, 2004, [Journal of Korean Oral Literature, 구비문학연구], V19, P19; Lee MH, 1996, J BIOL CHEM, V271, P3420; Li H, 2010, J BIOL CHEM, V285, P17789, DOI 10.1074/jbc.M109.082057; LING PD, 1995, J VIROL, V69, P1944, DOI 10.1128/JVI.69.3.1944-1950.1995; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Maier S, 2005, J VIROL, V79, P8784, DOI 10.1128/JVI.79.14.8784-8792.2005; Marchand V, 2011, RNA BIOL, V8, P325, DOI 10.4161/rna.8.2.13984; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Melcak I, 2000, MOL BIOL CELL, V11, P497, DOI 10.1091/mbc.11.2.497; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Mikula M, 2011, J BIOL CHEM, V286, P9763, DOI 10.1074/jbc.M110.213330; Naarmann IS, 2008, J BIOL CHEM, V283, P18461, DOI 10.1074/jbc.M710328200; Naarmann IS, 2010, RNA, V16, P2189, DOI 10.1261/rna.2211110; Neugebauer KM, 1997, GENE DEV, V11, P1148, DOI 10.1101/gad.11.9.1148; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; PAIK WK, 1967, BIOCHEM BIOPH RES CO, V29, P14, DOI 10.1016/0006-291X(67)90533-5; RICKINSON AB, 1987, J VIROL, V61, P1310, DOI 10.1128/JVI.61.5.1310-1317.1987; Ritchie SA, 2003, NUCLEIC ACIDS RES, V31, P1502, DOI 10.1093/nar/gkg246; ROSALES R, 1994, P NATL ACAD SCI USA, V91, P3794, DOI 10.1073/pnas.91.9.3794; SAUDER C, 1994, J GEN VIROL, V75, P3067, DOI 10.1099/0022-1317-75-11-3067; Sauder C, 1996, J GEN VIROL, V77, P991, DOI 10.1099/0022-1317-77-5-991; Smith WA, 2004, J BIOL CHEM, V279, P22795, DOI 10.1074/jbc.C300512200; Steinmetz EJ, 1997, CELL, V89, P491, DOI 10.1016/S0092-8674(00)80230-5; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Szczyrba J, 2011, MOL CANCER RES, V9, P791, DOI 10.1158/1541-7786.MCR-10-0573; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; TONG X, 1994, J VIROL, V68, P6188, DOI 10.1128/JVI.68.10.6188-6197.1994; TSUI SL, 1994, J VIROL, V68, P4287, DOI 10.1128/JVI.68.7.4287-4294.1994; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Uribe DJ, 2011, BIOCHEMISTRY-US, V50, P3796, DOI 10.1021/bi101633b; Voss MD, 2001, J VIROL, V75, P11781, DOI 10.1128/JVI.75.23.11781-11790.2001; Wei CC, 2006, J BIOL CHEM, V281, P25344, DOI 10.1074/jbc.M601945200; Wu DY, 2000, J VIROL, V74, P8893, DOI 10.1128/JVI.74.19.8893-8903.2000; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zimber-Strobl U, 2001, SEMIN CANCER BIOL, V11, P423, DOI 10.1006/scbi.2001.0409; ZIMBERSTROBL U, 1993, EMBO J, V12, P167, DOI 10.1002/j.1460-2075.1993.tb05642.x; ZIMBERSTROBL U, 1994, EMBO J, V13, P4973, DOI 10.1002/j.1460-2075.1994.tb06824.x; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200; Zou T, 2011, CELL MOL NEUROBIOL, V31, P541, DOI 10.1007/s10571-011-9647-8	81	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42106	10.1371/journal.pone.0042106	http://dx.doi.org/10.1371/journal.pone.0042106			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879910	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100045
J	Haass, W; Stehle, M; Nittka, S; Giehl, M; Schrotz-King, P; Fabarius, A; Hofmann, WK; Seifarth, W				Haass, Wiltrud; Stehle, Michael; Nittka, Stefanie; Giehl, Michelle; Schrotz-King, Petra; Fabarius, Alice; Hofmann, Wolf-Karsten; Seifarth, Wolfgang			The Proteolytic Activity of Separase in BCR-ABL-Positive Cells Is Increased by Imatinib	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; TYROSINE KINASE INHIBITOR; CLONAL EVOLUTION; CENTROSOME AMPLIFICATION; COHESIN; ABNORMALITIES; ABERRATIONS; INSTABILITY; EXPRESSION; LINE	Separase, an endopeptidase required for the separation of sister-chromatides in mitotic anaphase, triggers centriole disengagement during centrosome duplication. In cancer, separase is frequently overexpressed, pointing to a functional role as an aneuploidy promoter associated with centrosomal amplification and genomic instability. Recently, we have shown that centrosomal amplification and subsequent chromosomal aberrations are a hallmark of chronic myeloid leukemia (CML), increasing from chronic phase (CP) toward blast crisis (BC). Moreover, a functional linkage of p210BCR-ABL tyrosine kinase activity with centrosomal amplification and clonal evolution has been established in long-term cell culture experiments. Unexpectedly, therapeutic doses of imatinib (IM) did not counteract; instead induced similar centrosomal alterations in vitro. We investigated the influence of IM and p210BCR-ABL on Separase as a potential driver of centrosomal amplification in CML. Short-term cell cultures of p210BCR-ABL-negative (NHDF, UROtsa, HL-60, U937), positive (K562, LAMA-84) and inducible (U937p210BCR-ABL/c6 (Tet-ON)) human cell lines were treated with therapeutic doses of IM and analyzed by qRT-PCR, Western blot analysis and quantitative Separase activity assays. Decreased Separase protein levels were observed in all cells treated with IM in a dose dependent manner. Accordingly, in all p210BCR-ABL-negative cell lines, decreased proteolytic activity of Separase was found. In contrast, p210BCR-ABL-positive cells showed increased Separase proteolytic activity. This activation of Separase was consistent with changes in the expression levels of Separase regulators (Separase phosphorylation at serine residue 1126, Securin, CyclinB1 and PP2A). Our data suggest that regulation of Separase in IM-treated BCR-ABL-positive cells occurs on both the protein expression and the proteolytic activity levels. Activation of Separase proteolytic activity exclusively in p210BCR-ABL-positive cells during IM treatment may act as a driving force for centrosomal amplification, contributing to genomic instability, clonal evolution and resistance in CML.	[Haass, Wiltrud; Stehle, Michael; Giehl, Michelle; Fabarius, Alice; Hofmann, Wolf-Karsten; Seifarth, Wolfgang] Heidelberg Univ, Dept Hematol & Oncol, Mannheim Med Ctr, D-6800 Mannheim, Germany; [Nittka, Stefanie] Heidelberg Univ, Dept Clin Chem, Mannheim Med Ctr, D-6800 Mannheim, Germany; [Schrotz-King, Petra] German Canc Ctr DKFZ, Natl Ctr Tumor Dis NCT, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Haass, W (corresponding author), Heidelberg Univ, Dept Hematol & Oncol, Mannheim Med Ctr, D-6800 Mannheim, Germany.	wolfgang.seifarth@medma.uni-heidelberg.de			Deutsche Krebshilfe e.V., Bonn, Germany [108783]; Deutsche Krebshilfe e.V., 53113 Bonn, Germany [108783]	Deutsche Krebshilfe e.V., Bonn, Germany(Deutsche Krebshilfe); Deutsche Krebshilfe e.V., 53113 Bonn, Germany	This work was supported by grant 108783 to WS and AF from the Deutsche Krebshilfe e.V., Bonn, Germany (www.krebshilfe.de). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The study was supported by grant 108783 of the Deutsche Krebshilfe e.V., 53113 Bonn, Germany. We thank Susanne Brendel, Helga Kleiner and Stefanie Sandmann for excellent technical assistance. We are thankful to Anthony Walmsley for critically reading the manuscript.	Bacher U, 2005, CANCER GENET CYTOGEN, V157, P53, DOI 10.1016/j.cancergencyto.2004.06.011; Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; Barnes DJ, 2005, ONCOGENE, V24, P6432, DOI 10.1038/sj.onc.1208796; Basu D, 2009, ANAL BIOCHEM, V392, P133, DOI 10.1016/j.ab.2009.05.046; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; Clift D, 2009, GENE DEV, V23, P766, DOI 10.1101/gad.507509; Cortes J, 2004, HEMATOL ONCOL CLIN N, V18, P671, DOI 10.1016/j.hoc.2004.03.012; De Braekeleer E, 2011, EUR J HAEMATOL, V86, P361, DOI 10.1111/j.1600-0609.2011.01586.x; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Di Gion P, 2011, CLIN PHARMACOKINET, V50, P551, DOI 10.2165/11593320-000000000-00000; Diaz-Martinez LA, 2010, CELL CYCLE, V9, P1764, DOI 10.4161/cc.9.9.11525; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Fabarius A, 2005, LEUKEMIA, V19, P1573, DOI 10.1038/sj.leu.2403861; Fabarius A, 2008, HAEMATOL-HEMATOL J, V93, P1145, DOI 10.3324/haematol.12793; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Giehl M, 2007, LEUKEMIA, V21, P1971, DOI 10.1038/sj.leu.2404834; Giehl M, 2005, LEUKEMIA, V19, P1192, DOI 10.1038/sj.leu.2403779; Hochhaus A, 2009, BEST PRACT RES CL HA, V22, P367, DOI 10.1016/j.beha.2009.05.004; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Jabbour E, 2006, LEUKEMIA, V20, P1767, DOI 10.1038/sj.leu.2404318; Kovacs LAS, 2010, CELL CYCLE, V9, P1750, DOI 10.4161/cc.9.9.11792; Kumari A, 2012, BLOOD, V119, P530, DOI 10.1182/blood-2010-08-303495; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Meyer R, 2009, CLIN CANCER RES, V15, P2703, DOI 10.1158/1078-0432.CCR-08-2454; Nakamura A, 2009, J CELL BIOL, V187, P607, DOI 10.1083/jcb.200906019; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Nowicki MO, 2003, ONCOGENE, V22, P3952, DOI 10.1038/sj.onc.1206620; O'Dwyer ME, 2002, BLOOD, V100, P1628, DOI 10.1182/blood-2002-03-0777; Park KH, 2005, BREAST CANCER RES, V7, pR238, DOI 10.1186/bcr978; Patel H, 2009, BRIT J HAEMATOL, V146, P408, DOI 10.1111/j.1365-2141.2009.07772.x; Pati D, 2008, CELL CYCLE, V7, P3481, DOI 10.4161/cc.7.22.7048; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pihan GA, 2003, CANCER RES, V63, P1398; Podtcheko A, 2003, J CLIN ENDOCR METAB, V88, P1889, DOI 10.1210/jc.2002-021230; Rosenhahn J, 2007, INT J ONCOL, V31, P121; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schnittger S, 2010, GENE CHROMOSOME CANC, V49, P910, DOI 10.1002/gcc.20801; Schockel L, 2011, NAT CELL BIOL, V13, P966, DOI 10.1038/ncb2280; Simanovsky M, 2008, DIFFERENTIATION, V76, P908, DOI 10.1111/j.1432-0436.2008.00270.x; Terre C, 2004, LEUKEMIA, V18, P1340, DOI 10.1038/sj.leu.2403399; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Verma D, 2010, CANCER-AM CANCER SOC, V116, P2673, DOI 10.1002/cncr.25015; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Wang YM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-8; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; Weaver BAA, 2007, CANCER RES, V67, P10103, DOI 10.1158/0008-5472.CAN-07-2266; Yim H, 2011, CELL CYCLE, V10, P1374, DOI 10.4161/cc.10.9.15489; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang NG, 2008, P NATL ACAD SCI USA, V105, P13033, DOI 10.1073/pnas.0801610105	54	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42863	10.1371/journal.pone.0042863	http://dx.doi.org/10.1371/journal.pone.0042863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870341	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100177
J	Kumar, R; Mukhopadhyay, AK; Ghosh, P; Rao, DN				Kumar, Ritesh; Mukhopadhyay, Asish K.; Ghosh, Prachetash; Rao, Desirazu N.			Comparative Transcriptomics of H. pylori Strains AM5, SS1 and Their hpyAVIBM Deletion Mutants: Possible Roles of Cytosine Methylation	PLOS ONE			English	Article							MEMBRANE PROTEIN EXPRESSION; HELICOBACTER-PYLORI; COMPARATIVE GENOMICS; VIRULENCE GENES; PHASE VARIATION; WEST-BENGAL; METHYLTRANSFERASE; ADJACENT; PROFILE; IDENTIFICATION	Helicobacter pylori is an important human pathogen and one of the most successful chronic colonizers of the human body. H. pylori uses diverse mechanisms to modulate its interaction with the host in order to promote chronic infection and overcome host immune response. Restriction-modification genes are a major part of strain-specific genes present in H. pylori. The role of N-6 -adenine methylation in bacterial gene regulation and virulence is well established but not much is known about the effect of C-5 -cytosine methylation on gene expression in prokaryotes. In this study, it was observed by microarray analysis and RT-PCR, that deletion of an orphan C-5 -cytosine methyltransferase, hpyAVIBM in H. pylori strains AM5and SS1 has a significant effect on the expression of number of genes belonging to motility, adhesion and virulence. AM Delta DhpyAVIBM mutant strain has a different LPS profile and is able to induce high IL-8 production compared to wild-type. hpyAVIBM from strain 26695 is able to complement mutant SS1 and AM5 strains. This study highlights a possible significance of cytosine methylation in the physiology of H. pylori.	[Kumar, Ritesh; Rao, Desirazu N.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Mukhopadhyay, Asish K.; Ghosh, Prachetash] Natl Inst Cholera & Enter Dis, Div Bacteriol, Kolkata, India	Indian Institute of Science (IISC) - Bangalore; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Kumar, R (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	dnrao@biochem.iisc.ernet.in	Mukhopadhyay, Asish/ABE-7697-2020; KUMAR, RITESH/P-3347-2018; KUMAR, RITESH/P-1265-2019	KUMAR, RITESH/0000-0001-7170-8645; KUMAR, RITESH/0000-0001-7170-8645	CSIR; DST; Department of Biotechnology, Government of India	CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	RK thanks CSIR for a Senior Research Fellowship. DNR acknowledges DST for J.C.Bose Fellowship. Genomic DNA of H. pylori strain 26695 was kindly provided by New England Biolabs, USA. All members of the DNR laboratory are acknowledged for critical reading of the manuscript and useful discussions.; Funding for the work is from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Algood HMS, 2006, CLIN MICROBIOL REV, V19, P597, DOI 10.1128/CMR.00006-06; Ando T, 2000, MOL MICROBIOL, V37, P1052, DOI 10.1046/j.1365-2958.2000.02049.x; Appelmelk BJ, 1999, INFECT IMMUN, V67, P5361, DOI 10.1128/IAI.67.10.5361-5366.1999; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Baik SC, 2004, J BACTERIOL, V186, P949, DOI 10.1128/JB.186.4.949-955.2004; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Cao P, 1997, J BACTERIOL, V179, P2852, DOI 10.1128/jb.179.9.2852-2856.1997; Carlsohn E, 2006, J PROTEOME RES, V5, P3197, DOI 10.1021/pr060181p; Chattopadhyay S, 2002, J CLIN MICROBIOL, V40, P2622, DOI 10.1128/JCM.40.7.2622-2625.2002; Colbeck JC, 2006, INFECT IMMUN, V74, P4375, DOI 10.1128/IAI.00485-06; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Datta S, 2003, J CLIN MICROBIOL, V41, P3737, DOI 10.1128/JCM.41.8.3737-3743.2003; GIONCHETTI P, 1994, AM J GASTROENTEROL, V89, P883; Hallet B, 2001, CURR OPIN MICROBIOL, V4, P570, DOI 10.1016/S1369-5274(00)00253-8; Heusipp G, 2007, INT J MED MICROBIOL, V297, P1, DOI 10.1016/j.ijmm.2006.10.002; Hofreuter D, 1998, MOL MICROBIOL, V28, P1027, DOI 10.1046/j.1365-2958.1998.00879.x; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Joseph N, 2006, PROG NUCLEIC ACID RE, V81, P1, DOI 10.1016/S0079-6603(06)81001-9; Kranthi BV, 2009, BBA-GENE REGUL MECH, V1789, P460, DOI 10.1016/j.bbagrm.2009.05.004; Kriukiene E, 2005, BBA-PROTEINS PROTEOM, V1751, P194, DOI 10.1016/j.bbapap.2005.06.006; Kumar R, 2011, BIOCHEM J, V433, P487, DOI 10.1042/BJ20101668; Kumar R, 2010, FEBS J, V277, P1666, DOI 10.1111/j.1742-4658.2010.07593.x; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Lin LF, 2001, P NATL ACAD SCI USA, V98, P2740, DOI 10.1073/pnas.051612298; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; McClain MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-3; Montecucco C, 2003, MICROBES INFECT, V5, P715, DOI 10.1016/S1286-4579(03)00124-2; Mukhopadhyay AK, 2000, J BACTERIOL, V182, P3219, DOI 10.1128/JB.182.11.3219-3227.2000; Niehus E, 2004, MOL MICROBIOL, V52, P947, DOI 10.1111/j.1365-2958.2004.04006.x; Nilsson C, 2006, P NATL ACAD SCI USA, V103, P2863, DOI 10.1073/pnas.0511119103; Nilsson C, 2009, PLOS ONE, V3, pE3811; O'Toole PW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-164; Odenbreit S, 2009, INFECT IMMUN, V77, P3782, DOI 10.1128/IAI.00364-09; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Reisenauer A, 1999, J BACTERIOL, V181, P5135, DOI 10.1128/JB.181.17.5135-5139.1999; Salaun L, 2004, MICROBIOL-SGM, V150, P817, DOI 10.1099/mic.0.26993-0; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Shak JR, 2009, J BACTERIOL, V191, P6900, DOI 10.1128/JB.00706-09; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Skoglund A, 2007, J BACTERIOL, V189, P8914, DOI 10.1128/JB.00108-07; SOHAIL A, 1990, J BACTERIOL, V172, P4214, DOI 10.1128/jb.172.8.4214-4221.1990; Solnick JV, 2004, P NATL ACAD SCI USA, V101, P2106, DOI 10.1073/pnas.0308573100; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Takeuchi H, 2002, J INFECT DIS, V186, P1186, DOI 10.1086/343810; Tan SM, 2005, J BACTERIOL, V187, P7687, DOI 10.1128/JB.187.22.7687-7695.2005; TAYLOR DN, 1991, EPIDEMIOL REV, V13, P42, DOI 10.1093/oxfordjournals.epirev.a036078; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Wang G, 1999, TRENDS MICROBIOL, V7, P488, DOI 10.1016/S0966-842X(99)01632-7; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Xu Q, 2000, J BIOL CHEM, V275, P17086, DOI 10.1074/jbc.M910303199; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65; Yamaoka Y, 2000, P NATL ACAD SCI USA, V97, P7533, DOI 10.1073/pnas.130079797; Yamaoka Y, 2008, WORLD J GASTROENTERO, V14, P4265, DOI 10.3748/wjg.14.4265; Zabaleta J, 2004, J IMMUNOL, V173, P586, DOI 10.4049/jimmunol.173.1.586; Zheng Y, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn883	59	30	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42303	10.1371/journal.pone.0042303	http://dx.doi.org/10.1371/journal.pone.0042303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879937	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000307284100064
J	Saini, V; Hose, CD; Monks, A; Nagashima, K; Han, BN; Newton, DL; Millione, A; Shah, J; Hollingshead, MG; Hite, KM; Burkett, MW; Delosh, RM; Silvers, TE; Scudiero, DA; Shoemaker, RH				Saini, Vaibhav; Hose, Curtis D.; Monks, Anne; Nagashima, Kunio; Han, Bingnan; Newton, Dianne L.; Millione, Angelena; Shah, Jalpa; Hollingshead, Melinda G.; Hite, Karen M.; Burkett, Mark W.; Delosh, Rene M.; Silvers, Thomas E.; Scudiero, Dominic A.; Shoemaker, Robert H.			Identification of CBX3 and ABCA5 as Putative Biomarkers for Tumor Stem Cells in Osteosarcoma	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE; INITIATING CELLS; CANCER CELLS; LINE SAOS-2; EXPRESSION; MARKER; OCT-4; DIFFERENTIATION; INHIBITOR; PROTEIN	Recently, there has been renewed interest in the role of tumor stem cells (TSCs) in tumorigenesis, chemoresistance, and relapse of malignant tumors including osteosarcoma. The potential exists to improve osteosarcoma treatment through characterization of TSCs and identification of therapeutic targets. Using transcriptome, proteome, immunophenotyping for cell-surface markers, and bioinformatic analyses, heterogeneous expression of previously reported TSC or osteosarcoma markers, such as CD133, nestin, POU5F1 (OCT3/4), NANOG, SOX2, and aldehyde dehydrogenase, among others, was observed in vitro. However, consistently significantly lower CD326, CD24, CD44, and higher ABCG2 expression in TSC-enriched as compared with un-enriched osteosarcoma cultures was observed. In addition, consistently higher CBX3 expression in TSC-enriched osteosarcoma cultures was identified. ABCA5 was identified as a putative biomarker of TSCs and/or osteosarcoma. Lastly, in a high-throughput screen we identified epigenetic (5-azacytidine), anti-microtubule (vincristine), and anti-telomerase (3,11-difluoro-6,8,13-trimethyl-8H-quino [4,3,2-kl] acridinium methosulfate; RHPS4)-targeted therapeutic agents as candidates for TSC ablation in osteosarcoma.	[Saini, Vaibhav; Shoemaker, Robert H.] NCI, Screening Technol Branch, Dev Therapeut Program, Div Canc Treatment & Diag, Frederick, MD 21701 USA; [Hose, Curtis D.; Monks, Anne; Nagashima, Kunio; Han, Bingnan; Newton, Dianne L.; Millione, Angelena; Shah, Jalpa; Hite, Karen M.; Burkett, Mark W.; Delosh, Rene M.; Silvers, Thomas E.; Scudiero, Dominic A.] NCI, SAIC Frederick, Frederick, MD 21701 USA; [Hollingshead, Melinda G.] NCI, Biol Testing Branch, Div Canc Treatment & Diag, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Saini, V (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.	Shoemakr@mail.nih.gov	Shoemaker, Robert/GPK-1314-2022		National Cancer Institute (NCI); National Institutes of Health (NIH); Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute; NCI, NIH [HHSN261200800001E]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	VS was supported by a visiting fellowship, National Cancer Institute (NCI), and National Institutes of Health (NIH). The research was supported in part by the Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute, and in part with federal funds from the NCI, NIH, under contract HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Boman BM, 2008, J CLIN ONCOL, V26, P2795, DOI 10.1200/JCO.2008.17.7436; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Ek ETH, 2006, CRIT REV ONCOL HEMAT, V60, P1, DOI 10.1016/j.critrevonc.2006.03.006; Fan TM, 2010, EXPERT REV ANTICANC, V10, P1327, DOI 10.1586/ERA.10.107; Fritsche-Guenther R, 2010, HISTOPATHOLOGY, V57, P836, DOI 10.1111/j.1365-2559.2010.03713.x; GANGEMI RM, 2008, STEM CELLS; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Honoki K, 2010, ONCOL REP, V24, P501, DOI 10.3892/or_00000885; Hu YJ, 2007, CLIN CANCER RES, V13, P929, DOI 10.1158/1078-0432.CCR-06-1718; Huang DZ, 2009, STEM CELLS DEV, V18, P465, DOI 10.1089/scd.2008.0033; Huang P, 2011, CANCER RES, V71, P2938, DOI 10.1158/0008-5472.CAN-10-3524; Hurt EM, 2010, STEM CELLS, V28, P390, DOI 10.1002/stem.271; Joseph I, 2010, CANCER RES, V70, P9494, DOI 10.1158/0008-5472.CAN-10-0233; KAWAI A, 1990, CLIN ORTHOP RELAT R, P256; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Levings PP, 2009, CANCER RES, V69, P5648, DOI 10.1158/0008-5472.CAN-08-3580; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Marcato P, 2011, STEM CELLS, P2011; Martin J. W., 2011, Sarcoma, V2011, P282745, DOI 10.1155/2011/282745; Mathews LA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-267; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Moreb JS, 2008, CURR STEM CELL RES T, V3, P237, DOI 10.2174/157488808786734006; Moreb JS, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-87; MURRAY E, 1987, J BONE MINER RES, V2, P231; Prasmickaite L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010731; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rajendran G, 2010, J NEUROONCOL; RODAN SB, 1987, CANCER RES, V47, P4961; Saini V, 2010, CANCER SCI, V101, P16, DOI 10.1111/j.1349-7006.2009.01371.x; Schneider-Stock R, 2005, J PHARMACOL EXP THER, V312, P525, DOI 10.1124/jpet.104.074195; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Singh SK, 2003, CANCER RES, V63, P5821; Smith GH, 2001, MICROSC RES TECHNIQ, V52, P190, DOI 10.1002/1097-0029(20010115)52:2<190::AID-JEMT1005>3.0.CO;2-O; Stuelten CH, 2010, STEM CELLS, V28, P649, DOI 10.1002/stem.324; Takanashi M, 2009, AM J PATHOL, V174, P309, DOI 10.2353/ajpath.2009.080148; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Ucar D, 2009, CHEM-BIOL INTERACT, V178, P48, DOI 10.1016/j.cbi.2008.09.029; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Veselska R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-300; Wagner ER, 2010, PPAR RES, V2010, DOI 10.1155/2010/956427; Wang L, 2009, CANCER BIOL THER, V8; Wang L, 2010, INT J CANC; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855	51	71	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41401	10.1371/journal.pone.0041401	http://dx.doi.org/10.1371/journal.pone.0041401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870217	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100017
J	Talley, TS; Nguyen, KC; Nguyen, A				Talley, Theresa Sinicrope; Nguyen, Kim-Chi; Nguyen, Anthony			Testing the Effects of an Introduced Palm on a Riparian Invertebrate Community in Southern California	PLOS ONE			English	Article							LITTER-DWELLING ARTHROPODS; DIVERSITY; HABITATS; ECOLOGY; HETEROGENEITY; COLONIZATION; BIODIVERSITY; ASSEMBLAGES; MANAGEMENT; INVASIONS	Despite the iconic association of palms with semi-arid regions, most are introduced and can invade natural areas. Along the San Diego River (San Diego, California, USA), the introduced Canary Island date palm (Phoenix canariensis) forms dense patches among native riparian shrubs like arroyo willow (Salix lasiolepis). The structural differences between the palm and native shrubs are visually obvious, but little is known about palm's effects on the ecosystem. We tested for the effects of the palm on a riparian invertebrate community in June 2011 by comparing the faunal and environmental variables associated with palm and willow canopies, trunks and ground beneath each species. The palm invertebrate community had lower abundance and diversity, fewer taxa feeding on the host (e.g., specialized hemipterans), and more taxa likely using only the plant's physical structure (e.g., web-builders, oak moths, willow hemipterans). There were no observed effects on the ground-dwelling fauna. Faunal differences were due to the physical and trophic changes associated with palm presence, namely increased canopy density, unpalatable leaves, trunk rugosity, and litter accumulations. Palm presence and resulting community shifts may have further ecosystem-level effects through alteration of physical properties, food, and structural resources. These results were consistent with a recent study of invasive palm effects on desert spring arthropods, illustrating that effects may be relatively generalizable. Since spread of the palm is largely localized, but effects are dramatic where it does occur, we recommend combining our results with several further investigations in order to prioritize management decisions.	[Talley, Theresa Sinicrope; Nguyen, Kim-Chi] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Nguyen, Anthony] Univ Calif San Diego, Dept Biol, San Diego, CA 92103 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	Talley, TS (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	tstalley@ucsd.edu			NOAA [NA08OAR4170669, NA10OAR4170060]; California Sea Grant Project via NOAA's National Sea Grant College Program, U.S. Dept. of Commerce [R/ENV-209]	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); California Sea Grant Project via NOAA's National Sea Grant College Program, U.S. Dept. of Commerce	No external funding was received for this study. Some resources (supplies and research assistance) were donated by Paul Dayton through NOAA Grant nos. NA08OAR4170669 and NA10OAR4170060, California Sea Grant Project R/ENV-209, via NOAA's National Sea Grant College Program, U.S. Dept. of Commerce. The statements, findings, conclusions and recommendations are those of the researchers and do not necessarily reflect the views of the aforementioned organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CIT SAN DIEG; Bent AC, 1950, B US NATL MUSEUM, V197; Buffington ML, 1998, J INSECT CONSERV, V2, P99, DOI 10.1023/A:1009653021706; BULTMAN TL, 1984, AM MIDL NAT, V111, P165, DOI 10.2307/2425555; BURKHART B., 2005, Q NEWS CALIF INVASIV, V23, P4; Cal-IPC, 2006, CAL IPC PUBL; Chapin EA, 1925, USDA B, V1355; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; CORNETT JW, 2010, DESERT PALM OASIS; CORNETT JW, 1987, WHITE MOUNTAIN RES S, V2, P167; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Dennis P, 1998, ECOL ENTOMOL, V23, P253, DOI 10.1046/j.1365-2311.1998.00135.x; DOYLE AT, 1990, J MAMMAL, V71, P14, DOI 10.2307/1381312; Fleishman E, 2002, CONSERV BIOL, V16, P706, DOI 10.1046/j.1523-1739.2002.00539.x; Fleishman E, 2006, BIOL INVASIONS, V8, P1091, DOI 10.1007/s10530-005-7564-9; *FLOR EX PEST PLAN, 2009, WILDLAND WEEDS, V12, P13; GAINES DA, 1977, I ECOL PUBL, V15, P57; Gilman EF, 2009, PHOENIX CANARIENSIS; Gomez-Vidal S, 2006, MICRON, V37, P624, DOI 10.1016/j.micron.2006.02.003; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hancock MH, 2012, INSECT CONSERV DIVER, V5, P312, DOI 10.1111/j.1752-4598.2011.00162.x; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; Hickman J. C., 1993, JEPSON MANUAL HIGHER; HOBBS RJ, 1995, CONSERV BIOL, V9, P761, DOI 10.1046/j.1523-1739.1995.09040761.x; Holmquist JG, 2011, BIOL CONSERV, V144, P518, DOI 10.1016/j.biocon.2010.10.007; Hood WG, 2000, PLANT ECOL, V148, P105, DOI 10.1023/A:1009800327334; Humphrey JW, 1999, FOREST ECOL MANAG, V113, P11, DOI 10.1016/S0378-1127(98)00413-7; Keer GH, 2002, ECOL APPL, V12, P456, DOI 10.1890/1051-0761(2002)012[0456:SMCADW]2.0.CO;2; Kelly M, 2007, CALIFORNIA INVASIVE, V15, P13; Kelly M, 2007, CALIFORNIA INVASIVE, V15, P4; Kelly M, 2007, CALIFORNIA INVASIVE, V15, P15; Kus B, 2002, IRPARIAN BIRD CONSER; Lopez-Llorca LV, 1999, MICRON, V30, P325, DOI 10.1016/S0968-4328(99)00031-1; MAC ARTHUR ROBERT H., 1967; MINER KL, 1989, THESIS SAN DIEGO STA; NADKARNI NM, 1994, AM ZOOL, V34, P70; OLSON TE, 1989, US FOR SERV T R PSW, V110, P278; Pearson DE, 2009, OECOLOGIA, V159, P549, DOI 10.1007/s00442-008-1241-5; Perla B. S., 2008, ARIDLAND SPRINGS N A, P230; POWELL J. A., 1979, CALIFORNIA INSECTS; Reichard SH, 2001, BIOSCIENCE, V51, P103, DOI 10.1641/0006-3568(2001)051[0103:HAAPOI]2.0.CO;2; SAWYER JO, 1995, MANUAL CALIFORNIA VE; Schowalter TD, 2011, INSECT ECOLOGY: AN ECOSYSTEM APPROACH, 3RD EDITION, P1; Senior K, 2010, FRONT ECOL ENVIRON, V8, P62; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; SPENCE JR, 1994, CAN ENTOMOL, V126, P881, DOI 10.4039/Ent126881-3; Strong D., 1984, INSECTS PLANTS COMMU; Svenning JC, 2002, PALMS INVASIVE PALMS, V46, P1; Talley T. S., 2001, Biological Invasions, V3, P51, DOI 10.1023/A:1011453003168; Tanji KK, 2007, CHOOSE SALT TOLERANT; Trent H., 2010, J SAN DIEGO HIST, V56, P105; Triplehorn C., 2005, BORRER DELONGS INTRO, V7; Tuck R, 2012, SUNSET PALMS; UETZ GW, 1979, OECOLOGIA, V40, P29, DOI 10.1007/BF00388808; VITT LJ, 1994, J ZOOL, V234, P463, DOI 10.1111/j.1469-7998.1994.tb04860.x; WARD PS, 1987, HILGARDIA, V55, P1; Whitcraft CR, 2008, OECOLOGIA, V158, P259, DOI 10.1007/s00442-008-1144-5; Work TT, 2002, ENVIRON ENTOMOL, V31, P438, DOI 10.1603/0046-225X-31.3.438; Wu L, 2020, LANDSCAPE PLANT SALT; Zar J.H., 2009, BIOSTATISTICAL ANAL; Zona S., 2008, GARDEN HIST, V36, P301; Zuefle ME, 2008, BIOL INVASIONS, V10, P1159, DOI 10.1007/s10530-007-9193-y	63	12	13	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42460	10.1371/journal.pone.0042460	http://dx.doi.org/10.1371/journal.pone.0042460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879991	Green Published, gold			2022-12-27	WOS:000307284100099
J	Zinn, PO; Sathyan, P; Mahajan, B; Bruyere, J; Hegi, M; Majumder, S; Colen, RR				Zinn, Pascal O.; Sathyan, Pratheesh; Mahajan, Bhanu; Bruyere, John; Hegi, Monika; Majumder, Sadhan; Colen, Rivka R.			A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene Signature	PLOS ONE			English	Article							RECURSIVE PARTITIONING ANALYSIS; II CLINICAL-TRIALS; RECURRENT GLIOMA; PHASE-III; TUMOR; EXPRESSION; SURVIVAL; MULTIFORME; CANCER; TEMOZOLOMIDE	Background: Several studies have established Glioblastoma Multiforme (GBM) prognostic and predictive models based on age and Karnofsky Performance Status (KPS), while very few studies evaluated the prognostic and predictive significance of preoperative MR-imaging. However, to date, there is no simple preoperative GBM classification that also correlates with a highly prognostic genomic signature. Thus, we present for the first time a biologically relevant, and clinically applicable tumor Volume, patient Age, and KPS (VAK) GBM classification that can easily and non-invasively be determined upon patient admission. Methods: We quantitatively analyzed the volumes of 78 GBM patient MRIs present in The Cancer Imaging Archive (TCIA) corresponding to patients in The Cancer Genome Atlas (TCGA) with VAK annotation. The variables were then combined using a simple 3-point scoring system to form the VAK classification. A validation set (N = 64) from both the TCGA and Rembrandt databases was used to confirm the classification. Transcription factor and genomic correlations were performed using the gene pattern suite and Ingenuity Pathway Analysis. Results: VAK-A and VAK-B classes showed significant median survival differences in discovery (P = 0.007) and validation sets (P = 0.008). VAK-A is significantly associated with P53 activation, while VAK-B shows significant P53 inhibition. Furthermore, a molecular gene signature comprised of a total of 25 genes and microRNAs was significantly associated with the classes and predicted survival in an independent validation set (P = 0.001). A favorable MGMT promoter methylation status resulted in a 10.5 months additional survival benefit for VAK-A compared to VAK-B patients. Conclusions: The non-invasively determined VAK classification with its implication of VAK-specific molecular regulatory networks, can serve as a very robust initial prognostic tool, clinical trial selection criteria, and important step toward the refinement of genomics-based personalized therapy for GBM patients.	[Zinn, Pascal O.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Zinn, Pascal O.; Sathyan, Pratheesh; Majumder, Sadhan] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Colen, Rivka R.] Univ Texas MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA; [Zinn, Pascal O.; Hegi, Monika] Univ Lausanne Hosp, CHUV BH19 110, Dept Clin Neurosci, Lausanne, Switzerland; [Mahajan, Bhanu; Bruyere, John; Colen, Rivka R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zinn, PO (corresponding author), Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA.	zinn@bcm.edu	Colen, Rivka/Y-4062-2019; Hegi, Monika/O-4796-2015	Hegi, Monika/0000-0003-0855-6495	National Institutes of Health [R25 CA089017-06A2]; Cancer Imaging Program, DCTD/NCI/NIH; NATIONAL CANCER INSTITUTE [R25CA089017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Imaging Program, DCTD/NCI/NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants: R25 CA089017-06A2 (RRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Image data used in this research were obtained from The Cancer Imaging Archive (http://cancerimagingarchive.net/) sponsored by the Cancer Imaging Program, DCTD/NCI/NIH.	Ahmed Farid E., 2009, Cancer Genomics & Proteomics, V6, P281; Archip N, 2007, ACAD RADIOL, V14, P1242, DOI 10.1016/j.acra.2007.05.025; Babel I, 2009, MOL CELL PROTEOMICS, V8, P2382, DOI 10.1074/mcp.M800596-MCP200; Barajas RF, 2010, RADIOLOGY, V254, P564, DOI 10.1148/radiol.09090663; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031; Butowski N, 2007, J NEURO-ONCOL, V85, P87, DOI 10.1007/s11060-007-9388-1; Carson KA, 2007, J CLIN ONCOL, V25, P2601, DOI 10.1200/JCO.2006.08.1661; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; DWEEP H, 2011, J BIOMED INFORM; Etienne MC, 1998, CLIN CANCER RES, V4, P2383; Gering DT, 2001, J MAGN RESON IMAGING, V13, P967, DOI 10.1002/jmri.1139; Gould J, 2006, BIOINFORMATICS, V22, P1924, DOI 10.1093/bioinformatics/btl196; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Iliadis G, 2009, STRAHLENTHER ONKOL, V185, P743, DOI 10.1007/s00066-009-2015-7; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwamoto FM, 2009, CANCER-AM CANCER SOC, V115, P5534, DOI 10.1002/cncr.24612; Jukic DM, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-27; Kahle KT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09212; Lamborn KR, 2004, NEURO-ONCOLOGY, V6, P227, DOI 10.1215/S1152851703000620; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Li SW, 2009, CHINESE MED J-PEKING, V122, P1245, DOI 10.3760/cma.j.issn.0366-6999.2009.11.002; Luise C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015891; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Marko NF, 2008, GENOMICS, V91, P395, DOI 10.1016/j.ygeno.2008.01.002; Martin NL, 2005, ONCOGENE, V24, P6890, DOI 10.1038/sj.onc.1208840; McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536; Mirimanoff RO, 2006, J CLIN ONCOL, V24, P2563, DOI 10.1200/JCO.2005.04.5963; Park JK, 2010, J CLIN ONCOL, V28, P3838, DOI 10.1200/JCO.2010.30.0582; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pichon E, 2004, MED IMAGE ANAL, V8, P267, DOI 10.1016/j.media.2004.06.006; Pierre Bady DS, 2012, ACTA NEUROP IN PRESS; Podhajcer OL, 2008, CANCER METAST REV, V27, P523, DOI 10.1007/s10555-008-9135-x; Pope WB, 2008, RADIOLOGY, V249, P268, DOI 10.1148/radiol.2491072000; Resch U, 2008, BIOCHEM BIOPH RES CO, V375, P156, DOI 10.1016/j.bbrc.2008.07.142; Sanai N, 2011, J NEUROSURG; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Scott J, 2010, INT J RAD ONCOL BIOL; Siker ML, 2011, J NEURO-ONCOL, V104, P351, DOI 10.1007/s11060-010-0500-6; Squadrito ML, 2012, CELL REPORTS, V1, P141, DOI 10.1016/j.celrep.2011.12.005; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wong ET, 1999, J CLIN ONCOL, V17, P2572, DOI 10.1200/JCO.1999.17.8.2572; Wu WT, 2010, NEURO-ONCOLOGY, V12, P164, DOI 10.1093/neuonc/nop019; Zinn PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025451	49	66	70	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41522	10.1371/journal.pone.0041522	http://dx.doi.org/10.1371/journal.pone.0041522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870228	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100021
J	Horita, H; Kobayashi, M; Liu, WC; Oka, K; Jarvis, ED; Wada, K				Horita, Haruhito; Kobayashi, Masahiko; Liu, Wan-chun; Oka, Kotaro; Jarvis, Erich D.; Wada, Kazuhiro			Specialized Motor-Driven dusp1 Expression in the Song Systems of Multiple Lineages of Vocal Learning Birds	PLOS ONE			English	Article							BASAL GANGLIA PATHWAY; GENE-EXPRESSION; ZEBRA FINCH; AUDITORY RESPONSES; SEQUENCE ALIGNMENT; PERINEURONAL NETS; NEURAL PATHWAYS; ZENK GENE; BRAIN; FOREBRAIN	Mechanisms for the evolution of convergent behavioral traits are largely unknown. Vocal learning is one such trait that evolved multiple times and is necessary in humans for the acquisition of spoken language. Among birds, vocal learning is evolved in songbirds, parrots, and hummingbirds. Each time similar forebrain song nuclei specialized for vocal learning and production have evolved. This finding led to the hypothesis that the behavioral and neuroanatomical convergences for vocal learning could be associated with molecular convergence. We previously found that the neural activity-induced gene dual specificity phosphatase 1 (dusp1) was up-regulated in non-vocal circuits, specifically in sensory-input neurons of the thalamus and telencephalon; however, dusp1 was not up-regulated in higher order sensory neurons or motor circuits. Here we show that song motor nuclei are an exception to this pattern. The song nuclei of species from all known vocal learning avian lineages showed motor-driven up-regulation of dusp1 expression induced by singing. There was no detectable motor-driven dusp1 expression throughout the rest of the forebrain after non-vocal motor performance. This pattern contrasts with expression of the commonly studied activity-induced gene egr1, which shows motor-driven expression in song nuclei induced by singing, but also motor-driven expression in adjacent brain regions after non-vocal motor behaviors. In the vocal non-learning avian species, we found no detectable vocalizing-driven dusp1 expression in the forebrain. These findings suggest that independent evolutions of neural systems for vocal learning were accompanied by selection for specialized motor-driven expression of the dusp1 gene in those circuits. This specialized expression of dusp1 could potentially lead to differential regulation of dusp1-modulated molecular cascades in vocal learning circuits.	[Horita, Haruhito; Jarvis, Erich D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA; [Horita, Haruhito; Oka, Kotaro] Keio Univ, Sch Fundamental Sci & Technol, Yokohama, Kanagawa 223, Japan; [Horita, Haruhito; Wada, Kazuhiro] Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 060, Japan; [Kobayashi, Masahiko; Wada, Kazuhiro] Hokkaido Univ, Sch Life Sci, Sapporo, Hokkaido, Japan; [Liu, Wan-chun] Rockefeller Univ, Field Res Ctr, Millbrook, NY 12545 USA	Duke University; Howard Hughes Medical Institute; Keio University; Hokkaido University; Hokkaido University; Rockefeller University	Horita, H (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA.	jarvis@neuro.duke.edu; wada@sci.hokudai.ac.jp	Jarvis, Erich D/A-2319-2008; Oka, Kotaro/C-4918-2014	Jarvis, Erich D/0000-0001-8931-5049; Wada, Kazuhiro/0000-0001-8137-9144	National Institutes of Health (NIH) [R01DC7218]; NIH Director's Pioneer Award [DP1OD448]; Howard Hughes Medical Institute; Uehara Memorial Foundation; Inamori Foundation; Japan Student Services Organization fellowship;  [22120513];  [20033017]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007218] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22650089] Funding Source: KAKEN	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Uehara Memorial Foundation(Uehara Memorial Foundation); Inamori Foundation; Japan Student Services Organization fellowship; ; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Research was supported by National Institutes of Health (NIH) R01DC7218, NIH Director's Pioneer Award DP1OD448, and Howard Hughes Medical Institute grants to EDJ, Grant-in-Aid for Young Scientists (A) and for Scientific Research on Innovative Areas, Uehara Memorial Foundation, and Inamori Foundation to KW, Grants-in-Aid for Scientific Research on Innovative Areas (22120513, 20033017) to KO, and a Japan Student Services Organization fellowship to HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adret P, 2002, J COMP NEUROL, V454, P409, DOI 10.1002/cne.10459; Akutagawa E, 2010, J COMP NEUROL, V518, P3086, DOI 10.1002/cne.22383; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bleiweiss R, 1997, MOL BIOL EVOL, V14, P325, DOI 10.1093/oxfordjournals.molbev.a025767; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Bottjer SW, 2000, J COMP NEUROL, V420, P244; BRAUN K, 1985, CELL TISSUE RES, V240, P101, DOI 10.1007/BF00217563; Brenowitz E.A., 1991, Seminars in the Neurosciences, V3, P399, DOI 10.1016/1044-5765(91)90030-R; Cardin JA, 2003, J NEUROPHYSIOL, V90, P2884, DOI 10.1152/jn.00391.2003; Chen CC, 2012, JOVE-J VIS EXP, DOI 10.3791/3764; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Choi BH, 2006, J CELL SCI, V119, P1329, DOI 10.1242/jcs.02837; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Dubbeldam JL, 1998, ACTA ANAT, V163, P157; Durand SE, 1997, J COMP NEUROL, V377, P179, DOI 10.1002/(SICI)1096-9861(19970113)377:2<179::AID-CNE3>3.0.CO;2-0; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Gahr M, 2000, J COMP NEUROL, V426, P182; Gale SD, 2008, J COMP NEUROL, V508, P824, DOI 10.1002/cne.21700; Goldberg JH, 2011, J NEUROPHYSIOL, V105, P2729, DOI 10.1152/jn.00823.2010; Guillery RW, 1997, J COMP NEUROL, V386, P2, DOI 10.1002/(SICI)1096-9861(19970915)386:1<2::AID-CNE2>3.0.CO;2-6; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Hara E, 2007, EUR J NEUROSCI, V25, P3406, DOI 10.1111/j.1460-9568.2007.05600.x; Hara E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029457; Hara E, 2009, P ROY SOC B-BIOL SCI, V276, P279, DOI 10.1098/rspb.2008.1138; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Horita H, 2010, J COMP NEUROL, V518, P2873, DOI 10.1002/cne.22370; Horita H, 2008, EUR J NEUROSCI, V28, P2519, DOI 10.1111/j.1460-9568.2008.06535.x; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2000, NATURE, V406, P628, DOI 10.1038/35020570; Jarvis ED, 2000, J COMP NEUROL, V419, P1, DOI 10.1002/(SICI)1096-9861(20000327)419:1<1::AID-CNE1>3.0.CO;2-M; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; JOHNSON F, 1995, J COMP NEUROL, V358, P260, DOI 10.1002/cne.903580208; KARTEN HARVEY J., 1967; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Kimpo RR, 1997, NEURON, V18, P315, DOI 10.1016/S0896-6273(00)80271-8; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Kristiansen M, 2010, J NEUROSCI, V30, P10820, DOI 10.1523/JNEUROSCI.2824-10.2010; KROODSMA DE, 1991, ANIM BEHAV, V42, P477, DOI 10.1016/S0003-3472(05)80047-8; Kubikova L, 2007, EUR J NEUROSCI, V25, P2145, DOI 10.1111/j.1460-9568.2007.05368.x; Kuenzel WJ, 1988, STEREOTAXIC ATLAS BR, pviii; Liu YX, 2008, MOL CANCER RES, V6, P624, DOI 10.1158/1541-7786.MCR-07-2019; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lovell PV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003440; Luo MM, 1999, J NEUROSCI, V19, P6700; Luo MM, 2001, J NEUROSCI, V21, P6836, DOI 10.1523/JNEUROSCI.21-17-06836.2001; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; Matsunaga E, 2009, DEV GROWTH DIFFER, V51, P45, DOI 10.1111/j.1440-169X.2008.01080.x; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; MELLO CV, 1994, J NEUROSCI, V14, P6652; Mello CV, 1998, J COMP NEUROL, V395, P137; MELLO CV, 1995, J NEUROBIOL, V26, P145, DOI 10.1002/neu.480260112; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Morawski M, 2004, EXP NEUROL, V188, P309, DOI 10.1016/j.expneurol.2004.04.017; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mundy NI, 2007, PLOS BIOL, V5, P1842, DOI 10.1371/journal.pbio.0050250; Nabholz B, 2010, MOL PHYLOGENET EVOL, V57, P466, DOI 10.1016/j.ympev.2010.06.009; NOTTEBOHM F, 1971, ANIM BEHAV, V19, P313, DOI 10.1016/S0003-3472(71)80012-X; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1972, AM NAT, V106, P116, DOI 10.1086/282756; Nottebohm F., 1980, PROGR PSYCHOBIOLOGY, V9, P85; OKUHATA S, 1987, BRAIN RES BULL, V18, P35, DOI 10.1016/0361-9230(87)90031-1; PATON JA, 1981, J NEUROSCI, V1, P1279; Pinaud R, 2008, EUR J NEUROSCI, V27, P1409, DOI 10.1111/j.1460-9568.2008.06102.x; Pinaud R, 2007, J COMP NEUROL, V504, P601, DOI 10.1002/cne.21457; Poole JH, 2005, NATURE, V434, P455, DOI 10.1038/434455a; Poopatanapong A, 2006, J NEUROBIOL, V66, P1613, DOI 10.1002/neu.20329; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Reinke H, 1998, J COMP NEUROL, V391, P147; Rossler OG, 2008, ARCH BIOCHEM BIOPHYS, V470, P93, DOI 10.1016/j.abb.2007.11.008; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Soderstrom K, 2006, J COMP NEUROL, V496, P739, DOI 10.1002/cne.20963; STRIEDTER GF, 1994, J COMP NEUROL, V343, P35, DOI 10.1002/cne.903430104; Suh A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1448; Takaki M, 2001, J NEUROCHEM, V79, P679, DOI 10.1046/j.1471-4159.2001.00615.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031; Vates GE, 1997, J COMP NEUROL, V380, P275; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; Vowles DM, 1979, NEURAL ENDOCRINE ASP, P351; Wada K, 2004, J COMP NEUROL, V476, P44, DOI 10.1002/cne.20201; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wilbrecht L, 2003, MENT RETARD DEV D R, V9, P135, DOI 10.1002/mrdd.10073; WILD JM, 1994, BRAIN BEHAV EVOLUT, V44, P192, DOI 10.1159/000113577; Wild JM, 1997, J NEUROBIOL, V33, P653, DOI 10.1002/(SICI)1097-4695(19971105)33:5<653::AID-NEU11>3.0.CO;2-A; Wild JM, 1997, BRAIN RES, V755, P137, DOI 10.1016/S0006-8993(97)00026-7; Zakon HH, 2006, P NATL ACAD SCI USA, V103, P3675, DOI 10.1073/pnas.0600160103	108	33	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42173	10.1371/journal.pone.0042173	http://dx.doi.org/10.1371/journal.pone.0042173			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876306	Green Published, gold			2022-12-27	WOS:000307184700034
J	Jia, ZY; Rahmatpanah, FB; Chen, X; Lernhardt, W; Wang, YP; Xia, XQ; Sawyers, A; Sutton, M; McClelland, M; Mercola, D				Jia, Zhenyu; Rahmatpanah, Farah B.; Chen, Xin; Lernhardt, Waldemar; Wang, Yipeng; Xia, Xiao-Qin; Sawyers, Anne; Sutton, Manuel; McClelland, Michael; Mercola, Dan			Expression Changes in the Stroma of Prostate Cancer Predict Subsequent Relapse	PLOS ONE			English	Article							GENE-EXPRESSION; TUMOR MICROENVIRONMENT; ACTIVE SURVEILLANCE; TIME; DIAGNOSIS; MARKER; MEN	Biomarkers are needed to address overtreatment that occurs for the majority of prostate cancer patients that would not die of the disease but receive radical treatment. A possible barrier to biomarker discovery may be the polyclonal/multifocal nature of prostate tumors as well as cell-type heterogeneity between patient samples. Tumor-adjacent stroma (tumor microenvironment) is less affected by genetic alteration and might therefore yield more consistent biomarkers in response to tumor aggressiveness. To this end we compared Affymetrix gene expression profiles in stroma near tumor and identified a set of 115 probe sets for which the expression levels were significantly correlated with time-to-relapse. We also compared patients that chemically relapsed shortly after prostatectomy (<1 year), and patients that did not relapse in the first four years after prostatectomy. We identified 131 differentially expressed microarray probe sets between these two categories. 19 probe sets (15 genes overlapped between the two gene lists with p<0.0001). We developed a PAM-based classifier by training on samples containing stroma near tumor: 9 rapid relapse patient samples and 9 indolent patient samples. We then tested the classifier on 47 different samples, containing 90% or more stroma. The classifier predicted the risk status of patients with an average accuracy of 87%. This is the first general tumor microenvironment-based prognostic classifier. These results indicate that the prostate cancer microenvironment exhibits reproducible changes useful for predicting outcomes for patients.	[Jia, Zhenyu; Rahmatpanah, Farah B.; Chen, Xin; Sawyers, Anne; Sutton, Manuel; McClelland, Michael; Mercola, Dan] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92717 USA; [Lernhardt, Waldemar] Proveri, San Diego, CA USA; [Wang, Yipeng] AltheaDx, San Diego, CA USA; [Xia, Xiao-Qin] Chinese Acad Sci, Dept Bioinformat, Inst Hydrobiol, Wuhan, Hubei, Peoples R China; [McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA	University of California System; University of California Irvine; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Jia, ZY (corresponding author), Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92717 USA.	zjia@uci.edu; mmcclelland@sdibr.org; dmercola@uci.edu	Chen, Xin/ABA-3794-2020; mercola, dan/L-4182-2013	mercola, dan/0000-0002-0281-9840; McClelland, Michael/0000-0003-1788-9347; xia, xiao qin/0000-0002-8034-1096	National Institutes of Health Strategic Partners for the Evaluation of Cancer Signatures (SPECS) Consortium [U01 CA1148102]; National Cancer Institute Early Detection Research Network (EDRN) Consortium [U01 CA152738]; University of California of Irvine Faculty Career Development Award; Chao Family Comprehensive Cancer Center at University of California of Irvine; Department of Defense Congressionally Directed Medical Research Programs [W81XWH-08-1-0720]; University of California of Irvine Institute for Cancer Research from the National Cancer Institute [T32CA009054]; NATIONAL CANCER INSTITUTE [T32CA009054, P30CA062203, U01CA152738] Funding Source: NIH RePORTER	National Institutes of Health Strategic Partners for the Evaluation of Cancer Signatures (SPECS) Consortium; National Cancer Institute Early Detection Research Network (EDRN) Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of California of Irvine Faculty Career Development Award; Chao Family Comprehensive Cancer Center at University of California of Irvine; Department of Defense Congressionally Directed Medical Research Programs(United States Department of Defense); University of California of Irvine Institute for Cancer Research from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health Strategic Partners for the Evaluation of Cancer Signatures (SPECS) Consortium grant U01 CA1148102 and National Cancer Institute Early Detection Research Network (EDRN) Consortium grant U01 CA152738. This work was also supported by a University of California of Irvine Faculty Career Development Award (ZJ), a grant from the Chao Family Comprehensive Cancer Center at University of California of Irvine (ZJ and DAM). Also, this work was supported in part by Department of Defense Congressionally Directed Medical Research Programs grant W81XWH-08-1-0720, and by a University of California of Irvine Institute for Cancer Research Training Grant Fellowship (T32CA009054 from the National Cancer Institute) (FR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kofahi KA, 2002, IEEE T INF TECHNOL B, V6, P171, DOI 10.1109/TITB.2002.1006304; American Cancer Society, 2007, CANC FACTS FIG 2007; Ashida S, 2012, CLIN CANCER RES, V18, P1578, DOI 10.1158/1078-0432.CCR-11-2535; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Bul M, 2011, ACTA ONCOL, V50, P4, DOI 10.3109/0284186X.2010.522197; Burger MJ, 2002, INT J CANCER, V100, P228, DOI 10.1002/ijc.10468; D'Amico AV, 2011, NEW ENGL J MED, V365, P169, DOI 10.1056/NEJMe1103829; Dakhova O, 2009, CLIN CANCER RES, V15, P3979, DOI 10.1158/1078-0432.CCR-08-1899; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edwards S, 2005, BRIT J CANCER, V92, P376, DOI 10.1038/sj.bjc.6602261; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Guglielmi C, 1998, J CLIN ONCOL, V16, P3264, DOI 10.1200/JCO.1998.16.10.3264; Gurel B, 2010, AM J SURG PATHOL, V34, P1097, DOI 10.1097/PAS.0b013e3181e6cbf3; Hamid O, 2007, CLIN CANCER RES, V13, P215, DOI 10.1158/1078-0432.CCR-06-1450; Hayes JH, 2010, JAMA-J AM MED ASSOC, V304, P2373, DOI 10.1001/jama.2010.1720; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia ZY, 2011, CANCER RES, V71, P2476, DOI 10.1158/0008-5472.CAN-10-2585; Joesting MS, 2005, CANCER RES, V65, P10423, DOI 10.1158/0008-5472.CAN-05-0824; Lawrentschuk N, 2011, NAT REV UROL, V8, P312, DOI 10.1038/nrurol.2011.50; Lu SY, 2010, INT J CANCER, V126, P416, DOI 10.1002/ijc.24761; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maresh EL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-680; Mucci LA, 2008, CANCER EPIDEM BIOMAR, V17, P1682, DOI 10.1158/1055-9965.EPI-08-0044; Paul R, 1997, BRIT J UROL, V79, P37, DOI 10.1111/j.1464-410X.1997.tb00799.x; Planche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018640; Richardson AM, 2007, DIAGN MOL PATHOL, V16, P189, DOI 10.1097/PDM.0b013e3180de20ac; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Subramanian HN, 2002, AM J RHINOL, V16, P303, DOI 10.1177/194589240201600605; Sutcliffe P, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13050; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tomlins SA, 2009, EUR UROL, V56, P275, DOI 10.1016/j.eururo.2009.04.036; Trock BJ, 2012, BJU INT, V110, P56, DOI 10.1111/j.1464-410X.2011.10718.x; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang YP, 2010, CANCER RES, V70, P6448, DOI 10.1158/0008-5472.CAN-10-0021; Witkiewicz AK, 2011, CELL CYCLE, V10, P1794, DOI 10.4161/cc.10.11.15675; Zhang Y, 2007, PROSTATE CANCER P D, V10, P293, DOI 10.1038/sj.pcan.4500960	39	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41371	10.1371/journal.pone.0041371	http://dx.doi.org/10.1371/journal.pone.0041371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870216	Green Published, Green Submitted, gold			2022-12-27	WOS:000307212800017
J	Noike, M; Ono, Y; Araki, Y; Tanio, R; Higuchi, Y; Nitta, H; Hamano, Y; Toyomasu, T; Sassa, T; Kato, N; Dairi, T				Noike, Motoyoshi; Ono, Yusuke; Araki, Yuji; Tanio, Ryo; Higuchi, Yusuke; Nitta, Hajime; Hamano, Yoshimitsu; Toyomasu, Tomonobu; Sassa, Takeshi; Kato, Nobuo; Dairi, Tohru			Molecular Breeding of a Fungus Producing a Precursor Diterpene Suitable for Semi-Synthesis by Dissection of the Biosynthetic Machinery	PLOS ONE			English	Article							DIFFERENTIATION-INDUCING AGENT; PLANT-GROWTH REGULATOR; GENE-CLUSTER; COTYLENIN-A; FUNCTIONAL-ANALYSIS; FUSICOCCIN; IDENTIFICATION; ENZYMES; CLONING; ALPHA	Many clinically useful pharmaceuticals are semi-synthesized from natural products produced by actinobacteria and fungi. The synthetic protocols usually contain many complicated reaction steps and thereby result in low yields and high costs. It is therefore important to breed microorganisms that produce a compound most suitable for chemical synthesis. For a long time, desirable mutants have been obtained by random mutagenesis and mass screening. However, these mutants sometimes show unfavorable phenotypes such as low viability and low productivity of the desired compound. Fusicoccin (FC) A is a diterpene glucoside produced by the fungus Phomopsis amygdali. Both FC and the structurally-related cotylenin A (CN) have phytohormone-like activity. However, only CN exhibits anti-cancer activity. Since the CN producer lost its ability to proliferate during preservation, a study on the relationship between structure and activity was carried out, and elimination of the hydroxyl group at position 12 of FC was essential to mimic the CN-like activity. Based on detailed dissection of the biosynthetic machinery, we constructed a mutant producing a compound without a hydroxyl group at position 12 by gene-disruption. The mutant produced this compound as a sole metabolite, which can be easily and efficiently converted into an anti-cancer drug, and its productivity was equivalent to the sum of FC-related compounds produced by the parental strain. Our strategy would be applicable to development of pharmaceuticals that are semisynthesized from fungal metabolites.	[Noike, Motoyoshi; Ono, Yusuke; Araki, Yuji; Tanio, Ryo; Dairi, Tohru] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 060, Japan; [Higuchi, Yusuke; Nitta, Hajime; Kato, Nobuo] Osaka Univ, Inst Sci & Ind Res, Osaka, Japan; [Hamano, Yoshimitsu] Fukui Prefectural Univ, Dept Biosci, Fukui, Japan; [Toyomasu, Tomonobu; Sassa, Takeshi] Yamagata Univ, Dept Bioresource Engn, Yamagata 990, Japan	Hokkaido University; Osaka University; Fukui Prefectural University; Yamagata University	Noike, M (corresponding author), Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 060, Japan.	noike@eng.hokudai.ac.jp; dairi@eng.hokudai.ac.jp	Higuchi, Yusuke/I-1991-2018	Higuchi, Yusuke/0000-0002-5982-9660; Hamano, Yoshimitsu/0000-0001-5117-5116; Dairi, Tohru/0000-0002-3406-7970	Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan; MEXT, Japan [B01]; Naito Foundation; Foundation NAGASE Science Technology Development	Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Foundation NAGASE Science Technology Development	This work was supported in part by the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan, a Grant-in-Aid for Scientific Research on Innovative Areas, the Global COE Program (Project no. B01: Catalysis as the Basis for Innovation in Materials Science), MEXT, Japan, the Naito Foundation, and the Foundation NAGASE Science Technology Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Asahi K, 1997, BIOCHEM BIOPH RES CO, V238, P758, DOI 10.1006/bbrc.1997.7385; BALLIO A, 1968, EXPERIENTIA, V24, P631, DOI 10.1007/BF02153818; BARROW KD, 1971, J CHEM SOC C, P1259, DOI 10.1039/j39710001259; BARROW KD, 1973, J CHEM SOC PERK T 1, P1590, DOI 10.1039/p19730001590; BARROW KD, 1975, J CHEM SOC PERK T 1, P877, DOI 10.1039/p19750000877; Dairi T, 2005, J ANTIBIOT, V58, P227, DOI 10.1038/ja.2005.27; Hamano Y, 2002, J BIOL CHEM, V277, P37098, DOI 10.1074/jbc.M206382200; Hashimoto M, 2009, BIOORG MED CHEM LETT, V19, P5640, DOI 10.1016/j.bmcl.2009.08.026; Hayashi Y, 2008, J ANTIBIOT, V61, P164, DOI 10.1038/ja.2008.126; Hayashi Y, 2007, BIOSCI BIOTECH BIOCH, V71, P3072, DOI 10.1271/bbb.70477; Honma Y, 2005, GYNECOL ONCOL, V99, P680, DOI 10.1016/j.ygyno.2005.07.015; Honma Y, 2003, CANCER RES, V63, P3659; Honma Y, 2002, LEUKEMIA LYMPHOMA, V43, P1169, DOI 10.1080/10428190290026222; Kawakami K, 2012, ANTICANCER IN PRESS; Kawasaki T, 2006, J BACTERIOL, V188, P1236, DOI 10.1128/JB.188.4.1236-1244.2006; KIMURA N, 1993, J BACTERIOL, V175, P4427, DOI 10.1128/JB.175.14.4427-4435.1993; MacKinnon SL, 1999, PHYTOCHEMISTRY, V51, P215, DOI 10.1016/S0031-9422(98)00732-8; MARRE E, 1979, ANNU REV PLANT PHYS, V30, P273, DOI 10.1146/annurev.pp.30.060179.001421; Matsunawa M, 2006, LEUKEMIA LYMPHOMA, V47, P733, DOI 10.1080/10428190500375839; Minami A, 2009, BIOORG MED CHEM LETT, V19, P870, DOI 10.1016/j.bmcl.2008.11.108; Noike M, 2012, CHEMBIOCHEM, V13, P566, DOI 10.1002/cbic.201100725; Ono Y, 2011, J AM CHEM SOC, V133, P2548, DOI 10.1021/ja107785u; Sassa T, 2002, BIOSCI BIOTECH BIOCH, V66, P2356, DOI 10.1271/bbb.66.2356; SASSA T, 1971, AGR BIOL CHEM TOKYO, V35, P1415, DOI 10.1080/00021369.1971.10860078; Sassa T, 1998, BIOSCI BIOTECH BIOCH, V62, P1815, DOI 10.1271/bbb.62.1815; Tajima N, 2002, J PESTIC SCI, V27, P64; Toyomasu T, 2007, P NATL ACAD SCI USA, V104, P3084, DOI 10.1073/pnas.0608426104; Tudzynski B, 2005, APPL MICROBIOL BIOT, V66, P597, DOI 10.1007/s00253-004-1805-1; Tyo KE, 2007, TRENDS BIOTECHNOL, V25, P132, DOI 10.1016/j.tibtech.2007.01.003	30	17	29	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42090	10.1371/journal.pone.0042090	http://dx.doi.org/10.1371/journal.pone.0042090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870285	Green Published, gold			2022-12-27	WOS:000307212800058
J	Vordermeier, HM; Hewinson, RG; Wilkinson, RJ; Wilkinson, KA; Gideon, HP; Young, DB; Sampson, SL				Vordermeier, H. Martin; Hewinson, R. Glyn; Wilkinson, Robert J.; Wilkinson, Katalin A.; Gideon, Hannah P.; Young, Douglas B.; Sampson, Samantha L.			Conserved Immune Recognition Hierarchy of Mycobacterial PE/PPE Proteins during Infection in Natural Hosts	PLOS ONE			English	Article							CANDIDATE TUBERCULOSIS VACCINE; PREDICTED SECRETED ANTIGENS; COMPLETE GENOME SEQUENCE; PATHOGENIC MYCOBACTERIA; BOVINE TUBERCULOSIS; GENE-EXPRESSION; PE; SYSTEM; ESAT-6; IMMUNOGENICITY	The Mycobacterium tuberculosis genome contains two large gene families encoding proteins of unknown function, characterized by conserved N-terminal proline and glutamate (PE and PPE) motifs. The presence of a large number of PE/PPE proteins with repetitive domains and evidence of strain variation has given rise to the suggestion that these proteins may play a role in immune evasion via antigenic variation, while emerging data suggests that some family members may play important roles in mycobacterial pathogenesis. In this study, we examined cellular immune responses to a panel of 36 PE/PPE proteins during human and bovine infection. We observed a distinct hierarchy of immune recognition, reflected both in the repertoire of PE/PPE peptide recognition in individual cows and humans and in the magnitude of IFN-gamma responses elicited by stimulation of sensitized host cells. The pattern of immunodominance was strikingly similar between cattle that had been experimentally infected with Mycobacterium bovis and humans naturally infected with clinical isolates of M. tuberculosis. The same pattern was maintained as disease progressed throughout a four-month course of infection in cattle, and between humans with latent as well as active tuberculosis. Detailed analysis of PE/PPE responses at the peptide level suggests that antigenic cross-reactivity amongst related family members is a major determinant in the observed differences in immune hierarchy. Taken together, these results demonstrate that a subset of PE/PPE proteins are major targets of the cellular immune response to tuberculosis, and are recognized at multiple stages of infection and in different disease states. Thus this work identifies a number of novel antigens that could find application in vaccine development, and provides new insights into PE/PPE biology.	[Vordermeier, H. Martin; Hewinson, R. Glyn] Anim Hlth & Vet Labs Agcy Weybridge, TB Res Grp, Addlestone, Surrey, England; [Wilkinson, Robert J.; Wilkinson, Katalin A.; Gideon, Hannah P.] Univ Cape Town, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Wilkinson, Robert J.; Wilkinson, Katalin A.; Gideon, Hannah P.] Univ Cape Town, Dept Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Wilkinson, Robert J.; Wilkinson, Katalin A.; Young, Douglas B.] MRC Natl Inst Med Res, Div Mycobacterial Res, London, England; [Wilkinson, Robert J.; Young, Douglas B.; Sampson, Samantha L.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	Veterinary Laboratories Agency; University of Cape Town; University of Cape Town; MRC National Institute for Medical Research; Imperial College London	Vordermeier, HM (corresponding author), Anim Hlth & Vet Labs Agcy Weybridge, TB Res Grp, Addlestone, Surrey, England.	ssampson@imperial.ac.uk	Wilkinson, Katalin/AAF-6805-2020; Hewinson, Glyn/J-1902-2014; Vordermeier, H Martin/C-6936-2011; Wilkinson, Katalin/AAQ-7713-2021; Hewinson, Glyn/AAA-2364-2019	Wilkinson, Katalin/0000-0002-9796-2040; Hewinson, Glyn/0000-0002-5517-4281; Wilkinson, Robert/0000-0002-2753-1800; Gideon, Hannah/0000-0002-4443-2134; sampson, samantha/0000-0002-9596-8019	Wellcome Trust [WT078256MA, 084323, 088316]; United Kingdom Department for Environment, Food and Rural Affairs (Defra); ILULU consortium; European Union [Sante/2006/105-061]; European and Developing Countries Clinical Trials Partnership (EDCTP) [IP.07.32080.002]; Bill and Melinda Gates Foundation [6-74 37772]; Medical Research Council [U.1175.02.002.00014.01]; Medical Research Council [MC_U117588499] Funding Source: researchfish; MRC [MC_U117588499] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); United Kingdom Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); ILULU consortium; European Union(European Commission); European and Developing Countries Clinical Trials Partnership (EDCTP); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Wellcome Trust, with cattle experiments supported by the United Kingdom Department for Environment, Food and Rural Affairs (Defra) and human studies supported by the ILULU consortium, which is funded by a grant from the European Union (Sante/2006/105-061), European and Developing Countries Clinical Trials Partnership (EDCTP) (IP.07.32080.002) and the Bill and Melinda Gates Foundation GC#6-74 37772. SLS was funded by the Wellcome Trust (WT078256MA). RJW is funded by the Wellcome Trust (084323, 088316) and the Medical Research Council (U.1175.02.002.00014.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Bansal K, 2010, J BIOL CHEM, V285, P36511, DOI 10.1074/jbc.M110.158055; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Barbour A, 2002, MOBILE DNA, P972; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Bottai D, 2012, MOL MICROBIOL; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; Dean GS, 2008, TUBERCULOSIS, V88, P586, DOI 10.1016/j.tube.2008.01.004; Delogu G, 2001, INFECT IMMUN, V69, P5606, DOI 10.1128/IAI.69.9.5606-5611.2001; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; European Economic Community, 1980, OFFICIAL J L, VL047, P25; Flynn JL, 2005, TRENDS MICROBIOL, V13, P98, DOI 10.1016/j.tim.2005.01.005; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Golby P, 2007, MICROBIOL-SGM, V153, P3323, DOI 10.1099/mic.0.2007/009894-0; HERMANS PWM, 1992, J BACTERIOL, V174, P4157, DOI 10.1128/jb.174.12.4157-4165.1992; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Jones GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1344, DOI 10.1128/CVI.00261-10; Jones GJ, 2010, INFECT IMMUN, V78, P1326, DOI 10.1128/IAI.01246-09; Karboul A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-107; Koh KW, 2009, MOL IMMUNOL, V46, P1312, DOI 10.1016/j.molimm.2008.11.008; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Leroux-Roels I, 2010, CLIN VACCINE IMMUNOL, V17, P1763, DOI 10.1128/CVI.00133-10; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Pirson C, 2011, VET MICROBIOL, V148, P232, DOI 10.1016/j.vetmic.2010.08.019; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Reed SG, 2009, P NATL ACAD SCI USA, V106, P2301, DOI 10.1073/pnas.0712077106; Rehren G, 2007, TUBERCULOSIS, V87, P347, DOI 10.1016/j.tube.2007.02.004; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Talaat AM, 2007, J BACTERIOL, V189, P4265, DOI 10.1128/JB.00011-07; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Talarico S, 2008, TUBERCULOSIS, V88, P283, DOI 10.1016/j.tube.2008.01.001; Tsenova L, 2006, INFECT IMMUN, V74, P2392, DOI 10.1128/IAI.74.4.2392-2401.2006; Von Eschen K, 2009, HUM VACCINES, V5, P475, DOI 10.4161/hv.8570; Vordermeier HM, 2001, CLIN DIAGN LAB IMMUN, V8, P571, DOI 10.1128/CDLI.8.3.571-578.2001; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Whelan AO, 2008, VACCINE, V26, P166, DOI 10.1016/j.vaccine.2007.11.005	51	39	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40890	10.1371/journal.pone.0040890	http://dx.doi.org/10.1371/journal.pone.0040890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870206	gold, Green Published, Green Submitted			2022-12-27	WOS:000307212800012
J	Bjordahl, RL; Gapin, L; Marrack, P; Refaeli, Y				Bjordahl, Ryan L.; Gapin, Laurent; Marrack, Philippa; Refaeli, Yosef			iNKT Cells Suppress the CD8(+) T Cell Response to a Murine Burkitt's-Like B Cell Lymphoma	PLOS ONE			English	Article							V(ALPHA)14 NKT CELLS; TUMOR-IMMUNITY; ALPHA-GALACTOSYLCERAMIDE; AUTOIMMUNE-DISEASE; ANTITUMOR IMMUNITY; ADAPTIVE IMMUNITY; CUTTING EDGE; IFN-GAMMA; MICE; LYMPHOCYTES	The T cell response to B cell lymphomas differs from the majority of solid tumors in that the malignant cells themselves are derived from B lymphocytes, key players in immune response. B cell lymphomas are therefore well situated to manipulate their surrounding microenvironment to enhance tumor growth and minimize anti-tumor T cell responses. We analyzed the effect of T cells on the growth of a transplantable B cell lymphoma and found that iNKT cells suppressed the anti-tumor CD8(+) T cell response. Lymphoma cells transplanted into syngeneic wild type (WT) mice or Jalpha18(-/-) mice that specifically lack iNKT cells grew initially at the same rate, but only the mice lacking iNKT cells were able to reject the lymphoma. This effect was due to the enhanced activity of tumor-specific CD8(+) T cells in the absence of iNKT cells, and could be partially reversed by reconstitution of iNKT cells in Jalpha 18(-/-) mice. Treatment of tumor-bearing WT mice with alpha -galactosyl ceramide, an activating ligand for iNKT cells, reduced the number of tumor-specific CD8(+) T cells. In contrast, lymphoma growth in CD1d1(-/-) mice that lack both iNKT and type II NKT cells was similar to that in WT mice, suggesting that type II NKT cells are required for full activation of the anti-tumor immune response. This study reveals a tumor-promoting role for iNKT cells and suggests their capacity to inhibit the CD8(+) T cell response to B cell lymphoma by opposing the effects of type II NKT cells.	[Bjordahl, Ryan L.; Gapin, Laurent; Marrack, Philippa; Refaeli, Yosef] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Bjordahl, Ryan L.; Gapin, Laurent; Marrack, Philippa; Refaeli, Yosef] Univ Colorado, Denver, CO 80202 USA; [Marrack, Philippa] Howard Hughes Med Inst, Chevy Chase, MD USA; [Refaeli, Yosef] Univ Colorado, Sch Med, Charles C Gates Ctr Regenerat Med & Stem Cell Bio, Aurora, CO USA; [Refaeli, Yosef] Univ Colorado, Sch Med, Dept Dermatol, Aurora, CO USA	National Jewish Health; University of Colorado System; University of Colorado Denver; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Bjordahl, RL (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA.	Yosef.Refaeli@ucdenver.edu	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	United States Public Health Service, National Institutes of Health [R01 CA117802-06, P30 AR057212-02, P01 AI022295-24, R21 AI090450-01, R56 AI078246-01A1, AI-18785, AI-22295]; Cancer Research Institute; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA117802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090450, R37AI018785, P01AI022295, R56AI078246, T32AI007405, R56AI018785, R01AI018785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057212] Funding Source: NIH RePORTER	United States Public Health Service, National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by United States Public Health Service, National Institutes of Health grants R01 CA117802-06, P30 AR057212-02, and P01 AI022295-24 (to Y.R.), grants R21 AI090450-01 and R56 AI078246-01A1 (to L. G.), grants AI-18785 and AI-22295 (to P. M.), and the Cancer Research Institute Predoctoral Emphasis Pathway in Tumor Immunology Fellowship (to R. L. B.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Ambrosino E, 2007, J IMMUNOL, V179, P5126, DOI 10.4049/jimmunol.179.8.5126; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; Berzofsky JA, 2009, CURR MOL MED, V9, P667, DOI 10.2174/156652409788970706; Burdin N, 1998, J IMMUNOL, V161, P3271; Butcher BW, 2005, BONE MARROW TRANSPL, V36, P1, DOI 10.1038/sj.bmt.1705008; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Carnaud C, 1999, J IMMUNOL, V163, P4647; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Cuttner J, 2005, J RHEUMATOL, V32, P1884; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Grigg A, 2004, BIOL BLOOD MARROW TR, V10, P579, DOI 10.1016/j.bbmt.2004.05.008; Halder RC, 2007, J CLIN INVEST, V117, P2302, DOI 10.1172/JCI31602; Hammond KJL, 1998, J EXP MED, V187, P1047, DOI 10.1084/jem.187.7.1047; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kobayashi E, 1995, ONCOL RES, V7, P529; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Liu K, 2005, J EXP MED, V202, P1507, DOI 10.1084/jem.20050956; Mallevaey T, 2007, INFECT IMMUN, V75, P2171, DOI 10.1128/IAI.01178-06; Mars LT, 2002, J IMMUNOL, V168, P6007, DOI 10.4049/jimmunol.168.12.6007; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Mattarollo SR, 2010, J IMMUNOL, V184, P1242, DOI 10.4049/jimmunol.0902191; Molyneux EM, 2012, LANCET, V379, P1234, DOI 10.1016/S0140-6736(11)61177-X; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Refaeli Y, 2005, P NATL ACAD SCI USA, V102, P4097, DOI 10.1073/pnas.0409832102; Refaeli Y, 2008, PLOS BIOL, V6, P1208, DOI 10.1371/journal.pbio.0060152; Renukaradhya GJ, 2008, BLOOD, V111, P5637, DOI 10.1182/blood-2007-05-092866; Renukaradhya GJ, 2006, INT J CANCER, V118, P3045, DOI 10.1002/ijc.21764; SANTANA V, 1992, CLIN IMMUNOL IMMUNOP, V63, P205, DOI 10.1016/0090-1229(92)90224-C; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Smyth MJ, 2002, BLOOD, V99, P1259, DOI 10.1182/blood.V99.4.1259; Smyth MJ, 2001, INT IMMUNOL, V13, P459, DOI 10.1093/intimm/13.4.459; Swann JB, 2009, BLOOD, V113, P6382, DOI 10.1182/blood-2009-01-198564; Terabe M, 2006, CANCER RES, V66, P3869, DOI 10.1158/0008-5472.CAN-05-3421; Terabe M, 2005, J EXP MED, V202, P1627, DOI 10.1084/jem.20051381; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Terabe M, 2008, ADV CANCER RES, V101, P277, DOI 10.1016/S0065-230X(08)00408-9; Yang WH, 2011, INVEST OPHTH VIS SCI, V52, P3094, DOI 10.1167/iovs.10-7067; Zintzaras E, 2005, ARCH INTERN MED, V165, P2337, DOI 10.1001/archinte.165.20.2337	42	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42635	10.1371/journal.pone.0042635	http://dx.doi.org/10.1371/journal.pone.0042635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880059	Green Published, gold, Green Submitted			2022-12-27	WOS:000307437900047
J	Ding, SP; Jiang, T; He, JQ; Qin, BB; Lin, SY; Li, LJ				Ding, Shiping; Jiang, Tao; He, Jianqin; Qin, Beibei; Lin, Shuangyan; Li, Lanjuan			Tagging Single Nucleotide Polymorphisms in the IRF1 and IRF8 Genes and Tuberculosis Susceptibility	PLOS ONE			English	Article							SEQUENCE-BINDING-PROTEIN; FACTOR-I POLYMORPHISMS; TAG SNP SELECTION; IFN-GAMMA; B-CELL; INTERFERON; EXPRESSION; IMMUNITY	Genes encoding IRF1 and IRF8 protein have been proposed as candidate tuberculosis susceptibility genes. In order to elucidate whether the IRF1 and IRF8 variants were associated with tuberculosis susceptibility, we conducted a case-control study consisting of 495 controls and 452 ethnically matched cases with tuberculosis in a Chinese population. Seven haplotype tagging single-nucleotide polymorphisms (tagSNPs) (rs2057656; rs2706381; rs2070724; rs2070721; rs2549008; rs2549007; rs2706386) from HapMap database were analyzed, which provided an almost complete coverage of the genetic variations in the IRF1 gene. Fifteen tagSNPs (rs12924316; rs182511; rs305080; rs2292980; rs925994; rs424971; rs16939967; rs11117415; rs4843860; rs9926411; rs8064189; rs12929551; rs10514611; rs1044873; rs6638) were observed in the IRF8 gene. All these tagSNPs were genotyped by SNPstream genotyping and SNaPshot typing. None of the seven tagSNPs was individually associated with tuberculosis in the IRF1 gene. In the IRF8 gene, interestingly, we found that three tagSNPs (rs925994 and rs11117415 located in the intron region; rs10514611 located in the 3'UTR) were associated with risk of tuberculosis after Bonferroni correction. Per allele OR was 1.75 (95% CI 1.35 similar to 2.27,P = 0.002), 4.75 (95% CI 2.16 similar to 10.43, P = 0.002) and 3.39 (95% CI 1.60 similar to 7.20, P = 0.015) respectively. Luciferase reporter gene assay showed that the construct that contained the non-risk allele C of rs10514611 showed significantly higher luciferase activity than did the risk T allele (P<0.01), which implied rs10514611 was a potential functional SNP site. Our results indicated that the IRF8 gene might participate in genetic susceptibility to tuberculosis in a Chinese population.	[Ding, Shiping; He, Jianqin; Li, Lanjuan] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Ding, Shiping; Jiang, Tao; Qin, Beibei; Lin, Shuangyan] Zhejiang Univ, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Ding, SP (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn			"11th Five-Year" Major Science and Technology Projects of Infectious Disease about AIDS and Viral Hepatitis [2008ZX10003011]; Science and Technology Foundation of Public Welfare Profession of Zhejiang Province [2010C33025]; National Natural Science Foundation of China [81072339]; Opening Foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases [2010KF12]; Zhejiang Provincial Natural Science Foundation of China [Y2100347, LR12H26001]	"11th Five-Year" Major Science and Technology Projects of Infectious Disease about AIDS and Viral Hepatitis; Science and Technology Foundation of Public Welfare Profession of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the "11th Five-Year" Major Science and Technology Projects of Infectious Disease about AIDS and Viral Hepatitis (2008ZX10003011) and the Science and Technology Foundation of Public Welfare Profession of Zhejiang Province (2010C33025) and the National Natural Science Foundation of China (81072339) and the Opening Foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases (2010KF12) and Zhejiang Provincial Natural Science Foundation of China (Y2100347; LR12H26001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alter-Koltunoff M, 2008, J BIOL CHEM, V283, P2724, DOI 10.1074/jbc.M707704200; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Ding SP, 2008, HUM IMMUNOL, V69, P129, DOI 10.1016/j.humimm.2007.11.006; HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500; Lee YJ, 2007, HUM IMMUNOL, V68, P770, DOI 10.1016/j.humimm.2007.06.002; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Mangano VD, 2008, GENES IMMUN, V9, P122, DOI 10.1038/sj.gene.6364456; Marquis JF, 2009, J IMMUNOL, V182, P3008, DOI 10.4049/jimmunol.0800680; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; Okamoto M, 2005, CHEST, V128, P4030, DOI 10.1378/chest.128.6.4030; Qi CF, 2009, IMMUNOL RES, V45, P62, DOI 10.1007/s12026-008-8032-2; Qiao YM, 2004, J IMMUNOL, V172, P2935, DOI 10.4049/jimmunol.172.5.2935; Remus N, 2003, IMMUNOL RES, V28, P109, DOI 10.1385/IR:28:2:109; Schedel M, 2008, AM J RESP CRIT CARE, V177, P613, DOI 10.1164/rccm.200703-373OC; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; SURCEL HM, 1994, IMMUNOLOGY, V81, P171; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Turcotte K, 2005, J EXP MED, V201, P881, DOI 10.1084/jem.20042170; van der Eijk EA, 2007, AM J RESP CRIT CARE, V176, P1281, DOI 10.1164/rccm.200703-435OC; Vollstedt S, 2009, TUBERCULOSIS, V89, P71, DOI 10.1016/j.tube.2008.09.006; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; World Health Organization, 2009, GLOB TUB CONTR EP ST; Xu ZL, 2007, EUR J HUM GENET, V15, P1063, DOI 10.1038/sj.ejhg.5201875; Yamada H, 2002, MICROBIOL IMMUNOL, V46, P751, DOI 10.1111/j.1348-0421.2002.tb02760.x; Zhang K, 2004, GENOME RES, V14, P908, DOI 10.1101/gr.1837404; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	32	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42104	10.1371/journal.pone.0042104	http://dx.doi.org/10.1371/journal.pone.0042104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879909	Green Submitted, Green Published, gold			2022-12-27	WOS:000307810000016
J	Lovas, A; Weidemann, A; Albrecht, D; Wiechert, L; Weih, D; Weih, F				Lovas, Agnes; Weidemann, Anja; Albrecht, Daniela; Wiechert, Lars; Weih, Debra; Weih, Falk			p100 Deficiency Is Insufficient for Full Activation of the Alternative NF-kappa B Pathway: TNF Cooperates with p52-RelB in Target Gene Transcription	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; BREAST-CANCER; AUTOTAXIN EXPRESSION; LYMPHOTOXIN; IDENTIFICATION; CARCINOMA; PROMOTES; ALPHA; ROLES; RELB	Background: Constitutive activation of the alternative NF-kappa B pathway leads to marginal zone B cell expansion and disorganized spleen microarchitecture. Furthermore, uncontrolled alternative NF-kappa B signaling may result in the development and progression of cancer. Here, we focused on the question how does the constitutive alternative NF-kappa B signaling exert its effects in these malignant processes. Methodology/Principal Findings: To explore the consequences of unrestricted alternative NF-kappa B activation on genome-wide transcription, we compared gene expression profiles of wild-type and NF-kappa B2/p100-deficient (p100(-/-)) primary mouse embryonic fibroblasts (MEFs) and spleens. Microarray experiments revealed only 73 differentially regulated genes in p100(-/-) vs. wild-type MEFs. Chromatin immunoprecipitation (ChIP) assays showed in p100(-/-) MEFs direct binding of p52 and RelB to the promoter of the Enpp2 gene encoding ENPP2/Autotaxin, a protein with an important role in lymphocyte homing and cell migration. Gene ontology analysis revealed upregulation of genes with anti-apoptotic/proliferative activity (Enpp2/Atx, Serpina3g, Traf1, Rrad), chemotactic/locomotory activity (Enpp2/Atx, Ccl8), and lymphocyte homing activity (Enpp2/Atx, Cd34). Most importantly, biochemical and gene expression analyses of MEFs and spleen, respectively, indicated a marked crosstalk between classical and alternative NF-kappa B pathways. Conclusions/Significance: Our results show that p100 deficiency alone was insufficient for full induction of genes regulated by the alternative NF-kappa B pathway. Moreover, alternative NF-kappa B signaling strongly synergized both in vitro and in vivo with classical NF-kappa B activation, thereby extending the number of genes under the control of the p100 inhibitor of the alternative NF-kappa B signaling pathway.	[Lovas, Agnes; Weidemann, Anja; Wiechert, Lars; Weih, Debra; Weih, Falk] Fritz Lipmann Inst, Leibniz Inst Age Res, Res Grp Immunol, Jena, Germany; [Albrecht, Daniela] Biocontrol Jena GmbH, Jena, Germany; [Weih, Falk] Univ Jena, Fac Biol & Pharmacol, Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena	Lovas, A (corresponding author), Heidelberg Univ, Dept Inner Med 4, Med Clin, Heidelberg, Germany.	fweih@fli-leibniz.de			Leibniz-Institute for Age Research - Fritz-Lipmann-Institute	Leibniz-Institute for Age Research - Fritz-Lipmann-Institute	This work was supported by funds from the Leibniz-Institute for Age Research - Fritz-Lipmann-Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Boutin JA, 2009, CELL MOL LIFE SCI, V66, P3009, DOI 10.1007/s00018-009-0056-9; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Ciana P, 1997, ONCOGENE, V14, P1805, DOI 10.1038/sj.onc.1201015; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Corcoran DL, 2005, GENOME RES, V15, P840, DOI 10.1101/gr.2952005; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Euer N, 2002, ANTICANCER RES, V22, P733; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guo F, 2008, BLOOD, V112, P551, DOI 10.1182/blood-2007-11-125930; Guo F, 2007, BLOOD, V110, P2381, DOI 10.1182/blood-2007-02-075143; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Ishikawa H, 1997, J EXP MED, V186, P999, DOI 10.1084/jem.186.7.999; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Kehlen A, 2004, INT J CANCER, V109, P833, DOI 10.1002/ijc.20022; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Lee I, 2010, CANCER RES, V70, P4357, DOI 10.1158/0008-5472.CAN-09-3791; Lotzer K, 2010, ARTERIOSCL THROM VAS, V30, P395, DOI 10.1161/ATVBAHA.109.191395; Lovas A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-606; McCabe CD, 2005, NUCLEIC ACIDS RES, V33, P6782, DOI 10.1093/nar/gki979; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; Nadiminty N, 2006, P NATL ACAD SCI USA, V103, P7264, DOI 10.1073/pnas.0509808103; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Rozen S, 2000, Methods Mol Biol, V132, P365; Schneider K, 2004, IMMUNOL REV, V202, P49, DOI 10.1111/j.0105-2896.2004.00206.x; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Stassar MJJG, 2001, BRIT J CANCER, V85, P1372, DOI 10.1054/bjoc.2001.2074; Tseng YH, 2001, CANCER RES, V61, P2071; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Weih F, 2003, IMMUNOL REV, V195, P91, DOI 10.1034/j.1600-065X.2003.00064.x; WEIH F, 1994, ONCOGENE, V9, P3289; Wu JM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-71; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196; Yang Y, 1999, AM J RESP CELL MOL, V21, P216, DOI 10.1165/ajrcmb.21.2.3667; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004; Ying XY, 2005, AM J PATHOL, V166, P135, DOI 10.1016/S0002-9440(10)62239-0; Zapata JM, 2000, J IMMUNOL, V165, P5084, DOI 10.4049/jimmunol.165.9.5084; Zhang BC, 2007, BLOOD, V110, P743, DOI 10.1182/blood-2006-11-058446	51	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42741	10.1371/journal.pone.0042741	http://dx.doi.org/10.1371/journal.pone.0042741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880094	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000065
J	Castilho, AF; Aveleira, CA; Leal, EC; Simoes, NF; Fernandes, CR; Meirinhos, RI; Baptista, FI; Ambrosio, AF				Castilho, Aurea F.; Aveleira, Celia A.; Leal, Ermelindo C.; Simoes, Nuria F.; Fernandes, Carolina R.; Meirinhos, Rita I.; Baptista, Filipa I.; Ambrosio, Antonio F.			Heme Oxygenase-1 Protects Retinal Endothelial Cells against High Glucose- and Oxidative/Nitrosative Stress-Induced Toxicity	PLOS ONE			English	Article							OXIDATIVE STRESS; NITRIC-OXIDE; MITOCHONDRIAL SUPEROXIDE; DIABETIC-RETINOPATHY; CARBON-MONOXIDE; MULLER CELLS; APOPTOSIS; OVEREXPRESSION; INDUCTION; INJURY	Diabetic retinopathy is a leading cause of visual loss and blindness, characterized by microvascular dysfunction. Hyperglycemia is considered the major pathogenic factor for the development of diabetic retinopathy and is associated with increased oxidative/nitrosative stress in the retina. Since heme oxygenase-1 (HO-1) is an enzyme with antioxidant and protective properties, we investigated the potential protective role of HO-1 in retinal endothelial cells exposed to high glucose and oxidative/nitrosative stress conditions. Retinal endothelial cells were exposed to elevated glucose, nitric oxide (NO) and hydrogen peroxide (H2O2). Cell viability and apoptosis were assessed by MTT assay, Hoechst staining, TUNEL assay and Annexin V labeling. The production of reactive oxygen species (ROS) was detected by the oxidation of 2',7'-dichlorodihydrofluorescein diacetate. The content of HO-1 was assessed by immunobloting and immunofluorescence. HO activity was determined by bilirubin production. Long-term exposure (7 days) of retinal endothelial cells to elevated glucose decreased cell viability and had no effect on HO-1 content. However, a short-time exposure (24 h) to elevated glucose did not alter cell viability, but increased both the levels of intracellular ROS and HO-1 content. Moreover, the inhibition of HO with SnPPIX unmasked the toxic effect of high glucose and revealed the protection conferred by HO-1. Oxidative/nitrosative stress conditions increased cell death and HO-1 protein levels. These effects of elevated glucose and HO inhibition on cell death were confirmed in primary endothelial cells (HUVECs). When cells were exposed to oxidative/nitrosative stress conditions there was also an increase in retinal endothelial cell death and HO-1 content. The inhibition of HO enhanced ROS production and the toxic effect induced by exposure to H2O2 and NOC-18 (NO donor). Overexpression of HO-1 prevented the toxic effect induced by H2O2 and NOC-18. In conclusion, HO-1 exerts a protective effect in retinal endothelial cells exposed to hyperglycemic and oxidative/nitrosative stress conditions.	[Castilho, Aurea F.; Aveleira, Celia A.; Leal, Ermelindo C.; Simoes, Nuria F.; Fernandes, Carolina R.; Meirinhos, Rita I.; Baptista, Filipa I.; Ambrosio, Antonio F.] Univ Coimbra, Ctr Ophthalmol & Vis Sci, IBILI, Fac Med, Coimbra, Portugal	Universidade de Coimbra	Castilho, AF (corresponding author), Univ Coimbra, Ctr Ophthalmol & Vis Sci, IBILI, Fac Med, Coimbra, Portugal.	afambrosio@fmed.uc.pt	Baptista, Filipa/E-2828-2012; Aveleira, Célia/AAI-2455-2021; Aveleira, Célia A/L-1325-2014; Ambrósio, António F/I-3722-2012; Leal, Ermelindo C/G-3051-2010	Baptista, Filipa/0000-0001-7972-640X; Aveleira, Célia/0000-0002-2191-0682; Aveleira, Célia A/0000-0002-2191-0682; Ambrósio, António F/0000-0002-0477-1641; Leal, Ermelindo C/0000-0003-1748-9861; Castilho, Aurea/0000-0001-7012-5915	Faculty of Medicine, University of Coimbra, Portugal	Faculty of Medicine, University of Coimbra, Portugal	This work was supported by the Faculty of Medicine, University of Coimbra, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2003, CIRC RES, V93, P507, DOI 10.1161/01.RES.0000091828.36599.34; Akagi R, 2005, CONTRIB NEPHROL, V148, P70, DOI 10.1159/000086044; Alizadeh M, 2001, INVEST OPHTH VIS SCI, V42, P2706; [Anonymous], 1995, DIABETES, V44, P968; Arai-Gaun S, 2004, INVEST OPHTH VIS SCI, V45, P4226, DOI 10.1167/iovs.04-0450; Aveleira C, 2010, CYTOKINE, V49, P279, DOI 10.1016/j.cyto.2009.11.014; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Carbajal JM, 1998, BIOCHEM BIOPH RES CO, V249, P461, DOI 10.1006/bbrc.1998.9172; CRUSE I, 1988, J BIOL CHEM, V263, P3348; Cukiernik M, 2003, CURR EYE RES, V27, P301, DOI 10.1076/ceyr.27.5.301.17227; Cunha-Vaz JG, 2000, OPHTHALMOLOGICA, V214, P377, DOI 10.1159/000027528; Cunha-Vaz JG, 2001, OPHTHALMOLOGICA, V215, P7, DOI 10.1159/000050927; Du YP, 2004, AM J PHYSIOL-REG I, V287, pR735, DOI 10.1152/ajpregu.00080.2003; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; Du YP, 2002, J NEUROCHEM, V80, P771, DOI 10.1046/j.0022-3042.2001.00737.x; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Foresti R, 2001, AM J PHYSIOL-HEART C, V281, pH1976, DOI 10.1152/ajpheart.2001.281.5.H1976; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; Grammas P, 2003, MICROVASC RES, V65, P18, DOI 10.1016/S0026-2862(02)00016-X; Hayashi S, 1999, CIRC RES, V85, P663, DOI 10.1161/01.RES.85.8.663; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Hosoya K, 2001, EXP EYE RES, V72, P163, DOI 10.1006/exer.2000.0941; Kaizaki A, 2006, BRAIN RES, V1108, P39, DOI 10.1016/j.brainres.2006.06.011; Kowluru RA, 2005, ANTIOXID REDOX SIGN, V7, P1581, DOI 10.1089/ars.2005.7.1581; Kowluru RA, 2005, LIFE SCI, V76, P1051, DOI 10.1016/j.lfs.2004.10.017; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Leal EC, 2009, EXP EYE RES, V88, P983, DOI 10.1016/j.exer.2008.12.010; MAINES MD, 1986, J BIOL CHEM, V261, P411; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamura M, 2001, J BIOL CHEM, V276, P43748, DOI 10.1074/jbc.M108594200; Nakayama M, 2000, BIOCHEM BIOPH RES CO, V271, P665, DOI 10.1006/bbrc.2000.2683; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Nishikawa T, 2007, ANTIOXID REDOX SIGN, V9, P343, DOI 10.1089/ars.2006.1458; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Petrache I, 2000, AM J PHYSIOL-LUNG C, V278, pL312, DOI 10.1152/ajplung.2000.278.2.L312; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Reiter TA, 2005, FREE RADICAL BIO MED, V39, P1075, DOI 10.1016/j.freeradbiomed.2005.05.023; Salahudeen AA, 2001, TRANSPLANTATION, V72, P1498, DOI 10.1097/00007890-200111150-00005; Shibahara S, 2003, EXP BIOL MED, V228, P472, DOI 10.1177/15353702-0322805-08; Soares MP, 2002, ANTIOXID REDOX SIGN, V4, P321, DOI 10.1089/152308602753666370; Soares MP, 2001, IMMUNOL REV, V184, P275, DOI 10.1034/j.1600-065x.2001.1840124.x; Suttner DM, 1999, AM J PHYSIOL-LUNG C, V276, pL443, DOI 10.1152/ajplung.1999.276.3.L443; Ulyanova T, 2001, INVEST OPHTH VIS SCI, V42, P1370; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Zhang M, 2002, CELL RES, V12, P123, DOI 10.1038/sj.cr.7290118	46	73	78	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42428	10.1371/journal.pone.0042428	http://dx.doi.org/10.1371/journal.pone.0042428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879979	Green Submitted, gold, Green Published			2022-12-27	WOS:000307284100090
J	Chafe, SC; Pierce, JB; Mangroo, D				Chafe, Shawn C.; Pierce, Jacqueline B.; Mangroo, Dev			Nuclear-Cytoplasmic Trafficking of NTF2, the Nuclear Import Receptor for the RanGTPase, Is Subjected to Regulation	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; TRANSFER-RNA; PORE COMPLEX; TRANSPORT FACTOR; RAN-GTPASE; NUCLEOCYTOPLASMIC TRANSPORT; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; EXPORT RECEPTOR; POLY(ADP-RIBOSE) POLYMERASE	NTF2 is a cytosolic protein responsible for nuclear import of Ran, a small Ras-like GTPase involved in a number of critical cellular processes, including cell cycle regulation, chromatin organization during mitosis, reformation of the nuclear envelope following mitosis, and controlling the directionality of nucleocytoplasmic transport. Herein, we provide evidence for the first time that translocation of the mammalian NTF2 from the nucleus to the cytoplasm to collect Ran in the GDP form is subjected to regulation. Treatment of mammalian cells with polysorbitan monolaurate was found to inhibit nuclear export of tRNA and proteins, which are processes dependent on RanGTP in the nucleus, but not nuclear import of proteins. Inhibition of the export processes by polysorbitan monolaurate is specific and reversible, and is caused by accumulation of Ran in the cytoplasm because of a block in translocation of NTF2 to the cytoplasm. Nuclear import of Ran and the nuclear export processes are restored in polysorbitan monolaurate treated cells overproducing NTF2. Moreover, increased phosphorylation of a phospho-tyrosine protein and several phospho-threonine proteins was observed in polysorbitan monolaurate treated cells. Collectively, these findings suggest that nucleocytoplasmic translocation of NTF2 is regulated in mammalian cells, and may involve a tyrosine and/or threonine kinase-dependent signal transduction mechanism(s).	[Chafe, Shawn C.; Pierce, Jacqueline B.; Mangroo, Dev] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Chafe, SC (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	devakanand.mangroo@gmail.com			Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR); NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by operating grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institutes of Health Research (CIHR). JBP is the recipient of a NSERC Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Chafe SC, 2011, NUTR STRESS DOES NOT, V22; Chafe SC, 2010, MOL BIOL CELL, V21, P2483, DOI 10.1091/mbc.E10-03-0176; Chevalier SA, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-70; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Cook AG, 2010, CURR OPIN STRUC BIOL, V20, P247, DOI 10.1016/j.sbi.2010.01.012; Crampton N, 2009, MOL BIOL CELL, V20, P5106, DOI 10.1091/mbc.E09-05-0397; Czubryt MP, 2000, J CELL BIOL, V148, P7, DOI 10.1083/jcb.148.1.7; Davis JR, 2007, PHARM RES-DORDR, V24, P17, DOI 10.1007/s11095-006-9133-z; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Eswara MBK, 2009, MOL BIOL CELL, V20, P5007, DOI 10.1091/mbc.E09-06-0490; Feldherr C, 1998, J CELL SCI, V111, P1889; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Ghavidel A, 2007, CELL, V131, P915, DOI 10.1016/j.cell.2007.09.042; Gorlich D, 1996, CELL, V87, P21, DOI 10.1016/S0092-8674(00)81319-7; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Haberland J, 1999, BIOCHEM J, V343, P653, DOI 10.1042/0264-6021:3430653; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Hood JK, 1998, J BIOL CHEM, V273, P35142, DOI 10.1074/jbc.273.52.35142; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; KADOWAKI T, 1993, EMBO J, V12, P2929, DOI 10.1002/j.1460-2075.1993.tb05955.x; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kelley JB, 2007, MOL BIOL CELL, V18, P4365, DOI 10.1091/mbc.E07-01-0089; Kodiha M, 2008, CELL MOL LIFE SCI, V65, P1756, DOI 10.1007/s00018-008-7588-2; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Kodiha M, 2008, BBA-MOL CELL RES, V1783, P405, DOI 10.1016/j.bbamcr.2007.10.022; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Kodiha M, 2010, NUCLEUS-PHILA, V1, P237, DOI 10.4161/nucl.1.3.11444; Kodiha M, 2009, FEBS LETT, V583, P1987, DOI 10.1016/j.febslet.2009.05.011; Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lounsbury KM, 1997, J BIOL CHEM, V272, P551; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MOORE MS, 1994, P NATL ACAD SCI USA, V91, P10212, DOI 10.1073/pnas.91.21.10212; Moreno R, 2010, NUCLEIC ACIDS RES, V38, P6029, DOI 10.1093/nar/gkq439; Paschal BM, 1996, P NATL ACAD SCI USA, V93, P7679, DOI 10.1073/pnas.93.15.7679; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Pierce JB, 2010, NUCLEUS, V1; Porter FW, 2009, J VIROL, V83, P1941, DOI 10.1128/JVI.01752-08; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Ricour C, 2009, J GEN VIROL, V90, P177, DOI 10.1099/vir.0.005678-0; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; SCHLENSTEDT G, 1995, P NATL ACAD SCI USA, V92, P225, DOI 10.1073/pnas.92.1.225; Schwoebel ED, 2002, J CELL BIOL, V157, P963, DOI 10.1083/jcb.200111077; Shaheen HH, 2007, P NATL ACAD SCI USA, V104, P8845, DOI 10.1073/pnas.0700765104; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Steggerda SM, 2000, MOL BIOL CELL, V11, P703, DOI 10.1091/mbc.11.2.703; Steiner-Mosonyi M, 2004, BIOCHEM J, V378, P809, DOI 10.1042/BJ20031306; Suh KS, 2004, J BIOL CHEM, V279, P4632, DOI 10.1074/jbc.M311632200; Wu M, 2010, J BIOL CHEM, V285, P12055, DOI 10.1074/jbc.M109.088781; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024	63	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42501	10.1371/journal.pone.0042501	http://dx.doi.org/10.1371/journal.pone.0042501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880006	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100111
J	Hanke, ML; Angle, A; Kielian, T				Hanke, Mark L.; Angle, Amanda; Kielian, Tammy			MyD88-Dependent Signaling Influences Fibrosis and Alternative Macrophage Activation during Staphylococcus aureus Biofilm Infection	PLOS ONE			English	Article							DNA RELEASE; PATHOGENESIS; INFLAMMATION; RECOGNITION; METABOLISM; MECHANISMS; MONOCYTE; GROWTH	Bacterial biofilms represent a significant therapeutic challenge based on their ability to evade host immune and antibiotic-mediated clearance. Recent studies have implicated IL-1 beta in biofilm containment, whereas Toll-like receptors (TLRs) had no effect. This is intriguing, since both the IL-1 receptor (IL-1R) and most TLRs impinge on MyD88-dependent signaling pathways, yet the role of this key adaptor in modulating the host response to biofilm growth is unknown. Therefore, we examined the course of S. aureus catheter-associated biofilm infection in MyD88 knockout (KO) mice. MyD88 KO animals displayed significantly increased bacterial burdens on catheters and surrounding tissues during early infection, which coincided with enhanced dissemination to the heart and kidney compared to wild type (WT) mice. The expression of several proinflammatory mediators, including IL-6, IFN-gamma, and CXCL1 was significantly reduced in MyD88 KO mice, primarily at the later stages of infection. Interestingly, immunofluorescence staining of biofilm-infected tissues revealed increased fibrosis in MyD88 KO mice concomitant with enhanced recruitment of alternatively activated M2 macrophages. Taken in the context of previous studies with IL-1 beta, TLR2, and TLR9 KO mice, the current report reveals that MyD88 signaling is a major effector pathway regulating fibrosis and macrophage polarization during biofilm formation. Together these findings represent a novel example of the divergence between TLR and MyD88 action in the context of S. aureus biofilm infection.	[Hanke, Mark L.; Angle, Amanda; Kielian, Tammy] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center	Hanke, ML (corresponding author), Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68182 USA.	tkielian@unmc.edu	Hanke, Mark/H-7835-2013	Kielian, Tammy/0000-0001-7624-670X	National Insititutes of Health National Institute of Allergy and Infectious Disease [P01 AI083211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083211] Funding Source: NIH RePORTER	National Insititutes of Health National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Insititutes of Health National Institute of Allergy and Infectious Disease P01 AI083211 Project 4 to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Barron L, 2011, EUR J IMMUNOL, V41, P2509, DOI 10.1002/eji.201141869; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Bernthal NM, 2011, J ORTHOP RES, V29, P1621, DOI 10.1002/jor.21414; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; BURET A, 1991, J BIOMED MATER RES, V25, P865, DOI 10.1002/jbm.820250706; Cassat James E., 2007, V391, P127; Curran JN, 2006, WOUND REPAIR REGEN, V14, P376, DOI 10.1111/j.1743-6109.2006.00151.x; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Drago L, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-111; Duch JM, 2001, AM J KIDNEY DIS, V37, P149, DOI 10.1016/S0272-6386(01)80069-X; Fitzpatrick F, 2005, CLIN MICROBIOL INFEC, V11, P967, DOI 10.1111/j.1469-0691.2005.01274.x; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; GARVIN KL, 1995, J BONE JOINT SURG AM, V77, P1576, DOI 10.2106/00004623-199510000-00015; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hanke ML, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00062; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406; Longbrake EE, 2007, J NEUROCHEM, V102, P1083, DOI 10.1111/j.1471-4159.2007.04617.x; Lupher ML, 2006, ADV IMMUNOL, V89, P245, DOI 10.1016/S0065-2776(05)89006-6; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Mauviel A, 2005, METH MOLEC MED, V117, P69; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; MURRAY DG, 1995, JAMA-J AM MED ASSOC, V273, P1950, DOI 10.1001/jama.1995.03520480070043; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; PICKERING SJ, 1989, NEPHROL DIAL TRANSPL, V4, P62; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Rupp ME, 1999, INFECT IMMUN, V67, P2627, DOI 10.1128/IAI.67.5.2627-2632.1999; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Wagner C, 2011, INT J ARTIF ORGANS, V34, P811, DOI 10.5301/ijao.5000061; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	44	49	55	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42476	10.1371/journal.pone.0042476	http://dx.doi.org/10.1371/journal.pone.0042476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879997	Green Submitted, gold, Green Published			2022-12-27	WOS:000307284100103
J	Phillips, KM; Horst, RL; Koszewski, NJ; Simon, RR				Phillips, Katherine M.; Horst, Ronald L.; Koszewski, Nicholas J.; Simon, Ryan R.			Vitamin D-4 in Mushrooms	PLOS ONE			English	Article							AGARICUS-BISPORUS; BUTTON MUSHROOMS; BIOLOGICAL-ACTIVITY; STEROLS; ERGOSTEROL; MAMMARY; BIOAVAILABILITY; CARCINOGENESIS; METABOLITES	An unknown vitamin D compound was observed in the HPLC-UV chromatogram of edible mushrooms in the course of analyzing vitamin D-2 as part of a food composition study and confirmed by liquid chromatography-mass spectrometry to be vitamin D-4 (22-dihydroergocalciferol). Vitamin D-4 was quantified by HPLC with UV detection, with vitamin [H-3] itamin D-3 as an internal standard. White button, crimini, portabella, enoki, shiitake, maitake, oyster, morel, chanterelle, and UV-treated portabella mushrooms were analyzed, as four composites each of a total of 71 samples from U.S. retail suppliers and producers. Vitamin D-4 was present (>0.1 mu g/100 g) in a total of 18 composites and in at least one composite of each mushroom type except white button. The level was highest in samples with known UV exposure: vitamin D enhanced portabella, and maitake mushrooms from one supplier (0.2-7.0 and 22.5-35.4 mu g/100 g, respectively). Other mushrooms had detectable vitamin D-4 in some but not all samples. In one composite of oyster mushrooms the vitamin D-4 content was more than twice that of D-2 (6.29 vs. 2.59 mu g/100 g). Vitamin D-4 exceeded 2 mu g/100 g in the morel and chanterelle mushroom samples that contained D-4, but was undetectable in two morel samples. The vitamin D-4 precursor 22,23-dihydroergosterol was found in all composites (4.49-16.5 mg/100 g). Vitamin D-4 should be expected to occur in mushrooms exposed to UV light, such as commercially produced vitamin D enhanced products, wild grown mushrooms or other mushrooms receiving incidental exposure. Because vitamin D-4 coeluted with D-3 in the routine HPLC analysis of vitamin D-2 and an alternate mobile phase was necessary for resolution, researchers analyzing vitamin D-2 in mushrooms and using D-3 as an internal standard should verify that the system will resolve vitamins D-3 and D-4.	[Phillips, Katherine M.] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Horst, Ronald L.] Heartland Assays Inc, Ames, IA USA; [Koszewski, Nicholas J.] Iowa State Univ, Coll Vet Med, Dept Biomed Sci, Ames, IA USA; [Simon, Ryan R.] Cantox Hlth Sci Int, Mississauga, ON, Canada	Virginia Polytechnic Institute & State University; Iowa State University	Phillips, KM (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	kmpvpi@vt.edu		Phillips, Katherine/0000-0002-4586-8538	United States Department of Agriculture Agricultural Research Service as part of the National Food and Nutrient Analysis Program; USDA Nutrient Data Laboratory [59-1235-7-146]; Virginia Tech [59-1235-7-146]; United States Department of Agriculture; Mushroom Council	United States Department of Agriculture Agricultural Research Service as part of the National Food and Nutrient Analysis Program; USDA Nutrient Data Laboratory; Virginia Tech; United States Department of Agriculture(United States Department of Agriculture (USDA)); Mushroom Council	This work was supported by the United States Department of Agriculture Agricultural Research Service as part of the National Food and Nutrient Analysis Program, by cooperative agreement 59-1235-7-146 between the USDA Nutrient Data Laboratory and Virginia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Katherine Phillips is a Senior Research Scientist at Virginia Tech and has received funding from the United States Department of Agriculture for this work. She has also received funding from the Mushroom Council but the present study was initiated independently and not commissioned or funded by the Mushroom Council. Ronald Horst is Owner/Director of Heartland Assays LLC. Heartland Assays provides analytical and consulting services to many Academic and Commercial institutions regarding interpreting and application Vitamin D assays. These activities will not interfere with the objective presentation and sharing of information presented in the PLoS ONE manuscript. Nick Koszewski is an employee of Iowa State University, College of Veterinary Medicine and has on occasion acted as a consultant in the identification of vitamin D compounds. His activities will not interfere with the objective presentation and sharing of data presented in the PLoS ONE manuscript. Ryan Simon is an employee of Intertek Cantox a scientific and regulatory consulting company, Intertek Cantox has provided consulting services to the U.S. mushroom industry over the past three years. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aburjai T, 1998, PHYTOCHEMISTRY, V49, P2497, DOI 10.1016/S0031-9422(98)00246-5; Bills CE, 1938, J AMER MED ASSOC, V110, P2150, DOI 10.1001/jama.1938.62790260002009; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Boland R, 2003, PLANT SCI, V164, P357, DOI 10.1016/S0168-9452(02)00420-X; BROOKS CJW, 1968, LIPIDS, V3, P391, DOI 10.1007/BF02531277; Byford V, 2002, BBA-MOL CELL BIOL L, V1583, P151, DOI 10.1016/S1388-1981(02)00195-6; Chen TC, 2010, NUTR HEALTH SER, P35, DOI 10.1007/978-1-60327-303-9_2; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; DELUCA HF, 1968, ARCH BIOCHEM BIOPHYS, V124, P122, DOI 10.1016/0003-9861(68)90310-X; Feldman D, 2008, OSTEOPOROSIS, VOLS I AND II, 3RD EDITION, P317; Hirsch A.L., 2011, VITAMIN D, P73, DOI DOI 10.1016/B978-0-12-381978-9.10006-X; Holick MF, 2010, NUTR HEALTH SER, P1, DOI 10.1007/978-1-60327-303-9; HORST RL, 1984, ARCH BIOCHEM BIOPHYS, V231, P67, DOI 10.1016/0003-9861(84)90363-1; Horst RL, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P15; HORWITZ W, 1980, J ASSOC OFF ANA CHEM, V63, P1344; Jasinghe VJ, 2006, FOOD CHEM, V95, P638, DOI 10.1016/j.foodchem.2005.01.046; Jones G, 2010, ENDOCRIN METAB CLIN, V39, P447, DOI 10.1016/j.ecl.2010.02.003; KARMAKAR T, 1983, PHYTOCHEMISTRY, V22, P608, DOI 10.1016/0031-9422(83)83065-9; KENNY PTM, 1995, EUR MASS SPECTROM, V1, P411, DOI 10.1255/ejms.98; KORN ED, 1969, COMP BIOCHEM PHYSIOL, V30, P601, DOI 10.1016/0010-406X(69)92137-9; Koyyalamudi SR, 2011, J FOOD COMPOS ANAL, V24, P976, DOI 10.1016/j.jfca.2011.02.007; Koyyalamudi SR, 2009, J AGR FOOD CHEM, V57, P3351, DOI 10.1021/jf803908q; MATSUMOTO T, 1984, PHYTOCHEMISTRY, V23, P921, DOI 10.1016/S0031-9422(00)85067-0; Mattila P, 2002, FOOD CHEM, V76, P293, DOI 10.1016/S0308-8146(01)00275-8; Mattila P, 2001, J AGR FOOD CHEM, V49, P2343, DOI 10.1021/jf001525d; MATTILA PH, 1994, J AGR FOOD CHEM, V42, P2449, DOI 10.1021/jf00047a016; MCCORKINDALE NJ, 1969, PHYTOCHEMISTRY, V8, P861, DOI 10.1016/S0031-9422(00)85874-4; Mehta RG, 1997, JNCI-J NATL CANCER I, V89, P212, DOI 10.1093/jnci/89.3.212; Mehta RG, 2004, EUR J CANCER, V40, P2331, DOI 10.1016/j.ejca.2004.05.025; MERCER EI, 1976, PHYTOCHEMISTRY, V15, P283, DOI 10.1016/S0031-9422(00)89004-4; Moss GP, 1989, PURE APPL CHEM, V61, P1783; Murillo G, 2005, J STEROID BIOCHEM, V97, P129, DOI 10.1016/j.jsbmb.2005.06.008; NAPOLI JL, 1979, ARCH BIOCHEM BIOPHYS, V197, P119, DOI 10.1016/0003-9861(79)90226-1; Nasir H, 2003, ARCH INSECT BIOCHEM, V52, P175, DOI 10.1002/arch.10079; Outila TA, 1999, AM J CLIN NUTR, V69, P95; PATTERSON GW, 1969, COMP BIOCHEM PHYSIOL, V31, P391, DOI 10.1016/0010-406X(69)90019-X; Phillips KM, 2011, J AGR FOOD CHEM, V59, P7841, DOI 10.1021/jf104246z; Rangel-Castro JI, 2002, MYCOL RES, V106, P70, DOI 10.1017/S0953756201005299; Roberts JS, 2008, J AGR FOOD CHEM, V56, P4541, DOI 10.1021/jf0732511; Ross A. C., 2010, Dietary reference intakes for calcium and vitamin D; San Diego Gas & Electric, 2009, PROGR DES        SUM, P2; SECKBACH J, 1972, PLANT PHYSIOL, V49, P457, DOI 10.1104/pp.49.3.457; Shao SQ, 2010, J AGR FOOD CHEM, V58, P11616, DOI 10.1021/jf102285b; Simon RB, 2011, BURLINGTON MAG, V153, P59; Tachibana Y, 2001, STEROIDS, V66, P93, DOI 10.1016/S0039-128X(00)00208-7; Teichmann A, 2007, LWT-FOOD SCI TECHNOL, V40, P815, DOI 10.1016/j.lwt.2006.04.003; THOMPSON MJ, 1972, PHYTOCHEMISTRY, V11, P1781, DOI 10.1016/0031-9422(72)85036-2; U.S. Department of Agriculture Agricultural Research Service, 2011, USDA NATL NUTR DAT S; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Urbain P, 2010, CLIN NUTR S, V5, P15; Wang T, 2001, J PHOTOCH PHOTOBIO B, V62, P118, DOI 10.1016/S1011-1344(01)00160-9; Weete JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010899; Zhao XY, 2001, STEROIDS, V66, P293, DOI 10.1016/S0039-128X(00)00164-1	53	34	34	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e40702	10.1371/journal.pone.0040702	http://dx.doi.org/10.1371/journal.pone.0040702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870201	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100009
J	Rupprecht, A; Brauer, AU; Smorodchenko, A; Goyn, J; Hilse, KE; Shabalina, IG; Infante-Duarte, C; Pohl, EE				Rupprecht, Anne; Braeuer, Anja U.; Smorodchenko, Alina; Goyn, Justus; Hilse, Karolina E.; Shabalina, Irina G.; Infante-Duarte, Carmen; Pohl, Elena E.			Quantification of Uncoupling Protein 2 Reveals Its Main Expression in Immune Cells and Selective Up-Regulation during T-Cell Proliferation	PLOS ONE			English	Article							PREVENTS NEURONAL DEATH; NITRIC-OXIDE; MITOCHONDRIAL HYPERPOLARIZATION; ENERGY-METABOLISM; MESSENGER-RNA; UCP2; BRAIN; GENE; MICE; ACTIVATION	Uncoupling protein 2 (UCP2) is an inner mitochondrial membrane protein. Although the protein was discovered in 1997, its function and even its tissue distribution are still under debate. Here we present a quantitative analysis of mRNA and protein expression in various mice tissues, revealing that UCP2 is mainly expressed in organs and cells associated with the immune system. Although the UCP2 gene is present in the brain, as demonstrated using quantitative RT-PCR, the protein was not detectable in neurons under physiological conditions. Instead, we could detect UCP2 in microglia, which act in the immune defense of the central nervous system. In lymphocytes, activation led to a ten-fold increase of UCP2 protein expression simultaneously to the increase in levels of other mitochondrial proteins, whereas lymphocyte re-stimulation resulted in the selective increase of UCP2. The highest detected level of UCP2 expression in stimulated T-cells (0.54 ng/(mg total cellular protein)) was approximately 200 times lower than the level of UCP1 in brown adipose tissue from room temperature acclimated mice. Both the UCP2 expression pattern and the time course of up-regulation in stimulated T-cells imply UCP2's involvement in the immune response, probably by controlling the metabolism during cell proliferation.	[Rupprecht, Anne; Smorodchenko, Alina; Hilse, Karolina E.; Pohl, Elena E.] Univ Vet Med, Inst Physiol Pathophysiol & Biophys, Vienna, Austria; [Braeuer, Anja U.; Goyn, Justus] Charite, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany; [Shabalina, Irina G.] Stockholm Univ, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Infante-Duarte, Carmen] Expt & Clin Res Ctr, Berlin, Germany	University of Veterinary Medicine Vienna; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Stockholm University	Rupprecht, A (corresponding author), Univ Vet Med, Inst Physiol Pathophysiol & Biophys, Vienna, Austria.	elena.pohl@vetmeduni.ac.at	Bräuer, Anja/N-3692-2019; Smorodchenko, Alina/D-1880-2010; Smorodchenko, Alina/AAU-2854-2020; Pohl, Elena E./A-4025-2009; Braeuer, Anja/K-8339-2013; Shabalina, Irina/AAC-3720-2019; Shabalina, Irina G/A-4225-2011; Smorodchenko, Alina/ABB-2411-2020	Pohl, Elena E./0000-0002-0604-5950; Shabalina, Irina/0000-0002-2915-6450; Shabalina, Irina G/0000-0002-2915-6450; Infante Duarte, Carmen/0000-0003-3005-351X; Smorodchenko, Alina/0000-0003-1415-1531	Deutsche Forschungsgemeinschaft [Po 524/3, Po 524/5]; Sonnenfeld-Stiftung Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonnenfeld-Stiftung Berlin	This work was financially supported by Deutsche Forschungsgemeinschaft (Po 524/3, Po 524/5 to EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Bettina Brokowski, Rike Dannenberg and Thordis Hohnstein (Charite, Berlin) for the excellent technical assistance, Dr. D. Ricquier (BIOTRAM, Universite Paris Descartes) for generous gift of UCP2 knockout mice, Dr. B. Cannon and Dr. J. Nedergaard (The Wenner-Gren Institute, Stockholm University) for valuable discussion. hUCP2 was kindly provided by Dr. M. Jaburek and Dr. P. Jezek (Department of Membrane Transport Biophysics, Institute of Physiology, Academy of Sciences, Prague, Czech Republic). Some of the technical equipment for AUB was sponsored by the Sonnenfeld-Stiftung Berlin. We thank Graham Tebb for editorial assistance.	Alan L, 2009, J BIOENERG BIOMEMBR, V41, P71, DOI 10.1007/s10863-009-9201-2; Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Arsenijevic D, 2007, J NEUROIMMUNOL, V186, P121, DOI 10.1016/j.jneuroim.2007.03.013; Baffy G, 2011, BRIT J CANCER, V105, P469, DOI 10.1038/bjc.2011.245; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Bechmann I, 2002, BIOCHEM PHARMACOL, V64, P363, DOI 10.1016/S0006-2952(02)01166-8; Beck V, 2007, FASEB J, V21, P1137, DOI 10.1096/fj.06-7489com; Clavel S, 2003, NEUROREPORT, V14, P2015, DOI 10.1097/00001756-200311140-00002; Cortez-Pinto H, 1998, BIOCHEM BIOPH RES CO, V251, P313, DOI 10.1006/bbrc.1998.9473; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; de Bilbao F, 2004, J NEUROCHEM, V89, P1283, DOI 10.1111/j.1471-4159.2004.02432.x; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Diano S, 2003, ENDOCRINOLOGY, V144, P5014, DOI 10.1210/en.2003-0667; Dietrich MO, 2008, J NEUROSCI, V28, P10766, DOI 10.1523/JNEUROSCI.2744-08.2008; Elorza A, 2008, J BIOL CHEM, V283, P30461, DOI 10.1074/jbc.M805400200; Emre Y, 2010, FEBS LETT, V584, P1437, DOI 10.1016/j.febslet.2010.03.014; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Haines BA, 2010, J CEREBR BLOOD F MET, V30, P1825, DOI 10.1038/jcbfm.2010.52; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Horvath TL, 1999, J NEUROSCI, V19, P10417; Hurtaud C, 2007, CELL MOL LIFE SCI, V64, P1853, DOI 10.1007/s00018-007-7039-5; Hurtaud C, 2006, CELL MOL LIFE SCI, V63, P1780, DOI 10.1007/s00018-006-6129-0; Jaburek M, 2003, J BIOL CHEM, V278, P25825, DOI 10.1074/jbc.M302126200; Kizaki T, 2002, P NATL ACAD SCI USA, V99, P9392, DOI 10.1073/pnas.142206299; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Ledesma A., 2002, GENOME BIOL, V3, p3015.1, DOI DOI 10.1186/gb-2002-3-12-reviews3015; Lengacher S, 2004, J CEREBR BLOOD F MET, V24, P780, DOI 10.1097/01.WCB.0000122743.72175.52; Liu Yajun, 2009, BMC Physiology, V9, P17, DOI 10.1186/1472-6793-9-17; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunemann A, 2006, GLIA, V53, P412, DOI 10.1002/glia.20301; Mason EF, 2011, BBA-MOL CELL RES, V1813, P645, DOI 10.1016/j.bbamcr.2010.08.011; Mattiasson G, 2006, ANTIOXID REDOX SIGN, V8, P1, DOI 10.1089/ars.2006.8.1; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Mehta SL, 2009, J CEREBR BLOOD F MET, V29, P1069, DOI 10.1038/jcbfm.2009.4; Nagy G, 2007, FREE RADICAL BIO MED, V42, P1625, DOI 10.1016/j.freeradbiomed.2007.02.026; Nagy TR, 2004, NUTRITION, V20, P139, DOI 10.1016/j.nut.2003.09.024; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nicholls DG, 2001, BIOCHEM SOC T, V29, P751, DOI 10.1042/bst0290751; Nubel T, 2008, BBA-BIOENERGETICS, V1777, P48, DOI 10.1016/j.bbabio.2007.11.002; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Perl A, 2004, TRENDS IMMUNOL, V25, P360, DOI 10.1016/j.it.2004.05.001; Rask-Andersen M, 2010, BRAIN RES REV, V62, P147, DOI 10.1016/j.brainresrev.2009.10.007; Richard D, 1998, J COMP NEUROL, V397, P549; RICQUIER D, 1976, BIOCHEM BIOPH RES CO, V73, P577, DOI 10.1016/0006-291X(76)90849-4; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Robbins D, 2011, INT J MOL SCI, V12, P5285, DOI 10.3390/ijms12085285; Rousset S, 2007, FEBS LETT, V581, P479, DOI 10.1016/j.febslet.2007.01.010; Rousset S, 2006, CYTOKINE, V35, P135, DOI 10.1016/j.cyto.2006.07.012; Rupprecht A, 2010, BIOPHYS J, V98, P1503, DOI 10.1016/j.bpj.2009.12.4301; Shabalina IG, 2011, BIOCHEM SOC T, V39, P1305, DOI 10.1042/BST0391305; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Tagen M, 2009, J IMMUNOL, V183, P6313, DOI 10.4049/jimmunol.0803422; Turner JD, 2010, CIRC RES, V106, P730, DOI 10.1161/CIRCRESAHA.109.206631; Urbankova E, 2003, J BIOL CHEM, V278, P32497, DOI 10.1074/jbc.M303721200; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Yonezawa T, 2009, IUBMB LIFE, V61, P1123, DOI 10.1002/iub.264; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401	69	41	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41406	10.1371/journal.pone.0041406	http://dx.doi.org/10.1371/journal.pone.0041406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870219	Green Accepted, Green Published, gold			2022-12-27	WOS:000307284100018
J	Selvadurai, HJ; Mason, JO				Selvadurai, Hayden J.; Mason, John O.			Activation of Wnt/beta-Catenin Signalling Affects Differentiation of Cells Arising from the Cerebellar Ventricular Zone	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; BETA-CATENIN; PRECURSOR PROLIFERATION; GABAERGIC INTERNEURONS; SPORADIC MEDULLOBLASTOMAS; NEURONAL DIFFERENTIATION; INT-1 PROTOONCOGENE; PURKINJE-CELLS; SONIC HEDGEHOG; WHITE-MATTER	Development of the cerebellum proceeds under the precise spatio-temporal control of several key developmental signalling pathways, including the Wnt/beta-catenin pathway. We recently reported the activity of Wnt/beta-catenin signalling in the perinatal cerebellar ventricular zone (VZ), a germinal centre in the developing cerebellum that gives rise to GABAergic and glial cells. In order to investigate the normal function of Wnt/beta-catenin signalling in the VZ and the cell lineages it gives rise to, we used a combination of ex vivo cerebellar slice culture and in vivo genetic manipulation to dysregulate its activity during late embryonic development. Activation of the pathway at the cerebellar ventricular zone led to a reduction in the number of cells expressing the glial lineage markers Sox9 and GFAP and the interneuron marker Pax2, but had no consistent effect on either proliferation or apoptosis. Our findings suggest that activation of the Wnt/beta-catenin pathway in the cerebellar ventricular zone causes a shift in the cell types produced, most likely due to disruption of normal differentiation. Thus, we propose that regulation of Wnt/beta-catenin signalling levels are required for normal development of cells arising from the cerebellar ventricular zone during late embryogenesis.	[Selvadurai, Hayden J.; Mason, John O.] Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Selvadurai, HJ (corresponding author), Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Programme Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	john.mason@ed.ac.uk	Mason, John O/A-1926-2010	Mason, John O/0000-0002-0489-2400	Wellcome Trust [083209/Z/07/A]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by award number 083209/Z/07/A from the Wellcome Trust, www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; Baeza N, 2003, ONCOGENE, V22, P632, DOI 10.1038/sj.onc.1206156; Basson MA, 2008, DEVELOPMENT, V135, P889, DOI 10.1242/dev.011569; Benchabane H, 2009, ADV EXP MED BIOL, V656, P75, DOI 10.1007/978-1-4419-1145-2_7; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chenn Anjen, 2008, Organogenesis, V4, P76; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Eberhart CG, 2000, J NEUROPATH EXP NEUR, V59, P333, DOI 10.1093/jnen/59.4.333; Gibson P, 2010, NATURE, V33; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; Hashimoto M, 2003, J NEUROSCI, V23, P11342; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; He B, 2004, NEOPLASIA, V6, P7, DOI 10.1016/S1476-5586(04)80048-4; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Huang HT, 2000, AM J PATHOL, V156, P433, DOI 10.1016/S0002-9440(10)64747-5; Ivaniutsin U, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-3; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Kordes U, 2005, DEV BRAIN RES, V157, P209, DOI 10.1016/j.devbrainres.2005.03.009; Leto K, 2006, J NEUROSCI, V26, P11682, DOI 10.1523/JNEUROSCI.3656-06.2006; Leto K, 2009, J NEUROSCI, V29, P7079, DOI 10.1523/JNEUROSCI.0957-09.2009; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Milosevic A, 2004, MOL CELL NEUROSCI, V26, P342, DOI 10.1016/j.mcn.2004.02.008; Milosevic A, 2002, J COMP NEUROL, V452, P192, DOI 10.1002/cne.10384; Mizuhara E, 2010, DEV BIOL, V338, P202, DOI 10.1016/j.ydbio.2009.11.032; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Nolte C, 2001, GLIA, V33, P72; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; Pei Y, 2012, DEVELOPMENT; Pompolo S, 2001, BRAIN RES, V906, P143, DOI 10.1016/S0006-8993(01)02574-4; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schwalbe EC, 2011, CLIN CANC RES OFFICI; Selvadurai HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023012; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; Sudarov A, 2011, J NEUROSCI, V31, P11055, DOI 10.1523/JNEUROSCI.0479-11.2011; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Weisheit G, 2006, EUR J NEUROSCI, V24, P466, DOI 10.1111/j.1460-9568.2006.04915.x; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Yamada K, 2000, J COMP NEUROL, V418, P106; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Yu TA, 2011, DEVELOPMENT, V138, P2957, DOI 10.1242/dev.063784; Yuasa S, 1996, ANAT EMBRYOL, V194, P223; Zhou CJ, 2006, NEUROSCIENCE, V142, P1119, DOI 10.1016/j.neuroscience.2006.07.007; Zurawel RH, 1998, CANCER RES, V58, P896	63	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42572	10.1371/journal.pone.0042572	http://dx.doi.org/10.1371/journal.pone.0042572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880037	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100133
J	Wang, K; Zhang, R; Xiang, XH; He, F; Lin, LB; Ping, XJ; Yu, L; Han, JS; Zhao, GP; Zhang, QH; Cui, CL				Wang, Ke; Zhang, Rong; Xiang, Xiaohui; He, Fei; Lin, Libo; Ping, Xingjie; Yu, Lei; Han, Jisheng; Zhao, Guoping; Zhang, Qinghua; Cui, Cailian			Differences in Neural-Immune Gene Expression Response in Rat Spinal Dorsal Horn Correlates with Variations in Electroacupuncture Analgesia	PLOS ONE			English	Article							TAIL-FLICK TEST; NEUROPATHIC PAIN; INDIVIDUAL-DIFFERENCES; ACUPUNCTURE ANALGESIA; APJ RECEPTOR; MECHANISMS; CHOLECYSTOKININ; STIMULATION; APELIN; CORD	Background: Electroacupuncture (EA) has been widely used to alleviate diverse pains. Accumulated clinical experiences and experimental observations indicated that significant differences exist in sensitivity to EA analgesia for individuals of patients and model animals. However, the molecular mechanism accounting for this difference remains obscure. Methodology/Principal Findings: We classified model male rats into high-responder (HR; TFL changes >150) and non-responder (NR; TFL changes <= 0) groups based on changes of their pain threshold detected by tail-flick latency (TFL) before and after 2 Hz or 100 Hz EA treatment. Gene expression analysis of spinal dorsal horn (DH) revealed divergent expression in HR and NR after 2 Hz/100 Hz EA. The expression of the neurotransmitter system related genes was significantly highly regulated in the HR animals while the proinflammation cytokines related genes were up-regulated more significantly in NR than that in HR after 2 Hz and 100 Hz EA stimulation, especially in the case of 2 Hz stimulation. Conclusions/Significance: Our results suggested that differential regulation and coordination of neural-immune related genes might play an important role for individual variations in analgesic effects responding to EA in DH. It also provided new candidate genes related to EA responsiveness for future investigation.	[Wang, Ke; He, Fei; Lin, Libo; Zhao, Guoping; Zhang, Qinghua] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Wang, Ke; Xiang, Xiaohui; He, Fei; Zhao, Guoping; Zhang, Qinghua] Natl Engn Res Ctr Biochip Shanghai, Shanghai, Peoples R China; [Zhang, Rong; Xiang, Xiaohui; Ping, Xingjie; Han, Jisheng; Cui, Cailian] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Inst, Beijing 100871, Peoples R China; [Zhang, Rong; Xiang, Xiaohui; Ping, Xingjie; Han, Jisheng; Cui, Cailian] Peking Univ, Minist Educ, Key Lab Neurosci, Beijing 100871, Peoples R China; [Zhang, Rong; Xiang, Xiaohui; Ping, Xingjie; Han, Jisheng; Cui, Cailian] Peking Univ, Minist Publ Hlth, Beijing 100871, Peoples R China; [Yu, Lei] Dept Genet, Piscataway, NJ USA; [Yu, Lei] Rutgers State Univ, Ctr Alcohol Studies, Piscataway, NJ 08854 USA; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Peking University; Peking University; Peking University; Rutgers State University New Brunswick; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Wang, K (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China.	gpzhao@sibs.ac.cn; qinghua_zhang@shbiochip.com; clcui@bjmu.edu.cn	ping, xingjie/AAW-4597-2020; Zhang, Rong/O-5078-2017; Xiang, Xiaohui/D-8093-2015	Zhang, Rong/0000-0002-6889-5571; Zhao, Guo-Ping/0000-0002-7621-6620; Xiang, Xiaohui/0000-0002-5762-5007; Cui, Cailian/0000-0002-8638-8258	National Basic Research Program of China [973-2007CB512501]; China Postdoctoral Science Foundation [20100480643]; National Natural Science Foundation of China [30801491]	National Basic Research Program of China(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (No. 973-2007CB512501), China Postdoctoral Science Foundation (No. 20100480643), and National Natural Science Foundation of China (No. 30801491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RT, 2008, BRAIN RES, V1188, P54, DOI 10.1016/j.brainres.2007.10.060; [Anonymous], 1998, JAMA, V280, P1518; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Chae Y, 2006, J PHYSIOL SCI, V56, P425, DOI 10.2170/physiolsci.RP010206; Cidral-Filho FJ, 2011, NEUROSCIENCE; DAMORE A, 1992, J PHARMACOL TOXICOL, V27, P197, DOI 10.1016/1056-8719(92)90041-X; Fukazawa Y, 2007, J PHARMACOL SCI, V104, P159, DOI 10.1254/jphs.FP0070475; Gao YZ, 2007, AM J CHINESE MED, V35, P767, DOI 10.1142/S0192415X07005259; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Han JS, 2011, PAIN, V152, pS41, DOI 10.1016/j.pain.2010.10.012; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutchinson MR, 2008, BRAIN BEHAV IMMUN, V22, P1178, DOI 10.1016/j.bbi.2008.05.004; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kalea AZ, 2010, CURR OPIN INVEST DR, V11, P273; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kim SK, 2009, GENES BRAIN BEHAV, V8, P174, DOI 10.1111/j.1601-183X.2008.00459.x; Kim SK, 2007, BRAIN RES BULL, V74, P357, DOI 10.1016/j.brainresbull.2007.07.006; Ko ES, 2006, PEPTIDES, V27, P1841, DOI 10.1016/j.peptides.2006.01.002; Koo ST, 2008, PAIN, V135, P11, DOI 10.1016/j.pain.2007.04.034; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Lau WK, 2008, NEUROSCIENCE, V155, P463, DOI 10.1016/j.neuroscience.2008.06.016; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Lee G, 2002, NEUROSCI LETT, V325, P17, DOI 10.1016/S0304-3940(02)00214-8; Li HK, 2008, J PROTEOME RES, V7, P4775, DOI 10.1021/pr800352k; O'Carroll AM, 2000, BBA-GENE STRUCT EXPR, V1492, P72, DOI 10.1016/S0167-4781(00)00072-5; Paola FA, 2003, J SPINAL CORD MED, V26, P12; Park JH, 2010, BRAIN RES, V1322, P24, DOI 10.1016/j.brainres.2010.02.001; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Robinson GE, 2004, SCIENCE, V304, P397, DOI 10.1126/science.1095766; Silva JRT, 2011, J PAIN, V12, P51, DOI 10.1016/j.jpain.2010.04.008; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Somers DL, 2009, J PAIN, V10, P221, DOI 10.1016/j.jpain.2008.08.008; Strand AD, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030059; Sun JB, 2010, J MAGN RESON IMAGING, V32, P298, DOI 10.1002/jmri.22238; Tang NM, 1997, PAIN, V71, P71, DOI 10.1016/S0304-3959(97)03341-1; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tjolsen Arne, 1993, Tidsskrift for den Norske Laegeforening, V113, P2921; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Uceyler N, 2009, EXP BRAIN RES, V196, P67, DOI 10.1007/s00221-009-1755-z; Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6; Wan Y, 2001, PAIN, V91, P5, DOI 10.1016/S0304-3959(00)00416-4; Wang K, 2010, J NEUROCHEM, V113, P1436, DOI 10.1111/j.1471-4159.2010.06679.x; Wang LN, 2006, BRAIN RES, V1120, P46, DOI 10.1016/j.brainres.2006.08.077; Weyerbacher Amanda R, 2010, Pain, V148, P237, DOI 10.1016/j.pain.2009.11.003; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Xing GG, 2007, EXP NEUROL, V208, P323, DOI 10.1016/j.expneurol.2007.09.004; Xu N, 2009, PEPTIDES, V30, P1153, DOI 10.1016/j.peptides.2009.02.011; Yang NL, 2008, J CELL BIOCHEM, V103, P1760, DOI 10.1002/jcb.21562; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; ZHOU Y, 1993, NEUROPEPTIDES, V24, P139, DOI 10.1016/0143-4179(93)90077-N	55	13	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42331	10.1371/journal.pone.0042331	http://dx.doi.org/10.1371/journal.pone.0042331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879942	Green Published, gold			2022-12-27	WOS:000307284100069
J	Skedelj, V; Arsovska, E; Tomasic, T; Kroflic, A; Hodnik, V; Hrast, M; Bester-Rogac, M; Anderluh, G; Gobec, S; Bostock, J; Chopra, I; O'Neill, AJ; Randall, C; Zega, A				Skedelj, Veronika; Arsovska, Emilija; Tomasic, Tihomir; Kroflic, Ana; Hodnik, Vesna; Hrast, Martina; Bester-Rogac, Marija; Anderluh, Gregor; Gobec, Stanislav; Bostock, Julieanne; Chopra, Ian; O'Neill, Alex J.; Randall, Christopher; Zega, Anamarija			6-Arylpyrido[ 2,3-d]pyrimidines as Novel ATP-Competitive Inhibitors of Bacterial D-Alanine:D-Alanine Ligase	PLOS ONE			English	Article							ALANYL-D-ALANINE; ESCHERICHIA-COLI; IDENTIFICATION; BIOSYNTHESIS; PURIFICATION; RESISTANCE; PHOSPHATE; STRAINS; ENZYMES; DESIGN	Background: ATP-dependent D-alanine: D-alanine ligase (Ddl) is a part of biochemical machinery involved in peptidoglycan biosynthesis, as it catalyzes the formation of the terminal D-ala-D-ala dipeptide of the peptidoglycan precursor UDPMurNAc-pentapeptide. Inhibition of Ddl prevents bacterial growth, which makes this enzyme an attractive and viable target in the urgent search of novel effective antimicrobial drugs. To address the problem of a relentless increase in resistance to known antimicrobial agents we focused our attention to discovery of novel ATP-competitive inhibitors of Ddl. Methodology/Principal Findings: Encouraged by recent successful attempts to find selective ATP-competitive inhibitors of bacterial enzymes we designed, synthesized and evaluated a library of 6-arylpyrido[2,3-d]pyrimidine-based compounds as inhibitors of Escherichia coli DdlB. Inhibitor binding to the target enzyme was subsequently confirmed by surface plasmon resonance and studied with isothermal titration calorimetry. Since kinetic analysis indicated that 6-arylpyrido[2,3-d] pyrimidines compete with the enzyme substrate ATP, inhibitor binding to the ATP-binding site was additionally studied with docking. Some of these inhibitors were found to possess antibacterial activity against membrane-compromised and efflux pump-deficient strains of E. coli. Conclusions/Significance: We discovered new ATP-competitive inhibitors of DdlB, which may serve as a starting point for development of more potent inhibitors of DdlB that could include both, an ATP-competitive and D-Ala competitive moiety.	[Skedelj, Veronika; Arsovska, Emilija; Tomasic, Tihomir; Hrast, Martina; Gobec, Stanislav; Zega, Anamarija] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Kroflic, Ana; Bester-Rogac, Marija] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Hodnik, Vesna; Anderluh, Gregor] Univ Ljubljana, Infrastruct Ctr Surface Plasmon Resonance, Biotech Fac, Ljubljana, Slovenia; [Bostock, Julieanne; Chopra, Ian; O'Neill, Alex J.; Randall, Christopher] Univ Leeds, Antimicrobial Res Ctr, Leeds, W Yorkshire, England; [Bostock, Julieanne; Chopra, Ian; O'Neill, Alex J.; Randall, Christopher] Univ Leeds, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England	University of Ljubljana; University of Ljubljana; University of Ljubljana; University of Leeds; University of Leeds	Skedelj, V (corresponding author), Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.	anamarija.zega@ffa.uni-lj.si	Tomašič, Tihomir/S-1796-2018; Kroflič, Ana/AAW-9093-2021; Bester-Rogac, Marija/Y-2967-2019; Randall, Christopher/L-8647-2013; Bester-Rogac, Marija/S-3406-2018; Anderluh, Gregor/C-6905-2014; Kroflic, Ana/ABC-5977-2021	Tomašič, Tihomir/0000-0001-5534-209X; Kroflič, Ana/0000-0003-1722-8397; Bester-Rogac, Marija/0000-0003-4284-5987; Randall, Christopher/0000-0002-9565-8387; Bester-Rogac, Marija/0000-0003-4284-5987; Anderluh, Gregor/0000-0002-9916-8465; O'Neill, Alex/0000-0003-3222-5493; Gobec, Stanislav/0000-0002-9678-3083	Slovenian Research Agency [P1-0208]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency (Grant P1-0208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ACC DISC STUD 3 0; Bag S, 2010, BIOORGAN MED CHEM, V18, P3187, DOI 10.1016/j.bmc.2010.03.031; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Besong GE, 2005, ANGEW CHEM INT EDIT, V44, P6403, DOI 10.1002/anie.200501662; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P2017, DOI 10.1021/bi00222a002; Bugg TDH, 2011, TRENDS BIOTECHNOL, V29, P167, DOI 10.1016/j.tibtech.2010.12.006; DIXON RA, 1986, ANTIMICROB AGENTS CH, V29, P781, DOI 10.1128/AAC.29.5.781; Fan C, 1997, BIOCHEMISTRY-US, V36, P2531, DOI 10.1021/bi962431t; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Gholizadeh Y, 2001, PROTEIN SCI, V10, P836, DOI 10.1110/ps.39101; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hamby JM, 1997, J MED CHEM, V40, P2296, DOI 10.1021/jm970367n; Healy VL, 2000, CHEM BIOL, V7, P505, DOI 10.1016/S1074-5521(00)00135-6; Huber W, 1943, J AM CHEM SOC, V65, P2222, DOI 10.1021/ja01251a060; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Kovac A, 2007, BIOORG MED CHEM LETT, V17, P2047, DOI 10.1016/j.bmcl.2007.01.015; Kovac A, 2008, J MED CHEM, V51, P7442, DOI 10.1021/jm800726b; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lu PL, 2008, J CHEMOTHERAPY, V20, P202, DOI 10.1179/joc.2008.20.2.202; Miller JR, 2009, P NATL ACAD SCI USA, V106, P1737, DOI 10.1073/pnas.0811275106; MULLINS LS, 1990, J BIOL CHEM, V265, P8993; *NCCLS, 1997, M7A4 NCCLS, V17; NEUHAUS FC, 1962, J BIOL CHEM, V237, P778; NEUHAUS FC, 1981, PHARMACOL THERAPEUT, V14, P265, DOI 10.1016/0163-7258(81)90030-9; NEUHAUS FC, 1962, BIOCHEM BIOPH RES CO, V8, P377, DOI 10.1016/0006-291X(62)90011-6; O'Neill AJ, 2002, J ANTIMICROB CHEMOTH, V50, P839, DOI 10.1093/jac/dkf248; Papahatjis DP, 2003, J MED CHEM, V46, P3221, DOI 10.1021/jm020558c; Press W.H., 1992, NUMERICAL RECIPES, V2, P650; Sakamoto J, 2007, EUR J ORG CHEM, V2007, P2700, DOI 10.1002/ejoc.200700118; Shapiro E, 2002, ANTIMICROB AGENTS CH, V46, P2490, DOI 10.1128/AAC.46.8.2490-2497.2002; Silver LL, 2007, NAT REV DRUG DISCOV, V6, P41, DOI 10.1038/nrd2202; Skedelj V, 2011, J MED CHEM, V54, P915, DOI 10.1021/jm101121s; Sova M, 2009, BIOORG MED CHEM LETT, V19, P1376, DOI 10.1016/j.bmcl.2009.01.034; Stierand K, 2006, BIOINFORMATICS, V22, P1710, DOI 10.1093/bioinformatics/btl150; Timothy DHB, 1999, 3 10 BACTERIAL PEPTI, P241; Triola G, 2009, BIOORGAN MED CHEM, V17, P1079, DOI 10.1016/j.bmc.2008.02.046; Tytgat I, 2009, CURR MED CHEM, V16, P2566, DOI 10.2174/092986709788682029; van den Hoogenband A, 2006, TETRAHEDRON LETT, V47, P4361, DOI 10.1016/j.tetlet.2006.04.103; Vehar B, 2011, BIOORGAN MED CHEM, V19, P5137, DOI 10.1016/j.bmc.2011.07.020; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wong KK, 1998, ADV EXP MED BIOL, V456, P197; Wu DL, 2008, INT J ANTIMICROB AG, V32, P421, DOI 10.1016/j.ijantimicag.2008.06.010; ZAWADZKE LE, 1991, BIOCHEMISTRY-US, V30, P1673, DOI 10.1021/bi00220a033	46	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e39922	10.1371/journal.pone.0039922	http://dx.doi.org/10.1371/journal.pone.0039922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876277	Green Published, gold, Green Submitted			2022-12-27	WOS:000307184700005
J	Cheng, Q; Lu, L; Grafstrom, J; Olofsson, MH; Thorell, JO; Samen, E; Johansson, K; Ahlzen, HS; Stone-Elander, S; Linder, S; Arner, ESJ				Cheng, Qing; Lu, Li; Grafstrom, Jonas; Olofsson, Maria Hagg; Thorell, Jan-Olov; Samen, Erik; Johansson, Katarina; Ahlzen, Hanna-Stina; Stone-Elander, Sharon; Linder, Stig; Arner, Elias S. J.		Sel-tag Imaging Project	Combining [C-11]-AnxA5 PET Imaging with Serum Biomarkers for Improved Detection in Live Mice of Modest Cell Death in Human Solid Tumor Xenografts	PLOS ONE			English	Article							RECOMBINANT PROTEINS; GRAPHICAL ANALYSIS; ANNEXIN-V; APOPTOSIS; CYTOKERATIN-18; DRUG; PURIFICATION; CHEMOTHERAPY; CARCINOMAS; FORMS	Background: In vivo imaging using Annexin A5-based radioligands is a powerful technique for visualizing massive cell death, but has been less successful in monitoring the modest cell death typically seen in solid tumors after chemotherapy. Here we combined dynamic positron emission tomography (PET) imaging using Annexin A5 with a serum-based apoptosis marker, for improved sensitivity and specificity in assessment of chemotherapy-induced cell death in a solid tumor model. Methodology/Principal Findings: Modest cell death was induced by doxorubicin in a mouse xenograft model with human FaDu head and neck cancer cells. PET imaging was based on C-11-labeled Sel-tagged Annexin A5 ([C-11]-AnxA5-ST) and a size-matched control. 2-deoxy-2-[F-18] fluoro-D-glucose ([F-18]-FDG) was utilized as a tracer of tissue metabolism. Serum biomarkers for cell death were ccK18 and K18 (M30 Apoptosense (R) and M65). Apoptosis in tissue sections was verified ex vivo for validation. Both PET imaging using [C-11]-AnxA5-ST and serum ccK18/K18 levels revealed treatment-induced cell death, with ccK18 displaying the highest detection sensitivity. [F-18]-FDG uptake was not affected by this treatment in this tumor model. [C-11]-AnxA5-ST gave robust imaging readouts at one hour and its short half-life made it possible to perform paired scans in the same animal in one imaging session. Conclusions/Significance: The combined use of dynamic PET with [C-11]-AnxA5-ST, showing specific increases in tumor binding potential upon therapy, with ccK18/K18 serum measurements, as highly sensitive markers for cell death, enabled effective assessment of modest therapy-induced cell death in this mouse xenograft model of solid human tumors.	[Cheng, Qing; Johansson, Katarina; Ahlzen, Hanna-Stina; Stone-Elander, Sharon; Arner, Elias S. J.] Karolinska Inst, Div Biochem, Dept Med Biochem & Biophys, Stockholm, Sweden; [Lu, Li] Karolinska Univ Hosp, Dept Comparat Med, Karolinska Expt Res & Imaging Ctr, Stockholm, Sweden; [Lu, Li; Grafstrom, Jonas; Thorell, Jan-Olov; Samen, Erik; Stone-Elander, Sharon] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Olofsson, Maria Hagg; Linder, Stig] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Thorell, Jan-Olov; Samen, Erik; Stone-Elander, Sharon] Karolinska Univ Hosp, Dept Neuroradiol, PET Radiochem, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Cheng, Q (corresponding author), Karolinska Inst, Div Biochem, Dept Med Biochem & Biophys, Stockholm, Sweden.	Elias.Arner@ki.se	Johansson, Katarina/C-7654-2014; Arnér, Elias S.J./J-5832-2012; Arnér, Elias/K-6737-2019	Johansson, Katarina/0000-0003-3735-3611; Arnér, Elias S.J./0000-0002-4807-6114; Arnér, Elias/0000-0002-4807-6114; Cheng, Qing/0000-0002-3170-9333	Swedish Foundation for Strategic Research (SSF) [RBa08-0067]; Governmental Agency for Innovation Systems (VINNOVA) [2009-00179]; The Swedish Cancer Society (Cancerfonden) [2009/739]; The Swedish Research Council [2008-2654, 2004-5104, 2008-3186]; Karolinska Institutet	Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Governmental Agency for Innovation Systems (VINNOVA)(Vinnova); The Swedish Cancer Society (Cancerfonden); The Swedish Research Council(Swedish Research Council); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Foundation for Strategic Research (SSF) (RBa08-0067); Governmental Agency for Innovation Systems (VINNOVA) (2009-00179); The Swedish Cancer Society (Cancerfonden) (2009/739 to E.S.J.A.); The Swedish Research Council (2008-2654 to E.S.J.A., 2004-5104 and 2008-3186 to S. S. E.); and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Belhocine T, 2002, CLIN CANCER RES, V8, P2766; Ben-Haim S, 2009, J NUCL MED, V50, P88, DOI 10.2967/jnumed.108.054205; Blankenberg FG, 2009, APOPTOSIS IMAGING AN; Blankenberg FG, 2008, CANCER BIOL THER, V7, P1525, DOI 10.4161/cbt.7.10.6934; Blankenberg FG, 2008, J NUCL MED, V49, p81S, DOI 10.2967/jnumed.107.045898; Blankenberg Francis G, 2009, Proc Am Thorac Soc, V6, P469, DOI 10.1513/pats.200901-001AW; Blankenberg FG, 2009, ANTI-CANCER AGENT ME, V9, P944, DOI 10.2174/187152009789377727; Cheng Q, 2006, NAT PROTOC, V1, P604, DOI 10.1038/nprot.2006.87; Cheng Q, 2006, CHEMBIOCHEM, V7, P1976, DOI 10.1002/cbic.200600326; Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x; Dierckx RA, 2008, EUR J NUCL MED MOL I, V35, P1544, DOI 10.1007/s00259-008-0758-5; Greystoke A, 2011, BRIT J CANCER, V104, P719, DOI 10.1038/sj.bjc.6606082; Johansson L, 2004, NAT METHODS, V1, P61, DOI 10.1038/NMETH707; Kong G, 2000, CANCER RES, V60, P6950; Kramer G, 2006, BRIT J CANCER, V94, P1592, DOI 10.1038/sj.bjc.6603129; Kramer G, 2004, CANCER RES, V64, P1751, DOI 10.1158/0008-5472.CAN-03-2455; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Larsen P, 1997, APPL RADIAT ISOTOPES, V48, P153, DOI 10.1016/S0969-8043(96)00177-7; Linder S, 2004, CANCER LETT, V214, P1, DOI 10.1016/j.canlet.2004.06.032; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Logan J, 2011, J CEREBR BLOOD F MET, V31, P535, DOI 10.1038/jcbfm.2010.123; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Olofsson MH, 2009, CANCER BIOMARK, V5, P117, DOI 10.3233/CBM-2009-0597; Olofsson MH, 2007, CLIN CANCER RES, V13, P3198, DOI 10.1158/1078-0432.CCR-07-0009; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Samen E, 2009, EUR J NUCL MED MOL I, V36, P1283, DOI 10.1007/s00259-009-1111-3; Wistuba II, 2011, NAT REV CLIN ONCOL, V8, P135, DOI 10.1038/nrclinonc.2011.2; Wolf MB, 2006, BBA-GEN SUBJECTS, V1760, P267, DOI 10.1016/j.bbagen.2005.10.012	29	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42151	10.1371/journal.pone.0042151	http://dx.doi.org/10.1371/journal.pone.0042151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870292	gold, Green Published			2022-12-27	WOS:000307212800063
J	Hackenberg, M; Shi, BJ; Gustafson, P; Langridge, P				Hackenberg, Michael; Shi, Bu-Jun; Gustafson, Perry; Langridge, Peter			A Transgenic Transcription Factor (TaDREB3) in Barley Affects the Expression of MicroRNAs and Other Small Non-Coding RNAs	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; REPETITIVE ELEMENTS; ENDOGENOUS SIRNA; STRESS TOLERANCE; GENE-EXPRESSION; ORYZA-SATIVA; DROUGHT; PATHWAY; PLANTS; IDENTIFICATION	Transcription factors (TFs), microRNAs (miRNAs), small interfering RNAs (siRNAs) and other functional non-coding small RNAs (sRNAs) are important gene regulators. Comparison of sRNA expression profiles between transgenic barley over-expressing a drought tolerant TF (TaDREB3) and non-transgenic control barley revealed many group-specific sRNAs. In addition, 42% of the shared sRNAs were differentially expressed between the two groups (vertical bar log(2)vertical bar >1). Furthermore, TaDREB3-derived sRNAs were only detected in transgenic barley despite the existence of homologous genes in non-transgenic barley. These results demonstrate that the TF strongly affects the expression of sRNAs and siRNAs could in turn affect the TF stability. The TF also affects size distribution and abundance of sRNAs including miRNAs. About half of the sRNAs in each group were derived from chloroplast. A sRNA derived from tRNA-His(GUG) encoded by the chloroplast genome is the most abundant sRNA, accounting for 42.2% of the total sRNAs in transgenic barley and 28.9% in non-transgenic barley. This sRNA, which targets a gene (TC245676) involved in biological processes, was only present in barley leaves but not roots. 124 and 136 miRNAs were detected in transgenic and non-transgenic barley, respectively. miR156 was the most abundant miRNA and up-regulated in transgenic barley, while miR168 was the most abundant miRNA and up-regulated in non-transgenic barley. Eight out of 20 predicted novel miRNAs were differentially expressed between the two groups. All the predicted novel miRNA targets were validated using a degradome library. Our data provide an insight into the effect of TF on the expression of sRNAs in barley.	[Hackenberg, Michael] Univ Granada, Dept Genet, Granada, Spain; [Shi, Bu-Jun; Langridge, Peter] Univ Adelaide, Australian Ctr Plant Funct Genom, Adelaide, SA, Australia; [Gustafson, Perry] Univ Missouri, Div Plant Sci, Columbia, MO USA	University of Granada; University of Adelaide; University of Missouri System; University of Missouri Columbia	Hackenberg, M (corresponding author), Univ Granada, Dept Genet, Granada, Spain.	bujun.shi@acpfg.com.au; peter.langridge@acpfg.com.au	Hackenberg, Michael/A-2503-2009; Langridge, Peter/G-5864-2010; Hackenberg, Michael/X-9662-2018	Hackenberg, Michael/0000-0003-2248-3114; Langridge, Peter/0000-0001-9494-400X; Hackenberg, Michael/0000-0003-2248-3114	Australian Research Council; South Australian Government; Grains Research and Development Corporation	Australian Research Council(Australian Research Council); South Australian Government; Grains Research and Development Corporation(Grains R&D Corp)	This work was funded by the Australian Research Council, the South Australian Government and the Grains Research and Development Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Arteaga-Vazquez M, 2006, PLANT CELL, V18, P3355, DOI 10.1105/tpc.106.044420; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Chen ZY, 2006, GENETICA, V128, P21, DOI 10.1007/s10709-005-2486-0; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Giege R, 2008, NAT STRUCT MOL BIOL, V15, P1007, DOI 10.1038/nsmb.1498; Guo AY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-10; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Hsieh TH, 2002, PLANT PHYSIOL, V129, P1086, DOI 10.1104/pp.003442; Itaya A, 2008, BBA-GENE REGUL MECH, V1779, P99, DOI 10.1016/j.bbagrm.2007.09.003; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lung B, 2006, NUCLEIC ACIDS RES, V34, P3842, DOI 10.1093/nar/gkl448; Masotti A, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/659028; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Morran S, 2011, PLANT BIOTECHNOL J, V9, P230, DOI 10.1111/j.1467-7652.2010.00547.x; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Oh SJ, 2009, PLANT PHYSIOL, V150, P1368, DOI 10.1104/pp.109.137554; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Pederson T, 2010, RNA, V16, P1865, DOI 10.1261/rna.2266510; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Saski C, 2007, THEOR APPL GENET, V112, P1503; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; Seliverstov Alexander, 2006, Journal of Bioinformatics and Computational Biology, V4, P783, DOI 10.1142/S0219720006002235; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Sobala A, 2011, WIRES RNA, V2, P853, DOI 10.1002/wrna.96; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-289; Wicker T, 2002, TRENDS PLANT SCI, V7, P561, DOI 10.1016/S1360-1385(02)02372-5; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	24	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42030	10.1371/journal.pone.0042030	http://dx.doi.org/10.1371/journal.pone.0042030			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870277	Green Published, gold			2022-12-27	WOS:000307212800053
J	Ishiwata, T; Orosz, A; Wang, XH; Mustafi, SB; Pratt, GW; Christians, ES; Boudina, S; Abel, ED; Benjamin, IJ				Ishiwata, Takahiro; Orosz, Andras; Wang, Xiaohui; Mustafi, Soumyajit Banerjee; Pratt, Gregory W.; Christians, Elisabeth S.; Boudina, Sihem; Abel, E. Dale; Benjamin, Ivor J.			HSPB2 Is Dispensable for the Cardiac Hypertrophic Response but Reduces Mitochondrial Energetics following Pressure Overload In Mice	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; HEAT-SHOCK PROTEINS; MEMBER; GENE; PROTECTION; ISCHEMIA; FAMILY; MUSCLE; TISSUE; CRYAB	Background: CryAB (HspB5) and HspB2, two small heat shock genes located adjacently in the vertebrate genome, are hypothesized to play distinct roles. Mice lacking both cryab and hspb2 (DKO) are viable and exhibit adult-onset degeneration of skeletal muscle but confounding results from independent groups were reported for cardiac responses to different stressful conditions (i.e., ischemia/reperfusion or pressure overload). To determine the specific requirements of HSPB2 in heart, we generated cardiac-specific HSPB2 deficient (HSPB2cKO) mice and examined their cardiac function under basal conditions and following cardiac pressure overload. Methodology/Principal Findings: Transverse aortic constriction (TAC) or sham surgery was performed in HSPB2cKO mice and their littermates (HSPB2wt mice). Eight weeks after TAC, we found that expression of several small HSPs (HSPB2, 5, 6) was not markedly modified in HSPB2wt mice. Both cardiac function and the hypertrophic response remained similar in HSPB2cKO and HSPB2wt hearts. In addition, mitochondrial respiration and ATP production assays demonstrated that the absence of HSPB2 did not change mitochondrial metabolism in basal conditions. However, fatty acid supported state 3 respiration rate (ADP stimulated) in TAC operated HSPB2cKO hearts was significantly reduced in compared with TAC operated HSPB2wt mice (10.5 +/- 2.2 vs. 12.8 +/- 2.5 nmol O-2/min/mg dry fiber weight, P<0.05), and ATP production in HSPB2cKO hearts was significantly reduced in TAC compared with sham operated mice (29.8 +/- 0.2 vs. 21.1 +/- 1.8 nmol ATP/min/mg dry fiber weight, P<0.05). Although HSPB2 was not associated with mitochondria under cardiac stress, absence of HSPB2 led to changes in transcript levels of several metabolic and mitochondrial regulator genes. Conclusions/Significance: The present study indicates that HSPB2 can be replaced by other members of the multigene small HSP family under basal conditions while HSPB2 is implicated in the regulation of metabolic/mitochondrial function under cardiac stress such pressure overload.	[Ishiwata, Takahiro; Orosz, Andras; Wang, Xiaohui; Mustafi, Soumyajit Banerjee; Pratt, Gregory W.; Christians, Elisabeth S.; Benjamin, Ivor J.] Univ Utah, Sch Med, Lab Cardiac Dis Redox Signaling & Cell Regenerat, Div Cardiol, Salt Lake City, UT USA; [Boudina, Sihem; Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT USA; [Boudina, Sihem; Abel, E. Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA; [Benjamin, Ivor J.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ishiwata, T (corresponding author), Natl Def Med Coll, Dept Pediat, 3-2 Namiki, Tokorozawa, Saitama 359, Japan.	ivor.benjamin@hsc.utah.edu		Abel, E. Dale/0000-0001-5290-0738	National Institutes of Health [1DP1OD006438-02]; VA Merit Review Award; NHLBI [5R01HL074370-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074370] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review Award(US Department of Veterans Affairs); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	2009 National Institutes of Health Director's Pioneer Award 1DP1OD006438-02, VA Merit Review Award (IJB), and NHLBI 5R01HL074370-03 (IJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015; Abel ED, 1999, J CLIN INVEST, V104, P1703, DOI 10.1172/JCI7605; Benjamin IJ, 2007, AM J PHYSIOL-HEART C, V293, pH3201, DOI 10.1152/ajpheart.01363.2006; Boudina S, 2009, CIRCULATION, V119, P1272, DOI 10.1161/CIRCULATIONAHA.108.792101; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Bugger H, 2009, DIABETES, V58, P1986, DOI 10.2337/db09-0259; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Golenhofen N, 2006, PFLUG ARCH EUR J PHY, V451, P518, DOI 10.1007/s00424-005-1488-1; Hu P, 2003, AM J PHYSIOL-HEART C, V285, pH1261, DOI 10.1152/ajpheart.00108.2003; Hu ZP, 2008, J NEUROSCI RES, V86, P2125, DOI 10.1002/jnr.21682; Huang L, 2007, GENESIS, V45, P487, DOI 10.1002/dvg.20319; Iwaki A, 1997, GENOMICS, V45, P386, DOI 10.1006/geno.1997.4956; Kadono T, 2006, J MOL CELL CARDIOL, V40, P783, DOI 10.1016/j.yjmcc.2006.03.003; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1074, P201, DOI 10.1016/0304-4165(91)90062-L; Kumarapeli ARK, 2010, AM J TRANSL RES, V2, P390; Kumarapeli ARK, 2008, CIRC RES, V103, P1473, DOI 10.1161/CIRCRESAHA.108.180117; Martin JL, 1997, CIRCULATION, V96, P4343; Morrison LE, 2004, AM J PHYSIOL-HEART C, V286, pH847, DOI 10.1152/ajpheart.00715.2003; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Nakagawa M, 2001, EXP CELL RES, V271, P161, DOI 10.1006/excr.2001.5362; Pinz I, 2008, FASEB J, V22, P84, DOI 10.1096/fj.07-8130com; Prabhu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029810; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Riehle C, 2011, CIRC RES, V109, P783, DOI 10.1161/CIRCRESAHA.111.243964; Sacconi S, 2012, NEUROMUSCULAR DISORD, V22, P66, DOI 10.1016/j.nmd.2011.07.004; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765	31	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42118	10.1371/journal.pone.0042118	http://dx.doi.org/10.1371/journal.pone.0042118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870288	Green Submitted, gold, Green Published			2022-12-27	WOS:000307212800061
J	McLaughlin, HP; Caly, DL; McCarthy, Y; Ryan, RP; Dow, JM				McLaughlin, Heather Pearl; Caly, Delphine L.; McCarthy, Yvonne; Ryan, Robert Patrick; Dow, John Maxwell			An Orphan Chemotaxis Sensor Regulates Virulence and Antibiotic Tolerance in the Human Pathogen Pseudomonas aeruginosa	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; CATIONIC ANTIMICROBIAL PEPTIDES; RESPONSE REGULATOR; DI-GMP; CHEMOSENSORY SYSTEM; BIOFILM FORMATION; GENE-EXPRESSION; EFFLUX SYSTEM; POLYMYXIN-B; RESISTANCE	The synthesis of virulence factors by pathogenic bacteria is highly regulated and occurs in response to diverse environmental cues. An array of two component systems (TCSs) serves to link perception of different cues to specific changes in gene expression and/or bacterial behaviour. Those TCSs that regulate functions associated with virulence represent attractive targets for interference in anti-infective strategies for disease control. We have previously identified PA2572 as a putative response regulator required for full virulence of Pseudomonas aeruginosa, the opportunistic human pathogen, to Galleria mellonella (Wax moth) larvae. Here we have investigated the involvement of candidate sensors for signal transduction involving PA2572. Mutation of PA2573, encoding a probable methyl-accepting chemotaxis protein, gave rise to alterations in motility, virulence, and antibiotic resistance, functions which are also controlled by PA2572. Comparative transcriptome profiling of mutants revealed that PA2572 and PA2573 regulate expression of a common set of 49 genes that are involved in a range of biological functions including virulence and antibiotic resistance. Bacterial two-hybrid analysis indicated a REC-dependent interaction between PA2572 and PA2573 proteins. Finally expression of PA2572 in the PA2573 mutant background restored virulence to G. mellonella towards wild-type levels. The findings indicate a role for the orphan chemotaxis sensor PA2573 in the regulation of virulence and antibiotic tolerance in P. aeruginosa and indicate that these effects are exerted in part through signal transduction involving PA2572.	[McLaughlin, Heather Pearl; Caly, Delphine L.; McCarthy, Yvonne; Ryan, Robert Patrick; Dow, John Maxwell] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland	University College Cork	McLaughlin, HP (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland.	m.dow@ucc.ie		Ryan, Rober/0000-0002-7353-0913; Dow, Max/0000-0001-8245-2294	Science Foundation of Ireland [SFI07/NI.1/B955, SFI09/SSIRG/B1654]; Wellcome Trust [WT093314MA]	Science Foundation of Ireland(Science Foundation Ireland); Wellcome Trust(Wellcome TrustEuropean Commission)	This work has been supported by grants from Science Foundation of Ireland (SFI07/NI.1/B955, SFI09/SSIRG/B1654) through an investigator award (to J.M.D) and by the Wellcome Trust (WT093314MA) through a project grant (to J.M.D and R. P. R), which are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschlimann JR, 2003, PHARMACOTHERAPY, V23, P916, DOI 10.1592/phco.23.7.916.32722; Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Aires JR, 1999, ANTIMICROB AGENTS CH, V43, P2624, DOI 10.1128/AAC.43.11.2624; Barrett JF, 1998, ANTIMICROB AGENTS CH, V42, P1529, DOI 10.1128/AAC.42.7.1529; Chugani S, 2007, MICROB PATHOGENESIS, V42, P29, DOI 10.1016/j.micpath.2006.10.004; Dong Yi-Hu, 2008, Commun Integr Biol, V1, P88; Fernandez L, 2010, ANTIMICROB AGENTS CH, V54, P3372, DOI 10.1128/AAC.00242-10; Filiatrault MJ, 2005, INFECT IMMUN, V73, P3764, DOI 10.1128/IAI.73.6.3764-3772.2005; Fulcher NB, 2010, MOL MICROBIOL, V76, P889, DOI 10.1111/j.1365-2958.2010.07135.x; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Guvener ZT, 2007, MOL MICROBIOL, V66, P1459, DOI 10.1111/j.1365-2958.2007.06008.x; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Kohler T, 1999, ANTIMICROB AGENTS CH, V43, P424, DOI 10.1128/AAC.43.2.424; McGrath S, 2004, FEMS MICROBIOL LETT, V230, P27, DOI 10.1016/S0378-1097(03)00849-8; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Moskowitz SM, 2004, J BACTERIOL, V186, P575, DOI 10.1128/JB.186.2.575-579.2004; NICAS TI, 1985, J INFECT DIS, V152, P716, DOI 10.1093/infdis/152.4.716; Pan XZ, 2009, J BACTERIOL, V191, P2601, DOI 10.1128/JB.01309-08; Petters T, 2012, MOL MICROBIOL, V84, P147, DOI 10.1111/j.1365-2958.2012.08015.x; Poole K, 1996, MOL MICROBIOL, V21, P713, DOI 10.1046/j.1365-2958.1996.281397.x; Quale J, 2006, ANTIMICROB AGENTS CH, V50, P1633, DOI 10.1128/AAC.50.5.1633-1641.2006; Romling U, 2011, ENV MICROBIOL; Ryan RP, 2009, ENVIRON MICROBIOL, V11, P1126, DOI 10.1111/j.1462-2920.2008.01842.x; Ryan RP, 2012, TRENDS MICROBIOL, P1; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; TRIAS J, 1990, ANTIMICROB AGENTS CH, V34, P52, DOI 10.1128/AAC.34.1.52; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Wang WH, 2009, FEMS MICROBIOL LETT, V294, P150, DOI 10.1111/j.1574-6968.2009.01563.x; Westbrock-Wadman S, 1999, ANTIMICROB AGENTS CH, V43, P2975, DOI 10.1128/AAC.43.12.2975; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011	37	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42205	10.1371/journal.pone.0042205	http://dx.doi.org/10.1371/journal.pone.0042205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870303	gold, Green Published, Green Submitted			2022-12-27	WOS:000307212800068
J	Wagenhaus, B; Pohlmann, A; Dieringer, MA; Els, A; Waiczies, H; Waiczies, S; Schulz-Menger, J; Niendorf, T				Wagenhaus, Babette; Pohlmann, Andreas; Dieringer, Matthias Alexander; Els, Antje; Waiczies, Helmar; Waiczies, Sonia; Schulz-Menger, Jeanette; Niendorf, Thoralf			Functional and Morphological Cardiac Magnetic Resonance Imaging of Mice Using a Cryogenic Quadrature Radiofrequency Coil	PLOS ONE			English	Article							MURINE MODEL; MOUSE HEART; 9.4 TESLA; RF PROBE; MRI; SEGMENTATION; BRAIN	Cardiac morphology and function assessment by magnetic resonance imaging is of increasing interest for a variety of mouse models in pre-clinical cardiac research, such as myocardial infarction models or myocardial injury/remodeling in genetically or pharmacologically induced hypertension. Signal-to-noise ratio (SNR) constraints, however, limit image quality and blood myocardium delineation, which crucially depend on high spatial resolution. Significant gains in SNR with a cryogenically cooled RF probe have been shown for mouse brain MRI, yet the potential of applying cryogenic RF coils for cardiac MR (CMR) in mice is, as of yet, untapped. This study examines the feasibility and potential benefits of CMR in mice employing a 400 MHz cryogenic RF surface coil, compared with a conventional mouse heart coil array operating at room temperature. The cryogenic RF coil affords SNR gains of 3.0 to 5.0 versus the conventional approach and hence enables an enhanced spatial resolution. This markedly improved image quality - by better deliniation of myocardial borders and enhanced depiction of papillary muscles and trabeculae - and facilitated a more accurate cardiac chamber quantification, due to reduced intraobserver variability. In summary the use of a cryogenically cooled RF probe represents a valuable means of enhancing the capabilities of CMR of mice.	[Wagenhaus, Babette; Pohlmann, Andreas; Dieringer, Matthias Alexander; Els, Antje; Waiczies, Helmar; Waiczies, Sonia; Niendorf, Thoralf] Max Delbruck Ctr Mol Med, BUFF, Berlin, Germany; [Dieringer, Matthias Alexander; Schulz-Menger, Jeanette] Charite Working Grp Cardiac MRI, Expt & Clin Res Ctr, Berlin, Germany; [Dieringer, Matthias Alexander; Schulz-Menger, Jeanette] HELIOS Clin, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Wagenhaus, B (corresponding author), Max Delbruck Ctr Mol Med, BUFF, Berlin, Germany.	andreas.pohlmann@mdc-berlin.de	Niendorf, Thoralf/H-7738-2013; Pohlmann, Andreas/K-7869-2016; Waiczies, Sonia/H-4181-2012	Niendorf, Thoralf/0000-0001-7584-6527; Pohlmann, Andreas/0000-0002-8572-2568; Waiczies, Sonia/0000-0002-9916-9572; Schulz-Menger, Jeanette/0000-0003-3100-1092; Waiczies, Helmar/0000-0001-6651-4790	Max Delbruck Center for Molecular Medicine	Max Delbruck Center for Molecular Medicine(Helmholtz Association)	This study was funded by the Max Delbruck Center for Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKOKA S, 1993, MAGN RESON IMAGING, V11, P437, DOI 10.1016/0730-725X(93)90078-R; Azaouagh A, 2011, CLIN RES CARDIOL, V100, P383, DOI 10.1007/s00392-011-0295-2; Baltes C, 2010, NMR BIOMED; Baltes C, 2009, NMR BIOMED, V22, P834, DOI 10.1002/nbm.1396; Bovens SM, 2011, NMR BIOMED, V24, P307, DOI 10.1002/nbm.1593; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Epstein FH, 2007, NMR BIOMED, V20, P238, DOI 10.1002/nbm.1152; Heijman E, 2008, J MAGN RESON IMAGING, V27, P86, DOI 10.1002/jmri.21236; Heijman E, 2007, NMR BIOMED, V20, P439, DOI 10.1002/nbm.1110; Hiba B, 2007, MAGN RESON MED, V58, P745, DOI 10.1002/mrm.21355; INSKO EK, 1993, J MAGN RESON SER A, V103, P82, DOI 10.1006/jmra.1993.1133; Kirchhof P, 2006, CIRCULATION, V114, P1799, DOI 10.1161/CIRCULATIONAHA.106.624502; Ramirez MS, 2010, MAGN RESON MED, V63, P803, DOI 10.1002/mrm.22236; Ratering D, 2008, MAGN RESON MED, V59, P1440, DOI 10.1002/mrm.21629; Ratering D, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-43; Schneider JE, 2011, METHODS MOL BIOL, V771, P387, DOI 10.1007/978-1-61779-219-9_20; Schneider JE, 2011, MAGN RESON MED, V65, P60, DOI 10.1002/mrm.22605; Sosnovik DE, 2007, J MAGN RESON IMAGING, V26, P279, DOI 10.1002/jmri.20966; Urashima T, 2008, AM J PHYSIOL-HEART C, V295, pH1351, DOI 10.1152/ajpheart.91526.2007; Waiczies H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032796; Wiesmann F, 2002, AM J PHYSIOL-HEART C, V283, pH1065, DOI 10.1152/ajpheart.00802.2001; Young AA, 2009, J MAGN RESON IMAGING, V30, P514, DOI 10.1002/jmri.21873	22	29	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42383	10.1371/journal.pone.0042383	http://dx.doi.org/10.1371/journal.pone.0042383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870323	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000307212800086
J	Helyar, SJ; Limborg, MT; Bekkevold, D; Babbucci, M; van Houdt, J; Maes, GE; Bargelloni, L; Nielsen, RO; Taylor, MI; Ogden, R; Cariani, A; Carvalho, GR; Panitz, F				Helyar, Sarah J.; Limborg, Morten T.; Bekkevold, Dorte; Babbucci, Massimiliano; van Houdt, Jeroen; Maes, Gregory E.; Bargelloni, Luca; Nielsen, Rasmus O.; Taylor, Martin I.; Ogden, Rob; Cariani, Alessia; Carvalho, Gary R.; Panitz, Frank		FishPopTrace Consortium	SNP Discovery Using Next Generation Transcriptomic Sequencing in Atlantic Herring (Clupea harengus)	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM DISCOVERY; GENETIC-STRUCTURE; GENOME SEQUENCE; POPULATIONS; MARKERS; DIFFERENTIATION; IDENTIFICATION; CLUPEIFORMES; MANAGEMENT; THOUSANDS	The introduction of Next Generation Sequencing (NGS) has revolutionised population genetics, providing studies of non-model species with unprecedented genomic coverage, allowing evolutionary biologists to address questions previously far beyond the reach of available resources. Furthermore, the simple mutation model of Single Nucleotide Polymorphisms (SNPs) permits cost-effective high-throughput genotyping in thousands of individuals simultaneously. Genomic resources are scarce for the Atlantic herring (Clupea harengus), a small pelagic species that sustains high revenue fisheries. This paper details the development of 578 SNPs using a combined NGS and high-throughput genotyping approach. Eight individuals covering the species distribution in the eastern Atlantic were bar-coded and multiplexed into a single cDNA library and sequenced using the 454 GS FLX platform. SNP discovery was performed by de novo sequence clustering and contig assembly, followed by the mapping of reads against consensus contig sequences. Selection of candidate SNPs for genotyping was conducted using an in silico approach. SNP validation and genotyping were performed simultaneously using an Illumina 1,536 GoldenGate assay. Although the conversion rate of candidate SNPs in the genotyping assay cannot be predicted in advance, this approach has the potential to maximise cost and time efficiencies by avoiding expensive and time-consuming laboratory stages of SNP validation. Additionally, the in silico approach leads to lower ascertainment bias in the resulting SNP panel as marker selection is based only on the ability to design primers and the predicted presence of intron-exon boundaries. Consequently SNPs with a wider spectrum of minor allele frequencies (MAFs) will be genotyped in the final panel. The genomic resources presented here represent a valuable multi-purpose resource for developing informative marker panels for population discrimination, microarray development and for population genomic studies in the wild.	[Helyar, Sarah J.; Taylor, Martin I.; Carvalho, Gary R.; FishPopTrace Consortium] Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Coll Nat Sci, Bangor, Gwynedd, Wales; [Helyar, Sarah J.] Matis, Food Safety Environm & Genet, Reykjavik, Iceland; [Limborg, Morten T.; Bekkevold, Dorte] Tech Univ Denmark, Natl Inst Aquat Resources, Silkeborg, Denmark; [Babbucci, Massimiliano; Bargelloni, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, Italy; [van Houdt, Jeroen; Maes, Gregory E.] Katholieke Univ Leuven, Lab Biodivers & Evolutionary Genom, Louvain, Belgium; [Nielsen, Rasmus O.; Panitz, Frank] Aarhus Univ, Dept Mol Biol & Genet, Fac Sci & Technol, Tjele, Denmark; [Ogden, Rob] Royal Zool Soc Scotland, TRACE Wildlife Forens Network, Edinburgh, Midlothian, Scotland; [Cariani, Alessia] Univ Bologna, Dept Expt & Evolutionary Biol, Bologna, Italy	Bangor University; Technical University of Denmark; University of Padua; KU Leuven; Aarhus University; University of Bologna	Helyar, SJ (corresponding author), Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Coll Nat Sci, Bangor, Gwynedd, Wales.	sarah.helyar@matis.is	Limborg, Morten T/B-9633-2015; Cariani, Alessia/L-3459-2016; Taylor, Martin I/B-4298-2013; Bekkevold, Dorte/AAT-1098-2021; Maes, Gregory/C-5450-2008; Panitz, Frank/A-3281-2017; Maes, Gregory/N-4983-2019; Nielsen, Rasmus/D-4405-2009; Helyar, Sarah/C-4988-2013	Limborg, Morten T/0000-0002-7718-6531; Cariani, Alessia/0000-0002-5513-0086; Maes, Gregory/0000-0002-1531-7321; Panitz, Frank/0000-0002-6909-5162; Maes, Gregory/0000-0002-1531-7321; BABBUCCI, MASSIMILIANO/0000-0002-4060-4728; Nielsen, Rasmus/0000-0003-0513-6591; Helyar, Sarah/0000-0002-1600-997X; Bekkevold, Dorte/0000-0002-5297-032X	European Community [KBBE-212399]; European Commission [022717, 044133]; Scientific Research Fund Flanders (FWO-Flanders)	European Community(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Scientific Research Fund Flanders (FWO-Flanders)(FWO)	The research leading to these results received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no KBBE-212399 (FishPopTrace). In addition, MTL received financial support from the European Commission through the FP6 projects UNCOVER (Contract No. 022717) and RECLAIM (Contract No. 044133). GM is a post-doctoral researcher funded by the Scientific Research Fund Flanders (FWO-Flanders). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; [Anonymous], 2000, METHODS MOL BIOL; [Anonymous], 2011, 29 SESS COMM FISH; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Bai J, 2011, J WORLD AQUACULT SOC, V42, P444, DOI 10.1111/j.1749-7345.2011.00485.x; Bekkevold D, 2005, EVOLUTION, V59, P2656; Benjamini Y, 2001, ANN STAT, V29, P1165; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Corrigendum to Council Regulation, 2008, OFFICIAL J EUROPEA L, pL; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Geraldes A, 2011, MOL ECOL RESOUR, V11, P81, DOI 10.1111/j.1755-0998.2010.02960.x; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Kerstens HHD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-479; Larsson LC, 2007, MOL ECOL, V16, P1135, DOI 10.1111/j.1365-294X.2006.03217.x; Lavoue S, 2007, MOL PHYLOGENET EVOL, V43, P1096, DOI 10.1016/j.ympev.2006.09.018; Lepoittevin C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011034; Li CH, 2007, MOL PHYLOGENET EVOL, V44, P386, DOI 10.1016/j.ympev.2006.10.030; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; McPherson AA, 2001, J FISH BIOL, V59, P356, DOI 10.1006/jfbi.2001.1769; Milano I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028008; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; Nielsen EE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1845; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Ogden R, 2011, MOL ECOL RESOUR, V11, P109, DOI 10.1111/j.1755-0998.2010.02954.x; Pashley CH, 2006, J HERED, V97, P381, DOI 10.1093/jhered/esl013; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Ratan A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-130; Rosenblum EB, 2007, J HERED, V98, P331, DOI 10.1093/jhered/esm031; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Seeb JE, 2011, MOL ECOL RESOUR, V11, P335, DOI 10.1111/j.1755-0998.2010.02936.x; Smit A, 1996, REPEATMASKER OPEN 30; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Van Bers NEM, 2010, MOL ECOL, V19, P89, DOI 10.1111/j.1365-294X.2009.04486.x; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x	53	47	49	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42089	10.1371/journal.pone.0042089	http://dx.doi.org/10.1371/journal.pone.0042089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879907	Green Published, Green Accepted, gold			2022-12-27	WOS:000307437900020
J	Kramer, RSS; Jones, AL; Ward, R				Kramer, Robin S. S.; Jones, Alex L.; Ward, Robert			A Lack of Sexual Dimorphism in Width-to-Height Ratio in White European Faces Using 2D Photographs, 3D Scans, and Anthropometry	PLOS ONE			English	Article							FACIAL STRUCTURE; BODY; PREDICTS; CUES	Facial width-to-height ratio has received a great deal of attention in recent research. Evidence from human skulls suggests that males have a larger relative facial width than females, and that this sexual dimorphism is an honest signal of masculinity, aggression, and related traits. However, evidence that this measure is sexually dimorphic in faces, rather than skulls, is surprisingly weak. We therefore investigated facial width-to-height ratio in three White European samples using three different methods of measurement: 2D photographs, 3D scans, and anthropometry. By measuring the same individuals with multiple methods, we demonstrated high agreement across all measures. However, we found no evidence of sexual dimorphism in the face. In our third study, we also found a link between facial width-to-height ratio and body mass index for both males and females, although this relationship did not account for the lack of dimorphism in our sample. While we showed sufficient power to detect differences between male and female width-to-height ratio, our results failed to support the general hypothesis of sexual dimorphism in the face.	[Kramer, Robin S. S.; Jones, Alex L.; Ward, Robert] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales	Bangor University	Kramer, RSS (corresponding author), Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales.	r.ward@bangor.ac.uk	Jones, Alex L./J-2779-2019	Jones, Alex L./0000-0003-3600-3644; Kramer, Robin/0000-0001-8339-8832				Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; Cooper EA, 2012, J VISION, V12, DOI 10.1167/12.5.8; Dandajena TC, 2006, AM J ORTHOD DENTOFAC, V130, P196, DOI 10.1016/j.ajodo.2004.11.039; De Greef S, 2009, FORENSIC SCI MED PAT, V5, P60, DOI 10.1007/s12024-009-9085-9; Deaner RO, 2012, J RES PERS, V46, P235, DOI 10.1016/j.jrp.2012.01.005; Domaracki M, 2006, J FORENSIC SCI, V51, P5, DOI 10.1111/j.1556-4029.2005.00009.x; Fink B, 2003, ANN HUM BIOL, V30, P728, DOI 10.1080/03014460310001620153; Geniole SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030366; Greil H, 2006, COLLEGIUM ANTROPOL, V30, P637; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; Jones A, 2012, J EXP PSYCH IN PRESS; Kimmerle EH, 2008, J FORENSIC SCI, V53, P54, DOI 10.1111/j.1556-4029.2007.00627.x; Maynard SJ., 2003, ANIMAL SIGNALS; Ngeow W C, 2009, Indian J Dent Res, V20, P313, DOI 10.4103/0970-9290.57372; Ngeow WC, 2009, SINGAP MED J, V50, P525; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Rosas A, 2002, AM J PHYS ANTHROPOL, V117, P236, DOI 10.1002/ajpa.10023; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Simpson E, 2002, AM J PHYS ANTHROPOL, V33, P221; Stephan CN, 2005, J FORENSIC SCI, V50, P513; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; SUTTON PRN, 1969, AM J PHYS ANTHROPOL, V30, P303, DOI 10.1002/ajpa.1330300215; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Wong EM, 2011, PSYCHOL SCI, V22, P1478, DOI 10.1177/0956797611418838	27	55	58	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42705	10.1371/journal.pone.0042705	http://dx.doi.org/10.1371/journal.pone.0042705			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	987SL	22880088	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000307437900050
J	Young, S; Murray, K; Mwesigwa, J; Natureeba, P; Osterbauer, B; Achan, J; Arinaitwe, E; Clark, T; Ades, V; Plenty, A; Charlebois, E; Ruel, T; Kamya, M; Havlir, D; Cohan, D				Young, Sera; Murray, Katherine; Mwesigwa, Julia; Natureeba, Paul; Osterbauer, Beth; Achan, Jane; Arinaitwe, Emmanuel; Clark, Tamara; Ades, Veronica; Plenty, Albert; Charlebois, Edwin; Ruel, Theodore; Kamya, Moses; Havlir, Diane; Cohan, Deborah			Maternal Nutritional Status Predicts Adverse Birth Outcomes among HIV-Infected Rural Ugandan Women Receiving Combination Antiretroviral Therapy	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; BODY-MASS INDEX; RANDOMIZED CONTROLLED-TRIAL; UNINFECTED ZAMBIAN WOMEN; PREGNANCY OUTCOMES; INFANT-MORTALITY; WEIGHT-GAIN; HIV-1-INFECTED WOMEN; PRETERM DELIVERY; GESTATIONAL-AGE	Objective: Maternal nutritional status is an important predictor of birth outcomes, yet little is known about the nutritional status of HIV-infected pregnant women treated with combination antiretroviral therapy (cART). We therefore examined the relationship between maternal BMI at study enrollment, gestational weight gain (GWG), and hemoglobin concentration (Hb) among 166 women initiating cART in rural Uganda. Design: Prospective cohort. Methods: HIV-infected, ART-naive pregnant women were enrolled between 12 and 28 weeks gestation and treated with a protease inhibitor or non-nucleoside reverse transcriptase inhibitor-based combination regimen. Nutritional status was assessed monthly. Neonatal anthropometry was examined at birth. Outcomes were evaluated using multivariate analysis. Results: Mean GWG was 0.17 kg/week, 14.6% of women experienced weight loss during pregnancy, and 44.9% were anemic. Adverse fetal outcomes included low birth weight (LBW) (19.6%), preterm delivery (17.7%), fetal death (3.9%), stunting (21.1%), small-for-gestational age (15.1%), and head-sparing growth restriction (26%). No infants were HIV-infected. Gaining,0.1 kg/week was associated with LBW, preterm delivery, and a composite adverse obstetric/fetal outcome. Maternal weight at 7 months gestation predicted LBW. For each g/dL higher mean Hb, the odds of small-for-gestational age decreased by 52%. Conclusions: In our cohort of HIV-infected women initiating cART during pregnancy, grossly inadequate GWG was common. Infants whose mothers gained,0.1 kg/week were at increased risk for LBW, preterm delivery, and composite adverse birth outcomes. cART by itself may not be sufficient for decreasing the burden of adverse birth outcomes among HIV-infected women.	[Young, Sera] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Murray, Katherine; Plenty, Albert; Charlebois, Edwin] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Mwesigwa, Julia; Natureeba, Paul; Arinaitwe, Emmanuel] Makerere Univ Univ Calif San Francisco Res Collab, Kampala, Uganda; [Osterbauer, Beth; Clark, Tamara; Havlir, Diane] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Achan, Jane] Makerere Univ, Coll Hlth Sci, Dept Paediat & Child Hlth, Kampala, Uganda; [Ades, Veronica; Cohan, Deborah] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Ruel, Theodore] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Kamya, Moses] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda	Cornell University; University of California System; University of California San Francisco; Makerere University; University of California System; University of California San Francisco; Makerere University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Makerere University	Young, S (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	cohand@obgyn.ucsf.edu		Ades, Veronica/0000-0002-9163-7511; Young, Sera/0000-0002-1763-1218; Mwesigwa, Julia/0000-0003-2452-3677	National Institute for Child Health and Human Development; PEPFAR (President's Emergency Plan For AIDS Relief); Office of the Global AIDS Coordinator; Office of AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD060459, P01HD059454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH098902] Funding Source: NIH RePORTER	National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PEPFAR (President's Emergency Plan For AIDS Relief); Office of the Global AIDS Coordinator; Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The primary sponsor of the PROMOTE-Pregnant Women and Infants trial is the National Institute for Child Health and Human Development (http://www.nichd.nih.gov/). This nutritional sub-study was supported by PEPFAR (President's Emergency Plan For AIDS Relief), the Office of the Global AIDS Coordinator, and the Office of AIDS Research. Abbott Laboratories provides Lopinavir/ritonavir for the parent trial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS B, 1991, AM J OBSTET GYNECOL, V164, P785, DOI 10.1016/0002-9378(91)90516-T; Adam I, 2008, J TROP PEDIATRICS, V54, P202, DOI 10.1093/tropej/fmm110; ALGHAZALI W, 1989, BRIT J OBSTET GYNAEC, V96, P697, DOI 10.1111/j.1471-0528.1989.tb03285.x; American College of Obstetricians and Gynecologists, 2009, Obstet Gynecol, V113, P451, DOI 10.1097/AOG.0b013e31819930b0; [Anonymous], 2007, WHO CASE DEFINITIONS; Banda Y, 2007, TROP MED INT HEALTH, V12, P856, DOI 10.1111/j.1365-3156.2007.01857.x; Brahmbhatt H, 2006, JAIDS-J ACQ IMM DEF, V41, P504, DOI 10.1097/01.qai.0000188122.15493.0a; BRENNER WE, 1976, AM J OBSTET GYNECOL, V126, P555, DOI 10.1016/0002-9378(76)90748-1; Castetbon K, 1999, J TROP PEDIATRICS, V45, P152, DOI 10.1093/tropej/45.3.152; Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786, DOI 10.1136/bmj.315.7111.786; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Division of AIDS, 2009, TOX TABL GRAD SEV AD; Ehrenberg HM, 2003, AM J OBSTET GYNECOL, V189, P1726, DOI 10.1016/S0002-9378(03)00860-3; Ekouevi DK, 2008, AIDS, V22, P1815, DOI 10.1097/QAD.0b013e32830b8ab9; Elshibly EM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-244; Filteau S, 2009, TROP MED INT HEALTH, V14, P276, DOI 10.1111/j.1365-3156.2009.02220.x; Frederick IO, 2008, MATERN CHILD HLTH J, V12, P557, DOI 10.1007/s10995-007-0276-2; Iacovidou N, 2010, ANN NY ACAD SCI, V1205, P130, DOI 10.1111/j.1749-6632.2010.05657.x; Kelly A, 1996, INT J GYNECOL OBSTET, V53, P219, DOI 10.1016/0020-7292(96)02652-5; Kramer MS, 2005, PAEDIATR PERINAT EP, V19, P445, DOI 10.1111/j.1365-3016.2005.00681.x; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kruger H S, 2005, Curationis, V28, P40; Makasa M, 2007, TROP MED INT HEALTH, V12, P594, DOI 10.1111/j.1365-3156.2007.01836.x; Manji KP, 1998, E AFR MED J, V75, P382; Marazzi CM, 2007, EUR J PEDIATR, V166, P1305, DOI 10.1007/s00431-006-0405-8; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; Markestad T, 1997, ACTA OBSTET GYN SCAN, V76, P93; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; Maulik D, 2006, CLIN OBSTET GYNECOL, V49, P214, DOI 10.1097/00003081-200606000-00004; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mehta S, 2008, AM J CLIN NUTR, V87, P1639, DOI 10.1093/ajcn/87.6.1639; Narman N, 2007, SAMJ S AFR MED J, V97, P733; Pattinson RC, 2003, SAMJ S AFR MED J, V93, P445; POWIS K, 2011, 18 C RETR OPP INF BO; Rasmussen KM, 2010, OBSTET GYNECOL, V116, P1191, DOI 10.1097/AOG.0b013e3181f60da7; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Ruel MT, 2001, NESTLE NUTR WORKS SE, V47, P123; Shapiro RL, 2007, J INFECT DIS, V196, P562, DOI 10.1086/519847; TORO PL, 2010, 17 INT AIDS C MEX CI, V24, P515, DOI DOI 10.1097/QAD.0B013E3283350ECD; van der Mei J, 2000, TROP MED INT HEALTH, V5, P571; Villamor E, 2004, J NUTR, V134, P1424, DOI 10.1093/jn/134.6.1424; Villamor E, 2003, JAIDS-J ACQ IMM DEF, V32, P560, DOI 10.1097/00126334-200304150-00015; Viswanathan M, 2008, EDUC ASIA PAC REG-IS, V12, P1, DOI 10.1007/978-1-4020-5769-4; Wei RL, 2004, PEDIATR INFECT DIS J, V23, P530, DOI 10.1097/01.inf.0000129691.42964.eb; World Health Organization, 2006, GLOB DAT BOD MASS IN; Zaba B, 2005, EPIDEMIOLOGY, V16, P275, DOI 10.1097/01.ede.0000155507.47884.43	48	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41934	10.1371/journal.pone.0041934	http://dx.doi.org/10.1371/journal.pone.0041934			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879899	Green Published, gold, Green Submitted			2022-12-27	WOS:000307437900015
J	Bae, JW; Kim, DB; Choi, JY; Park, HJ; Lee, JD; Hur, DG; Bae, SH; Jung, DJ; Lee, SH; Kim, UK; Lee, KY				Bae, Jae Woong; Kim, Dong-Bin; Choi, Jae Young; Park, Hong-Joon; Lee, Jong Dae; Hur, Dong Gu; Bae, Seung-Hyun; Jung, Da Jung; Lee, Sang Heun; Kim, Un-Kyung; Lee, Kyu Yup			Molecular and Clinical Characterization of the Variable Phenotype in Korean Families with Hearing Loss Associated with the Mitochondrial A1555G Mutation	PLOS ONE			English	Article							12S RIBOSOMAL-RNA; NON-SYNDROMIC DEAFNESS; EXTREMELY LOW PENETRANCE; HAN CHINESE PEDIGREES; AMINOGLYCOSIDE OTOTOXICITY; INHERITED SUSCEPTIBILITY; SENSORINEURAL DEAFNESS; PEDIATRIC SUBJECTS; G7444A MUTATION; HUMAN MTDNA	Hearing loss, which is genetically heterogeneous, can be caused by mutations in the mitochondrial DNA (mtDNA). The A1555G mutation of the 12S ribosomal RNA (rRNA) gene in the mtDNA has been associated with both aminoglycoside-induced and non-syndromic hearing loss in many ethnic populations. Here, we report for the first time the clinical and genetic characterization of nine Korean pedigrees with aminoglycoside-induced and non-syndromic hearing loss. These Korean families carry in the A1555G mutation of 12S rRNA gene and exhibit variable penetrance and expressivity of hearing loss. Specifically, the penetrance of hearing loss in these families ranged between 28.6% and 75%, with an average of 60.8%. These results were higher than the 29.8% penetrance that was previously reported in a Chinese population but similar to the 65.4% and 54.1% penetrance observed in a large Arab-Israeli population and nineteen Spanish pedigrees, respectively. The mutational analysis of the complete mtDNA genome in these families showed that the haplogroups of the Korean population, which belongs to the eastern Asian population, were similar to those of the Chinese population but different from the Spanish population, which belongs to the European-Caucasian population. The mtDNA variants that may act as modifier factors were also found to be similar to the Chinese population. Although the mtDNA haplogroups and variants were similar to the eastern Asian population, we did find some differing phenotypes, although some subjects had the same variants. This result suggests that both the ethnic background and environmental factors lead to a variable phenotype of the A1555G mutation.	[Bae, Jae Woong; Kim, Dong-Bin; Bae, Seung-Hyun; Kim, Un-Kyung] Kyungpook Natl Univ, Dept Biol, Coll Nat Sci, Taegu, South Korea; [Choi, Jae Young] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Park, Hong-Joon] Soree Ear Clin, Seoul, South Korea; [Lee, Jong Dae] Soonchunhyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Puchon, South Korea; [Hur, Dong Gu] Gyeongsang Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Jinju, South Korea; [Jung, Da Jung; Lee, Sang Heun; Lee, Kyu Yup] Kyungpook Natl Univ, Dept Otolaryngol, Coll Med, Taegu, South Korea	Kyungpook National University; Yonsei University; Yonsei University Health System; Soonchunhyang University; Gyeongsang National University; Gyeongsang National University Hospital; Kyungpook National University	Bae, JW (corresponding author), Kyungpook Natl Univ, Dept Biol, Coll Nat Sci, Taegu, South Korea.	kimuk@knu.ac.kr; kylee@knu.ac.kr			Biomedical Research Institute Grant, Kyungpook National University Hospital	Biomedical Research Institute Grant, Kyungpook National University Hospital	This work was supported by Biomedical Research Institute Grant, Kyungpook National University Hospital (2011) (K.Y. Lee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; Bykhovskaya Y, 1998, AM J MED GENET, V77, P421, DOI 10.1002/(SICI)1096-8628(19980605)77:5<421::AID-AJMG13>3.0.CO;2-K; Casano RAMS, 1999, AM J OTOLARYNG, V20, P151, DOI 10.1016/S0196-0709(99)90062-5; Chen B, 2008, AM J MED GENET A, V146A, P1248, DOI 10.1002/ajmg.a.32285; Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100; Dai P, 2006, BIOCHEM BIOPH RES CO, V340, P194, DOI 10.1016/j.bbrc.2005.11.156; del Castillo FJ, 2003, J MED GENET, V40, P632, DOI 10.1136/jmg.40.8.632; Ding Y, 2009, J GENET GENOMICS, V36, P241, DOI 10.1016/S1673-8527(08)60111-3; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; FischelGhodsian N, 1997, AM J OTOLARYNG, V18, P173, DOI 10.1016/S0196-0709(97)90078-8; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 2000, HUM MOL GENET, V9, P1787, DOI 10.1093/hmg/9.12.1787; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Guan MX, 2004, ANN NY ACAD SCI, V1011, P259, DOI 10.1196/annals.1293.025; Hamasaki K, 1997, BIOCHEMISTRY-US, V36, P12323, DOI 10.1021/bi970962r; Lee H, 2006, INT J LEGAL MED, V120, P5, DOI 10.1007/s00414-005-0005-6; Li R, 2004, J MED GENET, V41, P615, DOI 10.1136/jmg.2004.020230; Li ZY, 2005, HUM GENET, V117, P9, DOI 10.1007/s00439-005-1276-1; Lu JX, 2010, MITOCHONDRION, V10, P69, DOI 10.1016/j.mito.2009.09.007; Matthijs G, 1996, EUR J HUM GENET, V4, P46; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MORTON NE, 1991, ANN HUM GENET, V55, P301, DOI 10.1111/j.1469-1809.1991.tb00857.x; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Tang XW, 2007, GENE, V393, P11, DOI 10.1016/j.gene.2007.01.001; Torroni A, 1999, AM J HUM GENET, V65, P1349, DOI 10.1086/302642; Torroni A, 1997, AM J HUM GENET, V60, P1107; Usami S, 2000, J MED GENET, V37, P38, DOI 10.1136/jmg.37.1.38; Van Camp G, 2000, CLIN GENET, V57, P409, DOI 10.1034/j.1399-0004.2000.570601.x; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; Wang XJ, 2008, PHARMACOGENET GENOM, V18, P1059, DOI 10.1097/FPC.0b013e3283131661; Yan QF, 2005, J BIOL CHEM, V280, P29151, DOI 10.1074/jbc.M504247200; Young WY, 2006, AM J MED GENET A, V140A, P2188, DOI 10.1002/ajmg.a.31434; Young WY, 2005, BIOCHEM BIOPH RES CO, V328, P1244, DOI 10.1016/j.bbrc.2005.01.085; Yuan HJ, 2005, AM J MED GENET A, V138A, P133, DOI 10.1002/ajmg.a.30952; Zhao LD, 2005, BIOCHEM BIOPH RES CO, V336, P967, DOI 10.1016/j.bbrc.2005.08.199; Zhu Y, 2006, BIOCHEM BIOPH RES CO, V342, P843, DOI 10.1016/j.bbrc.2006.02.027	40	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42463	10.1371/journal.pone.0042463	http://dx.doi.org/10.1371/journal.pone.0042463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879993	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000036
J	Yoon, HH; Orrock, JM; Foster, NR; Sargent, DJ; Smyrk, TC; Sinicrope, FA				Yoon, Harry H.; Orrock, Jared M.; Foster, Nathan R.; Sargent, Daniel J.; Smyrk, Thomas C.; Sinicrope, Frank A.			Prognostic Impact of FoxP3+Regulatory T Cells in Relation to CD8+T Lymphocyte Density in Human Colon Carcinomas	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; COLORECTAL-CANCER; MICROSATELLITE-INSTABILITY; MISMATCH REPAIR; REGULATORY CELLS; ADJUVANT CHEMOTHERAPY; FAVORABLE PROGNOSIS; OVARIAN-CANCER; FOXP3; SURVIVAL	Background: T-lymphocyte infiltration into colon carcinomas can influence clinical outcome, and interactions among T cell subsets may be more informative than either subset alone. Our objective was to examine the prognostic impact of tumor-infiltrating FoxP3(+) regulatory T cells (Tregs) in relation to cytotoxic CD8(+) T lymphocytes in patients with colon carcinomas characterized by DNA mismatch repair (MMR) status who participated in adjuvant chemotherapy trials. Methods: FoxP3(+) and CD8(+) densities in tumor epithelial and stromal compartments were analyzed by immunohistochemistry and quantified in resected, stage II and III colonic carcinomas (N = 216). Immune marker density was dichotomized at the median and categorized as high vs low. MMR status was classified as MMR deficient (dMMR) or proficient (pMMR). Cox models were adjusted for age, stage, and tumor grade. Results: The density of FoxP3+ infiltration was similar in tumor stroma and epithelia, whereas CD8+ was higher in stroma. The prognostic impact of FoxP3+ and CD8+ T cell infiltration was stronger in stroma vs epithelia, and the density of each marker in stroma was independently associated with improved overall survival (OS). However, the impact of FoxP3+ on survival was dependent upon CD8+ density (P interaction = .040). Among CD8+(low) tumors, FoxP3+(high) cases had significantly improved OS compared to FoxP3+(low) cases after adjustment for covariates (hazard ratio 0.43; 95% confidence interval 0.19 to 0.95; P = .030). In contrast, FoxP3+ was not prognostic among CD8+(high) tumors. FoxP3+ remained prognostic in CD8+(low) tumors after further adjustment for MMR or BRAF (V600E) mutation status. Additionally, these immune markers identified a pMMR subgroup with a similarly favorable OS as for dMMR tumors. Conclusions: The prognostic impact of FoxP3+ and CD8+ T cell density are inter-dependent, whereby FoxP3+ exerts a favorable influence on survival only in colon cancers with low CD8+ infiltration.	[Yoon, Harry H.; Sinicrope, Frank A.] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Orrock, Jared M.; Smyrk, Thomas C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Foster, Nathan R.; Sargent, Daniel J.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Sinicrope, Frank A.] Mayo Clin, Dept Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Yoon, HH (corresponding author), Mayo Clin, Dept Oncol, Rochester, MN 55905 USA.	Sinicrope.frank@mayo.edu		Sargent, Daniel/0000-0002-2684-4741	National Cancer Institute [K05CA-142885, CA25224-32CM]; NATIONAL CANCER INSTITUTE [K05CA142885, U10CA025224] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Cancer Institute K05CA-142885 (Senior Scientist Award to FAS) and by National Cancer Institute Grant CA25224-32CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2002, J CLIN ONCOL, V20, P1735, DOI 10.1200/JCO.2002.07.080; Badoual C, 2006, CLIN CANCER RES, V12, P465, DOI 10.1158/1078-0432.CCR-05-1886; Banerjea Ayan, 2005, World J Surg Oncol, V3, P26, DOI 10.1186/1477-7819-3-26; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Blatner NR, 2010, P NATL ACAD SCI USA, V107, P6430, DOI 10.1073/pnas.0913683107; Boland CR, 1998, CANCER RES, V58, P5248; Chang LY, 2012, CANCER RES, V72, P1092, DOI 10.1158/0008-5472.CAN-11-2493; Correale P, 2010, J IMMUNOTHER, V33, P435, DOI 10.1097/CJI.0b013e3181d32f01; Di Sabatino A, 2001, GUT, V49, P380, DOI 10.1136/gut.49.3.380; Elpek KG, 2007, J IMMUNOL, V178, P6840, DOI 10.4049/jimmunol.178.11.6840; Erdman SE, 2005, CANCER RES, V65, P3998, DOI 10.1158/0008-5472.CAN-04-3104; Erdman SE, 2003, CANCER RES, V63, P6042; Erdman SE, 2010, INT J CANCER, V126, P1651, DOI 10.1002/ijc.24923; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; French AJ, 2008, CLIN CANCER RES, V14, P3408, DOI 10.1158/1078-0432.CCR-07-1489; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Goode EL, 2011, CANCER EPIDEM BIOMAR, V20, P1638, DOI 10.1158/1055-9965.EPI-11-0455; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Guidoboni M, 2001, AM J PATHOL, V159, P297, DOI 10.1016/S0002-9440(10)61695-1; Halling KC, 1999, JNCI-J NATL CANCER I, V91, P1295, DOI 10.1093/jnci/91.15.1295; Hewish M, 2010, NAT REV CLIN ONCOL, V7, P197, DOI 10.1038/nrclinonc.2010.18; Hooper SJ, 2009, HEAD NECK-J SCI SPEC, V31, P1228, DOI 10.1002/hed.21140; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Ladoire S, 2011, CANCER IMMUNOL IMMUN, V60, P909, DOI 10.1007/s00262-011-1046-y; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Lee AM, 2006, J CLIN ONCOL, V24, P5052, DOI 10.1200/JCO.2006.06.4642; Ling Khoon Lin, 2007, Cancer Immun, V7, P7; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Morishima N, 2005, J IMMUNOL, V175, P1686, DOI 10.4049/jimmunol.175.3.1686; Nosho K, 2010, J PATHOL, V222, P350, DOI 10.1002/path.2774; O'Connell MJ, 2006, CLIN COLORECTAL CANC, V6, P133, DOI 10.3816/CCC.2006.n.030; Ogino S, 2009, CLIN CANCER RES, V15, P6412, DOI 10.1158/1078-0432.CCR-09-1438; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Phan V, 2008, CANCER IMMUNOL IMMUN, V57, P281, DOI 10.1007/s00262-007-0356-6; Quinn E, 2003, EUR J CANCER, V39, P469, DOI 10.1016/S0959-8049(02)00633-0; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Sinicrope FA, 2008, CLIN CANCER RES, V14, P5810, DOI 10.1158/1078-0432.CCR-07-5202; Sinicrope FA, 2007, INT J CANCER, V120, P1232, DOI 10.1002/ijc.22429; Sinicrope FA, 2010, NAT REV CLIN ONCOL, V7, P174, DOI 10.1038/nrclinonc.2009.235; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; Takemoto N, 2004, JPN J CLIN ONCOL, V34, P90, DOI 10.1093/jjco/hyh018; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Zhang YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-4	55	79	85	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42274	10.1371/journal.pone.0042274	http://dx.doi.org/10.1371/journal.pone.0042274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879926	gold, Green Published, Green Submitted			2022-12-27	WOS:000307810000023
J	Bonomi, M; Somigliana, E; Cacciatore, C; Busnelli, M; Rossetti, R; Bonetti, S; Paffoni, A; Mari, D; Ragni, G; Persani, L				Bonomi, Marco; Somigliana, Edgardo; Cacciatore, Chiara; Busnelli, Marta; Rossetti, Raffaella; Bonetti, Silvia; Paffoni, Alessio; Mari, Daniela; Ragni, Guido; Persani, Luca		Italian Network Study Ovarian	Blood Cell Mitochondrial DNA Content and Premature Ovarian Aging	PLOS ONE			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; COPY NUMBER; POLYMERASE-GAMMA; SKELETAL-MUSCLE; POOR RESPONSE; X-CHROMOSOME; IN-VITRO; FAILURE; OOCYTE; INSUFFICIENCY	Primary ovarian insufficiency (POI) is a critical fertility defect characterized by an anticipated and silent impairment of the follicular reserve, but its pathogenesis is largely unexplained. The frequent maternal inheritance of POI together with a remarkable dependence of ovarian folliculogenesis upon mitochondrial biogenesis and bioenergetics suggested the possible involvement of a generalized mitochondrial defect. Here, we verified the existence of a significant correlation between blood and ovarian mitochondrial DNA (mtDNA) content in a group of women undergoing ovarian hyperstimulation (OH), and then aimed to verify whether mtDNA content was significantly altered in the blood cells of POI women. We recruited 101 women with an impaired ovarian reserve: 59 women with premature ovarian failure (POF) and 42 poor responders (PR) to OH. A Taqman copy number assay revealed a significant mtDNA depletion (P<0.001) in both POF and PR women in comparison with 43 women of similar age and intact ovarian reserve, or 53 very old women with a previous physiological menopause. No pathogenic variations in the mitochondrial DNA polymerase gamma (POLG) gene were detected in 57 POF or PR women with low blood mtDNA content. In conclusion, blood cell mtDNA depletion is a frequent finding among women with premature ovarian aging, suggesting that a still undetermined but generalized mitochondrial defect may frequently predispose to POI which could then be considered a form of anticipated aging in which the ovarian defect may represent the first manifestation. The determination of mtDNA content in blood may become an useful tool for the POI risk prediction.	[Bonomi, Marco; Busnelli, Marta; Persani, Luca] Fdn Ist Ricovero & Cura Carattere Sci Ist Auxol I, Lab Ric Endocrinometab E, Milan, Italy; [Cacciatore, Chiara; Persani, Luca] Fdn Ist Ricovero & Cura Carattere Sci Ist Auxol I, UO Med Gen Indirizzo Endocrinometab, Milan, Italy; [Somigliana, Edgardo; Bonetti, Silvia; Paffoni, Alessio; Ragni, Guido] Fdn Ist Ricovero & Cura Carattere Sci Ca Granda O, Ctr Sterilita, Milan, Italy; [Cacciatore, Chiara; Rossetti, Raffaella; Mari, Daniela; Persani, Luca] Univ Milan, Dipartimento Sci Clin & Comunita, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Bonomi, M (corresponding author), Fdn Ist Ricovero & Cura Carattere Sci Ist Auxol I, Lab Ric Endocrinometab E, Milan, Italy.	luca.persani@unimi.it	Somigliana, Edgardo/Z-3749-2019; Petraglia, Felice/D-4373-2019; Tonacchera, Massimo/K-8523-2016; Persani, Luca/B-6543-2008; Mari, Daniela/K-5663-2016; Rossetti, Raffaella/B-4972-2013; Busnelli, Marta/AAR-5513-2021; Ricca, Ivana/AAA-4125-2021; Ricca, Ivana/I-4760-2018; Corbetta, Sabrina/H-5457-2011; Paffoni, Alessio/I-7404-2015; Renieri, Alessandra/K-5950-2016; fusi, franco/K-4637-2013; Cannavo, Salvatore/D-7608-2013; Nappi, Rossella/AAC-1793-2022; MAROZZI, ANNA/Q-7282-2017; Bonomi, Marco/T-6487-2019	Somigliana, Edgardo/0000-0002-0223-0032; Petraglia, Felice/0000-0002-8851-625X; Persani, Luca/0000-0003-2068-9581; Mari, Daniela/0000-0002-6950-0789; Rossetti, Raffaella/0000-0001-9112-6175; Busnelli, Marta/0000-0003-3387-2190; Ricca, Ivana/0000-0001-8939-1447; Ricca, Ivana/0000-0001-8939-1447; Corbetta, Sabrina/0000-0001-8140-3175; Paffoni, Alessio/0000-0003-3112-3161; PALLI, Domenico/0000-0002-5558-2437; cavallo, luciano/0000-0003-4787-8681; Renieri, Alessandra/0000-0002-0846-9220; fusi, franco/0000-0002-4349-0842; s, hema/0000-0002-3440-9475; tumino, rosario/0000-0003-2666-414X; Tonacchera, Massimo/0000-0001-5431-5823; Cannavo, Salvatore/0000-0001-8779-7283; Nappi, Rossella/0000-0003-1713-6396; zuffardi, orsetta/0000-0002-1466-4559; MAROZZI, ANNA/0000-0001-9007-2590; Vegetti, Walter/0000-0003-0422-643X; Bione, Silvia/0000-0002-3924-4606; Bonomi, Marco/0000-0001-5454-6074; Villa, Nicoletta/0000-0002-4439-9880; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Telethon Foundation - Italy [GGP09126A]; Istituto Auxologico Italiano, Italy [05C501]	Telethon Foundation - Italy(Fondazione Telethon); Istituto Auxologico Italiano, Italy	The financial support of Telethon Foundation - Italy (Grant no. GGP09126A) and Istituto Auxologico Italiano, Italy (Ricerca Corrente Funds: 05C501) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLAND NI, 1993, BIOL REPROD, V48, P798, DOI 10.1095/biolreprod48.4.798; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4; Davis CJ, 2000, HUM REPROD, V15, P2418, DOI 10.1093/humrep/15.11.2418; de Boer EJ, 2003, HUM REPROD, V18, P1544, DOI 10.1093/humrep/deg278; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Farhi J, 1997, HUM REPROD, V12, P241, DOI 10.1093/humrep/12.2.241; Gagnon A, 2009, AM J HUM BIOL, V21, P533, DOI 10.1002/ajhb.20893; Harris SE, 2009, MOL REPROD DEV, V76, P231, DOI 10.1002/mrd.20945; Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553; HUTCHINSON EW, 1991, GENETICS, V127, P729; Jansen RPS, 1998, MOL CELL ENDOCRINOL, V145, P81, DOI 10.1016/S0303-7207(98)00173-7; Johannsen DL, 2009, CURR OPIN PHARMACOL, V9, P780, DOI 10.1016/j.coph.2009.09.002; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lawson R, 2003, HUM REPROD, V18, P527, DOI 10.1093/humrep/deg101; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667; May-Panloup P, 2007, CURR TOP DEV BIOL, V77, P51, DOI 10.1016/S0070-2153(06)77003-X; Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076; Pang CY, 2008, FRONT BIOSCI-LANDMRK, V13, P3661, DOI 10.2741/2957; Perls TT, 1997, NATURE, V389, P133, DOI 10.1038/38148; Persani L, 2010, J MOL ENDOCRINOL, V45, P257, DOI 10.1677/JME-10-0070; Persani L, 2009, J AUTOIMMUN, V33, P35, DOI 10.1016/j.jaut.2009.03.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rizzolio F, 2009, J MED GENET, V46, P585, DOI 10.1136/jmg.2007.056093; Rossetti R, 2009, HUM MUTAT, V30, P804, DOI 10.1002/humu.20961; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Simpson JL, 2008, ANN NY ACAD SCI, V1135, P146, DOI 10.1196/annals.1429.019; Smith KR, 2009, J GERONTOL A-BIOL, V64, P740, DOI 10.1093/gerona/glp055; Spikings EC, 2007, BIOL REPROD, V76, P327, DOI 10.1095/biolreprod.106.054536; Tatone C, 2006, MOL HUM REPROD, V12, P655, DOI 10.1093/molehr/gal080; Tong ZB, 2010, FERTIL STERIL, V94, P2932, DOI 10.1016/j.fertnstert.2010.06.049; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Trinei M, 2006, BBA-BIOENERGETICS, V1757, P624, DOI 10.1016/j.bbabio.2006.05.029; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954; Vegetti W, 2000, MOL CELL ENDOCRINOL, V161, P53, DOI 10.1016/S0303-7207(99)00224-5; Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887; Welt CK, 2008, CLIN ENDOCRINOL, V68, P499, DOI 10.1111/j.1365-2265.2007.03073.x; Wycherley G, 2005, HUM REPROD, V20, P2757, DOI 10.1093/humrep/dei132	45	32	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42423	10.1371/journal.pone.0042423	http://dx.doi.org/10.1371/journal.pone.0042423			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879975	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100086
J	Dey, N; Ghosh-Choudhury, N; Kasinath, BS; Choudhury, GG				Dey, Nirmalya; Ghosh-Choudhury, Nandini; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh			TGF beta-Stimulated MicroRNA-21 Utilizes PTEN to Orchestrate AKT/mTORC1 Signaling for Mesangial Cell Hypertrophy and Matrix Expansion	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; SMOOTH-MUSCLE-CELLS; MAMMALIAN TARGET; RENAL FIBROSIS; HIGH GLUCOSE; PHOSPHATIDYLINOSITOL 3-KINASE; MESENCHYMAL TRANSITION; TUMOR SUPPRESSION; GENE-EXPRESSION; HIGH INSULIN	Transforming growth factor-beta (TGF beta) promotes glomerular hypertrophy and matrix expansion, leading to glomerulosclerosis. MicroRNAs are well suited to promote fibrosis because they can repress gene expression, which negatively regulate the fibrotic process. Recent cellular and animal studies have revealed enhanced expression of microRNA, miR-21, in renal cells in response to TGF beta. Specific miR-21 targets downstream of TGF beta receptor activation that control cell hypertrophy and matrix protein expression have not been studied. Using 3'UTR-driven luciferase reporter, we identified the tumor suppressor protein PTEN as a target of TGF beta-stimulated miR-21 in glomerular mesangial cells. Expression of miR-21 Sponge, which quenches endogenous miR-21 levels, reversed TGF beta-induced suppression of PTEN. Additionally, miR-21 Sponge inhibited TGF beta-stimulated phosphorylation of Akt kinase, resulting in attenuation of phosphorylation of its substrate GSK3 beta. Tuberin and PRAS40, two other Akt substrates, and endogenous inhibitors of mTORC1, regulate mesangial cell hypertrophy. Neutralization of endogenous miR-21 abrogated TGF beta-stimulated phosphorylation of tuberin and PRAS40, leading to inhibition of phosphorylation of S6 kinase, mTOR and 4EBP-1. Moreover, downregulation of miR-21 significantly suppressed TGF beta-induced protein synthesis and hypertrophy, which were reversed by siRNA-targeted inhibition of PTEN expression. Similarly, expression of constitutively active Akt kinase reversed the miR-21 Sponge-mediated inhibition of TGF beta-induced protein synthesis and hypertrophy. Furthermore, expression of constitutively active mTORC1 prevented the miR-21 Sponge-induced suppression of mesangial cell protein synthesis and hypertrophy by TGF beta. Finally, we show that miR-21 Sponge inhibited TGF beta-stimulated fibronectin and collagen expression. Suppression of PTEN expression and expression of both constitutively active Akt kinase and mTORC1 independently reversed this miR-21-mediated inhibition of TGF beta-induced fibronectin and collagen expression. Our results uncover an essential role of TGF beta-induced expression of miR-21, which targets PTEN to initiate a non-canonical signaling circuit involving Akt/mTORC1 axis for mesangial cell hypertrophy and matrix protein synthesis.	[Dey, Nirmalya; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA; [Ghosh-Choudhury, Nandini; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Vet Adm Res, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Dey, N (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu			National Institutes of Health (NIH) [RO1 DK50190, RO1 AR 52425, RO1 DK 077295, RC2A 036613]; VA (Veterans Administration) Research Service Merit Review grant; Juvenile Diabetes Research Foundation [1-2008-185]; VA Senior Research Career Scientist Award; VA Merit Review; Cancer Therapy and Research Center, San Antonio, Texas; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190, R01DK077295] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA (Veterans Administration) Research Service Merit Review grant; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); VA Senior Research Career Scientist Award; VA Merit Review(US Department of Veterans Affairs); Cancer Therapy and Research Center, San Antonio, Texas; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health (NIH) RO1 DK50190 grant to GGC supported this work. Part of this work was also supported by VA (Veterans Administration) Research Service Merit Review grant to GGC. GGC is also supported by Juvenile Diabetes Research Foundation 1-2008-185 grants and is recipient of VA Senior Research Career Scientist Award. NGC is supported by VA Merit Review, NIH RO1 AR 52425 grants and Ronald P. Williams Orthopedic Oncology Developmental Research Award from Cancer Therapy and Research Center, San Antonio, Texas. BSK is supported by NIH RO1 DK 077295, NIH RC2A 036613 and VA Merit Review Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Badal SS, 2012, J AM SOC NEPHROL, V23, P185, DOI 10.1681/ASN.2011121222; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhatt K, 2010, MOL MED, V16, P409, DOI 10.2119/molmed.2010.00002; Border WA, 1998, KIDNEY INT, V54, P1390, DOI 10.1046/j.1523-1755.1998.00127.x; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Chen JK, 2005, J AM SOC NEPHROL, V16, P1384, DOI 10.1681/ASN.2004100894; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; CHOUDHURY GG, 1994, KIDNEY INT, V46, P37, DOI 10.1038/ki.1994.242; CHOUDHURY GG, 1993, AM J PHYSIOL, V265, pF634, DOI 10.1152/ajprenal.1993.265.5.F634; Choudhury GG, 2004, CELL SIGNAL, V16, P31, DOI 10.1016/S0898-6568(03)00094-9; Choudhury GG, 1998, J CLIN INVEST, V101, P2751, DOI 10.1172/JCI1044; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Das F, 2012, J BIOL CHEM, V287, P3808, DOI 10.1074/jbc.M111.246397; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denby L, 2011, AM J PATHOL, V179, P661, DOI 10.1016/j.ajpath.2011.04.021; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2964, DOI 10.1681/ASN.2006070704; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Fujimoto M, 2003, BIOCHEM BIOPH RES CO, V305, P1002, DOI 10.1016/S0006-291X(03)00885-4; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Godlewski J, 2010, CELL CYCLE, V9, P2742, DOI 10.4161/cc.9.14.12248; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; Ho J, 2012, J AM SOC NEPHROL, V23, P400, DOI 10.1681/ASN.2011080797; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iwano M, 1996, KIDNEY INT, V49, P1120, DOI 10.1038/ki.1996.162; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jenkins RH, 2012, BIOCHEM J, V443, P407, DOI 10.1042/BJ20111861; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kopp JB, 1996, LAB INVEST, V74, P991; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leslie NR, 2011, TRENDS PHARMACOL SCI, V32, P131, DOI 10.1016/j.tips.2010.12.005; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Mahimainathan L, 2009, J BIOL CHEM, V284, P27790, DOI 10.1074/jbc.M109.028860; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Merkel O, 2010, P NATL ACAD SCI USA, V107, P16228, DOI 10.1073/pnas.1009719107; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nagalakshmi VK, 2011, KIDNEY INT, V79, P317, DOI 10.1038/ki.2010.385; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Putta S, 2012, J AM SOC NEPHROL, V23, P458, DOI 10.1681/ASN.2011050485; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Ruan QG, 2011, P NATL ACAD SCI USA, V108, P12030, DOI 10.1073/pnas.1101450108; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Sakaguchi M, 2006, BIOCHEM BIOPH RES CO, V340, P296, DOI 10.1016/j.bbrc.2005.12.012; Samarakoon R, 2005, J CELL PHYSIOL, V204, P236, DOI 10.1002/jcp.20279; Samarakoon R, 2008, J MOL CELL CARDIOL, V44, P527, DOI 10.1016/j.yjmcc.2007.12.006; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHULTZ PJ, 1988, AM J PHYSIOL, V255, pF674, DOI 10.1152/ajprenal.1988.255.4.F674; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; van Weering DHJ, 1998, MOL CELL BIOL, V18, P1802, DOI 10.1128/MCB.18.4.1802; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu L, 2000, NAT CELL BIOL, V2, P559, DOI 10.1038/35019649; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhdanova O, 2011, KIDNEY INT, V80, P719, DOI 10.1038/ki.2011.122; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168; Zhou L, 2010, AM J PHYSIOL-RENAL, V298, pF1006, DOI 10.1152/ajprenal.00675.2009; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	102	90	100	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42316	10.1371/journal.pone.0042316	http://dx.doi.org/10.1371/journal.pone.0042316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879939	gold, Green Submitted, Green Published			2022-12-27	WOS:000307284100066
J	Hsiao, CC; Lee, CH; Tsao, LY; Lo, HC				Hsiao, Chien-Chou; Lee, Chien-Hsing; Tsao, Lon-Yen; Lo, Hui-Chen			The Dose-Dependent Immunoregulatory Effects of the Nitric Oxide Synthase Inhibitor N-G-Nitro-L-Arginine Methyl Ester in Rats with Sub-Acute Peritonitis	PLOS ONE			English	Article							TOTAL PARENTERAL-NUTRITION; IMMUNE-SYSTEM; SEPSIS; METABOLISM; PERMEABILITY; ENDOTOXEMIA; RESPONSES; INJURY	Background: Chronic inflammation accompanied by arginine deficiency, immune dysfunction, and excess nitric oxide (NO) production is a clinical condition found in patients with peritonitis. A previous study showed that the nonselective NOS inhibitor N-G-nitro-L-arginine methyl ester (L-NAME) may facilitate the metabolism of the immune nutrient arginine without altering NO homeostasis in rats with sub-acute peritonitis. Here, we investigated the effects of L-NAME on the immunocytic subpopulation distribution and response. Materials and Methods: Male Wistar rats with cecal puncture-induced peritonitis were administered parenteral nutrition solutions supplemented with 0 (CPP group), 5 (LNA group), 25 (MNA group) or 50 (HNA group) mg.kg(-1).day(-1) of L-NAME for 7 days. Parenteral-fed sham-operated rats (TPN group) and orally-fed healthy rats (R group) were included as controls. Results: The TPN group had significantly increased spleen weights and levels of plasma nitrite/nitrate (NOx), circulating white blood cells (WBC), and splenocytic T cells, as well as significantly decreased levels of cytotoxic T-and B-leukocytes and B-splenocytes compared to the R group. The CPP group had significantly decreased levels of plasma NOx and concanavalin (Con) A-stimulated interferon (IFN)-gamma and interleukin (IL)-2 production by leukocytes and significantly increased production of Con A-stimulated tumor necrosis factor (TNF)-alpha and lipopolysaccharide (LPS)-stimulated IFN-gamma in the leukocytes. In addition, the LNA and MNA groups had significantly decreased spontaneous IL-6 and Con A-stimulated TNF-alpha and IFN-gamma production by the leukocytes while the HNA group had significantly increased LPS-stimulated TNF-alpha and Con A-stimulated IFN-gamma and IL-2 production by the splenocytes compared to the CPP group. Conclusions: Low-dose L-NAME infusion may suppress proinflammatory and T-helper-1 (Th1) response in leukocytes, and high-dose infusion may activate the proinflammatory response in splenic macrophages and Th1 response in T-splenocytes in rats with sub-acute peritonitis.	[Hsiao, Chien-Chou; Tsao, Lon-Yen] Changhua Christian Hosp, Clin Nutr Support Serv Team, Dept Pediat, Changhau, Taiwan; [Lee, Chien-Hsing] Changhua Christian Hosp, Div Pediat Surg, Changhau, Taiwan; [Lee, Chien-Hsing] Chang Jung Christian Univ, Grad Inst Med Sci, Tainan, Taiwan; [Lo, Hui-Chen] Fu Jen Catholic Univ, Dept Nutr Sci, New Taipei City, Taiwan	Changhua Christian Hospital; Changhua Christian Hospital; Chang Jung Christian University; Fu Jen Catholic University	Hsiao, CC (corresponding author), Changhua Christian Hosp, Clin Nutr Support Serv Team, Dept Pediat, Changhau, Taiwan.	041663@mail.fju.edu.tw	Lo, Hui-Chen/AAN-5906-2021		National Science Council of the Republic of China [NSC-90-2320-B-371-001]; Changhua Christian Hospital [CCH-4604]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Changhua Christian Hospital	This work was supported by the National Science Council of the Republic of China (http://web1.nsc.gov.tw/) under grant number NSC-90-2320-B-371-001 and by the Changhua Christian Hospital (http://www.cch.org.tw/) under grant number CCH-4604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUGHTONSMITH NK, 1993, BRIT J PHARMACOL, V110, P1189, DOI 10.1111/j.1476-5381.1993.tb13940.x; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chaturvedi R, 2010, GASTROENTEROLOGY, V139, P1686, DOI 10.1053/j.gastro.2010.06.060; Chaudhari UP, 2010, INT J PHARMACOL, V6, P183; Chen YH, 2012, JPEN J PARE IN PRESS; Cui L, 2000, NUTRITION, V16, P34, DOI 10.1016/S0899-9007(99)00185-9; Dioguardi FS, 2011, J NUTRIGENET NUTRIGE, V4, P90, DOI 10.1159/000327777; Edfeldt K, 2010, P NATL ACAD SCI USA, V107, P22593, DOI 10.1073/pnas.1011624108; Ferrier ML, 2001, KIDNEY INT, V60, P2343, DOI 10.1046/j.1523-1755.2001.00050.x; Gabbai FB, 1997, J IMMUNOL, V159, P6266; Gavin TP, 2000, J APPL PHYSIOL, V88, P1192, DOI 10.1152/jappl.2000.88.4.1192; GEROULANOS S, 1992, LANCET, V339, P435; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hallemeesch MM, 2002, CLIN NUTR, V21, P111, DOI 10.1054/clnu.2001.0513; Helmer KS, 2003, J SURG RES, V112, P70, DOI 10.1016/S0022-4804(03)00138-0; Hsiao CC, 2011, BIOL PHARM BULL, V34, P177, DOI 10.1248/bpb.34.177; Kobara M, 2003, BASIC RES CARDIOL, V98, P319, DOI 10.1007/s00395-003-0423-x; Lee PY, 2009, AM J PATHOL, V175, P2023, DOI 10.2353/ajpath.2009.090328; Lo HC, 2010, PEDIATR SURG INT, V26, P625, DOI 10.1007/s00383-010-2582-9; Luiking YC, 2007, CRIT CARE MED, V35, pS557, DOI 10.1097/01.CCM.0000279191.44730.A2; Morris DL, 1997, J PHARMACOL TOXICOL, V37, P37, DOI 10.1016/S1056-8719(96)00146-3; Muenzer JT, 2010, INFECT IMMUN, V78, P1582, DOI 10.1128/IAI.01213-09; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; NATHAN C, 1994, J BIOL CHEM, V269, P13725; Nieves C, 2007, JPEN-PARENTER ENTER, V31, P101, DOI 10.1177/0148607107031002101; Ninkovic MB, 2009, GEN PHYSIOL BIOPHYS, V28, P243; OCHOA JB, 1991, ANN SURG, V214, P621, DOI 10.1097/00000658-199111000-00013; Payen D, 1996, CLIN CHEST MED, V17, P333, DOI 10.1016/S0272-5231(05)70318-X; Peranzoni E, 2007, IMMUNOBIOLOGY, V212, P795, DOI 10.1016/j.imbio.2007.09.008; Pratt VC, 1996, JPEN-PARENTER ENTER, V20, P264, DOI 10.1177/0148607196020004264; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; SHOU J, 1994, AM J SURG, V167, P145, DOI 10.1016/0002-9610(94)90065-5; TAO RC, 1979, J NUTR, V109, P904, DOI 10.1093/jn/109.5.904; Wang HH, 2003, NEPHROL DIAL TRANSPL, V18, P1181, DOI 10.1093/ndt/gfg079; Wildhaber BE, 2005, J SURG RES, V123, P8, DOI 10.1016/j.jss.2004.06.015; Xie YW, 1996, CIRCULATION, V94, P2580, DOI 10.1161/01.CIR.94.10.2580; Yeh CL, 2005, BRIT J NUTR, V93, P267, DOI 10.1079/BJN20041326	37	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42467	10.1371/journal.pone.0042467	http://dx.doi.org/10.1371/journal.pone.0042467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879994	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100100
J	Parker, SJ; Meyerowitz, J; James, JL; Liddell, JR; Nonaka, T; Hasegawa, M; Kanninen, KM; Lim, S; Paterson, BM; Donnelly, PS; Crouch, PJ; White, AR				Parker, Sarah J.; Meyerowitz, Jodi; James, Janine L.; Liddell, Jeffrey R.; Nonaka, Takashi; Hasegawa, Masato; Kanninen, Katja M.; Lim, SinChun; Paterson, Brett M.; Donnelly, Paul S.; Crouch, Peter J.; White, Anthony R.			Inhibition of TDP-43 Accumulation by Bis(thiosemicarbazonato)-Copper Complexes	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; BINDING PROTEIN 43; STRESS GRANULES; COPPER; CU-II(ATSM); PARAQUAT; AGGREGATION; DISEASE; DAMAGE; DEATH	Amyotrophic lateral sclerosis (ALS) is a progressive, fatal, motor neuron disease with no effective long-term treatment options. Recently, TDP-43 has been identified as a key protein in the pathogenesis of some cases of ALS. Although the role of TDP-43 in motor neuron degeneration is not yet known, TDP-43 has been shown to accumulate in RNA stress granules (SGs) in cell models and in spinal cord tissue from ALS patients. The SG association may be an early pathological change to TDP-43 metabolism and as such a potential target for therapeutic intervention. Accumulation of TDP-43 in SGs induced by inhibition of mitochondrial activity can be inhibited by modulation of cellular kinase activity. We have also found that treatment of cells and animal models of neurodegeneration, including an ALS model, with bioavailable bis(thiosemicarbazonato)copper(II) complexes (Cu-II(btsc)s) can modulate kinase activity and induce neuroprotective effects. In this study we examined the effect of diacetylbis(-methylthiosemicarbazonato)copper(II) (Cu-II(atsm)) and glyoxalbis(-methylthiosemicarbazonato)copper(II) (Cu-II(gtsm)) on TDP-43-positive SGs induced in SH-SY5Y cells in culture. We found that the Cu-II(btsc)s blocked formation of TDP-43-and human antigen R (HuR)-positive SGs induced by paraquat. The Cu-II(btsc) s protected neurons from paraquat-mediated cell death. These effects were associated with inhibition of ERK phosphorylation. Co-treatment of cultures with either Cu-II(atsm) or an ERK inhibitor, PD98059 both prevented ERK activation and blocked formation of TDP-43-and HuR-positive SGs. Cu-II(atsm) treatment or ERK inhibition also prevented abnormal ubiquitin accumulation in paraquat-treated cells suggesting a link between prolonged ERK activation and abnormal ubiquitin metabolism in paraquat stress and inhibition by Cu. Moreover, Cu-II(atsm) reduced accumulation of C-terminal (219-414) TDP-43 in transfected SH-SY5Y cells. These results demonstrate that Cu-II(btsc) complexes could potentially be developed as a neuroprotective agent to modulate neuronal kinase function and inhibit TDP-43 aggregation. Further studies in TDP-43 animal models are warranted.	[Parker, Sarah J.; Meyerowitz, Jodi; James, Janine L.; Liddell, Jeffrey R.; Kanninen, Katja M.; Crouch, Peter J.; White, Anthony R.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Nonaka, Takashi; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Neuropathol & Cell Biol, Setagaya Ku, Tokyo 113, Japan; [Lim, SinChun; Paterson, Brett M.; Donnelly, Paul S.] Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic, Australia; [Lim, SinChun; Paterson, Brett M.; Donnelly, Paul S.] Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia; [Crouch, Peter J.; White, Anthony R.] Mental Hlth Res Inst, Parkville, Vic, Australia	University of Melbourne; Tokyo Metropolitan Institute of Medical Science; University of Melbourne; Florey Institute of Neuroscience & Mental Health	Parker, SJ (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia.	arwhite@unimelb.edu.au	Paterson, Brett M/A-2402-2016; Paterson, Brett Michael/GLS-2845-2022; Liddell, Jeffrey/AAH-3685-2021; Nonaka, Takashi/L-8572-2017; White, Anthony/P-5596-2016	Paterson, Brett M/0000-0002-7768-811X; Liddell, Jeffrey/0000-0002-0798-5338; Crouch, Peter/0000-0002-7777-4747; Nonaka, Takashi/0000-0002-0830-9403; White, Anthony/0000-0003-1802-9891	National Health and Medical Research Council of Australia; Australian Research Council (ARC); ARC; C. R. Roper Fellowship; Sigrid Juselius Foundation, Finland; Rotary Health Scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); ARC(Australian Research Council); C. R. Roper Fellowship; Sigrid Juselius Foundation, Finland(Sigrid Juselius Foundation); Rotary Health Scholarship	This work was supported by funding from the National Health and Medical Research Council of Australia and Australian Research Council (ARC). ARW is a recipient of an ARC Future Fellowship Award. PJC is recipient of a C. R. Roper Fellowship. KMK was supported by Sigrid Juselius Foundation, Finland. JLJ was supported by a Rotary Health Scholarship. The authors would also like to thank the Motor Neuron Disease Research Institute of Australia, Bethlehem Griffiths Research Foundation and CASS Foundation for the kind support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1; Banks GT, 2008, MAMM GENOME, V19, P299, DOI 10.1007/s00335-008-9117-x; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Beraldo H, 1998, TRANSIT METAL CHEM, V23, P67; Bica L, 2009, MOL BIOSYST, V5, P134, DOI 10.1039/b816577g; Blower PJ, 2003, DALTON T, P4416, DOI 10.1039/b307499d; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Caragounis A, 2010, FREE RADICAL BIO MED, V48, P1152, DOI 10.1016/j.freeradbiomed.2010.01.035; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Choi WS, 2010, J NEUROPATH EXP NEUR, V69, P511, DOI 10.1097/NEN.0b013e3181db8100; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Dearling JLJ, 2002, J BIOL INORG CHEM, V7, P249, DOI 10.1007/s007750100291; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Donnelly PS, 2008, J BIOL CHEM, V283, P4568, DOI 10.1074/jbc.M705957200; Donnelly PS, 2012, P NATL ACAD SCI USA, V109, P47, DOI 10.1073/pnas.1116227108; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Fodero-Tavoletti MT, 2010, J ALZHEIMERS DIS, V20, P49, DOI 10.3233/JAD-2010-1359; Fournier MJ, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-12; GINGRAS BA, 1962, CAN J CHEM, V40, P1053, DOI 10.1139/v62-161; Hung LW, 2012, J EXP MED, V209, P837, DOI 10.1084/jem.20112285; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Ito D, 2011, NEUROLOGY, V77, P1636, DOI 10.1212/WNL.0b013e3182343365; Izumi Y, 2011, YAKUGAKU ZASSHI, V131, P21, DOI 10.1248/yakushi.131.21; King AE, 2011, NEUROBIOL AGING, V32, P459, DOI 10.1016/j.neurobiolaging.2009.04.004; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Maine GN, 2009, BIOCHEM J, V417, P601, DOI 10.1042/BJ20080854; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Meyerowitz J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-57; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Niso-Santano M, 2010, FREE RADICAL BIO MED, V48, P1370, DOI 10.1016/j.freeradbiomed.2010.02.024; Nonaka T, 2009, HUM MOL GENET; Parker SJ, 2012, NEUROCHEM INT, V60, P415, DOI 10.1016/j.neuint.2012.01.019; Paterson BM, 2011, CHEM SOC REV, V40, P3005, DOI 10.1039/c0cs00215a; Price KA, 2011, METALLOMICS, V3, P1280, DOI 10.1039/c1mt00092f; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Schimmer AD, 2011, CURR CANCER DRUG TAR, V11, P325; Soon CPW, 2011, J BIOL CHEM, V286, P44035, DOI 10.1074/jbc.M111.274407; Swarup V, 2011, PROG NEURO-PSYCHOPH, V35, P363, DOI 10.1016/j.pnpbp.2010.08.006; Warraich ST, 2010, INT J BIOCHEM CELL B, V42, P1606, DOI 10.1016/j.biocel.2010.06.016; Yang W, 2007, J TOXICOL ENV HEAL A, V70, P1849, DOI 10.1080/15287390701459262; Yang W, 2009, TOXICOL LETT, V191, P203, DOI 10.1016/j.toxlet.2009.08.024; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	48	36	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42277	10.1371/journal.pone.0042277	http://dx.doi.org/10.1371/journal.pone.0042277			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879928	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100061
J	Verschuren, JJW; Trompet, S; Postmus, I; Sampietro, ML; Heijmans, BT; Houwing-Duistermaat, JJ; Slagboom, PE; Jukema, JW				Verschuren, Jeffrey J. W.; Trompet, Stella; Postmus, Iris; Sampietro, M. Lourdes; Heijmans, Bastiaan T.; Houwing-Duistermaat, Jeanine J.; Slagboom, P. Eline; Jukema, J. Wouter			Systematic Testing of Literature Reported Genetic Variation Associated with Coronary Restenosis: Results of the GENDER Study	PLOS ONE			English	Article							IN-STENT RESTENOSIS; GENOME-WIDE ASSOCIATION; NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; CLINICAL RESTENOSIS; METHYLENETETRAHYDROFOLATE REDUCTASE; PREDICT RESTENOSIS; RISK MARKER; POLYMORPHISM; RECEPTOR	Background: Coronary restenosis after percutaneous coronary intervention still remains a significant problem, despite all medical advances. Unraveling the mechanisms leading to restenosis development remains challenging. Many studies have identified genetic markers associated with restenosis, but consistent replication of the reported markers is scarce. The aim of the current study was to analyze the joined effect of previously in literature reported candidate genes for restenosis in the GENetic DEterminants of Restenosis (GENDER) databank. Methodology/Principal Findings: Candidate genes were selected using a MEDLINE search including the terms 'genetic polymorphism' and 'coronary restenosis'. The final set included 36 genes. Subsequently, all single nucleotide polymorphisms (SNPs) in the genomic region of these genes were analyzed in GENDER using set-based analysis in PLINK. The GENDER databank contains genotypic data of 2,571,586 SNPs of 295 cases with restenosis and 571 matched controls. The set, including all 36 literature reported genes, was, indeed, significantly associated with restenosis, p = 0.024 in the GENDER study. Subsequent analyses of the individual genes demonstrated that the observed association of the complete set was determined by 6 of the 36 genes. Conclusion: Despite overt inconsistencies in literature, with regard to individual candidate gene studies, this is the first study demonstrating that the joint effect of all these genes together, indeed, is associated with restenosis.	[Verschuren, Jeffrey J. W.; Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Trompet, Stella; Postmus, Iris] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Sampietro, M. Lourdes] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Houwing-Duistermaat, Jeanine J.] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands; [Trompet, Stella; Postmus, Iris; Heijmans, Bastiaan T.; Slagboom, P. Eline; Jukema, J. Wouter] Netherlands Consortium Hlth Ageing, Leiden, Netherlands; [Sampietro, M. Lourdes; Jukema, J. Wouter] ICIN, Utrecht, Netherlands; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Verschuren, JJW (corresponding author), Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands.	j.w.jukema@lumc.nl	Jukema, J. Wouter/ABD-6503-2021; Slagboom, P. Eline/R-4790-2016; Houwing-Duistermaat, Jeanne/V-9048-2018	Jukema, J. Wouter/0000-0002-3246-8359; Slagboom, P. Eline/0000-0002-2875-4723; Houwing-Duistermaat, Jeanine/0000-0002-4505-7137	Interuniversity Cardiology Institute of the Netherlands (ICIN); European Community [HEALTH-F2-2009-223004]; Center for Medical Systems Biology (CMSB); Netherlands Consortium for Healthy Ageing (NCHA); Netherlands Heart Foundation [2001D032]	Interuniversity Cardiology Institute of the Netherlands (ICIN); European Community(European Commission); Center for Medical Systems Biology (CMSB); Netherlands Consortium for Healthy Ageing (NCHA); Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was funded by grants from the Interuniversity Cardiology Institute of the Netherlands (ICIN) http://www.icin.nl/, the European Community Framework FP7 Programme under grant agreement [no HEALTH-F2-2009-223004; http://cordis.europa.eu/projects/90569_en.html], the Center for Medical Systems Biology (CMSB) [http://www.cmsb.nl], a center of excellence approved by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NWO), and the Netherlands Consortium for Healthy Ageing (NCHA) [http://www.healthy-ageing.nl]. JWJ is an established clinical investigator of the Netherlands Heart Foundation (2001D032) [http://www.hartstichting.nl/]. The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript.	Agema WRP, 2004, EUR HEART J, V25, P1163, DOI 10.1016/j.ehj.2004.05.006; Martinez-Rios MA, 2009, BIOCHEM GENET, V47, P707, DOI 10.1007/s10528-009-9268-9; Bottiger C, 2003, AM HEART J, V146, P855, DOI 10.1016/S0002-8703(03)00363-6; Chung SL, 2006, CATHETER CARDIO INTE, V67, P349, DOI 10.1002/ccd.20663; Deelen J, 2013, AGE, V35, P235, DOI 10.1007/s11357-011-9340-3; Falcone C, 2007, INT J IMMUNOPATH PH, V20, P771, DOI 10.1177/039463200702000413; Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; Gomma AH, 2002, EUR HEART J, V23, P1955, DOI 10.1053/euhj.2002.3400; Gorchakova O, 2003, EUR HEART J, V24, P820, DOI 10.1016/S0195-668X(02)00824-2; Gross C Michael, 2007, J Invasive Cardiol, V19, P261; Gui Hongsheng, 2011, BMC Res Notes, V4, P386, DOI 10.1186/1756-0500-4-386; Horibe H, 2004, ATHEROSCLEROSIS, V174, P181, DOI 10.1016/j.atherosclerosis.2004.01.022; Jukema JW, 2012, NAT REV CARDIOL, V9, P79, DOI 10.1038/nrcardio.2011.148; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Kastrati A, 2000, J AM COLL CARDIOL, V36, P2168, DOI 10.1016/S0735-1097(00)01014-7; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Koch W, 2004, DIABETOLOGIA, V47, P1126, DOI 10.1007/s00125-004-1406-7; Koch W, 2003, ARTERIOSCL THROM VAS, V23, P2229, DOI 10.1161/01.ATV.0000105055.68038.29; Koch W, 2003, CYTOKINE, V24, P161, DOI 10.1016/j.cyto.2003.08.004; Koch W, 2001, AM J CARDIOL, V88, P1120, DOI 10.1016/S0002-9149(01)02045-8; Kojima S, 2004, HEART, V90, P1069, DOI 10.1136/hrt.2002.007047; Kolz M, 2009, THROMB HAEMOSTASIS, V101, P317, DOI 10.1160/TH08-06-0411; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Ma L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015006; Mansego ML, 2011, J HYPERTENS, V29, P492, DOI 10.1097/HJH.0b013e328341f1b2; Marculescu R, 2003, THROMB HAEMOSTASIS, V90, P491, DOI 10.1160/TH03-01-0064; Monraats PS, 2007, GENES IMMUN, V8, P44, DOI 10.1038/sj.gene.6364343; Monraats PS, 2010, EXPERT OPIN THER TAR, V14, P243, DOI 10.1517/14728220903520929; Monraats PS, 2005, FASEB J, V19, P1998, DOI 10.1096/fj.05-4634com; Monraats PS, 2005, CIRCULATION, V112, P2417, DOI 10.1161/CIRCULATIONAHA.105.536268; Monraats PS, 2005, J AM COLL CARDIOL, V46, P1093, DOI 10.1016/j.jacc.2005.05.071; Monraats PS, 2005, THROMB HAEMOSTASIS, V93, P564, DOI 10.1160/TH04-11-0708; Neugebauer P, 2009, Vnitr Lek, V55, P1135; Niessner A, 2005, THROMB HAEMOSTASIS, V94, P1251, DOI 10.1160/TH05-06-0417; Niu WQ, 2010, HYPERTENS RES, V33, P1137, DOI 10.1038/hr.2010.156; O'Donnell CJ, 2011, NEW ENGL J MED, V365, P2098, DOI 10.1056/NEJMra1105239; Oguri M, 2007, ATHEROSCLEROSIS, V194, pE172, DOI 10.1016/j.atherosclerosis.2006.12.019; Oguri M, 2007, INT J MOL MED, V20, P533; Pons D, 2007, THROMB HAEMOSTASIS, V98, P1323, DOI 10.1160/TH07-04-0301; Pons D, 2011, HEART, V97, P143, DOI 10.1136/hrt.2010.199927; Pons D, 2009, DIS MARKERS, V26, P75, DOI [10.1155/2009/520653, 10.3233/DMA-2009-0609]; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rittersma SZH, 2004, AM J MED, V116, P499, DOI 10.1016/j.amjmed.2003.10.041; Rudez G, 2008, HUM MUTAT, V29, P375, DOI 10.1002/humu.20641; Sampietro ML, 2009, NETH HEART J, V17, P262, DOI 10.1007/BF03086261; Sampietro ML, 2011, HUM MOL GENET, V20, P4748, DOI 10.1093/hmg/ddr389; Shim CY, 2007, CARDIOLOGY, V107, P261, DOI 10.1159/000095516; Shimada K, 2004, INT J CARDIOL, V94, P87, DOI 10.1016/j.ijcard.2003.05.007; Swapna N, 2011, Indian J Hum Genet, V17, P201, DOI 10.4103/0971-6866.92104; Tiroch K, 2009, CARDIOLOGY, V112, P263, DOI 10.1159/000151695; Tiroch KA, 2010, AM HEART J, V160, P506, DOI 10.1016/j.ahj.2010.06.039; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; van Tiel CM, 2009, CIRCULATION, V120, P669, DOI 10.1161/CIRCULATIONAHA.108.842179; Wijpkema JS, 2006, PHARMACOGENET GENOM, V16, P331, DOI 10.1097/01.fpc.0000205001.07054.fa; Zee RYL, 2004, HUM GENET, V114, P386, DOI 10.1007/s00439-003-1080-8; Zee RYL, 2003, ATHEROSCLEROSIS, V171, P259, DOI 10.1016/S0021-9150(03)00294-6	56	12	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42401	10.1371/journal.pone.0042401	http://dx.doi.org/10.1371/journal.pone.0042401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879966	gold, Green Published			2022-12-27	WOS:000307284100080
J	Junemann, S; Prior, K; Szczepanowski, R; Harks, I; Ehmke, B; Goesmann, A; Stoye, J; Harmsen, D				Juenemann, Sebastian; Prior, Karola; Szczepanowski, Rafael; Harks, Inga; Ehmke, Benjamin; Goesmann, Alexander; Stoye, Jens; Harmsen, Dag			Bacterial Community Shift in Treated Periodontitis Patients Revealed by Ion Torrent 16S rRNA Gene Amplicon Sequencing	PLOS ONE			English	Article							MICROBIAL DIVERSITY; RARE BIOSPHERE; WRINKLES; HEALTHY	Periodontitis, one of the most common diseases in the world, is caused by a mixture of pathogenic bacteria and inflammatory host responses and often treated by antimicrobials as an adjunct to scaling and root planing (SRP). Our study aims to elucidate explorative and descriptive temporal shifts in bacterial communities between patients treated by SRP alone versus SRP plus antibiotics. This is the first metagenomic study using an Ion Torrent Personal Genome Machine (PGM). Eight subgingival plaque samples from four patients with chronic periodontitis, taken before and two months after intervention were analyzed. Amplicons from the V6 hypervariable region of the 16S rRNA gene were generated and sequenced each on a 314 chip. Sequencing reads were clustered into operational taxonomic units (OTUs, 3% distance), described by community metrics, and taxonomically classified. Reads ranging from 599,933 to 650,416 per sample were clustered into 1,648 to 2,659 non-singleton OTUs, respectively. Increased diversity (Shannon and Simpson) in all samples after therapy was observed regardless of the treatment type whereas richness (ACE) showed no correlation. Taxonomic analysis revealed different microbial shifts between both therapy approaches at all taxonomic levels. Most remarkably, the genera Porphyromonas, Tannerella, Treponema, and Filifactor all harboring periodontal pathogenic species were removed almost only in the group treated with SPR and antibiotics. For the species T. forsythia and P. gingivalis results were corroborated by real-time PCR analysis. In the future, hypothesis free metagenomic analysis could be the key in understanding polymicrobial diseases and be used for therapy monitoring. Therefore, as read length continues to increase and cost to decrease, rapid benchtop sequencers like the PGM might finally be used in routine diagnostic.	[Juenemann, Sebastian; Prior, Karola; Szczepanowski, Rafael; Harks, Inga; Ehmke, Benjamin; Harmsen, Dag] Univ Munster, Dept Periodontol, Munster, Germany; [Juenemann, Sebastian; Goesmann, Alexander; Stoye, Jens] Univ Bielefeld, Inst Bioinformat, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Goesmann, Alexander] Univ Bielefeld, Bioinformat Resource Facil, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Stoye, Jens] Univ Bielefeld, Genome Informat Grp, Fac Technol, D-33615 Bielefeld, Germany	University of Munster; University of Bielefeld; University of Bielefeld; University of Bielefeld	Junemann, S (corresponding author), Univ Munster, Dept Periodontol, Munster, Germany.	jueneman@cebitec.uni-bielefeld.de	Harmsen, Dag/J-3041-2012	Junemann, Sebastian/0000-0002-3714-0328; Goesmann, Alexander/0000-0002-7086-2568	German Federal Ministry of Education and Research (BMBF) [0313801N]; German Research Foundation [DFG EH 365/1-1]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG))	SJ was supported by a grant of the German Federal Ministry of Education and Research (BMBF) in the framework of the ParoPhylo project (0313801N). The multi-center study is funded by the German Research Foundation (DFG EH 365/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beikler T, 2004, J PERIODONTOL, V75, P169, DOI 10.1902/jop.2004.75.1.169; Bernal LA, 1998, ORAL MICROBIOL IMMUN, V13, P36, DOI 10.1111/j.1399-302X.1998.tb00748.x; CHAO A, 1984, SCAND J STAT, V11, P265; Cionca N, 2010, J PERIODONTOL, V81, P15, DOI 10.1902/jop.2009.090390; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ehmke B, 2005, J PERIODONTOL, V76, P749, DOI 10.1902/jop.2005.76.5.749; Friedrich MJ, 2008, JAMA-J AM MED ASSOC, V300, P777, DOI 10.1001/jama.300.7.777; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; Haffajee Anne D, 2003, Ann Periodontol, V8, P115, DOI 10.1902/annals.2003.8.1.115; Herrera D, 2002, J CLIN PERIODONTOL, V29, P136, DOI 10.1034/j.1600-051X.29.s3.8.x; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huber JA, 2009, ENVIRON MICROBIOL, V11, P1292, DOI 10.1111/j.1462-2920.2008.01857.x; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kumar PS, 2012, J CLIN PERIODONTOL, V39, P425, DOI 10.1111/j.1600-051X.2012.01856.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Linke B, 2011, BIOINFORMATICS, V27, P903, DOI 10.1093/bioinformatics/btr040; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Magurran A.E, 2003, MEASURING BIOL DIVER; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Riep B, 2009, J CLIN MICROBIOL, V47, P1705, DOI 10.1128/JCM.01387-08; Sambrook J., 2001, MOL CLONING LAB MANU; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Team R. D. C, 2011, R LANG ENV STAT COMP; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Valenza G, 2009, INT J MED MICROBIOL, V299, P427, DOI 10.1016/j.ijmm.2009.03.001; Winkel EG, 2001, J CLIN PERIODONTOL, V28, P296, DOI 10.1034/j.1600-051x.2001.028004296.x	42	95	102	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41606	10.1371/journal.pone.0041606	http://dx.doi.org/10.1371/journal.pone.0041606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870235	Green Published, Green Submitted, gold			2022-12-27	WOS:000307212800028
J	Lee, YC; Lee, MJ; Yu, HY; Chen, C; Hsu, CH; Lin, KP; Liao, KK; Chang, MH; Liao, YC; Soong, BW				Lee, Yi-Chung; Lee, Ming-Jen; Yu, Hsiang-Yu; Chen, Chien; Hsu, Chang-Hung; Lin, Kon-Ping; Liao, Kwong-Kum; Chang, Ming-Hong; Liao, Yi-Chu; Soong, Bing-Wen			PRRT2 Mutations in Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions in a Taiwanese Cohort	PLOS ONE			English	Article							PERICENTROMERIC REGION; CHOREOATHETOSIS; LOCUS	Background: Mutations in the PRRT2 gene have recently been identified in patients with familial paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC) and patients with sporadic PKD/IC from several ethnic groups. To extend these recent genetic reports, we investigated the frequency and identities of PRRT2 mutations in a cohort of Taiwanese patients with PKD/IC. Methodology and Principal Findings: We screened all 3 coding exons of PRRT2 for mutations in 28 Taiwanese patients with PKD/IC. Among them, 13 had familial PKD/IC and 15 were apparently sporadic cases. In total, 7 disparate mutations were identified in 13 patients, including 8 familial cases and 5 apparently sporadic cases. The mutations were not present in 500 healthy controls. Four mutations were novel. One patient had a missense mutation and all other patients carried PRRT2 mutations putatively resulting in a protein truncation. Haplotype analysis revealed that 5 of the 7 patients with the PRRT2 p.R217Pfs*8 mutation shared the same haplotype linked to the mutation. Conclusions and Significance: PRRT2 mutations account for 61.5% (8 out of 13) of familial PKD/IC and 33.3% (5 out of 15) of apparently sporadic PKD/IC in the Taiwanese cohort. Most patients with the PRRT2 p.R217Pfs*8 mutation in Taiwan likely descend from a single common ancestor. This study expands the spectrum of PKD/IC-associated PRRT2 mutations, highlights the pathogenic role of PRRT2 mutations in PKD/IC, and suggests genetic heterogeneity within idiopathic PKD.	[Lee, Yi-Chung; Yu, Hsiang-Yu; Chen, Chien; Lin, Kon-Ping; Liao, Kwong-Kum; Soong, Bing-Wen] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Lee, Yi-Chung; Yu, Hsiang-Yu; Chen, Chien; Lin, Kon-Ping; Liao, Kwong-Kum; Chang, Ming-Hong; Liao, Yi-Chu; Soong, Bing-Wen] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Lee, Yi-Chung; Soong, Bing-Wen] Natl Yang Ming Univ, Sch Med, Brain Res Ctr, Taipei 112, Taiwan; [Lee, Ming-Jen] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Hsu, Chang-Hung] Triserv Gen Hosp, Dept Neurol, Taipei, Taiwan; [Chang, Ming-Hong; Liao, Yi-Chu] Taichung Vet Gen Hosp, Neurol Sect, Taichung, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; Tri-Service General Hospital; Taichung Veterans General Hospital	Lee, YC (corresponding author), Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan.	ycli@vghtpe.gov.tw; bwsoong@ym.edu.tw	Lee, Yi-Chung/GZK-7162-2022; Lee, Yi-Chung/H-8813-2019	Lee, Yi-Chung/0000-0003-0102-164X; Yu, Hsiang-Yu/0000-0002-8183-1863; Liao, Yi-Chu/0000-0002-9644-2086; Lee, Ming-Jen/0000-0001-8732-2448	National Science Council [NSC99-2314-B-010-013-MY3, NSC100-2314-B-075-020-MY2]; Ministry of Education, Aim for the Top University Plan, to the Brain Research Center, National Yang-Ming University Taiwan [V100-E6-006]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan, to the Brain Research Center, National Yang-Ming University Taiwan	This study was partially funded by grants from the National Science Council (NSC99-2314-B-010-013-MY3, NSC100-2314-B-075-020-MY2), and a grant from Ministry of Education, Aim for the Top University Plan, to the Brain Research Center, National Yang-Ming University (V100-E6-006), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bennett LB, 2000, NEUROLOGY, V54, P125, DOI 10.1212/WNL.54.1.125; Bhatia KP, 2011, MOVEMENT DISORD, V26, P1157, DOI 10.1002/mds.23765; Bruno MK, 2004, NEUROLOGY, V63, P2280, DOI 10.1212/01.WNL.0000147298.05983.50; Chen WJ, 2011, NAT GENET, V43, P1252, DOI 10.1038/ng.1008; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Heron SE, 2012, AM J HUM GENET, V90, P152, DOI 10.1016/j.ajhg.2011.12.003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HY, 2012, CELL REP, V1, P2, DOI 10.1016/j.celrep.2011.11.001; Li JY, 2012, J MED GENET, V49, P76, DOI 10.1136/jmedgenet-2011-100635; Liu Q, 2012, J MED GENET, V49, P79, DOI 10.1136/jmedgenet-2011-100653; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Swoboda KJ, 2001, NEUROLOGY, V57, pS42; Szepetowski P, 1997, AM J HUM GENET, V61, P889, DOI 10.1086/514877; Tomita H, 2002, LANCET, V359, P2000, DOI 10.1016/S0140-6736(02)08835-9; Wang JL, 2011, BRAIN, V134, P3490, DOI 10.1093/brain/awr289	16	37	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e38543	10.1371/journal.pone.0038543	http://dx.doi.org/10.1371/journal.pone.0038543			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870186	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800001
J	Njouom, R; Caron, M; Besson, G; Ndong-Atome, GR; Makuwa, M; Pouillot, R; Nkoghe, D; Leroy, E; Kazanji, M				Njouom, Richard; Caron, Melanie; Besson, Guillaume; Ndong-Atome, Guy-Roger; Makuwa, Maria; Pouillot, Regis; Nkoghe, Dieudonne; Leroy, Eric; Kazanji, Mirdad			Phylogeography, Risk Factors and Genetic History of Hepatitis C Virus in Gabon, Central Africa	PLOS ONE			English	Article							HIGH PREVALENCE; HEPATOCELLULAR-CARCINOMA; MOLECULAR EPIDEMIOLOGY; RAPID TRANSMISSION; DRUG-USERS; RURAL AREA; GENOTYPE 2; INFECTION; RECOMBINANT; PREDOMINANCE	Background: The epidemiological and molecular characteristics of hepatitis C virus (HCV) infection in the general population have been poorly investigated in Africa. The aim of this study was to determine the prevalence, genotype distribution and epidemic history of HCV in the Gabonese general population. Methods/Principal Findings: A total of 4042 sera collected from adults in 220 villages in all nine administrative areas of the country were screened for antibodies to HCV. HCV NS5B region sequencing was performed for molecular characterization and population genetic analyses. Of 4042 tested sera, 455 (11.2%) were positive. The seroprevalence of HCV varied significantly by administrative area, with the highest rate in Ogooue-Lolo province (20.4%) and the lowest in Ogooue-Maritine province (3.7%). History of parenteral injections, past hospital admission and age over 55 years were independent risk factors for HCV infection (p<0.0001). Phylogenetic analyses showed that 91.9% of the strains were genotype 4 (HCV-4), 5.7% genotype 1 and 2.2% genotype 2. HCV-4 strains were highly heterogeneous, with more than eight subtypes; subtype 4e predominated (57.3%). Coalescence analyses indicated that subtype 4e was the oldest, with an estimated most recent common ancestor of 1702 [95% CI, 1418-1884]. The epidemic profile indicated that it spread exponentially during the first part of the 20th century, probably by iatrogenic transmission. Conclusions/Significance: These results confirm the endemicity of HCV subtype 4e in Gabon and show that its spread is due to a cohort effect, with previous, possibly iatrogenic events. More extensive epidemiological studies are needed to better characterize the route of transmission and the dissemination of HCV in Gabon.	[Njouom, Richard; Caron, Melanie; Besson, Guillaume; Ndong-Atome, Guy-Roger; Makuwa, Maria; Nkoghe, Dieudonne; Leroy, Eric; Kazanji, Mirdad] Ctr Int Rech Med Franceville, Franceville, Gabon; [Njouom, Richard; Pouillot, Regis] Reseau Int Inst Pasteur, Ctr Pasteur Cameroun, Yaounde, Cameroon; [Besson, Guillaume] Univ Pittsburgh, Med Ctr, Div Infect Dis, Pittsburgh, PA USA; [Nkoghe, Dieudonne] Minist Sante, Libreville, Gabon; [Kazanji, Mirdad] Reseau Int Inst Pasteur, Inst Pasteur Bangui, Bangui, Cent Afr Republ	Centre Pasteur du Cameroun; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Njouom, R (corresponding author), Ctr Int Rech Med Franceville, BP 769, Franceville, Gabon.	mirdad.kazanji@pasteur.fr	LEROY, Eric M/I-4347-2016; Pouillot, Regis/E-8103-2010	LEROY, Eric M/0000-0003-0022-0890; Pouillot, Regis/0000-0002-6107-5212	Gabonese Government; Total Gabon; French Foreign Ministry	Gabonese Government; Total Gabon(Total SA); French Foreign Ministry	The Centre International de Recherches Medicales de Franceville in Franceville, Gabon, is funded by the Gabonese Government, Total Gabon and the French Foreign Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from Total-Gabon; however, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Annex A., 2010, GLOB BURD DIS 2004 U; Becquart P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009126; Bhattacharya D, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-458; Cantaloube JF, 2010, J MED VIROL, V82, P562, DOI 10.1002/jmv.21724; Colina R, 2004, J GEN VIROL, V85, P31, DOI 10.1099/vir.0.19472-0; DELAPORTE E, 1993, T ROY SOC TROP MED H, V87, P636, DOI 10.1016/0035-9203(93)90269-V; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Gonzalez-Candelas F, 2011, VIRUSES-BASEL, V3, P2006, DOI 10.3390/v3102006; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; HIBBS RG, 1993, J INFECT DIS, V168, P789, DOI 10.1093/infdis/168.3.789; Kageyama S, 2006, J MED VIROL, V78, P1423, DOI 10.1002/jmv.20714; Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002; Khan A, 2009, J MED VIROL, V81, P1189, DOI 10.1002/jmv.21466; Kurbanov F, 2008, HEPATOL RES, V38, P457, DOI 10.1111/j.1872-034X.2007.00293.x; Legrand-Abravanel F, 2007, J VIROL, V81, P4357, DOI 10.1128/JVI.02639-06; Madhava V, 2002, LANCET INFECT DIS, V2, P293, DOI 10.1016/S1473-3099(02)00264-5; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Markov PV, 2009, J GEN VIROL, V90, P2086, DOI 10.1099/vir.0.011569-0; Mathei C, 2008, J VIRAL HEPATITIS, V15, P399, DOI 10.1111/j.1365-2893.2007.00950.x; Nakano T, 2004, J INFECT DIS, V190, P1098, DOI 10.1086/422606; Ndjomou J, 2003, J GEN VIROL, V84, P2333, DOI 10.1099/vir.0.19240-0; Ndong-Atome GR, 2008, J MED VIROL, V80, P1581, DOI 10.1002/jmv.21252; Nerrienet E, 2005, J MED VIROL, V76, P208, DOI 10.1002/jmv.20343; Njouom R, 2003, J MED VIROL, V71, P219, DOI 10.1002/jmv.10473; Njouom R, 2003, J MED VIROL, V69, P384, DOI 10.1002/jmv.10300; Njouom R, 2007, INFECT GENET EVOL, V7, P361, DOI 10.1016/j.meegid.2006.10.003; Njouom R, 2009, J GEN VIROL, V90, P2452, DOI 10.1099/vir.0.011981-0; Noguchi S, 1997, SCAND J INFECT DIS, V29, P23, DOI 10.3109/00365549709008659; Noppornpanth S, 2006, J VIROL, V80, P7569, DOI 10.1128/JVI.00312-06; Pasquier C, 2005, J MED VIROL, V77, P390, DOI 10.1002/jmv.20468; Pepin J, 2010, CLIN INFECT DIS, V51, P777, DOI 10.1086/656232; Pepin J, 2010, CLIN INFECT DIS, V51, P768, DOI 10.1086/656233; Pouillot R, 2008, INFECT GENET EVOL, V8, P676, DOI 10.1016/j.meegid.2008.06.001; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shin HR, 2000, HEPATOL RES, V17, P185, DOI 10.1016/S1386-6346(99)00074-1; Shobokshi OA, 2003, SAUDI MED J, V24, pS81; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; SIMMONDS P, 1994, J GEN VIROL, V75, P1053, DOI 10.1099/0022-1317-75-5-1053; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka Y, 2005, J HEPATOL, V42, P47, DOI 10.1016/j.jhep.2004.09.023; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099; TAWARAYA H, 1995, J MED VIROL, V45, P367, DOI 10.1002/jmv.1890450403; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Damme P, 2002, ACTA GASTRO-ENT BELG, V65, P78; Viazov S, 2010, J MED VIROL, V82, P232, DOI 10.1002/jmv.21631; XU LZ, 1994, J GEN VIROL, V75, P2393, DOI 10.1099/0022-1317-75-9-2393; Yoshii E, 1999, TOHOKU J EXP MED, V188, P311, DOI 10.1620/tjem.188.311; Zhou YQ, 2010, J CLIN VIROL, V49, P272, DOI 10.1016/j.jcv.2010.08.007	54	40	40	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42002	10.1371/journal.pone.0042002	http://dx.doi.org/10.1371/journal.pone.0042002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870274	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000307212800050
J	Parera, M; Martrus, G; Franco, S; Clotet, B; Martinez, MA				Parera, Mariona; Martrus, Gloria; Franco, Sandra; Clotet, Bonaventura; Angel Martinez, Miguel			Canine Hepacivirus NS3 Serine Protease Can Cleave the Human Adaptor Proteins MAVS and TRIF	PLOS ONE			English	Article							HEPATITIS-C VIRUS; CATALYTIC EFFICIENCY; HIV-1 INFECTION; GENETIC SCREEN; EVASION; INHIBITORS; SEQUENCE; HOMOLOG; CULTURE; SAMHD1	Canine hepacivirus (CHV) was recently identified in domestic dogs and horses. The finding that CHV is genetically the virus most closely related to hepatitis C virus (HCV) has raised the question of whether HCV might have evolved as the result of close contact between dogs and/or horses and humans. The aim of this study was to investigate whether the NS3/4A serine protease of CHV specifically cleaves human mitochondrial antiviral signaling protein (MAVS) and Toll-IL-1 receptor domain-containing adaptor inducing interferon-beta (TRIF). The proteolytic activity of CHV NS3/4A was evaluated using a bacteriophage lambda genetic screen. Human MAVS- and TRIF-specific cleavage sites were engineered into the lambda cI repressor. Upon infection of Escherichia coli cells coexpressing these repressors and a CHV NS3/4A construct, lambda phage replicated up to 2000-fold more efficiently than in cells expressing a CHV protease variant carrying the inactivating substitution S139A. Comparable results were obtained when several HCV NS3/4A constructs of genotype 1b were assayed. This indicates that CHV can disrupt the human innate antiviral defense signaling pathway and suggests a possible evolutionary relationship between CHV and HCV.	[Parera, Mariona; Martrus, Gloria; Franco, Sandra; Clotet, Bonaventura; Angel Martinez, Miguel] UAB, Hosp Univ Germans Trias & Pujol, Fundacio irsiCaixa, Badalona, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Parera, M (corresponding author), UAB, Hosp Univ Germans Trias & Pujol, Fundacio irsiCaixa, Badalona, Spain.	mmartinez@irsicaixa.es	Franco, Sandra/E-6114-2016; Franco, Sandra/S-6843-2019; Martinez, Miguel Angel/K-6435-2014	Franco, Sandra/0000-0003-4126-2202; Franco, Sandra/0000-0003-4126-2202; Martinez, Miguel Angel/0000-0002-6681-4950; Martrus, Gloria/0000-0003-2879-3201; Parera Sallent, Mariona/0000-0002-0756-8307	Spanish Ministry of Science and Innovation [BFU2010-15194, SAF2010-21617]; GALA CONTRA LA SIDA (Barcelona)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); GALA CONTRA LA SIDA (Barcelona)	This study was supported by grants from the Spanish Ministry of Science and Innovation (BFU2010-15194 and SAF2010-21617) and by GALA CONTRA LA SIDA (Barcelona 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio E, 2011, J VIROL, V85, P5961, DOI 10.1128/JVI.00308-11; Bukh J, 2011, P NATL ACAD SCI USA, V108, P12563, DOI 10.1073/pnas.1107612108; Burbelo PD, 2012, J VIROL; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Chevaliez S, 2007, WORLD J GASTROENTERO, V13, P2461, DOI 10.3748/wjg.v13.i17.2461; Fernandez G, 2007, J VIROL, V81, P2485, DOI 10.1128/JVI.01594-06; Franco S, 2007, HEPATOLOGY, V45, P899, DOI 10.1002/hep.21623; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gottwein JM, 2011, GASTROENTEROLOGY, V141, P1067, DOI 10.1053/j.gastro.2011.06.004; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lemon SM, 2010, J BIOL CHEM, V285, P22739, DOI 10.1074/jbc.R109.099556; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Liverton NJ, 2008, J AM CHEM SOC, V130, P4607, DOI 10.1021/ja711120r; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Martinez MA, 2000, ANTIMICROB AGENTS CH, V44, P1132, DOI 10.1128/AAC.44.5.1132-1139.2000; Martinez MA, 2003, ANTIMICROB AGENTS CH, V47, P1760, DOI 10.1128/AAC.47.5.1760-1765.2003; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Parera M, 2004, J VIROL, V78, P14057, DOI 10.1128/JVI.78.24.14057-14061.2004; Parera M, 2007, MOL BIOL EVOL, V24, P382, DOI 10.1093/molbev/msl168; Parera M, 2009, J MOL BIOL, V392, P243, DOI 10.1016/j.jmb.2009.07.015; Patel MR, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001282; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Ptashne M, 1986, GENETIC SWITCH; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; SAUER RT, 1978, NATURE, V276, P301, DOI 10.1038/276301a0; Scheel TKH, 2011, J VIROL, V85, P2891, DOI 10.1128/JVI.01605-10; Seiwert SD, 2008, ANTIMICROB AGENTS CH, V52, P4432, DOI 10.1128/AAC.00699-08; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Stapleton JT, 2011, J GEN VIROL, V92, P233, DOI 10.1099/vir.0.027490-0; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Suthar MS, 2009, CELL MICROBIOL, V11, P880, DOI 10.1111/j.1462-5822.2009.01311.x; Urbani A, 1999, BIOCHEMISTRY-US, V38, P5206, DOI 10.1021/bi982773u; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268	39	21	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42481	10.1371/journal.pone.0042481	http://dx.doi.org/10.1371/journal.pone.0042481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870331	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800095
J	Siqueira, WL; Bakkal, M; Xiao, YZ; Sutton, JN; Mendes, FM				Siqueira, Walter L.; Bakkal, Meltem; Xiao, Yizhi; Sutton, Jennifer N.; Mendes, Fausto M.			Quantitative Proteomic Analysis of the Effect of Fluoride on the Acquired Enamel Pellicle	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; DENTAL-CARIES; SALIVARY PROTEINS; IN-VIVO; APATITIC SURFACES; TYPE-1 FIMBRIAE; WHOLE SALIVA; HYDROXYAPATITE; ADSORPTION; DEMINERALIZATION	The acquired enamel pellicle (AEP) is a thin film formed by the selective adsorption of salivary proteins onto the enamel surface of teeth. The AEP forms a critical interface between the mineral phase of teeth (hydroxyapatite) and the oral microbial biofilm. This biofilm is the key feature responsible for the development of dental caries. Fluoride on enamel surface is well known to reduce caries by reducing the solubility of enamel to acid. Information on the effects of fluoride on AEP formation is limited. This study aimed to investigate the effects of fluoride treatment on hydroxyapatite on the subsequent formation of AEP. In addition, this study pioneered the use of label-free quantitative proteomics to better understand the composition of AEP proteins. Hydroxyapatite discs were randomly divided in 4 groups (n = 10 per group). Each disc was exposed to distilled water (control) or sodium fluoride solution (1, 2 or 5%) for 2 hours. Discs were then washed and immersed in human saliva for an additional 2 hours. AEP from each disc was collected and subjected to liquid chromatography electrospray ionization mass spectrometry for protein identification, characterization and quantification. A total of 45 proteins were present in all four groups, 12 proteins were exclusively present in the control group and another 19 proteins were only present in the discs treated with 5% sodium fluoride. Relative proteomic quantification was carried out for the 45 proteins observed in all four groups. Notably, the concentration of important salivary proteins, such as statherin and histatin 1, decrease with increasing levels of fluoride. It suggests that these proteins are repulsed when hydroxyapatite surface is coated with fluoride. Our data demonstrated that treatment of hydroxyapatite with fluoride (at high concentration) qualitatively and quantitatively modulates AEP formation, effects which in turn will likely impact the formation of oral biofilms.	[Siqueira, Walter L.; Bakkal, Meltem; Xiao, Yizhi] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada; [Siqueira, Walter L.; Bakkal, Meltem; Xiao, Yizhi] Univ Western Ontario, Schulich Sch Med & Dent, Sch Dent, London, ON, Canada; [Bakkal, Meltem] Marmara Univ, Sch Dent, Dept Pediat Dent, Istanbul, Turkey; [Sutton, Jennifer N.] Thermo Fisher Sci, Cambridge, MA USA; [Mendes, Fausto M.] Univ Sao Paulo, Fac Dent, Dept Pediat Dent, Sao Paulo, Brazil	Western University (University of Western Ontario); Western University (University of Western Ontario); Marmara University; Thermo Fisher Scientific; Universidade de Sao Paulo	Siqueira, WL (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada.	walter.siqueira@schulich.uwo.ca	Siqueira, Walter/ABE-4069-2021; Siqueira, Walter/ABE-8924-2020; Bakkal, Meltem/V-7366-2017; Mendes, Fausto/E-7067-2010	Siqueira, Walter/0000-0003-1921-3658; Bakkal, Meltem/0000-0001-9863-130X; Mendes, Fausto/0000-0003-1711-4103	Natural Sciences and Engineering Research Council of Canada (NSERC) [371813]; Canadian Institutes of Health Research (CIHR) [106657, 97577]; Canada Foundation for Innovation - Leaders Opportunity Fund (CFI-LOF) [25116]; CIHR New Investigator Award [113166]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation - Leaders Opportunity Fund (CFI-LOF)(Canada Foundation for Innovation); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR))	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC grant #371813), the Canadian Institutes of Health Research (CIHR grant # 106657 and grant # 97577) and the Canada Foundation for Innovation - Leaders Opportunity Fund (CFI-LOF grant # 25116). WLS is recipient of a CIHR New Investigator Award (grant # 113166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHASHIMI I, 1989, ARCH ORAL BIOL, V34, P289, DOI 10.1016/0003-9969(89)90070-8; BELCOURT A, 1978, J BIOL BUCCALE, V6, P65; Bennick A, 2002, CRIT REV ORAL BIOL M, V13, P184, DOI 10.1177/154411130201300208; CLARK WB, 1986, J DENT RES, V65, P1166, DOI 10.1177/00220345860650091001; Duan XT, 2009, J PROTEOME RES, V8, P2838, DOI 10.1021/pr900001t; Edgerton M, 2000, Adv Dent Res, V14, P16; Featherstone JDB, 2000, J AM DENT ASSOC, V131, P887, DOI 10.14219/jada.archive.2000.0307; FEATHERSTONE JDB, 1993, CRIT REV ORAL BIOL M, V4, P357, DOI 10.1177/10454411930040031401; Fejerskov O, 1997, COMMUNITY DENT ORAL, V25, P5, DOI 10.1111/j.1600-0528.1997.tb00894.x; GIBBONS RJ, 1988, INFECT IMMUN, V56, P2990, DOI 10.1128/IAI.56.11.2990-2993.1988; GIBBONS RJ, 1988, INFECT IMMUN, V56, P439, DOI 10.1128/IAI.56.2.439-445.1988; Hannig M, 2006, MG ORAL SCI, V19, P29, DOI 10.1159/000090585; Hara AT, 2006, CARIES RES, V40, P435, DOI 10.1159/000094290; HAY DI, 1967, ARCH ORAL BIOL, V12, P937, DOI 10.1016/0003-9969(67)90088-X; Hunter GK, 2010, LANGMUIR, V26, P18639, DOI 10.1021/la100401r; JENSEN JL, 1992, J DENT RES, V71, P1569, DOI 10.1177/00220345920710090501; KAWASAKI T, 1986, EUR J BIOCHEM, V155, P249, DOI 10.1111/j.1432-1033.1986.tb09483.x; KAWASAKI T, 1987, BIOCHEM INT, V15, P1137; Lendenmann U, 2000, Adv Dent Res, V14, P22; Marinho VCC, 2009, EUR ARCH PAEDIATR DE, V10, P183, DOI 10.1007/BF03262681; McDonald EE, 2011, J DENT RES, V90, P268, DOI 10.1177/0022034510388653; Ogaard B, 1990, J DENT RES, V69; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Petersen PE, 2004, COMMUNITY DENT ORAL, V32, P319, DOI 10.1111/j.1600-0528.2004.00175.x; Buzalaf MAR, 2011, MONOGR ORAL SCI, V22, P97, DOI 10.1159/000325151; RAJ PA, 1990, J BIOL CHEM, V265, P3898; RYKKE M, 1989, ACTA ODONTOL SCAND, V47, P245, DOI 10.3109/00016358909007709; Siqueira WL, 2007, ANN NY ACAD SCI, V1098, P504, DOI 10.1196/annals.1384.023; Siqueira WL, 2010, J DENT RES, V89, P626, DOI 10.1177/0022034510363384; Siqueira WL, 2007, J PROTEOME RES, V6, P2152, DOI 10.1021/pr060580k; Siqueira WL, 2011, PROTEOM CLIN APPL, V5, P575, DOI 10.1002/prca.201100046; Siqueira WL, 2009, ARCH ORAL BIOL, V54, P437, DOI 10.1016/j.archoralbio.2009.01.011; Siqueira WL, 2004, ORAL SURG ORAL MED O, V98, P76, DOI 10.1016/j.tripleo.2004.04.007; SONJU T, 1973, CARIES RES, V7, P30; Stenudd C, 2001, J DENT RES, V80, P2005, DOI 10.1177/00220345010800111101; Sutton J, 2008, PROTEOM CLIN APPL, V2, P862, DOI 10.1002/prca.200780057; Tanimoto K, 2008, J DENT RES, V87, P39, DOI 10.1177/154405910808700106; Vitorino R, 2005, BIOMED CHROMATOGR, V19, P214, DOI 10.1002/bmc.438; Vukosavljevic D, 2011, J CELL COMMUN SIGNAL, V5, P271, DOI 10.1007/s12079-011-0151-1; Webb BC, 1998, AUST DENT J, V43, P45, DOI 10.1111/j.1834-7819.1998.tb00152.x; XIE H, 1991, ORAL MICROBIOL IMMUN, V6, P257, DOI 10.1111/j.1399-302X.1991.tb00488.x; ZAHRADNIK RT, 1977, ARCH ORAL BIOL, V22, P585, DOI 10.1016/0003-9969(77)90070-X; ZAHRADNIK RT, 1978, J DENT RES, V57, P1036, DOI 10.1177/00220345780570110601	44	45	45	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42204	10.1371/journal.pone.0042204	http://dx.doi.org/10.1371/journal.pone.0042204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870302	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800067
J	Zhu, MM; Tong, JL; Xu, Q; Nie, F; Xu, XT; Xiao, SD; Ran, ZH				Zhu, Ming Ming; Tong, Jin Lu; Xu, Qi; Nie, Fang; Xu, Xi Tao; Xiao, Shu Dong; Ran, Zhi Hua			Increased JNK1 Signaling Pathway Is Responsible for ABCG2-Mediated Multidrug Resistance in Human Colon Cancer	PLOS ONE			English	Article							JUN NH2-TERMINAL KINASE; BINDING CASSETTE ABC; N-TERMINAL KINASE; CELL LUNG-CANCER; C-JUN; P-GLYCOPROTEIN; MITOXANTRONE-RESISTANCE; REGULATES EXPRESSION; SIDE POPULATION; STEM-CELL	Multidrug resistance remains a major obstacle to effective chemotherapy of colon cancer. ABCG2, as a half-transporter of the G subfamily of ATP-binding cassette transporter genes (ABC transporters), is known to play a crucial role in multidrug resistance. However, the molecular mechanism of controlling ABCG2 expression in drug resistance of colon cancer is unclear and scarcely reported. In the present study, we systematically investigate the potential role of the c-Jun NH2-terminal kinase (JNK) signal pathway in ABCG2-induced multidrug resistance in colon cancer. In the hydroxycamptothecin (HCPT) resistant cell line SW1116/HCPT from human colon cancer cell line SW1116, ABCG2 is the major factor for multidrug resistance, other than well-studied ABCB1 or ABCC1. Our findings indicate that blocking the JNK pathway by pathway inhibitor SP600125 reduces the expression level and transport function of ABCG2 in drug-resistant cells SW116/HCPT. Notably, the experiments of small interfering RNA directed against JNK1 and JNK2 show that only silence of JNK1 gene has the equal effect as SP600125 on dephosphorylation of transcription factor c-Jun and the expression of ABCG2 protein, while the corresponding phenomena were not observed after silence of JNK2 gene. Meanwhile, SP600125 induces the apoptosis of SW116/HCPT cells by promoting the cleavage of PARP and suppressing the anti-apoptotic protein survivin and bcl-2, and increases the sensitivity of SW1116/HCPT to HCPT. Taken together, our work demonstrated that JNK1/c-jun signaling pathway was involved in ABCG2-mediated multidrug resistance in colon cancer cells. Definitely, inhibition of the JNK1/c-jun pathway is useful for reversing ABCG2-mediated drug resistance in HCPT-resistant colon cancer cells.	[Ran, Zhi Hua] Shanghai Jiao Tong Univ, Sch Med, Div Gastroenterol & Hepatol, Renji Hosp,Shanghai Inst Digest Dis, Shanghai 200030, Peoples R China; Shanghai Jiao Tong Univ, Key Lab Gastroenterol & Hepatol, Minist Hlth, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhu, MM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Div Gastroenterol & Hepatol, Renji Hosp,Shanghai Inst Digest Dis, Shanghai 200030, Peoples R China.	zhihuaran@vip.163.com		ZHU, Mingming/0000-0002-1319-5199	National Natural Science Foundation of China [30770964]; Key laboratory Program of Science and Technology Commission of Shanghai Municipality [06DZ22027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key laboratory Program of Science and Technology Commission of Shanghai Municipality	This work was supported by the National Natural Science Foundation of China (No. 30770964, http://159.226.244.22/portal/proj_search.asp) and the Key laboratory Program of Science and Technology Commission of Shanghai Municipality (No. 06DZ22027, http://www.stcsm.gov.cn/structure/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikmets R, 1998, CANCER RES, V58, P5337; Bark H, 2008, FEBS LETT, V582, P2595, DOI 10.1016/j.febslet.2008.06.036; Brangi M, 1999, CANCER RES, V59, P5938; Chen Z, 2010, INT J CANCER, V126, P841, DOI 10.1002/ijc.24796; Comerford KM, 2004, CANCER RES, V64, P9057, DOI 10.1158/0008-5472.CAN-04-1919; Costa-Pereira AP, 2000, BRIT J CANCER, V82, P1827, DOI 10.1054/bjoc.2000.1149; Cripe LD, 2002, LEUKEMIA, V16, P799, DOI 10.1038/sj.leu.2402457; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Ding QM, 2001, BIOCHEM BIOPH RES CO, V284, P282, DOI 10.1006/bbrc.2001.4969; Ee PLR, 2004, CANCER RES, V64, P1247, DOI 10.1158/0008-5472.CAN-03-3583; Endo H, 2009, GUT, V58, P1637, DOI 10.1136/gut.2009.183624; Gancz D, 2009, MOL IMMUNOL, V47, P310, DOI 10.1016/j.molimm.2009.09.016; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Heasley LE, 2006, MOL CELLS, V21, P167; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hu HB, 2005, CLIN CANCER RES, V11, P2379, DOI 10.1158/1078-0432.CCR-04-2084; Kang CD, 2000, EXP CELL RES, V256, P300, DOI 10.1006/excr.2000.4807; Kim JH, 2009, BIOCHEM BIOPH RES CO, V387, P450, DOI 10.1016/j.bbrc.2009.07.036; Lemos C, 2008, INT J CANCER, V123, P1712, DOI 10.1002/ijc.23677; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Losa JH, 2003, ONCOGENE, V22, P3998, DOI 10.1038/sj.onc.1206608; Maliepaard M, 1999, CANCER RES, V59, P4559; Maliepaard M, 2001, CANCER RES, V61, P3458; Papachristou DJ, 2003, BONE, V32, P364, DOI 10.1016/S8756-3282(03)00026-7; Potapova O, 2001, J BIOL CHEM, V276, P28546, DOI 10.1074/jbc.M102075200; Rabindran SK, 2000, CANCER RES, V60, P47; Schwabedissen HEMZ, 2006, DRUG METAB DISPOS, V34, P524, DOI 10.1124/dmd.105.007591; Scovassi AI, 1999, MOL CELL BIOCHEM, V199, P125; Shinoda C, 2005, INT J CANCER, V117, P21, DOI 10.1002/ijc.21094; Singh A, 2010, MOL CANCER THER, V9, P2365, DOI 10.1158/1535-7163.MCT-10-0108; Staud F, 2005, INT J BIOCHEM CELL B, V37, P720, DOI 10.1016/j.biocel.2004.11.004; Tong C, 2007, AM J PATHOL, V171, P297, DOI 10.2353/ajpath.2007.061036; Tong JL, 2011, FEBS LETT, V585, P3560, DOI 10.1016/j.febslet.2011.10.021; Usuda J, 2007, LUNG CANCER, V58, P296, DOI 10.1016/j.lungcan.2007.05.019; Xu XT, 2012, BRIT J CANCER, V106, P1320, DOI 10.1038/bjc.2012.88; Yang YM, 2003, CLIN CANCER RES, V9, P391; Zhang G, 2011, CANCER SCI, V102, P1216, DOI 10.1111/j.1349-7006.2011.01930.x; Zhou J, 2006, CANCER RES, V66, P445, DOI 10.1158/0008-5472.CAN-05-1779; Zou J, 2006, CHIN J GASTROENTEROL, V11, P327	41	46	47	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41763	10.1371/journal.pone.0041763	http://dx.doi.org/10.1371/journal.pone.0041763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870247	gold, Green Published, Green Submitted			2022-12-27	WOS:000307212800033
J	Menning, A; Walter, A; Rudolph, M; Gashaw, I; Fritzemeier, KH; Roese, L				Menning, Astrid; Walter, Alexander; Rudolph, Marion; Gashaw, Isabella; Fritzemeier, Karl-Heinrich; Roese, Lars			Granulocytes and Vascularization Regulate Uterine Bleeding and Tissue Remodeling in a Mouse Menstruation Model	PLOS ONE			English	Article							ENDOMETRIAL REPAIR; PROGESTERONE WITHDRAWAL; EARLY-PREGNANCY; GROWTH-FACTOR; MICE; ANGIOGENESIS; DECIDUALIZATION; NEUTROPHILS; HYPOXIA	Menstruation-associated disorders negatively interfere with the quality of life of many women. However, mechanisms underlying pathogenesis of menstrual disorders remain poorly investigated up to date. Among others, this is based on a lack of appropriate pre-clinical animal models. We here employ a mouse menstruation model induced by priming mice with gonadal hormones and application of a physical stimulus into the uterus followed by progesterone removal. As in women, these events are accompanied by menstrual-like bleeding and tissue remodeling processes, i.e. disintegration of decidualized endometrium, as well as subsequent repair. We demonstrate that the onset of bleeding coincides with strong upregulation of inflammatory mediators and massive granulocyte influx into the uterus. Uterine granulocytes play a central role in regulating local tissue remodeling since depletion of these cells results in dysregulated expression of matrix modifying enzymes. As described here for the first time, uterine blood loss can be quantified by help of tampon-like cotton pads. Using this novel technique, we reveal that blood loss is strongly reduced upon inhibition of endometrial vascularization and thus, is a key regulator of menstrual bleeding. Taken together, we here identify angiogenesis and infiltrating granulocytes as critical determinants of uterine bleeding and tissue remodeling in a mouse menstruation model. Importantly, our study provides a technical and scientific basis allowing quantification of uterine blood loss in mice and thus, assessment of therapeutic intervention, proving great potential for future use in basic research and drug discovery.	[Menning, Astrid; Walter, Alexander; Rudolph, Marion; Gashaw, Isabella; Fritzemeier, Karl-Heinrich; Roese, Lars] Bayer HealthCare Pharmaceut, Therapeut Res Grp Oncol Gynecol Therapy, Berlin, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals	Menning, A (corresponding author), Bayer HealthCare Pharmaceut, Therapeut Res Grp Oncol Gynecol Therapy, Berlin, Germany.	astridmenning@yahoo.de		Gashaw, Isabella/0000-0001-5984-576X	Bayer HealthCare Pharmaceuticals	Bayer HealthCare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals)	This work has been financed by Bayer HealthCare Pharmaceuticals. All authors are employees of Bayer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, NIC CLIN GUID; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brasted M, 2003, BIOL REPROD, V69, P1273, DOI 10.1095/biolreprod.103.016550; Cheng CW, 2007, BIOL REPROD, V76, P871, DOI 10.1095/biolreprod.106.057950; COHEN PE, 1993, J REPROD FERTIL, V99, P219, DOI 10.1530/jrf.0.0990219; Critchley HOD, 1999, J CLIN ENDOCR METAB, V84, P240, DOI 10.1210/jc.84.1.240; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Fan XJ, 2008, FASEB J, V22, P3571, DOI 10.1096/fj.08-111401; FINN CA, 1984, J ENDOCRINOL, V100, P295, DOI 10.1677/joe.0.1000295; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fraser I, 2009, EXP REV OBSTET GYNEC, V4, P179, DOI [10.1586/17474108.4.2.179, DOI 10.1586/17474108.4.2.179]; HALLBERG L, 1964, SCAND J CLIN LAB INV, V16, P244, DOI 10.3109/00365516409060511; HALLBERG L, 1965, ACTA OBSTET GYN SCAN, VS 43, P57; Heryanto B, 2004, REPRODUCTION, V127, P613, DOI 10.1530/rep.1.00161; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; Jones RL, 2004, J CLIN ENDOCR METAB, V89, P6155, DOI 10.1210/jc.2004-0507; Kaitu'u TJ, 2005, BIOL REPROD, V73, P672, DOI 10.1095/biolreprod.105.042473; Kaitu'u-Lino TJ, 2007, CELL TISSUE RES, V328, P197, DOI 10.1007/s00441-006-0358-2; MARKEE JE, 1978, AM J OBSTET GYNECOL, V131, P558; Maybin JA, 2011, J CLIN ENDOCR METAB, V96, P2475, DOI 10.1210/jc.2010-2971; Maybin JA, 2011, AM J PATHOL, V178, P1245, DOI 10.1016/j.ajpath.2010.11.070; Maybin JA, 2011, MOL CELL ENDOCRINOL, V335, P42, DOI 10.1016/j.mce.2010.08.006; Million RP, 2008, NAT REV DRUG DISCOV, V7, P115, DOI 10.1038/nrd2507; Milne SA, 1999, J CLIN ENDOCR METAB, V84, P2563, DOI 10.1210/jc.84.7.2563; RICHES AC, 1973, J PHYSIOL-LONDON, V228, P279, DOI 10.1113/jphysiol.1973.sp010086; Rudolph M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032922; Salamonsen LA, 2000, HUM REPROD UPDATE, V6, P16, DOI 10.1093/humupd/6.1.16; Salamonsen LA, 2003, REPRODUCTION, V125, P301, DOI 10.1530/rep.0.1250301; Sonoda Y, 1998, J IMMUNOL, V160, P6159; Tang MY, 2010, ENDOCRINOLOGY, V151, P1320, DOI 10.1210/en.2009-1081; Xu XB, 2007, HUM REPROD, V22, P3184, DOI 10.1093/humrep/dem312	31	23	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41800	10.1371/journal.pone.0041800	http://dx.doi.org/10.1371/journal.pone.0041800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879894	Green Submitted, Green Published, gold			2022-12-27	WOS:000307437900013
J	Petridou, NI; Stylianou, P; Christodoulou, N; Rhoads, D; Guan, JL; Skourides, PA				Petridou, Nicoletta I.; Stylianou, Panayiota; Christodoulou, Neophytos; Rhoads, Daniel; Guan, Jun-Lin; Skourides, Paris A.			Activation of Endogenous FAK via Expression of Its Amino Terminal Domain in Xenopus Embryos	PLOS ONE			English	Article							FOCAL ADHESION KINASE; CELL-MATRIX ADHESIONS; SMOOTH-MUSCLE-CELLS; TYROSINE PHOSPHORYLATION; GROWTH-FACTOR; FERM DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; INTEGRIN; LAEVIS; PAXILLIN	Background: The Focal Adhesion Kinase is a well studied tyrosine kinase involved in a wide number of cellular processes including cell adhesion and migration. It has also been shown to play important roles during embryonic development and targeted disruption of the FAK gene in mice results in embryonic lethality by day 8.5. Principal Findings: Here we examined the pattern of phosphorylation of FAK during Xenopus development and found that FAK is phosphorylated on all major tyrosine residues examined from early blastula stages well before any morphogenetic movements take place. We go on to show that FRNK fails to act as a dominant negative in the context of the early embryo and that the FERM domain has a major role in determining FAK's localization at the plasma membrane. Finally, we show that autonomous expression of the FERM domain leads to the activation of endogenous FAK in a tyrosine 397 dependent fashion. Conclusions: Overall, our data suggest an important role for the FERM domain in the activation of FAK and indicate that integrin signalling plays a limited role in the in vivo activation of FAK at least during the early stages of development.	[Petridou, Nicoletta I.; Stylianou, Panayiota; Christodoulou, Neophytos; Rhoads, Daniel; Skourides, Paris A.] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Guan, Jun-Lin] Univ Michigan Med Sch, Dept Internal Med MMG, Ann Arbor, MI USA	University of Cyprus; University of Michigan System; University of Michigan	Petridou, NI (corresponding author), Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus.	skourip@ucy.ac.cy	Christodoulou, Neophytos/AAB-7645-2019	Christodoulou, Neophytos/0000-0003-4338-5847; Petridou, Nicoletta/0000-0002-8451-1195; Skourides, Paris/0000-0003-3502-5729	Cyprus Research Promotion Foundation [YGammaEIA/BIOSigma/0609(BE)/14]	Cyprus Research Promotion Foundation	Funding was provided by the Cyprus Research Promotion Foundation (Y Gamma EIA/BIO Sigma/0609(BE)/14). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cary Leslie A., 1999, Frontiers in Bioscience, V4, pD102, DOI 10.2741/Cary; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Chatzizacharias NA, 2010, HISTOL HISTOPATHOL, V25, P1039, DOI 10.14670/HH-25.1039; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Chen TH, 2011, ONCOGENE, V30, P153, DOI 10.1038/onc.2010.398; Cohen LA, 2005, J BIOL CHEM, V280, P8197, DOI 10.1074/jbc.M412021200; Cooley MA, 2000, MOL BIOL CELL, V11, P3247, DOI 10.1091/mbc.11.9.3247; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Crawford BD, 2003, MOL BIOL CELL, V14, P3065, DOI 10.1091/mbc.E02-08-0537; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DANKER K, 1993, MECH DEVELOP, V44, P155, DOI 10.1016/0925-4773(93)90064-5; DEMETRIOU MC, 2007, BIOCHEM BIOPH RES CO, V3, P779; EIDE BL, 1995, MOL CELL BIOL, V15, P2819; Fesenko I, 2000, MECH DEVELOP, V96, P51, DOI 10.1016/S0925-4773(00)00368-3; FEY J, 1990, DIFFERENTIATION, V42, P144, DOI 10.1111/j.1432-0436.1990.tb00755.x; Fonar Y, 2011, MOL BIOL CELL, V22, P2409, DOI 10.1091/mbc.E10-12-0932; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85; Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Hall JE, 2011, INT REV CEL MOL BIO, V288, P185, DOI 10.1016/B978-0-12-386041-5.00005-4; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Henry CA, 2001, DEV BIOL, V240, P474, DOI 10.1006/dbio.2001.0467; HENS MD, 1995, DEV BIOL, V170, P274, DOI 10.1006/dbio.1995.1214; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Jacamo RO, 2005, BIOCHEM BIOPH RES CO, V334, P1299, DOI 10.1016/j.bbrc.2005.07.034; JOOS TO, 1995, MECH DEVELOP, V50, P187, DOI 10.1016/0925-4773(94)00335-K; Kragtorp KA, 2006, DEVELOPMENT, V133, P685, DOI 10.1242/dev.02230; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Marsden M, 2001, DEVELOPMENT, V128, P3635; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peng X, 2011, CURR PROTEIN PEPT SC, V12, P52, DOI 10.2174/138920311795659452; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; RAFFERTY KA, 1969, CYTOGENETICS, V8, P427; Ramos JW, 1996, DEVELOPMENT, V122, P2873; Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361; Ren XD, 2000, J CELL SCI, V113, P3673; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sarrazin S, 2011, COLD SPRING HARB PER, V3; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Seong JY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1414; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Skourides PA, 1999, ONCOGENE, V18, P1165, DOI 10.1038/sj.onc.1202407; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Stylianou P, 2009, MECH DEVELOP, V126, P828, DOI 10.1016/j.mod.2009.07.008; Sundberg LJ, 2003, J BIOL CHEM, V278, P29783, DOI 10.1074/jbc.M303771200; Tachibana K, 1997, J BIOL CHEM, V272, P29083, DOI 10.1074/jbc.272.46.29083; Taylor JM, 2001, MOL CELL BIOL, V21, P1565, DOI 10.1128/MCB.21.5.1565-1572.2001; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; UBBELS GA, 1983, J EMBRYOL EXP MORPH, V77, P15; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; WINKLBAUER R, 1995, J CELL SCI, V108, P1575; Zachary I, 1997, INT J BIOCHEM CELL B, V29, P929, DOI 10.1016/S1357-2725(97)00008-3; ZHANG XA, 1995, GENE, V160, P219, DOI 10.1016/0378-1119(95)00153-W	71	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42577	10.1371/journal.pone.0042577	http://dx.doi.org/10.1371/journal.pone.0042577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880041	gold, Green Published, Green Submitted			2022-12-27	WOS:000307810000048
J	Castello, NA; Green, KN; LaFerla, FM				Castello, Nicholas A.; Green, Kim N.; LaFerla, Frank M.			Genetic Knockdown of Brain-Derived Neurotrophic Factor in 3xTg-AD Mice Does Not Alter A beta or Tau Pathology	PLOS ONE			English	Article							ONSET ALZHEIMERS-DISEASE; BDNF MESSENGER-RNA; TRANSGENIC MODEL; NEUROBLASTOMA-CELLS; PROMOTER ACTIVITY; IN-VIVO; POLYMORPHISM; MECHANISM; EXPRESSION; COGNITION	Brain-derived neurotrophic factor (BDNF) is a neurotrophin critically involved in cell survival, synaptic plasticity, and memory. BDNF has recently garnered significant attention as a potential therapeutic target for neurodegenerative diseases such as Alzheimer disease (AD), but emerging evidence suggests that BDNF may also be mechanistically involved in the pathogenesis of AD. AD patients have substantially reduced BDNF levels, which may be a result of A beta and tau pathology. Recent evidence, however, indicates reduced BDNF levels may also serve to drive pathology in neuronal cultures, although this has not yet been established in vivo. To further investigate the mechanistic role of BDNF in AD, we generated 3xTg-AD mice with a heterozygous BDNF knockout (BDNF+/-) and analyzed A beta and tau pathology. Aged 3xTg-AD/BDNF+/- mice have significantly reduced levels of brain BDNF, but have comparable levels of A beta and tau pathology to 3xTg-AD/BDNF+/+ mice. These findings indicate that chronic reduction of BDNF does not exacerbate the development of A beta and tau pathology, and instead suggests the reduced BDNF levels found in AD patients are a consequence of these pathologies.	[Castello, Nicholas A.; Green, Kim N.; LaFerla, Frank M.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA; [Castello, Nicholas A.; Green, Kim N.; LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Castello, NA (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA.	laferla@uci.edu			American Health Assistance Foundation; NIH [F31AG034061]; NATIONAL INSTITUTE ON AGING [F31AG034061, P50AG016573] Funding Source: NIH RePORTER	American Health Assistance Foundation(BrightFocus Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by a grant from the American Health Assistance Foundation (FML) and NIH F31AG034061 (NAC). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsu H, 2006, DEMENT GERIATR COGN, V22, P216, DOI 10.1159/000094933; Aliaga E, 2010, NEUROBIOL DIS, V37, P208, DOI 10.1016/j.nbd.2009.10.004; Arancibia S, 2008, NEUROBIOL DIS, V31, P316, DOI 10.1016/j.nbd.2008.05.012; Bartoletti A, 2002, J NEUROSCI, V22, P10072; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Bodner SM, 2005, AM J MED GENET B, V134B, P1, DOI 10.1002/ajmg.b.30154; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Elliott E, 2005, EUR J NEUROSCI, V22, P1081, DOI 10.1111/j.1460-9568.2005.04290.x; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Fukumoto N, 2010, AM J MED GENET B, V153B, P235, DOI 10.1002/ajmg.b.30986; Garzon DJ, 2007, J NEUROSCI, V27, P2628, DOI 10.1523/JNEUROSCI.5053-06.2007; Ge YW, 2002, ANN NY ACAD SCI, V973, P463, DOI 10.1111/j.1749-6632.2002.tb04684.x; Gorski JA, 2003, J NEUROSCI, V23, P6856; Green K, 2008, J NEUROSCI; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Green KN, 2011, ANN NEUROL, V69, P831, DOI 10.1002/ana.22325; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Holsinger RMD, 2000, MOL BRAIN RES, V76, P347, DOI 10.1016/S0169-328X(00)00023-1; Huang R, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044883; Kunugi H, 2001, MOL PSYCHIATR, V6, P83, DOI 10.1038/sj.mp.4000792; Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000; Matrone C, 2008, P NATL ACAD SCI USA, V105, P13139, DOI 10.1073/pnas.0806133105; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2005, P NATL ACAD SCI USA, V102, P3046, DOI 10.1073/pnas.0408500102; Olin D, 2005, NEUROSCI LETT, V381, P275, DOI 10.1016/j.neulet.2005.02.017; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Pitts AF, 2000, J COMP NEUROL, V418, P241, DOI 10.1002/(SICI)1096-9861(20000313)418:3<241::AID-CNE1>3.0.CO;2-M; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rohe M, 2009, J NEUROSCI, V29, P15472, DOI 10.1523/JNEUROSCI.3960-09.2009; Ruiz-Leon Y, 2001, J NEUROCHEM, V79, P278, DOI 10.1046/j.1471-4159.2001.00547.x; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Zheng ZQ, 2010, J BIOL CHEM, V285, P34708, DOI 10.1074/jbc.M110.150821	38	27	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e39566	10.1371/journal.pone.0039566	http://dx.doi.org/10.1371/journal.pone.0039566			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870188	Green Published, gold			2022-12-27	WOS:000307284100002
J	Song, L; Zhou, Q; Duan, P; Guo, P; Li, DW; Xu, Y; Li, ST; Luo, F; Zhang, ZH				Song, Lei; Zhou, Qiang; Duan, Ping; Guo, Ping; Li, Dianwei; Xu, Yuan; Li, Songtao; Luo, Fei; Zhang, Zehua			Successful Development of Small Diameter Tissue-Engineering Vascular Vessels by Our Novel Integrally Designed Pulsatile Perfusion-Based Bioreactor	PLOS ONE			English	Article							IN-VITRO; COLLAGEN; CULTURE; SYSTEM	Small-diameter (<4 mm) vascular constructs are urgently needed for patients requiring replacement of their peripheral vessels. However, successful development of constructs remains a significant challenge. In this study, we successfully developed small-diameter vascular constructs with high patency using our integrally designed computer-controlled bioreactor system. This computer-controlled bioreactor system can confer physiological mechanical stimuli and fluid flow similar to physiological stimuli to the cultured grafts. The medium circulating system optimizes the culture conditions by maintaining fixed concentration of O-2 and CO2 in the medium flow and constant delivery of nutrients and waste metabolites, as well as eliminates the complicated replacement of culture medium in traditional vascular tissue engineering. Biochemical and mechanical assay of newly developed grafts confirm the feasibility of the bioreactor system for small-diameter vascular engineering. Furthermore, the computer-controlled bioreactor is superior for cultured cell proliferation compared with the traditional non-computer-controlled bioreactor. Specifically, our novel bioreactor system may be a potential alternative for tissue engineering of large-scale small-diameter vascular vessels for clinical use.	[Song, Lei; Zhou, Qiang; Duan, Ping; Guo, Ping; Li, Dianwei; Xu, Yuan; Li, Songtao; Luo, Fei; Zhang, Zehua] Third Mil Med Univ, Affiliated Hosp 1, Dept Orthopaed, Chongqing, Peoples R China	Army Medical University	Song, L (corresponding author), Third Mil Med Univ, Affiliated Hosp 1, Dept Orthopaed, Chongqing, Peoples R China.	zqthl@yahoo.com.cn			National High Technology Research and Development Program (863) [2006AA02Z4E3]; National Natural Science Foundation of China [81027005]	National High Technology Research and Development Program (863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National High Technology Research and Development Program (863) (No. 2006AA02Z4E3) and the National Natural Science Foundation of China (No. 81027005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO J, 1994, AM J PHYSIOL, V267, pC679, DOI 10.1152/ajpcell.1994.267.3.C679; Ball SG, 2004, INT J BIOCHEM CELL B, V36, P714, DOI 10.1016/j.biocel.2003.10.015; Bordenave L, 2008, EXPERT REV MED DEVIC, V5, P337, DOI 10.1586/17434440.5.3.337; Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024; Cho SW, 2005, ANN SURG, V241, P506, DOI 10.1097/01.sla.0000154268.12239.ed; Crapo PM, 2011, J BIOMED MATER RES A, V96A, P673, DOI 10.1002/jbm.a.33019; EVANS BK, 1992, N-S ARCH PHARMACOL, V346, P362; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Gross S, 2007, J EXP MED, V204, P311, DOI 10.1084/jem.20061617; Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84; Kevil CG, 2001, ACTA PHYSIOL SCAND, V173, P151, DOI 10.1046/j.1365-201X.2001.00901.x; Kim Won Ho, 1993, Yonsei Medical Journal, V34, P45; Lohn M, 2001, J APPL PHYSIOL, V91, P1350, DOI 10.1152/jappl.2001.91.3.1350; McCulloch AD, 2004, TISSUE ENG, V10, P565, DOI 10.1089/107632704323061924; McFetridge PS, 2007, ASAIO J, V53, P623, DOI 10.1097/MAT.0b013e31812f3b7e; Miyatake SI, 1999, STROKE, V30, P2431, DOI 10.1161/01.STR.30.11.2431; Naito Y, 2012, CELLS TISSUES ORGANS, V195, P60, DOI 10.1159/000331405; Narita Y, 2004, TISSUE ENG, V10, P1224, DOI 10.1089/ten.2004.10.1224; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Niklason LE, 2002, ANN NY ACAD SCI, V961, P220, DOI 10.1111/j.1749-6632.2002.tb03089.x; Ou WF, 2011, BIOMATERIALS, V32, P3178, DOI 10.1016/j.biomaterials.2011.01.031; Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje; RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P639, DOI 10.1111/j.1476-5381.1987.tb11367.x; Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275; Sodian R, 2002, TISSUE ENG, V8, P863, DOI 10.1089/10763270260424222; Stock UA, 2001, TISSUE ENG, V7, P1, DOI 10.1089/107632701300003241; Tanaka Yoshio, 2004, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V2, P257, DOI 10.2174/1568016043356273; Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1053/ejvs.2002.1654; Thompson CA, 2002, TISSUE ENG, V8, P1083, DOI 10.1089/107632702320934173; Wang C, 2010, BIOMATERIALS, V31, P621, DOI 10.1016/j.biomaterials.2009.09.086; Williams C, 2004, TISSUE ENG, V10, P930, DOI 10.1089/1076327041348536; Xia ZY, 2003, J THORAC CARDIOV SUR, V126, P1404, DOI 10.1016/S0022-5223(03)00970-X; Yang J, 2005, TISSUE ENG, V11, P1876, DOI 10.1089/ten.2005.11.1876	33	27	27	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42569	10.1371/journal.pone.0042569	http://dx.doi.org/10.1371/journal.pone.0042569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880036	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100132
J	Chaffin, DO; Taylor, D; Skerrett, SJ; Rubens, CE				Chaffin, Donald O.; Taylor, Destry; Skerrett, Shawn J.; Rubens, Craig E.			Changes in the Staphylococcus aureus Transcriptome during Early Adaptation to the Lung	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; STATIONARY-PHASE SURVIVAL; DEVICE-RELATED INFECTION; GRAM-POSITIVE BACTERIA; SMALL-COLONY-VARIANT; METHICILLIN-RESISTANT; IN-VIVO; STRESS-RESPONSE; GLYCOPEPTIDE RESISTANCE; DETERMINANT PRODUCTION	Staphylococcus aureus is a common inhabitant of the human nasopharynx. It is also a cause of life-threatening illness, producing a potent array of virulence factors that enable survival in normally sterile sites. The transformation of S. aureus from commensal to pathogen is poorly understood. We analyzed S. aureus gene expression during adaptation to the lung using a mouse model of S. aureus pneumonia. Bacteria were isolated by bronchoalveolar lavage after residence in vivo for up to 6 hours. S. aureus in vivo RNA transcription was compared by microarray to that of shake flask grown stationary phase and early exponential phase cells. Compared to in vitro conditions, the in vivo transcriptome was dramatically altered within 30 minutes. Expression of central metabolic pathways changed significantly in response to the lung environment. Gluconeogenesis (fbs, pckA) was down regulated, as was TCA cycle and fermentation pathway gene expression. Genes associated with amino acid synthesis, RNA translation and nitrate respiration were upregulated, indicative of a highly active metabolic state during the first 6 hours in the lung. Virulence factors regulated by agr were down regulated in vivo and in early exponential phase compared to stationary phase cells. Over time in vivo, expression of ahpCF, involved in H2O2 scavenging, and uspA, which encodes a universal stress regulator, increased. Transcription of leukotoxic alpha and beta-type phenol-soluble modulins psm alpha 1-4 and psm beta 1-2 increased 13 and 8-fold respectively; hld mRNA, encoding delta-hemolysin, was increased 9-fold. These were the only toxins to be significantly upregulated in vivo. These data provide the first complete survey of the S. aureus transcriptome response to the mammalian airway. The results present intriguing contrasts with previous work in other in vitro and in vivo models and provide novel insights into the adaptive and temporal response of S. aureus early in the pathogenesis of pneumonia.	[Chaffin, Donald O.; Rubens, Craig E.] Seattle Childrens Hosp, Res Inst, Seattle, WA USA; [Taylor, Destry; Skerrett, Shawn J.; Rubens, Craig E.] Univ Washington, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle	Chaffin, DO (corresponding author), Seattle Childrens Hosp, Res Inst, Seattle, WA USA.	craig.rubens@seattlechildrens.org			National Institutes of Health [P50 HL073996]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL073996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was funded under National Institutes of Health grant award number P50 HL073996. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2007, INFECT IMMUN, V75, P4534, DOI 10.1128/IAI.00679-07; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; Andrews WW, 2008, OBSTET GYNECOL, V111, P113, DOI 10.1097/01.AOG.0000298344.04916.11; Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bischoff M, 2001, J BACTERIOL, V183, P5171, DOI 10.1128/JB.183.17.5171-5179.2001; Bore E, 2007, MICROBIOL-SGM, V153, P2289, DOI 10.1099/mic.0.2007/005942-0; Boyce JM, 2005, J CLIN MICROBIOL, V43, P5992, DOI 10.1128/JCM.43.12.5992-5995.2005; Cassat JE, 2005, J BACTERIOL, V187, P576, DOI 10.1128/JB.187.2.576-592.2005; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chang W, 2006, J BACTERIOL, V188, P1648, DOI 10.1128/JB.188.4.1648-1659.2006; Chatterjee I, 2007, J BACTERIOL, V189, P2936, DOI 10.1128/JB.01444-06; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Choudhry AE, 2003, ANTIMICROB AGENTS CH, V47, P2051, DOI 10.1128/AAC.47.6.2051-2055.2003; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Coulter SN, 1998, MOL MICROBIOL, V30, P393, DOI 10.1046/j.1365-2958.1998.01075.x; CROSSLEY K, 1979, J INFECT DIS, V139, P280, DOI 10.1093/infdis/139.3.280; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dunman PM, 2004, J CLIN MICROBIOL, V42, P4275, DOI 10.1128/JCM.42.9.4275-4283.2004; EMMETT M, 1975, CAN J MICROBIOL, V21, P729, DOI 10.1139/m75-107; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Fillinger S, 2000, J BIOL CHEM, V275, P14031, DOI 10.1074/jbc.275.19.14031; Francois P, 2007, J MICROBIOL METH, V68, P385, DOI 10.1016/j.mimet.2006.09.022; Garzoni C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-171; Geiger T, 2008, J BACTERIOL, V190, P3419, DOI 10.1128/JB.01927-07; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gillaspy A.F., 2006, GRAM POSITIVE PATHOG, P381; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; Goerke C, 2005, INFECT IMMUN, V73, P3415, DOI 10.1128/IAI.73.6.3415-3421.2005; Goerke C, 2004, INT J MED MICROBIOL, V294, P195, DOI 10.1016/j.ijmm.2004.06.013; Goerke C, 2001, MOL MICROBIOL, V40, P1439, DOI 10.1046/j.1365-2958.2001.02494.x; Heinemann M, 2005, BIOTECHNOL BIOENG, V92, P850, DOI 10.1002/bit.20663; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kahl BC, 2005, INFECT IMMUN, V73, P4119, DOI 10.1128/IAI.73.7.4119-4126.2005; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Kullik I, 1998, J BACTERIOL, V180, P4814, DOI 10.1128/JB.180.18.4814-4820.1998; Kumari DNP, 1998, J HOSP INFECT, V39, P127, DOI 10.1016/S0195-6701(98)90326-7; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Miller M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006708; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Novick RP, 2003, MICROBIOL-SGM, V149, P2709, DOI 10.1099/mic.0.26575-0; O'Connell NH, 2000, J HOSP INFECT, V45, P255, DOI 10.1053/jhin.2000.0768; Oie S, 1996, J HOSP INFECT, V34, P145, DOI 10.1016/S0195-6701(96)90140-1; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Pamp SJ, 2006, J BACTERIOL, V188, P4861, DOI 10.1128/JB.00194-06; PATTEE PA, 1975, J BACTERIOL, V124, P201, DOI 10.1128/JB.124.1.201-211.1975; Pelz A, 2005, J BIOL CHEM, V280, P32493, DOI 10.1074/jbc.M505070200; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Pragman AA, 2004, FEMS IMMUNOL MED MIC, V42, P147, DOI 10.1016/j.femsim.2004.05.005; Purves J, 2010, INFECT IMMUN, V78, P5223, DOI 10.1128/IAI.00762-10; Ray B, 2009, MICROB PATHOGENESIS, V47, P94, DOI 10.1016/j.micpath.2009.05.001; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Rezacova P, 2008, MOL MICROBIOL, V69, P895, DOI 10.1111/j.1365-2958.2008.06318.x; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Rogasch K, 2006, J BACTERIOL, V188, P7742, DOI 10.1128/JB.00555-06; Schlag S, 2008, J BACTERIOL, V190, P7847, DOI 10.1128/JB.00905-08; Schulthess B, 2009, ANTIMICROB AGENTS CH, V53, P1832, DOI 10.1128/AAC.01255-08; Seggewiss J, 2006, J BACTERIOL, V188, P7765, DOI 10.1128/JB.00774-06; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Shaw LN, 2006, J BACTERIOL, V188, P6070, DOI 10.1128/JB.00551-06; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000817; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Sieradzki K, 1998, MICROB DRUG RESIST, V4, P159, DOI 10.1089/mdr.1998.4.159; Singh VK, 2003, INT J ANTIMICROB AG, V21, P256, DOI 10.1016/S0924-8579(02)00359-X; Skerrett SJ, 2004, J IMMUNOL, V172, P3377, DOI 10.4049/jimmunol.172.6.3377; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Steinhuber A, 2003, J BACTERIOL, V185, P6278, DOI 10.1128/JB.185.21.6278-6286.2003; Suzuki M, 2009, J APPL MICROBIOL, V107, P1367, DOI 10.1111/j.1365-2672.2009.04321.x; ten Broeke-Smits NJP, 2010, J HOSP INFECT, V76, P211, DOI 10.1016/j.jhin.2010.07.011; ten Broeke-Smits NJP, 2010, NUCLEIC ACIDS RES, V38, P3263, DOI 10.1093/nar/gkq058; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; van Schaik W, 2005, CURR OPIN BIOTECH, V16, P218, DOI 10.1016/j.copbio.2005.01.008; van Wamel W, 2002, MICROB PATHOGENESIS, V33, P73, DOI 10.1006/mpat.2002.0513; VANDENESCH F, 1991, J BACTERIOL, V173, P6313, DOI 10.1128/jb.173.20.6313-6320.1991; Ventura CL, 2008, INFECT IMMUN, V76, P888, DOI 10.1128/IAI.01301-07; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Weinrick B, 2004, J BACTERIOL, V186, P8407, DOI 10.1128/JB.186.24.8407-8423.2004; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Wolf C, 2008, PROTEOMICS, V8, P3139, DOI 10.1002/pmic.200701062; Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210; Yang SJ, 2006, MOL MICROBIOL, V60, P458, DOI 10.1111/j.1365-2958.2006.05105.x; Yarwood JM, 2002, J BACTERIOL, V184, P1095, DOI 10.1128/jb.184.4.1095-1101.2002; Zhu YF, 2009, INFECT IMMUN, V77, P4256, DOI 10.1128/IAI.00195-09; Ziebuhr W, 1997, INFECT IMMUN, V65, P890, DOI 10.1128/IAI.65.3.890-896.1997	100	66	66	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41329	10.1371/journal.pone.0041329	http://dx.doi.org/10.1371/journal.pone.0041329			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876285	gold, Green Submitted, Green Published			2022-12-27	WOS:000307184700013
J	Ohmayer, U; Perez-Fernandez, J; Hierlmeier, T; Poll, G; Williams, L; Griesenbeck, J; Tschochner, H; Milkereit, P				Ohmayer, Uli; Perez-Fernandez, Jorge; Hierlmeier, Thomas; Poell, Gisela; Williams, Lydia; Griesenbeck, Joachim; Tschochner, Herbert; Milkereit, Philipp			Local Tertiary Structure Probing of Ribonucleoprotein Particles by Nuclease Fusion Proteins	PLOS ONE			English	Article							RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; CELLS; MATURATION; COMPLEX; DESIGN; SITES	Analyses of the conformational dynamics of the numerous cellular ribonucleoprotein particles (RNP) significantly contribute to the understanding of their modes of action. Here, we tested whether ribonuclease fusion proteins incorporated into RNPs can be used as molecular probes to characterize the local RNA environment of these proteins. Fusion proteins of micrococcal nuclease (MNase) with ribosomal proteins were expressed in S. cerevisae to produce in vivo recombinant ribosomes which have a ribonuclease tethered to specific sites. Activation of the MNase activity by addition of calcium led to specific rRNA cleavage events in proximity to the ribosomal binding sites of the fusion proteins. The dimensions of the RNP environment which could be probed by this approach varied with the size of the linker sequence between MNase and the fused protein. Advantages and disadvantages of the use of MNase fusion proteins for local tertiary structure probing of RNPs as well as alternative applications for this type of approach in RNP research are discussed.	[Ohmayer, Uli; Perez-Fernandez, Jorge; Hierlmeier, Thomas; Poell, Gisela; Williams, Lydia; Griesenbeck, Joachim; Tschochner, Herbert; Milkereit, Philipp] Univ Regensburg, Lehrstuhl Biochem 3, Regensburg, Germany	University of Regensburg	Ohmayer, U (corresponding author), Univ Regensburg, Lehrstuhl Biochem 3, Regensburg, Germany.	Joachim.Griesenbeck@vkl.uni-regensburg.de; Herbert.Tschochner@vkl.uni-regensburg.de; Philipp.Milkereit@vkl.uni-regensburg.de	Perez-Fernandez, Jorge/F-6937-2010	Perez-Fernandez, Jorge/0000-0002-0018-5493; Griesenbeck, Joachim/0000-0002-7817-6095	DFG [SFB 960]	DFG(German Research Foundation (DFG))	This work was supported by DFG grant SFB 960 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfinsen C.B., 1971, ENZYMES, V4; Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Ben-Shem A, 2011, STRUCTURE EUKARYOTIC; Burke D., 2000, METHODS YEAST GENETI; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Culver GM, 2000, METHOD ENZYMOL, V318, P461; Das SR, 2005, CURR OPIN CHEM BIOL, V9, P585, DOI 10.1016/j.cbpa.2005.10.009; Dast R, 2008, P NATL ACAD SCI USA, V105, P4144, DOI 10.1073/pnas.0709032105; Felden B, 2007, CURR OPIN MICROBIOL, V10, P286, DOI 10.1016/j.mib.2007.05.001; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Herschlag Dan, 2009, Methods Enzymol, V469, pxvii, DOI 10.1016/S0076-6879(09)69028-5; LOLL PJ, 1989, PROTEINS, V5, P183, DOI 10.1002/prot.340050302; Lomax JE, 2012, METHOD ENZYMOL, V502, P273, DOI 10.1016/B978-0-12-416039-2.00014-8; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Montgomerie S, 2008, NUCLEIC ACIDS RES, V36, pW202, DOI 10.1093/nar/gkn255; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schmid M, 2004, MOL CELL, V16, P147, DOI 10.1016/j.molcel.2004.09.007; TELFORD DJ, 1989, INT J BIOCHEM, V21, P127, DOI 10.1016/0020-711X(89)90100-6; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Venema J, 1998, METH MOL B, V77, P257; Weeks KM, 2010, CURR OPIN STRUC BIOL, V20, P295, DOI 10.1016/j.sbi.2010.04.001	25	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42449	10.1371/journal.pone.0042449	http://dx.doi.org/10.1371/journal.pone.0042449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876323	Green Published, Green Submitted, gold			2022-12-27	WOS:000307184700051
J	Wang, JB; Fan, JH; Liang, H; Li, J; Xiao, HJ; Wei, WQ; Dawsey, SM; Qiao, YL; Boffetta, P				Wang, Jian-Bing; Fan, Jin-Hu; Liang, Hao; Li, Jing; Xiao, Hui-Juan; Wei, Wen-Qiang; Dawsey, Sanford M.; Qiao, You-Lin; Boffetta, Paolo			Attributable Causes of Esophageal Cancer Incidence and Mortality in China	PLOS ONE			English	Article							RISK-FACTORS; ALCOHOL-DRINKING; GASTRIC CANCERS; CIGARETTE-SMOKING; BRITISH DOCTORS; LIFE-STYLE; TOOTH LOSS; DISEASE; COHORT; FRUIT	Background: To estimate the contribution of tobacco smoking, alcohol drinking, low vegetable intake and low fruit intake to esophageal cancer mortality and incidence in China. Methodology/Principal Findings: We calculated the proportion of esophageal cancer attributable to four known modifiable risk factors [population attributable fraction (PAF)]. Exposure data was taken from meta-analyses and large-scale national surveys of representative samples of the Chinese population. Data on relative risks were also from meta-analyses and large-scale prospective studies. Esophageal cancer mortality and incidence came from the 3rd national death cause survey and population-based cancer registries in China. We estimated that 87,065 esophageal cancer deaths (men 67,686; women: 19,379) and 108,206 cases (men: 83,968, women: 24,238) were attributable to tobacco smoking, alcohol drinking, low vegetable intake and low fruit intake in China in 2005. About 17.9% of esophageal cancer deaths among men and 1.9% among women were attributable to tobacco smoking. About 15.2% of esophageal cancer deaths in men and 1.3% in women were caused by alcohol drinking. Low vegetable intake was responsible for 4.3% esophageal cancer deaths in men and 4.1% in women. The fraction of esophageal cancer deaths attributable to low fruit intake was 27.1% in men and 28.0% in women. Overall, 46% of esophageal cancers (51% in men and 33% in women) were attributable to these four modifiable risk factors. Conclusions/Significance: Tobacco smoking, alcohol drinking, low vegetable intake and low fruit intake were responsible for 46% of esophageal cancer mortality and incidence in China in 2005. These findings provide useful data for developing guidelines for esophageal cancer prevention and control in China.	[Wang, Jian-Bing; Fan, Jin-Hu; Liang, Hao; Li, Jing; Wei, Wen-Qiang; Qiao, You-Lin] Chinese Acad Med Sci, Dept Canc Epidemiol, Peking Union Med Coll, Canc Inst Hosp, Beijing 100730, Peoples R China; [Wang, Jian-Bing; Dawsey, Sanford M.] NCI, Div Canc Epidemiol & Genet, Nutr Epidemiol Branch, Bethesda, MD 20892 USA; [Xiao, Hui-Juan] Tianjin Third Cent Hosp, Dept Nutr, Tianjin, Peoples R China; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Icahn School of Medicine at Mount Sinai	Wang, JB (corresponding author), Chinese Acad Med Sci, Dept Canc Epidemiol, Peking Union Med Coll, Canc Inst Hosp, Beijing 100730, Peoples R China.	qiaoy@cicams.ac.cn; paolo.boffetta@i-pri.org	Qiao, You-Lin/B-4139-2012; Boffetta, Paolo/AAI-7767-2021	Qiao, You-Lin/0000-0001-6380-0871; Boffetta, Paolo/0000-0002-3811-2791; fan, jinhu/0000-0003-3159-7893	International Agency for Research on Cancer (Lyon, France) [GEE/08/19]; National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics; NATIONAL CANCER INSTITUTE [ZIACP000185] Funding Source: NIH RePORTER	International Agency for Research on Cancer (Lyon, France); National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the International Agency for Research on Cancer (Lyon, France), Grant number: CRA No GEE/08/19. It was also supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2005, INT J EPIDEMIOL, V34, P467, DOI 10.1093/ije/dyh375; Abnet CC, 2001, CANCER CAUSE CONTROL, V12, P847, DOI 10.1023/A:1012290009545; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Castellsague X, 1999, INT J CANCER, V82, P657, DOI 10.1002/(SICI)1097-0215(19990827)82:5&lt;657::AID-IJC7&gt;3.0.CO;2-C; Chen Wan-qing, 2009, Zhonghua Zhong Liu Za Zhi, V31, P664; Chen Z, 2007, CHINESE HLTH, V12, P15; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; DOLL R, 1980, BRIT MED J, V280, P967, DOI 10.1136/bmj.280.6219.967; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GAO YT, 1994, INT J CANCER, V58, P192, DOI 10.1002/ijc.2910580208; Gu DF, 2004, AM J PUBLIC HEALTH, V94, P1972, DOI 10.2105/AJPH.94.11.1972; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; International Agency for Research on Cancer Academie des Sciences-Institut de France Academie de Medecine Federation Nationale des Centres de Lutte contre le Cancer, 2007, IARC WORK GROUP REP, V3; Islami F, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b929; Kamangar F, 2009, GASTROENTEROL CLIN N, V38, P27, DOI 10.1016/j.gtc.2009.01.004; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Liang H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-730; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Ministry of Health of the People's Republic of China, 2008, REP 3 NAT RETR SURV; Olsen JH, 1997, APMIS, V105, P141; Parkin DM, 2011, BRIT J CANCER, V105, pS77, DOI 10.1038/bjc.2011.489; PRC National Blood Pressure Survey Cooperative Group, 1995, CHIN J HYPERTENSION, V3, P50; Riboli E, 2003, AM J CLIN NUTR, V78, p559S, DOI 10.1093/ajcn/78.3.559S; Schneider M, 2007, SAMJ S AFR MED J, V97, P717; Schutze M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1584; Smith M, 2008, INT J CANCER, V122, P1604, DOI 10.1002/ijc.23198; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Wang JB, 2010, CANCER CAUSE CONTROL, V21, P959, DOI 10.1007/s10552-010-9523-8; Wei Wen-qiang, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P398; WENG XZ, 1987, CHINESE MED J-PEKING, V100, P886; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wu M, 2011, CANCER LETT, V308, P189, DOI 10.1016/j.canlet.2011.05.003; Wu M, 2011, CANCER CAUSE CONTROL, V22, P649, DOI 10.1007/s10552-011-9737-4; Xiang W, 2011, CANCER CAUSE CONTROL, V22, P1153, DOI 10.1007/s10552-011-9791-y; Xiao HJ, 2011, CHINESE J CANCER RES, V23, P171, DOI 10.1007/s11670-011-0171-7; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yu H., 2003, CHIN J PUBLIC HLTH, V19, P763	40	52	67	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42281	10.1371/journal.pone.0042281	http://dx.doi.org/10.1371/journal.pone.0042281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876312	Green Submitted, Green Published, gold			2022-12-27	WOS:000307184700040
J	Grandgeorge, M; Tordjman, S; Lazartigues, A; Lemonnier, E; Deleau, M; Hausberger, M				Grandgeorge, Marine; Tordjman, Sylvie; Lazartigues, Alain; Lemonnier, Eric; Deleau, Michel; Hausberger, Martine			Does Pet Arrival Trigger Prosocial Behaviors in Individuals with Autism?	PLOS ONE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; ANIMAL-ASSISTED THERAPY; SOCIAL-INTERACTION; DIAGNOSTIC INTERVIEW; FACILITATED THERAPY; SPECTRUM DISORDERS; EARLY RECOGNITION; JOINT ATTENTION; CHILDREN; OWNERSHIP	Alteration of social interactions especially prosocial behaviors - an important aspect of development - is one of the characteristics of autistic disorders. Numerous strategies or therapies are used to improve communication skills or at least to reduce social impairments. Animal-assisted therapies are used widely but their relevant benefits have never been scientifically evaluated. In the present study, we evaluated the association between the presence or the arrival of pets in families with an individual with autism and the changes in his or her prosocial behaviors. Of 260 individuals with autism - on the basis of presence or absence of pets - two groups of 12 individuals and two groups of 8 individuals were assigned to: study 1 (pet arrival after age of 5 versus no pet) and study 2 (pet versus no pet), respectively. Evaluation of social impairment was assessed at two time periods using the 36-items ADI-R algorithm and a parental questionnaire about their child-pet relationships. The results showed that 2 of the 36 items changed positively between the age of 4 to 5 (t(0)) and time of assessment (t(1)) in the pet arrival group (study 1): "offering to share" and "offering comfort". Interestingly, these two items reflect prosocial behaviors. There seemed to be no significant changes in any item for the three other groups. The interactions between individuals with autism and their pets were more - qualitatively and quantitatively - reported in the situation of pet arrival than pet presence since birth. These findings open further lines of research on the impact of pet's presence or arrival in families with an individual with autism. Given the potential ability of individuals with autism to develop prosocial behaviors, related studies are needed to better understand the mechanisms involved in the development of such child-pet relationship.	[Grandgeorge, Marine; Lazartigues, Alain; Lemonnier, Eric] CHRU Brest, Hop Bohars, Ctr Ressources Autisme, Bohars, France; [Grandgeorge, Marine; Hausberger, Martine] CNRS, UMR 6552, Lab Ethol Anim & Humaine, Rennes, France; [Tordjman, Sylvie] CHRU Guillaume Regnier, Rennes, France; [Deleau, Michel] Ctr Rech Psychol Cognit & Commun, Rennes, France	CHU Brest; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Grandgeorge, M (corresponding author), CHRU Brest, Hop Bohars, Ctr Ressources Autisme, Bohars, France.	marine.grandgeorge@chu-brest.fr	lemonnier, eric/K-1084-2016		Adrienne and Pierre Sommer Foundation; Fondation Sommer	Adrienne and Pierre Sommer Foundation; Fondation Sommer	The Adrienne and Pierre Sommer Foundation gave the financial support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no financial interests.; We are thankful to Dr. Ann Cloarec, researcher, Ethos laboratory and Zarrin Alavi, (for her pertinent advice) medical writer and translator, Brest University Hospital, Department of Internal Medicine and Chest Diseases; INSERM CIC 0502, to Pr Michel Botbol, CHRU Brest, to families for their participation, to the Fondation Sommer for their support and the French GIS CCS (Groupe d'Interet Scientifique - Comportement Cerveau et Societe)	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anastasi A., 1988, PSYCHOL TESTING; ANDERSON WP, 1992, MED J AUSTRALIA, V157, P298, DOI 10.5694/j.1326-5377.1992.tb137178.x; Bailey C, 1988, DISS ABSTR INT, V48; Baranek GT, 1999, J AUTISM DEV DISORD, V29, P213, DOI 10.1023/A:1023080005650; Barker SB, 2008, J VET MED EDUC, V35, P487, DOI 10.3138/jvme.35.4.487; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bass M, 2009, J AUTISM DEV DISORD, V39, P1261, DOI 10.1007/s10803-009-0734-3; Beck AM, 1996, ANNU REV PUBL HEALTH, V17, P247, DOI 10.1146/annurev.pu.17.050196.001335; Beck AM, 2001, ANTHROZOOS, V14, P19, DOI 10.2752/089279301786999599; BECK AM, 1984, J AM VET MED ASSOC, V184, P414; Blue G.F., 1986, CHILDHOOD ED, V63, DOI [10.1080/00094056.1986.10521747, DOI 10.1080/00094056.1986.10521747]; BRICKEL CM, 1982, PSYCHOL REP, V50, P71, DOI 10.2466/pr0.1982.50.1.71; BRUNER JS, 1972, AM PSYCHOL, V27, P687, DOI 10.1037/h0033144; Bryant B, 1986, RELEVANCE FAMILY NEI; Bryant B. K., 1990, Anthrozoos, V3, P253, DOI 10.2752/089279390787057469; Burrows KE, 2008, QUAL HEALTH RES, V18, P1642, DOI 10.1177/1049732308327088; Cain A. O., 1985, MARRIAGE FAM REV, V8, P5; Celani G, 2002, AUTISM, V6, P93, DOI 10.1177/1362361302006001007; Endenburg N, 1996, WALTHAM BOOK HUMAN A, p[1996, 7]; epperberg IM, 1991, J COMP PSYCHOL, V105, P286; Filiatre J. C., 1988, Anthrozoos, V2, P22, DOI 10.2752/089279389787058190; FILIATRE JC, 1986, BEHAV PROCESS, V12, P33, DOI 10.1016/0376-6357(86)90068-9; FRIEDMANN E, 1983, J NERV MENT DIS, V171, P461, DOI 10.1097/00005053-198308000-00002; FRIEDMANN E, 1980, PUBLIC HEALTH REP, V95, P307; Furman W., 1989, WILEY SERIES PERSONA, P151; Gasalberti Denise, 2006, J Pediatr Health Care, V20, P133, DOI 10.1016/j.pedhc.2005.12.015; Gelman R., 1981, SOCIAL COGNITIVE DEV, P43; George H., 1988, INNOVATIVE INTERVENT, P400; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Glascoe FP, 2005, MENT RETARD DEV D R, V11, P173, DOI 10.1002/mrdd.20068; Glascoe FP, 1997, PEDIATRICS, V99, P830, DOI 10.1542/peds.99.6.830; Grandgeorge M, 2010, COULD BOND ANIMAL AL, V2; Grandgeorge M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004683; Haggerty Davis J., 1989, Anthrozoos, V2, P189, DOI 10.2752/089279389787058046; Hills AM, 1995, ANTHROZOOS, V8, P132, DOI 10.2752/089279395787156347; Hinde R.A., 1979, UNDERSTANDING RELATI; Hubert Montagner, 1995, ENFANT ANIMAL ECOLE; Kaminski M, 2002, CHILD HEALTH CARE, V31, P321, DOI 10.1207/S15326888CHC3104_5; KASARI C, 1990, J AUTISM DEV DISORD, V20, P87, DOI 10.1007/BF02206859; Katcher AH., 2000, HDB ANIMAL ASSISTED, P461; Kenzer AL, 2011, RES AUTISM SPECT DIS, V5, P819, DOI 10.1016/j.rasd.2010.09.011; KIDD AH, 1985, PSYCHOL REP, V57, P15, DOI 10.2466/pr0.1985.57.1.15; Levinson B., 1962, MENT HYG, V179, P46; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C, 1997, J AUTISM DEV DISORD, V27, P501, DOI 10.1023/A:1025873925661; Macdonald A, 1981, INTERRELATIONS PEOPL; Martin F, 2002, WESTERN J NURS RES, V24, P657, DOI 10.1177/019394502320555403; Maurer M, 2011, PSYCHIAT ENFANT, V54, P575, DOI 10.3917/psye.542.0575; Maurer M, 2010, ANTHROZOOS, V23, P383, DOI 10.2752/175303710X12750451259453; McConnell SR, 2002, J AUTISM DEV DISORD, V32, P351, DOI 10.1023/A:1020537805154; Melson G. F., 1991, CHILDRENS ENV Q, V8, P55, DOI DOI 10.2307/41514782; Melson G. F., 2005, WHY WILD THINGS ARE; MILLOT JL, 1986, APPL ANIM BEHAV SCI, V16, P383, DOI 10.1016/0168-1591(86)90010-9; MILLOT JL, 1988, BEHAV PROCESS, V17, P1, DOI 10.1016/0376-6357(88)90046-0; MUNDY P, 1995, DEV PSYCHOPATHOL, V7, P63, DOI 10.1017/S0954579400006349; NATHANSON DE, 1993, ANTHROZOOS, V6, P17, DOI 10.2752/089279393787002367; Odendaal JSJ, 2000, J PSYCHOSOM RES, V49, P275, DOI 10.1016/S0022-3999(00)00183-5; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Osterling JA, 2002, DEV PSYCHOPATHOL, V14, P239, DOI 10.1017/S0954579402002031; Paul ES, 1996, APPL ANIM BEHAV SCI, V47, P17, DOI 10.1016/0168-1591(95)01007-6; Piaget J., 1962, PLAY DREAMS IMITATIO; Pierce K, 1997, J APPL BEHAV ANAL, V30, P157, DOI 10.1901/jaba.1997.30-157; Poresky RH, 1996, ANTHROZOOS, V9, P159, DOI 10.2752/089279396787001437; Poresky RH, 1989, COMPANION ANIMAL BON; Poulin-Dubois D, 2006, J COGN DEV, V7, P431, DOI 10.1207/s15327647jcd0704_1; RALLS K, 1985, CAN J ZOOL, V63, P1050, DOI 10.1139/z85-157; REDEFER LA, 1989, J AUTISM DEV DISORD, V19, P461, DOI 10.1007/BF02212943; ROGE B, 2009, ADAPTATION FRANCAISE; SALOMON A, 1981, CAN MENT HEALTH, V29, P9; Savage-Rumbaugh S., 1994, KANZI APE BRINK HUMA; SERPELL J, 1991, J ROY SOC MED, V84, P717, DOI 10.1177/014107689108401208; SIEGEL B, 1986, J AUTISM DEV DISORD, V16, P275, DOI 10.1007/BF01531660; Tager-Flusberg H, 2000, UNDERSTANDING LANGUA; Tager-Flusberg H, 2007, PEDIATR CLIN N AM, V54, P469, DOI 10.1016/j.pcl.2007.02.011; Tordjman S, 2001, MOL PSYCHIATR, V6, P434, DOI 10.1038/sj.mp.4000873; Travis LL, 1998, MENT RETARD DEV D R, V4, P65, DOI 10.1002/(SICI)1098-2779(1998)4:2<65::AID-MRDD2>3.0.CO;2-W; Triebenbacher SL, 1998, PSYCHOL REP, V82, P191, DOI 10.2466/PR0.82.1.191-200; Turner DC, 2003, ANTHROZOOS, V16, P213, DOI 10.2752/089279303786992143; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288; Wong HHL, 2006, J AUTISM DEV DISORD, V36, P901, DOI 10.1007/s10803-006-0131-0; World Health Organization, 1994, COMP INT DIAGN INT V	84	50	50	1	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41739	10.1371/journal.pone.0041739	http://dx.doi.org/10.1371/journal.pone.0041739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	984SU	22870246	Green Published, Green Submitted, gold			2022-12-27	WOS:000307212800032
J	Kertzscher, U; Schneider, T; Goubergrits, L; Affeld, K; Hanggi, D; Spuler, A				Kertzscher, Ulrich; Schneider, Torsten; Goubergrits, Leonid; Affeld, Klaus; Haenggi, Daniel; Spuler, Andreas			In Vitro Study of Cerebrospinal Fluid Dynamics in a Shaken Basal Cistern after Experimental Subarachnoid Hemorrhage	PLOS ONE			English	Article							CEREBRAL VASOSPASM; FORAMEN MAGNUM; CSF FLOW; BLOOD; VOLUME; MR; VISCOSITY; PROTEINS; PATTERNS; THERAPY	Background: Cerebral arterial vasospasm leads to delayed cerebral ischemia and constitutes the major delayed complication following aneurysmal subarachnoid hemorrhage. Cerebral vasospasm can be reduced by increased blood clearance from the subarachnoid space. Clinical pilot studies allow the hypothesis that the clearance of subarachnoid blood is facilitated by means of head shaking. A major obstacle for meaningful clinical studies is the lack of data on appropriate parameters of head shaking. Our in vitro study aims to provide these essential parameters. Methodology/Principal Findings: A model of the basal cerebral cistern was derived from human magnetic resonance imaging data. Subarachnoid hemorrhage was simulated by addition of dyed experimental blood to transparent experimental cerebrospinal fluid (CSF) filling the model of the basal cerebral cistern. Effects of various head positions and head motion settings (shaking angle amplitudes and shaking frequencies) on blood clearance were investigated using the quantitative dye washout method. Blood washout can be divided into two phases: Blood/CSF mixing and clearance. The major effect of shaking consists in better mixing of blood and CSF thereby increasing clearance rate. Without shaking, blood/CSF mixing and blood clearance in the basal cerebral cistern are hampered by differences in density and viscosity of blood and CSF. Blood clearance increases with decreased shaking frequency and with increased shaking angle amplitude. Head shaking facilitates clearance by varying the direction of gravitational force. Conclusions/Significance: From this in vitro study can be inferred that patient or head shaking with large shaking angles at low frequency is a promising therapeutic strategy to increase blood clearance from the subarachnoid space.	[Kertzscher, Ulrich; Schneider, Torsten; Goubergrits, Leonid] Charite, Biofluid Mech Lab, D-13353 Berlin, Germany; [Affeld, Klaus; Spuler, Andreas] Univ Dusseldorf, Dept Neurosurg, D-40225 Dusseldorf, Germany; [Haenggi, Daniel] Helios Klinikum Berlin Buch, Dept Neurosurg, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Heinrich Heine University Dusseldorf; Helios Kliniken	Kertzscher, U (corresponding author), Charite, Biofluid Mech Lab, D-13353 Berlin, Germany.	andreas.spuler@helios-kliniken.de	Goubergrits, Leonid/AAB-2332-2022	Goubergrits, Leonid/0000-0002-1961-3179; Spuler, Andreas/0000-0001-6031-179X; Kertzscher, Ulrich/0000-0003-1594-1295				Amin-Hanjani S, 2004, NEUROSURGERY, V54, P326, DOI 10.1227/01.NEU.0000103488.94855.4F; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Bloomfield IG, 1998, PEDIATR NEUROSURG, V28, P246, DOI 10.1159/000028659; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Ford MD, 2005, IEEE T MED IMAGING, V24, P1586, DOI 10.1109/TMI.2005.859204; Friedman JA, 2002, J NEUROSURG, V97, P401, DOI 10.3171/jns.2002.97.2.0401; Goubergrits L, 2008, ASAIO J, V54, P50, DOI 10.1097/MAT.0b013e31815c5e38; Gupta S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005171; Hanggi D, 2008, J NEUROSURG, V108, P1192, DOI 10.3171/JNS/2008/108/6/1192; HENRIKSSON L, 1976, NEURORADIOLOGY, V12, P103, DOI 10.1007/BF00333125; Hentschel S, 2010, AM J NEURORADIOL, V31, P997, DOI 10.3174/ajnr.A1995; HINGHOFERSZALKAY H, 1987, J APPL PHYSIOL, V63, P1003, DOI 10.1152/jappl.1987.63.3.1003; Kawamoto S, 2004, J NEUROSURG, V100, P236, DOI 10.3171/jns.2004.100.2.0236; KENNER T, 1989, BASIC RES CARDIOL, V84, P111, DOI 10.1007/BF01907921; Klimo P, 2004, J NEUROSURG, V100, P215, DOI 10.3171/jns.2004.100.2.0215; Naff NJ, 2001, NEUROSURGERY, V49, P614, DOI 10.1097/00006123-200109000-00015; Nakgomi T, 2008, ACTA NEUROCHIR SUPPL, V104, P329; Pierot L, 2010, RADIOLOGY, V256, P916, DOI 10.1148/radiol.10092209; Quigley MF, 2004, RADIOLOGY, V232, P229, DOI 10.1148/radiol.2321030666; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; Reilly C, 2004, J NEUROSURG, V101, P255, DOI 10.3171/jns.2004.101.2.0255; Rudin M, 2001, EXP NEUROL, V169, P56, DOI 10.1006/exnr.2001.7650; Schiffer E, 1999, BRIT J ANAESTH, V83, P943, DOI 10.1093/bja/83.6.943; Sequeira A., 2007, PORTRAIT STATE OF TH, P65; Sweetman B, 2011, ANN BIOMED ENG, V39, P484, DOI 10.1007/s10439-010-0141-0; TADA Y, 1994, IEEE ENG MED BIOL, V13, P497, DOI 10.1109/51.310990; THURSTON GB, 1979, BIORHEOLOGY, V16, P149; Timmel T, 2001, INT J ARTIF ORGANS, V24, P777, DOI 10.1177/039139880102401110	29	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41677	10.1371/journal.pone.0041677	http://dx.doi.org/10.1371/journal.pone.0041677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870243	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800030
J	Planaguma, J; Minsaas, L; Pons, M; Myhren, L; Garrido, G; Aragay, AM				Planaguma, Jesus; Minsaas, Laura; Pons, Monica; Myhren, Lene; Garrido, Georgina; Aragay, Anna M.			Filamin A-Hinge Region 1-EGFP: A Novel Tool for Tracking the Cellular Functions of Filamin A in Real-Time	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; ACTIN-BINDING PROTEIN; STRUCTURAL BASIS; TARGETS FILAMIN; DOMAIN; IDENTIFICATION; ACTIVATION; FILGAP; RHO; ACCUMULATION	Background: Filamin A (FLNa) is an actin-crosslinking protein necessary for stabilizing the cell surface, organizing protrusive activity and for promoting efficient cellular translocation. Recently, our group demonstrated the requirement of FLNa for the internalization of the chemokine receptor CCR2B. Methodology and Principal Findings: In order to study the role of FLNa in vitro and in real-time, we have developed a fluorescent FLNa-EGFP construct. In this novel imaging tool, we introduced the EGFP-tag inside the flexible hinge 1 region of FLNa between two calpain cleavage sites. Our findings indicate that the FLNa-EGFP construct was correctly expressed, cleaved by calpain and colocalized with actin filaments as shown by immunostaining experiments in the human melanoma cell lines A7 (FLNa-repleted) and M2 (FLNa-deficient). In addition, scanning-electron microscopy (SEM) and micropatterning studies also provided clear evidence that the cell rigidity was restored. FLNa-EGFP allowed us to demonstrate the interaction of FLNa with the chemokine receptor CCR2B in endocytic vesicles after CCL2 ligand stimulation. Through live-cell imaging studies we show that the CCR2B receptor in Rab5-positive vesicles moves along filamin A-positive fibers. Significance: Taken together, these results outline the functionality of the FLNa-EGFP and the importance of filamin A for receptor internalization and movement into endocytic vesicles.	[Planaguma, Jesus; Minsaas, Laura; Myhren, Lene; Aragay, Anna M.] Univ Bergen, Dept Biomed, Bergen, Norway; [Pons, Monica; Garrido, Georgina; Aragay, Anna M.] CSIC, Inst Biol Mol Barcelona, Barcelona, Spain	University of Bergen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Planaguma, J (corresponding author), IDIBAPS, Barcelona, Spain.	aarbmc@ibmb.csic.es	Aragay, Anna M/K-3813-2014; Pons, Monica/AAB-5309-2019; Garrido Antequera, Georgina/H-3469-2015	Aragay, Anna M/0000-0002-8240-4126; Garrido Antequera, Georgina/0000-0001-7702-7998	Ministerio de Ciencia e Innovacion [BFU2008-04262]; Helse Vest Norway	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Helse Vest Norway	The "Ministerio de Ciencia e Innovacion" (BFU2008-04262) and Helse Vest Norway supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Berry FB, 2005, MOL CELL BIOL, V25, P1415, DOI 10.1128/MCB.25.4.1415-1424.2005; BRESNICK AR, 1991, J BIOL CHEM, V266, P12989; BYERS HR, 1991, AM J PATHOL, V139, P423; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Ferland RJ, 2009, HUM MOL GENET, V18, P497, DOI 10.1093/hmg/ddn377; FOX JEB, 1985, J BIOL CHEM, V260, P1060; Garcia E, 2006, ARCH BIOCHEM BIOPHYS, V446, P140, DOI 10.1016/j.abb.2005.12.006; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Hjalm G, 2001, J BIOL CHEM, V276, P34880, DOI 10.1074/jbc.M100784200; Huang CF, 2006, FEBS LETT, V580, P1795, DOI 10.1016/j.febslet.2006.02.035; Ikonen E, 1997, J CELL SCI, V110, P2155; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kasza KE, 2009, BIOPHYS J, V96, P4326, DOI 10.1016/j.bpj.2009.02.035; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Minsaas L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012212; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Ozanne DM, 2000, MOL ENDOCRINOL, V14, P1618, DOI 10.1210/me.14.10.1618; Pi M, 2002, ENDOCRINOLOGY, V143, P3830, DOI 10.1210/en.2002-220240; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Shifrin Y, 2009, MOL BIOL CELL, V20, P1269, DOI 10.1091/mbc.E08-08-0872; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Ueda K, 2003, BIOCHEM BIOPH RES CO, V301, P886, DOI 10.1016/S0006-291X(03)00048-2; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; WINDER SJ, 1995, FEBS LETT, V357, P125, DOI 10.1016/0014-5793(94)01347-4	44	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40864	10.1371/journal.pone.0040864	http://dx.doi.org/10.1371/journal.pone.0040864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870205	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800011
J	Sadamoto, H; Takahashi, H; Okada, T; Kenmoku, H; Toyota, M; Asakawa, Y				Sadamoto, Hisayo; Takahashi, Hironobu; Okada, Taketo; Kenmoku, Hiromichi; Toyota, Masao; Asakawa, Yoshinori			De Novo Sequencing and Transcriptome Analysis of the Central Nervous System of Mollusc Lymnaea stagnalis by Deep RNA Sequencing	PLOS ONE			English	Article							GENE-EXPRESSION; ANNOTATION; ASSEMBLER; BLAST2GO; APLYSIA; GENOME; MEMORY	The pond snail Lymnaea stagnalis is among several mollusc species that have been well investigated due to the simplicity of their nervous systems and large identifiable neurons. Nonetheless, despite the continued attention given to the physiological characteristics of its nervous system, the genetic information of the Lymnaea central nervous system (CNS) has not yet been fully explored. The absence of genetic information is a large disadvantage for transcriptome sequencing because it makes transcriptome assembly difficult. We here performed transcriptome sequencing for Lymnaea CNS using an Illumina Genome Analyzer IIx platform and obtained 81.9 M of 100 base pair (bp) single end reads. For de novo assembly, five programs were used: ABySS, Velvet, OASES, Trinity and Rnnotator. Based on a comparison of the assemblies, we chose the Rnnotator dataset for the following blast searches and gene ontology analyses. The present dataset, 116,355 contigs of Lymnaea transcriptome shotgun assembly (TSA), contained longer sequences and was much larger compared to the previously reported Lymnaea expression sequence tag (EST) established by classical Sanger sequencing. The TSA sequences were subjected to blast analyses against several protein databases and Aplysia EST data. The results demonstrated that about 20,000 sequences had significant similarity to the reported sequences using a cutoff value of 1e-6, and showed the lack of molluscan sequences in the public databases. The richness of the present TSA data allowed us to identify a large number of new transcripts in Lymnaea and molluscan species.	[Sadamoto, Hisayo; Okada, Taketo] Tokushima Bunri Univ, Fac Pharmaceut Sci, Sanuki City, Kagawa, Japan; [Takahashi, Hironobu; Kenmoku, Hiromichi; Toyota, Masao; Asakawa, Yoshinori] Tokushima Bunri Univ, Inst Pharmacognosy, Tokushima, Japan	Tokushima Bunri University; Tokushima Bunri University	Sadamoto, H (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa Campus, Sanuki City, Kagawa, Japan.	sadamotoh@kph.bunri-u.ac.jp		Takahashi, Hironobu/0000-0003-0045-7716	Japan Society for the Promotion of Science [21770081, 24570091]; Senryaku Research from the Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [24651247] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Senryaku Research from the Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Society for the Promotion of Science (21770081 and 24570091 to HS) and Senryaku Research from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birzele F, 2010, NUCLEIC ACIDS RES, V38, P3999, DOI 10.1093/nar/gkq116; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dames Shale, 2010, J Biomol Tech, V21, P73; Davison A, 2005, PARASITOLOGY, V130, P539, DOI 10.1017/S0031182004006791; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Feng ZP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-451; Fiedler TJ, 2010, COMP BIOCHEM PHYS D, V5, P165, DOI 10.1016/j.cbd.2010.03.003; Filla A, 2004, ACTA BIOL HUNG, V55, P315, DOI 10.1556/ABiol.55.2004.1-4.37; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026509; Kawahara Miki R, 2011, PLOS ONE, V6; Kemenes G, 2009, CURR BIOL, V19, pR9, DOI 10.1016/j.cub.2008.10.013; Kemenes I, 2011, EUR J NEUROSCI, V33, P143, DOI 10.1111/j.1460-9568.2010.07479.x; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Kojima S, 1997, NEUROSCI LETT, V230, P179, DOI 10.1016/S0304-3940(97)00507-7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Poelchau MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-619; Ribeiro M, 2010, NEUROSCIENCE, V165, P794, DOI 10.1016/j.neuroscience.2009.11.008; Sadamoto B, 2004, ACTA BIOL HUNG, V55, P163, DOI 10.1556/ABiol.55.2004.1-4.20; Sadamoto H, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00025; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Suzuki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019534; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Nierop P, 2006, J BIOL CHEM, V281, P1680, DOI 10.1074/jbc.M508571200; Vehovszky A, 2002, NEUROSCIENCE, V115, P483, DOI 10.1016/S0306-4522(02)00414-1; Vehovszky A, 2000, BRAIN RES, V867, P188, DOI 10.1016/S0006-8993(00)02315-5; Ward JA, 2012, AM J BOT, V99, P267, DOI 10.3732/ajb.1100334; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	38	72	74	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42546	10.1371/journal.pone.0042546	http://dx.doi.org/10.1371/journal.pone.0042546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870333	gold, Green Submitted, Green Published			2022-12-27	WOS:000307212800096
J	Sweet, M; Kirkham, N; Bendall, M; Currey, L; Bythell, J; Heupel, M				Sweet, Michael; Kirkham, Nigel; Bendall, Mark; Currey, Leanne; Bythell, John; Heupel, Michelle			Evidence of Melanoma in Wild Marine Fish Populations	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; REEF; COMMUNITIES; XIPHOPHORUS; DISEASE; HYBRIDIZATION; GRADIENT; CANCER; ECOLOGY; CORALS	The increase in reports of novel diseases in a wide range of ecosystems, both terrestrial and marine, has been linked to many factors including exposure to novel pathogens and changes in the global climate. Prevalence of skin cancer in particular has been found to be increasing in humans, but has not been reported in wild fish before. Here we report extensive melanosis and melanoma (skin cancer) in wild populations of an iconic, commercially-important marine fish, the coral trout Plectropomus leopardus. The syndrome reported here has strong similarities to previous studies associated with UV induced melanomas in the well-established laboratory fish model Xiphophorus. Relatively high prevalence rates of this syndrome (15%) were recorded at two offshore sites in the Great Barrier Reef Marine Park (GBRMP). In the absence of microbial pathogens and given the strong similarities to the UV-induced melanomas, we conclude that the likely cause was environmental exposure to UV radiation. Further studies are needed to establish the large scale distribution of the syndrome and confirm that the lesions reported here are the same as the melanoma in Xiphophorus, by assessing mutation of the EGFR gene, Xmrk. Furthermore, research on the potential links of this syndrome to increases in UV radiation from stratospheric ozone depletion needs to be completed.	[Sweet, Michael; Bendall, Mark; Bythell, John] Newcastle Univ, Coral Hlth & Dis Lab, Sch Biol, Newcastle Inst Res Sustainabil, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kirkham, Nigel] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Currey, Leanne] James Cook Univ, Australian Inst Marine Sci, Sch Earth & Environm Sci, Fishing & Fisheries Res Ctr, Townsville, Qld 4811, Australia; [Bythell, John] Univ S Pacific, Res Off, Suva, Fiji	Newcastle University - UK; Newcastle University - UK; Australian Institute of Marine Science; James Cook University; University of the South Pacific	Sweet, M (corresponding author), Newcastle Univ, Coral Hlth & Dis Lab, Sch Biol, Newcastle Inst Res Sustainabil, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	michael.sweet@ncl.ac.uk	Sweet, Michael J/E-9661-2012; Bythell, John/ABE-6138-2021; Currey-Randall, Leanne/AAS-8975-2020; Bythell, John C/E-7962-2010	Sweet, Michael J/0000-0003-4983-8333; Bythell, John/0000-0003-2416-9786; Currey-Randall, Leanne/0000-0002-3772-1288; Bythell, John C/0000-0003-2416-9786; Heupel, Michelle/0000-0002-8245-7332	Natural Environment Research Council grant [NE/E006949]; Natural Environment Research Council [NE/H020616/1] Funding Source: researchfish; NERC [NE/H020616/1] Funding Source: UKRI	Natural Environment Research Council grant(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded by a Natural Environment Research Council grant (NE/E006949). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albor A, 2007, MOL CARCINOGEN, V46, P585, DOI 10.1002/mc.20344; Altinok Ilhan, 2003, Turkish Journal of Fisheries and Aquatic Sciences, V3, P131; ANDERS F, 1980, LINNEAN SOC S SERIES, V9, P211; Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Bythell JC, 2002, LETT APPL MICROBIOL, V34, P359, DOI 10.1046/j.1472-765X.2002.01097.x; Casadevall A, 2000, INFECT IMMUN, V68, P6511, DOI 10.1128/IAI.68.12.6511-6518.2000; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Dahms HU, 2010, AQUAT TOXICOL, V97, P3, DOI 10.1016/j.aquatox.2009.12.002; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ebrahimzadeh Mousavi HA, 2005, IRAN J FISH SCI, V5, P105; Fernandez AA, 2008, J FISH BIOL, V72, P292, DOI 10.1111/j.1095-8649.2007.01691.x; Fernandez A.A., 2011, COMP BIOCH PHYSL C; Frisch A, 2006, J FISH BIOL, V68, P1013, DOI 10.1111/j.0022-1112.2006.00977.x; Gao Z, 2008, APPL ENVIRON MICROB, V74, P6091, DOI 10.1128/AEM.01315-08; Gimenez-Conti I, 2001, MAR BIOTECHNOL, V3, pS100; Haeder DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI DOI 10.1039/C0PP90036B; Huang AH, 2006, J CLIN MICROBIOL, V44, P3299, DOI 10.1128/JCM.00417-06; Huang PH, 2009, NATURE, V459, P336, DOI 10.1038/459336a; Hubbard Karen, 2008, Ethn Dis, V18, pS2; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Kohout J, 2012, FISHERIES MANAG ECOL, V19, P252, DOI 10.1111/j.1365-2400.2011.00828.x; Lewis TJ, 2010, INTEGR CANCER THER, V9, P84, DOI 10.1177/1534735409355171; Lowe C, 1996, NATURE, V383, P677, DOI 10.1038/383677a0; Marie AD, 2012, CAN J FISH AQUAT SCI, V69, P884, DOI 10.1139/F2012-027; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Patton EE, 2010, J INVEST DERMATOL, V130, P14, DOI 10.1038/jid.2009.293; PORCHETHENNERE E, 1992, CELL TISSUE RES, V269, P167, DOI 10.1007/BF00384737; Ramaiah N, 2006, INDIAN J MAR SCI, V35, P380; Regneri J, 2012, COMP BIOCHEM PHYS C, V155, P71, DOI 10.1016/j.cbpc.2011.04.003; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Sanchez O, 2007, APPL ENVIRON MICROB, V73, P5962, DOI 10.1128/AEM.00817-07; SCHARTL A, 1995, CANCER RES, V55, P159; SETLOW RB, 1989, P NATL ACAD SCI USA, V86, P8922, DOI 10.1073/pnas.86.22.8922; SMITH RC, 1992, SCIENCE, V255, P952, DOI 10.1126/science.1546292; Sweet MJ, 2010, AQUAT MICROB ECOL, V61, P1, DOI 10.3354/ame01433; Sweet MJ, 2012, ENVIRON MICROBIOL, DOI [10.1111/j.1462-2920.2012.02746, DOI 10.1111/J.1462-2920.2012.02746]; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Vancov T, 2009, FEMS MICROBIOL LETT, V296, P91, DOI 10.1111/j.1574-6968.2009.01621.x; Vielkind J., 1978, Verhandlungen der Deutschen Zoologischen Gesellschaft, V71, P228; Wu Jia-bing, 2009, Journal of Forestry Research (Harbin), V20, P383, DOI 10.1007/s11676-009-0066-3	41	44	44	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41989	10.1371/journal.pone.0041989	http://dx.doi.org/10.1371/journal.pone.0041989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870273	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000307212800049
J	Gandhi, AK; Desai, JV; Ghatge, MS; di Salvo, ML; Di Biase, S; Danso-Danquah, R; Musayev, FN; Contestabile, R; Schirch, V; Safo, MK				Gandhi, Amit K.; Desai, Jigar V.; Ghatge, Mohini S.; di Salvo, Martino L.; Di Biase, Stefano; Danso-Danquah, Richmond; Musayev, Faik N.; Contestabile, Roberto; Schirch, Verne; Safo, Martin K.			Crystal Structures of Human Pyridoxal Kinase in Complex with the Neurotoxins, Ginkgotoxin and Theophylline: Insights into Pyridoxal Kinase Inhibition	PLOS ONE			English	Article							VITAMIN-B6 LEVELS; THERAPY; COCOA; PYRIDOXAL-5'-PHOSPHATE; GENOTOXICITY; ROSCOVITINE; DEFICIENCY; DEPRESSION; PROTEIN; BILOBA	Several drugs and natural compounds are known to be highly neurotoxic, triggering epileptic convulsions or seizures, and causing headaches, agitations, as well as other neuronal symptoms. The neurotoxic effects of some of these compounds, including theophylline and ginkgotoxin, have been traced to their inhibitory activity against human pyridoxal kinase (hPL kinase), resulting in deficiency of the active cofactor form of vitamin B-6, pyridoxal 5'-phosphate (PLP). Pyridoxal (PL), an inactive form of vitamin B-6 is converted to PLP by PL kinase. PLP is the B-6 vitamer required as a cofactor for over 160 enzymatic activities essential in primary and secondary metabolism. We have performed structural and kinetic studies on hPL kinase with several potential inhibitors, including ginkgotoxin and theophylline. The structural studies show ginkgotoxin and theophylline bound at the substrate site, and are involved in similar protein interactions as the natural substrate, PL. Interestingly, the phosphorylated product of ginkgotoxin is also observed bound at the active site. This work provides insights into the molecular basis of hPL kinase inhibition and may provide a working hypothesis to quickly screen or identify neurotoxic drugs as potential hPL kinase inhibitors. Such adverse effects may be prevented by administration of an appropriate form of vitamin B-6, or provide clues of how to modify these drugs to help reduce their hPL kinase inhibitory effects.	[Gandhi, Amit K.; Desai, Jigar V.; Ghatge, Mohini S.; Danso-Danquah, Richmond; Musayev, Faik N.; Schirch, Verne; Safo, Martin K.] Virginia Commonwealth Univ, Dept Med Chem, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA; [di Salvo, Martino L.; Di Biase, Stefano; Contestabile, Roberto] Univ Roma La Sapienza, Dipartimento Sci Biochim, I-00185 Rome, Italy; [di Salvo, Martino L.; Di Biase, Stefano; Contestabile, Roberto] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Rome, Italy	Virginia Commonwealth University; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Gandhi, AK (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA.	msafo@vcu.edu	Desai, Jigar V/I-3109-2019; Contestabile, Roberto/J-3467-2019; Musayev, Faik/AAY-2010-2020; Safo, Martin/AAJ-9833-2020; Ghatge, Mohini/AAY-3381-2020	Contestabile, Roberto/0000-0002-5235-9993; Desai, Jigar/0000-0002-8823-0796; di Salvo, Martino Luigi/0000-0003-1233-9338	AD Williams Fund; Jeffress Research Award; Progetti di Ricerca di Interesse Nazionale and Istituto Pasteur - Fondazione Cenci Bolognetti; National Cancer Institute of the National Institutes of Health [CA 16059-28]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER	AD Williams Fund; Jeffress Research Award; Progetti di Ricerca di Interesse Nazionale and Istituto Pasteur - Fondazione Cenci Bolognetti; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by grants from the AD Williams Fund and Jeffress Research Award (to MKS), and grants from Progetti di Ricerca di Interesse Nazionale and Istituto Pasteur - Fondazione Cenci Bolognetti (to MLdS and RC). The structural biology resources used in this study were also provided in-part by the National Cancer Institute of the National Institutes of Health to the VCU Massey Cancer Center [Grant CA 16059-28]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao AO, 1998, ANN PHARMACOTHER, V32, P889, DOI 10.1345/aph.17377; Apgar JL, 1998, CAFFEINE, P171; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; BARTEL PR, 1994, AM J CLIN NUTR, V60, P93, DOI 10.1093/ajcn/60.1.93; Bonner AB, 1999, VET HUM TOXICOL, V41, P175; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUSICK D, 1986, MUTAT RES, V169, P115, DOI 10.1016/0165-1218(86)90090-X; BRUSICK D, 1986, MUTAT RES, V169, P105, DOI 10.1016/0165-1218(86)90089-3; Cao P, 2006, J STRUCT BIOL, V154, P327, DOI 10.1016/j.jsb.2006.02.008; Clayton PT, 2006, J INHERIT METAB DIS, V29, P317, DOI 10.1007/s10545-005-0243-2; DELPORT R, 1993, RES COMMUN CHEM PATH, V79, P325; DELPORT R, 1988, INT J VITAM NUTR RES, V58, P67; DELPORT R, 1990, INT J VITAM NUTR RES, V60, P35; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fiehe K, 2000, J NAT PROD, V63, P185, DOI 10.1021/np990414+; Gandhi AK, 2009, BIOCHEM BIOPH RES CO, V381, P12, DOI 10.1016/j.bbrc.2009.01.170; GLENN GM, 1995, VET HUM TOXICOL, V37, P342; Jang YM, 2003, J BIOL CHEM, V278, P50040, DOI 10.1074/jbc.M309619200; Kastner U, 2007, FEBS J, V274, P1036, DOI 10.1111/j.1742-4658.2007.05654.x; Kajiyama Y, 2002, PEDIATRICS, V109, P325, DOI 10.1542/peds.109.2.325; Kuwahara Hiroya, 2008, Rinsho Shinkeigaku, V48, P125; LaineCessac P, 1997, BIOCHEM PHARMACOL, V54, P863, DOI 10.1016/S0006-2952(97)00252-9; Leistner E, 2010, J NAT PROD, V73, P86, DOI 10.1021/np9005019; Li MH, 2004, J BIOL CHEM, V279, P17459, DOI 10.1074/jbc.M312380200; Li MH, 2002, J BIOL CHEM, V277, P46385, DOI 10.1074/jbc.M208600200; McCormick DB, 1999, J NUTR, V129, P325; Musayev FN, 2007, PROTEIN SCI, V16, P2184, DOI 10.1110/ps.073022107; Newman JA, 2006, J MOL BIOL, V363, P520, DOI 10.1016/j.jmb.2006.08.013; NITSCH C, 1976, BRAIN RES, V105, P173, DOI 10.1016/0006-8993(76)90934-3; Safo MK, 2006, J BACTERIOL, V188, P4542, DOI 10.1128/JB.00122-06; Safo MK, 2004, J BACTERIOL, V186, P8074, DOI 10.1128/JB.186.23.8074-8082.2004; Seto Toshiyuki, 2000, No To Hattatsu, V32, P295; Spinneker A, 2007, NUTR HOSP, V22, P7; Steichen O, 2006, REV MAL RESPIR, V23, P157, DOI 10.1016/S0761-8425(06)71480-2; Tang L, 2005, J BIOL CHEM, V280, P31220, DOI 10.1074/jbc.M500805200; TARKA SM, 1982, CRC CR REV TOXICOL, V9, P275, DOI 10.3109/10408448209037495; TARKA SM, 1991, FOOD CHEM TOXICOL, V29, P7, DOI 10.1016/0278-6915(91)90057-E; Tutor-Crespo MJ, 2004, CLIN BIOCHEM, V37, P714, DOI 10.1016/j.clinbiochem.2004.03.007; UBBINK JB, 1990, ENZYME, V43, P72, DOI 10.1159/000468709; UBBINK JB, 1990, ANN NY ACAD SCI, V585, P285, DOI 10.1111/j.1749-6632.1990.tb28061.x; UBBINK JB, 1990, J NUTR, V120, P1352, DOI 10.1093/jn/120.11.1352; UBBINK JB, 1989, J LAB CLIN MED, V113, P15; WADA K, 1985, CHEM PHARM BULL, V33, P3555; Wada Keiji, 2005, Chudoku Kenkyu, V18, P11; WEIR MR, 1990, ANN ALLERGY, V65, P59; WEIR MR, 1991, VET HUM TOXICOL, V33, P118; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	48	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40954	10.1371/journal.pone.0040954	http://dx.doi.org/10.1371/journal.pone.0040954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22879864	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900062
J	Castagnini, M; Picchianti, M; Talluri, E; Biagini, M; Del Vecchio, M; Di Procolo, P; Norais, N; Nardi-Dei, V; Balducci, E				Castagnini, Marta; Picchianti, Monica; Talluri, Eleonora; Biagini, Massimiliano; Del Vecchio, Mariangela; Di Procolo, Paolo; Norais, Nathalie; Nardi-Dei, Vincenzo; Balducci, Enrico			Arginine-Specific Mono ADP-Ribosylation In Vitro of Antimicrobial Peptides by ADP-Ribosylating Toxins	PLOS ONE			English	Article							ENZYMATIC-ACTIVITY; CHOLERA-TOXIN; DEFENSINS; RIBOSYLTRANSFERASE; MECHANISM; PROTEINS; FAMILY; FORMS; ARG	Among the several toxins used by pathogenic bacteria to target eukaryotic host cells, proteins that exert ADP-ribosylation activity represent a large and studied family of dangerous and potentially lethal toxins. These proteins alter cell physiology catalyzing the transfer of the ADP-ribose unit from NAD to cellular proteins involved in key metabolic pathways. In the present study, we tested the capability of four of these toxins, to ADP-ribosylate alpha- and beta-defensins. Cholera toxin (CT) from Vibrio cholerae and heat labile enterotoxin (LT) from Escherichia coli both modified the human alpha-defensin (HNP-1) and beta-defensin-1 (HBD1), as efficiently as the mammalian mono-ADP-ribosyltransferase-1. Pseudomonas aeruginosa exoenzyme S was inactive on both HNP-1 and HBD1. Neisseria meningitidis NarE poorly recognized HNP-1 as a substrate but it was completely inactive on HBD1. On the other hand, HNP-1 strongly influenced NarE inhibiting its transferase activity while enhancing auto-ADP-ribosylation. We conclude that only some arginine-specific ADP-ribosylating toxins recognize defensins as substrates in vitro. Modifications that alter the biological activities of antimicrobial peptides may be relevant for the innate immune response. In particular, ADP-ribosylation of antimicrobial peptides may represent a novel escape mechanism adopted by pathogens to facilitate colonization of host tissues.	[Castagnini, Marta; Picchianti, Monica; Talluri, Eleonora; Biagini, Massimiliano; Del Vecchio, Mariangela; Di Procolo, Paolo; Norais, Nathalie; Nardi-Dei, Vincenzo] Novartis Vaccines & Diagnost, Siena, Italy; [Balducci, Enrico] Univ Camerino, Sch Biosci & Biotechnol, I-62032 Camerino, Italy; [Picchianti, Monica] Univ Siena, Dept Evolut Biol, I-53100 Siena, Italy	Novartis; University of Camerino; University of Siena	Castagnini, M (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	enrico.balducci@unicam.it		Balducci, Enrico/0000-0001-6147-9033	Novartis Vaccines Diagnostics; Province of Siena; Monte dei Paschi di Siena Foundation	Novartis Vaccines Diagnostics; Province of Siena; Monte dei Paschi di Siena Foundation	This study was supported by Novartis Vaccines & Diagnostics and by the Province of Siena and the Monte dei Paschi di Siena Foundation, which granted a fellowship to Marta Castagnini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; CERVANTESLAUREAN D, 1993, BIOCHEMISTRY-US, V32, P1528, DOI 10.1021/bi00057a017; de Leeuw E, 2009, FEBS LETT, V583, P2507, DOI 10.1016/j.febslet.2009.06.051; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Ganesan AK, 1998, J BIOL CHEM, V273, P7332, DOI 10.1074/jbc.273.13.7332; Giesemann T, 2008, GASTROENTEROLOGY, V134, P2049, DOI 10.1053/j.gastro.2008.03.008; Glowacki G, 2002, PROTEIN SCI, V11, P1657, DOI 10.1110/ps.0200602; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; KHARADIA SV, 1987, J BIOL CHEM, V262, P17379; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Kim C, 2006, BIOCHEM J, V399, P225, DOI 10.1042/BJ20060425; KochNolte F, 1997, GENOMICS, V39, P370, DOI 10.1006/geno.1996.4520; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Masignani V, 2003, MOL MICROBIOL, V50, P1055, DOI 10.1046/j.1365-2958.2003.03770.x; MATSUURA R, 1988, BIOCHEM J, V253, P923, DOI 10.1042/bj2530923; MCDONALD LJ, 1994, MOL CELL BIOCHEM, V138, P201, DOI 10.1007/BF00928462; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5849; MOSS J, 1981, P NATL ACAD SCI-BIOL, V78, P4809, DOI 10.1073/pnas.78.8.4809; MOSS J, 1976, P NATL ACAD SCI USA, V73, P4424, DOI 10.1073/pnas.73.12.4424; MOSS J, 1977, J BIOL CHEM, V252, P2455; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; MOSS J, 1979, J BIOL CHEM, V254, P6270; Okazaki IJ, 1996, J BIOL CHEM, V271, P22052, DOI 10.1074/jbc.271.36.22052; OKAZAKI IJ, 1994, BIOCHEMISTRY-US, V33, P12828, DOI 10.1021/bi00209a014; Paone G, 2002, P NATL ACAD SCI USA, V99, P8231, DOI 10.1073/pnas.122238899; Paone G, 2006, J BIOL CHEM, V281, P17054, DOI 10.1074/jbc.M603042200; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Riese MJ, 2002, J BIOL CHEM, V277, P12082, DOI 10.1074/jbc.M109039200; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yadollahi-Farsani M, 1999, EUR J BIOCHEM, V262, P342, DOI 10.1046/j.1432-1327.1999.00368.x; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	38	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41417	10.1371/journal.pone.0041417	http://dx.doi.org/10.1371/journal.pone.0041417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879887	Green Published, Green Submitted, gold			2022-12-27	WOS:000307437900010
J	Cooper, N; Kamilar, JM; Nunn, CL				Cooper, Natalie; Kamilar, Jason M.; Nunn, Charles L.			Host Longevity and Parasite Species Richness in Mammals	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; DISEASE; EVOLUTION; PATTERNS; RISK; CARNIVORES; DATABASE; DENSITY; RECORDS; RANGE	Hosts and parasites co-evolve, with each lineage exerting selective pressures on the other. Thus, parasites may influence host life-history characteristics, such as longevity, and simultaneously host life-history may influence parasite diversity. If parasite burden causes increased mortality, we expect a negative association between host longevity and parasite species richness. Alternatively, if long-lived species represent a more stable environment for parasite establishment, host longevity and parasite species richness may show a positive association. We tested these two opposing predictions in carnivores, primates and terrestrial ungulates using phylogenetic comparative methods and controlling for the potentially confounding effects of sampling effort and body mass. We also tested whether increased host longevity is associated with increased immunity, using white blood cell counts as a proxy for immune investment. Our analyses revealed weak relationships between parasite species richness and longevity. We found a significant negative relationship between longevity and parasite species richness for ungulates, but no significant associations in carnivores or primates. We also found no evidence for a relationship between immune investment and host longevity in any of our three groups. Our results suggest that greater parasite burden is linked to higher host mortality in ungulates. Thus, shorter-lived ungulates may be more vulnerable to disease outbreaks, which has implications for ungulate conservation, and may be applicable to other shortlived mammals.	[Cooper, Natalie; Nunn, Charles L.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Cooper, Natalie] Trinity Coll Dublin, Sch Nat Sci, Dublin, Ireland; [Cooper, Natalie] Trinity Coll Dublin, Trinity Ctr Biodivers Res, Dublin, Ireland; [Kamilar, Jason M.] Midwestern Univ, Dept Anat, Glendale, AZ USA; [Kamilar, Jason M.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA	Harvard University; Trinity College Dublin; Trinity College Dublin; Midwestern University; Arizona State University; Arizona State University-Tempe	Cooper, N (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	ncooper@tcd.ie	Cooper, Natalie/I-7976-2012	Cooper, Natalie/0000-0003-4919-8655; Kamilar, Jason/0000-0001-6082-9396	Harvard University	Harvard University	This work was funded by Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Anderson MJ, 2004, J REPROD IMMUNOL, V61, P31, DOI 10.1016/j.jri.2003.11.001; ANDERSON R M, 1991; [Anonymous], 1999, WALKERS MAMMALS WORL; BELL G, 1991, J ANIM ECOL, V60, P1047, DOI 10.2307/5430; Belsey DA, 1980, REGRESSION DIAGNOSTI; Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blumstein DT, 2008, BIOL LETTERS, V4, P146, DOI 10.1098/rsbl.2007.0606; Bordes F, 2009, AM NAT, V173, P467, DOI 10.1086/597227; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Ezenwa VO, 2006, OIKOS, V115, P526, DOI 10.1111/j.2006.0030-1299.15186.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; GAILLARD JM, 1989, OIKOS, V56, P59, DOI 10.2307/3566088; Garamszegi LZ, 2011, J EVOLUTION BIOL, V24, P184, DOI 10.1111/j.1420-9101.2010.02156.x; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Gregory RD, 1996, BIODIVERS CONSERV, V5, P985, DOI 10.1007/BF00054416; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; Huffman M.A., 2007, PRIMATES PERSPECTIVE, P677; *INT SPEC INF SYST, 2002, PHYS REF VAL CD ROM; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jones KE, 1997, FUNCT ECOL, V11, P751, DOI 10.1046/j.1365-2435.1997.00149.x; Kamilar JM, 2010, BIOL LETTERS, V6, P736, DOI 10.1098/rsbl.2010.0348; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Lindenfors P, 2007, GLOBAL ECOL BIOGEOGR, V16, P496, DOI 10.1111/j.1466-8238.2006.00301.x; McCallum H, 2006, PLOS BIOL, V4, P1671, DOI 10.1371/journal.pbio.0040342; Moore J., 2002, PARASITES BEHAV ANIM; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Morand S, 2000, P ROY SOC B-BIOL SCI, V267, P1999, DOI 10.1098/rspb.2000.1241; Musser G G, 1993, MAMMAL SPECIES WORLD; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; Nunn CL, 2005, EVOL ANTHROPOL, V14, P1, DOI 10.1002/evan.20041; Nunn CL, 2003, AM NAT, V162, P597, DOI 10.1086/378721; Nunn CL, 2003, P ROY SOC B-BIOL SCI, V270, P347, DOI 10.1098/rspb.2002.2249; Nunn CL, 2006, INFECT DIS PRIMATES; ORME C. D. L., 2012, CAPER COMP ANAL PHYL; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poulin R, 2000, Q REV BIOL, V75, P277, DOI 10.1086/393500; Previtali MA, 2012, OIKOS, V121, P1483, DOI 10.1111/j.1600-0706.2012.020215.x; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Samuel W.M., 2001, PARASITIC DIS WILD M; Stanko M, 2002, OECOLOGIA, V131, P289, DOI 10.1007/s00442-002-0889-5; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Thomas F, 2004, J EVOLUTION BIOL, V17, P542, DOI 10.1111/j.1420-9101.2004.00705.x; Torres J, 2006, BIODIVERS CONSERV, V15, P4619, DOI 10.1007/s10531-005-5824-8; Williams E. S., 2001, INFECT DIS WILD MAMM; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	60	37	37	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42190	10.1371/journal.pone.0042190	http://dx.doi.org/10.1371/journal.pone.0042190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879916	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000020
J	Steinstraesser, L; Hirsch, T; Schulte, M; Kueckelhaus, M; Jacobsen, F; Mersch, EA; Stricker, I; Afacan, N; Jenssen, H; Hancock, REW; Kindrachuk, J				Steinstraesser, Lars; Hirsch, Tobias; Schulte, Matthias; Kueckelhaus, Maximilian; Jacobsen, Frank; Mersch, Evgenija A.; Stricker, Ingo; Afacan, Nicole; Jenssen, Havard; Hancock, Robert E. W.; Kindrachuk, Jason			Innate Defense Regulator Peptide 1018 in Wound Healing and Wound Infection	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; ANTIBACTERIAL PEPTIDE; ANTIINFECTIVE PEPTIDE; LL-37; IMMUNITY; RECEPTOR; ANGIOGENESIS; CHEMOTAXIS; RELEASE; SURFACE	Innate defense regulators (IDRs) are synthetic immunomodulatory versions of natural host defense peptides (HDP). IDRs mediate protection against bacterial challenge in the absence of direct antimicrobial activity, representing a novel approach to anti-infective and anti-inflammatory therapy. Previously, we reported that IDR-1018 selectively induced chemokine responses and suppressed pro-inflammatory responses. As there has been an increasing appreciation for the ability of HDPs to modulate complex immune processes, including wound healing, we characterized the wound healing activities of IDR-1018 in vitro. Further, we investigated the efficacy of IDR-1018 in diabetic and non-diabetic wound healing models. In all experiments, IDR-1018 was compared to the human HDP LL-37 and HDP-derived wound healing peptide HB-107. IDR-1018 was significantly less cytotoxic in vitro as compared to either LL-37 or HB-107. Furthermore, administration of IDR-1018 resulted in a dose-dependent increase in fibroblast cellular respiration. In vivo, IDR-1018 demonstrated significantly accelerated wound healing in S. aureus infected porcine and non-diabetic but not in diabetic murine wounds. However, no significant differences in bacterial colonization were observed. Our investigation demonstrates that in addition to previously reported immunomodulatory activities IDR-1018 promotes wound healing independent of direct antibacterial activity. Interestingly, these effects were not observed in diabetic wounds. It is anticipated that the wound healing activities of IDR-1018 can be attributed to modulation of host immune pathways that are suppressed in diabetic wounds and provide further evidence of the multiple immunomodulatory activities of IDR-1018.	[Steinstraesser, Lars; Hirsch, Tobias; Schulte, Matthias; Kueckelhaus, Maximilian; Jacobsen, Frank; Mersch, Evgenija A.] Ruhr Univ Bochum, Dept Plast Surg, BG Univ Hosp Bergmannsheil, Bochum, Germany; [Stricker, Ingo] Ruhr Univ Bochum, Inst Pathol, BG Univ Hosp Bergmannsheil, Bochum, Germany; [Afacan, Nicole; Hancock, Robert E. W.; Kindrachuk, Jason] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada; [Jenssen, Havard] Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark	Ruhr University Bochum; Ruhr University Bochum; University of British Columbia; Roskilde University	Steinstraesser, L (corresponding author), Ruhr Univ Bochum, Dept Plast Surg, BG Univ Hosp Bergmannsheil, Univ Str 150, Bochum, Germany.	lars.steinstraesser@ruhr-uni-bochum.de	Hirsch, Tobias/AAS-6707-2021; Hancock, Robert E. W./E-1145-2013	Hirsch, Tobias/0000-0002-3641-2707; Hancock, Robert E. W./0000-0001-5989-8503; Jenssen, Havard/0000-0003-0007-0335; Kindrachuk, Jason/0000-0002-3305-7084	Foundation for the National Institutes of Health and Canadian Institutes for Health Research through the Grand Challenges in Global Health Initiative; Canadian Cystic Fibrosis Foundation; Deutsche Forschungsgemeinschaft [Ste1099, HI1279/4-1]	Foundation for the National Institutes of Health and Canadian Institutes for Health Research through the Grand Challenges in Global Health Initiative; Canadian Cystic Fibrosis Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Financial Support to REWH from the Foundation for the National Institutes of Health and Canadian Institutes for Health Research through the Grand Challenges in Global Health Initiative is gratefully acknowledged. REWH is the recipient of a Canada Research Chair. JK was supported by a fellowship from the Canadian Cystic Fibrosis Foundation. The work was additionally supported by the Deutsche Forschungsgemeinschaft (Ste1099 to LS and HI1279/4-1 to TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; COLEMAN DL, 1982, DIABETES, V31, P1; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U; Gallo RL, 2002, J ALLERGY CLIN IMMUN, V110, P823, DOI 10.1067/mai.2002.129801; GALLO RL, 1994, P NATL ACAD SCI USA, V91, P11035, DOI 10.1073/pnas.91.23.11035; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Hirsch T, 2008, PROTEIN PEPTIDE LETT, V15, P238; Hirsch T, 2009, J GENE MED, V11, P220, DOI 10.1002/jgm.1287; Jacobsen F, 2005, J ANTIMICROB CHEMOTH, V55, P735, DOI 10.1093/jac/dki067; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Lee HY, 2008, BIOCHEM BIOPH RES CO, V369, P573, DOI 10.1016/j.bbrc.2008.02.046; Lee PHA, 2004, WOUND REPAIR REGEN, V12, P351, DOI 10.1111/j.1067-1927.2004.012303.x; Li J, 2000, NAT MED, V6, P49, DOI 10.1038/71527; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; Oono T, 2002, ARCH DERMATOL RES, V294, P185, DOI 10.1007/s00403-002-0310-6; Otte JM, 2009, REGUL PEPTIDES, V156, P104, DOI 10.1016/j.regpep.2009.03.009; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Shi JS, 1996, P NATL ACAD SCI USA, V93, P6014, DOI 10.1073/pnas.93.12.6014; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Steinstraesser L, 2004, BURNS, V30, P619, DOI 10.1016/j.burns.2004.05.013; Steinstraesser L, 2006, ANN PLAS SURG, V56, P93, DOI 10.1097/01.sap.0000190883.30005.91; Steinstraesser L, 2008, MOL MED, V14, P528, DOI 10.2119/2008-00002.Steinstraesser; Steinstraesser L, 2009, INT J MOL SCI, V10, P3951, DOI 10.3390/ijms10093951; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Wieczorek M, 2010, CHEM BIOL, V17, P970, DOI 10.1016/j.chembiol.2010.07.007; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Zhang LJ, 2009, CURR OPIN INVEST DR, V10, P164	38	100	108	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e39373	10.1371/journal.pone.0039373	http://dx.doi.org/10.1371/journal.pone.0039373			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879874	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000002
J	Rieger, G; Savin-Williams, RC				Rieger, Gerulf; Savin-Williams, Ritch C.			The Eyes Have It: Sex and Sexual Orientation Differences in Pupil Dilation Patterns	PLOS ONE			English	Article							AROUSAL PATTERNS; VIEWING TIME; SIZE CHANGES; GENDER; RAPE; MEN; WOMEN; SPECIFICITY; IDENTITY; BEHAVIOR	Recent research suggests profound sex and sexual orientation differences in sexual response. These results, however, are based on measures of genital arousal, which have potential limitations such as volunteer bias and differential measures for the sexes. The present study introduces a measure less affected by these limitations. We assessed the' pupil dilation of 325 men and women of various sexual orientations to male and female erotic stimuli. Results supported hypotheses. In general, self-reported sexual orientation corresponded with pupil dilation to men and women. Among men, substantial dilation to both sexes was most common in bisexual-identified men. In contrast, among women, substantial dilation to both sexes was most common in heterosexual-identified women. Possible reasons for these differences are discussed. Because the measure of pupil dilation is less invasive than previous measures of sexual response, it allows for studying diverse age and cultural populations, usually not included in sexuality research.	[Rieger, Gerulf; Savin-Williams, Ritch C.] Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA	Cornell University	Rieger, G (corresponding author), Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA.	Gerulf@cornell.edu		Rieger, Gerulf/0000-0002-4875-2629	American Institutes of Bisexuality; United States Department of Agruculture's Federal Formula Funds [NYC-321421]	American Institutes of Bisexuality; United States Department of Agruculture's Federal Formula Funds	This research was funded by the American Institutes of Bisexuality (http://www.bisexual.org/home.html) and the United States Department of Agruculture's Federal Formula Funds (http://cuaes.cornell.edu/support/index.cfm) given to Cornell University for project NYC-321421. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JM, 2011, ARCH SEX BEHAV, V40, P1293, DOI 10.1007/s10508-011-9778-5; Bailey JM, 2009, NEBR SYM MOTIV, V54, P43; Bailey JM, 2000, J PERS SOC PSYCHOL, V78, P524, DOI 10.1037//0022-3514.78.3.524; Bartlett NH, 2006, ARCH SEX BEHAV, V35, P659, DOI 10.1007/s10508-006-9055-1; Beatty J., 2000, HDB PSYCHOPHYSIOLOGY, P142; Blanchard R, 2001, PSYCHOL ASSESSMENT, V13, P118, DOI 10.1037/1040-3590.13.1.118; Blanchard R, 2012, ARCH SEX BEHAV, V41, P13, DOI 10.1007/s10508-010-9675-3; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Burri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021982; Card RD, 1990, ANN SEX RES, V3, P381, DOI DOI 10.1177/107906329000300401; Cardoso FL, 2010, SEX CULT, V14, P306, DOI 10.1007/s12119-010-9076-8; Cardoso FL, 2008, SEX CULT, V12, P21, DOI 10.1007/s12119-007-9014-6; Cerny JA, 2011, ARCH SEX BEHAV, V40, P687, DOI 10.1007/s10508-011-9746-0; Chivers ML, 2007, J PERS SOC PSYCHOL, V93, P1108, DOI 10.1037/0022-3514.93.6.1108; Chivers ML, 2010, ARCH SEX BEHAV, V39, P5, DOI 10.1007/s10508-009-9556-9; Chivers ML, 2004, PSYCHOL SCI, V15, P736, DOI 10.1111/j.0956-7976.2004.00750.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Diamond L. M., 2008, SEXUAL FLUIDITY UNDE; Dixson A.F., 2010, ANIMAL HOMOSEXUALITY, P381; Drummond KD, 2008, DEV PSYCHOL, V44, P34, DOI 10.1037/0012-1649.44.1.34; ELLIS L, 1987, PSYCHOL BULL, V101, P233, DOI 10.1037/0033-2909.101.2.233; Freeman JB, 2010, PERS SOC PSYCHOL B, V36, P1318, DOI 10.1177/0146167210378755; GALDIKAS BMF, 1985, AM J PRIMATOL, V8, P87, DOI 10.1002/ajp.1350080202; Golde JA, 2000, J SEX RES, V37, P53, DOI 10.1080/00224490009552020; Goldinger SD, 2012, CURR DIR PSYCHOL SCI, V21, P90, DOI 10.1177/0963721412436811; Heaver B, 2011, MEMORY, V19, P398, DOI 10.1080/09658211.2011.575788; HESS ECKHARD H., 1965, J ABNORM PSYCHOL, V70, P165, DOI 10.1037/h0021978; Hines M, 2010, HDB LIFE SPAN DEV; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Imhoff R, 2010, ARCH SEX BEHAV, V39, P1275, DOI 10.1007/s10508-009-9595-2; Israel E, 2009, ARCH SEX BEHAV, V38, P551, DOI 10.1007/s10508-007-9246-4; Janssen E., 2002, HDB CONDUCTING RES H, P139; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Johnson KL, 2007, J PERS SOC PSYCHOL, V93, P321, DOI 10.1037/0022-3514.93.3.321; JOHNSON MH, 1995, DEV PSYCHOBIOL, V28, P281, DOI 10.1002/dev.420280504; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; KINSMAN G, 1995, LABOUR-TRAVAIL, P133; Kinsman G, 2001, WHOSE NATL SECURITY, P143; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Lippa RA, 2008, ARCH SEX BEHAV, V37, P173, DOI 10.1007/s10508-007-9267-z; Lippa RA, 2005, ANN REV SEX RES, V16, P119; Lykins AD, 2008, ARCH SEX BEHAV, V37, P219, DOI 10.1007/s10508-007-9208-x; MCKINNEY F, 1983, BEHAVIOUR, V86, P250, DOI 10.1163/156853983X00390; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Otero SC, 2011, PSYCHOPHYSIOLOGY, V48, P1346, DOI 10.1111/j.1469-8986.2011.01217.x; PALMER C, 1989, ETHNOLOGY, V28, P1, DOI 10.2307/3773639; Peplau LA, 2003, CURR DIR PSYCHOL SCI, V12, P37, DOI 10.1111/1467-8721.01221; Peplau LA, 2001, PERS RELATIONSHIP, V8, P1, DOI 10.1111/j.1475-6811.2001.tb00025.x; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Quinsey VL, 1996, ETHOL SOCIOBIOL, V17, P341, DOI 10.1016/S0162-3095(96)00060-X; Rahman Q, 2003, PERS INDIV DIFFER, V34, P1337, DOI 10.1016/S0191-8869(02)00140-X; Rieger G, 2005, PSYCHOL SCI, V16, P579, DOI 10.1111/j.1467-9280.2005.01578.x; Rieger G, 2012, 2 ROUTES BISEXUALITY; Rieger G, 2008, DEV PSYCHOL, V44, P46, DOI 10.1037/0012-1649.44.1.46; Rieger G, 2012, ARCH SEX BEHAV, V41, P529, DOI 10.1007/s10508-012-9942-6; Rieger G, 2010, ARCH SEX BEHAV, V39, P124, DOI 10.1007/s10508-008-9405-2; Rosenthal AM, 2011, BIOL PSYCHOL, V88, P112, DOI 10.1016/j.biopsycho.2011.06.015; Rupp HA, 2008, ARCH SEX BEHAV, V37, P206, DOI 10.1007/s10508-007-9217-9; Rupp HA, 2007, HORM BEHAV, V51, P524, DOI 10.1016/j.yhbeh.2007.01.008; SANDAY PR, 1981, J SOC ISSUES, V37, P5, DOI 10.1111/j.1540-4560.1981.tb01068.x; Savin-Williams R C, 2005, NEW GAY TEENAGER; Savin-Williams RC, 2012, ARCH SEX BEHAV, V41, P103, DOI 10.1007/s10508-012-9913-y; Sawatsky John, 1980, MEN SHADOWS RCMP SEC; Slaughter L, 1997, AM J OBSTET GYNECOL, V176, P609, DOI 10.1016/S0002-9378(97)70556-8; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Stief M, 2012, PERSONLAITY BISEXUAL; ten Donkelaar HJ, 2011, CLIN NEUROANATOMY, DOI [10.1007/1978-1003-1642-19134-19133_19112, DOI 10.1007/1978-1003-1642-19134-19133_19112]; THORNHILL R, 1983, ETHOL SOCIOBIOL, V4, P137, DOI 10.1016/0162-3095(83)90027-4; THORNHILL R, 1980, ANIM BEHAV, V28, P52, DOI 10.1016/S0003-3472(80)80007-8; Tollison CD., 1979, J BEHAV ASSESS, V1, P305, DOI [10.1007/BF01321372, DOI 10.1007/BF01321372]; WALLEN K, 1995, CHIC SEX HIST SOC, P57; Wilson G., 2005, BORN GAY PSYCHOBIOLO; WOLCHIK SA, 1985, ARCH SEX BEHAV, V14, P93, DOI 10.1007/BF01541656	74	108	108	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e40256	10.1371/journal.pone.0040256	http://dx.doi.org/10.1371/journal.pone.0040256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22870196	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100007
J	Roier, S; Leitner, DR; Iwashkiw, J; Schild-Prufert, K; Feldman, MF; Krohne, G; Reidl, J; Schild, S				Roier, Sandro; Leitner, Deborah R.; Iwashkiw, Jeremy; Schild-Pruefert, Kristina; Feldman, Mario F.; Krohne, Georg; Reidl, Joachim; Schild, Stefan			Intranasal Immunization with Nontypeable Haemophilus influenzae Outer Membrane Vesicles Induces Cross-Protective Immunity in Mice	PLOS ONE			English	Article							DNA-BINDING VESICLES; OTITIS-MEDIA; HEMOPHILUS-INFLUENZAE; VIBRIO-CHOLERAE; CONJUGATE VACCINE; DETOXIFIED LIPOOLIGOSACCHARIDE; NASOPHARYNGEAL COLONIZATION; FUNCTIONAL-CHARACTERIZATION; CHANGING EPIDEMIOLOGY; MUCOSAL IMMUNIZATION	Haemophilus influenzae is a Gram-negative human-restricted bacterium that can act as a commensal and a pathogen of the respiratory tract. Especially nontypeable H. influenzae (NTHi) is a major threat to public health and is responsible for several infectious diseases in humans, such as pneumonia, sinusitis, and otitis media. Additionally, NTHi strains are highly associated with exacerbations in patients suffering from chronic obstructive pulmonary disease. Currently, there is no licensed vaccine against NTHi commercially available. Thus, this study investigated the utilization of outer membrane vesicles (OMVs) as a potential vaccine candidate against NTHi infections. We analyzed the immunogenic and protective properties of OMVs derived from various NTHi strains by means of nasopharyngeal immunization and colonization studies with BALB/c mice. The results presented herein demonstrate that an intranasal immunization with NTHi OMVs results in a robust and complex humoral and mucosal immune response. Immunoprecipitation revealed the most important immunogenic proteins, such as the heme utilization protein, protective surface antigen D15, heme binding protein A, and the outer membrane proteins P1, P2, P5 and P6. The induced immune response conferred not only protection against colonization with a homologous NTHi strain, which served as an OMV donor for the immunization mixtures, but also against a heterologous NTHi strain, whose OMVs were not part of the immunization mixtures. These findings indicate that OMVs derived from NTHi strains have a high potential to act as a vaccine against NTHi infections.	[Roier, Sandro; Leitner, Deborah R.; Schild-Pruefert, Kristina; Reidl, Joachim; Schild, Stefan] Graz Univ, Inst Mol Biosci, Graz, Austria; [Iwashkiw, Jeremy; Feldman, Mario F.] Univ Alberta, Alberta Glyc Ctr, Dept Biol Sci, Edmonton, AB, Canada; [Krohne, Georg] Univ Wurzburg, Div Electron Microscopy, Bioctr, Wurzburg, Germany	University of Graz; University of Alberta; University of Wurzburg	Roier, S (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	stefan.schild@uni-graz.at	Reidl, Joachim/O-2107-2016; Feldman, Mario/A-2637-2014	Feldman, Mario/0000-0003-4497-0976; Schild, Kristina/0000-0002-0154-7310; Reidl, Joachim/0000-0001-5798-9524; Schild, Stefan/0000-0001-7842-0177	Austrian Science Fund (FWF) [W901-B12, I 662-B09]; Alberta Glycomics Centre; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Alberta Glycomics Centre; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF): grant W901-B12 (DK Molecular Enzymology) to SR and SS and grant I 662-B09 to JR. The authors acknowledge the Alberta Glycomics Centre for funding to MFF. MFF is a Canadian Institutes of Health Research (CIHR) new investigator and Alberta Heritage Foundation for Medical Research (AHFMR) scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2010, VACCINE, V28, P4073, DOI 10.1016/j.vaccine.2010.03.075; Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; [Anonymous], 2008, WORLD HLTH STAT 2008; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; BARENKAMP SJ, 1982, INFECT IMMUN, V36, P535, DOI 10.1128/IAI.36.2.535-540.1982; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Bertot GM, 2004, J INFECT DIS, V189, P1304, DOI 10.1086/382508; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bishop AL, 2010, INFECT IMMUN, V78, P4402, DOI 10.1128/IAI.00398-10; Bolduc GR, 2000, INFECT IMMUN, V68, P4505, DOI 10.1128/IAI.68.8.4505-4517.2000; CAMPAGNARI AA, 1987, INFECT IMMUN, V55, P882, DOI 10.1128/IAI.55.4.882-887.1987; CARLONE GM, 1986, J CLIN MICROBIOL, V24, P330, DOI 10.1128/JCM.24.3.330-332.1986; Chang A, 2011, HUM VACCINES, V7, P102, DOI 10.4161/hv.7.1.13351; CONCINO MF, 1982, J BACTERIOL, V152, P441; Dalseg R, 1999, VACCINE, V17, P2336, DOI 10.1016/S0264-410X(99)00046-8; DEICH RA, 1982, J BACTERIOL, V152, P855; Dworkin MS, 2007, CLIN INFECT DIS, V44, P810, DOI 10.1086/511861; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Engskog MKR, 2011, CARBOHYD RES, V346, P1241, DOI 10.1016/j.carres.2011.04.030; Erwin AL, 2007, TRENDS MICROBIOL, V15, P355, DOI 10.1016/j.tim.2007.06.004; FADEN H, 1989, J INFECT DIS, V160, P999, DOI 10.1093/infdis/160.6.999; GANKEMA H, 1980, INFECT IMMUN, V29, P704; Gaucher SP, 2000, BIOCHEMISTRY-US, V39, P12406, DOI 10.1021/bi001181k; GROENEVELD K, 1988, J INFECT DIS, V158, P360, DOI 10.1093/infdis/158.2.360; GROENEVELD K, 1989, INFECT IMMUN, V57, P3038, DOI 10.1128/IAI.57.10.3038-3044.1989; Gu XX, 1996, INFECT IMMUN, V64, P4047, DOI 10.1128/IAI.64.10.4047-4053.1996; Gu XX, 2003, VACCINE, V21, P2107, DOI 10.1016/S0264-410X(02)00768-5; Gu XX, 1997, INFECT IMMUN, V65, P4488, DOI 10.1128/IAI.65.11.4488-4493.1997; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Hirano T, 2003, FEMS IMMUNOL MED MIC, V35, P1; Hirano T, 2006, IMMUNOL LETT, V107, P131, DOI 10.1016/j.imlet.2006.08.005; HOEKSTRA D, 1976, BIOCHIM BIOPHYS ACTA, V455, P889, DOI 10.1016/0005-2736(76)90058-4; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Hong WZ, 2007, J BACTERIOL, V189, P8300, DOI 10.1128/JB.00532-07; Hong WZ, 2010, MICROBES INFECT, V12, P11, DOI 10.1016/j.micinf.2009.09.006; Hotomi M, 2005, VACCINE, V23, P1294, DOI 10.1016/j.vaccine.2004.08.042; Johnston JW, 2009, ENCY MICROBIOLOGY, P153; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; KESAVALU L, 1992, INFECT IMMUN, V60, P1455, DOI 10.1128/IAI.60.4.1455-1464.1992; Kim SH, 2009, BBA-BIOMEMBRANES, V1788, P2150, DOI 10.1016/j.bbamem.2009.08.001; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOOS BG, 1989, INFECT IMMUN, V57, P2751, DOI 10.1128/IAI.57.9.2751-2757.1989; Loosmore SM, 1997, INFECT IMMUN, V65, P3701, DOI 10.1128/IAI.65.9.3701-3707.1997; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Malley R, 2012, P NATL ACAD SCI USA, V109, P3623, DOI 10.1073/pnas.1121383109; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; Mason KW, 2004, VACCINE, V22, P3449, DOI 10.1016/j.vaccine.2004.02.027; McConnell MJ, 2011, VACCINE, V29, P5705, DOI 10.1016/j.vaccine.2011.06.001; MCGHEE JR, 1992, VACCINE, V10, P75, DOI 10.1016/0264-410X(92)90021-B; Meats E, 2003, J CLIN MICROBIOL, V41, P1623, DOI 10.1128/JCM.41.4.1623-1636.2003; MESTECKY J, 1992, ADV EXP MED BIOL, V327, P13; Michel LV, 2011, VACCINE, V29, P1624, DOI 10.1016/j.vaccine.2010.12.082; Morris SK, 2008, LANCET INFECT DIS, V8, P435, DOI 10.1016/S1473-3099(08)70152-X; Morton DJ, 2009, INT J MED MICROBIOL, V299, P479, DOI 10.1016/j.ijmm.2009.03.004; Morton DJ, 2004, MICROBIOL-SGM, V150, P3923, DOI 10.1099/mic.0.27238-0; Morton DJ, 2005, FEMS MICROBIOL LETT, V253, P193, DOI 10.1016/j.femsle.2005.09.016; MURPHY TF, 1985, INFECT IMMUN, V50, P15, DOI 10.1128/IAI.50.1.15-21.1985; MURPHY TF, 1983, J INFECT DIS, V147, P838, DOI 10.1093/infdis/147.5.838; Murphy TF, 2006, CURR OPIN INFECT DIS, V19, P225, DOI 10.1097/01.qco.0000224815.89363.15; Murphy TF, 2006, INFECT IMMUN, V74, P5169, DOI 10.1128/IAI.00692-06; Murphy Timothy F, 2009, Curr Infect Dis Rep, V11, P177, DOI 10.1007/s11908-009-0027-1; Novotny LA, 2008, INFECT IMMUN, V76, P967, DOI 10.1128/IAI.01395-07; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; OGRA PL, 1974, J IMMUNOL, V112, P488; Olofsson A, 2010, MOL MICROBIOL, V77, P1539, DOI 10.1111/j.1365-2958.2010.07307.x; Ostberg KL, 2009, MUCOSAL IMMUNOL, V2, P63, DOI 10.1038/mi.2008.70; Pang B, 2008, INFECT IMMUN, V76, P2037, DOI 10.1128/IAI.01716-07; PHILLIPS NJ, 1992, BIOCHEMISTRY-US, V31, P4515, DOI 10.1021/bi00133a019; Poolman JT, 2000, VACCINE, V19, pS108, DOI 10.1016/S0264-410X(00)00288-7; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Rahman MM, 1999, GLYCOBIOLOGY, V9, P1371, DOI 10.1093/glycob/9.12.1371; Rao VK, 1999, FEMS MICROBIOL REV, V23, P99, DOI 10.1016/S0168-6445(98)00039-4; Roberts R, 2008, VACCINE, V26, P4639, DOI 10.1016/j.vaccine.2008.07.004; Saunders NB, 1999, INFECT IMMUN, V67, P113, DOI 10.1128/IAI.67.1.113-119.1999; Schild S, 2009, INFECT IMMUN, V77, P472, DOI 10.1128/IAI.01139-08; Schild S, 2008, INFECT IMMUN, V76, P4554, DOI 10.1128/IAI.00532-08; Schild S, 2007, CELL HOST MICROBE, V2, P264, DOI 10.1016/j.chom.2007.09.004; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; Sexton Kerry, 2004, N Z Med J, V117, pU1015; Sharpe SW, 2011, INFECT IMMUN, V79, P4361, DOI 10.1128/IAI.05332-11; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHURIN PA, 1980, J PEDIATR-US, V97, P364, DOI 10.1016/S0022-3476(80)80182-X; Singh B, 2010, J INFECT DIS, V201, P414, DOI 10.1086/649782; SLOYER JL, 1976, J CLIN MICROBIOL, V4, P306; SPINOLA SM, 1986, J INFECT DIS, V154, P100, DOI 10.1093/infdis/154.1.100; Tong HH, 2000, INFECT IMMUN, V68, P4593, DOI 10.1128/IAI.68.8.4593-4597.2000; Tsang RSW, 2007, CLIN INFECT DIS, V44, P1611, DOI 10.1086/518283; Ulanova M, 2009, INFECT GENET EVOL, V9, P594, DOI 10.1016/j.meegid.2009.03.001; vanAlphen L, 1997, MICROBIOL-SGM, V143, P1423, DOI 10.1099/00221287-143-4-1423; Vetvik H, 1998, J IMMUNOL METHODS, V215, P163, DOI 10.1016/S0022-1759(98)00089-1; WENSINK J, 1981, EUR J BIOCHEM, V116, P331, DOI 10.1111/j.1432-1033.1981.tb05338.x; WHITMIRE WM, 1993, INFECT IMMUN, V61, P1460, DOI 10.1128/IAI.61.4.1460-1467.1993; Wu TH, 2005, VACCINE, V23, P5177, DOI 10.1016/j.vaccine.2005.06.014	98	61	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42664	10.1371/journal.pone.0042664	http://dx.doi.org/10.1371/journal.pone.0042664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880074	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100153
J	Stump, MR; Gong, QM; Zhou, ZF				Stump, Matthew R.; Gong, Qiuming; Zhou, Zhengfeng			Isoform-Specific Dominant-Negative Effects Associated with hERG1 G628S Mutation in Long QT Syndrome	PLOS ONE			English	Article							SPLICE-SITE MUTATION; RECTIFIER K+ CURRENT; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; PHARMACOLOGICAL RESCUE; ENDOPLASMIC-RETICULUM; TUMOR-CELLS; EXPRESSION; TRAFFICKING; DOMAIN	Background: Mutations in the human ether-a-go-go-related gene 1 (hERG1) cause type 2 long QT syndrome (LQT2). The hERG1 gene encodes a K+ channel with properties similar to the rapidly activating delayed rectifying K+ current in the heart. Several hERG1 isoforms with unique structural and functional properties have been identified. To date, the pathogenic mechanisms of LQT2 mutations have been predominantly described in the context of the hERG1a isoform. In the present study, we investigated the functional consequences of the LQT2 mutation G628S in the hERG1b and hERG1a(USO) isoforms. Methods: A double-stable, mammalian expression system was developed to characterize isoform-specific dominant-negative effects of G628S-containing channels when co-expressed at equivalent levels with wild-type hERG1a. Western blot and co-immunoprecipitation studies were performed to study the trafficking and co-assembly of wild-type and mutant hERG1 isoforms. Patch-clamp electrophysiology was performed to characterize hERG1 channel function and the isoform-specific dominant-negative effects associated with the G628S mutation. Conclusions: The non-functional hERG1a-G628S and hERG1b-G628S channels co-assembled with wild-type hERG1a and dominantly suppressed hERG1 current. In contrast, G628S-induced dominant-negative effects were absent in the context of the hERG1a(USO) isoform. hERG1a(USO)-G628S channels did not appreciably associate with hERG1a and did not significantly suppress hERG1 current when co-expressed at equivalent ratios or at ratios that approximate those found in cardiac tissue. These results suggest that the dominant-negative effects of LQT2 mutations may primarily occur in the context of the hERG1a and hERG1b isoforms.	[Stump, Matthew R.; Gong, Qiuming; Zhou, Zhengfeng] Oregon Hlth & Sci Univ, Dept Med, Div Cardiovasc Med, Portland, OR 97201 USA	Oregon Health & Science University	Stump, MR (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Div Cardiovasc Med, Portland, OR 97201 USA.	zhouzh@ohsu.edu			National Institutes of Health [HL-68854]; American Heart Association postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by the National Institutes of Health grant HL-68854 to ZZ (www.nhlbi.nih.gov/). MRS was supported by an American Heart Association postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Babij P, 1998, CIRC RES, V83, P668, DOI 10.1161/01.RES.83.6.668; Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Crociani O, 2003, J BIOL CHEM, V278, P2947, DOI 10.1074/jbc.M210789200; Crotti L, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-18; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Ficker E, 2000, J MOL CELL CARDIOL, V32, P2327, DOI 10.1006/jmcc.2000.1263; Gong QM, 2008, J MOL CELL CARDIOL, V44, P502, DOI 10.1016/j.yjmcc.2008.01.002; Gong QM, 2010, J BIOL CHEM, V285, P32233, DOI 10.1074/jbc.M109.095695; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Gong QM, 2004, J MOL CELL CARDIOL, V37, P1225, DOI 10.1016/j.yjmcc.2004.10.002; Gong QM, 2004, AM J PHYSIOL-HEART C, V287, pH652, DOI 10.1152/ajpheart.00052.2004; Guasti L, 2008, MOL CELL BIOL, V28, P5043, DOI 10.1128/MCB.00304-08; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Hou L, 2010, CIRC RES; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; Larsen AP, 2008, PFLUG ARCH EUR J PHY, V456, P1137, DOI 10.1007/s00424-008-0476-7; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; LeesMiller JP, 1997, CIRC RES, V81, P719; London B, 1997, CIRC RES, V81, P870; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; Sanguinetti MC, 2010, PFLUG ARCH EUR J PHY, V460, P265, DOI 10.1007/s00424-009-0758-8; SAUER B, 1990, New Biologist, V2, P441; Stump MR, 2011, AM J PHYSIOL-HEART C, V300, pH312, DOI 10.1152/ajpheart.00818.2010; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Vandenbroucke I I, 2001, Nucleic Acids Res, V29, pE68, DOI 10.1093/nar/29.13.e68; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	41	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42552	10.1371/journal.pone.0042552	http://dx.doi.org/10.1371/journal.pone.0042552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876326	Green Published, Green Submitted, gold			2022-12-27	WOS:000307184700054
J	Weigand, JE; Boeckel, JN; Gellert, P; Dimmeler, S				Weigand, Julia E.; Boeckel, Jes-Niels; Gellert, Pascal; Dimmeler, Stefanie			Hypoxia-Induced Alternative Splicing in Endothelial Cells	PLOS ONE			English	Article							GENE-EXPRESSION; DOWN-REGULATION; ROBO3 ISOFORMS; PROTEIN; RNA; TRANSCRIPTION; ANGIOGENESIS; SYNDECAN-2; PROMOTER; CUGBP1	Background: Adaptation to low oxygen by changing gene expression is vitally important for cell survival and tissue development. The sprouting of new blood vessels, initiated from endothelial cells, restores the oxygen supply of ischemic tissues. In contrast to the transcriptional response induced by hypoxia, which is mainly mediated by members of the HIF family, there are only few studies investigating alternative splicing events. Therefore, we performed an exon array for the genome-wide analysis of hypoxia-related changes of alternative splicing in endothelial cells. Methodology/Principal findings: Human umbilical vein endothelial cells (HUVECs) were incubated under hypoxic conditions (1% O-2) for 48 h. Genome-wide transcript and exon expression levels were assessed using the Affymetrix GeneChip Human Exon 1.0 ST Array. We found altered expression of 294 genes after hypoxia treatment. Upregulated genes are highly enriched in glucose metabolism and angiogenesis related processes, whereas downregulated genes are mainly connected to cell cycle and DNA repair. Thus, gene expression patterns recapitulate known adaptations to low oxygen supply. Alternative splicing events, until now not related to hypoxia, are shown for nine genes: six which are implicated in angiogenesis-mediated cytoskeleton remodeling (cask, itsn1, larp6, sptan1, tpm1 and robo1); one, which is involved in the synthesis of membrane-anchors (pign) and two universal regulators of gene expression (cugbp1 and max). Conclusions/Significance: For the first time, this study investigates changes in splicing in the physiological response to hypoxia on a genome-wide scale. Nine alternative splicing events, until now not related to hypoxia, are reported, considerably expanding the information on splicing changes due to low oxygen supply. Therefore, this study provides further knowledge on hypoxia induced gene expression changes and presents new starting points to study the hypoxia adaptation of endothelial cells.	[Weigand, Julia E.; Boeckel, Jes-Niels; Dimmeler, Stefanie] Goethe Univ Frankfurt, Inst Cardiovasc Regenerat, Ctr Mol Med, Frankfurt, Germany; [Gellert, Pascal] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Goethe University Frankfurt; Max Planck Society	Weigand, JE (corresponding author), Goethe Univ Frankfurt, Inst Cardiovasc Regenerat, Ctr Mol Med, Frankfurt, Germany.	weigand@bio.tu-darmstadt.de		Dimmeler, Stefanie/0000-0002-1045-2436; Weigand, Julia/0000-0003-4247-1348; Gellert, Pascal/0000-0001-9325-025X	DFG [Exc 147-1]	DFG(German Research Foundation (DFG))	The study was supported by the DFG (Exc 147-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson A, 2010, MICROVASC RES, V80, P65, DOI 10.1016/j.mvr.2010.02.001; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Cai L, 2010, J MOL BIOL, V395, P309, DOI 10.1016/j.jmb.2009.11.020; Camurri L, 2005, MOL CELL NEUROSCI, V30, P485, DOI 10.1016/j.mcn.2005.07.014; Challa AK, 2005, MECH DEVELOP, V122, P1073, DOI 10.1016/j.mod.2005.06.006; Chao HW, 2008, J CELL BIOL, V182, P141, DOI 10.1083/jcb.200712094; Clark K, 2002, FEBS LETT, V523, P12, DOI 10.1016/S0014-5793(02)02904-6; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Danesh-Meyer HV, 2012, BRAIN, V135, P506, DOI 10.1093/brain/awr338; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Del Rey MJ, 2010, ARTHRITIS RHEUM-US, V62, P3584, DOI 10.1002/art.27750; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gaber T, 2009, J RHEUMATOL, V36, P2655, DOI 10.3899/jrheum.090255; Gale NW, 1997, CELL TISSUE RES, V290, P227, DOI 10.1007/s004410050927; Gang HY, 2011, CIRC RES, V108, P1084, DOI 10.1161/CIRCRESAHA.110.238709; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Geiger K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026465; Gellert P, 2009, BIOINFORMATICS, V25, P3323, DOI 10.1093/bioinformatics/btp577; Glenn HL, 2010, AM J PHYSIOL-CELL PH, V298, pC46, DOI 10.1152/ajpcell.00387.2009; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gorospe M, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00007; Granes F, 1999, EXP CELL RES, V248, P439, DOI 10.1006/excr.1999.4437; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Hang XY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-126; Higashide S, 2004, J NEUROCHEM, V91, P1191, DOI 10.1111/j.1471-4159.2004.02798.x; Hirschfeld M, 2009, CANCER RES, V69, P2082, DOI 10.1158/0008-5472.CAN-08-1997; Hohenester E, 2006, BIOCHEM SOC T, V34, P418, DOI 10.1042/BST0340418; Hooker CW, 2006, J CELL SCI, V119, P208, DOI 10.1242/jcs.02815; Hsueh YP, 2009, ANN NEUROL, V66, P438, DOI 10.1002/ana.21755; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huichalaf CH, 2007, GENE, V396, P391, DOI 10.1016/j.gene.2007.04.022; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Liu Z, 2004, MOL CELL NEUROSCI, V26, P232, DOI 10.1016/j.mcn.2004.01.002; MAKELA TP, 1992, SCIENCE, V256, P373, DOI 10.1126/science.256.5055.373; Makino Y, 2002, J BIOL CHEM, V277, P32405, DOI 10.1074/jbc.C200328200; Matsushita S, 2006, J HISTOCHEM CYTOCHEM, V54, P343, DOI 10.1369/jhc.4A6611.2005; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mills JD, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.030; Moller-Levet CS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000571; Mori R, 2006, J CELL SCI, V119, P5193, DOI 10.1242/jcs.03320; Mykhalchenko V G, 2008, Ukr Biokhim Zh (1999), V80, P19; Noguer O, 2009, EXP CELL RES, V315, P795, DOI 10.1016/j.yexcr.2008.11.016; Nural HF, 2007, GENE EXPR PATTERNS, V7, P837, DOI 10.1016/j.modgep.2007.07.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Philippova M, 2006, ARTERIOSCL THROM VAS, V26, P2222, DOI 10.1161/01.ATV.0000238356.20565.92; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Qi J, 2005, BIOCHEM BIOPH RES CO, V328, P517, DOI 10.1016/j.bbrc.2005.01.014; Qu Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-211; Rattenbacher B, 2010, MOL CELL BIOL, V30, P3970, DOI 10.1128/MCB.00624-10; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Scheurer SB, 2004, PROTEOMICS, V4, P1737, DOI 10.1002/pmic.200300689; Sheldon H, 2009, FASEB J, V23, P513, DOI 10.1096/fj.07-098269; Shichiri M, 1999, MOL ENDOCRINOL, V13, P1353, DOI 10.1210/me.13.8.1353; Sorensen BS, 2010, ACTA ONCOL, V49, P895, DOI 10.3109/02841861003614343; Sugnet C W, 2004, Pac Symp Biocomput, P66; Sun QZ, 2010, INT J BIOCHEM CELL B, V42, P90, DOI 10.1016/j.biocel.2009.09.011; Sun Rong-ju, 2011, Zhonghua Shao Shang Za Zhi, V27, P156; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Ursitti JA, 2007, J MOL CELL CARDIOL, V42, P572, DOI 10.1016/j.yjmcc.2006.11.018; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Welch MD, 1999, TRENDS CELL BIOL, V9, P423, DOI 10.1016/S0962-8924(99)01651-7; Weng HF, 2009, CELL MOL BIOL LETT, V14, P273, DOI 10.2478/s11658-008-0046-1; Yu Y, 2008, HUM MOL GENET, V17, P3281, DOI 10.1093/hmg/ddn224; Yue Y, 2006, GENOMICS, V88, P772, DOI 10.1016/j.ygeno.2006.05.011; Zeevi-Levin N, 2005, CARDIOVASC RES, V66, P64, DOI 10.1016/j.cardiores.2005.01.014; Zhu LL, 2011, CELL REPROGRAM, V13, P113, DOI 10.1089/cell.2010.0043	79	58	60	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42697	10.1371/journal.pone.0042697	http://dx.doi.org/10.1371/journal.pone.0042697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876330	Green Published, gold, Green Submitted			2022-12-27	WOS:000307184700058
J	Gong, SQ; Epasinghe, J; Rueggeberg, FA; Niu, LN; Mettenberg, D; Yiu, CKY; Blizzard, JD; Wu, CD; Mao, J; Drisko, CL; Pashley, DH; Tay, FR				Gong, Shi-qiang; Epasinghe, Jeevani; Rueggeberg, Frederick A.; Niu, Li-na; Mettenberg, Donald; Yiu, Cynthia K. Y.; Blizzard, John D.; Wu, Christine D.; Mao, Jing; Drisko, Connie L.; Pashley, David H.; Tay, Franklin R.			An ORMOSIL-Containing Orthodontic Acrylic Resin with Concomitant Improvements in Antimicrobial and Fracture Toughness Properties	PLOS ONE			English	Article							QUATERNARY AMMONIUM-SALTS; DENTURE BASE RESIN; CANDIDA-ALBICANS; BACTERIAL ADHESION; BIOFILM FORMATION; ORAL COLONIZATION; CALCIUM-PHOSPHATE; SILANE COATINGS; IN-VITRO; TEMPERATURE	Global increase in patients seeking orthodontic treatment creates a demand for the use of acrylic resins in removable appliances and retainers. Orthodontic removable appliance wearers have a higher risk of oral infections that are caused by the formation of bacterial and fungal biofilms on the appliance surface. Here, we present the synthetic route for an antibacterial and antifungal organically-modified silicate (ORMOSIL) that has multiple methacryloloxy functionalities attached to a siloxane backbone (quaternary ammonium methacryloxy silicate, or QAMS). By dissolving the water-insoluble, rubbery ORMOSIL in methyl methacrylate, QAMS may be copolymerized with polymethyl methacrylate, and covalently incorporated in the pressure-processed acrylic resin. The latter demonstrated a predominantly contact-killing effect on Streptococcus mutans ATCC 36558 and Actinomyces naselundii ATCC 12104 biofilms, while inhibiting adhesion of Candida albicans ATCC 90028 on the acrylic surface. Apart from its favorable antimicrobial activities, QAMS-containing acrylic resins exhibited decreased water wettability and improved toughness, without adversely affecting the flexural strength and modulus, water sorption and solubility, when compared with QAMS-free acrylic resin. The covalently bound, antimicrobial orthodontic acrylic resin with improved toughness represents advancement over other experimental antimicrobial acrylic resin formulations, in its potential to simultaneously prevent oral infections during appliance wear, and improve the fracture resistance of those appliances.	[Gong, Shi-qiang; Mao, Jing] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Stomatol, Wuhan 430074, Peoples R China; [Epasinghe, Jeevani; Yiu, Cynthia K. Y.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Rueggeberg, Frederick A.; Mettenberg, Donald; Drisko, Connie L.; Pashley, David H.; Tay, Franklin R.] Georgia Hlth Sci Univ, Coll Dent Med, Augusta, GA USA; [Niu, Li-na] Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Peoples R China; [Blizzard, John D.] Quadsil Inc, Midland, MI USA; [Wu, Christine D.] Univ Illinois, Coll Dent, Chicago, IL USA	Huazhong University of Science & Technology; University of Hong Kong; University System of Georgia; Augusta University; Air Force Military Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gong, SQ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Stomatol, Wuhan 430074, Peoples R China.	maojing1999@yahoo.com; ftay@georgiahealth.edu	Yiu, Cynthia/B-2183-2009; niu, lina/GWR-3585-2022; Rueggeberg, Frederick/N-8182-2017; Gong, Shi-qiang/HGB-7742-2022	Gong, Shi-qiang/0000-0001-9796-4081; Rueggeberg, Frederick/0000-0003-1947-3337; /0000-0003-4090-6205	NIDCR [R01 DE015306-06]; Georgia Health Sciences University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015306] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Georgia Health Sciences University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grant R01 DE015306-06 from NIDCR (PI. David Pashley) and the ERA award from Georgia Health Sciences University (PI. Franklin Tay). The authors thank David Lang, Lang Dental Manufacturing Co. Inc., for supplying the Ortho-Jet acrylic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom B, 1999, APMIS, V107, P318, DOI 10.1111/j.1699-0463.1999.tb01560.x; An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4; Antonucci JM, 2012, DENT MATER, V28, P219, DOI 10.1016/j.dental.2011.10.004; ARENDORF T, 1985, J CLIN PERIODONTOL, V12, P360, DOI 10.1111/j.1600-051X.1985.tb00926.x; Batoni G, 2001, EUR J ORAL SCI, V109, P388, DOI 10.1034/j.1600-0722.2001.00089.x; Bjerklin K, 1983, Br J Orthod, V10, P21; Cannon RD, 1999, CRIT REV ORAL BIOL M, V10, P359, DOI 10.1177/10454411990100030701; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Cheng L, 2012, J DENT RES, V91, P460, DOI 10.1177/0022034512440579; Cheng L, 2012, DENT MATER, V28, P561, DOI 10.1016/j.dental.2012.01.005; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; de Paz LEC, 2009, APPL ENVIRON MICROB, V75, P1734, DOI 10.1128/AEM.02000-08; Gong SQ, 2012, ACTA BIOMATER, V8, P3270, DOI 10.1016/j.actbio.2012.05.031; Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0; Grave A M, 1985, Dent Mater, V1, P185, DOI 10.1016/S0109-5641(85)80015-4; HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Hibino K, 2009, INT J PAEDIATR DENT, V19, P301, DOI 10.1111/j.1365-263X.2009.00988.x; Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014; International Organization for Standardization, 2010, 207952 ISO; Ishida H, 1998, ANTIMICROB AGENTS CH, V42, P1641, DOI 10.1128/AAC.42.7.1641; ISQUITH AJ, 1972, APPL MICROBIOL, V24, P859, DOI 10.1128/AEM.24.6.859-863.1972; Jin Y, 2004, ARCH ORAL BIOL, V49, P789, DOI 10.1016/j.archoralbio.2004.04.011; Kanie T, 2000, DENT MATER, V16, P150, DOI 10.1016/S0109-5641(99)00097-4; Kassaee MZ, 2008, J APPL POLYM SCI, V110, P1699, DOI 10.1002/app.28762; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; King G, ACCESS ORTHODONTIC S; Kopecky F, 1996, PHARMAZIE, V51, P135; Leggat PA, 2003, INT DENT J, V53, P126, DOI 10.1111/j.1875-595X.2003.tb00736.x; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; MINAGI S, 1985, INFECT IMMUN, V47, P11, DOI 10.1128/IAI.47.1.11-14.1985; Monteiro DR, 2012, J PROSTHODONT, V21, P7, DOI 10.1111/j.1532-849X.2011.00772.x; Monticello RA, 2010, APPLIED BIOMEDICAL MICROBIOLOGY: A BIOFILMS APPROACH, P45; Morgan TD, 2000, J APPL MICROBIOL, V89, P617, DOI 10.1046/j.1365-2672.2000.01158.x; Oei JD, 2012, J BIOMED MATER RES B, V100B, P409, DOI 10.1002/jbm.b.31963; Oosterhof JJH, 2006, APPL ENVIRON MICROB, V72, P3673, DOI 10.1128/AEM.72.5.3673-3677.2006; OWEN MJ, 1980, IND ENG CHEM PROD RD, V19, P97, DOI 10.1021/i360073a023; Ozer RR, 2010, J APPL POLYM SCI, V118, P2397, DOI 10.1002/app.32221; PRATTTERPSTRA IH, 1989, J DENT RES, V68, P463, DOI 10.1177/00220345890680030501; Rantala LI, 2003, J ORAL REHABIL, V30, P501, DOI 10.1046/j.1365-2842.2003.01108.x; Regis RR, 2012, J PROSTHODONT, V21, P283, DOI 10.1111/j.1532-849X.2011.00815.x; Regis RR, 2011, J PROSTHODONT, V20, P372, DOI 10.1111/j.1532-849X.2011.00719.x; Lessa FCR, 2007, AM J ORTHOD DENTOFAC, V131, DOI 10.1016/j.ajodo.2006.09.042; Shinonaga Y, 2012, ACTA BIOMATER, V8, P1388, DOI 10.1016/j.actbio.2011.09.017; Sodagar A, 2012, J PROSTHODONT RES, V56, P120, DOI 10.1016/j.jpor.2011.06.002; Song J, 2011, COLLOID SURFACE B, V82, P651, DOI 10.1016/j.colsurfb.2010.10.027; Song L, 2011, TEXT RES J, V81, P504, DOI 10.1177/0040517510380776; Speranza G, 2004, BIOMATERIALS, V25, P2029, DOI 10.1016/j.biomaterials.2003.08.061; Tamura K, 2005, PEDIATR DENT J, V15, P212, DOI 10.1016/S0917-2394(05)70056-2; Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098; Vahdat N, 2001, J APPL POLYM SCI, V79, P1265, DOI 10.1002/1097-4628(20010214)79:7<1265::AID-APP140>3.0.CO;2-H; Vento-Zahra E, 2011, QUINTESSENCE INT, V42, P37; Wady AF, 2012, J APPL MICROBIOL, V112, P1163, DOI 10.1111/j.1365-2672.2012.05293.x; YAMAMOTO K, 1995, ANAL CHIM ACTA, V302, P75, DOI 10.1016/0003-2670(94)00428-O; Yiu CKY, 2006, BIOMATERIALS, V27, P1695, DOI 10.1016/j.biomaterials.2005.09.037; Zappini G, 2003, J PROSTHET DENT, V90, P578, DOI 10.1016/j.prosdent.2003.09.008	58	37	39	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42355	10.1371/journal.pone.0042355	http://dx.doi.org/10.1371/journal.pone.0042355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870322	Green Published, gold			2022-12-27	WOS:000307212800085
J	Zonneveld, LNL; van Rood, YR; Timman, R; Kooiman, CG; van't Spijker, A; Busschbach, JJV				Zonneveld, Lyonne N. L.; van Rood, Yanda R.; Timman, Reinier; Kooiman, Cornelis G.; van't Spijker, Adriaan; Busschbach, Jan J. V.			Effective Group Training for Patients with Unexplained Physical Symptoms: A Randomized Controlled Trial with a Non-Randomized One-Year Follow-Up	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; FUNCTIONAL SOMATIC SYMPTOMS; PRIMARY-CARE; PERSONALITY-DISORDERS; SOMATOFORM DISORDERS; GENERAL-PRACTITIONERS; HEALTH-CARE; DSM-III; SOMATIZATION DISORDER; MEDICAL-CARE	Background: Although cognitive-behavioral therapy for Unexplained Physical Symptoms (UPS) is effective in secondary care, studies done in primary care produced implementation problems and conflicting results. We evaluated the effectiveness of a cognitive-behavioral group training tailored to primary care patients and provided by a secondary community mental-health service reaching out into primary care. Methodology/Principal Findings: The effectiveness of this training was explored in a randomized controlled trial. In this trial, 162 patients with UPS classified as undifferentiated somatoform disorder or as chronic pain disorder were randomized either to the training or a waiting list. Both lasted 13 weeks. The preservation of the training's effect was analyzed in non-randomized follow-ups, for which the waiting group started the training after the waiting period. All patients attended the training were followed-up after three months and again after one year. The primary outcomes were the physical and the mental summary scales of the SF-36. Secondary outcomes were the other SF-36-scales and the SCL-90-R. The courses of the training's effects in the randomized controlled trial and the follow-ups were analyzed with linear mixed modeling. In the randomized controlled trial, the training had a significantly positive effect on the quality of life in the physical domain (Cohen's d = 0.38; p = .002), but this overall effect was not found in the mental domain. Regarding the secondary outcomes, the training resulted in reporting an improved physical (Cohen's d = 0.43; p = 0.01), emotional (Cohen's d = 0.44; p = .0.01), and social (Cohen's d = 0.36; p = 0.01) functioning, less pain and better functioning despite pain (Cohen's d = 0.51; p = <0.001), less physical symptoms (Cohen's d = -.23; p = 0.05) and less sleep difficulties (Cohen's d = -0.25; p = 0.04) than time in the waiting group. During the non-randomized follow-ups, there were no relapses. Conclusions/Significance: The cognitive-behavioral group training tailored for UPS in primary care and provided by an outreaching secondary mental-health service appears to be effective and to broaden the accessibility of treatment for UPS.	[Zonneveld, Lyonne N. L.] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, NL-1105 AZ Amsterdam, Netherlands; [Zonneveld, Lyonne N. L.] Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Zonneveld, Lyonne N. L.; Timman, Reinier; van't Spijker, Adriaan; Busschbach, Jan J. V.] Erasmus MC, Dept Med Psychol & Psychotherapy, Rotterdam, Netherlands; [van Rood, Yanda R.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Kooiman, Cornelis G.] Riagg Rijnmond, Dept Psychotherapy, Schiedam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Zonneveld, LNL (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	L.Zonneveld@amc.uva.nl	Busschbach, Jan/P-1584-2019	Busschbach, Jan/0000-0002-8602-0381				Aberson CL., 2019, APPL POWER ANAL BEHA, DOI 10.4324/9781315171500; Aiarzaguena JM, 2007, PSYCHOL MED, V37, P283, DOI 10.1017/S0033291706009536; Allen LA, 2002, PSYCHOSOM MED, V64, P939, DOI 10.1097/01.PSY.0000024231.11538.8F; Allen LA, 2010, PSYCHIAT CLIN N AM, V33, P579, DOI 10.1016/j.psc.2010.04.014; APA, 2012, DSM 5 WEB SIT; Arnold IA, 2004, J PSYCHOSOM RES, V57, P517, DOI 10.1016/j.jpsychores.2004.04.369; Arnold IA, 2006, PSYCHOSOMATICS, V47, P498, DOI 10.1176/appi.psy.47.6.498; Arnold IA, 2009, PSYCHOSOMATICS, V50, P515, DOI 10.1176/appi.psy.50.5.515; Arrindell WA, 2003, SCL 90 SYMPTOM CHECK; Barsky AJ, 2005, ARCH GEN PSYCHIAT, V62, P903, DOI 10.1001/archpsyc.62.8.903; Blankenstein AH, 2001, SOMATISING PATIENTS; Bornstein RF, 2008, J PSYCHOPATHOL BEHAV, V30, P154, DOI 10.1007/s10862-007-9052-2; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cunningham PJ, 2009, HEALTH AFFAIR, V28, pW490, DOI 10.1377/hlthaff.28.3.w490; Dammen T, 2000, PSYCHOSOMATICS, V41, P269, DOI 10.1176/appi.psy.41.3.269; De Waal MWM, 2004, BRIT J PSYCHIAT, V184, P470, DOI 10.1192/bjp.184.6.470; Deale A, 2001, SOC SCI MED, V52, P1859, DOI 10.1016/S0277-9536(00)00302-6; Dirkzwager AJE, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-33; Dowrick C, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-46; Escobar JI, 1998, PSYCHOSOM MED, V60, P466, DOI 10.1097/00006842-199807000-00012; Fink P, 2008, CURR OPIN PSYCHIATR, V21, P182, DOI 10.1097/YCO.0b013e3282f51254; First MB., 1996, STRUCTURED CLIN INTE; Garcia-Campayo J, 2007, J PSYCHOSOM RES, V62, P675, DOI 10.1016/j.jpsychores.2006.12.023; Garyfallos G, 1999, COMPR PSYCHIAT, V40, P299, DOI 10.1016/S0010-440X(99)90131-1; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Heins MJ, 2010, PSYCHOTHER PSYCHOSOM, V79, P249, DOI 10.1159/000315130; Henderson M, 2004, J PSYCHOSOM RES, V56, P251, DOI 10.1016/S0022-3999(03)00571-3; Henningsen P, 2003, PSYCHOSOM MED, V65, P528, DOI 10.1097/01.PSY.0000075977.90337.E7; Jackson JL, 2005, J GEN INTERN MED, V20, P1032, DOI 10.1111/j.1525-1497.2005.0241.x; Kathol RG, 2010, PSYCHOSOM MED, V72, P511, DOI 10.1097/PSY.0b013e3181e2c4a0; KATON W, 1984, COMPR PSYCHIAT, V25, P305, DOI 10.1016/0010-440X(84)90063-4; Kooiman CG, 2004, PSYCHOSOM MED, V66, P224, DOI 10.1097/01.psy.0000116714.38868.06; Kooiman CG, 2000, PSYCHOSOM MED, V62, P768, DOI 10.1097/00006842-200011000-00005; Kroenke K, 2003, INT J METH PSYCH RES, V12, P34, DOI 10.1002/mpr.140; Kroenke K, 2000, PSYCHOTHER PSYCHOSOM, V69, P205, DOI 10.1159/000012395; Kroenke K, 2007, PSYCHOSOM MED, V69, P881, DOI 10.1097/PSY.0b013e31815b00c4; Kroenke K, 2007, PSYCHOSOMATICS, V48, P277, DOI 10.1176/appi.psy.48.4.277; Lacy NL, 2004, ANN FAM MED, V2, P541, DOI 10.1370/afm.123; Larisch A, 2004, J PSYCHOSOM RES, V57, P507, DOI 10.1016/j.jpsychores.2004.04.372; Leibbrand R, 1999, COMPR PSYCHIAT, V40, P203, DOI 10.1016/S0010-440X(99)90004-4; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Longmore RJ, 2007, CLIN PSYCHOL REV, V27, P173, DOI 10.1016/j.cpr.2006.08.001; Maina G, 2005, J PERS DISORD, V19, P84, DOI 10.1521/pedi.19.1.84.62182; Moher D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c869; Morriss R, 2007, BRIT J PSYCHIAT, V191, P536, DOI 10.1192/bjp.bp.107.040683; Nezu AM, 2001, BEHAV THER, V32, P537, DOI 10.1016/S0005-7894(01)80035-6; Nimnuan C, 2001, J PSYCHOSOM RES, V51, P361, DOI 10.1016/S0022-3999(01)00223-9; Nordin TA, 2006, FAM MED, V38, P476; Noyes R, 2001, PSYCHOSOMATICS, V42, P320, DOI 10.1176/appi.psy.42.4.320; Peeters FPML, 1999, SOC PSYCH PSYCH EPID, V34, P323, DOI 10.1007/s001270050151; Peters S, 2009, J GEN INTERN MED, V24, P443, DOI 10.1007/s11606-008-0872-x; Raine R, 2002, BMJ-BRIT MED J, V325, P1082, DOI 10.1136/bmj.325.7372.1082; Reid S, 2001, BRIT MED J, V322, P767, DOI 10.1136/bmj.322.7289.767; Rosendal M, 2007, GEN HOSP PSYCHIAT, V29, P364, DOI 10.1016/j.genhosppsych.2007.03.005; ROST KM, 1992, GEN HOSP PSYCHIAT, V14, P322, DOI 10.1016/0163-8343(92)90066-J; Salmon P, 2007, J GEN INTERN MED, V22, P565, DOI 10.1007/s11606-006-0094-z; SHARPE M, 1992, J PSYCHOSOM RES, V36, P515, DOI 10.1016/0022-3999(92)90037-3; SMITH GR, 1986, ARCH INTERN MED, V146, P69, DOI 10.1001/archinte.146.1.69; Speckens A.E.M., 1996, BEHAV COGN PSYCHOTH, V24, P1, DOI [https://doi.org/10.1017/S1352465800016799, DOI 10.1017/S1352465800016799]; Speckens AEM, 1996, PSYCHOL MED, V26, P745, DOI 10.1017/S0033291700037764; SPECKENS AEM, 1995, J PSYCHOSOM RES, V39, P855, DOI 10.1016/0022-3999(95)00024-9; Speckens AEM, 1999, PROTOCOLLAIRE BEHAND, P199; Sumathipala A, 2008, BRIT J PSYCHIAT, V193, P51, DOI 10.1192/bjp.bp.107.043190; Sumathipala A, 2007, PSYCHOSOM MED, V69, P889, DOI 10.1097/PSY.0b013e31815b5cf6; Toft T, 2010, PSYCHOTHER PSYCHOSOM, V79, P227, DOI 10.1159/000313691; Uguz F, 2008, J PSYCHOSOM RES, V64, P225, DOI 10.1016/j.jpsychores.2007.08.006; Van Rood Y., 2008, HDB SOMATISATIE LICH, P269; Van Rood YR, 2001, BEHANDELINGSSTRATEGI, P17; VANHEMERT AM, 1993, PSYCHOL MED, V23, P167, DOI 10.1017/S0033291700038952; Verhaak PFM, 2006, FAM PRACT, V23, P414, DOI 10.1093/fampra/cml016; Ware J., 1993, SF 36 HLTH SURVEY MA; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Zonneveld LNL, 2009, GROUP TRAINING PATIE; Zonneveld LNL, 2005, DRAAIBOEK OMGAAN MET; Zonneveld LNL, 2010, CLIN PSYCHOL PSYCHOT, V17, P528, DOI 10.1002/cpp.685; Zonneveld LNL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-251	76	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42629	10.1371/journal.pone.0042629	http://dx.doi.org/10.1371/journal.pone.0042629			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	987SL	22880056	Green Published, Green Submitted, gold			2022-12-27	WOS:000307437900046
J	Kolotilin, I; Kaldis, A; Devriendt, B; Joensuu, J; Cox, E; Menassa, R				Kolotilin, Igor; Kaldis, Angelo; Devriendt, Bert; Joensuu, Jussi; Cox, Eric; Menassa, Rima			Production of a Subunit Vaccine Candidate against Porcine Post-Weaning Diarrhea in High-Biomass Transplastomic Tobacco	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; PSBA MESSENGER-RNA; HIGH-LEVEL EXPRESSION; F4 K88 FIMBRIAE; TRANSGENIC TOBACCO; ORAL IMMUNIZATION; MAJOR SUBUNIT; CHLOROPLAST TRANSFORMATION; NUCLEOTIDE-SEQUENCE; PROTEIN EXPRESSION	Post-weaning diarrhea (PWD) in piglets is a major problem in piggeries worldwide and results in severe economic losses. Infection with Enterotoxigenic Escherichia coli (ETEC) is the key culprit for the PWD disease. F4 fimbriae of ETEC are highly stable proteinaceous polymers, mainly composed of the major structural subunit FaeG, with a capacity to evoke mucosal immune responses, thus demonstrating a potential to act as an oral vaccine against ETEC-induced porcine PWD. In this study we used a transplastomic approach in tobacco to produce a recombinant variant of the FaeG protein, rFaeG(ntd/dsc), engineered for expression as a stable monomer by N-terminal deletion and donor strand-complementation (ntd/dsc). The generated transplastomic tobacco plants accumulated up to 2.0 g rFaeG(ntd/dsc) per 1 kg fresh leaf tissue (more than 1% of dry leaf tissue) and showed normal phenotype indistinguishable from wild type untransformed plants. We determined that chloroplast-produced rFaeG(ntd/dsc) protein retained the key properties of an oral vaccine, i.e. binding to porcine intestinal F4 receptors (F4R), and inhibition of the F4-possessing (F4+) ETEC attachment to F4R. Additionally, the plant biomass matrix was shown to delay degradation of the chloroplast-produced rFaeG(ntd/dsc) in gastrointestinal conditions, demonstrating a potential to function as a shelter-vehicle for vaccine delivery. These results suggest that transplastomic plants expressing the rFaeG(ntd/dsc) protein could be used for production and, possibly, delivery of an oral vaccine against porcine F4+ ETEC infections. Our findings therefore present a feasible approach for developing an oral vaccination strategy against porcine PWD.	[Kolotilin, Igor; Kaldis, Angelo; Menassa, Rima] Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, London, ON, Canada; [Devriendt, Bert; Cox, Eric] Univ Ghent, Fac Vet Med, Lab Vet Immunol, Merelbeke, Belgium; [Joensuu, Jussi] VTT Tech Res Ctr Finland, Espoo, Finland	Agriculture & Agri Food Canada; Ghent University; VTT Technical Research Center Finland	Kolotilin, I (corresponding author), Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, London, ON, Canada.	rima.menassa@agr.gc.ca	Devriendt, Bert/AAM-6666-2021	Devriendt, Bert/0000-0002-3222-8769; Menassa, Rima/0000-0003-3536-0332; Cox, Eric/0000-0003-4281-2990	A-base; Cellulosic Biofuels Network of the Agricultural Bioproducts Innovation Program of Agriculture and Agri-Food Canada	A-base; Cellulosic Biofuels Network of the Agricultural Bioproducts Innovation Program of Agriculture and Agri-Food Canada	This study was supported by A-base funding and the Cellulosic Biofuels Network of the Agricultural Bioproducts Innovation Program of Agriculture and Agri-Food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Adil, 2010, Recent Pat Biotechnol, DOI 10.2174/187220810793611464; Arlen PA, 2007, PLANT BIOTECHNOL J, V5, P511, DOI 10.1111/j.1467-7652.2007.00258.x; BAKKER D, 1992, MOL MICROBIOL, V6, P247, DOI 10.1111/j.1365-2958.1992.tb02006.x; BERTSCHINGER HU, 1999, DIS SWINE, P431; Bock R, 2007, CURR OPIN BIOTECH, V18, P100, DOI 10.1016/j.copbio.2006.12.001; Bock R, 2010, TRENDS BIOTECHNOL, V28, P246, DOI 10.1016/j.tibtech.2010.01.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calinescu C, 2007, INT J PHARMACEUT, V343, P18, DOI 10.1016/j.ijpharm.2007.04.017; Caloca MJ, 2007, COMP IMMUNOL MICROB, V30, P187, DOI 10.1016/j.cimid.2006.12.003; Caloca MJ, 2006, COMP IMMUNOL MICROB, V29, P225, DOI 10.1016/j.cimid.2006.06.001; CIOSEK D, 1983, COMP IMMUNOL MICROB, V6, P313, DOI 10.1016/0147-9571(83)90024-3; Clarke JL, 2011, PLANT MOL BIOL, V76, P211, DOI 10.1007/s11103-011-9767-z; Conley AJ, 2011, PLANT BIOTECHNOL J, V9, P434, DOI 10.1111/j.1467-7652.2010.00563.x; COX E, 1993, VET MICROBIOL, V34, P7, DOI 10.1016/0378-1135(93)90003-P; Daniell H, 2005, VACCINE, V23, P1779, DOI 10.1016/j.vaccine.2004.11.004; Daniell H, 2001, J MOL BIOL, V311, P1001, DOI 10.1006/jmbi.2001.4921; Daniell Henry, 2006, Biotechnology Journal, V1, P1071, DOI 10.1002/biot.200600145; De Cosa B, 2001, NAT BIOTECHNOL, V19, P71, DOI 10.1038/83559; DeGray G, 2001, PLANT PHYSIOL, V127, P852, DOI 10.1104/pp.010233; Drechsel O, 2011, NUCLEIC ACIDS RES, V39, P1427, DOI 10.1093/nar/gkq978; Eibl C, 1999, PLANT J, V19, P333, DOI 10.1046/j.1365-313X.1999.00543.x; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Farran I, 2008, PLANT BIOTECHNOL J, V6, P516, DOI 10.1111/j.1467-7652.2008.00334.x; Fernandez-San Millan A, 2003, PLANT BIOTECHNOL J, V1, P71, DOI 10.1046/j.1467-7652.2003.00008.x; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; GAASTRA W, 1983, FEMS MICROBIOL LETT, V18, P177, DOI 10.1111/j.1574-6968.1983.tb00474.x; GUINEE PAM, 1979, INFECT IMMUN, V23, P700; Hampson D. J., 1994, P171; Harris LJ, 2001, PHYSIOL MOL PLANT P, V58, P173, DOI 10.1006/pmpp.2001.0326; Huang YH, 2006, J MICROBIOL, V44, P548; Huang YH, 2003, INFECT IMMUN, V71, P5436, DOI 10.1128/IAI.71.9.5436-5439.2003; Joensuu JJ, 2006, VACCINE, V24, P2387, DOI 10.1016/j.vaccine.2005.11.056; Joensuu JJ, 2004, TRANSGENIC RES, V13, P295, DOI 10.1023/B:TRAG.0000034621.55404.70; Joensuu JJ, 2006, TRANSGENIC RES, V15, P359, DOI 10.1007/s11248-006-0010-7; Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021; JONES GW, 1972, INFECT IMMUN, V6, P918, DOI 10.1128/IAI.6.6.918-927.1972; JOSEPHSEN J, 1984, FEMS MICROBIOL LETT, V25, P301, DOI 10.1111/j.1574-6968.1984.tb01476.x; Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4; KLEMM P, 1981, EUR J BIOCHEM, V117, P617; Kota M, 1999, P NATL ACAD SCI USA, V96, P1840, DOI 10.1073/pnas.96.5.1840; Lee MYT, 2006, BIOTECHNOL BIOENG, V94, P1129, DOI 10.1002/bit.20948; Lossl AG, 2011, PLANT BIOTECHNOL J, V9, P527, DOI 10.1111/j.1467-7652.2011.00615.x; Ma JKC, 2005, EMBO REP, V6, P593, DOI 10.1038/sj.embor.7400470; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Maliga P, 2003, TRENDS BIOTECHNOL, V21, P20, DOI 10.1016/S0167-7799(02)00007-0; Matoba N, 2011, METHODS MOL BIOL, V701, P199, DOI 10.1007/978-1-61737-957-4_11; McCabe MS, 2008, PLANT BIOTECHNOL J, V6, P914, DOI 10.1111/j.1467-7652.2008.00365.x; McGhee J. R., 1999, MUCOSAL IMMUNOLOGY, P485; Melkebeek V, 2007, VET IMMUNOL IMMUNOP, V116, P199, DOI 10.1016/j.vetimm.2007.01.021; Menassa R, 2001, MOL BREEDING, V8, P177, DOI 10.1023/A:1013376407362; Menassa R, 2007, PLANT BIOTECHNOL J, V5, P50, DOI 10.1111/j.1467-7652.2006.00214.x; Merchant HA, 2011, EUR J PHARM SCI, V42, P3, DOI 10.1016/j.ejps.2010.09.019; Mol O, 1996, FEMS MICROBIOL REV, V19, P25, DOI 10.1016/0168-6445(96)00022-8; Molina A, 2004, PLANT BIOTECHNOL J, V2, P141, DOI 10.1046/j.1467-7652.2004.00057.x; Nadai M, 2009, TRANSGENIC RES, V18, P173, DOI 10.1007/s11248-008-9209-0; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; ORSKOV I, 1964, ACTA PATHOL MIC SC, V62, P439, DOI 10.1111/apm.1964.62.3.439; Rasschaert K, 2007, VET MICROBIOL, V123, P249, DOI 10.1016/j.vetmic.2007.02.017; Rice J., 2005, Animal Health Research Reviews, V6, P199, DOI 10.1079/AHR2005110; Ruf S, 2007, P NATL ACAD SCI USA, V104, P6998, DOI 10.1073/pnas.0700008104; Ruhlman T, 2010, PLANT PHYSIOL, V152, P2088, DOI 10.1104/pp.109.152017; RUSSELL TL, 1993, PHARMACEUT RES, V10, P187, DOI 10.1023/A:1018970323716; Sala F, 2003, VACCINE, V21, P803, DOI 10.1016/S0264-410X(02)00603-5; Shen HF, 2010, ACTA BIOCH BIOPH SIN, V42, P558, DOI 10.1093/abbs/gmq060; Snoeck V, 2004, J CONTROL RELEASE, V94, P143, DOI 10.1016/j.jconrel.2003.09.015; Sriraman R, 2004, PLANT BIOTECHNOL J, V2, P279, DOI 10.1111/j.1467-7652.2004.00078.x; STAUB JM, 1994, PLANT J, V6, P547, DOI 10.1046/j.1365-313X.1994.6040547.x; STAUB JM, 1993, EMBO J, V12, P601, DOI 10.1002/j.1460-2075.1993.tb05692.x; SVAB Z, 1990, P NATL ACAD SCI USA, V87, P8526, DOI 10.1073/pnas.87.21.8526; Svab Z, 2007, P NATL ACAD SCI USA, V104, P7003, DOI 10.1073/pnas.0700063104; The United States Pharmacopeia, 2011, GASTR FLUID SIM TS, V1, P968; The United States Pharmacopeia, 1990, GASTR FLUID SIM TS; The United States Pharmacopeia, 2011, PANCR, V3, P3803; The United States Pharmacopeia, 2011, INT FLUID SIM TS, V1, P969; Trebitsh T, 2000, MOL CELL BIOL, V20, P1116, DOI 10.1128/MCB.20.4.1116-1123.2000; Tregoning JS, 2003, NUCLEIC ACIDS RES, V31, P1174, DOI 10.1093/nar/gkg221; Van den Broeck W, 2002, VET IMMUNOL IMMUNOP, V85, P171, DOI 10.1016/S0165-2427(01)00429-9; Van den Broeck W, 1999, INFECT IMMUN, V67, P520, DOI 10.1128/IAI.67.2.520-526.1999; Van den Broeck W, 1999, VET MICROBIOL, V68, P255, DOI 10.1016/S0378-1135(99)00076-0; Van den Broeck W, 2000, VET MICROBIOL, V71, P223, DOI 10.1016/S0378-1135(99)00174-1; Van Molle I, 2007, J MOL BIOL, V368, P791, DOI 10.1016/j.jmb.2007.02.051; Van Molle I, 2009, J MOL BIOL, V394, P957, DOI 10.1016/j.jmb.2009.09.059; VERA A, 1995, CURR GENET, V27, P280, DOI 10.1007/BF00326161; Verdonck F, 2004, VACCINE, V22, P4291, DOI 10.1016/j.vaccine.2004.04.016; Verdonck F, 2004, VET MICROBIOL, V102, P215, DOI 10.1016/j.vetmic.2004.06.002; Verdonck F, 2008, VACCINE, V26, P5728, DOI 10.1016/j.vaccine.2008.08.017; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wirth S, 2006, J BIOTECHNOL, V125, P159, DOI 10.1016/j.jbiotec.2006.02.012; Yu LX, 2007, J BIOTECHNOL, V131, P362, DOI 10.1016/j.jbiotec.2007.07.942; Zhou F, 2008, PLANT BIOTECHNOL J, V6, P897, DOI 10.1111/j.1467-7652.2008.00356.x; Zhou F, 2007, PLANT J, V52, P961, DOI 10.1111/j.1365-313X.2007.03261.x	92	30	33	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42405	10.1371/journal.pone.0042405	http://dx.doi.org/10.1371/journal.pone.0042405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879967	Green Published, gold			2022-12-27	WOS:000307284100081
J	Nair, NU; Das Sahu, A; Bucher, P; Moret, BME				Nair, Nishanth Ulhas; Das Sahu, Avinash; Bucher, Philipp; Moret, Bernard M. E.			ChIPnorm: A Statistical Method for Normalizing and Identifying Differential Regions in Histone Modification ChIP-seq Libraries	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GENES; IDENTIFICATION; PROFILES; SITES	The advent of high-throughput technologies such as ChIP-seq has made possible the study of histone modifications. A problem of particular interest is the identification of regions of the genome where different cell types from the same organism exhibit different patterns of histone enrichment. This problem turns out to be surprisingly difficult, even in simple pairwise comparisons, because of the significant level of noise in ChIP-seq data. In this paper we propose a two-stage statistical method, called ChIPnorm, to normalize ChIP-seq data, and to find differential regions in the genome, given two libraries of histone modifications of different cell types. We show that the ChIPnorm method removes most of the noise and bias in the data and outperforms other normalization methods. We correlate the histone marks with gene expression data and confirm that histone modifications H3K27me3 and H3K4me3 act as respectively a repressor and an activator of genes. Compared to what was previously reported in the literature, we find that a substantially higher fraction of bivalent marks in ES cells for H3K27me3 and H3K4me3 move into a K27-only state. We find that most of the promoter regions in protein-coding genes have differential histone-modification sites. The software for this work can be downloaded from http://lcbb.epfl.ch/software.html.	[Nair, Nishanth Ulhas; Moret, Bernard M. E.] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lab Computat Biol & Bioinformat, Lausanne, Switzerland; [Das Sahu, Avinash] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Bucher, Philipp] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Bucher, Philipp; Moret, Bernard M. E.] Swiss Inst Bioinformat, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University System of Maryland; University of Maryland College Park; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Nair, NU (corresponding author), Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lab Computat Biol & Bioinformat, Lausanne, Switzerland.	philipp.bucher@isb-sib.ch; bernard.moret@epfl.ch	Nair, Nishanth Ulhas/AFZ-7133-2022	Nair, Nishanth Ulhas/0000-0002-8832-0329; Sahu, Avinash/0000-0002-2193-6276; Moret, Bernard/0000-0003-1549-4544	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NUN's work was supported by a grant from the Swiss National Science Foundation. The authors would like to thank the reviewers and the editor for their helpful comments.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brusslan JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033151; Buske OJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-415; Cheung MS, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr425; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dudoit S, 2002, STAT SINICA, V12, P111; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Lehninger A., 2005, LEHNINGER PRINCIPLES; Mardis ER, 2007, NAT METHODS, V4, P613, DOI 10.1038/nmeth0807-613; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taslim C, 2009, BIOINFORMATICS, V25, P2334, DOI 10.1093/bioinformatics/btp384; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Xu H, 2008, BIOINFORMATICS, V24, P2344, DOI 10.1093/bioinformatics/btn402; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	31	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e39573	10.1371/journal.pone.0039573	http://dx.doi.org/10.1371/journal.pone.0039573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870189	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100003
J	Nodehi, SM; Repp, R; Kellner, C; Brautigam, J; Staudinger, M; Schub, N; Peipp, M; Gramatzki, M; Humpe, A				Nodehi, Sahar Mohseni; Repp, Roland; Kellner, Christian; Braeutigam, Joachim; Staudinger, Matthias; Schub, Natalie; Peipp, Matthias; Gramatzki, Martin; Humpe, Andreas			Enhanced ADCC Activity of Affinity Maturated and Fc-Engineered Mini-Antibodies Directed against the AML Stem Cell Antigen CD96	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; LECTIN-LIKE MOLECULE-1; SINGLE-CHAIN FV; HUMAN IGG1; GAMMA-RIII; RECEPTOR; CYTOTOXICITY; EXPRESSION; BINDING	CD96, a cell surface antigen recently described to be preferentially expressed on acute myeloid leukemia (AML) leukemic stem cells (LSC) may represent an interesting target structure for the development of antibody-based therapeutic approaches. The v-regions from the CD96-specific hybridoma TH-111 were isolated and used to generate a CD96-specific single chain fragment of the variable regions (scFv). An affinity maturated variant resulting in 4-fold enhanced CD96-binding was generated by random mutagenesis and stringent selection using phage display. The affinity maturated scFv CD96-S32F was used to generate bivalent mini-antibodies by genetically fusing an IgG1 wild type Fc region or a variant with enhanced CD16a binding. Antibody dependent cell-mediated cytotoxicity (ADCC) experiments revealed that Fc engineering was essential to trigger significant effector cell-mediated lysis when the wild type scFv was used. The mini-antibody variant generated by fusing the affinity-maturated scFv with the optimized Fc variant demonstrated the highest ADCC activity (2.3-fold enhancement in efficacy). In conclusion, our data provide proof of concept that CD96 could serve as a target structure for effector cell-mediated lysis and demonstrate that both enhancing affinity for CD96 and for CD16a resulted in mini-antibodies with the highest cytolytic potential.	[Nodehi, Sahar Mohseni; Repp, Roland; Kellner, Christian; Staudinger, Matthias; Schub, Natalie; Peipp, Matthias; Gramatzki, Martin; Humpe, Andreas] Univ Kiel, Inst Zool, Dept Med 2, Div Stem Cell Transplantat & Immunotherapy, D-24098 Kiel, Germany; [Braeutigam, Joachim] Univ Kiel, Inst Zool, Dept Biol Struct, D-24098 Kiel, Germany	University of Kiel; University of Kiel	Nodehi, SM (corresponding author), Univ Kiel, Inst Zool, Dept Med 2, Div Stem Cell Transplantat & Immunotherapy, D-24098 Kiel, Germany.	a.humpe@med2.uni-kiel.de	Peipp, Matthias/A-8775-2013; Kellner, Christian/G-4238-2015	Kellner, Christian/0000-0002-2562-6902; Peipp, Matthias/0000-0002-5088-3804	Deutsche Jose Carreras Leukaemie Stiftung e.V. (Munich, Germany) [DJCLS R 08/01]; Wilhelm Sander-Stiftung (Neustadt, Germany) [2007.065.1]; FAZIT-Stiftung (Frankfurt am Main, Germany)	Deutsche Jose Carreras Leukaemie Stiftung e.V. (Munich, Germany); Wilhelm Sander-Stiftung (Neustadt, Germany); FAZIT-Stiftung (Frankfurt am Main, Germany)	This study was supported by research grant DJCLS R 08/01 from the Deutsche Jose Carreras Leukaemie Stiftung e.V. (Munich, Germany;http://www.carreras-stiftung.de/) and research grant 2007.065.1 from the Wilhelm Sander-Stiftung (Neustadt, Germany; http://www.sanst.de/cms/front_content.php), SMN was supported by the FAZIT-Stiftung (Frankfurt am Main, Germany; http://www.fazit-stiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS GP, 1993, CANCER RES, V53, P4026; Bakker ABH, 2004, CANCER RES, V64, P8443, DOI 10.1158/0008-5472.CAN-04-1659; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Burger R, 1999, LEUKEMIA RES, V23, P19, DOI 10.1016/S0145-2126(98)00133-7; CARROLL WL, 1988, MOL IMMUNOL, V25, P991, DOI 10.1016/0161-5890(88)90005-3; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; de Haij S, 2010, CANCER RES, V70, P3209, DOI 10.1158/0008-5472.CAN-09-4109; Desjarlais JR, 2007, DRUG DISCOV TODAY, V12, P898, DOI 10.1016/j.drudis.2007.08.009; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Gilliland D Gary, 2004, Hematology Am Soc Hematol Educ Program, P80; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Gramatzki M, 1998, EXP HEMATOL, V26, P1209; Guan Y, 2000, LEUKEMIA, V14, P2135, DOI 10.1038/sj.leu.2401975; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Hauswirth AW, 2007, EUR J CLIN INVEST, V37, P73, DOI 10.1111/j.1365-2362.2007.01746.x; Hayden-Ledbetter MS, 2009, CLIN CANCER RES, V15, P2739, DOI 10.1158/1078-0432.CCR-08-1694; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Jan M, 2011, P NATL ACAD SCI USA, V108, P5009, DOI 10.1073/pnas.1100551108; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kabat EA, 1991, SEQUENCES PROTEINS I; KAMELREID S, 1988, SCIENCE, V242, P1706, DOI 10.1126/science.2904703; Kellner C, 2008, J IMMUNOTHER, V31, P871, DOI 10.1097/CJI.0b013e318186c8b4; Kipriyanov SM, 1997, J IMMUNOL METHODS, V200, P69, DOI 10.1016/S0022-1759(96)00188-3; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Kugler M, 2010, BRIT J HAEMATOL, V150, P574, DOI 10.1111/j.1365-2141.2010.08300.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafrenie RM, 2007, EXPERT OPIN THER TAR, V11, P727, DOI 10.1517/14728222.11.6.727; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Majeti R, 2011, ONCOGENE, V30, P1009, DOI 10.1038/onc.2010.511; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; McCall AM, 2001, J IMMUNOL, V166, P6112, DOI 10.4049/jimmunol.166.10.6112; Munoz L, 2001, HAEMATOLOGICA, V86, P1261; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Peipp M, 2008, BLOOD, V112, P2390, DOI 10.1182/blood-2008-03-144600; Repp R, 2011, J IMMUNOL METHODS; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Sircar A, 2009, NUCLEIC ACIDS RES, V37, pW474, DOI 10.1093/nar/gkp387; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; Toleikis Lars, 2004, Methods Mol Med, V94, P447; Vercauteren SM, 2007, CYTOTHERAPY, V9, P194, DOI 10.1080/14653240601164042; Vidarsson G, 2001, J IMMUNOL METHODS, V249, P245, DOI 10.1016/S0022-1759(00)00337-9; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang JH, 2009, J BIOL CHEM, V284, P595, DOI 10.1074/jbc.M804089200; WANG PL, 1992, J IMMUNOL, V148, P2600; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Zhao XB, 2007, BLOOD, V110, P2569, DOI 10.1182/blood-2006-12-062927; Zhao XX, 2010, HAEMATOL-HEMATOL J, V95, P71, DOI 10.3324/haematol.2009.009811	53	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42426	10.1371/journal.pone.0042426	http://dx.doi.org/10.1371/journal.pone.0042426			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879978	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100088
J	Sant'Anna, MRV; Darby, AC; Brazil, RP; Montoya-Lerma, J; Dillon, VM; Bates, PA; Dillon, RJ				Sant'Anna, Mauricio R. V.; Darby, Alistair C.; Brazil, Reginaldo P.; Montoya-Lerma, James; Dillon, Viv M.; Bates, Paul A.; Dillon, Rod J.			Investigation of the Bacterial Communities Associated with Females of Lutzomyia Sand Fly Species from South America	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; VISCERAL LEISHMANIASIS; GUT BACTERIA; PHLEBOTOMUS-PAPATASI; SPOROGONIC DEVELOPMENT; PHYLOGENETIC ANALYSIS; MANAGEMENT REGIMENS; DIPTERA PSYCHODIDAE; NATURAL INFECTION; VECTOR COMPETENCE	Phlebotomine sand flies are vectors of Leishmania that are acquired by the female sand fly during blood feeding on an infected mammal. Leishmania parasites develop exclusively in the gut lumen during their residence in the insect before transmission to a suitable host during the next blood feed. Female phlebotomine sand flies are blood feeding insects but their life style of visiting plants as well as animals, and the propensity for larvae to feed on detritus including animal faeces means that the insect host and parasite are exposed to a range of microorganisms. Thus, the sand fly microbiota may interact with the developing Leishmania population in the gut. The aim of the study was to investigate and identify the bacterial diversity associated with wild adult female Lutzomyia sand flies from different geographical locations in the New World. The bacterial phylotypes recovered from 16S rRNA gene clone libraries obtained from wild caught adult female Lutzomyia sand flies were estimated from direct band sequencing after denaturing gradient gel electrophoresis of bacterial 16 rRNA gene fragments. These results confirm that the Lutzomyia sand flies contain a limited array of bacterial phylotypes across several divisions. Several potential plant-related bacterial sequences were detected including Erwinia sp. and putative Ralstonia sp. from two sand fly species sampled from 3 geographically separated regions in Brazil. Identification of putative human pathogens also demonstrated the potential for sand flies to act as vectors of bacterial pathogens of medical importance in addition to their role in Leishmania transmission.	[Sant'Anna, Mauricio R. V.; Bates, Paul A.; Dillon, Rod J.] Univ Lancaster, Sch Hlth & Med, Lancaster, England; [Darby, Alistair C.; Dillon, Viv M.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Brazil, Reginaldo P.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Bioquim & Fisiol Insetos, Rio De Janeiro, Brazil; [Montoya-Lerma, James] Univ Valle, Dept Biol, Cali, Valle, Colombia	Lancaster University; University of Liverpool; Fundacao Oswaldo Cruz; Universidad del Valle	Sant'Anna, MRV (corresponding author), Univ Lancaster, Sch Hlth & Med, Lancaster, England.	r.dillon@lancaster.ac.uk	Darby, Alistair/I-6485-2012; Brazil, Reginaldo Peçanha/AAF-6777-2019; Sant'Anna, Mauricio Roberto Via/AAQ-6084-2021; Sant'Anna, Mauricio Roberto Viana/AAQ-4093-2021	Darby, Alistair/0000-0002-3786-6209; Sant'Anna, Mauricio Roberto Viana/0000-0002-2504-0979; Dillon, Rod/0000-0002-3551-0030; Bates, Paul/0000-0001-6861-5421; Montoya-Lerma, James/0000-0003-2122-1323	Wellcome Trust [073405]; Leverhulme Trust [F/00 808/C]	Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust)	The work was supported by the Wellcome Trust http://www.wellcome.ac.uk (ref 073405) and the Leverhulme Trust http://www.leverhulme.ac.uk (ref F/00 808/C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acardi SA, 2010, MEM I OSWALDO CRUZ, V105, P796, DOI 10.1590/S0074-02762010000600011; ADLER S, 1957, ANNU REV ENTOMOL, V2, P203, DOI 10.1146/annurev.en.02.010157.001223; ALEXANDER B, 1994, ANN TROP MED PARASIT, V88, P543, DOI 10.1080/00034983.1994.11812902; Felipe IMA, 2011, MEM I OSWALDO CRUZ, V106, P207, DOI 10.1590/S0074-02762011000200015; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; Bloch KC, 1997, MEDICINE, V76, P30, DOI 10.1097/00005792-199701000-00003; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; CAMERON MM, 1994, B ENTOMOL RES, V84, P461, DOI 10.1017/S0007485300032685; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; de Oliveira Sandra Maria Pereira, 2000, Revista da Sociedade Brasileira de Medicina Tropical, V33, P319, DOI 10.1590/S0037-86822000000300012; de Pita-Pereira D, 2008, ACTA TROP, V107, P66, DOI 10.1016/j.actatropica.2008.04.015; Dillon RJ, 2008, J INVERTEBR PATHOL, V97, P265, DOI 10.1016/j.jip.2007.09.010; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dillon RJ, 2000, NATURE, V403, P851, DOI 10.1038/35002669; Dillon RJ, 1996, ANN TROP MED PARASIT, V90, P669, DOI 10.1080/00034983.1996.11813102; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Silva JGDE, 2007, CAD SAUDE PUBLICA, V23, P1715, DOI 10.1590/S0102-311X2007000700024; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; FELSENSTEIN, 2005, PHYLIP PHYLOGENY INF; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; Gouveia C, 2008, NEOTROP ENTOMOL, V37, P597, DOI 10.1590/S1519-566X2008000500016; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hillesland H, 2008, AM J TROP MED HYG, V79, P881, DOI 10.4269/ajtmh.2008.79.881; Kashima T, 2006, J INSECT PHYSIOL, V52, P816, DOI 10.1016/j.jinsphys.2006.05.003; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Losada L, 2010, GENOME BIOL EVOL, V2, P102, DOI 10.1093/gbe/evq003; McCaig AE, 2001, APPL ENVIRON MICROB, V67, P4554, DOI 10.1128/AEM.67.10.4554-4559.2001; McCarthy CB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001304; MURPHY KM, 1994, APPL ENVIRON MICROB, V60, P2508, DOI 10.1128/AEM.60.7.2508-2517.1994; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Oliveira S. M. P. de, 2001, Cadernos de Saude Publica, V17, P229, DOI 10.1590/S0102-311X2001000100024; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Ono M, 2001, J MED ENTOMOL, V38, P237, DOI 10.1603/0022-2585-38.2.237; PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Schlein Y, 1999, MED VET ENTOMOL, V13, P65, DOI 10.1046/j.1365-2915.1999.00138.x; SCHLEIN Y, 1994, AM J TROP MED HYG, V50, P20, DOI 10.4269/ajtmh.1994.50.1.TM0500010020; SCHLEIN Y, 1986, INSECT SCI APPL, V7, P231, DOI 10.1017/S1742758400009000; Schonfeld J, 2003, APPL ENVIRON MICROB, V69, P7248, DOI 10.1128/AEM.69.12.7248-7256.2003; Siddall ME, 2004, MOL PHYLOGENET EVOL, V30, P178, DOI 10.1016/S1055-7903(03)00184-2; Tekerekoglu MS, 2003, MICROBIOLOGICA, V26, P57; Volf P, 2002, FOLIA PARASIT, V49, P73, DOI 10.14411/fp.2002.014; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Webster G, 2002, APPL ENVIRON MICROB, V68, P20, DOI 10.1128/AEM.68.1.20-30.2002; Webster G, 2003, J MICROBIOL METH, V55, P155, DOI 10.1016/S0167-7012(03)00140-4; Webster G, 2006, FEMS MICROBIOL ECOL, V58, P65, DOI 10.1111/j.1574-6941.2006.00147.x; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x	53	50	52	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42531	10.1371/journal.pone.0042531	http://dx.doi.org/10.1371/journal.pone.0042531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880020	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000307284100121
J	Callander, GE; Ma, S; Ganella, DE; Wimmer, VC; Gundlach, AL; Thomas, WG; Bathgate, RAD				Callander, Gabrielle E.; Ma, Sherie; Ganella, Despina E.; Wimmer, Verena C.; Gundlach, Andrew L.; Thomas, Walter G.; Bathgate, Ross A. D.			Silencing Relaxin-3 in Nucleus Incertus of Adult Rodents: A Viral Vector-based Approach to Investigate Neuropeptide Function	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; SPONTANEOUS-ALTERNATION; PEPTIDE FAMILY; MODULATION; STRESS; GENE; OPTIMIZATION; EXPRESSION; NEURONS; BRAIN	Relaxin-3, the most recently identified member of the relaxin peptide family, is produced by GABAergic projection neurons in the nucleus incertus (NI), in the pontine periventricular gray. Previous studies suggest relaxin-3 is a modulator of stress responses, metabolism, arousal and behavioural activation. Knockout mice and peptide infusions in vivo have significantly contributed to understanding the function of this conserved neuropeptide. Yet, a definitive role remains elusive due to discrepancies between models and a propensity to investigate pharmacological effects over endogenous function. To investigate the endogenous function of relaxin-3, we generated a recombinant adeno-associated viral (rAAV) vector expressing microRNA against relaxin-3 and validated its use to knock down relaxin-3 in adult rats. Bilateral stereotaxic infusion of rAAV1/2 EmGFP miR499 into the NI resulted in significant reductions in relaxin-3 expression as demonstrated by ablation of relaxin-3-like immunoreactivity at 3, 6 and 9 weeks and by qRT-PCR at 12 weeks. Neuronal health was unaffected as transduced neurons in all groups retained expression of NeuN and stained for Nissl bodies. Importantly, qRT-PCR confirmed that relaxin-3 receptor expression levels were not altered to compensate for reduced relaxin-3. Behavioural experiments confirmed no detrimental effects on general health or well-being and therefore several behavioural modalities previously associated with relaxin-3 function were investigated. The validation of this viral vector-based model provides a valuable alternative to existing in vivo approaches and promotes a shift towards more physiologically relevant investigations of endogenous neuropeptide function.	[Callander, Gabrielle E.; Ganella, Despina E.; Bathgate, Ross A. D.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Callander, Gabrielle E.; Ma, Sherie; Ganella, Despina E.; Wimmer, Verena C.; Gundlach, Andrew L.; Bathgate, Ross A. D.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia; [Ma, Sherie] Univ Melbourne, Dept Med Austin Hlth, Melbourne, Vic 3010, Australia; [Gundlach, Andrew L.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia; [Thomas, Walter G.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; University of Melbourne; University of Melbourne; University of Queensland	Callander, GE (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.	Gabrielle.Callander@florey.edu.au; bathgate@unimelb.edu.au	Gundlach, Andrew L/X-6421-2018; Bathgate, Ross/ABE-6471-2020; Thomas, Walter/I-2208-2015	Gundlach, Andrew L/0000-0002-6066-9692; Bathgate, Ross/0000-0001-6301-861X; Thomas, Walter/0000-0003-0685-2952; Ma, Sherie/0000-0003-3597-9522; Wimmer, Verena/0000-0002-9931-8179	National Health and Medical Research Council of Australia (NHMRC) [1005988, 520299]; Victorian Government Operational Infrastructure Support Program; University of Melbourne; Australian Postgraduate Award; Senior Research Fellowships; NHMRC, Australia	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Operational Infrastructure Support Program; University of Melbourne(University of Melbourne); Australian Postgraduate Award(Australian Government); Senior Research Fellowships; NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by National Health and Medical Research Council of Australia (NHMRC, www.nhmrc.gov.au http://www.nhmrc.gov.au) project grants 1005988 (Andrew L. Gundlach, Ross A. D. Bathgate) and 520299 (Sherie Ma), and by the Victorian Government Operational Infrastructure Support Program (www.business.vic.gov.au http://www.business.vic.gov.au). Gabrielle E. Callander was a recipient of a Melbourne Research Scholarship from The University of Melbourne. Despina E. Ganella is a recipient of an Australian Postgraduate Award, Andrew L. Gundlach and Ross A. D. Bathgate were recipients of Senior Research Fellowships and Sherie Ma was the recipient of a Biomedical Postdoctoral Fellowship from NHMRC, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2010, NEUROPHARMACOLOGY, V58, P145, DOI 10.1016/j.neuropharm.2009.06.019; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Burazin TCD, 2002, J NEUROCHEM, V82, P1553, DOI 10.1046/j.1471-4159.2002.01114.x; Callander GE, 2009, ANN NY ACAD SCI, V1160, P261, DOI 10.1111/j.1749-6632.2008.03816.x; Chan LJ, 2011, PROTEIN PEPTIDE LETT, V18, P220; Chauveau F, 2012, NEUROPSYCHOPHARMACOL, V37, P1588, DOI 10.1038/npp.2012.3; Cisse RS, 2008, BEHAV NEUROSCI, V122, P549, DOI 10.1037/0735-7044.122.3.549; DeGroot A, 2003, NEUROSCIENCE, V117, P493, DOI 10.1016/S0306-4522(02)00651-6; Donizetti A, 2008, DEV DYNAM, V237, P3864, DOI 10.1002/dvdy.21786; During Matthew J, 2003, Methods Mol Med, V76, P221; Goto M, 2001, J COMP NEUROL, V438, P86, DOI 10.1002/cne.1303; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Haugaard-Kedstrom LM, 2011, J AM CHEM SOC, V133, P4965, DOI 10.1021/ja110567j; Hida T, 2006, J RECEPT SIG TRANSD, V26, P147, DOI 10.1080/10799890600623373; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; HOKFELT T, 1991, NEURON, V7, P867, DOI 10.1016/0896-6273(91)90333-U; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Kuei C, 2007, J BIOL CHEM, V282, P25425, DOI 10.1074/jbc.M701416200; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma S, 2007, NEUROSCIENCE, V144, P165, DOI 10.1016/j.neuroscience.2006.08.072; Ma S, 2009, J COMP NEUROL, V517, P856, DOI 10.1002/cne.22197; Ma S, 2009, LEARN MEMORY, V16, P730, DOI 10.1101/lm.1438109; McGowan BM, 2008, AM J PHYSIOL-ENDOC M, V295, pE278, DOI 10.1152/ajpendo.00028.2008; McGowan BM, 2007, AM J PHYSIOL-ENDOC M, V292, pE913, DOI 10.1152/ajpendo.00346.2006; McGowan BM, 2006, REGUL PEPTIDES, V136, P72, DOI 10.1016/j.regpep.2006.04.009; McGowan BMC, 2005, ENDOCRINOLOGY, V146, P3295, DOI 10.1210/en.2004-1532; McLaughlin JP, 2003, J NEUROSCI, V23, P5674, DOI 10.1523/jneurosci.23-13-05674.2003; Miyanioto Y, 2008, REGUL PEPTIDES, V145, P54, DOI 10.1016/j.regpep.2007.08.010; Olucha-Bordonau FE, 2003, J COMP NEUROL, V464, P62, DOI 10.1002/cne.10774; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Ragozzino ME, 1998, J NEUROSCI, V18, P1595; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Silvertown JD, 2010, REGUL PEPTIDES, V159, P44, DOI 10.1016/j.regpep.2009.09.007; Smith CM, 2012, GENES BRAIN BEHAV, V11, P94, DOI 10.1111/j.1601-183X.2011.00730.x; Smith CM, 2010, J COMP NEUROL, V518, P4016, DOI 10.1002/cne.22442; Smith CM, 2009, ANN NY ACAD SCI, V1160, P259, DOI 10.1111/j.1749-6632.2009.03952.x; Smith CM, 2009, ANN NY ACAD SCI, V1160, P236, DOI 10.1111/j.1749-6632.2009.03953.x; Stefani MR, 1998, BRAIN RES, V813, P50, DOI 10.1016/S0006-8993(98)00876-2; Sutton SW, 2009, ANN NY ACAD SCI, V1160, P242, DOI 10.1111/j.1749-6632.2008.03812.x; Sutton SW, 2004, NEUROENDOCRINOLOGY, V80, P298, DOI 10.1159/000083656; Tanaka M, 2005, EUR J NEUROSCI, V21, P1659, DOI 10.1111/j.1460-9568.2005.03980.x; Tanaka M, 2010, FEBS J, V277, P4990, DOI 10.1111/j.1742-4658.2010.07931.x; Veldwijk MR, 2002, MOL THER, V6, P272, DOI 10.1006/mthe.2002.0569; Watanabe Y, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00050; Watanabe Y, 2011, J MOL NEUROSCI, V43, P169, DOI 10.1007/s12031-010-9468-0; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	51	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42300	10.1371/journal.pone.0042300	http://dx.doi.org/10.1371/journal.pone.0042300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876314	Green Published, gold, Green Submitted			2022-12-27	WOS:000307184700042
J	Lassen, LB; Ballarin-Gonzalez, B; Schmitz, A; Fuchtbauer, A; Pedersen, FS; Fuchtbauer, EM				Lassen, Louise Berkhoudt; Ballarin-Gonzalez, Borja; Schmitz, Alexander; Fuchtbauer, Annette; Pedersen, Finn Skou; Fuchtbauer, Ernst-Martin			Nras Overexpression Results in Granulocytosis, T-Cell Expansion and Early Lethality in Mice	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; N-RAS; ONCOGENIC NRAS; H-RAS; K-RAS; ACTIVATION; EXPRESSION; GENE; CSF; IDENTIFICATION	NRAS is a proto-oncogene involved in numerous myeloid malignancies. Here, we report on a mouse line bearing a single retroviral long terminal repeat inserted into Nras. This genetic modification resulted in an increased level of wild type Nras mRNA giving the possibility of studying the function and activation of wild type NRAS. Flow cytometry was used to show a variable but significant increase of immature myeloid cells in spleen and thymus, and of T-cells in the spleen. At an age of one week, homozygous mice began to retard compared to their wild type and heterozygous littermates. Two weeks after birth, animals started to progressively lose weight and die before weaning. Heterozygous mice showed a moderate increase of T-cells and granulocytes but survived to adulthood and were fertile. In homozygous and heterozygous mice Gfi1 and Gcsf mRNA levels were upregulated, possibly explaining the increment in immature myeloid cells detected in these mice. The short latency period indicates that Nras overexpression alone is sufficient to cause dose-dependent granulocytosis and T-cell expansion.	[Lassen, Louise Berkhoudt; Ballarin-Gonzalez, Borja; Schmitz, Alexander; Fuchtbauer, Annette; Pedersen, Finn Skou; Fuchtbauer, Ernst-Martin] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Schmitz, Alexander] Aarhus Univ Hosp, Aalborg Hosp, Dept Haematol, DK-8000 Aarhus, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University	Lassen, LB (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	emf@mb.au.dk			Danish Cancer Society; Danish Medical Research Council; Danish Genetically Modified Animal Resource (DAGMAR); Danish Agency for Science, Technology, and Innovation	Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Genetically Modified Animal Resource (DAGMAR); Danish Agency for Science, Technology, and Innovation	This study was supported in part by grants from the Danish Cancer Society, the Danish Medical Research Council and the Danish Genetically Modified Animal Resource (DAGMAR) funded by the Danish Agency for Science, Technology, and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado Y, 2007, EXPERT OPIN EMERG DR, V12, P271, DOI 10.1517/14728214.12.2.271; BOS JL, 1989, CANCER RES, V49, P4682; Byrne JL, 1998, BRIT J HAEMATOL, V100, P256; DEMETRI GD, 1990, J CLIN INVEST, V86, P1261, DOI 10.1172/JCI114833; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Feola DJ, 2010, ANTIMICROB AGENTS CH, V54, P2437, DOI 10.1128/AAC.01424-09; GOUGH NM, 1985, EMBO J, V4, P645, DOI 10.1002/j.1460-2075.1985.tb03678.x; Ise K, 2000, ONCOGENE, V19, P2951, DOI 10.1038/sj.onc.1203600; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Lovmand J, 1998, J VIROL, V72, P5745, DOI 10.1128/JVI.72.7.5745-5756.1998; MacKenzie KL, 1999, BLOOD, V93, P2043, DOI 10.1182/blood.V93.6.2043.406k17_2043_2056; MANGUES R, 1992, ONCOGENE, V7, P2073; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Martin-Hernandez J, 2001, J VIROL, V75, P11907, DOI 10.1128/JVI.75.23.11907-11912.2001; Morris ES, 2009, NAT MED, V15, P436, DOI 10.1038/nm.1948; Ohba Y, 2003, EMBO J, V22, P859, DOI 10.1093/emboj/cdg087; Parikh C, 2007, CANCER RES, V67, P7139, DOI 10.1158/0008-5472.CAN-07-0778; Parikh C, 2006, BLOOD, V108, P2349, DOI 10.1182/blood-2004-08-009498; Perez de Castro I, 2003, CANCER RES, V63, P1615; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sierra MD, 2010, BLOOD, V115, P3970, DOI 10.1182/blood-2009-10-246967; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; VELLENGA E, 1988, BLOOD, V71, P1529; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wang JY, 2011, CELL CYCLE, V10, P2836, DOI 10.4161/cc.10.17.17195; Wang JY, 2011, BLOOD, V118, P368, DOI 10.1182/blood-2010-12-326058; Wang JY, 2010, BLOOD, V116, P5991, DOI 10.1182/blood-2010-04-281527; WERTZ K, 1994, TRANSGENICS, V1, P277; Zhang J, 2005, P NATL ACAD SCI USA, V102, P14605, DOI 10.1073/pnas.0507446102	38	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42216	10.1371/journal.pone.0042216	http://dx.doi.org/10.1371/journal.pone.0042216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876308	Green Published, gold			2022-12-27	WOS:000307184700036
J	Gea-Sorli, S; Bonjoch, L; Closa, D				Gea-Sorli, Sabrina; Bonjoch, Laia; Closa, Daniel			Differences in the Inflammatory Response Induced by Acute Pancreatitis in Different White Adipose Tissue Sites in the Rat	PLOS ONE			English	Article							FATTY-ACID COMPOSITION; LIPIDS; MACROPHAGES; SEVERITY; OBESITY	Background: There is increasing evidence of the role of adipose tissue on the systemic effects of acute pancreatitis. Patients with higher body mass index have increased risk of local and systemic complications and patients with android fat distribution and higher waist circumference are at greater risk for developing the severe form of the disease. Here we evaluated the changes on different areas of adipose tissue and its involvement on the inflammatory response in an experimental model of acute pancreatitis. Methods: Pancreatitis was induced in male Wistar rats by intraductal administration of sodium taurocholate. Orlistat was administered to inhibit lipase activity. Activation of peritoneal macrophages was evaluated by measuring IL1 beta and TNF alpha expression. Inflammation was evaluated by measuring myeloperoxidase activity in mesenteric, epididymal and retroperitoneal areas of adipose tissue. Changes in the expression of inflammatory mediator in these areas of adipose tissue were also evaluated by RT-PCR. Results: Pancreatitis induces the activation of peritoneal macrophages and a strong inflammatory response in mesenteric and epididymal sites of adipose tissue. By contrast, no changes were found in retroperitoneal adipose tissue. Inhibition of lipase prevented the activation of macrophages and the local inflammation in adipose tissue. Conclusions: Our results confirm the involvement of adipose tissue on the progression of systemic inflammatory response during acute pancreatitis. However, there is a considerable diversity in different adipose tissue sites. These differences need to be taken into account in order to understand the progression from local pancreatic damage to systemic inflammation during acute pancreatitis.	[Gea-Sorli, Sabrina] IIBB CSIC, IDIBAPS, Dept Expt Pathol, Barcelona, Spain; CIBEREHD, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Gea-Sorli, S (corresponding author), IIBB CSIC, IDIBAPS, Dept Expt Pathol, Barcelona, Spain.	daniel.closa@iibb.csic.es	Closa, Daniel/Y-3848-2019	Closa Autet, Daniel/0000-0003-3797-3095; Bonjoch, Laia/0000-0002-3351-0037	Ministerio de Ciencia e Innovacion [SAF 2009-07605]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This study was supported by the project SAF 2009-07605 and from Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO HJ, 1980, SCAND J GASTROENTERO, V15, P411, DOI 10.3109/00365528009181493; Romero MD, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-42; DETTELBACH MA, 1990, J BONE MINER RES, V5, P1249; Franco-Pons N, 2012, ANN SURG IN PRESS; Franco-Pons N, 2010, J PATHOL, V221, P175, DOI 10.1002/path.2691; Gea-Sorl S, 2011, J PATHOL, V223, P417, DOI 10.1002/path.2814; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Gutierrez PT, 2008, GUT, V57, P642, DOI 10.1136/gut.2007.127472; Hilal MA, 2008, OBES SURG, V18, P326, DOI 10.1007/s11695-007-9298-5; Hussain N, 1998, AM J RESP CELL MOL, V19, P867, DOI 10.1165/ajrcmb.19.6.3118; KLOPPEL G, 1993, PANCREAS, V8, P659; MALCOM GT, 1989, AM J CLIN NUTR, V50, P288, DOI 10.1093/ajcn/50.2.288; Martinez J, 2006, PANCREATOLOGY, V6, P206, DOI 10.1159/000092104; Mery CM, 2002, PANCREATOLOGY, V2, P543, DOI 10.1159/000066099; Navina S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002573; Sempere L, 2008, PANCREATOLOGY, V8, P257, DOI 10.1159/000134273; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Villena JA, 2001, INT J OBESITY, V25, P1275, DOI 10.1038/sj.ijo.0801680; Wolk A, 2001, J NUTR, V131, P828, DOI 10.1093/jn/131.3.828	19	15	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41933	10.1371/journal.pone.0041933	http://dx.doi.org/10.1371/journal.pone.0041933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870264	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800044
J	Liu, YX; Tai, JL; Li, GQ; Zhang, ZW; Xue, JH; Liu, HS; Zhu, H; Cheng, JD; Liu, YL; Li, AM; Zhang, Y				Liu, Yu-xiao; Tai, Jun-li; Li, Guo-qing; Zhang, Zhi-wen; Xue, Jing-hui; Liu, Hong-sheng; Zhu, Heng; Cheng, Ji-de; Liu, Yuan-ling; Li, An-ming; Zhang, Yi			Exposure to 1950-MHz TD-SCDMA Electromagnetic Fields Affects the Apoptosis of Astrocytes via Caspase-3-Dependent Pathway	PLOS ONE			English	Article							RADIOFREQUENCY RADIATION; CELL-PROLIFERATION; OXIDATIVE STRESS; GENE-EXPRESSION; MHZ; INDUCTION; TUMORS; BCL-2; DNA	The usage of mobile phone increases globally. However, there is still a paucity of data about the impact of electromagnetic fields (EMF) on human health. This study investigated whether EMF radiation would alter the biology of glial cells and act as a tumor-promoting agent. We exposed rat astrocytes and C6 glioma cells to 1950-MHz TD-SCDMA for 12, 24 and 48 h respectively, and found that EMF exposure had differential effects on rat astroctyes and C6 glioma cells. A 48 h of exposure damaged the mitochondria and induced significant apoptosis of astrocytes. Moreover, caspase-3, a hallmark of apoptosis, was highlighted in astrocytes after 48 h of EMF exposure, accompanied by a significantly increased expression of bax and reduced level of bcl-2. The tumorigenicity assays demonstrated that astrocytes did not form tumors in both control and exposure groups. In contrast, the unexposed and exposed C6 glioma cells show no significant differences in both biological feature and tumor formation ability. Therefore, our results implied that exposure to the EMF of 1950-MHz TD-SCDMA may not promote the tumor formation, but continuous exposure damaged the mitochondria of astrocytes and induce apoptosis through a caspase-3-dependent pathway with the involvement of bax and bcl-2.	[Liu, Yu-xiao; Zhang, Zhi-wen; Xue, Jing-hui; Liu, Hong-sheng; Li, An-ming] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Neurosurg, Beijing, Peoples R China; [Zhu, Heng; Cheng, Ji-de; Liu, Yuan-ling; Zhang, Yi] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Cell Biol, Beijing 100730, Peoples R China; [Li, Guo-qing] China Telecommun Technol Labs, Beijing, Peoples R China; [Tai, Jun-li] Jian Gong Hosp, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Liu, YX (corresponding author), Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Neurosurg, Beijing, Peoples R China.	anmingli301@163.com; zhangyi612@hotmail.com	zhu, dingdingabc/AAZ-7892-2020		National Key Basic Research Program of China [2010CB833604]; National Natural Sciences Foundation of China [31070996, 31171084]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Basic Research Program of China (Grant number 2010CB833604), the National Natural Sciences Foundation of China (Grant numbers 31070996, 31171084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey WR, 2000, CANCER RES, V60, P1857; Ammari M, 2008, TOXICOLOGY, V250, P70, DOI 10.1016/j.tox.2008.05.019; Ammari M, 2008, BIOMED PHARMACOTHER, V62, P273, DOI 10.1016/j.biopha.2008.03.002; Buttiglione M, 2007, J CELL PHYSIOL, V213, P759, DOI 10.1002/jcp.21146; Capri M, 2004, INT J RADIAT BIOL, V80, P389, DOI 10.1080/09553000410001702346; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cleary SF, 1996, FASEB J, V10, P913; Dasdag S, 2009, ELECTROMAGN BIOL MED, V28, P342, DOI 10.3109/15368370903206556; El-Hage N, 2006, GLIA, V53, P132, DOI 10.1002/glia.20262; Gerner C, 2010, INT ARCH OCC ENV HEA, V83, P691, DOI 10.1007/s00420-010-0513-7; Goodman R, 2002, J CELL PHYSIOL, V192, P16, DOI 10.1002/jcp.10098; Hirose H, 2010, BIOELECTROMAGNETICS, V31, P104, DOI 10.1002/bem.20532; Ivancsits S, 2002, MUTAT RES-GEN TOX EN, V519, P1, DOI 10.1016/S1383-5718(02)00109-2; Joubert V, 2007, BIOELECTROMAGNETICS, V28, P115, DOI 10.1002/bem.20274; Karaca E, 2011, J NEUROONCOL; Kismali G, 2012, INT J RADIAT BIOL, V88, P414, DOI 10.3109/09553002.2012.661517; La Regina M, 2003, RADIAT RES, V160, P143, DOI 10.1667/RR3028; Liu YX, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-85; Lonn S, 2005, AM J EPIDEMIOL, V161, P526, DOI 10.1093/aje/kwi091; Miyakoshi J, 2005, BIOELECTROMAGNETICS, V26, P251, DOI 10.1002/bem.20077; Narita K, 1997, IN VIVO, V11, P329; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; O'Connor RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011828; Perez-Bruzon RN, 2011, HISTOL HISTOPATHOL, V26, P1187, DOI 10.14670/HH-26.1187; Pinon LGP, 1997, DEVELOPMENT, V124, P4173; Sannino A, 2011, INT J RADIAT BIOL, V87, P993, DOI 10.3109/09553002.2011.574779; Sekijima M, 2010, J RADIAT RES, V51, P277, DOI 10.1269/jrr.09126; Stagg RB, 2001, RADIAT RES, V155, P584, DOI 10.1667/0033-7587(2001)155[0584:EOIACE]2.0.CO;2; Trillo MA, 2011, BIOELECTROMAGNETICS, V32, P340, DOI 10.1002/bem.20643; Trosic I, 2009, ARH HIG RADA TOKSIKO, V60, P109, DOI 10.2478/10004-1254-60-2009-1891; Velizarov S, 1999, BIOELECTROCH BIOENER, V48, P177, DOI 10.1016/S0302-4598(98)00238-4; Warren HG, 2003, LARYNGOSCOPE, V113, P663, DOI 10.1097/00005537-200304000-00015; Xu SC, 2010, BRAIN RES, V1311, P189, DOI 10.1016/j.brainres.2009.10.062; Yan JG, 2009, ELECTROMAGN BIOL MED, V28, P383, DOI 10.3109/15368370903287614; Zeni O, 2012, BIOELECTROMAGETICS	35	14	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42332	10.1371/journal.pone.0042332	http://dx.doi.org/10.1371/journal.pone.0042332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870319	gold, Green Published, Green Submitted			2022-12-27	WOS:000307212800082
J	Sasson, NJ; Dichter, GS; Bodfish, JW				Sasson, Noah J.; Dichter, Gabriel S.; Bodfish, James W.			Affective Responses by Adults with Autism Are Reduced to Social Images but Elevated to Images Related to Circumscribed Interests	PLOS ONE			English	Article							CIRCUMPLEX MODEL; JOINT ATTENTION; YOUNG-CHILDREN; HIGH-IQ; GAZE; GIRLS; BEHAVIOR; EMOTION; PLAY; PERCEPTION	Individuals with autism spectrum disorders (ASD) demonstrate increased visual attention and elevated brain reward circuitry responses to images related to circumscribed interests (CI), suggesting that a heightened affective response to CI may underlie their disproportionate salience and reward value in ASD. To determine if individuals with ASD differ from typically developing (TD) adults in their subjective emotional experience of CI object images, non-CI object images and social images, 213 TD adults and 56 adults with ASD provided arousal ratings (sensation of being energized varying along a dimension from calm to excited) and valence ratings (emotionality varying along dimension of approach to withdrawal) for a series of 114 images derived from previous research on CI. The groups did not differ on arousal ratings for any image type, but ASD adults provided higher valence ratings than TD adults for CI-related images, and lower valence ratings for social images. Even after co-varying the effects of sex, the ASD group, but not the TD group, gave higher valence ratings to CI images than social images. These findings provide additional evidence that ASD is characterized by a preference for certain categories of non-social objects and a reduced preference for social stimuli, and support the dissemination of this image set for examining aspects of the circumscribed interest phenotype in ASD.	[Sasson, Noah J.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [Dichter, Gabriel S.; Bodfish, James W.] Univ N Carolina, Sch Med, Carolina Inst Dev Disabil, Chapel Hill, NC USA	University of Texas System; University of Texas Dallas; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sasson, NJ (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA.	nsasson@utdallas.edu	Dichter, Gabriel S/K-6726-2015	Dichter, Gabriel S/0000-0003-3407-5417	National Institute of Mental Health [2R01MH073402, K23 MH081285]; Participant Registry Core of the UNC Carolina Institute for Developmental Disabilities [P30 HD03110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073402, K23MH081285] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Participant Registry Core of the UNC Carolina Institute for Developmental Disabilities; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institute of Mental Health 2R01MH073402 (Bodfish & Dichter), National Institute of Mental Health K23 MH081285 (Dichter), and the Participant Registry Core of the UNC Carolina Institute for Developmental Disabilities (P30 HD03110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2009, ARCH SEX BEHAV, V38, P427, DOI 10.1007/s10508-008-9430-1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; [Anonymous], 2011, J SEX MED, DOI DOI 10.1111/j.1743-6109.2011.02449.x; Attwood T, 2003, LEARNING AND BEHAVIOR PROBLEMS IN ASPERGER SYNDROME, P126; ATTWOOD T, 1998, ASPERGERS SYNDROME G; Auyeung B, 2009, PSYCHOL SCI, V20, P144, DOI 10.1111/j.1467-9280.2009.02279.x; Bar-Haim Y, 2006, J AUTISM DEV DISORD, V36, P131, DOI 10.1007/s10803-005-0046-1; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Barrett LF, 2007, ANNU REV PSYCHOL, V58, P373, DOI 10.1146/annurev.psych.58.110405.085709; BARTAK L, 1976, J AUTISM CHILD SCHIZ, V6, P109, DOI 10.1007/BF01538054; Boyd BA, 2007, J AUTISM DEV DISORD, V37, P1550, DOI 10.1007/s10803-006-0286-8; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brooks R, 2005, DEVELOPMENTAL SCI, V8, P535, DOI 10.1111/j.1467-7687.2005.00445.x; Bryson SE, 2007, J AUTISM DEV DISORD, V37, P12, DOI 10.1007/s10803-006-0328-2; Centers for Disease Control and Prevention, 2012, MMWR WEEKL PREV AUT; CHAWARSKA K, J CHILD PSY IN PRESS; Chawarska K, 2009, J AUTISM DEV DISORD, V39, P1663, DOI 10.1007/s10803-009-0803-7; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; DeLoache JS, 2007, DEV PSYCHOL, V43, P1579, DOI 10.1037/0012-1649.43.6.1579; Dichter GS, 2012, J AUTISM DEV DISORD, V42, P147, DOI 10.1007/s10803-011-1221-1; Dichter GS, 2012, SOC COGN AFFECT NEUR, V7, P160, DOI 10.1093/scan/nsq095; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Farroni T, 2007, COGNITION, V102, P396, DOI 10.1016/j.cognition.2006.01.007; Fecteau S, 2003, AUTISM, V7, P255, DOI 10.1177/1362361303007003003; FREEMAN BJ, 1981, AM J PSYCHIAT, V138, P25; Gerber AJ, 2008, NEUROPSYCHOLOGIA, V46, P2129, DOI 10.1016/j.neuropsychologia.2008.02.032; Ingudomnuku E, 2007, HORM BEHAV, V51, P597, DOI 10.1016/j.yhbeh.2007.02.001; Jadva V, 2010, ARCH SEX BEHAV, V39, P1261, DOI 10.1007/s10508-010-9618-z; Johnson MH, 2000, BRAIN COGNITION, V42, P124, DOI 10.1006/brcg.1999.1180; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Kanner L, 1943, NERV CHILD, V2, P217; Klin A, 2002, AM J PSYCHIAT, V159, P895, DOI 10.1176/appi.ajp.159.6.895; Klin A, 2007, RES PRACT PERS SEV D, V32, P89, DOI 10.2511/rpsd.32.2.89; Knickmeyer RC, 2008, J AUTISM DEV DISORD, V38, P1028, DOI 10.1007/s10803-007-0475-0; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; KOEGEL RL, 1974, J APPL BEHAV ANAL, V7, P521, DOI 10.1901/jaba.1974.7-521; Kringelbach ML, 2009, TRENDS COGN SCI, V13, P479, DOI 10.1016/j.tics.2009.08.006; Kylliainen A, 2006, J AUTISM DEV DISORD, V36, P517, DOI 10.1007/s10803-006-0091-4; Labar KS, 2007, CURR DIR PSYCHOL SCI, V16, P173, DOI 10.1111/j.1467-8721.2007.00498.x; Lam KSL, 2008, J CHILD PSYCHOL PSYC, V49, P1193, DOI 10.1111/j.1469-7610.2008.01944.x; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; LOVELAND KA, 1994, DEV PSYCHOPATHOL, V6, P433, DOI 10.1017/S0954579400006039; MERCIER C, 2000, AUTISM, V4, P406, DOI DOI 10.1177/1362361300004004006; Merin N, 2007, J AUTISM DEV DISORD, V37, P108, DOI 10.1007/s10803-006-0342-4; Meyer-Bahlburg HFL, 2004, ARCH SEX BEHAV, V33, P97, DOI 10.1023/B:ASEB.0000014324.25718.51; Nadig A, 2010, NEUROPSYCHOLOGIA, V48, P2730, DOI 10.1016/j.neuropsychologia.2010.05.020; Noland JS, 2010, DEVELOPMENTAL SCI, V13, P244, DOI 10.1111/j.1467-7687.2009.00882.x; Pasterski VL, 2005, CHILD DEV, V76, P264, DOI 10.1111/j.1467-8624.2005.00843.x; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Pierce K, 2011, ARCH GEN PSYCHIAT, V68, P101, DOI 10.1001/archgenpsychiatry.2010.113; Piven J, 1996, J AM ACAD CHILD PSY, V35, P523, DOI 10.1097/00004583-199604000-00019; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Rutherford MD, 2008, J AUTISM DEV DISORD, V38, P1371, DOI 10.1007/s10803-007-0525-7; Sasson NJ, 2006, J AUTISM DEV DISORD, V36, P381, DOI 10.1007/s10803-006-0076-3; Sasson NJ, 2011, J AUTISM DEV DISORD, V41, P242, DOI 10.1007/s10803-010-1038-3; Sasson NJ, 2008, AUTISM RES, V1, P31, DOI 10.1002/aur.4; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; South M, 2005, J AUTISM DEV DISORD, V35, P145, DOI 10.1007/s10803-004-1992-8; Spezio ML, 2007, NEUROPSYCHOLOGIA, V45, P144, DOI 10.1016/j.neuropsychologia.2006.04.027; Turner-Brown LM, 2011, AUTISM, V15, P437, DOI 10.1177/1362361310386507; VARNI JW, 1979, J ABNORM CHILD PSYCH, V7, P31, DOI 10.1007/BF00924508; Vismara LA, 2007, J POSIT BEHAV INTERV, V9, P214, DOI 10.1177/10983007070090040401; YIRMIYA N, 1989, J CHILD PSYCHOL PSYC, V30, P725, DOI 10.1111/j.1469-7610.1989.tb00785.x	68	57	57	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42457	10.1371/journal.pone.0042457	http://dx.doi.org/10.1371/journal.pone.0042457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	984SU	22870328	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800092
J	Shi, Y; Sheng, R; Zhong, TT; Xu, Y; Chen, XP; Yang, D; Sun, Y; Yang, FY; Hu, YZ; Zhou, NM				Shi, Ying; Sheng, Rong; Zhong, Tingting; Xu, Yu; Chen, Xiaopan; Yang, Dong; Sun, Yi; Yang, Fenyan; Hu, Yongzhou; Zhou, Naiming			Identification and Characterization of ZEL-H16 as a Novel Agonist of the Histamine H-3 Receptor	PLOS ONE			English	Article							G-PROTEIN; ACETYLCHOLINE-RELEASE; NORADRENALINE-RELEASE; MOLECULAR-CLONING; SEROTONIN RELEASE; SUBSTANTIA-NIGRA; H3 RECEPTORS; IN-VITRO; BP 2-94; BRAIN	The histamine H3 receptor (H3R) has been recognized as a promising target for the treatment of various central and peripheral nervous system diseases. In this study, a non-imidazole compound, ZEL-H16, was identified as a novel histamine H3 receptor agonist. ZEL-H16 was found to bind to human H3R with a Ki value of approximately 2.07 nM and 4.36 nM to rat H3R. Further characterization indicated that ZEL-H16 behaved as a partial agonist on the inhibition of forskolin-stimulated cAMP accumulation (the efficacy was 60% of that of histamine) and activation of ERK1/2 signaling (the efficacy was 50% of that of histamine) at H3 receptors, but acted as a full agonist just like histamin in the guinea-pig ileum contraction assay. These effects were blocked by pertussis toxin and H3 receptor specific antagonist thioperamide. ZEL-H16 showed no agonist or antagonist activities at the cloned human histamine H1, H2, and H4 receptors and other biogenic amine GPCRs in the CRE-driven reporter assay. Furthermore, our present data demonstrated that treatment of ZEL-H16 resulted in intensive H3 receptor internalization and delayed recycling to the cell surface as compared to that of control with treatment of histamine. Thus, ZEL-H16 is a novel and potent nonimidazole agonist of H3R, which might serve as a pharmacological tool for future investigations or as possible therapeutic agent of H3R.	[Shi, Ying; Zhong, Tingting; Chen, Xiaopan; Yang, Dong; Sun, Yi; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Sheng, Rong; Xu, Yu; Yang, Fenyan; Hu, Yongzhou] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Shi, Y (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	huyz@zju.edu.cn; znm2000@yahoo.com	Zhou, Naiming/AHC-1121-2022; yang, dongxiao/GWM-8493-2022	Chen, Xiaopan/0000-0003-4289-7541	National Natural Science Foundation of China [30670425]; Ministry of Science and Technology [2008AA02Z138]; National Key Tech Project for Major Creation of New drugs [2009ZX09501-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Key Tech Project for Major Creation of New drugs	This work was supported by grants from the National Natural Science Foundation of China (No. 30670425), the Ministry of Science and Technology (No. 2008AA02Z138) and the National Key Tech Project for Major Creation of New drugs (No. 2009ZX09501-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ares JJ, 1998, CURR PHARM DESIGN, V4, P17; ARRANG JM, 1983, NATURE, V302, P832, DOI 10.1038/302832a0; ARRANG JM, 1987, NEUROSCIENCE, V23, P149, DOI 10.1016/0306-4522(87)90279-X; ARRANG JM, 1987, NATURE, V327, P117, DOI 10.1038/327117a0; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Bonaventure P, 2007, BIOCHEM PHARMACOL, V73, P1084, DOI 10.1016/j.bcp.2006.10.031; Bongers G, 2007, BIOCHEM PHARMACOL, V73, P1195, DOI 10.1016/j.bcp.2007.01.008; Cecchi M, 1998, INFLAMM RES, V47, pS32; Celanire S, 2005, DRUG DISCOV TODAY, V10, P1613, DOI 10.1016/S1359-6446(05)03625-1; CIPRANDI G, 1992, DRUGS, V43, P154, DOI 10.2165/00003495-199243020-00003; CORUZZI G, 1991, N-S ARCH PHARMACOL, V343, P225, DOI 10.1007/BF00168615; Drutel G, 2001, MOL PHARMACOL, V59, P1; Esbenshade TA, 2006, MOL INTERV, V6, P77, DOI 10.1124/mi.6.2.5; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferrada C, 2008, NEUROPHARMACOLOGY, V55, P190, DOI 10.1016/j.neuropharm.2008.05.008; FINK K, 1990, N-S ARCH PHARMACOL, V342, P513; Francis H, 2007, LAB INVEST, V87, P473, DOI 10.1038/labinvest.3700533; GANTZ I, 1991, P NATL ACAD SCI USA, V88, P429, DOI 10.1073/pnas.88.2.429; GARBARG M, 1992, J PHARMACOL EXP THER, V263, P304; Garduno-Torres B, 2007, NEUROPHARMACOLOGY, V52, P527, DOI 10.1016/j.neuropharm.2006.08.001; Gbahou F, 2010, J PHARMACOL EXP THER, V334, P945, DOI 10.1124/jpet.110.168633; Hough LB, 2001, MOL PHARMACOL, V59, P415, DOI 10.1124/mol.59.3.415; Kitbunnadaj R, 2003, J MED CHEM, V46, P5445, DOI 10.1021/jm030905y; Korotkova TM, 2005, NEUROPHARMACOLOGY, V49, P129, DOI 10.1016/j.neuropharm.2005.03.001; Korotkova TM, 2002, NEUROSCI LETT, V320, P133, DOI 10.1016/S0304-3940(02)00050-2; KORTE A, 1990, BIOCHEM BIOPH RES CO, V168, P979, DOI 10.1016/0006-291X(90)91125-C; Kraus MM, 2001, INFLAMM RES, V50, pS74; Krueger KM, 2005, J PHARMACOL EXP THER, V314, P271, DOI 10.1124/jpet.104.078865; LEURS R, 1995, PHARMACOL THERAPEUT, V66, P413, DOI 10.1016/0163-7258(95)00006-3; Ligneau X, 1998, J PHARMACOL EXP THER, V287, P658; Lim HD, 2006, CURR TOP MED CHEM, V6, P1365, DOI 10.2174/15680266106061365; Liu CL, 2001, MOL PHARMACOL, V59, P420, DOI 10.1124/mol.59.3.420; Lovenberg TW, 1999, MOL PHARMACOL, V55, P1101, DOI 10.1124/mol.55.6.1101; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; MARTINEZMIR MI, 1990, BRAIN RES, V526, P322, DOI 10.1016/0006-8993(90)91240-H; Millan-Guerrero RO, 2006, CAN J NEUROL SCI, V33, P195, DOI 10.1017/S0317167100004960; Nguyen T, 2001, MOL PHARMACOL, V59, P427, DOI 10.1124/mol.59.3.427; Oda T, 2000, J BIOL CHEM, V275, P36781, DOI 10.1074/jbc.M006480200; OHKUBO T, 1995, EUR J PHARMACOL, V273, P83, DOI 10.1016/0014-2999(94)00668-W; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Rouleau A, 2000, J PHARMACOL EXP THER, V295, P219; Rouleau A, 1997, J PHARMACOL EXP THER, V281, P1085; Sasse A, 1999, J MED CHEM, V42, P4269, DOI 10.1021/jm991068w; Sasse A, 2000, BIOORGAN MED CHEM, V8, P1139, DOI 10.1016/S0968-0896(00)00050-X; Schlicker E, 1996, N-S ARCH PHARMACOL, V353, P482; SCHLICKER E, 1993, PHARMACOLOGY, V47, P111, DOI 10.1159/000139085; SCHLICKER E, 1994, FUND CLIN PHARMACOL, V8, P128, DOI 10.1111/j.1472-8206.1994.tb00789.x; SCHLICKER E, 1994, N-S ARCH PHARMACOL, V350, P34; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; Threlfell S, 2004, J NEUROSCI, V24, P8704, DOI 10.1523/JNEUROSCI.2690-04.2004; VOLLINGA RC, 1994, J MED CHEM, V37, P332, DOI 10.1021/jm00029a002; Wijtmans M, 2007, EXPERT OPIN INV DRUG, V16, P967, DOI 10.1517/13543784.16.7.967; YAMASHITA M, 1991, P NATL ACAD SCI USA, V88, P11515, DOI 10.1073/pnas.88.24.11515; Yoshimoto R, 2006, P NATL ACAD SCI USA, V103, P13866, DOI 10.1073/pnas.0506104103	54	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42185	10.1371/journal.pone.0042185	http://dx.doi.org/10.1371/journal.pone.0042185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870296	gold, Green Published, Green Submitted			2022-12-27	WOS:000307212800065
J	Fischer, S; Bayersdorfer, F; Harant, E; Reng, R; Arndt, S; Bosserhoff, AK; Schneuwly, S				Fischer, Susanne; Bayersdorfer, Florian; Harant, Eva; Reng, Renate; Arndt, Stephanie; Bosserhoff, Anja-Katrin; Schneuwly, Stephan			fussel (fuss) - A Negative Regulator of BMP Signaling in Drosophila melanogaster	PLOS ONE			English	Article							TRANSCRIPTIONAL COREPRESSOR; TUMOR-SUPPRESSOR; CO-REPRESSOR; BETA; GENE; SKI; DPP; GROWTH; SMAD; RECEPTOR	The TGF-beta/BMP signaling cascades control a wide range of developmental and physiological functions in vertebrates and invertebrates. In Drosophila melanogaster, members of this pathway can be divided into a Bone Morphogenic Protein (BMP) and an Activin-beta (Act-beta) branch, where Decapentaplegic (Dpp), a member of the BMP family has been most intensively studied. They differ in ligands, receptors and transmitting proteins, but also share some components, such as the Co-Smad Medea (Med). The essential role of Med is to form a complex with one of the two activating Smads, mothers against decapentaplegic (Mad) or dSmad, and to translocate together to the nucleus where they can function as transcriptional regulators of downstream target genes. This signaling cascade underlies different mechanisms of negative regulation, which can be exerted by inhibitory Smads, such as daughters against decapentaplegic (dad), but also by the Ski-Sno family. In this work we identified and functionally analyzed a new member of the Ski/Sno-family, fussel (fuss), the Drosophila homolog of the human functional suppressing element 15 (fussel-15). fuss codes for two differentially spliced transcripts with a neuronal expression pattern. The proteins are characterized by a Ski-Sno and a SAND homology domain. Overexpression studies and genetic interaction experiments clearly reveal an interaction of fuss with members of the BMP pathway, leading to a strong repression of BMP-signaling. The protein interacts directly with Medea and seems to reprogram the Smad pathway through its influence upon the formation of functional Mad/Medea complexes. This leads amongst others to a repression of downstream target genes of the Dpp pathway, such as optomotor blind (omb). Taken together we could show that fuss exerts a pivotal role as an antagonist of BMP signaling in Drosophila melanogaster.	[Fischer, Susanne; Bayersdorfer, Florian; Harant, Eva; Reng, Renate; Schneuwly, Stephan] Univ Regensburg, Inst Zool, D-8400 Regensburg, Germany; [Arndt, Stephanie; Bosserhoff, Anja-Katrin] Univ Regensburg, Inst Pathol, Regensburg, Germany	University of Regensburg; University of Regensburg	Fischer, S (corresponding author), Univ Regensburg, Inst Zool, Univ Str 31, D-8400 Regensburg, Germany.	stephan.schneuwly@biologie.uni-regensburg.de	Bosserhoff, Anja/GNH-4801-2022	Bosserhoff, Anja/0000-0001-8147-394X; Schneuwly, Stephan/0000-0001-7711-8902	University of Regensburg	University of Regensburg	This work was funded by the University of Regensburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Akimaru H, 1997, NAT GENET, V17, P211, DOI 10.1038/ng1097-211; Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Arguello JR, 2010, MOL BIOL EVOL, V27, P848, DOI 10.1093/molbev/msp291; Arndt S, 2005, LAB INVEST, V85, P1330, DOI 10.1038/labinvest.3700344; Arndt S, 2007, MOL CELL NEUROSCI, V34, P603, DOI 10.1016/j.mcn.2007.01.002; ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Barrio R, 2004, P NATL ACAD SCI USA, V101, P6021, DOI 10.1073/pnas.0401590101; Barrio R, 2007, DEV BIOL, V306, P66, DOI 10.1016/j.ydbio.2007.02.039; Bollenbach T, 2008, DEVELOPMENT, V135, P1137, DOI 10.1242/dev.012062; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Cao J, 2006, DROS INFORM SERV, V89, P131; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cifuentes FJ, 1997, P NATL ACAD SCI USA, V94, P11405, DOI 10.1073/pnas.94.21.11405; da Graca LS, 2004, DEVELOPMENT, V131, P435, DOI 10.1242/dev.00922; Das P, 1999, GENES CELLS, V4, P123, DOI 10.1046/j.1365-2443.1999.00244.x; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; DIAZBENJUMEA J, 1989, GENOME, V31, P612, DOI 10.1139/g89-114; DOCTOR JS, 1992, DEV BIOL, V151, P491, DOI 10.1016/0012-1606(92)90188-M; Eivers E, 2009, CYTOKINE GROWTH F R, V20, P357, DOI 10.1016/j.cytogfr.2009.10.017; Gesualdi SC, 2007, FLY, V1, P212, DOI 10.4161/fly.5116; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Henderson KD, 1998, BIOCHEM BIOPH RES CO, V252, P195, DOI 10.1006/bbrc.1998.9562; Jensen PA, 2009, MECH DEVELOP, V126, P950, DOI 10.1016/j.mod.2009.09.003; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Marquez RM, 2001, GENETICS, V157, P1639; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Minaki Y, 2008, GENE EXPR PATTERNS, V8, P418, DOI 10.1016/j.gep.2008.04.004; Mizuhara E, 2005, J BIOL CHEM, V280, P3645, DOI 10.1074/jbc.M411652200; Montagne J, 1996, DEVELOPMENT, V122, P2589; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Newfeld SJ, 1996, DEVELOPMENT, V122, P2099; O'Connor MB, 2006, DEVELOPMENT, V133, P183; OKANO H, 1994, GENE, V148, P203; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Pan D, 2009, EMBO J, V28, P3500, DOI 10.1038/emboj.2009.250; Parker L, 2004, PROG MOLEC, V34, P73; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Ramel MC, 2007, MECH DEVELOP, V124, P304, DOI 10.1016/j.mod.2006.12.006; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Shravage BV, 2007, DEVELOPMENT, V134, P2261, DOI 10.1242/dev.02856; Sturtevant MA, 1997, DEVELOPMENT, V124, P21; Tabata T, 2009, GENES CELLS, V14, P17, DOI 10.1111/j.1365-2443.2008.01246.x; Takaesu NT, 2006, GENETICS, V174, P1299, DOI 10.1534/genetics.106.064956; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Twombly V, 1996, DEVELOPMENT, V122, P1555; Waltzer L, 1999, EMBO J, V18, P1630, DOI 10.1093/emboj/18.6.1630; Wang BP, 2011, DEVELOPMENT, V138, P4487, DOI 10.1242/dev.067264; Wang W, 2000, P NATL ACAD SCI USA, V97, P14394, DOI 10.1073/pnas.97.26.14394; WHARTON KA, 1991, P NATL ACAD SCI USA, V88, P9214, DOI 10.1073/pnas.88.20.9214; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wilson JJ, 2004, STRUCTURE, V12, P785, DOI 10.1016/S0969-2126(04)00118-2; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; XIE T, 1994, SCIENCE, V263, P1756, DOI 10.1126/science.8134837; Zheng XY, 2006, EMBO J, V25, P615, DOI 10.1038/sj.emboj.7600962; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	69	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42349	10.1371/journal.pone.0042349	http://dx.doi.org/10.1371/journal.pone.0042349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879948	Green Published, gold			2022-12-27	WOS:000307437900031
J	Cherkis, KA; Temple, BRS; Chung, EH; Sondek, J; Dangl, JL				Cherkis, Karen A.; Temple, Brenda R. S.; Chung, Eui-Hwan; Sondek, John; Dangl, Jeffery L.			AvrRpm1 Missense Mutations Weakly Activate RPS2-Mediated Immune Response in Arabidopsis thaliana	PLOS ONE			English	Article							DISEASE RESISTANCE GENE; III EFFECTOR; POLY(ADP-RIBOSE) POLYMERASE; CATALYTIC FRAGMENT; CRYSTAL-STRUCTURES; CELL-DEATH; PROTEIN; RIN4; VIRULENCE; TARGET	Plants recognize microbes via specific pattern recognition receptors that are activated by microbe-associated molecular patterns (MAMPs), resulting in MAMP-triggered immunity (MTI). Successful pathogens bypass MTI in genetically diverse hosts via deployment of effectors (virulence factors) that inhibit MTI responses, leading to pathogen proliferation. Plant pathogenic bacteria like Pseudomonas syringae utilize a type III secretion system to deliver effectors into cells. These effectors can contribute to pathogen virulence or elicit disease resistance, depending upon the host plant genotype. In disease resistant genotypes, intracellular immune receptors, typically belonging to the nucleotide binding leucine-rich repeat family of proteins, perceive bacterial effector(s) and initiate downstream defense responses (effector triggered immunity) that include the hypersensitive response, and transcriptional re-programming leading to various cellular outputs that collectively halt pathogen growth. Nucleotide binding leucine-rich repeat sensors can be indirectly activated via perturbation of a host protein acting as an effector target. AvrRpm1 is a P. syringae type III effector. Upon secretion into the host cell, AvrRpm1 is acylated by host enzymes and directed to the plasma membrane, where it contributes to virulence. This is correlated with phosphorylation of Arabidopsis RIN4 in vivo. RIN4 is a negative regulator of MAMP-triggered immunity, and its modification in the presence of four diverse type III effectors, including AvrRpm1, likely enhances this RIN4 regulatory function. The RPM1 nucleotide binding leucine-rich repeat sensor perceives RIN4 perturbation in disease resistant plants, leading to a successful immune response. Here, demonstrate that AvrRpm1 has a fold homologous to the catalytic domain of poly(ADP-ribosyl) polymerase. Site-directed mutagenesis of each residue in the putative catalytic triad, His63-Tyr122-Asp185 of AvrRpm1, results in loss of both AvrRpm1-dependent virulence and AvrRpm1-mediated activation of RPM1, but, surprisingly, causes a gain of function: the ability to activate the RPS2 nucleotide binding leucine-rich repeat sensor.	[Cherkis, Karen A.; Chung, Eui-Hwan; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Dangl, Jeffery L.] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC USA; [Cherkis, Karen A.; Dangl, Jeffery L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Dangl, Jeffery L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Sondek, John] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Temple, Brenda R. S.; Sondek, John] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Sondek, John] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Temple, Brenda R. S.] Univ N Carolina, RL Juliano Struct Bioinformat Core Facil, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cherkis, KA (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	dangl@email.unc.edu		Sondek, John/0000-0002-1127-8310	National Institutes of Health (NIH) [GM057391, GM062299, GM081881]; National Science Foundation [IOS-0929410]; Department of Energy [DE-FG05-95ER20187]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081881, R01GM057391, R01GM062299] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0929410] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research is supported by National Institutes of Health (NIH) grants GM057391 and GM062299, National Science Foundation Arabidopsis 2010 program grant IOS-0929410, and Department of Energy grant DE-FG05-95ER20187 (to JLD) and NIH grant GM081881 (to JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2008, MOL PLANT MICROBE IN, V21, P646, DOI 10.1094/MPMI-21-5-0646; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Arnold DL, 2000, MOL PLANT PATHOL, V1, P195, DOI 10.1046/j.1364-3703.2000.00019.x; ASHFIELD T, 1995, GENETICS, V141, P1597; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Belkhadir Y, 2004, PLANT CELL, V16, P2822, DOI 10.1105/tpc.104.024117; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Chisholm ST, 2005, P NATL ACAD SCI USA, V102, P2087, DOI 10.1073/pnas.0409468102; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chung EH, 2011, CELL HOST MICROBE, V9, P125, DOI 10.1016/j.chom.2011.01.009; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Cunnac S, 2009, CURR OPIN MICROBIOL, V12, P53, DOI 10.1016/j.mib.2008.12.003; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fu ZQ, 2007, NATURE, V447, P284, DOI 10.1038/nature05737; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Hashida SN, 2009, ANN BOT-LONDON, V103, P819, DOI 10.1093/aob/mcp019; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Jeong BR, 2011, J BIOL CHEM, V286, P43272, DOI 10.1074/jbc.M111.290122; Kim HS, 2005, P NATL ACAD SCI USA, V102, P6496, DOI 10.1073/pnas.0500792102; Kim MG, 2009, PLANT J, V57, P645, DOI 10.1111/j.1365-313X.2008.03716.x; Kinoshita T, 2004, FEBS LETT, V556, P43, DOI [10.1016/S0014-5793(03)01362-0, 10.5940/jcrsj.46.421]; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lim MTS, 2004, PLANT J, V40, P790, DOI 10.1111/j.1365-313X.2004.02251.x; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Lindeberg M, 2009, MOL PLANT PATHOL, V10, P767, DOI 10.1111/j.1364-3703.2009.00587.x; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Miyashiro J, 2009, BIOORG MED CHEM LETT, V19, P4050, DOI 10.1016/j.bmcl.2009.06.016; Mudgett MB, 2000, P NATL ACAD SCI USA, V97, P13324, DOI 10.1073/pnas.230450797; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Oliver AW, 2004, NUCLEIC ACIDS RES, V32, P456, DOI 10.1093/nar/gkh215; Qi YP, 2011, MOL PLANT PATHOL, V12, P702, DOI 10.1111/J.1364-3703.2010.00704.X; RAZZELL WE, 1959, J BIOL CHEM, V234, P2114; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Ruf A, 1998, J MOL BIOL, V278, P57, DOI 10.1006/jmbi.1998.1673; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Singer AU, 2004, STRUCTURE, V12, P1669, DOI 10.1016/j.str.2004.06.023; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Sun JJ, 2004, NAT STRUCT MOL BIOL, V11, P868, DOI 10.1038/nsmb818; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Thomas WJ, 2009, PLANT J, V60, P919, DOI 10.1111/j.1365-313X.2009.03998.x; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Wang H, 2011, PLANTA, V233, P1287, DOI 10.1007/s00425-011-1415-y; Wang YJ, 2010, PLANT CELL, V22, P2033, DOI 10.1105/tpc.110.075697; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wilton M, 2010, P NATL ACAD SCI USA, V107, P2349, DOI 10.1073/pnas.0904739107; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007	71	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42633	10.1371/journal.pone.0042633	http://dx.doi.org/10.1371/journal.pone.0042633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880057	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000052
J	Tullus, A; Kupper, P; Sellin, A; Parts, L; Sober, J; Tullus, T; Lohmus, K; Sober, A; Tullus, H				Tullus, Arvo; Kupper, Priit; Sellin, Arne; Parts, Leopold; Sober, Jaak; Tullus, Tea; Lohmus, Krista; Sober, Anu; Tullus, Hardi			Climate Change at Northern Latitudes: Rising Atmospheric Humidity Decreases Transpiration, N-Uptake and Growth Rate of Hybrid Aspen	PLOS ONE			English	Article							VAPOR-PRESSURE DEFICIT; LEAF WATER STATUS; ECOSYSTEM CARBON; NUTRIENT-UPTAKE; AIR HUMIDITY; TREE GROWTH; CO2; FOREST; PRODUCTIVITY; PLANTATIONS	At northern latitudes a rise in atmospheric humidity and precipitation is predicted as a consequence of global climate change. We studied several growth and functional traits of hybrid aspen (Populus tremula L. xP. tremuloides Michx.) in response to elevated atmospheric humidity (on average 7% over the ambient level) in a free air experimental facility during three growing seasons (2008-2010) in Estonia, which represents northern temperate climate (boreo-nemoral zone). Data were collected from three humidified (H) and three control (C) plots, and analysed using nested linear models. Elevated air humidity significantly reduced height, stem diameter and stem volume increments and transpiration of the trees whereas these effects remained highly significant also after considering the side effects from soil-related confounders within the 2.7 ha study area. Tree leaves were smaller, lighter and had lower leaf mass per area (LMA) in H plots. The magnitude and significance of the humidity treatment effect - inhibition of above-ground growth rate - was more pronounced in larger trees. The lower growth rate in the humidified plots can be partly explained by a decrease in transpiration-driven mass flow of NO3- in soil, resulting in a significant reduction in the measured uptake of N to foliage in the H plots. The results suggest that the potential growth improvement of fast-growing trees like aspens, due to increasing temperature and atmospheric CO2 concentration, might be smaller than expected at high latitudes if a rise in atmospheric humidity simultaneously takes place.	[Tullus, Arvo; Tullus, Tea; Tullus, Hardi] Estonian Univ Life Sci, Dept Silviculture, Inst Forestry & Rural Engn, Tartu, Estonia; [Tullus, Arvo; Kupper, Priit; Sellin, Arne; Sober, Jaak; Lohmus, Krista; Sober, Anu] Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, EE-50090 Tartu, Estonia; [Parts, Leopold] Wellcome Trust Sanger Inst, Cambridge, England; [Parts, Leopold] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada	Estonian University of Life Sciences; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Wellcome Trust Sanger Institute; University of Toronto	Tullus, A (corresponding author), Estonian Univ Life Sci, Dept Silviculture, Inst Forestry & Rural Engn, Tartu, Estonia.	arvo.tullus@emu.ee	Tullus, Arvo/A-8680-2010; Tullus, Hardi/H-3777-2012; Sellin, Arne/AAA-5134-2020; Tullus, Tea/G-9770-2012	Tullus, Arvo/0000-0002-5945-7967; Tullus, Tea/0000-0001-7927-0756; Parts, Leopold/0000-0002-2618-670X	EU [MJD 257]; Estonian Science Foundation [7298, 7736, 7792, 8333, 9186]; Estonian Ministry of Education and Research [SF0182732s06]; European Regional Development Fund (Centre of Excellence in Environmental Adaptation); Wellcome Trust [WT077192/Z/05/Z]	EU(European Commission); Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Regional Development Fund (Centre of Excellence in Environmental Adaptation); Wellcome Trust(Wellcome TrustEuropean Commission)	AT was supported by the EU through the European Social Fund (Mobilitas postdoctoral grant MJD 257). Data collection, field work and laboratory analyses costs were covered by the Estonian Science Foundation grants Nos. 7298 (HT, TT), 7736 (PK), 7792 (KL), 8333 (A. Sellin) and 9186 (A. Sober). The authors from the University of Tartu received additional support from the Estonian Ministry of Education and Research (project No SF0182732s06) and the European Regional Development Fund (Centre of Excellence in Environmental Adaptation). LP was supported by the Wellcome Trust (grant WT077192/Z/05/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanen H, 2004, METSATIETEEN AIKAKAU, V1, P102; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Bovard BD, 2005, TREE PHYSIOL, V25, P31, DOI 10.1093/treephys/25.1.31; Burgess SSO, 2004, PLANT CELL ENVIRON, V27, P1023, DOI 10.1111/j.1365-3040.2004.01207.x; Calama R, 2005, SILVA FENN, V39, P37, DOI 10.14214/sf.394; Clifton-Brown JC, 1999, J EXP BOT, V50, P1393, DOI 10.1093/jexbot/50.337.1393; Cole CT, 2010, GLOBAL CHANGE BIOL, V16, P2186, DOI 10.1111/j.1365-2486.2009.02103.x; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Cramer MD, 2009, OECOLOGIA, V161, P15, DOI 10.1007/s00442-009-1364-3; del Amor FM, 2005, ACTA HORTIC, P523, DOI 10.17660/ActaHortic.2005.697.68; DeLucia EH, 2000, GLOBAL CHANGE BIOL, V6, P587, DOI 10.1046/j.1365-2486.2000.00338.x; Dessler AE, 2008, GEOPHYS RES LETT, V35; Dessler AE, 2009, SCIENCE, V323, P1020, DOI 10.1126/science.1171264; EINSPAHR DW, 1978, TAPPI, V61, P49; FORD MA, 1974, ANN BOT-LONDON, V38, P441, DOI 10.1093/oxfordjournals.aob.a084827; Gerten D, 2008, GLOBAL CHANGE BIOL, V14, P2365, DOI 10.1111/j.1365-2486.2008.01651.x; Gilserod HR, 1990, HORTSCIENCE, V25, P524; Grant RF, 2006, AGR FOREST METEOROL, V140, P152, DOI 10.1016/j.agrformet.2006.01.012; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hedenas H, 2007, BIOL CONSERV, V135, P380, DOI 10.1016/j.biocon.2006.10.008; Held IM, 2000, ANNU REV ENERG ENV, V25, P441, DOI 10.1146/annurev.energy.25.1.441; Hendrey GR, 1999, GLOBAL CHANGE BIOL, V5, P293, DOI 10.1046/j.1365-2486.1999.00228.x; Hogg EH, 2002, CAN J FOREST RES, V32, P823, DOI [10.1139/x01-152, 10.1139/X01-152]; Holscher D, 2005, TREES-STRUCT FUNCT, V19, P628, DOI 10.1007/s00468-005-0426-3; ISHIBASHI M, 1995, PLANT CELL ENVIRON, V18, P431, DOI 10.1111/j.1365-3040.1995.tb00377.x; Jarvis P, 2000, NATURE, V405, P904, DOI 10.1038/35016154; Karnosky DF, 2003, FUNCT ECOL, V17, P289, DOI 10.1046/j.1365-2435.2003.00733.x; Kerr G, 2003, CAN J FOREST RES, V33, P1196, DOI 10.1139/X03-041; Kont A, 2003, GLOBAL PLANET CHANGE, V36, P1, DOI 10.1016/S0921-8181(02)00149-2; Kouki Jari, 2004, Journal for Nature Conservation (Jena), V12, P41, DOI 10.1016/j.jnc.2003.08.002; Kupper P, 2011, ENVIRON EXP BOT, V72, P432, DOI 10.1016/j.envexpbot.2010.09.003; Lendzion J, 2008, FOREST ECOL MANAG, V256, P648, DOI 10.1016/j.foreco.2008.05.008; Leuschner C, 2002, FLORA, V197, P262, DOI 10.1078/0367-2530-00040; Liesebach M, 1999, FOREST ECOL MANAG, V121, P25, DOI 10.1016/S0378-1127(98)00554-4; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Liu N, 2006, CAN J BOT, V84, P294, DOI 10.1139/B05-171; Lohmus A, 2011, SCAND J FOREST RES, V26, P212, DOI 10.1080/02827581.2011.558850; Luo YQ, 2008, GLOBAL CHANGE BIOL, V14, P1986, DOI 10.1111/j.1365-2486.2008.01629.x; Messaoud Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014691; Monclus R, 2006, NEW PHYTOL, V169, P765, DOI 10.1111/j.1469-8137.2005.01630.x; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Oren R, 1999, PLANT CELL ENVIRON, V22, P1515, DOI 10.1046/j.1365-3040.1999.00513.x; Oren R, 2001, OECOLOGIA, V127, P549, DOI 10.1007/s004420000622; Pagani M, 2006, NATURE, V442, P671, DOI 10.1038/nature05043; Pataki DE, 1998, TREE PHYSIOL, V18, P307; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Rehfeldt GE, 2009, FOREST ECOL MANAG, V258, P2353, DOI 10.1016/j.foreco.2009.06.005; Reinhardt K, 2008, OECOLOGIA, V158, P229, DOI 10.1007/s00442-008-1128-5; Rytter L, 2006, FOREST ECOL MANAG, V236, P422, DOI 10.1016/j.foreco.2006.09.055; Sellin A, 2005, OECOLOGIA, V142, P388, DOI 10.1007/s00442-004-1748-3; Sellin A, 2004, ANN FOREST SCI, V61, P419, DOI 10.1051/forest:2004035; Soden BJ, 2005, SCIENCE, V310, P841, DOI 10.1126/science.1115602; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; TAYLOR G, 1986, NEW PHYTOL, V104, P347, DOI 10.1111/j.1469-8137.1986.tb02902.x; Trnka M, 2011, GLOBAL CHANGE BIOL, V17, P2298, DOI 10.1111/j.1365-2486.2011.02396.x; Tullus A, 2007, FOREST ECOL MANAG, V245, P118, DOI 10.1016/j.foreco.2007.04.006; Tullus A, 2012, SCAND J FOREST RES, V27, P10, DOI 10.1080/02827581.2011.628949; Tullus A, 2010, PLANT SOIL, V333, P129, DOI 10.1007/s11104-010-0330-5; Wentz FJ, 2007, SCIENCE, V317, P233, DOI 10.1126/science.1140746; WONG SC, 1993, VEGETATIO, V104, P211, DOI 10.1007/BF00048154; Wyckoff PH, 2005, CAN J FOREST RES, V35, P13, DOI 10.1139/x04-142; Xue QW, 2004, ENVIRON EXP BOT, V51, P167, DOI 10.1016/j.envexpbot.2003.09.003	64	56	56	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42648	10.1371/journal.pone.0042648	http://dx.doi.org/10.1371/journal.pone.0042648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880067	Green Published, Green Submitted, gold			2022-12-27	WOS:000307810000055
J	An, JY; Liew, AWC; Nelson, CC				An, Jiyuan; Liew, Alan Wee-Chung; Nelson, Colleen C.			Seed-Based Biclustering of Gene Expression Data	PLOS ONE			English	Article							ALGORITHM	Background: Accumulated biological research outcomes show that biological functions do not depend on individual genes, but on complex gene networks. Microarray data are widely used to cluster genes according to their expression levels across experimental conditions. However, functionally related genes generally do not show coherent expression across all conditions since any given cellular process is active only under a subset of conditions. Biclustering finds gene clusters that have similar expression levels across a subset of conditions. This paper proposes a seed-based algorithm that identifies coherent genes in an exhaustive, but efficient manner. Methods: In order to find the biclusters in a gene expression dataset, we exhaustively select combinations of genes and conditions as seeds to create candidate bicluster tables. The tables have two columns (a) a gene set, and (b) the conditions on which the gene set have dissimilar expression levels to the seed. First, the genes with less than the maximum number of dissimilar conditions are identified and a table of these genes is created. Second, the rows that have the same dissimilar conditions are grouped together. Third, the table is sorted in ascending order based on the number of dissimilar conditions. Finally, beginning with the first row of the table, a test is run repeatedly to determine whether the cardinality of the gene set in the row is greater than the minimum threshold number of genes in a bicluster. If so, a bicluster is outputted and the corresponding row is removed from the table. Repeating this process, all biclusters in the table are systematically identified until the table becomes empty. Conclusions: This paper presents a novel biclustering algorithm for the identification of additive biclusters. Since it involves exhaustively testing combinations of genes and conditions, the additive biclusters can be found more readily.	[An, Jiyuan; Nelson, Colleen C.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Liew, Alan Wee-Chung] Griffith Univ, Sch Informat & Commun Technol, Griffith, Qld, Australia	Queensland University of Technology (QUT); Griffith University	An, JY (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	j.an@qut.edu.au	An, Jiyuan/ABD-2471-2020; Liew, Alan Wee-Chung/F-6988-2011	Liew, Alan Wee-Chung/0000-0001-6718-7584; An, Jiyuan/0000-0002-8183-8248	Queensland Smart Futures Premier's Fellowship; Prostate Cancer Foundation of Australia [PCFA PG25]	Queensland Smart Futures Premier's Fellowship; Prostate Cancer Foundation of Australia	Funding provided by the Queensland Smart Futures Premier's Fellowship and the Prostate Cancer Foundation of Australia (PCFA PG25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1994, P 20 INT C VER LARG, P487; An JY, 2009, INT J INNOV COMPUT I, V5, P1419; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Cheng KO, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-210; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Cheng Y, BICLUSTERING EXPRESS; Dez C, 2004, CURR OPIN MICROBIOL, V7, P631, DOI 10.1016/j.mib.2004.10.007; Dharan S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S27; Gan XC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-209; Kriegel HP, 2009, ACM T KNOWL DISCOV D, V3, DOI 10.1145/1497577.1497578; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Wang H., 2002, P 2002 ACM SIGMOD IN, P394, DOI DOI 10.1145/564691.564737; Wang H, CLUSTERING PATTERN S; Yoon S, 2005, IEEE ACM T COMPUT BI, V2, P339, DOI 10.1109/TCBB.2005.55; Yoon S, 2004, ENHANCED PCLUSTERING; Zhao HY, 2008, J THEOR BIOL, V251, P264, DOI 10.1016/j.jtbi.2007.11.030; Zhao HY, 2012, CURR BIOINFORM, V7, P43, DOI 10.2174/157489312799304413	22	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42431	10.1371/journal.pone.0042431	http://dx.doi.org/10.1371/journal.pone.0042431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879981	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100092
J	Clerc, P; Carey, GB; Mehrabian, Z; Wei, M; Hwang, HH; Girnun, GD; Chen, HG; Martin, SS; Polster, BM				Clerc, Pascaline; Carey, Gregory B.; Mehrabian, Zara; Wei, Michael; Hwang, Hyehyun; Girnun, Geoffrey D.; Chen, Hegang; Martin, Stuart S.; Polster, Brian M.			Rapid Detection of an ABT-737-Sensitive Primed for Death State in Cells Using Microplate-Based Respirometry	PLOS ONE			English	Article							BCL-2 FAMILY-MEMBERS; BH3 MIMETIC ABT-737; CHRONIC LYMPHOCYTIC-LEUKEMIA; OUTER-MEMBRANE PERMEABILITY; CYTOCHROME-C RELEASE; BRAIN MITOCHONDRIA; CHROMOSOME-TRANSLOCATION; CANCER-CELLS; NEURAL CELL; APOPTOSIS	Cells that exhibit an absolute dependence on the anti-apoptotic BCL-2 protein for survival are termed "primed for death" and are killed by the BCL-2 antagonist ABT-737. Many cancers exhibit a primed phenotype, including some that are resistant to conventional chemotherapy due to high BCL-2 expression. We show here that 1) stable BCL-2 overexpression alone can induce a primed for death state and 2) that an ABT-737-induced loss of functional cytochrome c from the electron transport chain causes a reduction in maximal respiration that is readily detectable by microplate-based respirometry. Stable BCL-2 overexpression sensitized non-tumorigenic MCF10A mammary epithelial cells to ABT-737-induced caspase-dependent apoptosis. Mitochondria within permeabilized BCL-2 overexpressing cells were selectively vulnerable to ABT-737-induced cytochrome c release compared to those from control-transfected cells, consistent with a primed state. ABT-737 treatment caused a dose-dependent impairment of maximal O-2 consumption in MCF10A BCL-2 overexpressing cells but not in control-transfected cells or in immortalized mouse embryonic fibroblasts lacking both BAX and BAK. This impairment was rescued by delivering exogenous cytochrome c to mitochondria via saponin-mediated plasma membrane permeabilization. An ABT-737-induced reduction in maximal O-2 consumption was also detectable in SP53, JeKo-1, and WEHI-231 B-cell lymphoma cell lines, with sensitivity correlating with BCL-2: MCL-1 ratio and with susceptibility (SP53 and JeKo-1) or resistance (WEHI-231) to ABT-737-induced apoptosis. Multiplexing respirometry assays to ELISA-based determination of cytochrome c redistribution confirmed that respiratory inhibition was associated with cytochrome c release. In summary, cell-based respiration assays were able to rapidly identify a primed for death state in cells with either artificially overexpressed or high endogenous BCL-2. Rapid detection of a primed for death state in individual cancers by "bioenergetics-based profiling" may eventually help identify the subset of patients with chemoresistant but primed tumors who can benefit from treatment that incorporates a BCL-2 antagonist.	[Clerc, Pascaline; Mehrabian, Zara; Wei, Michael; Hwang, Hyehyun; Polster, Brian M.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Clerc, Pascaline; Mehrabian, Zara; Wei, Michael; Hwang, Hyehyun; Polster, Brian M.] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res Ctr, Baltimore, MD 21201 USA; [Carey, Gregory B.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Girnun, Geoffrey D.; Polster, Brian M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Chen, Hegang] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Martin, Stuart S.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Clerc, P (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA.	bpolster@anes.umm.edu		Polster, Brian/0000-0003-2571-7510	National Institutes of Health [NS064978]; NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	BMP received support from National Institutes of Health grant NS064978. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bodet L, 2011, BLOOD, V118, P3901, DOI 10.1182/blood-2010-11-317438; Brustovetsky T, 2005, J NEUROCHEM, V94, P980, DOI 10.1111/j.1471-4159.2005.03248.x; Buron N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009924; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Clerc P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034465; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Duan S, 2003, J BIOL CHEM, V278, P1346, DOI 10.1074/jbc.M209269200; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Gnaiger E, 2002, BIOCHEM SOC T, V30, P252, DOI 10.1042/bst0300252; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; High LM, 2010, MOL PHARMACOL, V77, P483, DOI 10.1124/mol.109.060780; Huber HJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.2; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Krippner A, 1996, J BIOL CHEM, V271, P21629, DOI 10.1074/jbc.271.35.21629; Kutuk O, 2008, CANCER RES, V68, P7985, DOI 10.1158/0008-5472.CAN-08-1418; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Martin S, 2001, TELECONNECT, V19, P10; Merino D, 2012, BLOOD, V119, P5807, DOI 10.1182/blood-2011-12-400929; Merlo GR, 1997, CELL GROWTH DIFFER, V8, P251; Milanesi E, 2006, J BIOL CHEM, V281, P10066, DOI 10.1074/jbc.M513708200; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Morales AA, 2011, BLOOD, V118, P1329, DOI 10.1182/blood-2011-01-327197; Nicholls DG, 2010, J VIS EXP, P2511; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; PEGORARO L, 1984, P NATL ACAD SCI-BIOL, V81, P7166, DOI 10.1073/pnas.81.22.7166; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Polster BM, 2003, J NEUROSCI, V23, P2735; Polster BM, 2001, J BIOL CHEM, V276, P37887; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Schuh RA, 2011, J NEUROSCI RES; Sears KT, 2008, INT J CANCER, V122, P1496, DOI 10.1002/ijc.23207; SOULE HD, 1990, CANCER RES, V50, P6075; Starkov AA, 2002, J NEUROCHEM, V83, P220, DOI 10.1046/j.1471-4159.2002.01153.x; Tagscherer KE, 2008, ONCOGENE, V27, P6646, DOI 10.1038/onc.2008.259; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Touzeau C, 2011, CLIN CANCER RES, V17, P5973, DOI 10.1158/1078-0432.CCR-11-0955; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	58	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42487	10.1371/journal.pone.0042487	http://dx.doi.org/10.1371/journal.pone.0042487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880001	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100108
J	Grey, J; Jackson, MC				Grey, Jonathan; Jackson, Michelle C.			'Leaves and Eats Shoots': Direct Terrestrial Feeding Can Supplement Invasive Red Swamp Crayfish in Times of Need	PLOS ONE			English	Article							PROCAMBARUS-CLARKII; LAKE NAIVASHA; INTRODUCED CRAYFISH; STABLE-ISOTOPES; DECAPODA; KENYA; FRACTIONATION; BIODIVERSITY; CAMBARIDAE; DIVERSITY	We used stable isotope analyses to characterise the feeding dynamics of a population of red swamp crayfish in Lake Naivasha, Kenya, after the crash of submerged macrophytes and associated macroinvertebrates, and during a natural drawdown of the lake water level. We expected a heavy reliance upon a diet of detrital matter to sustain the population as a consequence, and indeed, for the majority of the crayfish population caught from the lake, we saw a concomitant shift in isotopic values reflecting a dietary change. However, we also caught individual crayfish that had occupied the footprints of hippopotamus and effectively extended their range beyond the lake up to 40 m into the riparian zone. Isotopic analysis confirmed limited nocturnal observations that these individuals were consuming living terrestrial plants in the vicinity of the footprints. These are the first empirical data to demonstrate direct use of terrestrial resources by an aquatic crayfish species and further highlight the traits that make red swamp crayfish such opportunistic and successful invaders.	[Grey, Jonathan] Max Planck Inst Limnol, Dept Physiol Ecol, D-2320 Plon, Schleswig Holst, Germany; [Grey, Jonathan; Jackson, Michelle C.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	Max Planck Society; University of London; Queen Mary University London	Grey, J (corresponding author), Max Planck Inst Limnol, Dept Physiol Ecol, D-2320 Plon, Schleswig Holst, Germany.	j.grey@qmul.ac.uk		Jackson, Michelle/0000-0003-2227-1111; Grey, Jonathan/0000-0001-9069-2271	Max Planck Society; Earthwatch Institute, Boston	Max Planck Society(Max Planck SocietyFoundation CELLEX); Earthwatch Institute, Boston	JG was supported by the Max Planck Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to the National Council for Science and Technology, Kenya for research permission, and Dr. David Harper (Leicester University, England) of the 'Lakes of the Rift Valley' project funded by the Earthwatch Institute, Boston for logistical support. We also acknowledge the assistance of Velia Carn, Reuben Ngeete, numerous Earthwatch volunteers, and the late Joan Root. The comments of two very helpful reviewers greatly improved the manuscript.	Aquiloni L, 2011, BIOL INVASIONS, V13, P359, DOI 10.1007/s10530-010-9828-2; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Barbaresi S, 2000, BIOL INVASIONS, V2, P259, DOI DOI 10.1023/A:1010009701606; Britton JR, 2007, J FISH BIOL, V71, P239, DOI 10.1111/j.1095-8649.2007.01669.x; Britton JR, 2010, BIOL INVASIONS, V12, P3439, DOI 10.1007/s10530-010-9742-7; Capinha C, 2011, ECOGRAPHY, V34, P448, DOI 10.1111/j.1600-0587.2010.06369.x; CHIEN YH, 1980, PROG FISH CULT, V42, P67, DOI 10.1577/1548-8659(1980)42[67:POCIRF]2.0.CO;2; CORREIA AM, 1995, J CRUSTACEAN BIOL, V15, P248, DOI 10.2307/1548953; Crandall KA, 2008, HYDROBIOLOGIA, V595, P295, DOI 10.1007/s10750-007-9120-3; Cruz MJ, 2008, HERPETOL J, V18, P197; Cruz MJ, 2007, HYDROBIOLOGIA, V575, P191, DOI 10.1007/s10750-006-0376-9; Cumberlidge N, 2009, MONOGR BIOL, V89, P547; Foster John, 2007, V2, P91; Furse James M., 2004, Freshwater Crayfish, V14, P213; GAUDET J J, 1977, Aquatic Botany, V3, P1, DOI 10.1016/0304-3770(77)90002-X; Geiger W, 2005, BIOL INVASIONS, V7, P49, DOI 10.1007/s10530-004-9635-8; Gherardi F, 2010, ENCY INVASIVE INTRO, P129; Gherardi F, 2011, BIOL CONSERV, V144, P2585, DOI 10.1016/j.biocon.2011.07.020; Gorokhova E, 1999, CAN J FISH AQUAT SCI, V56, P2203, DOI 10.1139/cjfas-56-11-2203; Grey J, 2002, ISOT ENVIRON HEALT S, V38, P245, DOI 10.1080/10256010208033269; Grey J, 2006, POL J ECOL, V54, P563; Gutierrez-Yurrita PJ, 1999, CRUSTACEAN ISS, V11, P161; Hickley P, 2002, MANAGEMENT ECOLOGY L; Hofkin BV, 1991, BIOL CONTROL, V1, P183, DOI 10.1016/1049-9644(91)90065-8; HUNER JV, 1995, AM ZOOL, V35, P12; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031757; Larson ER, 2011, BIOL LETTERS, V7, P551, DOI 10.1098/rsbl.2011.0089; Larson ER, 2010, CONSERV BIOL, V24, P1099, DOI 10.1111/j.1523-1739.2010.01462.x; Lodge DM, 1998, AUST J ECOL, V23, P53, DOI 10.1111/j.1442-9993.1998.tb00705.x; Lowe K, 2010, J COMP PHYSIOL B, V180, P653, DOI 10.1007/s00360-010-0445-2; Matsuzaki SS, 2009, OECOLOGIA, V158, P673, DOI 10.1007/s00442-008-1180-1; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Olsson K, 2009, FRESHWATER BIOL, V54, P1731, DOI 10.1111/j.1365-2427.2009.02221.x; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Rodriguez CF, 2005, BIOL INVASIONS, V7, P75, DOI 10.1007/s10530-004-9636-7; Rudnick D, 2005, FRESHWATER BIOL, V50, P1323, DOI 10.1111/j.1365-2427.2005.01398.x; Smart AC, 2002, HYDROBIOLOGIA, V488, P129, DOI 10.1023/A:1023326530914; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Suring E, 2009, J EXP MAR BIOL ECOL, V370, P56, DOI 10.1016/j.jembe.2008.11.014; Yokoyama H, 2005, MAR ECOL PROG SER, V296, P115, DOI 10.3354/meps296115	41	39	42	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42575	10.1371/journal.pone.0042575	http://dx.doi.org/10.1371/journal.pone.0042575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880039	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100134
J	Majewski, T; Spiess, PE; Bondaruk, J; Black, P; Clarke, C; Benedict, W; Dinney, CP; Grossman, HB; Tang, KS; Czerniak, B				Majewski, Tadeusz; Spiess, Philippe E.; Bondaruk, Jolanta; Black, Peter; Clarke, Charlotte; Benedict, William; Dinney, Colin P.; Grossman, Herbert Barton; Tang, Kuang S.; Czerniak, Bogdan			Detection of Bladder Cancer Using Proteomic Profiling of Urine Sediments	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; ENHANCED LASER-DESORPTION; MASS-SPECTROMETRY; PROTEIN EXPRESSION; TREE ANALYSIS; SERUM; REPRODUCIBILITY; PATTERNS; QUANTIFICATION; IDENTIFICATION	We used protein expression profiles to develop a classification rule for the detection and prognostic assessment of bladder cancer in voided urine samples. Using the Ciphergen PBS II ProteinChip Reader, we analyzed the protein profiles of 18 pairs of samples of bladder tumor and adjacent urothelium tissue, a training set of 85 voided urine samples (32 controls and 53 bladder cancer), and a blinded testing set of 68 voided urine samples (33 controls and 35 bladder cancer). Using t-tests, we identified 473 peaks showing significant differential expression across different categories of paired bladder tumor and adjacent urothelial samples compared to normal urothelium. Then the intensities of those 473 peaks were examined in a training set of voided urine samples. Using this approach, we identified 41 protein peaks that were differentially expressed in both sets of samples. The expression pattern of the 41 protein peaks was used to classify the voided urine samples as malignant or benign. This approach yielded a sensitivity and specificity of 59% and 90%, respectively, on the training set and 80% and 100%, respectively, on the testing set. The proteomic classification rule performed with similar accuracy in low- and high-grade bladder carcinomas. In addition, we used hierarchical clustering with all 473 protein peaks on 65 benign voided urine samples, 88 samples from patients with clinically evident bladder cancer, and 127 samples from patients with a history of bladder cancer to classify the samples into Cluster A or B. The tumors in Cluster B were characterized by clinically aggressive behavior with significantly shorter metastasis-free and disease-specific survival.	[Majewski, Tadeusz; Bondaruk, Jolanta; Czerniak, Bogdan] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Spiess, Philippe E.; Black, Peter; Dinney, Colin P.; Grossman, Herbert Barton] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Clarke, Charlotte] Ciphergen Biosyst Inc, Fremont, CA USA; [Benedict, William] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Tang, Kuang S.] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Majewski, T (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	bczernia@mdanderson.org	Black, Peter/AAE-8424-2020	Black, Peter/0000-0002-2919-7068; Dinney, Colin/0000-0002-8969-711X	National Institute of Health [R01 CA 151489, P50 CA91846]; NATIONAL CANCER INSTITUTE [R01CA151489, P50CA091846] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health Grants R01 CA 151489 (BC) and GU SPORE Grant P50 CA91846 (Project 1, BC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbod MF, 2005, ARTIF INTELL, P109; Albrethsen J, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-8; Baggerly KA, 2005, JNCI-J NATL CANCER I, V97, P307, DOI 10.1093/jnci/dji008; Baggerly KA, 2004, ENDOCR-RELAT CANCER, V11, P583, DOI 10.1677/erc.1.00868; Baggerly KA, 2004, BIOINFORMATICS, V20, P777, DOI 10.1093/bioinformatics/btg484; Catto JWF, 2003, CLIN CANCER RES, V9, P4172; Cho WCS, 2007, EXPERT REV PROTEOMIC, V4, P401, DOI 10.1586/14789450.4.3.401; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Coffelt SB, 2008, CANCER RES, V68, P6482, DOI 10.1158/0008-5472.CAN-08-0044; Conrad DH, 2008, J GEN INTERN MED, V23, P78, DOI 10.1007/s11606-007-0411-1; Coombes KR, 2005, NAT BIOTECHNOL, V23, P291, DOI 10.1038/nbt0305-291; Coombes KR, 2005, PROTEOMICS, V5, P4107, DOI 10.1002/pmic.200401261; Diao L, 2011, CANCER INFORM, V10, P45, DOI 10.4137/CIN.S6438; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Droin N, 2009, J PROTEOMICS, V72, P918, DOI 10.1016/j.jprot.2009.01.002; FK M IA S, 1999, HISTOLOGICAL TYPING; Gaston KE, 2010, METHODS MOL BIOL, V641, P303, DOI 10.1007/978-1-60761-711-2_17; Gazdar AF, 2001, JNCI-J NATL CANCER I, V93, P413, DOI 10.1093/jnci/93.6.413; Goodison S, 2009, EXPERT REV PROTEOMIC, V6, P507, DOI 10.1586/EPR.09.70; Holterman DA, 2006, UROL ONCOL-SEMIN ORI, V24, P97, DOI 10.1016/j.urolonc.2005.07.010; Huang ZZ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007922; Kehinde EO, 2011, SCAND J UROL NEPHROL, V45, P113, DOI 10.3109/00365599.2010.533694; Khwaja FW, 2006, PROTEOMICS, V6, P6277, DOI 10.1002/pmic.200600135; Kim JH, 2005, LAB INVEST, V85, P532, DOI 10.1038/labinvest.3700250; Liu WW, 2005, EUR UROL, V47, P456, DOI 10.1016/j.eururo.2004.10.006; Lu M, 2007, BIOMARK INSIGHTS, V2, P347; Morris JS, 2005, BIOINFORMATICS, V21, P1764, DOI 10.1093/bioinformatics/bti254; Mueller J, 2005, EUR UROL, V47, P885, DOI 10.1016/j.eururo.2005.02.016; Muller CA, 2002, AM J PATHOL, V160, P1311, DOI 10.1016/S0002-9440(10)62558-8; Pan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027574; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Petricoin EF, 2003, J NUTR, V133, p2476S, DOI 10.1093/jn/133.7.2476S; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Pollard C, 2009, AM J PATHOL, V175, P1824, DOI 10.2353/ajpath.2009.090155; Qu YS, 2002, CLIN CHEM, V48, P1835; Roesch-Ely M, 2007, ONCOGENE, V26, P54, DOI 10.1038/sj.onc.1209770; Rogers MA, 2003, CANCER RES, V63, P6971; Sanchez-Carbayo M, 2004, CLIN BIOCHEM, V37, P562, DOI 10.1016/j.clinbiochem.2004.05.014; Schaub S, 2004, KIDNEY INT, V65, P323, DOI 10.1111/j.1523-1755.2004.00352.x; Schwamborn K, 2010, EXPERT REV PROTEOMIC, V7, P897, DOI 10.1586/EPR.10.82; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Sobin OH, 1999, TNM CLASSIFICATION M; Spiess PE, 2006, ARCH PATHOL LAB MED, V130, P844; Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294; Thulasiraman V, 2001, BIOTECHNIQUES, V30, P428, DOI 10.2144/01302pf02; Van Que N, 2011, Curr Urol Rep, V12, P34, DOI 10.1007/s11934-010-0151-3; Vlahou A, 2001, AM J PATHOL, V158, P1491, DOI 10.1016/S0002-9440(10)64100-4; Vorderwuelbecke S., 2005, NAT METHODS, V2, P393, DOI [10.1038/nmeth0505-393, DOI 10.1038/NMETH0505-393]; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185; Zhu W, 2003, P NATL ACAD SCI USA, V100, P14666, DOI 10.1073/pnas.2532248100	50	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42452	10.1371/journal.pone.0042452	http://dx.doi.org/10.1371/journal.pone.0042452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879988	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100097
J	Ou, XL; Gao, J; Wang, H; Wang, HS; Lu, HL; Sun, HY				Ou, Xue-ling; Gao, Jun; Wang, Huan; Wang, Hong-sheng; Lu, Hui-ling; Sun, Hong-yu			Predicting Human Age with Bloodstains by sjTREC Quantification	PLOS ONE			English	Article							RECENT THYMIC EMIGRANTS; PERIPHERAL-BLOOD; EXCISION CIRCLES; HIV-INFECTION; OUTPUT; PCR; INDIVIDUALS; GUIDELINES; DELETION; DNA	The age-related decline of signal joint T-cell receptor rearrangement excision circles (sjTRECs) in human peripheral blood has been demonstrated in our previous study and other reports. Until now, only a few studies on sjTREC detection in bloodstain samples were reported, which were based on a small sample of subjects of a limited age range, although bloodstains are much more frequently encountered in forensic practice. In this present study, we adopted the sensitive Taqman real-time quantitative polymerase chain reaction (qPCR) method to perform sjTREC quantification in bloodstains from individuals ranging from 0-86 years old (n = 264). The results revealed that sjTREC contents in human bloodstains were declined in an age-dependent manner (r = -0.8712). The formula of age estimation was Age = -7.1815Y-42.458 +/- 9.42 (Y dCt(TBP-sjTREC); 9.42 standard error). Furthermore, we tested for the influence of short-or long-storage time by analyzing fresh and stored bloodstains from the same individuals. Remarkably, no statistically significant difference in sjTREC contents was found between the fresh and old DNA samples over a 4-week of storage time. However, significant loss (0.16-1.93 dCt) in sjTREC contents was detected after 1.5 years of storage in 31 samples. Moreover, preliminary sjTREC quantification from up to 20-year-old bloodstains showed that though the sjTREC contents were detectable in all samples and highly correlated with donor age, a time-dependent decrease in the correlation coefficient r was found, suggesting the predicting accuracy of this described assay would be deteriorated in aged samples. Our findings show that sjTREC quantification might be also suitable for age prediction in bloodstains, and future researches into the time-dependent or other potential impacts on sjTREC quantification might allow further improvement of the predicting accuracy.	[Ou, Xue-ling; Lu, Hui-ling; Sun, Hong-yu] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Forens Med, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Jun] Sun Yat Sen Univ, Affiliated Hosp 1, Reprod Med Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Huan] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Gynaecol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Hong-sheng] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Microbial & Biochem Pharm, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Ou, XL (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Forens Med, Guangzhou 510275, Guangdong, Peoples R China.	sunhongyu2002@163.com	Ou, Xueling/W-9964-2019; Wang, Hongsheng/N-1940-2019; Sun, 宏钰/H-7885-2018	Ou, Xueling/0000-0003-2345-4980; Wang, Hongsheng/0000-0002-0054-4820; Sun, 宏钰/0000-0002-5926-4495	National Natural Science Foundation of China [81001352]; China Postdoctoral Science Foundation [20100470957]; Natural Science Foundation of Guangdong Province of China [10451008901004242]; Fundamental Research Funds for the Central Universities [09YKPY78]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	These studies are supported by the National Natural Science Foundation of China (grant no. 81001352), China Postdoctoral Science Foundation (grant no. 20100470957), Natural Science Foundation of Guangdong Province of China (grant no. 10451008901004242) and the Fundamental Research Funds for the Central Universities (09YKPY78). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Breit TM, 1997, J IMMUNOL, V159, P4341; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Ferrando-Martinez S, 2010, J IMMUNOL METHODS, V352, P111, DOI 10.1016/j.jim.2009.11.007; Ferrando-Martinez S, 2009, AGE, V31, P87, DOI 10.1007/s11357-008-9084-x; Geenen V, 2003, J ENDOCRINOL, V176, P305, DOI 10.1677/joe.0.1760305; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Lang PO, 2011, J IMMUNOL METHODS, V369, P133, DOI 10.1016/j.jim.2011.05.002; Lorenzi AR, 2008, J IMMUNOL METHODS, V339, P185, DOI 10.1016/j.jim.2008.09.013; Meissner C, 1997, INT J LEGAL MED, V110, P288, DOI 10.1007/s004140050089; Meissner C, 2010, FORENSIC SCI INT, V203, P34, DOI 10.1016/j.forsciint.2010.07.010; Ou XL, 2011, INT J LEGAL MED, V125, P603, DOI 10.1007/s00414-010-0528-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pido-Lopez J, 2001, CLIN EXP IMMUNOL, V125, P409, DOI 10.1046/j.1365-2249.2001.01640.x; Ren F, 2009, AM J FOREN MED PATH, V30, P252, DOI 10.1097/PAF.0b013e318187df8e; Ribeiro RM, 2007, IMMUNOL REV, V216, P21; Schmeling A, 2008, INT J LEGAL MED, V122, P457, DOI 10.1007/s00414-008-0254-2; Schmeling A, 2007, FORENSIC SCI INT, V165, P178, DOI 10.1016/j.forsciint.2006.05.016; Tsuji A, 2002, FORENSIC SCI INT, V126, P197, DOI 10.1016/S0379-0738(02)00086-5; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725; Zubakov D, 2010, CURR BIOL, V20, pR970, DOI 10.1016/j.cub.2010.10.022	23	42	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42412	10.1371/journal.pone.0042412	http://dx.doi.org/10.1371/journal.pone.0042412			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879970	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100083
J	Veenemans, J; Schouten, LRA; Ottenhof, MJ; Mank, TG; Uges, DRA; Mbugi, EV; Demir, AY; Kraaijenhagen, RJ; Savelkou, HFJ; Verhoef, H				Veenemans, Jacobien; Schouten, Laura R. A.; Ottenhof, Maarten J.; Mank, Theo G.; Uges, Donald R. A.; Mbugi, Erasto V.; Demir, Ayse Y.; Kraaijenhagen, Rob J.; Savelkou, Huub F. J.; Verhoef, Hans			Effect of Preventive Supplementation with Zinc and Other Micronutrients on Non-Malarial Morbidity in Tanzanian Pre-School Children: A Randomized Trial	PLOS ONE			English	Article							IRON SUPPLEMENTATION; GROWTH; PERMEABILITY; VITAMINS; COPPER; ALTERS	Background: The efficacy of preventive zinc supplementation against diarrhea and respiratory illness may depend on simultaneous supplementation with other micronutrients. We aimed to assess the effect of supplementation with zinc and multiple micronutrients on diarrhea and other causes of non-malarial morbidity. Methods and Findings: Rural Tanzanian children (n = 612) aged 6-60 months and with height-for-age z-score, < -1.5 SD were randomized to daily supplementation with zinc (10 mg) alone, multi-nutrients without zinc, multi-nutrients with zinc, or placebo. Children were followed for an average of 45 weeks. During follow-up, we recorded morbidity episodes. We found no evidence that concurrent supplementation with multi-nutrients influenced the magnitude of the effect of zinc on rates of diarrhea, respiratory illness, fever without localizing signs, or other illness (guardian-reported illness with symptoms involving skin, ears, eyes and abscesses, but excluding trauma or burns). Zinc supplementation reduced the hazard rate of diarrhea by 24% (4%-40%). By contrast, multi-nutrients seemed to increase this rate (HR; 95% CI: 1.19; 0.94-1.50), particularly in children with asymptomatic Giardia infection at baseline (2.03; 1.24-3.32). Zinc also protected against episodes of fever without localizing signs (0.75; 0.57-0.96), but we found no evidence that it reduced the overall number of clinic visits. Conclusions: We found no evidence that the efficacy of zinc supplements in reducing diarrhea rates is enhanced by concurrent supplementation with other micronutrients. By reducing rates of fever without localizing signs, supplementation with zinc may reduce inappropriate drug use with anti-malarial medications and antibiotics.	[Veenemans, Jacobien; Schouten, Laura R. A.; Ottenhof, Maarten J.; Mbugi, Erasto V.; Savelkou, Huub F. J.; Verhoef, Hans] Wageningen Univ, Cell Biol & Immunol Grp, Wageningen, Netherlands; [Veenemans, Jacobien] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Mank, Theo G.] Publ Hlth Lab, Dept Parasitol, Haarlem, Netherlands; [Uges, Donald R. A.] Univ Groningen, Univ Med Ctr, Dept Pharm, Lab Clin & Forens Toxicol & Drug Anal, Groningen, Netherlands; [Mbugi, Erasto V.] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Demir, Ayse Y.; Kraaijenhagen, Rob J.] Meander Med Ctr, Lab Clin Chem & Haematol, Amersfoort, Netherlands; [Verhoef, Hans] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London WC1, England	Wageningen University & Research; Amphia Hospital; University of Groningen; Muhimbili University of Health & Allied Sciences; Meander Medisch Centrum; University of London; London School of Hygiene & Tropical Medicine	Veenemans, J (corresponding author), Wageningen Univ, Cell Biol & Immunol Grp, Wageningen, Netherlands.	hans.verhoef@wur.nl	Verhoef, Hans/L-3024-2015; Mbugi, Erasto/CAG-4121-2022; Verhoef, Hans/AGD-5388-2022; Demir, Ayse Yasemin/GPF-7965-2022	Verhoef, Hans/0000-0002-9346-9689; mbugi, erasto/0000-0002-9943-4671	Netherlands Organisation for Scientific Research (NWO)/WOTRO [W93-413, WAO93-441]; UNICEF; Cornelis Visser Foundation; Wageningen University; Medical Research Council [MC_U123292699, MC_U123292701] Funding Source: researchfish; MRC [MC_U123292701, MC_U123292699] Funding Source: UKRI	Netherlands Organisation for Scientific Research (NWO)/WOTRO(Netherlands Organization for Scientific Research (NWO)); UNICEF; Cornelis Visser Foundation; Wageningen University(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Netherlands Organisation for Scientific Research (NWO)/WOTRO (W93-413, WAO93-441), UNICEF, Cornelis Visser Foundation and Wageningen University (Interdisciplinary Research and Education Fund). QuikRead tests and trimagnesium dicitrate were donated by Orion Diagnostica, Espoo, Finland and Jungbunzlauer, Ladenburg, Germany, respectively; supplements were manufactured and donated by Medisan, Heerenveen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D., 2013, STAT CONFIDENCE CONF; Brown KH, 2009, FOOD NUTR BULL, V30, pS179, DOI 10.1177/15648265090301S110; Brown KH, 2009, FOOD NUTR BULL, V30, pS12, DOI 10.1177/15648265090301S103; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; Chhagan MK, 2009, EUR J CLIN NUTR, V63, P850, DOI 10.1038/ejcn.2008.78; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Ferruzza S, 1999, ADV EXP MED BIOL, V448, P215; [FNB IOM], DIET REF INT UL VIT; Foster SL, 2001, J NUTR, V131, P1452, DOI 10.1093/jn/131.5.1452; Gera T, 2002, BMJ-BRIT MED J, V325, P1142, DOI 10.1136/bmj.325.7373.1142; Liu ZW, 2004, HUM EXP TOXICOL, V23, P369, DOI 10.1191/0960327104ht464oa; Long KZ, 2007, NUTR REV, V65, P218, DOI [10.1301/nr.2007.may.218-232, 10.1111/j.1753-4887.2007.tb00299.x]; Luabeya KKA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000541; Maggini S, 2007, BRIT J NUTR, V98, pS29, DOI 10.1017/S0007114507832971; Mank TG, 1997, EUR J CLIN MICROBIOL, V16, P615, DOI 10.1007/BF02447929; Nchito M, 2006, T ROY SOC TROP MED H, V100, P791, DOI 10.1016/j.trstmh.2005.10.016; Penny ME, 2004, AM J CLIN NUTR, V79, P457; Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013; Shrimpton R, 2005, BMJ-BRIT MED J, V330, P347, DOI 10.1136/bmj.330.7487.347; Veenemans J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001125; Veenemans J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001158; WHO/FAO, 2004, VIT MIN REQ HUM NUTR, VSecond; World Health Organization, 2000, MAN CHILD SER INF SE	23	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41630	10.1371/journal.pone.0041630	http://dx.doi.org/10.1371/journal.pone.0041630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870238	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000307284100025
J	Bhat, P; Yang, HX; Bogre, L; Devoto, A; Paccanaro, A				Bhat, Prajwal; Yang, Haixuan; Boegre, Laszlo; Devoto, Alessandra; Paccanaro, Alberto			Computational Selection of Transcriptomics Experiments Improves Guilt-by-Association Analyses	PLOS ONE			English	Article							MICROARRAY DATA; ARABIDOPSIS; NETWORKS; PLANT	The Guilt-by-Association (GBA) principle, according to which genes with similar expression profiles are functionally associated, is widely applied for functional analyses using large heterogeneous collections of transcriptomics data. However, the use of such large collections could hamper GBA functional analysis for genes whose expression is condition specific. In these cases a smaller set of condition related experiments should instead be used, but identifying such functionally relevant experiments from large collections based on literature knowledge alone is an impractical task. We begin this paper by analyzing, both from a mathematical and a biological point of view, why only condition specific experiments should be used in GBA functional analysis. We are able to show that this phenomenon is independent of the functional categorization scheme and of the organisms being analyzed. We then present a semi-supervised algorithm that can select functionally relevant experiments from large collections of transcriptomics experiments. Our algorithm is able to select experiments relevant to a given GO term, MIPS FunCat term or even KEGG pathways. We extensively test our algorithm on large dataset collections for yeast and Arabidopsis. We demonstrate that: using the selected experiments there is a statistically significant improvement in correlation between genes in the functional category of interest; the selected experiments improve GBA-based gene function prediction; the effectiveness of the selected experiments increases with annotation specificity; our algorithm can be successfully applied to GBA-based pathway reconstruction. Importantly, the set of experiments selected by the algorithm reflects the existing literature knowledge about the experiments. [A MATLAB implementation of the algorithm and all the data used in this paper can be downloaded from the paper website: http://www.paccanarolab.org/papers/CorrGene/].	[Bhat, Prajwal; Boegre, Laszlo; Devoto, Alessandra] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Bhat, Prajwal; Yang, Haixuan; Paccanaro, Alberto] Royal Holloway Univ London, Dept Comp Sci, Egham, Surrey, England; [Bhat, Prajwal; Yang, Haixuan; Boegre, Laszlo; Devoto, Alessandra; Paccanaro, Alberto] Royal Holloway Univ London, Ctr Syst & Synthet Biol, Egham, Surrey, England	University of London; Royal Holloway University London; University of London; Royal Holloway University London; University of London; Royal Holloway University London	Bhat, P (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England.	alessandra.devoto@rhul.ac.uk; alberto@cs.rhul.ac.uk	Paccanaro, Alberto/AAW-5625-2020		United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F00964X/1]; Agnes Grace Allen Endowment; School of Biological Sciences at Royal Holloway, University of London; BBSRC [BB/E003486/1, FP7-PEOPLE-ITN-2009-PIEF-GA-2009-255035]; Biotechnology and Biological Sciences Research Council [BB/E003486/1, BBS/B/13314, BB/F00964X/1, BB/K004131/1] Funding Source: researchfish; BBSRC [BB/K004131/1, BB/F00964X/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Agnes Grace Allen Endowment; School of Biological Sciences at Royal Holloway, University of London; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	HY and AP were supported by the United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) New Investigator Grant BB/F00964X/1 (http://www.bbsrc.ac.uk/). PB was supported by the Agnes Grace Allen Endowment and the School of Biological Sciences at Royal Holloway, University of London (http://www.rhul.ac.uk/home.aspx). AD was supported by the BBSRC New Investigator Grant BB/E003486/1 (http://www.bbsrc.ac.uk/). LB was supported by BBSRC grant FP7-PEOPLE-ITN-2009-PIEF-GA-2009-255035 (http://cordis.europa.eu/fp7/people/home_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r139; Avanci NC, 2010, GENET MOL RES, V9, P484, DOI 10.4238/vol9-1gmr754; Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Barber C, 2004, PLANT J CELL MOL BIO, V39, P70, DOI [10.1111/j.1365-313X.2004.02104.x, DOI 10.1111/J.1365-313X.2004.02104.X]; Casal JJ, 1998, PLANT PHYSIOL, V118, P19, DOI 10.1104/pp.118.1.19; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hastie T., 2009, UNSUPERVISED LEARNIN; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Quackenbush J, 2003, SCIENCE, V302, P240, DOI 10.1126/science.1090887; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906	17	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e39681	10.1371/journal.pone.0039681	http://dx.doi.org/10.1371/journal.pone.0039681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879875	gold, Green Published, Green Submitted			2022-12-27	WOS:000307437900002
J	Oda, M; Kanoh, Y; Watanabe, Y; Masai, H				Oda, Masako; Kanoh, Yutaka; Watanabe, Yoshihisa; Masai, Hisao			Regulation of DNA Replication Timing on Human Chromosome by a Cell-Type Specific DNA Binding Protein SATB1	PLOS ONE			English	Article							MATRIX-ATTACHMENT REGION; GLOBAL GENE REGULATOR; S-PHASE CHECKPOINT; FISSION YEAST; HUMAN GENOME; T-CELLS; IN-VIVO; DEPENDENT REGULATION; TH2 DIFFERENTIATION; CYCLE PROGRESSION	Background: Replication timing of metazoan DNA during S-phase may be determined by many factors including chromosome structures, nuclear positioning, patterns of histone modifications, and transcriptional activity. It may be determined by Mb-domain structures, termed as "replication domains", and recent findings indicate that replication timing is under developmental and cell type-specific regulation. Methodology/Principal Findings: We examined replication timing on the human 5q23/31 3.5-Mb segment in T cells and non-T cells. We used two independent methods to determine replication timing. One is quantification of nascent replicating DNA in cell cycle-fractionated stage-specific S phase populations. The other is FISH analyses of replication foci. Although the locations of early-and late-replicating domains were common between the two cell lines, the timing transition region (TTR) between early and late domains were offset by 200-kb. We show that Special AT-rich sequence Binding protein 1 (SATB1), specifically expressed in T-cells, binds to the early domain immediately adjacent to TTR and delays the replication timing of the TTR. Measurement of the chromosome copy number along the TTR during synchronized S phase suggests that the fork movement may be slowed down by SATB1. Conclusions: Our results reveal a novel role of SATB1 in cell type-specific regulation of replication timing along the chromosome.	[Oda, Masako; Kanoh, Yutaka; Watanabe, Yoshihisa; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Dept Genome Med, Tokyo 113, Japan	Tokyo Metropolitan Institute of Medical Science	Oda, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Dept Genome Med, Bunkyo Ku, Tokyo 113, Japan.	masai-hs@igakuken.or.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research (A) (to HM) and Grant-in-Aid for Scientific Research on Priority Area "Chromosome Cycle" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to HM). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrelo R, 2010, EMBO MOL MED, V2, P6, DOI 10.1002/emmm.200900053; Agrelo R, 2009, EPIGENETICS-US, V4, P568, DOI 10.4161/epi.4.8.10186; Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cadoret JC, 2008, P NATL ACAD SCI USA, V105, P15837, DOI 10.1073/pnas.0805208105; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Cai ST, 1999, METHODS, V19, P394, DOI 10.1006/meth.1999.0875; Chastain PD, 2006, CELL CYCLE, V5, P2160, DOI 10.4161/cc.5.18.3236; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; Dickinson LA, 1997, J BIOL CHEM, V272, P11463; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Farkash-Amar S, 2010, CHROMOSOME RES, V18, P115, DOI 10.1007/s10577-009-9091-5; Forbes E, 2010, IMMUNOL CELL BIOL, V88, P240, DOI 10.1038/icb.2009.101; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Gilbert DM, 2010, NAT REV GENET, V11, P673, DOI 10.1038/nrg2830; GILBERT DM, 1987, CELL, V50, P59, DOI 10.1016/0092-8674(87)90662-3; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; Gong FR, 2011, NUCLEIC ACIDS RES, V39, P4640, DOI 10.1093/nar/gkr023; Guan ZQ, 2009, J CELL BIOL, V187, P623, DOI 10.1083/jcb.200905144; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Hayashida T, 2006, J IMMUNOL, V176, P5446, DOI 10.4049/jimmunol.176.9.5446; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Karnani N, 2007, GENOME RES, V17, P865, DOI 10.1101/gr.5427007; Karnani N, 2011, GENE DEV, V25, P621, DOI 10.1101/gad.2029711; Karnani N, 2010, MOL BIOL CELL, V21, P393, DOI 10.1091/mbc.E09-08-0707; Knott SRV, 2012, CELL, V148, P99, DOI 10.1016/j.cell.2011.12.012; KohwiShigematsu T, 1997, BIOCHEMISTRY-US, V36, P12005, DOI 10.1021/bi971444j; Kumar PP, 2007, J VIROL, V81, P5617, DOI 10.1128/JVI.01405-06; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kumar PP, 2005, MOL CELL BIOL, V25, P1620, DOI 10.1128/MCB.25.5.1620-1633.2005; Kumar S, 2009, MOL CELL BIOL, V29, P602, DOI 10.1128/MCB.01319-08; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Matsumoto S, 2011, J CELL BIOL, V195, P387, DOI 10.1083/jcb.201107025; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; NAKAGOMI K, 1994, MOL CELL BIOL, V14, P1852, DOI 10.1128/MCB.14.3.1852; Nakayama Y, 2005, CELL CYCLE, V4, P1099; Nogami M, 2000, CHROMOSOMA, V108, P514, DOI 10.1007/s004120050403; Notani D, 2010, METHODS MOL BIOL, V647, P317, DOI 10.1007/978-1-60761-738-9_20; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Paul WE, 2010, IMMUNOL CELL BIOL, V88, P236, DOI 10.1038/icb.2010.2; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Purbey PK, 2009, MOL CELL BIOL, V29, P1321, DOI 10.1128/MCB.00822-08; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Schultz SS, 2010, MOL CELL BIOL, V30, P4521, DOI 10.1128/MCB.00380-10; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Strehl S, 1997, MOL CELL BIOL, V17, P6157, DOI 10.1128/MCB.17.10.6157; Todorovic V, 2005, MOL CELL, V19, P567, DOI 10.1016/j.molcel.2005.07.005; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004629; Watanabe Y, 2000, GENE, V252, P163, DOI 10.1016/S0378-1119(00)00208-0; Watanabe Y, 2002, HUM MOL GENET, V11, P13, DOI 10.1093/hmg/11.1.13; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200	74	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42375	10.1371/journal.pone.0042375	http://dx.doi.org/10.1371/journal.pone.0042375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879953	Green Submitted, Green Published, gold			2022-12-27	WOS:000307437900034
J	Favier, RP; Spee, B; Schotanus, BA; van den Ingh, TSGAM; Fieten, H; Brinkhof, B; Viebahn, CS; Penning, LC; Rothuizen, J				Favier, Robert P.; Spee, Bart; Schotanus, Baukje A.; van den Ingh, Ted S. G. A. M.; Fieten, Hille; Brinkhof, Bas; Viebahn, Cornelia S.; Penning, Louis C.; Rothuizen, Jan			COMMD1-Deficient Dogs Accumulate Copper in Hepatocytes and Provide a Good Model for Chronic Hepatitis and Fibrosis	PLOS ONE			English	Article							WILSON-DISEASE GENE; LIVER-REGENERATION; PROGENITOR CELLS; TOXICOSIS; MURR1; CONSEQUENCES; LOCALIZATION; REPOPULATION; ACTIVATION; EXPRESSION	New therapeutic concepts developed in rodent models should ideally be evaluated in large animal models prior to human clinical application. COMMD1-deficiency in dogs leads to hepatic copper accumulation and chronic hepatitis representing a Wilson's disease like phenotype. Detailed understanding of the pathogenesis and time course of this animal model is required to test its feasibility as a large animal model for chronic hepatitis. In addition to mouse models, true longitudinal studies are possible due to the size of these dogs permitting detailed analysis of the sequence of events from initial insult to final cirrhosis. Therefore, liver biopsies were taken each half year from five new born COMMD1-deficient dogs over a period of 42 months. Biopsies were used for H&E, reticulin, and rubeanic acid (copper) staining. Immunohistochemistry was performed on hepatic stellate cell (HSC) activation marker (alpha-smooth muscle actin, alpha-SMA), proliferation (Ki67), apoptosis (caspase-3), and bile duct and liver progenitor cell (LPC) markers keratin (K) 19 and 7. Quantitative RT-PCR and Western Blots were performed on gene products involved in the regenerative and fibrotic pathways. Maximum copper accumulation was reached at 12 months of age, which coincided with the first signs of hepatitis. HSCs were activated (alpha-MA) from 18 months onwards, with increasing reticulin deposition and hepatocytic proliferation in later stages. Hepatitis and caspase-3 activity (first noticed at 18 months) increased over time. Both HGF and TGF-beta 1 gene expression peaked at 24 months, and thereafter decreased gradually. Both STAT3 and c-MET showed an increased time-dependent activation. Smad2/3 phosphorylation, indicative for fibrogenesis, was present at all time-points. COMMD1-deficient dogs develop chronic liver disease and cirrhosis comparable to human chronic hepatitis, although at much higher pace. Therefore they represent a genetically-defined large animal model to test clinical applicability of new therapeutics developed in rodent models.	[Favier, Robert P.; Spee, Bart; Schotanus, Baukje A.; Fieten, Hille; Brinkhof, Bas; Viebahn, Cornelia S.; Penning, Louis C.; Rothuizen, Jan] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [van den Ingh, Ted S. G. A. M.] TCCI Consultancy BV, Utrecht, Netherlands	Utrecht University	Favier, RP (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	r.p.favier@uu.nl	Penning, Louis/AAC-7524-2019; Brinkhof, Bas/S-8687-2017	Brinkhof, Bas/0000-0003-3617-0709				[Anonymous], 2010, R LANG ENV STAT COMP; Bedossa P, 2003, J PATHOL, V200, P504, DOI 10.1002/path.1397; Bird TG, 2008, CELL TISSUE RES, V331, P283, DOI 10.1007/s00441-007-0542-z; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; Favier RP, 2005, MAMM GENOME, V16, P460, DOI 10.1007/s00335-004-2457-2; Ferenci P, 1996, HEPATOLOGY, V24, P952; Henderson NC, 2008, TOXICOLOGY, V254, P130, DOI 10.1016/j.tox.2008.08.017; Hoffmann G, 2006, J VET INTERN MED, V20, P856, DOI 10.1892/0891-6640(2006)20[856:CCHILR]2.0.CO;2; Hoogenraad TU, 1986, LANCET, V19, P170; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Katoonizadeh A, 2006, LIVER INT, V26, P1225, DOI 10.1111/j.1478-3231.2006.01377.x; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; Liu CH, 2003, J BIOL CHEM, V278, P11721, DOI 10.1074/jbc.M207728200; Lovicu M, 2006, J GASTROENTEROL, V41, P582, DOI 10.1007/s00535-006-1807-0; Mekonnen GA, 2007, VET PATHOL, V44, P803, DOI 10.1354/vp.44-6-803; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Muller T, 2003, J HEPATOL, V38, P164, DOI 10.1016/S0168-8278(02)00356-2; Roskams T, 2006, J HEPATOL, V45, P1, DOI 10.1016/j.jhep.2006.05.002; Sancho-Bru P, 2009, GUT, V58, P594, DOI 10.1136/gut.2008.171116; Sarkar B, 2011, METALLOMICS, V3, P20, DOI 10.1039/c0mt00031k; Schotanus BA, 2009, LIVER INT, V29, P1241, DOI 10.1111/j.1478-3231.2009.02024.x; Shibata C, 2006, LIVER TRANSPLANT, V12, P78, DOI 10.1002/lt.20558; Spee B, 2007, ANIM GENET, V38, P168, DOI 10.1111/j.1365-2052.2007.01580.x; Spee B, 2006, LIVER INT, V26, P716, DOI 10.1111/j.1478-3231.2006.01277.x; Strand S, 1998, NAT MED, V4, P588, DOI 10.1038/nm0598-588; SU LC, 1982, AM J PHYSIOL, V243, pG226, DOI 10.1152/ajpgi.1982.243.3.G226; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; Van den Ingh TSGAM, 2006, WSAVA STANDARDS CLIN, P85; van Sprundel RG, 2010, COMP HEPATOL, V18, P4; VANDENINGH TSGAM, 1988, VET QUART, V10, P84, DOI 10.1080/01652176.1988.9694154; Vonk WIM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029183	40	32	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42158	10.1371/journal.pone.0042158	http://dx.doi.org/10.1371/journal.pone.0042158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879914	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000307810000019
J	Hanson, KE; Pfeiffer, CD; Lease, ED; Balch, AH; Zaas, AK; Perfect, JR; Alexander, BD				Hanson, Kimberly E.; Pfeiffer, Christopher D.; Lease, Erika D.; Balch, Alfred H.; Zaas, Aimee K.; Perfect, John R.; Alexander, Barbara D.			beta-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; NEUTROPENIC CRITICALLY-ILL; FUNGAL-INFECTIONS; LIMULUS TEST; CANDIDEMIA; DIAGNOSIS; PLASMA; ASSAY; COLONIZATION; PROPHYLAXIS	Background: Invasive candidiasis (IC) is a devastating disease. While prompt antifungal therapy improves outcomes, empiric treatment based on the presence of fever has little clinical impact. B-D-Glucan (BDG) is a fungal cell wall component detectable in the serum of patients with early invasive fungal infection (IFI). We evaluated the utility of BDG surveillance as a guide for preemptive antifungal therapy in at-risk intensive care unit (ICU) patients. Methods: Patients admitted to the ICU for >= 3 days and expected to require at least 2 additional days of intensive care were enrolled. Subjects were randomized in 3:1 fashion to receive twice weekly BDG surveillance with preemptive anidulafungin in response to a positive test or empiric antifungal treatment based on physician preference. Results: Sixty-four subjects were enrolled, with 1 proven and 5 probable cases of IC identified over a 2.5 year period. BDG levels were higher in subjects with proven/probable IC as compared to those without an IFI (117 pg/ml vs. 28 pg/ml; p<0.001). Optimal assay performance required 2 sequential BDG determinations of >= 80 pg/ml to define a positive test (sensitivity 100%, specificity 75%, positive predictive value 30%, negative predictive value 100%). In all, 21 preemptive and 5 empiric subjects received systemic antifungal therapy. Receipt of preemptive antifungal treatment had a significant effect on BDG concentrations (p<0.001). Preemptive anidulafungin was safe and generally well tolerated with excellent outcome. Conclusions: BDG monitoring may be useful for identifying ICU patients at highest risk to develop an IFI as well as for monitoring treatment response. Preemptive strategies based on fungal biomarkers warrant further study.	[Hanson, Kimberly E.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Hanson, Kimberly E.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Pfeiffer, Christopher D.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR USA; [Lease, Erika D.; Zaas, Aimee K.; Perfect, John R.; Alexander, Barbara D.] Duke Univ, Dept Med, Durham, NC USA; [Balch, Alfred H.] Univ Utah, Dept Pediat, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Oregon Health & Science University; Duke University; Utah System of Higher Education; University of Utah	Hanson, KE (corresponding author), Univ Utah, Dept Med, Salt Lake City, UT 84112 USA.	kim.hanson@hsc.utah.edu; alexa011@mc.duke.edu		Alexander, Barbara/0000-0001-5868-0529; balch, alfred/0000-0002-2782-9885	Investigator-Initiated Research Grant from Pfizer Inc. [GA88517X]; Pfizer [KL2 RR-024127-01, K24 AI072522]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI072522] Funding Source: NIH RePORTER	Investigator-Initiated Research Grant from Pfizer Inc.; Pfizer(Pfizer); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an Investigator-Initiated Research Grant to KH and BA from Pfizer Inc. (GA88517X). Pfizer supplied the study drug as well as supported the salary of the study coordinators. A KL2 RR-024127-01 to KH and K24 AI072522 to BA were sources of salary support for the investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BD, 2010, J CLIN MICROBIOL, V48, P4083, DOI 10.1128/JCM.01183-10; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Digby J, 2003, CLIN DIAGN LAB IMMUN, V10, P882, DOI 10.1128/CDLI.10.5.882-885.2003; Ellis M, 2008, J MED MICROBIOL, V57, P287, DOI 10.1099/jmm.0.47479-0; Falagas ME, 2006, EUR J CLIN MICROBIOL, V25, P419, DOI 10.1007/s10096-006-0159-2; Fridkin SK, 2005, CLIN INFECT DIS, V41, P1240, DOI 10.1086/496935; IKEMURA K, 1989, J CLIN MICROBIOL, V27, P1965, DOI 10.1128/JCM.27.9.1965-1968.1989; Jaijakul SVJ, 2011, 1 3 B D GLUCAN BG PR; Kanamori H, 2009, TOHOKU J EXP MED, V217, P117, DOI 10.1620/tjem.217.117; Kanda H, 2001, KIDNEY INT, V60, P319, DOI 10.1046/j.1523-1755.2001.00802.x; KIMURA Y, 1995, SURG TODAY, V25, P790, DOI 10.1007/BF00311454; Leon C, 2006, CRIT CARE MED, V34, P730, DOI 10.1097/01.CCM.0000202208.37364.7D; Leon C, 2009, CRIT CARE MED, V37, P1624, DOI 10.1097/CCM.0b013e31819daa14; Marty FM, 2006, ANTIMICROB AGENTS CH, V50, P3450, DOI 10.1128/AAC.00658-06; Mennink-Kersten MASH, 2006, NEW ENGL J MED, V354, P2834, DOI 10.1056/NEJMc053340; Mohr JF, 2011, J CLIN MICROBIOL, V49, P58, DOI 10.1128/JCM.01240-10; Nagasawa Koichi, 2003, J Artif Organs, V6, P49, DOI 10.1007/s100470300008; OBAYASHI T, 1995, LANCET, V345, P17, DOI 10.1016/S0140-6736(95)91152-9; Odabasi Z, 2004, CLIN INFECT DIS, V39, P199, DOI 10.1086/421944; Ogawa M, 2004, INT J HEMATOL, V80, P97, DOI 10.1532/ijh97.04030; Ostrosky-Zeichner L, 2007, EUR J CLIN MICROBIOL, V26, P271, DOI 10.1007/s10096-007-0270-z; Ostrosky-Zeichner L, 2006, CRIT CARE MED, V34, P857, DOI 10.1097/01.CCM.0000201897.78123.44; Ostrosky-Zeichner L, 2005, CLIN INFECT DIS, V41, P654, DOI 10.1086/432470; Ostrosky-Zeichner LSJ, 2007, 47 INT C ANT AG CHEM; Ostrosky-Zeichner L, 2011, MYCOSES, V54, P46, DOI 10.1111/j.1439-0507.2009.01756.x; Ostrosky-Zeichner L, 2011, MED MYCOL, V49, P113, DOI 10.3109/13693786.2010.512300; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Parkins MD, 2007, J ANTIMICROB CHEMOTH, V60, P613, DOI 10.1093/jac/dkm212; Pfaller MA, 2000, ANTIMICROB AGENTS CH, V44, P747, DOI 10.1128/AAC.44.3.747-751.2000; Pfaller MA, 1998, J CLIN MICROBIOL, V36, P1886, DOI 10.1128/JCM.36.7.1886-1889.1998; Pickering JW, 2005, J CLIN MICROBIOL, V43, P5957, DOI 10.1128/JCM.43.12.5957-5962.2005; Playford EG, 2006, J ANTIMICROB CHEMOTH, V57, P628, DOI 10.1093/jac/dki491; Presterl E, 2009, INT J INFECT DIS, V13, P707, DOI 10.1016/j.ijid.2008.10.013; Rex JH, 2006, CRIT CARE MED, V34, P1286, DOI 10.1097/01.CCM.0000208110.36504.19; Schuster MG, 2008, ANN INTERN MED, V149, P83, DOI 10.7326/0003-4819-149-2-200807150-00004; Senn L, 2009, INTENS CARE MED, V35, P903, DOI 10.1007/s00134-009-1405-8; Takesue Y, 2004, WORLD J SURG, V28, P625, DOI 10.1007/s00268-004-7302-y; Usami M, 2002, TRANSFUSION, V42, P1189, DOI 10.1046/j.1537-2995.2002.00162.x; van Burik JAH, 2004, CLIN INFECT DIS, V39, P1407, DOI 10.1086/422312; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922	41	86	89	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42282	10.1371/journal.pone.0042282	http://dx.doi.org/10.1371/journal.pone.0042282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879929	gold, Green Published, Green Submitted			2022-12-27	WOS:000307810000024
J	Steers, NJ; Ratto-Kim, S; de Souza, MS; Currier, JR; Kim, JH; Michael, NL; Alving, CR; Rao, M				Steers, Nicholas J.; Ratto-Kim, Silvia; de Souza, Mark S.; Currier, Jeffrey R.; Kim, Jerome H.; Michael, Nelson L.; Alving, Carl R.; Rao, Mangala			HIV-1 Envelope Resistance to Proteasomal Cleavage: Implications for Vaccine Induced Immune Responses	PLOS ONE			English	Article							T-CELL RESPONSES; ANTIGEN PRESENTATION; CLASS-II; INVARIANT CHAIN; DENDRITIC CELLS; IN-VIVO; PROTEIN; GLYCOSYLATION; DEGRADATION; GENERATION	Background: Antigen processing involves many proteolytic enzymes such as proteasomes and cathepsins. The processed antigen is then presented on the cell surface bound to either MHC class I or class II molecules and induces/interacts with antigen-specific CD8+ and CD4+ T-cells, respectively. Preliminary immunological data from the RV144 phase III trial indicated that the immune responses were biased towards the Env antigen with a dominant CD4+ T-cell response. Methods: In this study, we examined the susceptibility of HIV-1 Env-A244 gp120 protein, one of the protein boost subunits of the RV144 Phase III vaccine trial, to proteasomes and cathepsins and identified the generated peptide epitope repertoire by mass spectrometry. The peptide fragments were tested for cytokine production in CD4(+) T-cell lines derived from RV144 volunteers. Results: Env-A244 was resistant to proteasomes, thus diminishing the possibility of the generation of class I epitopes by the classical MHC class I pathway. However, Env-A244 was efficiently cleaved by cathepsins generating peptide arrays identified by mass spectrometry that contained both MHC class I and class II epitopes as reported in the Los Alamos database. Each of the cathepsins generated distinct degradation patterns containing regions of light and dense epitope clusters. The sequence DKKQKVHALF that is part of the V2 loop of gp120 produced by cathepsins induced a polyfunctional cytokine response including the generation of IFN-gamma from CD4(+) T-cell lines-derived from RV144 vaccinees. This sequence is significant since antibodies to the V1/V2-loop region correlated inversely with HIV-1 infection in the RV144 trial. Conclusions: Based on our results, the susceptibility of Env-A244 to cathepsins and not to proteasomes suggests a possible mechanism for the generation of Env-specific CD4(+)T cell and antibody responses in the RV144 vaccinees.	[Steers, Nicholas J.; Ratto-Kim, Silvia; Currier, Jeffrey R.; Kim, Jerome H.; Michael, Nelson L.; Alving, Carl R.; Rao, Mangala] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Steers, Nicholas J.; Ratto-Kim, Silvia; Currier, Jeffrey R.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [de Souza, Mark S.] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Steers, NJ (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA.	mrao@hivresearch.org		Ratto-Kim, Silvia/0000-0003-2025-6399	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense)	This work was supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EW, 2008, CHEMBIOCHEM, V9, P294, DOI 10.1002/cbic.200700310; Boes M, 2005, EUR J IMMUNOL, V35, P2552, DOI 10.1002/eji.200526323; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Chapman HA, 2006, CURR OPIN IMMUNOL, V18, P78, DOI 10.1016/j.coi.2005.11.011; Creasy BM, 2011, CELL IMMUNOL, V267, P56, DOI 10.1016/j.cellimm.2010.11.004; Cresswell P, 2005, IMMUNOL REV, V207, P5, DOI 10.1111/j.0105-2896.2005.00320.x; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; de Souza MS, 2012, J IMMUNOL, V188, P5166, DOI 10.4049/jimmunol.1102756; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Gavioli R, 2004, J IMMUNOL, V173, P3838, DOI 10.4049/jimmunol.173.6.3838; Gavioli R, 2008, VACCINE, V26, P727, DOI 10.1016/j.vaccine.2007.11.040; Giodini A, 2010, CURR OPIN IMMUNOL, V22, P94, DOI 10.1016/j.coi.2010.01.023; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hirsch C, 2004, EMBO REP, V5, P201, DOI 10.1038/sj.embor.7400066; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Julg B, 2010, J VIROL, V84, P5540, DOI 10.1128/JVI.02031-09; Karasavvas N, 2011, AIDS RES HUM RETROV, V27, pA29; Kario E, 2008, J BIOL CHEM, V283, P244, DOI 10.1074/jbc.M706237200; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Lucchiari-Hartz M, 2003, P NATL ACAD SCI USA, V100, P7755, DOI 10.1073/pnas.1232228100; Munz C, 2010, CURR OPIN IMMUNOL, V22, P89, DOI 10.1016/j.coi.2010.01.016; Ramachandra L, 2009, CURR OPIN IMMUNOL, V21, P98, DOI 10.1016/j.coi.2009.01.001; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; RATTO S, 1995, J INFECT DIS, V171, P1420, DOI 10.1093/infdis/171.6.1420; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roche PA, 2011, J IMMUNOL, V187, P3150; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sakamoto T, 2006, FEBS LETT, V580, P6543, DOI 10.1016/j.febslet.2006.10.075; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Sharp ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021135; Steers NJ, 2011, J VIROL, V85, P1541, DOI 10.1128/JVI.01790-10; Steers NJ, 2009, J VIROL, V83, P7049, DOI 10.1128/JVI.00327-09; Stern LJ, 2006, CURR OPIN IMMUNOL, V18, P64, DOI 10.1016/j.coi.2005.11.005; Stove V, 2006, CURR HIV RES, V4, P57, DOI 10.2174/157016206775197583; Tenzer S, 2004, J IMMUNOL, V172, P1083, DOI 10.4049/jimmunol.172.2.1083; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turville S, 2003, J LEUKOCYTE BIOL, V74, P710, DOI 10.1189/jlb.0503208; van Hall T, 2007, J IMMUNOL, V178, P657, DOI 10.4049/jimmunol.178.2.657; Verweij MC, 2011, MOL IMMUNOL, V48, P835, DOI 10.1016/j.molimm.2010.12.008; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Watts C, 2004, NAT IMMUNOL, V5, P685, DOI 10.1038/ni1088; Yu B, 2010, J VIROL, V84, P1513, DOI 10.1128/JVI.01765-09; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m; Zolla-Pazner S, 2011, AIDS RES HUM RETROV, V27, pA21	54	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42579	10.1371/journal.pone.0042579	http://dx.doi.org/10.1371/journal.pone.0042579			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880042	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000049
J	Kalinina, OV; Oberwinkler, H; Glass, B; Krausslich, HG; Russell, RB; Briggs, JAG				Kalinina, Olga V.; Oberwinkler, Heike; Glass, Baerbel; Kraeusslich, Hans-Georg; Russell, Robert B.; Briggs, John A. G.			Computational Identification of Novel Amino-Acid Interactions in HIV Gag via Correlated Evolution	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENTS; CONTACT PREDICTION; PROTEIN EVOLUTION; INFORMATION; COVARIANCE; CONSERVATION; MUTATIONS; POSITIONS; MODELS	Pairs of amino acid positions that evolve in a correlated manner are proposed to play important roles in protein structure or function. Methods to detect them might fare better with families for which sequences of thousands of closely related homologs are available than families with only a few distant relatives. We applied co-evolution analysis to thousands of sequences of HIV Gag, finding that the most significantly co-evolving positions are proximal in the quaternary structures of the viral capsid. A reduction in infectivity caused by mutating one member of a significant pair could be rescued by a compensatory mutation of the other.	[Kalinina, Olga V.; Kraeusslich, Hans-Georg; Russell, Robert B.] Univ Heidelberg, Bioquant, CellNetworks, Heidelberg, Germany; [Oberwinkler, Heike; Glass, Baerbel; Kraeusslich, Hans-Georg] Univ Klinikum Heidelberg, Dept Infect Dis, Heidelberg, Germany; [Briggs, John A. G.] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Kalinina, OV (corresponding author), Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany.	robert.russell@bioquant.uni-heidelberg.de; briggs@embl.de	Russell, Rob/AAH-9145-2019; Briggs, John/J-3096-2012; Russell, Robert/GWU-6389-2022; Kalinina, Olga V/M-8482-2016	Russell, Rob/0000-0002-1905-4717; Russell, Robert/0000-0002-7213-1398; Kalinina, Olga V/0000-0002-9445-477X; Krausslich, Hans-Georg/0000-0002-8756-329X; Briggs, John/0000-0003-3990-6910	Deutsche Forschungsgemeinschaft [SPP 1175]; EMBO Long Term Fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO))	H-GK and JAGB and were supported by a grant from the Deutsche Forschungsgemeinschaft within SPP 1175. OVK was partially supported by an EMBO Long Term Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; GERSTEIN M, 1994, J MOL BIOL, V236, P1067, DOI 10.1016/0022-2836(94)90012-4; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kalinina OV, 2004, PROTEIN SCI, V13, P443, DOI 10.1110/ps.03191704; Kowarsch A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000923; Larson SM, 2000, J MOL BIOL, V303, P433, DOI 10.1006/jmbi.2000.4146; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Nickle DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000503; Olmea O, 1997, FOLD DES, V2, pS25, DOI 10.1016/S1359-0278(97)00060-6; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Russell RB, 1997, J MOL BIOL, V269, P423, DOI 10.1006/jmbi.1997.1019; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Travers SAA, 2007, MOL BIOL EVOL, V24, P2787, DOI 10.1093/molbev/msm213; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002	29	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42468	10.1371/journal.pone.0042468	http://dx.doi.org/10.1371/journal.pone.0042468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879995	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100101
J	Lam, V; Bigley, T; Terhune, SS; Wakatsuki, T				Lam, Vy; Bigley, Tarin; Terhune, Scott S.; Wakatsuki, Tetsuro			A Method for Quantifying Mechanical Properties of Tissue following Viral Infection	PLOS ONE			English	Article							HUMAN CYTOMEGALOVIRUS-INFECTION; GROWTH-FACTOR RECEPTOR; MUSCLE-CELL MIGRATION; GENE-EXPRESSION; UL131-128 GENES; CYTOCHALASIN-D; FIBROBLASTS; ADHESION; MYOFIBROBLASTS; ACTIN	Viral infection and replication involves the reorganization of the actin network within the host cell. Actin plays a central role in the mechanical properties of cells. We have demonstrated a method to quantify changes in mechanical properties of fabricated model three-dimensional (3D) connective tissue following viral infection. Using this method, we have characterized the impact of infection by the human herpesvirus, cytomegalovirus (HCMV). HCMV is a member of the herpesvirus family and infects a variety of cell types including fibroblasts. In the body, fibroblasts are necessary for maintaining connective tissue and function by creating mechanical force. Using this 3D connective tissue model, we observed that infection disrupted the cell's ability to generate force and reduced the cumulative contractile force of the tissue. The addition of HCMV viral particles in the absence of both viral gene expression and DNA replication was sufficient to disrupt tissue function. We observed that alterations of the mechanical properties are, in part, due to a disruption of the underlying complex actin microfilament network established by the embedded fibroblasts. Finally, we were able to prevent HCMV-mediated disruption of tissue function by the addition of human immune globulin against HCMV. This study demonstrates a method to quantify the impact of viral infection on mechanical properties which are not evident using conventional cell culture systems.	[Lam, Vy; Bigley, Tarin; Terhune, Scott S.; Wakatsuki, Tetsuro] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; [Bigley, Tarin; Terhune, Scott S.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Wakatsuki, Tetsuro] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Wakatsuki, Tetsuro] InvivoSci LLC, Madison, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Lam, V (corresponding author), Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA.	sterhune@mcw.edu		Bigley, Tarin/0000-0001-7443-9436; Wakatsuki, Tetsuro/0000-0002-2175-1132	MCW Research Development funds; NIH [R44 GM087784]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM087784] Funding Source: NIH RePORTER	MCW Research Development funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by MCW Research Development funds to S. T. and NIH R44 GM087784 to T. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele-Ohl S, 2012, AM J TRANSPLANT; Andreoni K A, 2001, Transpl Infect Dis, V3 Suppl 2, P25, DOI 10.1034/j.1399-3062.2001.00005.x; Arcangeletti MC, 2000, MICROBIOLOGICA, V23, P241; Bresnahan WA, 2000, SCIENCE, V288, P2373, DOI 10.1126/science.288.5475.2373; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Cha TA, 1996, J VIROL, V70, P78, DOI 10.1128/JVI.70.1.78-83.1996; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; Favoreel HW, 2007, TRENDS MICROBIOL, V15, P426, DOI 10.1016/j.tim.2007.08.003; Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101; Gerna G, 2005, J GEN VIROL, V86, P275, DOI 10.1099/vir.0.80474-0; Goldyn AM, 2009, J CELL SCI, V122, P3644, DOI 10.1242/jcs.054866; Goodrum FD, 2002, P NATL ACAD SCI USA, V99, P16255, DOI 10.1073/pnas.252630899; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hahn G, 2004, J VIROL, V78, P10023, DOI 10.1128/JVI.78.18.10023-10033.2004; Isaacson MK, 2007, J VIROL, V81, P6241, DOI 10.1128/JVI.00169-07; JONES NL, 1986, EUR J CELL BIOL, V41, P304; Kalejta RF, 2008, MICROBIOL MOL BIOL R, V72, P249, DOI 10.1128/MMBR.00040-07; KOLODNEY MS, 1995, P NATL ACAD SCI USA, V92, P10252, DOI 10.1073/pnas.92.22.10252; KOLODNEY MS, 1993, J BIOL CHEM, V268, P23850; Lam VY, 2011, J BIOMOL SCREEN, V16, P120, DOI 10.1177/1087057110388269; LOSSE D, 1982, ARCH VIROL, V71, P353, DOI 10.1007/BF01315066; Marquez JP, 2009, TISSUE ENG PART C-ME, V15, P181, DOI 10.1089/ten.tec.2008.0347; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Melnychuk RM, 2004, J VIROL, V78, P8382, DOI 10.1128/jvi.78.15.8382-8391.2004; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Michelson S, 2001, MICROBES INFECT, V3, P1005, DOI 10.1016/S1286-4579(01)01464-2; Miller MS, 2009, J VIROL, V83, P7015, DOI 10.1128/JVI.00398-09; Miron-Mendoza M, 2008, MOL BIOL CELL, V19, P2051, DOI 10.1091/mbc.E07-09-0930; Mocarski E.S, 2007, FIELDS VIROLOGY, P2702; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; Ogawa-Goto K, 2003, J VIROL, V77, P8541, DOI 10.1128/JVI.77.15.8541-8547.2003; Penfold MET, 2003, J VIROL, V77, P10404, DOI 10.1128/JVI.77.19.10404-10413.2003; Rhee S, 2009, EXP MOL MED; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Sharon-Friling R, 2006, P NATL ACAD SCI USA, V103, P19117, DOI 10.1073/pnas.0609353103; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; Sinzger C, 1999, J GEN VIROL, V80, P2867, DOI 10.1099/0022-1317-80-11-2867; Sinzger C, 2008, J GEN VIROL, V89, P359, DOI 10.1099/vir.0.83286-0; Sivakumar P, 2008, INFLAMM RES, V57, P410, DOI 10.1007/s00011-008-7166-y; Soroceanu L, 2008, NATURE, V455, P391, DOI 10.1038/nature07209; Streblow DN, 2008, CURR TOP MICROBIOL, V325, P397; Streblow DN, 2003, J BIOL CHEM, V278, P50456, DOI 10.1074/jbc.M307936200; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Taylor RT, 2005, J VIROL, V79, P3873, DOI 10.1128/JVI.79.6.3873-3877.2005; Terhune S, 2007, J VIROL, V81, P3109, DOI 10.1128/JVI.02124-06; Terhune SS, 2004, J VIROL, V78, P10390, DOI 10.1128/JVI.78.19.10390-10398.2004; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Ujihara Y, 2008, J PHYSIOL SCI, V58, P499, DOI 10.2170/physiolsci.RP007708; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Wakatsuki T, 2000, BIOPHYS J, V79, P2353, DOI 10.1016/S0006-3495(00)76481-2; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wang D, 2005, J VIROL, V79, P10330, DOI 10.1128/JVI.79.16.10330-10338.2005; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818	55	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42197	10.1371/journal.pone.0042197	http://dx.doi.org/10.1371/journal.pone.0042197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870300	Green Published, gold			2022-12-27	WOS:000307284100053
J	Lin, IT; Yang, HC; Chen, JH				Lin, In-Tsang; Yang, Hong-Chang; Chen, Jyh-Horng			Enlargement of the Field of View and Maintenance of a High Signal-to-Noise Ratio Using a Two-Element High-T-c Superconducting Array in a 3T MRI	PLOS ONE			English	Article							RF COIL; NMR; MICROSCOPY; RECEIVER; QUALITY; PROBE	This study examines the enlargement of the field of view (FOV) and the maintenance of a high signal-to-noise ratio (SNR) through the use of two high-temperature superconducting (HTS) resonators in a 3T MRI. Two Bi2Sr2Ca2Cu3Ox (Bi-2223) surface resonators, each of 4-cm diameter, were used in a 3T MRI. Professionally made copper resonators operate at 300 K, but each Bi-2223 resonator, operated at 77 K and demonstrated a 3.75 fold increase in SNR gain. For the same scanning time, the SNR of the images of a rat's brain and back, obtained using two small Bi-2223 surface resonators, was higher than that obtained using a single 8-cm surface resonator.	[Lin, In-Tsang; Chen, Jyh-Horng] Natl Taiwan Univ, Dept Elect Engn, Interdisciplinary MRI MRS Lab, Taipei 10764, Taiwan; [Yang, Hong-Chang] Natl Taiwan Univ, Dept Phys, Taipei, Taiwan	National Taiwan University; National Taiwan University	Lin, IT (corresponding author), Natl Taiwan Univ, Dept Elect Engn, Interdisciplinary MRI MRS Lab, Taipei 10764, Taiwan.	hcyang@phys.ntu.edu.tw; jhchen@ntu.edu.tw			National Health Research Institutes [NHRI-EX101- 10038EI]; National Science Council [NSC 100-2120-M002-015]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan)	The study is funded by National Health Research Institutes (http://www.nhri.org.tw), grant number NHRI-EX101- 10038EI and National Science Council (http://web1.nsc.gov.tw), grant number NSC 100-2120-M002-015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACK RD, 1993, SCIENCE, V259, P793, DOI 10.1126/science.8430331; Darrasse L, 2003, BIOCHIMIE, V85, P915, DOI 10.1016/j.biochi.2003.09.016; Ginefri JC, 1999, REV SCI INSTRUM, V70, P4730, DOI 10.1063/1.1150142; Ginefri JC, 2007, METHODS, V43, P54, DOI 10.1016/j.ymeth.2007.03.011; Grasso G, 2000, SUPERCOND SCI TECH, V13, pL15, DOI 10.1088/0953-2048/13/10/102; Hoult DI, 2002, CONCEPT MAGNETIC RES, V15, P262, DOI 10.1002/cmr.10047; HOULT DI, 1976, J MAGN RESON, V24, P71, DOI 10.1016/0022-2364(76)90233-X; Hurlston SE, 1999, MAGNET RESON MED, V41, P1032, DOI 10.1002/(SICI)1522-2594(199905)41:5<1032::AID-MRM23>3.3.CO;2-O; HYDE JS, 1986, J MAGN RESON, V70, P512, DOI 10.1016/0022-2364(86)90146-0; Keinan-Adamsky K, 2006, MAGN RESON MED, V55, P532, DOI 10.1002/mrm.20775; Kuo R, 2007, J MAGN RESON IMAGING, V25, P245, DOI 10.1002/jmri.20815; Lin IT, 2011, J APPL PHYS, V109, DOI 10.1063/1.3573600; Ma QY, 1999, IEEE T APPL SUPERCON, V9, P3565, DOI 10.1109/77.783800; Miller J, 1999, MAGNETIC RESONANCE M, V41; Neuberger T, 2008, NMR BIOMED; OKADA H, 1995, J MAGN RESON SER B, V107, P158, DOI 10.1006/jmrb.1995.1072; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Wosik J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2801384; Wright AC, 2000, MAGNET RESON MED, V43, P163, DOI 10.1002/(SICI)1522-2594(200002)43:2<163::AID-MRM1>3.0.CO;2-K; Wright SM, 1997, NMR BIOMED, V10, P394, DOI 10.1002/(SICI)1099-1492(199712)10:8<394::AID-NBM494>3.0.CO;2-0; WRIGHT SM, 1991, MAGNET RESON MED, V17, P252, DOI 10.1002/mrm.1910170128; Yang HC, 2007, SUPERCOND SCI TECH, V20, P777, DOI 10.1088/0953-2048/20/8/009; Yoshioka H, 2003, SKELETAL RADIOL, V32, P575, DOI 10.1007/s00256-003-0672-7; Yuan J, 2004, SUPERCOND SCI TECH, V17, P333, DOI 10.1088/0953-2048/17/3/006; Zhang XL, 2005, MAGN RESON MED, V53, P1234, DOI 10.1002/mrm.20462	26	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42509	10.1371/journal.pone.0042509	http://dx.doi.org/10.1371/journal.pone.0042509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880009	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100114
J	Menge, DNL; Hedin, LO; Pacala, SW				Menge, Duncan N. L.; Hedin, Lars O.; Pacala, Stephen W.			Nitrogen and Phosphorus Limitation over Long-Term Ecosystem Development in Terrestrial Ecosystems	PLOS ONE			English	Article							HYDROLOGIC CONTROLS; PRIMARY SUCCESSION; TEMPERATE FOREST; SOIL DEVELOPMENT; GLACIER BAY; NUTRIENT LIMITATION; INORGANIC NITROGEN; FIXATION; DYNAMICS; CYCLES	Nutrient limitation to net primary production (NPP) displays a diversity of patterns as ecosystems develop over a range of timescales. For example, some ecosystems transition from N limitation on young soils to P limitation on geologically old soils, whereas others appear to remain N limited. Under what conditions should N limitation and P limitation prevail? When do transitions between N and P limitation occur? We analyzed transient dynamics of multiple timescales in an ecosystem model to investigate these questions. Post-disturbance dynamics in our model are controlled by a cascade of rates, from plant uptake (very fast) to litter turnover (fast) to plant mortality (intermediate) to plant-unavailable nutrient loss (slow) to weathering (very slow). Young ecosystems are N limited when symbiotic N fixation (SNF) is constrained and P weathering inputs are high relative to atmospheric N deposition and plant N: P demand, but P limited under opposite conditions. In the absence of SNF, N limitation is likely to worsen through succession (decades to centuries) because P is mineralized faster than N. Over long timescales (centuries and longer) this preferential P mineralization increases the N: P ratio of soil organic matter, leading to greater losses of plant-unavailable N versus P relative to plant N: P demand. These loss dynamics favor N limitation on older soils despite the rising organic matter N: P ratio. However, weathering depletion favors P limitation on older soils when continual P inputs (e. g., dust deposition) are low, so nutrient limitation at the terminal equilibrium depends on the balance of these input and loss effects. If NPP switches from N to P limitation over long time periods, the transition time depends most strongly on the P weathering rate. At all timescales SNF has the capacity to overcome N limitation, so nutrient limitation depends critically on limits to SNF.	[Menge, Duncan N. L.; Hedin, Lars O.; Pacala, Stephen W.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Menge, Duncan N. L.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Menge, Duncan N. L.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Princeton University; National Center for Ecological Analysis & Synthesis; Stanford University	Menge, DNL (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	dmenge@princeton.edu		Menge, Duncan/0000-0003-4736-9844	National Science Foundation (NSF) [EF-0553768]; University of California, Santa Barbara; State of California; Carbon Mitigation Initiative; NSF [0614116]; Mellon Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Carbon Mitigation Initiative; NSF(National Science Foundation (NSF)); Mellon Foundation	This work was conducted in part while D.N.L.M. was a Postdoctoral Associate at the National Center for Ecological Analysis and Synthesis, a Center funded by the National Science Foundation (NSF) (www.nsf.gov; Grant #EF-0553768), the University of California, Santa Barbara (www.ucsb.edu), and the State of California (www.ca.gov). D.N.L.M. was also supported by the Carbon Mitigation Initiative (cmi.princeton.edu). L.O.H. was supported by a grant from the NSF (DEB #0614116) and the A. W. Mellon Foundation (www.mellon.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; ABRAMS P, 1987, THEOR POPUL BIOL, V32, P262, DOI 10.1016/0040-5809(87)90050-5; Adair EC, 2008, GLOBAL CHANGE BIOL, V14, P2636, DOI 10.1111/j.1365-2486.2008.01674.x; Agren GI, 1996, THEORETICAL ECOSYSTE; ARNONE JA, 1990, NEW PHYTOL, V116, P55, DOI 10.1111/j.1469-8137.1990.tb00510.x; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Baisden WT, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001822; Barron AR, 2011, OECOLOGIA, V165, P511, DOI 10.1007/s00442-010-1838-3; BINKLEY D, 1992, ECOLOGY, V73, P2022, DOI 10.2307/1941452; Binkley D., 1994, BIOL MANAGEMENT RED, P57; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; BORMANN BT, 1990, J ECOL, V78, P561, DOI 10.2307/2260884; Buendia C, 2010, BIOGEOSCIENCES, V7, P2025, DOI 10.5194/bg-7-2025-2010; Chadwick OA, 1999, NATURE, V397, P491, DOI 10.1038/17276; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; CHAPIN FS, 1994, ECOL MONOGR, V64, P149, DOI 10.2307/2937039; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Compton JE, 2003, ECOSYSTEMS, V6, P773, DOI 10.1007/s10021-002-0207-4; CREWS TE, 1995, ECOLOGY, V76, P1407, DOI 10.2307/1938144; CROCKER RL, 1955, J ECOL, V43, P427, DOI 10.2307/2257005; D'Odorico P, 2003, ADV WATER RESOUR, V26, P59, DOI 10.1016/S0309-1708(02)00095-7; Daufresne T, 2005, P NATL ACAD SCI USA, V102, P9212, DOI 10.1073/pnas.0406427102; DeAngelis D. L., 1992, DYNAMICS NUTR CYCLIN; FIELD CB, 1992, ANNU REV ECOL SYST, V23, P201, DOI 10.1146/annurev.es.23.110192.001221; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Goodale CL, 2000, ECOSYSTEMS, V3, P433, DOI 10.1007/s100210000039; GUTSCHICK VP, 1981, AM NAT, V118, P607, DOI 10.1086/283858; Hall SJ, 1999, NATURE, V400, P152, DOI 10.1038/22094; Hall SJ, 2003, ECOL MONOGR, V73, P107, DOI 10.1890/0012-9615(2003)073[0107:NSOTRF]2.0.CO;2; Hedin LO, 2009, ANNU REV ECOL EVOL S, V40, P613, DOI 10.1146/annurev.ecolsys.37.091305.110246; Hedin LO, 2003, ECOLOGY, V84, P2231, DOI 10.1890/02-4066; HEDIN LO, 1995, ECOLOGY, V76, P493, DOI 10.2307/1941208; Holloway JM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001862; Hulme PE, 1996, J ECOL, V84, P43, DOI 10.2307/2261698; JACKSON LE, 1989, SOIL BIOL BIOCHEM, V21, P409, DOI 10.1016/0038-0717(89)90152-1; Klausmeier CA, 2007, J THEOR BIOL, V246, P278, DOI 10.1016/j.jtbi.2006.12.032; Knops JMH, 2000, ECOSCIENCE, V7, P166, DOI 10.1080/11956860.2000.11682585; Lambers H., 2008, PLANT PHYSL ECOLOGY; Likens G. E., 1995, BIOGEOCHEMISTRY FORE; LUDWIG D, 1978, J ANIM ECOL, V47, P315, DOI 10.2307/3939; Manzoni S, 2004, NONLINEAR PROC GEOPH, V11, P589, DOI 10.5194/npg-11-589-2004; McGroddy ME, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003005; McMurtrie RE, 1996, GLOBAL CHANGE BIOL, V2, P49, DOI 10.1111/j.1365-2486.1996.tb00048.x; Menge DNL, 2008, P NATL ACAD SCI USA, V105, P1573, DOI 10.1073/pnas.0711411105; Menge DNL, 2007, GLOBAL CHANGE BIOL, V13, P2582, DOI 10.1111/j.1365-2486.2007.01456.x; Menge DNL, 2011, ECOSYSTEMS, V14, P519, DOI 10.1007/s10021-011-9426-x; Menge DNL, 2011, THEOR ECOL-NETH, V4, P163, DOI 10.1007/s12080-010-0110-0; Menge DNL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012056; Menge DNL, 2009, AM NAT, V174, P465, DOI 10.1086/605377; Menge DNL, 2009, ECOLOGY, V90, P2190, DOI 10.1890/08-0877.1; Menge DNL, 2009, J THEOR BIOL, V257, P104, DOI 10.1016/j.jtbi.2008.10.032; Menge DNL, 2009, AM NAT, V173, P164, DOI 10.1086/595749; Nasholm T, 1998, NATURE, V392, P914, DOI 10.1038/31921; Okin GS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002145; Padilla DK, 1996, EVOL ECOL, V10, P105, DOI 10.1007/BF01239351; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Pearson HL, 2002, ECOSYSTEMS, V5, P587, DOI 10.1007/s10021-002-0172-y; Pearson HL, 2001, ECOL APPL, V11, P1381, DOI 10.2307/3060927; Peltzer DA, 2010, ECOL MONOGR, V80, P509, DOI 10.1890/09-1552.1; Perakis SS, 2002, NATURE, V415, P416, DOI 10.1038/415416a; Perakis SS, 2005, ECOLOGY, V86, P96, DOI 10.1890/04-0415; Perakis SS, 2001, ECOLOGY, V82, P2245, DOI 10.1890/0012-9658(2001)082[2245:FAFONI]2.0.CO;2; Porder S, 2007, ECOSYSTEMS, V10, P158, DOI 10.1007/s10021-006-9011-x; Porder S, 2011, BIOGEOCHEMISTRY, V102, P153, DOI 10.1007/s10533-010-9428-3; Porporato A, 2003, ADV WATER RESOUR, V26, P45, DOI 10.1016/S0309-1708(02)00094-5; Providoli I, 2006, SOIL BIOL BIOCHEM, V38, P1645, DOI 10.1016/j.soilbio.2005.11.019; Rastetter EB, 2001, ECOSYSTEMS, V4, P369, DOI 10.1007/s10021-001-0018-z; RASTETTER EB, 1992, ECOLOGY, V73, P1157, DOI 10.2307/1940666; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; REYNOLDS HL, 1993, AM NAT, V141, P51, DOI 10.1086/285460; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; RITCHIE ME, 1995, ECOLOGY, V76, P2648, DOI 10.2307/2265835; Ruess RW, 2009, ECOSYSTEMS, V12, P489, DOI 10.1007/s10021-009-9237-5; Runyan CW, 2012, ADV WATER RESOUR, V35, P94, DOI 10.1016/j.advwatres.2011.10.004; SCHIMEL JP, 1989, SOIL BIOL BIOCHEM, V21, P1059, DOI 10.1016/0038-0717(89)90044-8; Selmants PC, 2010, ECOLOGY, V91, P474, DOI 10.1890/09-0243.1; Selmants PC, 2008, GLOBAL BIOGEOCHEMICA, V22, P13; Smil V, 2000, ANNU REV ENERG ENV, V25, P53, DOI 10.1146/annurev.energy.25.1.53; Stevens P. R, 1968, CHRONOSEQUENCE SOILS; SWAP R, 1992, TELLUS B, V44, P133, DOI 10.1034/j.1600-0889.1992.t01-1-00005.x; Tilman D., 1982, Monographs in Population Biology, pi; Treseder KK, 2001, ECOLOGY, V82, P946, DOI 10.1890/0012-9658(2001)082[0946:EOSNAO]2.0.CO;2; Turner BL, 2007, ECOSYSTEMS, V10, P1166, DOI 10.1007/s10021-007-9086-z; Uliassi DD, 2002, ECOLOGY, V83, P88, DOI 10.1890/0012-9658(2002)083[0088:LTSNFI]2.0.CO;2; van den Berg HA, 2002, J MATH BIOL, V44, P276, DOI 10.1007/s002850100123; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; Vitousek, 2004, NUTR CYCLING LIMITAT; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Vitousek PM, 1998, SUCCESSES, LIMITATIONS, AND FRONTIERS IN ECOSYSTEM SCIENCE, P432; VITOUSEK PM, 1993, BIOGEOCHEMISTRY, V23, P197, DOI 10.1007/BF00023752; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; Vitousek PM, 1999, BIOGEOCHEMISTRY, V46, P179, DOI 10.1007/BF01007579; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; von Liebig J, 1840, ORGANIC CHEM ITS APP; Walker L.R., 2003, PRIMARY SUCCESSION E, DOI 10.1017/cbo9780511615078; Walker L. R., 1993, PRIMARY SUCCESSION L, P249; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; ZAK DR, 1990, ECOLOGY, V71, P651, DOI 10.2307/1940319	103	84	90	0	206	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42045	10.1371/journal.pone.0042045	http://dx.doi.org/10.1371/journal.pone.0042045			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870281	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100043
J	Ward, SE; Kim, HS; Komurov, K; Mendiratta, S; Tsai, PL; Schmolke, M; Satterly, N; Manicassamy, B; Forst, CV; Roth, MG; Garcia-Sastre, A; Blazewska, KM; McKenna, CE; Fontoura, BM; White, MA				Ward, Samuel E.; Kim, Hyun Seok; Komurov, Kakajan; Mendiratta, Saurabh; Tsai, Pei-Ling; Schmolke, Mirco; Satterly, Neal; Manicassamy, Balaji; Forst, Christian V.; Roth, Michael G.; Garcia-Sastre, Adolfo; Blazewska, Katarzyna M.; McKenna, Charles E.; Fontoura, Beatriz M.; White, Michael A.			Host Modulators of H1N1 Cytopathogenicity	PLOS ONE			English	Article							NS1 PROTEIN; VIRUS; IDENTIFICATION; CONTRIBUTES; INHIBITION; ACTIVATION; RESISTANCE; INDUCTION; INFECTION; COMPLEX	Influenza A virus infects 5-20% of the population annually, resulting in similar to 35,000 deaths and significant morbidity. Current treatments include vaccines and drugs that target viral proteins. However, both of these approaches have limitations, as vaccines require yearly development and the rapid evolution of viral proteins gives rise to drug resistance. In consequence additional intervention strategies, that target host factors required for the viral life cycle, are under investigation. Here we employed arrayed whole-genome siRNA screening strategies to identify cell-autonomous molecular components that are subverted to support H1N1 influenza A virus infection of human bronchial epithelial cells. Integration across relevant public data sets exposed druggable gene products required for epithelial cell infection or required for viral proteins to deflect host cell suicide checkpoint activation. Pharmacological inhibition of representative targets, RGGT and CHEK1, resulted in significant protection against infection of human epithelial cells by the A/WS/33 virus. In addition, chemical inhibition of RGGT partially protected against H5N1 and the 2009 H1N1 pandemic strain. The observations reported here thus contribute to an expanding body of studies directed at decoding vulnerabilities in the command and control networks specified by influenza virulence factors.	[Ward, Samuel E.; Kim, Hyun Seok; Mendiratta, Saurabh; Tsai, Pei-Ling; Satterly, Neal; Fontoura, Beatriz M.; White, Michael A.] Univ Texas SW Med Sch, Dept Cell Biol, Dallas, TX 75390 USA; [Komurov, Kakajan] Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol, Cincinnati, OH USA; [Komurov, Kakajan] Cincinnati Childrens Hosp, Med Ctr, Div Canc Biol Human Genet & Biomed Informat, Cincinnati, OH USA; [Schmolke, Mirco; Manicassamy, Balaji; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Forst, Christian V.] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Roth, Michael G.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA; [Blazewska, Katarzyna M.] Tech Univ Lodz, Inst Organ Chem, PL-90924 Lodz, Poland; [Blazewska, Katarzyna M.; McKenna, Charles E.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Lodz University of Technology; University of Southern California	Ward, SE (corresponding author), Univ Texas SW Med Sch, Dept Cell Biol, Dallas, TX 75390 USA.	Michael.White@utsouthwestern.edu	Schmolke, Mirco/AAI-9081-2020; Błażewska, Katarzyna/M-3722-2018	Schmolke, Mirco/0000-0002-2491-3029; Błażewska, Katarzyna/0000-0002-1218-7111; Roth, Michael/0000-0002-9056-332X; Manicassamy, Balaji/0000-0003-1964-0967; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Forst, Christian/0000-0003-0229-9459	National Institutes of Health [AI083614, CA071443, CA129451, HHSN266200700010C, AI095320]; Robert Welch Foundation [I-1414]; NATIONAL CANCER INSTITUTE [P30CA142543, R01CA071443, R01CA129451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089539, R00AI095320, R21AI083614, R01AI079110, K99AI095320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (AI083614, CA071443, CA129451, HHSN266200700010C and AI095320) and the Robert Welch Foundation (I-1414, www.welch1.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Baron RA, 2009, J BIOL CHEM, V284, P6861, DOI 10.1074/jbc.M806952200; Blazewska KM, 2011, CHEM COMMUN, V47, P6395, DOI 10.1039/c1cc10876j; Bortz E, 2011, MBIO, V2, DOI 10.1128/mBio.00151-11; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Haye K, 2009, J VIROL, V83, P6849, DOI 10.1128/JVI.02323-08; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Jackson JR, 2000, CANCER RES, V60, P566; Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Knipe DM, 2001, FIELDS VIROLOGY, V1, P1487; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Komurov K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000889; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; Mata MA, 2011, NAT CHEM BIOL, V7, P712, DOI [10.1038/NCHEMBIO.645, 10.1038/nchembio.645]; McKenna CE, 2010, J MED CHEM, V53, P3454, DOI 10.1021/jm900232u; Meunier I, 2011, J GEN VIROL, V92, P1635, DOI 10.1099/vir.0.032193-0; Micillo E, 2000, ALLERGY, V55, P42; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Solorzano A, 2005, J VIROL, V79, P7535, DOI 10.1128/JVI.79.12.7535-7543.2005; Sui BQ, 2009, VIROLOGY, V387, P473, DOI 10.1016/j.virol.2009.02.046; Tisoncik JR, 2011, J GEN VIROL, V92, P2093, DOI 10.1099/vir.0.032060-0; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; Vaughan MB, 2006, DIFFERENTIATION, V74, P141, DOI 10.1111/j.1432-0436.2006.00069.x; Vreede FT, 2010, VIRULENCE, V1, P436, DOI 10.4161/viru.1.5.12967; Wang XD, 2010, BIOCHEM BIOPH RES CO, V395, P141, DOI 10.1016/j.bbrc.2010.03.160; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zhao B, 2002, J BIOL CHEM, V277, P46609, DOI 10.1074/jbc.M201233200; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	41	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e39284	10.1371/journal.pone.0039284	http://dx.doi.org/10.1371/journal.pone.0039284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876275	Green Submitted, Green Published, gold			2022-12-27	WOS:000307184700003
J	Blanchette, C; Lacayo, CI; Fischer, NO; Hwang, M; Thelen, MP				Blanchette, Craig; Lacayo, Catherine I.; Fischer, Nicholas O.; Hwang, Mona; Thelen, Michael P.			Enhanced Cellulose Degradation Using Cellulase-Nanosphere Complexes	PLOS ONE			English	Article							TRACHEARY ELEMENTS; CELL; LIGNIN; BINDING; HYDROLYSIS; CULTURES; ENZYMES	Enzyme catalyzed conversion of plant biomass to sugars is an inherently inefficient process, and one of the major factors limiting economical biofuel production. This is due to the physical barrier presented by polymers in plant cell walls, including semi-crystalline cellulose, to soluble enzyme accessibility. In contrast to the enzymes currently used in industry, bacterial cellulosomes organize cellulases and other proteins in a scaffold structure, and are highly efficient in degrading cellulose. To mimic this clustered assembly of enzymes, we conjugated cellulase obtained from Trichoderma viride to polystyrene nanospheres (cellulase: NS) and tested the hydrolytic activity of this complex on cellulose substrates from purified and natural sources. Cellulase: NS and free cellulase were equally active on soluble carboxymethyl cellulose (CMC); however, the complexed enzyme displayed a higher affinity in its action on microcrystalline cellulose. Similarly, we found that the cellulase: NS complex was more efficient in degrading natural cellulose structures in the thickened walls of cultured wood cells. These results suggest that nanoparticle-bound enzymes can improve catalytic efficiency on physically intractable substrates. We discuss the potential for further enhancement of cellulose degradation by physically clustering combinations of different glycosyl hydrolase enzymes, and applications for using cellulase: NS complexes in biofuel production.	[Blanchette, Craig; Lacayo, Catherine I.; Fischer, Nicholas O.; Hwang, Mona; Thelen, Michael P.] Lawrence Livermore Natl Lab, Phys & Life Sci, Livermore, CA 94550 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Blanchette, C (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci, Livermore, CA 94550 USA.	blanchette2@llnl.gov; mthelen@llnl.gov	Thelen, Michael/C-6834-2008; Fischer, Nicholas/AAE-2409-2019; Thelen, Michael P/G-2032-2014	Thelen, Michael/0000-0002-2479-5480; Fischer, Nicholas/0000-0001-7575-4390; Thelen, Michael P/0000-0002-2479-5480	Department of Energy/Basic Energy Research BR [KP1601010]	Department of Energy/Basic Energy Research BR(United States Department of Energy (DOE))	This work was supported by Department of Energy/Basic Energy Research B&R#: KP1601010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benova-Kakosova A, 2006, PLANT PHYSIOL, V142, P696, DOI 10.1104/pp.106.085712; Blanchette CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006056; Bommarius AS, 2008, METAB ENG, V10, P370, DOI 10.1016/j.ymben.2008.06.008; Bowman MC, 2008, J AM CHEM SOC, V130, P6896, DOI 10.1021/ja710321g; BREUIL C, 1985, ENZYME MICROB TECH, V7, P327, DOI 10.1016/0141-0229(85)90111-5; Carlson CB, 2007, ACS CHEM BIOL, V2, P119, DOI 10.1021/cb6003788; Cha J, 2007, J MICROBIOL BIOTECHN, V17, P1782; Cha T, 2005, PROTEOMICS, V5, P416, DOI 10.1002/pmic.200400948; Dashtban M, 2010, CRIT REV BIOTECHNOL, V30, P302, DOI 10.3109/07388551.2010.490938; Dincer A, 2007, J MOL CATAL B-ENZYM, V45, P10, DOI 10.1016/j.molcatb.2006.10.005; Ding SY, 2008, CURR OPIN BIOTECH, V19, P218, DOI 10.1016/j.copbio.2008.04.008; Ding SY, 2006, BIOTECHNIQUES, V41, P435, DOI 10.2144/000112244; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Fierobe HP, 2001, J BIOL CHEM, V276, P21257, DOI 10.1074/jbc.M102082200; Grabber JH, 2005, CROP SCI, V45, P820, DOI 10.2135/cropsci2004.0191; Imai M, 2004, BIOCHEM ENG J, V17, P79, DOI 10.1016/S1369-703X(03)00141-4; Jordan J, 2011, J MOL CATAL B-ENZYM, V68, P139, DOI 10.1016/j.molcatb.2010.09.010; Kiessling LL, 2000, CURR OPIN CHEM BIOL, V4, P696, DOI 10.1016/S1367-5931(00)00153-8; Kumar L, 2012, BIORESOURCE TECHNOL, V103, P201, DOI 10.1016/j.biortech.2011.09.091; Lacayo CI, 2010, PLANT PHYSIOL, V154, P121, DOI 10.1104/pp.110.155242; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; LAMED R, 1983, ISRAEL J MED SCI, V19, P674; LEAVITT SW, 1993, ANAL CHEM, V65, P87, DOI 10.1021/ac00049a017; Liu J, 2006, BIOCHEM ENG J, V30, P82, DOI 10.1016/j.bej.2006.02.005; Milioni D, 2001, PLANT MOL BIOL, V47, P221, DOI 10.1023/A:1010647902487; Montet X, 2006, J MED CHEM, V49, P6087, DOI 10.1021/jm060515m; Mortell KH, 1996, J AM CHEM SOC, V118, P2297, DOI 10.1021/ja953574q; Oda Y, 2012, CURR OPIN PLANT BIOL, V15, P38, DOI 10.1016/j.pbi.2011.10.005; ROBERTS AW, 1994, PLANT PHYSIOL, V105, P699, DOI 10.1104/pp.105.2.699; Tassa C, 2010, BIOCONJUGATE CHEM, V21, P14, DOI 10.1021/bc900438a; TAYLOR JG, 1992, PLANT J, V2, P959, DOI 10.1111/j.1365-313X.1992.00959.x; Yoshida M, 2008, BIOSCI BIOTECH BIOCH, V72, P805, DOI 10.1271/bbb.70689	33	29	33	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42116	10.1371/journal.pone.0042116	http://dx.doi.org/10.1371/journal.pone.0042116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870287	Green Published, Green Submitted, gold			2022-12-27	WOS:000307212800060
J	Burgess, A; Huang, YX; Waspe, AC; Ganguly, M; Goertz, DE; Hynynen, K				Burgess, Alison; Huang, Yuexi; Waspe, Adam C.; Ganguly, Milan; Goertz, David E.; Hynynen, Kullervo			High-Intensity Focused Ultrasound (HIFU) for Dissolution of Clots in a Rabbit Model of Embolic Stroke	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; ACUTE ISCHEMIC-STROKE; BLOOD-BRAIN-BARRIER; IN-VITRO; PHASED-ARRAY; THROMBOLYSIS; SURGERY; SONOTHROMBOLYSIS; DISRUPTION; THERAPY	It is estimated that only 2-6% of patients receive thrombolytic therapy for acute ischemic stroke suggesting that alternative therapies are necessary. In this study, we investigate the potential for high intensity focused ultrasound (HIFU) to initiate thrombolysis in an embolic model of stroke. Iron-loaded blood clots were injected into the middle cerebral artery (MCA) of New Zealand White rabbits, through the internal carotid artery and blockages were confirmed by angiography. MRI was used to localize the iron-loaded clot and target the HIFU beam for treatment. HIFU pulses (1.5 MHz, 1 ms bursts, 1 Hz pulse repetition frequency, 20 s duration) were applied to initiate thrombolysis. Repeat angiograms and histology were used to assess reperfusion and vessel damage. Using 275 W of acoustic power, there was no evidence of reperfusion in post-treatment angiograms of 3 rabbits tested. In a separate group of animals, 415 W of acoustic power was applied and reperfusion was observed in 2 of the 4 (50%) animals treated. In the last group of animals, acoustic power was further increased to 550 W, which led to the reperfusion in 5 of 7 (similar to 70%) animals tested. Histological analysis confirmed thatthe sonicated vessels remained intact after HIFU treatment. Hemorrhage was detected outside of the sonication site, likely due to the proximity of the target vessel with the base of the rabbit skull. These results demonstrate the feasibility of using HIFU, as a stand-alone method, to cause effective thrombolysis without immediate damage to the targeted vessels. HIFU, combined with imaging modalities used to identify and assess stroke patients, could dramatically reduce the time to achieve flow restoration in patients thereby significantly increasing the number of patients which benefit from thrombolysis treatments.	[Burgess, Alison; Huang, Yuexi; Waspe, Adam C.; Ganguly, Milan; Goertz, David E.; Hynynen, Kullervo] Sunnybrook Res Inst, Toronto, ON, Canada; [Waspe, Adam C.; Goertz, David E.; Hynynen, Kullervo] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Burgess, A (corresponding author), Sunnybrook Res Inst, Toronto, ON, Canada.	aburgess@sri.utoronto.ca			National Institute of Health [R01 EB009032]; Heart and Stroke Foundation of Canada; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009032] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by the National Institute of Health grant # R01 EB009032 (Kullervo Hynynen). Alison Burgess was partially funded by a fellowship awarded by the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alexandrov AV, 2008, STROKE, V39, P1464, DOI 10.1161/STROKEAHA.107.505727; Alexandrov AV, 2004, NEW ENGL J MED, V351, P2170, DOI 10.1056/NEJMoa041175; Barber PA, 2001, NEUROLOGY, V56, P1015, DOI 10.1212/WNL.56.8.1015; Baron C, 2009, ULTRASOUND MED BIOL, V35, P1148, DOI 10.1016/j.ultrasmedbio.2008.11.014; BLINC A, 1993, BLOOD, V81, P2636; Brown AT, 2011, INVEST RADIOL, V46, P202, DOI 10.1097/RLI.0b013e318200757a; Chopra R, 2009, MED PHYS, V36, P1867, DOI 10.1118/1.3115680; Clement GT, 2005, J ULTRAS MED, V24, P1117, DOI 10.7863/jum.2005.24.8.1117; Connor CW, 2004, IEEE T BIO-MED ENG, V51, P1693, DOI 10.1109/TBME.2004.831516; Culp BC, 2007, J VASC INTERV RADIOL, V18, P187, DOI 10.1016/j.jvir.2006.12.720; Daffertshofer M, 2005, STROKE, V36, P1441, DOI 10.1161/01.STR.0000170707.86793.1a; Datta S, 2008, ULTRASOUND MED BIOL, V34, P1421, DOI 10.1016/j.ultrasmedbio.2008.01.016; Datta S, 2006, ULTRASOUND MED BIOL, V32, P1257, DOI 10.1016/j.ultrasmedbio.2006.04.008; Duck F.A., 1990, MED PHYS, V18; Elias JW, 2011, C NEUR SURG 2011 ANN; Fagan SC, 1998, EXP NEUROL, V150, P153, DOI 10.1006/exnr.1997.6756; Flores R, 2011, INVEST RADIOL, V46, P419, DOI 10.1097/RLI.0b013e31820e143a; FRANCIS CW, 1995, ULTRASOUND MED BIOL, V21, P419, DOI 10.1016/0301-5629(94)00119-X; Holscher T, 2011, J NEUROL NEUROPHYS S, pS1; Hynynen K, 2004, MAGN RESON MED, V52, P100, DOI 10.1002/mrm.20118; Hynynen K, 1997, RADIOLOGY, V204, P247, DOI 10.1148/radiology.204.1.9205255; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Lapchak PA, 2008, STROKE, V39, P3073, DOI 10.1161/STROKEAHA.108.516393; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Martin E, 2009, ANN NEUROL, V66, P858, DOI 10.1002/ana.21801; Maxwell AD, 2011, J VASC INTERV RADIOL, V22, P369, DOI 10.1016/j.jvir.2010.10.007; Maxwell AD, 2009, ULTRASOUND MED BIOL, V35, P1982, DOI 10.1016/j.ultrasmedbio.2009.07.001; McDannold N, 2005, ULTRASOUND MED BIOL, V31, P1527, DOI 10.1016/j.ultrasmedbio.2005.07.010; McDannold N, 2010, NEUROSURGERY, V66, P323, DOI 10.1227/01.NEU.0000360379.95800.2F; Molina CA, 2006, STROKE, V37, P425, DOI 10.1161/01.STR.0000199064.94588.39; O'Reilly MA, 2010, PHYS MED BIOL, V55, P5251, DOI 10.1088/0031-9155/55/18/001; OLERUD JE, 1987, J INVEST DERMATOL, V88, P615, DOI 10.1111/1523-1747.ep12470221; Rosenschein U, 2000, CIRCULATION, V102, P238, DOI 10.1161/01.CIR.102.2.238; Song JH, 2012, IEEE T BIO-MED ENG, V59, P435, DOI 10.1109/TBME.2011.2174057; Song JH, 2010, IEEE T BIO-MED ENG, V57, P124, DOI 10.1109/TBME.2009.2028739; Westermark S, 1999, CLIN SCI, V97, P67, DOI 10.1042/CS19980379; Wright C, 2012, INVEST RADIOL, V47, P217, DOI 10.1097/RLI.0b013e31823cc75c	37	65	69	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42311	10.1371/journal.pone.0042311	http://dx.doi.org/10.1371/journal.pone.0042311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870315	Green Submitted, gold, Green Published			2022-12-27	WOS:000307212800078
J	Hughes, AD; Brunner, L; Cook, EJ; Kelly, MS; Wilson, B				Hughes, Adam D.; Brunner, Lars; Cook, Elizabeth J.; Kelly, Maeve S.; Wilson, Ben			Echinoderms Display Morphological and Behavioural Phenotypic Plasticity in Response to Their Trophic Environment	PLOS ONE			English	Article							ECHINOID PSAMMECHINUS-MILIARIS; URCHIN PARACENTROTUS-LIVIDUS; KELP FOREST ECOSYSTEMS; SEA-URCHIN; RESOURCE-ALLOCATION; REPRODUCTIVE-CYCLE; COVERING BEHAVIOR; FOOD AVAILABILITY; FIELD CONDITIONS; GROWTH ZONES	The trophic interactions of sea urchins are known to be the agents of phase shifts in benthic marine habitats such as tropical and temperate reefs. In temperate reefs, the grazing activity of sea urchins has been responsible for the destruction of kelp forests and the formation of 'urchin barrens', a rocky habitat dominated by crustose algae and encrusting invertebrates. Once formed, these urchin barrens can persist for decades. Trophic plasticity in the sea urchin may contribute to the stability and resilience of this alternate stable state by increasing diet breadth in sea urchins. This plasticity promotes ecological connectivity and weakens species interactions and so increases ecosystem stability. We test the hypothesis that sea urchins exhibit trophic plasticity using an approach that controls for other typically confounding environmental and genetic factors. To do this, we exposed a genetically homogenous population of sea urchins to two very different trophic environments over a period of two years. The sea urchins exhibited a wide degree of phenotypic trophic plasticity when exposed to contrasting trophic environments. The two populations developed differences in their gross morphology and the test microstructure. In addition, when challenged with unfamiliar prey, the response of each group was different. We show that sea urchins exhibit significant morphological and behavioural phenotypic plasticity independent of their environment or their nutritional status.	[Hughes, Adam D.; Brunner, Lars; Cook, Elizabeth J.; Kelly, Maeve S.; Wilson, Ben] Scottish Assoc Marine Sci, Dept Ecol, Oban, Argyll, Scotland	UHI Millennium Institute	Hughes, AD (corresponding author), Scottish Assoc Marine Sci, Dept Ecol, Oban, Argyll, Scotland.	adam.hughes@sams.ac.uk	Hughes, Adam D/J-7867-2013; Hughes, Adam D/L-1088-2016	Cottier-Cook, Elizabeth/0000-0002-1466-6802; Wilson, Ben/0000-0002-1546-4962	Natural Environment Research Council, UK; NERC [dml010002] Funding Source: UKRI; Natural Environment Research Council [dml010002] Funding Source: researchfish	Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council (http://www.nerc.ac.uk/) UK, under the Oceans 2025 programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Allardyce BJ, 2010, J MORPHOL, V271, P61, DOI 10.1002/jmor.10781; Balch T, 2000, MAR ECOL PROG SER, V205, P139, DOI 10.3354/meps205139; Barnes DKA, 2001, MAR BIOL, V138, P1205, DOI 10.1007/s002270100543; BLACK R, 1982, MAR BIOL, V71, P101, DOI 10.1007/BF00396997; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; CHAPMAN ARO, 1981, MAR BIOL, V62, P307, DOI 10.1007/BF00397697; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Coll M, 2002, ANNU REV ENTOMOL, V47, P267, DOI 10.1146/annurev.ento.47.091201.145209; Crook AC, 1999, J MAR BIOL ASSOC UK, V79, P1117, DOI 10.1017/S002531549900137X; Crook AC, 2001, MAR ECOL-P S Z N I, V22, P231, DOI 10.1046/j.1439-0485.2001.01727.x; Crook AC, 2000, J MAR BIOL ASSOC UK, V80, P177, DOI 10.1017/S0025315499001721; Urriago JD, 2011, J EXP MAR BIOL ECOL, V399, P17, DOI 10.1016/j.jembe.2011.01.004; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Ebert TA, 1996, OCEANOL ACTA, V19, P347; Ebert TA, 2003, FISH B-NOAA, V101, P915; EBERT TA, 1980, B MAR SCI, V30, P467; EDWARDS PB, 1991, J EXP MAR BIOL ECOL, V145, P205, DOI 10.1016/0022-0981(91)90176-W; Estes JA, 2004, B MAR SCI, V74, P621; GAGE JD, 1991, MAR BIOL, V110, P217, DOI 10.1007/BF01313707; Gagnon P, 2003, J EXP MAR BIOL ECOL, V290, P179, DOI 10.1016/S0022-0981(03)00077-7; Guillou M, 2000, J EXP MAR BIOL ECOL, V245, P183, DOI 10.1016/S0022-0981(99)00162-8; Hagen NT, 2008, MAR BIOL, V153, P907, DOI 10.1007/s00227-007-0863-1; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Hernandez JC, 2010, J EXP BIOL, V213, P520, DOI 10.1242/jeb.029959; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hughes AD, 2006, MAR BIOL, V148, P789, DOI 10.1007/s00227-005-0124-0; Hughes AD, 2005, MAR ECOL PROG SER, V305, P101, DOI 10.3354/meps305101; Kelly M, 2007, DEV AQUACULTURE FISH, P287; Kelly MS, 2000, J MAR BIOL ASSOC UK, V80, P909, DOI 10.1017/S0025315400002897; LANG C, 1976, MAR BIOL, V36, P321, DOI 10.1007/BF00389193; Lawrence J.M., 1975, Oceanography mar Biol, V13, P213; Lessios HA, 2001, P ROY SOC B-BIOL SCI, V268, P2347, DOI 10.1098/rspb.2001.1806; LINDAHL PER ERIC, 1929, ACTA ZOOL [STOCKHOLM], V10, P401; Ling SD, 2009, MAR ECOL PROG SER, V374, P113, DOI 10.3354/meps07729; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McClanahan TR, 1999, ECOSYSTEMS, V2, P511, DOI 10.1007/s100219900099; Moore H. B., 1935, Journal of the Marine Biological Association Plymouth NS, V20, P109; Moya-Larano J, 2011, PHILOS T R SOC B, V366, P1425, DOI 10.1098/rstb.2010.0241; NORTH WJ, 1970, SCIENCE, V167, P209, DOI 10.1126/science.167.3915.209-a; Otero-Villanueva MDM, 2006, J MAR BIOL ASSOC UK, V86, P773, DOI 10.1017/S0025315406013695; PEARSE JS, 1975, AM ZOOL, V15, P731; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Russell MP, 1998, J EXP MAR BIOL ECOL, V220, P1, DOI 10.1016/S0022-0981(97)00079-8; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Selden R, 2009, MAR BIOL, V156, P1057, DOI 10.1007/s00227-009-1150-0; Sivertsen K, 2006, J APPL PHYCOL, V18, P599, DOI 10.1007/s10811-006-9064-4; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Verling E, 2002, MAR BIOL, V140, P391, DOI 10.1007/s002270100689	50	17	17	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41243	10.1371/journal.pone.0041243	http://dx.doi.org/10.1371/journal.pone.0041243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870211	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800014
J	Jensen, H; Folkersen, L; Skov, S				Jensen, Helle; Folkersen, Lasse; Skov, Soren			Regulation and Gene Expression Profiling of NKG2D Positive Human Cytomegalovirus-Primed CD4(+) T-Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; RHEUMATOID-ARTHRITIS; INTRACELLULAR SEQUESTRATION; SURFACE EXPRESSION; FUNCTIONAL SUBSETS; EFFECTOR FUNCTIONS; GLYCOPROTEIN UL16; HUMAN CD94; FACTOR TOX; IFN-GAMMA	NKG2D is a stimulatory receptor expressed by natural killer (NK) cells, CD8(+) T-cells, and gamma delta T-cells. NKG2D expression is normally absent from CD4(+) T-cells, however recently a subset of NKG2D(+) CD4(+) T-cells has been found, which is specific for human cytomegalovirus (HCMV). This particular subset of HCMV-specific NKG2D(+) CD4(+) T-cells possesses effector-like functions, thus resembling the subsets of NKG2D(+) CD4(+) T-cells found in other chronic inflammations. However, the precise mechanism leading to NKG2D expression on HCMV-specific CD4(+) T-cells is currently not known. In this study we used genome-wide analysis of individual genes and gene set enrichment analysis (GSEA) to investigate the gene expression profile of NKG2D(+) CD4(+) T-cells, generated from HCMV-primed CD4(+) T-cells. We show that the HCMV-primed NKG2D(+) CD4(+) T-cells possess a higher differentiated phenotype than the NKG2D(-) CD4(+) T-cells, both at the gene expression profile and cytokine profile. The ability to express NKG2D at the cell surface was primarily determined by the activation or differentiation status of the CD4(+) T-cells and not by the antigen presenting cells. We observed a correlation between CD94 and NKG2D expression in the CD4(+) T-cells following HCMV stimulation. However, knock-down of CD94 did not affect NKG2D cell surface expression or signaling. In addition, we show that NKG2D is recycled at the cell surface of activated CD4(+) T-cells, whereas it is produced de novo in resting CD4(+) T-cells. These findings provide novel information about the gene expression profile of HCMV-primed NKG2D(+) CD4(+) T-cells, as well as the mechanisms regulating NKG2D cell surface expression.	[Jensen, Helle; Skov, Soren] Univ Copenhagen, Sect Biomed, Immunol Lab, Fac Life Sci, Copenhagen, Denmark; [Folkersen, Lasse] Karolinska Inst, Atherosclerosis Res Unit, Dept Med, Stockholm, Sweden	University of Copenhagen; Karolinska Institutet	Jensen, H (corresponding author), Univ Copenhagen, Sect Biomed, Immunol Lab, Fac Life Sci, Copenhagen, Denmark.	hellejensen@fastmail.fm; sosk@life.ku.dk		Skov, Soren/0000-0003-0732-0026; Folkersen, Lasse/0000-0003-0708-9530	Gigtforeningen; Mogens Svarre Mogensens Fond; Frimodt-Heineke Fonden; Ekspeditionssekretaer cand.jur. Torkil Steenbecks legat; Augustinus Fonden; Grosserer LF Foghts Fond; Oldermand, slagtermester Peter Ryholts Legat; Grosserer Valdemar Foersom og hustru Thyra Foersom, fodt Ottos Fond; Direktor Jacob Madsen og hustru Olga Madsens Fond; Beckett-Fonden	Gigtforeningen; Mogens Svarre Mogensens Fond; Frimodt-Heineke Fonden; Ekspeditionssekretaer cand.jur. Torkil Steenbecks legat; Augustinus Fonden; Grosserer LF Foghts Fond; Oldermand, slagtermester Peter Ryholts Legat; Grosserer Valdemar Foersom og hustru Thyra Foersom, fodt Ottos Fond; Direktor Jacob Madsen og hustru Olga Madsens Fond; Beckett-Fonden	This study was supported by: Gigtforeningen; Mogens Svarre Mogensens Fond; Frimodt-Heineke Fonden; Ekspeditionssekretaer cand.jur. Torkil Steenbecks legat; Augustinus Fonden; Grosserer LF Foghts Fond; Oldermand, slagtermester Peter Ryholts Legat; Grosserer Valdemar Foersom og hustru Thyra Foersom, fodt Ottos Fond; Direktor Jacob Madsen og hustru Olga Madsens Fond and Beckett-Fonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Allez M, 2007, GASTROENTEROLOGY, V132, P2346, DOI 10.1053/j.gastro.2007.03.025; Andresen L, 2007, J IMMUNOL, V179, P8235, DOI 10.4049/jimmunol.179.12.8235; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; ARAMBURU J, 1991, J IMMUNOL, V147, P714; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashiru O, 2009, J VIROL, V83, P12345, DOI 10.1128/JVI.01175-09; Bangs SC, 2009, J IMMUNOL, V182, P1962, DOI 10.4049/jimmunol.0802596; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bennett NJ, 2010, J IMMUNOL, V185, P1093, DOI 10.4049/jimmunol.1000789; Capraru D, 2008, CLIN IMMUNOL, V127, P144, DOI 10.1016/j.clim.2007.12.004; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; CHANG CW, 1995, EUR J IMMUNOL, V25, P2433, DOI 10.1002/eji.1830250904; Chen HW, 2006, CLIN IMMUNOL, V119, P21, DOI 10.1016/j.clim.2005.11.003; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Dai ZP, 2009, J EXP MED, V206, P793, DOI 10.1084/jem.20081648; Das H, 2001, IMMUNITY, V15, P83, DOI 10.1016/S1074-7613(01)00168-6; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; Eagle RA, 2009, EUR J IMMUNOL, V39, P3207, DOI 10.1002/eji.200939502; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisele G, 2006, BRAIN, V129, P2416, DOI 10.1093/brain/awl205; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Kaneko K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3475; Kobayashi T, 2007, INFLAMM BOWEL DIS, V13, P837, DOI 10.1002/ibd.20113; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lieto LD, 2003, J IMMUNOL, V171, P5277, DOI 10.4049/jimmunol.171.10.5277; LIPPINCOTTSCHWARTZ J, 1991, J CELL BIOL, V112, P567, DOI 10.1083/jcb.112.4.567; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Meyers JH, 2002, J IMMUNOL, V169, P5382, DOI 10.4049/jimmunol.169.10.5382; Nachmani D, 2010, NAT IMMUNOL, V11, P806, DOI 10.1038/ni.1916; Namekawa T, 1998, ARTHRITIS RHEUM, V41, P2108; Nanki T, 2002, ARTHRITIS RHEUM, V46, P2878, DOI 10.1002/art.10622; Ogawa K, 2001, J IMMUNOL, V166, P6404, DOI 10.4049/jimmunol.166.10.6404; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Pena SV, 1997, J IMMUNOL, V158, P2680; Pingiotti E, 2007, ANN NY ACAD SCI, V1107, P32, DOI 10.1196/annals.1381.004; Reddehase MJ, 2002, NAT REV IMMUNOL, V2, P831, DOI 10.1038/nri932; Roda-Navarro P, 2009, J BIOL CHEM, V284, P16463, DOI 10.1074/jbc.M808561200; Saez-Borderias A, 2006, EUR J IMMUNOL, V36, P3198, DOI 10.1002/eji.200636682; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2000, CURR TOP MICROBIOL, V251, P167; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Spies T, 2008, NAT IMMUNOL, V9, P1013, DOI 10.1038/ni0908-1013; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Vetter CS, 2004, BRIT J CANCER, V91, P1495, DOI 10.1038/sj.bjc.6602123; Yang D, 2009, MOL IMMUNOL, V46, P1432, DOI 10.1016/j.molimm.2008.12.010; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	54	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41577	10.1371/journal.pone.0041577	http://dx.doi.org/10.1371/journal.pone.0041577			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870231	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800025
J	Wang, H; Wu, YF; Ojcius, DM; Yang, XF; Zhang, CL; Ding, SBA; Lin, XA; Yan, J				Wang, Huan; Wu, Yifei; Ojcius, David M.; Yang, X. Frank; Zhang, Chenglin; Ding, Shibiao; Lin, Xu'ai; Yan, Jie			Leptospiral Hemolysins Induce Proinflammatory Cytokines through Toll-Like Receptor 2-and 4-Mediated JNK and NF-kappa B Signaling Pathways	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INTERROGANS SEROVAR ICTEROHAEMORRHAGIAE; ESCHERICHIA-COLI; LISTERIA-SEELIGERI; GAMMA-INTERFERON; GENE-EXPRESSION; ALPHA-HEMOLYSIN; CELL ACTIVATION; INNATE IMMUNITY; PROTEIN TOXIN	Background: Infection with pathogenic Leptospira species causes serious systemic inflammation in patients. Although a few leptospiral proinflammatory molecules have been identified, Leptospira likely encodes other unidentified strong inflammation stimulators. The pathogenic L. interrogans genome encodes numerous putative hemolysin genes. Since hemolysins from other bacteria can cause inflammatory reactions, we hypothesized that leptospiral hemolysins may function as proinflammatory stimulators that contribute to the strong inflammation associated with Leptospira infection. Methodology/Principal Findings: We first used cytokine protein microarrays for systematic analysis of serum cytokine profiles in leptospirosis patients and leptospire-infected mice. We found that IL-1 beta, IL-6 and TNF-alpha were the main proinflammatory cytokines in the sera of both the patients and the mice. We then analyzed eight putative hemolysins in L. interrogans strain Lai. The results showed that five of them, Sph1, Sph2, Sph3, HlpA and TlyA were secreted and had hemolytic activity. More importantly, these five hemolysins induced the strong production of IL-1 beta, IL-6 and TNF-alpha in human and mouse macrophages (although a bit lower in the latter). Furthermore, blockade of TLR2 or TLR4 with either antibodies or inhibitors of the NF-kappa B or JNK signaling pathways significantly reduced the production of hemolysin-induced IL-1 beta, IL-6 and TNF-alpha. Macrophages isolated from TLR2-, TLR4-or double TLR2-and 4-deficient mice also confirmed that the leptospiral hemolysins that induce proinflammatory cytokines are both TLR2-and TLR4-dependent. Conclusions/Significance: Our findings demonstrate that L. interrogans secretes many hemolysins that function as powerful inducers of proinflammatory cytokines through both TLR2-and TLR4-dependent JNK and NF-kappa B pathways.	[Wang, Huan; Wu, Yifei; Zhang, Chenglin; Ding, Shibiao; Lin, Xu'ai; Yan, Jie] Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Huan; Yan, Jie] Zhejiang Univ, Sch Med, State Key Lab Diag & Treatment Infect Dis, Div Basic Med Microbiol,Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Ojcius, David M.] Univ Calif, Hlth Sci Res Inst & Mol Cell Biol, Merced, CA USA; [Yang, X. Frank] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA	Zhejiang University; Zhejiang University; University of California System; University of California Merced; Indiana University System; Indiana University Bloomington	Wang, H (corresponding author), Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou 310003, Zhejiang, Peoples R China.	lxai122@163.com; Med_bp@zju.edu.cn	Ojcius, David/ABE-6557-2020; Zhang, Cheng/GRS-8698-2022		National Natural Science Foundation of China [30970112]; National Key Lab for Diagnosis and Treatment of Infectious Diseases of China, the First Affiliated Hospital, Medical School of Zhejiang University [2010ZZ09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Lab for Diagnosis and Treatment of Infectious Diseases of China, the First Affiliated Hospital, Medical School of Zhejiang University	This work was supported by the National Natural Science Foundation of China (Grant No. 30970112, to JY), and the National Key Lab for Diagnosis and Treatment of Infectious Diseases of China, the First Affiliated Hospital, Medical School of Zhejiang University (Grant No. 2010ZZ09, to JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Arcidiacono D, 2008, CELL MICROBIOL, V10, P899, DOI 10.1111/j.1462-5822.2007.01092.x; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Braun JS, 1999, INFECT IMMUN, V67, P3750, DOI 10.1128/IAI.67.8.3750-3756.1999; Carrillo-Casas EM, 2008, CURR MICROBIOL, V56, P539, DOI 10.1007/s00284-008-9096-x; Carvalho E, 2010, CURR MICROBIOL, V60, P134, DOI 10.1007/s00284-009-9519-3; Carvalho E, 2009, FEBS LETT, V583, P1381, DOI 10.1016/j.febslet.2009.03.050; CERAMI A, 1992, CLIN IMMUNOL IMMUNOP, V62, pS3, DOI 10.1016/0090-1229(92)90035-M; Chassin C, 2009, J IMMUNOL, V183, P2669, DOI 10.4049/jimmunol.0900506; Cinco M, 1996, FEMS MICROBIOL LETT, V138, P211, DOI 10.1016/0378-1097(96)00109-7; de Fost M, 2003, CLIN DIAGN LAB IMMUN, V10, P332, DOI 10.1128/CDLI.10.2.332-335.2003; DeCoursey TE, 1996, J MEMBRANE BIOL, V152, P141, DOI 10.1007/s002329900093; Dellinger RP, 2003, CLIN INFECT DIS, V36, P1259, DOI 10.1086/374835; Dessing MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007993; Diament D, 2002, INFECT IMMUN, V70, P1677, DOI 10.1128/IAI.70.4.1677-1683.2002; Dong HY, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-223; Doran KS, 2002, J INFECT DIS, V185, P196, DOI 10.1086/338475; Dragneva Y, 2001, INFECT IMMUN, V69, P2630, DOI 10.1128/IAI.69.4.2630-2635.2001; ESTAVOYER JM, 1991, REV INFECT DIS, V13, P1245; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Gleason TG, 1998, INFECT IMMUN, V66, P4215; Gouaux E, 1997, PROTEIN SCI, V6, P2631; Hauka P, 2008, BIOCHEM BIOPH RES CO, V372, P948, DOI 10.1016/j.bbrc.2008.05.106; Hawiger J, 2001, IMMUNOL RES, V23, P99, DOI 10.1385/IR:23:2-3:099; Hunt S, 2010, ADV EXP MED BIOL, V677, P116; Ito Y, 2005, INT IMMUNOL, V17, P1597, DOI 10.1093/intimm/dxh341; Ito Y, 2003, INFECT IMMUN, V71, P234, DOI 10.1128/IAI.71.1.234-241.2003; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jin DD, 2009, INFECT IMMUN, V77, P799, DOI 10.1128/IAI.00914-08; Jongyota W, 2008, ASIAN PAC J ALLERGY, V26, P229; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kohda C, 2002, INFECT IMMUN, V70, P1334, DOI 10.1128/IAI.70.3.1334-1341.2002; Koizumi N, 2003, J MED MICROBIOL, V52, P585, DOI 10.1099/jmm.0.05148-0; KUSAMA H, 1983, J CLIN MICROBIOL, V17, P317, DOI 10.1128/JCM.17.2.317-322.1983; Lavelle EC, 2003, J IMMUNOL, V171, P2384, DOI 10.4049/jimmunol.171.5.2384; Lee SH, 2002, INFECT IMMUN, V70, P315, DOI 10.1128/IAI.70.1.315-322.2002; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Liao SM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-253; Lowanitchapat A, 2010, COMP IMMUNOL MICROB, V33, P423, DOI 10.1016/j.cimid.2009.05.001; Luo DJ, 2009, VACCINE, V28, P243, DOI 10.1016/j.vaccine.2009.09.089; Matsuda N, 2006, J PHARMACOL SCI, V101, P189, DOI 10.1254/jphs.CRJ06010X; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022; Nally JE, 2005, INFECT IMMUN, V73, P7014, DOI 10.1128/IAI.73.10.7014-7017.2005; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Pereira MM, 1998, EXP TOXICOL PATHOL, V50, P191, DOI 10.1016/S0940-2993(98)80083-3; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Porksakorn C, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/84318; Priya CG, 2008, INVEST OPHTH VIS SCI, V49, P5419, DOI 10.1167/iovs.08-2174; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Rose F, 2001, INFECT IMMUN, V69, P897, DOI 10.1128/IAI.69.2.897-905.2001; Ruckdeschel K, 1997, INFECT IMMUN, V65, P4813, DOI 10.1128/IAI.65.11.4813-4821.1997; Santos CS, 2010, J MED MICROBIOL, V59, P1101, DOI 10.1099/jmm.0.021089-0; Schreier S, 2009, BIOL RES, V42, P5, DOI [10.4067/S0716-97602009000100001, /S0716-97602009000100001]; Stassen M, 2003, INFECT IMMUN, V71, P6171, DOI 10.1128/IAI.71.11.6171-6177.2003; Sun AH, 2011, BIOMED ENVIRON SCI, V24, P291, DOI 10.3967/0895-3988.2011.03.013; Tajiki MH, 1996, CLIN INFECT DIS, V23, P1177, DOI 10.1093/clinids/23.5.1177; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taneike I, 2002, FEBS LETT, V524, P219, DOI 10.1016/S0014-5793(02)03027-2; Tsiotou AG, 2005, MED SCI MONITOR, V11, pRA76; Tsuchiya K, 2005, INFECT IMMUN, V73, P3869, DOI 10.1128/IAI.73.7.3869-3877.2005; Vernel-Pauillac F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000582; Viriyakosol S, 2006, INFECT IMMUN, V74, P887, DOI 10.1128/IAI.74.2.887-895.2006; Warren R, 2011, MICROB PATHOGENESIS, V50, P12, DOI 10.1016/j.micpath.2010.10.002; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Xue F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000857; Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119; Zhang CL, 2012, MICROBES INFECT, V14, P317, DOI 10.1016/j.micinf.2011.11.007; Zhang D, 2008, INNATE IMMUN-LONDON, V14, P99, DOI 10.1177/1753425907088244; Zhang L, 2012, MOL MICROBIOL, V83, P1006, DOI 10.1111/j.1365-2958.2012.07985.x; Zhang YX, 2008, BMB REP, V41, P119, DOI 10.5483/BMBRep.2008.41.2.119	75	44	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42266	10.1371/journal.pone.0042266	http://dx.doi.org/10.1371/journal.pone.0042266			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870312	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800075
J	Weingartner, A; Kemmer, G; Muller, FD; Zampieri, RA; dos Santos, MG; Schiller, J; Pomorski, TG				Weingaertner, Adrien; Kemmer, Gerdi; Mueller, Frederic D.; Zampieri, Ricardo Andrade; dos Santos, Marcos Gonzaga; Schiller, Juergen; Pomorski, Thomas Guenther			Leishmania Promastigotes Lack Phosphatidylserine but Bind Annexin V upon Permeabilization or Miltefosine Treatment	PLOS ONE			English	Article							MALDI-TOF MS; MASS-SPECTROMETRY; DONOVANI PROMASTIGOTES; TRYPANOSOMA-BRUCEI; APOPTOTIC MIMICRY; KENNEDY PATHWAY; BLOOD-STREAM; CELL-DEATH; PHOSPHOLIPIDS; ASYMMETRY	The protozoan parasite Leishmania is an intracellular pathogen infecting and replicating inside vertebrate host macrophages. A recent model suggests that promastigote and amastigote forms of the parasite mimic mammalian apoptotic cells by exposing phosphatidylserine (PS) at the cell surface to trigger their phagocytic uptake into host macrophages. PS presentation at the cell surface is typically analyzed using fluorescence-labeled annexin V. Here we show that Leishmania promastigotes can be stained by fluorescence-labeled annexin V upon permeabilization or miltefosine treatment. However, combined lipid analysis by thin-layer chromatography, mass spectrometry and 31 P nuclear magnetic resonance (NMR) spectroscopy revealed that Leishmania promastigotes lack any detectable amount of PS. Instead, we identified several other phospholipid classes such phosphatidic acid, phosphatidylethanolamine; phosphatidylglycerol and phosphatidylinositol as candidate lipids enabling annexin V staining.	[Weingaertner, Adrien] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany; [Kemmer, Gerdi; Pomorski, Thomas Guenther] Univ Copenhagen, Dept Plant Biol & Biotechnol, Copenhagen C, Denmark; [Mueller, Frederic D.] Humboldt Univ, Inst Chem, D-10099 Berlin, Germany; [Zampieri, Ricardo Andrade; dos Santos, Marcos Gonzaga] Univ Sao Paulo, Dept Fisiol, Inst Biociencias, Sao Paulo, Brazil; [Schiller, Juergen] Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany; [Weingaertner, Adrien] Helmholtz Ctr Infekt Res, Braunschweig, Germany	Humboldt University of Berlin; University of Copenhagen; Humboldt University of Berlin; Universidade de Sao Paulo; Leipzig University	Weingartner, A (corresponding author), Humboldt Univ, Inst Biol, D-10099 Berlin, Germany.	tgp@life.ku.dk	Pomorski, Thomas Günther/G-4804-2014; Santos, Marcos/E-1993-2013; Kemmer, Gerdi Christine/C-1691-2015; Zampieri, Ricardo/D-3706-2018	Pomorski, Thomas Günther/0000-0002-4889-0829; Kemmer, Gerdi Christine/0000-0002-4686-5531; 	FAZIT (AW); Research Training Group 1121 of the German Research Foundation; Carlsberg Foundation; "Center for Synthetic Biology" at Copenhagen University; UNIK research initiative of the Danish Ministry of Science, Technology and Innovation	FAZIT (AW); Research Training Group 1121 of the German Research Foundation; Carlsberg Foundation(Carlsberg Foundation); "Center for Synthetic Biology" at Copenhagen University; UNIK research initiative of the Danish Ministry of Science, Technology and Innovation	This work was supported by FAZIT (AW), Research Training Group 1121 of the German Research Foundation (AW, TGP), and the Carlsberg Foundation (TGP). TGP and GK gratefully acknowledge financial support from "Center for Synthetic Biology" at Copenhagen University funded by the UNIK research initiative of the Danish Ministry of Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzate JF, 2006, APOPTOSIS, V11, P161, DOI 10.1007/s10495-006-4570-z; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BUTIKOFER P, 1990, J BIOL CHEM, V265, P16035; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Eibisch M, 2011, RAPID COMMUN MASS SP, V25, P2619, DOI 10.1002/rcm.5161; Emoto K, 1997, EXP CELL RES, V232, P430, DOI 10.1006/excr.1997.3521; ESKO JD, 1983, J BIOL CHEM, V258, P3051; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Fuchs B, 2008, ANAL BIOANAL CHEM, V392, P849, DOI 10.1007/s00216-008-2301-8; Fuchs B, 2011, PROG LIPID RES, V50, P132, DOI 10.1016/j.plipres.2010.10.001; Gellermann GP, 2006, BIOL CHEM, V387, P1267, DOI 10.1515/BC.2006.157; Gibellini F, 2009, MOL MICROBIOL, V73, P826, DOI 10.1111/j.1365-2958.2009.06764.x; Hein EM, 2010, RAPID COMMUN MASS SP, V24, P2083, DOI 10.1002/rcm.4614; Hein EM, 2009, RAPID COMMUN MASS SP, V23, P1636, DOI 10.1002/rcm.4042; Henriques C, 2003, PARASITOL RES, V89, P123, DOI 10.1007/s00436-002-0728-y; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P1591, DOI 10.1016/j.jasms.2007.05.017; Imbert L, 2012, ANAL BIOANAL CHEM, V402, P1169, DOI 10.1007/s00216-011-5520-3; Jimenez-Ruiz A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-104; Khademvatan S, 2011, KOREAN J PARASITOL, V49, P17, DOI 10.3347/kjp.2011.49.1.17; Wanderley JLM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005733; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Murphy R. C, 2002, MASS SPECTROMETRY PH; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Petkovic M, 2001, ANALYST, V126, P1042, DOI 10.1039/b101921j; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Rakotomanga M, 2007, ANTIMICROB AGENTS CH, V51, P1425, DOI 10.1128/AAC.01123-06; Richmond GS, 2010, PARASITOLOGY, V137, P1357, DOI 10.1017/S0031182010000715; Rohlfing A, 2007, ANAL CHEM, V79, P5793, DOI 10.1021/ac070633x; Schiller J, 1999, ANAL BIOCHEM, V267, P46, DOI 10.1006/abio.1998.3001; Schiller J, 2007, CURR ANAL CHEM, V3, P283, DOI 10.2174/157341107782109635; Schiller J, 2007, EUR BIOPHYS J BIOPHY, V36, P517, DOI 10.1007/s00249-006-0090-6; Schiller J, 2007, FRONT BIOSCI-LANDMRK, V12, P2568, DOI 10.2741/2255; Shi J, 2008, J THROMB HAEMOST, V6, P1167, DOI 10.1111/j.1538-7836.2008.03010.x; Signorell A, 2008, J BIOL CHEM, V283, P23636, DOI 10.1074/jbc.M803600200; Singh N, 2009, PARASITOL RES, V105, P1317, DOI 10.1007/s00436-009-1557-z; Sun G, 2008, ANAL CHEM, V80, P7576, DOI 10.1021/ac801200w; Tepper AD, 2000, J CELL BIOL, V150, P155, DOI 10.1083/jcb.150.1.155; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Wanderley JLM, 2005, BRAZ J MED BIOL RES, V38, P807, DOI 10.1590/S0100-879X2005000600001; WASSEF MK, 1985, LIPIDS, V20, P108, DOI 10.1007/BF02534216; Weingartner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012443; Williamson P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000729; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Yoneyama KAG, 2006, J LIPID RES, V47, P2171, DOI 10.1194/jlr.M600285-JLR200; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zhang K, 2003, EMBO J, V22, P6016, DOI 10.1093/emboj/cdg584; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565; Zhang K, 2010, MOL BIOCHEM PARASIT, V170, P55, DOI 10.1016/j.molbiopara.2009.12.004; Zheng LA, 2010, RAPID COMMUN MASS SP, V24, P2074, DOI 10.1002/rcm.4618; Zufferey R, 2003, J BIOL CHEM, V278, P44708, DOI 10.1074/jbc.M308063200	55	60	60	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42070	10.1371/journal.pone.0042070	http://dx.doi.org/10.1371/journal.pone.0042070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870283	Green Published, Green Submitted, gold			2022-12-27	WOS:000307212800056
J	Currier, RB; Calvete, JJ; Sanz, L; Harrison, RA; Rowley, PD; Wagstaff, SC				Currier, Rachel B.; Calvete, Juan J.; Sanz, Libia; Harrison, Robert A.; Rowley, Paul D.; Wagstaff, Simon C.			Unusual Stability of Messenger RNA in Snake Venom Reveals Gene Expression Dynamics of Venom Replenishment	PLOS ONE			English	Article							VIPERA-PALAESTINAE; BOMBINA-ORIENTALIS; MOLECULAR-CLONING; PRECURSOR CDNAS; GLAND; PROTEINS; ENZYMES; TOAD; IDENTIFICATION; EUKARYOTES	Venom is a critical evolutionary innovation enabling venomous snakes to become successful limbless predators; it is therefore vital that venomous snakes possess a highly efficient venom production and delivery system to maintain their predatory arsenal. Here, we exploit the unusual stability of messenger RNA in venom to conduct, for the first time, quantitative PCR to characterise the dynamics of gene expression of newly synthesised venom proteins following venom depletion. Quantitative PCR directly from venom enables real-time dynamic studies of gene expression in the same animals because it circumvents the conventional requirement to sacrifice snakes to extract mRNA from dissected venom glands. Using qPCR and proteomic analysis, we show that gene expression and protein re-synthesis triggered by venom expulsion peaks between days 3-7 of the cycle of venom replenishment, with different protein families expressed in parallel. We demonstrate that venom re-synthesis occurs very rapidly following depletion of venom stores, presumably to ensure venomous snakes retain their ability to efficiently predate and remain defended from predators. The stability of mRNA in venom is biologically fascinating, and could significantly empower venom research by expanding opportunities to produce transcriptomes from historical venom stocks and rare or endangered venomous species, for new therapeutic, diagnostic and evolutionary studies.	[Currier, Rachel B.; Harrison, Robert A.; Rowley, Paul D.; Wagstaff, Simon C.] Sch Trop Med, Alistair Reid Venom Res Unit, Liverpool, Merseyside, England; [Calvete, Juan J.; Sanz, Libia] Inst Biomed Valencia, Lab Prot Estruct, Valencia, Spain	Liverpool School of Tropical Medicine; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Currier, RB (corresponding author), Sch Trop Med, Alistair Reid Venom Res Unit, Liverpool, Merseyside, England.	r.harrison@liverpool.ac.uk	Calvete, Juan/P-2555-2019; Calvete, Juan J/K-9619-2014	Calvete, Juan/0000-0001-5026-3122; Calvete, Juan J/0000-0001-5026-3122; Wagstaff, Simon/0000-0003-0577-5537; Currier, Rachel/0000-0002-0381-3029; Sanz, Libia/0000-0003-4991-9598	Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/F012675/1]; Biotechnology and Biological Sciences Research Council [BB/F012675/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a Biotechnology and Biological Sciences Research Council (BBSRC) studentship awarded to RB Currier and BBSRC research grant awarded to Dr. RA Harrison and Dr. SC Wagstaff (BB/F012675/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BROWN RS, 1975, AM J PHYSIOL, V229, P1675, DOI 10.1152/ajplegacy.1975.229.6.1675; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calvete JJ, 2011, EXPERT REV PROTEOMIC, V8, P739, DOI [10.1586/EPR.11.61, 10.1586/epr.11.61]; Carneiro SM, 2007, TOXICON, V49, P106, DOI 10.1016/j.toxicon.2006.04.020; Casewell NR, 2011, MOL BIOL EVOL, V28, P2637, DOI 10.1093/molbev/msr091; Casewell NR, 2011, MOL BIOL EVOL, V28, P1157, DOI 10.1093/molbev/msq302; Chen TB, 2006, TOXICON, V47, P288, DOI 10.1016/j.toxicon.2005.11.004; Chen TB, 2005, PEPTIDES, V26, P377, DOI 10.1016/j.peptides.2004.10.021; Chen TB, 2003, REGUL PEPTIDES, V115, P115, DOI 10.1016/S0167-0115(03)00146-0; Chen TB, 2003, PEPTIDES, V24, P873, DOI 10.1016/S0196-9781(03)00165-7; Chen TB, 2003, PEPTIDES, V24, P853, DOI 10.1016/S0196-9781(03)00167-0; Chen TB, 2002, ANAL BIOCHEM, V311, P152, DOI 10.1016/S0003-2697(02)00404-9; Currier RB, 2010, TOXICON, V55, P864, DOI 10.1016/j.toxicon.2009.12.009; Dhananjaya BL, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1, DOI 10.1134/S0006297910010013; Fasoli E, 2010, J PROTEOMICS, V73, P932, DOI 10.1016/j.jprot.2009.12.006; FRANCIS B, 1992, TOXICON, V30, P1239, DOI 10.1016/0041-0101(92)90440-G; FREITAS MA, 1992, TOXICON, V30, P461, DOI 10.1016/0041-0101(92)90542-D; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; IBM, 2009, PAWS STAT COMM SYNT; Juaez P, 2006, J MOL EVOL, V63, P142, DOI 10.1007/s00239-005-0268-z; Kordis D, 2002, PERSPECTIVES IN MOLECULAR TOXINOLOGY, P401; MACKESSY SP, 1991, J MORPHOL, V208, P109, DOI 10.1002/jmor.1052080106; Mackessy SP, 2006, ZOOL ANZ, V245, P147, DOI 10.1016/j.jcz.2006.01.003; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; Odell GV, 1998, TOXICON, V36, P1801, DOI 10.1016/S0041-0101(98)00084-1; ORON U, 1973, J CELL BIOL, V56, P177, DOI 10.1083/jcb.56.1.177; ORON U, 1978, BIOCHEM J, V174, P733, DOI 10.1042/bj1740733; ORON U, 1978, J CELL BIOL, V78, P488, DOI 10.1083/jcb.78.2.488; PAINE MJI, 1992, TOXICON, V30, P379, DOI 10.1016/0041-0101(92)90534-C; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Sousa JRF, 2001, TOXICON, V39, P787, DOI 10.1016/S0041-0101(00)00208-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VILJOEN CC, 1979, TOXICON, V17, P77, DOI 10.1016/0041-0101(79)90258-7; Wagstaff SC, 2008, BIOCHEM BIOPH RES CO, V365, P650, DOI 10.1016/j.bbrc.2007.11.027; Wagstaff SC, 2006, GENE, V377, P21, DOI 10.1016/j.gene.2006.03.008	39	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41888	10.1371/journal.pone.0041888	http://dx.doi.org/10.1371/journal.pone.0041888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879897	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000307437900014
J	Natarajan, K; Senapati, S				Natarajan, Kathiresan; Senapati, Sanjib			Understanding the Basis of Drug Resistance of the Mutants of alpha beta-Tubulin Dimer via Molecular Dynamics Simulations	PLOS ONE			English	Article							COMMON PHARMACOPHORE; FREE-ENERGIES; EPOTHILONE; MUTATIONS; BINDING; TAXOL; MECHANISMS; STABILITY; TAXANES; TARGET	The vital role of tubulin dimer in cell division makes it an attractive drug target. Drugs that target tubulin showed significant clinical success in treating various cancers. However, the efficacy of these drugs is attenuated by the emergence of tubulin mutants that are unsusceptible to several classes of tubulin binding drugs. The molecular basis of drug resistance of the tubulin mutants is yet to be unraveled. Here, we employ molecular dynamics simulations, protein-ligand docking, and MMPB(GB) SA analyses to examine the binding of anticancer drugs, taxol and epothilone to the reported point mutants of tubulin - T274I, R282Q, and Q292E. Results suggest that the mutations significantly alter the tubulin structure and dynamics, thereby weaken the interactions and binding of the drugs, primarily by modifying the M loop conformation and enlarging the pocket volume. Interestingly, these mutations also affect the tubulin distal sites that are associated with microtubule building processes.	[Natarajan, Kathiresan; Senapati, Sanjib] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Natarajan, K (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	sanjibs@iitm.ac.in	Natarajan, Dr.Kathiresan/GRX-7735-2022; Natarajan, Kathiresan/D-8656-2014	Natarajan, Kathiresan/0000-0003-2255-5966	Council of Scientific and Industrial Research (CSIR), Govt. of India; CSIR	Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was financially supported by Council of Scientific and Industrial Research (CSIR), Govt. of India. KN acknowledges CSIR for the research fellowship. The computer resources of Computer Centre, IIT Madras are gratefully acknowledged. The funders had no role in study, design, data collection, and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 1996, INS 2; BOLLAG DM, 1995, CANCER RES, V55, P2325; Case D.A., 2022, AMBER 2020; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Forli S, 2010, CHEMMEDCHEM, V5, P35, DOI 10.1002/cmdc.200900303; Frisch G. W., 2013, GAUSSIAN 09; Giannakakou P, 2000, P NATL ACAD SCI USA, V97, P2904, DOI 10.1073/pnas.040546297; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; Gonzalez-Garay ML, 1999, J BIOL CHEM, V274, P23875, DOI 10.1074/jbc.274.34.23875; Goodin S, 2004, J CLIN ONCOL, V22, P2015, DOI 10.1200/JCO.2004.12.001; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hasegawa S, 2002, INT J CANCER, V101, P46, DOI 10.1002/ijc.10575; He LF, 2000, BIOCHEMISTRY-US, V39, P3972, DOI 10.1021/bi992518p; He LF, 2001, MOL CANCER THER, V1, P3; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kingston DGI, 2005, CELL CYCLE, V4, P279, DOI 10.4161/cc.4.2.1408; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kowalski J, 1997, TAXOL R, V272, P2534; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Li YK, 2000, BIOCHEMISTRY-US, V39, P616, DOI 10.1021/bi992044u; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mitra A, 2008, BIOPHYS J, V95, P3252, DOI 10.1529/biophysj.108.133884; Monzo M, 1999, J CLIN ONCOL, V17, P1786, DOI 10.1200/JCO.1999.17.6.1786; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mozzetti S, 2008, CANCER RES, V68, P10197, DOI 10.1158/0008-5472.CAN-08-2091; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; Ojima I, 1999, P NATL ACAD SCI USA, V96, P4256, DOI 10.1073/pnas.96.8.4256; Perakyla M, 2001, PROTEIN ENG, V14, P753, DOI 10.1093/protein/14.10.753; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Verrills NM, 2003, CHEM BIOL, V10, P597, DOI 10.1016/S1074-5521(03)00141-8; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang YF, 2005, CELL CYCLE, V4, P1847, DOI 10.4161/cc.4.12.2264; Yang CPH, 2005, MOL CANCER THER, V4, P987, DOI 10.1158/1535-7163.MCT-05-0024	43	32	32	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42351	10.1371/journal.pone.0042351	http://dx.doi.org/10.1371/journal.pone.0042351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879949	Green Published, gold, Green Submitted			2022-12-27	WOS:000307437900032
J	Erb, PL; McShea, WJ; Guralnick, RP				Erb, Peter L.; McShea, William J.; Guralnick, Robert P.			Anthropogenic Influences on Macro-Level Mammal Occupancy in the Appalachian Trail Corridor	PLOS ONE			English	Article							FOXES VULPES-VULPES; WHITE-TAILED DEER; WILDLIFE RESPONSES; MESOPREDATOR RELEASE; SPECIES DISTRIBUTION; CITIZEN SCIENCE; BIODIVERSITY; RECREATION; PATTERNS; MODELS	Anthropogenic effects on wildlife are typically assessed at the local level, but it is often difficult to extrapolate to larger spatial extents. Macro-level occupancy studies are one way to assess impacts of multiple disturbance factors that might vary over different geographic extents. Here we assess anthropogenic effects on occupancy and distribution for several mammal species within the Appalachian Trail (AT), a forest corridor that extends across a broad section of the eastern United States. Utilizing camera traps and a large volunteer network of citizen scientists, we were able to sample 447 sites along a 1024 km section of the AT to assess the effects of available habitat, hunting, recreation, and roads on eight mammal species. Occupancy modeling revealed the importance of available forest to all species except opossums (Didelphis virginiana) and coyotes (Canis latrans). Hunting on adjoining lands was the second strongest predictor of occupancy for three mammal species, negatively influencing black bears (Ursus americanus) and bobcats (Lynx rufus), while positively influencing raccoons (Procyon lotor). Modeling also indicated an avoidance of high trail use areas by bears and proclivity towards high use areas by red fox (Vulpes vulpes). Roads had the lowest predictive power on species occupancy within the corridor and were only significant for deer. The occupancy models stress the importance of compounding direct and indirect anthropogenic influences operating at the regional level. Scientists and managers should consider these human impacts and their potential combined influence on wildlife persistence when assessing optimal habitat or considering management actions.	[Erb, Peter L.; Guralnick, Robert P.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Erb, Peter L.; McShea, William J.] Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Guralnick, Robert P.] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Colorado System; University of Colorado Boulder	Erb, PL (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	Peter.Erb@colorado.edu		McShea, William/0000-0002-8102-0200	Smithsonian Institution; University of Colorado Museum of Natural History; Department of Ecology and Evolutionary Biology at CU-Boulder; Appalachian Trail Conservancy	Smithsonian Institution(Smithsonian Institution); University of Colorado Museum of Natural History; Department of Ecology and Evolutionary Biology at CU-Boulder; Appalachian Trail Conservancy	Funding was provided by the Smithsonian Institution (www.si.edu), the University of Colorado Museum of Natural History (cumuseum.colorado.edu), the Department of Ecology and Evolutionary Biology at CU-Boulder (ebio.colorado.edu) and the Appalachian Trail Conservancy (www.appalachiantrail.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins CA, 1998, J ZOOL, V244, P335, DOI 10.1111/j.1469-7998.1998.tb00038.x; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; BERINGER JJ, 1990, INT C BEAR, V8, P85; BOYLE SA, 1985, WILDLIFE SOC B, V13, P110; Brown TL, 2000, WILDLIFE SOC B, V28, P797; Campbell Joseph, 2019, THESIS DURHAM U; CARBAUGH B, 1975, J WILDLIFE MANAGE, V39, P570, DOI 10.2307/3800400; CEBALLOS G, 1995, CONSERV BIOL, V9, P559, DOI 10.1046/j.1523-1739.1995.09030559.x; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Contesse P, 2004, MAMM BIOL, V69, P81, DOI 10.1078/1616-5047-00123; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Darrah AJ, 2010, WATERBIRDS, V33, P367, DOI 10.1675/063.033.0314; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Dufour C, 2008, APPALACHIAN TRAIL ME; Fahrig L, 2009, ECOL SOC, V14; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Gehrt SD, 2003, WILDLIFE SOC B, V31, P836; George SL, 2006, BIOL CONSERV, V133, P107, DOI 10.1016/j.biocon.2006.05.024; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HARRIS S, 1986, J ANIM ECOL, V55, P605, DOI 10.2307/4742; Hines JE., 2006, PRESENCESOFTWARE EST; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Johnson CJ, 2005, WILDLIFE MONOGR, P1; KASWORM WF, 1990, INT C BEAR, V8, P79; Kays Roland W., 2008, P110; Kelly MJ, 2008, NORTHEAST NAT, V15, P249, DOI 10.1656/1092-6194(2008)15[249:CTOCTS]2.0.CO;2; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Kroll AJ, 2007, J WILDLIFE MANAGE, V71, P1089, DOI 10.2193/2006-037; Li S, 2010, BIODIVERS CONSERV, V19, P3195, DOI 10.1007/s10531-010-9886-x; Li S, 2010, IBIS, V152, P299, DOI 10.1111/j.1474-919X.2009.00989.x; Linkie M, 2007, BIOL CONSERV, V137, P20, DOI 10.1016/j.biocon.2007.01.016; Long RA, 2011, LANDSCAPE ECOL, V26, P327, DOI 10.1007/s10980-010-9547-1; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McShea WJ, 2009, BIOL CONSERV, V142, P3108, DOI 10.1016/j.biocon.2009.08.009; McShea WJ, 2005, BIOL CONSERV, V125, P101, DOI 10.1016/j.biocon.2005.03.013; MENGE BA, 1990, TRENDS ECOL EVOL, V5, P52, DOI 10.1016/0169-5347(90)90048-I; MILLER S.D., 1990, INT C BEAR RES MANAG, V8, P357; Miller SG, 2001, WILDLIFE SOC B, V29, P124; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Olson GS, 2005, J WILDLIFE MANAGE, V69, P918, DOI 10.2193/0022-541X(2005)069[0918:MOSODF]2.0.CO;2; Potere D, 2007, PHOTOGRAMM ENG REM S, V73, P783, DOI 10.14358/PERS.73.7.783; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Ricketts T. H., 1999, TERRESTRIAL ECOREGIO; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; ROLLEY RE, 1985, J WILDLIFE MANAGE, V49, P283, DOI 10.2307/3801517; Smith MD, 2003, P SOC PHOTO-OPT INS, V5131, P31; Stephenson S.L., 1993, BIODIVERSITY SE US U, P255; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; Theobald DM, 1997, LANDSCAPE URBAN PLAN, V39, P25, DOI 10.1016/S0169-2046(97)00041-8; Trolle M, 2003, J MAMMAL, V84, P607, DOI 10.1644/1545-1542(2003)084<0607:EOODIT>2.0.CO;2; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; White D, 1997, CONSERV BIOL, V11, P349, DOI 10.1046/j.1523-1739.1997.95458.x; Whittaker D, 1998, WILDLIFE SOC B, V26, P312; Williamson JF, 1983, URSUS, V5, P302	61	48	51	2	164	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42574	10.1371/journal.pone.0042574	http://dx.doi.org/10.1371/journal.pone.0042574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880038	gold, Green Published, Green Submitted			2022-12-27	WOS:000307810000047
J	Fink, AE; Bender, KJ; Trussell, LO; Otis, TS; DiGregorio, DA				Fink, Ann E.; Bender, Kevin J.; Trussell, Laurence O.; Otis, Thomas S.; DiGregorio, David A.			Two-Photon Compatibility and Single-Voxel, Single-Trial Detection of Subthreshold Neuronal Activity by a Two-Component Optical Voltage Sensor	PLOS ONE			English	Article							MEMBRANE-POTENTIAL CHANGES; GABA(A) RECEPTOR FUNCTION; RESONANCE ENERGY-TRANSFER; SENSITIVE DYES; CEREBELLAR SYNAPSE; DENDRITIC SPINES; PYRAMIDAL NEURONS; IN-SITU; CELLS; EXCITATION	Minimally invasive measurements of neuronal activity are essential for understanding how signal processing is performed by neuronal networks. While optical strategies for making such measurements hold great promise, optical sensors generally lack the speed and sensitivity necessary to record neuronal activity on a single-trial, single-neuron basis. Here we present additional biophysical characterization and practical improvements of a two-component optical voltage sensor (2cVoS), comprised of the neuronal tracer dye, DiO, and dipicrylamine (DiO/DPA). Using laser spot illumination we demonstrate that membrane potential-dependent fluorescence changes can be obtained in a wide variety of cell types within brain slices. We show a correlation between membrane labeling and the sensitivity of the magnitude of fluorescence signal, such that neurons with the brightest membrane labeling yield the largest Delta F/F values per action potential (AP; similar to 40%). By substituting a blue-shifted donor for DiO we confirm that DiO/DPA works, at least in part, via a Forster resonance energy transfer (FRET) mechanism. We also describe a straightforward iontophoretic method for labeling multiple neurons with DiO and show that DiO/DPA is compatible with two-photon (2P) imaging. Finally, exploiting the high sensitivity of DiO/DPA, we demonstrate AP-induced fluorescence transients (fAPs) recorded from single spines of hippocampal pyramidal neurons and single-trial measurements of subthreshold synaptic inputs to granule cell dendrites. Our findings suggest that the 2cVoS, DiO/DPA, enables optical measurements of trial-to-trial voltage fluctuations with very high spatial and temporal resolution, properties well suited for monitoring electrical signals from multiple neurons within intact neuronal networks.	[Fink, Ann E.; DiGregorio, David A.] Dept Neurosci, Unit Dynam Neuronal Imaging, Paris, France; [Fink, Ann E.; DiGregorio, David A.] Inst Pasteur, CNRS, URA 2182, Paris, France; [Bender, Kevin J.; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Bender, Kevin J.; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Otis, Thomas S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fink, AE (corresponding author), Dept Neurosci, Unit Dynam Neuronal Imaging, Paris, France.	david.digregorio@pasteur.fr		Fink, Ann/0000-0002-9380-8644	Centre National de la Recherche Scientifique through the Actions Thematiques et Incitatives sur Programme; Fondation Fyssen; Fondation pour la Recherche Medicale; Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche [ANR-07-NEUR-008, ANR-2010-BLANC-1411]; Ecole des Neurosciences de Paris; NIH [NS 68408, NS028901, K99/R00: DC011080]; McKnight Foundation; European Community [237644]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS068408, R37NS028901, R01NS028901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC011080] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique through the Actions Thematiques et Incitatives sur Programme; Fondation Fyssen; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche(French National Research Agency (ANR)); Ecole des Neurosciences de Paris; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; European Community(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the Centre National de la Recherche Scientifique through the Actions Thematiques et Incitatives sur Programme, Fondation Fyssen, Fondation pour la Recherche Medicale, Federation pour la Recherche sur le Cerveau, Agence Nationale de la Recherche (ANR-07-NEUR-008 and ANR-2010-BLANC-1411), Ecole des Neurosciences de Paris to DD and by NIH grant NS 68408 and the McKnight Foundation to TSO. AF was also supported by Marie Curie Individual Fellowship 237644 within the 7th European Community Framework Program (FP7-PEOPLE-IIF-2008). LT was supported by NIH grant NS028901. KB was supported by NIH grant K99/R00: DC011080. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker CD, 2011, BIOPHYS J, V101, pL11, DOI 10.1016/j.bpj.2011.06.021; Antic S, 1999, J NEUROPHYSIOL, V82, P1615, DOI 10.1152/jn.1999.82.3.1615; Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746; Bender KJ, 2003, J NEUROSCI, V23, P8759; Bradley J, 2009, J NEUROSCI, V29, P9197, DOI 10.1523/JNEUROSCI.1240-09.2009; Canepari M, 2010, BIOPHYS J, V98, P2032, DOI 10.1016/j.bpj.2010.01.024; Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y; Cathala L, 2003, J NEUROSCI, V23, P6074, DOI 10.1523/JNEUROSCI.23-14-06074.2003; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chanda B, 2005, NAT NEUROSCI, V8, P1619, DOI 10.1038/nn1558; Chisari M, 2011, BRIT J PHARMACOL, V164, P667, DOI 10.1111/j.1476-5381.2011.01396.x; Clegg Robert M., 1995, Current Opinion in Biotechnology, V6, P103, DOI 10.1016/0958-1669(95)80016-6; COHEN LB, 1978, REV PHYSIOL BIOCH P, V83, P35, DOI 10.1007/3-540-08907-1_2; DiFranco M, 2007, J GEN PHYSIOL, V130, P581, DOI 10.1085/jgp.200709831; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Djurisic M, 2004, J NEUROSCI, V24, P6703, DOI 10.1523/JNEUROSCI.0307-04.2004; Dombeck DA, 2005, J NEUROPHYSIOL, V94, P3628, DOI 10.1152/jn.00416.2005; Fisher JAN, 2005, J NEUROSCI METH, V148, P94, DOI 10.1016/j.jneumeth.2005.06.027; Fisher JAN, 2008, J NEUROPHYSIOL, V99, P1545, DOI 10.1152/jn.00929.2007; Fromherz P, 2007, EUR BIOPHYS J; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; GONZALEZ JE, 1995, BIOPHYS J, V69, P1272, DOI 10.1016/S0006-3495(95)80029-9; HAUGLAND RP, 1969, P NATL ACAD SCI USA, V63, P23, DOI 10.1073/pnas.63.1.23; Holthoff K, 2010, J PHYSIOL-LONDON, V588, P1085, DOI 10.1113/jphysiol.2009.184960; Kirkby PA, 2010, OPT EXPRESS, V18, P13720, DOI 10.1364/OE.18.013720; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Kuhn B, 2004, BIOPHYS J, V87, P631, DOI 10.1529/biophysj.104.040477; Mennerick S, 2010, J NEUROSCI, V30, P2871, DOI 10.1523/JNEUROSCI.5607-09.2010; Miller EW, 2012, P NATL ACAD SCI USA, V109, P2114, DOI 10.1073/pnas.1120694109; Nuriya M, 2006, P NATL ACAD SCI USA, V103, P786, DOI 10.1073/pnas.0510092103; Obaid AL, 2004, J NEUROSCI METH, V134, P179, DOI 10.1016/j.jneumeth.2003.11.011; Otsu Y, 2008, J NEUROSCI METH, V173, P259, DOI 10.1016/j.jneumeth.2008.06.015; Palmer LM, 2010, J PHYSIOL-LONDON, V588, P1709, DOI 10.1113/jphysiol.2010.188300; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; Peterka DS, 2011, NEURON, V69, P9, DOI 10.1016/j.neuron.2010.12.010; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Sjulson L, 2008, J NEUROSCI, V28, P5582, DOI 10.1523/JNEUROSCI.0055-08.2008; Sjulson L, 2007, PHYSIOLOGY, V22, P47, DOI 10.1152/physiol.00036.2006; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; WAGGONER AS, 1979, ANNU REV BIOPHYS BIO, V8, P47, DOI 10.1146/annurev.bb.08.060179.000403; Wang DS, 2010, BIOPHYS J, V99, P2355, DOI 10.1016/j.bpj.2010.07.037; Zhou WL, 2007, J NEUROSCI METH, V164, P225, DOI 10.1016/j.jneumeth.2007.05.002	43	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41434	10.1371/journal.pone.0041434	http://dx.doi.org/10.1371/journal.pone.0041434			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870221	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100020
J	Hass, CJ; Malczak, P; Nocera, J; Stegemoller, EL; Shukala, A; Malaty, I; Jacobson, CE; Okun, MS; McFarland, N				Hass, Chris J.; Malczak, Paul; Nocera, Joe; Stegemoeller, Elizabeth L.; Shukala, Aparna; Malaty, Irene; Jacobson, Charles E.; Okun, Michael S.; McFarland, Nick			Quantitative Normative Gait Data in a Large Cohort of Ambulatory Persons with Parkinson's Disease	PLOS ONE			English	Article							DWELLING OLDER-ADULTS; WALKING SPEED; RISK; VARIABILITY; PEOPLE; PARAMETERS; MOBILITY; OUTCOMES; BRAIN	Background: Gait performance is widely evaluated to assess health status in older adult populations. While several investigators have presented normative values for spatiotemporal gait parameters drawn from older adult populations, the literature has been void of large-scale cohort studies, which are needed in order to provide quantitative, normative gait data in persons with Parkinson's disease. The aim of this investigation was to provide reference values for clinically important gait characteristics in a large sample of ambulatory persons with Parkinson's disease to aid both clinicians and researchers in their evaluations and treatments of gait impairment. Methodology/Principal Findings: Gait performance was collected in 310 individuals with idiopathic Parkinson's disease as they walked across a pressure sensitive walkway. Fourteen quantitative gait parameters were measured and evaluated with respect to Hoehn and Yahr disease staging and gender. Disease duration and age were controlled for in all analyses. Individuals with the greatest Parkinson's disability walked significantly slower with shorter steps and stride lengths than the mild and moderately affected groups. Further, the most affected patients spent more time with both feet on the ground, and walked with a wider base of support than the moderately disabled patients. No differences were detected between the mild and moderate disability groups on any of the gait parameters evaluated. Conclusions/Significance: Reference values for 14 gait parameters in a large cohort of ambulatory patients with Parkinson's disease are provided and these may be highly useful for assessing and interpreting an individual's gait dysfunction. It is important for clinicians and researchers to appreciate the lack of change in quantitative parameters as PD patients move from mild to moderate gait impairment.	[Hass, Chris J.; Malczak, Paul; Nocera, Joe; Stegemoeller, Elizabeth L.; Shukala, Aparna; Malaty, Irene; Jacobson, Charles E.; Okun, Michael S.; McFarland, Nick] Univ Florida, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA; [Hass, Chris J.; Malczak, Paul; Stegemoeller, Elizabeth L.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA; [Nocera, Joe] Univ Florida, Malcom Randall VAMC, Brain Rehabil Res Ctr, Gainesville, FL USA; [Nocera, Joe] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA; [Stegemoeller, Elizabeth L.; Shukala, Aparna; Malaty, Irene; Jacobson, Charles E.; Okun, Michael S.; McFarland, Nick] Univ Florida, Dept Neurol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Hass, CJ (corresponding author), Univ Florida, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA.	cjhass@hhp.ufl.edu	Shukla, Aparna Wagle/AAN-1344-2020; Malaty, Irene/AAE-2553-2020; McFarland, Nikolaus R/I-4209-2017	McFarland, Nikolaus R/0000-0002-8699-8857; WAGLE SHUKLA, APARNA/0000-0002-9757-9973; Okun, Michael/0000-0002-6247-9358; Jacobson, Charles/0000-0002-7598-5217	National Institutes of Health [NIH R21AG033284-1R2]; University of Florida National Parkinson's Disease Center of Excellence; Allen Family; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS067024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida National Parkinson's Disease Center of Excellence; Allen Family; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part by National Institutes of Health (NIH R21AG033284-1R2), University of Florida National Parkinson's Disease Center of Excellence, and the generosity of the Allen Family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; Bohannon RW, 1996, J ORTHOP SPORT PHYS, V24, P86, DOI 10.2519/jospt.1996.24.2.86; Brach JS, 2007, J GERONTOL A-BIOL, V62, P983, DOI 10.1093/gerona/62.9.983; Callisaya ML, 2011, AGE AGEING, V40, P481, DOI 10.1093/ageing/afr055; Callisaya ML, 2010, AGE AGEING, V39, P191, DOI 10.1093/ageing/afp250; Frank JS, 2003, AM J PREV MED, V25, P157, DOI 10.1016/S0749-3797(03)00179-X; HIMANN JE, 1988, MED SCI SPORT EXER, V20, P161, DOI 10.1249/00005768-198820020-00010; Hollman JH, 2011, GAIT POSTURE, V34, P111, DOI 10.1016/j.gaitpost.2011.03.024; Judge JO, 1996, J AM GERIATR SOC, V44, P1332, DOI 10.1111/j.1532-5415.1996.tb01404.x; Katzel LI, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/241754; MURRAY MP, 1969, J GERONTOL, V24, P169, DOI 10.1093/geronj/24.2.169; Nisenzon AN, 2011, PARKINSONISM RELAT D, V17, P89, DOI 10.1016/j.parkreldis.2010.09.005; Nordin E, 2010, GAIT POSTURE, V32, P92, DOI 10.1016/j.gaitpost.2010.03.012; Oh-Park M, 2010, J AM GERIATR SOC, V58, P1512, DOI 10.1111/j.1532-5415.2010.02962.x; Ostir GV, 2007, AM J EPIDEMIOL, V166, P599, DOI 10.1093/aje/kwm121; Rabadi MH, 2005, NEUROREHAB NEURAL RE, V19, P20; Rosano C, 2006, NEUROEPIDEMIOLOGY, V26, P52, DOI 10.1159/000089240; Rosano C, 2012, AGE AGEING, V41, P58, DOI 10.1093/ageing/afr113; Rosano C, 2008, J GERONTOL A-BIOL, V63, P1380, DOI 10.1093/gerona/63.12.1380; Samson MM, 2001, AGING CLIN EXP RES, V13, P16, DOI 10.1007/BF03351489; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Verghese J, 2007, J NEUROL NEUROSUR PS, V78, P929, DOI 10.1136/jnnp.2006.106914; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033	24	61	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42337	10.1371/journal.pone.0042337	http://dx.doi.org/10.1371/journal.pone.0042337			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22879945	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100071
J	Hu, XP; Wu, JQ; Zhu, LP; Wang, X; Xu, B; Wang, RY; Ou, XT; Weng, XH				Hu, Xiu-Ping; Wu, Ji-Qin; Zhu, Li-Ping; Wang, Xuan; Xu, Bin; Wang, Rui-Ying; Ou, Xue-Ting; Weng, Xin-Hua			Association of Fc gamma Receptor IIB Polymorphism with Cryptococcal Meningitis in HIV-Uninfected Chinese Patients	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RIIA CD32; IIIB POLYMORPHISMS; GENE POLYMORPHISMS; SUSCEPTIBILITY; DISEASE; FCGR2B; GENOTYPE; BINDING; PHAGOCYTOSIS	Background: As important regulators of the immune system, the human Fc gamma receptors (Fc gamma Rs) have been demonstrated to play important roles in the pathogenesis of various infectious diseases. The aim of the present study was to identify the association between FCGR polymorphisms and cryptococcal meningitis. Methodology/Principal Findings: In this case control genetic association study, we genotyped four functional polymorphisms in low-affinity Fc gamma Rs, including FCGR2A 131H/R, FCGR3A 158F/V, FCGR3B NA1/NA2, and FCGR2B 232I/T, in 117 patients with cryptococcal meningitis and 190 healthy controls by multiplex SNaPshot technology. Among the 117 patients with cryptococcal meningitis, 59 had predisposing factors. In patients with cryptococcal meningitis, the FCGR2B 232I/I genotype was over-presented (OR = 1.652, 95% CI [1.02-2.67]; P = 0.039) and the FCGR2B 232I/T genotype was under-presented (OR = 0.542, 95% CI [0.33-0.90]; P = 0.016) in comparison with control group. In cryptococcal meningitis patients without predisposing factors, FCGR2B 232I/I genotype was also more frequently detected (OR = 1.958, 95% CI [1.05-3.66]; P = 0.033), and the FCGR2B 232I/T genotype was also less frequently detected (OR = 0.467, 95% CI [0.24-0.91]; P = 0.023) than in controls. No significant difference was found among FCGR2A 131H/R, FCGR3A 158F/V, and FCGR3B NA1/NA2 genotype frequencies between patients and controls. Conclusion/Significance: We found for the first time associations between cryptococcal meningitis and FCGR2B 232I/T genotypes, which suggested that Fc gamma RIIB might play an important role in the central nervous system infection by Cryptococcus in HIV-uninfected individuals.	[Hu, Xiu-Ping; Wu, Ji-Qin; Zhu, Li-Ping; Wang, Xuan; Xu, Bin; Wang, Rui-Ying; Ou, Xue-Ting; Weng, Xin-Hua] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China	Fudan University	Hu, XP (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China.	zhulp@fudan.edu.cn		Wang, Ruiying/0000-0002-3638-4582	National Natural Science Foundation of China [81071333]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [No. 81071333]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreson R, 2006, NUCLEIC ACIDS RES, V34, pW651, DOI 10.1093/nar/gkl125; BREDIUS RGM, 1994, IMMUNOLOGY, V83, P624; Bruin M, 2004, BRIT J HAEMATOL, V127, P561, DOI 10.1111/j.1365-2141.2004.05235.x; Chai L, 2010, J DENT RES, V89, P705, DOI 10.1177/0022034510365444; Chau TTH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-199; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen JY, 2006, ARTHRITIS RHEUM-US, V54, P3908, DOI 10.1002/art.22220; Chiapello LS, 2008, INT IMMUNOL, V20, P1527, DOI 10.1093/intimm/dxn112; Chu ZT, 2004, TISSUE ANTIGENS, V63, P21, DOI 10.1111/j.1399-0039.2004.00142.x; Clatworthy MR, 2004, J EXP MED, V199, P717, DOI 10.1084/jem.20032197; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Di Cristofaro J, 2010, J MOL DIAGN, V12, P453, DOI 10.2353/jmoldx.2010.090222; Endeman H, 2009, CLIN VACCINE IMMUNOL, V16, P1087, DOI 10.1128/CVI.00037-09; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; Forthal DN, 2007, J IMMUNOL, V179, P7916, DOI 10.4049/jimmunol.179.11.7916; Hessner MJ, 1996, TRANSFUSION, V36, P895, DOI 10.1046/j.1537-2995.1996.361097017176.x; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Koene HR, 1997, BLOOD, V90, P1109, DOI 10.1182/blood.V90.3.1109.1109_1109_1114; Kyogoku C, 2002, ARTHRITIS RHEUM, V46, P1242, DOI 10.1002/art.10257; Kyogoku C, 2002, GENES IMMUN, V3, P488, DOI 10.1038/sj.gene.6363921; Li XL, 2003, ARTHRITIS RHEUM, V48, P3242, DOI 10.1002/art.11313; Lui G, 2006, QJM-INT J MED, V99, P143, DOI 10.1093/qjmed/hcl014; Magnusson V, 2004, ARTHRITIS RHEUM, V50, P1348, DOI 10.1002/art.20151; McGaha TL, 2005, SCIENCE, V307, P590, DOI 10.1126/science.1105160; Meletiadis J, 2007, MED MYCOL, V45, P513, DOI 10.1080/13693780701390140; Molle I, 2008, LEUKEMIA LYMPHOMA, V49, P1116, DOI 10.1080/10428190802074585; Monari C, 2006, J IMMUNOL, V177, P6842, DOI 10.4049/jimmunol.177.10.6842; Moore T, 2003, J INFECT DIS, V188, P617, DOI 10.1086/377134; Nasr A, 2007, SCAND J IMMUNOL, V66, P87, DOI 10.1111/j.1365-3083.2007.01947.x; Ou XT, 2011, J INFECT DIS, V203, P1686, DOI 10.1093/infdis/jir152; Pappas PG, 2001, CLIN INFECT DIS, V33, P690, DOI 10.1086/322597; Platonov AE, 1998, CLIN INFECT DIS, V27, P746, DOI 10.1086/514935; REILLY AF, 1994, CLIN DIAGN LAB IMMUN, V1, P640, DOI 10.1128/CDLI.1.6.640-644.1994; Sadki K, 2010, J GENET GENOMICS, V37, P257, DOI 10.1016/S1673-8527(09)60044-8; Siriboonrit U, 2003, TISSUE ANTIGENS, V61, P374, DOI 10.1034/j.1399-0039.2003.00047.x; Sole-Violan J, 2011, CRIT CARE MED, V39, P1388, DOI 10.1097/CCM.0b013e31820eda74; van der Pol WL, 2003, IMMUNOGENETICS, V55, P240, DOI 10.1007/s00251-003-0574-9; van Schie RCAA, 2000, CLIN DIAGN LAB IMMUN, V7, P676, DOI 10.1128/CDLI.7.4.676-681.2000; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034400; WARMERDAM PAM, 1991, J IMMUNOL, V147, P1338; Wenink MH, 2009, J IMMUNOL, V183, P4509, DOI 10.4049/jimmunol.0900153; Willcocks LC, 2010, P NATL ACAD SCI USA, V107, P7881, DOI 10.1073/pnas.0915133107; Wu JM, 1997, J CLIN INVEST, V100, P1059, DOI 10.1172/JCI119616; Xu G, 2007, J CLIN LAB ANAL, V21, P298, DOI 10.1002/jcla.20189; Yuan FF, 2005, TISSUE ANTIGENS, V66, P291, DOI 10.1111/j.1399-0039.2005.00476.x; Zhou XJ, 2010, NEPHROL DIAL TRANSPL, V25, P97, DOI 10.1093/ndt/gfp374; Zhu LP, 2010, MED MYCOL, V48, P570, DOI 10.3109/13693780903437876; Zonios DI, 2007, MEDICINE, V86, P78, DOI 10.1097/md.0b013e31803b52f5	49	37	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42439	10.1371/journal.pone.0042439	http://dx.doi.org/10.1371/journal.pone.0042439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879986	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100095
J	Jednorog, K; Altarelli, I; Monzalvo, K; Fluss, J; Dubois, J; Billard, C; Dehaene-Lambertz, G; Ramus, F				Jednorog, Katarzyna; Altarelli, Irene; Monzalvo, Karla; Fluss, Joel; Dubois, Jessica; Billard, Catherine; Dehaene-Lambertz, Ghislaine; Ramus, Franck			The Influence of Socioeconomic Status on Children's Brain Structure	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; COGNITIVE-DEVELOPMENT; NEURAL MECHANISMS; CHILDHOOD POVERTY; CORTICAL NETWORKS; MATERNAL-CARE; GYRIFICATION; HIPPOCAMPUS; ATTENTION; PRESCHOOL	Children's cognitive abilities and school achievements are deeply affected by parental socioeconomic status (SES). Numerous studies have reported lower cognitive performance in relation to unfavorable environments, but little is known about the effects of SES on the child's neural structures. Here, we systematically explore the association between SES and brain anatomy through MRI in a group of 23 healthy 10-year-old children with a wide range of parental SES. We confirm behaviorally that language is one of the cognitive domains most affected by SES. Furthermore, we observe widespread modifications in children's brain structure. A lower SES is associated with smaller volumes of gray matter in bilateral hippocampi, middle temporal gyri, left fusiform and right inferior occipito-temporal gyri, according to both volume-and surface-based morphometry. Moreover, we identify local gyrification effects in anterior frontal regions, supportive of a potential developmental lag in lower SES children. In contrast, we found no significant association between SES and white matter architecture. These findings point to the potential neural mediators of the link between unfavourable environmental conditions and cognitive skills.	[Jednorog, Katarzyna; Altarelli, Irene; Ramus, Franck] Ecole Normale Super, Dept Etud Cognit, F-75231 Paris, France; [Jednorog, Katarzyna] Nencki Inst Expt Biol, Warsaw, Poland; [Monzalvo, Karla; Dubois, Jessica; Dehaene-Lambertz, Ghislaine] Inst Natl Sante & Rech Med, Cognit Neuroimaging Unit, Gif Sur Yvette, France; [Monzalvo, Karla; Dubois, Jessica; Dehaene-Lambertz, Ghislaine] Inst BioImaging, Div Life Sci, Comissariat Energie Atom, Gif Sur Yvette, France; [Monzalvo, Karla; Fluss, Joel; Dubois, Jessica; Billard, Catherine; Dehaene-Lambertz, Ghislaine] Univ Paris 11, Orsay, France; [Fluss, Joel; Billard, Catherine] AP HP, Paris, France; [Fluss, Joel] Hop Univ Geneve, Geneva, Switzerland	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); University of Geneva	Jednorog, K (corresponding author), Ecole Normale Super, Dept Etud Cognit, 24 Rue Lhomond, F-75231 Paris, France.	k.jednorog@nencki.gov.pl; irene.altarelli@ens.fr	Dehaene, Ghislaine/O-3633-2017; Ramus, Franck/A-1755-2009; Dubois, Jessica/P-2461-2014; Jednoróg, Katarzyna/AFO-8052-2022	Dehaene, Ghislaine/0000-0003-2221-9081; Ramus, Franck/0000-0002-1122-5913; Dubois, Jessica/0000-0003-4865-8111; Jednoróg, Katarzyna/0000-0003-3072-6956	Ecole des Neurosciences de Paris; Fyssen Foundation; Agence Nationale de la Recherche	Ecole des Neurosciences de Paris; Fyssen Foundation; Agence Nationale de la Recherche(French National Research Agency (ANR))	Research was supported by Ecole des Neurosciences de Paris, Fyssen Foundation, and grants from Agence Nationale de la Recherche (Genedys and Socodev). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Blanton RE, 2001, PSYCHIAT RES-NEUROIM, V107, P29, DOI 10.1016/S0925-4927(01)00091-9; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Bredy TW, 2004, EUR J NEUROSCI, V20, P1355, DOI 10.1111/j.1460-9568.2004.03599.x; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Chiang MC, 2011, NEUROIMAGE, V54, P2308, DOI 10.1016/j.neuroimage.2010.10.015; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dickinson D., 1987, EARLY CHILD RES Q, V2, P1, DOI [DOI 10.1016/0885-2006(87)90010-X, 10.1016/0885-2006(87)90010-X]; Dodd B, 2003, CLIN LINGUIST PHONET, V17, P617, DOI 10.1080/0269920031000111348; Evans GW, 2009, P NATL ACAD SCI USA, V106, P6545, DOI 10.1073/pnas.0811910106; Farah MJ, 2008, DEVELOPMENTAL SCI, V11, P793, DOI 10.1111/j.1467-7687.2008.00688.x; Farah MJ, 2006, BRAIN RES, V1110, P166, DOI 10.1016/j.brainres.2006.06.072; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fluss J, 2009, J DEV BEHAV PEDIATR, V30, P206, DOI 10.1097/DBP.0b013e3181a7ed6c; Frodl T, 2010, J PSYCHIATR RES, V44, P799, DOI 10.1016/j.jpsychires.2010.01.006; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Gianaros PJ, 2007, SOC COGN AFFECT NEUR, V2, P161, DOI 10.1093/scan/nsm013; GORMAN KS, 1995, J NUTR, V125, pS2239, DOI 10.1093/jn/125.suppl_8.2239S; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hanson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018712; Hawley DF, 2012, HIPPOCAMPUS, V22, P1338, DOI 10.1002/hipo.20970; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Kesler SR, 2006, NEUROPSYCHOLOGIA, V44, P445, DOI 10.1016/j.neuropsychologia.2005.05.015; Khomsi A, 1999, LECT MOTS COMPREHENS; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kishiyama MM, 2009, J COGNITIVE NEUROSCI, V21, P1106, DOI 10.1162/jocn.2009.21101; Lefavrais P, 1965, REV PSYCHOL APPL, V15; Lege M, 1976, TEST VOCABULAIRE DEN; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Mezzacappa E, 2004, CHILD DEV, V75, P1373, DOI 10.1111/j.1467-8624.2004.00746.x; Molfese VJ, 2003, J LEARN DISABIL-US, V36, P59, DOI 10.1177/00222194030360010701; Monzalvo K, 2012, NEUROIMAGE, V61, P258, DOI 10.1016/j.neuroimage.2012.02.035; Noble KG, 2005, J DEV BEHAV PEDIATR, V26, P370, DOI 10.1097/00004703-200510000-00006; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Otero GA, 1997, ELECTROEN CLIN NEURO, V102, P512, DOI 10.1016/S0013-4694(97)95213-9; Otero GA, 2003, CLIN NEUROPHYSIOL, V114, P1918, DOI 10.1016/S1388-2457(03)00173-1; Raizada RDS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.003.2010; Ritsher JEB, 2001, BRIT J PSYCHIAT, V178, pS84, DOI 10.1192/bjp.178.40.s84; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sprenger-Charolles L., 2005, EUR REV APPL PSYCHOL, V55, P157, DOI DOI 10.1016/J.ERAP.2004.11.002; Stevens C, 2009, DEVELOPMENTAL SCI, V12, P634, DOI 10.1111/j.1467-7687.2009.00807.x; Tomalski P, 2010, CURR OPIN PSYCHIATR, V23, P233, DOI 10.1097/YCO.0b013e3283387a8c; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; WALLACH L, 1977, J EDUC PSYCHOL, V69, P36, DOI 10.1037/0022-0663.69.1.36; Wechsler D., 2005, WISC 4 ECHELLE INTEL; White T, 2011, DEV PSYCHOPATHOL, V23, P339, DOI 10.1017/S0954579410000842	53	170	172	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42486	10.1371/journal.pone.0042486	http://dx.doi.org/10.1371/journal.pone.0042486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22880000	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100107
J	Sornom, P; Gismondi, E; Vellinger, C; Devin, S; Ferard, JF; Beisel, JN				Sornom, Pascal; Gismondi, Eric; Vellinger, Celine; Devin, Simon; Ferard, Jean-Francois; Beisel, Jean-Nicolas			Effects of Sublethal Cadmium Exposure on Antipredator Behavioural and Antitoxic Responses in the Invasive Amphipod Dikerogammarus villosus	PLOS ONE			English	Article							ANTIOXIDANT ENZYME-ACTIVITIES; RELEASED CHEMICAL CUES; GAMMARUS-PULEX L; LIPID-PEROXIDATION; PREDATOR AVOIDANCE; CRUSTACEA; PREY; COMMUNICATION; TOXICITY; SUSCEPTIBILITY	Amphipods are recognised as an important component of freshwater ecosystems and are frequently used as an ecotoxicological test species. Despite this double interest, there is still a lack of information concerning toxic impacts on ecologically relevant behaviours. The present study investigated the influence of cadmium (Cd), a non-essential heavy metal, on both antipredator behaviours and antitoxic responses in the invasive amphipod Dikerogammarus villosus under laboratory conditions. Amphipod behaviour (i.e. refuge use, aggregation with conspecifics, exploration and mobility) was recorded following a 4-min test-exposure to 500 mu g Cd/L with or without a 24-h Cd pre-exposure and in the presence or absence of a high perceived risk of predation (i.e. water scented by fish predators and injured conspecifics). Following behavioural tests, malondialdehyde (MDA) levels, a biomarker for toxic effect, and energy reserves (i.e. lipid and glycogen contents) were assessed. Cd exposures induced (1) cell damage reflected by high MDA levels, (2) erratic behaviour quantified by decreasing refuge use and exploration, and increasing mobility, and (3) a depletion in energy reserves. No significant differences were observed between 4-min test-exposed and 24-h pre-exposed individuals. Gammarids exposed to Cd had a disturbed perception of the alarm stimuli, reflected by increased time spent outside of refuges and higher mobility compared to gammarids exposed to unpolluted water. Our results suggest that Cd exposure rapidly disrupts the normal behavioural responses of gammarids to alarm substances and alters predator-avoidance strategies, which could have potential impacts on aquatic communities.	[Sornom, Pascal; Gismondi, Eric; Vellinger, Celine; Devin, Simon; Ferard, Jean-Francois; Beisel, Jean-Nicolas] Univ Lorraine, CNRS UMR 7146, Lab Interact, Metz, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Sornom, P (corresponding author), Univ Lorraine, CNRS UMR 7146, Lab Interact, Metz, France.	pascal.sornom@umail.univ-metz.fr	Beisel, Jean-Nicolas/H-4392-2011; Gismondi, Eric/ABC-4356-2020	Beisel, Jean-Nicolas/0000-0002-1935-7689; VELLINGER, Celine/0000-0002-5448-8705; Gismondi, Eric/0000-0003-3102-3443; Devin, Simon/0000-0003-4431-4987				Abjornsson K, 2004, ECOLOGY, V85, P1859, DOI 10.1890/03-0074; Abjornsson Kajsa, 2000, Aquatic Ecology, V34, P379, DOI 10.1023/A:1011442331229; Barata C, 2005, COMP BIOCHEM PHYS C, V140, P175, DOI 10.1016/j.cca.2005.01.013; Baumgartner D, 2002, ARCH HYDROBIOL, V155, P353; BEHRENS WA, 1991, LIPIDS, V26, P232, DOI 10.1007/BF02543977; bij de Vaate A, 2002, CAN J FISH AQUAT SCI, V59, P1159, DOI 10.1139/F02-098; Bronmark C, 2000, OIKOS, V88, P103, DOI 10.1034/j.1600-0706.2000.880112.x; CAMPBELL JI, 1974, EXPERIENTIA, V30, P1396, DOI 10.1007/BF01919655; CARGILL AS, 1985, FRESHWATER BIOL, V15, P455, DOI 10.1111/j.1365-2427.1985.tb00215.x; Chivers DP, 1996, ANIM BEHAV, V52, P315, DOI 10.1006/anbe.1996.0177; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Dahl J, 1998, P ROY SOC B-BIOL SCI, V265, P1339, DOI 10.1098/rspb.1998.0439; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; DEMEESTER L, 1993, ECOLOGY, V74, P1467; Devin S, 2001, ANN LIMNOL-INT J LIM, V37, P21, DOI 10.1051/limn/2001001; Durou C, 2008, BIOMARQUEURS EVALUAT, P273; Dutra BK, 2009, COMP BIOCHEM PHYS C, V149, P640, DOI 10.1016/j.cbpc.2009.01.005; Eckmann Reiner, 2008, Aquatic Invasions, V3, P184, DOI 10.3391/ai.2008.3.2.9; Endler J.A., 1991, P169; Felten V, 2008, AQUAT TOXICOL, V86, P413, DOI 10.1016/j.aquatox.2007.12.002; Geret F, 2002, AQUAT LIVING RESOUR, V15, P61, DOI 10.1016/S0990-7440(01)01147-0; Geret F, 2002, BIOMARKERS, V7, P242, DOI 10.1080/13547500210125040; Gerhardt A, 1995, ENVIRON SCI POLLUT R, V2, P15, DOI 10.1007/BF02987506; Gismondi E, 2012, ENVIRON POLLUT, V160, P17, DOI 10.1016/j.envpol.2011.09.021; Gonzalo C, 2010, B ENVIRON CONTAM TOX, V85, P472, DOI 10.1007/s00128-010-0132-8; Guerlet E, 2008, CHEMOSPHERE, V72, P697, DOI 10.1016/j.chemosphere.2008.04.013; Hanazato T, 1999, ENVIRON POLLUT, V105, P137, DOI 10.1016/S0269-7491(98)00203-6; Hellou J, 2011, ENVIRON SCI POLLUT R, V18, P1, DOI 10.1007/s11356-010-0367-2; Honda RT, 2008, AQUAT TOXICOL, V89, P204, DOI 10.1016/j.aquatox.2008.07.001; HOWELL R, 1985, HYDROBIOLOGIA, V123, P245, DOI 10.1007/BF00034386; Hunter K, 2004, ENVIRON TOXICOL CHEM, V23, P1311, DOI 10.1897/03-369; Kaldonski N, 2008, NATURWISSENSCHAFTEN, V95, P839, DOI 10.1007/s00114-008-0392-x; Kalmijn A.J., 1988, P83; Kelleher B, 1998, ARCH HYDROBIOL, V143, P363; Khan FR, 2010, AQUAT TOXICOL, V96, P124, DOI 10.1016/j.aquatox.2009.10.010; Kinzler W, 2009, AQUAT ECOL, V43, P457, DOI 10.1007/s10452-008-9206-7; Kusch RC, 2008, ENVIRON TOXICOL CHEM, V27, P705, DOI 10.1897/07-273.1; Lefcort H, 1998, ARCH ENVIRON CON TOX, V35, P447, DOI 10.1007/s002449900401; Lefcort H, 2000, ARCH ENVIRON CON TOX, V38, P311, DOI 10.1007/s002449910041; Lurling M, 2007, TRENDS ECOL EVOL, V22, P374, DOI 10.1016/j.tree.2007.04.002; Maazouzi C, 2008, ENVIRON POLLUT, V156, P221, DOI 10.1016/j.envpol.2007.12.010; MacNeil C, 1999, ECOGRAPHY, V22, P686, DOI 10.1111/j.1600-0587.1999.tb00518.x; Mathis A, 1997, ETHOLOGY, V103, P33; MCCAHON CP, 1988, AQUAT TOXICOL, V13, P183, DOI 10.1016/0166-445X(88)90051-3; Medoc V, 2009, ANIM BEHAV, V77, P1235, DOI 10.1016/j.anbehav.2009.01.029; Pennuto C, 2008, AQUAT ECOL, V42, P629, DOI 10.1007/s10452-007-9139-6; Perrot-Minnot MJ, 2007, INT J PARASITOL, V37, P645, DOI 10.1016/j.ijpara.2006.12.005; Plaistow SJ, 2001, INT J PARASITOL, V31, P346, DOI 10.1016/S0020-7519(01)00115-1; Platvoet D, 2009, BIOL INVASIONS, V11, P2085, DOI 10.1007/s10530-009-9488-2; Pockl M, 2007, FRESHWATER BIOL, V52, P50, DOI 10.1111/j.1365-2427.2006.01671.x; Pockl M, 2009, BIOL INVASIONS, V11, P2021, DOI 10.1007/s10530-009-9485-5; Roast SD, 2001, AQUAT TOXICOL, V52, P217, DOI 10.1016/S0166-445X(00)00153-3; Sancho E, 1998, ECOTOX ENVIRON SAFE, V41, P168, DOI 10.1006/eesa.1998.1689; Scott GR, 2003, J EXP BIOL, V206, P1779, DOI 10.1242/jeb.00353; Sih A., 1987, P203; Sornom P, 2010, ENVIRON POLLUT, V158, P1288, DOI 10.1016/j.envpol.2010.01.022; Sparkes TC, 1996, OECOLOGIA, V106, P166, DOI 10.1007/BF00328595; STUHLBACHER A, 1992, ARCH ENVIRON CON TOX, V22, P319; SULLIVAN BK, 1983, MAR BIOL, V77, P299, DOI 10.1007/BF00395819; Vellinger C, 2012, ENVIRON POLLUT, V160, P66, DOI 10.1016/j.envpol.2011.09.002; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Wallace WG, 2000, ENVIRON TOXICOL CHEM, V19, P962, DOI 10.1002/etc.5620190425; Wallace WG, 2004, AQUAT TOXICOL, V69, P289, DOI 10.1016/j.aquatox.2004.05.010; WILLIAMS DD, 1985, OIKOS, V44, P280, DOI 10.2307/3544701; WILLIAMS KA, 1985, ARCH HYDROBIOL, V102, P461; Wisenden BD, 1999, ETHOLOGY, V105, P407, DOI 10.1046/j.1439-0310.1999.00399.x; Wisenden BD, 2001, J CHEM ECOL, V27, P1249, DOI 10.1023/A:1010376215052; Wright D. A., 1994, Environmental Reviews, V2, P187	68	19	19	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42435	10.1371/journal.pone.0042435	http://dx.doi.org/10.1371/journal.pone.0042435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879985	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100094
J	Won, YJ; Ono, F; Ikeda, SR				Won, Yu-Jin; Ono, Fumihito; Ikeda, Stephen R.			Characterization of Na+ and Ca2+ Channels in Zebrafish Dorsal Root Ganglion Neurons	PLOS ONE			English	Article							ROHON-BEARD NEURONS; VOLTAGE-DEPENDENT MODULATION; PROGRAMMED CELL-DEATH; BETA-GAMMA-SUBUNITS; NERVE GROWTH-FACTOR; CALCIUM-CHANNELS; SENSORY NEURONS; ADULT-RAT; IN-VIVO; N-TYPE	Background: Dorsal root ganglia (DRG) somata from rodents have provided an excellent model system to study ion channel properties and modulation using electrophysiological investigation. As in other vertebrates, zebrafish (Danio rerio) DRG are organized segmentally and possess peripheral axons that bifurcate into each body segment. However, the electrical properties of zebrafish DRG sensory neurons, as compared with their mammalian counterparts, are relatively unexplored because a preparation suitable for electrophysiological studies has not been available. Methodology/Principal Findings: We show enzymatically dissociated DRG neurons from juvenile zebrafish expressing Isl2b-promoter driven EGFP were easily identified with fluorescence microscopy and amenable to conventional whole-cell patch-clamp studies. Two kinetically distinct TTX-sensitive Na+ currents (rapidly-and slowly-inactivating) were discovered. Rapidly-inactivating I-Na were preferentially expressed in relatively large neurons, while slowly-inactivating I-Na was more prevalent in smaller DRG neurons. RT-PCR analysis suggests zscn1aa/ab, zscn8aa/ab, zscn4ab and zscn5Laa are possible candidates for these I-Na components. Voltage-gated Ca2+ currents (I-Ca) were primarily (87%) comprised of a high-voltage activated component arising from v-conotoxin GVIA-sensitive Ca(V)2.2 (N-type) Ca2+ channels. A few DRG neurons (8%) displayed a miniscule low-voltage-activated component. I-Ca in zebrafish DRG neurons were modulated by neurotransmitters via either voltage-dependent or -independent G-protein signaling pathway with large cell-to-cell response variability. Conclusions/Significance: Our present results indicate that, as in higher vertebrates, zebrafish DRG neurons are heterogeneous being composed of functionally distinct subpopulations that may correlate with different sensory modalities. These findings provide the first comparison of zebrafish and rodent DRG neuron electrical properties and thus provide a basis for future studies.	[Won, Yu-Jin; Ikeda, Stephen R.] NIAAA, Sect Transmitter Signaling, Lab Mol Physiol, NIH, Bethesda, MD USA; [Ono, Fumihito] NIAAA, Sect Model Synapt Syst, Lab Mol Physiol, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Won, YJ (corresponding author), NIAAA, Sect Transmitter Signaling, Lab Mol Physiol, NIH, Bethesda, MD USA.	sikeda@mail.nih.gov		ono, fumihito/0000-0001-7532-5262; Ikeda, Stephen/0000-0002-4088-9508	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000430, ZIAAA000437] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the intramural program at the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ME, 1993, MOL PHARMACOL, V44, P681; Amaya F, 2000, MOL CELL NEUROSCI, V15, P331, DOI 10.1006/mcne.1999.0828; An M, 2002, J COMP NEUROL, V446, P267, DOI 10.1002/cne.10214; BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chopra SS, 2010, CIRC RES, V106, P1342, DOI 10.1161/CIRCRESAHA.109.213132; Dib-Hajj SD, 1999, FEBS LETT, V462, P117, DOI 10.1016/S0014-5793(99)01519-7; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Dirajlal S, 2003, J NEUROPHYSIOL, V89, P513, DOI 10.1152/jn.00371.2002; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; Fang X, 2005, J PHYSIOL-LONDON, V565, P927, DOI 10.1113/jphysiol.2005.086199; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P47, DOI 10.1113/jphysiol.1985.sp015574; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Honjo Y, 2008, DEVELOPMENT, V135, P2615, DOI 10.1242/dev.022178; Honjo Y, 2011, J ANAT, V218, P271, DOI 10.1111/j.1469-7580.2010.01337.x; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; Ikeda Stephen R, 2004, Methods Mol Biol, V259, P167; Kim CJ, 1997, J NEUROPHYSIOL, V77, P1418, DOI 10.1152/jn.1997.77.3.1418; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lawson SN, 2002, EXP PHYSIOL, V87, P239, DOI 10.1113/eph8702350; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; McDonough SI, 2005, BIOPHYS J, V88, P211, DOI 10.1529/biophysj.104.051714; McLean DL, 2004, J COMP NEUROL, V480, P57, DOI 10.1002/cne.20281; MENSE S, 1990, ANAT EMBRYOL, V181, P1; MINTZ IM, 1991, P NATL ACAD SCI USA, V88, P6628, DOI 10.1073/pnas.88.15.6628; MOISES HC, 1994, J NEUROSCI, V14, P5903; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; Novak AE, 2006, DEV DYNAM, V235, P1962, DOI 10.1002/dvdy.20811; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Pineda RH, 2005, J NEUROPHYSIOL, V93, P3582, DOI 10.1152/jn.01070.2004; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; Priestley JV, 2002, CAN J PHYSIOL PHARM, V80, P495, DOI 10.1139/y02-034; RANDALL A, 1995, J NEUROSCI, V15, P2995; Reyes R, 2004, DEV DYNAM, V229, P30, DOI 10.1002/dvdy.10488; SCROGGS RS, 1992, J NEUROSCI, V12, P1789; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stucky CL, 1999, J NEUROSCI, V19, P6497; Svoboda KR, 2001, DEVELOPMENT, V128, P3511; TAUSSIG R, 1992, NEURON, V8, P799, DOI 10.1016/0896-6273(92)90100-R; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; TOKUMOTO M, 1995, DEV BIOL, V171, P578, DOI 10.1006/dbio.1995.1306; Ungos JM, 2003, DEVELOPMENT, V130, P5351, DOI 10.1242/dev.00722; WEIS JS, 1968, J EMBRYOL EXP MORPH, V19, P121; Widmark J, 2011, MOL BIOL EVOL, V28, P859, DOI 10.1093/molbev/msq257; Won YJ, 2011, J NEUROPHYSIOL, V105, P442, DOI 10.1152/jn.00625.2010; Wright MA, 2010, J NEUROSCI, V30, P14513, DOI 10.1523/JNEUROSCI.4025-10.2010; Wright MA, 2010, DEVELOPMENT, V137, P3047, DOI 10.1242/dev.052696	54	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42602	10.1371/journal.pone.0042602	http://dx.doi.org/10.1371/journal.pone.0042602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880050	gold, Green Submitted, Green Published			2022-12-27	WOS:000307284100140
J	Chen, Y; Siewers, V; Nielsen, J				Chen, Yun; Siewers, Verena; Nielsen, Jens			Profiling of Cytosolic and Peroxisomal Acetyl-CoA Metabolism in Saccharomyces cerevisiae	PLOS ONE			English	Article							COENZYME-A SYNTHETASE; CITRATE SYNTHASES; BUDDING YEAST; LOCALIZATION; GROWTH; GENE; MITOCHONDRIA; DISRUPTION; TRANSPORT; MEMBRANE	As a key intracellular metabolite, acetyl-coenzyme A (acetyl-CoA) plays a major role in various metabolic pathways that link anabolism and catabolism. In the yeast Saccharomyces cerevisiae, acetyl-CoA involving metabolism is compartmentalized, and may vary with the nutrient supply of a cell. Membranes separating intracellular compartments are impermeable to acetyl-CoA and no direct transport between the compartments occurs. Thus, without carnitine supply the glyoxylate shunt is the sole possible route for transferring acetyl-CoA from the cytosol or the peroxisomes into the mitochondria. Here, we investigate the physiological profiling of different deletion mutants of ACS1, ACS2, CIT2 and MLS1 individually or in combination under alternative carbon sources, and study how various mutations alter carbon distribution. Based on our results a detailed model of carbon distribution about cytosolic and peroxisomal acetyl-CoA metabolism in yeast is suggested. This will be useful to further develop yeast as a cell factory for the biosynthesis of acetyl-CoA-derived products.	[Chen, Yun; Siewers, Verena; Nielsen, Jens] Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden	Chalmers University of Technology	Chen, Y (corresponding author), Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	nielsenj@chalmers.se	Chen, Yun/G-6645-2017; Siewers, Verena/AAV-4902-2020; Nielsen, Jens/Q-1347-2017	Chen, Yun/0000-0002-2146-6008; Siewers, Verena/0000-0002-9502-9804; Nielsen, Jens/0000-0002-9955-6003	Firmenich; Knut and Alice Wallenberg Foundation; Chalmers Foundation	Firmenich; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Chalmers Foundation	The authors thank Firmenich, the Knut and Alice Wallenberg Foundation and the Chalmers Foundation for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2012, FEMS YEAST RES, V12, P598, DOI 10.1111/j.1567-1364.2012.00809.x; DEVIRGILIO C, 1992, YEAST, V8, P1043, DOI 10.1002/yea.320081207; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HARTIG A, 1992, NUCLEIC ACIDS RES, V20, P5677, DOI 10.1093/nar/20.21.5677; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; KAPLAN RS, 1995, J BIOL CHEM, V270, P4108, DOI 10.1074/jbc.270.8.4108; KIM KS, 1986, MOL CELL BIOL, V6, P1936, DOI 10.1128/MCB.6.6.1936; KISPAL G, 1988, J BIOL CHEM, V263, P11145; KLEIN HP, 1979, J BACTERIOL, V137, P179, DOI 10.1128/JB.137.1.179-184.1979; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Kunze M, 2002, EUR J BIOCHEM, V269, P915, DOI 10.1046/j.0014-2956.2001.02727.x; Lee JG, 2006, J BIOCHEM, V140, P121, DOI 10.1093/jb/mvj136; Lee YJ, 2011, YEAST, V28, P153, DOI 10.1002/yea.1828; LEWIN AS, 1990, MOL CELL BIOL, V10, P1399, DOI 10.1128/MCB.10.4.1399; Okubo Y, 2010, J BACTERIOL, V192, P1813, DOI 10.1128/JB.01166-09; Ostergaard S, 2000, MICROBIOL MOL BIOL R, V64, P34, DOI 10.1128/MMBR.64.1.34-50.2000; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; PRONK JT, 1994, MICROBIOL-SGM, V140, P601, DOI 10.1099/00221287-140-3-601; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Regev-Rudzki N, 2009, MOL MICROBIOL, V72, P297, DOI 10.1111/j.1365-2958.2009.06659.x; RICKEY TM, 1986, MOL CELL BIOL, V6, P488, DOI 10.1128/MCB.6.2.488; ROSENKRANTZ M, 1986, MOL CELL BIOL, V6, P4509, DOI 10.1128/MCB.6.12.4509; Swiegers JH, 2001, YEAST, V18, P585, DOI 10.1002/yea.712; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; van Roermund CWT, 1999, EMBO J, V18, P5843, DOI 10.1093/emboj/18.21.5843; VANDENBERG MA, 1995, EUR J BIOCHEM, V231, P704; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; WEINHOUSE S, 1951, J BIOL CHEM, V191, P707	32	86	89	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42475	10.1371/journal.pone.0042475	http://dx.doi.org/10.1371/journal.pone.0042475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876324	Green Submitted, Green Published, gold			2022-12-27	WOS:000307184700052
J	De Meester, N; Derycke, S; Moens, T				De Meester, Nele; Derycke, Sofie; Moens, Tom			Differences in Time until Dispersal between Cryptic Species of a Marine Nematode Species Complex	PLOS ONE			English	Article							FREE-LIVING MARINE; MEIOFAUNAL COLONIZATION; FOOD AVAILABILITY; GENETIC-STRUCTURE; ACTIVE EMERGENCE; TRADE-OFFS; ESTUARINE; COEXISTENCE; REPRODUCTION; MIGRATION	Co-occurrence of closely related species may be achieved in environments with fluctuating dynamics, where competitively inferior species can avoid competition through dispersal. Here we present an experiment in which we compared active dispersal abilities (time until first dispersal, number and gender of dispersive adults, and nematode densities at time of dispersal) in Litoditis marina, a common bacterivorous nematode species complex comprising four often co-occurring cryptic species, Pm I, II, III, and IV, as a function of salinity and food distribution. The experiment was conducted in microcosms consisting of an inoculation plate, connection tube, and dispersal plate. Results show species-specific dispersal abilities with Pm I dispersing almost one week later than Pm III. The number of dispersive adults at time of first dispersal was species-specific, with one dispersive female in Pm I and Pm III and a higher, gender-balanced, number in Pm II and Pm IV. Food distribution affected dispersal: in absence of food in the inoculation plate, all species dispersed after ca four days. When food was available Pm I dispersed later, and at the same time and densities irrespective of food conditions in the dispersal plate (food vs no food), suggesting density-dependent dispersal. Pm III dispersed faster and at a lower population density. Salinity affected dispersal, with slower dispersal at higher salinity. These results suggest that active dispersal in Litoditis marina is common, density-dependent, and with species, gender-and environment-specific dispersal abilities. These differences can lead to differential responses under suboptimal conditions and may help to explain temporary coexistence at local scales.	[De Meester, Nele; Derycke, Sofie; Moens, Tom] Univ Ghent, Marine Biol Unit, Dept Biol, B-9000 Ghent, Belgium; [De Meester, Nele; Derycke, Sofie] Univ Ghent, Ctr Mol Phylogeny & Evolut, B-9000 Ghent, Belgium	Ghent University; Ghent University	De Meester, N (corresponding author), Univ Ghent, Marine Biol Unit, Dept Biol, B-9000 Ghent, Belgium.	nele.demeester@ugent.be	Moens, Tom/AAB-8701-2019		Ghent University [B/09941, B/11644]; FWO [B/07715]	Ghent University(Ghent University); FWO(FWO)	SD is a postdoctoral fellow of the Flemish Fund for Scientific Research FWO. Financial support for this study came from the special research fund (BOF) of Ghent University through projects B/09941and B/11644 and from the FWO through project B/07715. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2008, P NATL ACAD SCI USA, V105, P12382, DOI 10.1073/pnas.0805039105; ARMONIES W, 1988, MAR ECOL PROG SER, V43, P151, DOI 10.3354/meps043151; Begon M, 1996, INTERSPECIFIC COMPET, P265; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boeckner MJ, 2009, HYDROBIOLOGIA, V624, P91, DOI 10.1007/s10750-008-9669-5; BOILEAU MG, 1992, J EVOLUTION BIOL, V5, P25, DOI 10.1046/j.1420-9101.1992.5010025.x; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; CHANDLER GT, 1983, J EXP MAR BIOL ECOL, V69, P175, DOI 10.1016/0022-0981(83)90066-7; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Commito JA, 2002, J EXP MAR BIOL ECOL, V268, P237, DOI 10.1016/S0022-0981(01)00386-0; Coomans A, 2000, NEMATOLOGY, V2, P3, DOI 10.1163/156854100508845; Darwin C, 1859, ORIGIN SPECIES MEANS; De Meester N, 2011, MAR BIOL, V158, P2717, DOI 10.1007/s00227-011-1769-5; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Derycke S, 2008, ZOOL J LINN SOC-LOND, V152, P1, DOI 10.1111/j.1096-3642.2007.00365.x; Derycke S, 2007, LIMNOL OCEANOGR, V52, P992, DOI 10.4319/lo.2007.52.3.0992; Derycke S, 2006, GENETICA, V128, P307, DOI 10.1007/s10709-006-6944-0; Derycke S, 2012, MOL ECOL RESOUR, V12, P607, DOI 10.1111/j.1755-0998.2012.03128.x; Dietrich G., 1957, ALLGEMEINE MEERESKUN; dos Santos GAP, 2008, J EXP MAR BIOL ECOL, V355, P27, DOI 10.1016/j.jembe.2007.11.015; Fonseca G, 2008, BIOL J LINN SOC, V94, P737, DOI 10.1111/j.1095-8312.2008.01015.x; Gallucci F, 2008, MAR ECOL PROG SER, V367, P173, DOI 10.3354/meps07537; Gerhardt HC, 2005, ANIM BEHAV, V70, P39, DOI 10.1016/j.anbehav.2004.09.021; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Guilini K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018912; HARRISON GW, 1979, AM NAT, V113, P659, DOI 10.1086/283424; Harvey SC, 2009, J EXP ZOOL PART B, V312B, P224, DOI 10.1002/jez.b.21287; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Hockelmann C, 2004, LIMNOL OCEANOGR, V49, P1809, DOI 10.4319/lo.2004.49.5.1809; Hughes CL, 2003, P ROY SOC B-BIOL SCI, V270, pS147, DOI 10.1098/rsbl.2003.0049; Ims R, 2001, DISPERSAL; INGLIS WILLIAM G., 1961, BULL BRIT MUS [NAT HIST] ZOOL, V7, P320; Kaiser M, 2005, PETROLEUM ACCOUN JUL, P1; Kuussaari M, 1996, J ANIM ECOL, V65, P791, DOI 10.2307/5677; Lambshead PJD, 2003, J BIOGEOGR, V30, P475, DOI 10.1046/j.1365-2699.2003.00843.x; Langellotto GA, 2000, ECOLOGY, V81, P865, DOI 10.1890/0012-9658(2000)081[0865:ATOBFC]2.0.CO;2; LEE JJ, 1977, HELGOLAND WISS MEER, V30, P272, DOI 10.1007/BF02207841; Lurz PWW, 1997, ANIM BEHAV, V54, P427, DOI 10.1006/anbe.1996.0486; Mare M. F., 1942, Journal of the Marine Biological Association Plymouth, V25, P517; Moens T, 2000, MAR ECOL PROG SER, V205, P185, DOI 10.3354/meps205185; Moens T, 1999, MAR ECOL PROG SER, V184; Moens T, 2005, AQUAT MICROB ECOL, V40, P77, DOI 10.3354/ame040077; Moens T, 1998, HELGOLANDER MEERESUN, V52, P115, DOI 10.1007/BF02908742; Moens T, 1996, J EXP MAR BIOL ECOL, V197, P177, DOI 10.1016/0022-0981(95)00163-8; Moens T, 2000, J EXP MAR BIOL ECOL, V243, P115, DOI 10.1016/S0022-0981(99)00113-6; MOLE S, 1993, OECOLOGIA, V93, P121, DOI 10.1007/BF00321201; Neira C, 2001, DEEP-SEA RES PT I, V48, P2453, DOI 10.1016/S0967-0637(01)00018-8; OLAFSSON E, 1990, MAR ECOL PROG SER, V65, P241, DOI 10.3354/meps065241; Oro D, 2004, P ROY SOC B-BIOL SCI, V271, P387, DOI 10.1098/rspb.2003.2609; Ortells R, 2003, FRESHWATER BIOL, V48, P2194, DOI 10.1046/j.1365-2427.2003.01159.x; PALMER MA, 1988, MAR ECOL PROG SER, V48, P81, DOI 10.3354/meps048081; Perrin Nicolas, 2001, P123; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; R Core Team, 2018, R LANG ENV STAT COMP; RALIN D B, 1968, Southwestern Naturalist, V13, P283, DOI 10.2307/3669222; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Saastamoinen M, 2008, AM NAT, V171, pE701, DOI 10.1086/587531; Schratzberger M, 2004, MAR BIOL, V145, P69, DOI 10.1007/s00227-004-1302-1; Snyder RE, 2003, ECOL LETT, V6, P301, DOI 10.1046/j.1461-0248.2003.00434.x; Srinivasan J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001237; Sudhaus W., 2011, Journal of Nematode Morphology and Systematics, V14, P113; SUDHAUS W, 1974, Faunistisch-Oekologische Mitteilungen, V4, P365; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; Thomas CFG, 1999, J ARACHNOL, V27, P294; Thomas MC, 2011, ZOOLOGIA-CURITIBA, V28, P449, DOI 10.1590/S1984-46702011000400006; TIETJEN JH, 1972, OECOLOGIA, V10, P167, DOI 10.1007/BF00347988; Ullberg J, 2003, MAR BIOL, V143, P867, DOI 10.1007/s00227-003-1139-z; Ullberg J, 2004, THESIS STOCKHOLM U S; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; VRANKEN G, 1983, NEMATOLOGICA, V29, P468, DOI 10.1163/187529283X00348; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wetzel MA, 2002, MAR BIOL, V141, P679, DOI 10.1007/s00227-002-0863-0; Wiens John A., 2001, P96; WINSTON MR, 1995, AM NAT, V145, P527, DOI 10.1086/285754; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zhang DY, 2004, ECOL LETT, V7, P165, DOI 10.1111/j.1461-0248.2004.00569.x; Zhou H, 2001, J EXP MAR BIOL ECOL, V256, P99, DOI 10.1016/S0022-0981(00)00310-5	79	19	19	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42674	10.1371/journal.pone.0042674	http://dx.doi.org/10.1371/journal.pone.0042674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876328	gold, Green Published			2022-12-27	WOS:000307184700056
J	Isemura, T; Kaga, A; Tabata, S; Somta, P; Srinives, P; Shimizu, T; Jo, U; Vaughan, DA; Tomooka, N				Isemura, Takehisa; Kaga, Akito; Tabata, Satoshi; Somta, Prakit; Srinives, Peerasak; Shimizu, Takehiko; Jo, Uken; Vaughan, Duncan A.; Tomooka, Norihiko			Construction of a Genetic Linkage Map and Genetic Analysis of Domestication Related Traits in Mungbean (Vigna radiata)	PLOS ONE			English	Article							BEAN PHASEOLUS-VULGARIS; BRUCHID RESISTANCE GENE; ANGULARIS WILLD. OHWI; SSR MARKERS; L. WILCZEK; MICROSATELLITE MARKERS; POWDERY MILDEW; QTL ANALYSIS; SEED WEIGHT; GENOME	The genetic differences between mungbean and its presumed wild ancestor were analyzed for domestication related traits by QTL mapping. A genetic linkage map of mungbean was constructed using 430 SSR and EST-SSR markers from mungbean and its related species, and all these markers were mapped onto 11 linkage groups spanning a total of 727.6 cM. The present mungbean map is the first map where the number of linkage groups coincided with the haploid chromosome number of mungbean. In total 105 QTLs and genes for 38 domestication related traits were identified. Compared with the situation in other Vigna crops, many linkage groups have played an important role in the domestication of mungbean. In particular the QTLs with high contribution were distributed on seven out of 11 linkage groups. In addition, a large number of QTLs with small contribution were found. The accumulation of many mutations with large and/or small contribution has contributed to the differentiation between wild and cultivated mungbean. The useful QTLs for seed size, pod dehiscence and pod maturity that have not been found in other Asian Vigna species were identified in mungbean, and these QTLs may play the important role as new gene resources for other Asian Vigna species. The results provide the foundation that will be useful for improvement of mungbean and related legumes.	[Isemura, Takehisa; Kaga, Akito; Jo, Uken; Vaughan, Duncan A.; Tomooka, Norihiko] Natl Inst Agrobiol Sci, Genet Resources Ctr, Biodivers Res Unit, Tsukuba, Ibaraki, Japan; [Tabata, Satoshi] Kazusa DNA Res Inst, Dept Plant Genome Res, Kisarazu, Chiba, Japan; [Somta, Prakit; Srinives, Peerasak] Kasetsart Univ, Dept Agron, Fac Agr Kamphaeng Saen, Nakhon Pathom, Thailand; [Shimizu, Takehiko] Inst Soc Technoinnovat Agr Forestry & Fisheries, Res Div Plants 1, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; Kazusa DNA Research Institute; Kasetsart University	Isemura, T (corresponding author), Natl Inst Agrobiol Sci, Genet Resources Ctr, Biodivers Res Unit, Tsukuba, Ibaraki, Japan.	tomooka@affrc.go.jp			Japanese Ministry of the Education, Culture, Sports, Science and Technology [18390009]	Japanese Ministry of the Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grants-in Aid for Scientific Research of the Japanese Ministry of the Education, Culture, Sports, Science and Technology (No. 18390009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Chaitieng B, 2002, PLANT BREEDING, V121, P521, DOI 10.1046/j.1439-0523.2002.00751.x; Chankaew S, 2011, MOL BREEDING, V28, P255, DOI 10.1007/s11032-010-9478-1; Chen JJ, 2004, J AGR FOOD CHEM, V52, P2256, DOI 10.1021/jf030662i; Chen XF, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-129; Cheng Z, 2011, 14 NIAS INT WORKSH G, P83; DOEBLEY J, 1995, GENETICS, V141, P333; FATOKUN CA, 1992, GENETICS, V132, P841; Fernandez GCJ, 1988, AVRDC MUNGBEAN IMPRO, P58; Fukuoka H, 2005, BIOTECHNIQUES, V39, P472, DOI 10.2144/000112025; Fuller DQ, 2006, ENVIRON ARCHAEOL, V11, P219, DOI 10.1179/174963106x123232; Gaitan-Solis E, 2002, CROP SCI, V42, P2128, DOI 10.2135/cropsci2002.2128; GOPINATHAN MC, 1985, ANN BOT-LONDON, V56, P723; Guerra-Sanz JM, 2004, PLANT BREEDING, V123, P87, DOI 10.1046/j.0179-9541.2003.00929.x; Han OK, 2005, THEOR APPL GENET, V111, P1278, DOI 10.1007/s00122-005-0046-8; Hisano H, 2007, DNA RES, V14, P271, DOI 10.1093/dnares/dsm025; Humphry ME, 2005, PLANT BREEDING, V124, P292, DOI 10.1111/j.1439-0523.2005.01084.x; Humphry ME, 2003, GENOME, V46, P738, DOI 10.1139/G03-057; Humphry ME, 2002, THEOR APPL GENET, V105, P160, DOI 10.1007/s00122-002-0909-1; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Isemura T, 2007, ANN BOT-LONDON, V100, P1053, DOI 10.1093/aob/mcm155; Isemura T, 2010, ANN BOT-LONDON, V106, P927, DOI 10.1093/aob/mcq188; James AT, 1999, AUST J BOT, V47, P601, DOI 10.1071/BT97068; Kaga A, 1998, MOL GEN GENET, V258, P378, DOI 10.1007/s004380050744; Kaga A, 1996, THEOR APPL GENET, V93, P658, DOI 10.1007/BF00224059; Kaga A, 2008, GENETICS, V178, P1013, DOI 10.1534/genetics.107.078451; Kasettranan W., 2010, Journal of Crop Science and Biotechnology, V13, P155, DOI 10.1007/s12892-010-0052-z; Kikuchi K, 2006, ANN BOT-LONDON, V98, P545, DOI 10.1093/aob/mcl145; KITAMURA K, 1988, JPN J BREED, V38, P459; Koinange EMK, 1996, CROP SCI, V36, P1037, DOI 10.2135/cropsci1996.0011183X003600040037x; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Lambrides C.J., 2007, PULSES SUGAR TUBER C, P69, DOI [10.1007/978-3-540-34516-9_4, DOI 10.1007/978-3-540-34516-9_4]; Lambrides CJ, 2004, J HERED, V95, P532, DOI 10.1093/jhered/esh078; Lambrides CJ, 2000, AUST J AGR RES, V51, P415, DOI 10.1071/AR99052; Li CD, 2001, CROP SCI, V41, P189, DOI 10.2135/cropsci2001.411189x; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; Mei L, 2009, GENOME, V52, P589, DOI 10.1139/G09-031; Menancio-Hautea D., 1993, GENETIC MAPS 1992 CO; MENANCIOHAUTEA D, 1993, THEOR APPL GENET, V86, P797, DOI 10.1007/BF00212605; Miyagi M, 2004, THEOR APPL GENET, V110, P151, DOI 10.1007/s00122-004-1821-7; Poncet V, 2000, THEOR APPL GENET, V100, P147, DOI 10.1007/s001220050020; Sangiri C, 2007, AUST J BOT, V55, P837, DOI 10.1071/BT07105; Saravanakumar P, 2004, AUST J BOT, V52, P417, DOI 10.1071/BT03091; Sato S, 2005, DNA RES, V12, P301, DOI 10.1093/dnares/dsi018; Senthil N., 2011, 14 NIAS INT WORKSH G, P53; Somta P, 2008, MOL ECOL RESOUR, V8, P1155, DOI 10.1111/j.1755-0998.2008.02219.x; Somta P, 2009, CONSERV GENET, V10, P1939, DOI 10.1007/s10592-009-9860-x; Somta P, 2009, BREEDING SCI, V59, P149, DOI 10.1270/jsbbs.59.149; Srinives P., 2011, 14 NIAS INT WORKSH G, P63; Tomooka N., 2002, ASIAN VIGNA GENUS VI; Ullah H, 2011, PAK J BOT, V43, P301; Van Ooijien JW., 2006, JOIN MAP 4 0 SOFTWAR; Wang XW, 2004, THEOR APPL GENET, V109, P352, DOI 10.1007/s00122-004-1634-8; Weeden NF, 2007, ANN BOT-LONDON, V100, P1017, DOI 10.1093/aob/mcm122; Xiong LX, 1999, THEOR APPL GENET, V98, P243, DOI 10.1007/s001220051064; YOUNG ND, 1993, THEOR APPL GENET, V87, P243, DOI 10.1007/BF00223772; YOUNG ND, 1992, THEOR APPL GENET, V84, P839, DOI 10.1007/BF00227394; Yu K, 2000, J HERED, V91, P429, DOI 10.1093/jhered/91.6.429	58	97	106	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41304	10.1371/journal.pone.0041304	http://dx.doi.org/10.1371/journal.pone.0041304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876284	Green Published, gold, Green Submitted			2022-12-27	WOS:000307184700012
J	Hahn, T; Kettle, CJ; Ghazoul, J; Frei, ER; Matter, P; Pluess, AR				Hahn, Thomas; Kettle, Chris J.; Ghazoul, Jaboury; Frei, Esther R.; Matter, Philippe; Pluess, Andrea R.			Patterns of Genetic Variation across Altitude in Three Plant Species of Semi-Dry Grasslands	PLOS ONE			English	Article							CLIMATE-CHANGE; CENTRAL POPULATIONS; COMPUTER-PROGRAM; WIND POLLINATION; DIVERSITY; ALPINE; EXTINCTION; DIFFERENTIATION; FRAGMENTATION; CONSERVATION	Background: Environmental gradients caused by altitudinal gradients may affect genetic variation within and among plant populations and inbreeding within populations. Populations in the upper range periphery of a species may be important source populations for range shifts to higher altitude in response to climate change. In this study we investigate patterns of population genetic variation at upper peripheral and lower more central altitudes in three common plant species of semi-dry grasslands in montane landscapes. Methodology/Principal Findings: In Briza media, Trifolium montanum and Ranunculus bulbosus genetic diversity, inbreeding and genetic relatedness of individuals within populations and genetic differentiation among populations was characterized using AFLP markers. Populations were sampled in the Swiss Alps at 1800 (upper periphery of the study organisms) and at 1200 m a.s.l. Genetic diversity was not affected by altitude and only in B. media inbreeding was greater at higher altitudes. Genetic differentiation was slightly greater among populations at higher altitudes in B. media and individuals within populations were more related to each other compared to individuals in lower altitude populations. A similar but less strong pattern of differentiation and relatedness was observed in T. montanum, while in R. bulbosus there was no effect of altitude. Estimations of population size and isolation of populations were similar, both at higher and lower altitudes. Conclusions/Significance: Our results suggest that altitude does not affect genetic diversity in the grassland species under study. Genetic differentiation of populations increased only slightly at higher elevation, probably due to extensive (historic) gene flow among altitudes. Potentially pre-adapted genes might therefore spread easily across altitudes. Our study indicates that populations at the upper periphery are not genetically depauperate or isolated and thus may be important source populations for migration under climate change.	[Hahn, Thomas; Kettle, Chris J.; Ghazoul, Jaboury; Frei, Esther R.; Matter, Philippe; Pluess, Andrea R.] ETH, Inst Terr Ecosyst, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hahn, T (corresponding author), ETH, Inst Terr Ecosyst, Zurich, Switzerland.	thomas.hahn@env.ethz.ch	Ghazoul, Jaboury/B-2121-2018; Kettle, Chris/A-6160-2011	Frei, Esther R./0000-0003-1910-7900	Swiss National Science Foundation (SNF) [3100A0-116277]; Competence Center Environment and Sustainability (CCES) BioChange	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Competence Center Environment and Sustainability (CCES) BioChange	This project was financially supported by Swiss National Science Foundation (SNF) No. 3100A0-116277 (http://www.snf.ch/E/Pages/default.aspx), and Competence Center Environment and Sustainability (CCES) BioChange (http://www.cces.ethz.ch/projects/clench/BioChange). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, PFLANZENSOZIOLOGISCH; [Anonymous], 2004, FLORA ALPINA; [Anonymous], TWW BUND TROCK WEID; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; [Anonymous], LANDNUTZUNG BIOL VIE; [Anonymous], 1999, LEBENSRAUME SCHWEIZ; ARROYO MTK, 1985, PLANT SYST EVOL, V149, P187, DOI 10.1007/BF00983305; Auffret AG, 2011, APPL VEG SCI, V14, P291, DOI 10.1111/j.1654-109X.2011.01124.x; Bingham RA, 2000, INT J PLANT SCI, V161, P403, DOI 10.1086/314272; Brundli U.-B., 2010, SCHWEIZERISCHES LAND; Bruun HH, 2002, AMBIO, V31, P425, DOI 10.1639/0044-7447(2002)031[0425:TPIOLH]2.0.CO;2; Burel F., 2003, LANDSCAPE ECOLOGY CO; Byars SG, 2009, ANN BOT-LONDON, V103, P885, DOI 10.1093/aob/mcp018; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Dasmahapatra KK, 2008, HEREDITY, V100, P286, DOI 10.1038/sj.hdy.6801075; Dixon JM, 2002, J ECOL, V90, P737, DOI 10.1046/j.1365-2745.2002.00684.x; Duan YW, 2009, PLANT BIOLOGY, V11, P796, DOI 10.1111/j.1438-8677.2009.00195.x; Eckstein RL, 2006, MOL ECOL, V15, P2367, DOI 10.1111/j.1365-294X.2006.02944.x; Fischer SF, 1996, J APPL ECOL, V33, P1206, DOI 10.2307/2404699; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Frei E, 2010, BOT HELV, V120, P117, DOI 10.1007/s00035-010-0076-y; Glemin S, 2006, P ROY SOC B-BIOL SCI, V273, P3011, DOI 10.1098/rspb.2006.3657; Goodell K, 1997, AM J BOT, V84, P1362, DOI 10.2307/2446134; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Hannah L, 2011, CONSERV BIOL, V25, P1139, DOI 10.1111/j.1523-1739.2011.01788.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HARPER JOHN L., 1957, JOUR ECOL, V45, P287; Hautier Y, 2009, J PLANT ECOL, V2, P125, DOI 10.1093/jpe/rtp011; Herrera CM, 2008, HEREDITY, V100, P275, DOI 10.1038/sj.hdy.6801072; Heywood John S., 1993, American Journal of Botany, V80, P545, DOI [10.1002/j.1537-2197.1993.tb13838.x, 10.2307/2445370]; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Hulber K, 2010, FUNCT ECOL, V24, P245, DOI 10.1111/j.1365-2435.2009.01645.x; Jacquemyn H, 2009, ANN BOT-LONDON, V103, P777, DOI 10.1093/aob/mcn253; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Larcher W, 2006, SITZUNGBERICHTE ANZE, V212, P3; Lauber K., 2001, FLORA HELVETICA; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Lopez PG, 2010, AM J BOT, V97, P423, DOI 10.3732/ajb.0900208; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Malo JE, 2002, DIVERS DISTRIB, V8, P365, DOI 10.1046/j.1472-4642.2002.00161.x; MANTEL N, 1967, CANCER RES, V27, P209; McMahon SM, 2011, TRENDS ECOL EVOL, V26, P249, DOI 10.1016/j.tree.2011.02.012; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; MURRAY BG, 1974, HEREDITY, V33, P285, DOI 10.1038/hdy.1974.94; NEI M, 1978, GENETICS, V89, P583; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; Ohsawa T, 2008, GLOBAL ECOL BIOGEOGR, V17, P152, DOI 10.1111/j.1466-8238.2007.00357.x; OUBORG NJ, 1991, OECOLOGIA, V86, P359, DOI 10.1007/BF00317601; OYAMA K, 1993, J PLANT RES, V106, P143, DOI 10.1007/BF02344418; Pannell JR, 1999, EVOLUTION, V53, P664, DOI 10.1111/j.1558-5646.1999.tb05362.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Plank, 1981, DRY GRASSLANDS EUROP; Pluess AR, 2011, MOL ECOL, V20, P473, DOI 10.1111/j.1365-294X.2010.04972.x; Pluess AR, 2004, AM J BOT, V91, P2013, DOI 10.3732/ajb.91.12.2013; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REGAL PJ, 1982, ANNU REV ECOL SYST, V13, P497, DOI 10.1146/annurev.es.13.110182.002433; Richards CM, 1999, EVOLUTION, V53, P63, DOI [10.2307/2640920, 10.1111/j.1558-5646.1999.tb05333.x]; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schleuning M, 2009, BASIC APPL ECOL, V10, P61, DOI 10.1016/j.baae.2007.12.002; Shi MM, 2011, PLOS ONE, V6; STEINBACH K, 1994, PHYTON-ANN REI BOT A, V34, P203; Tamura S, 2000, PLANT ECOL, V147, P185, DOI 10.1023/A:1009870521175; Thiel-Egenter C, 2009, GLOBAL ECOL BIOGEOGR, V18, P78, DOI 10.1111/j.1466-8238.2008.00421.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; VEKEMANS X, 2002, AFLP SURV VERSION 1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wagner V, 2011, AM J BOT, V98, P1173, DOI 10.3732/ajb.1000385; Weber JJ, 2012, AM J BOT; WEIMARCK A, 1968, HEREDITAS-GENETISK A, V60, P157; Whitlock R, 2008, MOL ECOL RESOUR, V8, P725, DOI 10.1111/j.1755-0998.2007.02073.x; Yakimowski SB, 2008, NEW PHYTOL, V180, P534, DOI 10.1111/j.1469-8137.2008.02582.x; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Young AG, 2002, BIOL CONSERV, V106, P71, DOI 10.1016/S0006-3207(01)00230-0; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x; Ziello C, 2009, CLIM RES, V39, P227, DOI 10.3354/cr00822	82	36	39	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41608	10.1371/journal.pone.0041608	http://dx.doi.org/10.1371/journal.pone.0041608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870236	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800029
J	Yoon, CH; Rho, SB; Kim, ST; Kho, S; Park, J; Jang, IS; Woo, S; Kim, SS; Lee, JH; Lee, SH				Yoon, Cheol-Hee; Rho, Seung Bae; Kim, Seong-Tae; Kho, Seongho; Park, Junsoo; Jang, Ik-Soon; Woo, Seonock; Kim, Sung Soon; Lee, Je-Ho; Lee, Seung-Hoon			Crucial Role of TSC-22 in Preventing the Proteasomal Degradation of p53 in Cervical Cancer	PLOS ONE			English	Article							BETA-STIMULATED CLONE-22; SALIVARY-GLAND CANCER; GROWTH-FACTOR-BETA; DOWN-REGULATION; CELL LINE; IN-VIVO; MDM2; SUPPRESSOR; GENE; PROTEIN	The p53 tumor suppressor function can be compromised in many tumors by the cellular antagonist HDM2 and human papillomavirus oncogene E6 that induce p53 degradation. Restoration of p53 activity has strong therapeutic potential. Here, we identified TSC-22 as a novel p53-interacting protein and show its novel function as a positive regulator of p53. We found that TSC-22 level was significantly down-regulated in cervical cancer tissues. Moreover, over-expression of TSC-22 was sufficient to inhibit cell proliferation, promote cellular apoptosis in cervical cancer cells and suppress growth of xenograft tumors in mice. Expression of also TSC-22 enhanced the protein level of p53 by protecting it from poly-ubiquitination. When bound to the motif between amino acids 100 and 200 of p53, TSC-22 inhibited the HDM2- and E6-mediated p53 polyubiquitination and degradation. Consequently, ectopic over-expression of TSC-22 activated the function of p53, followed by increased expression of p21(Waf1/Cip1) and PUMA in human cervical cancer cell lines. Interestingly, TSC-22 did not affect the interaction between p53 and HDM2. Knock-down of TSC-22 by small interfering RNA clearly enhanced the polyubiquitination of p53, leading to the degradation of p53. These results suggest that TSC-22 acts as a tumor suppressor by safeguarding p53 from poly-ubiquitination mediated-degradation.	[Yoon, Cheol-Hee] Natl Inst Hlth, Div Aids, Ctr Immunol & Pathol, Chungbuk, South Korea; [Kim, Seong-Tae; Kho, Seongho; Lee, Seung-Hoon] Yongin Univ, Dept Life Sci, Yongin, Gyeonggi Do, South Korea; [Rho, Seung Bae] Natl Canc Ctr, Res Inst, Goyang Si, Gyeonggi Do, San Marino; [Park, Junsoo] Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea; [Jang, Ik-Soon] Daegeon Ctr, Korea Basic Sci Inst, Daegion, South Korea; [Woo, Seonock] Korea Ocean Res & Dev Inst, S Sea Environm Res Dept, Geoje, South Korea; [Lee, Je-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Yongin University; Yonsei University; Korea Basic Science Institute (KBSI); Korea Institute of Ocean Science & Technology (KIOST); Sungkyunkwan University (SKKU); Samsung Medical Center	Yoon, CH (corresponding author), Natl Inst Hlth, Div Aids, Ctr Immunol & Pathol, Chungbuk, South Korea.	jeholee@gmail.com; shlee@yongin.ac.kr		Jang, Ik Soon/0000-0003-2092-6372	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [20110026217]; Korea Basic Science Institute NAP grant [T3278B]; Korea National Institute of Health	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Basic Science Institute NAP grant; Korea National Institute of Health	This research was mainly supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (20110026217) and partially assisted by the Korea Basic Science Institute NAP grant (T3278B) and the internal grant from Korea National Institute of Health. The funders had no role in study design, data collection and analysis, dicision to publish, or preparation of the manuscript.	Ahn H, 2011, MOL CELL BIOCH; Choi SJ, 2005, MOL CELL BIOCHEM, V271, P23, DOI 10.1007/s11010-005-3456-7; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dobens LL, 1997, MECH DEVELOP, V65, P197, DOI 10.1016/S0925-4773(97)00080-4; Hashiguchi A, 2004, DEV GROWTH DIFFER, V46, P535; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Higashitsuji H, 2005, CANCER CELL, V8, P75, DOI 10.1016/j.ccr.2005.06.006; Iida M, 2007, TOXICOL SCI, V99, P43, DOI 10.1093/toxsci/kfm138; Kawamata H, 1998, BRIT J CANCER, V77, P71, DOI 10.1038/bjc.1998.11; Kawamata H, 2004, CURR CANCER DRUG TAR, V4, P521, DOI 10.2174/1568009043332844; Kester HA, 1999, J BIOL CHEM, V274, P27439, DOI 10.1074/jbc.274.39.27439; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lee ES, 2007, FEBS LETT, V581, P4325, DOI 10.1016/j.febslet.2007.08.001; Lee JH, 2008, FEBS LETT, V582, P1210, DOI 10.1016/j.febslet.2008.01.066; Lee SH, 2005, CANCER RES, V65, P137; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Nakamura M, 2011, CANC SCI; Nakashiro K, 1998, CANCER RES, V58, P549; Ohta S, 1997, BIOCHEM J, V324, P777, DOI 10.1042/bj3240777; Omotehara F, 2000, ONCOL REP, V7, P737; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; SHIBANUMA M, 1992, J BIOL CHEM, V267, P10219; Shostak KO, 2005, EXP ONCOL, V27, P314; Shostak KO, 2003, J SURG ONCOL, V82, P57, DOI 10.1002/jso.10180; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Uchida D, 2000, LAB INVEST, V80, P955, DOI 10.1038/labinvest.3780098; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yan XH, 2011, MOL CELL BIOL, V31, P3700, DOI 10.1128/MCB.05448-11; Yoon CH, EMBO REP, V11, P393; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Yu JH, 2009, BLOOD, V113, P5558, DOI 10.1182/blood-2009-02-205732; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	37	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42006	10.1371/journal.pone.0042006	http://dx.doi.org/10.1371/journal.pone.0042006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870275	gold, Green Submitted, Green Published			2022-12-27	WOS:000307212800051
J	Kadowaki, K; Inouye, BD; Miller, TE				Kadowaki, Kohmei; Inouye, Brian D.; Miller, Thomas E.			Assembly-History Dynamics of a Pitcher-Plant Protozoan Community in Experimental Microcosms	PLOS ONE			English	Article							ALTERNATIVE STABLE STATES; BETA DIVERSITY; SUCCESSION; CONSEQUENCES; CONVERGENCE; FUNGI; WOOD	Background: History drives community assembly through differences both in density (density effects) and in the sequence in which species arrive (sequence effects). Density effects arise from predictable population dynamics, which are free of history, but sequence effects are due to a density-free mechanism, arising solely from the order and timing of immigration events. Few studies have determined how components of immigration history (timing, number of individuals, frequency) alter local dynamics to determine community assembly, beyond addressing when immigration history produces historically contingent assembly. Methods/Findings: We varied density and sequence effects independently in a two-way factorial design to follow community assembly in a three-species aquatic protozoan community. A superior competitor, Colpoda steinii, mediated alternative community states; early arrival or high introduction density allowed this species to outcompete or suppress the other competitors (Poterioochromonas malhamensis and Eimeriidae gen. sp.). Multivariate analysis showed that density effects caused greater variation in community states, whereas sequence effects altered the mean community composition. Conclusions: A significant interaction between density and sequence effects suggests that we should refine our understanding of priority effects. These results highlight a practical need to understand not only the "ingredients" (species) in ecological communities but their "recipes" as well.	[Kadowaki, Kohmei; Inouye, Brian D.; Miller, Thomas E.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Kadowaki, K (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	kadowaki.koumei.6w@kyoto-u.ac.jp	Kadowaki, Kohmei/K-8117-2019	Kadowaki, Kohmei/0000-0003-0512-1621	U.S. National Science Foundation [DEB-0816838, DEB-0716891]; Division Of Environmental Biology [0816838] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the U.S. National Science Foundation to BDI (DEB-0816838) and TEM (DEB-0716891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Beckerman AP, 2002, TRENDS ECOL EVOL, V17, P263, DOI 10.1016/S0169-5347(02)02469-2; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Collinge SK, 2009, ECOLOGY, V90, P3313, DOI 10.1890/08-2155.1; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Diamond J.M., 1975, P342; DRAKE JA, 1991, AM NAT, V137, P1, DOI 10.1086/285143; Fukami T, 2004, ECOLOGY, V85, P3234, DOI 10.1890/04-0340; Fukami T, 2011, ECOL LETT, V14, P973, DOI 10.1111/j.1461-0248.2011.01663.x; Fukami T, 2010, ECOL LETT, V13, P675, DOI 10.1111/j.1461-0248.2010.01465.x; GROVER JP, 1994, J ANIM ECOL, V63, P484, DOI 10.2307/5565; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; Houseman GR, 2008, ECOLOGY, V89, P2172, DOI 10.1890/07-1228.1; Kennedy PG, 2009, ECOLOGY, V90, P2098, DOI 10.1890/08-1291.1; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; Miller TE, 2002, ECOLOGY, V83, P898, DOI 10.1890/0012-9658(2002)083[0898:EOCSOI]2.0.CO;2; Miller TE, 2012, OECOLOGIA IN PRESS; Miller TE, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P122; MORRIS WF, 1989, ECOLOGY, V70, P697, DOI 10.2307/1940220; Oksanen J., 2016, R PACKAG; Palmer TM, 2002, OECOLOGIA, V133, P372, DOI 10.1007/s00442-002-1026-1; Petraitis PS, 2005, J EXP MAR BIOL ECOL, V326, P14, DOI 10.1016/j.jembe.2005.05.013; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROBINSON JV, 1987, ECOLOGY, V68, P587, DOI 10.2307/1938464; SCHAFFER WM, 1981, ECOL MONOGR, V51, P383, DOI 10.2307/2937321; SHORROCKS B, 1994, J ANIM ECOL, V63, P799, DOI 10.2307/5257; Shurin JB, 2004, J THEOR BIOL, V227, P359, DOI 10.1016/j.jtbi.2003.11.013; Urban MC, 2004, ECOLOGY, V85, P2971, DOI 10.1890/03-0631; Weslien J, 2011, J ANIM ECOL, V80, P1155, DOI 10.1111/j.1365-2656.2011.01860.x; WILBUR HM, 1985, ECOLOGY, V66, P1106, DOI 10.2307/1939162; Young TP, 2001, ECOL RESTOR, V19, P5, DOI [10.3368/er.19.1.5, DOI 10.3368/ER.19.1.5]	33	11	12	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42651	10.1371/journal.pone.0042651	http://dx.doi.org/10.1371/journal.pone.0042651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880069	gold, Green Submitted, Green Published			2022-12-27	WOS:000307437900048
J	Wu, CY; Yeh, YC; Chan, JT; Yang, YC; Yang, JR; Liu, MT; Wu, HS; Hsiao, PW				Wu, Chia-Ying; Yeh, Yi-Chun; Chan, Jia-Tsrong; Yang, Yu-Chih; Yang, Ji-Rong; Liu, Ming-Tsan; Wu, Ho-Sheng; Hsiao, Pei-Wen			A VLP Vaccine Induces Broad-Spectrum Cross-Protective Antibody Immunity against H5N1 and H1N1 Subtypes of Influenza A Virus	PLOS ONE			English	Article							HELPER T-CELLS; HA2 GLYCOPOLYPEPTIDE; FUSION PEPTIDE; HEMAGGLUTININ; NEURAMINIDASE; MICE; PARTICLES; INFECTION; BINDING; ORIGIN	The recent threats of influenza epidemics and pandemics have prioritized the development of a universal vaccine that offers protection against a wider variety of influenza infections. Here, we demonstrate a genetically modified virus-like particle (VLP) vaccine, referred to as H5M2eN1-VLP, that increased the antigenic content of NA and induced rapid recall of antibody against HA(2) after viral infection. As a result, H5M2eN1-VLP vaccination elicited a broad humoral immune response against multiple viral proteins and caused significant protection against homologous RG-14 (H5N1) and heterologous A/California/07/2009 H1N1 (CA/07) and A/PR/8/34 H1N1 (PR8) viral lethal challenges. Moreover, the N1-VLP (lacking HA) induced production of a strong NA antibody that also conferred significant cross protection against H5N1 and heterologous CA/07 but not PR8, suggesting the protection against N1-serotyped viruses can be extended from avian-origin to CA/07 strain isolated in humans, but not to evolutionally distant strains of human-derived. By comparative vaccine study of an HA-based VLP (H5N1-VLP) and NA-based VLPs, we found that H5N1-VLP vaccination induced specific and strong protective antibodies against the HA(1) subunit of H5, thus restricting the breadth of cross-protection. In summary, we present a feasible example of direction of VLP vaccine immunity toward NA and HA(2), which resulted in cross protection against both seasonal and pandemic influenza strains, that could form the basis for future design of a better universal vaccine.	[Wu, Chia-Ying; Yeh, Yi-Chun; Yang, Yu-Chih; Yang, Ji-Rong; Hsiao, Pei-Wen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Chan, Jia-Tsrong] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Yang, Ji-Rong; Hsiao, Pei-Wen] Natl Taiwan Univ, Inst Biotechnol, Coll Bioresources & Agr, Taipei 10764, Taiwan; [Yang, Ji-Rong; Liu, Ming-Tsan; Wu, Ho-Sheng] Ctr Dis Control, Dept Hlth, Taipei, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; Centers For Disease Control - Taiwan	Wu, CY (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.	pwhsiao@gate.sinica.edu.tw	Hsiao, Pei-Wen/V-5653-2018	Hsiao, Pei-Wen/0000-0002-3589-6754	Genome Summit Project-III of Academia Sinica; National Science Council [NSC 95-2745-B-001-003]; Academia Sinica Postdoctoral Fellows Program	Genome Summit Project-III of Academia Sinica; National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica Postdoctoral Fellows Program	This study was financially supported by the Genome Summit Project-III of Academia Sinica (P. W. Hsiao), the National Science Council (NSC 95-2745-B-001-003), and the Academia Sinica Postdoctoral Fellows Program (C.Y. Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; Bot A, 1998, J VIROL, V72, P6637, DOI 10.1128/JVI.72.8.6637-6645.1998; Bright RA, 2009, VACCINE, V27, P6366, DOI 10.1016/j.vaccine.2009.02.084; Cassetti Maria Cristina, 2005, Vaccine, V23, P1529, DOI 10.1016/j.vaccine.2004.09.004; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Cohen FS, 2001, NAT STRUCT BIOL, V8, P653, DOI 10.1038/90341; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; Eichelberger M, 2008, VACCINE, V26, P4299, DOI 10.1016/j.vaccine.2008.06.012; Ghosh A, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-6; Gocnik M, 2008, J GEN VIROL, V89, P958, DOI 10.1099/vir.0.83524-0; Gocnik M, 2007, J GEN VIROL, V88, P951, DOI 10.1099/vir.0.82563-0; GRAVES PN, 1983, VIROLOGY, V126, P106, DOI 10.1016/0042-6822(83)90465-8; Horvath A, 1998, IMMUNOL LETT, V60, P127, DOI 10.1016/S0165-2478(97)00137-5; Huber VC, 2010, J VIROL, V84, P4105, DOI 10.1128/JVI.02621-09; JOHANSSON BE, 1987, P NATL ACAD SCI USA, V84, P6869, DOI 10.1073/pnas.84.19.6869; JOHANSSON BE, 1987, J IMMUNOL, V139, P2015; Khurana S, 2011, J VIROL, V85, P10945, DOI 10.1128/JVI.05406-11; Kilbourne E D, 1976, Hosp Pract, V11, P15; Kilbourne ED, 1976, HOSP PRACT, V11, P21; Lai JCC, 2010, J GEN VIROL, V91, P2322, DOI 10.1099/vir.0.019935-0; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Maurer-Stroh S, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-18; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; Price GE, 2000, J VIROL, V74, P3996, DOI 10.1128/JVI.74.9.3996-4003.2000; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Sandbulte MR, 2009, INFLUENZA OTHER RESP, V3, P233, DOI 10.1111/j.1750-2659.2009.00094.x; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Takahashi Y, 2009, J INFECT DIS, V199, P1629, DOI 10.1086/598954; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009784	35	36	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42363	10.1371/journal.pone.0042363	http://dx.doi.org/10.1371/journal.pone.0042363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879951	Green Published, gold, Green Submitted			2022-12-27	WOS:000307437900033
J	Haque, R; Chun, E; Howell, JC; Sengupta, T; Chen, D; Kim, H				Haque, Rashidul; Chun, Eugene; Howell, Jennifer C.; Sengupta, Trisha; Chen, Dan; Kim, Hana			MicroRNA-30b-Mediated Regulation of Catalase Expression in Human ARPE-19 Cells	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; ARYLALKYLAMINE N-ACETYLTRANSFERASE; MITOCHONDRIAL-DNA DAMAGE; OXIDATIVE STRESS; GENE-EXPRESSION; MICROARRAY ANALYSIS; OCULAR NEOVASCULARIZATION; MACULAR DEGENERATION; MESSENGER-RNA; HUMAN RPE	Background: Oxidative injury to retinal pigment epithelium (RPE) and retinal photoreceptors has been linked to a number of retinal diseases, including age-related macular degeneration (AMD). Reactive oxygen species (ROS)-mediated gene expression has been extensively studied at transcriptional levels. Also, the post-transcriptional control of gene expression at the level of translational regulation has been recently reported. However, the microRNA (miRNA/miR)-mediated post-transcriptional regulation in human RPE cells has not been thoroughly looked at. Increasing evidence points to a potential role of miRNAs in diverse physiological processes. Methodology/Principal Findings: We demonstrated for the first time in a human retinal pigment epithelial cell line (ARPE-19) that the post-transcriptional control of gene expression via miRNA modulation regulates human catalase, an important and potent component of cell's antioxidant defensive network, which detoxifies hydrogen peroxide (H2O2) radicals. Exposure to several stress-inducing agents including H2O2 has been reported to alter miRNA expression profile. Here, we demonstrated that a sublethal dose of H2O2 (200 mu M) up-regulated the expression of miR-30b, a member of the miR-30 family, which inhibited the expression of endogenous catalase both at the transcript and protein levels. However, antisense (antagomirs) of miR-30b was not only found to suppress the miR-30b mimics-mediated inhibitions, but also to dramatically increase the expression of catalase even under an oxidant environment. Conclusions/Significance: We propose that a microRNA antisense approach could enhance cytoprotective mechanisms against oxidative stress by increasing the antioxidant defense system.	[Haque, Rashidul; Chun, Eugene; Howell, Jennifer C.; Sengupta, Trisha; Chen, Dan; Kim, Hana] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA	Emory University	Haque, R (corresponding author), Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA.	rhaque@emory.edu			Research to Prevent Blindnes (RPB) [R01EY004864, P30EY006360]; NATIONAL EYE INSTITUTE [R01EY004864, P30EY006360] Funding Source: NIH RePORTER	Research to Prevent Blindnes (RPB); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Research to Prevent Blindnes (RPB), R01EY004864, P30EY006360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov JP, 2011, TOXICOL SCI, V120, P428, DOI 10.1093/toxsci/kfr007; Algvere PV, 2006, ACTA OPHTHALMOL SCAN, V84, P4, DOI 10.1111/j.1600-0420.2005.00627.x; Alizadeh M, 2001, INVEST OPHTH VIS SCI, V42, P2706; Babizhayev MA, 2010, AM J THER, V22, P22; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Ballinger SW, 1999, EXP EYE RES, V68, P765, DOI 10.1006/exer.1998.0661; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Burn DJ, 2006, CURR OPIN NEUROL, V19, P572, DOI 10.1097/01.wco.0000247607.34697.a2; Cai JY, 2000, PROG RETIN EYE RES, V19, P205, DOI 10.1016/S1350-9462(99)00009-9; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chaum E, 2009, J CELL BIOCHEM, V108, P1280, DOI 10.1002/jcb.22358; Davies MJ, 1999, FREE RADICAL BIO MED, V27, P1151, DOI 10.1016/S0891-5849(99)00206-3; Delcourt C, 1999, OPHTHALMOLOGY, V106, P215, DOI 10.1016/S0161-6420(99)90059-3; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Girard A, 2006, NUTRITION, V22, P758, DOI 10.1016/j.nut.2006.05.006; Guy J, 1998, P NATL ACAD SCI USA, V95, P13847, DOI 10.1073/pnas.95.23.13847; Haque R, 2011, J NEUROCHEM, V119, P6, DOI 10.1111/j.1471-4159.2011.07397.x; Haque R, 2010, J NEUROCHEM, V113, P1296, DOI 10.1111/j.1471-4159.2010.06698.x; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ho TC, 2006, APOPTOSIS, V11, P1899, DOI 10.1007/s10495-006-9403-6; Hollyfield JG, 2010, INVEST OPHTH VIS SCI, V51, P1276, DOI 10.1167/iovs.09-4478; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Kim Min-Ho, 2003, Korean J Ophthalmol, V17, P19; King A, 2004, PHOTOCHEM PHOTOBIOL, V79, P470, DOI 10.1562/LE-03-17.1; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Levine RL, 2002, FREE RADICAL BIO MED, V32, P790, DOI 10.1016/S0891-5849(02)00765-7; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P6308, DOI 10.1167/iovs.10-6632; Liu Xiqiang, 2009, Cancer Genomics & Proteomics, V6, P131; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Madsen-Bouterse SA, 2010, ANTIOXID REDOX SIGN, V13, P797, DOI 10.1089/ars.2009.2932; Meister G, 2007, CELL, V131, P25, DOI 10.1016/j.cell.2007.09.021; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; MICELI MV, 1994, EXP CELL RES, V214, P242, DOI 10.1006/excr.1994.1254; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nenoi M, 2001, CANCER RES, V61, P5885; Onyango Isaac G., 2006, Current Alzheimer Research, V3, P339, DOI 10.2174/156720506778249489; Rex TS, 2004, HUM GENE THER, V15, P960, DOI 10.1089/hum.2004.15.960; Sarna T, 2003, EXP EYE RES, V76, P89, DOI 10.1016/S0014-4835(02)00247-6; Schlieve CR, 2006, INVEST OPHTH VIS SCI, V47, P3878, DOI 10.1167/iovs.05-1010; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; STINSON AM, 1991, EXP EYE RES, V52, P213, DOI 10.1016/0014-4835(91)90261-C; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; TATE DJ, 1995, INVEST OPHTH VIS SCI, V36, P1271; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vandenbroucke K, 2008, MOL BIOL EVOL, V25, P507, DOI 10.1093/molbev/msm276; Weigel AL, 2002, FREE RADICAL BIO MED, V33, P1419, DOI 10.1016/S0891-5849(02)01082-1; Winkler BS, 1999, MOL VIS, V5; Wu JM, 2006, SURV OPHTHALMOL, V51, P461, DOI 10.1016/j.survophthal.2006.06.009; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	62	75	79	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42542	10.1371/journal.pone.0042542	http://dx.doi.org/10.1371/journal.pone.0042542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880027	Green Submitted, Green Published, gold			2022-12-27	WOS:000307810000044
J	Wan, X; Kim, MI; Kim, MJ; Kim, I				Wan, Xinlong; Kim, Man Il; Kim, Min Jee; Kim, Iksoo			Complete Mitochondrial Genome of the Free-Living Earwig, Challia fletcheri (Dermaptera: Pygidicranidae) and Phylogeny of Polyneoptera	PLOS ONE			English	Article							DNA-SEQUENCE; NUCLEOTIDE-SEQUENCE; GENE REARRANGEMENTS; CONTROL REGION; RICH REGION; ALIGNED 18S; ORGANIZATION; MODEL; HEXAPODA; INSECTA	The insect order Dermaptera, belonging to Polyneoptera, includes similar to 2,000 extant species, but no dermapteran mitochondrial genome has been sequenced. We sequenced the complete mitochondrial genome of the free-living earwig, Challia fletcheri, compared its genomic features to other available mitochondrial sequences from polyneopterous insects. In addition, the Dermaptera, together with the other known polyneopteran mitochondrial genome sequences (protein coding, ribosomal RNA, and transfer RNA genes), were employed to understand the phylogeny of Polyneoptera, one of the least resolved insect phylogenies, with emphasis on the placement of Dermaptera. The complete mitochondrial genome of C. fletcheri presents the following several unusual features: the longest size in insects is 20,456 bp; it harbors the largest tandem repeat units (TRU) among insects; it displays T- and G-skewness on the major strand and A- and C-skewness on the minor strand, which is a reversal of the general pattern found in most insect mitochondrial genomes, and it possesses a unique gene arrangement characterized by a series of gene translocations and/or inversions. The reversal pattern of skewness is explained in terms of inversion of replication origin. All phylogenetic analyses consistently placed Dermaptera as the sister to Plecoptera, leaving them as the most basal lineage of Polyneoptera or sister to Ephemeroptera, and placed Odonata consistently as the most basal lineage of the Pterygota.	[Wan, Xinlong; Kim, Man Il; Kim, Min Jee; Kim, Iksoo] Chonnam Natl Univ, Coll Agr & Life Sci, Kwangju, South Korea; [Kim, Man Il] Natl Forens Serv, Western Dist Off, Jangseong Gun, Jeonnam Do Prov, South Korea	Chonnam National University; National Forensic Service	Wan, X (corresponding author), Chonnam Natl Univ, Coll Agr & Life Sci, Kwangju, South Korea.	ikkim81@chonnam.ac.kr			National Institute of Biological Resources - "The Genetic Evaluation of Important Biological Resources"	National Institute of Biological Resources - "The Genetic Evaluation of Important Biological Resources"	This work was supported by research grants from the National Institute of Biological Resources - "The Genetic Evaluation of Important Biological Resources" awarded to Iksoo Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2003, SHIN TSUKUSHI KONCHU, V7, P41; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bae JS, 2004, MOL PHYLOGENET EVOL, V32, P978, DOI 10.1016/j.ympev.2004.03.009; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boudreaux H. B., 1979, ARTHROPOD PHYLOGENY; BOYCE TM, 1989, GENETICS, V123, P825; BROWN WM, 1985, MOL EVOLUTION GENETI; Cameron SL, 2006, MOL PHYLOGENET EVOL, V38, P274, DOI 10.1016/j.ympev.2005.09.020; Cameron SL, 2008, GENOME, V51, P800, DOI 10.1139/G08-066; Cameron SL, 2007, GENOME, V50, P188, DOI 10.1139/G06-148; Cameron SL, 2009, ZOOL SCR, V38, P575, DOI 10.1111/j.1463-6409.2009.00392.x; Carapelli A, 2005, CRUSTACEAN ISS, V16, P295, DOI 10.1201/9781420037548.ch12; Carapelli A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S8; Carpenter F. M., 1992, TREATISE INVERTEBRAT, V4; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cedric G, 2005, ENTOMOLOGY; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Comandi S, 2009, GENE, V439, P25, DOI 10.1016/j.gene.2009.02.020; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; DEBRUIJN MHL, 1983, NATURE, V304, P234, DOI 10.1038/304234a0; Doston EM, 2001, INSECT MOL BIOL, V10, P205; Dowton M, 1999, MOL BIOL EVOL, V16, P298, DOI 10.1093/oxfordjournals.molbev.a026111; Dowton M, 2001, TRENDS ECOL EVOL, V16, P269, DOI 10.1016/S0169-5347(01)02182-6; Dowton M, 2009, MOL BIOL EVOL, V26, P1607, DOI 10.1093/molbev/msp072; FAURON CMR, 1980, NUCLEIC ACIDS RES, V8, P2439, DOI 10.1093/nar/8.11.2439; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fenn JD, 2007, INSECT MOL BIOL, V16, P239, DOI 10.1111/j.1365-2583.2006.00721.x; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; Giles E. T., 1963, Transactions of the Royal Entomological Society of London, V115, P95; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gullan PJ, 2010, INSECT OUTLINE ENTOM, V4th; Haas F, 2000, ARTHROPOD STRUCT DEV, V29, P137, DOI 10.1016/S1467-8039(00)00025-6; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Hennig W., 1981, INSECT PHYLOGENY; Hennig W., 1969, STAMMESGESCHICHTE IN; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inohira K, 1997, MOL BIOL EVOL, V14, P814, DOI 10.1093/oxfordjournals.molbev.a025822; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kim MJ, 2011, MOL PHYLOGENET EVOL, V61, P436, DOI 10.1016/j.ympev.2011.07.013; Kim MJ, 2010, AFR J BIOTECHNOL, V9, P735; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kjer Karl M., 2006, Arthropod Systematics & Phylogeny, V64, P35; Kjer KM, 2004, SYST BIOL, V53, P506, DOI 10.1080/10635150490445922; Komoto N, 2012, GENOME, V55, P222, DOI [10.1139/g2012-007, 10.1139/G2012-007]; Kristensen N.P., 1991, P125; Kukalova-Peck J., 1991, P141; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lavrov DV, 2005, SYST BIOL, V54, P651, DOI 10.1080/10635150500221044; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Lin CP, 2010, GENE, V468, P20, DOI 10.1016/j.gene.2010.08.001; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-156; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Masta SE, 2009, MOL PHYLOGENET EVOL, V50, P117, DOI 10.1016/j.ympev.2008.10.010; Nardi F, 2003, SCIENCE, V299, P1887, DOI 10.1126/science.1078607; Nardi F, 2001, MOL BIOL EVOL, V18, P1293, DOI 10.1093/oxfordjournals.molbev.a003914; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Podsiadlowski L, 2006, GENE, V381, P49, DOI 10.1016/j.gene.2006.06.009; Podsiadlowski L, 2006, INSECT MOL BIOL, V15, P253, DOI 10.1111/j.1365-2583.2006.00640.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Sheffield NC, 2010, MITOCHONDR DNA, V21, P87, DOI 10.3109/19401736.2010.500812; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Silvestre D, 2006, GENET MOL BIOL, V29, P572, DOI 10.1590/S1415-47572006000300030; Simon S, 2009, MOL BIOL EVOL, V26, P2719, DOI 10.1093/molbev/msp191; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Terry MD, 2005, CLADISTICS, V21, P240, DOI 10.1111/j.1096-0031.2005.00062.x; Thao MLL, 2004, CURR MICROBIOL, V48, P140, DOI 10.1007/s00284-003-4157-7; Thompson J.D., 1997, NUCLEIC ACIDS RES, V24, P173; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; Willmann R, 2004, ASSEMBLING THE TREE OF LIFE, P330; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yoon Il-Byong, 1996, Korean Journal of Entomology, V26, P403; Yoshizawa K, 2005, MOL PHYLOGENET EVOL, V37, P572, DOI 10.1016/j.ympev.2005.05.008; Yoshizawa K, 2011, SYST ENTOMOL, V36, P377, DOI 10.1111/j.1365-3113.2011.00572.x; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024; Zhang JY, 2008, ANN ENTOMOL SOC AM, V101, P1131, DOI 10.1603/0013-8746-101.6.1131; Zhang YY, 2010, MOL BIOL REP, V37, P3509, DOI 10.1007/s11033-009-9944-1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	89	40	44	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42056	10.1371/journal.pone.0042056	http://dx.doi.org/10.1371/journal.pone.0042056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879905	Green Published, Green Submitted, gold			2022-12-27	WOS:000307810000013
J	Xia, CW; Lin, XL; Liu, W; Lloyd, H; Zhang, YY				Xia, Canwei; Lin, Xuanlong; Liu, Wei; Lloyd, Huw; Zhang, Yanyun			Acoustic Identification of Individuals within Large Avian Populations: A Case Study of the Brownish-Flanked Bush Warbler, South-Central China	PLOS ONE			English	Article							PENGUINS; BEHAVIOR; BIRDS; CALL; SONG	Acoustic identification is increasingly being used as a non-invasive method for identifying individuals within avian populations. However, most previous studies have utilized small samples of individuals (<30). The feasibility of using acoustic identification of individuals in larger avian populations has never been seriously tested. In this paper, we assess the feasibility of using distinct acoustic signals to identify individuals in a large avian population (139 colour-banded individuals) of Brownish-flanked Bush Warbler (Cettia fortipes) in the Dongzhai National Nature Reserve, south-central China. Most spectro-temporal variables we measured show greater variation among individuals than within individual. Although there was slight decline in the correct rate of individual identification with increasing sample sizes, the total mean correct rate yielded by discriminant function analysis was satisfactory, with more than 98% of songs correctly recognized to the corresponding individuals. We also found that using a part of randomly selected measured variables was sufficient to obtain a high correct rate of individual identification. We believe that our work will increase confidence in the use of using acoustic recognition techniques for avian population monitoring programs.	[Xia, Canwei; Lin, Xuanlong; Zhang, Yanyun] Beijing Normal Univ, Minist Educ, Key Lab Biodivers & Ecol Engn, Coll Life Sci, Beijing 100875, Peoples R China; [Liu, Wei] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Lloyd, Huw] Manchester Metropolitan Univ, Sch Sci & Environm, Div Biol & Conservat Ecol, Manchester M15 6BH, Lancs, England	Beijing Normal University; Chinese Academy of Sciences; Institute of Botany, CAS; Manchester Metropolitan University	Xia, CW (corresponding author), Beijing Normal Univ, Minist Educ, Key Lab Biodivers & Ecol Engn, Coll Life Sci, Beijing 100875, Peoples R China.	zhangyy@bnu.edu.cn			National Natural Science Foundation of China [31172098]; Foundation for Excellent Doctoral Dissertation of Beijing Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Excellent Doctoral Dissertation of Beijing Normal University	This work was supported by the National Natural Science Foundation of China (No. 31172098) and the Foundation for Excellent Doctoral Dissertation of Beijing Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunner P, 2010, J AVIAN BIOL, V41, P388, DOI 10.1111/j.1600-048X.2009.04967.x; Burgerhout E, 2011, NATURWISSENSCHAFTEN, V98, P631, DOI 10.1007/s00114-011-0805-0; Charrier I, 2003, MAR MAMMAL SCI, V19, P161, DOI 10.1111/j.1748-7692.2003.tb01099.x; Charrier I, 2001, POLAR BIOL, V24, P378, DOI 10.1007/s003000100231; Dawson DK, 2009, J APPL ECOL, V46, P1201, DOI 10.1111/j.1365-2664.2009.01731.x; DELHOYO A, 2006, HDB BIRDS WORLD, V11; Dixon A, 2011, VET REC, V169, P308, DOI 10.1136/vr.d5778; Dugger KM, 2006, AUK, V123, P858, DOI 10.1642/0004-8038(2006)123[858:EOFBOF]2.0.CO;2; Fox EJS, 2008, ANIM BEHAV, V75, P1187, DOI 10.1016/j.anbehav.2007.11.003; Klenova AV, 2009, J ETHOL, V27, P401, DOI 10.1007/s10164-008-0133-9; Laiolo P, 2007, J AVIAN BIOL, V38, P672, DOI 10.1111/j.2007.0908-8857.04006.x; Martens J, 1995, BONNER ZOOLOLOGISCHE, P38; Mennill DJ, 2011, IBIS, V153, P235, DOI 10.1111/j.1474-919X.2011.01119.x; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; Park SR, 2000, AUK, V117, P228, DOI 10.1642/0004-8038(2000)117[0228:STFIII]2.0.CO;2; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Terry Andrew M.R., 2005, Frontiers in Zoology, V2, P1; Thomas RJ, 1999, ANIM BEHAV, V57, P277, DOI 10.1006/anbe.1998.0956; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Wegrzyn E, 2009, ORNIS FENNICA, V86, P61; Xia CW, 2010, CONDOR, V112, P591, DOI 10.1525/cond.2010.090021	21	22	23	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42528	10.1371/journal.pone.0042528	http://dx.doi.org/10.1371/journal.pone.0042528			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880018	gold, Green Published, Green Submitted			2022-12-27	WOS:000307810000041
J	Boyd, CM; Vollenweider, D; Puhan, MA				Boyd, Cynthia M.; Vollenweider, Daniela; Puhan, Milo A.			Informing Evidence-Based Decision-Making for Patients with Comorbidity: Availability of Necessary Information in Clinical Trials for Chronic Diseases	PLOS ONE			English	Article							ELIGIBILITY CRITERIA; INDIVIDUAL PATIENTS; COMPETING RISKS; SELF-MANAGEMENT; HEART-FAILURE; PREVALENCE; OUTCOMES; QUALITY; CARE; MULTIMORBIDITY	Background: The population with multiple chronic conditions is growing. Prior studies indicate that patients with comorbidities are frequently excluded from trials but do not address whether information is available in trials to draw conclusions about treatment effects for these patients. Methods and Findings: We conducted a literature survey of trials from 11 Cochrane Reviews for four chronic diseases (diabetes, heart failure, chronic obstructive pulmonary disease, and stroke). The Cochrane Reviews systematically identified and summarized trials on the effectiveness of diuretics, metformin, anticoagulants, longacting beta-agonists alone or in combination with inhaled corticosteroids, lipid lowering agents, exercise and diet. Eligible studies were reports of trials included in the Cochrane reviews and additional papers that described the methods of these trials. We assessed the exclusion and inclusion of people with comorbidities, the reporting of comorbidities, and whether comorbidities were considered as potential modifiers of treatment effects. Overall, the replicability of both the inclusion criteria (mean [standard deviation (SD)]: 6.0 (2.1), range (min-max): 1-9.5) and exclusion criteria(mean(SD): 5.3 (2.1), range: 1-9.5) was only moderate. Trials excluded patients with many common comorbidities. The proportion of exclusions for comorbidities ranged from 042 percent for heart failure, 0-55 percent for COPD, 0-44 percent for diabetes, and 0-39 percent for stroke. Seventy of the 161 trials (43.5%) described the prevalence of any comorbidity among participants with the index disease. The reporting of comorbidities in trials was very limited, in terms of reporting an operational definition and method of ascertainment for the presence of comorbidity and treatments for the comorbidity. It was even less common that the trials assessed whether comorbidities were potential modifiers of treatment effects. Conclusions: Comorbidities receive little attention in chronic disease trials. Given the public health importance of people with multiple chronic conditions, trials should better report on comorbidities and assess the effect comorbidities have on treatment outcomes.	[Boyd, Cynthia M.] Johns Hopkins Univ, Dept Med, Div Geriatr Med & Gerontol, Baltimore, MD 21218 USA; [Vollenweider, Daniela] Johns Hopkins Univ, Dept Med, Div Gen Internal Med, Baltimore, MD USA; [Puhan, Milo A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Boyd, CM (corresponding author), Johns Hopkins Univ, Dept Med, Div Geriatr Med & Gerontol, Baltimore, MD 21218 USA.	cyboyd@jhmi.edu	Puhan, Milo/ABE-6298-2020	Puhan, Milo/0000-0003-4721-1879	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R21HS018597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG032910] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Algra A, 2006, COCHRANE DB SYST REV, V3; [Anonymous], 2010, MULT CHRON COND STRA; Appleton S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001104.pub2; Bayliss EA, 2007, ANN FAM MED, V5, P395, DOI 10.1370/afm.722; Blumle A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1828; Boyd C, 2010, FULL REPORT CLARIFYI, V19; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Boyd CM, 2010, PUBLIC HEALTH REV, V32, P451, DOI 10.1007/BF03391611; Boyd CM, 2011, J AM GERIATR SOC, V59, P797, DOI 10.1111/j.1532-5415.2011.03391.x; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Davies EJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003331.pub3; Druss BG, 2002, HEALTH AFFAIR, V21, P105, DOI 10.1377/hlthaff.21.4.105; Druss BG, 2001, HEALTH AFFAIR, V20, P233, DOI 10.1377/hlthaff.20.6.233; Faris R, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003838.PUB2; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Greenfield S, 2009, ANN INTERN MED, V151, P854, DOI 10.7326/0003-4819-151-12-200912150-00005; Harrison M, 2012, PATIENT EDUC COUNS, V87, P67, DOI 10.1016/j.pec.2011.06.007; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; Hurria A, 2011, J CLIN ONCOL, V29, P4217, DOI 10.1200/JCO.2011.37.5717; Jadad AR, 2011, JAMA-J AM MED ASSOC, V306, P2670, DOI 10.1001/jama.2011.1886; Kent D, 2008, NEW ENGL J MED, V358, P1199; Kent D, 2007, AM SCI, V95, P60, DOI 10.1511/2007.63.1016; Kent DM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-30; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Kent DM, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-48; Koller MT, 2012, STAT MED, V31, P1089, DOI 10.1002/sim.4384; Kravitz RL, 2004, MILBANK Q, V82, P661, DOI 10.1111/j.0887-378X.2004.00327.x; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; Lugtenberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025987; Manktelow BN, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002091.pub2; Nannini LJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006829; Organisation of Economic Cooperation and Development, 50 ANN C; Orozco LJ, 2008, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003054.PUB3; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Ring A, 2011, J CLIN ONCOL, V29, P4266, DOI 10.1200/JCO.2011.35.5545; Saenz A, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002966.PUB3; Saunders DH, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003316.PUB2; Schnell K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-26; Smith SM, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X514756; Stanton MW., 2006, HIGH CONCENTRATION U; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; Varadhan R, 2010, MED CARE, V48, pS96, DOI 10.1097/MLR.0b013e3181d99107; Vollenweider D, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-73; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Weiss CO, 2007, JAMA-J AM MED ASSOC, V298, P1160, DOI 10.1001/jama.298.10.1160-a; Weiss CO, 2011, AGING CLIN  IN PRESS; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007	53	74	75	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41601	10.1371/journal.pone.0041601	http://dx.doi.org/10.1371/journal.pone.0041601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22870234	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100023
J	Frick, C; Lang, S; Kotchoubey, B; Sieswerda, S; Dinu-Biringer, R; Berger, M; Veser, S; Essig, M; Barnow, S				Frick, Carina; Lang, Simone; Kotchoubey, Boris; Sieswerda, Simkje; Dinu-Biringer, Ramona; Berger, Moritz; Veser, Sandra; Essig, Marco; Barnow, Sven			Hypersensitivity in Borderline Personality Disorder during Mindreading	PLOS ONE			English	Article							MENTALIZATION-BASED TREATMENT; FACIAL EXPRESSIONS; NORMAL ADULTS; EMOTION; RECOGNITION; MIND; BRAIN; EYES; INTELLIGENCE; EMPATHY	Background: One of the core symptoms of borderline personality disorder (BPD) is the instability in interpersonal relationships. This might be related to existent differences in mindreading between BPD patients and healthy individuals. Methods: We examined the behavioural and neurophysiological (fMRI) responses of BPD patients and healthy controls (HC) during performance of the 'Reading the Mind in the Eyes' test (RMET). Results: Mental state discrimination was significantly better and faster for affective eye gazes in BPD patients than in HC. At the neurophysiological level, this was manifested in a stronger activation of the amygdala and greater activity of the medial frontal gyrus, the left temporal pole and the middle temporal gyrus during affective eye gazes. In contrast, HC subjects showed a greater activation in the insula and the superior temporal gyri. Conclusion: These findings indicate that BPD patients are highly vigilant to social stimuli, maybe because they resonate intuitively with mental states of others.	[Frick, Carina; Lang, Simone; Sieswerda, Simkje; Dinu-Biringer, Ramona; Berger, Moritz; Barnow, Sven] Heidelberg Univ, Dept Clin Psychol & Psychotherapy, Heidelberg, Germany; [Kotchoubey, Boris; Veser, Sandra] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Berger, Moritz; Essig, Marco] German Canc Res Ctr, Heidelberg, Germany; [Essig, Marco] Univ Erlangen Nurnberg, Dept Neuroradiol, D-91054 Erlangen, Germany	Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); University of Erlangen Nuremberg	Frick, C (corresponding author), Heidelberg Univ, Dept Clin Psychol & Psychotherapy, Heidelberg, Germany.	simone.lang@googlemail.com		essig, marco/0000-0002-7964-2297; Gerigk, Carina/0000-0003-2400-6530	European Union Grant DECODER	European Union Grant DECODER	The study was partially supported by the European Union Grant DECODER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Barnow S, 2009, BIOL PSYCHIAT, V65, P313, DOI 10.1016/j.biopsych.2008.08.016; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; Bateman A, 2010, WORLD PSYCHIATRY, V9, P11, DOI 10.1002/j.2051-5545.2010.tb00255.x; Bland Ann R, 2004, Issues Ment Health Nurs, V25, P655, DOI 10.1080/01612840490486692; Calarge C, 2003, AM J PSYCHIAT, V160, P1954, DOI 10.1176/appi.ajp.160.11.1954; Dadds MR, 2006, BRIT J PSYCHIAT, V2, P189; Donegan NH, 2003, BIOL PSYCHIAT, V54, P1284, DOI 10.1016/S0006-3223(03)00636-X; Eizirik M, 2009, REV BRAS PSIQUIATR, V31, P72, DOI 10.1590/S1516-44462009000100016; Fertuck EA, 2009, PSYCHOL MED, V39, P1979, DOI 10.1017/S003329170900600X; Fonagy P, 2008, J PERS DISORD, V22, P4, DOI 10.1521/pedi.2008.22.1.4; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Fydrich T., 1997, SKID 2 STRUKTURIERTE; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Ghiassi V, 2010, PSYCHOTHER RES, V20, P657, DOI 10.1080/10503307.2010.501040; Guitart-Masip M, 2009, PROG NEURO-PSYCHOPH, V33, P1537, DOI 10.1016/j.pnpbp.2009.08.022; Gunderson JG, 2007, AM J PSYCHIAT, V164, P1637, DOI 10.1176/appi.ajp.2007.07071125; HARVEY PD, 1989, J CLIN PSYCHOL, V45, P786, DOI 10.1002/1097-4679(198909)45:5<786::AID-JCLP2270450515>3.0.CO;2-P; Herpertz SC, 2001, BIOL PSYCHIAT, V50, P292, DOI 10.1016/S0006-3223(01)01075-7; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Jehna M, 2011, BRAIN RES, V1393, P73, DOI 10.1016/j.brainres.2011.04.007; Juruena MF, 2010, J INT NEUROPSYCH SOC, V16, P383, DOI 10.1017/S1355617709991172; Kawashima R, 1999, BRAIN, V122, P779, DOI 10.1093/brain/122.4.779; Koenigsberg HW, 2009, PSYCHIAT RES-NEUROIM, V172, P192, DOI 10.1016/j.pscychresns.2008.07.010; Koenigsberg HW, 2002, AM J PSYCHIAT, V159, P784, DOI 10.1176/appi.ajp.159.5.784; KROHN A, 1974, INT J PSYCHOANAL PSY, V3, P142; Kuhner C., 2006, DTSCH BEARBEITUNG HD, VII; Lang S, 2012, NEUROIMAGE, V59, P1727, DOI 10.1016/j.neuroimage.2011.08.061; Lang S, 2011, COGN AFFECT BEHAV NE, V11, P386, DOI 10.3758/s13415-011-0035-0; Levine D, 1997, J NERV MENT DIS, V185, P240, DOI 10.1097/00005053-199704000-00004; Limberg A, 2011, BIOL PSYCHIAT, V69, P574, DOI 10.1016/j.biopsych.2010.10.024; Linehan M. M., 1993, COGNITIVE BEHAV TREA; Lynch TR, 2006, EMOTION, V6, P647, DOI 10.1037/1528-3542.6.4.647; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Minzenberg MJ, 2007, PSYCHIAT RES-NEUROIM, V155, P231, DOI 10.1016/j.pscychresns.2007.03.006; Minzenberg MJ, 2006, J NERV MENT DIS, V194, P341, DOI 10.1097/01.nmd.0000218341.54333.4e; Minzenberg MJ, 2006, COMPR PSYCHIAT, V47, P468, DOI 10.1016/j.comppsych.2006.03.005; Morris JS, 2002, NEUROIMAGE, V17, P214, DOI 10.1006/nimg.2002.1220; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paris Joel, 2005, Ann Clin Psychiatry, V17, P41, DOI 10.1080/10401230590905461; Preissler S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00182; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rizzolatti G, 1999, ARCH ITAL BIOL, V137, P85; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schilling L, 2012, PSYCHIAT CLIN NEUROS, V66, P322, DOI 10.1111/j.1440-1819.2012.02334.x; Scott LN, 2011, PERSONAL DISORD, V2, P98, DOI 10.1037/a0020011; Sharp C, 2011, J AM ACAD CHILD PSY, V50, P563, DOI 10.1016/j.jaac.2011.01.017; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Spitzer RL, 1990, STRUCTURED CLIN INTE; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Unoka Z, 2011, PSYCHIAT RES, V189, P419, DOI 10.1016/j.psychres.2011.02.010; Wagner AW, 1999, J PERS DISORD, V13, P329, DOI 10.1521/pedi.1999.13.4.329	57	105	106	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41650	10.1371/journal.pone.0041650	http://dx.doi.org/10.1371/journal.pone.0041650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22870240	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100027
J	Gras, LM; Smid, JH; Wagenaar, JA; de Boer, AG; Havelaar, AH; Friesema, IHM; French, NP; Busani, L; van Pelt, W				Gras, Lapo Mughini; Smid, Joost H.; Wagenaar, Jaap A.; de Boer, Albert G.; Havelaar, Arie H.; Friesema, Ingrid H. M.; French, Nigel P.; Busani, Luca; van Pelt, Wilfrid			Risk Factors for Campylobacteriosis of Chicken, Ruminant, and Environmental Origin: A Combined Case-Control and Source Attribution Analysis	PLOS ONE			English	Article							FRAGMENT LENGTH POLYMORPHISM; DISEASE BURDEN; JEJUNI CLONES; NETHERLANDS; INFECTIONS; COLI; HUMANS; IDENTIFICATION; ASSOCIATION; PREVALENCE	Background: Campylobacteriosis contributes strongly to the disease burden of food-borne pathogens. Case-control studies are limited in attributing human infections to the different reservoirs because they can only trace back to the points of exposure, which may not point to the original reservoirs because of cross-contamination. Human Campylobacter infections can be attributed to specific reservoirs by estimating the extent of subtype sharing between strains from humans and reservoirs using multilocus sequence typing (MLST). Methodology/Principal Findings: We investigated risk factors for human campylobacteriosis caused by Campylobacter strains attributed to different reservoirs. Sequence types (STs) were determined for 696 C. jejuni and 41 C. coli strains from endemic human cases included in a case-control study. The asymmetric island model, a population genetics approach for modeling Campylobacter evolution and transmission, attributed these cases to four putative animal reservoirs (chicken, cattle, sheep, pig) and to the environment (water, sand, wild birds) considered as a proxy for other unidentified reservoirs. Most cases were attributed to chicken (66%) and cattle (21%), identified as the main reservoirs in The Netherlands. Consuming chicken was a risk factor for campylobacteriosis caused by chicken-associated STs, whereas consuming beef and pork were protective. Risk factors for campylobacteriosis caused by ruminant-associated STs were contact with animals, barbecuing in non-urban areas, consumption of tripe, and never/seldom chicken consumption. Consuming game and swimming in a domestic swimming pool during springtime were risk factors for campylobacteriosis caused by environment-associated STs. Infections with chicken-and ruminant-associated STs were only partially explained by food-borne transmission; direct contact and environmental pathways were also important. Conclusion/Significance: This is the first case-control study in which risk factors for campylobacteriosis are investigated in relation to the attributed reservoirs based on MLST profiles. Combining epidemiological and source attribution data improved campylobacteriosis risk factor identification and characterization, generated hypotheses, and showed that genotype-based source attribution is epidemiologically sensible.	[Gras, Lapo Mughini; Busani, Luca] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Gras, Lapo Mughini; Smid, Joost H.; Havelaar, Arie H.; Friesema, Ingrid H. M.; van Pelt, Wilfrid] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, RIVM, NL-3720 BA Bilthoven, Netherlands; [Gras, Lapo Mughini] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Wagenaar, Jaap A.; de Boer, Albert G.] Cent Vet Inst Wageningen UR, Dept Bacteriol, Lelystad, Netherlands; [Wagenaar, Jaap A.; de Boer, Albert G.] TSEs, Lelystad, Netherlands; [Wagenaar, Jaap A.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Wagenaar, Jaap A.] World Hlth Org Collaborating Ctr Reference & Res, OIE Reference Lab Campylobacteriosis, Lelystad, Netherlands; [Havelaar, Arie H.] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [French, Nigel P.] Massey Univ, Infect Dis Res Ctr, Palmerston North, New Zealand	Istituto Superiore di Sanita (ISS); Netherlands National Institute for Public Health & the Environment; University of Bologna; Wageningen University & Research; Utrecht University; World Health Organization; Utrecht University; Massey University	Gras, LM (corresponding author), Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, Viale Regina Elena 299, I-00161 Rome, Italy.	lapo.mughinigras2@unibo.it	French, Nigel/F-5725-2011; Busani, Luca/J-9253-2012; Havelaar, Arie H./P-8495-2014; Friesema, Ingrid HM/H-6601-2019	French, Nigel/0000-0002-6334-0657; Busani, Luca/0000-0002-6081-2794; Havelaar, Arie H./0000-0002-6456-5460; Friesema, Ingrid HM/0000-0001-9943-0518	Italian Ministry of Health - Centro di Controllo delle Malattie [9254]	Italian Ministry of Health - Centro di Controllo delle Malattie	LMG receives a PhD grant from the Italian Ministry of Health - Centro di Controllo delle Malattie "Stima di base dell'incidenza delle gastroenteriti acute in Italia e integrazione dei dati di notifica, ricovero e laboratorio per la valutazione dell'impatto sulla salute" (Grant no. 9254 Jan 14 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acke E, 2006, VET REC, V158, P51, DOI 10.1136/vr.158.2.51; Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1437; Ang CW, 2011, EPIDEMIOL INFECT, V139, P1361, DOI 10.1017/S0950268810002359; Bessell PR, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-80; de Jong AEI, 2008, J APPL MICROBIOL, V105, P615, DOI 10.1111/j.1365-2672.2008.03778.x; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; Doorduyn Y, 2008, EPIDEMIOL INFECT, V136, P1225, DOI 10.1017/S095026880700996X; Doorduyn Y, 2006, EPIDEMIOL INFECT, V134, P617, DOI 10.1017/S0950268805005406; Doorduyn Y, 2010, EPIDEMIOL INFECT, V138, P1391, DOI 10.1017/S095026881000052X; Duim B, 2003, J CLIN MICROBIOL, V41, P5593, DOI 10.1128/JCM.41.12.5593-5597.2003; EFSA (European Food Safety Authority), 2009, EFSA J, V7, P358, DOI [10.2903/j.efsa.2009.1438, DOI 10.2903/J.EFSA.2009.1438, 10.2903/j.efsa.2010.1496]; European Food Safety Authority, 2011, EFSA Journal, V9, P2090; Fermer C, 1999, J CLIN MICROBIOL, V37, P3370; Fitch BR, 2005, J CLIN MICROBIOL, V43, P4221, DOI 10.1128/JCM.43.8.4221-4224.2005; French N, 2005, ENVIRON MICROBIOL, V7, P1116, DOI 10.1111/j.1462-2920.2005.00782.x; Friesema IHM, 2011, EPIDEMIOL INFECT, V139, P1081, DOI 10.1017/S0950268810002050; Friesema IHM, 2012, EMERG INFECT DIS, V18, P466, DOI 10.3201/eid1803.111024; Haagsma JA, 2010, EPIDEMIOL INFECT, V138, P1650, DOI 10.1017/S0950268810000531; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Jones K, 2001, J APPL MICROBIOL, V90, p68S, DOI 10.1046/j.1365-2672.2001.01355.x; Kapperud G, 2003, AM J EPIDEMIOL, V158, P234, DOI 10.1093/aje/kwg139; Karenlampi R, 2007, APPL ENVIRON MICROB, V73, P148, DOI 10.1128/AEM.01488-06; Korczak BM, 2009, J CLIN MICROBIOL, V47, P1996, DOI 10.1128/JCM.00237-09; Mangen M. J. J., 2005, Acta Agricultura Scandinavica. Section C, Food Economics, V2, P35, DOI 10.1080/16507540510033451; Manning G, 2003, APPL ENVIRON MICROB, V69, P6370, DOI 10.1128/AEM.69.11.6370-6379.2003; Marshall SM, 1999, J CLIN MICROBIOL, V37, P4158, DOI 10.1128/JCM.37.12.4158-4160.1999; McCarthy ND, 2007, EMERG INFECT DIS, V13, P267, DOI 10.3201/eid1302.060620; McTavish SM, 2008, EPIDEMIOL INFECT, V136, P1244, DOI 10.1017/S0950268807009892; Mullner P, 2010, EPIDEMIOL INFECT, V138, P1372, DOI 10.1017/S0950268809991579; Mullner P, 2009, INFECT GENET EVOL, V9, P1311, DOI 10.1016/j.meegid.2009.09.003; Mullner P, 2009, RISK ANAL, V29, P970, DOI 10.1111/j.1539-6924.2009.01224.x; Neimann J, 2003, EPIDEMIOL INFECT, V130, P353, DOI 10.1017/S0950268803008355; Pires SM, 2009, FOODBORNE PATHOG DIS, V6, P417, DOI 10.1089/fpd.2008.0208; Rijksinstituut voor Volksgezondheid en Milieu, 2011, STAAT ZOON 2010; Rubin DB, 2004, MULTIPLE IMPUTATION; Ruiter H, 2004, CAMPYLOBACTER WATER; Schouls LM, 2003, J CLIN MICROBIOL, V41, P15, DOI 10.1128/JCM.41.1.15-26.2003; Sheppard SK, 2010, APPL ENVIRON MICROB, V76, P5269, DOI 10.1128/AEM.00124-10; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Smid JH, 2009, 15 INT WORKSH CAMP H; Stafford RJ, 2007, EPIDEMIOL INFECT, V135, P978, DOI 10.1017/S0950268806007576; Strachan NJC, 2009, J INFECT DIS, V199, P1205, DOI 10.1086/597417; Studahl A, 2000, EPIDEMIOL INFECT, V125, P269, DOI 10.1017/S0950268899004562; Sturmer T, 2001, EPIDEMIOLOGY, V12, P101; Swift L, 2004, EUR J EPIDEMIOL, V19, P219, DOI 10.1023/B:EJEP.0000020453.84296.f6; van Asselt ED, 2008, POULTRY SCI, V87, P2166, DOI 10.3382/ps.2007-00520; van Pelt W, 2003, EPIDEMIOL INFECT, V130, P431, DOI 10.1017/S0950268803008392; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203	51	132	132	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42599	10.1371/journal.pone.0042599	http://dx.doi.org/10.1371/journal.pone.0042599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880049	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100139
J	Heng, TSP; Reiseger, JJ; Fletcher, AL; Leggatt, GR; White, OJ; Vlahos, K; Frazer, IH; Turner, SJ; Boyd, RL				Heng, Tracy S. P.; Reiseger, Jessica J.; Fletcher, Anne L.; Leggatt, Graham R.; White, Olivia J.; Vlahos, Katerina; Frazer, Ian H.; Turner, Stephen J.; Boyd, Richard L.			Impact of Sex Steroid Ablation on Viral, Tumour and Vaccine Responses in Aged Mice	PLOS ONE			English	Article							INFLUENZA; DIVERSITY; TRANSPLANTATION; REGENERATION; LYMPHOCYTES; GENERATION; INDUCTION; CELLS	Recent evidence suggests that the decline in resistance to viral infections with age occurs predominantly as a result of a gradual loss of naive antigen-specific T cells. As such, restoration of the naive T cell repertoire to levels seen in young healthy adults may improve defence against infection in the aged. We have previously shown that sex steroid ablation (SSA) rejuvenates the ageing thymus and increases thymic export of naive T cells, but it remains unclear whether T cell responses are improved. Using mouse models of clinically relevant diseases, we now demonstrate that SSA increases the number of naive T cells able to respond to antigen, thereby enhancing effector responses in aged mice. Specifically, aged mice exhibit a delay in clearing influenza A virus, which correlates with diminished specific cytotoxic activity. This is due to a decreased magnitude of response and not an intrinsic defect in effector T cell function. Upon SSA, aged mice exhibit increased T cell responsiveness that restores efficient viral clearance. We further demonstrate that SSA decreases the incidence of an inducible tumour in aged mice and can potentially increase their responsiveness to a low-dose human papillomavirus vaccine in clearing pre-formed tumours. As thymectomy abrogates the increase in T cell numbers and responsiveness following SSA, we propose that the T cell effects of SSA are dependent on thymic reactivation and subsequent replenishment of the peripheral T cell pool with newly emigrated naive T cells. These findings have important implications for strategies to improve protection from infection and responsiveness to vaccination in the aged.	[Heng, Tracy S. P.; Reiseger, Jessica J.; Fletcher, Anne L.; Vlahos, Katerina; Boyd, Richard L.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia; [Fletcher, Anne L.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Leggatt, Graham R.; White, Olivia J.; Frazer, Ian H.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Woolloongabba, Qld, Australia; [Turner, Stephen J.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Monash University; Harvard University; Dana-Farber Cancer Institute; University of Queensland; University of Melbourne	Heng, TSP (corresponding author), Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia.	tracy.heng@monash.edu; richard.boyd@monash.edu	Turner, Stephen/GXM-4654-2022; Heng, Tracy/B-9847-2015; Leggatt, Graham/G-1924-2010; Heng, Tracy/AAR-5712-2021; Frazer, Ian/A-1137-2007	Heng, Tracy/0000-0003-4147-8986; Leggatt, Graham/0000-0002-4078-5653; Heng, Tracy/0000-0003-4147-8986; Turner, Stephen/0000-0002-1002-0000; Fletcher, Anne/0000-0003-1534-1142; Frazer, Ian/0000-0002-8002-4680	Australian National Health and Medical Research Council; Norwood Immunology Ltd; NHMRC RD Wright Fellowship; Pfizer Senior Research Fellowship; Queensland Government Smart State Fellowship	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Norwood Immunology Ltd; NHMRC RD Wright Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Pfizer Senior Research Fellowship; Queensland Government Smart State Fellowship	This work was supported by program grants from the Australian National Health and Medical Research Council, Norwood Immunology Ltd, an NHMRC RD Wright Fellowship and Pfizer Senior Research Fellowship to ST, and a Queensland Government Smart State Fellowship to IF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN W, 1990, J IMMUNOL, V144, P3980; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; BENDER BS, 1991, IMMUNOLOGY, V72, P514; CASTRO JE, 1974, PROC R SOC SER B-BIO, V186, P387, DOI 10.1098/rspb.1974.0056; Dudakov JA, 2009, J IMMUNOL, V182, P6247, DOI 10.4049/jimmunol.0802446; Fernando GJP, 1998, J IMMUNOL, V161, P2421; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Goronzy JJ, 2005, CURR OPIN IMMUNOL, V17, P468, DOI 10.1016/j.coi.2005.07.020; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009; Heng TSP, 2010, CURR OPIN PHARMACOL, V10, P425, DOI 10.1016/j.coph.2010.04.006; Heng TSP, 2005, J IMMUNOL, V175, P2982, DOI 10.4049/jimmunol.175.5.2982; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Lin KY, 1996, CANCER RES, V56, P21; Mbawuike Innocent N., 1993, Viral Immunology, V6, P55, DOI 10.1089/vim.1993.6.55; McElhaney JE, 2005, VACCINE, V23, P3294, DOI 10.1016/j.vaccine.2005.01.080; Po JLZ, 2002, MECH AGEING DEV, V123, P1167, DOI 10.1016/S0047-6374(02)00010-6; POTTER M, 1962, NATURE, V193, P1086, DOI 10.1038/1931086a0; Roden AC, 2004, J IMMUNOL, V173, P6098, DOI 10.4049/jimmunol.173.10.6098; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; Sutherland JS, 2008, CLIN CANCER RES, V14, P1138, DOI 10.1158/1078-0432.CCR-07-1784; Sutherland JS, 2005, J IMMUNOL, V175, P2741, DOI 10.4049/jimmunol.175.4.2741; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Valkenburg SA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002544; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140	28	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42677	10.1371/journal.pone.0042677	http://dx.doi.org/10.1371/journal.pone.0042677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880080	Green Published, gold			2022-12-27	WOS:000307284100156
J	Meyer, JP; Qiu, JJ; Chen, NE; Larkin, GL; Altice, FL				Meyer, Jaimie P.; Qiu, Jingjun; Chen, Nadine E.; Larkin, Gregory L.; Altice, Frederick L.			Emergency Department Use by Released Prisoners with HIV: An Observational Longitudinal Study	PLOS ONE			English	Article							DISORDERS IDENTIFICATION TEST; HUMAN-IMMUNODEFICIENCY-VIRUS; HEALTH-SERVICES UTILIZATION; SUBSTANCE-ABUSE TREATMENT; ADDICTION SEVERITY INDEX; ANTIRETROVIRAL THERAPY; INFECTED PRISONERS; VULNERABLE POPULATIONS; BEHAVIORAL-MODEL; PHYSICIAN SCALE	Background: Many people living with HIV access healthcare systems through the emergency department (ED), and increased ED use may be indicative of disenfranchisement with primary HIV care, under-managed comorbid disease, or coincide with use of other healthcare resources. The goal of this study was to investigate ED use by HIV-infected prisoners transitioning to communities. Methods: We evaluated ED use by 151 HIV-infected released prisoners who were enrolled in a randomized controlled trial of directly administered versus self-administered antiretroviral therapy in Connecticut. Primary outcomes were quantity and type of ED visits and correlates of ED use were evaluated with multivariate models by Poisson regression. Results: In the 12 months post-release, there were 227 unique ED contacts made by 85/151 (56%) subjects. ED visits were primarily for acute febrile syndromes (32.6%) or pain (20.3%), followed by substance use issues (19.4%), trauma (18%), mental illness (11%), and social access issues (4.4%). Compared to those not utilizing the ED, users were more likely to be white, older, and unmarried, with less trust in their physician and poorer perceived physical health but greater social support. In multivariate models, ED use was correlated with moderate to severe depression (IRR = 1.80), being temporarily housed (IRR = 0.54), and alcohol addiction severity (IRR = 0.21) but not any surrogates of HIV severity. Conclusions: EDs are frequent sources of care after prison-release with visits often reflective of social and psychiatric instability. Future interventions should attempt to fill resource gaps, engage released prisoners in continuous HIV care, and address these substantial needs.	[Meyer, Jaimie P.; Qiu, Jingjun; Chen, Nadine E.; Altice, Frederick L.] Yale Univ, Sch Med, Dept Med, AIDS Program, New Haven, CT 06510 USA; [Larkin, Gregory L.] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT USA; [Larkin, Gregory L.] Univ Auckland, Sch Med, Dept Surg, Div Emergency Med, Auckland, New Zealand; [Chen, Nadine E.] Univ Calif San Diego, Sch Med, Dept Med, Div Global Publ Hlth, San Diego, CA 92103 USA; [Altice, Frederick L.] Yale Univ, Sch Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT USA	Yale University; Yale University; University of Auckland; University of California System; University of California San Diego; Yale University	Meyer, JP (corresponding author), Yale Univ, Sch Med, Dept Med, AIDS Program, New Haven, CT 06510 USA.	jaimie.meyer@yale.edu	Meyer, Jaimie/U-1582-2019	Meyer, Jaimie/0000-0001-5735-385X; LARKIN, GREGORY LUKE/0000-0002-8655-7824	National Institute on Drug Abuse [R01 DA017059, K24 DA017072, K23 DA033858]; National Institutes of Allergy and Infectious Diseases [T32 AI007517]; National Institute of Mental Health [T32 MH020031]; American Foundation for Suicide Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007517, R01AI041440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072, K23DA033858, R01DA017059] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); American Foundation for Suicide Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Primary funding for this research was provided by the National Institute on Drug Abuse (R01 DA017059, FLA). The authors would also like to acknowledge career development funding from the National Institutes of Allergy and Infectious Diseases (T32 AI007517 for JPM), the National Institute of Mental Health (T32 MH020031 for JPM), the National Institute on Drug Abuse (K24 DA017072 for FLA and K23 DA033858 for JPM) and the American Foundation for Suicide Prevention (Distinguished Investigator Award for GLL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Aday LA, 1997, HDB HLTH BEHAV RES; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Altice F, 2011, DAART SUPERIOR SELF; Altice FL, 2007, CLIN INFECT DIS, V45, P770, DOI 10.1086/521166; Andersen R, 1968, BEHAV MODELS FAMILIE; ANDERSON LA, 1990, PSYCHOL REP, V67, P1091, DOI 10.2466/pr0.1990.67.3f.1091; Baillargeon J, 2008, JAMA-J AM MED ASSOC, V98, P661; Baillargeon J, 2010, AIDS PATIENT CARE ST, V24, P389, DOI 10.1089/apc.2009.0303; Baillargeon J, 2009, JAMA-J AM MED ASSOC, V301, P848, DOI 10.1001/jama.2009.202; Baillargeon JG, 2010, PUBLIC HEALTH REP, V125, P64, DOI 10.1177/00333549101250S109; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Browne A, 1999, INT J LAW PSYCHIAT, V22, P301, DOI 10.1016/S0160-2527(99)00011-4; Chen NE, 2011, AIDS BEHAV; Connecticut Department of Correction, 2011, STATISTICS; Cunningham WE, 2006, MED CARE, V44, P1038, DOI 10.1097/01.mlr.0000242942.17968.69; D'Amore J, 2001, ACAD EMERG MED, V8, P1051, DOI 10.1111/j.1553-2712.2001.tb01114.x; Frank J, 2012, C EM DEP UT MENT HLT; Freburger JK, 2003, ARTHRIT RHEUM-ARTHR, V49, P51, DOI 10.1002/art.10925; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Huba G, 1996, MODULE 46 SOCIAL SUP; James D, 2005, SUBSTANCE DEPENDENCE; James D. J., 2006, HIGHLIGHTS MENTAL HL; Josephs JS, 2010, HIV MED, V11, P74, DOI 10.1111/j.1468-1293.2009.00748.x; Kidder DP, 2007, AM J PUBLIC HEALTH, V97, P2238, DOI 10.2105/AJPH.2006.090209; Leserman J, 2005, PSYCHOSOM MED, V67, P500, DOI 10.1097/01.psy.0000160459.78182.d9; Liebschutz JM, 2000, ARCH INTERN MED, V160, P1659, DOI 10.1001/archinte.160.11.1659; Lim S, 2012, AM J EPIDEMIOL, V175, P519, DOI 10.1093/aje/kwr327; Masson CL, 2004, AIDS CARE, V16, P744, DOI 10.1080/09540120412331269585; MAUSKOPF J, 1994, HEALTH SERV RES, V29, P489; MCLELLAN AT, 1985, J NERV MENT DIS, V173, P412, DOI 10.1097/00005053-198507000-00005; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Meade CS, 2009, AIDS PATIENT CARE ST, V23, P259, DOI 10.1089/apc.2008.0210; Najavits LM, 1998, J STUD ALCOHOL, V59, P56, DOI 10.15288/jsa.1998.59.56; Niska R, 2010, NATL HOSP AMBULATORY; Palepu A, 2004, ANTIVIR THER, V9, P713; Palepu A, 2003, J SUBST ABUSE TREAT, V25, P37, DOI 10.1016/S0740-5472(03)00064-3; Pollock HA, 2002, J GEN INTERN MED, V17, P341, DOI 10.1046/j.1525-1497.2002.10663.x; Prekker ME, 2009, J TRAUMA, V66, P1688, DOI 10.1097/TA.0b013e31817db0f1; Qualitymetric, 2010, SF36V2 HLTH SURV; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Ruger JP, 2004, ACAD EMERG MED, V11, P1311, DOI 10.1197/j.aem.2004.07.008; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Saber-Tehrani AS, 2012, CONTEMP CLIN TRIALS, V33, P436, DOI 10.1016/j.cct.2011.11.002; Schwarz R, 2012, J SUBSTANCE ABUSE TR; Shults RA, 2009, J SAFETY RES, V40, P329, DOI 10.1016/j.jsr.2009.06.001; Sohler NL, 2007, AIDS PATIENT CARE ST, V21, pS68, DOI 10.1089/apc.2007.9985; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Springer SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038335; Springer SA, 2011, CLIN INFECT DIS, V53, P469, DOI 10.1093/cid/cir446; Springer SA, 2011, AM J DRUG ALCOHOL AB, V37, P12, DOI 10.3109/00952990.2010.540280; Springer SA, 2010, J URBAN HEALTH, V87, P592, DOI 10.1007/s11524-010-9438-4; Stein JA, 2007, J HEALTH PSYCHOL, V12, P791, DOI 10.1177/1359105307080612; Stephenson BL, 2005, PUBLIC HEALTH REP, V120, P84, DOI 10.1177/003335490512000114; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P666, DOI 10.2105/AJPH.2008.144279; Wohl D, 2010, AIDS BEHAV S1, V125; Wohl DA, 2011, AIDS BEHAV, V15, P356, DOI 10.1007/s10461-010-9843-4; Wyatt GE, 2005, J HEALTH CARE POOR U, V16, P9, DOI 10.1353/hpu.2005.0120	62	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42416	10.1371/journal.pone.0042416	http://dx.doi.org/10.1371/journal.pone.0042416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22879972	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100085
J	Mills, RF; Peaston, KA; Runions, J; Williams, LE				Mills, Rebecca F.; Peaston, Kerry A.; Runions, John; Williams, Lorraine E.			HvHMA2, a P-1B-ATPase from Barley, Is Highly Conserved among Cereals and Functions in Zn and Cd Transport	PLOS ONE			English	Article							P-TYPE ATPASE; HEAVY-METAL TRANSPORT; ARABIDOPSIS-THALIANA; P-1B-TYPE ATPASE; THLASPI-CAERULESCENS; ZINC HOMEOSTASIS; BINDING SITES; CADMIUM; RICE; TRANSLOCATION	Manipulation of crops to improve their nutritional value (biofortification) and optimisation of plants for removal of toxic metals from contaminated soils (phytoremediation) are major goals. Identification of membrane transporters with roles in zinc and cadmium transport would be useful for both aspects. The P-1B-ATPases play important roles in heavy metal allocation and detoxification in Arabidopsis and it is now important to elucidate their roles in monocots. We identified nine P-1B-ATPases in barley and this study focuses on the functional characterization of HvHMA2, providing evidence for its role in heavy metal transport. HvHMA2 was cloned using information from EST analysis and 59 RACE. It possesses the conserved aspartate that is phosphorylated during the reaction cycle of P-type pumps and has motifs and key residues characteristic of P-1B-ATPases, falling into the P1B-2 subclass. Homologous sequences occur in three major sub-families of the Poaceae (Gramineae). Heterologous expression in Saccharomyces cerevisiae demonstrates that HvHMA2 functions as a Zn and Cd pump. Mutagenesis studies show that proposed cation coordination sites of the P1B-2 pumps are crucial for the metal responses conferred by HvHMA2 in yeast. HvHMA2 expression suppresses the Zn-deficient phenotype of the Arabidopsis hma2hma4 mutant indicating that HvHMA2 functions as a Zn pump in planta and could play a role in root to shoot Zn transport. When expressed in Arabidopsis, HvHMA2 localises predominantly to the plasma membrane.	[Mills, Rebecca F.; Peaston, Kerry A.; Williams, Lorraine E.] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [Runions, John] Oxford Brookes Univ, Sch Life Sci, Oxford OX3 0BP, England	University of Southampton; Oxford Brookes University	Mills, RF (corresponding author), Univ Southampton, Ctr Biol Sci, Highfield Campus, Southampton, Hants, England.	lew@soton.ac.uk			European Union [FOOD-CT-2006-016253]	European Union(European Commission)	This work was supported by the European Union Framework Programme 6 as part of the Integrated Project Public health impact of long-term, lowlevel mixed element exposure in susceptible population strata (PHIME) (contract no FOOD-CT-2006-016253); it reflects only the authors' views. The Community is not liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Baekgaard L, 2010, J BIOL CHEM, V285, P31243, DOI 10.1074/jbc.M110.111260; Bernard C, 2004, FEBS LETT, V569, P140, DOI 10.1016/j.febslet.2004.05.036; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Clemens S, 2002, J BIOL CHEM, V277, P18215, DOI 10.1074/jbc.M201031200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Courbot M, 2007, PLANT PHYSIOL, V144, P1052, DOI 10.1104/pp.106.095133; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dutta SJ, 2007, BIOCHEMISTRY-US, V46, P3692, DOI 10.1021/bi0616394; Dutta SJ, 2006, BIOCHEMISTRY-US, V45, P5923, DOI 10.1021/bi0523456; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Eren E, 2004, PLANT PHYSIOL, V136, P3712, DOI 10.1104/pp.104.046292; Eren E, 2007, BIOCHEM, V46, P754; Gong W, 2004, PLANT PHYSIOL, V135, P773, DOI 10.1104/pp.104.042176; Hall JL, 2003, J EXP BOT, V54, P2601, DOI 10.1093/jxb/erg303; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Kim YY, 2009, PLANT J, V58, P737, DOI 10.1111/j.1365-313X.2009.03818.x; Kobayashi Y, 2008, PLANT PHYSIOL, V148, P969, DOI 10.1104/pp.108.119933; Kurup S, 2005, PLANT J, V42, P444, DOI 10.1111/j.1365-313X.2005.02386.x; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee S, 2007, PLANT PHYSIOL, V145, P831, DOI 10.1104/pp.107.102236; LeShane ES, 2010, J BIOL CHEM, V285, P6327, DOI 10.1074/jbc.M109.074633; LYU PC, 1991, P NATL ACAD SCI USA, V88, P5317, DOI 10.1073/pnas.88.12.5317; Mills RF, 2008, PLANT PHYSIOL, V146, P116, DOI 10.1104/pp.107.110817; Mills RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013388; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; Miyadate H, 2011, NEW PHYTOL, V189, P190, DOI 10.1111/j.1469-8137.2010.03459.x; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Moreno I, 2008, J BIOL CHEM, V283, P9633, DOI 10.1074/jbc.M800736200; Nocito FF, 2011, PLANT CELL ENVIRON, V34, P994, DOI 10.1111/j.1365-3040.2011.02299.x; Okkeri J, 2006, BBA-BIOENERGETICS, V1757, P1485, DOI 10.1016/j.bbabio.2006.06.008; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; Puig S, 2009, CURR OPIN PLANT BIOL, V12, P299, DOI 10.1016/j.pbi.2009.04.008; Satoh-Nagasawa N, 2012, PLANT CELL PHYSIOL, V53, P213, DOI 10.1093/pcp/pcr166; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Siemianowski O, 2011, PLANT BIOTECHNOL J, V9, P64, DOI 10.1111/j.1467-7652.2010.00531.x; Sinclair SA, 2007, NEW PHYTOL, V174, P39, DOI 10.1111/j.1469-8137.2007.02030.x; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Talukdar S, 2008, PLANT SOIL, V306, P85, DOI 10.1007/s11104-007-9412-4; Tauris B, 2009, J EXP BOT, V60, P1333, DOI 10.1093/jxb/erp023; Ueno D, 2011, J EXP BOT, V62, P2265, DOI 10.1093/jxb/erq383; Ueno D, 2010, P NATL ACAD SCI USA, V107, P16500, DOI 10.1073/pnas.1005396107; Verbruggen N, 2009, CURR OPIN PLANT BIOL, V12, P364, DOI 10.1016/j.pbi.2009.05.001; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Williams LE, 2000, BBA-BIOMEMBRANES, V1465, P104, DOI 10.1016/S0005-2736(00)00133-4; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Williams L, 2009, CURR OPIN PLANT BIOL, V12, P247, DOI 10.1016/j.pbi.2009.05.009; Williams LE, 2010, PLANT CELL MONOGR, V17, P95, DOI 10.1007/978-3-642-10613-2_5; Wong CKE, 2009, NEW PHYTOL, V181, P71, DOI 10.1111/j.1469-8137.2008.02638.x; Wong CKE, 2009, NEW PHYTOL, V181, P79, DOI 10.1111/j.1469-8137.2008.02637.x; Wu CC, 2004, BIOCHEM BIOPH RES CO, V324, P1034, DOI 10.1016/j.bbrc.2004.09.160	57	61	67	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42640	10.1371/journal.pone.0042640	http://dx.doi.org/10.1371/journal.pone.0042640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880063	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000307284100147
J	Valentin-Vargas, A; Toro-Labrador, G; Massol-Deya, AA				Valentin-Vargas, Alexis; Toro-Labrador, Gladys; Massol-Deya, Arturo A.			Bacterial Community Dynamics in Full-Scale Activated Sludge Bioreactors: Operational and Ecological Factors Driving Community Assembly and Performance	PLOS ONE			English	Article							WASTE-WATER TREATMENT; T-RFLP DATA; MICROBIAL COMMUNITY; TREATMENT-PLANT; POPULATION-DYNAMICS; TREATMENT SYSTEMS; DIVERSITY; REMOVAL; SOLIDS; TAXA	The assembling of bacterial communities in conventional activated sludge (CAS) bioreactors was thought, until recently, to be chaotic and mostly unpredictable. Studies done over the last decade have shown that specific, and often, predictable random and non-random factors could be responsible for that process. These studies have also motivated a "structure-function'' paradigm that is yet to be resolved. Thus, elucidating the factors that affect community assembly in the bioreactors is necessary for predicting fluctuations in community structure and function. For this study activated sludge samples were collected during a one-year period from two geographically distant CAS bioreactors of different size. Combining community fingerprinting analysis and operational parameters data with a robust statistical analysis, we aimed to identify relevant links between system performance and bacterial community diversity and dynamics. In addition to revealing a significant beta-diversity between the bioreactors' communities, results showed that the largest bioreactor had a less dynamic but more efficient and diverse bacterial community throughout the study. The statistical analysis also suggests that deterministic factors, as opposed to stochastic factors, may have a bigger impact on the community structure in the largest bioreactor. Furthermore, the community seems to rely mainly on mechanisms of resistance and functional redundancy to maintain functional stability. We suggest that the ecological theories behind the Island Biogeography model and the species-area relationship were appropriate to predict the assembly of bacterial communities in these CAS bioreactors. These results are of great importance for engineers and ecologists as they reveal critical aspects of CAS systems that could be applied towards improving bioreactor design and operation.	[Valentin-Vargas, Alexis; Toro-Labrador, Gladys; Massol-Deya, Arturo A.] Univ Puerto Rico Mayaguez, Dept Biol, Mayaguez, PR USA	University of Puerto Rico; University of Puerto Rico Mayaguez	Valentin-Vargas, A (corresponding author), Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA.	valentin.alexis@gmail.com						Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; APHA, 2012, 3120 APHA, V22nd; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Ayarza JM, 2011, MICROB ECOL, V61, P486, DOI 10.1007/s00248-010-9762-y; BALMER P, 1994, WATER SCI TECHNOL, V30, P7, DOI 10.2166/wst.1994.0147; Bell T, 2005, SCIENCE, V308, P1884, DOI 10.1126/science.1111318; BENEDICT RG, 1971, WATER RES, V5, P1023, DOI 10.1016/0043-1354(71)90036-4; Bitton G, 2011, WASTEWATER MICROBIOL; Blackwood CB, 2003, APPL ENVIRON MICROB, V69, P926, DOI 10.1128/AEM.69.2.926-932.2003; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; Caro-Quintero A, 2009, THESIS U PUERTO RICO; Carvalho G, 2007, WATER RES, V41, P4383, DOI 10.1016/j.watres.2007.06.065; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; Curtis TP, 2006, WATER SCI TECHNOL, V54, P227, DOI 10.2166/wst.2006.391; Curtis TP, 2003, ENVIRON SCI TECHNOL, V37, p64A, DOI 10.1021/es0323493; Daims H, 2006, TRENDS BIOTECHNOL, V24, P483, DOI 10.1016/j.tibtech.2006.09.002; de los Reyes FL, 2010, WATER RES, V44, P4948, DOI 10.1016/j.watres.2010.07.038; DIAS FF, 1964, APPL MICROBIOL, V12, P412, DOI 10.1128/AEM.12.5.412-417.1964; Dollhopf SL, 2001, MICROB ECOL, V42, P495, DOI 10.1007/s00248-001-0027-7; Eschenhagen M, 2003, WATER RES, V37, P3224, DOI 10.1016/S0043-1354(03)00136-2; Fierer N, 2011, AM J BOT, V98, P439, DOI 10.3732/ajb.1000498; Forney LJ, 2001, ECOTOX ENVIRON SAFE, V49, P40, DOI 10.1006/eesa.2001.2034; Gentile ME, 2007, APPL ENVIRON MICROB, V73, P680, DOI 10.1128/AEM.01519-06; Graham DW, 2004, FRONT ECOL ENVIRON, V2, P199, DOI 10.1890/1540-9295(2004)002[0199:DESAOE]2.0.CO;2; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Han H, 2010, BIORESOURCE TECHNOL, V101, P3463, DOI 10.1016/j.biortech.2009.12.121; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hiraishi A, 2003, ENVIRON MICROBIOL, V5, P765, DOI 10.1046/j.1462-2920.2003.00473.x; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Hoshino T, 2006, FEMS MICROBIOL ECOL, V55, P459, DOI 10.1111/j.1574-6941.2005.00047.x; Hubbell Stephen P., 2001, V32, pi; Jenkins D, 2008, WATER ENVIRON RES, V80, P677, DOI 10.2175/106143008X276679; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Jones PA, 2010, CHEM ENG J, V164, P16, DOI 10.1016/j.cej.2010.07.061; Kaewpipat K, 2002, WATER SCI TECHNOL, V46, P19, DOI 10.2166/wst.2002.0450; Kim YM, 2011, WATER RES, V45, P5785, DOI 10.1016/j.watres.2011.08.063; Kindt R, 2005, TREE DIVERSITY ANAL; Legendre P., 2012, NUMERICAL ECOLOGY; LIGHTHART B, 1969, J WATER POLLUT CON F, V41, pR267; Loy A, 2002, ENCY ENV MICROBIOLOG, P26; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Manefield M, 2007, MICROB ECOL, V53, P348, DOI 10.1007/s00248-006-9167-0; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Matsuda M, 2010, WATER SCI TECHNOL, V61, P2843, DOI 10.2166/wst.2010.212; Mills AL, 2003, 2003012509 SAE INT; Miura Y, 2007, WATER RES, V41, P627, DOI 10.1016/j.watres.2006.11.005; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Onuki M, 2000, WATER SCI TECHNOL, V42, P17, DOI 10.2166/wst.2000.0353; Padayachee P., 2006, Water SA, V32, P679; Palacios C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003853; PATIL GP, 1982, J AM STAT ASSOC, V77, P548, DOI 10.2307/2287709; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rodriguez-Martinez Enid M, 2006, Int J Environ Res Public Health, V3, P292, DOI 10.3390/ijerph2006030036; Saikaly PE, 2005, APPL ENVIRON MICROB, V71, P5814, DOI 10.1128/AEM.71.10.5814-5822.2005; Saikaly PE, 2004, MICROB ECOL, V48, P274, DOI 10.1007/s00248-003-1027-6; Sanapareddy N, 2009, APPL ENVIRON MICROB, V75, P1688, DOI 10.1128/AEM.01210-08; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Seviour R, 2010, MICROBIAL ECOLOGY OF ACTIVATED SLUDGE, P1; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; TERBRAAK CJF, 1994, J VEG SCI, V5, P361, DOI 10.2307/3235860; TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223; van der Gast CJ, 2008, ENVIRON MICROBIOL, V10, P1411, DOI 10.1111/j.1462-2920.2007.01550.x; van der Gast CJ, 2008, ADV APPL MICROBIOL, V64, P167, DOI 10.1016/S0065-2164(08)00406-1; van der Gast CJ, 2006, ENVIRON MICROBIOL, V8, P1048, DOI 10.1111/j.1462-2920.2006.00996.x; VANVEEN WL, 1973, A VAN LEEUW J MICROB, V39, P189, DOI 10.1007/BF02578852; WAGNER M, 1993, APPL ENVIRON MICROB, V59, P1520, DOI 10.1128/AEM.59.5.1520-1525.1993; Wagner M, 2002, ANTON LEEUW INT J G, V81, P665, DOI 10.1023/A:1020586312170; Wang X, 2010, J APPL MICROBIOL, V109, P1218, DOI 10.1111/j.1365-2672.2010.04742.x; Wang XH, 2011, BIORESOURCE TECHNOL, V102, P2352, DOI 10.1016/j.biortech.2010.10.095; Wang XH, 2010, J ENVIRON SCI-CHINA, V22, P627, DOI 10.1016/S1001-0742(09)60155-8; Watanabe K, 1998, APPL ENVIRON MICROB, V64, P1203; Wells GF, 2011, WATER RES, V45, P5476, DOI 10.1016/j.watres.2011.08.006; Wilderer PA, 2002, WATER RES, V36, P370, DOI 10.1016/S0043-1354(01)00220-2; Yuan Zhiguo, 2008, Reviews in Environmental Science and Bio/Technology, V7, P243, DOI 10.1007/s11157-008-9134-y	81	77	82	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42524	10.1371/journal.pone.0042524	http://dx.doi.org/10.1371/journal.pone.0042524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880016	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100118
J	Wu, B; Li, Y; Wang, CS; Vigneron, DB; Zhang, XL				Wu, Bing; Li, Ye; Wang, Chunsheng; Vigneron, Daniel B.; Zhang, Xiaoliang			Multi-Reception Strategy with Improved SNR for Multichannel MR Imaging	PLOS ONE			English	Article							TO-NOISE RATIO; COIL DESIGN; VOLUME COIL; RADIOFREQUENCY COIL; ARRAY; RECONSTRUCTION; SMASH; ACQUISITION; PERFORMANCE; HARMONICS	A multi-reception strategy with extended GRAPPA is proposed in this work to improve MR imaging performance at ultra-high field MR systems with limited receiver channels. In this method, coil elements are separated to two or more groups under appropriate grouping criteria. Those groups are enabled in sequence for imaging first, and then parallel acquisition is performed to compensate for the redundant scan time caused by the multiple receptions. To efficiently reconstruct the data acquired from elements of each group, a specific extended GRAPPA was developed. This approach was evaluated by using a 16-element head array on a 7 Tesla whole-body MRI scanner with 8 receive channels. The in-vivo experiments demonstrate that with the same scan time, the 16-element array with twice receptions and acceleration rate of 2 can achieve significant SNR gain in the periphery area of the brain and keep nearly the same SNR in the center area over an eight-element array, which indicates the proposed multi-reception strategy and extended GRAPPA are feasible to improve image quality for MRI systems with limited receive channels. This study also suggests that it is advantageous for a MR system with N receiver channels to utilize a coil array with more than N elements if an appropriate acquisition strategy is applied.	[Wu, Bing; Li, Ye; Wang, Chunsheng; Vigneron, Daniel B.; Zhang, Xiaoliang] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Vigneron, Daniel B.; Zhang, Xiaoliang] Univ Calif Berkeley, Univ Calif San Francisco Univ Calif Berkeley Join, Berkeley, CA 94720 USA; [Vigneron, Daniel B.; Zhang, Xiaoliang] Calif Inst Quantitat Biosci, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California San Francisco	Wu, B (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	xiaoliang.zhang@ucsf.edu			National Institutes of Health [EB004453, EB008699, P41EB013598]; QB3; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008699, P41EB013598, R01EB004453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); QB3; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding provided by National Institutes of Health grants EB004453, EB008699 and P41EB013598, www.nih.gov, and QB3, qb3.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriany G, 2005, MAGN RESON MED, V53, P434, DOI 10.1002/mrm.20321; Banerjee S, 2006, MAGN RESON MED, V56, P1075, DOI 10.1002/mrm.21059; Breuer FA, 2009, MAGN RESON MED, V62, P739, DOI 10.1002/mrm.22066; Bydder M, 2002, MAGNET RESON MED, V47, P160, DOI 10.1002/mrm.10044; de Zwart JA, 2004, MAGNET RESON MED, V51, P22, DOI 10.1002/mrm.10678; Gilbert KM, 2010, MAGN RESON MED, V64, P1640, DOI 10.1002/mrm.22574; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Jakob PM, 1998, MAGN RESON MATER PHY, V7, P42; King SB, 2010, MAGN RESON MED, V63, P1346, DOI 10.1002/mrm.22295; Ledden PJ, 2005, P 13 ISMRM ANN M MIA, P322; Li Y, 2011, QUANT IMAGING MED SU, V1, P24, DOI 10.3978/j.issn.2223-4292.2011.11.04; Li Y, 2011, MED PHYS, V38, P4086, DOI 10.1118/1.3598112; Liang ZP, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 AND 2, P1204; Lin FH, 1999, IEEE T MED IMAGING, V18, P1129, DOI 10.1109/42.819323; McKenzie CA, 2004, RADIOLOGY, V230, P589, DOI 10.1148/radiol.2302021230; McKenzie CA, 2002, MAGNET RESON MED, V47, P529, DOI 10.1002/mrm.10087; McKenzie CA, 2001, MAGNET RESON MED, V46, P619, DOI 10.1002/mrm.1236; Ohliger MA, 2004, MAGNET RESON MED, V52, P628, DOI 10.1002/mrm.20195; Ohliger MA, 2003, MAGNET RESON MED, V50, P1018, DOI 10.1002/mrm.10597; Pang Y, 2011, QUANT IMAGING MED SU, V1, P4, DOI 10.3978/j.issn.2223-4292.2011.11.02; Pang Y, 2012, MAGN RESON MED, V67, P965, DOI 10.1002/mrm.23073; Pang Y, 2011, CONCEPT MAGN RESON B, V39B, P206, DOI 10.1002/cmr.b.20209; Pang Y, 2012, MAGN RESON IMAGING, V30, P290, DOI 10.1016/j.mri.2011.09.022; Pang Y, 2011, IEEE T MED IMAGING, V30, P1965, DOI 10.1109/TMI.2011.2160192; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Qu P, 2005, J MAGN RESON, V174, P60, DOI 10.1016/j.jmr.2005.01.015; Reykowski A., 2004, P 12 ANN M ISMRM KYO, P1587; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Sodickson DK, 1997, MAGNET RESON MED, V38, P591, DOI 10.1002/mrm.1910380414; Spence DK, 2005, P ANN INT IEEE EMBS, P4286, DOI 10.1109/IEMBS.2005.1615412; Traficante D.D., 1991, CONCEPT MAGNETIC RES, V3, P83, DOI [10.1002/cmr.1820030203, DOI 10.1002/CMR.1820030203]; Vaughan T, 2006, MAGN RESON MED, V56, P1274, DOI 10.1002/mrm.21073; Vossen M, 2011, J MAGN RESON, V208, P291, DOI 10.1016/j.jmr.2010.11.004; WALD LL, 1995, MAGNET RESON MED, V34, P433, DOI 10.1002/mrm.1910340321; Wang CS, 2012, MAGN RESON IMAGING, V30, P78, DOI 10.1016/j.mri.2011.08.007; Wang Z, 2005, MAGN RESON MED, V54, P738, DOI 10.1002/mrm.20601; Weiger M, 2001, MAGNET RESON MED, V45, P495, DOI 10.1002/1522-2594(200103)45:3<495::AID-MRM1065>3.0.CO;2-V; Wiesinger F, 2004, MAGNET RESON MED, V52, P376, DOI 10.1002/mrm.20183; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925; Wu B, 2010, P 18 ANN M ISMRM STO, P3860; Wu B, 2012, MAGN RESON MED, V68, P1332, DOI 10.1002/mrm.24121; Wu B, 2012, IEEE T MED IMAGING, V31, P183, DOI 10.1109/TMI.2011.2166273; Wu B, 2010, IEEE T BIO-MED ENG, V57, P397, DOI 10.1109/TBME.2009.2030170; Wu B, 2010, IEEE T MED IMAGING, V29, P179, DOI 10.1109/TMI.2009.2033597; Zhang Xiaoliang, 2012, OMICS J Radiol, V1, pe110; Zhang XL, 2005, MAGN RESON MED, V53, P1234, DOI 10.1002/mrm.20462; Zhang XL, 2005, IEEE T BIO-MED ENG, V52, P495, DOI 10.1109/TBME.2004.842968; Zhang XL, 2003, J MAGN RESON, V161, P242, DOI 10.1016/S1090-7807(03)00004-1; Zhang XL, 2001, MAGNET RESON MED, V46, P443, DOI 10.1002/mrm.1212	49	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42237	10.1371/journal.pone.0042237	http://dx.doi.org/10.1371/journal.pone.0042237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879921	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100057
J	Jacobs, JH; Archer, BN; Baker, MG; Cowling, BJ; Heffernan, RT; Mercer, G; Uez, O; Hanshaoworakul, W; Viboud, C; Schwartz, J; Tchetgen, ET; Lipsitch, M				Jacobs, Jessica Hartman; Archer, Brett Nicholas; Baker, Michael G.; Cowling, Benjamin J.; Heffernan, Richard T.; Mercer, Geoff; Uez, Osvaldo; Hanshaoworakul, Wanna; Viboud, Cecile; Schwartz, Joel; Tchetgen, Eric Tchetgen; Lipsitch, Marc			Searching for Sharp Drops in the Incidence of Pandemic A/H1N1 Influenza by Single Year of Age	PLOS ONE			English	Article							ORIGINAL ANTIGENIC SIN; A H1N1 VIRUS; PREEXISTING IMMUNITY; ANTIBODY; INFECTION; RESPONSES; HUMANS	Background: During the 2009 H1N1 pandemic (pH1N1), morbidity and mortality sparing was observed among the elderly population; it was hypothesized that this age group benefited from immunity to pH1N1 due to cross-reactive antibodies generated from prior infection with antigenically similar influenza viruses. Evidence from serologic studies and genetic similarities between pH1N1 and historical influenza viruses suggest that the incidence of pH1N1 cases should drop markedly in age cohorts born prior to the disappearance of H1N1 in 1957, namely those at least 52-53 years old in 2009, but the precise range of ages affected has not been delineated. Methods and Findings: To test for any age-associated discontinuities in pH1N1 incidence, we aggregated laboratory-confirmed pH1N1 case data from 8 jurisdictions in 7 countries, stratified by single year of age, sex (when available), and hospitalization status. Using single year of age population denominators, we generated smoothed curves of the weighted risk ratio of pH1N1 incidence, and looked for sharp drops at varying age bandwidths, defined as a significantly negative second derivative. Analyses stratified by hospitalization status and sex were used to test alternative explanations for observed discontinuities. We found that the risk of laboratory-confirmed infection with pH1N1 declines with age, but that there was a statistically significant leveling off or increase in risk from about 45 to 50 years of age, after which a sharp drop in risk occurs until the late fifties. This trend was more pronounced in hospitalized cases and in women and was independent of the choice in smoothing parameters. The age range at which the decline in risk accelerates corresponds to the cohort born between 1951-1959 (hospitalized) and 1953-1960 (not hospitalized). Conclusions: The reduced incidence of pH1N1 disease in older individuals shows a detailed age-specific pattern consistent with protection conferred by exposure to influenza A/H1N1 viruses circulating before 1957.	[Jacobs, Jessica Hartman; Schwartz, Joel; Tchetgen, Eric Tchetgen; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Archer, Brett Nicholas] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Baker, Michael G.] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Heffernan, Richard T.] Wisconsin Dept Hlth Serv, Div Publ Hlth, Madison, WI USA; [Mercer, Geoff] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Uez, Osvaldo] Minist Publ Hlth, Natl Inst Epidemiol, ANLIS, Buenos Aires, DF, Argentina; [Hanshaoworakul, Wanna] Minist Publ Hlth, Dept Dis Control, Tiwanond, Nonthaburi, Thailand; [Viboud, Cecile] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Tchetgen, Eric Tchetgen] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Otago; University of Hong Kong; Australian National University; Ministry of Public Health - Thailand; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Jacobs, JH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	jhartman44@gmail.com	Archer, Brett Nicholas/A-5610-2012; Tchetgen, Eric Tchetgen/AAF-6160-2021; Cowling, Benjamin John/C-4263-2009	Archer, Brett Nicholas/0000-0002-4144-1094; Cowling, Benjamin John/0000-0002-6297-7154; Lipsitch, Marc/0000-0003-1504-9213	National Institute Of General Medical Sciences [U54GM088558]; MedImmune Inc.; Roche; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute Of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MedImmune Inc.(AstraZenecaMedimmune); Roche(Roche Holding); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was supported by the National Institute Of General Medical Sciences [Award Number U54GM088558], http://www.nigms.nih.gov/. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BJC has received research funding from MedImmune Inc. and consults for Crucell MV. ML declares consulting income/honoraria from Pfizer, Novartis, Avian/Pandemic Flu Registry (Outcome Sciences, supported by Roche), and AIR Worldwide. The following co-authors are editors: Benjamin J Cowling and Cecile Viboud. This does not alter the authors` adherence to all the PLoS ONE policies on sharing data and materials.	Adalja AA, 2010, EMERG INFECT DIS, V16, P1028, DOI [10.3201/eid1606.091563, 10.3201/eid1606.091653]; Balter S, 2010, EMERG INFECT DIS, V16, P1259, DOI 10.3201/eid1608.091847; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Booy R, 2011, MED J AUSTRALIA, V194, P19, DOI 10.5694/j.1326-5377.2011.tb04139.x; Broberg E, 2011, CLIN VACCINE IMMUNOL, V18, P1205, DOI 10.1128/CVI.05072-11; Chaudhuri P, 1999, J AM STAT ASSOC, V94, P807, DOI 10.2307/2669996; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Fisman DN, 2009, NEW ENGL J MED, V361, P2000, DOI 10.1056/NEJMc0907256; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Ikonen N, 2010, EURO SURVEILL, V15; Instituto Nacional de Estadistica y Censos, 2010, CUADR P2 TOT PAIS PO; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Khurana S, 2012, J INFECT DIS, V205, P610, DOI 10.1093/infdis/jir791; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Klein SL, 2010, BIOL SEX DIFFER, V1, P5; Lemaitre M, 2011, CLIN MICROBIOL INFEC, V17, P732, DOI 10.1111/j.1469-0691.2010.03352.x; Mak GC, 2010, J MED VIROL, V82, P1809, DOI 10.1002/jmv.21895; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; McVernon J, 2010, EURO SURVEILL, V15, pii; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Prachayangprecha S, 2010, J HEALTH POPUL NUTR, V28, P537, DOI 10.3329/jhpn.v28i6.6601; R Core Team, 2020, R LANG ENV STAT COMP; Reichert T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-5; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Siegel, 2004, METHODS MAT DEMOGRAP; Simonsen L, 2005, THREAT PANDEMIC INFL, P89, DOI DOI 10.2105/AJPH.2007.119933; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sonderegger D., 2008, SIZER SIGNIFICANT ZE; Statistics South Africa, 2009, MID POP EST 2009; VAILLANT L, 2009, EURO SURVEILL, V14; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Viboud C, 2010, PLOS CURR; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; WHO, 2010, WKLY EPIDEMIOL REC, V85, P229; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231	40	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42328	10.1371/journal.pone.0042328	http://dx.doi.org/10.1371/journal.pone.0042328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876316	Green Published, gold, Green Submitted			2022-12-27	WOS:000307184700044
J	Johnson, SE; Barrick, D				Johnson, Scott E.; Barrick, Douglas			Dissecting and Circumventing the Requirement for RAM in CSL-Dependent Notch Signaling	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL LEUKEMIA; RBP-J; HUMAN HOMOLOG; TRANSCRIPTION COMPLEXES; DROSOPHILA SUPPRESSOR; INTRACELLULAR DOMAIN; BINDING-PROTEIN; ANKYRIN REPEATS; MOUSE NOTCH1	The Notch signaling pathway is an intercellular communication network vital to metazoan development. Notch activation leads to the nuclear localization of the intracellular portion (NICD) of the Notch receptor. Once in the nucleus, NICD binds the transcription factor CSL through a bivalent interaction involving the high-affinity RAM region and the lower affinity ANK domain, converting CSL from a transcriptionally-repressed to an active state. This interaction is believed to directly displace co-repressor proteins from CSL and recruit co-activator proteins. Here we investigate the consequences of this bivalent organization in converting CSL from the repressed to active form. One proposed function of RAM is to promote the weak ANK: CSL interaction; thus, fusion of CSL-ANK should bypass this function of RAM. We find that a CSL-ANK fusion protein is transcriptionally active in reporter assays, but that the addition of RAM in trans further increases transcriptional activity, suggesting another role of RAM in activation. A single F235L point substitution, which disrupts co-repressor binding to CSL, renders the CSL-ANK fusion fully active and refractory to further stimulation by RAM in trans. These results suggest that in the context of a mammalian CSL-ANK fusion protein, the main role of RAM is to displace co-repressor proteins from CSL.	[Johnson, Scott E.; Barrick, Douglas] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA	Johns Hopkins University	Johnson, SE (corresponding author), Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA.	barrick@jhu.edu			National Institutes of Health [GM060001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health grant GM060001 to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Bertagna A, 2008, BIOCHEM SOC T, V36, P157, DOI 10.1042/BST0360157; BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Engel ME, 2010, MOL CELL BIOL, V30, P1852, DOI 10.1128/MCB.01342-09; Friedmann DR, 2008, J BIOL CHEM, V283, P14781, DOI 10.1074/jbc.M709501200; Fuchs KP, 2001, EUR J BIOCHEM, V268, P4639, DOI 10.1046/j.1432-1327.2001.02387.x; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Ilagan MXG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001656; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jeffries S, 2002, MOL CELL BIOL, V22, P3927, DOI 10.1128/MCB.22.11.3927-3941.2002; Johnson SE, 2010, J BIOL CHEM, V285, P6681, DOI 10.1074/jbc.M109.019968; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kato H, 1997, DEVELOPMENT, V124, P4133; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; KODOYIANNI V, 1992, MOL BIOL CELL, V3, P1199, DOI 10.1091/mbc.3.11.1199; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; Maier D, 2011, MOL BIOL CELL, V22, P3242, DOI 10.1091/mbc.E11-05-0420; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Roehl H, 1996, EMBO J, V15, P7002, DOI 10.1002/j.1460-2075.1996.tb01092.x; ROEHL H, 1993, NATURE, V364, P632, DOI 10.1038/364632a0; Salat D, 2008, MOL CELL BIOL, V28, P3502, DOI 10.1128/MCB.01966-07; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Taniguchi Y, 1998, MOL CELL BIOL, V18, P644, DOI 10.1128/MCB.18.1.644; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; VanderWielen BD, 2011, J BIOL CHEM, V286, P14892, DOI 10.1074/jbc.M110.181156; Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Zweifel ME, 2003, PROTEIN SCI, V12, P2622, DOI 10.1110/ps.03279003	49	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e39093	10.1371/journal.pone.0039093	http://dx.doi.org/10.1371/journal.pone.0039093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876274	Green Submitted, Green Published, gold			2022-12-27	WOS:000307184700002
J	Sun, JF; Najafzadeh, MJ; van den Ende, AHGG; Vicente, VA; Feng, PY; Xi, LY; De Hoog, GS				Sun, Jiufeng; Najafzadeh, Mohammed J.; van den Ende, Albertus H. G. Gerrits; Vicente, Vania A.; Feng, Peiying; Xi, Liyan; De Hoog, Gerrit S.			Molecular Characterization of Pathogenic Members of the Genus Fonsecaea Using Multilocus Analysis	PLOS ONE			English	Article							MELANIN-LIKE PIGMENTS; YEAST-LIKE FUNGI; IN-VITRO; INFECTION; CHROMOBLASTOMYCOSIS; DERMATITIDIS; DIVERSITY; LACCASE; CDC42; POLYMORPHISM	Members of the fungal genus Fonsecaea causing human chromoblastomycosis show substantial geographic structuring. Genetic identity of clinical and environmental strains suggests transmission from plant debris, while the evolutionary processes that have led to spatially separated populations have remained unexplained. Sequences of ITS, BT2, ACT1, Cdc42, Lac and HmgA were analyzed, either by direct sequencing or by cloning. Thirty-seven clinical and environmental Fonsecaea strains from Central and South America, Asia, Africa and Europe were sequenced and possible recombination events were calculated. Phylogenetic trees of Cdc42, Lac and HmgA were statistically supported, but ITS, BT2 and ACT1 trees were not. The Standardized Index of Association (I-A(S)) did not detect recombination (I-A(S) = 0.4778), neither did the Phi-test for separate genes. In Fonsecaea nubica non-synonymous mutations causing functional changes were observed in Lac gene, even though no selection pressures were detected with the neutrality test (Tajima D test, p>0.05). Genetic differentiation of populations for each gene showed separation of American, African and Asian populations. Strains of clinical vs. environmental origin showed genetic distances that were comparable or lower than found in geographic differentiation. In conclusion, here we demonstrated clonality of sibling species using multilocus data, geographic structuring of populations, and a low functional and structural selective constraint during evolution of the genus Fonsecaea.	[Sun, Jiufeng; Xi, Liyan; De Hoog, Gerrit S.] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Jiufeng] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Dept Parasitol,Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Jiufeng; Najafzadeh, Mohammed J.; van den Ende, Albertus H. G. Gerrits; Feng, Peiying; De Hoog, Gerrit S.] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [Najafzadeh, Mohammed J.; De Hoog, Gerrit S.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1012 WX Amsterdam, Netherlands; [Najafzadeh, Mohammed J.] Mashhad Univ Med Sci, Sch Med, Ghaem Hosp, Canc Mol Pathol Res Ctr, Mashhad, Iran; [Najafzadeh, Mohammed J.] Mashhad Univ Med Sci, Dept Parasitol & Mycol, Mashhad, Iran; [Vicente, Vania A.] Univ Fed Parana, Dept Basic Pathol, BR-80060000 Curitiba, Parana, Brazil; [Feng, Peiying] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China; [De Hoog, Gerrit S.] Peking Univ, Hlth Sci Ctr, Res Ctr Med Mycol, Beijing 100871, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); University of Amsterdam; Mashhad University Medical Science; Mashhad University Medical Science; Universidade Federal do Parana; Sun Yat Sen University; Peking University	Sun, JF (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China.	xiliyan@mail.sysu.edu.cn; de.hoog@cbs.knaw.nl	Najafzadeh, M. J./M-9910-2019; sun, Jiufeng/CAG-6546-2022; vicente, vania/AAF-3464-2020; Najafzadeh, Mohammad Javad/F-9986-2017	Najafzadeh, M. J./0000-0002-0590-1073; vicente, vania/0000-0002-2953-4861; sun, jiufeng/0000-0003-1047-929X	National Natural Science Foundation of China [U0932009]; Federation of European Biochemical Societies (FEBS) Chinese European Visiting Fellowships [CEVF-00007]; International Program of Project 985 at Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Federation of European Biochemical Societies (FEBS) Chinese European Visiting Fellowships; International Program of Project 985 at Sun Yat-sen University	This work was supported by National Natural Science Foundation of China (No.U0932009) and The Federation of European Biochemical Societies (FEBS) Chinese European Visiting Fellowships (No. CEVF-00007), and was partly supported by the International Program of Project 985 at Sun Yat-sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; Attapattu MC, 1997, MYCOPATHOLOGIA, V137, P145, DOI 10.1023/A:1006819530825; Badali H, 2008, STUD MYCOL, P175, DOI 10.3114/sim.2008.61.18; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; CHASKES S, 1978, J CLIN MICROBIOL, V7, P146; COOPER CR, 1993, INFECT IMMUN, V61, P2069, DOI 10.1128/IAI.61.5.2069-2081.1993; de Hoog GS, 2003, J CLIN MICROBIOL, V41, P4767, DOI 10.1128/JCM.41.10.4767-4778.2003; de Hoog GS, 2004, MED MYCOL, V42, P405, DOI 10.1080/13693780410001661464; Deng S, 2008, STUD MYCOL, P121, DOI 10.3114/sim.2008.61.12; Dong F, 2005, INFECT IMMUN, V73, P1868, DOI 10.1128/IAI.73.3.1868-1872.2005; Esterre P, 1996, AM J TROP MED HYG, V55, P45, DOI 10.4269/ajtmh.1996.55.45; Gomez BL, 2001, INFECT IMMUN, V69, P5760, DOI 10.1128/IAI.69.9.5760-5767.2001; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Henikoff JG, 1996, COMPUT APPL BIOSCI, V12, P135; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Kawasaki M, 1999, MED MYCOL, V37, P435, DOI 10.1046/j.1365-280X.1999.00210.x; Kombila M, 1995, Sante, V5, P235; Kumar SVS, 2003, BIOTECHNOL BIOENG, V83, P386, DOI 10.1002/bit.10681; Lyons JI, 2003, MICROB ECOL, V45, P270, DOI 10.1007/s00248-002-1055-7; Mander GJ, 2006, APPL ENVIRON MICROB, V72, P5020, DOI 10.1128/AEM.00060-06; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martinez RL, 2007, CLIN DERMATOL, V25, P188, DOI 10.1016/j.clindermatol.2006.05.007; Morris-Jones R, 2005, INFECT IMMUN, V73, P6147, DOI 10.1128/IAI.73.9.6147-6150.2005; Najafzadeh MJ, 2010, MED MYCOL, V48, P800, DOI 10.3109/13693780903503081; Najafzadeh MJ, 2009, MED MYCOL, V47, P17, DOI 10.1080/13693780802527178; Najafzadeh MJ, 2011, EMERG INFECT DIS, V17, P464, DOI [10.3201/1703.100555, 10.3201/eid1703.100555]; Nosanchuk JD, 2004, FEMS MICROBIOL LETT, V239, P187, DOI 10.1016/j.femsle.2004.08.040; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosanchuk JD, 2002, INFECT IMMUN, V70, P5124, DOI 10.1128/IAI.70.9.5124-5131.2002; Polerecky L, 2009, APPL ENVIRON MICROB, V75, P758, DOI 10.1128/AEM.00819-08; Queiroz-Telles F, 2009, MED MYCOL, V47, P3, DOI 10.1080/13693780802538001; Salgado Claudio Guedes, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P33, DOI 10.1590/S0036-46652004000100006; Silva JP, 1998, MYCOPATHOLOGIA, V143, P171, DOI 10.1023/A:1006957415346; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Sterflinger K, 1998, ANTON LEEUW INT J G, V74, P271, DOI 10.1023/A:1001753131034; Sun JF, 2011, MYCOPATHOLOGIA, V172, P373, DOI 10.1007/s11046-011-9439-1; Sun J, 2010, J MICROBIOL METH, V80, P19, DOI 10.1016/j.mimet.2009.10.002; Szaniszlo P J, 1993, Arch Med Res, V24, P251; TAJIMA F, 1989, GENETICS, V123, P585; Tanabe Hiroshi, 2004, Nihon Ishinkin Gakkai Zasshi, V45, P105, DOI 10.3314/jjmm.45.105; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai HF, 2001, J BIOL CHEM, V276, P29292, DOI 10.1074/jbc.M101998200; Vicente VA, 2008, STUD MYCOL, P137, DOI 10.3114/sim.2008.61.14; Wheeler M, 2000, INFECT IMMUN, V68, P3696, DOI 10.1128/IAI.68.6.3696-3703.2000; Xi LY, 2009, MED MYCOL, V47, P27, DOI 10.1080/13693780802468209; Xie Z, 2012, MOL BIOL REP, V39, P839, DOI 10.1007/s11033-011-0806-2; Ye XC, 2000, J BACTERIOL, V182, P4941, DOI 10.1128/JB.182.17.4941-4950.2000	47	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41512	10.1371/journal.pone.0041512	http://dx.doi.org/10.1371/journal.pone.0041512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876287	gold, Green Published			2022-12-27	WOS:000307184700015
J	Jian, HH; Xu, J; Xiao, X; Wang, FP				Jian, Huahua; Xu, Jun; Xiao, Xiang; Wang, Fengping			Dynamic Modulation of DNA Replication and Gene Transcription in Deep-Sea Filamentous Phage SW1 in Response to Changes of Host Growth and Temperature	PLOS ONE			English	Article							SHEWANELLA-PIEZOTOLERANS WP3; PLASMID COPY NUMBER; COLD-SHOCK RESPONSE; MINUS-STRAND ORIGIN; ESCHERICHIA-COLI; MESSENGER-RNA; ESCAPE SYNTHESIS; WEST PACIFIC; BACTERIOPHAGE; LAMBDA	Little is known about the response of deep-sea virus and their relationship with their host towards environmental change. Although viruses are thought to play key roles in the deep-sea ecological evolution and biogeochemical cycling, these roles are yet to be defined. This study aims to delineate the relationship between a deep-sea filamentous phage SW1 and its host Shewanella piezotolerans (S. piezotolerans) WP3, and their response towards temperature change. The copy number of SW1's replicative form (RF-) DNA and single-stranded (ss-) DNA along the different growth phases of WP3 were quantified at 20 degrees C and 4 degrees C, respectively. The copy number of SW1 RF-DNA was found to be temperature and growth phase-dependent, while the ssDNA of SW1 was only produced at 4 degrees C. This is the first report showing low-temperature dependence of phage DNA replication. The transcription of SW1 key genes fpsA and fpsR were also found to be induced at low temperature during all the monitored growth periods of WP3. Additionally, the transcription of SW1 was found to be induced by cold-shock while its DNA replication was not changed. Our data demonstrates a dynamic change of virus DNA replication and transcription in accordance with host growth, and the low temperature adapted mechanisms for SW1 activities in the deep sea. This low temperature adapted deep-sea virus-bacterium system could serve as an ideal model to further study the mechanism and relationship of deep-sea virus-bacteria ecosystems.	[Jian, Huahua] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China; [Jian, Huahua; Xu, Jun; Xiao, Xiang; Wang, Fengping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Jian, Huahua; Xu, Jun; Xiao, Xiang; Wang, Fengping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Ocean Engn, Shanghai 200030, Peoples R China; [Wang, Fengping] Shanghai Jiao Tong Univ, Key Lab Syst Biomed, Minist Educ, Shanghai 200030, Peoples R China	Xiamen University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, FP (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	fengpingw@sjtu.edu.cn	Jian, Huahua/E-6732-2016; xiao, xiang/GWU-6035-2022	Jian, Huahua/0000-0001-5507-497X	National Science Foundation of China [40830213, 41076078]; Science and Technology Commission of Shanghai Municipality [10JC1406700]; State Key Laboratory of Ocean Engineering in China [GKZD010053-1]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); State Key Laboratory of Ocean Engineering in China	This work was supported by National Science Foundation of China (grant No. 40830213, 41076078); a grant from the Science and Technology Commission of Shanghai Municipality (grant No. 10JC1406700), and a grant from the State Key Laboratory of Ocean Engineering in China (grant No. GKZD010053-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2011, ISME J, V5, P843, DOI 10.1038/ismej.2010.182; Danovaro R, 2008, NATURE, V454, P1084, DOI 10.1038/nature07268; Davis BM, 2003, CURR OPIN MICROBIOL, V6, P35, DOI 10.1016/S1369-5274(02)00005-X; Fang L, 1999, FEMS MICROBIOL LETT, V176, P39, DOI 10.1016/S0378-1097(99)00216-5; Fang L, 1997, MOL MICROBIOL, V23, P355, DOI 10.1046/j.1365-2958.1997.2351592.x; Frye JG, 2005, J BACTERIOL, V187, P1485, DOI 10.1128/JB.187.4.1485-1492.2005; FUKASAWA T, 1978, MOL GEN GENET, V167, P83, DOI 10.1007/BF00270324; Gabig M, 1998, MOL GEN GENET, V258, P494, DOI 10.1007/s004380050760; Gao HC, 2006, J BACTERIOL, V188, P4560, DOI 10.1128/JB.01908-05; GILADI H, 1995, P NATL ACAD SCI USA, V92, P2184, DOI 10.1073/pnas.92.6.2184; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; Gualerzi CO, 2003, J MOL BIOL, V331, P527, DOI 10.1016/S0022-2836(03)00732-0; Hebraud Michel, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P211; Higashitani A, 1997, P NATL ACAD SCI USA, V94, P2909, DOI 10.1073/pnas.94.7.2909; Higashitani N, 1996, GENES CELLS, V1, P829, DOI 10.1046/j.1365-2443.1996.d01-279.x; Horiuchi K, 1997, GENES CELLS, V2, P425, DOI 10.1046/j.1365-2443.1997.1360334.x; Johnson RM, 1968, J ARIZONA ACAD SCI, V5, p28 , DOI 10.2307/40022820; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Li SK, 2008, ARCH MICROBIOL, V189, P549, DOI 10.1007/s00203-007-0347-1; Li SK, 2006, EXTREMOPHILES, V10, P97, DOI 10.1007/s00792-005-0476-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marvin DA, 1998, CURR OPIN STRUC BIOL, V8, P150, DOI 10.1016/S0959-440X(98)80032-8; Obuchowski M, 1997, J BACTERIOL, V179, P5987, DOI 10.1128/jb.179.19.5987-5991.1997; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Sambrook J., 2001, MOL CLONING LAB MANU; Skulj M, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-6; TAYLOR K, 1995, FEMS MICROBIOL REV, V17, P109; Wang F, 2007, J BACTERIOL, V189, P7151, DOI 10.1128/JB.00569-07; Wang F, 2009, J BACTERIOL, V191, P2574, DOI 10.1128/JB.00498-08; Wang FP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001937; Wang FP, 2004, EXTREMOPHILES, V8, P165, DOI 10.1007/s00792-003-0365-0; Wegrzyn A, 2001, ARCH MICROBIOL, V175, P86, DOI 10.1007/s002030000245; WEGRZYN G, 1995, J BIOTECHNOL, V43, P139; WEGRZYN G, 2001, RRD VIROLOGY I, V3, P375; Wegrzyn G, 2002, MICROB CELL FACT, V1, DOI 10.1186/1475-2859-1-2; Wells LE, 2006, AQUAT MICROB ECOL, V45, P15, DOI 10.3354/ame045015; WIEBE WJ, 1968, MAR BIOL, V1, P244, DOI 10.1007/BF00347117; WILLARD M, 1968, J MOL BIOL, V32, P37, DOI 10.1016/0022-2836(68)90143-5; Xiao X, 2007, INT J SYST EVOL MICR, V57, P60, DOI 10.1099/ijs.0.64500-0; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x	42	23	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41578	10.1371/journal.pone.0041578	http://dx.doi.org/10.1371/journal.pone.0041578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870232	Green Published, Green Submitted, gold			2022-12-27	WOS:000307212800026
J	Lescarbeau, RM; Seib, FP; Prewitz, M; Werner, C; Kaplan, DL				Lescarbeau, Reynald M.; Seib, F. Philipp; Prewitz, Marina; Werner, Carsten; Kaplan, David L.			In Vitro Model of Metastasis to Bone Marrow Mediates Prostate Cancer Castration Resistant Growth through Paracrine and Extracellular Matrix Factors	PLOS ONE			English	Article							LNCAP CELLS; ANDROGEN RECEPTOR; NEUROENDOCRINE DIFFERENTIATION; FACTORS INDUCE; PROGRESSION; DEPRIVATION; PHOSPHORYLATION; OSTEOBLASTS; EXPRESSION; SIGNATURE	The spread of prostate cancer cells to the bone marrow microenvironment and castration resistant growth are key steps in disease progression and significant sources of morbidity. However, the biological significance of mesenchymal stem cells (MSCs) and bone marrow derived extracellular matrix (BM-ECM) in this process is not fully understood. We therefore established an in vitro engineered bone marrow tissue model that incorporates hMSCs and BM-ECM to facilitate mechanistic studies of prostate cancer cell survival in androgen-depleted media in response to paracrine factors and BM-ECM. hMSC-derived paracrine factors increased LNCaP cell survival, which was in part attributed to IGFR and IL6 signaling. In addition, BM-ECM increased LNCaP and MDA-PCa-2b cell survival in androgen-depleted conditions, and induced chemoresistance and morphological changes in LNCaPs. To determine the effect of BM-ECM on cell signaling, the phosphorylation status of 46 kinases was examined. Increases in the phosphorylation of MAPK pathway-related proteins as well as sustained Akt phosphorylation were observed in BM-ECM cultures when compared to cultures grown on plasma-treated polystyrene. Blocking MEK1/2 or the PI3K pathway led to a significant reduction in LNCaP survival when cultured on BM-ECM in androgen-depleted conditions. The clinical relevance of these observations was determined by analyzing Erk phosphorylation in human bone metastatic prostate cancer versus non-metastatic prostate cancer, and increased phosphorylation was seen in the metastatic samples. Here we describe an engineered bone marrow model that mimics many features observed in patients and provides a platform for mechanistic in vitro studies.	[Lescarbeau, Reynald M.; Seib, F. Philipp; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Prewitz, Marina; Werner, Carsten] Leibniz Inst Polymer Res Dresden, Dresden, Germany	Tufts University; Leibniz Institut fur Polymerforschung Dresden	Lescarbeau, RM (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu	Werner, Carsten/F-8127-2010; Prewitz, Marina/G-4482-2013; Werner, Carsten/AAF-1510-2019	Werner, Carsten/0000-0003-0189-3448; Reinsch, Marina/0000-0003-1054-6456; Seib, Philipp/0000-0002-1955-1975	National Institutes of Health (Tissue Engineering Resource Center) [P41 EB002520-05]; Mildred Scheel Postdoctoral fellowship from the German Cancer Aid; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	National Institutes of Health (Tissue Engineering Resource Center); Mildred Scheel Postdoctoral fellowship from the German Cancer Aid; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health grant P41 EB002520-05 (Tissue Engineering Resource Center) (DL Kaplan). FP Seib is supported by a Mildred Scheel Postdoctoral fellowship from the German Cancer Aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4; Andresen C., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P148; Blaszczyk N, 2004, CLIN CANCER RES, V10, P1860, DOI 10.1158/1078-0432.CCR-0974-3; Charafe-Jaufrret E, 2004, J PATHOL, V202, P265, DOI 10.1002/path.1515; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj.neo.7900224; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Lee JT, 2005, INT J ONCOL, V26, P1637; Lee SO, 2004, PROSTATE, V60, P178, DOI 10.1002/pros.20045; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Martin-Orozco RM, 2007, NEOPLASIA, V9, P614, DOI 10.1593/neo.07337; Moreau JE, 2007, CANCER RES, V67, P10304, DOI 10.1158/0008-5472.CAN-07-2483; Mostaghel EA, 2008, BEST PRACT RES CL EN, V22, P243, DOI 10.1016/j.beem.2008.01.003; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Pathi SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008849; Reichert JC, 2010, BIOMATERIALS, V31, P7928, DOI 10.1016/j.biomaterials.2010.06.055; Seib FP, 2009, TISSUE ENG PT A, V15, P3161, DOI 10.1089/ten.TEA.2008.0600; Seib FP, 2009, EUR J CELL BIOL, V88, P257, DOI 10.1016/j.ejcb.2009.01.003; Shigemura K, 2009, PROSTATE, V69, P949, DOI 10.1002/pros.20944; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Thomas F, 2010, PROSTATE, V70, P856, DOI 10.1002/pros.21119; Vincent T, 2005, LEUKEMIA LYMPHOMA, V46, P803, DOI 10.1080/10428190500051448; Wang G, 2009, CANCER RES, V69, P3433, DOI 10.1158/0008-5472.CAN-08-3506; Wang G, 2008, CANCER RES, V68, P9918, DOI 10.1158/0008-5472.CAN-08-1718; Yang J, 2001, CANCER RES, V61, P5652; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084	27	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40372	10.1371/journal.pone.0040372	http://dx.doi.org/10.1371/journal.pone.0040372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870197	gold, Green Published, Green Submitted			2022-12-27	WOS:000307212800006
J	Mi, JX; Liu, JX; Wen, JJ				Mi, Jian-Xun; Liu, Jin-Xing; Wen, Jiajun			New Robust Face Recognition Methods Based on Linear Regression	PLOS ONE			English	Article							REPRESENTATION; EIGENFACES	Nearest subspace (NS) classification based on linear regression technique is a very straightforward and efficient method for face recognition. A recently developed NS method, namely the linear regression-based classification (LRC), uses downsampled face images as features to perform face recognition. The basic assumption behind this kind method is that samples from a certain class lie on their own class-specific subspace. Since there are only few training samples for each individual class, which will cause the small sample size (SSS) problem, this problem gives rise to misclassification of previous NS methods. In this paper, we propose two novel LRC methods using the idea that every class-specific subspace has its unique basis vectors. Thus, we consider that each class-specific subspace is spanned by two kinds of basis vectors which are the common basis vectors shared by many classes and the class-specific basis vectors owned by one class only. Based on this concept, two classification methods, namely robust LRC 1 and 2 (RLRC 1 and 2), are given to achieve more robust face recognition. Unlike some previous methods which need to extract class-specific basis vectors, the proposed methods are developed merely based on the existence of the class-specific basis vectors but without actually calculating them. Experiments on three well known face databases demonstrate very good performance of the new methods compared with other state-of-the-art methods.	[Mi, Jian-Xun; Liu, Jin-Xing; Wen, Jiajun] Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen, Guangdong, Peoples R China; [Mi, Jian-Xun; Liu, Jin-Xing; Wen, Jiajun] Key Lab Network Oriented Intelligent Computat, Shenzhen, Guangdong, Peoples R China	Harbin Institute of Technology; University Town of Shenzhen	Mi, JX (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen, Guangdong, Peoples R China.	mijianxun@gmail.com	Mi, Jianxun/J-9670-2014; Mi, Jianxun/U-3642-2019	Mi, Jianxun/0000-0002-7531-4341; 				Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244; Bartlett MS, 2002, IEEE T NEURAL NETWOR, V13, P1450, DOI 10.1109/TNN.2002.804287; Basri R, 2003, IEEE T PATTERN ANAL, V25, P218, DOI 10.1109/TPAMI.2003.1177153; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042, DOI 10.1109/34.254061; Caldara R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009708; Cevikalp H, 2005, IEEE T PATTERN ANAL, V27, P4, DOI 10.1109/TPAMI.2005.9; Chien JT, 2002, IEEE T PATTERN ANAL, V24, P1644, DOI 10.1109/TPAMI.2002.1114855; Felisberti FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012939; Georghiades AS, 2001, IEEE T PATTERN ANAL, V23, P643, DOI 10.1109/34.927464; Gulmezoglu MB, 2001, IEEE T SPEECH AUDI P, V9, P655, DOI 10.1109/89.943343; Jiang XD, 2008, IEEE T PATTERN ANAL, V30, P383, DOI 10.1109/TPAMI.2007.70708; Lakshmi C, 2009, 2009 SECOND INTERNATIONAL CONFERENCE ON MACHINE VISION, PROCEEDINGS, ( ICMV 2009), P13, DOI 10.1109/ICMV.2009.16; Lee KC, 2005, IEEE T PATTERN ANAL, V27, P684, DOI 10.1109/TPAMI.2005.92; Lu JW, 2003, IEEE T NEURAL NETWOR, V14, P195, DOI 10.1109/TNN.2002.806647; Martinez A., 1998, AR FACE DATABASE CVC; Naseem I, 2010, IEEE T PATTERN ANAL, V32, P2106, DOI 10.1109/TPAMI.2010.128; PENTLAND A, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P84, DOI 10.1109/CVPR.1994.323814; Pentland A, 1994, VIEW BASED MODULAR E, P84; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Ruiz-Del-Solar J, 2005, IEEE T SYST MAN CY C, V35, P315, DOI 10.1109/TSMCC.2005.848201; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Shan SG, 2003, INT J IMAG SYST TECH, V13, P23, DOI 10.1002/ima.10047; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Xu Y, 2012, NEUROCOMPUTING, V79, P125, DOI 10.1016/j.neucom.2011.10.013; Xu Y, 2011, IEEE T CIRC SYST VID, V21, P1255, DOI 10.1109/TCSVT.2011.2138790; Yang A.Y., 2007, IEEE T PATTERN UNPUB; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097; Zhang L, 2011, SPARSE REPRESENTATIO; Zhao W, 2003, ACM COMPUT SURV, V35, P399, DOI 10.1145/954339.954342	31	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42461	10.1371/journal.pone.0042461	http://dx.doi.org/10.1371/journal.pone.0042461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879992	gold, Green Published			2022-12-27	WOS:000307437900041
J	Zha, YH; Ding, E; Yang, LQ; Mao, L; Wang, XW; McCarthy, BA; Huang, S; Ding, HF				Zha, Yunhong; Ding, Emily; Yang, Liqun; Mao, Ling; Wang, Xiangwei; McCarthy, Brian A.; Huang, Shuang; Ding, Han-Fei			Functional Dissection of HOXD Cluster Genes in Regulation of Neuroblastoma Cell Proliferation and Differentiation	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; HIGH-RISK NEUROBLASTOMA; RETINOIC ACID; HOMEOBOX GENES; NEURONAL DIFFERENTIATION; 13-CIS-RETINOIC ACID; NERVOUS-SYSTEM; STEM-CELLS; EXPRESSION; ACTIVATION	Retinoic acid (RA) can induce growth arrest and neuronal differentiation of neuroblastoma cells and has been used in clinic for treatment of neuroblastoma. It has been reported that RA induces the expression of several HOXD genes in human neuroblastoma cell lines, but their roles in RA action are largely unknown. The HOXD cluster contains nine genes (HOXD1, HOXD3, HOXD4, and HOXD8-13) that are positioned sequentially from 39 to 59, with HOXD1 at the 39 end and HOXD13 the 59 end. Here we show that all HOXD genes are induced by RA in the human neuroblastoma BE(2)-C cells, with the genes located at the 39 end being activated generally earlier than those positioned more 59 within the cluster. Individual induction of HOXD8, HOXD9, HOXD10 or HOXD12 is sufficient to induce both growth arrest and neuronal differentiation, which is associated with downregulation of cell cycle-promoting genes and upregulation of neuronal differentiation genes. However, induction of other HOXD genes either has no effect (HOXD1) or has partial effects (HOXD3, HOXD4, HOXD11 and HOXD13) on BE(2)-C cell proliferation or differentiation. We further show that knockdown of HOXD8 expression, but not that of HOXD9 expression, significantly inhibits the differentiation-inducing activity of RA. HOXD8 directly activates the transcription of HOXC9, a key effector of RA action in neuroblastoma cells. These findings highlight the distinct functions of HOXD genes in RA induction of neuroblastoma cell differentiation.	[Zha, Yunhong; Yang, Liqun; Mao, Ling; Wang, Xiangwei; McCarthy, Brian A.; Ding, Han-Fei] Georgia Hlth Sci Univ, Med Coll Georgia, Ctr Canc, Augusta, GA USA; [Zha, Yunhong; Yang, Liqun; Mao, Ling; Wang, Xiangwei; McCarthy, Brian A.; Ding, Han-Fei] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Pathol, Augusta, GA USA; [Huang, Shuang] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA USA; [Ding, Emily] Lakeside High Sch, Evans, GA USA; [Zha, Yunhong] Three Gorges Univ, First Peoples Hosp Yichang, Coll Med, Dept Neurol, Yichang, Hubei, Peoples R China; [Mao, Ling] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430074, Hubei, Peoples R China; [Wang, Xiangwei] Third Mil Med Univ, Affiliated Hosp 2, Dept Urol, Chongqing, Peoples R China	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; China Three Gorges University; Huazhong University of Science & Technology; Army Medical University	Zha, YH (corresponding author), Georgia Hlth Sci Univ, Med Coll Georgia, Ctr Canc, Augusta, GA USA.	hding@georgiahealth.edu	Wu, Yuqi/AAL-9861-2020	Ding, Han-Fei/0000-0001-5702-3439	National Institutes of Health [CA124982]; Georgia Cancer Coalition Distinguished Scholar Award; National Science Foundation of China [NSFC 81101905]; National Natural Science Foundation of China [81172443]; NATIONAL CANCER INSTITUTE [R01CA124982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition Distinguished Scholar Award; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grant CA124982 and a Georgia Cancer Coalition Distinguished Scholar Award to HD. LM was supported in part by the National Science Foundation of China (NSFC 81101905) and XW by the National Natural Science Foundation of China (No. 81172443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam G, 2009, AM J PATHOL, V175, P856, DOI 10.2353/ajpath.2009.090019; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Ambros IM, 2002, CANCER, V94, P1574, DOI 10.1002/cncr.10359; Beckwith J B, 1968, J Pediatr Surg, V3, P106; BONCINELLI E, 1991, TRENDS GENET, V7, P329, DOI 10.1016/0168-9525(91)90423-N; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; GAETANO C, 1991, CELL GROWTH DIFFER, V2, P487; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Hahn CK, 2008, P NATL ACAD SCI USA, V105, P9751, DOI 10.1073/pnas.0710413105; HUGHES M, 1974, CANCER, V34, P1706, DOI 10.1002/1097-0142(197411)34:5<1706::AID-CNCR2820340519>3.0.CO;2-J; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; LAWRENCE PA, 1994, CELL, V78, P181, DOI 10.1016/0092-8674(94)90289-5; Lufkin T, 1996, CURR OPIN GENET DEV, V6, P575, DOI 10.1016/S0959-437X(96)80086-4; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Manohar CF, 1996, TUMOR BIOL, V17, P34, DOI 10.1159/000217965; MANOHAR CF, 1993, BIOCHEM MOL BIOL INT, V30, P733; Mao L, 2011, CANCER RES, V71, P4314, DOI 10.1158/0008-5472.CAN-11-0051; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Marshall H, 1996, FASEB J, V10, P969, DOI 10.1096/fasebj.10.9.8801179; Matsuo T, 1998, ONCOGENE, V16, P3337, DOI 10.1038/sj.onc.1201830; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; MAVILIO F, 1988, DIFFERENTIATION, V37, P73, DOI 10.1111/j.1432-0436.1988.tb00798.x; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; PEVERALI FA, 1990, DIFFERENTIATION, V45, P61, DOI 10.1111/j.1432-0436.1990.tb00458.x; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; ROSS RA, 1995, CELL GROWTH DIFFER, V6, P449; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; SAWHNEY N, 1992, J PATHOL, V168, P161, DOI 10.1002/path.1711680202; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; SIDELL N, 1982, J NATL CANCER I, V68, P589; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SIMEONE A, 1991, MECH DEVELOP, V33, P215, DOI 10.1016/0925-4773(91)90029-6; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; STRUBING C, 1995, MECH DEVELOP, V53, P275, DOI 10.1016/0925-4773(95)00446-8; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Volchenboum SL, 2009, J CLIN ONCOL, V27, P1003, DOI 10.1200/JCO.2008.20.2739; Yahagi Naohisa, 2004, Congenital Anomalies, V44, P18, DOI 10.1111/j.1741-4520.2003.00004.x; Zhao YX, 2002, DEV BIOL, V244, P21, DOI 10.1006/dbio.2002.0595	50	30	33	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e40728	10.1371/journal.pone.0040728	http://dx.doi.org/10.1371/journal.pone.0040728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879880	gold, Green Published, Green Submitted			2022-12-27	WOS:000307437900004
J	Luo, J; Chen, YC; Wu, YH; Shi, PL; She, J; Zhou, P				Luo, Ji; Chen, Youchao; Wu, Yanhong; Shi, Peili; She, Jia; Zhou, Peng			Temporal-Spatial Variation and Controls of Soil Respiration in Different Primary Succession Stages on Glacier Forehead in Gongga Mountain, China	PLOS ONE			English	Article							MICROBIAL BIOMASS; CO2 EFFLUX; STAND AGE; CARBON; TEMPERATURE; FOREST; VEGETATION; NITROGEN; VARIABILITY; PATTERNS	Soil respiration (SR) is an important process in the global carbon cycle. It is difficult to estimate SR emission accurately because of its temporal and spatial variability. Primary forest succession on Glacier forehead provides the ideal environment for examining the temporal-spatial variation and controlling factors of SR. However, relevant studies on SR are relatively scarce, and variations, as well as controlling factors, remain uncertain in this kind of region. In this study, we used a static chamber system to measure SR in six sites which represent different stages of forest succession on forehead of a temperate glacier in Gongga Mountain, China. Our results showed that there was substantial temporal (coefficient of variation (CV) ranged from 39.3% to 73.9%) and spatial (CV ranged from 12.3% to 88.6%) variation in SR. Soil temperature (ST) at 5 cm depth was the major controlling factor of temporal variation in all six sites. Spatial variation in SR was mainly caused by differences in plant biomass and Total N among the six sites. Moreover, soil moisture (SM), microbial biomass carbon (MBC), soil organic carbon (SOC), pH and bulk density could influence SR by directly or indirectly affecting plant biomass and Total N. Q(10) values (ranged from 2.1 to 4.7) increased along the forest succession, and the mean value (3.3) was larger than that of temperate ecosystems, which indicated a general tendency towards higher-Q(10) in colder ecosystems than in warmer ecosystems. Our findings provided valuable information for understanding temporal-spatial variation and controlling factors of SR.	[Luo, Ji; Chen, Youchao; Wu, Yanhong; She, Jia; Zhou, Peng] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China; [Chen, Youchao; She, Jia; Zhou, Peng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Shi, Peili] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Luo, J (corresponding author), Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China.	whchenyouchao@yahoo.com.cn	Peili, SHi/AAT-6450-2021	shi, pei li/0000-0002-1120-0003	Chinese Academy of Science [KZCX2-YW-BR-21, KZCX2-EW-309]; National Natural Science Foundation of China [40871042]	Chinese Academy of Science(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Knowledge Innovation Project of the Chinese Academy of Science (Grants KZCX2-YW-BR-21 and KZCX2-EW-309) and the National Natural Science Foundation of China (Grant 40871042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekku Y.S., 2004, POLAR BIOSCI, V17, P36; BOWDEN RD, 1993, CAN J FOREST RES, V23, P1402, DOI 10.1139/x93-177; Bremner DJ, 1996, METHOD SOIL ANAL, P539; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Chen QS, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003538; Chen ZJ, 2002, J SOIL WATER CONSERV, V16, P119; [程根伟 Cheng Genwei], 2002, [生态学报, Acta Ecologica Sinica], V22, P1049; Cote L, 2000, SOIL BIOL BIOCHEM, V32, P1079, DOI 10.1016/S0038-0717(00)00017-1; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; De Kovel CGF, 2000, PLANT ECOL, V149, P43, DOI 10.1023/A:1009898622773; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Epron D, 2004, FOREST ECOL MANAG, V202, P149, DOI 10.1016/j.foreco.2004.07.019; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Franzluebbers K, 2002, SOIL SCI SOC AM J, V66, P254, DOI 10.2136/sssaj2002.0254; HANSON PJ, 1993, TREE PHYSIOL, V13, P1, DOI 10.1093/treephys/13.1.1; Jackson RB, 2000, METHODS IN ECOSYSTEM SCIENCE, P199; JENKINSON DS, 1976, SOIL BIOL BIOCHEM, V8, P189, DOI 10.1016/0038-0717(76)90003-1; Jia GM, 2005, FOREST ECOL MANAG, V217, P117, DOI 10.1016/j.foreco.2005.05.055; Li X., 1995, MOUNTAIN RES, V13, P109; Li ZX, 2010, QUATERN INT, V218, P166, DOI 10.1016/j.quaint.2008.09.005; Liu Ying, 2005, Yingyong Shengtai Xuebao, V16, P1581; Longdoz B, 2000, GLOB CHANGE BIOL, V6, P907, DOI 10.1046/j.1365-2486.2000.00369.x; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nicol GW, 2005, ENVIRON MICROBIOL, V7, P337, DOI 10.1111/j.1462-2920.2005.00698.x; Piao SL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003339; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Robbins JA, 2010, ARCT ANTARCT ALP RES, V42, P351, DOI 10.1657/1938-4246-42.3.351; Rustad LE, 2000, BIOGEOCHEMISTRY, V48, P1, DOI 10.1023/A:1006255431298; Saiz G, 2006, PLANT SOIL, V287, P161, DOI 10.1007/s11104-006-9052-0; Saiz G, 2006, GLOBAL CHANGE BIOL, V12, P1007, DOI 10.1111/j.1365-2486.2006.01145.x; Shen RenFang, 1997, Pedosphere, V7, P297; SMITH JL, 1985, SOIL BIOL BIOCHEM, V17, P11, DOI 10.1016/0038-0717(85)90083-5; Soe ARB, 2005, TREE PHYSIOL, V25, P1427, DOI 10.1093/treephys/25.11.1427; Su Z, 2002, QUATERN INT, V97-8, P123, DOI 10.1016/S1040-6182(02)00057-5; Thuille A, 2000, TREE PHYSIOL, V20, P849; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; Wang WJ, 2003, SOIL BIOL BIOCHEM, V35, P273, DOI 10.1016/S0038-0717(02)00274-2; Wang X, 2010, CAN J FOREST RES, V40, P788, DOI 10.1139/X10-010; Yan JH, 2006, GLOBAL CHANGE BIOL, V12, P810, DOI 10.1111/j.1365-2486.2006.01141.x; Yan JH, 2007, PEDOSPHERE, V17, P397, DOI 10.1016/S1002-0160(07)60048-4; Yan JH, 2009, SOIL BIOL BIOCHEM, V41, P991, DOI 10.1016/j.soilbio.2008.12.018; [易志刚 Yi Zhigang], 2003, [生态学报, Acta Ecologica Sinica], V23, P1673; Yu X, 2011, PLSO ONE, P6; Yuste JC, 2003, TREE PHYSIOL, V23, P1263, DOI 10.1093/treephys/23.18.1263; [张金波 ZHANG Jinbo], 2005, [环境科学学报, Acta Scientiae Circumstantiae], V25, P1537; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013	49	32	38	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42354	10.1371/journal.pone.0042354	http://dx.doi.org/10.1371/journal.pone.0042354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879950	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000028
J	Marten, F; Tsaneva-Atanasova, K; Giuggioli, L				Marten, Frank; Tsaneva-Atanasova, Krasimira; Giuggioli, Luca			Bacterial Secretion and the Role of Diffusive and Subdiffusive First Passage Processes	PLOS ONE			English	Article							III SECRETION; PROTEIN-TRANSPORT; HOST-CELLS; SALMONELLA; EFFECTORS; DYNAMICS; ESCAPE; IPAC	By funneling protein effectors through needle complexes located on the cellular membrane, bacteria are able to infect host cells during type III secretion events. The spatio-temporal mechanisms through which these events occur are however not fully understood, due in part to the inherent challenges in tracking single molecules moving within an intracellular medium. As a result, theoretical predictions of secretion times are still lacking. Here we provide a model that quantifies, depending on the transport characteristics within bacterial cytoplasm, the amount of time for a protein effector to reach either of the available needle complexes. Using parameters from Shigella flexneri we are able to test the role that translocators might have to activate the needle complexes and offer semi-quantitative explanations of recent experimental observations.	[Marten, Frank; Tsaneva-Atanasova, Krasimira; Giuggioli, Luca] Univ Bristol, Dept Engn Math, Bristol, Avon, England; [Giuggioli, Luca] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Giuggioli, Luca] Univ Bristol, Bristol Ctr Complex Sci, Bristol, Avon, England	University of Bristol; University of Bristol; University of Bristol	Marten, F (corresponding author), Univ Bristol, Dept Engn Math, Bristol, Avon, England.	Luca.Giuggioli@bristol.ac.uk	Tsaneva-Atanasova, Krasimira T/AAG-6766-2019; Giuggioli, Luca/J-2881-2012	Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; Giuggioli, Luca/0000-0002-2325-4682	Engineering and Physical Sciences Research Council (EPSRC) [EP/E501214/1, EP/E032249/1, EP/H024786/1]; Medical Research Council (MRC) [MR/J002097/1]; MRC [MR/J002097/1] Funding Source: UKRI; Medical Research Council [MR/J002097/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding of this work has come from different sources, namely the Engineering and Physical Sciences Research Council (EPSRC) grants EP/E501214/1, EP/E032249/1, EP/H024786/1 and the Medical Research Council (MRC) grant MR/J002097/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton G., 1989, ELEMENTS GREENS FUNC; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Brutinel ED, 2008, CURR OPIN MICROBIOL, V11, P128, DOI 10.1016/j.mib.2008.02.010; Chevalier C, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/2/025002; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Enninga J, 2005, NAT METHODS, V2, P959, DOI 10.1038/NMETH804; Enninga J, 2009, CELL MICROBIOL, V11, P1462, DOI 10.1111/j.1462-5822.2009.01360.x; Galan JE, 1999, CURR OPIN MICROBIOL, V2, P46, DOI 10.1016/S1369-5274(99)80008-3; Germano G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066102; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Giuggioli L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002008; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; HIGH N, 1992, EMBO J, V11, P1991, DOI 10.1002/j.1460-2075.1992.tb05253.x; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; Innocenti B, 2008, J NEUROPHYSIOL, V99, P25, DOI 10.1152/jn.00737.2007; Jaumouille V, 2008, EMBO J, V27, P447, DOI 10.1038/sj.emboj.7601976; Kenkre VM, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051907; Loverdo C, 2008, NAT PHYS, V4, P134, DOI 10.1038/nphys830; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Mills E, 2008, CELL HOST MICROBE, V3, P104, DOI 10.1016/j.chom.2007.11.007; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Moser T, 2006, CELL TISSUE RES, V326, P347, DOI 10.1007/s00441-006-0276-3; Redner S, 2007, GUIDE 1 PASSAGE PROC; Rudner DZ, 2002, COLD SPRING HARB PER, V2, P1; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Schmitz F, 2009, NEUROSCIENTIST, V15, P611, DOI 10.1177/1073858409340253; Schuss Z, 2007, P NATL ACAD SCI USA, V104, P16098, DOI 10.1073/pnas.0706599104; Simpson N, 2010, METHODS MOL BIOL, V619, P241, DOI 10.1007/978-1-60327-412-8_14; Tamano K, 2002, METHOD ENZYMOL, V358, P385; Tsaneva-Atanasova K, 2009, BIOPHYS J, V96, P840, DOI 10.1016/j.bpj.2008.10.036; Van Engelenburg SB, 2010, NAT METHODS, V7, P325, DOI [10.1038/NMETH.1437, 10.1038/nmeth.1437]; Verkman AS, 2002, TRENDS BIOCHEM SCI, V27, P27, DOI 10.1016/S0968-0004(01)02003-5; Winnen B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002178	36	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e41421	10.1371/journal.pone.0041421	http://dx.doi.org/10.1371/journal.pone.0041421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879888	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000006
J	Rey-Giraud, F; Hafner, M; Ries, CH				Rey-Giraud, Flora; Hafner, Mathias; Ries, Carola H.			In Vitro Generation of Monocyte-Derived Macrophages under Serum-Free Conditions Improves Their Tumor Promoting Functions	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; DENDRITIC CELLS; M2 MACROPHAGES; INTERFERON-GAMMA; IRON HOMEOSTASIS; POLARIZATION; ACTIVATION; DIFFERENTIATION; PROGRESSION; RECEPTORS	The tumor promoting role of M2 macrophages has been described in in vivo models and the presence of macrophages in certain tumor types has been linked to a poor clinical outcome. In light of burgeoning activities to clinically develop new therapies targeting tumor-associated macrophages (TAMs), reliable in vitro models faithfully mimicking the tumor promoting functions of TAMs are required. Generation and activation of human monocyte-derived macrophages (MDM) in vitro, described as M1 or M2 macrophages attributed with tumoricidal or tumor-promoting functions, respectively, has been widely reported using mainly serum containing culture methods. In this study, we compared the properties of macrophages originating from monocytes cultured either in media containing serum together with M-CSF for M2 and GM-CSF for M1 macrophages or in serum-free media supplemented with M-CSF or GM-CSF and cytokines such as IL-4, IL-10 to induce activated M2 or LPS together with IFN-gamma to generate activated M1 phenotype. We observed differences in cell morphology as well as increased surface receptor expression levels in serum-containing culture whereas similar or higher cytokine production levels were detected under serum-free culture conditions. More importantly, MDM differentiated under serum-free conditions displayed enhanced tumoricidal activity for M1 and tumor promoting property for M2 macrophages in contrast to MDM differentiated in the presence of serum. Moreover, evaluation of MDM phagocytic activity in serum free condition resulted in greater phagocytic properties of M2 compared to M1. Our data therefore confirm the tumor promoting properties of M2 macrophages in vitro and encourage the targeting of TAMs for cancer therapy.	[Rey-Giraud, Flora; Ries, Carola H.] Roche Diagnost GmbH, Pharma Res & Early Dev, Penzberg, Germany; [Rey-Giraud, Flora; Hafner, Mathias] Mannheim Univ Appl Sci, Inst Mol & Cell Biol, Mannheim, Germany	Roche Holding	Rey-Giraud, F (corresponding author), Roche Diagnost GmbH, Pharma Res & Early Dev, Penzberg, Germany.	carola.ries@roche.com						Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; BECKER S, 1990, CELL IMMUNOL, V129, P351, DOI 10.1016/0008-8749(90)90211-9; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2008, J IMMUNOL, V180, P2011, DOI 10.4049/jimmunol.180.4.2011; Bonecchi R, 2000, J IMMUNOL, V164, P3862, DOI 10.4049/jimmunol.164.7.3862; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Cairo G, 2010, HAEMATOL-HEMATOL J, V95, P1801, DOI 10.3324/haematol.2010.030239; Corna G, 2010, HAEMATOL-HEMATOL J, V95, P1814, DOI 10.3324/haematol.2010.023879; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Delneste Y, 2003, BLOOD, V101, P143, DOI 10.1182/blood-2002-04-1164; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542; Kawamura K, 2009, PATHOL INT, V59, P300, DOI 10.1111/j.1440-1827.2009.02369.x; Komohara Y, 2011, CANCER SCI, V102, P1424, DOI 10.1111/j.1349-7006.2011.01945.x; Koning N, 2010, J INNATE IMMUN, V2, P195, DOI 10.1159/000252803; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Mantovani A, 2001, TRENDS IMMUNOL, V22, P328, DOI 10.1016/S1471-4906(01)01941-X; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; MUNN DH, 1995, CANCER IMMUNOL IMMUN, V41, P46, DOI 10.1007/s002620050198; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Palucka KA, 1998, J IMMUNOL, V160, P4587; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sica A, 2010, EUR J IMMUNOL, V40, P2131, DOI 10.1002/eji.201040736; Smith W, 1998, EUR J IMMUNOL, V28, P2498, DOI 10.1002/(SICI)1521-4141(199808)28:08<2498::AID-IMMU2498>3.0.CO;2-Q; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Way KJ, 2009, J LEUKOCYTE BIOL, V85, P766, DOI 10.1189/jlb.1108689	34	161	172	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42656	10.1371/journal.pone.0042656	http://dx.doi.org/10.1371/journal.pone.0042656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880072	Green Submitted, Green Published, gold			2022-12-27	WOS:000307810000057
J	Choi, MY; Wang, Y; Wong, LLY; Lu, BT; Chen, WY; Huang, JD; Tanner, JA; Watt, RM				Choi, Mei Y.; Wang, Ying; Wong, Leo L. Y.; Lu, Bing-tai; Chen, Wen-yang; Huang, Jian-Dong; Tanner, Julian A.; Watt, Rory M.			The Two PPX-GppA Homologues from Mycobacterium tuberculosis Have Distinct Biochemical Activities	PLOS ONE			English	Article							ESCHERICHIA-COLI; INORGANIC POLYPHOSPHATE; STRINGENT RESPONSE; PENTAPHOSPHATE PHOSPHOHYDROLASE; EXOPOLYPHOSPHATASE PPX; KINASE; VIRULENCE; (P)PPGPP; PERSISTENCE; PPGPP	Inorganic polyphosphate (poly-P), guanosine pentaphosphate (pppGpp) and guanosine tetraphosphate (ppGpp) are ubiquitous in bacteria. These molecules play a variety of important physiological roles associated with stress resistance, persistence, and virulence. In the bacterial pathogen Mycobacterium tuberculosis, the identities of the proteins responsible for the metabolism of polyphosphate and (p) ppGpp remain to be fully established. M. tuberculosis encodes two PPX-GppA homologues, Rv0496 (MTB-PPX1) and Rv1026, which share significant sequence similarity with bacterial exopolyphosphatase (PPX) and guanosine pentaphosphate 5'-phosphohydrolase (GPP) proteins. Here we delineate the respective biochemical activities of the Rv0496 and Rv1026 proteins and benchmark these against the activities of the PPX and GPP proteins from Escherichia coli. We demonstrate that Rv0496 functions as an exopolyphosphatase, showing a distinct preference for relatively short-chain poly-P substrates. In contrast, Rv1026 has no detectable exopolyphosphatase activities. Analogous to the E. coli PPX and GPP enzymes, the exopolyphosphatase activities of Rv0496 are inhibited by pppGpp and, to a lesser extent, by ppGpp alarmones, which are produced during the bacterial stringent response. However, neither Rv0496 nor Rv1026 have the ability to hydrolyze pppGpp to ppGpp; a reaction catalyzed by E. coli PPX and GPP. Both the Rv0496 and Rv1026 proteins have modest ATPase and to a lesser extent ADPase activities. pppGpp alarmones inhibit the ATPase activities of Rv1026 and, to a lesser extent, the ATPase activities of Rv0496. We conclude that PPX-GppA family proteins may not possess all the catalytic activities implied by their name and may play distinct biochemical roles involved in polyphosphate and (p) ppGpp metabolic pathways.	[Choi, Mei Y.; Lu, Bing-tai; Chen, Wen-yang; Watt, Rory M.] Univ Hong Kong, Prince Philip Dent Hosp, Fac Dent, Sai Ying Pun, Hong Kong, Peoples R China; [Wang, Ying] Wuhan Ctr Dis Prevent & Control, Wuhan, Hubei Province, Peoples R China; [Wong, Leo L. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Huang, Jian-Dong; Tanner, Julian A.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Biochem, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Choi, MY (corresponding author), Univ Hong Kong, Prince Philip Dent Hosp, Fac Dent, Sai Ying Pun, Hong Kong, Peoples R China.	rmwatt@hku.hk	Watt, Rory M./B-2177-2009; Tanner, Julian A./C-4412-2009; /C-4277-2009	Watt, Rory M./0000-0002-8718-1988; Tanner, Julian A./0000-0002-5459-1526; /0000-0001-7531-2816; Chen, Wenyang/0000-0002-2480-6282	Infection and Immunology Strategic Research Theme of the University of Hong Kong; Research Grants Council of Hong Kong through a General Research Fund (GRF) [705007]	Infection and Immunology Strategic Research Theme of the University of Hong Kong; Research Grants Council of Hong Kong through a General Research Fund (GRF)	RMW acknowledges financial support from the Infection and Immunology Strategic Research Theme of the University of Hong Kong and the Research Grants Council of Hong Kong through a General Research Fund (GRF) award [#705007]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2009, J BACTERIOL, V191, P2248, DOI 10.1128/JB.01726-08; AKIYAMA M, 1993, J BIOL CHEM, V268, P633; Alvarado J, 2006, STRUCTURE, V14, P1263, DOI 10.1016/j.str.2006.06.009; [Anonymous], 2004, BIOCH INORGANIC POLY; Avarbock A, 2005, BIOCHEMISTRY-US, V44, P9913, DOI 10.1021/bi0505316; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Bolesch DG, 2000, J BIOL CHEM, V275, P33814, DOI 10.1074/jbc.M002039200; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; CLARK JE, 1987, ANAL BIOCHEM, V161, P280, DOI 10.1016/0003-2697(87)90452-0; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Gottesman S, 2001, SCIENCE, V293, P614, DOI 10.1126/science.1063371; HARA A, 1983, J BIOL CHEM, V258, P1678; Hardiman T, 2008, ANAL BIOCHEM, V383, P337, DOI 10.1016/j.ab.2008.07.042; Hsieh PC, 1996, BIOCHEMISTRY-US, V35, P9772, DOI 10.1021/bi9528659; Jagannathan V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014336; KEASLING JD, 1993, P NATL ACAD SCI USA, V90, P7029, DOI 10.1073/pnas.90.15.7029; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kristensen O, 2004, BIOCHEMISTRY-US, V43, P8894, DOI 10.1021/bi049083c; Kristensen O, 2008, J MOL BIOL, V375, P1469, DOI 10.1016/j.jmb.2007.11.073; KROHN M, 1995, ANAL BIOCHEM, V225, P188, DOI 10.1006/abio.1995.1138; Kulaev I, 2000, ANNU REV MICROBIOL, V54, P709, DOI 10.1146/annurev.micro.54.1.709; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Lindner SN, 2009, APPL ENVIRON MICROB, V75, P3161, DOI 10.1128/AEM.02705-08; Manganelli R, 2007, MOL MICROBIOL, V65, P258, DOI 10.1111/j.1365-2958.2007.05819.x; McGrath JW, 2003, ADV APPL MICROBIOL, V52, P75, DOI 10.1016/S0065-2164(03)01003-7; Mittal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027398; OKI T, 1975, BIOCHIM BIOPHYS ACTA, V410, P262, DOI 10.1016/0005-2744(75)90228-4; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Raffaelli N, 2004, BIOCHEMISTRY-US, V43, P7610, DOI 10.1021/bi049650w; Rangarajan ES, 2006, J MOL BIOL, V359, P1249, DOI 10.1016/j.jmb.2006.04.031; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; REIZER J, 1993, TRENDS BIOCHEM SCI, V18, P247, DOI 10.1016/0968-0004(93)90172-J; Rifat D, 2009, J INFECT DIS, V200, P1126, DOI 10.1086/605700; Sable SB, 2005, INFECT IMMUN, V73, P3547, DOI 10.1128/IAI.73.6.3547-3558.2005; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shi TY, 2011, CURR MICROBIOL, V63, P470, DOI 10.1007/s00284-011-0004-4; Shi XB, 2004, P NATL ACAD SCI USA, V101, P17061, DOI 10.1073/pnas.0407787101; Shum KT, 2011, BIOCHEMISTRY-US, V50, P3261, DOI 10.1021/bi2001455; Srivastava V, 2007, MICROBIOL-SGM, V153, P659, DOI 10.1099/mic.0.2006/000547-0; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; Sureka K, 2009, MOL MICROBIOL, V74, P1187, DOI 10.1111/j.1365-2958.2009.06925.x; SUZUKI H, 1972, BIOCHIM BIOPHYS ACTA, V268, P381, DOI 10.1016/0005-2744(72)90333-6; Thayil SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028076; Zhang QA, 2010, J BIOL CHEM, V285, P34259, DOI 10.1074/jbc.M110.154393	51	27	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42561	10.1371/journal.pone.0042561	http://dx.doi.org/10.1371/journal.pone.0042561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880033	Green Submitted, gold, Green Published			2022-12-27	WOS:000307284100129
J	Rushmore, J; Leonhardt, SD; Drea, CM				Rushmore, Julie; Leonhardt, Sara D.; Drea, Christine M.			Sight or Scent: Lemur Sensory Reliance in Detecting Food Quality Varies with Feeding Ecology	PLOS ONE			English	Article							RED COLOBUS MONKEYS; TRICHROMATIC VISION; OLFACTORY SENSITIVITY; RINGTAILED LEMUR; SQUIRREL-MONKEYS; SCRAMBLE COMPETITION; EVOLUTION; CUES; SELECTION; VOLATILE	Visual and olfactory cues provide important information to foragers, yet we know little about species differences in sensory reliance during food selection. In a series of experimental foraging studies, we examined the relative reliance on vision versus olfaction in three diurnal, primate species with diverse feeding ecologies, including folivorous Coquerel's sifakas (Propithecus coquereli), frugivorous ruffed lemurs (Varecia variegata spp), and generalist ring-tailed lemurs (Lemur catta). We used animals with known color-vision status and foods for which different maturation stages (and hence quality) produce distinct visual and olfactory cues (the latter determined chemically). We first showed that lemurs preferentially selected high-quality foods over low-quality foods when visual and olfactory cues were simultaneously available for both food types. Next, using a novel apparatus in a series of discrimination trials, we either manipulated food quality (while holding sensory cues constant) or manipulated sensory cues (while holding food quality constant). Among our study subjects that showed relatively strong preferences for high-quality foods, folivores required both sensory cues combined to reliably identify their preferred foods, whereas generalists could identify their preferred foods using either cue alone, and frugivores could identify their preferred foods using olfactory, but not visual, cues alone. Moreover, when only high-quality foods were available, folivores and generalists used visual rather than olfactory cues to select food, whereas frugivores used both cue types equally. Lastly, individuals in all three of the study species predominantly relied on sight when choosing between low-quality foods, but species differed in the strength of their sensory biases. Our results generally emphasize visual over olfactory reliance in foraging lemurs, but we suggest that the relative sensory reliance of animals may vary with their feeding ecology.	[Rushmore, Julie; Leonhardt, Sara D.; Drea, Christine M.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27706 USA; [Rushmore, Julie] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Leonhardt, Sara D.] Leuphana Univ, Dept Ecol, Luneburg, Germany; [Leonhardt, Sara D.; Drea, Christine M.] Duke Univ, Dept Biol, Durham, NC USA	Duke University; University System of Georgia; University of Georgia; Leuphana University Luneburg; Duke University	Rushmore, J (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27706 USA.	cdrea@duke.edu	Leonhardt, Sara/AAI-6901-2020	Leonhardt, Sara/0000-0002-8154-9569	National Science Foundation [BCS-0409367, IOS-0719003]; Duke University's Molly Glander Awards; Undergraduate Research Support grants; German Academic Exchange Program (DAAD), Nordamerika Vollzeitstipendium	National Science Foundation(National Science Foundation (NSF)); Duke University's Molly Glander Awards; Undergraduate Research Support grants; German Academic Exchange Program (DAAD), Nordamerika Vollzeitstipendium(Deutscher Akademischer Austausch Dienst (DAAD))	Funding was provided by National Science Foundation grants (BCS-0409367 and IOS-0719003), Duke University's Molly Glander Awards (http://lemur.duke.edu/research/funding-opportunities/) and Undergraduate Research Support grants (http://undergraduateresearch.duke.edu/), and a German Academic Exchange Program (DAAD), Nordamerika Vollzeitstipendium (http://www.daad.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adipietro KA, 2012, PLOS GENET IN PRESS; Albone ES, 1984, MAMMALIAN SEMIOCHEMI; Allman J.M., 1999, EVOLVING BRAINS; Aujard F, 1997, PHYSIOL BEHAV, V62, P1003, DOI 10.1016/S0031-9384(97)00206-0; Azodanlou R, 2004, EUR FOOD RES TECHNOL, V218, P167, DOI 10.1007/s00217-003-0822-0; Balkenius A, 2006, J COMP PHYSIOL A, V192, P431, DOI 10.1007/s00359-005-0081-6; Barton RA, 2006, AM J PRIMATOL, V68, P545, DOI 10.1002/ajp.20251; Bolen RH, 1997, J COMP PSYCHOL, V111, P152; Bosque C, 2003, COMP BIOCHEM PHYS A, V135, P321, DOI 10.1016/S1095-6433(03)00080-1; Boulet M, 2010, J EVOLUTION BIOL, V23, P1558, DOI 10.1111/j.1420-9101.2010.02007.x; Boulet M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-281; Britt A, 2000, FOLIA PRIMATOL, V71, P133, DOI 10.1159/000021741; Caine NG, 2010, BIOL LETTERS, V6, P36, DOI 10.1098/rsbl.2009.0591; Campbell Christina J., 2011, PRIMATES PERSPECTIVE; Catania KC, 2006, NATURE, V444, P1024, DOI 10.1038/4441024a; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; Chapman CA, 2002, COMP BIOCHEM PHYS A, V133, P861, DOI 10.1016/S1095-6433(02)00209-X; CHAPMAN GW, 1991, J AGR FOOD CHEM, V39, P867, DOI 10.1021/jf00005a010; Charpentier MJE, 2008, MOL ECOL, V17, P3225, DOI 10.1111/j.1365-294X.2008.03831.x; Charpentier MJE, 2010, ANIM BEHAV, V80, P101, DOI 10.1016/j.anbehav.2010.04.005; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Church SC, 1998, P ROY SOC B-BIOL SCI, V265, P1509, DOI 10.1098/rspb.1998.0465; CHYAU CC, 1992, J AGR FOOD CHEM, V40, P846, DOI 10.1021/jf00017a028; Crawford JC, 2011, P ROY SOC B-BIOL SCI, V278, P122, DOI 10.1098/rspb.2010.1203; Dearing MD, 2005, ANNU REV ECOL EVOL S, V36, P169, DOI 10.1146/annurev.ecolsys.36.102003.152617; Delbarco-Trillo J, 2011, J EVOLUTION BIOL, V24, P82, DOI 10.1111/j.1420-9101.2010.02145.x; delBarco-Trillo J, 2012, PHILOS T R SOC B, V367, P1909, DOI 10.1098/rstb.2011.0225; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; Dominy NJ, 2004, AM J PRIMATOL, V62, P189, DOI 10.1002/ajp.20015; Dominy NJ, 2001, EVOL ANTHROPOL, V10, P171, DOI 10.1002/evan.1031; DOUCET CM, 1993, OIKOS, V67, P201, DOI 10.2307/3545464; Drapier M, 2003, INT J PRIMATOL, V24, P295, DOI 10.1023/A:1023097116080; DREA CM, 1995, ANIM LEARN BEHAV, V23, P1, DOI 10.3758/BF03198009; Dudley R, 2002, ADDICTION, V97, P381, DOI 10.1046/j.1360-0443.2002.00002.x; Dudley R, 2000, Q REV BIOL, V75, P3, DOI 10.1086/393255; Early DM, 1998, J ANIM SCI, V76, P728; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Fobes JL, 1982, PRIMATE BEHAV, P220; Glew RH, 2005, EUR FOOD RES TECHNOL, V221, P113, DOI 10.1007/s00217-005-1201-9; Goff SA, 2006, SCIENCE, V311, P815, DOI 10.1126/science.1112614; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; Heth G, 2002, BEHAV ECOL SOCIOBIOL, V52, P53, DOI 10.1007/s00265-002-0476-0; Hiramatsu C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003356; Hiramatsu C, 2009, ANIM BEHAV, V77, P1421, DOI 10.1016/j.anbehav.2009.02.012; Honkavaara J, 2002, OIKOS, V98, P505, DOI 10.1034/j.1600-0706.2002.980315.x; Irwin MT, 2007, AM J PRIMATOL, V69, P471, DOI 10.1002/ajp.20353; Isbell LA, 1991, BEHAV ECOL, V2, P143, DOI 10.1093/beheco/2.2.143; Jetz W, 2001, BEHAV ECOL, V12, P134, DOI 10.1093/beheco/12.2.134; JOHNSTON RE, 2000, NEUROBIOLOGY TASTE S, P101; Kappeler PM, 1984, LESSER APES EVOLUTIO, P228; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kirk E. Christopher, 2004, P539; Koivula M, 1997, ANIM BEHAV, V54, P873, DOI 10.1006/anbe.1996.0513; Kuhn U, 2004, PLANT CELL ENVIRON, V27, P1469, DOI 10.1111/j.1365-3040.2004.01252.x; Kuhn U, 2004, GLOBAL CHANGE BIOL, V10, P663, DOI 10.1111/j.1529-8817.2003.00771.x; Kulahci IG, 2008, P R SOC B, V275, P797, DOI 10.1098/rspb.2007.1176; KYRIAZAKIS I, 1993, BRIT J NUTR, V69, P617, DOI 10.1079/BJN19930064; Laska M, 2000, CHEM SENSES, V25, P47, DOI 10.1093/chemse/25.1.47; Laska M, 2003, PHYSIOL BEHAV, V78, P321, DOI 10.1016/S0031-9384(02)00976-9; Laska M, 2002, BEHAV BRAIN RES, V134, P165, DOI 10.1016/S0166-4328(01)00464-8; Laska M, 2002, J EXP BIOL, V205, P1633; Laska M, 2007, AM J PRIMATOL, V69, P282, DOI 10.1002/ajp.20345; Leonhardt SD, 2009, BEHAV ECOL, V20, P1, DOI 10.1093/beheco/arn106; Liman ER, 2003, P NATL ACAD SCI USA, V100, P3328, DOI 10.1073/pnas.0636123100; LOUGHRIN JH, 1992, PHYTOCHEMISTRY, V31, P1537, DOI 10.1016/0031-9422(92)83101-4; Lucas PW, 2003, EVOLUTION, V57, P2636, DOI 10.1554/03-168; Lucas PW, 1998, FOLIA PRIMATOL, V69, P139, DOI 10.1159/000021576; MAISELS F, 1994, INT J PRIMATOL, V15, P681, DOI 10.1007/BF02737427; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; Melin AD, 2009, INT J PRIMATOL, V30, P753, DOI 10.1007/s10764-009-9383-9; MERTL AS, 1976, FOLIA PRIMATOL, V26, P151, DOI 10.1159/000155736; Muller-Schwarze D, 2006, CHEM ECOLOGY VERTEBR; New JG, 2000, BRAIN BEHAV EVOLUT, V59, P177; Odeen A, 2010, J COMP PHYSIOL A, V196, P91, DOI 10.1007/s00359-009-0474-z; Osbourn AE, 2009, PLANT-DERIVED NATURAL PRODUCTS: SYNTHESIS, FUNCTION, AND APPLICATION, P1, DOI 10.1007/978-0-387-85498-4; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Piep M, 2008, ANIM BEHAV, V75, P871, DOI 10.1016/j.anbehav.2007.07.008; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; Regan BC, 1998, VISION RES, V38, P3321, DOI 10.1016/S0042-6989(97)00462-8; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; RICHARD A, 1974, FOLIA PRIMATOL, V22, P178, DOI 10.1159/000155624; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Sauther ML, 1999, EVOL ANTHROPOL, V8, P120, DOI 10.1002/(SICI)1520-6505(1999)8:4<120::AID-EVAN3>3.0.CO;2-O; Schilling A., 1979, P461; Scordato ES, 2007, CHEM SENSES, V32, P493, DOI 10.1093/chemse/bjm018; Scordato ES, 2007, ANIM BEHAV, V73, P301, DOI 10.1016/j.anbehav.2006.08.006; Siemers BM, 2007, INT J PRIMATOL, V28, P291, DOI 10.1007/s10764-007-9135-7; Siitari H, 1999, P ROY SOC B-BIOL SCI, V266, P2125, DOI 10.1098/rspb.1999.0897; Smith C, 2004, P ROY SOC B-BIOL SCI, V271, P949, DOI 10.1098/rspb.2004.2690; Smith T, 2006, OLFACTION AND THE BRAIN, P135, DOI 10.1017/CBO9780511543623.010; Snaith TV, 2005, BEHAV ECOL SOCIOBIOL, V59, P185, DOI 10.1007/s00265-005-0023-x; Sokal R. R., 1981, BIOMETRY; Stephens D.W., 1986, pi; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; Tan Y, 1999, NATURE, V402, P36, DOI 10.1038/46947; Thies W, 1998, BEHAV ECOL SOCIOBIOL, V42, P397, DOI 10.1007/s002650050454; Vasey N, 2000, AM J PHYS ANTHROPOL, V112, P411, DOI 10.1002/1096-8644(200007)112:3<411::AID-AJPA10>3.0.CO;2-R; Vasey N., 2003, NAT HIST MADAG, P1332; Wrangham R. W., 1977, P503; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; YEAGER CP, 1989, INT J PRIMATOL, V10, P497, DOI 10.1007/BF02739363	102	31	31	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41558	10.1371/journal.pone.0041558	http://dx.doi.org/10.1371/journal.pone.0041558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870229	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100022
J	Schmickl, R; Paule, J; Klein, J; Marhold, K; Koch, MA				Schmickl, Roswitha; Paule, Juraj; Klein, Johannes; Marhold, Karol; Koch, Marcus A.			The Evolutionary History of the Arabidopsis arenosa Complex: Diverse Tetraploids Mask the Western Carpathian Center of Species and Genetic Diversity	PLOS ONE			English	Article							CHLOROPLAST DNA; EASTERN ALPS; RELATIVES; ORIGIN; COLONIZATION; BRASSICACEAE; POPULATIONS; REFUGIA; DIFFERENTIATION; SPECIATION	The Arabidopsis arenosa complex is closely related to the model plant Arabidopsis thaliana. Species and subspecies in the complex are mainly biennial, predominantly outcrossing, herbaceous, and with a distribution range covering most parts of latitudes and the eastern reaches of Europe. In this study we present the first comprehensive evolutionary history of the A. arenosa species complex, covering its natural range, by using chromosome counts, nuclear AFLP data, and a maternally inherited marker from the chloroplast genome [trnL intron (trnL) and trnL/F intergenic spacer (trnL/F-IGS) of tRNA(Leu) and tRNA(Phe), respectively]. We unravel the broad-scale cytogeographic and phylogeographic patterns of diploids and tetraploids. Diploid cytotypes were exclusively found on the Balkan Peninsula and in the Carpathians while tetraploid cytotypes were found throughout the remaining distribution range of the A. arenosa complex. Three centers of genetic diversity were identified: the Balkan Peninsula, the Carpathians, and the unglaciated Eastern and Southeastern Alps. All three could have served as long-term refugia during Pleistocene climate oscillations. We hypothesize that the Western Carpathians were and still are the cradle of speciation within the A. arenosa complex due to the high species number and genetic diversity and the concurrence of both cytotypes there.	[Schmickl, Roswitha; Koch, Marcus A.] Heidelberg Univ, Dept Biodivers & Plant Systemat, Ctr Organismal Studies COS Heidelberg, Heidelberg, Germany; [Paule, Juraj] Senckenberg Res Inst, Frankfurt, Germany; [Klein, Johannes] Johannes Gutenberg Univ Mainz, Inst Spezielle Bot & Bot Garten, Mainz, Germany; [Marhold, Karol] Inst Bot SAS, Dept Vasc Plant Taxon, Bratislava, Slovakia	Ruprecht Karls University Heidelberg; Senckenberg Gesellschaft fur Naturforschung (SGN); Johannes Gutenberg University of Mainz; Slovak Academy of Sciences	Schmickl, R (corresponding author), Heidelberg Univ, Dept Biodivers & Plant Systemat, Ctr Organismal Studies COS Heidelberg, Heidelberg, Germany.	marcus.koch@cos.uni-heidelberg.de	Schmickl, Roswitha/H-1624-2014; Klein, Johannes T/D-7141-2013; Marhold, Karol/B-4699-2011; Paule, Juraj/A-2998-2017; Koch, Marcus A/A-4924-2011	Schmickl, Roswitha/0000-0002-0632-5143; Klein, Johannes T/0000-0003-2736-8094; Marhold, Karol/0000-0002-7658-0844; Paule, Juraj/0000-0001-5375-7689; Koch, Marcus A/0000-0002-1693-6829	DFG [KO 2302/5-2]	DFG(German Research Foundation (DFG))	This research was supported by DFG grant KO 2302/5-2 (to MAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 1999, NOVON, V9, P296, DOI 10.2307/3391724; Al-Shehbaz Ihsan A, 2002, Arabidopsis Book, V1, pe0001, DOI 10.1199/tab.0001; [Anonymous], 2009, LANG ENV STAT COMP; Beck JB, 2008, MOL ECOL, V17, P902, DOI 10.1111/j.1365-294X.2007.03615.x; Birks HJB, 2008, PLANT ECOL DIVERS, V1, P147, DOI 10.1080/17550870802349146; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Carstens BC, 2007, MOL ECOL, V16, P619, DOI 10.1111/j.1365-294X.2006.03167.x; Cieslak E, 2007, TAXON, V56, P112; Clauss MJ, 2006, TRENDS PLANT SCI, V11, P449, DOI 10.1016/j.tplants.2006.07.005; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Dennell RW, 2011, QUATERNARY SCI REV, V30, P1511, DOI 10.1016/j.quascirev.2009.11.027; Doyle J. J., 1987, PHYTOCHEM B, P11; Ehlers J., 2004, QUATERNARY GLACIATIO; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fer T, 2007, PRESLIA, V79, P367; Frenzel B, 1964, VERHANDLUNGEN ZOOLOG, V103, P110; GREGORIUS HR, 1978, MATH BIOSCI, V41, P253, DOI 10.1016/0025-5564(78)90040-8; Hayek Av, 1908, FLORA STEIERMARK, V1-2; Heuertz M, 2004, MOL ECOL, V13, P3437, DOI 10.1111/j.1365-294X.2004.02333.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Jakobsson M, 2006, MOL BIOL EVOL, V23, P1217, DOI 10.1093/molbev/msk006; Jorgensen MH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-346; Koch M, 2003, PLANT SYST EVOL, V242, P137, DOI 10.1007/s00606-003-0048-4; Koch MA, 2005, MOL BIOL EVOL, V22, P1032, DOI 10.1093/molbev/msi092; Koch MA, 2008, TAXON, V57, P933, DOI 10.1002/tax.573021; Koch MA, 2007, P NATL ACAD SCI USA, V104, P6272, DOI 10.1073/pnas.0701338104; Kolar F, 2009, ANN BOT-LONDON, V103, P963, DOI 10.1093/aob/mcp016; Kolnik M, 2007, CHROMOSOME NUMBER SU, P94; Kosman E, 2005, MOL ECOL, V14, P415, DOI 10.1111/j.1365-294X.2005.02416.x; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Mesiek J, 1998, ZOZNAM NIZSICH VYSSI, P395; Mesiek J, 1970, PRESLIA, V42, P225; Meusel H., 1965, VERGLEICHENDE CHOROL, VVolume 1; Nei M., 1987, MOL EVOLUTIONARY GEN; Niklfeld H, 1972, JB VEREINS SCHUTZE A, V37, P1; OKane SL, 1997, NOVON, V7, P323, DOI 10.2307/3391949; PAWLOWSKI B, 1970, Vegetatio, V21, P181; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Ronikier M, 2008, MOL ECOL, V17, P1763, DOI 10.1111/j.1365-294X.2008.03664.x; Sall T, 2003, J EVOLUTION BIOL, V16, P1019, DOI 10.1046/j.1420-9101.2003.00554.x; Schmickl R, 2011, P NATL ACAD SCI USA, V108, P14192, DOI 10.1073/pnas.1104212108; Schmickl R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-98; Schonswetter P, 2007, J PLANT RES, V120, P721, DOI 10.1007/s10265-007-0108-x; Schonswetter P, 2003, MOL ECOL, V12, P3373, DOI 10.1046/j.1365-294X.2003.01984.x; Soltis DE, 2010, TAXON, V59, P1387, DOI 10.1002/tax.595006; Stuessy TF, 2004, AM J BOT, V91, P889, DOI 10.3732/ajb.91.6.889; TEMPLETON AR, 1992, GENETICS, V132, P619; Tribsch A, 2003, TAXON, V52, P477, DOI 10.2307/3647447; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Willis KJ, 1996, ENDEAVOUR, V20, P110, DOI 10.1016/0160-9327(96)10019-3; Zimmermann A, 1972, DISS BOT, V18, P1	56	39	43	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42691	10.1371/journal.pone.0042691	http://dx.doi.org/10.1371/journal.pone.0042691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880083	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100158
J	Schmucker, C; Ehlken, C; Agostini, HT; Antes, G; Ruecker, G; Lelgemann, M; Loke, YK				Schmucker, Christine; Ehlken, Christoph; Agostini, Hansjuergen T.; Antes, Gerd; Ruecker, Gerta; Lelgemann, Monika; Loke, Yoon K.			A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: Off-Label versus Goldstandard	PLOS ONE			English	Review							RANDOMIZED CLINICAL-TRIAL; VERTEPORFIN PHOTODYNAMIC THERAPY; VISION-RELATED FUNCTION; MACULAR DEGENERATION; INTRAVITREAL BEVACIZUMAB; SUBGROUP ANALYSIS; CANCER-PATIENTS; AVASTIN; PHARMACOKINETICS; TRIAMCINOLONE	Background: We set out a systemic review to evaluate whether off-label bevacizumab is as safe as licensed ranibizumab, and whether bevacizumab can be justifiably offered to patients as a treatment for age-related macular degeneration with robust evidence of no differential risk. Methods and Findings: Medline, Embase and the Cochrane Library were searched with no limitations of language and year of publication. We included RCTs with a minimum follow-up of one year which investigated bevacizumab or ranibizumab in direct comparison or against any other control group (indirect comparison). Direct comparison (3 trials, 1333 patients): The one year data show a significantly higher rate of ocular adverse effects (AE) with bevacizumab compared to ranibizumab (RR = 2.8; 95% CI 1.2-6.5). The proportion of patients with serious infections and gastrointestinal disorders was also higher with bevacizumab than with ranibizumab (RR = 1.3; 95% CI 1.0-1.7). Arterial thromboembolic events were equally distributed among the groups. Indirect comparison: Ranibizumab versus any control (5 trials, 4054 patients): The two year results of three landmark trials showed that while absolute rates of serious ocular AE were low (<= 2.1%), relative harm was significantly raised (RR = 3.1; 95% CI 1.1-8.9). A significant increase in nonocular haemorrhage was also observed with ranibizumab (RR = 1.7; 95% CI 1.1-2.7). Bevacizumab versus any control (3 trials, 244 patients): We were unable to judge the safety profile of bevacizumab due to the poor quality of AE monitoring and reporting in the trials. Conclusions: Evidence from head-to-head trials raises concern about an increased risk of ocular and multiple systemic AE with bevacizumab. Therefore, clinicians and patients should continue to carefully weight up the benefits and harms when choosing between the two treatment options. We also emphasize the need for studies that are powered not just for efficacy, but for defined safety outcomes based on the signals detected in this systematic review.	[Schmucker, Christine; Antes, Gerd] Univ Med Ctr Freiburg, Dept Med Biometry & Stat, Inst Med Biometry & Med Informat, German Cochrane Inst, Freiburg, Germany; [Ehlken, Christoph; Agostini, Hansjuergen T.] Univ Med Ctr Freiburg, Univ Eye Hosp, Freiburg, Germany; [Loke, Yoon K.] Univ E Anglia, Sch Med, Norwich NR4 7TJ, Norfolk, England; [Lelgemann, Monika] German Hlth Insurance Funds, Med Advisory Serv, Essen, Germany	University of Freiburg; University of Freiburg; University of East Anglia	Schmucker, C (corresponding author), Univ Med Ctr Freiburg, Dept Med Biometry & Stat, Inst Med Biometry & Med Informat, German Cochrane Inst, Freiburg, Germany.	schmucker@cochrane.de	Rücker, Gerta/B-2965-2009	Rücker, Gerta/0000-0002-2192-2560; Schmucker, Christine/0000-0002-1188-3158	German Federal Ministry of Education and Research [01KG1020]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This research was supported by a grant from the German Federal Ministry of Education and Research (Grant number: 01KG1020, http://www.gesundheitsforschung-bmbf.de/de/4312.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2010, AM J OPHTHALMOL, V150, P315, DOI 10.1016/j.ajo.2010.04.011; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P2179, DOI 10.1016/j.ophtha.2007.09.012; Bashshur ZF, 2007, ARCH OPHTHALMOL-CHIC, V125, P1357, DOI 10.1001/archopht.125.10.1357; Biswas P, 2011, INDIAN J OPHTHALMOL, V59, P191, DOI 10.4103/0301-4738.81023; Boyer DS, 2007, OPHTHALMOLOGY, V114, P246, DOI 10.1016/j.ophtha.2006.10.045; Boyer DS, 2009, OPHTHALMOLOGY, V116, P1731, DOI 10.1016/j.ophtha.2009.05.024; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Bressler NM, 2009, ARCH OPHTHALMOL-CHIC, V127, P13, DOI 10.1001/archophthalmol.2008.562; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Centre for Reviews and Dissemination, 2008, SYST REV CRDS GUID U, P177; Chang TS, 2007, ARCH OPHTHALMOL-CHIC, V125, P1460, DOI 10.1001/archopht.125.11.1460; Chen CY, 2007, AM J OPHTHALMOL, V143, P510, DOI 10.1016/j.ajo.2006.10.004; Chou R, 2010, J CLIN EPIDEMIOL, V63, P502, DOI 10.1016/j.jclinepi.2008.06.007; Costagliola C, 2010, BRIT J OPHTHALMOL, V94, P180, DOI 10.1136/bjo.2009.159343; Curtis LH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI 10.1001/archophthalmol.2010.223; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Food and Drug Administration, 2006, HIGHL PRESCR INF LUC; Gaudreault J, 2007, RETINA-J RET VIT DIS, V27, P1260, DOI 10.1097/IAE.0b013e318134eecd; Hapani S, 2010, ONCOLOGY-BASEL, V79, P27, DOI 10.1159/000314980; KAHN HA, 1977, AM J EPIDEMIOL, V106, P17, DOI 10.1093/oxfordjournals.aje.a112428; Kaiser PK, 2007, AM J OPHTHALMOL, V144, P850, DOI 10.1016/j.ajo.2007.08.012; Kaiser PK, 2007, OPHTHALMOLOGY, V114, P1868, DOI 10.1016/j.ophtha.2007.04.030; Lazic R, 2007, OPHTHALMOLOGY, V114, P1179, DOI 10.1016/j.ophtha.2007.03.006; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Michels S, 2006, BRIT J OPHTHALMOL, V90, P1333, DOI 10.1136/bjo.2006.102293; R Core Team, 2018, R LANG ENV STAT COMP; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rosenfeld PJ, 2005, OPHTHAL SURG LAS IM, V36, P331, DOI 10.3928/1542-8877-20050701-14; Sacu S, 2009, EYE, V23, P2223, DOI 10.1038/eye.2008.423; Schmidt-Erfurth U, 2011, OPHTHALMOLOGY, V118, P831, DOI 10.1016/j.ophtha.2010.09.004; Schmucker C, 2011, BRIT J OPHTHALMOL, V95, P308, DOI 10.1136/bjo.2009.178574; Steinbrook R, 2006, NEW ENGL J MED, V355, P1409, DOI 10.1056/NEJMp068185; Subramanian ML, 2010, EYE, V24, P1708, DOI 10.1038/eye.2010.147; The Royal College of Ophthalmologists Statement, 2011, BEV AV US MED OPHTH; Tufail A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2459; US Food and Drug Administration (FDA) MedWatch, 2005, SAF AV BEV; Van der Reis MI, 2011, RETINA-J RET VIT DIS, V31, P1449, DOI 10.1097/IAE.0b013e3182278ab4; Weigert G, 2008, BRIT J OPHTHALMOL, V92, P356, DOI 10.1136/bjo.2007.125823; Wu L, 2008, GRAEF ARCH CLIN EXP, V246, P81, DOI 10.1007/s00417-007-0660-z	43	92	96	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42701	10.1371/journal.pone.0042701	http://dx.doi.org/10.1371/journal.pone.0042701			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880086	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100160
J	Yadav, G; Babu, S				Yadav, Gitanjali; Babu, Suresh			NEXCADE: Perturbation Analysis for Complex Networks	PLOS ONE			English	Article							POLLINATION NETWORKS; SYSTEMS; CENTRALITY; COEXTINCTIONS; ROBUSTNESS; COMMUNITY; TOLERANCE; LETHALITY	Recent advances in network theory have led to considerable progress in our understanding of complex real world systems and their behavior in response to external threats or fluctuations. Much of this research has been invigorated by demonstration of the 'robust, yet fragile' nature of cellular and large-scale systems transcending biology, sociology, and ecology, through application of the network theory to diverse interactions observed in nature such as plant-pollinator, seed-dispersal agent and host-parasite relationships. In this work, we report the development of NEXCADE, an automated and interactive program for inducing disturbances into complex systems defined by networks, focusing on the changes in global network topology and connectivity as a function of the perturbation. NEXCADE uses a graph theoretical approach to simulate perturbations in a user-defined manner, singly, in clusters, or sequentially. To demonstrate the promise it holds for broader adoption by the research community, we provide pre-simulated examples from diverse real-world networks including eukaryotic protein-protein interaction networks, fungal biochemical networks, a variety of ecological food webs in nature as well as social networks. NEXCADE not only enables network visualization at every step of the targeted attacks, but also allows risk assessment, i.e. identification of nodes critical for the robustness of the system of interest, in order to devise and implement context-based strategies for restructuring a network, or to achieve resilience against link or node failures. Source code and license for the software, designed to work on a Linux-based operating system (OS) can be downloaded at http://www.nipgr.res.in/nexcade_download.html. In addition, we have developed NEXCADE as an OS-independent online web server freely available to the scientific community without any login requirement at http://www.nipgr.res.in/nexcade.html.	[Yadav, Gitanjali] Natl Inst Plant Genome Res, Computat Biol Lab, New Delhi, India; [Babu, Suresh] Ambedkar Univ, Sch Human Ecol, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Ambedkar University Delhi	Yadav, G (corresponding author), Natl Inst Plant Genome Res, Computat Biol Lab, New Delhi, India.	gy@nipgr.res.in		Yadav, Gitanjali/0000-0001-6591-9964; Babu, Suresh/0000-0002-3004-3066	Department of Biotechnology, Government of India; Man & Biosphere Programme of the Ministry of Environment and Forests, Government of India; BTIS grant of DBT, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Man & Biosphere Programme of the Ministry of Environment and Forests, Government of India; BTIS grant of DBT, India	This work was funded by an Innovative Young Biotechnologist Award grant from the Department of Biotechnology, Government of India, awarded to Gitanjali Yadav. Financial support to Suresh Babu was provided by the Man & Biosphere Programme of the Ministry of Environment and Forests, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; G.Y thanks Director, NIPGR for support. Laboratory resources provided under BTIS grant of DBT, India, are gratefully acknowledged.	Albert R, 2000, PHYS REV LETT, V84, P5660, DOI 10.1103/PhysRevLett.84.5660; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bao G, 2010, CELL MOL BIOENG, V3, P91, DOI 10.1007/s12195-010-0109-z; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Chia NY, 2011, WILEY INTERDISCIPLIN; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Dunne JA, 2009, PHILOS T R SOC B, V364, P1711, DOI 10.1098/rstb.2008.0219; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Fruchterman TMJ, 1990, GRAPH DRAWING FORCE; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Harary F, 1994, GRAPH THEORY; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Kaneko K, 2006, LIFE INTRO COMPLEX S; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Li F, 2010, BIOINFORMATICS, V26, P275, DOI 10.1093/bioinformatics/btp634; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Magtanong L, 2011, NAT BIOTECHNOL, V29, P505, DOI 10.1038/nbt.1855; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Navratil V, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-13; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Nussinov R, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/030301; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; Shammas SL, 2011, BIOPHYS J, V100, P2783, DOI 10.1016/j.bpj.2011.04.039; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Zhu J, 2008, ADV GENET, V60, P603, DOI 10.1016/S0065-2660(07)00421-X	43	19	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41827	10.1371/journal.pone.0041827	http://dx.doi.org/10.1371/journal.pone.0041827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870252	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100033
J	Asakura, K; Izumi, Y; Yamauchi, Y; Nakatsuka, S; Inoue, M; Yashiro, H; Abe, T; Sato, Y; Nomori, H				Asakura, Keisuke; Izumi, Yotaro; Yamauchi, Yoshikane; Nakatsuka, Seishi; Inoue, Masanori; Yashiro, Hideki; Abe, Takayuki; Sato, Yuji; Nomori, Hiroaki			Incidence of Pleural Recurrence after Computed Tomography-Guided Needle Biopsy in Stage I Lung Cancer	PLOS ONE			English	Article							CHEST-WALL IMPLANTATION; GROUND-GLASS OPACITY; TIME CT FLUOROSCOPY; ASPIRATION BIOPSY; RISK; METASTASIS; EXPERIENCE; GUIDANCE	Objective: A risk of tumor seeding after percutaneous needle biopsy has been reported in various organs, including the lung. This study retrospectively evaluated the proportion of ipsilateral pleural recurrence after computed tomography-guided needle biopsy (CTNB) in p-stage I lung cancer patients. Methods: Of the 321 patients diagnosed with p-stage I lung cancer, 124 underwent CTNB before surgery, while 197 underwent non-CTNB procedures, including bronchoscopic biopsy in 188 patients and thoracoscopic wedge resection in 9. These patients were retrospectively analyzed. Results: While the tumor size was significantly larger in the non-CTNB group (25 +/- 9 mm) in comparison to the CTNB group (19 +/- 9 mm) (p<0.001), percentage of pleural, vascular, or lymphatic invasions were comparable between the two groups. Eight patients developed ipsilateral pleural recurrences, one (1%) in the CTNB group, and 7 (4%) in the non-CTNB group. Of these, 3 patients developed pleural recurrence only at first, 1 (1%) in the CTNB group, and 2 (1%) in the non-CTNB group. The differences in the proportions of these pleural recurrences between the 2 groups were not significant. Subgroup analyses by baseline characteristics such as tumor size, pT stage, or microscopic pleural invasion, showed that proportions of pleural recurrences in CTNB group were not high compared with non-CTNB group in each subgroup. Analysis of progression-free survival showed that recurrences in CTNB were not high compared with non-CTNB. Conclusions: The pleural recurrence was not significantly increased after CTNB in p-stage I lung cancer patients in this particular study.	[Asakura, Keisuke; Izumi, Yotaro; Yamauchi, Yoshikane; Nomori, Hiroaki] Keio Univ, Sch Med, Dept Surg, Div Gen Thorac Surg, Tokyo 160, Japan; [Nakatsuka, Seishi; Inoue, Masanori; Yashiro, Hideki] Keio Univ, Sch Med, Dept Diagnost Radiol, Tokyo 160, Japan; [Abe, Takayuki; Sato, Yuji] Keio Univ, Sch Med, Clin Res Ctr, Tokyo 160, Japan	Keio University; Keio University; Keio University	Asakura, K (corresponding author), Keio Univ, Sch Med, Dept Surg, Div Gen Thorac Surg, Tokyo 160, Japan.	yotaroizumi@a2.keio.jp	Yamauchi, Yoshikane/I-1952-2019	Yamauchi, Yoshikane/0000-0002-3374-2399; Asakura, Keisuke/0000-0002-4491-3456				Daly B, 1999, RADIOLOGY, V211, P309, DOI 10.1148/radiology.211.2.r99ma51309; Gianfelice D, 2000, J VASC INTERV RADIOL, V11, P879, DOI 10.1016/S1051-0443(07)61805-3; Goldstraw P, 2009, IASLC STAGING MANUAL, P113; Ibukuro K, 2009, AM J ROENTGENOL, V193, pW430, DOI 10.2214/AJR.08.2214; Inoue M, 2011, ANN THORAC SURG, V91, P1066, DOI 10.1016/j.athoracsur.2010.12.032; Kara M, 2001, EUR J CARDIO-THORAC, V20, P868, DOI 10.1016/S1010-7940(01)00866-1; Katada K, 1996, RADIOLOGY, V200, P851, DOI 10.1148/radiology.200.3.8756943; Kim JH, 2003, EUR J CARDIO-THORAC, V23, P828, DOI 10.1016/S1010-7940(03)00095-2; Matsuguma H, 2005, ANN THORAC SURG, V80, P2026, DOI 10.1016/j.athoracsur.2005.06.074; Raftopoulos Y, 2000, J THORAC CARDIOV SUR, V119, P1288, DOI 10.1067/mtc.2000.105888; REDWOOD N, 1989, THORAX, V44, P826, DOI 10.1136/thx.44.10.826; Saji H, 2002, CHEST, V121, P1521, DOI 10.1378/chest.121.5.1521; SEYFER AE, 1989, ANN THORAC SURG, V48, P284, DOI 10.1016/0003-4975(89)90091-X; Shimizu K, 2006, LUNG CANCER-J IASLC, V51, P173, DOI 10.1016/j.lungcan.2005.10.019; Tsukada H, 2000, AM J ROENTGENOL, V175, P239, DOI 10.2214/ajr.175.1.1750239; VORAVUD N, 1992, CHEST, V102, P313, DOI 10.1378/chest.102.1.313; Wisnivesky JP, 2006, AM J RESP CRIT CARE, V174, P684, DOI 10.1164/rccm.200602-160OC; Yamauchi Y, 2011, EUR J RADIOL, V79, pE85, DOI 10.1016/j.ejrad.2011.03.088; Yoshikawa T, 2000, JPN J CLIN ONCOL, V30, P450, DOI 10.1093/jjco/hyd120	19	16	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42043	10.1371/journal.pone.0042043	http://dx.doi.org/10.1371/journal.pone.0042043			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876299	Green Published, Green Submitted, gold			2022-12-27	WOS:000307184700027
J	He, LH; Linden, DJ; Sapirstein, A				He, Lihua; Linden, David J.; Sapirstein, Adam			Astrocyte Inositol Triphosphate Receptor Type 2 and Cytosolic Phospholipase A(2) Alpha Regulate Arteriole Responses in Mouse Neocortical Brain Slices	PLOS ONE			English	Article							ARACHIDONIC-ACID EPOXYGENASE; PROSTANOID RECEPTORS; NITRIC-OXIDE; FUNCTIONAL HYPEREMIA; VASCULAR-RESPONSES; PROSTAGLANDIN E-2; BLOOD-FLOW; RAT-BRAIN; 20-HETE; NEURONS	Functional hyperemia of the cerebral vascular system matches regional blood flow to the metabolic demands of the brain. One current model of neurovascular control holds that glutamate released by neurons activates group I metabotropic glutamate receptors (mGluRs) on astrocytes, resulting in the production of diffusible messengers that act to regulate smooth muscle cells surrounding cerebral arterioles. The acute mouse brain slice is an experimental system in which changes in arteriole diameter can precisely measured with light microscopy. Stimulation of the brain slice triggers specific cellular responses that can be correlated to changes in arteriole diameter. Here we used inositol trisphosphate receptor type 2 (IP(3)R2) and cytosolic phospholipase A(2) alpha (cPLA(2)alpha) deficient mice to determine if astrocyte mGluR activation coupled to IP(3)R2-mediated Ca2+ release and subsequent cPLA(2)alpha activation is required for arteriole regulation. We measured changes in astrocyte cytosolic free Ca2+ and arteriole diameters in response to mGluR agonist or electrical field stimulation in acute neocortical mouse brain slices maintained in 95% or 20% O-2. Astrocyte Ca2+ and arteriole responses to mGluR activation were absent in IP(3)R2(-/-) slices. Astrocyte Ca2+ responses to mGluR activation were unchanged by deletion of cPLA(2)alpha but arteriole responses to either mGluR agonist or electrical stimulation were ablated. The valence of changes in arteriole diameter (dilation/constriction) was dependent upon both stimulus and O-2 concentration. Neuron-derived NO and activation of the group I mGluRs are required for responses to electrical stimulation. These findings indicate that an mGluR/IP(3)R2/cPLA(2)alpha signaling cascade in astrocytes is required to transduce neuronal glutamate release into arteriole responses.	[He, Lihua; Sapirstein, Adam] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Linden, David J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	He, LH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	Asapirs1@JHMI.edu			Anesthesia Departmental Grant (Johns Hopkins University School of Medicine); American Heart Association; National Institutes of Health [NS048978]; Johns Hopkins University Brain Sciences Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048978] Funding Source: NIH RePORTER	Anesthesia Departmental Grant (Johns Hopkins University School of Medicine); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Brain Sciences Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an Anesthesia Departmental Grant (Johns Hopkins University School of Medicine), an American Heart Association Grant in Aid (AS), and grants from the National Institutes of Health: NS048978 (AS) and the Johns Hopkins University Brain Sciences Institute (DJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; Alkayed NJ, 1996, STROKE, V27, P971, DOI 10.1161/01.STR.27.5.971; Alkayed NJ, 1996, AM J PHYSIOL-HEART C, V271, pH1541, DOI 10.1152/ajpheart.1996.271.4.H1541; Alonso-Galicia M, 1999, STROKE, V30, P2727, DOI 10.1161/01.STR.30.12.2727; AlonsoGalicia M, 1997, HYPERTENSION, V29, P320, DOI 10.1161/01.HYP.29.1.320; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Balboa MA, 2002, FEBS LETT, V531, P12, DOI 10.1016/S0014-5793(02)03481-6; Barkoudah E, 2004, AM J PHYSIOL-HEART C, V287, pH1459, DOI 10.1152/ajpheart.00369.2004; Bingham CO, 1999, P ASSOC AM PHYSICIAN, V111, P516, DOI 10.1046/j.1525-1381.1999.99321.x; Blanco VM, 2008, AM J PHYSIOL-HEART C, V294, pH2855, DOI 10.1152/ajpheart.91451.2007; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; BORG C, 1994, J BIOL CHEM, V269, P6109; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; DORN GW, 1992, J BIOL CHEM, V267, P24897; Feletou M, 2010, PFLUG ARCH EUR J PHY, V459, P941, DOI 10.1007/s00424-010-0812-6; FERGUS A, 1995, BRAIN RES, V694, P78, DOI 10.1016/0006-8993(95)00768-L; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; Girouard H, 2010, P NATL ACAD SCI USA, V107, P3811, DOI 10.1073/pnas.0914722107; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Han WK, 2003, J BIOL CHEM, V278, P24153, DOI 10.1074/jbc.M300424200; Harder DR, 1998, STROKE, V29, P229, DOI 10.1161/01.STR.29.1.229; Harder DR, 2000, ACTA PHYSIOL SCAND, V168, P543, DOI 10.1046/j.1365-201x.2000.00707.x; Hertle DN, 2007, NEUROSCIENCE, V150, P625, DOI 10.1016/j.neuroscience.2007.09.058; Kishimoto K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-42; Kitaura H, 2007, NEUROSCI RES, V59, P160, DOI 10.1016/j.neures.2007.06.1469; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Lautens LL, 1998, BRAIN RES, V809, P18, DOI 10.1016/S0006-8993(98)00806-3; Leis HJ, 2008, BRIT J PHARMACOL, V155, P731, DOI 10.1038/bjp.2008.304; Leslie CC, 2010, BIOCHIMIE, V92, P620, DOI 10.1016/j.biochi.2010.03.001; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Liu XG, 2008, AM J PHYSIOL-HEART C, V295, pH619, DOI 10.1152/ajpheart.01211.2007; Ma JY, 1996, AM J PHYSIOL-HEART C, V270, pH1085, DOI 10.1152/ajpheart.1996.270.3.H1085; Mashimo M, 2008, J CELL SCI, V121, P3015, DOI 10.1242/jcs.032987; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Norel X, 2007, THESCIENTIFICWORLDJO, V7, P1359, DOI 10.1100/tsw.2007.184; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Schnackenberg CG, 2000, AM J PHYSIOL-RENAL, V279, pF302, DOI 10.1152/ajprenal.2000.279.2.F302; Sharp AH, 1999, J COMP NEUROL, V406, P207; Shen Y, 2007, P NATL ACAD SCI USA, V104, P6078, DOI 10.1073/pnas.0605427104; Shibata N, 2010, ACTA NEUROPATHOL, V119, P345, DOI 10.1007/s00401-009-0636-7; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Song HW, 2006, BIOCHEMISTRY-US, V45, P1061, DOI 10.1021/bi052065q; Sugimoto Y, 2000, PROG LIPID RES, V39, P289, DOI 10.1016/S0163-7827(00)00008-4; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tang EHC, 2008, CARDIOVASC RES, V78, P130, DOI 10.1093/cvr/cvm112; Tucker DE, 2009, J BIOL CHEM, V284, P9596, DOI 10.1074/jbc.M807299200; van Rodijnen WF, 2007, AM J PHYSIOL-RENAL, V292, pF1094, DOI 10.1152/ajprenal.00351.2005; Vives V, 2003, J COMP NEUROL, V457, P404, DOI 10.1002/cne.10552; Xu J, 2003, PROSTAG LEUKOTR ESS, V69, P437, DOI 10.1016/j.plefa.2003.08.016; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	56	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42194	10.1371/journal.pone.0042194	http://dx.doi.org/10.1371/journal.pone.0042194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876307	Green Submitted, gold, Green Published			2022-12-27	WOS:000307184700035
J	Balagopal, A; Gama, L; Franco, V; Russell, JN; Quinn, J; Higgins, Y; Smeaton, LM; Clements, JE; Thomas, DL; Gupta, A				Balagopal, Ashwin; Gama, Lucio; Franco, Veronica; Russell, Julia N.; Quinn, Jeffrey; Higgins, Yvonne; Smeaton, Laura M.; Clements, Janice E.; Thomas, David L.; Gupta, Amita		NWCS 319 ACTG 5175 Study Team	Detection of Microbial Translocation in HIV and SIV Infection Using the Limulus Amebocyte Lysate Assay is Masked by Serum and Plasma	PLOS ONE			English	Article							DISEASE PROGRESSION; ACTIVATION; ENDOTOXIN; LPS	Objective: Microbial translocation (MT) is thought to be a major contributor to the pathogenesis of HIV-related immune activation, and circulating lipopolysaccharide (LPS) from Gram-negative bacteria is the principle measurement of this process. However, related research has been impeded by inconsistent LPS test results. Methods: Specimens were obtained from HIV-infected adults enrolled in the PEARLS study (ACTG A5175) and HIV-HCV co-infected participants enrolled in a study of liver disease staging using MRI elastography. Pig-tailed macaque specimens were obtained from SIV-infected and -uninfected animals. Samples were tested for LPS using the LAL assay with diazo-coupling modifications to improve sensitive detection. Results: When exogenous LPS was added to macaque plasma, >25% inhibition of LPS detection was found in 10/10 (100%) samples at 20% plasma concentration compared to control; in contrast 5/10 (50%) samples at 2% plasma concentration (p = 0.07) and 0/10 (0%) at 0.1% plasma concentration (p=0.004) showed >25% inhibition of LPS detection. Similarly, when LPS was added to human serum, >25% inhibition of LPS detection was found in 5/12 (42%) of samples at 2% serum concentration compared to control, while 0/12 (0%) of samples in 0.1% serum showed >25% inhibition of LPS detection (p=0.07). Likewise, LPS detection in human sera without exogenous LPS was improved by dilution: LPS was detected in 2/12 (17%) human samples in 2% serum, ranging from 3,436-4,736 pg/mL, compared to 9/12 (75%) samples in 0.1% serum, ranging from 123 pg/mL -60,131 pg/mL (p = 0.016). In a separate validation cohort of HIV-HCV co-infected participants sampled at two different times on the same day, LPS measured in 0.2% plasma and with diazo-coupling was closely correlated between the first and second samples (R = 0.66, p < 0.05). Conclusions: Undiluted serum and plasma mask LPS detection. The extent of MT may be substantially underestimated.	[Balagopal, Ashwin; Franco, Veronica; Quinn, Jeffrey; Higgins, Yvonne; Thomas, David L.; Gupta, Amita] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA; [Gama, Lucio; Russell, Julia N.; Clements, Janice E.] Johns Hopkins Univ, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Smeaton, Laura M.] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard T.H. Chan School of Public Health	Balagopal, A (corresponding author), Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA.	abalago1@jhmi.edu		Gama, Lucio/0000-0001-9511-012X; Quinn, Jeffrey/0000-0002-4734-5108; Gupta, Amita/0000-0001-7036-2718	National Institute of Mental Health (NIMH) [P01 MH070306]; National Institute of Allergy and Infectious Diseases (NIAID) [R01 DA016078, R01 AI080417, K08 AI081544, U01 AI068634, U01 AI068636]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080417, U01AI068634, P30AI050410, U01AI068636, K08AI081544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH070306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016078] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project described was supported by Grant Numbers K08 AI081544 (A. B.) from National Institute of Allergy and Infectious Diseases (NIAID), P01 MH070306 (J.C.) from National Institute of Mental Health (NIMH), U01 AI068634, U01 AI068636 (AIDS Clinical Trials Group), R01 DA016078 (D. T.), and R01 AI080417 (A. G.) from National Institute of Allergy and Infectious Diseases (NIAID). The contents herein are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; GAN EV, 1975, J INVEST DERMATOL, V64, P139, DOI 10.1111/1523-1747.ep12533302; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; HURLEY JC, 1991, J CLIN PATHOL, V44, P849, DOI 10.1136/jcp.44.10.849; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; LEVIN J, 1970, J LAB CLIN MED, V75, P903; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Redd AD, 2011, J INFECT DIS; Redd AD, 2010, JAIDS-J ACQ IMM DEF, V54, P556, DOI 10.1097/QAI.0b013e3181e0cdea; Redd AD, 2009, P NATL ACAD SCI USA, V106, P6718, DOI 10.1073/pnas.0901983106; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118	14	25	27	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41258	10.1371/journal.pone.0041258	http://dx.doi.org/10.1371/journal.pone.0041258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870212	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800015
J	Connell, S; Meade, KG; Allan, B; Lloyd, AT; Kenny, E; Cormican, P; Morris, DW; Bradley, DG; O'Farrelly, C				Connell, Sarah; Meade, Kieran G.; Allan, Brenda; Lloyd, Andrew T.; Kenny, Elaine; Cormican, Paul; Morris, Derek W.; Bradley, Daniel G.; O'Farrelly, Cliona			Avian Resistance to Campylobacter jejuni Colonization Is Associated with an Intestinal Immunogene Expression Signature Identified by mRNA Sequencing	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; TOLL-LIKE RECEPTORS; GUILLAIN-BARRE-SYNDROME; 2 GENETIC LINES; EPITHELIAL-CELLS; CYTOKINE RESPONSES; CECAL COLONIZATION; IN-VITRO; DIFFERENTIAL EXPRESSION; MATERNAL ANTIBODIES	Campylobacter jejuni is the most common cause of human bacterial gastroenteritis and is associated with several post-infectious manifestations, including onset of the autoimmune neuropathy Guillain-Barre syndrome, causing significant morbidity and mortality. Poorly-cooked chicken meat is the most frequent source of infection as C. jejuni colonizes the avian intestine in a commensal relationship. However, not all chickens are equally colonized and resistance seems to be genetically determined. We hypothesize that differences in immune response may contribute to variation in colonization levels between susceptible and resistant birds. Using high-throughput sequencing in an avian infection model, we investigate gene expression associated with resistance or susceptibility to colonization of the gastrointestinal tract with C. jejuni and find that gut related immune mechanisms are critical for regulating colonization. Amongst a single population of 300 4-week old chickens, there was clear segregation in levels of C. jejuni colonization 48 hours post-exposure. RNAseq analysis of caecal tissue from 14 C. jejuni-susceptible and 14 C. jejuni-resistant birds generated over 363 million short mRNA sequences which were investigated to identify 219 differentially expressed genes. Significantly higher expression of genes involved in the innate immune response, cytokine signaling, B cell and T cell activation and immunoglobulin production, as well as the renin-angiotensin system was observed in resistant birds, suggesting an early active immune response to C. jejuni. Lower expression of these genes in colonized birds suggests suppression or inhibition of a clearing immune response thus facilitating commensal colonization and generating vectors for zoonotic transmission. This study describes biological processes regulating C. jejuni colonization of the avian intestine and gives insight into the differential immune mechanisms incited in response to commensal bacteria in general within vertebrate populations. The results reported here illustrate how an exaggerated immune response may be elicited in a subset of the population, which alters host-microbe interactions and inhibits the commensal state, therefore having wider relevance with regard to inflammatory and autoimmune disease.	[Connell, Sarah; Bradley, Daniel G.] Univ Dublin, Smurfit Inst Genet, Trinity Coll, Dublin, Ireland; [Allan, Brenda] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Lloyd, Andrew T.; O'Farrelly, Cliona] Univ Dublin, Sch Biochem & Immunol, Trinity Coll, Dublin, Ireland; [Kenny, Elaine; Cormican, Paul; Morris, Derek W.] Univ Dublin, Trinity Genome Sequencing Lab, Inst Mol Med, Trinity Coll, Dublin, Ireland; [Kenny, Elaine; Cormican, Paul; Morris, Derek W.] Univ Dublin, Dept Psychiat, Trinity Coll, Dublin, Ireland	Trinity College Dublin; University of Saskatchewan; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Connell, S (corresponding author), Univ Dublin, Smurfit Inst Genet, Trinity Coll, Dublin, Ireland.	saconnel@tcd.ie	Meade, Kieran/K-7562-2015; Meade, Kieran G/HDN-5926-2022; Morris, Derek/AAW-8343-2021; Kenny, Elaine/D-1644-2014	Meade, Kieran G/0000-0002-3051-8586; Morris, Derek/0000-0002-3413-570X; Bradley, Daniel G/0000-0001-7335-7092; Connell, Sarah/0000-0003-4431-1364; O'Farrelly, Cliona/0000-0002-0616-2874; Lloyd, Andrew/0000-0001-9989-7652; Kenny, Elaine/0000-0003-4676-3436	Irish Department of Agriculture and Food's Food Institutional Research Measure [06_RDD_486]; Trinity Centre for High Performance Computing; Science Foundation Ireland	Irish Department of Agriculture and Food's Food Institutional Research Measure; Trinity Centre for High Performance Computing; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This research was funded by the The Irish Department of Agriculture and Food's Food Institutional Research Measure (http://www.agriculture.gov.ie/research/foodinstitutionalresearchmeasurefirm) - Grant No: 06_RDD_486. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all staff who assisted with animal infection experiments in the Vaccine and Infectious Disease Organization at the University of Saskatchewan. Next generation sequencing was performed in the Trinity Genome Sequencing Laboratory supported by the Trinity Centre for High Performance Computing, core facilities funded by Science Foundation Ireland.	Alemka A, 2010, J MED MICROBIOL, V59, P898, DOI 10.1099/jmm.0.019315-0; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ang CW, 2007, CLIN MICROBIOL INFEC, V13, P915, DOI 10.1111/j.1469-0691.2007.01765.x; Bakhiet M, 2004, J INFECTION, V48, P236, DOI 10.1016/j.jinf.2003.11.006; Bar-Shira E, 2003, DEV COMP IMMUNOL, V27, P147, DOI 10.1016/S0145-305X(02)00076-9; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; Berer K, 2011, NATURE; Borrmann E, 2007, VET MICROBIOL, V124, P115, DOI 10.1016/j.vetmic.2007.04.041; Boyd Y, 2005, IMMUNOGENETICS, V57, P248, DOI 10.1007/s00251-005-0790-6; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Byrne CM, 2007, MICROBIOL-SGM, V153, P561, DOI 10.1099/mic.0.2006/000711-0; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; CAWTHRAW S, 1994, AVIAN DIS, V38, P341, DOI 10.2307/1591960; Cawthraw SA, 2010, AVIAN DIS, V54, P86, DOI 10.1637/9004-072709-Reg.1; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Chen ML, 2006, INFECT IMMUN, V74, P6581, DOI 10.1128/IAI.00958-06; Cox NA, 2006, AVIAN DIS, V50, P450, DOI 10.1637/7481-120205R.1; Cox NA, 2009, POULTRY SCI, V88, P2449, DOI 10.3382/ps.2009-00195; Cox NA, 2005, AVIAN DIS, V49, P155, DOI 10.1637/7234-070704R; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; Dhillon AS, 2006, AVIAN DIS, V50, P55, DOI 10.1637/7411-071405R.1; Ewald SJ, 2011, IMMUNOGENETICS, V63, P363, DOI 10.1007/s00251-010-0509-1; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Haghighi HR, 2006, CLIN VACCINE IMMUNOL, V13, P975, DOI 10.1128/CVI.00161-06; Hanel I, 2004, VET MICROBIOL, V101, P75, DOI 10.1016/j.vetmic.2004.04.004; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Hermans D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-82; Hickey TE, 1999, INFECT IMMUN, V67, P88, DOI 10.1128/IAI.67.1.88-93.1999; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hoch NE, 2009, AM J PHYSIOL-REG I, V296, pR208, DOI 10.1152/ajpregu.90521.2008; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hu L, 2006, MICROB PATHOGENESIS, V40, P91, DOI 10.1016/j.micpath.2005.11.004; Johanesen PA, 2006, INFECT IMMUN, V74, P3437, DOI 10.1128/IAI.01740-05; Jones MA, 2003, INFECT IMMUN, V71, P2626, DOI 10.1128/IAI.71.5.2626-2633.2003; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Ko JH, 2004, ANIM GENET, V35, P119, DOI 10.1111/j.1365-2052.2004.01096.x; Ko JH, 2002, GENOME RES, V12, P595, DOI 10.1101/gr.210702. Article published online before print in March ; Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; Koskinen R, 1998, J IMMUNOL, V160, P4943; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Lamb-Rosteski JM, 2008, INFECT IMMUN, V76, P3390, DOI 10.1128/IAI.01698-07; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson CL, 2008, MICROBIOL-SGM, V154, P3835, DOI 10.1099/mic.0.2008/021279-0; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Li X, 2008, POULTRY SCI, V87, P1742, DOI 10.3382/ps.2008-00136; Li XY, 2011, ANIM GENET, V42, P491, DOI 10.1111/j.1365-2052.2010.02168.x; Li XY, 2012, IMMUNOGENETICS, V64, P59, DOI 10.1007/s00251-011-0557-1; Li XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011827; Li YP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-107; Lippmann J, 2011, CELL MICROBIOL, V13, P1668, DOI 10.1111/j.1462-5822.2011.01646.x; LOWENTHAL JW, 1994, IMMUNOL CELL BIOL, V72, P115, DOI 10.1038/icb.1994.18; MacCallum AJ, 2006, MICROBIOL-SGM, V152, P3661, DOI 10.1099/mic.0.29234-0; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2012, TRENDS IMMUNOL, V33, P160, DOI 10.1016/j.it.2012.02.002; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McCarthy N, 2001, AM J EPIDEMIOL, V153, P610, DOI 10.1093/aje/153.6.610; Meade KG, 2009, IMMUNOGENETICS, V61, P101, DOI 10.1007/s00251-008-0346-7; MINGARI MC, 1984, NATURE, V312, P641, DOI 10.1038/312641a0; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MYSZEWSKI MA, 1990, AVIAN DIS, V34, P588, DOI 10.2307/1591249; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Okwan-Duodu D, 2010, J BIOL CHEM, V285, P39051, DOI 10.1074/jbc.M110.163782; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Pone EJ, 2010, CRIT REV IMMUNOL, V30, P1; RALPH P, 1984, J IMMUNOL, V133, P2442; Rathinam VAK, 2009, INFECT IMMUN, V77, P2499, DOI 10.1128/IAI.01562-08; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Richardson LJ, 2011, AVIAN DIS, V55, P375, DOI 10.1637/9613-121310-Reg.1; Ruiz-Ortega M, 1998, J IMMUNOL, V161, P430; Sahin O, 2001, APPL ENVIRON MICROB, V67, P3951, DOI 10.1128/AEM.67.9.3951-3957.2001; Scharfstein J, 2008, BIOL CHEM, V389, P1015, DOI 10.1515/BC.2008.126; Shaughnessy RG, 2011, VET IMMUNOL IMMUNOP, V142, P64, DOI 10.1016/j.vetimm.2011.04.010; Shaughnessy RG, 2009, VET IMMUNOL IMMUNOP, V132, P191, DOI 10.1016/j.vetimm.2009.06.007; Shen XZ, 2008, J BIOL CHEM, V283, P9957, DOI 10.1074/jbc.M709574200; Shen XZ, 2007, AM J PATHOL, V170, P2122, DOI 10.2353/ajpath.2007.061205; Smith CK, 2008, FEMS IMMUNOL MED MIC, V54, P114, DOI 10.1111/j.1574-695X.2008.00458.x; Smith CK, 2005, INFECT IMMUN, V73, P2094, DOI 10.1128/IAI.73.4.2094-2100.2005; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; STERN NJ, 1990, AVIAN DIS, V34, P602, DOI 10.2307/1591251; Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; Van Deun K, 2008, VET MICROBIOL, V130, P285, DOI 10.1016/j.vetmic.2007.11.027; Wassenaar TM, 1999, MICROBES INFECT, V1, P1023, DOI 10.1016/S1286-4579(99)80520-6; Watson RO, 2005, CELL MICROBIOL, V7, P655, DOI 10.1111/j.1462-5822.2004.00498.x; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yin CG, 2010, POULTRY SCI, V89, P2259, DOI 10.3382/ps.2010-00826; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zheng J, 2008, INFECT IMMUN, V76, P4498, DOI 10.1128/IAI.01317-07	99	37	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40409	10.1371/journal.pone.0040409	http://dx.doi.org/10.1371/journal.pone.0040409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870198	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800007
J	Fischer, M; Snajder, R; Pabinger, S; Dander, A; Schossig, A; Zschocke, J; Trajanoski, Z; Stocker, G				Fischer, Maria; Snajder, Rene; Pabinger, Stephan; Dander, Andreas; Schossig, Anna; Zschocke, Johannes; Trajanoski, Zlatko; Stocker, Gernot			SIMPLEX: Cloud-Enabled Pipeline for the Comprehensive Analysis of Exome Sequencing Data	PLOS ONE			English	Article							HUMAN GENOME; DNA; ALIGNMENT; VARIANTS; MUTATIONS; SOFTWARE; GENE; ALGORITHMS; CAPTURE; FORMAT	In recent studies, exome sequencing has proven to be a successful screening tool for the identification of candidate genes causing rare genetic diseases. Although underlying targeted sequencing methods are well established, necessary data handling and focused, structured analysis still remain demanding tasks. Here, we present a cloud-enabled autonomous analysis pipeline, which comprises the complete exome analysis workflow. The pipeline combines several in-house developed and published applications to perform the following steps: (a) initial quality control, (b) intelligent data filtering and pre-processing, (c) sequence alignment to a reference genome, (d) SNP and DIP detection, (e) functional annotation of variants using different approaches, and (f) detailed report generation during various stages of the workflow. The pipeline connects the selected analysis steps, exposes all available parameters for customized usage, performs required data handling, and distributes computationally expensive tasks either on a dedicated high-performance computing infrastructure or on the Amazon cloud environment (EC2). The presented application has already been used in several research projects including studies to elucidate the role of rare genetic diseases. The pipeline is continuously tested and is publicly available under the GPL as a VirtualBox or Cloud image at http://simplex.i-med.ac.at; additional supplementary data is provided at http://www.icbi.at/exome.	[Fischer, Maria; Snajder, Rene; Pabinger, Stephan; Dander, Andreas; Trajanoski, Zlatko; Stocker, Gernot] Innsbruck Med Univ, Div Bioinformat, Bioctr, Innsbruck, Austria; [Snajder, Rene; Dander, Andreas] Ctr Personalized Canc Med, Innsbruck, Austria; [Schossig, Anna; Zschocke, Johannes] Innsbruck Med Univ, Div Human Genet, Bioctr, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Fischer, M (corresponding author), Innsbruck Med Univ, Div Bioinformat, Bioctr, Innsbruck, Austria.	maria.fischer@i-med.ac.at; gernot@stocker.bz	Trajanoski, Zlatko/AAT-6703-2021; Stocker, Gernot/Q-2461-2019; Zschocke, Johannes/C-5885-2013	Zschocke, Johannes/0000-0002-0046-8274; Pabinger, Stephan/0000-0001-9876-5965; Snajder, Rene/0000-0002-7318-976X; Stocker, Gernot/0000-0001-8326-1852	GENAU Bioinformatics Network (BIN III); "Bioinformatics Tyrol" project of the "Standortagentur Tyrol"; COMET Center ONCOTYROL	GENAU Bioinformatics Network (BIN III); "Bioinformatics Tyrol" project of the "Standortagentur Tyrol"; COMET Center ONCOTYROL	This work was funded by GENAU Bioinformatics Network (BIN III), by the "Bioinformatics Tyrol" project of the "Standortagentur Tyrol," and by the COMET Center ONCOTYROL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S4; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asmann YW, 2012, BIOINFORMATICS, V28, P277, DOI 10.1093/bioinformatics/btr612; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Bao SY, 2011, J HUM GENET, V56, P406, DOI 10.1038/jhg.2011.43; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Blanca JM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-285; Cavallo A, 2005, BIOINFORMATICS, V21, P1443, DOI 10.1093/bioinformatics/bti220; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chapman B, NEXT GENERATION SEQU; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Deng XT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-267; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dolan PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-250; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Durbin R, 2009, BIOINFORMATICS; Ge DL, 2011, BIOINFORMATICS, V27, P1998, DOI 10.1093/bioinformatics/btr317; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Ku CS, 2011, HUM GENET, V129, P351, DOI 10.1007/s00439-011-0964-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez-Alcantara A, 2009, BIOINFORMATICS; McPherson JD, 2009, NAT METHODS, V6, pS2, DOI [10.1038/NMETH.F.268, 10.1038/nmeth.f.268]; Metzker ML, 2009, NAT REV GENET; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pandey Ram Vinay, 2010, BMC Res Notes, V3, P3, DOI 10.1186/1756-0500-3-3; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Qi J, 2010, BIOINFORMATICS, V26, P127, DOI 10.1093/bioinformatics/btp615; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Sana ME, 2011, BIOINFORMATICS, V27, P9, DOI 10.1093/bioinformatics/btq603; Schadt EE, 2010, NAT REV GENET, V11, P647, DOI 10.1038/nrg2857; Schossig A, 2012, AM J HUM GENET, V90, P701, DOI 10.1016/j.ajhg.2012.02.012; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wetterstrand K.A., DNA SEQUENCING COSTS; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	52	24	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41948	10.1371/journal.pone.0041948	http://dx.doi.org/10.1371/journal.pone.0041948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870267	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800046
J	Horvath, DM; Stall, RE; Jones, JB; Pauly, MH; Vallad, GE; Dahlbeck, D; Staskawicz, BJ; Scott, JW				Horvath, Diana M.; Stall, Robert E.; Jones, Jeffrey B.; Pauly, Michael H.; Vallad, Gary E.; Dahlbeck, Doug; Staskawicz, Brian J.; Scott, John W.			Transgenic Resistance Confers Effective Field Level Control of Bacterial Spot Disease in Tomato	PLOS ONE			English	Article							CAMPESTRIS PV-VESICATORIA; RACE T3; GENE AVRBS2; AVIRULENCE; PATHOGEN; COPPER; VIRUS; INHERITANCE; PERFORMANCE; QUALITY	We investigated whether lines of transgenic tomato (Solanum lycopersicum) expressing the Bs2 resistance gene from pepper, a close relative of tomato, demonstrate improved resistance to bacterial spot disease caused by Xanthomonas species in replicated multi-year field trials under commercial type growing conditions. We report that the presence of the Bs2 gene in the highly susceptible VF 36 background reduced disease to extremely low levels, and VF 36-Bs2 plants displayed the lowest disease severity amongst all tomato varieties tested, including commercial and breeding lines with host resistance. Yields of marketable fruit from transgenic lines were typically 2.5 times that of the non-transformed parent line, but varied between 1.5 and 11.5 fold depending on weather conditions and disease pressure. Trials were conducted without application of any copper-based bactericides, presently in wide use despite negative impacts on the environment. This is the first demonstration of effective field resistance in a transgenic genotype based on a plant R gene and provides an opportunity for control of a devastating pathogen while eliminating ineffective copper pesticides.	[Horvath, Diana M.; Pauly, Michael H.] Two Blades Fdn, Evanston, IL USA; [Stall, Robert E.; Jones, Jeffrey B.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Vallad, Gary E.; Scott, John W.] Univ Florida, Gulf Coast Res & Educ Ctr, Wimauma, FL USA; [Dahlbeck, Doug; Staskawicz, Brian J.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Berkeley	Horvath, DM (corresponding author), Two Blades Fdn, Evanston, IL USA.	dmh@2blades.org			Two Blades Foundation; Florida Tomato Committee	Two Blades Foundation; Florida Tomato Committee	Project support was provided in part by the Two Blades Foundation (2blades.org) and the Florida Tomato Committee. The funders had no role in study design, data collection and analysis, or decision to publish. 2Blades staff participated in the drafting of the manuscript.	Astua-Monge G, 2000, MOL PLANT MICROBE IN, V13, P1346, DOI 10.1094/MPMI.2000.13.12.1346; Biffen RH, 1905, J AGR SCI, V1, P4, DOI 10.1017/S0021859600000137; Bravo-Almonacid F, 2012, TRANSGENIC RES, V21, P967, DOI 10.1007/s11248-011-9584-9; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Fan JH, 2011, J SOIL SEDIMENT, V11, P639, DOI 10.1007/s11368-011-0349-0; Ferreira SA, 2002, PLANT DIS, V86, P101, DOI 10.1094/PDIS.2002.86.2.101; Fuchs M, 2007, ANNU REV PHYTOPATHOL, V45, P173, DOI 10.1146/annurev.phyto.45.062806.094434; Glades Crop Care, 1999, CROP PROF S FLOR TOM; Green J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030973; GROENEWEGEN C, 1994, HORTSCIENCE, V29, P1088, DOI 10.21273/HORTSCI.29.9.1088; Halterman DA, 2008, PLANT DIS, V92, P339, DOI 10.1094/PDIS-92-3-0339; Horsfall J, 1945, PHYTOPATHOLOGY, V36, P655; Huang CH, 2011, PLANT DIS MANAGEMENT, V5, pV066; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Krens FA, 2011, TRANSGENIC RES, V20, P1113, DOI 10.1007/s11248-011-9484-z; Li J, 2010, MOL GENET GENOMICS, V283, P427, DOI 10.1007/s00438-010-0527-6; MARCO GM, 1983, PLANT DIS, V67, P779, DOI 10.1094/PD-67-779; Olson SM, 2007, VEGETABLE PRODUCTION, P409; POHRONEZNY K, 1983, HORTSCIENCE, V18, P69; Robbins MD, 2009, PHYTOPATHOLOGY, V99, P1037, DOI 10.1094/PHYTO-99-9-1037; Rowell B., 1999, HortTechnology, V9, P641; Rowell B, 2001, HORTTECHNOLOGY, V11, P648, DOI 10.21273/HORTTECH.11.4.648; Sasu MA, 2009, P NATL ACAD SCI USA, V106, P19067, DOI 10.1073/pnas.0905106106; Scott JW, 2001, J AM SOC HORTIC SCI, V126, P436, DOI 10.21273/JASHS.126.4.436; Scott JW, 1996, RPT TOMATO GENT COOP, V46; STALL R. E., 1962, PLANT DIS REPTR, V46, P389; STALL RE, 1986, PHYTOPATHOLOGY, V76, P240, DOI 10.1094/Phyto-76-240; Swords KMM, 1996, J BACTERIOL, V178, P4661, DOI 10.1128/jb.178.15.4661-4669.1996; Tai TH, 1999, P NATL ACAD SCI USA, V96, P14153, DOI 10.1073/pnas.96.24.14153; Thayer PL, 1962, FLORIDA AGR EXPT STA, V1523, P163; Toor GS, 2010, P FLORIDA TOMATO I, P8; Vallad GE, 2011, PLANT DIS MANAGEMENT, V5, pV061; Vallad GE, 2011, PLANT DIS MANAGEMENT, V5, pV067; Vishnevetsky J, 2011, TRANSGENIC RES, V20, P61, DOI 10.1007/s11248-010-9392-7; WANG JF, 1994, PHYTOPATHOLOGY, V84, P702, DOI 10.1094/Phyto-84-702; Wichmann G, 2005, APPL ENVIRON MICROB, V71, P2418, DOI 10.1128/AEM.71.5.2418-2432.2005; Zhang MP, 2010, NUCLEIC ACIDS RES, V38, P6513, DOI 10.1093/nar/gkq524; Zhang S, 2011, PLANT DIS MANAGEMENT, V5, pV016; Zhao BY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002408	39	108	110	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42036	10.1371/journal.pone.0042036	http://dx.doi.org/10.1371/journal.pone.0042036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870280	gold, Green Published, Green Submitted			2022-12-27	WOS:000307212800055
J	Lonnell, N; Hylander, K; Jonsson, BG; Sundberg, S				Lonnell, Niklas; Hylander, Kristoffer; Jonsson, Bengt Gunnar; Sundberg, Sebastian			The Fate of the Missing Spores - Patterns of Realized Dispersal beyond the Closest Vicinity of a Sporulating Moss	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; WOOD-DECAYING FUNGI; SEED DISPERSAL; COLONIZATION; BRYOPHYTES; WIND; DEPOSITION; MECHANISMS; SPHAGNUM; ISLANDS	It is well-known that many species with small diaspores can disperse far during extended temporal scales (many years). However, studies on short temporal scales usually only cover short distances (in, e.g., bryophytes up to 15 m). By using a novel experimental design, studying the realized dispersal, we extend this range by almost two orders of magnitude. We recorded establishment of the fast-growing moss Discelium nudum on introduced suitable substrates, placed around a translocated, sporulating mother colony. Around 2,000 pots with acidic clay were placed at different distances between 5 m and 600 m, in four directions, on a raised bog, with increased pot numbers with distance. The experiment was set up in April-May and the realized dispersal (number of colonized pots) was recorded in September. Close to the mother colony (up to 10 m), the mean colonization rates (ratio of colonized pots) exceeded 50%. At distances between 10 and 50 m colonization dropped sharply, but beyond 50 m the mean colonization rates stabilized and hardly changed (1-3%). The estimated density of spores causing establishments at the further distances (2-6 spores/m(2)) was realistic when compared to the estimated spore output from the central colonies. Our study supports calculations from earlier studies, limited to short distances, that a majority of the spores disperse beyond the nearest vicinity of a source. The even colonization pattern at further distances raises interesting questions about under what conditions spores are transported and deposited. However, it is clear that regular establishment is likely at the km-scale for this and many other species with similar spore output and dispersal mechanism.	[Lonnell, Niklas; Hylander, Kristoffer] Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden; [Jonsson, Bengt Gunnar] Mid Sweden Univ, Dept Nat Sci Engn & Math, Sundsvall, Sweden; [Sundberg, Sebastian] Uppsala Univ, Evolutionary Biol Ctr, Dept Plant Ecol & Evolut, Uppsala, Sweden; [Sundberg, Sebastian] Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden	Stockholm University; Mid-Sweden University; Uppsala University; Swedish University of Agricultural Sciences	Lonnell, N (corresponding author), Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden.	niklas.lonnell@botan.su.se		Sundberg, Sebastian/0000-0001-7966-9097	Swedish research council Formas [217-2008-1193]	Swedish research council Formas(Swedish Research CouncilSwedish Research Council Formas)	This research was funded by a grant from the Swedish research council Formas (217-2008-1193, www.formas.se) to Kristoffer Hylander. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnell H.W., 1875, SKANDINAVISKA LOFMOS; Aune K, 2005, BIOL CONSERV, V124, P89, DOI 10.1016/j.biocon.2005.01.015; AYLOR DE, 1990, ANNU REV PHYTOPATHOL, V28, P73, DOI 10.1146/annurev.py.28.090190.000445; AYLOR DE, 1985, ATMOS ENVIRON, V19, P803, DOI 10.1016/0004-6981(85)90069-1; AYLOR DE, 1987, PHYTOPATHOLOGY, V77, P1442, DOI 10.1094/Phyto-77-1442; Boros A., 1993, ATLAS RECENT EUROPEA; BREMER P, 1990, LINDBERGIA, V16, P3; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Bullock JM, 2002, DISPERSAL ECOLOGY, P279; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Cousens R, 2008, DISPERSAL IN PLANTS: A POPULATION PERSPECTIVE, P1; Cronberg N, 2002, J ECOL, V90, P925, DOI 10.1046/j.1365-2745.2002.00723.x; D Fontaneto, 2011, BIOGEOGRAPHY MICROSC; DURING HJ, 1979, LINDBERGIA, V5, P2; Edman M, 2004, ECOL APPL, V14, P893, DOI 10.1890/03-5103; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Gjerde I, 2012, ECOLOGY, V93, P749, DOI 10.1890/11-1018.1; GREENE DF, 1995, CAN J BOT, V73, P1036, DOI 10.1139/b95-113; Gregory PH, 1973, MICROBIOLOGY ATMOSPH; Hill MO, 2006, J BRYOL, V28, P198, DOI 10.1179/174328206X119998; Hill MO., 2007, BRYOATT ATTRIBUTES B; Hutsemekers V, 2008, DIVERS DISTRIB, V14, P483, DOI 10.1111/j.1472-4642.2007.00454.x; Hylander K, 2009, ECOLOGY, V90, P160, DOI 10.1890/08-0042.1; Jonsson MT, 2008, J ECOL, V96, P1065, DOI 10.1111/j.1365-2745.2008.01411.x; Lobel S, 2006, J ECOL, V94, P856, DOI 10.1111/j.1365-2745.2006.01114.x; Lonnell N, 2011, PLANT ECOL, V3, P1; MILES CJ, 1992, J BRYOL, V17, P355, DOI 10.1179/jbr.1992.17.2.355; Miller NG, 2004, AM J BOT, V91, P1173, DOI 10.3732/ajb.91.8.1173; Munoz J, 2004, SCIENCE, V304, P1144, DOI 10.1126/science.1095210; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Nichols J., 2001, DISPERSAL; Norros V, 2012, OIKOS, V121, P961, DOI 10.1111/j.1600-0706.2012.20052.x; NYHOLM E, 1989, ILLUSTRATED FLORA NO; Okland RH, 2003, ECOLOGY, V84, P1909; Pohjamo M, 2006, EVOL ECOL, V20, P415, DOI 10.1007/s10682-006-0011-2; Pounden E, 2008, J ECOL, V96, P591, DOI 10.1111/j.1365-2745.2008.01380.x; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Roads E, 2003, J HATTORI BOT LAB, P305; SHAW J, 1985, BRYOLOGIST, V88, P263, DOI 10.2307/3243035; Smith A.J.E., 2004, MOSS FLORA BRITAIN I, DOI [10.1017/cbo9780511541858, DOI 10.1017/CBO9780511541858]; Snall T, 2004, ECOGRAPHY, V27, P757, DOI 10.1111/j.0906-7590.2004.04026.x; SODERSTROM L, 1989, J BRYOL, V15, P793; Sundberg S, 2006, J BIOGEOGR, V33, P1479, DOI 10.1111/j.1365-2699.2006.01520.x; Sundberg S, 2005, OIKOS, V108, P115, DOI 10.1111/j.0030-1299.2005.12916.x; Sundberg S, ECOGRAPHY IN PRESS, DOI [10.1111/j.1600-0587.2012.07664.x, DOI 10.1111/J.1600-0587.2012.07664.X]; Tackenberg O, 2003, ECOL MONOGR, V73, P173, DOI 10.1890/0012-9615(2003)073[0173:MLDOPD]2.0.CO;2; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Wilkinson DM, 2012, J BIOGEOGR, V39, P89, DOI 10.1111/j.1365-2699.2011.02569.x	51	47	50	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41987	10.1371/journal.pone.0041987	http://dx.doi.org/10.1371/journal.pone.0041987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22870183	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000306950200143
J	Frank, E; Wu, YZ; Piyaratna, N; Body, WJ; Snikeris, P; South, T; Gerdin, AK; Bjursell, M; Bohlooly-Y, M; Storlien, L; Huang, XF				Frank, Elisabeth; Wu, Yizhen; Piyaratna, Naomi; Body, William James; Snikeris, Peta; South, Timothy; Gerdin, Anna-Karin; Bjursell, Mikael; Bohlooly-Y, Mohammad; Storlien, Leonard; Huang, Xu-Feng			Metabolic Parameters and Emotionality Are Little Affected in G-Protein Coupled Receptor 12 (Gpr12) Mutant Mice	PLOS ONE			English	Article							MOUSE MODELS; DEFICIENT MICE; MESSENGER-RNA; ANIMAL-MODELS; EXPRESSION; DIET; IDENTIFICATION; RESISTANT; SEVERITY; C57BL/6J	Background: G-protein coupled receptors (GPR) bear the potential to serve as yet unidentified drug targets for psychiatric and metabolic disorders. GPR12 is of major interest given its putative role in metabolic function and its unique brain distribution, which suggests a role in emotionality and affect. We tested Gpr12 deficient mice in a series of metabolic and behavioural tests and subjected them to a well-established high-fat diet feeding protocol. Methodology/Principal Findings: Comparing the mutant mice with wild type littermates, no significant differences were seen in body weight, fatness or weight gain induced by a high-fat diet. The Gpr12 mutant mice displayed a modest but significant lowering of energy expenditure and a trend to lower food intake on a chow diet, but no other metabolic parameters, including respiratory rate, were altered. No emotionality-related behaviours (assessed by light-dark box, tail suspension, and open field tests) were affected by the Gpr12 gene mutation. Conclusions/Significance: Studying metabolic and emotionality parameters in Gpr12 mutant mice did not reveal a major phenotypic impact of the gene mutation. Compared to previous results showing a metabolic phenotype in Gpr12 mice with a mixed 129 and C57Bl6 background, we suggest that a more pure C57Bl/6 background due to further backcrossing might have reduced the phenotypic penetrance.	[Frank, Elisabeth; Snikeris, Peta; Huang, Xu-Feng] Schizophrenia Res Inst, Sydney, NSW, Australia; [Frank, Elisabeth; Wu, Yizhen; Piyaratna, Naomi; Body, William James; Snikeris, Peta; South, Timothy; Huang, Xu-Feng] Univ Wollongong, Sch Hlth Sci, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Gerdin, Anna-Karin; Bjursell, Mikael; Bohlooly-Y, Mohammad] AstraZeneca R&D, Molndal, Sweden; [Storlien, Leonard] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia	University of Wollongong; AstraZeneca; University of Sydney	Frank, E (corresponding author), Schizophrenia Res Inst, Sydney, NSW, Australia.	efrank@uow.edu.au	Huang, Xu-Feng/H-7408-2015; Snikeris, Peta/L-9082-2017; Huang, Xu-Feng/D-6053-2013	Huang, Xu-Feng/0000-0002-5895-2253; Snikeris, Peta/0000-0002-2334-1102; Huang, Xu-Feng/0000-0002-5895-2253	Schizophrenia Research Institute, Australia; NSW Ministry of Health; AstraZeneca, Sweden; Schizophrenia Research Institute; AstraZeneca	Schizophrenia Research Institute, Australia; NSW Ministry of Health; AstraZeneca, Sweden(AstraZeneca); Schizophrenia Research Institute; AstraZeneca(AstraZeneca)	This work was supported by the Schizophrenia Research Institute, Australia, (www.schizophreniaresearch.org.au) utilising infrastructure funding from NSW Ministry of Health, and by AstraZeneca, Sweden. The Schizophrenia Research Institute supported the project by salary and budget for EF and PS. AstraZeneca (www.astrazeneca.com) employs AKG, MB and MBY, and financially supported the studies. The funding bodies had, however, no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard A, 2007, GLIA, V55, P777, DOI 10.1002/glia.20477; Bellmann-Sickert K, 2010, TRENDS PHARMACOL SCI, V31, P434, DOI 10.1016/j.tips.2010.06.003; Bjursell M, 2006, DIABETES, V55, P725, DOI 10.2337/diabetes.55.03.06.db05-1302; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Bjursell M, 2006, BIOCHEM BIOPH RES CO, V348, P359, DOI 10.1016/j.bbrc.2006.07.090; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Bresnick JN, 2003, ASSAY DRUG DEV TECHN, V1, P239, DOI 10.1089/15406580360545053; Catapano LA, 2007, BBA-BIOMEMBRANES, V1768, P976, DOI 10.1016/j.bbamem.2006.09.025; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; EIDNE KA, 1991, FEBS LETT, V292, P243, DOI 10.1016/0014-5793(91)80876-5; Flint J, 2008, CURR OPIN GENET DEV, V18, P235, DOI 10.1016/j.gde.2008.07.002; Frank E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007821; Gerdin AK, 2006, BIOCHEM BIOPH RES CO, V349, P825, DOI 10.1016/j.bbrc.2006.08.103; Girirajan S, 2009, EUR J MED GENET, V52, P224, DOI 10.1016/j.ejmg.2008.12.002; Haluzik M, 2004, ENDOCRINOLOGY, V145, P3258, DOI 10.1210/en.2004-0219; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Huang XF, 2005, MOL BRAIN RES, V135, P150, DOI 10.1016/j.molbrainres.2004.12.013; Huang XF, 2003, MOL BRAIN RES, V115, P21, DOI 10.1016/S0169-328X(03)00174-8; Ignatov A, 2003, J NEUROSCI, V23, P907; Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x; Joost P, 2002, GENOME BIOL, V3; Kishi T, 2005, MOL PSYCHIATR, V10, P132, DOI 10.1038/sj.mp.4001638; Lassalle JM, 2008, BEHAV BRAIN RES, V191, P104, DOI 10.1016/j.bbr.2008.03.017; Lee AWS, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001729; Li C, 2011, PHARMACOL THERAPEUT, V129, P307, DOI 10.1016/j.pharmthera.2010.10.006; Lin ZJ, 2008, ARCH PHARM RES, V31, P1108, DOI 10.1007/s12272-001-1276-4; Lu Xiaoming, 2012, Mol Cell Biochem, V366, P101, DOI 10.1007/s11010-012-1287-x; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; Maeda N, 2007, ATHEROSCLEROSIS, V195, P75, DOI 10.1016/j.atherosclerosis.2006.12.006; McCutcheon JE, 2008, EUR J NEUROSCI, V27, P683, DOI 10.1111/j.1460-9568.2008.06043.x; Mouri A, 2007, NEUROCHEM INT, V51, P173, DOI 10.1016/j.neuint.2007.06.019; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Sartori SB, 2011, FUTUR NEUROL, V6, P531, DOI 10.2217/FNL.11.34; SONG ZH, 1994, FEBS LETT, V351, P375, DOI 10.1016/0014-5793(94)00888-4; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4; Voikar V, 2005, GENES BRAIN BEHAV, V4, P240, DOI 10.1111/j.1601-183X.2004.00103.x; Waeber C, 2004, DRUG NEWS PERSPECT, V17, P365, DOI 10.1358/dnp.2004.17.6.829028; Wotjak CT, 2005, MINI-REV MED CHEM, V5, P659, DOI 10.2174/1389557054368763; Yagi H, 2009, NEUROSCI LETT, V461, P190, DOI 10.1016/j.neulet.2009.06.012	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42395	10.1371/journal.pone.0042395	http://dx.doi.org/10.1371/journal.pone.0042395			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879962	Green Published, Green Submitted, gold			2022-12-27	WOS:000307437900037
J	Nelson, JL; Zavaleta, ES				Nelson, Joanna L.; Zavaleta, Erika S.			Salt Marsh as a Coastal Filter for the Oceans: Changes in Function with Experimental Increases in Nitrogen Loading and Sea-Level Rise	PLOS ONE			English	Article							NUTRIENT OVER-ENRICHMENT; SALICORNIA-VIRGINICA; SPARTINA-FOLIOSA; BIOGEOCHEMICAL CYCLES; SOUTHERN CALIFORNIA; ELEVATED CO2; RIVER-BASIN; EUTROPHICATION; ECOSYSTEM; CONSEQUENCES	Coastal salt marshes are among Earth's most productive ecosystems and provide a number of ecosystem services, including interception of watershed-derived nitrogen (N) before it reaches nearshore oceans. Nitrogen pollution and climate change are two dominant drivers of global-change impacts on ecosystems, yet their interacting effects at the land-sea interface are poorly understood. We addressed how sea-level rise and anthropogenic N additions affect the salt marsh ecosystem process of nitrogen uptake using a field-based, manipulative experiment. We crossed simulated sea-level change and ammonium-nitrate (NH4NO3)-addition treatments in a fully factorial design to examine their potentially interacting effects on emergent marsh plants in a central California estuary. We measured above-and belowground biomass and tissue nutrient concentrations seasonally and found that N-addition had a significant, positive effect on a) aboveground biomass, b) plant tissue N concentrations, c) N stock sequestered in plants, and d) shoot: root ratios in summer. Relative sea-level rise did not significantly affect biomass, with the exception of the most extreme sea-level-rise simulation, in which all plants died by the summer of the second year. Although there was a strong response to N-addition treatments, salt marsh responses varied by season. Our results suggest that in our site at Coyote Marsh, Elkhorn Slough, coastal salt marsh plants serve as a robust N trap and coastal filter; this function is not saturated by high background annual N inputs from upstream agriculture. However, if the marsh is drowned by rising seas, as in our most extreme sea-level rise treatment, marsh plants will no longer provide the ecosystem service of buffering the coastal ocean from eutrophication.	[Nelson, Joanna L.; Zavaleta, Erika S.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Nelson, JL (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA.	jnelson@stanfordalumni.org			National Oceanic and Atmospheric Administration/National Estuarine Research Reserve Graduate Research Fellowship [NA08NOS4200268]; CA Environmental Quality Initiative; Garden Club of America Coastal Wetlands scholarship; University of California Santa Cruz: STEPS (Science, Technology, Engineering, Policy and Society "Institute, at University of California, Santa Cruz); University of California Santa Cruz, STARS (Services for Transfer and Re-entry Students'' at University of California, Santa Cruz); Marilyn C. Davis Scholarship; Center for Dynamics at the Land-Sea Interface; Environmental Studies department	National Oceanic and Atmospheric Administration/National Estuarine Research Reserve Graduate Research Fellowship; CA Environmental Quality Initiative; Garden Club of America Coastal Wetlands scholarship; University of California Santa Cruz: STEPS (Science, Technology, Engineering, Policy and Society "Institute, at University of California, Santa Cruz); University of California Santa Cruz, STARS (Services for Transfer and Re-entry Students'' at University of California, Santa Cruz); Marilyn C. Davis Scholarship; Center for Dynamics at the Land-Sea Interface; Environmental Studies department	The following sources of funding awarded to J.L. Nelson supported the research: National Oceanic and Atmospheric Administration/National Estuarine Research Reserve Graduate Research Fellowship (grant number NA08NOS4200268); Phi Beta Kappa; CA Environmental Quality Initiative; Garden Club of America Coastal Wetlands scholarship; and from the University of California Santa Cruz: STEPS (Science, Technology, Engineering, Policy and Society "Institute, at University of California, Santa Cruz), STARS (Services for Transfer and Re-entry Students'' at University of California, Santa Cruz), the Marilyn C. Davis Scholarship, the Center for Dynamics at the Land-Sea Interface, and the Environmental Studies department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P., 1990, SALTMARSH ECOLOGY; Ahrens TD, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006661; [Anonymous], 2007, BIOGEOCHEMISTRY ESTU; Boesch DF, 2002, ESTUARIES, V25, P886, DOI 10.1007/BF02804914; Boyer KE, 1999, RESTOR ECOL, V7, P74, DOI 10.1046/j.1526-100X.1999.07109.x; Boyer KE, 2001, WETLANDS, V21, P315, DOI 10.1672/0277-5212(2001)021[0315:SVIASC]2.0.CO;2; Brand A, 2012, ECOLOGICAL IN PRESS; Breschini SJ, 2002, HORTSCIENCE, V37, P1061, DOI 10.21273/HORTSCI.37.7.1061; Brew DS, 2010, J COASTAL RES, V26, P912, DOI 10.2112/08-1174.1; Bricker, 2007, EFFECTS NUTR ENRICHM; Brin LD, 2010, MAR ECOL PROG SER, V400, P3, DOI 10.3354/meps08460; Caffrey J.M., 2002, CHANGES CALIFORNIA E; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; COVIN JD, 1988, WETLANDS, V8, P51, DOI 10.1007/BF03160808; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; Day JW, 2008, ESTUAR COAST, V31, P477, DOI 10.1007/s12237-008-9047-6; Day JW, 2004, OCEAN COAST MANAGE, V47, P671, DOI 10.1016/j.ocecoaman.2004.12.007; Deegan Linda A., 2007, Ecological Applications, V17, pS42, DOI 10.1890/06-0452.1; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Drake DC, 2009, ECOLOGY, V90, P2535, DOI 10.1890/08-1051.1; Elkorn_Slough_National_Estuarine_Research_Reserve, 2011, TID WETL PROJ; Elsey-Quirk T, 2011, ESTUAR COAST, V34, P470, DOI 10.1007/s12237-011-9379-5; Emmett R, 2000, ESTUARIES, V23, P765, DOI 10.2307/1352998; Faeth P, 2002, ESTUARIES, V25, P869, DOI 10.1007/BF02804912; FIELD CB, 1999, CONFRONTING CLIMATE; Fogel BN, 2004, J ECOL, V92, P589, DOI 10.1111/j.0022-0477.2004.00903.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gillespie A, 2011, MORRO BAY SEDIMENT L; Gosselink J.G., 2000, WETLANDS; Griffith KA, 2008, ECOLOGY PARASITIC PL; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Haines B., 1985, PHYSL ECOLOGY N AM P, P323; Hopkinson CS, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P991, DOI 10.1016/B978-0-12-372522-6.00022-0; HOPKINSON CS, 1984, ECOLOGY, V65, P961, DOI 10.2307/1938068; Howarth R, 2011, FRONT ECOL ENVIRON, V9, P18, DOI 10.1890/100008; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Howes B.L., 1996, ESTUARINE SHORES EVO, P287; Jannasch HW, 2008, LIMNOL OCEANOGR-METH, V6, P263, DOI 10.4319/lom.2008.6.263; Johnson KS, 2004, LAND OCEAN BIOGEOCHE; Kennedy V.S, 1984, ESTUARY FILTER; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Lindig-Cisneros R, 2002, ESTUARIES, V25, P1174, DOI 10.1007/BF02692214; Little C., 2009, BIOL ROCKY SHORES, Patent No. [1711.11065, 171111065]; Los Huertos MW, 1999, THESIS U CALIFORNIA; Lowe PB, 1999, MARSH LOSS ELKHORN S; MAHALL BE, 1976, J ECOL, V64, P793, DOI 10.2307/2258809; Martone RG, 2008, OECOLOGIA, V158, P151, DOI 10.1007/s00442-008-1129-4; McGlathery KJ, 2007, MAR ECOL PROG SER, V348, P1, DOI 10.3354/meps07132; Mendelssohn IA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P59; Mitsch WJ, 2001, BIOSCIENCE, V51, P373, DOI 10.1641/0006-3568(2001)051[0373:RNLTTG]2.0.CO;2; Mitsch WJ, 2006, ECOL ENG, V26, P55, DOI 10.1016/j.ecoleng.2005.09.005; Mitsch WJ, 2005, ECOL ENG, V24, P267, DOI 10.1016/j.ecoleng.2005.02.005; MORRIS JT, 1991, ANNU REV ECOL SYST, V22, P257, DOI 10.1146/annurev.es.22.110191.001353; Moseman-Valtierra S, 2011, ATMOS ENVIRON, V45, P4390, DOI 10.1016/j.atmosenv.2011.05.046; National Research Council, 2000, CLEAN COAST WAT UND; Nicholls RJ, 2011, PHILOS T R SOC A, V369, P161, DOI 10.1098/rsta.2010.029; Nidzieko NJ, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005864; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; Nyman JA, 2006, ESTUAR COAST SHELF S, V69, P370, DOI 10.1016/j.ecss.2006.05.041; Phillips B, 2002, CHANGES CALIFORNIA E, P237; Plant JN, 2009, COASTAL ESTUARINE RE; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Schile LM, 2011, WETLANDS, V31, P1165, DOI 10.1007/s13157-011-0227-y; Seitzinger SP, 1998, GLOBAL BIOGEOCHEM CY, V12, P93, DOI 10.1029/97GB03657; Short F.T., 1984, ESTUARY FILTER, P395, DOI 10.1016/b978-0-12-405070-9.50024-4; Simoes MP, 2011, AQUAT BOT, V94, P119, DOI 10.1016/j.aquabot.2011.01.001; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sousa AI, 2008, ENVIRON POLLUT, V156, P628, DOI 10.1016/j.envpol.2008.06.022; Stevenson J.C., 2009, HUMAN IMPACTS SALT M, P171; TEAL JM, 1962, ECOLOGY, V43, P614, DOI 10.2307/1933451; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Turner RE, 2011, ESTUAR COAST, V34, P1084, DOI 10.1007/s12237-010-9341-y; Turner RE, 2009, LIMNOL OCEANOGR, V54, P1634, DOI 10.4319/lo.2009.54.5.1634; VALIELA I, 1973, Estuarine and Coastal Marine Science, V1, P261, DOI 10.1016/0302-3524(73)90039-X; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Ward KM, 2003, ESTUARIES, V26, P116, DOI 10.1007/BF02691699; Watson EB, 2011, RESTOR ECOL, V19, P765, DOI 10.1111/j.1526-100X.2010.00722.x; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zedler JB, 1996, ECOL APPL, V6, P84, DOI 10.2307/2269555	83	69	69	2	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e38558	10.1371/journal.pone.0038558	http://dx.doi.org/10.1371/journal.pone.0038558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879873	Green Submitted, Green Published, gold			2022-12-27	WOS:000307437900001
J	ter Horst, AC; Cole, J; van Lier, R; Steenbergen, B				ter Horst, Arjan C.; Cole, Jonathan; van Lier, Rob; Steenbergen, Bert			The Effect of Chronic Deafferentation on Mental Imagery: A Case Study	PLOS ONE			English	Article							MOTOR IMAGERY; CORTICOSPINAL EXCITABILITY; HAND RECOGNITION; VISUO-MOTOR; ROTATION; ANESTHESIA; POSTURE; REPRESENTATIONS; INTEGRATION; STRATEGIES	Visual- and motor imagery rely primarily on perceptual and motor processes, respectively. In healthy controls, the type of imagery used to solve a task depends on personal preference, task instruction, and task properties. But how does the chronic loss of proprioceptive and tactile sensory inputs from the body periphery influence mental imagery? In a unique case study, we investigated the imagery capabilities of the chronically deafferented patient IW when he was performing a mental rotation task. We found that IW's motor imagery processes were impaired and that visual imagery processes were enhanced compared to controls. These results suggest that kinaesthetic afferent signals from the body periphery play a crucial role in enabling and maintaining central sensorimotor representations and hence the ability to incorporate kinaesthetic information into the imagery processes.	[ter Horst, Arjan C.; van Lier, Rob; Steenbergen, Bert] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [ter Horst, Arjan C.; Steenbergen, Bert] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Cole, Jonathan] Bournemouth Univ, Poole Hosp, Poole BH12 5BB, Dorset, England	Radboud University Nijmegen; Radboud University Nijmegen; Bournemouth University; Poole Hospital	ter Horst, AC (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	a.terhorst@donders.ru.nl	van Lier, Rob/E-1654-2012	van Lier, Rob/0000-0002-4705-5725; Steenbergen, Bert/0000-0001-8863-2624				Bosbach S, 2005, NAT NEUROSCI, V8, P1295, DOI 10.1038/nn1535; Bosbach S, 2006, NEUROPSYCHOLOGIA, V44, P2950, DOI 10.1016/j.neuropsychologia.2006.06.018; Cole C, 1998, BODY SELF; COLE JD, 1992, J PHYSIOL-LONDON, V449, P503, DOI 10.1113/jphysiol.1992.sp019099; Curtze C, 2009, EXP BRAIN RES; de Lange FP, 2008, CORTEX, V44, P494, DOI 10.1016/j.cortex.2007.09.002; de Lange FP, 2006, NEUROIMAGE, V33, P609, DOI 10.1016/j.neuroimage.2006.07.017; de Lange FP, 2005, J COGNITIVE NEUROSCI, V17, P97, DOI 10.1162/0898929052880039; de Vignemont F, 2005, CURR BIOL, V15, P1286, DOI 10.1016/j.cub.2005.06.067; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; Decety J, 1996, BEHAV BRAIN RES, V72, P127; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Funk M, 2008, J INT NEUROPSYCH SOC, V14, P81, DOI 10.1017/S1355617708080041; Gandevia SC, 1999, J PHYSIOL-LONDON, V514, P609, DOI 10.1111/j.1469-7793.1999.609ae.x; Gentilucci M, 1998, COGNITIVE BRAIN RES, V6, P185, DOI 10.1016/S0926-6410(97)00034-7; Grush R, 2004, BEHAV BRAIN SCI, V27, P377, DOI 10.1017/S0140525X04000093; Guillot A., 2010, NEUROPHYSIOLOGICAL F; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P414, DOI 10.1017/S0048577202001105; Helmich RC, 2007, NEUROPSYCHOLOGIA, V45, P2201, DOI 10.1016/j.neuropsychologia.2007.02.024; Ionta S, 2007, EXP BRAIN RES, V183, P1, DOI 10.1007/s00221-007-1020-2; Ionta S, 2009, EXP BRAIN RES, V195, P207, DOI 10.1007/s00221-009-1770-0; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Karadi K, 2001, PERCEPT MOTOR SKILL, V93, P333, DOI 10.2466/PMS.93.5.333-337; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Martucci KT, 2011, ANESTHESIOLOGY, V114, P21, DOI 10.1097/ALN.0b013e3182016521; Mercier C, 2008, CEREB CORTEX, V18, P272, DOI 10.1093/cercor/bhm052; Miall RC, 2007, EXP BRAIN RES, V176, P432, DOI 10.1007/s00221-006-0626-0; Miall RC, 1995, EXP BRAIN RES, V107, P267; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Nico D, 2004, BRAIN, V127, P120, DOI 10.1093/brain/awh006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olsson CJ, 2010, SCAND J MED SCI SPOR, V20, P711, DOI 10.1111/j.1600-0838.2010.01101.x; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; SEKIYAMA K, 1982, PERCEPT PSYCHOPHYS, V32, P89, DOI 10.3758/BF03204268; Silva S, 2011, ANESTHESIOLOGY, V114, P126, DOI 10.1097/ALN.0b013e31820164f1; ter Horst AC, 2012, PSYCHOPHYSIOLOGY, V49, P566, DOI 10.1111/j.1469-8986.2011.01322.x; ter Horst AC, 2011, EXP BRAIN RES, V212, P635, DOI 10.1007/s00221-011-2748-2; ter Horst AC, 2010, EXP BRAIN RES, V203, P347, DOI 10.1007/s00221-010-2235-1; Tomasino B, 2004, J COGNITIVE NEUROSCI, V16, P878, DOI 10.1162/089892904970753; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Vargas CD, 2004, CEREB CORTEX, V14, P1200, DOI 10.1093/cercor/bhh080; Ziemann U, 1998, J NEUROSCI, V18, P1115	43	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42742	10.1371/journal.pone.0042742	http://dx.doi.org/10.1371/journal.pone.0042742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880095	Green Published, gold, Green Accepted			2022-12-27	WOS:000307437900052
J	Lopman, BA; Pitzer, VE; Sarkar, R; Gladstone, B; Patel, M; Glasser, J; Gambhir, M; Atchison, C; Grenfell, BT; Edmunds, WJ; Kang, G; Parashar, UD				Lopman, Benjamin A.; Pitzer, Virginia E.; Sarkar, Rajiv; Gladstone, Beryl; Patel, Manish; Glasser, John; Gambhir, Manoj; Atchison, Christina; Grenfell, Bryan T.; Edmunds, W. John; Kang, Gagandeep; Parashar, Umesh D.			Understanding Reduced Rotavirus Vaccine Efficacy in Low Socio-Economic Settings	PLOS ONE			English	Article							DOUBLE-BLIND; CHILDREN; SAFETY; GASTROENTERITIS; IMMUNOGENICITY; DIARRHEA; INFANTS; MORTALITY; INFECTION; DISEASE	Introduction: Rotavirus vaccine efficacy ranges from >90% in high socio-economic settings (SES) to 50% in low SES. With the imminent introduction of rotavirus vaccine in low SES countries, understanding reasons for reduced efficacy in these settings could identify strategies to improve vaccine performance. Methods: We developed a mathematical model to predict rotavirus vaccine efficacy in high, middle and low SES based on data specific for each setting on incidence, protection conferred by natural infection and immune response to vaccination. We then examined factors affecting efficacy. Results: Vaccination was predicted to prevent 93%, 86% and 51% of severe rotavirus gastroenteritis in high, middle and low SES, respectively. Also predicted was that vaccines are most effective against severe disease and efficacy declines with age in low but not high SES. Reduced immunogenicity of vaccination and reduced protection conferred by natural infection are the main factors that compromise efficacy in low SES. Discussion: The continued risk of severe disease in non-primary natural infections in low SES is a key factor underpinning reduced efficacy of rotavirus vaccines. Predicted efficacy was remarkably consistent with observed clinical trial results from different SES, validating the model. The phenomenon of reduced vaccine efficacy can be predicted by intrinsic immunological and epidemiological factors of low SES populations. Modifying aspects of the vaccine (e. g. improving immunogenicity in low SES) and vaccination program (e. g. additional doses) may bring improvements.	[Lopman, Benjamin A.; Patel, Manish; Glasser, John; Gambhir, Manoj; Parashar, Umesh D.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Pitzer, Virginia E.; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Pitzer, Virginia E.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Sarkar, Rajiv; Gladstone, Beryl] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [Gambhir, Manoj; Kang, Gagandeep] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreaks Anal & Modelling, London, England; [Atchison, Christina; Edmunds, W. John] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	Centers for Disease Control & Prevention - USA; Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Christian Medical College & Hospital (CMCH) Vellore; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Lopman, BA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	blopman@cdc.gov	Sarkar, Rajiv/AAU-7203-2021	Sarkar, Rajiv/0000-0003-0616-3129; Atchison, Christina/0000-0001-8304-7389; Gambhir, Manoj/0000-0002-4831-6261; Pitzer, Virginia/0000-0003-1015-2289	National Institutes of Health [R01 GM083983-01]; Bill and Melinda Gates Foundation; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Global Alliance for Vaccines and Immunisation (GAVI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Global Alliance for Vaccines and Immunisation (GAVI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (R01 GM083983-01), the Bill and Melinda Gates Foundation, the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, the Fogarty International Center, National Institutes of Health (V. E. P and B. G.). Additional Support for this project was provided by Program for Appropriate Technology in Health (PATH) through funding from the Global Alliance for Vaccines and Immunisation (GAVI). The views expressed by the authors do not necessarily reflect the views of GAVI and/or PATH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2009, VACCINE, V28, P422, DOI 10.1016/j.vaccine.2009.10.032; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P533; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Atchison C, 2010, VACCINE, V28, P3118, DOI 10.1016/j.vaccine.2010.02.060; Bhandari N, 2009, J INFECT DIS, V200, P421, DOI 10.1086/600104; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boom JA, 2010, PEDIATRICS, V125, pE199, DOI 10.1542/peds.2009-1021; Braeckman T, 2011, PEDIATR INFECT DIS J, V30, pS21, DOI 10.1097/INF.0b013e3181fefc51; Buttery JP, 2011, PEDIATR INFECT DIS J, V30, pS25, DOI 10.1097/INF.0b013e3181fefdee; Cooper PJ, 2000, J INFECT DIS, V182, P1199, DOI 10.1086/315837; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; de Palma O, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2825; FARRINGTON CP, 1992, INT J EPIDEMIOL, V21, P1014, DOI 10.1093/ije/21.5.1014; Field EJ, 2010, PEDIATRICS, V126, pE506, DOI 10.1542/peds.2010-0443; Gladstone BP, 2011, NEW ENGL J MED, V365, P337, DOI 10.1056/NEJMoa1006261; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; HALLORAN ME, 1992, AM J EPIDEMIOL, V136, P328, DOI 10.1093/oxfordjournals.aje.a116498; JOHN TJ, 1972, AM J EPIDEMIOL, V96, P263, DOI 10.1093/oxfordjournals.aje.a121457; Justino MC, 2011, PEDIAT INFECT DIS J; Lagos R, 1999, J INFECT DIS, V180, P1709, DOI 10.1086/315051; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Moon SS, 2010, PEDIATR INFECT DIS J, V29, P919, DOI 10.1097/INF.0b013e3181e232ea; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nelson EAS, 2010, LANCET, V376, P568, DOI 10.1016/S0140-6736(10)60896-3; Pasetti MF, 2011, IMMUNOL REV, V239, P125, DOI 10.1111/j.1600-065X.2010.00970.x; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Phillips G, 2010, AM J EPIDEM IN PRESS; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Sahni LC, 2010, VACCINE, V28, P6314, DOI 10.1016/j.vaccine.2010.06.109; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2006, J INFECT DIS, V194, P370, DOI 10.1086/505151; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	38	97	97	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e41720	10.1371/journal.pone.0041720	http://dx.doi.org/10.1371/journal.pone.0041720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879893	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000307810000009
J	Yu, G; Yao, WM; Wang, J; Ma, X; Xiao, W; Li, H; Xia, D; Yang, Y; Deng, KL; Xiao, HB; Wang, BH; Guo, XL; Guan, W; Hu, ZQ; Bai, YQ; Xu, H; Liu, JH; Zhang, X; Ye, ZQ				Yu, Gan; Yao, Weimin; Wang, Ji; Ma, Xin; Xiao, Wei; Li, Heng; Xia, Ding; Yang, Yang; Deng, Kangli; Xiao, Haibing; Wang, Bohan; Guo, Xiaolin; Guan, Wei; Hu, Zhiquan; Bai, Yinqi; Xu, Hua; Liu, Jihong; Zhang, Xu; Ye, Zhangqun			LncRNAs Expression Signatures of Renal Clear Cell Carcinoma Revealed by Microarray	PLOS ONE			English	Article							LONG NONCODING RNAS; TUMOR SUPPRESSION; GENE-EXPRESSION; KIDNEY CANCER; CHROMATIN; IDENTIFICATION; TRANSCRIPTION; INACTIVATION; PROSTATE; DISEASE	Background: Long noncoding RNAs (lncRNAs) are an important class of pervasive genes involved in a variety of biological functions. They are aberrantly expressed in many types of cancers. In this study, we described lncRNAs profiles in 6 pairs of human renal clear cell carcinoma (RCCC) and the corresponding adjacent nontumorous tissues (NT) by microarray. Methodology/Principal Findings: With abundant and varied probes accounting 33,045 LncRNAs in our microarray, the number of lncRNAs that expressed at a certain level could be detected is 17157. From the data we found there were thousands of lncRNAs that differentially expressed (>= 2 fold-change) in RCCC tissues compared with NT and 916 lncRNAs differentially expressed in five or more of six RCCC samples. Compared with NT, many lncRNAs were significantly up-regulated or down-regulated in RCCC. Our data showed that down-regulated lncRNAs were more common than up-regulated ones. ENST00000456816, X91348, BC029135, NR_024418 were evaluated by qPCR in sixty-three pairs of RCCC and NT samples. The four lncRNAs were aberrantly expressed in RCCC compared with matched histologically normal renal tissues. Conclusions/Significance: Our study is the first one to determine genome-wide lncRNAs expression patterns in RCCC by microarray. The results displayed that clusters of lncRNAs were aberrantly expressed in RCCC compared with NT samples, which revealed that lncRNAs differentially expressed in tumor tissues and normal tissues may exert a partial or key role in tumor development. Taken together, this study may provide potential targets for future treatment of RCCC and novel insights into cancer biology.	[Yu, Gan; Yao, Weimin; Xiao, Wei; Li, Heng; Xia, Ding; Yang, Yang; Deng, Kangli; Xiao, Haibing; Wang, Bohan; Guo, Xiaolin; Guan, Wei; Hu, Zhiquan; Xu, Hua; Liu, Jihong; Ye, Zhangqun] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430074, Peoples R China; [Wang, Ji] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Wang, Ji] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Ma, Xin; Zhang, Xu] Peoples Liberat Army Gen Hosp, Mil Postgrad Med Coll, Dept Urol, Beijing, Peoples R China; [Bai, Yinqi] BGI Shenzhen, Shenzhen, Peoples R China	Huazhong University of Science & Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Chinese People's Liberation Army General Hospital; Beijing Genomics Institute (BGI)	Yu, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430074, Peoples R China.	xuhua@mail.hust.edu.cn	Wang, Ji/I-5795-2012		National Natural Science Foundation of China [31072238, 31172441, 81170650]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31072238, 31172441, 81170650). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azeem K, 2011, BIOMED PAP, V155, P231, DOI 10.5507/bp.2011.029; Bertozzi D, 2011, CELL CYCLE, V10, P3189, DOI 10.4161/cc.10.18.17183; BRESLOW N, 1977, INT J CANCER, V20, P680, DOI 10.1002/ijc.2910200506; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dall'Oglio MF, 2010, INT BRAZ J UROL, V36, P410, DOI 10.1590/S1677-55382010000400004; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hessels D, 2009, NAT REV UROL, V6, P255, DOI 10.1038/nrurol.2009.40; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ifere Godwin O, 2009, Recent Pat DNA Gene Seq, V3, P151; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Oosterwijk E, 2011, EUR UROL, V60, P622, DOI 10.1016/j.eururo.2011.06.048; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ren S., 2012, CELL RES; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; SHUIN T, 1994, CANCER RES, V54, P2852; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Sutherland HF, 1996, AM J HUM GENET, V59, P23; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; van Rooijen E, 2010, DIS MODEL MECH, V3, P343, DOI 10.1242/dmm.004036; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735	42	90	96	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42377	10.1371/journal.pone.0042377	http://dx.doi.org/10.1371/journal.pone.0042377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879955	gold, Green Submitted, Green Published			2022-12-27	WOS:000307810000029
J	Achilli, A; Iommarini, L; Olivieri, A; Pala, M; Kashani, BH; Reynier, P; La Morgia, C; Valentino, ML; Liguori, R; Pizza, F; Barboni, P; Sadun, F; De Negri, AM; Zeviani, M; Dollfus, H; Moulignier, A; Ducos, G; Orssaud, C; Bonneau, D; Procaccio, V; Leo-Kottler, B; Fauser, S; Wissinger, B; Amati-Bonneau, P; Torroni, A; Carelli, V				Achilli, Alessandro; Iommarini, Luisa; Olivieri, Anna; Pala, Maria; Kashani, Baharak Hooshiar; Reynier, Pascal; La Morgia, Chiara; Valentino, Maria Lucia; Liguori, Rocco; Pizza, Fabio; Barboni, Piero; Sadun, Federico; De Negri, Anna Maria; Zeviani, Massimo; Dollfus, Helene; Moulignier, Antoine; Ducos, Ghislaine; Orssaud, Christophe; Bonneau, Dominique; Procaccio, Vincent; Leo-Kottler, Beate; Fauser, Sascha; Wissinger, Bernd; Amati-Bonneau, Patrizia; Torroni, Antonio; Carelli, Valerio			Rare Primary Mitochondrial DNA Mutations and Probable Synergistic Variants in Leber's Hereditary Optic Neuropathy	PLOS ONE			English	Article							RESPIRATORY COMPLEX-I; PRIMARY LHON MUTATION; ND6 GENE; MTDNA MUTATIONS; HOT-SPOT; CLINICAL-FEATURES; SEQUENCE-ANALYSIS; G14459A MUTATION; DISEASE; FAMILIES	Background: Leber's hereditary optic neuropathy (LHON) is a maternally inherited blinding disorder, which in over 90% of cases is due to one of three primary mitochondrial DNA (mtDNA) point mutations (m. 11778G>A, m. 3460G>A and m. 14484T>C, respectively in MT-ND4, MT-ND1 and MT-ND6 genes). However, the spectrum of mtDNA mutations causing the remaining 10% of cases is only partially and often poorly defined. Methodology/Principal Findings: In order to improve such a list of pathological variants, we completely sequenced the mitochondrial genomes of suspected LHON patients from Italy, France and Germany, lacking the three primary common mutations. Phylogenetic and conservation analyses were performed. Sixteen mitochondrial genomes were found to harbor at least one of the following nine rare LHON pathogenic mutations in genes MT-ND1 (m.3700G>A/p.A132T, m>3733G>A-C/p.E143K-Q, m.4171C>A/p.L289M), MT-ND4L (m.10663T>C/p.V65A) and MT-ND6 (m.14459G>A/p.A72V, m.14495A>G/p.M64I, m.14482C>A/p.L60S, and m.14568C>T/p.G36S). Phylogenetic analyses revealed that these substitutions were due to independent events on different haplogroups, whereas interspecies comparisons showed that they affected conserved amino acid residues or domains in the ND subunit genes of complex I. Conclusions/Significance: Our findings indicate that these nine substitutions are all primary LHON mutations. Therefore, despite their relative low frequency, they should be routinely tested for in all LHON patients lacking the three common mutations. Moreover, our sequence analysis confirms the major role of haplogroups J1c and J2b (over 35% in our probands versus 6% in the general population of Western Europe) and other putative synergistic mtDNA variants in LHON expression.	[Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Iommarini, Luisa; La Morgia, Chiara; Valentino, Maria Lucia; Liguori, Rocco; Pizza, Fabio; Barboni, Piero; Carelli, Valerio] Univ Bologna, IRCCS Ist Sci Neurol Bologna, Bologna, Italy; [Iommarini, Luisa; La Morgia, Chiara; Valentino, Maria Lucia; Liguori, Rocco; Pizza, Fabio; Barboni, Piero; Carelli, Valerio] Univ Bologna, Dipartimento Sci Neurol, Bologna, Italy; [Olivieri, Anna; Pala, Maria; Kashani, Baharak Hooshiar; Torroni, Antonio] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy; [Reynier, Pascal; Bonneau, Dominique; Procaccio, Vincent; Amati-Bonneau, Patrizia] U1083 CNRS6214, UMR INSERM, Angers, France; [Reynier, Pascal; Bonneau, Dominique; Procaccio, Vincent] Univ Angers, Sch Med, Angers, France; [Reynier, Pascal; Bonneau, Dominique; Procaccio, Vincent; Amati-Bonneau, Patrizia] Univ Hosp Angers, Dept Biochem & Genet, Angers, France; [Barboni, Piero] Studio Oculist DAzeglio, Bologna, Italy; [Sadun, Federico] Osped San Giovanni Evangelista, Tivoli, Italy; [De Negri, Anna Maria] Azienda San Camillo Forlanini, Rome, Italy; [Zeviani, Massimo] Fdn C Besta Neurol Inst IRCCS, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Unit Mol Neurogenet, Milan, Italy; [Dollfus, Helene] Hop Univ Strasbourg, Ctr Reference Affect Rares Genet Ophtalmol, Strasbourg, France; [Moulignier, Antoine] Fdn Ophtalmol Adolphe de Rothschild, Serv Neurol, Paris, France; [Ducos, Ghislaine] St Jean Languedoc Clin, Dept Ophthalmol, Toulouse, France; [Orssaud, Christophe] AP HP, HEGP, Ctr Reference Malad Rares Ophtalmol, Paris, France; [Wissinger, Bernd] Univ Clin Tuebingen, Ctr Ophthalmol, Inst Ophthalm Res, Mol Genet Lab, Tubingen, Germany; [Fauser, Sascha] Univ Cologne, Ctr Ophthalmol, Dept Vitreoretinal Surg, D-50931 Cologne, Germany	University of Perugia; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Bologna; University of Pavia; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Universite de Franche-Comte; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Azienda Ospedaliera San Camillo-Forlanini; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Cologne	Achilli, A (corresponding author), Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy.	valerio.carelli@unibo.it	Pizza, Fabio/AAC-1794-2020; Zeviani, Massimo/K-2891-2014; Bonneau, Dominique/K-6110-2015; Torroni, Antonio/E-1557-2011; Orssaud, Christophe/ACM-6549-2022; sadun, federico/AAF-6588-2019; Liguori, Rocco/AAB-7860-2020; OLIVIERI, ANNA/I-9235-2012; Reynier, Pascal/K-3677-2015; amati-bonneau, patrizia/K-6198-2015; Barboni, Piero/AAA-9936-2020; Zeviani, Massimo/AAU-2632-2021; Iommarini, Luisa/J-2328-2018; Achilli, Alessandro/I-9236-2012; La Morgia, Chiara/H-6765-2012	Torroni, Antonio/0000-0002-4163-4478; OLIVIERI, ANNA/0000-0002-3941-8098; Barboni, Piero/0000-0002-0118-4177; Zeviani, Massimo/0000-0002-9067-5508; Iommarini, Luisa/0000-0002-6804-7302; Achilli, Alessandro/0000-0001-6871-3451; Liguori, Rocco/0000-0002-1815-1013; VALENTINO, MARIA LUCIA/0000-0001-5323-0115; Pala, Maria/0000-0001-9202-8331; MOULIGNIER, Antoine/0000-0001-7566-0175; Bonneau, Dominique/0000-0002-6886-0969; Dollfus, Helene/0000-0002-2249-895X; LA MORGIA, Chiara/0000-0002-4639-8929; procaccio, Vincent/0000-0002-1537-4684; Reynier, Pascal/0000-0003-0802-4608; CARELLI, VALERIO/0000-0003-4923-6404; PIZZA, FABIO/0000-0003-2294-9551	Progetti Ricerca Interesse Nazionale (Italian Ministry of the University); FIRB-Futuro in Ricerca (Italian Ministry of the University); Fondazione Alma Mater Ticinensis; Telethon-Italy [1005, 1015, GGP06233]; ERARE European consortium on optic atrophies	Progetti Ricerca Interesse Nazionale (Italian Ministry of the University); FIRB-Futuro in Ricerca (Italian Ministry of the University); Fondazione Alma Mater Ticinensis; Telethon-Italy(Fondazione Telethon); ERARE European consortium on optic atrophies	This study was supported by Progetti Ricerca Interesse Nazionale 2009 (Italian Ministry of the University) (to AA and AT); FIRB-Futuro in Ricerca 2008 (Italian Ministry of the University) (to AA and AO); Fondazione Alma Mater Ticinensis (to AT); Telethon-Italy grants 1005 (to MZ and VC), 1015 (to MZ), GGP06233 (to VC); and ERARE European consortium on optic atrophies (to DB and BW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295; Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Besch D, 1999, GRAEF ARCH CLIN EXP, V237, P745, DOI 10.1007/s004170050307; Blok MJ, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045716; Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8; Brown MD, 2001, AM J MED GENET, V104, P331, DOI 10.1002/1096-8628(2001)104:4<331::AID-AJMG10054>3.0.CO;2-8; Brown MD, 2001, HUM GENET, V109, P33, DOI 10.1007/s004390100538; BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Carelli V, 1999, ANN NEUROL, V45, P320, DOI 10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.0.CO;2-L; Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236; Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209; CUI S, 2007, OPHTHALMOLOGY, V16, P382; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Fauser S, 2002, BIOCHEM BIOPH RES CO, V295, P342, DOI 10.1016/S0006-291X(02)00672-1; Fauser Sascha, 2002, Ophthalmic Genet, V23, P191, DOI 10.1076/opge.23.3.191.7881; Ferre M, 2009, HUM MUTAT, V30, pE692, DOI 10.1002/humu.21025; Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002; Gonzalez-Halphen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.107; Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456; Howell N, 1998, AM J HUM GENET, V62, P196, DOI 10.1086/301675; Howell N, 2002, J NEURO-OPHTHALMOL, V22, P262, DOI 10.1097/00041327-200212000-00002; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109; Jia XY, 2010, BIOCHEM BIOPH RES CO, V403, P237, DOI 10.1016/j.bbrc.2010.11.017; JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206; Kim JY, 2002, ANN NEUROL, V51, P630, DOI 10.1002/ana.10177; Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; La Morgia C, 2008, NEUROLOGY, V70, P762, DOI 10.1212/01.wnl.0000295505.74234.d0; LERTRIT P, 1992, AM J HUM GENET, V51, P457; Luberichs J, 2002, GRAEF ARCH CLIN EXP, V240, P96, DOI 10.1007/s00417-001-0423-1; MACKEY D, 1992, AM J HUM GENET, V51, P1218; MITOMAP, HUM MIT GEN DAT; Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473; Newman NJ, 2005, WALSH HOYTS CLIN NEU, P482; NOVOTNY EJ, 1986, NEUROLOGY, V36, P1053, DOI 10.1212/WNL.36.8.1053; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449; Torroni A, 1997, AM J HUM GENET, V60, P1107; Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443; Valentino ML, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037507; Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236; Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VERGANI L, 1995, BIOCHEM BIOPH RES CO, V210, P880, DOI 10.1006/bbrc.1995.1740; Wissinger B, 1997, BIOCHEM BIOPH RES CO, V234, P511, DOI 10.1006/bbrc.1997.6660; Yang JH, 2009, BIOCHEM BIOPH RES CO, V386, P693, DOI 10.1016/j.bbrc.2009.06.102; Yang JH, 2009, BIOCHEM BIOPH RES CO, V386, P50, DOI 10.1016/j.bbrc.2009.05.127; Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002; Zhang AM, 2009, BIOCHEM BIOPH RES CO, V386, P392, DOI 10.1016/j.bbrc.2009.06.051; Zhang JJ, 2010, BIOCHEM BIOPH RES CO, V399, P647, DOI 10.1016/j.bbrc.2010.07.135; Zhang SR, 2008, MITOCHONDRION, V8, P205, DOI 10.1016/j.mito.2008.02.003; Zhao FX, 2009, BIOCHEM BIOPH RES CO, V389, P466, DOI 10.1016/j.bbrc.2009.08.168	61	64	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42242	10.1371/journal.pone.0042242	http://dx.doi.org/10.1371/journal.pone.0042242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879922	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000307284100058
J	Henke, A; Grace, OC; Ashley, GR; Stewart, GD; Riddick, ACP; Yeun, H; O'Donnell, M; Anderson, RA; Thomson, AA				Henke, Alexander; Grace, O. Cathal; Ashley, George R.; Stewart, Grant D.; Riddick, Antony C. P.; Yeun, Henry; O'Donnell, Marie; Anderson, Richard A.; Thomson, Axel A.			Stromal Expression of Decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in Developing Prostate and Decreased Levels of Decorin in Prostate Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; BRANCHING MORPHOGENESIS; REACTIVE STROMA; RECEPTOR; INHIBITION; FIBROBLASTS; DIFFERENTIATION; PROGRESSION; MESENCHYME	Background and Aim: During prostate development, mesenchymal-epithelial interactions regulate organ growth and differentiation. In adult prostate, stromal-epithelial interactions are important for tissue homeostasis and also play a significant role in prostate cancer. In this study we have identified molecules that show a mesenchymal expression pattern in the developing prostate, and one of these showed reduced expression in prostate cancer stroma. Methodology and Principal Findings: Five candidate molecules identified by transcript profiling of developmental prostate mesenchyme were selected using a wholemount in situ hybridisation screen and studied Decorin (Dcn), Semaphorin6D (Sema6D), SPARC/Osteonectin (SPARC), Sprouty1 (Spry-1) and Tsukushi (Tsku). Expression in rat tissues was evaluated using wholemount in situ hybridisation (postnatal day (P) 0.5) and immunohistochemistry (embryonic day (E) E17.5, E19.5; P0.5; P6; 28 & adult). Four candidates (Decorin, SPARC, Spry-1, Tsukushi) were immunolocalised in human foetal prostate (weeks 14, 16, 19) and expression of Decorin was evaluated on a human prostate cancer tissue microarray. In embryonic and perinatal rats Decorin, Semaphorin6D, SPARC, Spry-1 and Tsukushi were expressed with varying distribution patterns throughout the mesenchyme at E17.5, E19.5, P0.5 and P6.5. In P28 and adult prostates there was either a decrease in the expression (Semaphorin6D) or a switch to epithelial expression of SPARC, and Spry-1, whereas Decorin and Tsukushi were specific to mesenchyme/stroma at all ages. Expression of Decorin, SPARC, Spry-1 and Tsukushi in human foetal prostates paralleled that in rat. Decorin showed mesenchymal and stromal-specific expression at all ages and was further examined in prostate cancer, where stromal expression was significantly reduced compared with non-malignant prostate. Conclusion and Significance: We describe the spatio-temporal expression of Decorin, Semaphorin6D, SPARC, Spry-1 and Tsukushi in developing prostate and observed similar mesenchymal expression patterns in rat and human. Additionally, Decorin showed reduced expression in prostate cancer stroma compared to non-malignant prostate stroma.	[Henke, Alexander; Grace, O. Cathal; Ashley, George R.; Anderson, Richard A.; Thomson, Axel A.] Queenss Med Res Inst, Ctr Reprod Hlth, MRC, Edinburgh, Midlothian, Scotland; [Stewart, Grant D.; Riddick, Antony C. P.; Yeun, Henry; O'Donnell, Marie] Univ Edinburgh, Inst Genet & Mol Med, Div Pathol, Edinburgh Urol Canc Grp, Edinburgh, Midlothian, Scotland	University of Edinburgh	Henke, A (corresponding author), Univ Clin Cologne, Lab Immunotherapy, Cologne, Germany.	dr.a.henke@gmail.com; axelthomson@gmail.com	Thomson, Axel/A-7893-2013	Stewart, Grant D./0000-0003-3188-9140	Medical Research Council [WBSe 1276.00.003.00004.01]; Prostate Cancer Charity; MRC [MC_U127684421, G1100357, G1002033, G1002118] Funding Source: UKRI; Medical Research Council [G1100357, G1002033, G1002118, MC_U127684421] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Prostate Cancer Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the Medical Research Council (WBSe 1276.00.003.00004.01) and the Prostate Cancer Charity (http://www.prostate-cancer.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbulut S, 2010, MOL BIOL CELL, V21, P3487, DOI 10.1091/mbc.E10-02-0123; Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Ashley GR, 2010, DIFFERENTIATION, V80, P89, DOI 10.1016/j.diff.2010.06.003; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Bi XL, 2012, CARCINOGENESIS, V33, P326, DOI 10.1093/carcin/bgr293; Blum G, 2003, J BIOL CHEM, V278, P40442, DOI 10.1074/jbc.M305490200; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Caruana G, 2006, GENE EXPR PATTERNS, V6, P807, DOI 10.1016/j.modgep.2006.02.001; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200; Coulson-Thomas VJ, 2010, EXP CELL RES, V316, P3207, DOI 10.1016/j.yexcr.2010.08.005; CUNHA GR, 1983, RECENT PROG HORM RES, V39, P559; CUNHA GR, 1983, J CELL BIOL, V96, P1662, DOI 10.1083/jcb.96.6.1662; FLEISCHMAJER R, 1991, J STRUCT BIOL, V106, P82, DOI 10.1016/1047-8477(91)90065-5; Francisco IFS, 2004, INT J CANCER, V112, P213, DOI 10.1002/ijc.20388; Franco OE, 2011, CANCER RES, V71, P1272, DOI 10.1158/0008-5472.CAN-10-3142; Gerdes MJ, 2004, PROSTATE, V58, P299, DOI 10.1002/pros.10327; Gorlov IP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-599; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HAYASHI N, 1991, CANCER RES, V51, P4924; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Ito A, 2010, BIOCHEM BIOPH RES CO, V402, P813, DOI 10.1016/j.bbrc.2010.10.127; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kassen A, 1996, PROSTATE, V28, P89, DOI 10.1002/(SICI)1097-0045(199602)28:2<89::AID-PROS3>3.0.CO;2-I; Kiskowski MA, 2011, CANCER RES, V71, P3459, DOI 10.1158/0008-5472.CAN-10-2999; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Kuriyama S, 2006, DEVELOPMENT, V133, P75, DOI 10.1242/dev.02178; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; MCNEAL JE, 1978, INVEST UROL, V15, P340; Morris SA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001004; Ohta K, 2004, DEV CELL, V7, P347, DOI 10.1016/j.devcel.2004.08.014; Ohta K, 2006, DEVELOPMENT, V133, P3777, DOI 10.1242/dev.02579; Olumi AF, 1999, CANCER RES, V59, P5002; Orr B, 2012, ONCOGENE, V31, P1130, DOI 10.1038/onc.2011.312; Orr B, 2010, PROSTATE; Orr B, 2009, ENDOCRINOLOGY, V150, P463, DOI 10.1210/en.2008-0383; Prins GS, 1996, DEV GENET, V18, P99; Pritchard C, 2009, CANCER RES, V69, P1739, DOI 10.1158/0008-5472.CAN-07-6817; Putzke AP, 2011, AM J PATHOL, V179, P400, DOI 10.1016/j.ajpath.2011.03.028; Ricciardelli C, 1998, CLIN CANCER RES, V4, P963; Said N, 2009, ONCOGENE, V28, P3487, DOI 10.1038/onc.2009.205; Stander M, 1999, CELL TISSUE RES, V296, P221, DOI 10.1007/s004410051283; Steer DL, 2004, DEV BIOL, V272, P310, DOI 10.1016/j.ydbio.2004.04.029; Stock C, 2011, J CELL PHYSIOL, V226, P2641, DOI 10.1002/jcp.22612; STRANDJORD TP, 1995, AM J RESP CELL MOL, V13, P279, DOI 10.1165/ajrcmb.13.3.7654384; SUGIMURA Y, 1986, PROSTATE, V9, P217, DOI 10.1002/pros.2990090302; Thomson AA, 2001, REPRODUCTION, V121, P187, DOI 10.1530/rep.0.1210187; Timms BG, 2008, DIFFERENTIATION, V76, P565, DOI 10.1111/j.1432-0436.2008.00278.x; Tomlinson DC, 2004, ENDOCRINOLOGY, V145, P4292, DOI 10.1210/en.2004-0526; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Trevino V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016492; Tuxhorn JA, 2002, CANCER RES, V62, P6021; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Vanpoucke G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r213; YAMAGUCHI Y, 1988, NATURE, V336, P244, DOI 10.1038/336244a0; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zhao JS, 1999, AM J PHYSIOL-LUNG C, V277, pL412, DOI 10.1152/ajplung.1999.277.2.L412	61	35	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42516	10.1371/journal.pone.0042516	http://dx.doi.org/10.1371/journal.pone.0042516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880013	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100116
J	Jobse, BN; Rhem, RG; McCurry, CAJR; Wang, IQ; Labiris, NR				Jobse, Brian N.; Rhem, Rod G.; McCurry, Cory A. J. R.; Wang, Iris Q.; Labiris, N. Renee			Imaging Lung Function in Mice Using SPECT/CT and Per-Voxel Analysis	PLOS ONE			English	Article							GAS ELIMINATION TECHNIQUE; SMALL-ANIMAL SPECT; BLOOD-FLOW; PULMONARY VENTILATION; COMPUTED-TOMOGRAPHY; RAT MODEL; PERFUSION; AGE; GRAVITY	Chronic lung disease is a major worldwide health concern but better tools are required to understand the underlying pathologies. Ventilation/perfusion (V/Q) single photon emission computed tomography (SPECT) with per-voxel analysis allows for non-invasive measurement of regional lung function. A clinically adapted V/Q methodology was used in healthy mice to investigate V/Q relationships. Twelve week-old mice were imaged to describe normal lung function while 36 week-old mice were imaged to determine how age affects V/Q. Mice were ventilated with Technegas (TM) and injected with Tc-99m-macroaggregated albumin to trace ventilation and perfusion, respectively. For both processes, SPECT and CT images were acquired, co-registered, and quantitatively analyzed. On a per-voxel basis, ventilation and perfusion were moderately correlated (R = 0.58 +/- 0.03) in 12 week old animals and a mean log(V/Q) ratio of -0.07 +/- 0.01 and standard deviation of 0.36 +/- 0.02 were found, defining the extent of V/Q matching. In contrast, 36 week old animals had significantly increased levels of V/Q mismatching throughout the periphery of the lung. Measures of V/Q were consistent across healthy animals and differences were observed with age demonstrating the capability of this technique in quantifying lung function. Per-voxel analysis and the ability to non-invasively assess lung function will aid in the investigation of chronic lung disease models and drug efficacy studies.	[Jobse, Brian N.; Rhem, Rod G.; McCurry, Cory A. J. R.; Wang, Iris Q.; Labiris, N. Renee] McMaster Univ, Dept Med, Div Respirol, Hamilton, ON, Canada; [Jobse, Brian N.] McMaster Univ, Dept Pathol & Mol Med, Div Resp Dis & Allergy, McMaster Immunol Res Ctr, Hamilton, ON, Canada; [Jobse, Brian N.; Labiris, N. Renee] St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Jobse, BN (corresponding author), McMaster Univ, Dept Med, Div Respirol, Hamilton, ON, Canada.	labir@mcmaster.ca			Firestone Institute of Respiratory Health-AstraZeneca; Department of Medicine Career Award; AstraZeneca	Firestone Institute of Respiratory Health-AstraZeneca; Department of Medicine Career Award; AstraZeneca(AstraZeneca)	Funding provided by Firestone Institute of Respiratory Health-AstraZeneca Collaboration Unrestricted Grant; NRL holds an internal Department of Medicine Career Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially funded by an AstraZeneca Collaboration Unrestricted Grant. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alfaro V, 2001, CLIN EXP PHARMACOL P, V28, P419, DOI 10.1046/j.1440-1681.2001.3455.x; Cardus J, 1997, AM J RESP CRIT CARE, V156, P648, DOI 10.1164/ajrccm.156.2.9606016; Dolovich Myrna, 2004, Proc Am Thorac Soc, V1, P329, DOI 10.1513/pats.200404-030MS; Fain SB, 2005, ACAD RADIOL, V12, P1385, DOI 10.1016/j.acra.2005.08.005; Farncombe TH, 2008, MED PHYS, V35, P1785, DOI 10.1118/1.2905031; Franc BL, 2008, J NUCL MED, V49, P1651, DOI 10.2967/jnumed.108.055442; Froese AR, 2007, EUR RESPIR J, V30, P1082, DOI 10.1183/09031936.00000507; Funk T, 2004, MED PHYS, V31, P2680, DOI 10.1118/1.1781553; Galvin I, 2007, BRIT J ANAESTH, V98, P420, DOI 10.1093/bja/aem036; GLENNY RW, 1991, J APPL PHYSIOL, V71, P620, DOI 10.1152/jappl.1991.71.2.620; HOLLAND J, 1968, J CLIN INVEST, V47, P81, DOI 10.1172/JCI105717; Jobse BN, 2009, EUR RESPIR J, V33, P1437, DOI 10.1183/09031936.00087508; Jogi J, 2011, EUR J NUCL MED MOL I, V38, P1344, DOI 10.1007/s00259-011-1757-5; Jones PW, 2006, EUR RESPIR J, V27, P822, DOI 10.1183/09031936.06.00145104; Khaltaev N, 2007, GLOBAL SURVEILLANCE; King GG, 2010, SEMIN NUCL MED, V40, P467, DOI 10.1053/j.semnuclmed.2010.07.006; Koba W, 2011, SEMIN NUCL MED, V41, P151, DOI 10.1053/j.semnuclmed.2010.12.003; Kreck TC, 2001, J APPL PHYSIOL, V91, P1741, DOI 10.1152/jappl.2001.91.4.1741; Levitski MG, 2007, PULMONARY PHYSL, P113; Littleton SW, 2012, RESPIROLOGY, V17, P43, DOI 10.1111/j.1440-1843.2011.02096.x; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Marsh S, 2011, AUSTRALAS PHYS ENG S, V34, P63, DOI 10.1007/s13246-011-0059-3; Miller MR, 2011, CHEST, V139, P52, DOI 10.1378/chest.10-0189; Mistry NN, 2010, MAGN RESON MED, V63, P728, DOI 10.1002/mrm.22221; Petersson J, 2012, J APPL PHYSL; Press W, 2007, POWELLS METHODS MULT, P509; Senden TJ, 1997, J NUCL MED, V38, P1327; Sprung J, 2006, CAN J ANAESTH, V53, P1244, DOI 10.1007/BF03021586; Suga K, 2010, ANN NUCL MED, V24, P269, DOI 10.1007/s12149-010-0369-7; Togao O, 2011, J MAGN RESON IMAGING; TRAVIS EL, 1985, RADIOTHER ONCOL, V4, P341, DOI 10.1016/S0167-8140(85)80122-5; Wagner PD, 2008, INTENS CARE MED, V34, P994, DOI 10.1007/s00134-008-1108-6; WEST JB, 1960, J APPL PHYSIOL, V15, P405, DOI 10.1152/jappl.1960.15.3.405	33	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42187	10.1371/journal.pone.0042187	http://dx.doi.org/10.1371/journal.pone.0042187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870297	gold, Green Published			2022-12-27	WOS:000307284100050
J	Maeng, CH; Lee, J; van Hummelen, P; Park, SH; Palescandolo, E; Jang, J; Park, HY; Kang, SY; MacConaill, L; Kim, KM; Shim, YM				Maeng, Chi Hoon; Lee, Jeeyun; van Hummelen, Paul; Park, Se Hoon; Palescandolo, Emanuele; Jang, Jiryeon; Park, Ha Young; Kang, So Young; MacConaill, Laura; Kim, Kyoung-Mee; Shim, Young-Mog			High-Throughput Genotyping in Metastatic Esophageal Squamous Cell Carcinoma Identifies Phosphoinositide-3-Kinase and BRAF Mutations	PLOS ONE			English	Article							HUMAN CANCER; PIK3CA; GENE; SURVIVAL	Background: Given the high incidence of metastatic esophageal squamous cell carcinoma, especially in Asia, we screened for the presence of somatic mutations using OncoMap platform with the aim of defining subsets of patients who may be potential candidate for targeted therapy. Methods and Materials: We analyzed 87 tissue specimens obtained from 80 patients who were pathologically confirmed with esophageal squamous cell carcinoma and received 5-fluoropyrimidine/platinum-based chemotherapy. OncoMap 4.0, a mass-spectrometry based assay, was used to interrogate 471 oncogenic mutations in 41 commonly mutated genes. Tumor specimens were prepared from primary cancer sites in 70 patients and from metastatic sites in 17 patients. In order to test the concordance between primary and metastatic sites from the patient for mutations, we analyzed 7 paired (primary-metastatic) specimens. All specimens were formalin-fixed paraffin embedded tissues and tumor content was >70%. Results: In total, we have detected 20 hotspot mutations out of 80 patients screened. The most frequent mutation was PIK3CA mutation (four E545K, five H1047R and one H1047L) (N = 10, 11.5%) followed by MLH1 V384D (N = 7, 8.0%), TP53 (R306, R175H and R273C) (N = 3, 3.5%), BRAF V600E (N = 1, 1.2%), CTNNB1 D32N (N = 1, 1.2%), and EGFR P733L (N = 1, 1.2%). Distributions of somatic mutations were not different according to anatomic sites of esophageal cancer (cervical/upper, mid, lower). In addition, there was no difference in frequency of mutations between primary-metastasis paired samples. Conclusions: Our study led to the detection of potentially druggable mutations in esophageal SCC which may guide novel therapies in small subsets of esophageal cancer patients.	[Maeng, Chi Hoon; Lee, Jeeyun; Park, Se Hoon; Jang, Jiryeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea; [van Hummelen, Paul; Palescandolo, Emanuele; MacConaill, Laura] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [van Hummelen, Paul; Palescandolo, Emanuele; MacConaill, Laura] Harvard Univ, Sch Med, Boston, MA USA; [Park, Ha Young; Kang, So Young; Kim, Kyoung-Mee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Shim, Young-Mog] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Maeng, CH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea.	jyunlee@skku.edu	Maeng, Chi Hoon/AAI-8539-2020; Lee, Jeeyun/I-7171-2015; Lee, Jee Yun/C-9646-2011; Park, Se Hoon/GMX-1199-2022	Park, Se Hoon/0000-0001-5084-9326; MAENG, Chi Hoon/0000-0002-4450-3350; van hummelen, paul/0000-0002-4801-8600	Ministry for Health & Welfare Affairs, Republic of Korea [A092255, A101130]; Samsung Biomedical Research Institute [SBRI-CB11031, SBRI-CB02202]; Sungkyunkwan University [S-2009-1181-000]	Ministry for Health & Welfare Affairs, Republic of Korea; Samsung Biomedical Research Institute(Samsung); Sungkyunkwan University	This paper was supported by grants from the Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (A092255 & A101130), a grant from Samsung Biomedical Research Institute (#SBRI-CB11031, SBRI-CB02202), and a grant from Sungkyunkwan University (#S-2009-1181-000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenis A, 2010, ONCOLOGY-BASEL, V79, P46, DOI 10.1159/000318029; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Campbell IG, 2005, CLIN CANCER RES, V11, P7042, DOI 10.1158/1078-0432.CCR-05-1024; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Choy E, CANCER IN PRESS; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Gholipour C, 2008, DIS ESOPHAGUS, V21, P322, DOI 10.1111/j.1442-2050.2007.00776.x; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kong DX, 2010, EUR J CANCER, V46, P1111, DOI 10.1016/j.ejca.2010.01.005; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Mao C, 2011, ANN ONCOL; Matulonis UA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024433; Mori R, 2008, J SURG RES, V145, P320, DOI 10.1016/j.jss.2007.03.044; Qin TJ, 2009, WORLD J GASTROENTERO, V15, P871, DOI 10.3748/wjg.15.871; Rossini A, 2010, MUTAT RES-GEN TOX EN, V696, P10, DOI 10.1016/j.mrgentox.2009.11.005; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Tanaka H, 2011, CLIN CANCER RES, V17, P3272, DOI 10.1158/1078-0432.CCR-10-2882; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975	23	37	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41655	10.1371/journal.pone.0041655	http://dx.doi.org/10.1371/journal.pone.0041655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870241	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100028
J	Suzuki, M; Ohsaki, Y; Tatematsu, T; Shinohara, Y; Maeda, T; Cheng, JL; Fujimoto, T				Suzuki, Michitaka; Ohsaki, Yuki; Tatematsu, Tsuyako; Shinohara, Yuki; Maeda, Takashi; Cheng, Jinglei; Fujimoto, Toyoshi			Translation Inhibitors Induce Formation of Cholesterol Ester-Rich Lipid Droplets	PLOS ONE			English	Article							MACROPHAGE FOAM CELLS; LYSOSOMAL ACID LIPASE; CAENORHABDITIS-ELEGANS; AUTOPHAGY; TIP47; FAT; CYCLOHEXIMIDE; RECRUITMENT; METABOLISM; EXPRESSION	Lipid droplets (LDs) in non-adipocytes contain triglycerides (TG) and cholesterol esters (CE) in variable ratios. TG-rich LDs are generated when unsaturated fatty acids are administered, but the conditions that induce CE-rich LD formation are less well characterized. In the present study, we found that protein translation inhibitors such as cycloheximide (CHX) induced generation of CE-rich LDs and that TIP47 (perilipin 3) was recruited to the LDs, although the expression of this protein was reduced drastically. Electron microscopy revealed that LDs formed in CHX-treated cells possess a distinct electron-dense rim that is not found in TG-rich LDs, whose formation is induced by oleic acid. CHX treatment caused upregulation of mTORC1, but the CHX-induced increase in CE-rich LDs occurred even when rapamycin or Torin1 was given along with CHX. Moreover, the increase in CE was seen in both wild-type and autophagy-deficient Atg5-null mouse embryonic fibroblasts, indicating that mTORC1 activation and suppression of autophagy are not necessary to induce the observed phenomenon. The results showed that translation inhibitors cause a significant change in the lipid ester composition of LDs by a mechanism independent of mTORC1 signaling and autophagy.	[Suzuki, Michitaka; Ohsaki, Yuki; Tatematsu, Tsuyako; Shinohara, Yuki; Maeda, Takashi; Cheng, Jinglei; Fujimoto, Toyoshi] Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, Nagoya, Aichi 4648601, Japan	Nagoya University	Suzuki, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, Nagoya, Aichi 4648601, Japan.	tfujimot@med.nagoya-u.ac.jp	Fujimoto, Toyoshi/ABH-9058-2020	Fujimoto, Toyoshi/0000-0002-3601-7977	Global COE Program "Integrated Molecular Medicine for Neuronal and Neoplastic Disorders" of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government [21390053, 23113711]; Kazato Research Foundation; Takeda Science Foundation	Global COE Program "Integrated Molecular Medicine for Neuronal and Neoplastic Disorders" of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government; Kazato Research Foundation(Kazato Research Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by Grants-in-Aid for Scientific Research (21390053, 23113711) and the Global COE Program "Integrated Molecular Medicine for Neuronal and Neoplastic Disorders" of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (http://www.mext.go.jp/english/) (to MS, TF) and by grants from the Kazato Research Foundation (http://www.kazato.org/english/index.html) and the Takeda Science Foundation (http://www.takeda-sci.or.jp/index.html) (to YO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe-Dohmae S, 2000, BIOCHEMISTRY-US, V39, P11092, DOI 10.1021/bi0008175; Aslanidis C, 1996, GENOMICS, V33, P85, DOI 10.1006/geno.1996.0162; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Cheng JL, 2009, HISTOCHEM CELL BIOL, V132, P281, DOI 10.1007/s00418-009-0615-z; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Escary JL, 1998, ARTERIOSCL THROM VAS, V18, P991, DOI 10.1161/01.ATV.18.6.991; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; FEWSTER ME, 1969, J CHROMATOGR, V43, P120, DOI 10.1016/S0021-9673(00)99173-8; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Han JH, 1999, J LIPID RES, V40, P830; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; MCGOOKEY DJ, 1983, J CELL BIOL, V97, P1156, DOI 10.1083/jcb.97.4.1156; Murphy D.J., 2011, PROTOPLASMA; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Ohsaki Y, 2006, BIOCHEM BIOPH RES CO, V347, P279, DOI 10.1016/j.bbrc.2006.06.074; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; PESTKA S, 1971, ANNU REV MICROBIOL, V25, P487, DOI 10.1146/annurev.mi.25.100171.002415; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; REZ G, 1973, VIRCHOWS ARCH B, V12, P123; RUMPELT HJ, 1978, AM J PATHOL, V91, P49; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Zechner R, 2009, NATURE, V458, P1118, DOI 10.1038/4581118a	37	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42379	10.1371/journal.pone.0042379	http://dx.doi.org/10.1371/journal.pone.0042379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879956	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100075
J	Joshi, J; Karanth, KP				Joshi, Jahnavi; Karanth, K. Praveen			Coalescent Method in Conjunction with Niche Modeling Reveals Cryptic Diversity among Centipedes in the Western Ghats of South India	PLOS ONE			English	Article							SPECIES DELIMITATION; SCOLOPENDRID CENTIPEDES; BOUNDARIES; COMPLEX; DNA; TAXONOMY; DISTRIBUTIONS; SYSTEMATICS; MORPHOLOGY; PHYLOGENY	Background: There has been growing interest in integrative taxonomy that uses data from multiple disciplines for species delimitation. Typically, in such studies, monophyly is taken as a proxy for taxonomic distinctiveness and these units are treated as potential species. However, monophyly could arise due to stochastic processes. Thus here, we have employed a recently developed tool based on coalescent approach to ascertain the taxonomic distinctiveness of various monophyletic units. Subsequently, the species status of these taxonomic units was further tested using corroborative evidence from morphology and ecology. This inter-disciplinary approach was implemented on endemic centipedes of the genus Digitipes (Attems 1930) from the Western Ghats (WG) biodiversity hotspot of India. The species of the genus Digitipes are morphologically conserved, despite their ancient late Cretaceous origin. Principal Findings: Our coalescent analysis based on mitochondrial dataset indicated the presence of nine putative species. The integrative approach, which includes nuclear, morphology, and climate datasets supported distinctiveness of eight putative species, of which three represent described species and five were new species. Among the five new species, three were morphologically cryptic species, emphasizing the effectiveness of this approach in discovering cryptic diversity in less explored areas of the tropics like the WG. In addition, species pairs showed variable divergence along the molecular, morphological and climate axes. Conclusions: A multidisciplinary approach illustrated here is successful in discovering cryptic diversity with an indication that the current estimates of invertebrate species richness for the WG might have been underestimated. Additionally, the importance of measuring multiple secondary properties of species while defining species boundaries was highlighted given variable divergence of each species pair across the disciplines.	[Joshi, Jahnavi; Karanth, K. Praveen] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Joshi, J (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	karanth@ces.iisc.ernet.in	Joshi, Jahnavi/AAX-2434-2020	Joshi, Jahnavi/0000-0002-6015-4138				Attems C., 1930, Das Tierreich Lieferung, V54, P1; Balakrishnan R, 2005, SYST BIOL, V54, P689, DOI 10.1080/10635150590950308; Biju SD, 2009, ZOOL J LINN SOC-LOND, V155, P374, DOI 10.1111/j.1096-3642.2008.00466.x; Biju SD, 2003, NATURE, V425, P711, DOI 10.1038/nature02019; Biju SD, 2005, COPEIA, P29, DOI 10.1643/CH-04-194R1; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Bond JE, 2002, EVOLUTION, V56, P1123; Cadena CD, 2010, BIOL J LINN SOC, V99, P152, DOI 10.1111/j.1095-8312.2009.01333.x; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; de Queiroz K, 2005, BIOESSAYS, V27, P1263, DOI 10.1002/bies.20325; de Queiroz Kevin, 2005, Proceedings of the California Academy of Sciences, V56, P196; Depraz A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-171; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Edgecombe GD, 2002, SYST ENTOMOL, V27, P31, DOI 10.1046/j.0307-6970.2001.00163.x; Edgecombe GD, 2007, ANNU REV ENTOMOL, V52, P151, DOI 10.1146/annurev.ento.52.110405.091326; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Farris JS, 1995, CLADISTICS, V11, P377, DOI 10.1111/j.1096-0031.1995.tb00096.x; Giri VB, 2009, ZOOTAXA, P49, DOI 10.11646/zootaxa.2164.1.5; Hawlitschek O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016662; Hendrixson BE, 2005, MOL PHYLOGENET EVOL, V36, P405, DOI 10.1016/j.ympev.2005.01.021; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irfan-Ullah M, 2007, BIODIVERS CONSERV, V16, P1917, DOI 10.1007/s10531-006-9110-1; JANGI BS, 1984, J SCI IND RES INDIA, V43, P27; Joshi J, 2011, MOL PHYLOGENET EVOL, V60, P287, DOI 10.1016/j.ympev.2011.04.024; Kumara Honnavalli N., 2009, Endangered Species Research, V7, P29, DOI 10.3354/esr00185; Leache AD, 2009, P NATL ACAD SCI USA, V106, P12418, DOI 10.1073/pnas.0906380106; Lewis J. G. E., 2003, African Invertebrates, V44, P61; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nixon KC, 1999, WINCLADA BETA VER 09; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rodrigo A, 2008, PHILOS T R SOC B, V363, P3893, DOI 10.1098/rstb.2008.0173; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Ruiz-Sanchez E, 2010, MOL PHYLOGENET EVOL, V54, P344, DOI 10.1016/j.ympev.2009.10.035; Sambrook J., 2001, MOL CLONING LAB MANU; Sanders KL, 2006, BIOL J LINN SOC, V87, P343, DOI 10.1111/j.1095-8312.2006.00568.x; Schlick-Steiner BC, 2006, MOL PHYLOGENET EVOL, V40, P259, DOI 10.1016/j.ympev.2006.03.005; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Stockman AK, 2007, MOL ECOL, V16, P3374, DOI 10.1111/j.1365-294X.2007.03389.x; Sureshan P. M., 2006, Zoos Print Journal, V21, P2285; Sureshan PM, 2003, ZOOS PRINT J, V19, P1401; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506	55	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42225	10.1371/journal.pone.0042225	http://dx.doi.org/10.1371/journal.pone.0042225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876311	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000307184700039
J	Ritlop, C; Monat, C; Cousineau, B				Ritlop, Christine; Monat, Caroline; Cousineau, Benoit			Isolation and Characterization of Functional Tripartite Group II Introns Using a Tn5-Based Genetic Screen	PLOS ONE			English	Article							BASE-PAIRING INTERACTIONS; LACTOCOCCUS-LACTIS; REVERSE-TRANSCRIPTASE; CONJUGATIVE TRANSFER; RNA; MITOCHONDRIA; ELEMENTS; PRS01; PLANT	Background: Group II introns are RNA enzymes that splice themselves from pre-mRNA transcripts. Most bacterial group II introns harbour an open reading frame (ORF), coding for a protein with reverse transcriptase, maturase and occasionally DNA binding and endonuclease activities. Some ORF-containing group II introns were shown to be mobile retroelements that invade new DNA target sites. From an evolutionary perspective, group II introns are hypothesized to be the ancestors of the spliceosome-dependent nuclear introns and the small nuclear RNAs (snRNAs - U1, U2, U4, U5 and U6) that are important functional elements of the spliceosome machinery. The ability of some group II introns fragmented in two or three pieces to assemble and undergo splicing in trans supports the theory that spliceosomal snRNAs evolved from portions of group II introns. Methodology/Principal Findings: We used a transposon-based genetic screen to explore the ability of the Ll.LtrB group II intron from the Gram-positive bacterium Lactococcus lactis to be fragmented into three pieces in vivo. Trans-splicing tripartite variants of Ll. LtrB were selected using a highly efficient and sensitive trans-splicing/conjugation screen. We report that numerous fragmentation sites located throughout Ll. LtrB support tripartite trans-splicing, showing that this intron is remarkably tolerant to fragmentation. Conclusions/Significance: This work unveils the great versatility of group II intron fragments to assemble and accurately trans-splice their flanking exons in vivo. The selected introns represent the first evidence of functional tripartite group II introns in bacteria and provide experimental support for the proposed evolutionary relationship between group II introns and snRNAs.	[Ritlop, Christine; Monat, Caroline; Cousineau, Benoit] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	McGill University	Ritlop, C (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.	benoit.cousineau@mcgill.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) to B. C. B. C. is a FRSQ Chercheur-Boursier Junior 2 and a McGill University William Dawson Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belhocine K, 2004, MOL MICROBIOL, V51, P1459, DOI 10.1111/j.1365-2958.2004.03923.x; Belhocine K, 2008, RNA, V14, P1782, DOI 10.1261/rna.1083508; Belhocine K, 2007, NUCLEIC ACIDS RES, V35, P2257, DOI 10.1093/nar/gkl1146; BONEN L, 1993, FASEB J, V7, P40, DOI 10.1096/fasebj.7.1.8422973; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; Byrd DR, 1997, MOL MICROBIOL, V25, P1011, DOI 10.1046/j.1365-2958.1997.5241885.x; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; Dai LX, 2008, MOL CELL, V30, P472, DOI 10.1016/j.molcel.2008.04.001; Fedorova O, 2003, J MOL BIOL, V330, P197, DOI 10.1016/S0022-2836(03)00594-1; Fedorova O, 2007, BIOL CHEM, V388, P665, DOI 10.1515/BC.2007.090; GOLDSCHMIDTCLERMONT M, 1991, CELL, V65, P135, DOI 10.1016/0092-8674(91)90415-U; Goryshin IY, 1998, J BIOL CHEM, V273, P7367, DOI 10.1074/jbc.273.13.7367; JACQUIER A, 1990, J MOL BIOL, V213, P437, DOI 10.1016/S0022-2836(05)80206-2; JACQUIER A, 1990, TRENDS BIOCHEM SCI, V15, P351, DOI 10.1016/0968-0004(90)90075-M; JARRELL KA, 1988, MOL CELL BIOL, V8, P2361, DOI 10.1128/MCB.8.6.2361; Klein JR, 2004, J BACTERIOL, V186, P1991, DOI 10.1128/JB.186.7.1991-1998.2004; Knoop V, 1997, MOL GEN GENET, V255, P269, DOI 10.1007/s004380050497; LAMBOWITZ AM, 2010, COLD SPRING HARB PER; Matsuura M, 1997, GENE DEV, V11, P2910, DOI 10.1101/gad.11.21.2910; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Mills DA, 1996, J BACTERIOL, V178, P3531, DOI 10.1128/jb.178.12.3531-3538.1996; MILLS DA, 1994, APPL ENVIRON MICROB, V60, P4413, DOI 10.1128/AEM.60.12.4413-4420.1994; O'Sullivan D, 2000, MOL MICROBIOL, V36, P866, DOI 10.1046/j.1365-2958.2000.01901.x; Qin PZ, 1998, CURR OPIN STRUC BIOL, V8, P301, DOI 10.1016/S0959-440X(98)80062-6; Quiroga C, 2011, RNA, V17, P2212, DOI 10.1261/rna.028886.111; Reznikoff WS, 2004, METH MOL B, V260, P83, DOI 10.1385/1-59259-755-6:083; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; Shearman C, 1996, MOL MICROBIOL, V21, P45, DOI 10.1046/j.1365-2958.1996.00610.x; Toor N, 2008, NAT STRUCT MOL BIOL, V15, P1221, DOI 10.1038/nsmb.1509; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Valadlkhan S, 2007, BIOL CHEM, V388, P693, DOI 10.1515/BC.2007.080	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41589	10.1371/journal.pone.0041589	http://dx.doi.org/10.1371/journal.pone.0041589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876289	Green Submitted, gold, Green Published			2022-12-27	WOS:000307184700017
J	Bruno, A; Costantino, G; de Fabritiis, G; Pastor, M; Selent, J				Bruno, Agostino; Costantino, Gabriele; de Fabritiis, Gianni; Pastor, Manuel; Selent, Jana			Membrane-Sensitive Conformational States of Helix 8 in the Metabotropic Glu2 Receptor, a Class C GPCR	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MOLECULAR-DYNAMICS SIMULATIONS; A(2A) ADENOSINE RECEPTOR; GLUTAMATE-RECEPTOR; HEPTAHELICAL DOMAIN; CRYSTAL-STRUCTURE; ACTIVATION MECHANISM; ALLOSTERIC MODULATOR; BINDING-SITE; RHODOPSIN	The recent elucidation of the X-ray structure of several class A GPCRs clearly indicates that the amphipathic helix 8 (H8) is a conserved structural domain in most crystallized GPCRs. Very little is known about the presence and the possible role of an analogous H8 domain in the distantly related class C GPCRs. In this study, we investigated the structural properties for the H8 domain of the mGluR2 receptor, a class C GPCR, by applying extended molecular dynamics simulations. Our study indicates that the amphipathic H8 adopts membrane-sensitive conformational states, which depend on the membrane composition. Cholesterol-rich membranes stabilize the helical structure of H8 whereas cholesterol-depleted membranes induce a disruption of H8. The observed link between membrane cholesterol levels and H8 conformational states suggests that H8 behaves as a sensor of cholesterol concentration.	[Bruno, Agostino; Pastor, Manuel; Selent, Jana] Univ Pompeu Fabra, Comp Assisted Drug Design Lab, Res Programme Biomed Informat GRIB, Barcelona, Spain; [Bruno, Agostino; Costantino, Gabriele] Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy; [de Fabritiis, Gianni] Univ Pompeu Fabra, Computat Biochem & Biophys Lab, Res Programme Biomed Informat GRIB, Barcelona, Spain	Pompeu Fabra University; University of Parma; Pompeu Fabra University	Bruno, A (corresponding author), Univ Pompeu Fabra, Comp Assisted Drug Design Lab, Res Programme Biomed Informat GRIB, Barcelona, Spain.	gabriele.costantino@unipr.it; jana.selent@upf.edu	Selent, Jana/E-6912-2015; Gasull, Martina/J-4076-2019; Bruno, Agostino/F-3929-2014; Pastor, Manuel/A-1566-2010	Selent, Jana/0000-0002-1844-4449; Bruno, Agostino/0000-0002-2731-980X; Pastor, Manuel/0000-0001-8850-1341; De Fabritiis, Gianni/0000-0003-3913-4877	La MARATO de TV3 Foundation [091010]; Spanish Ministerio de Educacion y Ciencia [SAF2009-13609-C04-04]; CINECA consortium	La MARATO de TV3 Foundation; Spanish Ministerio de Educacion y Ciencia(Spanish Government); CINECA consortium(CINECA, Italy)	The authors gratefully acknowledge financial support from La MARATO de TV3 Foundation (Ref.-No. 091010) and the Spanish Ministerio de Educacion y Ciencia (SAF2009-13609-C04-04). GC and AB gratefully acknowledge the CINECA consortium for the support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KH, 2010, BIOCHEMISTRY-US, V49, P502, DOI 10.1021/bi901619r; Binder H, 2001, J PHYS CHEM B, V105, P12378, DOI 10.1021/jp010118h; Binet V, 2004, J BIOL CHEM, V279, P29085, DOI 10.1074/jbc.M400930200; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Bruno A, 2011, FUTURE MED CHEM, V3, P665, DOI [10.4155/fmc.11.27, 10.4155/FMC.11.27]; Bruno A, 2009, J CHEM INF MODEL, V49, P1602, DOI 10.1021/ci900067g; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Costanzi S, 2010, CHIM OGGI, V28, P26; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Dowal L, 2011, P NATL ACAD SCI USA, V108, P2951, DOI 10.1073/pnas.1014863108; El Far O, 2001, J BIOL CHEM, V276, P30662, DOI 10.1074/jbc.M102573200; Eroglu C, 2003, P NATL ACAD SCI USA, V100, P10219, DOI 10.1073/pnas.1737042100; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Fredericks WJ, 2011, DNA CELL BIOL, V30, P851, DOI 10.1089/dna.2011.1315; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Gamba Z, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3026662; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Horvath I, 2008, BBA-BIOMEMBRANES, V1778, P1653, DOI 10.1016/j.bbamem.2008.02.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Javitt DC, 2010, ISR J PSYCHIATR REL, V47, P4; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kaye RG, 2011, MOL PHARMACOL, V79, P701, DOI 10.1124/mol.110.070177; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Khelashvili G, 2009, PROTEINS, V76, P403, DOI 10.1002/prot.22355; Kirchberg K, 2011, P NATL ACAD SCI USA, V108, P18690, DOI 10.1073/pnas.1015461108; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Kuwasako K, 2011, PEPTIDES, V32, P144, DOI 10.1016/j.peptides.2010.10.005; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Lundstrom L, 2011, BRIT J PHARMACOL, V164, P521, DOI 10.1111/j.1476-5381.2011.01409.x; Lyman E, 2009, STRUCTURE, V17, P1660, DOI 10.1016/j.str.2009.10.010; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; Miedlich SU, 2004, J BIOL CHEM, V279, P7254, DOI 10.1074/jbc.M307191200; Mihailescu M, 2011, J MEMBRANE BIOL, V239, P63, DOI 10.1007/s00232-010-9326-6; Mobarec JC, 2009, J MED CHEM, V52, P5207, DOI 10.1021/jm9005252; Monnier C, 2011, EMBO J, V30, P32, DOI 10.1038/emboj.2010.270; Moreno JL, 2011, NEUROSCI LETT, V493, P76, DOI 10.1016/j.neulet.2011.01.046; Obiol-Pardo C, 2011, PROTEINS, V79, P1695, DOI 10.1002/prot.23021; Olausson BES, 2012, J AM CHEM SOC, V134, P4324, DOI 10.1021/ja2108382; Park PSH, 2009, BIOCHEMISTRY-US, V48, P4294, DOI 10.1021/bi900417b; Parker MS, 2010, AMINO ACIDS, V38, P1, DOI 10.1007/s00726-009-0316-x; PIN JP, 1994, EMBO J, V13, P342, DOI 10.1002/j.1460-2075.1994.tb06267.x; Pin JP, 2004, BIOL CELL, V96, P335, DOI 10.1016/j.biolcel.2004.03.005; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rondard P, 2011, NEUROPHARMACOLOGY, V60, P82, DOI 10.1016/j.neuropharm.2010.08.009; Saiz L, 2001, BIOPHYS J, V81, P204, DOI 10.1016/S0006-3495(01)75692-5; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Spooren W, 2010, CURR TOP BEHAV NEURO, V2, P391, DOI 10.1007/7854_2010_36; Stern CM, 2010, CELL MOL LIFE SCI, V67, P3785, DOI 10.1007/s00018-010-0447-y; Tiburu EK, 2011, AAPS J, V13, P92, DOI 10.1208/s12248-010-9244-7; Topiol S, 2009, BIOCHEM PHARMACOL, V78, P11, DOI 10.1016/j.bcp.2009.02.012; Vanejevs M, 2008, J MED CHEM, V51, P634, DOI 10.1021/jm0611298; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	69	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42023	10.1371/journal.pone.0042023	http://dx.doi.org/10.1371/journal.pone.0042023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870276	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800052
J	Goren-Inbar, N; Freikman, M; Garfinkel, Y; Goring-Morris, NA; Grosman, L				Goren-Inbar, Naama; Freikman, Michael; Garfinkel, Yosef; Goring-Morris, Nigel A.; Grosman, Leore			The Earliest Matches	PLOS ONE			English	Article							SITE; FIRE	Cylindrical objects made usually of fired clay but sometimes of stone were found at the Yarmukian Pottery Neolithic sites of Sha'ar HaGolan and Munhata (first half of the 8th millennium BP) in the Jordan Valley. Similar objects have been reported from other Near Eastern Pottery Neolithic sites. Most scholars have interpreted them as cultic objects in the shape of phalli, while others have referred to them in more general terms as "clay pestles," "clay rods," and "cylindrical clay objects." Re-examination of these artifacts leads us to present a new interpretation of their function and to suggest a reconstruction of their technology and mode of use. We suggest that these objects were components of fire drills and consider them the earliest evidence of a complex technology of fire ignition, which incorporates the cylindrical objects in the role of matches.	[Goren-Inbar, Naama; Freikman, Michael; Garfinkel, Yosef; Goring-Morris, Nigel A.; Grosman, Leore] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel	Hebrew University of Jerusalem	Goren-Inbar, N (corresponding author), Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel.	goren@cc.huji.ac.il	Garfinkel, Yosef/AAE-6626-2021; Grosman, Leore/C-7010-2014; Grosman, Leore/GRJ-0792-2022	Grosman, Leore/0000-0002-6976-6202; Grosman, Leore/0000-0002-6976-6202; Goring-Morris, Adrian Nigel/0000-0003-1673-7747				Alperson-Afil N, 2010, ACHEULIAN SITE GESHE, P120; [Anonymous], [No title captured]; Bar-Yosef Mayer D.E., 2005, PAL ORIENT, V31, P176, DOI DOI 10.3406/PALEO.2005.4796; Bar-Yosef O, 1980, QADMONIOT SINAI SINA, P11; Bar-Yosef O, 2005, 200000 YEAR RECORD P, V48, P17; Bar-Yosef O., 1991, INT MONOGRAPHS PREHI, P81; Belfer-Cohen A, 2010, GILGAL EARLY NEOLITH, P177; BELFERCOHEN A, 1991, ANNU REV ANTHROPOL, V20, P167, DOI 10.1146/annurev.an.20.100191.001123; Cauvin Jacques, 1977, ANN AM SCH ORIENTAL, V44, P19; Collina-Girard J., 1993, BULL SOC PREHIST FR, V90, P159; Collina-Girard J, 1998, FEU AVANT ALLUMETTES, P146; Davidson DS, 1947, AM ANTHROPOL, V49, P426, DOI 10.1525/aa.1947.49.3.02a00040; de Contenson H, 1992, PREHISTOIRE RAS SHAM, P283; Dollfus G, 1972, CDFAI, V1, P17; Dorrell PG, 1983, APPENDIX A STONE VES, P485; Edwards P., 1991, NATUFIAN CULTURE LEV, V1, P123; Francis PH, 1961, ORIGIN DEV FIRE ARMS, P124; Freikman M, 2006, THESIS HEBREW U JERU, P137; Fujii S., 2006, ADAJ, V50, P9; Fujii S., 2008, ADAJ, V52, P446; Fujii S, 2007, ANN DEP ANTIQ JORDAN, V51, P373; Fujii S, 2009, ADAJ, V53, P173; Garfinkel Y, 1999, YARMUKIANS NEOLITHIC, P96; Garfinkel Y, 1992, POTTERY ASSEMBLAGES, P360; GARFINKEL Y., 1993, PALEORIENT, V19, P115, DOI DOI 10.3406/PALEO.1993.4587; Garfinkel Y, 1995, HUMAN ANIMAL FIGURIN, P127; Garfinkel Y, 1987, J ISRAEL PREHIST SOC, V20, P79; Garfinkel Y, 2009, QEDEM REPORTS, P308; Garfinkel Y, 2010, SYMBOLIC DIMENSIONS, P353; Garfinkel Y, 2002, SHAAR HAGOLAN, P262; Getzov N., 2009, J ISRAEL PREHISTORIC, V39, P81; Gopher A, 1996, CAMB ARCHAEOL J, V6, P255, DOI DOI 10.1017/S0959774300001736; Gopher A, 1993, PALEORIENT, V19, P55, DOI DOI 10.3406/PALEO.1993.4583; Gopher A, 1995, GROUNDSTONE ASSEMBLA, P168; Gopher A., 1997, EARLY NEOLITHIC VI 1, P151; Goren Y, 2008, GEOARCHAEOLOGY, V23, P779, DOI 10.1002/gea.20241; Goring-Morris AN, 2005, NEW ENCY ARCHAEOLOGI, P1907; Goring-Morris AN, 1987, EDGE TERMINAL PLEIST, P526; Goring-Morris N, OXFORD HDB ARCHAEOLO; Grosman L, 2007, CURR ANTHROPOL, V48, P732, DOI 10.1086/520966; Harrison H.S., 1954, HIST TECHNOL, V1, P216; Hershman D., 2010, GILGAL EXCAVATIONS E, P185; Hough W, 1888, P US NAT MUS WASH, V73, P531; Hough Walter, 1890, AM ANTHROPOL, V3, P359, DOI DOI 10.1525/AA.1890.3.4.02A00070; Kaplan Jacob, 1958, ERETZ ISRAEL, V5, P9; Karkanas P, 2007, J HUM EVOL, V53, P197, DOI 10.1016/j.jhevol.2007.04.002; KINGERY WD, 1988, J FIELD ARCHAEOL, V15, P219, DOI 10.2307/530304; Kirkbride D., 1966, PALEST EXPLOR Q, V98, P5, DOI [10.1179/peq.1966.98.1.8., DOI 10.1179/PEQ.1966.98.1.8]; M Stekelis, 1972, YARMOUKIAN CULTURE N, P45; March RJ, INT MONOGRA IN PRESS; Marder O, 2007, PALEORIENT, V32, P79; Martin PS, 1934, AM ANTHROPOL, V36, P94, DOI 10.1525/aa.1934.36.1.02a00080; Matthews R, 2002, EXPLORING UPPER MESO, P446; MCGUIRE J. D, 1892, AM ANTHR A, V45, P165; Noy T., 1979, PALEORIENT, V5, P233; Perrot J, 1964, SYRIA, V41, P323; Petrie WMF, 1884, J ANTHR I, V13, P88; Petrie WMF, 1917, TOOLS WEAPONS, P71; ROLLEFSON GO, 1992, B AM SCH ORIENTAL RE, P1, DOI 10.2307/1357113; Schick T, 1977, ERETZ ISRAEL, V13, P97; Schiegl S, 1996, J ARCHAEOL SCI, V23, P763, DOI 10.1006/jasc.1996.0071; Simmons AH, 2006, J FIELD ARCHAEOL, V31, P77, DOI 10.1179/009346906791072052; Simmons T., 2007, BAR INT SERIES, V1603, P1; VALLA FR, 2001, J ISRAEL PREHISTORIC, V31, P43; Yeivin E., 1979, TEL AVIV, V6, P99, DOI DOI 10.1179/033443579788441154	65	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42213	10.1371/journal.pone.0042213	http://dx.doi.org/10.1371/journal.pone.0042213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	984SU	22870306	gold, Green Published			2022-12-27	WOS:000307212800069
J	Jiang, L; Cheng, TC; Zhao, P; Yang, Q; Wang, GH; Jin, SK; Lin, P; Xiao, Y; Xia, QY				Jiang, Liang; Cheng, Tingcai; Zhao, Ping; Yang, Qiong; Wang, Genhong; Jin, Shengkai; Lin, Ping; Xiao, Yang; Xia, Qingyou			Resistance to BmNPV via Overexpression of an Exogenous Gene Controlled by an Inducible Promoter and Enhancer in Transgenic Silkworm, Bombyx mori	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; DELAYED-EARLY GENE; OVER-EXPRESSION; DNA-REPLICATION; HOMOLOGOUS DNA; CELL-LINES; BACULOVIRUS; INSECT; NUCLEOPOLYHEDROVIRUS; IDENTIFICATION	The hycu-ep32 gene of Hyphantria cunea NPV can inhibit Bombyx mori nucleopolyhedrovirus (BmNPV) multiplication in co-infected cells, but it is not known whether the overexpression of the hycu-ep32 gene has an antiviral effect in the silkworm, Bombyx mori. Thus, we constructed four transgenic vectors, which were under the control of the 39 K promoter of BmNPV (39 KP), Bombyx mori A4 promoter (A4P), hr3 enhancer of BmNPV combined with 39 KP, and hr3 combined with A4P. Transgenic lines were created via embryo microinjection using practical diapause silkworm. qPCR revealed that the expression level of hycu-ep32 could be induced effectively after BmNPV infection in transgenic lines where hycu-ep32 was controlled by hr3 combined with 39 KP (i.e., HEKG). After oral inoculation of BmNPV with 3 x 10(5) occlusion bodies per third instar, the mortality with HEKG-B was approximately 30% lower compared with the non-transgenic line. The economic characteristics of the transgenic lines remained unchanged. These results suggest that overexpression of an exogenous antiviral gene controlled by an inducible promoter and enhancer is a feasible method for breeding silkworms with a high antiviral capacity.	[Jiang, Liang; Cheng, Tingcai; Zhao, Ping; Wang, Genhong; Jin, Shengkai; Lin, Ping; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Yang, Qiong; Xiao, Yang] Guangdong Acad Agr Sci, Sericulture & Farm Prod Proc Res Inst, Guangzhou, Guangdong, Peoples R China	Southwest University - China; Guangdong Academy of Agricultural Sciences	Jiang, L (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn	Wang, Genhong/AAC-3055-2019	Wang, Genhong/0000-0002-5598-7282; cheng, tingcai/0000-0002-3862-0817; Xia, Qingyou/0000-0002-9263-2886	National Basic Research Program of China [2012CB114600]; National Hi-Tech Research and Development Program of China [2011AA100306]; Foundation for Sci & Tech Research Project of Chongqing [CSTC2009AA1024]; National Natural Science Foundation of China [30901054]; Production, Education & Research of Guangdong and Ministry of Education [2010A090200079]	National Basic Research Program of China(National Basic Research Program of China); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Foundation for Sci & Tech Research Project of Chongqing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Production, Education & Research of Guangdong and Ministry of Education	This work was funded by the National Basic Research Program of China (No. 2012CB114600), http://www.973.gov.cn/Default_3.aspx; the National Hi-Tech Research and Development Program of China (No. 2011AA100306), http://www.863.gov.cn/; the Foundation for Sci & Tech Research Project of Chongqing (CSTC2009AA1024), http://www.cstc.gov.cn/; the National Natural Science Foundation of China (No. 30901054), http://www.nsfc.gov.cn/Portal0/default152.htm; and the Production, Education & Research of Guangdong and Ministry of Education (No. 2010A090200079), http://cxy.gdstc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; CARSON DD, 1991, J VIROL, V65, P945, DOI 10.1128/JVI.65.2.945-951.1991; de Bilbao F, 2009, J NEUROCHEM, V110, P12, DOI 10.1111/j.1471-4159.2009.06098.x; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; GONG M, 1994, VIROLOGY, V204, P38, DOI 10.1006/viro.1994.1508; GUARINO LA, 1986, J VIROL, V60, P224, DOI 10.1128/JVI.60.1.224-229.1986; GUARINO LA, 1986, J VIROL, V57, P563, DOI 10.1128/JVI.57.2.563-571.1986; GUARINO LA, 1986, J VIROL, V60, P215, DOI 10.1128/JVI.60.1.215-223.1986; GUARINO LA, 1994, VIROLOGY, V200, P328, DOI 10.1006/viro.1994.1197; HUH NE, 1990, J GEN VIROL, V71, P2195, DOI 10.1099/0022-1317-71-9-2195; Isobe R, 2004, ARCH VIROL, V149, P1931, DOI 10.1007/s00705-004-0349-0; Jiang L, 2012, ARCH VIROL, V157, P1323, DOI 10.1007/s00705-012-1309-8; Kanginakudru S, 2007, INSECT MOL BIOL, V16, P635, DOI 10.1111/j.1365-2583.2007.00753.x; KEDDIE BA, 1989, SCIENCE, V243, P1728, DOI 10.1126/science.2648574; KOOL M, 1993, J GEN VIROL, V74, P2661, DOI 10.1099/0022-1317-74-12-2661; KOOL M, 1994, P NATL ACAD SCI USA, V91, P11212, DOI 10.1073/pnas.91.23.11212; Lin X, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-32; LU A, 1993, VIROLOGY, V195, P710, DOI 10.1006/viro.1993.1422; Lu M, 1997, J BIOL CHEM, V272, P30724, DOI 10.1074/jbc.272.49.30724; MORRIS TD, 1992, J VIROL, V66, P7397, DOI 10.1128/JVI.66.12.7397-7405.1992; Nishiyama S, 2010, BIOCHEM BIOPH RES CO, V401, P26, DOI 10.1016/j.bbrc.2010.08.143; NISSEN MS, 1989, J VIROL, V63, P493, DOI 10.1128/JVI.63.2.493-503.1989; Ohshima M, 1999, J BIOCHEM-TOKYO, V125, P431, DOI 10.1093/oxfordjournals.jbchem.a022304; PULLEN SS, 1995, J VIROL, V69, P156, DOI 10.1128/JVI.69.1.156-165.1995; Rahman MM, 2004, VIRUS RES, V101, P109, DOI 10.1016/j.virusres.2003.12.027; Rodems SM, 1997, J VIROL, V71, P9270, DOI 10.1128/JVI.71.12.9270-9277.1997; RODEMS SM, 1993, J VIROL, V67, P5776, DOI 10.1128/JVI.67.10.5776-5785.1993; Shirata N, 2010, VIROLOGY, V398, P149, DOI 10.1016/j.virol.2009.11.049; Slack J, 2007, ADV VIRUS RES, V69, P99, DOI 10.1016/S0065-3527(06)69003-9; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Thomas JL, 2002, INSECT BIOCHEM MOLEC, V32, P247, DOI 10.1016/S0965-1748(01)00150-3; TJIA ST, 1979, VIROLOGY, V99, P399, DOI 10.1016/0042-6822(79)90018-7; Viswanathan P, 2003, J BIOL CHEM, V278, P52564, DOI 10.1074/jbc.M309351200; Wally O, 2010, PLANTA, V232, P1229, DOI 10.1007/s00425-010-1252-4; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210	36	46	54	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41838	10.1371/journal.pone.0041838	http://dx.doi.org/10.1371/journal.pone.0041838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870254	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800037
J	Lancel, S; Montaigne, D; Marechal, X; Marciniak, C; Hassoun, SM; Decoster, B; Ballot, C; Blazejewski, C; Corseaux, D; Lescure, B; Motterlini, R; Neviere, R				Lancel, Steve; Montaigne, David; Marechal, Xavier; Marciniak, Camille; Hassoun, Sidi Mohamed; Decoster, Brigitte; Ballot, Caroline; Blazejewski, Caroline; Corseaux, Delphine; Lescure, Bernadette; Motterlini, Roberto; Neviere, Remi			Carbon Monoxide Improves Cardiac Function and Mitochondrial Population Quality in a Mouse Model of Metabolic Syndrome	PLOS ONE			English	Article							IN-VIVO; OXIDATIVE STRESS; HEME OXYGENASE-1; PROTEIN-KINASE; BIOGENESIS; MICE; AUTOPHAGY; EXPRESSION; MOLECULE; RESPIRATION	Aims: Metabolic syndrome induces cardiac dysfunction associated with mitochondria abnormalities. As low levels of carbon monoxide (CO) may improve myocardial and mitochondrial activities, we tested whether a CO-releasing molecule (CORM-3) reverses metabolic syndrome-induced cardiac alteration through changes in mitochondrial biogenesis, dynamics and autophagy. Methods and Results: Mice were fed with normal diet (ND) or high-fat diet (HFD) for twelve weeks. Then, mice received two intraperitoneal injections of CORM-3 (10 mg.kg(-1)), with the second one given 16 hours after the first. Contractile function in isolated hearts and mitochondrial parameters were evaluated 24 hours after the last injection. Mitochondrial population was explored by electron microscopy. Changes in mitochondrial dynamics, biogenesis and autophagy were assessed by western-blot and RT-qPCR. Left ventricular developed pressure was reduced in HFD hearts. Mitochondria from HFD hearts presented reduced membrane potential and diminished ADP-coupled respiration. CORM-3 restored both cardiac and mitochondrial functions. Size and number of mitochondria increased in the HFD hearts but not in the CORM-3-treated HFD group. CORM-3 modulated HFD-activated mitochondrial fusion and biogenesis signalling. While autophagy was not activated in the HFD group, CORM-3 increased the autophagy marker LC3-II. Finally, ex vivo experiments demonstrated that autophagy inhibition by 3-methyladenine abolished the cardioprotective effects of CORM-3. Conclusion: CORM-3 may modulate pathways controlling mitochondrial quality, thus leading to improvements of mitochondrial efficiency and HFD-induced cardiac dysfunction.	[Lancel, Steve; Montaigne, David; Marechal, Xavier; Marciniak, Camille; Hassoun, Sidi Mohamed; Decoster, Brigitte; Ballot, Caroline; Blazejewski, Caroline; Neviere, Remi] Univ Lille 2, EA4484, Dept Physiol, Lille, France; [Corseaux, Delphine] Univ Lille 2, EA2693, Lille, France; [Lescure, Bernadette] Univ Paris 06, INSERM, IFR65, Irssa, Paris, France; [Motterlini, Roberto] Paris Est Univ, INSERM, U955, Fac Med, Creteil, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Lancel, S (corresponding author), Univ Lille 2, EA4484, Dept Physiol, Lille, France.	steve.lancel@univ-lille2.fr	Montaigne, David/R-6066-2018; Corseaux, Delphine/R-4360-2018; Motterlini, Roberto/Q-1890-2019; Lancel, Steve/C-4387-2012; , Lancel/H-9047-2019; Marechal, Xavier/R-5762-2018; Motterlini, Roberto/G-2489-2013; Corseaux, Delphine/P-4821-2019	Montaigne, David/0000-0002-2346-863X; Corseaux, Delphine/0000-0001-8642-1508; Motterlini, Roberto/0000-0003-2684-2612; , Lancel/0000-0002-3292-5433; Marechal, Xavier/0000-0001-6399-7811; Motterlini, Roberto/0000-0003-2684-2612; Corseaux, Delphine/0000-0001-8642-1508; Neviere, Remi/0000-0002-7966-0110	Universite Lille 2- Ministere de l'Enseignement Superieur et de la Recherche [EA4484]; CPER "cardiodiabete 2008'' - FEDER Region Nord Pas-de-Calais [08480265]; Fondation de France [2009002501]; Fondation Coeur et Arteres [FCA09T6]	Universite Lille 2- Ministere de l'Enseignement Superieur et de la Recherche; CPER "cardiodiabete 2008'' - FEDER Region Nord Pas-de-Calais(Region Hauts-de-France); Fondation de France(Fondation de France); Fondation Coeur et Arteres	This work was supported by EA4484- Universite Lille 2- Ministere de l'Enseignement Superieur et de la Recherche; CPER "cardiodiabete 2008'' - FEDER Region Nord Pas-de-Calais 08480265; Fondation de France 2009002501 and Fondation Coeur et Arteres FCA09T6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre L, 2010, AM J RESP CRIT CARE, V181, P587, DOI 10.1164/rccm.200905-0794OC; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Carreira RS, 2010, AUTOPHAGY, V6, P462, DOI 10.4161/auto.6.4.11553; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Grilli A, 2003, ANN CLIN LAB SCI, V33, P208; Guo YR, 2004, AM J PHYSIOL-HEART C, V286, pH1649, DOI 10.1152/ajpheart.00971.2003; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Lee SJ, 2011, AM J RESP CELL MOL, V45, P867, DOI 10.1165/rcmb.2010-0352OC; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lo Iacono L, 2011, FREE RADICAL BIO MED, V50, P1556, DOI 10.1016/j.freeradbiomed.2011.02.033; Loennechen JP, 1999, PHARMACOL TOXICOL, V85, P192, DOI 10.1111/j.1600-0773.1999.tb00091.x; Marechal X, 2011, CLIN SCI, V121, P405, DOI 10.1042/CS20110069; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Ndisang JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE1029, DOI 10.1152/ajpendo.90241.2008; Neviere R, 2010, CRIT CARE MED, V38, P2031, DOI 10.1097/CCM.0b013e3181eedafb; Nicholls D., 2002, BIOENERGETICS, V3; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; PACE N, 1950, SCIENCE, V111, P652, DOI 10.1126/science.111.2894.652; REGAN TJ, 1977, J CLIN INVEST, V60, P885, DOI 10.1172/JCI108843; Rhodes MA, 2009, AM J PHYSIOL-HEART C, V297, pH392, DOI 10.1152/ajpheart.00164.2009; Somoza B, 2007, ENDOCRINOLOGY, V148, P924, DOI 10.1210/en.2006-0914; Soni H, 2011, TOXICOL APPL PHARM, V253, P70, DOI 10.1016/j.taap.2011.03.013; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Urquhart P, 2007, J PHARMACOL EXP THER, V321, P656, DOI 10.1124/jpet.106.117218; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314	32	49	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41836	10.1371/journal.pone.0041836	http://dx.doi.org/10.1371/journal.pone.0041836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870253	gold, Green Published, Green Submitted			2022-12-27	WOS:000307212800036
J	Price, GA; Holmes, RK				Price, Gregory A.; Holmes, Randall K.			Evaluation of TcpF-A2-CTB Chimera and Evidence of Additive Protective Efficacy of Immunizing with TcpF and CTB in the Suckling Mouse Model of Cholera	PLOS ONE			English	Article							TOXIN-B-SUBUNIT; SOLUBLE COLONIZATION FACTOR; OUTER-MEMBRANE VESICLES; VIBRIO-CHOLERAE; INTRANASAL IMMUNIZATION; COREGULATED PILUS; EL-TOR; MUCOSAL IMMUNIZATION; ANTIBODY-RESPONSES; CLASSICAL BIOTYPE	The secreted colonization factor, TcpF, which is produced by Vibrio cholerae 01 and 0139, has generated interest as a potential protective antigen in the development of a subunit vaccine against cholera. This study evaluated immunogenicity/protective efficacy of a TcpF holotoxin-like chimera (TcpF-A2-CTB) following intraperitoneal immunization compared to TcpF alone, a TcpF+CTB mixture, or CTB alone. Immunization with the TcpF-A2-CTB chimera elicited significantly greater amounts of anti-TcpF IgG than immunization with the other antigens (P<0.05). Protective efficacy was measured using 6-day-old pups reared from immunized dams and orogastrically challenged with a lethal dose of El Tor V. cholerae 01 Inaba strain N16961. Protection from death, and weight loss analysis at 24 and 48 hours post-infection demonstrated that immunization with TcpF alone was poorly protective. However, immunization with TcpF+CTB was highly protective and showed a trend toward greater protection than immunization with CTB alone (82% vs 64% survival). Immunization with the TcpF-A2-CTB chimera demonstrated less protection (50% survival) than immunization with the TcpF+CTB mixture. The TcpF-A2-CTB chimera used for this study contained the heterologous classical CTB variant whereas the El Tor CTB variant (expressed by the challenge strain) was used in the other immunization groups. For all immunization groups that received CTB, quantitative ELISA data demonstrated that the amounts of serum IgG directed against the homologous immunizing CTB antigen was statistically greater than the amount to the heterologous CTB antigen (P <= 0.003). This finding provides a likely explanation for the poorer protection observed following immunization with the TcpF-A2-CTB chimera and the relatively high level of protection seen after immunization with homologous CTB alone. Though immunization with TcpF alone provided no protection, the additive protective effect when TcpF was combined with CTB demonstrates its possible value as a component of a multivalent subunit vaccine against Vibrio cholerae 01 and 0139.	[Price, Gregory A.; Holmes, Randall K.] Univ Colorado, Dept Microbiol, Sch Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Price, GA (corresponding author), Miriam Hosp, Dept Infect Dis, Providence, RI 02906 USA.	randall.holmes@ucdenver.edu			National Institutes of Health [R01-AI31940]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grant R01-AI31940. No other grants contributed to support of this work. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaruzzaman M, 2004, EMERG INFECT DIS, V10, P2057, DOI 10.3201/eid1011.040682; Bergquist C, 1997, INFECT IMMUN, V65, P2676, DOI 10.1128/IAI.65.7.2676-2684.1997; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Curlin GT, 1975, P 11 JOINT C CHOL US, P314; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; DERTZBAUGH MT, 1993, INFECT IMMUN, V61, P384, DOI 10.1128/IAI.61.2.384-390.1993; Fazil MH, 2011, J MOL MODEL; Goel AK, 2010, INFECT GENET EVOL, V10, P815, DOI 10.1016/j.meegid.2009.06.022; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; HAJISHENGALLIS G, 1995, J IMMUNOL, V154, P4322; Hang L, 2003, P NATL ACAD SCI USA, V100, P8508, DOI 10.1073/pnas.1431769100; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; HOLMGREN J, 1973, Scandinavian Journal of Infectious Diseases, V5, P77, DOI 10.3109/inf.1973.5.issue-1.15; HOLMGREN J, 1977, NATURE, V269, P602, DOI 10.1038/269602a0; Isaka M, 1998, VACCINE, V16, P1620, DOI 10.1016/S0264-410X(98)00066-8; Isaka M, 2001, VACCINE, V19, P1460, DOI 10.1016/S0264-410X(00)00348-0; JOBLING MG, 1992, INFECT IMMUN, V60, P4915, DOI 10.1128/IAI.60.11.4915-4924.1992; Kirn TJ, 2003, MOL MICROBIOL, V49, P81, DOI 10.1046/j.1365-2958.2003.03546.x; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; Kirn TJ, 2005, INFECT IMMUN, V73, P4461, DOI 10.1128/IAI.73.8.4461-4470.2005; Krebs SJ, 2011, J BACTERIOL, V193, P5260, DOI 10.1128/JB.00378-11; Kundu J, 2009, FEMS IMMUNOL MED MIC, V56, P179, DOI 10.1111/j.1574-695X.2009.00563.x; LEVINE MM, 1979, T ROY SOC TROP MED H, V73, P3, DOI 10.1016/0035-9203(79)90119-6; Li X, 2004, INFECT IMMUN, V72, P7306, DOI 10.1128/IAI.72.12.7306-7310.2004; Manning PA, 1997, GENE, V192, P63, DOI 10.1016/S0378-1119(97)00036-X; MARCHLEWICZ BA, 1983, DIAGN MICR INFEC DIS, V1, P129, DOI 10.1016/0732-8893(83)90042-1; MCKENZIE SJ, 1984, J IMMUNOL, V133, P1818; Megli CJ, 2011, J MOL BIOL, V409, P146, DOI 10.1016/j.jmb.2011.03.027; Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Noriki H, 1976, P 12 JOINT C CHOL US, P302; PIERCE NF, 1982, INFECT IMMUN, V37, P687, DOI 10.1128/IAI.37.2.687-694.1982; Plotkin SA, 2008, VACCINES, pxvii; Price GA, 2005, INFECT IMMUN, V73, P3945, DOI 10.1128/IAI.73.7.3945-3953.2005; Rask C, 2000, APMIS, V108, P178, DOI 10.1034/j.1600-0463.2000.d01-42.x; Raychoudhuri A, 2009, EMERG INFECT DIS, V15, P131, DOI 10.3201/eid1501.080543; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Schild S, 2009, INFECT IMMUN, V77, P472, DOI 10.1128/IAI.01139-08; Schild S, 2008, INFECT IMMUN, V76, P4554, DOI 10.1128/IAI.00532-08; Sinclair D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008603.pub2; SRIVASTAVA R, 1979, INDIAN J MED RES, V70, P369; Sultan F, 1998, INFECT IMMUN, V66, P462, DOI 10.1128/IAI.66.2.462-468.1998; TAMPLIN ML, 1989, J GEN MICROBIOL, V135, P1195; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; UJIIYE A, 1968, Tropical Medicine, V10, P65; WHO UNICEF, 2010, PROGR SAN DRINK WAT; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P117; Wu HY, 1998, VACCINE, V16, P286, DOI 10.1016/S0264-410X(97)00168-0; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456	50	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42434	10.1371/journal.pone.0042434	http://dx.doi.org/10.1371/journal.pone.0042434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879984	Green Published, Green Submitted, gold			2022-12-27	WOS:000307437900039
J	Schlafer, S; Raarup, MK; Wejse, PL; Nyvad, B; Stadler, BM; Sutherland, DS; Birkedal, H; Meyer, RL				Schlafer, Sebastian; Raarup, Merete K.; Wejse, Peter L.; Nyvad, Bente; Stadler, Brigitte M.; Sutherland, Duncan S.; Birkedal, Henrik; Meyer, Rikke L.			Osteopontin Reduces Biofilm Formation in a Multi-Species Model of Dental Biofilm	PLOS ONE			English	Article							PLAQUE; LACTOFERRIN; STREPTOCOCCI; REMOVAL	Background: Combating dental biofilm formation is the most effective means for the prevention of caries, one of the most widespread human diseases. Among the chemical supplements to mechanical tooth cleaning procedures, non-bactericidal adjuncts that target the mechanisms of bacterial biofilm formation have gained increasing interest in recent years. Milk proteins, such as lactoferrin, have been shown to interfere with bacterial colonization of saliva-coated surfaces. We here study the effect of bovine milk osteopontin (OPN), a highly phosphorylated whey glycoprotein, on a multispecies in vitro model of dental biofilm. While considerable research effort focuses on the interaction of OPN with mammalian cells, there are no data investigating the influence of OPN on bacterial biofilms. Methodology/Principal Findings: Biofilms consisting of Streptococcus oralis, Actinomyces naeslundii, Streptococcus mitis, Streptococcus downei and Streptococcus sanguinis were grown in a flow cell system that permitted in situ microscopic analysis. Crystal violet staining showed significantly less biofilm formation in the presence of OPN, as compared to biofilms grown without OPN or biofilms grown in the presence of caseinoglycomacropeptide, another phosphorylated milk protein. Confocal microscopy revealed that OPN bound to the surface of bacterial cells and reduced mechanical stability of the biofilms without affecting cell viability. The bacterial composition of the biofilms, determined by fluorescence in situ hybridization, changed considerably in the presence of OPN. In particular, colonization of S. mitis, the best biofilm former in the model, was reduced dramatically. Conclusions/Significance: OPN strongly reduces the amount of biofilm formed in a well-defined laboratory model of acidogenic dental biofilm. If a similar effect can be observed in vivo, OPN might serve as a valuable adjunct to mechanical tooth cleaning procedures.	[Schlafer, Sebastian; Stadler, Brigitte M.; Sutherland, Duncan S.; Meyer, Rikke L.] Aarhus Univ, Fac Sci & Technol, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark; [Schlafer, Sebastian; Nyvad, Bente] Aarhus Univ, Fac Hlth, Dept Dent, Aarhus, Denmark; [Schlafer, Sebastian; Meyer, Rikke L.] Aarhus Univ, Fac Sci & Technol, Dept Biosci, Aarhus, Denmark; [Raarup, Merete K.] Aarhus Univ, Stereol & Elect Microscopy Res Lab, Aarhus, Denmark; [Raarup, Merete K.] Aarhus Univ, MIND Ctr, Aarhus, Denmark; [Wejse, Peter L.] Arla Foods Amba, Viby J, Denmark; [Birkedal, Henrik] Aarhus Univ, Fac Sci & Technol, Dept Chem, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Schlafer, S (corresponding author), Aarhus Univ, Fac Sci & Technol, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark.	sebastian.schlafer@hotmail.de; rikke.meyer@biology.au.dk	Stadler, Brigitte/I-2661-2013; Sutherland, Duncan S/E-4385-2010; Birkedal, Henrik/AAD-3128-2020; Meyer, Rikke Louise/AAB-5377-2021; Schlafer, Sebastian/I-8788-2018	Sutherland, Duncan S/0000-0002-5045-9915; Birkedal, Henrik/0000-0002-4201-2179; Meyer, Rikke Louise/0000-0002-6485-5134; Stadler, Brigitte/0000-0002-7335-3945; Nyvad, Bente/0000-0002-9545-0447; Schlafer, Sebastian/0000-0003-2463-1926	Danish National Advanced Technology Foundation through ProSURF platform project (Protein-Based Functionalisation of Surfaces); Carlsberg Foundation	Danish National Advanced Technology Foundation through ProSURF platform project (Protein-Based Functionalisation of Surfaces); Carlsberg Foundation(Carlsberg Foundation)	This work was funded by the Danish National Advanced Technology Foundation (http://hoejteknologifonden.dk) through the ProSURF platform project (Protein-Based Functionalisation of Surfaces) and by the Carlsberg Foundation (http://www.carlsbergfondet.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair Steven M., 1998, Pediatric Dentistry, V20, P101; Allaker RP, 2009, INT J ANTIMICROB AG, V33, P8, DOI 10.1016/j.ijantimicag.2008.07.014; Arslan SY, 2009, ORAL MICROBIOL IMMUN, V24, P411, DOI 10.1111/j.1399-302X.2009.00537.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; Gaffar A, 1997, EUR J ORAL SCI, V105, P502, DOI 10.1111/j.1600-0722.1997.tb00237.x; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Guggenheim B, 1999, CARIES RES, V33, P446, DOI 10.1159/000016550; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hirota K, 2011, J DENT RES, V90, P900, DOI 10.1177/0022034511402996; Loy A, 2003, NUCLEIC ACIDS RES, V31, P514, DOI 10.1093/nar/gkg016; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; Niemi LD, 2009, CARIES RES, V43, P171, DOI 10.1159/000213888; Oho T, 2002, INFECT IMMUN, V70, P5279, DOI 10.1128/IAI.70.9.5279-5282.2002; ONG G, 1990, J CLIN PERIODONTOL, V17, P463, DOI 10.1111/j.1600-051X.1990.tb02345.x; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Prasad KVV, 2011, AM J DENT, V24, P60; Schlafer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025299; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Sodek J, 2006, J DENT RES, V85, P404, DOI 10.1177/154405910608500503; van der Weijden GA, 2005, J CLIN PERIODONTOL, V32, P214, DOI 10.1111/j.1600-051X.2005.00795.x; Wakabayashi H, 2009, ANTIMICROB AGENTS CH, V53, P3308, DOI 10.1128/AAC.01688-08; Younson J, 2004, MOL DIVERS, V8, P121, DOI 10.1023/B:MODI.0000025655.93643.fa	25	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41534	10.1371/journal.pone.0041534	http://dx.doi.org/10.1371/journal.pone.0041534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879891	Green Published, gold			2022-12-27	WOS:000307437900012
J	Harel, S; Tu, EY; Weisberg, S; Esquilin, M; Chambers, SM; Liu, B; Carson, CT; Studer, L; Reizis, B; Tomishima, MJ				Harel, Sivan; Tu, Edmund Y.; Weisberg, Stuart; Esquilin, Manuel; Chambers, Stuart M.; Liu, Becky; Carson, Christian T.; Studer, Lorenz; Reizis, Boris; Tomishima, Mark J.			ZFX Controls the Self-Renewal of Human Embryonic Stem Cells	PLOS ONE			English	Article							DERIVATION; LINES	Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) offer great promise in regenerative medicine and disease modeling due to their unlimited self-renewal and broad differentiation capacity. There is evidence that the growth properties and critical signaling pathways differ between murine and human ESCs; therefore, it is essential to perform functional studies to test the putatively conserved mechanisms of pluripotent stem cell self-renewal between species. Previously, we identified the transcription factor Zfx as a key regulator of self-renewal in murine ESCs. Here we extend those findings to human ESCs. ZFX knockdown in hESCs hindered clonal growth and decreased colony size after serial replating. ZFX overexpression enhanced clone formation in the presence of Y-27632, increased colony size at low density and decreased expression of differentiation-related genes in human ESCs. ZFX-overexpressing hESCs resisted spontaneous differentiation but could be directed to differentiate into endodermal and neural cell fates when provided with the appropriate cues. Thus, ZFX acts as a molecular rheostat regulating the balance between self-renewal and differentiation in hESCs, revealing the close evolutionary conservation of the self-renewal mechanisms in murine and human ESCs.	[Harel, Sivan; Weisberg, Stuart; Esquilin, Manuel; Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10027 USA; [Tu, Edmund Y.; Chambers, Stuart M.; Liu, Becky; Studer, Lorenz; Tomishima, Mark J.] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Carson, Christian T.] BD Biosci, La Jolla, CA USA	Columbia University; Memorial Sloan Kettering Cancer Center	Harel, S (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10027 USA.	bvr2101@columbia.edu; tomishim@mskcc.org	Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; Reizis, Boris/0000-0003-1140-7853; Weisberg, Stuart/0000-0002-8698-5976	The Starr Foundation; NYSTEM [C024175-01]; National Institutes of Health [HL084353]; Becton, Dickinson and Company; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084353] Funding Source: NIH RePORTER	The Starr Foundation; NYSTEM; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Becton, Dickinson and Company; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by The Starr Foundation (MJT and LS; www.starrfoundation.org), NYSTEM grant C024175-01 (MJT and LS; www.nystem.ny.org), National Institutes of Health grant HL084353 (to BR) and Becton, Dickinson and Company (CTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Do JT, 2009, TRENDS PHARMACOL SCI, V30, P296, DOI 10.1016/j.tips.2009.03.003; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; O'Connor MD, 2008, STEM CELLS, V26, P1109, DOI 10.1634/stemcells.2007-0801; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Placantonakis DG, 2009, STEM CELLS, V27, P521, DOI 10.1634/stemcells.2008-0884; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang ZD, 2001, GENOME RES, V11, P137, DOI 10.1101/gr.159001; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yang XW, 1999, NAT GENET, V22, P327, DOI 10.1038/11896; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42302	10.1371/journal.pone.0042302	http://dx.doi.org/10.1371/journal.pone.0042302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879936	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100063
J	Harron, K; Lee, T; Ball, T; Mok, Q; Gamble, C; Macrae, D; Gilbert, R				Harron, Katie; Lee, Twin; Ball, Tracy; Mok, Quen; Gamble, Carrol; Macrae, Duncan; Gilbert, Ruth		CATCH Team	Making Co-Enrolment Feasible for Randomised Controlled Trials in Paediatric Intensive Care	PLOS ONE			English	Article							LABEL DRUG-USE; CLINICAL-TRIALS; UNIT; MALARIA; CHILD; WARDS	Aims: Enrolling children into several trials could increase recruitment and lead to quicker delivery of optimal care in paediatric intensive care units (PICU). We evaluated decisions taken by clinicians and parents in PICU on co-enrolment for two large pragmatic trials: the CATCH trial (CATheters in CHildren) comparing impregnated with standard central venous catheters (CVCs) for reducing bloodstream infection in PICU and the CHIP trial comparing tight versus standard control of hyperglycaemia. Methods: We recorded the period of trial overlap for all PICUs taking part in both CATCH and CHiP and reasons why clinicians decided to co-enrol children or not into both studies. We examined parental decisions on co-enrolment by measuring recruitment rates and reasons for declining consent. Results: Five PICUs recruited for CATCH and CHiP during the same period (an additional four opened CATCH after having closed CHiP). Of these five, three declined co-enrolment (one of which delayed recruiting elective patients for CATCH whilst CHiP was running), due to concerns about jeopardising CHiP recruitment, asking too much of parents, overwhelming amounts of information to explain to parents for two trials and a policy against co-enrolment. Two units co-enrolled in order to maximise recruitment to both trials. At the first unit, 35 parents were approached for both trials. 17/35 consented to both; 13/35 consented to one trial only; 5/35 declined both. Consent rates during co-enrolment were 29/35 (82%) and 18/35 (51%) for CATCH and CHiP respectively compared with 78% and 51% respectively for those approached for a single trial within this PICU. The second unit did not record data on approaches or refusals, but successfully co-enrolled one child. Conclusions: Co-enrolment did not appear to jeopardise recruitment or overwhelm parents. Strategies for seeking consent for multiple trials need to be developed and should include how to combine information for parents and patients.	[Harron, Katie; Gilbert, Ruth] UCL, Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England; [Lee, Twin; Mok, Quen] Great Ormond St Hosp Sick Children, Paediat Intens Care Unit, London, England; [Ball, Tracy; Gamble, Carrol] Univ Liverpool, Clin Trials Res Ctr, Liverpool L69 3BX, Merseyside, England; [Macrae, Duncan] Royal Brompton Hosp, Paediat Intens Care Unit, London SW3 6LY, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Liverpool; Royal Brompton Hospital	Harron, K (corresponding author), UCL, Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England.	R.Gilbert@ucl.ac.uk	Macrae, Duncan/AAC-9564-2020; Mok, Quen/AAA-2648-2019; Gamble, Carrol/AAE-9895-2019; Hughes, Dyfrig/H-5252-2012	Mok, Quen/0000-0003-4807-9275; Gamble, Carrol/0000-0002-3021-1955; Harron, Katie/0000-0002-3418-2856; Macrae, Duncan/0000-0002-7158-6585; Gilbert, Ruth/0000-0001-9347-2709; Hughes, Dyfrig/0000-0001-8247-7459	National Institute for Health Research Health Technology Assessment (NIHR HTA) programme [08/13/47]; Medical Research Council [G0400546B, G0800792, G0400546] Funding Source: researchfish; MRC [G0400546, G0800792] Funding Source: UKRI	National Institute for Health Research Health Technology Assessment (NIHR HTA) programme(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme (project number 08/13/47). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Medical Sciences, 2011, NEW PATHW REG GOV HL; Angus DC, 2010, CRIT CARE MED, V38, P527, DOI 10.1097/CCM.0b013e3181c0259d; Brocklehurst P, 1997, BRIT J OBSTET GYNAEC, V104, P765, DOI 10.1111/j.1471-0528.1997.tb12016.x; Burgess E, 2003, ARCH DIS CHILD-FETAL, V88, P280; Burnet K, 2004, EUR J CANCER CARE, V13, P32, DOI 10.1111/j.1365-2354.2003.00439.x; Conroy S, 2000, BRIT MED J, V320, P79, DOI 10.1136/bmj.320.7227.79; Cook DJ, 2008, CRIT CARE MED, V36, P2100, DOI 10.1097/CCM.0b013e31817c00b0; Department of Health Health Service Directorate, 1997, FRAM FUT, V8, P16; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Ellenberg SS, 1992, JAMA-J AM MED ASSOC, P562; Golec Lisa, 2004, J Perinatol, V24, P783, DOI 10.1038/sj.jp.7211198; Harron K, 2011, INTENS CARE MED, V37, P1641, DOI 10.1007/s00134-011-2343-9; Howie SRC, 2011, B WORLD HEALTH ORGAN, V89, P46, DOI 10.2471/BLT.10.080010; Lang TA, 2008, T ROY SOC TROP MED H, V102, P7, DOI 10.1016/j.trstmh.2007.08.008; Larntz K, 1996, STAT MED, V15, P2445, DOI 10.1002/(SICI)1097-0258(19961130)15:22<2445::AID-SIM462>3.0.CO;2-8; Maitland K, 2011, NEW ENGL J MED; Menon K, 2011, INTENS CARE MED, P1; Morley CJ, 2005, ARCH DIS CHILD-FETAL, V90, P225, DOI 10.1136/adc.2004.061986; MRC, 2007, MED RES INV CHILDR; National Audit Office Report (HC 255 2002-2003), 2003, 25520022003 HC NAT A; Nichol G, 2010, RESUSCITATION, V81, P792, DOI 10.1016/j.resuscitation.2010.03.014; Randolph AG, 2009, CRIT CARE MED, V37, pS107, DOI 10.1097/CCM.0b013e3181921c9d; Shilling V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021604; Turner S, 1996, LANCET, V347, P549, DOI 10.1016/S0140-6736(96)91182-4; Turner S, 1998, BRIT MED J, V316, P343, DOI 10.1136/bmj.316.7128.343; Universities of Leeds and Leicester, 2011, PAED INT CAR AUD  NE	26	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41791	10.1371/journal.pone.0041791	http://dx.doi.org/10.1371/journal.pone.0041791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870249	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000307284100031
J	Labbe, J; Murat, C; Morin, E; Tuskan, GA; Le Tacon, F; Martin, F				Labbe, Jessy; Murat, Claude; Morin, Emmanuelle; Tuskan, Gerald A.; Le Tacon, Francois; Martin, Francis			Characterization of Transposable Elements in the Ectomycorrhizal Fungus Laccaria bicolor	PLOS ONE			English	Article							INVERTED-REPEAT ELEMENTS; GENOME SEQUENCE; MAIZE; EVOLUTION; GENES; RETROTRANSPOSONS; ORGANIZATION; FAMILY; IDENTIFICATION; SUBSTITUTIONS	Background: The publicly available Laccaria bicolor genome sequence has provided a considerable genomic resource allowing systematic identification of transposable elements (TEs) in this symbiotic ectomycorrhizal fungus. Using a TE-specific annotation pipeline we have characterized and analyzed TEs in the L. bicolor S238N-H82 genome. Methodology/Principal Findings: TEs occupy 24% of the 60 Mb L. bicolor genome and represent 25,787 full-length and partial copy elements distributed within 171 families. The most abundant elements were the Copia-like. TEs are not randomly distributed across the genome, but are tightly nested or clustered. The majority of TEs exhibits signs of ancient transposition except some intact copies of terminal inverted repeats (TIRS), long terminal repeats (LTRs) and a large retrotransposon derivative (LARD) element. There were three main periods of TE expansion in L. bicolor: the first from 57 to 10 Mya, the second from 5 to 1 Mya and the most recent from 0.5 Mya ago until now. LTR retrotransposons are closely related to retrotransposons found in another basidiomycete, Coprinopsis cinerea. Conclusions: This analysis 1) represents an initial characterization of TEs in the L. bicolor genome, 2) contributes to improve genome annotation and a greater understanding of the role TEs played in genome organization and evolution and 3) provides a valuable resource for future research on the genome evolution within the Laccaria genus.	[Labbe, Jessy; Murat, Claude; Morin, Emmanuelle; Le Tacon, Francois; Martin, Francis] Lorraine Univ Interact Arbres Microorganismes, INRA, UMR, Ctr Nancy Champenoux, Nancy, France; [Labbe, Jessy; Tuskan, Gerald A.] Oak Ridge Natl Lab, BioSci Div, Oak Ridge, TN USA	INRAE; United States Department of Energy (DOE); Oak Ridge National Laboratory	Labbe, J (corresponding author), Lorraine Univ Interact Arbres Microorganismes, INRA, UMR, Ctr Nancy Champenoux, Nancy, France.	labbejj@ornl.gov	Murat, Claude/AAA-5226-2020; morin, emmanuelle/AAA-1246-2019; Labbe, Jessy/G-9532-2011; Tuskan, Gerald/A-6225-2011	Murat, Claude/0000-0003-0685-7307; morin, emmanuelle/0000-0002-7268-972X; Labbe, Jessy/0000-0003-0368-2054; Tuskan, Gerald/0000-0003-0106-1289	INRA; Region Lorraine Research Council; Plant-Microbe Interfaces Scientific Focus Area project at Oak Ridge National Laboratory (ORNL); Office of Biological and Environmental Research at the United States Department of Energy Office of Science; UT-Battelle, LLC [DE-AC05-00OR22725]	INRA; Region Lorraine Research Council(Region Grand-Est); Plant-Microbe Interfaces Scientific Focus Area project at Oak Ridge National Laboratory (ORNL); Office of Biological and Environmental Research at the United States Department of Energy Office of Science(United States Department of Energy (DOE)); UT-Battelle, LLC	This work was supported by INRA, the Region Lorraine Research Council and by the Plant-Microbe Interfaces Scientific Focus Area project at Oak Ridge National Laboratory (ORNL) sponsored by Office of Biological and Environmental Research at the United States Department of Energy Office of Science. ORNL is managed by UT-Battelle, LLC, under contract DE-AC05-00OR22725 for the United States Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi H, 2001, MOL GENET GENOMICS, V266, P471, DOI 10.1007/s004380100563; ARCOT SS, 1995, GENOMICS, V29, P136, DOI 10.1006/geno.1995.1224; Baker Scott E., 2008, Fungal Biology Reviews, V22, P1, DOI 10.1016/j.fbr.2008.03.001; Barabaschi D, 2012, MOL BIOTECHNOL, V50, P250, DOI 10.1007/s12033-011-9443-1; Baucom RS, 2009, GENOME RES, V19, P243, DOI 10.1101/gr.083360.108; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Boeke J. D., 1997, P343; Boeke JD, 1989, MOBILE DNA, P335; BUREAU TE, 1994, P NATL ACAD SCI USA, V91, P1411, DOI 10.1073/pnas.91.4.1411; BUREAU TE, 1994, PLANT CELL, V6, P907, DOI 10.1105/tpc.6.6.907; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; DECARIS B, 1978, MOL GEN GENET, V162, P69, DOI 10.1007/BF00333852; Deninger PL, 1989, ASM, V19, P619; Diez J, 2003, CURR GENET, V43, P34, DOI 10.1007/s00294-002-0363-2; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Fu HH, 2001, P NATL ACAD SCI USA, V98, P8903, DOI 10.1073/pnas.141221898; Halling RE, 2001, ANN MO BOT GARD, V88, P5, DOI 10.2307/2666128; Harley J.L., 1983, MYCORRHIZAL SYMBIOSI; Hu JP, 2000, PLANT MOL BIOL, V42, P667, DOI 10.1023/A:1006355510883; Iwamoto M, 2003, MOL GENET GENOMICS, V268, P771, DOI 10.1007/s00438-002-0797-8; Jiang N, 2001, PLANT CELL, V13, P2553, DOI 10.1105/tpc.13.11.2553; Johnson LJ, 2007, EVOL BIOL, V34, P121, DOI 10.1007/s11692-007-9012-5; Kempken F, 1998, FUNGAL GENET BIOL, V25, P110, DOI 10.1006/fgbi.1998.1091; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Kidwell MG, 2000, TRENDS ECOL EVOL, V15, P95, DOI 10.1016/S0169-5347(99)01817-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Labbe J, 2008, NEW PHYTOL, V180, P316, DOI 10.1111/j.1469-8137.2008.02614.x; Labbe J, 2011, CURR GENET, V57, P75, DOI 10.1007/s00294-010-0328-9; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Metzgar D, 2000, GENOME RES, V10, P72; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Miller WJ, 1999, GENETICA, V107, P197, DOI 10.1023/A:1004070603792; Morgante M, 2006, CURR OPIN BIOTECH, V17, P168, DOI 10.1016/j.copbio.2006.03.001; Morgante M, 2007, CURR OPIN PLANT BIOL, V10, P149, DOI 10.1016/j.pbi.2007.02.001; Muszewska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029425; Niculita-Hirzel H, 2008, NEW PHYTOL, V180, P329, DOI 10.1111/j.1469-8137.2008.02525.x; Novikova O, 2009, FUNCT INTEGR GENOMIC, V9, P27, DOI 10.1007/s10142-008-0093-8; Plett JM, 2012, FUNGAL GENET BIOL, V49, P199, DOI 10.1016/j.fgb.2012.01.002; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Ryberg M, 2012, P ROY SOC B-BIOL SCI, V279, P2003, DOI 10.1098/rspb.2011.2428; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandmeyer S, 1998, GENOME RES, V8, P416, DOI 10.1101/gr.8.5.416; Slot JC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001097; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tikhonov AP, 1999, P NATL ACAD SCI USA, V96, P7409, DOI 10.1073/pnas.96.13.7409; Walbot V, 2001, P NATL ACAD SCI USA, V98, P8163, DOI 10.1073/pnas.161278798; Wenzl P, 2005, MOL BIOL EVOL, V22, P308, DOI 10.1093/molbev/msi018; Wostemeyer J, 2002, CURR GENET, V41, P189, DOI 10.1007/s00294-002-0306-y; Yang LX, 2009, P NATL ACAD SCI USA, V106, P19922, DOI 10.1073/pnas.0908008106; Zhu Y, 2000, GENET RES, V76, P227, DOI 10.1017/S001667230000478X	60	38	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e40197	10.1371/journal.pone.0040197	http://dx.doi.org/10.1371/journal.pone.0040197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870194	Green Submitted, gold, Green Published			2022-12-27	WOS:000307284100006
J	Talens, S; Leebeek, FWG; Demmers, JAA; Rijken, DC				Talens, Simone; Leebeek, Frank W. G.; Demmers, Jeroen A. A.; Rijken, Dingeman C.			Identification of Fibrin Clot-Bound Plasma Proteins	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; VENOUS THROMBOEMBOLISM; CROSS-LINKING; RISK; DISEASE; PROTEOMICS; COMPONENT; ARTERIAL; THROMBIN; INHIBITION	Several proteins are known to bind to a fibrin network and to change clot properties or function. In this study we aimed to get an overview of fibrin clot-bound plasma proteins. A plasma clot was formed by adding thrombin, CaCl2 and aprotinin to citrated platelet-poor plasma and unbound proteins were washed away with Tris-buffered saline. Non-covalently bound proteins were extracted, separated with 2D gel electrophoresis and visualized with Sypro Ruby. Excised protein spots were analyzed with mass spectrometry. The identity of the proteins was verified by checking the mass of the protein, and, if necessary, by Western blot analysis. Next to established fibrin-binding proteins we identified several novel fibrin clot-bound plasma proteins, including alpha(2)-macroglobulin, carboxypeptidase N, alpha(1)-antitrypsin, haptoglobin, serum amyloid P, and the apolipoproteins A-I, E, J, and A-IV. The latter six proteins are associated with high-density lipoprotein particles. In addition we showed that high-density lipoprotein associated proteins were also present in fibrinogen preparations purified from plasma. Most plasma proteins in a fibrin clot can be classified into three groups according to either blood coagulation, protease inhibition or high-density lipoprotein metabolism. The presence of high-density lipoprotein in clots might point to a role in hemostasis.	[Talens, Simone; Leebeek, Frank W. G.; Rijken, Dingeman C.] Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands; [Demmers, Jeroen A. A.] Erasmus Univ, Prote Ctr, Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Talens, S (corresponding author), Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands.	d.rijken@erasmusmc.nl	Demmers, Jeroen/F-4046-2016	Demmers, Jeroen/0000-0002-8757-9611				Angles-Cano E, 2001, ANN NY ACAD SCI, V936, P261; Asztalos BF, 2004, ARTERIOSCL THROM VAS, V24, P2181, DOI 10.1161/01.ATV.0000146325.93749.a8; CHU CT, 1994, ANN NY ACAD SCI, V737, P291, DOI 10.1111/j.1749-6632.1994.tb44319.x; de Haas CJC, 2000, INFECT IMMUN, V68, P4954, DOI 10.1128/IAI.68.9.4954-4960.2000; Eichinger S, 2007, CIRCULATION, V115, P1609, DOI 10.1161/CIRCULATIONAHA.106.649954; Flinterman LE, 2010, BRIT J HAEMATOL, V149, P118, DOI 10.1111/j.1365-2141.2009.08074.x; Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Griffin JH, 1999, J CLIN INVEST, V103, P219, DOI 10.1172/JCI5006; HARPEL PC, 1979, J BIOL CHEM, V254, P8669; Henderson RJ, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-27; Holst AG, 2010, CIRCULATION, V121, P1896, DOI 10.1161/CIRCULATIONAHA.109.921460; Howes JM, 2012, DIABETES VASC DIS RE, V9, P216, DOI 10.1177/1479164111432788; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; HUH MM, 1988, BLOOD, V71, P1693; IINO M, 1995, EUR J BIOCHEM, V232, P90, DOI 10.1111/j.1432-1033.1995.tb20785.x; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; KOOPMAN J, 1992, J CLIN INVEST, V90, P238, DOI 10.1172/JCI115841; KUNITAKE ST, 1994, BIOCHEMISTRY-US, V33, P1988, DOI 10.1021/bi00174a003; LEE WM, 1992, NEW ENGL J MED, V326, P1335; Mahmoodi BK, 2008, CIRCULATION, V118, P1659, DOI 10.1161/CIRCULATIONAHA.108.780759; MUI PTK, 1977, AM J PHYSIOL, V233, pH346, DOI 10.1152/ajpheart.1977.233.3.H346; NAIR CH, 1991, THROMB RES, V61, P315, DOI 10.1016/0049-3848(91)90109-A; Ohkura N, 1997, BLOOD, V90, P1883, DOI 10.1182/blood.V90.5.1883; Oslakovic C, 2010, J CLIN INVEST, V120, P1396, DOI 10.1172/JCI42260; Oslakovic C, 2009, J BIOL CHEM, V284, P5896, DOI 10.1074/jbc.M807286200; Park CT, 2000, BLOOD, V95, P198, DOI 10.1182/blood.V95.1.198.001k31_198_204; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Prandoni P, 2007, J INTERN MED, V262, P341, DOI 10.1111/j.1365-2796.2007.01815.x; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; Reiner AP, 2001, THROMB HAEMOSTASIS, V85, P584; Rezaee F, 2006, PROTEOMICS, V6, P721, DOI 10.1002/pmic.200500191; Rijken DC, 2006, BIOCHEM BIOPH RES CO, V350, P191, DOI 10.1016/j.bbrc.2006.09.018; Rosenson RS, 2011, CLIN CHEM, V57, P392, DOI 10.1373/clinchem.2010.155333; Sahni A, 2004, BLOOD, V104, P409, DOI 10.1182/blood-2004-01-0126; Smalberg JH, 2011, ARTERIOSCL THROM VAS, V31, P485, DOI 10.1161/ATVBAHA.110.213371; TAKEBE M, 1995, THROMB HAEMOSTASIS, V73, P662; Talens S, 2011, J HEPATOL, V54, P908, DOI 10.1016/j.jhep.2010.08.026; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Valnickova Z, 1998, J BIOL CHEM, V273, P27220, DOI 10.1074/jbc.273.42.27220; Weisel JW, 2007, J THROMB HAEMOST, V5, P116, DOI 10.1111/j.1538-7836.2007.02504.x; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wolberg AS, 2010, HAEMOPHILIA, V16, P7, DOI 10.1111/j.1365-2516.2010.02253.x	45	44	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41966	10.1371/journal.pone.0041966	http://dx.doi.org/10.1371/journal.pone.0041966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870270	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100041
J	Zhang, DQ; Belenky, MA; Sollars, PJ; Pickard, GE; McMahon, DG				Zhang, Dao-Qi; Belenky, Michael A.; Sollars, Patricia J.; Pickard, Gary E.; McMahon, Douglas G.			Melanopsin Mediates Retrograde Visual Signaling in the Retina	PLOS ONE			English	Article							INNER PLEXIFORM LAYER; GANGLION-CELLS; DOPAMINERGIC-NEURONS; BIPOLAR CELLS; MOUSE RETINA; AXON COLLATERALS; DENDRITES; SYNAPSES; VISION; INPUT	The canonical flow of visual signals proceeds from outer to inner retina (photoreceptors -> bipolar cells -> ganglion cells). However, melanopsin-expressing ganglion cells are photosensitive and functional sustained light signaling to retinal dopaminergic interneurons persists in the absence of rods and cones. Here we show that the sustained-type light response of retinal dopamine neurons requires melanopsin and that the response is mediated by AMPA-type glutamate receptors, defining a retrograde retinal visual signaling pathway that fully reverses the usual flow of light signals in retinal circuits.	[Zhang, Dao-Qi] Oakland Univ, Eye Res Inst, Rochester, MI 48063 USA; [Belenky, Michael A.] Hebrew Univ Jerusalem, Dept Cell & Anim Biol, Jerusalem, Israel; [Sollars, Patricia J.; Pickard, Gary E.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE USA; [Pickard, Gary E.] Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE USA; [McMahon, Douglas G.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA	Oakland University; Hebrew University of Jerusalem; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Medical Center; Vanderbilt University	Zhang, DQ (corresponding author), Oakland Univ, Eye Res Inst, Rochester, MI 48063 USA.	zhang@oakland.edu; douglas.g.mcmahon@vanderbilt.edu			NIH [R01 EY09256, R01 EY017809]; Vanderbilt Vision Core Grant [P30 EY008126]; Oakland University Research Excellent Fund; Midwest Eye Bank Research Grant Award; NATIONAL EYE INSTITUTE [R01EY017809, P30EY008126, R01EY009256] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Vision Core Grant; Oakland University Research Excellent Fund; Midwest Eye Bank Research Grant Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by NIH R01 EY09256 to DGM, the Vanderbilt Vision Core Grant P30 EY008126, NIH R01 EY017809 to PJS and GEP, Oakland University Research Excellent Fund and Midwest Eye Bank Research Grant Award to D-QZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; Contini M, 2010, J COMP NEUROL, V518, P2035, DOI 10.1002/cne.22320; DACEY DM, 1985, J COMP NEUROL, V242, P247, DOI 10.1002/cne.902420207; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; DOWLING JE, 1978, PROC R SOC SER B-BIO, V201, P7, DOI 10.1098/rspb.1978.0030; Dumitrescu ON, 2009, J COMP NEUROL, V517, P226, DOI 10.1002/cne.22158; Fukaya M, 2006, EUR J NEUROSCI, V24, P2177, DOI 10.1111/j.1460-9568.2006.05081.x; Grimes WN, 2012, VISUAL NEUROSCI, V29, P41, DOI 10.1017/S0952523811000241; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hoshi H, 2009, J NEUROSCI, V29, P8875, DOI 10.1523/JNEUROSCI.0912-09.2009; Jackson CR, 2012, J NEUROSCI, V32, P9359, DOI 10.1523/JNEUROSCI.0711-12.2012; Peterson BB, 1998, VISUAL NEUROSCI, V15, P377, DOI 10.1017/S0952523898152161; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; SAKAI HM, 1986, NATURE, V319, P495, DOI 10.1038/319495a0; Thoreson WB, 2012, PROGR RETINAL EYE RE, P1; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Vugler AA, 2007, EXP NEUROL, V205, P26, DOI 10.1016/j.expneurol.2007.01.032; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105; Zhang DQ, 2007, J NEUROSCI, V27, P692, DOI 10.1523/JNEUROSCI.4478-06.2007; Zhang DQ, 2004, NEUROREPORT, V15, P1761, DOI 10.1097/01.wnr.0000135699.75775.41	22	57	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42647	10.1371/journal.pone.0042647	http://dx.doi.org/10.1371/journal.pone.0042647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880066	Green Published, gold			2022-12-27	WOS:000307284100150
J	Lennartsson, J; Hakansson, N; Wennergren, U; Jonsson, A				Lennartsson, Jenny; Hakansson, Nina; Wennergren, Uno; Jonsson, Annie			SpecNet: A Spatial Network Algorithm that Generates a Wide Range of Specific Structures	PLOS ONE			English	Article							OUTBREAKS; COMPONENT; GRAPHS; POINT	Network measures are used to predict the behavior of different systems. To be able to investigate how various structures behave and interact we need a wide range of theoretical networks to explore. Both spatial and non-spatial methods exist for generating networks but they are limited in the ability of producing wide range of network structures. We extend an earlier version of a spatial spectral network algorithm to generate a large variety of networks across almost all the theoretical spectra of the following network measures: average clustering coefficient, degree assortativity, fragmentation index, and mean degree. We compare this extended spatial spectral network-generating algorithm with a non-spatial algorithm regarding their ability to create networks with different structures and network measures. The spatial spectral network-generating algorithm can generate networks over a much broader scale than the non-spatial and other known network algorithms. To exemplify the ability to regenerate real networks, we regenerate networks with structures similar to two real Swedish swine transport networks. Results show that the spatial algorithm is an appropriate model with correlation coefficients at 0.99. This novel algorithm can even create negative assortativity and managed to achieve assortativity values that spans over almost the entire theoretical range.	[Lennartsson, Jenny; Hakansson, Nina; Jonsson, Annie] Univ Skovde, Syst Biol Res Ctr, Skovde, Sweden; [Hakansson, Nina; Wennergren, Uno] Linkoping Univ, Dept Phys & Measurement Technol, S-58183 Linkoping, Sweden	University of Skovde; Linkoping University	Lennartsson, J (corresponding author), Univ Skovde, Syst Biol Res Ctr, Skovde, Sweden.	annie.jonsson@his.se		Hakansson, Nina/0000-0003-2929-1617	Swedish Civil Contingencies Agency (MSB); Foreign Animal Disease Modeling program of the Science and Technology Directorate, Department of Homeland Security [ST-108-000017]	Swedish Civil Contingencies Agency (MSB); Foreign Animal Disease Modeling program of the Science and Technology Directorate, Department of Homeland Security	This work was partially funded by the Swedish Civil Contingencies Agency (MSB), and the authors also received support from the Foreign Animal Disease Modeling program of the Science and Technology Directorate, Department of Homeland Security (grant ST-108-000017). No additional external funding received for this study. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Ames GM, 2011, P ROY SOC B-BIOL SCI, V278, P3544, DOI 10.1098/rspb.2011.0290; Asano T, 1995, J COMPUT SYST SCI, V51, P503, DOI 10.1006/jcss.1995.1086; Badham J, 2008, THEOR POPUL BIOL, V74, P161, DOI 10.1016/j.tpb.2008.06.002; Badham J, 2010, JASSS-J ARTIF SOC S, V13, DOI 10.18564/jasss.1501; Badham J, 2010, THEOR POPUL BIOL, V77, P71, DOI 10.1016/j.tpb.2009.11.003; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Bell DC, 1999, SOC NETWORKS, V21, P1, DOI 10.1016/S0378-8733(98)00010-0; BENDER EA, 1978, J COMB THEORY A, V24, P296, DOI 10.1016/0097-3165(78)90059-6; Boily MC, 2007, MATH POPUL STUD, V14, P237, DOI 10.1080/08898480701612873; Borgatti S, 2003, KEY PLAYER PROBLEM D; Catanzaro M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.027103; Christley R. M., 2005, Society for Veterinary Epidemiology and Preventive Medicine. Proceedings of a meeting held at Nairn, Inverness, Scotland, 30th March-1st April 2005, P234; Christley RM, 2005, AM J EPIDEMIOL, V162, P1024, DOI 10.1093/aje/kwi308; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Gastner MT, 2006, EUR PHYS J B, V49, P247, DOI 10.1140/epjb/e2006-00046-8; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hakansson N, 2010, ADV COMPLEX SYST, V13, P239, DOI 10.1142/S0219525910002517; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Keeling M, 2005, THEOR POPUL BIOL, V67, P1, DOI 10.1016/j.tpb.2004.08.002; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Molloy M, 1998, COMB PROBAB COMPUT, V7, P295, DOI 10.1017/S0963548398003526; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Mugglestone MA, 2001, ENVIRON ECOL STAT, V8, P237, DOI 10.1023/A:1011339607376; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Pusch A, 2008, PHYS REV E, V77; Serrano MA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036133; Sevtsuk A, 2010, J URBAN TECHNOL, V17, P41, DOI 10.1080/10630731003597322; Shirley MDF, 2005, ECOL COMPLEX, V2, P287, DOI 10.1016/j.ecocom.2005.04.005; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Webb CR, 2005, PREV VET MED, V68, P3, DOI 10.1016/j.prevetmed.2005.01.003; Weber S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046111; Yook SH, 2002, P NATL ACAD SCI USA, V99, P13382, DOI 10.1073/pnas.172501399	41	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42679	10.1371/journal.pone.0042679	http://dx.doi.org/10.1371/journal.pone.0042679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876329	Green Submitted, Green Published, gold			2022-12-27	WOS:000307184700057
J	Gatheral, T; Reed, DM; Moreno, L; Gough, PJ; Votta, BJ; Sehon, CA; Rickard, DJ; Bertin, J; Lim, E; Nicholson, AG; Mitchell, JA				Gatheral, Timothy; Reed, Daniel M.; Moreno, Laura; Gough, Peter J.; Votta, Bart J.; Sehon, Clark A.; Rickard, David J.; Bertin, John; Lim, Eric; Nicholson, Andrew G.; Mitchell, Jane A.			A Key Role for the Endothelium in NOD1 Mediated Vascular Inflammation: Comparison to TLR4 Responses	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NUCLEOTIDE OLIGOMERIZATION DOMAIN; PATTERN-RECOGNITION RECEPTORS; NITRIC-OXIDE SYNTHASE; KAPPA-B ACTIVATION; SEVERE SEPSIS; ORGAN-CULTURE; SMOOTH-MUSCLE; SEPTIC SHOCK; INDUCTION	Understanding the mechanisms by which pathogens induce vascular inflammation and dysfunction may reveal novel therapeutic targets in sepsis and related conditions. The intracellular receptor NOD1 recognises peptidoglycan which features in the cell wall of Gram negative and some Gram positive bacteria. NOD1 engagement generates an inflammatory response via activation of NFkB and MAPK pathways. We have previously shown that stimulation of NOD1 directly activates blood vessels and causes experimental shock in vivo. In this study we have used an ex vivo vessel-organ culture model to characterise the relative contribution of the endothelium in the response of blood vessels to NOD1 agonists. In addition we present the novel finding that NOD1 directly activates human blood vessels. Using human cultured cells we confirm that endothelial cells respond more avidly to NOD1 agonists than vascular smooth muscle cells. Accordingly we have sought to pharmacologically differentiate NOD1 and TLR4 mediated signalling pathways in human endothelial cells, focussing on TAK1, NFkB and p38 MAPK. In addition we profile novel inhibitors of RIP2 and NOD1 itself, which specifically inhibit NOD1 ligand induced inflammatory signalling in the vasculature. This paper is the first to demonstrate activation of whole human artery by NOD1 stimulation and the relative importance of the endothelium in the sensing of NOD1 ligands by vessels. This data supports the potential utility of NOD1 and RIP2 as therapeutic targets in human disease where vascular inflammation is a clinical feature, such as in sepsis and septic shock.	[Gatheral, Timothy; Reed, Daniel M.; Moreno, Laura; Lim, Eric; Nicholson, Andrew G.; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Moreno, Laura] Univ Complutense Madrid, Sch Med, Dept Pharmacol, Madrid, Spain; [Gough, Peter J.; Votta, Bart J.; Sehon, Clark A.; Rickard, David J.; Bertin, John] GlaxoSmithKline, Immunoinflammat Therapeut Area, Pattern Recognit Receptor Discovery Performance U, Philadelphia, PA USA; [Lim, Eric; Nicholson, Andrew G.] Royal Brompton & Harefield NHS Fdn Trust, London, England; [Mitchell, Jane A.] ICMS, London, England	Imperial College London; Complutense University of Madrid; GlaxoSmithKline; Royal Brompton & Harefield NHS Foundation Trust	Gatheral, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	j.a.mitchell@ic.ac.uk	Moreno, Laura/A-9433-2010	Moreno, Laura/0000-0001-9028-2299; Reed, Daniel/0000-0002-8326-5957; Gatheral, Timothy/0000-0003-2677-8729	British Heart Foundation [FS/09/017/26810]; Wellcome Trust [0852551Z108/Z]	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by the British Heart Foundation (grant number FS/09/017/26810) and the Wellcome Trust (grant number 0852551Z108/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barochia A, 2011, EXPERT OPIN DRUG MET, V7, P479, DOI 10.1517/17425255.2011.558190; BishopBailey D, 1997, BRIT J PHARMACOL, V121, P125, DOI 10.1038/sj.bjp.0701100; Cartwright N, 2007, AM J RESP CRIT CARE, V175, P595, DOI 10.1164/rccm.200608-1103OC; Cartwright N, 2007, SHOCK, V27, P40, DOI 10.1097/01.shk.0000235127.59492.db; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jimenez R, 2005, P NATL ACAD SCI USA, V102, P4637, DOI 10.1073/pnas.0407655101; Jourdan KB, 1997, BIOCHEM BIOPH RES CO, V233, P668, DOI 10.1006/bbrc.1997.6523; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Magalhaes JG, 2011, EUR J IMMUNOL, V41, P1445, DOI 10.1002/eji.201040827; Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9; Marti-Carvajal AJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004388.pub4; Martin G, 2009, CRIT CARE, V13, DOI 10.1186/cc7936; McDonald C, 2005, J BIOL CHEM, V280, P20177, DOI 10.1074/jbc.R500001200; Mitchell JA, 2007, BIOCHEM SOC T, V35, P1449, DOI 10.1042/BST0351449; Mitchell JA, 2007, J ENDOCRINOL, V193, P323, DOI 10.1677/JOE-07-0067; Mitka M, 2011, JAMA-J AM MED ASSOC, V306, P2439, DOI 10.1001/jama.2011.1755; Moreno L, 2010, BRIT J PHARMACOL, V160, P1997, DOI 10.1111/j.1476-5381.2010.00814.x; Myhre AE, 2006, SHOCK, V25, P227, DOI 10.1097/01.shk.0000191378.55274.37; Netea MG, 2011, NEW ENGL J MED, V364, P60, DOI 10.1056/NEJMra1001976; Nishio H, 2011, ARTERIOSCLER THROMB; Opitz B, 2006, J IMMUNOL, V176, P484, DOI 10.4049/jimmunol.176.1.484; Opitz B, 2005, CIRC RES, V96, P319, DOI 10.1161/01.RES.0000155721.83594.2c; Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Patel GP, 2011, AM J RESP CRIT CARE; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; SZABO C, 1993, BRIT J PHARMACOL, V108, P786, DOI 10.1111/j.1476-5381.1993.tb12879.x; van Heel DA, 2005, EUR J IMMUNOL, V35, P2471, DOI 10.1002/eji.200526296; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006	36	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42386	10.1371/journal.pone.0042386	http://dx.doi.org/10.1371/journal.pone.0042386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870324	Green Published, gold, Green Submitted			2022-12-27	WOS:000307212800087
J	Philipose, S; Konya, V; Lazarevic, M; Pasterk, LM; Marsche, G; Frank, S; Peskar, BA; Heinemann, A; Schuligoi, R				Philipose, Sonia; Konya, Viktoria; Lazarevic, Mirjana; Pasterk, Lisa M.; Marsche, Gunther; Frank, Sasa; Peskar, Bernhard A.; Heinemann, Akos; Schuligoi, Rufina			Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation	PLOS ONE			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; PROSTAGLANDIN D-2 RECEPTOR; EXTENDED-RELEASE NIACIN/LAROPIPRANT; HUMAN PLATELETS; NICOTINIC-ACID; IN-VITRO; ENDOTHELIAL-CELLS; CYCLIC-AMP; HUMAN BASOPHILS; SMOOTH-MUSCLE	The use of the lipid lowering agent niacin is hampered by a frequent flush response which is largely mediated by prostaglandin (PG) D-2. Therefore, concomitant administration of the D-type prostanoid (DP) receptor antagonist laropiprant has been proposed to be a useful approach in preventing niacin-induced flush. However, antagonizing PGD(2), which is a potent inhibitor of platelet aggregation, might pose the risk of atherothrombotic events in cardiovascular disease. In fact, we found that in vitro treatment of platelets with laropiprant prevented the inhibitory effects of PGD(2) on platelet function, i.e. platelet aggregation, Ca2+ flux, P-selectin expression, activation of glycoprotein IIb/IIIa and thrombus formation. In contrast, laropiprant did not prevent the inhibitory effects of acetylsalicylic acid or niacin on thrombus formation. At higher concentrations, laropiprant by itself attenuated platelet activation induced by thromboxane (TP) and E-type prostanoid (EP)-3 receptor stimulation, as demonstrated in assays of platelet aggregation, Ca2+ flux, P-selectin expression, and activation of glycoprotein IIb/IIIa. Inhibition of platelet function exerted by EP4 or I-type prostanoid (IP) receptors was not affected by laropiprant. These in vitro data suggest that niacin/laropiprant for the treatment of dyslipidemias might have a beneficial profile with respect to platelet function and thrombotic events in vascular disease.	[Philipose, Sonia; Konya, Viktoria; Lazarevic, Mirjana; Pasterk, Lisa M.; Marsche, Gunther; Peskar, Bernhard A.; Heinemann, Akos; Schuligoi, Rufina] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria; [Frank, Sasa] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria	Medical University of Graz; Medical University of Graz	Philipose, S (corresponding author), Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria.	akos.heinemann@medunigraz.at		Marsche, Gunther/0000-0002-2422-5381; Konya, Viktoria/0000-0002-7999-9093; Heinemann, Akos/0000-0002-8554-2372	PhD Program in Molecular Medicine of the Medical University of Graz; Jubilaumsfonds of the Austrian National Bank (OeNB) [13487, 14263]; Austrian Science Fund (FWF) [P22521-B18, P19473-B05, P21004-B02, P22976-B18]; Austrian Science Fund (FWF) [P 21004, P 22521, P 22976] Funding Source: researchfish	PhD Program in Molecular Medicine of the Medical University of Graz; Jubilaumsfonds of the Austrian National Bank (OeNB); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Dr. Philipose was funded by the PhD Program in Molecular Medicine of the Medical University of Graz. This study was supported by the Jubilaumsfonds of the Austrian National Bank (OeNB, grants 13487 and 14263) and the Austrian Science Fund (FWF; grants P22521-B18, P19473-B05, P21004-B02 and P22976-B18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI M, 1977, THROMB RES, V11, P485, DOI 10.1016/0049-3848(77)90202-X; ANHUT H, 1978, N-S ARCH PHARMACOL, V305, P247, DOI 10.1007/BF00498818; Armstrong RA, 1996, PHARMACOL THERAPEUT, V72, P171, DOI 10.1016/S0163-7258(96)00103-9; Bays HE, 2010, J CLIN LIPIDOL, V4, P515, DOI 10.1016/j.jacl.2010.08.020; Bearer EL, 2000, CELL MOTIL CYTOSKEL, V47, P351, DOI 10.1002/1097-0169(200012)47:4<351::AID-CM8>3.0.CO;2-8; Bishop-Bailey D, 1998, ARTERIOSCL THROM VAS, V18, P1655, DOI 10.1161/01.ATV.18.10.1655; BishopBailey D, 1997, ARTERIOSCL THROM VAS, V17, P1644, DOI 10.1161/01.ATV.17.9.1644; Bodor ET, 2008, BRIT J PHARMACOL, V153, pS68, DOI 10.1038/sj.bjp.0707528; Bohm E, 2004, J BIOL CHEM, V279, P7663, DOI 10.1074/jbc.M310270200; Brinton EA, 2011, AM J CARDIOVASC DRUG, V11, P179, DOI 10.2165/11592560-000000000-00000; BUTT E, 1994, J BIOL CHEM, V269, P14509; Camacho M, 1998, CIRC RES, V83, P353, DOI 10.1161/01.RES.83.4.353; Curvers J, 2008, TRANSFUSION, V48, P1439, DOI 10.1111/j.1537-2995.2008.01738.x; Eguchi Y, 1997, P NATL ACAD SCI USA, V94, P14689, DOI 10.1073/pnas.94.26.14689; FEINSTEIN MB, 1983, BIOCHEM BIOPH RES CO, V113, P598, DOI 10.1016/0006-291X(83)91768-0; GILES H, 1989, BRIT J PHARMACOL, V96, P291, DOI 10.1111/j.1476-5381.1989.tb11816.x; GRAY SJ, 1992, BRIT J CLIN PHARMACO, V34, P344, DOI 10.1111/j.1365-2125.1992.tb05641.x; GRESELE P, 1988, J PHARMACOL EXP THER, V246, P301; Gross S, 2007, J EXP MED, V204, P311, DOI 10.1084/jem.20061617; Hanson J, 2010, J CLIN INVEST, V120, P2910, DOI 10.1172/JCI42273; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Heinemann A, 2003, PHARMACOLOGY, V67, P49, DOI 10.1159/000066786; Heptinstall S, 2008, PLATELETS, V19, P605, DOI 10.1080/09537100802351073; HIRATA M, 1994, P NATL ACAD SCI USA, V91, P11192, DOI 10.1073/pnas.91.23.11192; Hu H, 2005, THROMB RES, V116, P241, DOI 10.1016/j.thromres.2004.12.015; Hyo S, 2007, ARCH OTOLARYNGOL, V133, P693, DOI 10.1001/archotol.133.7.693; Inoue T, 2008, ATHEROSCLEROSIS, V201, P385, DOI 10.1016/j.atherosclerosis.2008.03.010; ITO S, 1989, PROSTAG LEUKOTR ESS, V37, P219, DOI 10.1016/0952-3278(89)90033-1; Iyu D, 2010, PLATELETS, V21, P329, DOI 10.3109/09537101003718065; Jones RL, 2011, BRIT J PHARMACOL, V162, P521, DOI 10.1111/j.1476-5381.2010.01039.x; Kamanna VS, 2009, INT J CLIN PRACT, V63, P1369, DOI 10.1111/j.1742-1241.2009.02099.x; Karanam B, 2007, DRUG METAB DISPOS, V35, P1196, DOI 10.1124/dmd.107.014696; Kobayashi K, 2011, EUR J PHARMACOL, V660, P375, DOI 10.1016/j.ejphar.2011.03.032; Kohler D, 2011, CIRCULATION, V123, P2579, DOI 10.1161/CIRCULATIONAHA.110.014555; Kuriyama S, 2010, THROMB HAEMOSTASIS, V104, P796, DOI 10.1160/TH10-01-0043; Lai E, 2008, CLIN PHARMACOL THER, V83, P840, DOI 10.1038/sj.clpt.6100345; Lai E, 2010, PLATELETS, V21, P191, DOI 10.3109/09537100903521611; Laky M, 2011, THROMB RES, V128, P155, DOI 10.1016/j.thromres.2011.02.016; Maccubbin D, 2008, INT J CLIN PRACT, V62, P1959, DOI 10.1111/j.1742-1241.2008.01938.x; McKenney J, 2010, J CLIN LIPIDOL, V4, P105, DOI 10.1016/j.jacl.2010.02.002; MORROW JD, 1989, PROSTAGLANDINS, V38, P263, DOI 10.1016/0090-6980(89)90088-9; NAGAKAWA Y, 1985, THROMB RES, V40, P543, DOI 10.1016/0049-3848(85)90291-9; NOZAKI S, 1987, INT J CLIN PHARM TH, V25, P643; OELZ O, 1977, PROSTAGLANDINS, V13, P225, DOI 10.1016/0090-6980(77)90004-1; OLSSON AG, 1983, LANCET, V2, P565; Papaliodis D, 2008, J PHARMACOL EXP THER, V327, P665, DOI 10.1124/jpet.108.141333; Philipose S, 2010, ARTERIOSCL THROM VAS, V30, P2416, DOI 10.1161/ATVBAHA.110.216374; Rossi F, 2001, HAEMATOLOGICA, V86, P192; Saareks V, 2002, PHARMACOL TOXICOL, V90, P338, DOI 10.1034/j.1600-0773.2002.900608.x; Sanyal S, 2010, DRUG TODAY, V46, P371, DOI 10.1358/dot.2010.46.6.1464844; SCHLEIMER RP, 1985, J ALLERGY CLIN IMMUN, V76, P369, DOI 10.1016/0091-6749(85)90656-6; Schratl P, 2007, J IMMUNOL, V179, P4792, DOI 10.4049/jimmunol.179.7.4792; Schuligoi R, 2007, BIOCHEM PHARMACOL, V74, P107, DOI 10.1016/j.bcp.2007.03.023; Schuligoi R, 2009, J LEUKOCYTE BIOL, V85, P136, DOI 10.1189/jlb.0608387; Serebruany V, 2010, THROMB HAEMOSTASIS, V104, P311, DOI 10.1160/TH10-01-0015; SHIO H, 1972, PROSTAGL, V1, P29, DOI 10.1016/0090-6980(72)90063-9; Smith JP, 2010, THROMB RES, V126, pE23, DOI 10.1016/j.thromres.2010.04.003; SMITH JB, 1992, BIOCHEM J, V283, P889, DOI 10.1042/bj2830889; Soler M, 2000, CIRC RES, V87, P504; SVENSSON J, 1976, ACTA PHYSIOL SCAND, V98, P285, DOI 10.1111/j.1748-1716.1976.tb10313.x; Taba Y, 2000, CIRC RES, V86, P967, DOI 10.1161/01.RES.86.9.967; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; URADE Y, 1989, J IMMUNOL, V143, P2982; VANE JR, 1995, AM J CARDIOL, V75, pA3, DOI 10.1016/S0002-9149(99)80377-4; VEZZA R, 1993, BLOOD, V82, P2704; Vinall SL, 2007, IMMUNOLOGY, V121, P577, DOI 10.1111/j.1365-2567.2007.02606.x; WATANABE T, 1982, J BIOL CHEM, V257, P4847; WATTS IS, 1991, BRIT J PHARMACOL, V102, P497, DOI 10.1111/j.1476-5381.1991.tb12200.x; Yiu KH, 2010, EXPERT OPIN INV DRUG, V19, P437, DOI 10.1517/13543781003623223	69	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40222	10.1371/journal.pone.0040222	http://dx.doi.org/10.1371/journal.pone.0040222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870195	Green Published, gold			2022-12-27	WOS:000307212800005
J	Stumpf, RP; Wynne, TT; Baker, DB; Fahnenstiel, GL				Stumpf, Richard P.; Wynne, Timothy T.; Baker, David B.; Fahnenstiel, Gary L.			Interannual Variability of Cyanobacterial Blooms in Lake Erie	PLOS ONE			English	Article							LAURENTIAN GREAT-LAKES; MICROCYSTIS-AERUGINOSA; SATELLITE DETECTION; SAGINAW BAY; MERIS; ECOSYSTEM; CHLOROPHYLL; QUALITY; MUSSELS; BIOMASS	After a 20-year absence, severe cyanobacterial blooms have returned to Lake Erie in the last decade, in spite of negligible change in the annual load of total phosphorus (TP). Medium-spectral Resolution Imaging Spectrometer (MERIS) imagery was used to quantify intensity of the cyanobacterial bloom for each year from 2002 to 2011. The blooms peaked in August or later, yet correlate to discharge (Q) and TP loads only for March through June. The influence of the spring TP load appears to have started in the late 1990 s, after Dreissenid mussels colonized the lake, as hindcasts prior to 1998 are inconsistent with the observed blooms. The total spring Q or TP load appears sufficient to predict bloom magnitude, permitting a seasonal forecast prior to the start of the bloom.	[Stumpf, Richard P.; Wynne, Timothy T.] NOAA, Natl Ctr Coastal Ocean Sci, Silver Spring, MD USA; [Baker, David B.] Univ Heidelberg, Natl Ctr Water Qual Res, Tiffin, OH USA; [Fahnenstiel, Gary L.] NOAA, Great Lakes Environm Res Lab, Muskegon, MI USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); Heidelberg University USA; National Oceanic Atmospheric Admin (NOAA) - USA	Stumpf, RP (corresponding author), NOAA, Natl Ctr Coastal Ocean Sci, Silver Spring, MD USA.	Richard.stumpf@noaa.gov	Fahnenstiel, Gary/ABD-6133-2020; Stumpf, Richard/L-5237-2019	Stumpf, Richard/0000-0001-5531-6860	NASA [NNH08ZDA001N]; NOAA Oceans and Human Health Initiative;  [NNH09AL53I]	NASA(National Aeronautics & Space Administration (NASA)); NOAA Oceans and Human Health Initiative(National Oceanic Atmospheric Admin (NOAA) - USA); 	This study was partially funded by NASA Applied Science Program announcement NNH08ZDA001N, contract NNH09AL53I, and the NOAA Oceans and Human Health Initiative. MERIS imagery was provided by the European Space Agency (Category-1 Proposal C1P.9975). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, LAKELINES; Binding CE, 2012, J PLANKTON RES, V34, P569, DOI 10.1093/plankt/fbs021; Binding CE, 2011, J PLANKTON RES, V33, P1847, DOI 10.1093/plankt/fbr079; Bridgeman TB, 2012, J GREAT LAKES RES, V38, P90, DOI 10.1016/j.jglr.2011.09.010; Brookes JD, 2011, SCIENCE, V334, P46, DOI 10.1126/science.1207349; Budd J.W., 2001, VERH INT VEREIN LIMN, V27, P3787; Budd JW, 2001, LIMNOL OCEANOGR, V46, P213, DOI 10.4319/lo.2001.46.2.0213; Carmichael W, 2008, ADV EXP MED BIOL, V619, P105, DOI 10.1007/978-0-387-75865-7_4; Chaffin JD, 2011, J GREAT LAKES RES, V37, P92, DOI 10.1016/j.jglr.2010.11.016; Conroy JD, 2005, J GREAT LAKES RES, V31, P89, DOI 10.1016/S0380-1330(05)70307-5; Culver DA, 1999, TOXICITY ECOLOGICAL; European Space Agency, 2012, MERIS PROD ALG; Evans MA, 2010, ENVIRON RES LETT, V6, P1; Gower J, 2005, INT J REMOTE SENS, V26, P2005, DOI 10.1080/01431160500075857; Gower JFR, 1999, INT J REMOTE SENS, V20, P1771, DOI 10.1080/014311699212470; Graham JL, 2010, ENVIRON SCI TECHNOL, V44, P7361, DOI 10.1021/es1008938; Hunter PD, 2008, LIMNOL OCEANOGR, V53, P2391, DOI 10.4319/lo.2008.53.6.2391; Joosse PJ, 2011, CAN J SOIL SCI, V91, P317, DOI [10.4141/CJSS10005, 10.4141/cjss10005]; KAHRU M, 1994, AMBIO, V23, P469; Kutovaya OA, 2012, HARMFUL ALGAE, V15, P71, DOI 10.1016/j.hal.2011.11.007; Kutser T, 2004, LIMNOL OCEANOGR, V49, P2179, DOI 10.4319/lo.2004.49.6.2179; Long BM, 2001, APPL ENVIRON MICROB, V67, P278, DOI 10.1128/AEM.67.1.278-283.2001; MAKAREWICZ JC, 1991, BIOSCIENCE, V41, P216, DOI 10.2307/1311411; McGillicuddy DJ, 2011, LIMNOL OCEANOGR, V56, P2411, DOI 10.4319/lo.2011.56.6.2411; Millie DF, 2009, AQUAT ECOL, V43, P915, DOI 10.1007/s10452-009-9238-7; Mocko D., 2012, NASAGSFCHSL NLDAS PR, DOI [10.5067/Z62LT6J96R4F, DOI 10.5067/Z62LT6J96R4F]; Nalepa TF, 1995, J GREAT LAKES RES, V21, P411, DOI 10.1016/S0380-1330(95)71055-3; NOAA, 2012, HARMF ALG BLOOMS LAK; O'Dell J, 1993, 600R93100 EPA ENV MO; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richards RP, 2010, J SOIL WATER CONSERV, V65, P450, DOI 10.2489/jswc.65.6.450; Richards RP, 2002, J ENVIRON QUAL, V31, P6, DOI 10.2134/jeq2002.0006; Rinta-Kanto JM, 2005, ENVIRON SCI TECHNOL, V39, P4198, DOI 10.1021/es048249u; Ruiz-Verdu A, 2008, REMOTE SENS ENVIRON, V112, P3996, DOI 10.1016/j.rse.2007.11.019; Twiss MR, 2012, J GREAT LAKES RES, V38, P18, DOI 10.1016/j.jglr.2011.12.008; US Environmental Protection Agency, 1986, PHOSPH DIET LOW LAK; Vanderploeg HA, 2002, CAN J FISH AQUAT SCI, V59, P1209, DOI 10.1139/F02-087; Wang J, 2012, J CLIMATE, V25, P1318, DOI 10.1175/2011JCLI4066.1; Wynne TT, 2008, INT J REMOTE SENS, V29, P3665, DOI 10.1080/01431160802007640; Wynne TT, 2010, LIMNOL OCEANOGR, V55, P2025, DOI 10.4319/lo.2010.55.5.2025	41	286	290	9	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42444	10.1371/journal.pone.0042444	http://dx.doi.org/10.1371/journal.pone.0042444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870327	Green Published, Green Submitted, gold			2022-12-27	WOS:000307212800091
J	Anikeeva, N; Gakamsky, D; Scholler, J; Sykulev, Y				Anikeeva, Nadia; Gakamsky, Dimitry; Scholler, Jorgen; Sykulev, Yuri			Evidence that the Density of Self Peptide-MHC Ligands Regulates T-Cell Receptor Signaling	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; ANTIGEN RECOGNITION; IMMUNOLOGICAL SYNAPSE; TETRASPAN MICRODOMAINS; CYTOLYTIC ACTIVITY; QUANTUM DOTS; CD8; ACTIVATION; COMPLEX; TCR	Noncognate or self peptide-MHC (pMHC) ligands productively interact with T-cell receptor (TCR) and are always in a large access over the cognate pMHC on the surface of antigen presenting cells. We assembled soluble cognate and noncognate pMHC class I (pMHC-I) ligands at designated ratios on various scaffolds into oligomers that mimic pMHC clustering and examined how multivalency and density of the pMHCs in model clusters influences the binding to live CD8 T cells and the kinetics of TCR signaling. Our data demonstrate that the density of self pMHC-I proteins promotes their interaction with CD8 co-receptor, which plays a critical role in recognition of a small number of cognate pMHC-I ligands. This suggests that MHC clustering on live target cells could be utilized as a sensitive mechanism to regulate T cell responsiveness.	[Anikeeva, Nadia; Sykulev, Yuri] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [Anikeeva, Nadia; Sykulev, Yuri] Thomas Jefferson Univ, Kimmel Canc Inst, Philadelphia, PA 19107 USA; [Gakamsky, Dimitry] Edinburgh Instruments Ltd, Livingston, Scotland; [Scholler, Jorgen] Immudex Inc, Copenhagen, Denmark	Jefferson University; Jefferson University	Anikeeva, N (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	ysykulev@lac.jci.tju.edu	Gakamsky, Dmitry/H-6947-2013		National Institute of Health [AI52812, CA131973]; Royal Society Industry Fellowship; NATIONAL CANCER INSTITUTE [R21CA131973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052812, R56AI052812] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society Industry Fellowship(Royal Society of London); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by National Institute of Health AI52812, CA131973 grants to YS and a Royal Society Industry Fellowship to DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anikeeva N, 2003, J IMMUNOL METHODS, V277, P75, DOI 10.1016/S0022-1759(03)00179-0; Anikeeva N, 2003, BIOCHEMISTRY-US, V42, P4709, DOI 10.1021/bi026864+; Anikeeva N, 2006, P NATL ACAD SCI USA, V103, P16846, DOI 10.1073/pnas.0607771103; Anikeeva N, 2011, NANOTECHNOLOGY 2011: BIO SENSORS, INSTRUMENTS, MEDICAL, ENVIRONMENT AND ENERGY, NSTI-NANOTECH 2011, VOL 3, P443; Anikeeva N, 2011, IMMUNOL RES, V51, P183, DOI 10.1007/s12026-011-8252-8; Anikeeva N, 2009, CLIN IMMUNOL, V130, P98, DOI 10.1016/j.clim.2008.08.025; Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Capps GG, 2004, BIOPHYS J, V86, P2896, DOI 10.1016/S0006-3495(04)74341-6; Cebecauer M, 2005, J BIOL CHEM, V280, P23820, DOI 10.1074/jbc.M500654200; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Cho BK, 2001, P NATL ACAD SCI USA, V98, P1723, DOI 10.1073/pnas.98.4.1723; Cochran JR, 2001, J BIOL CHEM, V276, P28068, DOI 10.1074/jbc.M103280200; Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y; Ditlev JA, 2012, J CELL BIOL, V197, P643, DOI 10.1083/jcb.201111113; Edidin M, 2010, IMMUNOL RES, V47, P265, DOI 10.1007/s12026-009-8159-9; ELOVAARA I, 1993, J EXP MED, V177, P1567, DOI 10.1084/jem.177.6.1567; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Gakamsky DM, 2000, BIOCHEMISTRY-US, V39, P11163, DOI 10.1021/bi000763z; Gakamsky DM, 2005, BIOPHYS J, V89, P2121, DOI 10.1529/biophysj.105.061671; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Gascoigne NRJ, 2010, CURR TOP MICROBIOL, V340, P171, DOI 10.1007/978-3-642-03858-7_9; Gaspar R, 2001, J IMMUNOL, V166, P5078, DOI 10.4049/jimmunol.166.8.5078; Germain RN, 2002, ADV EXP MED BIOL, V512, P97; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Hwang J, 1998, BIOPHYS J, V74, P2184, DOI 10.1016/S0006-3495(98)77927-5; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Kao C, 2005, INT IMMUNOL, V17, P1607, DOI 10.1093/intimm/dxh340; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750; Kumar R, 2011, IMMUNITY, V35, P375, DOI 10.1016/j.immuni.2011.08.010; Kundu SK, 1998, AIDS RES HUM RETROV, V14, P1669, DOI 10.1089/aid.1998.14.1669; Lebedeva T, 2004, IMMUNOLOGY, V113, P460, DOI 10.1111/j.1365-2567.2004.01985.x; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Ma ZY, 2008, PLOS BIOL, V6, P328, DOI 10.1371/journal.pbio.0060043; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Maeurer M, 2001, TRENDS IMMUNOL, V22, P599, DOI 10.1016/S1471-4906(01)02061-0; Massilamany C, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-40; MATKO J, 1994, J IMMUNOL, V152, P3353; Nagy P, 2006, BIOCHEM BIOPH RES CO, V347, P758, DOI 10.1016/j.bbrc.2006.06.157; Pecht I, 2005, FEBS LETT, V579, P3336, DOI 10.1016/j.febslet.2005.04.025; Raine T, 2006, RHEUMATOLOGY, V45, P1338, DOI 10.1093/rheumatology/kel305; Reth M, 2001, TRENDS IMMUNOL, V22, P356, DOI 10.1016/S1471-4906(01)01964-0; Sapsford KE, 2007, J PHYS CHEM C, V111, P11528, DOI 10.1021/jp073550t; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Scholler J, 2010, J IMMUNOL METHODS, V360, P1, DOI 10.1016/j.jim.2010.05.008; Segura JM, 2008, J BIOL CHEM, V283, P24254, DOI 10.1074/jbc.M803549200; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; Sykulev Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3153pe50; Takada K, 2009, J EXP MED, V206, P2253, DOI 10.1084/jem.20082553; TSOMIDES TJ, 1991, P NATL ACAD SCI USA, V88, P11276, DOI 10.1073/pnas.88.24.11276; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; Valmori D, 1998, J IMMUNOL, V160, P1750; Vogt AB, 2002, IMMUNOL REV, V189, P136, DOI 10.1034/j.1600-065X.2002.18912.x; Wooldridge L, 2010, J IMMUNOL, V185, P4625, DOI 10.4049/jimmunol.1001480; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Yachi PP, 2007, J EXP MED, V204, P2747, DOI 10.1084/jem.20062610; Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; Zhong LY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005945	68	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e41466	10.1371/journal.pone.0041466	http://dx.doi.org/10.1371/journal.pone.0041466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22870225	Green Published, gold, Green Submitted			2022-12-27	WOS:000307378500005
J	Hein, R; Maranian, M; Hopper, JL; Kapuscinski, MK; Southey, MC; Park, DJ; Schmidt, MK; Broeks, A; Hogervorst, FBL; Bueno-de-Mesquit, HB; Muir, KR; Lophatananon, A; Rattanamongkongul, S; Puttawibul, P; Fasching, PA; Hein, A; Ekici, AB; Beckmann, MW; Fletcher, O; Johnson, N; Silva, ID; Peto, J; Sawyer, E; Tomlinson, I; Kerin, M; Miller, N; Marmee, F; Schneeweiss, A; Sohn, C; Burwinkel, B; Guenel, P; Cordina-Duverger, E; Menegaux, F; Truong, T; Bojesen, SE; Nordestgaard, BG; Flyger, H; Milne, RL; Perez, JIA; Zamora, MP; Benitez, J; Anton-Culver, H; Ziogas, A; Bernstein, L; Clarke, CA; Brenner, H; Muller, H; Arndt, V; Stegmaier, C; Rahman, N; Seal, S; Turnbull, C; Renwick, A; Meindl, A; Schott, S; Bartram, CR; Schmutzler, RK; Brauch, H; Hamann, U; Ko, YD; Wang-Gohrke, S; Dork, T; Schurmann, P; Karstens, JH; Hillemanns, P; Nevanlinna, H; Heikkinen, T; Aittomaki, K; Blomqvist, C; Bogdanova, NV; Zalutsky, IV; Antonenkova, NN; Bermisheva, M; Prokovieva, D; Farahtdinova, A; Khusnutdinova, E; Lindblom, A; Margolin, S; Mannermaa, A; Kataja, V; Kosma, VM; Hartikainen, J; Chen, XQ; Beesley, J; Lambrechts, D; Zhao, H; Neven, P; Wildiers, H; Nickels, S; Flesch-Janys, D; Radice, P; Peterlongo, P; Manoukian, S; Barile, M; Couch, FJ; Olson, JE; Wang, XS; Fredericksen, Z; Giles, GG; Baglietto, L; McLean, CA; Severi, G; Offit, K; Robson, M; Gaudet, MM; Vijai, J; Alnaes, GG; Kristensen, V; Borresen-Dale, AL; John, EM; Miron, A; Winqvist, R; Pylkas, K; Jukkola-Vuorinen, A; Grip, M; Andrulis, IL; Knight, JA; Glendon, G; Mulligan, AM; Figueroa, JD; Garcia-Closas, M; Lissowska, J; Sherman, ME; Hooning, M; Martens, JWM; Seynaeve, C; Collee, M; Hall, P; Humpreys, K; Czene, K; Liu, JJ; Cox, A; Brock, IW; Cross, SS; Reed, MWR; Ahmed, S; Ghoussaini, M; Pharoah, PDP; Kang, D; Yoo, KY; Noh, DY; Jakubowska, A; Jaworska, K; Durda, K; Zlowocka, E; Sangrajrang, S; Gaborieau, V; Brennan, P; McKay, J; Shen, CY; Yu, JC; Hsu, HM; Hou, MF; Orr, N; Schoemaker, M; Ashworth, A; Swerdlow, A; Trentham-Dietz, A; Newcomb, PA; Titus, L; Egan, KM; Chenevix-Trench, G; Antoniou, AC; Humphreys, MK; Morrison, J; Chang-Claude, J; Easton, DF; Dunning, AM				Hein, Rebecca; Maranian, Melanie; Hopper, John L.; Kapuscinski, Miroslaw K.; Southey, Melissa C.; Park, Daniel J.; Schmidt, Marjanka K.; Broeks, Annegien; Hogervorst, Frans B. L.; Bueno-de-Mesquit, H. Bas; Muir, Kenneth R.; Lophatananon, Artitaya; Rattanamongkongul, Suthee; Puttawibul, Puttisak; Fasching, Peter A.; Hein, Alexander; Ekici, Arif B.; Beckmann, Matthias W.; Fletcher, Olivia; Johnson, Nichola; Silva, Isabel dos Santos; Peto, Julian; Sawyer, Elinor; Tomlinson, Ian; Kerin, Michael; Miller, Nicola; Marmee, Frederick; Schneeweiss, Andreas; Sohn, Christof; Burwinkel, Barbara; Guenel, Pascal; Cordina-Duverger, Emilie; Menegaux, Florence; Truong, Therese; Bojesen, Stig E.; Nordestgaard, Borge G.; Flyger, Henrik; Milne, Roger L.; Arias Perez, Jose Ignacio; Pilar Zamora, M.; Benitez, Javier; Anton-Culver, Hoda; Ziogas, Argyrios; Bernstein, Leslie; Clarke, Christina A.; Brenner, Hermann; Mueller, Heiko; Arndt, Volker; Stegmaier, Christa; Rahman, Nazneen; Seal, Sheila; Turnbull, Clare; Renwick, Anthony; Meindl, Alfons; Schott, Sarah; Bartram, Claus R.; Schmutzler, Rita K.; Brauch, Hiltrud; Hamann, Ute; Ko, Yon-Dschun; Wang-Gohrke, Shan; Doerk, Thilo; Schuermann, Peter; Karstens, Johann H.; Hillemanns, Peter; Nevanlinna, Heli; Heikkinen, Tuomas; Aittomaki, Kristiina; Blomqvist, Carl; Bogdanova, Natalia V.; Zalutsky, Iosif V.; Antonenkova, Natalia N.; Bermisheva, Marina; Prokovieva, Darya; Farahtdinova, Albina; Khusnutdinova, Elza; Lindblom, Annika; Margolin, Sara; Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana; Chen, Xiaoqing; Beesley, Jonathan; Lambrechts, Diether; Zhao, Hui; Neven, Patrick; Wildiers, Hans; Nickels, Stefan; Flesch-Janys, Dieter; Radice, Paolo; Peterlongo, Paolo; Manoukian, Siranoush; Barile, Monica; Couch, Fergus J.; Olson, Janet E.; Wang, Xianshu; Fredericksen, Zachary; Giles, Graham G.; Baglietto, Laura; McLean, Catriona A.; Severi, Gianluca; Offit, Kenneth; Robson, Mark; Gaudet, Mia M.; Vijai, Joseph; Alnaes, Grethe Grenaker; Kristensen, Vessela; Borresen-Dale, Anne-Lise; John, Esther M.; Miron, Alexander; Winqvist, Robert; Pylkas, Katri; Jukkola-Vuorinen, Arja; Grip, Mervi; Andrulis, Irene L.; Knight, Julia A.; Glendon, Gord; Mulligan, Anna Marie; Figueroa, Jonine D.; Garcia-Closas, Montserrat; Lissowska, Jolanta; Sherman, Mark E.; Hooning, Maartje; Martens, John W. M.; Seynaeve, Caroline; Collee, Margriet; Hall, Per; Humpreys, Keith; Czene, Kamila; Liu, Jianjun; Cox, Angela; Brock, Ian W.; Cross, Simon S.; Reed, Malcolm W. R.; Ahmed, Shahana; Ghoussaini, Maya; Pharoah, Paul D. P.; Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Jakubowska, Anna; Jaworska, Katarzyna; Durda, Katarzyna; Zlowocka, Elzbieta; Sangrajrang, Suleeporn; Gaborieau, Valerie; Brennan, Paul; McKay, James; Shen, Chen-Yang; Yu, Jyh-Cherng; Hsu, Huan-Ming; Hou, Ming-Feng; Orr, Nick; Schoemaker, Minouk; Ashworth, Alan; Swerdlow, Anthony; Trentham-Dietz, Amy; Newcomb, Polly A.; Titus, Linda; Egan, Kathleen M.; Chenevix-Trench, Georgia; Antoniou, Antonis C.; Humphreys, Manjeet K.; Morrison, Jonathan; Chang-Claude, Jenny; Easton, Douglas F.; Dunning, Alison M.		GENICA Network; kConFab Investigators; AOCS Grp	Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)	PLOS ONE			English	Article							SUSCEPTIBILITY LOCUS; CHINESE	The 6q25.1 locus was first identified via a genome-wide association study (GWAS) in Chinese women and marked by single nucleotide polymorphism (SNP) rs2046210, approximately 180 Kb upstream of ESR1. There have been conflicting reports about the association of this locus with breast cancer in Europeans, and a GWAS in Europeans identified a different SNP, tagged here by rs12662670. We examined the associations of both SNPs in up to 61,689 cases and 58,822 controls from forty-four studies collaborating in the Breast Cancer Association Consortium, of which four studies were of Asian and 39 of European descent. Logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI). Case-only analyses were used to compare SNP effects in Estrogen Receptor positive (ER+) versus negative (ER-) tumours. Models including both SNPs were fitted to investigate whether the SNP effects were independent. Both SNPs are significantly associated with breast cancer risk in both ethnic groups. Per-allele ORs are higher in Asian than in European studies [rs2046210: OR (A/G) = 1.36 (95% CI 1.26-1.48), p = 7.6x10(-14) in Asians and 1.09 (95% CI 1.07-1.11), p = 6.8x10(-18) in Europeans. rs12662670: OR (G/T) = 1.29 (95% CI 1.19-1.41), p = 1.2x10(-9) in Asians and 1.12 (95% CI 1.08-1.17), p = 3.8x10(-9) in Europeans]. SNP rs2046210 is associated with a significantly greater risk of ER- than ER+ tumours in Europeans [OR (ER-) = 1.20 (95% CI 1.15-1.25), p = 1.8x10(-17) versus OR (ER+) = 1.07 (95% CI 1.04-1.1), p = 1.3x10(-7), p(heterogeneity) = 5.1x10(-6)]. In these Asian studies, by contrast, there is no clear evidence of a differential association by tumour receptor status. Each SNP is associated with risk after adjustment for the other SNP. These results suggest the presence of two variants at 6q25.1 each independently associated with breast cancer risk in Asians and in Europeans. Of these two, the one tagged by rs2046210 is associated with a greater risk of ER- tumours.	[Hein, Rebecca; Nickels, Stefan; Chang-Claude, Jenny] German Canc Res Ctr, Unit Genet Epidemiol, Div Canc Epidemiol, Heidelberg, Germany; [Hein, Rebecca] Univ Cologne, PMV Primarmed Versorgung Res Grp, Dept Child & Adolescent Psychiat & Psychotherapy, D-50931 Cologne, Germany; [Maranian, Melanie; Ahmed, Shahana; Ghoussaini, Maya; Pharoah, Paul D. P.; Dunning, Alison M.] Univ Cambridge, Dept Oncol, Cambridge, England; [Hopper, John L.; Kapuscinski, Miroslaw K.; Giles, Graham G.; Baglietto, Laura; Severi, Gianluca] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Park, Daniel J.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Melbourne, Vic, Australia; [Hogervorst, Frans B. L.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Family Canc Clin, Amsterdam, Netherlands; [Bueno-de-Mesquit, H. Bas] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Muir, Kenneth R.; Lophatananon, Artitaya] Univ Warwick, Hlth Sci Res Inst, Warwick Med Sch, Warwick, England; [Rattanamongkongul, Suthee] Srinakhrainwirot Univ, Dept Prevent Med, Ongkharak, Nakhon Nayok, Thailand; [Puttawibul, Puttisak] Prince Songkla Univ, Sch Med, Dept Surg, Hat Yai, Thailand; [Fasching, Peter A.; Hein, Alexander; Beckmann, Matthias W.] Univ Hosp Erlangen, Univ Breast Ctr, Dept Gynecol & Obstet, Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany; [Fletcher, Olivia; Johnson, Nichola; Garcia-Closas, Montserrat; Orr, Nick; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Silva, Isabel dos Santos; Peto, Julian] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Sawyer, Elinor] Kings Coll London, Natl Inst Hlth Res, Guys & St Thomas Natl Hlth Serv Fdn Trust, Div Canc Studies,Comprehens Biomed Res Ctr, London WC2R 2LS, England; [Tomlinson, Ian] Univ Oxford, Welcome Trust Ctr Human Genet, Oxford, England; [Tomlinson, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Tomlinson, Ian] Oxford Natl Inst Hlth Res, Comprehens Biomed Res Ctr, Oxford, England; [Kerin, Michael] Univ Hosp Galway, Inst Clin Sci, Galway, Ireland; [Miller, Nicola; Marmee, Frederick; Schneeweiss, Andreas; Sohn, Christof; Burwinkel, Barbara; Schott, Sarah] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany; [Marmee, Frederick; Schneeweiss, Andreas] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany; [Burwinkel, Barbara] German Canc Res Ctr, Mol Epidemiol Grp, Heidelberg, Germany; [Guenel, Pascal; Cordina-Duverger, Emilie; Menegaux, Florence; Truong, Therese] Inserm Natl Inst Hlth & Med Res, U1018, CESP Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Guenel, Pascal; Cordina-Duverger, Emilie; Menegaux, Florence; Truong, Therese] Univ Paris 11, Unite Mixte Rech 1018, Villejuif, France; [Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Gen Populat Study, Herlev Univ Hosp, Copenhagen, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Dept Clin Biochem, Herlev Univ Hosp, Copenhagen, Denmark; [Flyger, Henrik] Univ Copenhagen, Dept Breast Surg, Herlev Univ Hosp, Copenhagen, Denmark; [Milne, Roger L.] Spanish Natl Canc Res Ctr CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain; [Arias Perez, Jose Ignacio] Hosp Monte Naranco, Serv Cirugia Gen & Especialidades, Oviedo, Spain; [Pilar Zamora, M.] Hosp Univ La Paz, Serv Oncol Med, Madrid, Spain; [Benitez, Javier] Spanish Natl Canc Res Ctr CNIO, Canc Genet Grp, Madrid, Spain; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Bernstein, Leslie] City Hope Natl Med Ctr, Dept Populat Sci, Duarte, CA USA; [Brenner, Hermann; Mueller, Heiko; Arndt, Volker] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-6900 Heidelberg, Germany; [Stegmaier, Christa] Saarland Canc Registry, Saarbrucken, Germany; [Rahman, Nazneen; Seal, Sheila; Turnbull, Clare; Renwick, Anthony] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Meindl, Alfons] Tech Univ Munich, Klinikum Rechts Isar, Div Obstet & Gynecol, D-8000 Munich, Germany; [Schmutzler, Rita K.] Univ Hosp, Ctr Familial Breast & Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp, CIO, Cologne, Germany; [Bartram, Claus R.] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany; [Brauch, Hiltrud] Univ Tubingen, Dr Margarete Fischer Bosch Inst Clin Pharmacol, Tubingen, Germany; [Hamann, Ute] Deutsch Krebsforschungszentrum DKFZ, Heidelberg, Germany; [Ko, Yon-Dschun] Evangel Kliniken Bonn gGmbH, Johanniter Krankenhaus, Dept Internal Med, Bonn, Germany; Univ Bonn, Inst Pathol, Bonn, Germany; [GENICA Network] Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany; [Wang-Gohrke, Shan] Univ Ulm, Dept Obstet & Gynecol, Ulm, Germany; [Doerk, Thilo; Schuermann, Peter; Hillemanns, Peter; Bogdanova, Natalia V.] Hannover Med Sch, Clin Obstet, D-3000 Hannover, Germany; [Doerk, Thilo; Schuermann, Peter; Hillemanns, Peter; Bogdanova, Natalia V.] Hannover Med Sch, Clin Gynaecol, D-3000 Hannover, Germany; [Karstens, Johann H.; Bogdanova, Natalia V.; Mannermaa, Arto] Hannover Med Sch, Clin Radiat Oncol, D-3000 Hannover, Germany; [Nevanlinna, Heli; Heikkinen, Tuomas] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Aittomaki, Kristiina] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Blomqvist, Carl] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Zalutsky, Iosif V.; Antonenkova, Natalia N.] NN Alexandrov Res Inst Oncol & Med Radiol, Minsk, BELARUS; [Bermisheva, Marina; Prokovieva, Darya; Farahtdinova, Albina; Khusnutdinova, Elza] Russian Acad Sci, Inst Biochem & Genet, Ufa Sci Ctr, Ufa 450001, Russia; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Margolin, Sara; Mannermaa, Arto] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Kosma, Veli-Matti; Hartikainen, Jaana] Univ Eastern Finland, Sch Med, Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana] Kuopio Univ Hosp, Bioctr Kuopio, SF-70210 Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana] Kuopio Univ Hosp, Dept Clin Pathol, SF-70210 Kuopio, Finland; [Kataja, Vesa] Univ Eastern Finland, Sch Med, Inst Clin Med, Kuopio, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Dept Oncol, SF-70210 Kuopio, Finland; [Chen, Xiaoqing; Beesley, Jonathan; Chenevix-Trench, Georgia] Queensland Inst Med Res, Canc Div, Brisbane, Qld 4006, Australia; [kConFab Investigators] Peter MacCallum Canc Ctr, Kathleen Cuningham Fdn Consortium Res Familial Br, Melbourne, Vic, Australia; [AOCS Grp] Peter MacCallum Canc Ctr, AOCS, Melbourne, Vic, Australia; [Lambrechts, Diether; Zhao, Hui] Katholieke Univ KU Leuven, Vesalius Res Ctr, Louvain, Belgium; [Neven, Patrick; Wildiers, Hans] Univ Hosp Gasthuisberg, Multidisciplinary Breast Ctr, B-3000 Louvain, Belgium; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Dept Canc Epidemiol, Clin Canc Registry, Hamburg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, Hamburg, Germany; [Radice, Paolo; Peterlongo, Paolo] Fdn IRCCS Ist Nazl Tumori INT, Unit Mol Bases Genet Risk & Genet Testing, Dept Prevent & Predict Med, Milan, Italy; [Radice, Paolo; Peterlongo, Paolo] Fdn Ist FIRC Fdn Italiana Ric Canc Oncol Mol IFOM, Milan, Italy; [Manoukian, Siranoush] Fdn Inst Recuvero & Cura Carattere Sci IRCCS Ist, Unit Med Genet, Dept Prevent & Predict Med, Milan, Italy; [Barile, Monica] Ist Europeo Oncol, Div Canc Prevent & Genet, Milan, Italy; [Couch, Fergus J.; Olson, Janet E.; Fredericksen, Zachary] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Wang, Xianshu] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Giles, Graham G.; Baglietto, Laura; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [McLean, Catriona A.] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic, Australia; [Offit, Kenneth; Vijai, Joseph] Mem Sloan Kettering Canc Ctr, Clin Genet Serv, Dept Med & Canc Biol & Genet, New York, NY 10021 USA; [Robson, Mark] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; [Gaudet, Mia M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Alnaes, Grethe Grenaker; Kristensen, Vessela; Borresen-Dale, Anne-Lise] Radiumhosp, Oslo Univ Hosp, Dept Genet, Inst Canc Res, Oslo, Norway; [Kristensen, Vessela; Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Fac Div Ahus, Oslo, Norway; [John, Esther M.] Canc Prevent Inst Calif, Dept Epidemiol, Fremont, CA USA; [John, Esther M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Miron, Alexander] Dana Farber Canc Inst, Deptartment Canc Biol, Boston, MA 02115 USA; [Winqvist, Robert; Pylkas, Katri] Univ Oulu, Oulu Univ Hosp, Canc Genet Lab, Dept Clin Genet, Oulu, Finland; [Winqvist, Robert; Pylkas, Katri] Univ Oulu, Oulu Univ Hosp, Bioctr Oulu, Oulu, Finland; [Jukkola-Vuorinen, Arja] Univ Oulu, Oulu Univ Hosp, Dept Oncol, Oulu, Finland; [Grip, Mervi] Univ Oulu, Dept Surg, Oulu Univ Hosp, Oulu, Finland; [Andrulis, Irene L.; Glendon, Gord] Canc Care Ontario, Ontario Canc Genet Network, Toronto, ON, Canada; [Andrulis, Irene L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Knight, Julia A.] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mulligan, Anna Marie] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mulligan, Anna Marie] St Michaels Hosp, Dept Lab Med, Toronto, ON M5B 1W8, Canada; [Mulligan, Anna Marie] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Figueroa, Jonine D.; Garcia-Closas, Montserrat; Sherman, Mark E.] Natl Canc Inst, Div Canc Epidemiol & Genet, Rockville, MD USA; [Garcia-Closas, Montserrat] Inst Canc Res, Epidemiol Sect, London SW3 6JB, England; [Garcia-Closas, Montserrat] Inst Canc Res, Genet Sect, London SW3 6JB, England; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Hooning, Maartje; Seynaeve, Caroline] Erasmus Univ, Med Ctr, Dept Med Oncol, Family Canc Clin, Rotterdam, Netherlands; [Martens, John W. M.] Erasmus Univ, Med Ctr, Dept Med Oncol, Josephine Nefkens Inst, Rotterdam, Netherlands; [Collee, Margriet] Erasmus Univ, Med Ctr, Dept Clin Genet, Family Canc Clin, Rotterdam, Netherlands; [Hall, Per; Humpreys, Keith; Czene, Kamila] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Liu, Jianjun] Genome Inst Singapore, Singapore, Singapore; [Cox, Angela; Brock, Ian W.] Univ Sheffield, Inst Canc Studies, Dept Oncol, Sheffield, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Acad Unit Pathol, Dept Neurosci, Sheffield, S Yorkshire, England; [Reed, Malcolm W. R.] Univ Sheffield, Acad Unit Surg Oncol, Dept Oncol, Sheffield, S Yorkshire, England; [Pharoah, Paul D. P.; Antoniou, Antonis C.; Humphreys, Manjeet K.; Morrison, Jonathan; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Kang, Daehee; Yoo, Keun-Young] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Noh, Dong-Young] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Jakubowska, Anna; Jaworska, Katarzyna; Durda, Katarzyna; Zlowocka, Elzbieta] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Jaworska, Katarzyna] Warsaw Med Univ, Postgrad Sch Mol Med, Warsaw, Poland; [Sangrajrang, Suleeporn] Natl Canc Inst, Mol Epidemiol Unit, Bangkok, Thailand; [Gaborieau, Valerie; Brennan, Paul; McKay, James] Int Agcy Res Canc, Genet Epidemiol Grp, F-69372 Lyon, France; [Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Shen, Chen-Yang] Taiwan Biobank, Taipei, Taiwan; [Yu, Jyh-Cherng; Hsu, Huan-Ming] Tri Serv Gen Hosp, Dept Surg, Taipei, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Chung Ho Mem Hosp, Ctr Canc, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Schoemaker, Minouk; Swerdlow, Anthony] Inst Canc Res, Epidemiol Sect, Sutton, Surrey, England; [Trentham-Dietz, Amy; Newcomb, Polly A.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA; [Newcomb, Polly A.] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA; [Titus, Linda] Dartmouth Hitchcock Med Ctr, Dept Community & Family Med, Dept Pediat, Dartmouth Med Sch, Lebanon, NH 03766 USA; [Egan, Kathleen M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Div Populat Sci, Tampa, FL 33612 USA	Helmholtz Association; German Cancer Research Center (DKFZ); University of Cologne; University of Cambridge; University of Melbourne; University of Melbourne; Netherlands Cancer Institute; Netherlands National Institute for Public Health & the Environment; University of Warwick; Prince of Songkla University; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Erlangen Nuremberg; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; Ollscoil na Gaillimhe-University of Galway; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitario La Paz; Centro Nacional de Investigaciones Oncologicas (CNIO); University of California System; University of California Irvine; City of Hope; Helmholtz Association; German Cancer Research Center (DKFZ); University of London; Institute of Cancer Research - UK; Technical University of Munich; University of Cologne; University of Cologne; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); University of Bonn; Ruhr University Bochum; Ulm University; Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Karolinska Institutet; Karolinska Institutet; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; KU Leuven; KU Leuven; University Hospital Leuven; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); Mayo Clinic; Mayo Clinic; Cancer Council Victoria; Florey Institute of Neuroscience & Mental Health; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; American Cancer Society; University of Oslo; University of Oslo; Cancer Prevention Institute of California; Stanford University; Harvard University; Dana-Farber Cancer Institute; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Cancer Care Ontario; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Sheffield; University of Sheffield; University of Sheffield; University of Cambridge; Seoul National University (SNU); Seoul National University (SNU); Pomeranian Medical University; Medical University of Warsaw; National Cancer Institute - Thailand; World Health Organization; International Agency for Research on Cancer (IARC); Academia Sinica - Taiwan; Tri-Service General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of London; Institute of Cancer Research - UK; University of Wisconsin System; University of Wisconsin Madison; Fred Hutchinson Cancer Center; Dartmouth College; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Hein, R (corresponding author), German Canc Res Ctr, Unit Genet Epidemiol, Div Canc Epidemiol, Heidelberg, Germany.	rebecca.hein@uk-koeln.de; alisond@srl.cam.ac.uk	Figueroa, Jonine/AAG-1065-2022; Pierotti, Marco Alessandro/AAC-4728-2022; Kerin, Michael J/D-6748-2013; Ekici, Arif B/C-3971-2013; Pillay, Nischalan/F-9536-2012; Khusnutdinova, Elza Kamilevna/A-4810-2013; Fasching, Peter A/ABH-9912-2020; Dörk, Thilo/J-8620-2012; Pharoah, Paul/V-6658-2019; Baglietto, Laura/AAB-9051-2019; Schneeweiss, Andreas/HHS-4098-2022; Margolin, Sara/AAX-9034-2020; Figueroa, Jonine/GWD-1322-2022; Reed, Malcolm Walter/AAG-9219-2020; Arndt, Volker/B-4999-2014; Figueroa, Jonine/AFK-2752-2022; Severi, Gianluca/H-3774-2018; Flyger, Henrik/AAM-6494-2021; Hartikainen, Jaana M/E-6256-2015; Brüning, Thomas/G-8120-2015; Schmidt, Marjanka K/G-9058-2011; Guenel, Pascal/H-3728-2018; Lissowska, Jolanta/AAH-3252-2020; Verdrengh, Evelien/H-4571-2012; Jakubowska, Anna/O-8050-2014; Schott, Sarah/D-5242-2018; Joseph, Vijai/J-9158-2013; Peissel, Bernard/E-8187-2017; Bujan, Pablo Menendez/W-3736-2017; manoukian, siranoush/E-7132-2017; Bernard, Loris/K-5953-2014; Yoo, Keun-Young/J-5548-2012; Bowtell, David/H-1007-2016; wildiers, hans/AAV-8158-2021; Garcia-Closas, Montserrat/F-3871-2015; Nordestgaard, Borge Gronne/ABF-1310-2020; Knight, Julia/R-5617-2019; Menegaux, Florence/H-4261-2018; Noh, Dong-Young/G-5531-2011; Andrulis, Irene L./E-7267-2013; Lambrechts, Diether/AAJ-3167-2020; Brenner, Hermann/B-4627-2017; Chenevix-Trench, Georgia/AAV-2014-2020; /AAM-5330-2020; truong, therese/A-2837-2013; Brenner, Hermann/ABE-6383-2020; Arndt, Volker/AAI-7282-2020; Severi, Gianluca/Q-1824-2019; Turnbull, Clare/AAA-6596-2019; Garcia-Closas, Montserrat/AAZ-6930-2021; Guenel, Pascal/AAS-7688-2021; Bogdanova, Natalia V./Y-2205-2019; Miller, Nicola/F-4009-2018; Hein, Alexander/F-6999-2010; Knight, Julia/A-6843-2012; Zaffaroni, Daniela/I-8731-2017; Haviv, Izhak/E-3782-2015; Liu, Jianjun/AAK-4989-2020; Peterlongo, Paolo/Q-4717-2018; Gonzalez-Neira, Anna/C-5791-2015; Rahman, Nazneen/D-2802-2013; Radice, Paolo/O-3119-2013	Figueroa, Jonine/0000-0002-5100-623X; Pierotti, Marco Alessandro/0000-0002-7431-8332; Ekici, Arif B/0000-0001-6099-7066; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Fasching, Peter A/0000-0003-4885-8471; Dörk, Thilo/0000-0002-9458-0282; Pharoah, Paul/0000-0001-8494-732X; Figueroa, Jonine/0000-0002-5100-623X; Reed, Malcolm Walter/0000-0001-7442-2132; Arndt, Volker/0000-0001-9320-8684; Figueroa, Jonine/0000-0002-5100-623X; Severi, Gianluca/0000-0001-7157-419X; Hartikainen, Jaana M/0000-0001-8267-1905; Brüning, Thomas/0000-0001-9560-5464; Schmidt, Marjanka K/0000-0002-2228-429X; Guenel, Pascal/0000-0002-8359-518X; Lissowska, Jolanta/0000-0003-2695-5799; Jakubowska, Anna/0000-0002-5650-0501; Schott, Sarah/0000-0002-1714-1147; Joseph, Vijai/0000-0002-7933-151X; Peissel, Bernard/0000-0001-9233-3571; Bujan, Pablo Menendez/0000-0001-9372-1007; manoukian, siranoush/0000-0002-6034-7562; Bowtell, David/0000-0001-9089-7525; Garcia-Closas, Montserrat/0000-0003-1033-2650; Knight, Julia/0000-0002-7610-7635; Menegaux, Florence/0000-0003-3363-6411; Lambrechts, Diether/0000-0002-3429-302X; Brenner, Hermann/0000-0002-6129-1572; Chenevix-Trench, Georgia/0000-0002-1878-2587; truong, therese/0000-0002-2943-6786; Brenner, Hermann/0000-0002-6129-1572; Arndt, Volker/0000-0001-9320-8684; Severi, Gianluca/0000-0001-7157-419X; Garcia-Closas, Montserrat/0000-0003-1033-2650; Guenel, Pascal/0000-0002-8359-518X; Miller, Nicola/0000-0002-5416-7047; Hein, Alexander/0000-0003-2601-3398; Zaffaroni, Daniela/0000-0002-6995-2216; Haviv, Izhak/0000-0002-0837-5005; Liu, Jianjun/0000-0002-3255-3019; Peterlongo, Paolo/0000-0001-6951-6855; Gonzalez-Neira, Anna/0000-0002-5421-2020; Margolin, Sara/0000-0002-5526-5570; Rahman, Nazneen/0000-0003-4376-0440; Swerdlow, Anthony/0000-0001-5550-4159; McLean, Catriona/0000-0002-0302-5727; Turnbull, Clare/0000-0002-1734-5772; Thorne, Heather/0000-0003-3610-2511; Czene, Kamila/0000-0002-3233-5695; Dunning, Alison Margaret/0000-0001-6651-7166; Blomqvist, Carl/0000-0003-3041-1938; Colleran, Gabrielle/0000-0002-1684-6671; Mulligan, Anna Marie/0000-0002-7239-5297; Park, Daniel/0000-0002-6354-0931; Robson, Mark/0000-0002-3109-1692; Cox, Angela/0000-0002-5138-1099; Winqvist, Robert/0000-0003-0932-9104; Kataja, Vesa/0000-0003-4846-4843; Southey, Melissa/0000-0002-6313-9005; Beesley, Jonathan/0000-0003-1942-325X; Heikkinen, Tuomas/0000-0003-1154-6204; Roth, Rebecca/0000-0002-2841-4921; Pylkas, Katri/0000-0002-2449-0521; Giles, Graham/0000-0003-4946-9099; Kerin, Michael/0000-0003-4164-5561; Kang, Daehee/0000-0003-4031-5878; Radice, Paolo/0000-0001-6298-4111; Baglietto, Laura/0000-0002-8193-7529; Cross, Simon/0000-0003-2044-1754; Nevanlinna, Heli/0000-0002-0916-2976; Brauch, Hiltrud/0000-0001-7531-2736; Schoemaker, Minouk/0000-0001-8403-2234; Hou, Ming-Feng/0000-0001-6030-9702	European Community [223175, HEALTH-F2-2009-223175]; Cancer Research-UK [C1287/A10118, C1287/A12014, C8197/A10865]; European Union [BM0606]; Joseph Mitchell Trust; United States National Cancer Institute, National Institutes of Health (NIH) [RFA-CA-06-503]; National Health and Medical Research Council of Australia; New South Wales Cancer Council; Victorian Health Promotion Foundation (Australia); Victorian Breast Cancer Research Consortium; Dutch Cancer Society [NKI 2001-2423; 2007-3839, DDHK 2004-3124, DDHK 2009-4318]; Dutch National Genomics Initiative; Breast Cancer Research Trust; ELAN-Fond of the University Hospital of Erlangen; Cancer Research UK; Breakthrough Breast Cancer; National Health Service (NHS); National Cancer Research Network (NCRN); National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre; Guy's & St. Thomas' National Health Service Foundation Trust; King's College London; Oxford Biomedical Research Centre; Dietmar-Hopp Foundation; Helmholtz Society; Fondation de France; French National Institute of Cancer [INCa]; French Agency for Environmental and Occupational Health [ANSES (ex-AFSSET)]; French League Against Cancer; National Research Agency (ANR); Chief Physician Johan Boserup and Lise Boserup Fund; Danish Medical Research Council; Herlev Hospital; Genome Spain Foundation; Red Tematica de Investigacion Cooperativa en Cancer; Asociacion Espanola Contra el Cancer; Fondo de Investigacion Sanitario [PI081120, PI081583]; California Breast Cancer Act; National Institutes of Health [R01 CA77398, R01CA122340, R01 CA128978]; Lon V Smith Foundation [LVS39420]; California Breast Cancer Research Fund [97-10500]; California Department of Public Health [103885]; Baden Wurttemberg Ministry of Science, Research and Arts; German Cancer Aid (Deutsche Krebshilfe); Cancer Research UK [C8620/A8372, C8620/A8857, C490/A11021]; US Military Acquisition (ACQ) Activity, Era of Hope Award [W81XWH-05-1-0204]; Institute of Cancer Research (UK) a Medical Research Council (UK); Deutsche Krebshilfe [107054]; Center of Molecular Medicine, Cologne; Dietmar Hopp Foundation; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart; University of Tubingen, Germany; Department of Internal Medicine, Evangelische Kliniken Bonn GmbH, Johanniter Krankenhaus, Bonn, Germany; Institute of Pathology, University of Bonn, Bonn, Germany; Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Bochum, Germany; Deutsche Krebshilfe e.V. [70492, 70-2892-BR I]; Hannover Medical School; German Research Foundation [DFG] [Do761/2-1]; Helsinki University Central Hospital Research Fund, Academy of Finland [132473]; Finnish Cancer Society; Sigrid Juselius Foundation; short-term fellowships from the German Academic Exchange Program; Friends of Hannover Medical School; German Federal Ministry of Research and Education [RUS08/017]; Swedish Cancer Society; Stockholm Cancer Society; Kuopio University Hospital of North Savo; Finnish Cancer Organizations; Academy of Finland; University of Eastern Finland; National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC); Queensland Cancer Fund; Cancer Council of New South Wales, Victoria, Tasmania; Cancer Council of New South Wales, Victoria, South Australia; Cancer Foundation of Western Australia; NHMRC [145684, 288704, 454508, 199600]; United States Army Medical Research and Materiel Command [DAMD17-01-1-0729]; Cancer Council of Tasmania and Cancer Foundation of Western Australia; Stichting tegen Kanker [232-2008, 196-2010]; Hamburg Cancer Society; German Cancer Research Center; Federal Ministry of Education and Research (BMBF) Germany [01KH0402]; Ministero della Salute; Ministero dell'Universita e Ricerca [RBLAO3-BETH]; Fondazione Italiana per la Ricerca sul Cancro; Associazione Italiana per la Ricerca sul Cancro [4017]; Fondazione IRCCS Istituto Nazionale Tumori [561000]; Specialized Program of Research Excellence (SPORE) in Breast Cancer [CA116201]; VicHealth; Cancer Council Victoria; Australian National Health and Medical Research Council (NHMRC) [209057, 251553, 504711]; Breast Cancer Research Foundation; Sharon Levine Corzine Fund; Niehaus Cancer Research Initiative; Andrew Sabin Family Fund; Charles Krasne Research Fund; Norman and Carol Stone Research Initiative; Norwegian Research council [155218/V40, 175240/S10, FUGE-NFR 181600/V11]; Swizz Bridge Award; Finnish Cancer Foundation; University of Oulu; Oulu University Hospital; National Cancer Institute, National Institutes of Health [RFA] [CA-06-503]; University of Melbourne [U01 CA69638]; Cancer Care Ontario; National Cancer Institute, Department of Health and Human Services, USA; Marit and Hans Rausing Initiative Against Breast Cancer; Agency for Science, Technology and Research of Singapore (ASTAR); United States National Institutes of Health (NIH); Susan G. Komen Breast Cancer Foundation; Yorkshire Cancer Research; Breast Cancer Campaign; Ministry of Health and Welfare, Republic of Korea [AO30001]; Polish Foundation of Science; National Cancer Institute Thailand; Institute of Biomedical Sciences, Academia Sinica, Taiwan; National Institute of Health [CA58860, CA92044]; Massachusetts center [R01CA47305]; Wisconsin center [R01 CA47147]; New Hampshire center [R01CA69664];  [PBZ_KBN_122/P05/2004]; NATIONAL CANCER INSTITUTE [K07CA092044, P50CA116201, R01CA058860, R01CA047305, U01CA069638, R01CA077398, R01CA069664, U01CA058860, R01CA122340, R01CA047147, R01CA128978, U01CA069467, U01CA069417] Funding Source: NIH RePORTER; Cancer Research UK [10118, 15106, 11022, 11174] Funding Source: researchfish; National Institute for Health Research [03/DHCS/03/G121/51] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish	European Community(European Commission); Cancer Research-UK(Cancer Research UK); European Union(European Commission); Joseph Mitchell Trust; United States National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Cancer Council(Cancer Council New South Wales); Victorian Health Promotion Foundation (Australia); Victorian Breast Cancer Research Consortium; Dutch Cancer Society(KWF Kankerbestrijding); Dutch National Genomics Initiative; Breast Cancer Research Trust; ELAN-Fond of the University Hospital of Erlangen; Cancer Research UK(Cancer Research UK); Breakthrough Breast Cancer; National Health Service (NHS); National Cancer Research Network (NCRN); National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Guy's & St. Thomas' National Health Service Foundation Trust; King's College London(General Electric); Oxford Biomedical Research Centre; Dietmar-Hopp Foundation; Helmholtz Society(Helmholtz Association); Fondation de France(Fondation de France); French National Institute of Cancer [INCa](Institut National du Cancer (INCA) France); French Agency for Environmental and Occupational Health [ANSES (ex-AFSSET)]; French League Against Cancer; National Research Agency (ANR)(French National Research Agency (ANR)); Chief Physician Johan Boserup and Lise Boserup Fund; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Herlev Hospital; Genome Spain Foundation; Red Tematica de Investigacion Cooperativa en Cancer; Asociacion Espanola Contra el Cancer; Fondo de Investigacion Sanitario; California Breast Cancer Act; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lon V Smith Foundation; California Breast Cancer Research Fund; California Department of Public Health; Baden Wurttemberg Ministry of Science, Research and Arts; German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Cancer Research UK(Cancer Research UK); US Military Acquisition (ACQ) Activity, Era of Hope Award; Institute of Cancer Research (UK) a Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Krebshilfe(Deutsche Krebshilfe); Center of Molecular Medicine, Cologne; Dietmar Hopp Foundation; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart; University of Tubingen, Germany; Department of Internal Medicine, Evangelische Kliniken Bonn GmbH, Johanniter Krankenhaus, Bonn, Germany; Institute of Pathology, University of Bonn, Bonn, Germany; Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Bochum, Germany; Deutsche Krebshilfe e.V.(Deutsche Krebshilfe); Hannover Medical School; German Research Foundation [DFG](German Research Foundation (DFG)); Helsinki University Central Hospital Research Fund, Academy of Finland(Academy of Finland); Finnish Cancer Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation); short-term fellowships from the German Academic Exchange Program; Friends of Hannover Medical School; German Federal Ministry of Research and Education; Swedish Cancer Society(Swedish Cancer Society); Stockholm Cancer Society; Kuopio University Hospital of North Savo; Finnish Cancer Organizations; Academy of Finland(Academy of Finland); University of Eastern Finland; National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland Cancer Fund; Cancer Council of New South Wales, Victoria, Tasmania(Cancer Council New South Wales); Cancer Council of New South Wales, Victoria, South Australia(Cancer Council New South Wales); Cancer Foundation of Western Australia(Cancer Council Western Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council of Tasmania and Cancer Foundation of Western Australia(Cancer Council Western Australia); Stichting tegen Kanker; Hamburg Cancer Society; German Cancer Research Center; Federal Ministry of Education and Research (BMBF) Germany(Federal Ministry of Education & Research (BMBF)); Ministero della Salute(Ministry of Health, Italy); Ministero dell'Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione IRCCS Istituto Nazionale Tumori; Specialized Program of Research Excellence (SPORE) in Breast Cancer; VicHealth; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Breast Cancer Research Foundation; Sharon Levine Corzine Fund; Niehaus Cancer Research Initiative; Andrew Sabin Family Fund; Charles Krasne Research Fund; Norman and Carol Stone Research Initiative; Norwegian Research council(Research Council of NorwayEuropean Commission); Swizz Bridge Award; Finnish Cancer Foundation; University of Oulu; Oulu University Hospital; National Cancer Institute, National Institutes of Health [RFA]; University of Melbourne(University of Melbourne); Cancer Care Ontario; National Cancer Institute, Department of Health and Human Services, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Marit and Hans Rausing Initiative Against Breast Cancer; Agency for Science, Technology and Research of Singapore (ASTAR)(Agency for Science Technology & Research (A*STAR)); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Yorkshire Cancer Research; Breast Cancer Campaign; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Polish Foundation of Science; National Cancer Institute Thailand(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Institute of Biomedical Sciences, Academia Sinica, Taiwan(Academia Sinica - Taiwan); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts center; Wisconsin center; New Hampshire center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); The Francis Crick Institute	This work was partly supported by the European Community's Seventh Framework Programme (COGS; http://cogseu.org/) [grant agreement number 223175, grant number HEALTH-F2-2009-223175]. The Breast Cancer Association Consortium (BCAC) is funded by Cancer Research-UK (http://science.cancerresearchuk.org/) [C1287/A10118 and C1287/A12014]. Meetings of the BCAC have been funded by the European Union COST programme (http://www.srl.cam.ac.uk/consortia/cost/index.html) [BM0606]. D. F. E. is a Principal Research Fellow of Cancer Research-UK. A. C. A. is a Cancer Research-UK Senior Cancer Research Fellow. A. M. D has been funded by Cancer Research-UK [C8197/A10865] and The Joseph Mitchell Trust. The Australian Breast Cancer Family Study (ABCFS) and Northern California Breast Cancer Family Registry (NC-BCFR) work was supported by the United States National Cancer Institute, National Institutes of Health (NIH) [RFA-CA-06-503]; and through cooperative agreements with members of the Breast Cancer Family Registry (BCFR); and Principal Investigators, including Cancer Care Ontario [U01 CA69467]; Northern California Cancer Center [U01 CA69417]; University of Melbourne [U01 CA69638]. Samples from the NC-BCFR were processed and distributed by the Coriell Institute for Medical Research. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the BCFR, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government or the BCFR. The ABCFS was also supported by the National Health and Medical Research Council of Australia; the New South Wales Cancer Council; the Victorian Health Promotion Foundation (Australia); and the Victorian Breast Cancer Research Consortium. J.L.H. is a National Health and Medical Research Council (NHMRC) Australia Fellow and a Victorian Breast Cancer Research Consortium Group Leader. M. C. S. is a NHMRC Senior Research Fellow and a Victorian Breast Cancer Research Consortium Group Leader. The Amsterdam Breast Cancer Study (ABCS) study was supported by the Dutch Cancer Society [NKI 2001-2423; 2007-3839]; and the Dutch National Genomics Initiative. The Asian Cancer Program (ACP) study was supported by the Breast Cancer Research Trust. The Bavarian Breast Cancer Cases and Controls (BBCC) study was partly supported by ELAN-Fond of the University Hospital of Erlangen. The British Breast Cancer Study (BBCS) study is supported by Cancer Research UK; and Breakthrough Breast Cancer; and acknowledges National Health Service (NHS) funding to the National Institute for Health Research (NIHR) Biomedical Research Centre; and the National Cancer Research Network (NCRN). Breast Cancer in Galway Genetic Study (BIGGS) is supported by National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre [to E. S.]; Guy's & St. Thomas' National Health Service Foundation Trust in partnership with King's College London [to E. S.]; and the Oxford Biomedical Research Centre [to I. T.]. The Breast Cancer Study of the University Clinic Heidelberg (BSUCH) study was supported by the Dietmar-Hopp Foundation; and the Helmholtz Society. The CECILE Breast Cancer Study (CECILE) study was supported by Fondation de France (2007), French National Institute of Cancer [INCa grant 2007, 2008, 2009]; French Agency for Environmental and Occupational Health [ANSES (ex-AFSSET) grant 2008 and 2009]; the French League Against Cancer; and National Research Agency (ANR).; The Copenhagen General Population Study (CGPS) was supported by the Chief Physician Johan Boserup and Lise Boserup Fund; the Danish Medical Research Council; and Herlev Hospital. The Spanish National Cancer Centre Breast Cancer Study (CNIO-BCS) was supported by the Genome Spain Foundation; the Red Tematica de Investigacion Cooperativa en Cancer and grants from the Asociacion Espanola Contra el Cancer and the Fondo de Investigacion Sanitario [PI081120 to J.B., PI081583 to R. L. M.]. The California Teachers Study (CTS) was supported by the California Breast Cancer Act of 1993; National Institutes of Health [R01 CA77398]; the Lon V Smith Foundation [LVS39420]; and the California Breast Cancer Research Fund [contract 97-10500]. Collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885. The ESTHER Breast Cancer Study (ESTHER) study was supported by a grant from the Baden Wurttemberg Ministry of Science, Research and Arts. Additional cases were recruited in the context of the VERDI study, which was supported by a grant from the German Cancer Aid (Deutsche Krebshilfe). The ICR Familial Breast Cancer Study (FBCS) is supported by funds from Cancer Research UK [C8620/A8372; C8620/A8857]; a US Military Acquisition (ACQ) Activity, Era of Hope Award [W81XWH-05-1-0204]; the Institute of Cancer Research (UK) a Medical Research Council (UK) Clinical Research Fellowship [to C. T.]. The FBCS acknowledges National Health Service (NHS) funding to the Royal Marsden/Institute of Cancer Research, National Institute for Health Research (NIHR) Specialist Cancer. The German Consortium for Hereditary Breast & Ovarian Cancer (GC-HBOC) was supported by Deutsche Krebshilfe [107054]; the Center of Molecular Medicine, Cologne; the Helmholtz society; and the Dietmar Hopp Foundation [to B. B.]. The Gene Environment Interaction and Breast Cancer in Germany (GENICA) network was supported by the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, and the University of Tubingen, Germany [to C.J. and H. B.]; the Department of Internal Medicine, Evangelische Kliniken Bonn GmbH, Johanniter Krankenhaus, Bonn, Germany [to Y.D.K. and C.B.]; the Institute of Pathology, University of Bonn, Bonn, Germany [to HP. F.]; Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany [to U. H.]; the Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Bochum, Germany [to T. B., B. P., S. R., A. S. and V. H.]. The Genetic Epidemiology Study of Breast Cancer by Age 50 (GESBC) was supported by the Deutsche Krebshilfe e.V. [70492]; and genotyping in part by the state of Baden-Wurttemberg through the Medical Faculty of the University of Ulm [P.685]. The Hannover Breast Cancer Study (HABCS) study was supported by an intramural grant from Hannover Medical School; and by a grant from the German Research Foundation [DFG, Do761/2-1]. The Helsinki Breast Cancer Study (HEBCS) study has been financially supported by the Helsinki University Central Hospital Research Fund, Academy of Finland [132473]; the Finnish Cancer Society; and the Sigrid Juselius Foundation. The Hannover-Minsk Breast Cancer Study (HMBCS) was supported by short-term fellowships from the German Academic Exchange Program [to N.B.]; and the Friends of Hannover Medical School [to N.B.].; The Hannover-Ufa Breast Cancer Study (HUBCS) was supported by a grant from the German Federal Ministry of Research and Education [RUS08/017]. The Karolinska Breast Cancer Study (KARBAC) was supported by the Swedish Cancer Society and the Stockholm Cancer Society. The Kuopio Breast Cancer Project (KBCP) was financially supported by the special Government Funding (EVO) of Kuopio University Hospital grants, Cancer Fund of North Savo; the Finnish Cancer Organizations; the Academy of Finland; and by the strategic funding of the University of Eastern Finland. Kathleen Cuningham Foundation Consortium for research into Familial Breast Cancer/Australian Ovarian Cancer Study (KConFab/AOCS) is supported by grants from the National Breast Cancer Foundation; the National Health and Medical Research Council (NHMRC); the Queensland Cancer Fund; the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia; and the Cancer Foundation of Western Australia. The kConFab Clinical Follow Up Study was funded by the NHMRC [145684; 288704; 454508]. Financial support for the AOCS was provided by the United States Army Medical Research and Materiel Command [DAMD17-01-1-0729]; the Cancer Council of Tasmania and Cancer Foundation of Western Australia; and the NHMRC [199600]. G. C. T. and P. W. are supported by the NHMRC. Leuven Multidisciplinary Breast Centre (LMBC) is supported by the 'Stichting tegen Kanker' [232-2008; 196-2010]. The Mammary Carcinoma Risk Factor Investigation (MARIE) study was supported by the Deutsche Krebshilfe e.V. [70-2892-BR I]; the Hamburg Cancer Society; the German Cancer Research Center; and the genotype work in part by the Federal Ministry of Education and Research (BMBF) Germany [01KH0402]. Milan Breast Cancer Study Group (MBCSG) was supported by grants from Ministero della Salute (Extraordinary National Cancer Program 2006 "Alleanza contro il Cancro", and "Progetto Tumori Femminili") [to P. R.]; Ministero dell'Universita e Ricerca (RBLAO3-BETH) [to P. R.]; Fondazione Italiana per la Ricerca sul Cancro (Special Project "Hereditary tumors"); Associazione Italiana per la Ricerca sul Cancro (4017) [to P. P.]; and by funds from Italian citizens who allocated the 5/1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects "561000"). The Mayo Clinic Breast Cancer Study (MCBCS) was supported by National Institutes of Health grants [R01CA122340; R01 CA128978]; and a Specialized Program of Research Excellence (SPORE) in Breast Cancer [CA116201]. Melbourne Collaborative Cohort Study (MCCS) cohort recruitment was funded by VicHealth; and Cancer Council Victoria. The MCCS was further supported by Australian National Health and Medical Research Council (NHMRC) grants [209057; 251553; 504711]; and by infrastructure provided by Cancer Council Victoria. The Memorial Sloan-Kettering Cancer Center (MSKCC) was supported by the Breast Cancer Research Foundation; the Sharon Levine Corzine Fund; the Niehaus Cancer Research Initiative; the Andrew Sabin Family Fund; the Charles Krasne Research Fund; and the Norman and Carol Stone Research Initiative. The Norwegian Breast Cancer Study (NBCS) was supported by grants from the Norwegian Research council [155218/V40, 175240/S10 to A. L. B. D.; FUGE-NFR 181600/V11 to V.N.K.]; and a Swizz Bridge Award [to A. L. B. D.].; The Oulu Breast Cancer Study (OBCS) was supported by research grants from the Finnish Cancer Foundation; the Sigrid Juselius Foundation; the Academy of Finland; the University of Oulu; and the Oulu University Hospital. The Ontario Familial Breast Cancer Registry (OFBCR) work was supported by the National Cancer Institute, National Institutes of Health [RFA # CA-06-503]; and through cooperative agreements with members of the Breast Cancer Family Registry (BCFR); and Principal Investigators, including Cancer Care Ontario [U01 CA69467]; Northern California Cancer Center [U01 CA69417]; and University of Melbourne [U01 CA69638]; and by Cancer Care Ontario. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the BCFR, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government or the BCFR. The National Cancer Institute Polish Breast Cancer Study (PBCS) was supported by Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA. The Rotterdam Breast Cancer Study (RBCS) was funded by the Dutch Cancer Society [DDHK 2004-3124; DDHK 2009-4318]. The Singapore and Sweden Breast Cancer Study (SASBAC) was funded by the Marit and Hans Rausing Initiative Against Breast Cancer; the Agency for Science, Technology and Research of Singapore (ASTAR); the United States National Institutes of Health (NIH); and the Susan G. Komen Breast Cancer Foundation. The Sheffield Breast Cancer Study (SBCS) was funded by Yorkshire Cancer Research; and the Breast Cancer Campaign. The Study of Epidemiology and Risk factors in Cancer Heredity (SEARCH) study is funded by a programme grant from Cancer Research UK [C490/A11021] and laboratory infrastructure by [C8197/A10123]. The Seoul Breast Cancer Study (SEBCS) was supported by the Korea Health 21 R&D Project [AO30001], Ministry of Health and Welfare, Republic of Korea. The IHCC-Szczecin Breast Cancer Study (SZBCS) was supported by Grant PBZ_KBN_122/P05/2004; and the Polish Foundation of Science [to K.J.]. Katarzyna Jaworska is a fellow of International PhD program, Postgraduate School of Molecular Medicine, Warsaw Medical University. The International Agency for Research on Cancer-Thai Breast Cancer Study (TBCS) was funded by The National Cancer Institute Thailand. The Taiwanese Breast Cancer Study (TWBCS) is supported by the Taiwan Biobank project of the Institute of Biomedical Sciences, Academia Sinica, Taiwan. The University of California, Irvine, Breast Cancer Study (UCIBCS) component of this research was supported by the National Institute of Health [CA58860; CA92044]; and the Lon V Smith Foundation [LVS39420]. The UK Breakthrough Generations Study (UKBGS) is funded by Breakthrough Breast Cancer. The US Three State Study (US3SS) study was supported by Massachusetts [R01CA47305 to K. M. E.]; Wisconsin [R01 CA47147 to P.A.N.]; and New Hampshire [R01CA69664 to L. T.-E.] centers; and Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2011, HUM MOL GENET, V20, P3304, DOI 10.1093/hmg/ddr226; Cai QY, 2011, CANCER RES, V71, P1344, DOI 10.1158/0008-5472.CAN-10-2733; Dunbier AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001382; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865; Laird N M, 1990, Int J Technol Assess Health Care, V6, P5; Li WF, 2010, HUM GENET, V127, P249, DOI 10.1007/s00439-009-0773-z; Long JR, 2010, CANCER EPIDEM BIOMAR, V19, P2357, DOI 10.1158/1055-9965.EPI-10-0054; R Development Core Team, 2005, R LANG ENV STAT COMP; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Xie H, 2011, J BONE MINER RES, V26, P156, DOI 10.1002/jbmr.169; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	13	45	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42380	10.1371/journal.pone.0042380	http://dx.doi.org/10.1371/journal.pone.0042380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879957	Green Published, gold, Green Accepted			2022-12-27	WOS:000307437900035
J	Nischalke, HD; Schmitz, V; Luda, C; Aldenhoff, K; Berger, C; Feldmann, G; Sauerbruch, T; Spengler, U; Nattermann, J				Nischalke, Hans Dieter; Schmitz, Volker; Luda, Carolin; Aldenhoff, Katharina; Berger, Cordula; Feldmann, Georg; Sauerbruch, Tilman; Spengler, Ulrich; Nattermann, Jacob			Detection of IGF2BP3, HOXB7, and NEK2 mRNA Expression in Brush Cytology Specimens as a New Diagnostic Tool in Patients with Biliary Strictures	PLOS ONE			English	Article							ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; IN-SITU HYBRIDIZATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; PANCREATICOBILIARY MALIGNANCIES; KINESIN OVEREXPRESSION; PREOPERATIVE DIAGNOSIS; COLORECTAL-CANCER; BIOPSY SPECIMENS; FORCEPS BIOPSY	Introduction: It is a challenging task to distinguish between benign and malignant lesions in patients with biliary strictures. Here we analyze whether determination of target gene mRNA levels in intraductal brush cytology specimens may be used to improve the diagnosis of bile duct carcinoma. Materials and Methods: Brush cytology specimens from 119 patients with biliary strictures (malignant: n = 72; benign: n = 47) were analyzed in a retrospective cohort study. mRNA of IGF-II mRNA-binding protein 3 (IGF2BP3), homeobox B7 (HOXB7), Forkhead box M1 (FOXM1), kinesin family member 2C (KIF2C) and serine/threonine kinase NEK2 was determined by semi-quantitative RT-PCR using the Delta Ct method. Results: IGF2BP3 (p < 0.0001), HOXB7 (p < 0.0001), and NEK2 (p < 0.0001) mRNA expression levels were significantly increased in patients with cholangiocarcinoma or pancreatic cancer. Median DCt values differed by 3.5 cycles (IGF2BP3), 2.8 cycles (HOXB7) and 1.3 cycles (NEK2) corresponding to 11-fold, 7-fold and 2.5-fold increased mRNA levels in malignant versus benign samples. Sensitivity to detect biliary cancer was 76.4% for IGF2BP3 (80.9% specificity); 72.2% for HOXB7 (78.7% specificity) and 65.3% for NEK2 (72.3% specificity), whereas routine cytology reached only 43.1% sensitivity (85.4% specificity). Diagnostic precision was further improved, when all three molecular markers were assessed in combination (77.8% sensitivity, 87.2% specificity) and achieved 87.5% sensitivity and 87.2% specificity when molecular markers were combined with routine cytology. Conclusions: Our data suggest that measuring IGF2BP3, HOXB7 and NEK2 mRNA levels by RT-PCR in addition to cytology has the potential to improve detection of malignant biliary disorders from brush cytology specimens.	[Nischalke, Hans Dieter; Schmitz, Volker; Luda, Carolin; Aldenhoff, Katharina; Berger, Cordula; Sauerbruch, Tilman; Spengler, Ulrich; Nattermann, Jacob] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Feldmann, Georg] Univ Bonn, Ctr Integrated Oncol Cologne Bonn, Dept Internal Med 3, Bonn, Germany	University of Bonn; University of Bonn	Nischalke, HD (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	nischalke@ukb.uni-bonn.de		Nischalke, Hans Dieter/0000-0002-3457-0023	Deutsche Krebshilfe (German Cancer Aid) [107865]; Deutsche Forschungsgemeinschaft [SFB TR57 TP12]; H.W. & J. Hector Foundation [M42]; German Cancer Foundation (Deutsche Krebshilfe) [109215, 109929]; European Community [HEALTH-F2-2011-256986]	Deutsche Krebshilfe (German Cancer Aid)(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); H.W. & J. Hector Foundation; German Cancer Foundation (Deutsche Krebshilfe)(Deutsche Krebshilfe); European Community(European Commission)	This study was funded by the Deutsche Krebshilfe (German Cancer Aid) (http://www.krebshilfe.de/english.html) grant 107865 to Hans Dieter Nischalke and Ulrich Spengler, the SFB TR57 TP12 of the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) to Jacob Nattermann and Ulrich Spengler and the H.W. & J. Hector Foundation (http://www.hector-stiftung.de/) M42 to Jacob Nattermann. GF was supported by the German Cancer Foundation (Deutsche Krebshilfe) grants number 109215 and 109929 as well as by the European Community's Seventh Framework Program [FP7-2007-2013] under grant agreement HEALTH-F2-2011-256986. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli L, 2011, AM J HEMATOL, V86, pE64, DOI 10.1002/ajh.22164; Chan DW, 2008, J PATHOL, V215, P245, DOI 10.1002/path.2355; Chapman MH, 2012, J HEPATOL; de Bellis M, 2002, GASTROINTEST ENDOSC, V56, P720, DOI 10.1067/mge.2002.129219; de Bellis M, 2002, GASTROINTEST ENDOSC, V56, P552, DOI 10.1067/mge.2002.128132; Feldmann G, 2006, ENDOSCOPY, V38, P604, DOI 10.1055/s-2006-925065; Fishman DS, 2009, WORLD J GASTROENTERO, V15, P1353, DOI 10.3748/wjg.15.1353; Fraser MM, 2005, CANCER RES, V65, P6228, DOI 10.1158/0008-5472.CAN-05-0650; Fritcher EGB, 2010, CURR OPIN GASTROEN, V26, P259, DOI 10.1097/MOG.0b013e3283383bd0; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Glasbrenner B, 1999, ENDOSCOPY, V31, P712; Gnjatic S, 2010, INT J CANCER, V127, P381, DOI 10.1002/ijc.25058; Gray S, 2011, J PANCREAS, V12, P216; Hann LE, 2000, SEMIN SURG ONCOL, V19, P94, DOI 10.1002/1098-2388(200009)19:2<94::AID-SSU3>3.0.CO;2-X; Hansel DE, 2003, AM J PATHOL, V163, P217, DOI 10.1016/S0002-9440(10)63645-0; Itoi T, 2000, GASTROINTEST ENDOSC, V52, P380, DOI 10.1067/mge.2000.108303; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kipp BR, 2010, J MOL DIAGN; Kobel M, 2009, MODERN PATHOL, V22, P469, DOI 10.1038/modpathol.2008.206; Kokuryo T, 2007, CANCER RES, V67, P9637, DOI 10.1158/0008-5472.CAN-07-1489; Lankisch TO, 2011, HEPATOLOGY, V53, P875, DOI 10.1002/hep.24103; Levy MJ, 2007, GASTROINTEST ENDOSC, V66, P483, DOI 10.1016/j.gie.2007.03.1053; Ligato S, 2008, DIAGN CYTOPATHOL, V36, P561, DOI 10.1002/dc.20836; Menias CO, 2008, RADIOGRAPHICS, V28, P1115, DOI 10.1148/rg.284075148; Morales CP, 1998, GASTROINTEST ENDOSC, V48, P402, DOI 10.1016/S0016-5107(98)70011-2; Mori R, 2008, PROSTATE, V68, P1555, DOI 10.1002/pros.20815; Nakamura Y, 2007, BRIT J CANCER, V97, P543, DOI 10.1038/sj.bjc.6603905; Nehls O, 2004, SEMIN LIVER DIS, V24, P139, DOI 10.1055/s-2004-828891; Niiyama H, 1999, CANCER, V85, P2138, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2138::AID-CNCR7>3.0.CO;2-8; Obama K, 2005, HEPATOLOGY, V41, P1339, DOI 10.1002/hep.20718; Ponsioen CY, 1999, ENDOSCOPY, V31, P305; Principe A, 2003, HEPATO-GASTROENTEROL, V50, P1246; PUGLIESE V, 1995, GASTROINTEST ENDOSC, V42, P520, DOI 10.1016/S0016-5107(95)70004-8; Rodriguez JA, 2005, WORLD J SURG, V29, P297, DOI 10.1007/s00268-004-7843-0; RUPP M, 1990, ACTA CYTOL, V34, P221; RYAN ME, 1991, GASTROINTEST ENDOSC, V37, P139, DOI 10.1016/S0016-5107(91)70671-8; RYAN ME, 1994, GASTROINTEST ENDOSC, V40, P133, DOI 10.1016/S0016-5107(94)70154-7; Schaeffer DF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-59; Schoefl R, 1997, SCAND J GASTROENTERO, V32, P363, DOI 10.3109/00365529709007685; Shi CJ, 2009, J MOL DIAGN, V11, P583, DOI 10.2353/jmoldx.2009.090061; Shimo A, 2008, CANCER SCI, V99, P62, DOI 10.1111/j.1349-7006.2007.00635.x; Siddiqui AA, 2012, CLIN GASTROENTEROL H, V10, P466, DOI 10.1016/j.cgh.2011.12.021; Stewart CJR, 2000, DIAGN CYTOPATHOL, V23, P308, DOI 10.1002/1097-0339(200011)23:5<308::AID-DC4>3.0.CO;2-H; Suzuki K, 2010, CANCER SCI, V101, P1163, DOI 10.1111/j.1349-7006.2010.01504.x; Takano T, 1999, J CLIN ENDOCR METAB, V84, P951, DOI 10.1210/jc.84.3.951; Takano T, 1999, CANCER RES, V59, P4542; Wang SL, 2011, HISTOPATHOLOGY, V59, P631, DOI 10.1111/j.1365-2559.2011.03941.x; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wang ZW, 2010, PHARM RES-DORDR, V27, P1159, DOI 10.1007/s11095-010-0106-x; Weglarz L, 2006, ACTA BIOCHIM POL, V53, P349; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Yantiss RK, 2005, AM J SURG PATHOL, V29, P188, DOI 10.1097/01.pas.0000149688.98333.54; Zhao H, 2007, DIAGN CYTOPATHOL, V35, P700, DOI 10.1002/dc.20739	54	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42141	10.1371/journal.pone.0042141	http://dx.doi.org/10.1371/journal.pone.0042141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879911	Green Submitted, Green Published, gold			2022-12-27	WOS:000307437900021
J	Buskohl, PR; Sun, ML; Thompson, RP; Butcher, JT				Buskohl, Philip R.; Sun, Michelle L.; Thompson, Robert P.; Butcher, Jonathan T.			Serotonin Potentiates Transforming Growth Factor-beta3 Induced Biomechanical Remodeling in Avian Embryonic Atrioventricular Valves	PLOS ONE			English	Article							MESENCHYMAL CELL-TRANSFORMATION; CRANIAL NEURAL CREST; FACTOR-BETA; INTERSTITIAL-CELLS; HEART DEVELOPMENT; CARDIAC MORPHOGENESIS; VASOACTIVE AGENTS; PROGENITOR CELLS; MOUSE EMBRYO; CHICK-EMBRYO	Embryonic heart valve primordia (cushions) maintain unidirectional blood flow during development despite an increasingly demanding mechanical environment. Recent studies demonstrate that atrioventricular (AV) cushions stiffen over gestation, but the molecular mechanisms of this process are unknown. Transforming growth factor-beta (TGF beta) and serotonin (5-HT) signaling modulate tissue biomechanics of postnatal valves, but less is known of their role in the biomechanical remodeling of embryonic valves. In this study, we demonstrate that exogenous TGF beta 3 increases AV cushion biomechanical stiffness and residual stress, but paradoxically reduces matrix compaction. We then show that TGF beta 3 induces contractile gene expression (RhoA, aSMA) and extracellular matrix expression (col1 alpha 2) in cushion mesenchyme, while simultaneously stimulating a twofold increase in proliferation. Local compaction increased due to an elevated contractile phenotype, but global compaction appeared reduced due to proliferation and ECM synthesis. Blockade of TGF beta type I receptors via SB431542 inhibited the TGF beta 3 effects. We next showed that exogenous 5-HT does not influence cushion stiffness by itself, but synergistically increases cushion stiffness with TGF beta 3 co-treatment. 5-HT increased TGF beta 3 gene expression and also potentiated TGF beta 3 induced gene expression in a dose-dependent manner. Blockade of the 5HT2b receptor, but not 5-HT2a receptor or serotonin transporter (SERT), resulted in complete cessation of TGF beta 3 induced mechanical strengthening. Finally, systemic 5-HT administration in ovo induced cushion remodeling related defects, including thinned/atretic AV valves, ventricular septal defects, and outflow rotation defects. Elevated 5-HT in ovo resulted in elevated remodeling gene expression and increased TGF beta signaling activity, supporting our ex-vivo findings. Collectively, these results highlight TGF beta/5-HT signaling as a potent mechanism for control of biomechanical remodeling of AV cushions during development.	[Buskohl, Philip R.] Cornell Univ, Dept Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Sun, Michelle L.; Butcher, Jonathan T.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Thompson, Robert P.] Med Univ S Carolina, Dept Cell Biol & Regenerat Med, Charleston, SC 29425 USA	Cornell University; Cornell University; Medical University of South Carolina	Buskohl, PR (corresponding author), Cornell Univ, Dept Mech & Aerosp Engn, Ithaca, NY 14853 USA.	jtb47@cornell.edu	Butcher, Jonathan/AAE-8239-2020; Butcher, Jonathan T/D-2280-2012	Butcher, Jonathan/0000-0002-9309-6296; Butcher, Jonathan T/0000-0002-9309-6296	American Heart Association [0830384N]; National Institutes of Health [HL110328, HL91452]; Hartwell Foundation; National Science Foundation [CBET-0955172, DGE0841291]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091452, R01HL110328] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was funded by the American Heart Association (0830384N, JTB; www.heart.org), National Institutes of Health (HL110328, JTB; HL91452, RPT; www.NIH.gov), The Hartwell Foundation (JTB; www.thehartwellfoundation.org) and the National Science Foundation (CBET-0955172, JTB; DGE0841291, PRB; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 1997, ANN BIOMED ENG, V25, P581, DOI 10.1007/BF02684197; ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4; Azhar M, 2011, DEV DYNAM, V240, P2127, DOI 10.1002/dvdy.22702; Azhar M, 2009, DEV DYNAM, V238, P431, DOI 10.1002/dvdy.21854; Balachandran K, 2011, CARDIOVASC PATHOL; Bartram U, 2001, CIRCULATION, V103, P2745; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Boyer AS, 1999, DEV BIOL, V208, P530, DOI 10.1006/dbio.1999.9211; Buskohl PR, 2012, J BIOMECH, V45, P895, DOI 10.1016/j.jbiomech.2011.11.032; Butcher JT, 2007, PHILOS T R SOC B, V362, P1489, DOI 10.1098/rstb.2007.2130; Butcher JT, 2007, CIRC RES, V100, P1503, DOI 10.1161/CIRCRESAHA.107.148684; Butcher JT, 2007, DEV DYNAM, V236, P802, DOI 10.1002/dvdy.20962; Camenisch TD, 2002, DEV BIOL, V248, P170, DOI 10.1006/dbio.2002.0731; Chen Q, 2009, J BIOL CHEM, V284, P292, DOI 10.1074/jbc.M807233200; Chiu YN, 2010, TISSUE ENG PT A, V16, P3375, DOI 10.1089/ten.tea.2010.0027; Choi DS, 1997, DEVELOPMENT, V124, P1745; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; Disatian S, 2009, J HEART VALVE DIS, V18, P44; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; El-Hamamsy I, 2009, J AM COLL CARDIOL, V53, P1448, DOI 10.1016/j.jacc.2008.11.056; Elangbam CS, 2008, EXP TOXICOL PATHOL, V60, P253, DOI 10.1016/j.etp.2008.03.005; Fukumoto T, 2005, DEV NEUROSCI-BASEL, V27, P349, DOI 10.1159/000088451; FUNG YC, 1991, ANN BIOMED ENG, V19, P237, DOI 10.1007/BF02584301; Guilluy C, 2007, J BIOL CHEM, V282, P2918, DOI 10.1074/jbc.M604195200; Gustafsson BI, 2005, CIRCULATION, V111, P1517, DOI 10.1161/01.CIR.0000159356.42064.48; Hafizi S, 2000, J HEART VALVE DIS, V9, P454; Hauso O, 2007, REGUL PEPTIDES, V143, P39, DOI 10.1016/j.regpep.2007.02.009; Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; HU N, 1989, CIRC RES, V65, P1665, DOI 10.1161/01.RES.65.6.1665; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jaffre F, 2009, CIRC RES, V104, P113, DOI 10.1161/CIRCRESAHA.108.180976; Jian B, 2002, AM J PATHOL, V161, P2111, DOI 10.1016/S0002-9440(10)64489-6; KELLER BB, 1991, CIRC RES, V68, P226, DOI 10.1161/01.RES.68.1.226; Kern CB, 2007, DEV DYNAM, V236, P671, DOI 10.1002/dvdy.21059; Kruithof BPT, 2007, DEV BIOL, V302, P208, DOI 10.1016/j.ydbio.2006.09.024; Lauder JM, 2000, INT J DEV NEUROSCI, V18, P653, DOI 10.1016/S0736-5748(00)00032-0; LAUDER JM, 1988, PROG BRAIN RES, V73, P365; Levin M, 2006, DEV NEUROSCI-BASEL, V28, P171, DOI 10.1159/000091915; Liu YL, 2011, AM J RESP CELL MOL, V44, P548, DOI 10.1165/rcmb.2010-0078OC; Massague J, 2000, GENE DEV, V14, P627; Mekontso-Dessap A, 2006, CIRCULATION, V113, P81, DOI 10.1161/CIRCULATIONAHA.105.554667; Merlob P, 2009, BIRTH DEFECTS RES A, V85, P837, DOI 10.1002/bdra.20615; Merryman WD, 2007, CARDIOVASC PATHOL, V16, P268, DOI 10.1016/j.carpath.2007.03.006; MILLAN FA, 1991, DEVELOPMENT, V111, P131; Miller CE, 2005, MICROSC MICROANAL, V11, P216, DOI 10.1017/S1431927605050464; MOISEIWITSCH JRD, 1995, P NATL ACAD SCI USA, V92, P7182, DOI 10.1073/pnas.92.16.7182; Monassier L, 2010, PHARMACOL THERAPEUT, V128, P559, DOI 10.1016/j.pharmthera.2010.08.004; Nakajima Y, 1997, J CELL BIOL, V136, P193, DOI 10.1083/jcb.136.1.193; Nebigil CG, 2001, CIRCULATION, V103, P2973, DOI 10.1161/01.CIR.103.24.2973; Norris RA, 2008, DEV BIOL, V316, P200, DOI 10.1016/j.ydbio.2008.01.003; Norris RA, 2009, DEV DYNAM, V238, P1052, DOI 10.1002/dvdy.21933; Oyama MA, 2010, J VET INTERN MED, V24, P27, DOI 10.1111/j.1939-1676.2009.0411.x; Pavone LM, 2009, J MOL CELL CARDIOL, V47, P691, DOI 10.1016/j.yjmcc.2009.07.021; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; POTTS JD, 1989, DEV BIOL, V134, P392, DOI 10.1016/0012-1606(89)90111-5; POTTS JD, 1992, DEV DYNAM, V193, P340, DOI 10.1002/aja.1001930407; Qi X, 2007, DEV BIOL, V311, P136, DOI 10.1016/j.ydbio.2007.08.022; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Roth BL, 1998, PHARMACOL THERAPEUT, V79, P231, DOI 10.1016/S0163-7258(98)00019-9; Sadler TW, 2011, REPROD TOXICOL, V32, P484, DOI 10.1016/j.reprotox.2011.09.004; Sedmera D, 1999, ANAT RECORD, V254, P238, DOI 10.1002/(SICI)1097-0185(19990201)254:2<238::AID-AR10>3.0.CO;2-V; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Todorovic V, 2011, DEV DYNAM, V240, P176, DOI 10.1002/dvdy.22521; Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa; Warnock JN, 2010, J HEART VALVE DIS, V19, P86; Watts SW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005682; Xu J, 2002, AM J PATHOL, V161, P2209, DOI 10.1016/S0002-9440(10)64497-5; Yabanoglu S, 2009, J MOL CELL CARDIOL, V46, P518, DOI 10.1016/j.yjmcc.2008.12.019; Yalcin HC, 2010, AM J PHYSL HEART CIR; Yalcin HC, 2011, DEV DYNAM, V240, P23, DOI 10.1002/dvdy.22512; YAVARONE MS, 1993, TERATOLOGY, V47, P573, DOI 10.1002/tera.1420470609; Zhao RG, 2011, ACTA BIOMATER, V7, P1220, DOI 10.1016/j.actbio.2010.11.004	74	19	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42527	10.1371/journal.pone.0042527	http://dx.doi.org/10.1371/journal.pone.0042527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880017	Green Submitted, Green Published, gold			2022-12-27	WOS:000307810000040
J	Johnson, LDS; Jameson, SC				Johnson, Lisa D. S.; Jameson, Stephen C.			TGF-beta Sensitivity Restrains CD8+T Cell Homeostatic Proliferation by Enforcing Sensitivity to IL-7 and IL-15	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CD8(+) T-CELLS; VERSUS-HOST-DISEASE; IN-VIVO; C-MYC; RECEPTOR; SURVIVAL; EXPRESSION; NAIVE; MICE	The pleiotropic cytokine TGF-beta has been implicated in the regulation of numerous aspects of the immune response, including naive T cell homeostasis. Previous studies found that impairing TGF-beta responsiveness (through expression of a dominant-negative TGF-beta RII [DNRII] transgene) leads to accumulation of memory phenotype CD8 T cells, and it was proposed that this resulted from enhanced IL-15 sensitivity. Here we show naive DNRII CD8 T cells exhibit enhanced lymphopenia-driven proliferation and generation of "homeostatic'' memory cells. However, this enhanced response occurred in the absence of IL-15 and, unexpectedly, even in the combined absence of IL-7 and IL-15, which were thought essential for CD8 T cell homeostatic expansion. DNRII transgenic CD8 T cells still require access to self Class I MHC for homeostatic proliferation, arguing against generalized dysregulation of homeostatic cues. These findings suggest TGF-beta responsiveness is critical for enforcing sensitivity to homeostatic cytokines that limit maintenance and composition of the CD8 T cell pool. (154 words).	[Johnson, Lisa D. S.; Jameson, Stephen C.] Univ Minnesota, Ctr Immunol, Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Johnson, LDS (corresponding author), Univ Minnesota, Ctr Immunol, Lab Med & Pathol, Minneapolis, MN 55455 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013; Johnson, Lisa DS/E-4218-2013	Jameson, Stephen C/0000-0001-9137-1146; Johnson, Lisa DS/0000-0002-2019-6560	NIH [R01AI075168, R37AI38903]; UMN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038903, R01AI075168] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UMN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by awards from the NIH (R01AI075168 and R37AI38903, to S.C.J.) and by UMN departmental support (to SCJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banovic T, 2005, BLOOD, V106, P2206, DOI 10.1182/blood-2005-01-0062; Bianchi T, 2006, BLOOD, V107, P3992, DOI 10.1182/blood-2005-09-3851; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Boyman O, 2007, CURR OPIN IMMUNOL, V19, P320, DOI 10.1016/j.coi.2007.04.015; CAPOCASALE RJ, 1995, P NATL ACAD SCI USA, V92, P5501, DOI 10.1073/pnas.92.12.5501; Chen WJ, 2001, J EXP MED, V194, P439, DOI 10.1084/jem.194.4.439; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Chung B, 2008, BIOL BLOOD MARROW TR, V14, P16, DOI 10.1016/j.bbmt.2007.07.015; Coomes SM, 2010, TRANSPLANTATION, V90, P1139, DOI 10.1097/TP.0b013e3181efd018; Genestier L, 1999, J EXP MED, V189, P231, DOI 10.1084/jem.189.2.231; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kieper WC, 2001, J IMMUNOL, V166, P5515, DOI 10.4049/jimmunol.166.9.5515; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Li WQ, 2010, MOL CELL BIOL, V30, P590, DOI 10.1128/MCB.01006-09; Lucas PJ, 2006, BLOOD, V108, P2789, DOI 10.1182/blood-2006-05-025676; Lucas PJ, 2000, J EXP MED, V191, P1187, DOI 10.1084/jem.191.7.1187; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; McKarns SC, 2005, J IMMUNOL, V174, P2071, DOI 10.4049/jimmunol.174.4.2071; Mehal WZ, 2005, INT IMMUNOL, V17, P531, DOI 10.1093/intimm/dxh233; Modiano JF, 2008, IMMUNOL RES; O'Reilly LA, 2009, J IMMUNOL, V183, P261, DOI 10.4049/jimmunol.0803853; Palmer MJ, 2011, IMMUNOL CELL BIOL, V89, P581, DOI 10.1038/icb.2011.5; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Sandau MM, 2007, J IMMUNOL, V179, P120, DOI 10.4049/jimmunol.179.1.120; Sanjabi S, 2009, IMMUNITY, V31, P131, DOI 10.1016/j.immuni.2009.04.020; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Sinha ML, 2002, BLOOD, V100, P2642, DOI 10.1182/blood-2002-04-1082; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Thiant S, 2010, BONE MARROW TRANSPL, V45, P1546, DOI 10.1038/bmt.2010.13; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Zhang N, 2012, NATURE IMMUNOLOGY	42	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42268	10.1371/journal.pone.0042268	http://dx.doi.org/10.1371/journal.pone.0042268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879925	Green Submitted, Green Published, gold			2022-12-27	WOS:000307810000022
J	Boleij, H; Salomons, AR; van Sprundel, M; Arndt, SS; Ohl, F				Boleij, Hetty; Salomons, Amber R.; van Sprundel, Mariska; Arndt, Saskia S.; Ohl, Frauke			Not All Mice Are Equal: Welfare Implications of Behavioural Habituation Profiles in Four 129 Mouse Substrains	PLOS ONE			English	Article							EARLY GENE-EXPRESSION; ANXIETY-LIKE BEHAVIOR; COGNITIVE PERFORMANCE; PATHOLOGICAL ANXIETY; ANIMAL-WELFARE; STRAINS; TRAIT; ENVIRONMENT; KNOCKOUT; C57BL/6	Safeguarding the welfare of animals is an important aim when defining housing and management standards in animal based, experimental research. While such standards are usually defined per animal species, it is known that considerable differences between laboratory mouse strains exist, for example with regard to their emotional traits. Following earlier experiments, in which we found that 129P3 mice show a lack of habituation of anxiety related behaviour after repeated exposure to an initially novel environment (non-adaptive profile), we here investigated four other 129 inbred mouse substrains (129S2/SvPas, 129S2/SvHsd (exp 1); 129P2 and 129X1 (exp 2)) on habituation of anxiety related behaviour. Male mice of each strain were repeatedly placed in the modified hole board test, measuring anxiety-related behaviour, exploratory and locomotor behaviour. The results reveal that all four substrains show a lack of habituation behaviour throughout the period of testing. Although not in all of the substrains a possible confounding effect of general activity can be excluded, our findings suggest that the genetic background of the 129 substrains may increase their vulnerability to cope with environmental challenges, such as exposure to novelty. This vulnerability might negatively affect the welfare of these mice under standard laboratory conditions when compared with other strains. Based on our findings we suggest to consider (sub) strain-specific guidelines and protocols, taking the (subs) train-specific adaptive capabilities into account.	[Boleij, Hetty; Salomons, Amber R.; van Sprundel, Mariska; Arndt, Saskia S.; Ohl, Frauke] Univ Utrecht, Fac Vet Med, Dept Anim Sci & Soc, Div Anim Welf & Lab Anim Sci, Utrecht, Netherlands; [Boleij, Hetty; Salomons, Amber R.; Arndt, Saskia S.; Ohl, Frauke] Rudolf Magnus Inst Neurosci, NL-3508 TA Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Boleij, H (corresponding author), Univ Utrecht, Fac Vet Med, Dept Anim Sci & Soc, Div Anim Welf & Lab Anim Sci, Utrecht, Netherlands.	h.boleij@uu.nl			Faculty of Veterinary Medicine, Utrecht University	Faculty of Veterinary Medicine, Utrecht University	The work was financially supported by the Faculty of Veterinary Medicine, Utrecht University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov U, 2008, NEUROSCI LETT, V443, P223, DOI 10.1016/j.neulet.2008.07.075; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Belzung C, 1997, BEHAV PHARMACOL, V8, P541, DOI 10.1097/00008877-199711000-00012; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Bolivar VJ, 2009, NEUROBIOL LEARN MEM, V92, P206, DOI 10.1016/j.nlm.2009.02.002; Bothe GWM, 2005, COMPARATIVE MED, V55, P326; Bothe GWM, 2004, GENES BRAIN BEHAV, V3, P149, DOI 10.1111/j.1601-183x.2004.00064.x; Bracke MBM, 2006, J AGR ENVIRON ETHIC, V19, P77, DOI 10.1007/s10806-005-4493-7; Brambell F.W.R, 1965, REPORT TECHNICAL COM; Camp M, 2009, GENES BRAIN BEHAV, V8, P744, DOI 10.1111/j.1601-183X.2009.00519.x; Casellas J, 2011, ANIMAL, V5, P1, DOI 10.1017/S1751731110001667; Chesler EJ, 2002, NEUROSCI BIOBEHAV R, V26, P907, DOI 10.1016/S0149-7634(02)00103-3; Clement Y, 2002, BRAIN RES BULL, V57, P57, DOI 10.1016/S0361-9230(01)00637-2; Clement Y, 2009, PLOS ONE, V4, pA74, DOI 10.1371/journal.pone.0007745; Cook MN, 2002, BEHAV NEUROSCI, V116, P600, DOI 10.1037//0735-7044.116.4.600; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Visser L, 2006, GENES BRAIN BEHAV, V5, P458, DOI 10.1111/j.1601-183X.2005.00181.x; Eisenstein EM, 2006, REV NEUROSCIENCE, V17, P533; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Hefner K, 2008, J NEUROSCI, V28, P8074, DOI 10.1523/JNEUROSCI.4904-07.2008; Jensen P, 2010, ANIM WELFARE, V19, P7; Kim D, 2005, GENES BRAIN BEHAV, V4, P302, DOI 10.1111/j.1601-183X.2005.00133.x; Knierim U, 2009, ANIM WELFARE, V18, P451; Korte SM, 2007, PHYSIOL BEHAV, V92, P422, DOI 10.1016/j.physbeh.2006.10.018; Laarakker MC, 2008, BEHAV GENET, V38, P159, DOI 10.1007/s10519-007-9188-6; Livesey PJ, 1986, LEARNING EMOTION BIO; Montkowski A, 1997, BRAIN RES, V762, P12, DOI 10.1016/S0006-8993(97)00370-3; National Research Counci, 2010, GUIDE CARE USE LAB A; O'Keefe J, 1999, HIPPOCAMPUS, V9, P352, DOI 10.1002/(SICI)1098-1063(1999)9:4<352::AID-HIPO3>3.0.CO;2-1; Ohl F, 2012, VET J, V192, P13, DOI 10.1016/j.tvjl.2011.05.019; Ohl F, 2003, EUR J NEUROSCI, V17, P128, DOI 10.1046/j.1460-9568.2003.02436.x; Ohl F, 2002, BEHAV NEUROSCI, V116, P464, DOI 10.1037//0735-7044.116.3.464; Ohl F, 2001, J PSYCHIAT RES, V35, P147, DOI 10.1016/S0022-3956(01)00017-6; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Pratte M, 2009, BEHAV BRAIN RES, V203, P54, DOI 10.1016/j.bbr.2009.04.011; Salomons AR, 2010, GENES BRAIN BEHAV, V9, P1, DOI 10.1111/j.1601-183X.2009.00527.x; Salomons AR, 2012, COGN AFFECT BEHAV NE, V12, P794, DOI 10.3758/s13415-012-0109-7; Salomons AR, 2010, BEHAV BRAIN RES, V215, P95, DOI 10.1016/j.bbr.2010.06.035; Salomons AR, 2010, BEHAV BRAIN RES, V209, P241, DOI 10.1016/j.bbr.2010.01.050; Salomons AR, 2009, SCAND J LAB ANIM SCI, V36, P37; Sik A, 2003, BEHAV BRAIN RES, V147, P49, DOI 10.1016/S0166-4328(03)00117-7; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Tang XD, 2005, PHYSIOL BEHAV, V84, P105, DOI 10.1016/j.physbeh.2004.10.017; van der Staay FJ, 2010, GENES BRAIN BEHAV, V9, P849, DOI 10.1111/j.1601-183X.2010.00628.x; Webster A.J.F, 1994, ANIMAL WELFARE COOL; Yeates JW, 2008, VET J, V175, P293, DOI 10.1016/j.tvjl.2007.05.009	47	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42544	10.1371/journal.pone.0042544	http://dx.doi.org/10.1371/journal.pone.0042544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880028	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100126
J	Guenin, S; Mouallif, M; Deplus, R; Lampe, X; Krusy, N; Calonne, E; Delbecque, K; Kridelka, F; Fuks, F; Ennaji, MM; Delvenne, P				Guenin, Samuel; Mouallif, Mustapha; Deplus, Rachel; Lampe, Xavier; Krusy, Nathalie; Calonne, Emilie; Delbecque, Katty; Kridelka, Frederic; Fuks, Francois; Ennaji, My Mustapha; Delvenne, Philippe			Aberrant Promoter Methylation and Expression of UTF1 during Cervical Carcinogenesis	PLOS ONE			English	Article							CHROMATIN-ASSOCIATED PROTEIN; DNA-METHYLATION; OCT4 EXPRESSION; STEM-CELLS; CANCER; CARCINOMA; GENES; DIFFERENTIATION; MARKERS; HYPERMETHYLATION	Promoter methylation profiles are proposed as potential prognosis and/or diagnosis biomarkers in cervical cancer. Up to now, little is known about the promoter methylation profile and expression pattern of stem cell (SC) markers during tumor development. In this study, we were interested to identify SC genes methylation profiles during cervical carcinogenesis. A genome-wide promoter methylation screening revealed a strong hypermethylation of Undifferentiated cell Transcription Factor 1 (UTF1) promoter in cervical cancer in comparison with normal ectocervix. By direct bisulfite pyrosequencing of DNA isolated from liquid-based cytological samples, we showed that UTF1 promoter methylation increases with lesion severity, the highest level of methylation being found in carcinoma. This hypermethylation was associated with increased UTF1 mRNA and protein expression. By using quantitative RT-PCR and Western Blot, we showed that both UTF1 mRNA and protein are present in epithelial cancer cell lines, even in the absence of its two main described regulators Oct4A and Sox2. Moreover, by immunofluorescence, we confirmed the nuclear localisation of UTF1 in cell lines. Surprisingly, direct bisulfite pyrosequencing revealed that the inhibition of DNA methyltransferase by 5-aza-29-deoxycytidine was associated with decreased UTF1 gene methylation and expression in two cervical cancer cell lines of the four tested. These findings strongly suggest that UTF1 promoter methylation profile might be a useful biomarker for cervical cancer diagnosis and raise the questions of its role during epithelial carcinogenesis and of the mechanisms regulating its expression.	[Guenin, Samuel; Mouallif, Mustapha; Krusy, Nathalie; Delvenne, Philippe] Univ Liege, Lab Expt Pathol, Grp Interdisciplinaire Genoprote Appl GIGA Canc, Liege, Belgium; [Mouallif, Mustapha; Ennaji, My Mustapha] Univ Hassan II Mohammedia, Lab Virol & Hyg & Microbiol, Mohammadia, Morocco; [Deplus, Rachel; Lampe, Xavier; Calonne, Emilie; Fuks, Francois] Free Univ Brussels, Lab Canc Epigenet, Brussels, Belgium; [Delbecque, Katty] CHU Sart Tilman, Dept Pathol, B-4000 Liege, Belgium; [Kridelka, Frederic] CHU Sart Tilman, Dept Obstet & Gynecol, B-4000 Liege, Belgium	University of Liege; Hassan II University of Casablanca; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Liege; University of Liege	Guenin, S (corresponding author), Univ Liege, Lab Expt Pathol, Grp Interdisciplinaire Genoprote Appl GIGA Canc, Liege, Belgium.	samuel.guenin@gmail.com	Ennaji, Moulay Mustapha/AAE-7386-2020; Ennaji, Moulay Mustapha/AAF-1514-2020	Ennaji, Moulay Mustapha/0000-0001-5809-0270	Program of the Walloon Region [616476]; Belgian Fund for Medical Scientific Research (FNRS); Neoangio; Averroes Program of the European Commission; F.R.S-FNRS	Program of the Walloon Region; Belgian Fund for Medical Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Neoangio; Averroes Program of the European Commission; F.R.S-FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Program of the Walloon Region (Neoangio No 616476) and the Belgian Fund for Medical Scientific Research (FNRS). Samuel Guenin and Xavier Lampe are supported by Neoangio. Mustapha Mouallif is supported by a grant from the Averroes Program of the European Commission and by a Televie grant from the F.R.S-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Romaih K, 2008, NEOPLASIA, V10, P471, DOI 10.1593/neo.08174; Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Arafa M, 2008, APPL IMMUNOHISTO M M, V16, P422, DOI 10.1097/PAI.0b013e318166fd42; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bortolomai I, 2010, CELL CYCLE, V9, P1194, DOI 10.4161/cc.9.6.11108; Cantz T, 2008, STEM CELLS, V26, P692, DOI 10.1634/stemcells.2007-0657; Chik F, 2012, ADV EXP MED BIOL, V720, P91, DOI 10.1007/978-1-4614-0254-1_8; Chung SH, 2010, TRENDS ENDOCRIN MET, V21, P504, DOI 10.1016/j.tem.2010.03.005; Cox GS, 1998, BBA-GENE STRUCT EXPR, V1396, P67, DOI 10.1016/S0167-4781(97)00175-9; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dehan P, 2009, EXPERT REV MOL DIAGN, V9, P651, DOI 10.1586/ERM.09.53; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Feng DQ, 2009, ONCOL REP, V22, P1129, DOI 10.3892/or_00000545; Feng QH, 2005, JNCI-J NATL CANCER I, V97, P273, DOI 10.1093/jnci/dji041; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forte A, 2009, MOL MED, V15, P392, DOI 10.2119/molmed.2009.00068; Gronniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971; Hall S, 1996, GYNECOL ONCOL, V62, P353, DOI 10.1006/gyno.1996.0248; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hantusch B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-20; Herfs M, 2010, AM J PATHOL, V176, P1941, DOI 10.2353/ajpath.2010.090804; Hietanen S, 2000, P NATL ACAD SCI USA, V97, P8501, DOI 10.1073/pnas.97.15.8501; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Jackson K, 2011, DIGEST DIS SCI, V56, P125, DOI 10.1007/s10620-010-1422-z; Ji J, 2010, HUM PATHOL, V41, P1438, DOI 10.1016/j.humpath.2009.11.021; Kahn SL, 2008, CANCER CYTOPATHOL, V114, P57, DOI 10.1002/cncr.23258; Kalantari M, 2008, VIROLOGY, V374, P292, DOI 10.1016/j.virol.2007.12.016; Kim JH, 2010, GYNECOL ONCOL, V116, P99, DOI 10.1016/j.ygyno.2009.09.032; Kim TW, 2010, INT J ONCOL, V36, P1105, DOI 10.3892/ijo_00000592; Kooistra SM, 2010, STEM CELLS, V28, P1703, DOI 10.1002/stem.497; Kooistra SM, 2009, STEM CELL RES, V2, P211, DOI 10.1016/j.scr.2009.02.001; Kristensen DM, 2008, HUM REPROD, V23, P775, DOI 10.1093/humrep/den010; Lim EH, 2010, GYNECOL ONCOL, V119, P225, DOI 10.1016/j.ygyno.2010.07.028; Liu DB, 2011, TUMOR BIOL, V32, P941, DOI 10.1007/s13277-011-0196-z; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Melone MAB, 2009, CANCER BIOL THER, V8, P1300, DOI 10.4161/cbt.8.13.8890; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller T, 2009, CELL MOL LIFE SCI, V66, P495, DOI 10.1007/s00018-008-8623-z; Nabilsi NH, 2009, ONCOGENE, V28, P2046, DOI 10.1038/onc.2009.62; Nishimoto M, 2005, MOL CELL BIOL, V25, P5084, DOI 10.1128/MCB.25.12.5084-5094.2005; Overmeer RM, 2009, J PATHOL, V219, P327, DOI 10.1002/path.2598; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; Pellacani D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-94; Reinisch CM, 2007, J CUTAN PATHOL, V34, P174, DOI 10.1111/j.1600-0560.2006.00587.x; Reinisch CM, 2011, INT J EXP PATHOL, V92, P326, DOI 10.1111/j.1365-2613.2011.00769.x; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Sun C, 2011, GYNECOL ONCOL, V121, P59, DOI 10.1016/j.ygyno.2011.01.013; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Takahashi Y, 2012, BREAST CANCER-TOKYO, V19, P242, DOI 10.1007/s12282-011-0272-7; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Wang P, 2010, AM J CLIN PATHOL, V134, P604, DOI 10.1309/AJCPB44HBKINJNYU; Wang X, 2010, STEM CELLS, V28, P885, DOI 10.1002/stem.419; Wentzensen N, 2009, GYNECOL ONCOL, V112, P293, DOI 10.1016/j.ygyno.2008.10.012; Xuan YH, 2006, MODERN PATHOL, V19, P1139, DOI 10.1038/modpathol.3800600; Zhao SD, 2011, J PATHOL, V223, P672, DOI 10.1002/path.2827; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhao ZR, 2010, P NATL ACAD SCI USA, V107, P5605, DOI 10.1073/pnas.0910578107; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	60	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42704	10.1371/journal.pone.0042704	http://dx.doi.org/10.1371/journal.pone.0042704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880087	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100161
J	Hansen, JJ; Huang, Y; Peterson, DA; Goeser, L; Fan, TJ; Chang, EB; Sartor, RB				Hansen, Jonathan J.; Huang, Yong; Peterson, Daniel A.; Goeser, Laura; Fan, Ting-Jia; Chang, Eugene B.; Sartor, R. Balfour			The Colitis-Associated Transcriptional Profile of Commensal Bacteroides thetaiotaomicron Enhances Adaptive Immune Responses to a Bacterial Antigen	PLOS ONE			English	Article							CROHNS-DISEASE; HIGH PREVALENCE; MOUSE MODEL; MICROBIOTA; SUSCEPTIBILITY; GASTRITIS; HLA-B27	Background: Inflammatory bowel diseases (IBD) may be caused in part by aberrant immune responses to commensal intestinal microbes including the well-characterized anaerobic gut commensal Bacteroides thetaiotaomicron (B. theta). Healthy, germ-free HLA-B27 transgenic (Tg) rats develop chronic colitis when colonized with complex gut commensal bacteria whereas non-transgenic (nTg) rats remain disease-free. However, the role of B. theta in causing disease in Tg rats is unknown nor is much known about how gut microbes respond to host inflammation. Methods: Tg and nTg rats were monoassociated with a human isolate of B. theta. Colonic inflammation was assessed by histologic scoring and tissue pro-inflammatory cytokine measurement. Whole genome transcriptional profiling of B. theta recovered from ceca was performed using custom GeneChips and data analyzed using dChip, Significance Analysis of Microarrays, and Gene Set Enrichment Analysis (GSEA) software. Western Blots were used to determine adaptive immune responses to a differentially expressed B. theta gene. Results: B. theta monoassociated Tg rats, but not nTg or germ-free controls, developed chronic colitis. Transcriptional profiles of cecal B. theta were significantly different in Tg vs. nTg rats. GSEA revealed that genes in KEGG canonical pathways involved in bacterial growth and metabolism were downregulated in B. theta from Tg rats with colitis though luminal bacterial concentrations were unaffected. Bacterial genes in the Gene Ontology molecular function "receptor activity", most of which encode nutrient binding proteins, were significantly upregulated in B. theta from Tg rats and include a SusC homolog that induces adaptive immune responses in Tg rats. Conclusions: B. theta induces colitis in HLA-B27 Tg rats, which is associated with regulation of bacterial genes in metabolic and nutrient binding pathways that may affect host immune responses. These studies of the host-microbial dialogue may lead to the identification of novel microbial targets for IBD therapies.	[Hansen, Jonathan J.; Goeser, Laura; Fan, Ting-Jia; Sartor, R. Balfour] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA; [Hansen, Jonathan J.; Sartor, R. Balfour] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Huang, Yong; Chang, Eugene B.] Univ Chicago, Dept Med, Gastroenterol Sect, Med Ctr, Chicago, IL 60637 USA; [Peterson, Daniel A.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Sartor, R. Balfour] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Chicago; University of Chicago Medical Center; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill	Hansen, JJ (corresponding author), Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA.	jjhansen@med.unc.edu			NIH [K08 DK087896]; Crohn's and Colitis Foundation of America [2662]; Center for Gastrointestinal Biology and Disease [NIH P30 DK34987, NIH R01 DK53347, NIH P40 RR18803]; Crohn's and Colitis Foundation of America Gnotobiotic Animal Facility; University of Chicago Host-Microbe Core of the Digestive Disease Research Core Center [NIH DK42086]; Helmsley Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, P30DK042086, K08DK087896, R01DK053347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Center for Gastrointestinal Biology and Disease; Crohn's and Colitis Foundation of America Gnotobiotic Animal Facility; University of Chicago Host-Microbe Core of the Digestive Disease Research Core Center; Helmsley Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH K08 DK087896 (J.J.H.), a Career Development Award from the Crohn's and Colitis Foundation of America 2662 (J.J.H.), Center for Gastrointestinal Biology and Disease grant NIH P30 DK34987 (Robert S. Sandler, PI), NIH R01 DK53347 (R. B. S.), NIH P40 RR18803 (R. B. S.), Crohn's and Colitis Foundation of America Gnotobiotic Animal Facility (R. B. S.), University of Chicago Host-Microbe Core of the Digestive Disease Research Core Center (NIH DK42086, E. B. C.), and Helmsley Foundation (E. B. C., R. B. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh A, 2009, ALIMENT PHARM THER, V29, P75, DOI 10.1111/j.1365-2036.2008.03860.x; Ashorn S, 2009, INFLAMM BOWEL DIS, V15, P199, DOI 10.1002/ibd.20535; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Carroll IM, 2007, AM J PHYSIOL-GASTR L, V293, pG729, DOI 10.1152/ajpgi.00132.2007; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Edwards LA, 2011, INFLAMM BOWEL DIS, V17, P1201, DOI 10.1002/ibd.21501; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Hansen JJ, 2007, INFLAMM BOWEL DIS, P19; Hansen J, 2010, CURR OPIN GASTROEN, V26, P564, DOI 10.1097/MOG.0b013e32833f1195; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Janowitz HD, 1998, INFLAMM BOWEL DIS, V4, P29, DOI 10.1097/00054725-199802000-00006; Keshavarzian A, 2003, GUT, V52, P720, DOI 10.1136/gut.52.5.720; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Patwa LG, 2011, GASTROENTEROLOGY, V141, P1842, DOI 10.1053/j.gastro.2011.06.064; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Rath HC, 1999, INFECT IMMUN, V67, P2969, DOI 10.1128/IAI.67.6.2969-2974.1999; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vine CE, 2011, FEMS MICROBIOL LETT; Wang YW, 2010, APPL MICROBIOL BIOT, V88, P1333, DOI 10.1007/s00253-010-2921-8; Wei B, 2001, INFECT IMMUN, V69, P6044, DOI 10.1128/IAI.69.10.6044-6054.2001; Weiss DS, 2004, MOL MICROBIOL, V54, P588, DOI 10.1111/j.1365-2958.2004.04283.x; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	43	30	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42645	10.1371/journal.pone.0042645	http://dx.doi.org/10.1371/journal.pone.0042645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880065	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100149
J	Lagomarcino, AJ; Miller, AI				Lagomarcino, Anne J.; Miller, Arnold I.			The Relationship between Genus Richness and Geographic Area in Late Cretaceous Marine Biotas: Epicontinental Sea versus Open-Ocean-Facing Settings	PLOS ONE			English	Article							PHANEROZOIC TRENDS; DIVERSITY; EXTINCTION; CURVES; ISLAND	For present-day biotas, close relationships have been documented between the number of species in a given region and the area of the region. To date, however, there have been only limited studies of these relationships in the geologic record, particularly for ancient marine biotas. The recent development of large-scale marine paleontological databases, in conjunction with enhanced geographical mapping tools, now allow for their investigation. At the same time, there has been renewed interest in comparing the environmental and paleobiological properties of two broad-scale marine settings: epicontinental seas, broad expanses of shallow water covering continental areas, and open-ocean-facing settings, shallow shelves and coastlines that rim ocean basins. Recent studies indicate that spatial distributions of taxa and the kinetics of taxon origination and extinction may have differed in these two settings. Against this backdrop, we analyze regional Genus-Area Relationships (GARs) of Late Cretaceous marine invertebrates in epicontinental sea and open-ocean settings using data from the Paleobiology Database. We present a new method for assessing GARs that is particularly appropriate for fossil data when the geographic distribution of these data is patchy and uneven. Results demonstrate clear relationships between genus richness and area for regions worldwide, but indicate that as area increases, genus richness increases more per unit area in epicontinental seas than in open-ocean settings. This difference implies a greater degree of compositional heterogeneity as a function of geographic area in epicontinental sea settings, a finding that is consistent with the emerging understanding of physical differences in the nature of water masses between the two marine settings.	[Lagomarcino, Anne J.; Miller, Arnold I.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Lagomarcino, AJ (corresponding author), Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA.	anne.lagomarcino@gmail.com	Lagomarcino, Anne J/Q-6060-2018	Lagomarcino, Anne J/0000-0002-3893-5771	Theodore Roosevelt Memorial Fund of the American Museum of Natural History; Geological Society of America Graduate Student Research Grant; Paleontological Society Student Research Grant; Mid-American Paleontology Society (MAPS) Outstanding Research Awards; University of Cincinnati, Department of Geology, Caster Award; National Aeronautics and Space Administration (NASA) grant [NNX10AQ44G]	Theodore Roosevelt Memorial Fund of the American Museum of Natural History; Geological Society of America Graduate Student Research Grant; Paleontological Society Student Research Grant; Mid-American Paleontology Society (MAPS) Outstanding Research Awards; University of Cincinnati, Department of Geology, Caster Award; National Aeronautics and Space Administration (NASA) grant	This work was supported by the following: Theodore Roosevelt Memorial Fund of the American Museum of Natural History 2009 (http://www.amnh.org/); Geological Society of America Graduate Student Research Grant 2009 (http://www.geosociety.org/); Paleontological Society Student Research Grant, Mid-American Paleontology Society (MAPS) Outstanding Research Awards 2009 (http://www.paleosoc.org/index.html); University of Cincinnati, Department of Geology, Caster Award 2010 (http://www.artsci.uc.edu/geology/); and National Aeronautics and Space Administration (NASA) grant number NNX10AQ44G (Program in Exobiology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison PA, 2005, SEDIMENT GEOL, V179, P175, DOI 10.1016/j.sedgeo.2005.05.004; Allison PA, 2006, PALAIOS, V21, P513, DOI 10.2110/palo.2006.S06; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; [Anonymous], 2010, R LANG ENV STAT COMP; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; BABINOT JF, 1992, PALAEOGEOGR PALAEOCL, V92, P283, DOI 10.1016/0031-0182(92)90088-M; BAMBACH R K, 1977, Paleobiology, V3, P152; Barnosky AD, 2005, PLOS BIOL, V3, P1356, DOI 10.1371/journal.pbio.0030266; Blakey R, 2010, COLORADO PLATEAU STR; Braden B., 1986, COLL MATH J, V17, P326, DOI [10.2307/2686282, DOI 10.1080/07468342.1986.11972974]; Carrasco MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008331; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Dengler J, 2009, J BIOGEOGR, V36, P728, DOI 10.1111/j.1365-2699.2008.02038.x; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Marui Y, 2004, PALEOBIOLOGY, V30, P222, DOI 10.1666/0094-8373(2004)030<0222:SCFLSO>2.0.CO;2; May RM, 2000, SCIENCE, V290, P2084, DOI 10.1126/science.290.5499.2084; Miller AI, 2009, SCIENCE, V326, P1106, DOI 10.1126/science.1180061; Miller AI, 2009, PALEOBIOLOGY, V35, P612, DOI 10.1666/0094-8373-35.4.612; Mitchell AJ, 2010, SEDIMENT GEOL, V228, P81, DOI 10.1016/j.sedgeo.2010.03.008; Mitchell AJ, 2010, SEDIMENTOLOGY, V57, P359, DOI 10.1111/j.1365-3091.2009.01082.x; Panchuk KM, 2006, J SEDIMENT RES, V76, P200, DOI 10.2110/jsr.2006.017; Peters SE, 2007, PALEOBIOLOGY, V33, P165, DOI 10.1666/06067.1; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Ricklefs RE, 1999, J ANIM ECOL, V68, P1142, DOI 10.1046/j.1365-2656.1999.00358.x; Rosenzweig ML, 1999, ECOGRAPHY, V22, P614, DOI 10.1111/j.1600-0587.1999.tb00510.x; Scheiner SM, 2004, GLOBAL ECOL BIOGEOGR, V13, P479, DOI 10.1111/j.1466-822X.2004.00127.x; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; SEPKOSKI J J JR, 1976, Paleobiology, V2, P298; Smith KT, 2008, EVOL ECOL RES, V10, P987; Tjorve E, 2003, J BIOGEOGR, V30, P827, DOI 10.1046/j.1365-2699.2003.00877.x; Walker LJ, 2002, J GEOL, V110, P75, DOI 10.1086/324318; Wells MR, 2005, SEDIMENTOLOGY, V52, P715, DOI 10.1111/j.1365-3091.2005.00718.x; [No title captured]	35	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e40472	10.1371/journal.pone.0040472	http://dx.doi.org/10.1371/journal.pone.0040472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870199	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100008
J	Logotheti, S; Papaevangeliou, D; Michalopoulos, I; Sideridou, M; Tsimaratou, K; Christodoulou, I; Pyrillou, K; Gorgoulis, V; Vlahopoulos, S; Zoumpourlis, V				Logotheti, Stella; Papaevangeliou, Dimitra; Michalopoulos, Ioannis; Sideridou, Maria; Tsimaratou, Katerina; Christodoulou, Ioannis; Pyrillou, Katerina; Gorgoulis, Vassilis; Vlahopoulos, Spiros; Zoumpourlis, Vassilis			Progression of Mouse Skin Carcinogenesis Is Associated with Increased Er alpha Levels and Is Repressed by a Dominant Negative Form of Er alpha	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; ORGAN TRANSPLANT RECIPIENTS; FACTOR-BINDING SITES; BREAST-CANCER CELLS; ENDOGENOUS ESTROGEN; SIGNALING PROTECTS; TUMOR-GROWTH; EXPRESSION; GENE; MECHANISMS	Estrogen receptors (ER), namely ER alpha and ER beta, are hormone-activated transcription factors with an important role in carcinogenesis. In the present study, we aimed at elucidating the implication of ER alpha in skin cancer, using chemicallyinduced mouse skin tumours, as well as cell lines representing distinct stages of mouse skin oncogenesis. First, using immunohistochemical staining we showed that ER alpha is markedly increased in aggressive mouse skin tumours in vivo as compared to the papilloma tumours, whereas ER beta levels are low and become even lower in the aggressive spindle tumours of carcinogen-treated mice. Then, using the multistage mouse skin carcinogenesis model, we showed that ER alpha gradually increases during promotion and progression stages of mouse skin carcinogenesis, peaking at the most aggressive stage, whereas ER beta levels only slightly change throughout skin carcinogenesis. Stable transfection of the aggressive, spindle CarB cells with a dominant negative form of ER alpha (dnER alpha) resulted in reduced ER alpha levels and reduced binding to estrogen responsive elements (ERE)-containing sequences. We characterized two highly conserved EREs on the mouse ER alpha promoter through which dnER alpha decreased endogenous ER alpha levels. The dnER alpha-transfected CarB cells presented altered protein levels of cytoskeletal and cell adhesion molecules, slower growth rate and impaired anchorage-independent growth in vitro, whereas they gave smaller tumours with extended latency period of tumour onset in vivo. Our findings suggest an implication of ER alpha in the aggressiveness of spindle mouse skin cancer cells, possibly through regulation of genes affecting cell shape and adhesion, and they also provide hints for the effective targeting of spindle cancer cells by dnER alpha .	[Logotheti, Stella; Papaevangeliou, Dimitra; Christodoulou, Ioannis; Pyrillou, Katerina; Vlahopoulos, Spiros; Zoumpourlis, Vassilis] Natl Hellen Res Fdn, Biomed Applicat Unit, Inst Biol Med Chem & Biotechnol, Athens, Greece; [Michalopoulos, Ioannis] Acad Athens, Ctr Immunol & Transplantat, Biomed Res Fdn, Athens, Greece; [Sideridou, Maria; Tsimaratou, Katerina; Gorgoulis, Vassilis] Univ Athens, Sch Med, Mol Carcinogenesis Grp, Dept Histol & Embryol, GR-11527 Athens, Greece	National Hellenic Research Foundation; Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens	Logotheti, S (corresponding author), Natl Hellen Res Fdn, Biomed Applicat Unit, Inst Biol Med Chem & Biotechnol, Athens, Greece.	vzub@eie.gr	Gorgoulis, Vassilis/AAD-3630-2019; , 0000-0001-8991-8712/S-4398-2016; Vlahopoulos, Spiros A/A-1186-2014; Vlahopoulos, Spiros/AAK-6362-2020	Gorgoulis, Vassilis/0000-0001-9001-4112; , 0000-0001-8991-8712/0000-0001-8991-8712; Vlahopoulos, Spiros A/0000-0001-6245-3863; Vlahopoulos, Spiros/0000-0001-6245-3863; Pyrillou, Katerina/0000-0003-0375-7810; Logotheti, Stella/0000-0001-8249-2202	USA - Greek bilateral cooperation grant [05NON-EU-3]; GSRT	USA - Greek bilateral cooperation grant; GSRT(Greek Ministry of Development-GSRT)	This work was supported by a USA - Greek bilateral cooperation grant (05NON-EU-3) funded by the GSRT (http://www.startupgreece.gov.gr/content/general-secretariat-research-and-technology-gsrt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hendy A, 2004, AM J OBSTET GYNECOL, V191, P1621, DOI 10.1016/j.ajog.2004.04.022; Bakas P, 2008, FERTIL STERIL, V90, P1878, DOI 10.1016/j.fertnstert.2007.09.019; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castles CG, 1997, J STEROID BIOCHEM, V62, P155, DOI 10.1016/S0960-0760(97)00023-X; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Chantzi NI, 2011, STEROIDS, V76, P974, DOI 10.1016/j.steroids.2011.05.010; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen K, 2005, BRIT J DERMATOL, V152, P518, DOI 10.1111/J.1365-2133.2005.06347.X; Cho JL, 2008, PHOTOCH PHOTOBIO SCI, V7, P120, DOI 10.1039/b709856a; Cho JL, 2010, PHOTOCH PHOTOBIO SCI, V9, P608, DOI 10.1039/b9pp00168a; Copland JA, 2009, BIOESSAYS, V31, P629, DOI 10.1002/bies.200800138; Covaleda AMS, 2008, TOXICOL SCI, V105, P303, DOI 10.1093/toxsci/kfn141; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Hall JM, 2002, J BIOL CHEM, V277, P44455, DOI 10.1074/jbc.M200849200; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Helguero LA, 2005, ONCOGENE, V24, P6605, DOI 10.1038/sj.onc.1208807; Hooghe B, 2008, NUCLEIC ACIDS RES, V36, pW128, DOI 10.1093/nar/gkn195; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; INCE BA, 1995, ENDOCRINOLOGY, V136, P3194, DOI 10.1210/en.136.8.3194; INCE BA, 1993, J BIOL CHEM, V268, P14026; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Lazennec G, 1999, MOL ENDOCRINOL, V13, P969, DOI 10.1210/me.13.6.969; Lee EJ, 2001, MOL MED, V7, P773, DOI 10.1007/BF03401968; Lindberg K, 2010, J CELL PHYSIOL, V222, P156, DOI 10.1002/jcp.21932; Liu MM, 2002, J BIOL CHEM, V277, P24353, DOI 10.1074/jbc.M201829200; Logotheti S, 2010, FEBS J, V277, P3014, DOI 10.1111/j.1742-4658.2010.07710.x; Mancuso M, 2009, CARCINOGENESIS, V30, P340, DOI 10.1093/carcin/bgn243; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Papassava P, 2004, CANCER RES, V64, P8573, DOI 10.1158/0008-5472.CAN-03-0955; Pozzi M, 1998, J CELL BIOL, V142, P587; PRESTON DS, 1992, NEW ENGL J MED, V327, P1649, DOI 10.1056/NEJM199212033272307; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; SAPINO A, 1986, CANCER RES, V46, P2526; Schodin DJ, 1995, J BIOL CHEM, V270, P31163, DOI 10.1074/jbc.270.52.31163; Shaaban AM, 2005, AM J SURG PATHOL, V29, P1593, DOI 10.1097/01.pas.0000184807.38037.75; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; STOLER AB, 1993, J CELL BIOL, V122, P1103, DOI 10.1083/jcb.122.5.1103; Terhorst D, 2009, BRIT J DERMATOL, V161, P85, DOI 10.1111/j.1365-2133.2009.09454.x; Widyarini S, 2006, P NATL ACAD SCI USA, V103, P12837, DOI 10.1073/pnas.0603642103; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; ZACHOS G, 1995, INT J ONCOL, V6, P595; Zoumpourlis V, 2003, CARCINOGENESIS, V24, P1159, DOI 10.1093/carcin/bgg067	43	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41957	10.1371/journal.pone.0041957	http://dx.doi.org/10.1371/journal.pone.0041957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870269	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100040
J	Zimin, AV; Kelley, DR; Roberts, M; Marcais, G; Salzberg, SL; Yorke, JA				Zimin, Aleksey V.; Kelley, David R.; Roberts, Michael; Marcais, Guillaume; Salzberg, Steven L.; Yorke, James A.			Mis-Assembled "Segmental Duplications" in Two Versions of the Bos taurus Genome	PLOS ONE			English	Article								We analyzed the whole genome sequence coverage in two versions of the Bos taurus genome and identified all regions longer than five kilobases (Kbp) that are duplicated within chromosomes with >99% sequence fidelity in both copies. We call these regions High Fidelity Duplications (HFDs). The two assemblies were Btau 4.2, produced by the Human Genome Sequencing Center at Baylor College of Medicine, and UMD Bos taurus 3.1 (UMD 3.1), produced by our group at the University of Maryland. We found that Btau 4.2 has a far greater number of HFDs, 3111 versus only 69 in UMD 3.1. Read coverage analysis shows that 39 million base pairs (Mbp) of sequence in HFDs in Btau 4.2 appear to be a result of a mis-assembly and therefore cannot be qualified as segmental duplications. UMD 3.1 has only 0.41 Mbp of sequence in HFDs that are due to a mis-assembly.	[Zimin, Aleksey V.; Kelley, David R.; Roberts, Michael; Marcais, Guillaume; Yorke, James A.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Salzberg, Steven L.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA	University System of Maryland; University of Maryland College Park; Johns Hopkins University	Zimin, AV (corresponding author), Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA.	alekseyz@ipst.umd.edu	Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019	Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432	NSF [DMS0616585]; NIH [R01HG0294501]; USDA [CSREES 2008-04049]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006102, R01HG006677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported under NSF grant DMS0616585, NIH Grant R01HG0294501 and USDA grant CSREES 2008-04049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Liu GE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-571; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Tellam RL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-193; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	6	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42680	10.1371/journal.pone.0042680	http://dx.doi.org/10.1371/journal.pone.0042680			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880081	gold, Green Submitted, Green Published			2022-12-27	WOS:000307284100157
J	Lucas, G; Lluis-Ganella, C; Subirana, I; Musameh, MD; Gonzalez, JR; Nelson, CP; Senti, M; Schwartz, SM; Siscovick, D; O'Donnell, CJ; Melander, O; Salomaa, V; Purcell, S; Altshuler, D; Samani, NJ; Kathiresan, S; Elosua, R				Lucas, Gavin; Lluis-Ganella, Carla; Subirana, Isaac; Musameh, Muntaser D.; Ramon Gonzalez, Juan; Nelson, Christopher P.; Senti, Mariano; Schwartz, Stephen M.; Siscovick, David; O'Donnell, Christopher J.; Melander, Olle; Salomaa, Veikko; Purcell, Shaun; Altshuler, David; Samani, Nilesh J.; Kathiresan, Sekar; Elosua, Roberto		Myocardial Infarction Genetics Con; Wellcome Trust Case Control Consor	Hypothesis-Based Analysis of Gene-Gene Interactions and Risk of Myocardial Infarction	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; EPISTASIS; LOCI; POLYMORPHISMS; HERITABILITY; CHOLESTEROL; STRATEGIES	The genetic loci that have been found by genome-wide association studies to modulate risk of coronary heart disease explain only a fraction of its total variance, and gene-gene interactions have been proposed as a potential source of the remaining heritability. Given the potentially large testing burden, we sought to enrich our search space with real interactions by analyzing variants that may be more likely to interact on the basis of two distinct hypotheses: a biological hypothesis, under which MI risk is modulated by interactions between variants that are known to be relevant for its risk factors; and a statistical hypothesis, under which interacting variants individually show weak marginal association with MI. In a discovery sample of 2,967 cases of early-onset myocardial infarction (MI) and 3,075 controls from the MIGen study, we performed pair-wise SNP interaction testing using a logistic regression framework. Despite having reasonable power to detect interaction effects of plausible magnitudes, we observed no statistically significant evidence of interaction under these hypotheses, and no clear consistency between the top results in our discovery sample and those in a large validation sample of 1,766 cases of coronary heart disease and 2,938 controls from the Wellcome Trust Case-Control Consortium. Our results do not support the existence of strong interaction effects as a common risk factor for MI. Within the scope of the hypotheses we have explored, this study places a modest upper limit on the magnitude that epistatic risk effects are likely to have at the population level (odds ratio for MI risk 1.3-2.0, depending on allele frequency and interaction model).	[Lucas, Gavin; Lluis-Ganella, Carla; Subirana, Isaac; Senti, Mariano; Elosua, Roberto] IMIM, Barcelona, Spain; [Lluis-Ganella, Carla; Ramon Gonzalez, Juan; Elosua, Roberto] Epidemiol & Publ Hlth Network CIBERESP, Barcelona, Spain; [Musameh, Muntaser D.; Nelson, Christopher P.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Musameh, Muntaser D.; Nelson, Christopher P.; Samani, Nilesh J.] Glenfield Gen Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Ramon Gonzalez, Juan] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Ramon Gonzalez, Juan] IMIM Hosp Mar Res Inst, Barcelona, Spain; [Senti, Mariano] Pompeu Fabra Univ, Barcelona, Spain; [Schwartz, Stephen M.; Siscovick, David] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Schwartz, Stephen M.; Siscovick, David] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [O'Donnell, Christopher J.] NHLBI, Framingham, MA USA; [O'Donnell, Christopher J.] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [O'Donnell, Christopher J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Melander, Olle] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Hypertens & Cardiovasc Dis, Malmo, Sweden; [Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Purcell, Shaun] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Purcell, Shaun] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Altshuler, David; Kathiresan, Sekar] Broad Inst MIT & Harvard, Cambridge, MA USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study; Harvard University; Harvard Medical School; Massachusetts General Hospital; Lund University; Skane University Hospital; Finland National Institute for Health & Welfare; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lucas, G (corresponding author), IMIM, Barcelona, Spain.	glucas@imim.es	Senti, M/D-4309-2014; Altshuler, David M/A-4476-2009; Gonzalez, Juan R/B-7860-2018; Lluís-Ganella, Carla/G-5998-2012; Ramos, Rafel/D-9627-2016; Ramos, Rafel/P-2083-2019; Erdmann, Jeanette/A-4417-2009; Erdmann, Jeanette/P-7513-2014	Altshuler, David M/0000-0002-7250-4107; Gonzalez, Juan R/0000-0003-3267-2146; Lluís-Ganella, Carla/0000-0001-7609-5497; Ramos, Rafel/0000-0001-7970-5537; Ramos, Rafel/0000-0001-7970-5537; Erdmann, Jeanette/0000-0002-4486-6231; Hattersley, Andrew/0000-0001-5620-473X; Schwartz, Stephen/0000-0001-7499-8502; Marrugat, Jaume/0000-0003-3320-554X; Melander, Olle/0000-0002-2581-484X; Nelson, Christopher/0000-0001-8025-2897; Piazza, Alberto/0000-0002-2355-4183; Senti, Mariano/0000-0002-6983-3831; Berzuini, Carlo/0000-0001-6056-0489; Iles, Mark/0000-0002-2603-6509; Lucas, Gavin/0000-0003-4166-9416; Ouwehand, Willem/0000-0002-7744-1790; ELOSUA, ROBERTO/0000-0001-8235-0095	National Institutes of Health, USA [R01 HL087676]; Wellcome Trust [085475]; ACC1O [RD08-1-0024]; European Regional Development Fund (ERDF-FEDER); Spanish Ministry of Science and Innovation through Carlos III Health Institute (CIBER Epidemiologia y Salud Publica, Red HERACLES and GENOMet network) [RD06/0009, PI061254, PI09/90506, MTM2010-09526-E]; Catalan Research and Technology Innovation Interdepartmental Commission [SGR 1195]; Fundacio La Marato de TV3 [1081810, 080431]; Academy of Finland [129494, 139635]; Juan de la Cierva Program, Ministerio de Educacion [JCI-2009-04684]; National Institute for Health Research [NF-SI-0611-10219, CL-2010-11-001] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD013107] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056931, R21HL098938, ZIAHL006175, ZIAHL006002, ZIAHL006173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK080140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); ACC1O; European Regional Development Fund (ERDF-FEDER)(European Commission); Spanish Ministry of Science and Innovation through Carlos III Health Institute (CIBER Epidemiologia y Salud Publica, Red HERACLES and GENOMet network); Catalan Research and Technology Innovation Interdepartmental Commission; Fundacio La Marato de TV3; Academy of Finland(Academy of Finland); Juan de la Cierva Program, Ministerio de Educacion; National Institute for Health Research(National Institute for Health Research (NIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Myocardial Infarction Genetics Consortium (MIGen) was funded by grant R01 HL087676 from the National Institutes of Health, USA. The Wellcome Trust Case-Control Consortium 2 was funded by the Wellcome Trust under award 085475. This work was supported by a grant from ACC1O (RD08-1-0024), the European Regional Development Fund (ERDF-FEDER), the Spanish Ministry of Science and Innovation through the Carlos III Health Institute (CIBER Epidemiologia y Salud Publica, Red HERACLES RD06/0009, PI061254, PI09/90506 and the GENOMet network, MTM2010-09526-E), the Catalan Research and Technology Innovation Interdepartmental Commission (SGR 1195) and Fundacio La Marato de TV3 (1081810; 080431). VS was supported by the Academy of Finland (grants # 129494 and 139635). GL was funded by the Juan de la Cierva Program, Ministerio de Educacion (JCI-2009-04684). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bell JT, 2011, ANN HUM GENET, V75, P10, DOI 10.1111/j.1469-1809.2010.00629.x; Bhattacharya K, 2011, GENET EPIDEMIOL, V35, P800, DOI 10.1002/gepi.20629; Burga A, 2011, NATURE, V480, P250, DOI 10.1038/nature10665; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hindorff LA, 2009, CATALOG PUBLISHED GE; Hu XH, 2010, CELL RES, V20, P854, DOI 10.1038/cr.2010.68; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Liu Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001338; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Moskvina V, 2011, BIOL PSYCHIAT, V70, P198, DOI 10.1016/j.biopsych.2011.01.034; Okser S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001146; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Ruczinski I, 2003, J COMPUT GRAPH STAT, V12, P475, DOI 10.1198/1061860032238; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Segurado R, 2011, EUR J HUM GENET, V19, P577, DOI 10.1038/ejhg.2010.250; Steffens M, 2010, HUM HERED, V69, P268, DOI 10.1159/000295896; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Turner SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019586; World Health Organization, 2009, GOOD CLIN LAB PRACT, P28; Yang C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S26; Zdravkovic S, 2002, J INTERN MED, V252, P247, DOI 10.1046/j.1365-2796.2002.01029.x	34	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41730	10.1371/journal.pone.0041730	http://dx.doi.org/10.1371/journal.pone.0041730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876292	Green Submitted, gold, Green Published			2022-12-27	WOS:000307184700020
J	Sykaras, AG; Demenis, C; Case, RM; McLaughlin, JT; Smith, CP				Sykaras, Alexandros G.; Demenis, Claire; Case, R. Maynard; McLaughlin, John T.; Smith, Craig P.			Duodenal Enteroendocrine I-Cells Contain mRNA Transcripts Encoding Key Endocannabinoid and Fatty Acid Receptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; VAGAL AFFERENT NEURONS; CHOLECYSTOKININ SECRETION; GLYCEMIC CONTROL; ENDOCRINE CELL; EXPRESSION; GUT; RELEASE; GPR119	Enteroendocrine cells have a critical role in regulation of appetite and energy balance. I-cells are a subtype of enteroendocrine cells localized in duodenum that release cholecystokinin in response to ingested fat and amino-acids. Despite their potentially pivotal role in nutrient sensing and feeding behaviour, native I-cells have previously been difficult to isolate and study. Here we describe a robust protocol for the isolation and characterization of native duodenal I-cells and additionally, using semi-quantitative RT-PCR we determined that mouse duodenal I-cells contain mRNA transcripts encoding key fatty acid and endocannabinoid receptors including the long chain fatty acid receptors GPR40/FFAR1, GPR120/O3FAR1; short chain fatty acid receptors GPR41/FFAR3 and GPR43/FFAR2; the oleoylethanolamide receptor GPR119 and the classic endocannabinoid receptor CB1. These data suggest that I-cells sense a wide range of gut lumen nutrients and also have the capacity to respond to signals of fatty-acid derivatives or endocannabinoid peptides.	[Sykaras, Alexandros G.; Demenis, Claire; Case, R. Maynard; Smith, Craig P.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Sykaras, Alexandros G.] Univ Crete, Fac Med, Grad Programme Mol Basis Human Dis, Iraklion, Crete, Greece; [McLaughlin, John T.] Univ Manchester, Sch Med, Sch Translat Med, Manchester, Lancs, England	University of Manchester; University of Crete; University of Manchester	Sykaras, AG (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Craig.smith@manchester.ac.uk	Sykaras, Alexandros/AAO-1565-2020	Sykaras, Alexandros/0000-0002-2972-0138; McLaughlin, John/0000-0001-6158-5135	BBSRC	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to thank members of the BSF (University of Manchester) for animal husbandry, Mr Michael Smiga and Dr Andy Hayes (University of Manchester, Genomic Technologies Core Facility) for PicoChip analysis and their advice about RNA amplification, and Mr Michael Jackson (University of Manchester, Flow Cytometry facility) for help with FACS analysis. We would like to thank Ms Xiaoxing Huang for excellent technical assistance in genotyping and animal experiments. We are indebted to Professor Graham Dockray (University of Liverpool, UK) for his donation of anti-CCK antibody. CD holds a BBSRC studentship.	Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; BUCHAN AMJ, 1978, GUT, V19, P403, DOI 10.1136/gut.19.5.403; Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Burdyga G, 2006, AM J PHYSIOL-GASTR L, V290, pG1289, DOI 10.1152/ajpgi.00543.2005; Chandra Rashmi, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P63, DOI 10.1097/MED.0b013e3280122850; CHANG SK, 1994, GASTROENTEROLOGY, V107, P28, DOI 10.1016/0016-5085(94)90057-4; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; D'Argenio G, 2007, J MOL MED, V85, P523, DOI 10.1007/s00109-007-0192-3; de Lartigue G, 2010, ENDOCRINOLOGY, V151, P3589, DOI 10.1210/en.2010-0106; Di Marzo V, 2011, P NATL ACAD SCI USA, V108, P12567, DOI 10.1073/pnas.1109567108; Diakogiannaki E, 2011, PSYSL BEHAV, V106, P387; DiPatrizio NV, 2011, P NATL ACAD SCI USA, V108, P12904, DOI 10.1073/pnas.1104675108; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Engelstoft MS, 2008, CELL METAB, V8, P447, DOI 10.1016/j.cmet.2008.11.004; Flock G, 2011, ENDOCRINOLOGY, V152, P374, DOI 10.1210/en.2010-1047; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Hansen KB, 2011, J CLIN ENDOCR METAB, V96, pE1409, DOI 10.1210/jc.2011-0647; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Lauffer LM, 2009, DIABETES, V58, P1058, DOI 10.2337/db08-1237; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; LIDDLE RA, 1985, J CLIN INVEST, V75, P1144, DOI 10.1172/JCI111809; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Liou AP, 2011, AM J PHYSIOL-GASTR L, V300, pG538, DOI 10.1152/ajpgi.00342.2010; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; McLaughlin J, 1999, GASTROENTEROLOGY, V116, P46, DOI 10.1016/S0016-5085(99)70227-1; McLaughlin JT, 1998, J PHYSIOL-LONDON, V513, P11, DOI 10.1111/j.1469-7793.1998.011by.x; Moran Gordon W, 2008, Therap Adv Gastroenterol, V1, P51, DOI 10.1177/1756283X08093943; Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Overton HA, 2008, BRIT J PHARMACOL, V153, pS76, DOI 10.1038/sj.bjp.0707529; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Parker HE, 2009, DIABETOLOGIA, V52, P289, DOI 10.1007/s00125-008-1202-x; POLAK JM, 1975, LANCET, V2, P1016; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Rindi G, 2004, ANN NY ACAD SCI, V1014, P1, DOI 10.1196/annals.1294.001; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; SMITH GP, 1985, AM J PHYSIOL, V249, pR638, DOI 10.1152/ajpregu.1985.249.5.R638; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Tolhurst G, 2012, DIABETES; Tolhurst G, 2009, J PHYSIOL-LONDON, V587, P27, DOI 10.1113/jphysiol.2008.164012; Tolhurst G, 2011, ENDOCRINOLOGY, V152, P405, DOI 10.1210/en.2010-0956; Wang Y, 2011, AM J PHYSIOL-GASTR L, V300, pG528, DOI 10.1152/ajpgi.00387.2010; Wright K, 2005, GASTROENTEROLOGY, V129, P437, DOI 10.1053/j.gastro.2005.05.026	50	95	96	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42373	10.1371/journal.pone.0042373	http://dx.doi.org/10.1371/journal.pone.0042373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876318	Green Published, Green Submitted, gold			2022-12-27	WOS:000307184700046
J	Takaoka, Y; Shimizu, Y; Hasegawa, H; Ouchi, Y; Qiao, SL; Nagahara, M; Ichihara, M; Lee, JD; Adachi, K; Hamaguchi, M; Iwamoto, T				Takaoka, Yuji; Shimizu, Yuko; Hasegawa, Hitoki; Ouchi, Yasuo; Qiao, Shanlou; Nagahara, Miki; Ichihara, Masatoshi; Lee, Jiing-Dwan; Adachi, Koichi; Hamaguchi, Michinari; Iwamoto, Takashi			Forced Expression of miR-143 Represses ERK5/c-Myc and p68/p72 Signaling in Concert with miR-145 in Gut Tumors of Apc(Min) Mice	PLOS ONE			English	Article							DEAD-BOX; C-MYC; MICRORNA; P68; RNA; MICROPROCESSOR; PROGRESSION; COMPLEX; COLON; GENE	Recently, miR-143 and miR-145 have been shown to belong to a subset of microRNAs whose expression is controlled by a complex of a tumor suppressor p53 and DEAD-box RNA helicase subunits p68/p72. While accumulating studies have acknowledged that both miRNAs function as tumor suppressors and are similarly regulated, evidence of their coordinated action against tumorigenesis has been poorly presented. Herein, we establish transgenic mice that express miR-143 under the control of the CAG regulatory unit. When crossbred with Apc(Min/+) mice, the development of tumors in the small intestines is significantly attenuated. In the transgenic small intestine tumors, the endogenous miR-145 is also enhanced and the expression of c-Myc and p68/p72, both of which have been reported to be pivotal for gut tumor development, is suppressed, corresponding to the downregulation of ERK5. We demonstrate that the combination of miR-143 and miR-145 inhibits the expression of c-Myc in human colon cancer cells, whereas miR-145 retards that of p72. Moreover, we show the possibilities that miR-145 modulates p72 expression through its 39 untranslated region and that c-Myc downregulation is involved in both p68 suppression and miR-145 induction. These findings suggest that forced expression of miR-143, probably interacting with endogenous miR-145, inhibits ERK5/c-Myc and p68/p72/beta-catenin signaling and hampers small intestine tumor development in Apc(Min/+) mice. This unique cascade, in turn, may prevent overproduction of a subset of tumor suppressive miRNAs by repressing their own modulators, p68/p72.	[Takaoka, Yuji; Shimizu, Yuko; Qiao, Shanlou; Ichihara, Masatoshi; Iwamoto, Takashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan; [Hasegawa, Hitoki; Ouchi, Yasuo; Nagahara, Miki; Iwamoto, Takashi] Chubu Univ, Ctr Educ Lab Anim Res, Kasugai, Aichi 487, Japan; [Hasegawa, Hitoki; Hamaguchi, Michinari] Nagoya Univ, Div Canc Biol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Lee, Jiing-Dwan] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Adachi, Koichi] Nagoya Univ, Grad Sch Med, Radioisotope Res Ctr Med Div, Nagoya, Aichi 4648601, Japan	Chubu University; Chubu University; Nagoya University; Scripps Research Institute; Nagoya University	Takaoka, Y (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan.	iwamoto@isc.chubu.ac.jp			Center of Excellence Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology [S0801055];  [19590408]	Center of Excellence Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology; 	This study was supported in part by Grants-in-Aid for Scientific Research (C) (no 19590408) and Center of Excellence Project for Private Universities (no. S0801055) from the Ministry of Education, Culture, Sports, Science, and Technology. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bommer GT, 2007, CANCER CELL, V11, P391, DOI 10.1016/j.ccr.2007.04.015; Bui Thi V, 2010, Genes Cancer, V1, P568; Buzzi N, 2009, MOL CELL BIOCHEM, V328, P201, DOI 10.1007/s11010-009-0090-9; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Heinlein UAO, 1998, J PATHOL, V184, P345, DOI 10.1002/(SICI)1096-9896(199804)184:4<345::AID-PATH1243>3.0.CO;2-6; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; IWAMOTO T, 1990, ONCOGENE, V5, P535; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; McCart AE, 2008, PATHOL RES PRACT, V204, P479, DOI 10.1016/j.prp.2008.03.004; Mendell JT, 2009, NAT GENET, V41, P768, DOI 10.1038/ng0709-768; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mishra PJ, 2009, J CLIN INVEST, V119, P2119, DOI 10.1172/JCI40107; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Rossler OG, 2000, NUCLEIC ACIDS RES, V28, P932, DOI 10.1093/nar/28.4.932; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tsutsui M, 2008, BIOCHEM BIOPH RES CO, V372, P856, DOI 10.1016/j.bbrc.2008.05.141; Winter J, 2011, METHODS MOL BIOL, V676, P3, DOI 10.1007/978-1-60761-863-8_1; Yamada Y, 2007, CANCER SCI, V98, P6, DOI 10.1111/j.1349-7006.2006.00348.x; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036	39	31	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42137	10.1371/journal.pone.0042137	http://dx.doi.org/10.1371/journal.pone.0042137			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876303	Green Submitted, gold, Green Published			2022-12-27	WOS:000307184700031
J	Li, J; Gao, XH; Bian, Q; Guo, ZY; Mei, XB; Yu, G; Wu, H; Lai, XL; Chen, W				Li, Juan; Gao, Xian Hua; Bian, Qi; Guo, Zhi Yong; Mei, Xiao Bin; Yu, Guang; Wu, Hao; Lai, Xue Li; Chen, Wei			Comparative Study of Scientific Publications in Urology and Nephrology Journals Originating from USA, China and Japan (2001-2010)	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; UNITED-STATES; GASTROENTEROLOGY; HEPATOLOGY; BURDEN; EUROPE; IMPACT; SHARE	Background: In the past decade, scientific research has developed rapidly in China, but the growth seems to vary widely between different disciplines. In this study, we aimed to compare the quantity and quality of publications in urology and nephrology journals from USA, China and Japan. Methods: Journals listed in the "Urology and Nephrology" category of Science Citation Index Expanded subject categories were included. Scientific papers in these journals written by researchers from USA, Japan and China were retrieved from the "PubMed" and "Web of Knowledge" online databases. Results: The annual number of total scientific articles increased significantly from 2001 to 2010 in China, and has ranked second in the world since 2006. In the field of urology and nephrology, the annual number increased significantly from 2001 to 2010 in USA and China; but not in Japan. The share of articles increased significantly over time in China, decreased significantly in Japan, and remained unchanged in USA. In 2010, USA contributed 32.17% of the total world output in urology and nephrology field and ranked 1 st; Japan contributed 5.19% and ranked 5th; China contributed 3.83% and ranked 9th. Publications from USA had the highest accumulated IFs and the highest total citations of articles (USA>Japan>China, p<0.001). No significant difference was found in average IF among the three countries. USA published the most articles in the top 10 urology and nephrology journals (USA(35165)>Japan(6704)>China(2233), p<0.001). Researchers from USA published more clinical trials and randomized controlled trials than Japan and China (USA>Japan>China, p<0.001). Conclusion: Although China has undergone significant increase in annual number and percentage of scientific publication in urology and nephrology journals in the past decade, it still lags far behind USA and Japan in the field of urology and nephrology in terms of quantity and quality.	[Li, Juan; Bian, Qi; Guo, Zhi Yong; Mei, Xiao Bin; Yu, Guang; Wu, Hao; Lai, Xue Li; Chen, Wei] Second Mil Med Univ, Changhai Hosp, Dept Nephrol, Shanghai, Peoples R China; [Gao, Xian Hua] Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Li, J (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Nephrol, Shanghai, Peoples R China.	zhiyong_guo@126.com	Bian, Qi/GOP-1906-2022	Gao, Xian Hua/0000-0001-8020-6946				Andersen Julia, 2006, Journal of Microbiology Immunology and Infection, V39, P436; [Anonymous], 2010, ISI J CITATION REPOR; Chen Z, 2007, PHILOS T R SOC B, V362, P947, DOI 10.1098/rstb.2007.2025; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Cyranoski D, 2004, NATURE, V431, P116, DOI 10.1038/431116b; Cyranoski D, 2003, NATURE, V426, P752, DOI 10.1038/426752a; Foley RN, 2009, CURR DIABETES REP, V9, P460, DOI 10.1007/s11892-009-0075-9; Goh KL, 2008, J GASTROEN HEPATOL, V23, P341, DOI 10.1111/j.1440-1746.2008.05352.x; Ha TC, 2006, ANN ACAD MED SINGAP, V35, P911; Kou J, 2012, CLIN RES PROMOTES DE, DOI [10.3109/0886022X.0882011.0653776, DOI 10.3109/0886022X.0882011.0653776]; Kovesdy CP, 2012, LANCET, V379, P783, DOI 10.1016/S0140-6736(12)60115-9; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Lin SY, 2003, KIDNEY INT, V63, P108, DOI 10.1046/j.1523-1755.63.s83.22.x; Maeda K, 2003, J GASTROENTEROL, V38, P816, DOI 10.1007/s00535-003-1153-4; Philipson L, 2005, JAMA-J AM MED ASSOC, V294, P1394, DOI 10.1001/jama.294.11.1394; Rahman M, 2005, ACAD RADIOL, V12, P825, DOI 10.1016/j.acra.2005.03.061; Rahman M, 2003, JPN J OPHTHALMOL, V47, P221, DOI 10.1016/S0021-5155(02)00668-8; Sorrentino D, 2000, DIGESTION, V61, P77, DOI 10.1159/000007738; Soteriades ES, 2005, BRIT MED J, V331, P192, DOI 10.1136/bmj.331.7510.192; Szokol JW, 2003, ANESTH ANALG, V96, P513, DOI 10.1097/00000539-200302000-00039; Wells WA, 2007, J CELL BIOL, V176, P376, DOI 10.1083/jcb.200701150; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zuo L, 2010, CLIN NEPHROL, V74, pS20	23	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42200	10.1371/journal.pone.0042200	http://dx.doi.org/10.1371/journal.pone.0042200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870301	gold, Green Published, Green Submitted			2022-12-27	WOS:000307212800066
J	Rosenkranz, MA; Busse, WW; Sheridan, JF; Crisafi, GM; Davidson, RJ				Rosenkranz, Melissa A.; Busse, William W.; Sheridan, John F.; Crisafi, Gina M.; Davidson, Richard J.			Are There Neurophenotypes for Asthma? Functional Brain Imaging of the Interaction between Emotion and Inflammation in Asthma	PLOS ONE			English	Article							INSULAR CORTEX; PHYSIOLOGICAL CONDITION; NEURAL CIRCUITRY; ANTERIOR INSULA; PAIN; DYSPNEA; RESPONSES; INTEROCEPTION; INTERFERENCE; INCREASES	Background: Asthma is a chronic inflammatory disease noteworthy for its vulnerability to stress and emotion-induced symptom intensification. The fact that psychological stress and mood and anxiety disorders appear to increase expression of asthma symptoms suggests that neural signaling between the brain and lung at least partially modulates the inflammatory response and lung function. However, the precise nature of the neural pathways implicated in modulating asthma symptoms is unknown. Moreover, the extent to which variations in neural signaling predict different phenotypes of disease expression has not been studied. Methods and Results: We used functional magnetic resonance imaging to measure neural signals in response to asthma-specific emotional cues, following allergen exposure, in asthmatics with a dual response to allergen challenge (significant inflammation), asthmatics with only an immediate response (minimal inflammation), and healthy controls. The anterior insular cortex was differentially activated by asthma-relevant cues, compared to general negative cues, during the development of the late phase of the dual response in asthmatics. Moreover, the degree of this differential activation predicted changes in airway inflammation. Conclusions: These findings indicate that neurophenotypes for asthma may be identifiable by neural reactivity of brain circuits known to be involved in processing emotional information. Those with greater activation in the anterior insula, in response to asthma-relevant psychological stimuli, exhibit greater inflammatory signals in the lung and increased severity of disease and may reflect a subset of asthmatics most vulnerable to the development of psychopathology. This approach offers an entirely new target for potential therapeutic intervention in asthma.	[Rosenkranz, Melissa A.; Davidson, Richard J.] Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53715 USA; [Busse, William W.; Crisafi, Gina M.] Univ Wisconsin, Dept Med, Madison, WI USA; [Sheridan, John F.] Ohio State Univ, Div Oral Biol, Columbus, OH 43210 USA; [Sheridan, John F.] Ohio State Univ, Inst Behav Med Res, Columbus, OH 43210 USA; [Davidson, Richard J.] Univ Wisconsin, Lab Affect Neurosci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Wisconsin System; University of Wisconsin Madison	Rosenkranz, MA (corresponding author), Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53715 USA.	marosenk@wisc.edu	Rosenkranz, Melissa/AFU-7196-2022	Rosenkranz, Melissa/0000-0001-8432-9011; Sheridan, John/0000-0002-6927-0266; Davidson, Richard/0000-0002-8506-4964	MacArthur Foundation Mind Brain, Body, and Health Initiative; National Center for Research Resources [P20 RR0202645]; National Institute of Child Health and Human Development [P30 HD003352]; National Institute of Mental Health [R01 MH043454]; National Heart Lung and Blood Institute [R01 HL69116]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043454] Funding Source: NIH RePORTER	MacArthur Foundation Mind Brain, Body, and Health Initiative; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants from the MacArthur Foundation Mind Brain, Body, and Health Initiative, National Center for Research Resources (P20 RR0202645), National Institute of Child Health and Human Development (P30 HD003352), National Institute of Mental Health (R01 MH043454), and National Heart Lung and Blood Institute (R01 HL69116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bagaev V, 2006, AUTON NEUROSCI-BASIC, V125, P16, DOI 10.1016/j.autneu.2006.01.006; Bradley M.M., 1999, NIMH CTR STUDY EMOTI; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Davenport PW, 2000, AM J RESP CRIT CARE, V161, P1830, DOI 10.1164/ajrccm.161.6.9903077; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Fauroux B, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-61; Harrison NA, 2009, BIOL PSYCHIAT, V66, P407, DOI 10.1016/j.biopsych.2009.03.015; Kemeny ME, 2007, J ALLERGY CLIN IMMUN, V119, P1375, DOI 10.1016/j.jaci.2007.03.016; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V299, P158, DOI 10.1001/jama.2007.54-a; Kullowatz A, 2008, PSYCHOSOM MED, V70, P468, DOI 10.1097/PSY.0b013e31816f9c2f; LEMANSKE RF, 1989, J CLIN INVEST, V83, P1, DOI 10.1172/JCI113843; Liu LY, 2002, AM J RESP CRIT CARE, V165, P1062, DOI 10.1164/ajrccm.165.8.2109065; Liu LY, 2000, J ALLERGY CLIN IMMUN, V106, P1063; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Mitterschiffthaler MT, 2008, PSYCHOL MED, V38, P247, DOI 10.1017/S0033291707001523; MUFSON EJ, 1982, J COMP NEUROL, V212, P23, DOI 10.1002/cne.902120103; MUFSON EJ, 1981, NEUROSCIENCE, V6, P1231, DOI 10.1016/0306-4522(81)90184-6; O'Byrne P, 1998, J ALLERGY CLIN IMMUN, V102, pS85, DOI 10.1016/S0091-6749(98)70036-3; Olausson H, 2005, NEUROSCI LETT, V389, P1, DOI 10.1016/j.neulet.2005.06.065; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Price DD, 2007, PAIN, V127, P63, DOI 10.1016/j.pain.2006.08.001; Ritz T, 2011, AM J RESP CRIT CARE, V183, P26, DOI 10.1164/rccm.201005-0691OC; Rosenkranz MA, 2005, P NATL ACAD SCI USA, V102, P13319, DOI 10.1073/pnas.0504365102; Rosenkranz MA, 2009, NEUROIMAGE, V47, P972, DOI 10.1016/j.neuroimage.2009.05.042; Schon D, 2008, AM J RESP CRIT CARE, V178, P1173, DOI 10.1164/rccm.200805-731OC; Slavich GM, 2010, P NATL ACAD SCI USA, V107, P14817, DOI 10.1073/pnas.1009164107; Strine TW, 2008, J ASTHMA, V45, P123, DOI 10.1080/02770900701840238; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; von Leupoidt A, 2009, AM J RESP CRIT CARE, V180, P232, DOI 10.1164/rccm.200902-0300OC; von Leupoldt A, 2008, AM J RESP CRIT CARE, V177, P1026, DOI 10.1164/rccm.200712-1821OC; von Leupoldt A, 2009, NEUROIMAGE, V48, P200, DOI 10.1016/j.neuroimage.2009.06.015; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; YASUI Y, 1991, J COMP NEUROL, V303, P355, DOI 10.1002/cne.903030303	47	60	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40921	10.1371/journal.pone.0040921	http://dx.doi.org/10.1371/journal.pone.0040921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870208	gold, Green Submitted, Green Published			2022-12-27	WOS:000307212800013
J	Verheggen, FJ; Diez, L; Sablon, L; Fischer, C; Bartram, S; Haubruge, E; Detrain, C				Verheggen, Francois J.; Diez, Lise; Sablon, Ludovic; Fischer, Christophe; Bartram, Stefan; Haubruge, Eric; Detrain, Claire			Aphid Alarm Pheromone as a Cue for Ants to Locate Aphid Partners	PLOS ONE			English	Article							LADY BEETLE; (E)-BETA-FARNESENE; MUTUALISM; PLANT	The mutualistic relationships that occur between myrmecophilous aphids and ants are based on the rich food supply that honeydew represents for ants and on the protection they provide against aphid natural enemies. While aphid predators and parasitoids actively forage for oviposition sites by using aphid semiochemicals, scouts of aphid-tending ant species would also benefit from locating honeydew resources by orienting toward aphid pheromone sources. The present study aims to provide additional information on the use of Aphis fabae alarm pheromone, i.e. (E)-beta-farnesene (E beta F), by ant scouts. The perception and behavioral impact of E beta F on Lasius niger were investigated using electroantennography and two bio-assays measuring their attraction and orientation towards aphid semiochemicals. Pronounced electrical depolarizations were observed from L. niger scout antennae to stimulations of A. fabae alarm pheromone, while other sesquiterpenes elicited weak or no responses. L. niger scouts were significantly attracted toward E beta F in a four-arm olfactometer, as well as in an two-choice bioassay. These laboratory results suggest for the first time that low amounts of aphid alarm pheromone can be used by L. niger scouts as a cue indicating the presence of aphid colonies and could therefore mediate the aphid-ant partnership in the field.	[Verheggen, Francois J.; Sablon, Ludovic; Haubruge, Eric] Univ Liege, Dept Funct & Evolutionary Entomol, Gembloux Agrobio Tech, Gembloux, Belgium; [Diez, Lise; Detrain, Claire] Univ Brussels, Dept Social Ecol, Brussels, Belgium; [Fischer, Christophe] Univ Liege, Dept Analyt Chem, Gembloux Agrobio Tech, Gembloux, Belgium; [Bartram, Stefan] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany	University of Liege; University of Liege; Max Planck Society	Verheggen, FJ (corresponding author), Univ Liege, Dept Funct & Evolutionary Entomol, Gembloux Agrobio Tech, Gembloux, Belgium.	entomologie.gembloux@ulg.ac.be		Haubruge, Eric/0000-0002-8138-0476; Bartram, Stefan/0000-0002-8574-2817; Verheggen, Francois/0000-0002-5849-1661	FNRS (Fonds National de la Recherche Scientifique) [2.4600.09]; CURAGx PhD grant; F.R.I.A. grants	FNRS (Fonds National de la Recherche Scientifique)(Fonds de la Recherche Scientifique - FNRS); CURAGx PhD grant; F.R.I.A. grants(Fonds de la Recherche Scientifique - FNRS)	Dr. Detrain is senior research assistant at Belgian foundation for scientific research (FNRS). The authors work has been funded by a FNRS (Fonds National de la Recherche Scientifique) grant (no2.4600.09). Dr. Sablon is financially supported by a CURAGx PhD grant. Dr. Fischer and Dr. Diez are financially supported by F.R.I.A. grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Abassi S, 2000, J CHEM ECOL, V26, P1765, DOI 10.1023/A:1005555300476; Almohamad R, 2008, J APPL ENTOMOL, V132, P601, DOI 10.1111/j.1439-0418.2008.01309.x; Detrain C, 2010, PHYSIOL ENTOMOL, V35, P168, DOI 10.1111/j.1365-3032.2010.00730.x; Detrain C, 2008, ADV INSECT PHYSIOL, V35, P123, DOI 10.1016/S0065-2806(08)00002-7; Francis F, 2005, J APPL ENTOMOL, V129, P6, DOI 10.1111/j.1439-0418.2005.00925.x; Holldobler B., 1990, pi; Leroy PD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1347; Lohman DJ, 2006, ECOL ENTOMOL, V31, P41, DOI 10.1111/j.0307-6946.2006.00758.x; Mailleux AC, 2003, P ROY SOC B-BIOL SCI, V270, P1609, DOI 10.1098/rspb.2003.2398; Mailleux AC, 2000, ANIM BEHAV, V59, P1061, DOI 10.1006/anbe.2000.1396; Micha SG, 1996, CHEMOECOLOGY, V7, P132, DOI 10.1007/BF01245965; NAULT LR, 1976, SCIENCE, V192, P1349, DOI 10.1126/science.1273595; Outreman Y, 2010, APHID BIODIVERSITY UNDER ENVIRONMENTAL CHANGE: PATTERNS AND PROCESSES, P171, DOI 10.1007/978-90-481-8601-3_10; PICKETT JA, 1980, J CHEM ECOL, V6, P349, DOI 10.1007/BF01402913; Sakata H, 1995, RES POPUL ECOL, V37, P159, DOI 10.1007/BF02515816; Verheggen FJ, 2008, J CHEM ECOL, V34, P301, DOI 10.1007/s10886-008-9434-2; Verheggen FJ, 2007, J CHEM ECOL, V33, P2148, DOI 10.1007/s10886-007-9370-6; Verheggen FJ, 2009, BEHAV ECOL, V20, P283, DOI 10.1093/beheco/arp009; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; Zhu JW, 1999, J CHEM ECOL, V25, P1163, DOI 10.1023/A:1020846212465	20	24	26	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41841	10.1371/journal.pone.0041841	http://dx.doi.org/10.1371/journal.pone.0041841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870255	gold, Green Published			2022-12-27	WOS:000307212800038
J	Davison, J; Opik, M; Zobel, M; Vasar, M; Metsis, M; Moora, M				Davison, John; Oepik, Maarja; Zobel, Martin; Vasar, Martti; Metsis, Madis; Moora, Mari			Communities of Arbuscular Mycorrhizal Fungi Detected in Forest Soil Are Spatially Heterogeneous but Do Not Vary throughout the Growing Season	PLOS ONE			English	Article							HYACINTHOIDES-NON-SCRIPTA; SPECIES RICHNESS; MOLECULAR DIVERSITY; PLANT; SCALE; BIODIVERSITY; DYNAMICS; GLOMEROMYCOTA; AMPLIFICATION; ASSEMBLAGES	Despite the important ecosystem role played by arbuscular mycorrhizal fungi (AMF), little is known about spatial and temporal variation in soil AMF communities. We used pyrosequencing to characterise AMF communities in soil samples (n = 44) from a natural forest ecosystem. Fungal taxa were identified by BLAST matching of reads against the MaarjAM database of AMF SSU rRNA gene diversity. Sub-sampling within our dataset and experimental shortening of a set of long reads indicated that our approaches to taxonomic identification and diversity analysis were robust to variations in pyrosequencing read length and numbers of reads per sample. Different forest plots (each 10610 m and separated from one another by 30 m) contained significantly different soil AMF communities, and the pairwise similarity of communities decreased with distance up to 50 m. However, there were no significant changes in community composition between different time points in the growing season (May-September). Spatial structure in soil AMF communities may be related to the heterogeneous vegetation of the natural forest study system, while the temporal stability of communities suggests that AMF in soil represent a fairly constant local species pool from which mycorrhizae form and disband during the season.	[Davison, John; Oepik, Maarja; Zobel, Martin; Vasar, Martti; Moora, Mari] Univ Tartu, Dept Bot, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Metsis, Madis] Tallinn Univ Technol, Ctr Biol Integrated Syst, Tallinn, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Tallinn University of Technology	Davison, J (corresponding author), Univ Tartu, Dept Bot, Inst Ecol & Earth Sci, Ulikooli 18, EE-50090 Tartu, Estonia.	john.davison@ut.ee	Öpik, Maarja/A-1765-2008; Metsis, Madis/F-7080-2016; Zobel, Martin/H-1336-2015; Moora, Mari/D-1961-2009	Öpik, Maarja/0000-0001-8025-7460; Metsis, Madis/0000-0003-1667-677X; Zobel, Martin/0000-0001-7957-6704; Moora, Mari/0000-0002-4819-7506	Estonian Science Foundation [9050, 9157, 7738]; EU LIFE Programme [LIFE08 ENV/EE/000258]; European Regional Development Fund (Center of Excellence FIBIR - Frontiers In Biodiversity Research);  [SF0180098s08]	Estonian Science Foundation; EU LIFE Programme; European Regional Development Fund (Center of Excellence FIBIR - Frontiers In Biodiversity Research); 	This research was funded by grants from the Estonian Science Foundation (9050, 9157, 7738), targeted financing (SF0180098s08), the EU LIFE Programme (LIFE08 ENV/EE/000258), and the European Regional Development Fund (Center of Excellence FIBIR - Frontiers In Biodiversity Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alguacil MM, 2011, SOIL BIOL BIOCHEM, V43, P1498, DOI 10.1016/j.soilbio.2011.03.026; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Bainard LD, 2011, AGR ECOSYST ENVIRON, V144, P13, DOI 10.1016/j.agee.2011.07.014; Balestrini R, 2010, ENV MICROBIOL REP, V2, P594, DOI 10.1111/j.1758-2229.2010.00160.x; Beauregard MS, 2010, MICROB ECOL, V59, P379, DOI 10.1007/s00248-009-9583-z; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Boerner REJ, 1996, MYCORRHIZA, V6, P79, DOI 10.1007/s005720050111; Carvalho LM, 2003, PLANT SOIL, V251, P227, DOI 10.1023/A:1023016317269; Chelius MK, 1999, MYCORRHIZA, V9, P61, DOI 10.1007/s005720050264; CLAPP JP, 1995, NEW PHYTOL, V130, P259, DOI 10.1111/j.1469-8137.1995.tb03047.x; Dai ML, 2012, CAN J MICROBIOL, V58, P81, DOI [10.1139/W11-111, 10.1139/w11-111]; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1111/j.1574-6941.2001.tb00841.x; Davison J, 2011, FEMS MICROBIOL ECOL, V78, P103, DOI 10.1111/j.1574-6941.2011.01103.x; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; Hassan SED, 2011, MOL ECOL, V20, P3469, DOI 10.1111/j.1365-294X.2011.05142.x; Helgason T, 2002, J ECOL, V90, P371, DOI 10.1046/j.1365-2745.2001.00674.x; Helgason T, 1999, MOL ECOL, V8, P659, DOI 10.1046/j.1365-294x.1999.00604.x; Hempel S, 2007, ENVIRON MICROBIOL, V9, P1930, DOI 10.1111/j.1462-2920.2007.01309.x; Jansa J, 2002, MYCORRHIZA, V12, P225, DOI [10.1007/s005572-002-0163-z, 10.1007/s00572-002-0163-z]; JOHNSON NC, 1991, OECOLOGIA, V86, P349, DOI 10.1007/BF00317600; Jumpponen A, 2011, MYCORRHIZA, V21, P453, DOI 10.1007/s00572-010-0358-7; Kivlin SN, 2011, SOIL BIOL BIOCHEM, V43, P2294, DOI 10.1016/j.soilbio.2011.07.012; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Konig S, 2010, APPL ENVIRON MICROB, V76, P3765, DOI 10.1128/AEM.02951-09; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Lankau RA, 2011, NEW PHYTOL, V189, P536, DOI 10.1111/j.1469-8137.2010.03481.x; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Lekberg Y, 2011, ECOLOGY, V92, P1292, DOI 10.1890/10-1516.1; Liang ZB, 2008, SOIL BIOL BIOCHEM, V40, P956, DOI 10.1016/j.soilbio.2007.11.016; Liu RJ, 2003, MYCORRHIZA, V13, P123, DOI 10.1007/s00572-002-0207-4; Liu Y, 2009, FEMS MICROBIOL ECOL, V67, P81, DOI 10.1111/j.1574-6941.2008.00597.x; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Ma WK, 2005, SOIL BIOL BIOCHEM, V37, P1589, DOI 10.1016/j.soilbio.2005.01.020; Mangan SA, 2010, ECOLOGY, V91, P2594, DOI 10.1890/09-0396.1; Martinez-Garcia LB, 2011, SOIL BIOL BIOCHEM, V43, P682, DOI 10.1016/j.soilbio.2010.12.006; Merryweather J, 1998, NEW PHYTOL, V138, P117, DOI 10.1046/j.1469-8137.1998.00888.x; MORTON JB, 1993, MYCOTAXON, V48, P491; Mummey DL, 2008, FEMS MICROBIOL ECOL, V64, P260, DOI 10.1111/j.1574-6941.2008.00475.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Oehl F, 2004, OECOLOGIA, V138, P574, DOI 10.1007/s00442-003-1458-2; Oehl F, 2009, AGR ECOSYST ENVIRON, V134, P257, DOI 10.1016/j.agee.2009.07.008; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Oksanen J, 2010, R PACKAGE VERSION 1; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Opik M, 2008, NEW PHYTOL, V179, P867, DOI 10.1111/j.1469-8137.2008.02515.x; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Pellegrino E, 2012, NEW PHYTOL, V194, P810, DOI 10.1111/j.1469-8137.2012.04090.x; Pivato B, 2007, NEW PHYTOL, V176, P197, DOI 10.1111/j.1469-8137.2007.02151.x; Porter TM, 2011, NEW PHYTOL, V192, P775, DOI 10.1111/j.1469-8137.2011.03838.x; Pringle A, 2002, AM J BOT, V89, P1439, DOI 10.3732/ajb.89.9.1439; Robinson-Boyer L, 2009, FUNGAL ECOL, V2, P1, DOI 10.1016/j.funeco.2008.11.001; Sanders IR, 2004, NEW PHYTOL, V164, P415, DOI 10.1111/j.1469-8137.2004.01208.x; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Schwartz MW, 2006, ECOL LETT, V9, P501, DOI 10.1111/j.1461-0248.2006.00910.x; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170; van der Gast CJ, 2011, ENVIRON MICROBIOL, V13, P241, DOI 10.1111/j.1462-2920.2010.02326.x; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; Verbruggen E, 2012, MOL ECOL, V21, P2341, DOI 10.1111/j.1365-294X.2012.05534.x; Wolfe BE, 2007, MYCORRHIZA, V17, P175, DOI 10.1007/s00572-006-0089-y; Wu FS, 2011, PLANT SOIL, V342, P233, DOI 10.1007/s11104-010-0688-4; Yang C, 2010, MICROB ECOL, V59, P724, DOI 10.1007/s00248-009-9629-2; ZOBEL K, 1993, J VEG SCI, V4, P489, DOI 10.2307/3236076; ZOBEL M, 1989, ANN BOT FENN, V26, P171	74	120	127	2	166	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41938	10.1371/journal.pone.0041938	http://dx.doi.org/10.1371/journal.pone.0041938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879900	gold, Green Published, Green Submitted			2022-12-27	WOS:000307437900016
J	Bouwense, SAW; Olesen, SS; Drewes, AM; Poley, JW; van Goor, H; Wilder-Smith, OHG				Bouwense, Stefan A. W.; Olesen, Soren S.; Drewes, Asbjorn M.; Poley, Jan-Werner; van Goor, Harry; Wilder-Smith, Oliver H. G.			Effects of Pregabalin on Central Sensitization in Patients with Chronic Pancreatitis in a Randomized, Controlled Trial	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; NEUROPATHIC PAIN; THORACOSCOPIC SPLANCHNICECTOMY; VISCERAL PAIN; HYPERALGESIA; GABAPENTIN; MECHANISMS; MODULATION; MANAGEMENT	Background: Intense abdominal pain is the dominant feature of chronic pancreatitis. During the disease changes in central pain processing, e. g. central sensitization manifest as spreading hyperalgesia, can result from ongoing nociceptive input. The aim of the present study is to evaluate the effect of pregabalin on pain processing in chronic pancreatitis as assessed by quantitative sensory testing (QST). Methods: This randomized, double-blind, placebo-controlled trial evaluated effects of pregabalin on pain processing. QST was used to quantify pain processing by measuring thresholds to painful electrical and pressure stimulation in six body dermatomes. Descending endogenous pain modulation was quantified using the conditioned pain modulation (CPM) paradigm to elicit a DNIC (diffuse noxious inhibitory controls) response. The main effect parameter was the change in the sum of all body pain threshold values after three weeks of study treatment versus baseline values between both treatment groups. Results: 64 patients were analyzed. No differences in change in sum of pain thresholds were present for pregabalin vs. placebo after three weeks of treatment. For individual dermatomes, change vs. baseline pain thresholds was significantly greater in pregabalin vs. placebo patients for electric pain detection threshold in C5 (P = 0.005), electric pain tolerance threshold in C5 (P = 0.04) and L1 (P = 0.05), and pressure pain tolerance threshold in T4 (P = 0.004). No differences were observed between pregabalin and placebo regarding conditioned pain modulation. Conclusion: Our study provides first evidence that pregabalin has moderate inhibitory effects on central sensitization manifest as spreading hyperalgesia in chronic pancreatitis patients. These findings suggest that QST can be of clinical use for monitoring pain treatments in the context of chronic pain.	[Bouwense, Stefan A. W.; van Goor, Harry] Radboud Univ Nijmegen, Med Ctr, Dept Surg, Pain & Nocicept Neurosci Res Grp, NL-6525 ED Nijmegen, Netherlands; [Olesen, Soren S.; Drewes, Asbjorn M.] Aarhus Univ Hosp, Aalborg Hosp, Dept Gastroenterol & Hepatol, Aalborg, Denmark; [Drewes, Asbjorn M.] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Aalborg, Denmark; [Poley, Jan-Werner] Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Wilder-Smith, Oliver H. G.] Radboud Univ Nijmegen, Med Ctr, Pain & Nocicept Neurosci Res Grp, Dept Anaesthesiol Pain & Palliat Care, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen	Bouwense, SAW (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Surg, Pain & Nocicept Neurosci Res Grp, NL-6525 ED Nijmegen, Netherlands.	o.wildersmith@anes.umcn.nl	van Goor, H./H-8035-2014; Bouwense, Stefan/P-6468-2015; Wilder-Smith, Oliver H.G./E-7541-2012; Drewes, Asbjørn/AAR-7479-2021	van Goor, H./0000-0003-0323-4876; Bouwense, Stefan/0000-0002-7600-9429; Wilder-Smith, Oliver H.G./0000-0003-4390-2381; Drewes, Asbjørn/0000-0001-7465-964X; Schou Olesen, Soren/0000-0003-3916-3168	Pfizer Research and Development; Hertha Christensen's Foundation; Christenson-Ceson's Family Foundation	Pfizer Research and Development; Hertha Christensen's Foundation; Christenson-Ceson's Family Foundation	Supported by a free grant from Pfizer Research and Development, Hertha Christensen's Foundation, and Christenson-Ceson's Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren-Sandberg A, 2002, EUR J GASTROEN HEPAT, V14, P957, DOI 10.1097/00042737-200209000-00006; Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Arendt-Nielsen L, 2007, REGION ANESTH PAIN M, V32, P382, DOI 10.1016/j.rapm.2007.05.002; Bolay H, 2002, NEUROLOGY, V59, pS2, DOI 10.1212/WNL.59.5_suppl_2.S2; Bouwense SAW, 2011, REGION ANESTH PAIN M, V36, P303, DOI 10.1097/AAP.0b013e3182177022; Buchgreitz L, 2008, BRAIN, V131, P3232, DOI 10.1093/brain/awn199; Buscher HCJL, 2007, EUR J PAIN, V11, P437, DOI 10.1016/j.ejpain.2006.06.001; Buscher HCJL, 2002, BRIT J SURG, V89, P158, DOI 10.1046/j.1365-2168.2002.01988.x; Buscher HCJL, 2008, SURGERY, V143, P715, DOI 10.1016/j.surg.2008.03.001; Buscher HG, 2006, EUR J PAIN, V10, P363, DOI 10.1016/j.ejpain.2005.06.006; Cervero F, 2000, GUT, V47, P56; CERVERO F, 1995, ANN MED, V27, P235, DOI 10.3109/07853899509031965; Cole LJ, 2010, NEUROBIOL AGING, V31, P494, DOI 10.1016/j.neurobiolaging.2008.04.012; Diener MK, 2008, ANN SURG, V247, P950, DOI 10.1097/SLA.0b013e3181724ee7; Dimcevski G, 2007, PANCREAS, V35, P22, DOI 10.1097/mpa.0b013e31805c1762; Dimcevski G, 2007, GASTROENTEROLOGY, V132, P1546, DOI 10.1053/j.gastro.2007.01.037; Drewes AM, 2008, GUT, V57, P1616, DOI 10.1136/gut.2007.146621; Fernandez-de-las-Penas C, 2009, BRAIN, V132, P1472, DOI 10.1093/brain/awp050; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Freynhagen R, 2005, PAIN, V115, P254, DOI 10.1016/j.pain.2005.02.032; Gilron I, 2005, NEW ENGL J MED, V352, P1324, DOI 10.1056/NEJMoa042580; Gottrup H, 2004, ANESTHESIOLOGY, V101, P1400; Houghton LA, 2007, GUT, V56, P1218, DOI 10.1136/gut.2006.110858; LAYER P, 1994, GASTROENTEROLOGY, V107, P1481, DOI 10.1016/0016-5085(94)90553-3; Liu XG, 1998, NEUROSCIENCE, V86, P1209, DOI 10.1016/S0306-4522(98)00107-9; Magerl W, 2010, PAIN, V151, P598, DOI 10.1016/j.pain.2010.07.026; Nir RR, 2010, EUR J PAIN; Olesen SS, 2011, ALIMENT PHARM THER, V34, P878, DOI 10.1111/j.1365-2036.2011.04802.x; Olesen SS, 2011, GASTROENTEROLOGY, V141, P536, DOI 10.1053/j.gastro.2011.04.003; Olesen SS, 2010, CLIN GASTROENTEROL H, V8, P724, DOI 10.1016/j.cgh.2010.03.005; Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Siddall PJ, 2006, NEUROLOGY, V67, P1792, DOI 10.1212/01.wnl.0000244422.45278.ff; STEER ML, 1995, NEW ENGL J MED, V332, P1482, DOI 10.1056/NEJM199506013322206; van Esch AAJ, 2006, DIGEST LIVER DIS, V38, P518, DOI 10.1016/j.dld.2006.02.002; WATSON CP, 1982, NEUROLOGY, V32, P671, DOI 10.1212/WNL.32.6.671; Yarnitsky D, 2012, PAIN	37	65	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42096	10.1371/journal.pone.0042096	http://dx.doi.org/10.1371/journal.pone.0042096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879908	Green Published, Green Submitted, gold			2022-12-27	WOS:000307810000015
J	Florian, RV				Florian, Razvan V.			The Chronotron: A Neuron That Learns to Fire Temporally Precise Spike Patterns	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; SPINY STELLATE NEURONS; SYNAPTIC PLASTICITY; ERROR-BACKPROPAGATION; RECURRENT NETWORKS; THETA OSCILLATIONS; DISTAL DENDRITES; PHASE PRECESSION; VISUAL-CORTEX; FINITE MEMORY	In many cases, neurons process information carried by the precise timings of spikes. Here we show how neurons can learn to generate specific temporally precise output spikes in response to input patterns of spikes having precise timings, thus processing and memorizing information that is entirely temporally coded, both as input and as output. We introduce two new supervised learning rules for spiking neurons with temporal coding of information (chronotrons), one that provides high memory capacity (E-learning), and one that has a higher biological plausibility (I-learning). With I-learning, the neuron learns to fire the target spike trains through synaptic changes that are proportional to the synaptic currents at the timings of real and target output spikes. We study these learning rules in computer simulations where we train integrate-and-fire neurons. Both learning rules allow neurons to fire at the desired timings, with sub-millisecond precision. We show how chronotrons can learn to classify their inputs, by firing identical, temporally precise spike trains for different inputs belonging to the same class. When the input is noisy, the classification also leads to noise reduction. We compute lower bounds for the memory capacity of chronotrons and explore the influence of various parameters on chronotrons' performance. The chronotrons can model neurons that encode information in the time of the first spike relative to the onset of salient stimuli or neurons in oscillatory networks that encode information in the phases of spikes relative to the background oscillation. Our results show that firing one spike per cycle optimizes memory capacity in neurons encoding information in the phase of firing relative to a background rhythm.	Romanian Inst Sci & Technol, Ctr Cognit & Neural Studies Coneural, Cluj Napoca, Romania	Romanian Institute of Science & Technology	Florian, RV (corresponding author), Romanian Inst Sci & Technol, Ctr Cognit & Neural Studies Coneural, Cluj Napoca, Romania.	florian@rist.ro	Florian, Răzvan Valentin/A-1033-2010; Florian, Răzvan Valentin/I-7321-2019	Florian, Răzvan Valentin/0000-0002-4181-4727; Florian, Răzvan Valentin/0000-0002-4181-4727	Romanian National Authority for Scientific Research (PNCDI II, Parteneriate) [11-039/2007]; Max Planck - Coneural Partner Group	Romanian National Authority for Scientific Research (PNCDI II, Parteneriate); Max Planck - Coneural Partner Group(Max Planck Society)	This work has been sponsored by a grant of the Romanian National Authority for Scientific Research (PNCDI II, Parteneriate, contract no. 11-039/2007) and by the Max Planck - Coneural Partner Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin HH, 2004, ESAAN 2004 P EUR S A, P355; Andersen P., 2007, HIPPOCAMPUS BOOK; [Anonymous], 1998, NEURAL NETWORKS COMP; Ariav G, 2003, J NEUROSCI, V23, P7750; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Barak O, 2006, NEURAL COMPUT, V18, P2343, DOI 10.1162/neco.2006.18.10.2343; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Berry SD, 2001, NEUROBIOL LEARN MEM, V76, P298, DOI 10.1006/nlme.2001.4025; Bohte S. M., 2000, SPIKEPROP ERROR BACK, P419; Bohte Sander M., 2004, Natural Computing, V3, P195, DOI 10.1023/B:NACO.0000027755.02868.60; Bohte SM, 2002, NEUROCOMPUTING, V48, P17, DOI 10.1016/S0925-2312(01)00658-0; Booij O, 2004, THESIS U AMSTERDAM N; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Carey MR, 2009, NEURON, V62, P112, DOI 10.1016/j.neuron.2009.02.022; Carnell A, 2005, P EUR S ART NEUR NET; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; D'Haene M, 2009, NEURAL COMPUT, V21, P1068, DOI 10.1162/neco.2008.02-08-707; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; ECCLES J, 1976, NOTES REC ROY SOC, V30, P219, DOI 10.1098/rsnr.1976.0015; Edelmann E, 2011, FRONTIERS SYNAPTIC N, V3; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Fang HJ, 2010, NEURAL COMPUT, V22, P1060, DOI 10.1162/neco.2009.10-08-885; Fino E, 2005, J NEUROSCI, V25, P11279, DOI 10.1523/JNEUROSCI.4476-05.2005; Fino E, 2010, J PHYSIOL-LONDON, V588, P3045, DOI 10.1113/jphysiol.2010.188466; Florian RV, 2008, LECT NOTES COMPUT SC, V5164, P368, DOI 10.1007/978-3-540-87559-8_38; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Florian RV, 2006, LECT NOTES COMPUT SC, V4131, P718; Florian RV, 2005, Seventh International Symposium on Symbolic and Numeric Algorithms for Scientific Computing, Proceedings, P299; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; GERSTNER W, 1993, BIOL CYBERN, V69, P503, DOI 10.1007/BF00199450; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gerstner W, 2002, SPIKING NEURON MODEL; Gerstner W, 2010, FRONTIERS SYNAPTIC N, V2; Gerstner W., 2001, HDB BIOL PHYS, P469; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Han VZ, 2000, NEURON, V27, P611, DOI 10.1016/S0896-6273(00)00070-2; Havenith MN, 2011, J NEUROSCI, V31, P8570, DOI 10.1523/JNEUROSCI.2817-10.2011; Hertz JA, 2018, INTRO THEORY NEURAL; Hopfield JJ, 2001, P NATL ACAD SCI USA, V98, P1282, DOI 10.1073/pnas.031567098; Huang YY, 2004, P NATL ACAD SCI USA, V101, P859, DOI 10.1073/pnas.2237201100; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Izumi Y, 2008, J NEUROSCI, V28, P9557, DOI 10.1523/JNEUROSCI.3346-08.2008; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; Jaeger H., 2001, 148 GMD; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jin DZ, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015010; Jin DZ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021905; Junek S, 2010, NEURON, V67, P872, DOI 10.1016/j.neuron.2010.08.005; Kaiser F, 2007, LECT NOTES COMPUT SC, V4668, P380; Kasinski A., 2006, International Journal of Applied Mathematics and Computer Science, V16, P101; Kasinski A, 2005, LECT NOTES COMPUT SC, V3696, P145, DOI 10.1007/11550822_24; La Camera G, 2004, NEURAL COMPUT, V16, P2101, DOI 10.1162/0899766041732468; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Legenstein R, 2005, NEURAL COMPUT, V17, P2337, DOI 10.1162/0899766054796888; Legenstein RA, 2006, ADV NEURAL INFORM PR, V17, P865; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Maass W, 2007, PLOS COMPUT BIOL, V3, P15, DOI 10.1371/journal.pcbi.0020165; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; McKennoch S, 2006, IEEE IJCNN, P3970; McKennoch S, 2009, NEURAL COMPUT, V21, P9, DOI 10.1162/neco.2008.09-07-610; McNaughton N, 2006, HIPPOCAMPUS, V16, P1102, DOI 10.1002/hipo.20235; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Montemurro MA, 2007, J NEUROPHYSIOL, V98, P1871, DOI 10.1152/jn.00593.2007; Moore SC, 2002, THESIS U BATH UK; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakama T, 2009, NEUROCOMPUTING, V73, P151, DOI 10.1016/j.neucom.2009.05.017; Paugam-Moisy H, 2007, EUR S ART NEUR NETW; Pawlak V., 2010, FRONT SYNAPTIC NEURO, V2, P146, DOI DOI 10.3389/FNSYN.2010.00146; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Pfister JP, 2006, NEURAL COMPUT, V18, P1318, DOI 10.1162/neco.2006.18.6.1318; Ponulak F, 2006, P EUR S ART NEUR NET; Ponulak F., 2006, PHD POZN U TECHNOL, V46, P47; Ponulak F, 2006, D91 SECURESCM; Ponulak F, 2005, D91 SECURESCM; Ponulak F, 2008, INT J APPL MATH COMP, V18, P117, DOI 10.2478/v10006-008-0011-1; Ponulak F, 2010, NEURAL COMPUT, V22, P467, DOI 10.1162/neco.2009.11-08-901; Rauch A, 2003, J NEUROPHYSIOL, V90, P1598, DOI 10.1152/jn.00293.2003; Reich DS, 1997, J NEUROPHYSIOL, V77, P2836, DOI 10.1152/jn.1997.77.5.2836; Rokem A, 2006, J NEUROPHYSIOL, V95, P2541, DOI 10.1152/jn.00891.2005; Ruf B, 1997, NEURAL PROCESS LETT, V5, P9, DOI 10.1023/A:1009697008681; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schrauwen B, 2004, IEEE IJCNN, P471, DOI 10.1109/IJCNN.2004.1379954; Schrauwen B, 2006, P 2006 INT JOINT C N, P3463; Schrauwen Benjamin, 2007, PROC EUR S ARTIF NEU, P471; Seager MA, 2002, P NATL ACAD SCI USA, V99, P1616, DOI 10.1073/pnas.032662099; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sugisaki E, 2011, NEUROSCIENCE, V192, P91, DOI 10.1016/j.neuroscience.2011.06.064; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Tino P, 2006, NEURAL COMPUT, V18, P591, DOI 10.1162/089976606775623360; Tino P, 2005, LECT NOTES COMPUT SC, V3611, P666; Troyer TW, 1997, NEURAL COMPUT, V9, P971, DOI 10.1162/neco.1997.9.5.971; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Tzounopoulos T, 2007, NEURON, V54, P291, DOI 10.1016/j.neuron.2007.03.026; Urbanczik R, 2009, NEURAL COMPUT, V21, P340, DOI 10.1162/neco.2008.09-07-605; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; Voegtlin T., 2007, ADV NEURAL INFORM PR, V19, P1457; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Xin JG, 2001, IEEE IJCNN, P1772, DOI 10.1109/IJCNN.2001.938430; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106	116	122	130	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e40233	10.1371/journal.pone.0040233	http://dx.doi.org/10.1371/journal.pone.0040233			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879876	Green Published, Green Submitted, gold			2022-12-27	WOS:000307810000003
J	Kapoor, SK; Raman, AV; Sachdeva, KS; Satyanarayana, S				Kapoor, Sunil K.; Raman, A. Venkat; Sachdeva, Kuldeep Singh; Satyanarayana, Srinath			How Did the TB Patients Reach DOTS Services in Delhi? A Study of Patient Treatment Seeking Behavior	PLOS ONE			English	Article							INDIA; CARE; HIV/AIDS	Setting: Revised National Tuberculosis Control Programme (RNTCP), Delhi, India. Objective: To ascertain the number and sequence of providers visited by TB patients before availing treatment services from DOTS; to describe the duration between onset of symptoms to treatment. Study design: A cross sectional, qualitative study. Information was gathered through in-depth interviews of TB patients registered during the month of Oct, 2012 for availing TB treatment under the Revised National TB Control Programme from four tuberculosis diagnosis and treatment centers in Delhi. Results: Out of the 114 patients who registered, 108 participated in the study. The study showed that informal providers and retail chemists were the first point of contact and source of clinical advice for two-third of the patients, while the rest sought medical care from qualified providers directly. Most patients sought medical care from more than two providers, before being diagnosed as TB. Female TB patients and patients with extra-pulmonary TB had long mean duration between onset of symptoms to initiation of treatment (6.3 months and 8.4 months respectively). Conclusion: The pathways followed by TB patients, illustrated in this study, provide valuable lessons on the importance of different types of providers (both formal and informal) in the health system in a society like India and the delays in the diagnosis and treatment of tuberculosis.	[Kapoor, Sunil K.] Harrow Med Ctr, Noida, India; [Raman, A. Venkat] Univ Delhi, Fac Management Studies, New Delhi, India; [Sachdeva, Kuldeep Singh] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India; [Satyanarayana, Srinath] SE Asia Reg Off, New Delhi, India	University of Delhi	Kapoor, SK (corresponding author), Harrow Med Ctr, Noida, India.	sunil_kapoor96@yahoo.com; drsrinaths@gmail.com		Satyanarayana, Srinath/0000-0002-5420-2551				Bajpai V, 2010, NATL MED J INDIA, V23, P231; Central TB Division, 2010, UN ACC TB CAR PRACT; Central Tuberculosis Division, 2011, ANN REP REV NAT TUB; Charles N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012379; Chavali Annapurna, 2010, INFORMAL PROVISION H; Delhi State TB Cell, 2011, DOTS SERV DELH; Gautham Meenakshi, 2011, Indian J Med Res, V134, P627, DOI 10.4103/0971-5916.90987; Mignone J, 2007, AIDS CARE, V19, P152, DOI 10.1080/09540120600780542; Price Waterhouse Coopers, 2007, HLTH CAR IND EM MARK; Raman A. Venkat, 2008, PUBLIC PRIVATE PRATN; Sheikh K, 2006, T ROY SOC TROP MED H, V100, P312, DOI 10.1016/j.trstmh.2005.04.023; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Stop TB Department, 2011, GLOB PLAN STOP TB 20; The Union South-East Asia Regional Office New Delhi, 2010, PROJ AXSH GLOB FUND; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar MW, 2003, INT J TUBERC LUNG D, V7, P1113; World Health Organisation Geneva, 2012, GLOB TUB CONTR 2011; Yesudian CAK, 2011, HLTH SEEKING BEHAV U	18	88	88	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42458	10.1371/journal.pone.0042458	http://dx.doi.org/10.1371/journal.pone.0042458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879990	Green Published, Green Submitted, gold			2022-12-27	WOS:000307810000035
J	De Vlaminck, I; Henighan, T; van Loenhout, MTJ; Burnham, DR; Dekker, C				De Vlaminck, Iwijn; Henighan, Thomas; van Loenhout, Marijn T. J.; Burnham, Daniel R.; Dekker, Cees			Magnetic Forces and DNA Mechanics in Multiplexed Magnetic Tweezers	PLOS ONE			English	Article							PERSISTENCE LENGTH; MOLECULE; ELASTICITY	Magnetic tweezers (MT) are a powerful tool for the study of DNA-enzyme interactions. Both the magnet-based manipulation and the camera-based detection used in MT are well suited for multiplexed measurements. Here, we systematically address challenges related to scaling of multiplexed magnetic tweezers (MMT) towards high levels of parallelization where large numbers of molecules (say 10 3) are addressed in the same amount of time required by a single-molecule measurement. We apply offline analysis of recorded images and show that this approach provides a scalable solution for parallel tracking of the xyz-positions of many beads simultaneously. We employ a large field-of-view imaging system to address many DNA-bead tethers in parallel. We model the 3D magnetic field generated by the magnets and derive the magnetic force experienced by DNA-bead tethers across the large field of view from first principles. We furthermore experimentally demonstrate that a DNA-bead tether subject to a rotating magnetic field describes a bicircular, Limac, on rotation pattern and that an analysis of this pattern simultaneously yields information about the force angle and the position of attachment of the DNA on the bead. Finally, we apply MMT in the high-throughput investigation of the distribution of the induced magnetic moment, the position of attachment of DNA on the beads, and DNA flexibility. The methods described herein pave the way to kilo-molecule level magnetic tweezers experiments.	[De Vlaminck, Iwijn; Henighan, Thomas; van Loenhout, Marijn T. J.; Burnham, Daniel R.; Dekker, Cees] Delft Univ Technol, Kavli Inst Nanosci, Delft, Netherlands	Delft University of Technology	De Vlaminck, I (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Delft, Netherlands.	c.dekker@tudelft.nl	Burnham, Daniel/A-3261-2014; De Vlaminck, Iwijn/P-6479-2015	De Vlaminck, Iwijn/0000-0001-6085-7311; Burnham, Daniel/0000-0002-3017-8964; Dekker, Cees/0000-0001-6273-071X	Stichting voor Fundamenteel Onderzoek der Materie (FOM); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); Netherlands America Fulbright Foundation	Stichting voor Fundamenteel Onderzoek der Materie (FOM)(FOM (The Netherlands)); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands America Fulbright Foundation	This work was supported by a 'DNA-in-action' grant from the "Stichting voor Fundamenteel Onderzoek der Materie (FOM)'', which is financially supported by the "Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)''. Thomas Henighan thanks the Netherlands America Fulbright Foundation for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abels JA, 2005, BIOPHYS J, V88, P2737, DOI 10.1529/biophysj.104.052811; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Danilowicz C, 2005, ANAL CHEM, V77, P3023, DOI 10.1021/ac050057+; De Vlaminck I, 2011, NANO LETT; De Vlaminck I, 2012, MOL CELL; De Vlaminck I, 2012, ANNU REV BIOPHYS, V41, P453, DOI 10.1146/annurev-biophys-122311-100544; De Vlaminck I, 2010, NUCLEIC ACIDS RES, V38, P4133, DOI 10.1093/nar/gkq067; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Hall LM, 1992, COLL MATH J, V23, P20, DOI DOI 10.1080/07468342.1992.11973429; Halvorsen K, 2010, BIOPHYS J, V98, pL53, DOI 10.1016/j.bpj.2010.03.012; Holthausen JT, 2011, NUCL ACIDS RES; Jackson JD, 1999, AM J PHYS, V67, P107, DOI 10.1119/1.19203; Klaue D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.028302; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Kruithof M, 2008, BIOPHYS J, V94, P2343, DOI 10.1529/biophysj.107.121673; Leach J, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026301; Lipfert J, 2009, BIOPHYS J, V96, P5040, DOI 10.1016/j.bpj.2009.03.055; Maier B, 2000, P NATL ACAD SCI USA, V97, P12002, DOI 10.1073/pnas.97.22.12002; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Ribeck N, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2981687; Segall DE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088306; Seol Y, 2007, BIOPHYS J, V93, P4360, DOI 10.1529/biophysj.107.112995; Severin PMD, 2011, LAB CHIP, V11, P856, DOI [10.1039/c0lc00302f, 10.1039/c01c00302f]; Strick TR, 2003, REP PROG PHYS, V66, P1, DOI 10.1088/0034-4885/66/1/201; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; te Velthuis AJW, 2010, BIOPHYS J, V100, p481a; van Aelst K, 2010, P NATL ACAD SCI USA, V107, P9123, DOI 10.1073/pnas.1001637107; van Loenhout MTJ, 2012, BIOPHYS J, V102, P2362, DOI 10.1016/j.bpj.2012.03.073; van Loenhout MTJ, 2009, NUCLEIC ACIDS RES, V37, P4089, DOI 10.1093/nar/gkp326; Xiao BT, 2010, NUCLEIC ACIDS RES, V38, P6176, DOI 10.1093/nar/gkq435	31	51	53	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41432	10.1371/journal.pone.0041432	http://dx.doi.org/10.1371/journal.pone.0041432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870220	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100019
J	Liu, CC; Mauk, MG; Hart, R; Bonizzoni, M; Yan, GY; Bau, HH				Liu, Changchun; Mauk, Michael G.; Hart, Robert; Bonizzoni, Mariangela; Yan, Guiyun; Bau, Haim H.			A Low-Cost Microfluidic Chip for Rapid Genotyping of Malaria-Transmitting Mosquitoes	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; POLYMERASE-CHAIN-REACTION; ANOPHELES-GAMBIAE; SAMPLE PREPARATION; IDENTIFICATION; DNA; DIFFERENTIATION; POLYMORPHISM; MICROARRAY; ARABIENSIS	Background: Vector control is one of the most effective measures to prevent the transmission of malaria, a disease that causes over 600,000 deaths annually. Around 30-40 Anopheles mosquito species are natural vectors of malaria parasites. Some of these species cannot be morphologically distinguished, but have behavioral and ecological differences. Emblematic of this is the Anopheles gambiae species complex. The correct identification of vector species is fundamental to the development of control strategies and epidemiological studies of disease transmission. Methodology/Principal Findings: An inexpensive, disposable, field-deployable, sample-to-answer, microfluidic chip was designed, constructed, and tested for rapid molecular identification of Anopheles gambiae and Anopheles arabiensis. The chip contains three isothermal amplification reactors. One test reactor operates with specific primers to amplify Anopheles gambiae DNA, another with specific primers for Anopheles arabiensis DNA, and the third serves as a negative control. A mosquito leg was crushed on an isolation membrane. Two discs, laden with mosquito tissue, were punched out of the membrane and inserted into the two test chambers. The isolated, disc-bound DNA served as a template in the amplification processes. The amplification products were detected with intercalating fluorescent dye that was excited with a blue light-emitting diode. The emitted light was observed by eye and recorded with a cell-phone camera. When the target consisted of Anopheles gambiae, the reactor containing primers specific to An. gambiae lit up while the other two reactors remained dark. When the target consisted of Anopheles arabiensis, the reactor containing primers specific to An. arabiensis lit up while the other two reactors remained dark. Conclusions/Significance: The microfluidic chip provides a means to identify mosquito type through molecular analysis. It is suitable for field work, allowing one to track the geographical distribution of mosquito populations and community structure alterations due to environmental changes and malaria intervention measures.	[Liu, Changchun; Mauk, Michael G.; Hart, Robert; Bau, Haim H.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA; [Bonizzoni, Mariangela; Yan, Guiyun] Univ Calif Irvine, Coll Hlth Sci, Irvine, CA USA	University of Pennsylvania; University of California System; University of California Irvine	Liu, CC (corresponding author), Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.	bau@seas.upenn.edu	Bau, Haim H/D-1161-2009; bonizzoni, mariangela/AAM-9035-2021	bonizzoni, mariangela/0000-0003-0568-8564	National Institutes of Health/National Institute of Dental and Craniofacial Research [U01DE017855]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [1K25AI099160-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI099160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE017855] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by National Institutes of Health/National Institute of Dental and Craniofacial Research grant U01DE017855 and National Institutes of Health/National Institute of Allergy and Infectious Diseases grant 1K25AI099160-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aonuma H, 2008, BIOCHEM BIOPH RES CO, V376, P671, DOI 10.1016/j.bbrc.2008.09.061; Bonizzoni M, 2009, AM J TROP MED HYG, V81, P1030, DOI 10.4269/ajtmh.2009.09-0333; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bynum WF, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P49; Cao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033176; CARLSON DA, 1979, ANN TROP MED PARASIT, V73, P589, DOI 10.1080/00034983.1979.11687301; Chen DF, 2010, BIOMED MICRODEVICES, V12, P705, DOI 10.1007/s10544-010-9423-4; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Collins FH, 1996, INSECT MOL BIOL, V5, P1, DOI 10.1111/j.1365-2583.1996.tb00034.x; Collins FH, 2000, B WORLD HEALTH ORGAN, V78, P1412; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Coosemans M, 1998, AM J TROP MED HYG, V58, P70, DOI 10.4269/ajtmh.1998.58.70; Cortes AL, 2009, AVIAN DIS, V53, P510, DOI 10.1637/8871-041009-Reg.1; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Curtis KA, 2009, J MED VIROL, V81, P966, DOI 10.1002/jmv.21490; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Dineva MA, 2007, ANALYST, V132, P1193, DOI 10.1039/b705672a; Djogbenou L, 2010, ACTA TROP, V114, P116, DOI 10.1016/j.actatropica.2010.02.001; Easley CJ, 2006, P NATL ACAD SCI USA, V103, P19272, DOI 10.1073/pnas.0604663103; FAVIA G, 1994, P NATL ACAD SCI USA, V91, P10315, DOI 10.1073/pnas.91.22.10315; Garros C, 2004, AM J TROP MED HYG, V70, P583, DOI 10.4269/ajtmh.2004.70.583; Jamjoom Manal, 2009, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V39, P227; Kim J, 2009, LAB CHIP, V9, P606, DOI 10.1039/b807915c; Liu CC, 2011, MICROFLUID NANOFLUID, V11, P209, DOI 10.1007/s10404-011-0788-3; Liu CC, 2011, LAB CHIP, V11, P2686, DOI 10.1039/c1lc20345b; Liu CC, 2011, ANALYST, V136, P2069, DOI 10.1039/c1an00007a; Liu CC, 2011, LAB CHIP, V11, P1688, DOI 10.1039/c1lc20089e; Liu CC, 2009, LAB CHIP, V9, P768, DOI 10.1039/b814322f; Liu RH, 2004, ANAL CHEM, V76, P1824, DOI 10.1021/ac0353029; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Lui C, 2009, SENSORS-BASEL, V9, P3713, DOI 10.3390/s90503713; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; PASKEWITZ SM, 1990, MED VET ENTOMOL, V4, P367, DOI 10.1111/j.1365-2915.1990.tb00453.x; Qiu XB, 2011, BIOMED MICRODEVICES, V13, P809, DOI 10.1007/s10544-011-9551-5; Rajendram D, 2006, J MICROBIOL METH, V67, P582, DOI 10.1016/j.mimet.2006.05.010; Ramirez JL, 2009, CURR MOL MED, V9, P116, DOI 10.2174/156652409787581600; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Walker ED, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-23; Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066	41	41	45	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42222	10.1371/journal.pone.0042222	http://dx.doi.org/10.1371/journal.pone.0042222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879919	gold, Green Published			2022-12-27	WOS:000307284100056
J	Ren, XH; Xu, JY; Cooper, JP; Kang, MH; Erdreich-Epstein, A				Ren, Xiuhai; Xu, Jingying; Cooper, Jason P.; Kang, Min H.; Erdreich-Epstein, Anat			c-Abl Is an Upstream Regulator of Acid Sphingomyelinase in Apoptosis Induced by Inhibition of Integrins alpha v beta 3 and alpha v beta 5	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; TYROSINE KINASE; DNA-DAMAGE; CERAMIDE GENERATION; CARCINOMA-CELLS; BRAIN-TUMORS; PHASE-I; MODULATION; ACTIN; ALPHA(V)BETA(3)	Inhibition of integrins alpha v beta 3/alpha v beta 5 by the cyclic function-blocking peptide, RGDfV (Arg-Gly-Asp-Phe-Val) can induce apoptosis in both normal cells and tumor cells. We show that RGDfV induced apoptosis in ECV-304 carcinoma cells, increased activity and mRNA expression of acid sphingomyelinase (ASM), and increased ceramides C-16, C-18:0, C-24:0 and C-24:1 while decreasing the corresponding sphingomyelins. siRNA to ASM decreased RGDfV-induced apoptosis as measured by TUNEL, PARP cleavage, mitochondrial depolarization, and caspase-3 and caspase-8 activities, as well as by annexinV in a 3D collagen model. These findings indicate a causal role for ASM in RGDfV-induced apoptosis in ECV-304. We have shown that c-Abl, a non-receptor tyrosine kinase, also mediates RGDfV-induced apoptosis. However, c-Abl, has not been previously linked to ASM in any system. Here we show that STI-571 (imatinib, inhibitor of c-Abl) inhibited RGDfV-induced ASM activity. Furthermore, STI-571 and c-Abl-siRNA both inhibited RGDfV-induced increase in ASM mRNA, but ASM-siRNA did not affect c-Abl phosphorylation or expression, supporting that c-Abl regulates the RGDfV-induced increase in ASM expression. These studies implicate ASM as a mediator of apoptosis induced by inhibition of integrins avb3/avb5, and for the first time place c-Abl as an upstream regulator of ASM expression and activity.	[Ren, Xiuhai; Xu, Jingying; Erdreich-Epstein, Anat] Univ So Calif, Keck Sch Med, Dept Pediat, Div Hematol Oncol, Los Angeles, CA 90033 USA; [Ren, Xiuhai; Xu, Jingying; Erdreich-Epstein, Anat] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Cooper, Jason P.; Kang, Min H.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Lubbock, TX 79430 USA; [Erdreich-Epstein, Anat] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	University of Southern California; Children's Hospital Los Angeles; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Southern California	Ren, XH (corresponding author), Univ So Calif, Keck Sch Med, Dept Pediat, Div Hematol Oncol, Los Angeles, CA 90033 USA.	epstein@usc.edu	Xu, Jingying/G-2036-2010	Cooper, Jason P/0000-0003-0023-8054; Kang, Min H/0000-0003-3603-7035; Erdreich-Epstein, Anat/0000-0003-4269-4373	National Institutes of Health [CA98568]; Children's Hospital Los Angeles Saban Research Institute Pre-doctoral Fellowship Award; Grayson's Gift; Nautica Malibu Triathlon Fund; Rachel Ann Hage Neuro-Oncology Fund; Bogart Pediatric Cancer Research Program; T. J. Martell Foundation for Leukemia, Cancer, and AIDS Research; NATIONAL CANCER INSTITUTE [R01CA098568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital Los Angeles Saban Research Institute Pre-doctoral Fellowship Award; Grayson's Gift; Nautica Malibu Triathlon Fund; Rachel Ann Hage Neuro-Oncology Fund; Bogart Pediatric Cancer Research Program; T. J. Martell Foundation for Leukemia, Cancer, and AIDS Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant CA98568 from the National Institutes of Health to AE. JX was supported in part by a Children's Hospital Los Angeles Saban Research Institute Pre-doctoral Fellowship Award. The work was also supported in part by Grayson's Gift and by support from the Nautica Malibu Triathlon Fund, the Rachel Ann Hage Neuro-Oncology Fund, the Bogart Pediatric Cancer Research Program, and the T. J. Martell Foundation for Leukemia, Cancer, and AIDS Research (AE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi A, 2007, METHOD ENZYMOL, V426, P85, DOI 10.1016/S0076-6879(07)26005-7; Barila D, 2003, MOL CELL BIOL, V23, P2790, DOI 10.1128/MCB.23.8.2790-2799.2003; Bello L, 2001, NEUROSURGERY, V49, P380, DOI 10.1097/00006123-200108000-00022; BHATTACHARYA S, 1995, J BIOL CHEM, V270, P16781, DOI 10.1074/jbc.270.28.16781; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Erdreich-Epstein A, 2005, BLOOD, V105, P4353, DOI 10.1182/blood-2004-08-3098; Erdreich-Epstein A, 2002, J BIOL CHEM, V277, P49531, DOI 10.1074/jbc.M209962200; Erdreich-Epstein A, 2000, CANCER RES, V60, P712; FELDINGHABERMANN B, 1992, J CLIN INVEST, V89, P2018, DOI 10.1172/JCI115811; Friedlander M, 1996, P NATL ACAD SCI USA, V93, P9764, DOI 10.1073/pnas.93.18.9764; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Genersch E, 2003, EUR J CELL BIOL, V82, P105, DOI 10.1078/0171-9335-00297; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Gong JG, 1999, NATURE, V399, P806; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; Gulbins Erich, 2002, Subcell Biochem, V36, P229; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Koos B, 2010, CANCER-AM CANCER SOC, V116, P5075, DOI 10.1002/cncr.25420; Kroesen BJ, 2001, J BIOL CHEM, V276, P13606, DOI 10.1074/jbc.M009517200; Lewis JM, 2002, P NATL ACAD SCI USA, V99, P3627, DOI 10.1073/pnas.062698499; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; MacDonald TJ, 2001, NEUROSURGERY, V48, P151, DOI 10.1097/00006123-200101000-00026; MacDonald TJ, 2008, J CLIN ONCOL, V26, P919, DOI 10.1200/JCO.2007.14.1812; Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Maupas-Schwalm F, 2009, CELL SIGNAL, V21, P1925, DOI 10.1016/j.cellsig.2009.08.010; MCGAHON AJ, 1995, J BIOL CHEM, V270, P22625, DOI 10.1074/jbc.270.38.22625; Meltser V, 2011, CELL DEATH DIFFER, V18, P2, DOI 10.1038/cdd.2010.132; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Nabors LB, 2007, J CLIN ONCOL, V25, P1651, DOI 10.1200/JCO.2006.06.6514; OBEID LM, 1995, J CELL BIOCHEM, V58, P191, DOI 10.1002/jcb.240580208; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Rebillard A, 2008, ONCOGENE, V27, P6590, DOI 10.1038/onc.2008.257; Rebillard A, 2010, EUR J CANCER, V46, P1445, DOI 10.1016/j.ejca.2010.01.034; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; Salesse S, 2002, ONCOGENE, V21, P8547, DOI 10.1038/sj.onc.1206082; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; SAWYERS CL, 1994, CELL, V77, P121, DOI 10.1016/0092-8674(94)90240-2; Schlieben S, 1996, LEUKEMIA, V10, P957; Siskind LJ, 2010, J BIOL CHEM, V285, P11818, DOI 10.1074/jbc.M109.078121; Stromblad S, 1996, J CLIN INVEST, V98, P426, DOI 10.1172/JCI118808; Taga T, 2002, INT J CANCER, V98, P690, DOI 10.1002/ijc.10265; Truong T, 2003, P NATL ACAD SCI USA, V100, P10281, DOI 10.1073/pnas.1635435100; van Bokhoven A, 2001, CANCER RES, V61, P6340; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Xu JY, 2010, BLOOD, V115, P2709, DOI 10.1182/blood-2009-05-223776; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	58	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42291	10.1371/journal.pone.0042291	http://dx.doi.org/10.1371/journal.pone.0042291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879933	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100062
J	Cvirn, G; Schlagenhauf, A; Leschnik, B; Koestenberger, M; Roessler, A; Jantscher, A; Vrecko, K; Juergens, G; Hinghofer-Szalkay, H; Goswami, N				Cvirn, Gerhard; Schlagenhauf, Axel; Leschnik, Bettina; Koestenberger, Martin; Roessler, Andreas; Jantscher, Andreas; Vrecko, Karoline; Juergens, Guenther; Hinghofer-Szalkay, Helmut; Goswami, Nandu			Coagulation Changes during Presyncope and Recovery	PLOS ONE			English	Article							PLASMA-VOLUME CHANGES; BLOOD-COAGULATION; PSYCHOLOGICAL STRESS; FIBRINOLYSIS; AGGREGATION; MECHANISM; PRESSURE; PARADOX	Orthostatic stress activates the coagulation system. The extent of coagulation activation with full orthostatic load leading to presyncope is unknown. We examined in 7 healthy males whether presyncope, using a combination of head up tilt (HUT) and lower body negative pressure (LBNP), leads to coagulation changes as well as in the return to baseline during recovery. Coagulation responses (whole blood thrombelastometry, whole blood platelet aggregation, endogenous thrombin potential, markers of endothelial activation and thrombin generation), blood cell counts and plasma mass density (for volume changes) were measured before, during, and 20 min after the orthostatic stress. Maximum orthostatic load led to a 25% plasma volume loss. Blood cell counts, prothrombin levels, thrombin peak, endogenous thrombin potential, and tissue factor pathway inhibitor levels increased during the protocol, commensurable with hemoconcentration. The markers of endothelial activation (tissue factor, tissue plasminogen activator), and thrombin generation (F1+2, prothrombin fragments 1 and 2, and TAT, thrombin-antithrombin complex) increased to an extent far beyond the hemoconcentration effect. During recovery, the markers of endothelial activation returned to initial supine values, but F1+2 and TAT remained elevated, suggestive of increased coagulability. Our findings of increased coagulability at 20 min of recovery from presyncope may have greater clinical significance than short-term procoagulant changes observed during standing. While our experiments were conducted in healthy subjects, the observed hypercoagulability during graded orthostatic challenge, at presyncope and in recovery may be an important risk factor particularly for patients already at high risk for thromboembolic events (e. g. those with coronary heart disease, atherosclerosis or hypertensives).	[Cvirn, Gerhard; Vrecko, Karoline; Juergens, Guenther] Med Univ Graz, Inst Physiol Chem, Graz, Austria; [Schlagenhauf, Axel; Leschnik, Bettina; Koestenberger, Martin] Med Univ Graz, Dept Paediat, Graz, Austria; [Roessler, Andreas; Jantscher, Andreas; Hinghofer-Szalkay, Helmut; Goswami, Nandu] Med Univ Graz, Inst Physiol, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Cvirn, G (corresponding author), Med Univ Graz, Inst Physiol Chem, Graz, Austria.	nandu.goswami@medunigraz.at	Roessler, Andreas/A-5751-2008; Schlagenhauf, Axel/AAK-9598-2021; Koestenberger, Martin/J-5008-2019; Goswami, Nandu/B-4021-2011	Roessler, Andreas/0000-0001-9543-8870; Schlagenhauf, Axel/0000-0003-3408-6415; Koestenberger, Martin/0000-0003-1766-7859; 				Bassenge E, 1996, PROG CARDIOVASC DIS, V39, P209, DOI 10.1016/S0033-0620(96)80002-8; BAUER KA, 2001, HEMOSTASIS THROMBOSI, P1113; Cvirn G, 2007, BLOOD COAGUL FIBRIN, V18, P585, DOI 10.1097/MBC.0b013e328285d832; Dielis AWJH, 2005, HYPERTENSION, V46, P1236, DOI 10.1161/01.HYP.0000193538.20705.23; FILEP J, 1987, THROMB RES, V45, P7, DOI 10.1016/0049-3848(87)90252-0; Goswami N, 2009, PHYSIOL RES, V58, P311, DOI 10.33549/physiolres.931431; Goswami N, 2012, PHYSIOL BEHAV, V106, P569, DOI 10.1016/j.physbeh.2012.02.022; Goswami N, 2010, INT J PSYCHOPHYSIOL, V75, P54, DOI 10.1016/j.ijpsycho.2009.11.005; HAGAN RD, 1978, J APPL PHYSIOL, V45, P414, DOI 10.1152/jappl.1978.45.3.414; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Hinghofer-Szalkay H, 2011, EUR J CLIN INVEST, V41, P1180, DOI 10.1111/j.1365-2362.2011.02523.x; Hinghofer-Szalkay H, 2011, EUR J APPL PHYSIOL, V111, P163, DOI 10.1007/s00421-010-1646-9; Hinghofer-Szalkay HG, 2008, AM J PHYSIOL-GASTR L, V295, pG332, DOI 10.1152/ajpgi.00042.2008; HINGHOFERSZALKAY H, 1986, AM J PHYSIOL, V250, pH68, DOI 10.1152/ajpheart.1986.250.1.H68; HINGHOFERSZALKAY H, 1987, J APPL PHYSIOL, V63, P1003, DOI 10.1152/jappl.1987.63.3.1003; Hitosugi M, 2000, THROMB RES, V100, P409, DOI 10.1016/S0049-3848(00)00348-0; Jacob G, 1998, J APPL PHYSIOL, V84, P914; Jacob G, 2005, MAYO CLIN PROC, V80, P611, DOI 10.4065/80.5.611; JEN CYJ, 1984, J LAB CLIN MED, V103, P115; Laszlo Z, 2001, PHYSIOL RES, V50, P71; Lin MC, 1997, J CLIN INVEST, V99, P737, DOI 10.1172/JCI119219; Masoud M, 2008, HYPERTENSION, V51, P1545, DOI 10.1161/HYPERTENSIONAHA.108.112003; Michiels JJ, 2006, SEMIN THROMB HEMOST, V32, P589, DOI 10.1055/s-2006-949664; Papousek I, 2010, BIOL PSYCHOL, V83, P108, DOI 10.1016/j.biopsycho.2009.11.008; Rossler A, 1999, HYPERTENSION, V34, P1147, DOI 10.1161/01.HYP.34.5.1147; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Sorensen B, 2003, J THROMB HAEMOST, V1, P551, DOI 10.1046/j.1538-7836.2003.00075.x; Thrall G, 2007, THROMB RES, V120, P819, DOI 10.1016/j.thromres.2007.01.004; Trementino L, 2010, NEUROENDOCRINOLOGY, V92, P55, DOI 10.1159/000314349; von Kanel R, 2003, J APPL PHYSIOL, V94, P1455, DOI 10.1152/japplphysiol.00892.2002; von Kanel R, 2001, PSYCHOSOM MED, V63, P531, DOI 10.1097/00006842-200107000-00003; Wirtz PH, 2006, J HYPERTENS, V24, P2409, DOI 10.1097/HJH.0b013e32801098e5	32	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42221	10.1371/journal.pone.0042221	http://dx.doi.org/10.1371/journal.pone.0042221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876309	gold, Green Published			2022-12-27	WOS:000307184700037
J	Frick, WF; Stepanian, PM; Kelly, JF; Howard, KW; Kuster, CM; Kunz, TH; Chilson, PB				Frick, Winifred F.; Stepanian, Phillip M.; Kelly, Jeffrey F.; Howard, Kenneth W.; Kuster, Charles M.; Kunz, Thomas H.; Chilson, Phillip B.			Climate and Weather Impact Timing of Emergence of Bats	PLOS ONE			English	Article							FREE-TAILED BATS; TADARIDA-BRASILIENSIS; ECOLOGICAL RESPONSES; PHENOLOGY; DECLINES; QPE	Interest in forecasting impacts of climate change have heightened attention in recent decades to how animals respond to variation in climate and weather patterns. One difficulty in determining animal response to climate variation is lack of long-term datasets that record animal behaviors over decadal scales. We used radar observations from the national NEXRAD network of Doppler weather radars to measure how group behavior in a colonially-roosting bat species responded to annual variation in climate and daily variation in weather over the past 11 years. Brazilian free-tailed bats (Tadarida brasiliensis) form dense aggregations in cave roosts in Texas. These bats emerge from caves daily to forage at high altitudes, which makes them detectable with Doppler weather radars. Timing of emergence in bats is often viewed as an adaptive trade-off between emerging early and risking predation or increased competition and emerging late which restricts foraging opportunities. We used timing of emergence from five maternity colonies of Brazilian free-tailed bats in south-central Texas during the peak lactation period (15 June-15 July) to determine whether emergence behavior was associated with summer drought conditions and daily temperatures. Bats emerged significantly earlier during years with extreme drought conditions than during moist years. Bats emerged later on days with high surface temperatures in both dry and moist years, but there was no relationship between surface temperatures and timing of emergence in summers with normal moisture levels. We conclude that emergence behavior is a flexible animal response to climate and weather conditions and may be a useful indicator for monitoring animal response to long-term shifts in climate.	[Frick, Winifred F.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Stepanian, Phillip M.; Kuster, Charles M.; Chilson, Phillip B.] Univ Oklahoma, Sch Meteorol, Norman, OK 73019 USA; [Stepanian, Phillip M.; Kuster, Charles M.; Chilson, Phillip B.] Univ Oklahoma, Atmospher Radar Res Ctr, Norman, OK 73019 USA; [Kelly, Jeffrey F.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Kelly, Jeffrey F.] Univ Oklahoma, Oklahoma Biol Survey, Norman, OK 73019 USA; [Howard, Kenneth W.] NOAA, Natl Severe Storms Lab, Norman, OK 73069 USA; [Kunz, Thomas H.] Boston Univ, Dept Biol, Ctr Ecol & Conservat Biol, Boston, MA 02215 USA	University of California System; University of California Santa Cruz; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; National Oceanic Atmospheric Admin (NOAA) - USA; Boston University	Frick, WF (corresponding author), Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA.	wfrick@ucsc.edu	Frick, Winifred F/G-3501-2012; Kelly, Jeffrey F/B-2029-2015; Frick, Winifred/ABA-3519-2020; Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Chilson, Phillip B./C-8491-2012	Kelly, Jeffrey F/0000-0002-8255-7990; Frick, Winifred/0000-0002-9469-1839; 	NSF [DBI-0905881, EPS 0919466]; National Oceanic and Atmospheric Administration National Severe Storms Laboratory [NA08OAR4320904]; University of Oklahoma	NSF(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration National Severe Storms Laboratory(National Oceanic Atmospheric Admin (NOAA) - USA); University of Oklahoma	WFF was supported by NSF DBI-0905881. JFK was supported by NSF EPS 0919466. PBC was funded in part through the National Oceanic and Atmospheric Administration National Severe Storms Laboratory Grant NA08OAR4320904. PBC and PMS were partially supported through internal funding from the University of Oklahoma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2008, J ANIM ECOL, V77, P1115, DOI 10.1111/j.1365-2656.2008.01447.x; Adams RA, 2010, ECOLOGY, V91, P2437, DOI 10.1890/09-0091.1; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Buler JJ, 2009, IEEE T GEOSCI REMOTE, V47, P2741, DOI 10.1109/TGRS.2009.2014463; BULLOCK DJ, 1987, J ZOOL, V211, P267, DOI 10.1111/j.1469-7998.1987.tb01533.x; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Chilson PB, ECOSPHERE; Chilson PB, 2012, B AM METEOROLOGICAL, V93, P1; Diehl RH, 2002, BIRD CONSERVATION IM, P876; Duverge PL, 2000, ECOGRAPHY, V23, P32, DOI 10.1034/j.1600-0587.2000.230104.x; FENTON MB, 1994, ANIM BEHAV, V48, P9, DOI 10.1006/anbe.1994.1207; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Gauthreaux SA, 2008, INTEGR COMP BIOL, V48, P12, DOI 10.1093/icb/icn021; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hawkins BA, 1998, AM NAT, V152, P480, DOI 10.1086/286184; Hodgson JA, 2011, GLOBAL CHANGE BIOL, V17, P1289, DOI 10.1111/j.1365-2486.2010.02308.x; Horn JW, 2008, INTEGR COMP BIOL, V48, P24, DOI 10.1093/icb/icn051; Ibanez I, 2010, PHILOS T R SOC B, V365, P3247, DOI 10.1098/rstb.2010.0120; JONES G, 1994, PHILOS T R SOC B, V346, P445, DOI 10.1098/rstb.1994.0161; Kelly JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00257.1; Langston C, 2007, J ATMOS OCEAN TECH, V24, P776, DOI 10.1175/JTECH2001.1; Lee YF, 2001, ZOOL STUD, V40, P309; McCracken GF, 2008, INTEGR COMP BIOL, V48, P107, DOI 10.1093/icb/icn033; PALMER WC, 1965, 45 WEATH BUR RES; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Reichard JD, 2009, J MAMMAL, V90, P1478, DOI 10.1644/08-MAMM-A-266R1.1; Rydell J, 1996, OIKOS, V76, P243, DOI 10.2307/3546196; Sarkar D., 2019, NLME LINEAR NONLINEA; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Team RDC, 2012, R LANG ENV STAT COMP; Vasiloff SV, 2007, B AM METEOROL SOC, V88, P1899, DOI 10.1175/BAMS-88-12-1899; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whickam H, 2009, GGPLOT2 ELEGANT GRAP; Yela JL, 1997, ENVIRON ENTOMOL, V26, P1283, DOI 10.1093/ee/26.6.1283; Zhang J, 2005, J ATMOS OCEAN TECH, V22, P30, DOI 10.1175/JTECH-1689.1; Zhang J, 2004, ERAD PUBLICATION SER, V2, P105; Zhang J, 2011, B AM METEOROL SOC, V92, P1321, DOI 10.1175/2011BAMS-D-11-00047.1; Zuur Alain F., 2009, P1	39	40	43	2	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42737	10.1371/journal.pone.0042737	http://dx.doi.org/10.1371/journal.pone.0042737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876331	Green Published, gold			2022-12-27	WOS:000307184700059
J	Spang, K; Gillam, B; Fahle, M				Spang, Karoline; Gillam, Barbara; Fahle, Manfred			Electrophysiological Correlates of Binocular Stereo Depth without Binocular Disparities	PLOS ONE			English	Article							TEXTURE SEGREGATION; PHANTOM SURFACE; RANDOM-DOT; PERCEPTION; OCCLUSION; CONTOURS; SLANT	A small region of background presented to only one eye in an otherwise binocular display may, under certain conditions, be resolved in the visual system by interpreting the region as a small gap between two similar objects placed at different depths, with the gap hidden in one eye by parallax. This has been called monocular gap stereopsis. We investigated the electrophysiological correlate of this type of stereopsis by means of sum potential recordings in 12 observers, comparing VEP's for this stimulus ("Gillam Stereo", Author BG has strong reservations about this term) with those for similar stimuli containing disparity based depth and with no depth (flat). In addition we included several control stimuli. The results show a pronounced early negative potential at a latency of around 170 ms (N170) for all stimuli containing non-identical elements, be they a difference caused by binocular disparity or by completely unmatched monocular contours. A second negative potential with latency around 270 ms (N270), on the other hand, is present only with stimuli leading to fusion and the perception of depth. This second component is similar for disparity-based stereopsis and monocular gap, or "Gillam Stereo" although slightly more pronounced for the former. We conjecture that the first component is related to the detection of differences between the images of the two eyes that may then either be fused, leading to stereopsis and the corresponding second potential, or else to inhibition and rivalry without a later trace in the VEP. The finding that that "Gillam Stereo" leads to cortical responses at the same short latencies as disparity based stereopsis indicates that it may partly rely on quite early cortical mechanisms.	[Spang, Karoline; Fahle, Manfred] Univ Bremen, Ctr Cognit Sci, D-28359 Bremen, Germany; [Gillam, Barbara] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Fahle, Manfred] City Univ London, Henry Wellcome Labs Vis Sci, London EC1V 0HB, England	University of Bremen; University of New South Wales Sydney; City University London	Spang, K (corresponding author), Univ Bremen, Ctr Cognit Sci, D-28359 Bremen, Germany.	kspang@uni-bremen.de						ANDERSON BL, 1994, NATURE, V367, P365, DOI 10.1038/367365a0; ANDERSON BL, 1995, PSYCHOL REV, V102, P705, DOI 10.1037/0033-295X.102.4.705; BACH M, 1992, VISION RES, V32, P417, DOI 10.1016/0042-6989(92)90233-9; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Cook M, 2004, J EXP PSYCHOL HUMAN, V30, P92, DOI 10.1037/0096-1523.30.1.92; Fahle M, 2003, VISION RES, V43, P7, DOI 10.1016/S0042-6989(02)00265-1; Gillam B, 1999, VISION RES, V39, P493, DOI 10.1016/S0042-6989(98)00131-X; Gillam B, 1999, VISION RES, V39, P109, DOI 10.1016/S0042-6989(98)00052-2; Gillam B, 2011, VISION 3D ENV, P43; Grove PM, 2005, PERCEPTION, V34, P1083, DOI 10.1068/p5274; Grove PM, 2002, VISION RES, V42, P1859, DOI 10.1016/S0042-6989(02)00083-4; Hakkinen J, 2001, VISION RES, V41, P187, DOI 10.1016/S0042-6989(00)00231-5; Harris JM, 2009, VISION RES, V49, P2666, DOI 10.1016/j.visres.2009.06.021; Herrmann C. S., 2005, EVENT RELATED POTENT, P229; Herrmann CS, 2001, NEUROREPORT, V12, P901, DOI 10.1097/00001756-200104170-00007; JULESZ B, 1980, P NATL ACAD SCI-BIOL, V77, P2348, DOI 10.1073/pnas.77.4.2348; MCKEE SP, 1983, VISION RES, V23, P191, DOI 10.1016/0042-6989(83)90142-6; Mitsudo H, 2005, VISION RES, V45, P1365, DOI 10.1016/j.visres.2004.12.002; NAKAYAMA K, 1990, VISION RES, V30, P1811, DOI 10.1016/0042-6989(90)90161-D; Pianta MJ, 2003, VISION RES, V43, P1, DOI 10.1016/S0042-6989(02)00399-1; Pianta MJ, 2003, VISION RES, V43, P1937, DOI 10.1016/S0042-6989(03)00252-9; Skrandies W, 2001, CLIN ELECTROENCEPHAL, V32, P152, DOI 10.1177/155005940103200310; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; WESEMANN W, 1987, GRAEF ARCH CLIN EXP, V225, P429, DOI 10.1007/BF02334171; YIANNIKAS C, 1983, ELECTROEN CLIN NEURO, V55, P427, DOI 10.1016/0013-4694(83)90131-1	26	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e40562	10.1371/journal.pone.0040562	http://dx.doi.org/10.1371/journal.pone.0040562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876281	Green Published, gold			2022-12-27	WOS:000307184700009
J	Worley, B; Richard, G; Harbison, GS; Powers, R				Worley, Bradley; Richard, Georgia; Harbison, Gerard S.; Powers, Robert			C-13 NMR Reveals No Evidence of n-pi* Interactions in Proteins	PLOS ONE			English	Article							CHEMICAL-SHIFTS; ENERGETICS; SECONDARY; DATABASE; AMIDE; STATE	An n-pi* interaction between neighboring carbonyl groups has been postulated to stabilize protein structures. Such an interaction would affect the C-13 chemical shielding of the carbonyl groups, whose paramagnetic component is dominated by n-pi* and pi-pi* excitations. Model compound calculations indicate that both the interaction energetics and the chemical shielding of the carbonyl group are instead dominated by a classical dipole-dipole interaction. A set of high-resolution protein structures with associated carbonyl C-13 chemical shift assignments verifies this correlation and provides no evidence for an inter-carbonyl n-pi* interaction.	[Worley, Bradley; Richard, Georgia; Harbison, Gerard S.; Powers, Robert] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Worley, B (corresponding author), Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA.	rpowers3@unl.edu	Powers, Robert/AAK-3431-2020	Powers, Robert/0000-0001-9948-6837; Richard, Georgia/0000-0002-7803-621X	National Institute of Allergy and Infectious Diseases [R21AI081154]; National Institutes of Health [RR015468-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081154] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part from the National Institute of Allergy and Infectious Diseases (grant number R21AI081154) to RP. The research was performed in facilities renovated with support from the National Institutes of Health (grant number RR015468-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abragam A., 1961, PRINCIPLES NUCL MAGN; ASAKAWA N, 1992, J AM CHEM SOC, V114, P3261, DOI 10.1021/ja00035a016; Bartlett GJ, 2010, NAT CHEM BIOL, V6, P615, DOI [10.1038/NCHEMBIO.406, 10.1038/nchembio.406]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058; Choudhary A, 2009, J AM CHEM SOC, V131, P7244, DOI 10.1021/ja901188y; Cisnetti F, 2004, CHEMPHYSCHEM, V5, P807, DOI 10.1002/cphc.200301041; De JWH, 1970, MOL PHYS, V18, P31; DEDIOS AC, 1993, SCIENCE, V260, P1491, DOI 10.1126/science.8502992; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Frisch G. W., 2013, GAUSSIAN 09; Gao JM, 2009, NAT STRUCT MOL BIOL, V16, P684, DOI 10.1038/nsmb.1610; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Knudsen Michael, 2010, Human Genomics, V4, P207; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Markwick PRL, 2004, J AM CHEM SOC, V126, P11424, DOI 10.1021/ja047859r; Mera H, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125109; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Pace CN, 2009, NAT STRUCT MOL BIOL, V16, P681, DOI 10.1038/nsmb0709-681; Pearson W R, 2000, Methods Mol Biol, V132, P185; RAMSEY NF, 1950, PHYS REV, V78, P699, DOI 10.1103/PhysRev.78.699; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; SAVITSKY GB, 1965, J PHYS CHEM-US, V69, P3105, DOI 10.1021/j100893a048; Shakhnovich E, 2009, P NATL ACAD SCI USA, V106, P11823, DOI 10.1073/pnas.0906228106; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; Wylie BJ, 2007, J AM CHEM SOC, V129, P5318, DOI 10.1021/ja0701199; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005	32	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42075	10.1371/journal.pone.0042075	http://dx.doi.org/10.1371/journal.pone.0042075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876300	Green Submitted, gold, Green Published			2022-12-27	WOS:000307184700028
J	Mandke, P; Wyatt, N; Fraser, J; Bates, B; Berberich, SJ; Markey, MP				Mandke, Pooja; Wyatt, Nicholas; Fraser, Jillian; Bates, Benjamin; Berberich, Steven J.; Markey, Michael P.			MicroRNA-34a Modulates MDM4 Expression via a Target Site in the Open Reading Frame	PLOS ONE			English	Article							MALIGNANT GLIOMAS; DOWN-REGULATION; SPLICE VARIANT; HDMX GENE; P53; AMPLIFICATION; OVEREXPRESSION; MIR-34A; ACTIVATION; DEGRADATION	Background: MDM4, also called MDMX or HDMX in humans, is an important negative regulator of the p53 tumor suppressor. MDM4 is overexpressed in about 17% of all cancers and more frequently in some types, such as colon cancer or retinoblastoma. MDM4 is known to be post-translationally regulated by MDM2-mediated ubiquitination to decrease its protein levels in response to genotoxic stress, resulting in accumulation and activation of p53. At the transcriptional level, MDM4 gene regulation has been less clearly understood. We have reported that DNA damage triggers loss of MDM4 mRNA and a concurrent increase in p53 activity. These experiments attempt to determine a mechanism for down-regulation of MDM4 mRNA. Methodology/Principal Findings: Here we report that MDM4 mRNA is a target of hsa-mir-34a (miR-34a). MDM4 mRNA contains a lengthy 39 untranslated region; however, we find that it is a miR-34a site within the open reading frame (ORF) of exon 11 that is responsible for the repression. Overexpression of miR-34a, but not a mutant miR-34a, is sufficient to decrease MDM4 mRNA levels to an extent identical to those of known miR-34a target genes. Likewise, MDM4 protein levels are decreased by miR-34a overexpression. Inhibition of endogenous miR-34a increased expression of miR-34a target genes and MDM4. A portion of MDM4 exon 11 containing this 8mer-A1 miR-34a site fused to a luciferase reporter gene is sufficient to confer responsiveness, being inhibited by additional expression of exogenous mir-34a and activated by inhibition of miR34a. Conclusions/Significance: These data establish a mechanism for the observed DNA damage-induced negative regulation of MDM4 and potentially provide a novel means to manipulate MDM4 expression without introducing DNA damage.	[Mandke, Pooja; Wyatt, Nicholas; Fraser, Jillian; Bates, Benjamin; Berberich, Steven J.; Markey, Michael P.] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Mandke, P (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	michael.markey@wright.edu	Mandke, Pooja/AAX-6329-2021	Mandke, Pooja/0000-0001-5410-6968; Markey, Michael/0000-0002-8593-2290	American Cancer Society, Ohio Division	American Cancer Society, Ohio Division(American Cancer Society)	Expression plasmids for miR-34a and mutant miR-34a were kindly provided by Dr. Moshe Oren. This work was supported in part by a grant from the American Cancer Society, Ohio Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Allende-Vega N., 2012, ONCOGENE, P53; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; Bartel F, 2004, VERH DEUT G, V88, P199; Bartel F, 2005, INT J CANCER, V117, P469, DOI 10.1002/ijc.21206; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Garcia D, 2011, GENE DEV, V25, P1746, DOI 10.1101/gad.16722111; Giglio S, 2005, CANCER RES, V65, P9687, DOI 10.1158/0008-5472.CAN-05-0450; Gilkes DM, 2008, MOL CELL BIOL, V28, P1999, DOI 10.1128/MCB.01633-07; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Lal A, 2012, PLOS GENET, V7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Li CG, 2002, MOL CELL BIOL, V22, P7562, DOI 10.1128/MCB.22.21.7562-7571.2002; Li MY, 2011, MOL CELL, V43, P1023, DOI 10.1016/j.molcel.2011.08.020; Mancini F, 2009, CELL CYCLE, V8, P3854, DOI 10.4161/cc.8.23.10089; Markey M, 2008, ONCOGENE, V27, P6657, DOI 10.1038/onc.2008.266; Markey MP, 2011, FRONT BIOSCI-LANDMRK, V16, P1144, DOI 10.2741/3780; Ohtsubo C, 2009, CANCER SCI, V100, P1291, DOI 10.1111/j.1349-7006.2009.01180.x; Ovcharenko D, 2011, EXP HEMATOL, V39, P1030, DOI 10.1016/j.exphem.2011.07.008; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Phillips A, 2010, J BIOL CHEM, V285, P29111, DOI 10.1074/jbc.M110.129726; Rasband W.S., 1997, IMAGEJ; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rickman DS, 2001, CANCER RES, V61, P6885; Riemenschneider MJ, 2003, INT J CANCER, V104, P752, DOI 10.1002/ijc.11023; Riemenschneider MJ, 1999, CANCER RES, V59, P6091; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Takagi S, 2010, J BIOL CHEM, V285, P4415, DOI 10.1074/jbc.M109.085431; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wirsing A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027438; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753	54	70	76	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42034	10.1371/journal.pone.0042034	http://dx.doi.org/10.1371/journal.pone.0042034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870278	gold, Green Published, Green Submitted			2022-12-27	WOS:000307212800054
J	Zarie, ES; Kaidas, V; Gedamu, D; Mishra, YK; Adelung, R; Furkert, FH; Scherliess, R; Steckel, H; Groessner-Schreiber, B				Zarie, Eman S.; Kaidas, Viktor; Gedamu, Dawit; Mishra, Yogendra K.; Adelung, Rainer; Furkert, Franz H.; Scherliess, Regina; Steckel, Hartwig; Groessner-Schreiber, Birte			Solvent Free Fabrication of Micro and Nanostructured Drug Coatings by Thermal Evaporation for Controlled Release and Increased Effects	PLOS ONE			English	Article							DELIVERY; NANOPARTICLES; SOLUBILITY; DEVICES; DESIGN; WATER	Nanostructuring of drug delivery systems offers many promising applications like precise control of dissolution and release kinetics, enhanced activities, flexibility in terms of surface coatings, integration into implants, designing the appropriate scaffolds or even integrating into microelectronic chips etc. for different desired applications. In general such kind of structuring is difficult due to unintentional mixing of chemical solvents used during drug formulations. We demonstrate here the successful solvent-free fabrication of micro-nanostructured pharmaceutical molecules by simple thermal evaporation (TE). The evaporation of drug molecules and their emission to a specific surface under vacuum led to controlled assembling of the molecules from vapour phase to solid phase. The most important aspects of thermal evaporation technique are: solvent-free, precise control of size, possibility of fabricating multilayer/hybrid, and free choice of substrates. This could be shown for twenty eight pharmaceutical substances of different chemical structures which were evaporated on surfaces of titanium and glass discs. Structural investigations of different TE fabricated drugs were performed by atomic force microscopy, scanning electron microscopy and Raman spectroscopy which revealed that these drug substances preserve their structurality after evaporation. Titanium discs coated with antimicrobial substances by thermal evaporation were subjected to tests for antibacterial or antifungal activities, respectively. A significant increase in their antimicrobial activity was observed in zones of inhibition tests compared to controls of the diluted substances on the discs made of paper for filtration. With thermal evaporation, we have successfully synthesized solvent-free nanostructured drug delivery systems in form of multilayer structures and in hybrid drug complexes respectively. Analyses of these substances consolidated that thermal evaporation opens up the possibility to convert dissoluble drug substances into the active forms by their transfer onto a specific surface without the need of their prior dissolution.	[Zarie, Eman S.; Kaidas, Viktor; Gedamu, Dawit; Mishra, Yogendra K.; Adelung, Rainer] Univ Kiel, Inst Mat Sci, D-24098 Kiel, Germany; [Furkert, Franz H.; Scherliess, Regina; Steckel, Hartwig] Univ Kiel, Dept Pharmaceut & Biopharmaceut, Kiel, Germany; [Groessner-Schreiber, Birte] Univ Kiel, Dept Operat Dent & Periodontol, Arnold Heller Kiel, Germany	University of Kiel; University of Kiel; University of Kiel	Zarie, ES (corresponding author), Univ Kiel, Inst Mat Sci, Kaiserstr, D-24098 Kiel, Germany.	ra@tf.uni-kiel.de	Adelung, Rainer/AAU-1027-2021; Mishra, Yogendra Kumar/G-6241-2010	Adelung, Rainer/0000-0002-2617-678X; Mishra, Yogendra Kumar/0000-0002-8786-9379; Scherliess, Regina/0000-0001-8685-5672	Egyptian government; Alexander von Humboldt foundation; Deutsche Forschungsgemeinschaft (DFG); DFG founded Inflammation at Interfaces cluster	Egyptian government; Alexander von Humboldt foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG founded Inflammation at Interfaces cluster	The authors gratefully acknowledge several grants: E. S. Z. a Ph. D. grant from Egyptian government, Y. K. M. a postdoctoral grant from Alexander von Humboldt foundation and R. A. a Heisenberg Professorship by the Deutsche Forschungsgemeinschaft (DFG). Furthermore, R. A. wants to thank the DFG founded Inflammation at Interfaces cluster for its support.	Bergstrom CAS, 2007, J MED CHEM, V50, P5858, DOI 10.1021/jm0706416; Chrisey DB, 2003, CHEM REV, V103, P553, DOI 10.1021/cr010428w; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Derle D, 2010, INT J CURRENT PHARM, V2, P10; Ginty PJ, 2005, MATER TODAY, V8, P42, DOI 10.1016/S1369-7021(05)71036-1; Good DJ, 2009, CRYST GROWTH DES, V9, P2252, DOI 10.1021/cg801039j; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0; Katz HE, 2009, ANNU REV MATER RES, V39, P71, DOI 10.1146/annurev-matsci-082908-145433; Kreuter J, 2008, TUMORI J, V94, P271; Kulkarni AP, 2004, CHEM MATER, V16, P4556, DOI 10.1021/cm0494731; Langer R, 1998, NATURE, V392, P5; Lipinski CA, 2004, BIOTECH PHARM ASPECT, V1, P93; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Mattox D. M., 2003, FDN VACUUM COATING T; Merisko-Liversidge EM, 2008, TOXICOL PATHOL, V36, P43, DOI 10.1177/0192623307310946; Mishima K, 2008, ADV DRUG DELIVER REV, V60, P411, DOI 10.1016/j.addr.2007.02.003; Montali A, 2006, INJURY, V37, P81, DOI 10.1016/j.injury.2006.04.013; Nakazawa G, 2008, NAT CLIN PRACT CARD, V5, P1, DOI 10.1038/ncpcardio1093; Patel R.P., 2009, INDIAN J SCI TECHNOL, V2, P44, DOI 10.17485/ijst/2009/v2i10.3; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Pierige F, 2008, ADV DRUG DELIVER REV, V60, P286, DOI 10.1016/j.addr.2007.08.029; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4; Takagi T, 2006, MOL PHARMACEUT, V3, P631, DOI 10.1021/mp0600182; Urban GA, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/1/012001; Vehring R, 2008, PHARM RES-DORDR, V25, P999, DOI 10.1007/s11095-007-9475-1; Venables J A, 2000, INTRO SURFACE THIN F; Wang WC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.225504; Weszka J., 2009, J ACHIEVEMENTS MAT M, V35, P29; Xinming Li, 2008, Cont Lens Anterior Eye, V31, P57, DOI 10.1016/j.clae.2007.09.002; Yang YZ, 2008, VACUUM, V83, P569, DOI 10.1016/j.vacuum.2008.04.062; Zaporojtchenko V, 2006, NANOTECHNOLOGY, V17, P4904, DOI 10.1088/0957-4484/17/19/020; Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463	33	17	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40746	10.1371/journal.pone.0040746	http://dx.doi.org/10.1371/journal.pone.0040746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870203	Green Submitted, Green Published, gold			2022-12-27	WOS:000307212800009
J	Lin, S; Gu, HP; Xu, M; Cui, XJ; Zhang, YY; Gao, W; Yuan, G				Lin, Sen; Gu, Huiping; Xu, Ming; Cui, Xiaojie; Zhang, Youyi; Gao, Wei; Yuan, Gu			The Formation and Stabilization of a Novel G-Quadruplex in the 5 '-Flanking Region of the Relaxin Gene	PLOS ONE			English	Article							TELOMERIC G-QUADRUPLEX; RELEVANT G-QUADRUPLEX; AUTOMATED DOCKING; BERBERINE DERIVATIVES; CIRCULAR-DICHROISM; DNA; BINDING; RECOGNITION; PROMOTER; TARGET	It has been reported that binding of STAT3 protein to the 5'-flanking region of the relaxin gene may result in downregulation of the relaxin expression. There is a Guanine(G)-rich segment located in about 3.8 Kb upstream of the relaxin gene and very close to the STAT3's binding site. In our study, NMR spectroscopy revealed the formation of G-quadruplex by this G-rich strand, and the result was confirmed by ESI mass spectrometry and CD spectroscopy. The theoretical structure of RLX G-quadruplex was constructed and refined by molecular modeling. When this relaxin G-quadruplex was stabilized by berberine(Delta Tm=10 degrees C), a natural alkaloid from a Chinese herb, the gene expression could be up-regulated in a dose-dependent manner which was proved by luciferase assay. This result is different from the general G-quadruplex function that inhibiting the telomere replication or down-regulating many oncogenes expression. Therefore, our study reported a novel G- quadruplex in the relaxin gene and complemented the regulation mechanism about gene expression by G- quadruplexes.	[Lin, Sen; Cui, Xiaojie; Yuan, Gu] Peking Univ, Beijing Natl Lab Mol Sci, Key Lab Bioorgan Chem & Mol Engn, Minist Educ,Dept Chem Biol,Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Gu, Huiping; Xu, Ming; Zhang, Youyi; Gao, Wei] Peking Univ, Key Lab Mol Cardiovasc Sci, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Minist Hlth,Hosp 3,Minist Educ,Inst Vasc Med, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Peking University; Peking University	Lin, S (corresponding author), Peking Univ, Beijing Natl Lab Mol Sci, Key Lab Bioorgan Chem & Mol Engn, Minist Educ,Dept Chem Biol,Coll Chem & Mol Engn, Beijing 100871, Peoples R China.	xuminghi@bjmu.edu.cn; guyuan@pku.edu.cn			National Natural Science Foundation of China [90913004, 81070196]; Program for New Century Excellent Talents in University; Beijing Talents Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Beijing Talents Foundation	This work was supported by the National Natural Science Foundation of China (no. 90913004 and 81070196) and Program for New Century Excellent Talents in University and Beijing Talents Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Arora A, 2008, FEBS J, V275, P3971, DOI 10.1111/j.1742-4658.2008.06541.x; Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557; Bishop GR, 2007, BIOPHYS CHEM, V126, P165, DOI 10.1016/j.bpc.2006.07.009; BRYANTGREENWOOD GD, 1994, ENDOCR REV, V15, P5, DOI 10.1210/er.15.1.5; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheatham TE, 2001, BIOPOLYMERS, V56, P232; Cosconati S, 2009, J AM CHEM SOC, V131, P16336, DOI 10.1021/ja9063662; da Silva MW, 2007, METHODS, V43, P264, DOI 10.1016/j.ymeth.2007.05.007; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P2440, DOI 10.1093/nar/gkm009; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; Du XJ, 2003, CARDIOVASC RES, V57, P395, DOI 10.1016/S0008-6363(02)00663-6; Franceschin M, 2006, BIOORG MED CHEM LETT, V16, P1707, DOI 10.1016/j.bmcl.2005.12.001; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Grand CL, 2002, EUR J CANCER, V38, pS106; Guo K, 2008, NUCLEIC ACIDS RES, V36, P4598, DOI 10.1093/nar/gkn380; Han HY, 2000, TRENDS PHARMACOL SCI, V21, P136, DOI 10.1016/S0165-6147(00)01457-7; Hounsou C, 2007, CHEMMEDCHEM, V2, P655, DOI 10.1002/cmdc.200600286; Keniry MA, 2001, BIOPOLYMERS, V56, P123, DOI 10.1002/1097-0282(2000/2001)56:3<123::AID-BIP10010>3.0.CO;2-3; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Li HH, 2009, CHEM-EUR J, V15, P2445, DOI 10.1002/chem.200801922; Liao WQ, 2005, FEBS J, V272, P1845, DOI 10.1111/j.1742-4658.2005.04614.x; Liu XH, 2010, CARDIOVASC RES, V88, P150, DOI 10.1093/cvr/cvq181; Ma Y, 2009, BIOORG MED CHEM LETT, V19, P3414, DOI 10.1016/j.bmcl.2009.05.030; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Mergny JL, 1998, NAT MED, V4, P1366, DOI 10.1038/3949; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muller S, 2010, NAT CHEM, V2, P1095, DOI 10.1038/NCHEM.842; Negri AL, 2004, J NEPHROL, V17, P496; Neidle S, 2002, NAT REV DRUG DISCOV, V1, P383, DOI 10.1038/nrd793; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phan AT, 2010, FEBS J, V277, P1107, DOI 10.1111/j.1742-4658.2009.07464.x; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Ranjan N, 2010, BIOCHEMISTRY-US, V49, P9891, DOI 10.1021/bi101517e; Rizzo A, 2009, NUCLEIC ACIDS RES, V37, P5353, DOI 10.1093/nar/gkp582; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sherwood O. David, 1994, P861; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Soloff MS, 2003, GENE, V323, P149, DOI 10.1016/j.gene.2003.09.015; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913; Zhang WJ, 2007, BIOORGAN MED CHEM, V15, P5493, DOI 10.1016/j.bmc.2007.05.050; Zhou J, 2007, CHEM-EUR J, V13, P945, DOI 10.1002/chem.200600424	45	19	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31201	10.1371/journal.pone.0031201	http://dx.doi.org/10.1371/journal.pone.0031201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22876305	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700031
J	Jin, HY; Song, B; Oudit, GY; Davidge, ST; Yu, HM; Jiang, YY; Gao, PJ; Zhu, DL; Ning, G; Kassiri, Z; Penninger, JM; Zhong, JC				Jin, Hai-Yan; Song, Bei; Oudit, Gavin Y.; Davidge, Sandra T.; Yu, Hui-Min; Jiang, Yan-Yan; Gao, Ping-Jin; Zhu, Ding-Liang; Ning, Guang; Kassiri, Zamaneh; Penninger, Josef M.; Zhong, Jiu-Chang			ACE2 Deficiency Enhances Angiotensin II-Mediated Aortic Profilin-1 Expression, Inflammation and Peroxynitrite Production	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CONVERTING ENZYME 2; SPONTANEOUSLY HYPERTENSIVE-RATS; VASCULAR INFLAMMATION; OXIDATIVE STRESS; NAD(P)H OXIDASE; NULL MICE; OVEREXPRESSION; HYPERTROPHY; DYSFUNCTION	Inflammation and oxidative stress play a crucial role in angiotensin (Ang) II-mediated vascular injury. Angiotensin-converting enzyme 2 (ACE2) has recently been identified as a specific Ang II-degrading enzyme but its role in vascular biology remains elusive. We hypothesized that loss of ACE2 would facilitate Ang II-mediated vascular inflammation and peroxynitrite production. 10-week wildtype (WT, Ace2(+/y)) and ACE2 knockout (ACE2KO, Ace2(-/y)) mice received with mini-osmotic pumps with Ang II (1.5 mg.kg(-1).d(-1)) or saline for 2 weeks. Aortic ACE2 protein was obviously reduced in WT mice in response to Ang II related to increases in profilin-1 protein and plasma levels of Ang II and Ang-(1-7). Loss of ACE2 resulted in greater increases in Ang II-induced mRNA expressions of inflammatory cytokines monocyte chemoattractant protein-1 (MCP-1), interleukin (IL)-1 beta, and IL-6 without affecting tumor necrosis factor-alpha in aortas of ACE2KO mice. Furthermore, ACE2 deficiency led to greater increases in Ang II-mediated profilin-1 expression, NADPH oxidase activity, and superoxide and peroxynitrite production in the aortas of ACE2KO mice associated with enhanced phosphorylated levels of Akt, p70S6 kinase, extracellular signal-regulated kinases (ERK1/2) and endothelial nitric oxide synthase (eNOS). Interestingly, daily treatment with AT1 receptor blocker irbesartan (50 mg/kg) significantly prevented Ang II-mediated aortic profilin-1 expression, inflammation, and peroxynitrite production in WT mice with enhanced ACE2 levels and the suppression of the Akt-ERK-eNOS signaling pathways. Our findings reveal that ACE2 deficiency worsens Ang II-mediated aortic inflammation and peroxynitrite production associated with the augmentation of profilin-1 expression and the activation of the Akt-ERK-eNOS signaling, suggesting potential therapeutic approaches by enhancing ACE2 action for patients with vascular diseases.	[Jin, Hai-Yan; Song, Bei; Gao, Ping-Jin; Zhu, Ding-Liang; Ning, Guang; Zhong, Jiu-Chang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Jin, Hai-Yan; Song, Bei; Gao, Ping-Jin; Zhu, Ding-Liang; Zhong, Jiu-Chang] Shanghai Res Inst Hypertens, Shanghai Key Lab Vasc Biol, Shanghai, Peoples R China; [Oudit, Gavin Y.; Davidge, Sandra T.; Jiang, Yan-Yan; Kassiri, Zamaneh] Univ Alberta, Dept Med, Div Cardiol, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Davidge, Sandra T.; Jiang, Yan-Yan] Univ Alberta, Dept Obstet, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Davidge, Sandra T.; Jiang, Yan-Yan] Univ Alberta, Dept Gynecol, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Yu, Hui-Min] Guangdong Gen Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Yu, Hui-Min] Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria	Chinese Academy of Sciences; Shanghai Jiao Tong University; University of Alberta; University of Alberta; University of Alberta; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Jin, HY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China.	jiuchangzhong@yahoo.com.cn	Penninger, Josef M/I-6860-2013; Buchko, Garry/G-6173-2015	Penninger, Josef M/0000-0002-8194-3777; Davidge, Sandra/0000-0002-5559-4905; Buchko, Garry/0000-0002-3639-1061	National Natural Science Foundation of China [30973522, 81170246]; Shanghai Pujiang Talents Program [11PJ1408300]; Health Bureau of Shanghai [2011347]; Canadian Institute for Health Research [86602, 84279]; Alberta Innovates-Health Solutions; Shanghai Jiao Tong University School of Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Talents Program(Shanghai Pujiang Program); Health Bureau of Shanghai; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Shanghai Jiao Tong University School of Medicine	This work was supported by National Natural Science Foundation of China (Grants. 30973522 & 81170246 to JCZ), Shanghai Pujiang Talents Program (11PJ1408300 to JCZ), Scientific Research Project of Health Bureau of Shanghai (2011347 to HYJ), the Canadian Institute for Health Research (Grants 86602 to GYO, 84279 to ZK), the Alberta Innovates-Health Solutions (JCZ and GYO), and "New Hundred Talents Program" of Shanghai Jiao Tong University School of Medicine to JCZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027923; Batlle D, 2010, CIRC RES, V107, P822, DOI 10.1161/CIRCRESAHA.110.229831; Bodiga S, 2011, CARDIOVASC RES, V91, P151, DOI 10.1093/cvr/cvr036; Briones AM, 2010, CURR HYPERTENS REP, V12, P135, DOI 10.1007/s11906-010-0100-z; Caglayan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013608; Cheng JF, 2011, VASC PHARMACOL, V55, P34, DOI 10.1016/j.vph.2011.04.003; Clarke NE, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/307315; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Ebrahimian T, 2011, HYPERTENSION, V57, P245, DOI 10.1161/HYPERTENSIONAHA.110.159889; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Gragasin FS, 2003, ARTERIOSCL THROM VAS, V23, P38, DOI 10.1161/01.ATV.0000047868.93732.B7; Guo YJ, 2008, ARCH MED RES, V39, P149, DOI 10.1016/j.arcmed.2007.07.010; Hassona MDH, 2011, J CARDIOVASC PHARM, V57, P550, DOI 10.1097/FJC.0b013e318212b1c2; Horrevoets AJG, 2007, CIRC RES, V101, P328, DOI 10.1161/CIRCRESAHA.107.158881; Ishibashi M, 2004, CIRC RES, V94, P1203, DOI 10.1161/01.RES.0000126924.23467.A3; Kagota S, 2009, J PHARMACOL SCI, V109, P556, DOI 10.1254/jphs.08273FP; Kasina S, 2006, NITRIC OXIDE-BIOL CH, V14, P65, DOI 10.1016/j.niox.2005.09.008; Kassiri Z, 2009, CIRC-HEART FAIL, V2, P446, DOI 10.1161/CIRCHEARTFAILURE.108.840124; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Moustafa-Bayoumi M, 2007, J BIOL CHEM, V282, P37632, DOI 10.1074/jbc.M703227200; Oudit GY, 2007, CARDIOVASC RES, V75, P29, DOI 10.1016/j.cardiores.2007.04.007; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Romeo GR, 2007, CIRC RES, V101, P357, DOI 10.1161/CIRCRESAHA.107.151399; Schiffrin EL, 2012, HYPERTENSION, V59, P367, DOI 10.1161/HYPERTENSIONAHA.111.187021; Sriramula S, 2011, CARDIOVASC RES, V92, P401, DOI 10.1093/cvr/cvr242; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Wind S, 2010, HYPERTENSION, V56, P490, DOI 10.1161/HYPERTENSIONAHA.109.149187; Xia HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022682; Zhong JC, 2008, BRIT J PHARMACOL, V153, P66, DOI 10.1038/sj.bjp.0707482; Zhong JC, 2004, HYPERTENSION, V44, P907, DOI 10.1161/01.HYP.0000146400.57221.74; Zhong JC, 2007, CARDIOVASC RES, V74, P388, DOI 10.1016/j.cardiores.2007.02.002; Zhong JC, 2011, REGUL PEPTIDES, V166, P90, DOI 10.1016/j.regpep.2010.09.005; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244; Zhong JC, 2010, CIRCULATION, V122, P717, DOI 10.1161/CIRCULATIONAHA.110.955369	35	71	77	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38502	10.1371/journal.pone.0038502	http://dx.doi.org/10.1371/journal.pone.0038502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22879982	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343900051
J	Xu, D; Gao, ZQ; Zhang, XW; Fan, X; Wang, YT; Li, DM; Wang, W; Zhuang, ZM; Ye, NH				Xu, Dong; Gao, Zhengquan; Zhang, Xiaowen; Fan, Xiao; Wang, Yitao; Li, Demao; Wang, Wei; Zhuang, Zhimeng; Ye, Naihao			Allelopathic Interactions between the Opportunistic Species Ulva prolifera and the Native Macroalga Gracilaria lichvoides	PLOS ONE			English	Article							RED SEAWEED; GROWTH; EPIPHYTES; CONFERTA; CHLOROPHYTA; RHODOPHYTA; INVASION; LACTUCA	Allelopathy, one type of direct plant competition, can be a potent mechanism through which plant communities are structured. The aim of this study was to determine whether allelopathic interactions occur between the opportunistic green tide-forming species Ulva prolifera and the native macroalga Gracilaria lichvoides, both of which were collected from the coastline of East China sea. In laboratory experiments, the presence of G. lichvoides at 1.25 g wet weight L-1 significantly inhibited growth and photosynthesis of U. prolifera at concentrations of 1.25, 2.50, and 3.75 g wet weight L-1 (p < 0.05) in both semi-continuous co-culture assays and in co-culture assays without nutrient supplementation. In contrast, although U. prolifera had a density effect on G. lichvoides, the differences among treatments were not significant (p > 0.05). Culture medium experiments further confirmed that some allelochemicals may be released by both of the tested macroalgae, and these could account for the observed physiological inhibition of growth and photosynthesis. Moreover, the native macroalgae G. lichvoides was a stronger competitor than the opportunistic species U. prolifera. Collectively, the results of the present study represent a significant advance in exploring ecological questions about the effects of green tide blooms on the macroalgal community.	[Xu, Dong; Zhang, Xiaowen; Fan, Xiao; Wang, Wei; Zhuang, Zhimeng; Ye, Naihao] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Gao, Zhengquan] Shandong Univ Technol, Sch Life Sci, Zibo, Peoples R China; [Wang, Yitao] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Peoples R China; [Li, Demao] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin Key Lab Ind Biol Syst & Bioproce Engn, Tianjin, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Shandong University of Technology; Qingdao Agricultural University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Xu, D (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China.	yenh@ysfri.ac.cn			Shandong Science and Technology plan project [2011GHY11528]; Hi-Tech Research and Development Program (863) of China [2012AA052103]; Specialized Fund for the Basic Research Operating expenses Program [20603022012004, 2010-ts-03]; National Natural Science Foundation of China [41176153]; Natural Science Foundation of Shandong Province [2009ZRA02075]; Qingdao Municipal Science and Technology plan project [11-3-1-5-hy]; National Marine Public Welfare Research Project [200805069]; National Science & Technology Pillar Program [2008BAD95B11, 2010BAC68B03]	Shandong Science and Technology plan project; Hi-Tech Research and Development Program (863) of China(National High Technology Research and Development Program of China); Specialized Fund for the Basic Research Operating expenses Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Qingdao Municipal Science and Technology plan project; National Marine Public Welfare Research Project; National Science & Technology Pillar Program	This work was supported by Shandong Science and Technology plan project (2011GHY11528), the Hi-Tech Research and Development Program (863) of China (2012AA052103), the Specialized Fund for the Basic Research Operating expenses Program (20603022012004, 2010-ts-03), National Natural Science Foundation of China (41176153), Natural Science Foundation of Shandong Province (2009ZRA02075), Qingdao Municipal Science and Technology plan project (11-3-1-5-hy), National Marine Public Welfare Research Project (200805069), and the National Science & Technology Pillar Program, (2008BAD95B11, 2010BAC68B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsler CD, 2006, ADV BOT RES, V43, P1, DOI 10.1016/S0065-2296(05)43001-3; Blunt JW, 2010, NAT PROD REP, V27, P165, DOI 10.1039/b906091j; Charlier Roger H., 2007, Environmental Research, Engineering and Management, V41, P52; Fletcher RL., 1996, MARINE BENTHIC VEGET, P7, DOI [10.1007/978-3-642-61398-2_2, DOI 10.1007/978-3-642-61398-2_2]; Frankenstein G., 2000, BLOOMS ULVOIDS PUGET; Friedlander M, 1996, J APPL PHYCOL, V8, P21, DOI 10.1007/BF02186217; FRIEDLANDER M, 1991, BOT MAR, V34, P161, DOI 10.1515/botm.1991.34.3.161; Huo YZ, 2011, HARMFUL ALGAE, V10, P411, DOI 10.1016/j.hal.2011.02.003; Jarchow ME, 2009, PLANT ECOL, V204, P113, DOI 10.1007/s11258-009-9573-8; Ji XQ, 2011, CHIN J OCEANOL LIMN, V29, P840, DOI 10.1007/s00343-011-0512-x; Klein J, 2005, MAR ECOL PROG SER, V290, P79, DOI 10.3354/meps290079; Lapointe BE, 2010, HARMFUL ALGAE, V9, P1, DOI 10.1016/j.hal.2009.06.001; Leliaert F, 2008, MARINE POLLUTION B, V56, P15; Leliaert F, 2009, PHYCOL RES, V57, P147, DOI 10.1111/j.1440-1835.2009.00532.x; Liu DY, 2009, MAR POLLUT BULL, V58, P888, DOI 10.1016/j.marpolbul.2009.01.013; Liu F, 2010, J APPL PHYCOL, V22, P531, DOI 10.1007/s10811-009-9489-7; Lundholm N, 2005, MAR ECOL PROG SER, V288, P21, DOI 10.3354/meps288021; Macias Francisco A., 2008, Phytochemistry Reviews, V7, P155, DOI 10.1007/s11101-007-9065-1; Mineur F, 2008, J MAR BIOL ASSOC UK, V88, P693, DOI 10.1017/S0025315408001409; Nan CR, 2008, AQUAT BOT, V89, P9, DOI 10.1016/j.aquabot.2008.01.005; Pang SJ, 2010, MAR ENVIRON RES, V69, P207, DOI 10.1016/j.marenvres.2009.10.007; Pereira R. C., 2008, P25, DOI 10.1007/978-3-540-74181-7_2; Raffaelli DG, 1998, OCEANOGR MAR BIOL<D>, V36, P97; Schmidt LE, 2001, MAR ECOL PROG SER, V216, P67, DOI 10.3354/meps216067; SVIRSKI E, 1993, HYDROBIOLOGIA, V261, P391; Tait LW, 2011, MAR ECOL PROG SER, V421, P97, DOI 10.3354/meps08909; Tang YZ, 2011, HARMFUL ALGAE, V10, P480, DOI 10.1016/j.hal.2011.03.003; Valentine JP, 2003, J EXP MAR BIOL ECOL, V295, P63, DOI 10.1016/S0022-0981(03)00272-7; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; Walters LJ, 2006, FRONT ECOL ENVIRON, V4, P75, DOI 10.1890/1540-9295(2006)004[0075:EACUDO]2.0.CO;2; Wang RJ, 2007, J SEA RES, V58, P189, DOI 10.1016/j.seares.2007.03.002; Wang Y, 2007, AQUAT BOT, V86, P139, DOI 10.1016/j.aquabot.2006.09.013; Wang Y, 2009, J APPL PHYCOL, V21, P375, DOI 10.1007/s10811-008-9380-y; Wasson K, 2005, BIOL INVASIONS, V7, P935, DOI 10.1007/s10530-004-2995-2; White LF, 2011, J EXP MAR BIOL ECOL, V405, P111, DOI 10.1016/j.jembe.2011.05.024; Williams SL, 2007, ANNU REV ECOL EVOL S, V38, P327, DOI 10.1146/annurev.ecolsys.38.091206.095543; Wonham MJ, 2006, ECOL LETT, V9, P663, DOI 10.1111/j.1461-0248.2006.00913.x; Worm B, 2001, OECOLOGIA, V128, P281, DOI 10.1007/s004420100648; Ye NH, 2011, ECOL RES, V26, P477, DOI 10.1007/s11284-011-0821-8; Zhang XW, 2011, LIMNOL OCEANOGR, V56, P233, DOI 10.4319/lo.2011.56.1.0233; Zhang XW, 2010, J APPL PHYCOL, V22, P173, DOI 10.1007/s10811-009-9437-6	41	66	68	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33648	10.1371/journal.pone.0033648	http://dx.doi.org/10.1371/journal.pone.0033648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496758	gold, Green Published, Green Submitted			2022-12-27	WOS:000305014500014
J	Zhang, X; Mao, Y; Huang, ZX; Qu, M; Chen, J; Ding, SX; Hong, JN; Sun, TT				Zhang, Xiang; Mao, Yong; Huang, Zixia; Qu, Meng; Chen, Jun; Ding, Shaoxiong; Hong, Jingni; Sun, Tiantian			Transcriptome Analysis of the Octopus vulgaris Central Nervous System	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GROWTH-PERFORMANCE; ENDOTHELIAL-CELLS; MOLECULAR ANATOMY; TISSUES; IDENTIFICATION; SYNAPTOTAGMIN; LOCALIZATION; PERMEABILITY; MICROVESSELS	Background: Cephalopoda are a class of Mollusca species found in all the world's oceans. They are an important model organism in neurobiology. Unfortunately, the lack of neuronal molecular sequences, such as ESTs, transcriptomic or genomic information, has limited the development of molecular neurobiology research in this unique model organism. Results: With high-throughput Illumina Solexa sequencing technology, we have generated 59,859 high quality sequences from 12,918,391 paired-end reads. Using BLASTx/BLASTn, 12,227 contigs have blast hits in the Swissprot, NR protein database and NT nucleotide database with E-value cutoff 1e(-5). The comparison between the Octopus vulgaris central nervous system (CNS) library and the Aplysia californica/Lymnaea stagnalis CNS ESTs library yielded 5.93%/13.45% of O. vulgaris sequences with significant matches (1e(-5)) using BLASTn/tBLASTx. Meanwhile the hit percentage of the recently published Schistocerca gregaria, Tilapia or Hirudo medicinalis CNS library to the O. vulgaris CNS library is 21.03%-46.19%. We constructed the Phylogenetic tree using two genes related to CNS function, Synaptotagmin-7 and Synaptophysin. Lastly, we demonstrated that O. vulgaris may have a vertebrate-like Blood-Brain Barrier based on bioinformatic analysis. Conclusion: This study provides a mass of molecular information that will contribute to further molecular biology research on O. vulgaris. In our presentation of the first CNS transcriptome analysis of O. vulgaris, we hope to accelerate the study of functional molecular neurobiology and comparative evolutionary biology.	[Chen, Jun; Ding, Shaoxiong] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Zhang, Xiang; Qu, Meng; Ding, Shaoxiong] Xiamen Univ, Lab Marine Biodivers & Global Change, Xiamen, Peoples R China; [Zhang, Xiang; Mao, Yong; Huang, Zixia; Qu, Meng; Chen, Jun; Ding, Shaoxiong; Hong, Jingni; Sun, Tiantian] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Zhang, X (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	sxding@xmu.edu.cn	Huang, Zixia/AAO-6936-2021; Ding, SX/G-4137-2010; zhang, menghui/Q-3752-2016; Xu, Jia/GSD-6115-2022	Li, Xiaoying/0000-0002-9383-5757; zhang, menghui/0000-0002-9274-487X; Huang, Zixia/0000-0002-1298-0486; Zhang, Xu/0000-0003-2406-9478; Xu, Jia/0000-0002-3341-7668	National fund for oceanography research in Public Interest [201005013]; National Key Technology RD Program [2011BAD13]	National fund for oceanography research in Public Interest; National Key Technology RD Program(National Key Technology R&D Program)	This work was supported by the National fund for oceanography research in Public Interest (201005013) and the National Key Technology R&D Program (2011BAD13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT VR, 1987, J BIOL CHEM, V262, P9404; Begley DJ, 1996, J PHARM PHARMACOL, V48, P136, DOI 10.1111/j.2042-7158.1996.tb07112.x; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Cha SH, 2001, MOL PHARMACOL, V59, P1277, DOI 10.1124/mol.59.5.1277; Choi YK, 2008, BMB REP, V41, P345, DOI 10.5483/BMBRep.2008.41.5.345; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Erickson Kathryn K., 2007, Angiogenesis, V10, P103, DOI 10.1007/s10456-007-9067-z; Feng ZP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-451; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Gutnick T, 2011, CURR BIOL, V21, P460, DOI 10.1016/j.cub.2011.01.052; HARDEBO JE, 1980, ANN NEUROL, V8, P1, DOI 10.1002/ana.410080102; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Hormiga JA, 2010, J BIOTECHNOL, V149, P209, DOI 10.1016/j.jbiotec.2009.12.008; KALARIA RN, 1987, J NEUROCHEM, V49, P856, DOI 10.1111/j.1471-4159.1987.tb00973.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lee BY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-278; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Macagno ER, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-407; Monteiro A, 2011, HARMFUL ALGAE, V10, P732, DOI 10.1016/j.hal.2011.06.004; Morita T, 2010, MAR POLLUT BULL, V60, P1193, DOI 10.1016/j.marpolbul.2010.03.031; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Perales-Raya C, 2010, FISH RES, V106, P171, DOI 10.1016/j.fishres.2010.05.003; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Prato E, 2010, AQUACULTURE, V309, P203, DOI 10.1016/j.aquaculture.2010.09.036; Quintana D, 2008, AQUACULTURE, V280, P161, DOI 10.1016/j.aquaculture.2008.04.017; Raimundo J, 2010, CHEMOSPHERE, V81, P1314, DOI 10.1016/j.chemosphere.2010.08.029; Raimundo J, 2010, COMP BIOCHEM PHYS C, V152, P139, DOI 10.1016/j.cbpc.2010.03.009; Raimundo J, 2010, ECOTOX ENVIRON SAFE, V73, P1543, DOI 10.1016/j.ecoenv.2010.07.034; Raimundo J, 2010, ENVIRON POLLUT, V158, P2094, DOI 10.1016/j.envpol.2010.03.005; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Seixas P, 2008, AQUACULTURE, V283, P83, DOI 10.1016/j.aquaculture.2008.06.019; Seixas P, 2010, AQUACULTURE, V300, P156, DOI 10.1016/j.aquaculture.2009.12.021; Shih JC, 2004, CURR MED CHEM, V11, P1995, DOI 10.2174/0929867043364757; Shomrat T, 2010, NEUROSCIENCE, V169, P52, DOI 10.1016/j.neuroscience.2010.04.050; Simionescu M, 2002, MICROSC RES TECHNIQ, V57, P269, DOI 10.1002/jemt.10086; Sobrino I, 2011, FISH RES, V108, P283, DOI 10.1016/j.fishres.2010.12.022; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Ueno M, 2007, CURR MED CHEM, V14, P1199, DOI 10.2174/092986707780597943; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vargas-Yanez M, 2009, FISH RES, V99, P159, DOI 10.1016/j.fishres.2009.05.013; Vazquez-Rowe I, 2012, MAR POLICY, V36, P180, DOI 10.1016/j.marpol.2011.05.002; Villanueva R, 2009, AQUACULTURE, V286, P277, DOI 10.1016/j.aquaculture.2008.09.032; Vorbrodt AW, 2008, BRAIN CELL BIOL, V36, P203, DOI 10.1007/s11068-008-9038-3; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; Weksler BB, 2005, FASEB J; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng J, 2011, PLOS ONE, V6; Zheng W, 2003, TOXICOL APPL PHARM, V192, P1, DOI 10.1016/S0041-008X(03)00251-5; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	59	285	298	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40320	10.1371/journal.pone.0040320	http://dx.doi.org/10.1371/journal.pone.0040320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768275	Green Submitted, Green Published, gold			2022-12-27	WOS:000305892100249
J	Strode, C; de Melo-Santos, M; Magalhaes, T; Araujo, A; Ayres, C				Strode, Clare; de Melo-Santos, Maria; Magalhaes, Tereza; Araujo, Ana; Ayres, Contancia			Expression Profile of Genes during Resistance Reversal in a Temephos Selected Strain of the Dengue Vector, Aedes aegypti	PLOS ONE			English	Article							INSECTICIDE-RESISTANCE; ANOPHELES-GAMBIAE; DETOXIFICATION GENES; CULEX-QUINQUEFASCIATUS; LARVAL TOLERANCE; FIELD-EVALUATION; MALARIA VECTORS; MOSQUITO; CULICIDAE; DIPTERA	Background: The mosquito Aedes aegypti is one of the most important disease vectors because it transmits two major arboviruses, dengue and yellow fever, which cause significant global morbidity and mortality. Chemical insecticides form the cornerstone of vector control. The organophosphate temephos a larvicide recommended by WHO for controlling Ae. aegypti, however, resistance to this compound has been reported in many countries, including Brazil. Methodology/Principal Findings: The aim of this study was to identify genes implicated in metabolic resistance in an Ae. aegypti temephos resistant strain, named RecR, through microarray analysis. We utilized a custom 'Ae. aegypti detox chip' and validated microarray data through RT-PCR comparing susceptible and resistant individuals. In addition, we analyzed gene expression in 4th instar larvae from a reversed susceptible strain (RecRev), exposed and unexposed to temephos. The results obtained revealed a set of 13 and 6 genes significantly over expressed in resistant adult mosquitoes and larvae, respectively. One of these genes, the cytochrome P450 CYP6N12, was up-regulated in both stages. RT-PCR confirmed the microarray results and, additionally, showed no difference in gene expression between temephos exposed and unexposed RecRev mosquitoes. This suggested that the differences in the transcript profiles among the strains are heritable due to a selection process and are not caused by immediate insecticide exposure. Reversal of temephos resistance was demonstrated and, importantly, there was a positive correlation between a decrease in the resistance ratio and an accompanying decrease in the expression levels of previously over expressed genes. Some of the genes identified here have also been implicated in metabolic resistance in other mosquito species and insecticide resistant populations of Ae. aegypti. Conclusions/Significance: The identification of gene expression signatures associated to insecticide resistance and their suppression could greatly aid the development of improved strategies of vector control.	[Strode, Clare] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [de Melo-Santos, Maria; Magalhaes, Tereza; Araujo, Ana; Ayres, Contancia] Ctr Pesquisas Aggeu Magalhaes FIOCRUZ, Dept Entomol, Recife, PE, Brazil	Liverpool School of Tropical Medicine; University of Liverpool; Fundacao Oswaldo Cruz	Strode, C (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England.	c.strode@liv.ac.uk	Magalhaes, Tereza/V-6632-2019; Ball, Becky/E-6573-2011; Magalhaes, Catarina/A-6836-2016	Strode, Clare/0000-0003-2833-8073; Cary, Stephen/0000-0002-2876-2387; Ball, Becky/0000-0001-8592-1316; Magalhaes, Catarina/0000-0001-9576-2398; Ruprecht, Ulrike/0000-0002-0898-7677	National Council for Scientific and Technological Development 384 (CNPq Pronex grant) [550116/2010-9]; Fundacao de Amparo a Ciencia e Tecnologia do 385 Estado de Pernambuco (FACEPE) [APQ 1361-4.00/08]	National Council for Scientific and Technological Development 384 (CNPq Pronex grant); Fundacao de Amparo a Ciencia e Tecnologia do 385 Estado de Pernambuco (FACEPE)	This work was funded by National Council for Scientific and Technological Development 384 (CNPq Pronex grant 550116/2010-9) and Fundacao de Amparo a Ciencia e Tecnologia do 385 Estado de Pernambuco (FACEPE, Grant ID: APQ 1361-4.00/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham G, 2011, TROP MED INT HEALTH, V16, P492, DOI 10.1111/j.1365-3156.2010.02717.x; Boyer S, 2006, ENVIRON TOXICOL CHEM, V25, P470, DOI 10.1897/05-267R2.1; Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Duangkaew P, 2011, ARCH INSECT BIOCHEM, V76, P236, DOI 10.1002/arch.20413; ffrench-Constant RH, 1998, PHILOS T R SOC B, V353, P1685, DOI 10.1098/rstb.1998.0319; Lan Q., 1992, Insect Molecular Biology, V1, P71, DOI 10.1111/j.1365-2583.1993.tb00107.x; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Liu N, 1996, BIOCHEM GENET, V34, P133, DOI 10.1007/BF02396246; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Macoris MD, 2003, MEM I OSWALDO CRUZ, V98, P703, DOI 10.1590/S0074-02762003000500020; Magalhaes T, 2008, EXP PARASITOL, V120, P364, DOI 10.1016/j.exppara.2008.09.003; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015; Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; Peixoto CA, 2008, PARASITOL RES, V103, P717, DOI 10.1007/s00436-008-1020-6; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Raghavendra K, 2011, ACTA TROP, V118, P50, DOI 10.1016/j.actatropica.2011.02.001; Raghavendra K, 2011, J VECTOR DIS, V48, P18; Raghavendra K, 2010, INDIAN J MED RES, V132, P260; Raghavendra K, 2010, PARASITOL RES, V107, P1291, DOI 10.1007/s00436-010-2001-0; Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005; Saude Md, 2006, QUANTIFICATION METHO, P1; Sharma SK, 2010, ACTA TROP, V116, P24, DOI 10.1016/j.actatropica.2010.05.002; Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; de Melo-Santos MAV, 2009, BIOL CONTROL, V49, P186, DOI 10.1016/j.biocontrol.2009.01.011; Vaughan A, 1997, BIOCHEM J, V325, P359, DOI 10.1042/bj3250359; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Wang JF, 1998, J MED ENTOMOL, V35, P716, DOI 10.1093/jmedent/35.5.716; WHO, 2021, DENGUE DENGUE HAEMOR; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108	43	57	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e39439	10.1371/journal.pone.0039439	http://dx.doi.org/10.1371/journal.pone.0039439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	23028563	Green Published, Green Accepted, gold			2022-12-27	WOS:000307212800002
J	Kong, XB; Liu, KW; Wang, HB; Zhang, SF; Zhang, Z				Kong, Xiang-Bo; Liu, Kui-Wei; Wang, Hong-Bin; Zhang, Su-Fang; Zhang, Zhen			Identification and Behavioral Evaluation of Sex Pheromone Components of the Chinese Pine Caterpillar Moth, Dendrolimus tabulaeformis	PLOS ONE			English	Article							MASS-SPECTROMETRY; ATTRACTANT; ACETATES; SUPERANS	Background: The Chinese pine caterpillar moth, Dendrolimus tabulaeformis Tsai and Liu (Lepidoptera: Lasiocampidae) is the most important defoliator of coniferous trees in northern China. Outbreaks occur over enormous areas and often lead to the death of forests during 2-3 successive years of defoliation. The sex pheromone of D. tabulaeformis was investigated to define its chemistry and behavioral activity. Methodology/Principal Findings: Sex pheromone was collected from calling female D. tabulaeformis by headspace solid phase microextraction (SPME) and by solvent extraction of pheromone glands. Extracts were analyzed by coupled gas chromatography/mass spectrometry (GC-MS) and coupled GC-electroantennographic detection (GC-EAD), using antennae from male moths. Five components from the extracts elicited antennal responses. These compounds were identified by a combination of retention indices, electron impact mass spectral matches, and derivatization as (Z)-5-dodecenyl acetate (Z5-12:OAc), (Z)-5-dodecenyl alcohol (Z5-12:OH), (5Z,7E)-5,7-dodecadien-1-yl acetate (Z5,E7-12:OAc), (5Z,7E)-5,7-dodecadien-1-yl propionate (Z5,E7-12:OPr), and (5Z,7E)-5,7-dodecadien-1-ol (Z5,E7-12:OH). Behavioral assays showed that male D. tabulaeformis strongly discriminated against incomplete and aberrant blend ratios. The correct ratio of Z5,E7-12:OAc, Z5,E7-12:OH, and Z5,E7-12:OPr was essential for optimal upwind flight and source contact. The two monoenes, Z5-12:OAc and Z5-12:OH, alone or binary mixtures, had no effect on behavioral responses when added to the optimal three-component blend. Conclusions/Significance: The fact that deviations from the optimal ratio of 100:100:4.5 of Z5,E7-12:OAc, Z5,EZ7-12:OH, and Z5,E7-12:OPr resulted in marked decreases in male responses suggests that biosynthesis of the pheromone components is precisely controlled. The optimal blend of the sex pheromone components of D. tabulaeformis worked out in this study should find immediate use in monitoring this pest in Chinese forests.	[Kong, Xiang-Bo; Liu, Kui-Wei; Wang, Hong-Bin; Zhang, Su-Fang; Zhang, Zhen] Chinese Acad Forestry, State Forestry Adm, Res Inst Forest Ecol Environm & Protect, Key Lab Forest Protect, Beijing, Peoples R China; [Liu, Kui-Wei] Shandong Agr Univ, Inst Plant Protect, Tai An, Shandong, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Shandong Agricultural University	Kong, XB (corresponding author), Chinese Acad Forestry, State Forestry Adm, Res Inst Forest Ecol Environm & Protect, Key Lab Forest Protect, Beijing, Peoples R China.	zhangzhen@caf.ac.cn	Wang, Hongbin/N-5851-2018	Wang, Hongbin/0000-0002-3355-2448; Zhang, Weijie/0000-0002-6462-6067	CAF [CAFRIFEEP201002]; National Natural Science Foundation of China [30771737]	CAF; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Nonprofit Institute Research Grant of CAF (CAFRIFEEP201002), and partially supported from the National Natural Science Foundation of China (Grant No. 30771737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO T, 1982, AGR BIOL CHEM TOKYO, V46, P709, DOI 10.1080/00021369.1982.10865117; BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; Klun JA, 2000, J ENTOMOL SCI, V35, P158, DOI 10.18474/0749-8004-35.2.158; Kong XB, 2001, CHINESE SCI BULL, V46, P2077; Kong XB, 2007, J CHEM ECOL, V33, P1316, DOI 10.1007/s10886-007-9313-2; Kong Xiang-Bo, 2003, Acta Entomologica Sinica, V46, P131; Kong XB, 2007, ENTOMOL EXP APPL, V124, P37, DOI 10.1111/j.1570-7458.2007.00562.x; Kong XB, 2011, J CHEM ECOL, V37, P412, DOI 10.1007/s10886-011-9932-5; Kovalev B. G., 1993, Chemistry of Natural Compounds, V29, P135, DOI 10.1007/BF00631042; LINN CE, 1986, J CHEM ECOL, V12, P659, DOI 10.1007/BF01012100; Marques FD, 2000, J BRAZIL CHEM SOC, V11, P592; McElfresh JS, 1999, J CHEM ECOL, V25, P687, DOI 10.1023/A:1020876229787; Meng X.-z., 1983, Scientia Silvae Sinicae, V19, P137; Millar JG, 2000, ANNU REV ENTOMOL, V45, P575, DOI 10.1146/annurev.ento.45.1.575; PRIESNER E, 1984, Z NATURFORSCH C, V39, P1192; Yan JJ, 1991, FOREST INSECTS CHINA, P961; YOUNG DC, 1990, J CHROMATOGR, V522, P295, DOI 10.1016/0021-9673(90)85199-6; Zhao Cheng-Hua, 1993, Acta Entomologica Sinica, V36, P247	18	136	145	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33381	10.1371/journal.pone.0033381	http://dx.doi.org/10.1371/journal.pone.0033381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22876288	Green Published, Green Submitted, gold			2022-12-27	WOS:000303129700057
